data_2klf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2klf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.693 0.282 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.32 179.81 6.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -137.07 47.56 0.95 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.413 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -149.6 155.34 40.11 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -152.12 117.64 5.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 58' ' ' ASP . 47.6 t -111.61 135.94 49.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.127 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 37' ' ' VAL . 11.7 tt -132.3 127.45 57.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.329 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.616 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -103.53 126.77 50.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.407 178.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.515 HG22 HD13 ' A' ' 11' ' ' ILE . 4.6 mm -146.35 139.19 20.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -112.84 39.79 2.44 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.816 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.47 -11.43 35.86 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.636 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.9 t70 65.92 68.82 0.45 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.15 0.475 . . . . 0.0 110.395 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 162.64 -172.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.167 0.508 . . . . 0.0 111.74 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.06 22.73 67.84 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 116.26 1.264 . . . . 0.0 116.26 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -35.33 33.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.972 0.886 . . . . 0.0 111.205 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 11.3 t30 -65.54 -52.57 51.49 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 111.786 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.61 -48.96 26.52 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.83 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.413 ' O ' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -59.5 -50.51 73.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.904 0.852 . . . . 0.0 110.331 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.97 -37.87 87.1 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 56.7 mt-10 -66.28 -36.84 84.01 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.46 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 283' ' ' TYR . 41.0 t -68.03 -61.61 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.96 -0.462 . . . . 0.0 110.46 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -49.22 -35.16 19.28 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.288 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -50.14 67.42 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 122.515 1.15 . . . . 0.0 108.479 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -52.1 -43.21 63.8 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.32 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.594 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.5 m-30 -65.77 -29.71 70.25 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.762 0.791 . . . . 0.0 111.013 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.728 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 1.1 tm-20 -71.14 -52.54 18.69 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.029 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -52.36 -28.42 19.42 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 125.159 1.537 . . . . 0.0 111.245 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.711 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -86.07 -37.5 18.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.188 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.711 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 3.5 t 160.0 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.462 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 156.75 38.55 0.02 OUTLIER Glycine 0 N--CA 1.465 0.581 0 C-N-CA 114.712 -3.613 . . . . 0.0 119.318 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.728 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.6 mp -139.92 134.98 37.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 121.576 2.688 . . . . 0.0 115.422 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -140.89 104.76 4.75 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 9.4 p -103.7 134.1 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.5 p -118.33 146.82 44.07 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.136 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.668 ' HA ' HG22 ' A' ' 9' ' ' ILE . 9.5 t -130.9 120.79 48.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.511 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 30.8 tt0 -112.99 144.44 42.57 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -131.79 73.9 78.2 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.724 0.297 . . . . 0.0 111.236 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 43' ' ' LEU . 43.0 Cg_endo -89.98 -173.75 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.057 2.505 . . . . 0.0 112.82 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -96.01 -40.31 9.33 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -85.38 0.35 52.42 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.619 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HG ' ' CD1' ' A' ' 10' ' ' TRP . 4.9 tt -21.57 -45.97 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 1.062 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 1.5 pp20? -68.68 -54.16 17.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.399 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 3.5 tt0 -69.66 -41.22 75.83 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.055 0.455 . . . . 0.0 109.797 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -56.28 -56.24 23.49 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.011 0.91 . . . . 0.0 109.834 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.581 ' CG ' HG12 ' A' ' 60' ' ' ILE . 1.3 t80 -44.15 -61.26 2.14 Favored Pre-proline 0 C--N 1.349 0.556 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.127 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 1.062 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 37.0 Cg_exo -61.5 -25.36 79.55 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 121.347 1.365 . . . . 0.0 113.341 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -81.58 -37.1 28.22 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 122.143 0.973 . . . . 0.0 111.034 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.461 HG21 ' N ' ' A' ' 51' ' ' ALA . 19.2 m -77.28 -40.0 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.59 0 CA-C-O 122.001 0.905 . . . . 0.0 109.797 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.461 ' N ' HG21 ' A' ' 50' ' ' VAL . . . -49.78 -37.98 32.26 Favored 'General case' 0 C--N 1.374 1.666 0 C-N-CA 126.074 1.75 . . . . 0.0 110.999 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.25 -40.64 23.45 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-N 114.144 -1.389 . . . . 0.0 113.519 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -63.22 1.15 Allowed 'General case' 0 C--N 1.346 0.429 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.015 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.08 69.39 0.05 OUTLIER Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.216 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -96.37 -64.94 1.0 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.8 -120.78 5.58 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.661 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 72.4 Cg_exo -49.83 109.56 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.187 1.925 . . . . 0.0 110.978 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.572 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 15.6 t0 159.27 113.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.608 0.363 . . . . 0.0 110.77 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.616 ' O ' ' HB2' ' A' ' 10' ' ' TRP . 0.7 OUTLIER -98.5 173.24 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.957 -177.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.788 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -131.06 130.08 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.697 -177.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 70.2 t80 -121.8 112.21 18.08 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -166.84 161.94 15.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.463 ' N ' ' CD1' ' A' ' 62' ' ' TRP . . . -34.95 151.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.626 ' HB3' HG23 ' A' ' 261' ' ' VAL . 2.7 t60 -77.26 -28.94 53.69 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -47.37 -59.29 3.31 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.6 mtp85 -78.51 -26.95 45.99 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.712 -0.617 . . . . 0.0 109.648 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.478 ' CE2' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.64 -28.69 70.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.52 ' O ' ' HB1' ' A' ' 71' ' ' ALA . . . -61.97 -58.74 11.47 Favored Glycine 0 CA--C 1.49 -1.495 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 177.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.29 -60.43 8.84 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 111.848 -2.176 . . . . 0.0 111.598 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.598 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 22.2 m-85 -48.81 -37.56 19.62 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.959 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . . . -56.5 -38.95 72.47 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.338 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -78.51 -56.3 4.54 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.342 -0.224 . . . . 0.0 111.556 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 m -113.91 -27.19 7.83 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 70' ' ' TYR . . . -63.41 -89.7 0.03 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.861 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.57 ' C ' ' CB ' ' A' ' 268' ' ' ALA . 0.2 OUTLIER -179.02 63.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.959 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -116.36 140.11 49.68 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 173.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.959 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . -90.33 88.13 7.08 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.763 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.499 ' HA ' ' CG1' ' A' ' 104' ' ' ILE . 1.2 mt-10 -47.36 100.09 0.02 OUTLIER 'General case' 0 C--O 1.23 0.076 0 CA-C-O 120.821 0.343 . . . . 0.0 110.434 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mt -47.66 159.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.554 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.424 ' CG2' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -88.26 175.15 4.37 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.424 ' HD2' ' CG2' ' A' ' 80' ' ' THR . 76.1 Cg_endo -79.76 133.56 10.38 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.344 2.029 . . . . 0.0 113.399 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.71 -170.11 2.15 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.809 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 -78.18 0.59 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.237 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.03 -23.02 67.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -62.12 -59.31 5.24 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.77 0.319 . . . . 0.0 110.236 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -77.08 -28.43 54.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.71 -10.84 59.67 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -92.26 -18.19 23.75 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -90.59 -176.84 4.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.277 0.49 . . . . 0.0 111.297 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.557 ' CB ' ' CZ3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -94.49 165.72 16.81 Favored Pre-proline 0 C--N 1.341 0.238 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.581 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 6.3 Cg_exo -75.4 -24.09 12.53 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.826 2.351 . . . . 0.0 115.248 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CE1' ' NE2' ' A' ' 325' ' ' GLN . 4.2 m-85 -87.31 -63.5 1.3 Allowed 'General case' 0 C--O 1.245 0.832 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.467 ' HB ' ' CE3' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -63.19 -24.68 67.99 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.557 ' CZ3' ' CB ' ' A' ' 90' ' ' TYR . 5.9 m-90 -93.75 -24.31 17.86 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.48 0.712 . . . . 0.0 111.345 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 8.1 t0 -73.63 -23.53 59.89 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.653 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.419 ' CB ' ' CG1' ' A' ' 261' ' ' VAL . . . -62.91 -42.95 99.96 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 261' ' ' VAL . 44.5 t -108.62 54.13 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.424 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . 0.9 OUTLIER -130.85 140.28 50.23 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.03 -0.419 . . . . 0.0 110.786 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 101' ' ' GLY . 57.0 m-85 -112.34 174.72 5.75 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -48.05 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 56.16 38.14 75.65 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.268 -0.968 . . . . 0.0 110.752 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 -177.27 5.5 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 168.34 130.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.617 ' CD1' ' O ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -115.67 38.86 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . 165.22 175.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 263' ' ' SER . 5.3 p90 -117.51 133.41 23.26 Favored Pre-proline 0 C--N 1.343 0.288 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.985 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.642 ' HA ' ' HB3' ' A' ' 263' ' ' SER . 96.0 Cg_endo -79.37 149.76 21.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.433 2.088 . . . . 0.0 113.315 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 262' ' ' LEU . 1.3 mm -149.32 38.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.009 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . . . 177.33 124.65 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.399 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.424 ' O ' ' CG2' ' A' ' 320' ' ' THR . 4.1 p -107.01 114.99 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.325 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -99.36 132.79 44.44 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 320' ' ' THR . . . -168.3 -174.13 2.18 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.493 1.517 . . . . 0.0 110.077 -167.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.486 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 2.0 tp -146.65 136.98 23.73 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 111.542 -2.572 . . . . 0.0 116.35 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.427 ' C ' ' CD1' ' A' ' 226' ' ' ILE . 0.2 OUTLIER -131.42 164.74 25.05 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.59 -178.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.439 ' HA ' HD11 ' A' ' 226' ' ' ILE . 0.9 OUTLIER -92.6 132.17 37.09 Favored 'General case' 0 C--N 1.342 0.257 0 O-C-N 121.972 -0.455 . . . . 0.0 110.289 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.451 ' CD1' ' CD2' ' A' ' 242' ' ' TYR . 19.1 tt -113.88 131.19 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.258 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.411 ' CE2' ' OG1' ' A' ' 245' ' ' THR . 17.8 m-85 -104.24 132.64 50.27 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.744 ' O ' ' O ' ' A' ' 122' ' ' LEU . 45.8 m-80 -87.29 123.98 32.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.203 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -98.03 -87.98 0.32 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 119' ' ' LYS . 26.4 t0 -19.72 -63.67 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.5 pp -125.87 38.9 4.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.744 ' O ' ' O ' ' A' ' 118' ' ' ASN . 90.9 mt -158.41 113.22 1.7 Allowed Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.101 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -92.63 124.17 0.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.196 1.264 . . . . 0.0 111.45 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.547 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 11.9 p-10 -97.47 161.64 25.28 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 81.5 Cg_endo -77.1 167.86 24.25 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.676 2.917 . . . . 0.0 112.315 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.34 -47.94 0.08 OUTLIER 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.084 2.522 . . . . 0.0 113.654 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.63 -10.06 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.4 p -117.2 140.21 49.82 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.218 0.917 . . . . 0.0 113.278 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -71.14 -27.73 63.77 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 172.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.498 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.5 OUTLIER -44.61 -24.0 0.16 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.19 -23.3 67.37 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.509 ' O ' ' CB ' ' A' ' 136' ' ' ASP . 5.8 mt -40.52 -59.73 1.86 Allowed Pre-proline 0 N--CA 1.477 0.924 0 CA-C-O 121.11 0.481 . . . . 0.0 112.147 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 4.6 Cg_endo -46.63 -45.39 19.87 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 121.251 1.301 . . . . 0.0 110.701 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.13 -58.91 2.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 139' ' ' LEU . 36.9 mt -67.37 -36.84 82.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.68 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.511 ' HA ' ' CD1' ' A' ' 139' ' ' LEU . 7.7 t0 -73.43 -41.41 63.27 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 5.2 tttt -48.77 -41.94 34.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.123 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.37 -38.1 84.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.189 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.578 ' HB3' ' C ' ' A' ' 144' ' ' LYS . 1.2 mt -63.18 -47.96 80.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.87 -44.6 29.55 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.05 -24.25 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.601 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -111.7 -60.56 1.83 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.62 46.76 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 CA-C-O 118.777 -1.013 . . . . 0.0 111.379 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.578 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.1 OUTLIER -157.04 -172.41 4.02 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.939 1.87 . . . . 0.0 111.128 -176.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 222' ' ' THR . 49.3 m -139.82 167.17 22.72 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.56 ' N ' HD11 ' A' ' 139' ' ' LEU . . . -83.57 -30.57 26.91 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 224' ' ' MET . 0.8 OUTLIER -137.54 127.94 26.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -176.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -132.21 137.87 47.74 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.975 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 1.026 ' O ' ' O ' ' A' ' 150' ' ' ASN . 7.1 p90 -171.33 174.72 4.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.53 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 1.026 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -20.45 -169.77 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 206' ' ' ALA . 0.1 OUTLIER -168.64 33.58 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.351 -0.843 . . . . 0.0 110.544 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.455 ' CB ' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER 172.05 33.99 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 169.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.883 ' O ' ' OG1' ' A' ' 157' ' ' THR . 14.1 pt-20 -115.16 152.74 47.03 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 121.125 1.784 . . . . 0.0 114.376 -176.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.815 ' O ' ' N ' ' A' ' 156' ' ' PHE . 5.1 Cg_exo -77.27 -136.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 124.643 3.562 . . . . 0.0 105.044 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 1.189 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 20.1 m-85 40.88 -68.37 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 120.51 1.505 . . . . 0.0 112.991 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.815 ' N ' ' O ' ' A' ' 154' ' ' PRO . 2.2 t80 -88.51 -58.63 2.48 Favored 'General case' 0 C--O 1.26 1.616 0 CA-C-N 118.705 0.684 . . . . 0.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.883 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 7.0 p -60.16 -42.92 95.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 118.276 -1.37 . . . . 0.0 107.854 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.438 ' HA ' ' CE3' ' A' ' 158' ' ' TRP . 0.0 OUTLIER -49.65 -55.75 21.04 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 1.189 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 84.0 Cg_exo -43.7 -47.26 9.81 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.025 2.483 . . . . 0.0 113.493 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 mp -60.84 -56.38 21.91 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.07 0.85 . . . . 0.0 109.094 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 188' ' ' ALA . 3.7 mt -51.73 -23.6 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.388 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.428 ' CB ' ' HB2' ' A' ' 256' ' ' LYS . . . -79.83 -22.4 43.04 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.047 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 253' ' ' GLN . . . -42.03 -55.81 3.04 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.515 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 1.3 m-20 -64.19 -51.89 61.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 119.449 1.022 . . . . 0.0 112.393 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 169.34 26.14 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 117.924 -2.084 . . . . 0.0 117.117 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.59 89.65 0.7 Allowed Glycine 0 CA--C 1.522 0.526 0 CA-C-N 119.157 1.479 . . . . 0.0 112.66 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -75.11 157.75 34.21 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.184 0.492 . . . . 0.0 111.061 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.523 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.82 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 111.352 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.839 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 4.9 m-85 -112.98 171.87 7.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.215 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 1.19 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER -101.21 107.96 19.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.13 115.42 23.7 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.577 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.877 ' O ' ' N ' ' A' ' 174' ' ' GLY . 19.7 mt-10 -136.35 101.53 4.7 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.449 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 53.0 t30 44.28 -64.31 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 123.796 0.685 . . . . 0.0 111.079 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.877 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -71.64 -73.35 0.83 Allowed Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 116.016 -0.538 . . . . 0.0 114.172 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -175.19 158.12 2.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.797 0.799 . . . . 0.0 109.688 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 1.19 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 17.4 p90 -44.37 -35.89 2.59 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.006 1.384 . . . . 0.0 109.068 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.575 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 0.9 OUTLIER 72.92 -79.48 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.778 -2.465 . . . . 0.0 110.839 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 8.1 tp 168.66 -41.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -8.15 51.93 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.72 93.84 4.2 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.357 0.98 . . . . 0.0 109.36 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.435 HG12 ' CE2' ' A' ' 339' ' ' PHE . 2.6 t -116.33 112.41 39.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -118.48 40.05 2.4 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.745 -1.217 . . . . 0.0 113.553 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -79.97 -47.52 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -81.43 57.26 3.21 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.149 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -102.06 179.52 4.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.244 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.09 -30.49 36.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.486 0.66 . . . . 0.0 111.559 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.515 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -74.71 -40.69 36.83 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.39 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 161' ' ' ILE . . . -59.69 -48.93 79.74 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -59.62 -60.27 4.11 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.551 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.38 -40.69 50.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.972 0.891 . . . . 0.0 112.004 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -64.86 -60.61 6.69 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.431 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.6 tp -58.97 -25.79 63.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 3.1 m -61.94 -49.56 75.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.448 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 1.3 p90 -61.28 -35.52 77.55 Favored 'General case' 0 C--N 1.345 0.413 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.88 -46.84 83.09 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 44.8 t -57.78 -31.42 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.454 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -45.72 89.35 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.725 0.774 . . . . 0.0 110.841 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.85 -54.37 47.63 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.903 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.415 ' HA ' ' CB ' ' A' ' 203' ' ' HIS . 10.8 tt -65.98 -35.13 74.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.387 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.07 -38.58 70.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.148 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -113.03 -34.85 5.59 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 120.785 3.624 . . . . 0.0 120.785 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.72 -70.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CE1' HD12 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -47.8 -37.11 12.88 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.22 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.1 mtp 61.68 -77.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 203' ' ' HIS . 4.9 t-20 -86.38 -178.75 6.53 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.464 ' HA ' HD22 ' A' ' 151' ' ' LEU . . . -155.24 36.44 0.38 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -97.24 -2.81 41.96 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.444 ' HB ' ' CD1' ' A' ' 151' ' ' LEU . 29.5 m -55.2 118.98 4.83 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.53 -174.28 4.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -70.12 -45.45 66.86 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.69 -33.63 66.63 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.829 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.406 HG21 ' CG2' ' A' ' 208' ' ' THR . 1.4 mp -77.38 -48.71 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.881 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.41 68.07 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.538 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 2.5 tp10 -60.58 -46.3 90.73 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.16 -36.11 74.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.641 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.13 -57.79 11.31 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.538 ' CE2' ' HA ' ' A' ' 214' ' ' GLU . 0.0 OUTLIER -61.12 -28.35 69.04 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -53.45 -45.49 69.51 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -23.96 58.96 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.89 53.63 22.23 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.404 -0.817 . . . . 0.0 115.009 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -109.33 37.01 2.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.516 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 145' ' ' SER . 14.3 t -140.33 140.02 35.53 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.592 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -104.11 38.53 1.83 Allowed 'General case' 0 C--N 1.349 0.559 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -176.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.592 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 3.0 tmm? 167.69 137.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 89.1 m -147.78 159.92 43.3 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.674 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.526 HD13 ' HG ' ' A' ' 247' ' ' LEU . 2.3 tp -115.68 112.13 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.473 ' HB2' ' CD1' ' A' ' 232' ' ' TRP . 1.7 p30 -148.07 165.01 32.09 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.877 -0.514 . . . . 0.0 112.152 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 113' ' ' LEU . . . -160.23 -177.75 33.61 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 119.905 -1.14 . . . . 0.0 111.092 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.93 69.73 0.11 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.225 1.95 . . . . 0.0 111.979 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.473 ' N ' ' O ' ' A' ' 228' ' ' GLY . 9.2 t90 -157.93 -59.6 0.08 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.455 ' CB ' ' CE3' ' A' ' 230' ' ' TRP . . . -89.69 -34.68 16.15 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.777 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.473 ' CD1' ' HB2' ' A' ' 227' ' ' ASN . 0.3 OUTLIER -124.56 79.93 1.8 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.716 0.293 . . . . 0.0 111.287 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.3 m -71.04 -43.89 66.93 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.316 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -100.5 77.22 1.9 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.476 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 tt -45.7 136.94 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.605 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.09 -172.93 3.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.594 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.49 78.42 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.658 0.266 . . . . 0.0 110.937 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.0 m -113.14 52.58 0.79 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.403 ' CD ' HD12 ' A' ' 122' ' ' LEU . 0.9 OUTLIER 61.63 112.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.705 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.2 m -52.9 -40.11 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.533 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -83.36 104.3 13.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.716 0.293 . . . . 0.0 110.727 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.451 ' CD2' ' CD1' ' A' ' 116' ' ' ILE . 47.7 p90 -148.55 142.54 25.87 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.336 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -85.53 162.7 36.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.075 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.8 106.49 13.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.911 0.356 . . . . 0.0 111.524 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.411 ' OG1' ' CE2' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -126.56 166.9 16.43 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -172.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.8 154.21 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.169 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 226' ' ' ILE . 0.1 OUTLIER -58.23 156.17 22.51 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 120.327 1.421 . . . . 0.0 110.256 -178.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.45 ' HD2' ' HG ' ' A' ' 247' ' ' LEU . 72.2 Cg_endo -79.44 -165.97 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.532 2.155 . . . . 0.0 112.466 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 40.8 p -106.3 168.16 9.34 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.308 0.575 . . . . 0.0 111.444 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' A' ' 253' ' ' GLN . 0.5 OUTLIER -166.05 126.44 1.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.851 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 36.93 31.11 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.992 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.36 27.49 48.05 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.612 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.476 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 23.7 mm100 -156.6 151.17 20.34 Favored Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 117.479 0.639 . . . . 0.0 112.661 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -91.89 138.88 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.392 2.728 . . . . 0.0 112.093 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.405 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 52.6 m -57.85 142.7 45.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.201 0.524 . . . . 0.0 112.176 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -86.16 108.91 19.24 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.981 -178.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.442 ' HD2' ' HA3' ' A' ' 327' ' ' GLY . 4.8 Cg_exo -79.82 147.2 19.12 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.984 2.456 . . . . 0.0 112.501 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 1.1 m-85 -79.78 136.51 36.75 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 329' ' ' ILE . 27.2 t -92.09 124.46 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -117.59 125.78 6.64 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.196 -1.478 . . . . 0.0 114.764 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.626 HG23 ' HB3' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -121.89 103.5 13.57 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.588 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 69.7 mt -86.11 103.84 15.14 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.563 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.642 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 68.9 p -133.05 139.68 47.31 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 118.142 2.645 . . . . 0.0 118.142 -172.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.788 ' HA ' ' O ' ' A' ' 60' ' ' ILE . . . -95.06 113.36 25.05 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.472 ' CA ' ' HB2' ' A' ' 105' ' ' ALA . . . -102.55 163.26 16.51 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.367 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.624 ' O ' ' O ' ' A' ' 267' ' ' ASN . 0.8 OUTLIER -89.78 134.49 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 176.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.959 ' O ' ' N ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -13.52 -167.38 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.956 1 C-N-CA 132.156 4.183 . . . . 0.0 117.165 -171.525 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.642 ' HA ' ' N ' ' A' ' 77' ' ' ALA . . . -107.39 119.91 40.71 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 110.651 -2.977 . . . . 0.0 104.143 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 268' ' ' ALA . . . 104.94 -65.8 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.217 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 269' ' ' ALA . 2.4 p 155.46 103.07 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.476 ' O ' ' C ' ' A' ' 272' ' ' ASN . 15.5 Cg_endo -99.38 102.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.457 2.772 . . . . 0.0 113.446 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 271' ' ' PRO . 91.1 m-20 26.76 74.19 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.946 0.403 . . . . 0.0 111.646 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -64.67 -31.61 72.9 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 277' ' ' LYS . 0.7 OUTLIER -53.48 -57.5 10.44 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.875 -0.515 . . . . 0.0 112.366 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.91 -53.48 49.71 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.59 94.15 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -63.29 -40.59 97.8 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 -54.15 7.19 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.438 ' CZ ' HG12 ' A' ' 23' ' ' VAL . 8.8 t80 -55.52 -58.72 6.61 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.71 -43.17 37.02 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.776 0.798 . . . . 0.0 111.065 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -74.27 -34.56 63.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.095 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -93.6 -15.89 24.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.462 ' CE2' ' CG1' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -112.5 -60.2 1.9 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.463 0.574 . . . . 0.0 110.594 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 290' ' ' LEU . 1.1 tp -43.12 -33.01 0.79 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.862 0.755 . . . . 0.0 109.798 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.5 mp -86.29 42.24 0.98 Allowed 'General case' 0 C--N 1.342 0.239 0 CA-C-O 120.92 0.391 . . . . 0.0 110.481 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' TYR . 12.9 p -144.47 154.58 43.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 1.7 m-20 -63.8 -13.98 49.0 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.586 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 2.0 tp10 -77.86 -48.24 16.92 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 121.719 -0.613 . . . . 0.0 110.986 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.66 -61.81 2.84 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.627 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 303' ' ' ALA . 0.1 OUTLIER -57.39 -47.74 80.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.0 OUTLIER -79.42 -26.39 41.85 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -68.36 -38.41 81.4 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.458 ' HA ' ' OD2' ' A' ' 296' ' ' ASP . 61.3 t -66.07 -61.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.638 ' HB2' ' CE1' ' A' ' 307' ' ' TYR . 57.8 t30 -33.53 -52.33 0.39 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.738 1.215 . . . . 0.0 112.516 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -58.41 -49.62 76.62 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER -57.19 -45.7 83.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -47.57 169.06 0.13 Allowed Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.28 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -90.67 -72.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.549 2.833 . . . . 0.0 112.853 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.31 -69.14 0.11 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.644 0.259 . . . . 0.0 110.482 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 301' ' ' ALA . . . -79.9 139.25 21.15 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . 159.98 -174.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.242 0.521 . . . . 0.0 110.861 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 108' ' ' ILE . 0.3 OUTLIER -149.91 175.07 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.421 179.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 307' ' ' TYR . . . 172.02 70.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.429 ' CB ' ' O ' ' A' ' 303' ' ' ALA . 3.1 tp 82.26 142.56 0.07 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -48.07 -55.95 8.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -177.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.7 t -53.67 -48.93 69.0 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.879 0.847 . . . . 0.0 111.549 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.638 ' CE1' ' HB2' ' A' ' 294' ' ' ASN . 33.0 t80 -70.46 -19.66 62.94 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.282 176.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 309' ' ' GLU . 0.0 OUTLIER -65.14 -38.15 89.68 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.424 ' N ' ' HG3' ' A' ' 308' ' ' GLU . 3.4 tt0 -66.19 -54.62 23.01 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.838 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.4 -51.23 70.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.244 0.545 . . . . 0.0 109.614 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.457 HD23 HG13 ' A' ' 317' ' ' ILE . 0.2 OUTLIER -59.79 -41.87 92.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.628 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 313' ' ' LYS . . . -47.22 -29.83 2.61 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 312' ' ' ALA . 5.2 ttpt -31.16 -42.96 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.637 0.256 . . . . 0.0 111.506 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.34 135.82 69.02 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.384 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.26 -20.66 56.39 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.529 2.153 . . . . 0.0 113.575 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.556 ' O ' ' OG1' ' A' ' 320' ' ' THR . 7.3 mmt180 -61.42 -58.91 6.28 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.457 HG13 HD23 ' A' ' 311' ' ' LEU . 3.3 mm -49.3 -55.35 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.48 -45.4 13.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.791 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.34 -35.64 63.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.397 0.618 . . . . 0.0 110.267 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 316' ' ' ARG . 0.2 OUTLIER -59.44 -42.69 92.49 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.249 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 60.1 mtm -76.31 -42.01 46.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.143 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -46.96 60.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.446 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -78.28 -41.96 32.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.486 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.54 -36.7 24.35 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . 0.422 ' NE2' ' CE1' ' A' ' 92' ' ' PHE . 2.1 tt0 -85.28 -34.03 22.0 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -93.41 60.68 3.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 111.028 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' ' 257' ' ' PRO . . . -160.67 -139.57 2.69 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.338 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -128.84 117.27 20.77 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.5 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 34.5 mt -83.88 124.09 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.51 ' O ' ' O ' ' A' ' 331' ' ' PRO . 10.9 mtm -42.53 132.43 2.84 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.855 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 176' ' ' TYR . 75.8 Cg_exo -50.28 -156.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.052 2.502 . . . . 0.0 112.605 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -146.65 40.32 1.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.954 0.407 . . . . 0.0 111.158 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.2 160.4 64.27 Favored Pre-proline 0 C--N 1.34 0.185 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.714 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.11 -13.56 23.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.626 2.217 . . . . 0.0 113.515 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.56 -21.17 62.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.17 -34.58 2.78 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.144 -0.347 . . . . 0.0 111.827 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.43 -35.31 71.9 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.834 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.24 72.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.919 0.39 . . . . 0.0 111.723 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.438 ' CZ ' ' CG2' ' A' ' 183' ' ' VAL . 0.2 OUTLIER -78.39 -55.75 4.99 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.79 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -43.42 -45.28 6.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.061 0.458 . . . . 0.0 110.177 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.464 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 34.7 t80 -70.72 -41.08 72.37 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.662 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.412 ' CB ' ' CD2' ' A' ' 361' ' ' LEU . . . -69.68 -46.05 66.94 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.411 ' O ' ' CG2' ' A' ' 347' ' ' VAL . 31.7 t -70.51 -35.03 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.15 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 341' ' ' TYR . 0.0 OUTLIER -69.73 -36.73 76.12 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 349' ' ' ASN . 95.0 m -66.71 -58.52 4.94 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -49.58 -50.39 42.69 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.394 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 343' ' ' VAL . 63.0 t -50.99 -56.93 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 24.8 mt -59.03 -27.39 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.575 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.6 OUTLIER -64.47 -38.68 91.87 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.297 0.57 . . . . 0.0 111.242 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -80.13 -26.58 39.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.359 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.18 -16.88 51.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 2.9 p -111.26 -6.68 14.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.561 1.073 . . . . 0.0 113.376 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 85.61 -2.65 87.88 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.604 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -88.58 35.18 0.76 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 115.808 -2.044 . . . . 0.0 107.605 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -70.82 -174.53 0.94 Allowed 'General case' 0 CA--C 1.547 0.838 1 N-CA-C 125.303 5.297 . . . . 0.0 125.303 -158.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.421 ' N ' ' OD1' ' A' ' 349' ' ' ASN . 4.5 t 159.84 44.76 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 110.365 -3.107 . . . . 0.0 104.252 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' A' ' 346' ' ' ALA . 7.7 p -72.44 -56.4 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.516 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 1.6 m-20 -48.78 -45.06 39.49 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.563 0.697 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.19 -55.78 5.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.938 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -52.37 -44.71 65.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 122.413 1.101 . . . . 0.0 112.65 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.412 ' CD2' ' CB ' ' A' ' 342' ' ' ALA . 1.7 tm? -77.28 -41.56 40.38 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.052 -1.885 . . . . 0.0 110.594 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.607 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 5.2 tttt -60.19 -56.42 21.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.083 0.944 . . . . 0.0 109.129 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -53.05 -37.21 61.4 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.596 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 361' ' ' LEU . . . -49.96 -48.12 52.25 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.479 ' HA ' ' CG2' ' A' ' 368' ' ' ILE . 41.5 tt0 -54.3 -44.89 72.37 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.5 m -57.16 -43.33 82.43 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.495 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -71.2 -57.47 4.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.025 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 368' ' ' ILE . 0.0 OUTLIER -54.45 -33.21 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.265 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.537 ' HA ' ' CG1' ' A' ' 178' ' ' ILE . 41.2 p -94.86 -15.91 23.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.664 0.269 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -142.93 136.86 29.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.954 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.82 -101.72 0.65 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.28 -170.9 1.94 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.319 -0.94 . . . . 0.0 110.01 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.478 ' CD1' ' CE1' ' A' ' 279' ' ' PHE . 0.0 OUTLIER -119.59 123.25 43.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 1.7 t -121.88 111.94 32.89 Favored 'Isoleucine or valine' 0 C--O 1.26 1.62 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 4.0 mt -133.52 126.79 52.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.544 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.538 ' CD1' ' HA ' ' A' ' 60' ' ' ILE . 1.9 p-90 -98.72 135.29 40.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.611 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 10' ' ' TRP . 1.5 mp -154.27 137.59 7.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 O-C-N 122.102 -0.374 . . . . 0.0 110.763 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -120.73 125.74 48.39 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.782 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.44 29.37 14.31 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.882 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 58.8 t0 -102.03 -80.23 0.51 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.166 0.483 . . . . 0.0 110.436 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 6.2 mttm 101.42 -5.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.898 0.879 . . . . 0.0 111.162 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' HA3' ' CB ' ' A' ' 296' ' ' ASP . . . -76.38 64.76 2.82 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 115.359 0.904 . . . . 0.0 115.359 -176.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -78.72 -32.49 46.84 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.348 -0.426 . . . . 0.0 111.284 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 3.3 t-20 -68.47 -46.79 68.81 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 111.347 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.514 ' HA2' ' HG2' ' A' ' 22' ' ' GLU . . . -70.67 -47.52 40.48 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.983 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.583 ' O ' HG21 ' A' ' 23' ' ' VAL . 1.2 mt -59.56 -50.78 72.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.434 0.617 . . . . 0.0 110.336 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -68.76 -39.27 80.33 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.514 ' HG2' ' HA2' ' A' ' 19' ' ' GLY . 11.0 pt-20 -66.21 -35.91 81.66 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.244 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.583 HG21 ' O ' ' A' ' 20' ' ' LEU . 11.3 m -68.63 -60.34 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.464 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' HA3' HG13 ' A' ' 35' ' ' VAL . . . -49.54 -34.19 19.49 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.736 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -57.77 -50.14 74.26 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 122.442 1.115 . . . . 0.0 109.005 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.67 -43.59 62.77 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 112.977 -1.92 . . . . 0.0 109.787 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.711 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -66.36 -26.05 67.09 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.096 -1.003 . . . . 0.0 111.151 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.686 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -73.15 -52.01 15.78 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.304 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -52.76 -28.01 20.41 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 124.683 1.24 . . . . 0.0 110.478 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.638 ' O ' ' CG2' ' A' ' 31' ' ' THR . 1.2 m-20 -84.64 -37.93 20.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 117.634 -1.174 . . . . 0.0 108.819 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.638 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.89 37.74 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 171.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.35 38.62 0.02 OUTLIER Glycine 0 N--CA 1.465 0.633 0 C-N-CA 114.796 -3.573 . . . . 0.0 119.545 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.711 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 22.3 mm -140.05 138.73 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 122.157 2.979 . . . . 0.0 116.956 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -142.36 104.4 4.42 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 20' ' ' LEU . 28.6 m -89.35 130.34 38.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -174.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 p -116.51 140.47 49.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.135 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 6.2 m -130.05 119.68 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.498 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -110.43 134.82 51.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.63 71.26 3.55 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 120.829 0.347 . . . . 0.0 111.617 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 39.1 Cg_endo -95.12 -160.95 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.931 3.088 . . . . 0.0 112.72 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.91 -62.63 1.11 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 0.15 34.45 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.602 ' HB3' ' HG2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -56.8 -28.37 61.29 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.218 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 1.047 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -47.32 -54.26 11.5 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.547 -0.721 . . . . 0.0 110.25 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mt-10 -71.85 -50.16 31.93 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.279 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' O ' HG22 ' A' ' 50' ' ' VAL . 32.7 mtmt -59.71 -56.36 22.87 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.122 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.67 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 7.2 t80 -44.38 -57.92 5.8 Favored Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 1.047 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 25.6 Cg_exo -66.03 -35.91 32.15 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 120.977 1.118 . . . . 0.0 114.251 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -66.63 -52.24 47.24 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 123.038 1.399 . . . . 0.0 107.549 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 47' ' ' PHE . 14.7 m -61.22 -21.85 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.555 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' A' ' 48' ' ' PRO . . . -59.84 -29.47 68.29 Favored 'General case' 0 C--N 1.395 2.563 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.644 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.16 -24.59 34.93 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 124.991 1.316 . . . . 0.0 112.008 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.5 m -47.89 -30.96 4.57 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 167.93 -19.09 0.08 OUTLIER Glycine 0 CA--C 1.526 0.724 0 C-N-CA 119.891 -1.147 . . . . 0.0 114.644 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER 155.77 -71.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.719 1.26 . . . . 0.0 111.561 179.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 40.44 -158.46 0.03 OUTLIER Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.031 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.674 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 10.9 Cg_exo -35.81 143.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.887 3.058 . . . . 0.0 112.78 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -123.51 35.44 4.85 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 117.478 -1.689 . . . . 0.0 113.877 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.46 HG23 HD12 ' A' ' 59' ' ' ILE . 2.8 mt -150.57 127.92 2.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 119.662 1.119 . . . . 0.0 113.692 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.538 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -139.4 123.29 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 118.872 0.76 . . . . 0.0 110.034 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.523 ' O ' ' CZ2' ' A' ' 10' ' ' TRP . 2.6 m-85 -104.62 128.53 52.68 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.13 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.567 ' CZ3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -166.0 166.67 17.17 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 119.188 0.904 . . . . 0.0 109.723 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.11 165.99 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 120.479 1.49 . . . . 0.0 110.319 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 67' ' ' PHE . 2.7 p80 -77.05 -29.3 55.1 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.477 0.656 . . . . 0.0 112.059 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -58.46 -36.08 73.15 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.425 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -85.43 -35.26 21.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 3.2 t80 -54.85 -32.82 61.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 172.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.441 ' HA2' ' CD1' ' A' ' 99' ' ' TYR . . . -58.19 -65.35 3.58 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.32 -41.44 16.46 Favored Glycine 0 C--N 1.355 1.639 0 CA-C-N 113.268 -1.466 . . . . 0.0 110.609 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.426 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.3 m-85 -59.49 -46.46 88.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.473 ' CB ' ' CD1' ' A' ' 99' ' ' TYR . . . -50.35 -51.32 46.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.843 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -78.25 -27.15 47.49 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 t -71.63 -17.67 62.25 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.85 11.34 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.231 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.409 ' CD1' ' CB ' ' A' ' 48' ' ' PRO . 3.6 mm? -121.76 57.15 1.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.941 0.4 . . . . 0.0 111.533 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.433 ' CD2' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -179.07 142.01 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.401 0.62 . . . . 0.0 112.127 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.569 ' O ' ' CG2' ' A' ' 104' ' ' ILE . . . -59.94 176.98 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.527 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -139.74 80.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.375 0.27 . . . . 0.0 110.489 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.0 pt -70.99 162.19 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.108 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.92 118.35 69.17 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.875 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -79.87 146.79 18.75 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.571 2.181 . . . . 0.0 112.158 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -136.0 163.67 29.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.863 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -49.06 78.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.631 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.73 -23.64 63.36 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.822 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.5 ' CE2' ' CZ2' ' A' ' 94' ' ' TRP . 19.3 t80 -68.74 -58.65 3.91 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.916 0.389 . . . . 0.0 110.352 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -77.12 -24.7 51.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -76.36 -45.24 32.87 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 89' ' ' LEU . 3.9 pttp -51.54 -41.71 61.27 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.495 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.431 ' N ' ' HG3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -103.92 -175.14 2.71 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.6 0.238 . . . . 0.0 110.663 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CG ' ' CE2' ' A' ' 92' ' ' PHE . 0.9 OUTLIER -69.5 131.0 90.19 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.693 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.44 -38.0 82.52 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.515 2.143 . . . . 0.0 112.711 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.452 ' CE2' ' CG ' ' A' ' 90' ' ' TYR . 45.1 p90 -73.22 -43.61 60.97 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 120.549 0.214 . . . . 0.0 111.275 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.435 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 45.0 m -62.14 -25.42 67.73 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.5 ' CZ2' ' CE2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -92.45 -26.49 17.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.216 0.531 . . . . 0.0 111.202 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -21.29 60.07 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.813 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.08 -50.17 65.04 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.685 0.278 . . . . 0.0 110.722 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 107' ' ' PRO . 11.7 p -94.7 60.11 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.01 138.83 48.39 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.063 -1.023 . . . . 0.0 109.753 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 101' ' ' GLY . 31.5 t80 -107.64 138.68 43.43 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.344 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -59.11 78.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.811 0.339 . . . . 0.0 110.108 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 133.11 -18.23 4.49 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.36 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.441 ' CG ' ' HB3' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.7 123.75 12.83 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.125 0.962 . . . . 0.0 111.843 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.82 74.68 1.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.569 ' CG2' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -129.46 91.3 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 121.668 0.747 . . . . 0.0 112.634 -177.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . 159.54 -177.22 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.502 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -136.63 142.86 40.68 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.16 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.441 ' HB3' HG11 ' A' ' 97' ' ' VAL . 84.4 Cg_endo -82.02 156.88 17.77 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.499 2.132 . . . . 0.0 112.437 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.651 ' N ' ' O ' ' A' ' 262' ' ' LEU . 28.2 mt -119.44 -135.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.501 ' H ' ' CG2' ' A' ' 108' ' ' ILE . . . -79.48 157.44 27.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 302' ' ' VAL . 4.2 m -110.02 114.41 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.817 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -101.9 164.94 11.46 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.154 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.8 146.72 8.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.848 0.832 . . . . 0.0 111.267 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HB2' ' CD2' ' A' ' 156' ' ' PHE . 3.2 pp -79.02 128.06 32.78 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.101 -1.408 . . . . 0.0 107.482 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 227' ' ' ASN . 24.8 p -131.35 165.85 22.55 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 tp -99.2 135.13 41.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.99 133.84 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.418 ' CD2' HG21 ' A' ' 245' ' ' THR . 12.1 p90 -122.08 142.02 50.79 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.842 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 1.4 t-20 -89.29 126.91 35.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.488 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.34 -3.61 28.5 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.064 -0.398 . . . . 0.0 110.37 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.22 -62.76 1.19 Allowed 'General case' 0 C--N 1.34 0.177 0 CA-C-O 121.252 0.548 . . . . 0.0 110.498 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 39.82 2.31 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.644 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.842 ' HB3' ' O ' ' A' ' 118' ' ' ASN . 1.3 tp -131.68 89.72 38.83 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.354 0.597 . . . . 0.0 110.65 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.433 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 81.0 Cg_exo -44.5 162.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.465 2.777 . . . . 0.0 112.571 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 23.0 m-20 -60.12 110.7 3.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 122.449 1.119 . . . . 0.0 111.793 -170.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 58.9 Cg_endo -69.88 168.31 22.09 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 125.238 3.959 . . . . 0.0 114.14 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.415 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 56.9 Cg_endo -92.34 -154.05 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 123.34 2.693 . . . . 0.0 115.501 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -125.52 -91.7 0.52 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 t -46.4 155.53 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.058 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.433 ' CZ2' ' CD2' ' A' ' 147' ' ' LEU . 10.0 t-105 -69.67 -33.49 72.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 174.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 133' ' ' PRO . 1.9 mm-40 -44.98 -24.17 0.2 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.731 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -72.67 -26.51 61.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.484 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 25.6 mm -40.64 -57.33 3.19 Favored Pre-proline 0 N--CA 1.478 0.974 0 CA-C-O 121.29 0.567 . . . . 0.0 111.982 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 6.0 Cg_endo -48.27 -39.09 34.76 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 N-CA-C 109.399 -1.039 . . . . 0.0 109.399 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.35 -58.56 3.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.415 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 0.3 OUTLIER -68.65 -36.34 78.44 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.039 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.482 ' HA ' HD11 ' A' ' 139' ' ' LEU . 21.6 t0 -72.85 -40.15 65.95 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -46.82 -47.37 21.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.402 176.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.74 -39.6 94.69 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.405 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -60.81 -49.84 75.87 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -44.52 29.67 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -45.89 -26.3 0.67 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -108.04 -58.57 1.96 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.058 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.8 43.93 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 CA-C-O 118.824 -0.986 . . . . 0.0 111.036 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.492 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 4.0 mttt -155.34 -172.22 4.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.636 1.718 . . . . 0.0 111.086 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.449 ' N ' HD22 ' A' ' 139' ' ' LEU . 47.9 m -142.4 160.71 39.74 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -75.15 -28.67 60.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.433 ' CD2' ' CZ2' ' A' ' 129' ' ' TRP . 0.7 OUTLIER -152.6 133.05 13.74 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -176.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.421 ' HB2' ' CB ' ' A' ' 222' ' ' THR . 7.9 tpt -132.3 140.72 48.7 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.907 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 150' ' ' ASN . 34.8 p90 -172.7 175.21 3.48 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.665 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 149' ' ' PHE . 45.2 m-80 -37.74 170.69 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.683 0.615 . . . . 0.0 110.828 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.449 ' CB ' ' O ' ' A' ' 208' ' ' THR . 2.1 tm? -114.64 -59.66 1.99 Allowed 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -102.75 36.01 2.32 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 116.788 -1.965 . . . . 0.0 114.862 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.675 ' O ' ' HB ' ' A' ' 157' ' ' THR . 4.6 mm-40 -88.3 144.35 33.95 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 121.18 1.809 . . . . 0.0 114.61 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.934 ' O ' ' N ' ' A' ' 156' ' ' PHE . 6.0 Cg_exo -77.71 -135.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.285 1 C-N-CA 125.787 4.325 . . . . 0.0 106.04 176.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 1.149 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 1.2 m-85 27.17 -54.88 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.934 ' N ' ' O ' ' A' ' 154' ' ' PRO . 14.9 m-85 -87.88 -58.8 2.44 Favored 'General case' 0 C--O 1.26 1.625 0 C-N-CA 124.486 1.114 . . . . 0.0 110.761 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.675 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 24.1 m -57.24 -44.6 83.99 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.491 ' CZ2' ' CG2' ' A' ' 343' ' ' VAL . 4.8 m95 -52.31 -55.02 35.51 Favored Pre-proline 0 C--N 1.348 0.521 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.534 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 1.149 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 87.5 Cg_exo -43.4 -49.53 7.47 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.387 2.058 . . . . 0.0 114.124 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.509 ' HB3' ' CE2' ' A' ' 250' ' ' PHE . 1.5 pp -79.18 -56.95 3.98 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 120.529 -1.357 . . . . 0.0 113.241 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.627 ' CA ' ' HA3' ' A' ' 191' ' ' GLY . 1.1 pt -61.19 -13.17 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 164' ' ' ASP . . . -124.95 -46.4 1.83 Allowed 'General case' 0 N--CA 1.471 0.622 1 N-CA-C 124.147 4.869 . . . . 0.0 124.147 -178.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.84 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . . . -54.58 49.72 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -176.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 162' ' ' ALA . 10.2 m-20 -122.1 -58.83 1.7 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.727 0.694 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.68 1.68 2.09 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.23 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.12 95.79 1.09 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.104 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -67.08 139.55 57.57 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.026 0.413 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.486 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . . . -43.6 -74.65 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.742 0.782 . . . . 0.0 111.643 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.576 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 32.3 m-85 -112.33 173.9 6.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.708 ' O ' ' O ' ' A' ' 175' ' ' LYS . 6.3 ttmt -100.68 108.06 19.83 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.933 ' HA ' ' O ' ' A' ' 175' ' ' LYS . 27.5 m-85 -84.05 111.33 19.2 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.134 176.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 173' ' ' ASN . 18.0 mt-10 -104.89 101.17 10.77 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.597 ' C ' ' O ' ' A' ' 172' ' ' GLU . 8.8 m120 34.8 73.52 0.08 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 65.67 70.69 1.04 Allowed Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.171 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.933 ' O ' ' HA ' ' A' ' 171' ' ' TYR . 3.8 tptp -177.67 122.75 0.12 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.522 1.161 . . . . 0.0 112.98 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.608 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -114.63 -19.8 10.96 Favored 'General case' 0 N--CA 1.512 2.653 0 CA-C-O 122.907 1.337 . . . . 0.0 109.14 175.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 6.5 m-20 38.84 -85.8 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 111.523 -2.58 . . . . 0.0 111.725 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 7.3 tp 171.86 -41.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -65.9 -12.7 56.62 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 71.9 m-20 -120.59 93.53 4.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.994 0.816 . . . . 0.0 109.127 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.407 ' CG2' ' CG ' ' A' ' 365' ' ' GLN . 32.2 m -115.95 112.55 40.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.69 39.79 2.39 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.736 -1.221 . . . . 0.0 114.065 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 168' ' ' ALA . 2.1 t -78.27 -43.54 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.506 ' HA ' ' CB ' ' A' ' 188' ' ' ALA . 5.8 p-10 -66.22 57.01 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.458 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 183' ' ' VAL . 0.7 OUTLIER -102.98 -172.34 2.1 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.37 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.689 ' O ' ' HG3' ' A' ' 189' ' ' LYS . . . -38.79 -48.59 1.54 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.244 0.545 . . . . 0.0 112.346 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.13 -32.3 52.89 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-O 118.975 -0.903 . . . . 0.0 113.053 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.506 ' CB ' ' HA ' ' A' ' 184' ' ' ASP . . . -60.07 -54.96 39.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.33 1.565 . . . . 0.0 107.301 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -52.64 -39.42 61.77 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.31 76.29 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 111.954 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.627 ' HA3' ' CA ' ' A' ' 161' ' ' ILE . . . -56.48 -60.59 8.7 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.711 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -59.76 -30.93 69.2 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.194 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.5 m -74.94 -53.7 8.53 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.477 ' CD2' ' HA2' ' A' ' 191' ' ' GLY . 0.1 OUTLIER -62.09 -33.62 74.78 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.863 0.364 . . . . 0.0 110.16 178.149 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.92 -48.32 77.04 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 192' ' ' LEU . 76.1 t -56.48 -30.66 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.11 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -46.65 84.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.569 0.699 . . . . 0.0 111.006 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -51.42 68.27 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.151 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 204' ' ' MET . 46.3 mm -63.41 -45.97 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.686 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.19 -36.71 52.67 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 118.437 -0.792 . . . . 0.0 112.02 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -113.0 -34.61 5.68 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 120.962 3.69 . . . . 0.0 120.962 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -79.41 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.702 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -101.47 -6.01 24.51 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 8.4 ttt 45.18 35.44 1.72 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.597 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -146.52 165.96 27.88 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -152.35 32.57 0.52 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -99.0 -3.45 34.88 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -55.18 120.27 6.76 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 119.757 -0.777 . . . . 0.0 108.92 178.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 213' ' ' ALA . 8.5 m-20 -94.77 -175.29 3.53 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.158 -0.339 . . . . 0.0 111.621 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -70.71 -45.26 65.27 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.136 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.95 -25.54 48.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.449 0.642 . . . . 0.0 110.771 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.7 mt -81.47 -52.01 14.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -51.11 -36.81 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.46 -45.55 86.9 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.26 -39.38 69.73 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.795 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.54 -56.06 25.98 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.97 -28.69 70.26 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -55.79 -41.56 74.27 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.512 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -23.9 59.13 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.12 42.71 58.02 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.405 ' HB3' ' HG3' ' A' ' 144' ' ' LYS . 1.4 mp0 -110.57 37.09 2.86 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.94 1.37 . . . . 0.0 110.794 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.421 ' CB ' ' HB2' ' A' ' 148' ' ' MET . 8.9 t -139.2 138.62 37.04 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 224' ' ' MET . . . -92.93 38.2 1.03 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -177.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 162.4 149.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 87.0 m -147.89 160.05 43.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.137 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.2 pt -116.5 113.26 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -146.85 165.48 29.6 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.283 -177.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 232' ' ' TRP . . . -79.82 -154.4 9.18 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 119.341 -1.409 . . . . 0.0 113.495 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.71 -50.91 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.816 2.344 . . . . 0.0 114.115 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.449 ' CZ2' ' HB3' ' A' ' 299' ' ' LEU . 12.7 p-90 -135.78 -54.72 0.77 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.42 ' HB2' ' CE3' ' A' ' 230' ' ' TRP . . . -135.11 46.37 2.43 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.408 ' CB ' ' HA3' ' A' ' 228' ' ' GLY . 6.0 t-105 -91.64 -44.4 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.665 0.269 . . . . 0.0 110.432 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -114.42 38.14 3.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.045 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 54.07 87.92 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.634 0.254 . . . . 0.0 111.105 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 237' ' ' THR . 0.2 OUTLIER -155.08 -43.82 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.401 ' N ' HG12 ' A' ' 235' ' ' ILE . 0.0 OUTLIER 45.09 -84.88 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 235' ' ' ILE . 15.6 p -67.18 138.0 56.66 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.651 0.262 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 22.1 p -134.51 158.87 42.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.898 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.85 176.62 0.07 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.984 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.64 -60.86 2.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.024 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -108.99 99.9 9.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.722 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -117.46 127.59 54.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.075 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 117' ' ' TYR . . . -96.71 114.13 4.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.205 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.72 137.01 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.579 -0.365 . . . . 0.0 110.829 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.418 HG21 ' CD2' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -141.18 167.93 21.0 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.071 0.548 . . . . 0.0 111.613 -172.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.6 m -72.75 152.23 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 248' ' ' PRO . 1.9 mp -58.73 159.54 12.64 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 119.903 1.229 . . . . 0.0 110.682 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 247' ' ' LEU . 72.4 Cg_endo -78.66 -162.67 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.552 2.168 . . . . 0.0 113.063 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.4 p -94.91 144.31 25.77 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 160' ' ' LEU . 62.2 m-85 -144.61 111.2 5.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.96 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.04 31.98 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.196 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 105.78 29.98 4.75 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.423 ' OE1' ' HD2' ' A' ' 254' ' ' PRO . 0.1 OUTLIER -156.68 167.1 15.14 Favored Pre-proline 0 N--CA 1.467 0.375 0 CA-C-N 119.1 1.45 . . . . 0.0 112.302 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.423 ' HD2' ' OE1' ' A' ' 253' ' ' GLN . 67.7 Cg_endo -93.08 23.73 0.5 Allowed 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.43 2.753 . . . . 0.0 114.48 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 0.7 OUTLIER 72.21 133.61 0.04 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 178.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.84 ' HB2' ' HB2' ' A' ' 163' ' ' ALA . 10.5 mttt -86.38 106.39 10.11 Favored Pre-proline 0 CA--C 1.512 -0.499 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.795 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.723 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 94.8 Cg_endo -78.9 143.87 18.62 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.201 1.267 . . . . 0.0 109.719 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -89.19 119.32 29.58 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 324' ' ' ALA . 6.2 m -115.2 99.86 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 118.247 0.476 . . . . 0.0 112.148 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -90.86 156.69 24.7 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.782 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.473 HG13 ' CG ' ' A' ' 64' ' ' HIS . 2.1 p -118.19 106.49 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -72.3 129.61 38.82 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 117.54 -1.664 . . . . 0.0 107.115 178.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.486 ' HA ' HG13 ' A' ' 108' ' ' ILE . 2.9 p -140.85 130.0 23.48 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 118.624 2.824 . . . . 0.0 118.624 -172.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.516 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . . . -88.88 111.98 22.72 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 105' ' ' ALA . . . -100.78 164.27 18.64 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.475 ' HB ' HD11 ' A' ' 104' ' ' ILE . 3.7 mt -88.21 123.05 40.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 118.723 1.262 . . . . 0.0 107.617 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -64.59 145.73 55.71 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.73 -25.5 60.48 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.132 -0.355 . . . . 0.0 110.947 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -49.5 -60.0 3.25 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.471 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.94 131.77 8.87 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.652 0.263 . . . . 0.0 111.279 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.37 -42.57 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.497 2.131 . . . . 0.0 112.999 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 276' ' ' ALA . 4.2 m-20 47.8 81.08 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.533 0.206 . . . . 0.0 110.787 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.12 -54.07 7.77 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -58.48 -57.29 13.58 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 8.3 tt -59.72 -42.88 94.08 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.658 0.266 . . . . 0.0 111.472 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.519 ' HB3' HD13 ' A' ' 280' ' ' LEU . . . -72.9 -33.41 65.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.612 ' O ' ' CB ' ' A' ' 281' ' ' GLU . 1.1 tmtt? -63.58 -58.7 6.13 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 121.413 0.625 . . . . 0.0 112.165 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.508 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 3.6 tp10 -68.06 -34.55 76.66 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.699 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.486 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 54.9 t80 -74.04 -60.02 2.45 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.963 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 276' ' ' ALA . 5.8 mp -75.01 -43.13 55.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 118.373 -1.331 . . . . 0.0 113.05 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.612 ' CB ' ' O ' ' A' ' 277' ' ' LYS . 0.2 OUTLIER -73.65 -37.73 65.21 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.518 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 3.9 t30 -87.99 -20.61 25.61 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 285' ' ' LEU . 0.2 OUTLIER -104.06 -74.45 0.64 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 177.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.493 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 0.5 OUTLIER -36.22 -30.63 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 281' ' ' GLU . 3.2 mm? -98.35 43.49 1.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.896 0.316 . . . . 0.0 111.792 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.5 p -144.89 157.78 44.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 11.2 m-20 -61.18 -15.17 31.15 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 2.3 mm-40 -78.32 -46.91 18.92 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.316 0.507 . . . . 0.0 110.498 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -81.06 -53.46 3.92 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 284' ' ' LEU . 17.6 mt -50.07 -49.24 51.97 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.452 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 1.4 tp10 -78.14 -27.41 48.2 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.912 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -71.92 -38.06 69.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 119.776 1.171 . . . . 0.0 108.405 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 290' ' ' LEU . 14.7 p -65.92 -38.03 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.441 ' N ' HG11 ' A' ' 293' ' ' VAL . 24.5 t30 -74.95 -41.88 58.75 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.458 1.103 . . . . 0.0 113.374 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -65.09 -42.74 93.76 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.482 ' CB ' ' HA3' ' A' ' 16' ' ' GLY . 33.4 m-20 -56.68 -64.53 0.84 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -97.63 105.24 25.12 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.814 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -100.18 93.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.62 2.88 . . . . 0.0 112.305 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.449 ' HB3' ' CZ2' ' A' ' 230' ' ' TRP . 0.0 OUTLIER -143.33 -74.29 0.27 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.526 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -144.0 173.6 24.71 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.084 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 311' ' ' LEU . . . -129.93 131.24 45.93 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 110' ' ' VAL . 10.9 p -179.8 39.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.085 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.431 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . -111.06 -138.21 0.37 Allowed 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 285' ' ' LEU . 22.0 tp -39.63 121.24 1.2 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -30.33 -63.15 0.14 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.514 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 95.7 p -48.88 -44.73 40.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.966 0.889 . . . . 0.0 110.933 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.479 ' CG ' ' HB3' ' A' ' 290' ' ' LEU . 3.1 t80 -75.87 -25.05 55.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.909 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -68.54 -39.78 80.99 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -68.66 -61.33 1.87 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.288 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -46.78 -56.61 5.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.872 0.368 . . . . 0.0 111.169 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.461 ' HB3' ' CB ' ' A' ' 301' ' ' ALA . 0.3 OUTLIER -64.43 -45.58 86.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.641 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 308' ' ' GLU . . . -46.84 -28.7 1.65 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -31.22 -42.21 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.19 137.12 84.33 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.784 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.72 -21.8 70.94 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.631 2.22 . . . . 0.0 113.252 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -59.71 -59.14 5.9 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.646 0.26 . . . . 0.0 111.559 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.438 HG23 ' HB3' ' A' ' 301' ' ' ALA . 3.0 mp -50.91 -55.6 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.91 -39.07 8.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.163 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.08 -52.74 64.43 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 122.058 0.932 . . . . 0.0 108.837 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.41 ' OG1' HG22 ' A' ' 110' ' ' VAL . 3.2 p -56.84 -37.57 71.43 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 113.625 -1.625 . . . . 0.0 109.85 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.4 ttp -70.93 -44.59 65.86 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -58.56 -57.38 13.21 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' A' ' 327' ' ' GLY . 6.5 m-20 -50.45 -38.71 45.0 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.44 ' HA ' ' CG1' ' A' ' 259' ' ' VAL . . . -57.35 -43.19 83.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.603 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -57.33 -42.06 81.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.228 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -106.19 26.41 9.81 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.887 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.723 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -114.66 157.64 14.85 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.618 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.86 135.66 36.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 330' ' ' MET . 39.0 mt -86.45 115.43 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 118.906 0.775 . . . . 0.0 110.87 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.492 ' C ' ' O ' ' A' ' 329' ' ' ILE . 0.0 OUTLIER -28.27 130.84 0.2 Allowed Pre-proline 0 N--CA 1.47 0.568 0 N-CA-C 111.412 0.153 . . . . 0.0 111.412 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.426 ' HG2' ' CE1' ' A' ' 169' ' ' PHE . 62.4 Cg_exo -51.79 -164.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.893 2.395 . . . . 0.0 113.152 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -150.73 39.29 0.71 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.343 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.421 HG13 ' CE1' ' A' ' 176' ' ' TYR . 1.2 pp -132.58 163.23 52.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.026 0.441 . . . . 0.0 111.911 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.21 -37.86 7.56 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.046 2.497 . . . . 0.0 112.403 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -45.98 -21.79 0.16 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 4.0 tpp -45.49 -35.61 3.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.956 0.344 . . . . 0.0 110.978 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.5 t -61.12 -40.33 93.36 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.78 0.324 . . . . 0.0 110.19 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.12 -37.61 85.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.764 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.457 ' CD2' HD13 ' A' ' 368' ' ' ILE . 23.4 t80 -74.04 -55.74 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.624 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 344' ' ' ARG . 2.3 t-105 -49.91 -43.61 49.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.494 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.79 -52.2 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.9 -44.17 81.5 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.491 ' CG2' ' CZ2' ' A' ' 158' ' ' TRP . 5.0 p -71.7 -29.42 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -75.03 -49.18 20.63 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 349' ' ' ASN . 69.9 p -57.33 -57.94 10.42 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.683 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.79 -41.22 6.76 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.861 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 343' ' ' VAL . 54.9 t -59.04 -47.69 89.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 6.7 mt -66.97 -28.24 42.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.8 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.683 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.9 OUTLIER -67.94 -27.63 66.78 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.66 0.267 . . . . 0.0 110.913 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.51 -44.76 23.62 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.54 -9.39 59.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 9.4 t -101.72 -46.03 5.06 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 142.1 0.77 1.4 Allowed Glycine 0 N--CA 1.464 0.504 0 C-N-CA 117.054 -2.498 . . . . 0.0 118.074 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.46 32.38 4.66 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 113.232 -3.387 . . . . 0.0 114.916 173.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.542 ' HB3' ' CB ' ' A' ' 360' ' ' ALA . 0.0 OUTLIER -158.24 119.22 3.43 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 34.3 p -78.73 146.88 33.65 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.5 p -41.97 -45.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 16.0 m-20 -71.58 -49.67 38.26 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.01 -46.38 57.39 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.475 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 355' ' ' GLN . . . -54.16 -49.47 69.21 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.282 1.039 . . . . 0.0 113.593 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 47.3 mt -74.71 -36.69 62.7 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.283 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 365' ' ' GLN . 14.7 tttm -65.13 -56.7 11.41 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 122.351 1.072 . . . . 0.0 110.581 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.34 -37.45 83.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.749 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -49.61 -43.98 46.87 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 362' ' ' LYS . 0.0 OUTLIER -60.62 -44.74 95.97 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.57 -44.15 56.57 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.34 0.591 . . . . 0.0 110.168 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.08 -46.22 90.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.269 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.457 HD13 ' CD2' ' A' ' 339' ' ' PHE . 6.7 pt -81.19 -5.65 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.837 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 10.8 p -135.28 42.81 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.619 0.247 . . . . 0.0 110.616 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.248 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.665 0.269 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -138.95 -179.45 5.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.98 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.7 66.04 0.55 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HA ' HG12 ' A' ' 33' ' ' ILE . 2.3 tttp -153.18 157.49 40.36 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.465 ' HB2' HD11 ' A' ' 33' ' ' ILE . 24.7 tp -146.48 124.75 12.24 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.79 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' A' ' 58' ' ' ASP . 99.3 t -111.74 132.9 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.488 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.706 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 5.4 mp -135.21 125.15 43.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.063 0.459 . . . . 0.0 111.412 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.458 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -106.04 121.04 43.31 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 15.3 mt -158.09 137.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.063 0.458 . . . . 0.0 111.252 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -156.07 41.98 0.39 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.59 -35.21 0.57 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.698 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 3.3 m-20 -90.05 -105.51 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER 161.91 -172.6 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.03 0.919 . . . . 0.0 113.204 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.66 100.58 0.32 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 113.733 -1.576 . . . . 0.0 115.423 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -36.33 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.984 -0.608 . . . . 0.0 111.167 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 12.1 t-20 -64.84 -43.94 91.4 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 296' ' ' ASP . . . -71.99 -49.01 23.99 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.631 -0.795 . . . . 0.0 114.043 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -50.18 74.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.789 0.795 . . . . 0.0 110.371 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.29 82.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 53.9 tt0 -65.8 -36.98 85.02 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.42 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.6 -61.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 122.063 -0.398 . . . . 0.0 110.377 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -49.31 -32.49 14.32 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.278 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -58.37 -50.84 72.23 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 122.503 1.144 . . . . 0.0 109.183 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -42.81 61.96 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 113.05 -1.886 . . . . 0.0 109.515 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.6 ' O ' ' HB ' ' A' ' 31' ' ' THR . 10.8 t80 -64.26 -32.23 73.74 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.316 0.579 . . . . 0.0 110.691 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 32' ' ' GLY . 26.8 tt0 -68.78 -46.62 68.25 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.897 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -25.6 54.27 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -176.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.7 -33.61 21.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 27' ' ' PHE . 1.8 m -95.75 -133.5 0.2 Allowed 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 111.115 -2.766 . . . . 0.0 104.792 173.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 28' ' ' GLU . . . -173.59 42.71 0.15 Allowed Glycine 0 C--N 1.291 -1.94 0 N-CA-C 106.869 -2.492 . . . . 0.0 106.869 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.501 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -113.95 152.14 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -105.71 105.78 15.98 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.655 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.422 ' CG2' ' CD1' ' A' ' 9' ' ' ILE . 10.7 p -84.49 131.32 34.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.0 p -116.71 141.24 48.46 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.379 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 27.0 m -136.74 119.97 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 1.7 mp0 -109.42 141.87 41.2 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -113.65 81.27 5.47 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 120.638 0.256 . . . . 0.0 111.483 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.475 ' CG ' ' HG ' ' A' ' 43' ' ' LEU . 38.1 Cg_endo -90.83 -172.55 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.31 2.673 . . . . 0.0 113.005 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -114.05 -44.97 3.1 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.622 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -81.03 0.61 35.01 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.475 ' HG ' ' CG ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -19.77 -39.81 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 1.05 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -63.49 -55.06 27.06 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.273 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mp0 -74.07 -41.75 61.25 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.154 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -57.97 -57.82 11.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.24 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.699 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 34.7 t80 -41.73 -60.99 1.61 Allowed Pre-proline 0 C--N 1.355 0.828 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.26 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 1.05 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 25.0 Cg_exo -62.4 -19.83 68.51 Favored 'Trans proline' 0 C--O 1.25 1.106 0 CA-C-N 120.17 1.096 . . . . 0.0 111.704 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -81.07 -34.13 32.93 Favored 'General case' 0 C--O 1.259 1.599 0 CA-C-O 122.644 1.211 . . . . 0.0 110.683 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 47' ' ' PHE . 2.7 m -80.13 -40.86 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 CA-C-O 122.287 1.041 . . . . 0.0 110.308 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.06 -37.21 20.36 Favored 'General case' 0 C--N 1.381 1.958 0 CA-C-N 113.226 -1.806 . . . . 0.0 110.096 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.27 -35.74 30.77 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.555 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -172.49 64.57 0.03 OUTLIER 'General case' 0 C--N 1.34 0.169 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.606 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . -167.12 44.18 0.25 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 119.566 -1.302 . . . . 0.0 115.008 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 3.5 m-20 155.75 -86.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.74 -106.16 0.9 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 18.6 Cg_endo -57.11 132.99 54.77 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.938 1.759 . . . . 0.0 108.316 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.766 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 20.7 t0 157.97 126.9 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 118.717 0.69 . . . . 0.0 112.855 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.462 HG23 ' HA ' ' A' ' 266' ' ' ILE . 9.5 mt -107.87 162.85 5.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.547 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 6.3 tt -138.16 127.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.706 ' O ' ' HE3' ' A' ' 62' ' ' TRP . 3.1 m-85 -85.94 148.07 25.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.706 ' HE3' ' O ' ' A' ' 61' ' ' PHE . 1.6 t-105 -168.54 153.38 6.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 120.119 1.327 . . . . 0.0 108.518 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 67' ' ' PHE . . . -77.21 -175.51 3.68 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.73 1.15 . . . . 0.0 108.746 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.573 ' HB2' ' HB ' ' A' ' 261' ' ' VAL . 22.4 t-80 -77.9 -44.89 25.71 Favored 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.578 ' HB3' ' CG ' ' A' ' 330' ' ' MET . 0.8 OUTLIER -52.91 -59.44 4.52 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 1.6 mtt85 -70.6 -29.86 66.37 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.541 ' CB ' ' O ' ' A' ' 63' ' ' ALA . 7.3 t80 -62.46 -39.7 94.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 72' ' ' GLN . . . -46.99 -67.62 1.4 Allowed Glycine 0 CA--C 1.488 -1.652 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.886 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 73' ' ' SER . . . -76.44 -71.84 1.15 Allowed Glycine 0 C--N 1.341 0.839 0 CA-C-N 114.485 -0.857 . . . . 0.0 112.612 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.709 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 12.7 m-30 -41.82 -57.5 2.33 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.423 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 67' ' ' PHE . . . -75.61 -56.63 4.51 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.625 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 4.8 tm0? -63.8 -12.9 39.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.621 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 48.4 t -82.84 -26.75 31.36 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.119 -0.363 . . . . 0.0 111.78 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 166.99 -32.09 0.2 Allowed Glycine 0 C--N 1.339 0.735 0 C-N-CA 119.414 -1.374 . . . . 0.0 114.772 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.709 ' HG ' ' O ' ' A' ' 70' ' ' TYR . 1.8 pp -86.72 61.8 7.03 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 118.195 0.998 . . . . 0.0 111.743 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.19 143.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.238 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.96 115.13 29.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.716 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.58 ' HA ' HG13 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -53.99 151.44 6.77 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.2 pt -90.96 155.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.276 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.25 175.31 4.25 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.097 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.52 139.46 14.41 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.776 2.318 . . . . 0.0 112.952 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.21 -162.19 1.26 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.303 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.404 ' N ' ' HD3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -117.07 -58.6 2.04 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.318 -0.239 . . . . 0.0 111.237 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.69 70.18 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.634 0.254 . . . . 0.0 111.417 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.405 ' CD2' ' HG2' ' A' ' 281' ' ' GLU . 0.1 OUTLIER -73.75 -59.08 2.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.464 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -56.93 -27.33 60.86 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.3 -31.07 57.99 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.8 29.62 2.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.567 ' HA ' ' CD1' ' A' ' 94' ' ' TRP . 19.7 mt -104.8 107.8 18.95 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.173 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -89.1 -179.19 1.19 Allowed Pre-proline 0 N--CA 1.452 -0.361 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 7.4 Cg_exo -74.08 -39.0 1.86 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.326 2.017 . . . . 0.0 115.603 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -87.65 -63.61 1.28 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.586 ' OG1' ' CE3' ' A' ' 94' ' ' TRP . 1.2 p -64.78 -26.99 68.59 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -175.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.586 ' CE3' ' OG1' ' A' ' 93' ' ' THR . 5.2 m-90 -89.2 -24.93 22.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.015 0.926 . . . . 0.0 111.001 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 2.5 t70 -72.97 -26.81 61.49 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.125 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.442 ' CB ' ' CG2' ' A' ' 261' ' ' VAL . . . -71.72 -38.63 70.47 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 105' ' ' ALA . 40.7 t -100.02 44.74 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.03 140.21 51.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 119.16 -0.448 . . . . 0.0 109.9 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.9 t80 -109.3 174.7 5.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.529 1.059 . . . . 0.0 109.433 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -61.32 75.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.724 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 138.97 -55.69 0.66 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.173 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -145.93 -178.29 6.04 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 117.126 0.463 . . . . 0.0 111.316 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.36 146.28 42.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.226 0.536 . . . . 0.0 112.39 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.695 HG12 ' O ' ' A' ' 104' ' ' ILE . 4.1 tt -122.32 58.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.131 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . 159.03 176.04 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' CD2' ' HB1' ' A' ' 264' ' ' ALA . 0.0 OUTLIER -139.02 127.91 14.0 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 115.542 -0.754 . . . . 0.0 108.974 177.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.549 ' HA ' ' HB3' ' A' ' 263' ' ' SER . 86.3 Cg_endo -79.6 162.06 24.71 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 122.886 2.391 . . . . 0.0 113.479 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.643 ' N ' ' O ' ' A' ' 262' ' ' LEU . 1.4 pp -167.99 38.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.256 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -178.11 119.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.319 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.423 ' CG1' HD12 ' A' ' 317' ' ' ILE . 14.4 p -110.7 105.5 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.861 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.453 ' HA ' ' CG2' ' A' ' 320' ' ' THR . 1.9 pt-20 -102.46 161.8 13.42 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.788 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.68 146.87 8.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.741 0.781 . . . . 0.0 111.614 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.604 ' HB2' ' CE2' ' A' ' 156' ' ' PHE . 2.1 pp -79.75 125.27 29.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.1 OUTLIER -135.09 160.5 38.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -176.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 226' ' ' ILE . 8.2 tt -92.55 132.07 37.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.438 HG22 HD12 ' A' ' 116' ' ' ILE . 4.1 tt -114.48 133.69 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.439 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 9.8 p90 -118.46 140.05 50.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 0.7 OUTLIER -89.25 128.08 35.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.611 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.06 -43.82 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.223 -0.298 . . . . 0.0 110.59 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -65.21 0.71 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.638 0.733 . . . . 0.0 110.84 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 tt -110.24 64.99 0.61 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.98 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.764 ' HB3' ' O ' ' A' ' 118' ' ' ASN . 2.1 tp -157.18 88.68 2.59 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 119.976 -0.689 . . . . 0.0 112.638 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.619 ' O ' HD11 ' A' ' 122' ' ' LEU . 9.1 Cg_endo -48.26 162.98 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.192 2.594 . . . . 0.0 110.176 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -59.48 108.38 1.35 Allowed Pre-proline 0 N--CA 1.468 0.436 0 C-N-CA 118.186 -1.406 . . . . 0.0 109.686 -172.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 58.2 Cg_endo -93.31 168.6 2.28 Favored 'Trans proline' 0 C--N 1.369 1.627 1 C-N-CA 125.812 4.341 . . . . 0.0 115.868 -175.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 135' ' ' LEU . 4.7 Cg_exo -39.94 156.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.618 3.546 . . . . 0.0 115.572 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -136.07 -20.88 1.45 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.28 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.7 m -133.82 155.23 50.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -59.47 -54.32 48.03 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.406 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -24.25 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.577 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 134' ' ' ALA . 6.8 mt-10 -79.17 -27.92 42.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.63 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 7.2 mt -43.99 -54.25 11.57 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 121.385 0.612 . . . . 0.0 111.368 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 51.9 Cg_exo -49.07 -39.22 41.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 N-CA-C 109.511 -0.996 . . . . 0.0 109.511 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.11 -58.57 3.2 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.601 ' HB3' ' HD3' ' A' ' 126' ' ' PRO . 0.2 OUTLIER -69.07 -37.09 78.3 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.171 -178.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 49.0 t0 -73.09 -40.77 64.73 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -47.52 -45.11 26.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 118.599 -1.24 . . . . 0.0 108.949 177.001 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -64.28 -39.81 94.68 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.698 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.739 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -61.22 -49.17 78.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.75 -44.62 28.27 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.04 -25.19 0.53 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.497 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -100.01 -63.68 1.11 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.73 39.39 0.02 OUTLIER Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.014 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.739 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 0.5 OUTLIER -173.77 176.18 2.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.516 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.8 m -109.26 166.97 10.46 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.474 ' CB ' ' CD1' ' A' ' 139' ' ' LEU . . . -73.31 -16.1 61.38 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 224' ' ' MET . 1.6 pt? -148.74 133.07 17.49 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 117.633 2.457 . . . . 0.0 117.633 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.451 ' N ' ' O ' ' A' ' 224' ' ' MET . 28.3 mmt -132.34 138.89 47.94 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.671 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.975 ' O ' ' O ' ' A' ' 150' ' ' ASN . 2.3 p90 -172.48 175.28 3.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.65 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.975 ' O ' ' O ' ' A' ' 149' ' ' PHE . 1.3 m120 -28.68 -147.74 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 123.897 0.748 . . . . 0.0 112.201 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.447 ' HB2' HG22 ' A' ' 208' ' ' THR . 2.8 mt 169.66 41.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.824 -1.172 . . . . 0.0 110.615 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER 173.11 34.05 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 169.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.666 ' O ' ' HB ' ' A' ' 157' ' ' THR . 4.1 mp0 -119.46 155.13 54.38 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 121.113 1.779 . . . . 0.0 114.405 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.859 ' O ' ' N ' ' A' ' 156' ' ' PHE . 86.1 Cg_endo -77.59 -135.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 125.201 3.934 . . . . 0.0 105.466 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 1.182 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 4.0 m-85 39.83 -65.19 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 120.312 1.415 . . . . 0.0 113.073 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.859 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -89.5 -59.89 2.09 Favored 'General case' 0 C--O 1.259 1.593 0 C-N-CA 124.483 1.113 . . . . 0.0 111.36 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 5.9 m -58.88 -43.29 90.89 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.441 ' HA ' HG12 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -51.54 -55.34 30.31 Favored Pre-proline 0 C--N 1.35 0.612 0 C-N-CA 120.299 -0.561 . . . . 0.0 109.96 177.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 1.182 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 87.6 Cg_exo -43.48 -50.62 6.7 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.596 2.197 . . . . 0.0 113.349 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.5 mp -64.06 -56.8 12.34 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 119.571 1.078 . . . . 0.0 109.972 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 158' ' ' TRP . 42.3 pt -54.31 -17.32 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.707 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.38 -25.75 51.2 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.7 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -42.13 -59.31 1.81 Allowed 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.481 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 6.3 t70 -64.35 -17.45 63.72 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 136.61 23.0 0.53 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 118.722 -1.704 . . . . 0.0 117.146 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.5 160.25 41.51 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 119.331 1.565 . . . . 0.0 111.779 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -163.08 168.1 21.39 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.504 0.652 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.47 -79.31 0.42 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.614 0.721 . . . . 0.0 111.343 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.668 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 14.3 m-85 -112.15 168.73 9.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.87 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 1.258 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -103.94 115.8 31.1 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.434 ' CE1' ' CD2' ' A' ' 176' ' ' TYR . 0.2 OUTLIER -86.48 114.38 23.18 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.378 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 173' ' ' ASN . 1.2 tt0 -106.47 100.71 10.22 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 172' ' ' GLU . 35.7 m-80 39.03 78.63 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.32 6.52 80.43 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.86 124.37 5.91 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 121.44 2.62 . . . . 0.0 113.388 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 1.258 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.2 p90 -96.92 -23.12 16.48 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.599 1.19 . . . . 0.0 109.724 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 2.8 m-20 65.82 -82.43 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.911 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 7.1 tp 172.21 -43.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -16.62 17.11 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 119.167 -0.444 . . . . 0.0 111.769 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 170' ' ' LYS . 4.0 m-20 -112.92 93.93 4.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 365' ' ' GLN . 15.4 m -118.06 120.12 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.314 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.42 52.57 3.81 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 119.479 -1.344 . . . . 0.0 112.86 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.406 HG23 ' CE2' ' A' ' 339' ' ' PHE . 14.5 t -90.93 -17.84 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.409 -0.895 . . . . 0.0 109.366 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.72 52.24 0.72 Allowed 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.858 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.56 160.65 16.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.375 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.75 -25.92 59.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.383 0.611 . . . . 0.0 111.706 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -76.4 -36.43 39.08 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.866 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.17 66.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -60.44 3.85 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.544 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.31 -41.04 50.43 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.829 0.823 . . . . 0.0 111.609 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.469 ' HA2' ' CE2' ' A' ' 194' ' ' PHE . . . -58.89 -60.7 8.42 Favored Glycine 0 C--O 1.237 0.338 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.839 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.2 mt -61.32 -23.93 66.07 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.577 -0.367 . . . . 0.0 110.092 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.447 ' O ' ' CG1' ' A' ' 196' ' ' VAL . 98.1 m -62.69 -53.46 54.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.658 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.469 ' CE2' ' HA2' ' A' ' 191' ' ' GLY . 4.3 p90 -61.83 -33.88 74.95 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.42 HD21 ' CE1' ' A' ' 194' ' ' PHE . 0.2 OUTLIER -61.33 -51.2 69.84 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.671 178.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 193' ' ' THR . 7.8 p -58.66 -28.75 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.958 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.417 ' N ' HG13 ' A' ' 196' ' ' VAL . 3.0 t0 -57.87 -49.36 76.96 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 121.399 0.618 . . . . 0.0 109.779 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.4 tt -62.33 -59.14 5.42 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.748 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 204' ' ' MET . 4.3 mt -53.8 -45.16 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -61.71 -34.14 75.27 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -91.09 3.35 55.0 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.4 -81.11 0.63 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.72 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.48 -24.07 5.94 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.418 ' N ' ' O ' ' A' ' 199' ' ' ILE . 1.4 ptm 74.44 13.42 3.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.948 0.34 . . . . 0.0 110.8 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -148.88 104.96 3.5 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 151' ' ' LEU . . . -99.16 72.01 1.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.22 -4.27 27.48 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.593 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.447 HG22 ' HB2' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -57.24 123.9 16.95 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.1 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 213' ' ' ALA . 0.5 OUTLIER -94.48 -174.74 3.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.6 p90 -70.18 -45.1 67.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.239 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.432 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.4 OUTLIER -77.87 -25.53 48.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.943 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.45 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 2.9 mp -81.68 -51.76 14.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -50.39 -37.35 37.03 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.61 -45.62 86.15 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.77 -38.8 67.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.874 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.01 -56.7 18.3 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -61.46 -29.13 69.76 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.8 -40.54 76.11 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.572 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.23 -23.93 59.24 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.4 33.12 61.63 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 115.3 0.88 . . . . 0.0 115.3 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -109.02 36.9 2.71 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.147 1.474 . . . . 0.0 111.4 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 148' ' ' MET . 0.5 OUTLIER -140.23 137.91 34.66 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 178.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -104.58 38.18 1.95 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.573 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 170.55 138.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.0 t -148.17 159.37 44.01 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.533 ' HB ' ' CE1' ' A' ' 156' ' ' PHE . 8.5 pt -116.05 111.92 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.755 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.584 ' HA ' ' HE2' ' A' ' 156' ' ' PHE . 89.6 m-20 -148.67 164.78 33.31 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 121.874 -0.516 . . . . 0.0 111.939 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 230' ' ' TRP . . . -86.57 114.89 4.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.413 -1.375 . . . . 0.0 109.861 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.663 ' O ' ' HB3' ' A' ' 230' ' ' TRP . 75.2 Cg_exo -50.15 72.94 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.974 2.45 . . . . 0.0 114.548 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.663 ' HB3' ' O ' ' A' ' 229' ' ' PRO . 0.4 OUTLIER 150.96 -30.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 177.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.32 -85.91 0.55 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -52.22 -31.89 34.18 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.346 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -54.47 3.48 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.585 0.231 . . . . 0.0 111.172 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.6 m120 65.91 -74.48 0.06 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.219 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 5.8 mt 65.72 -68.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 74.76 -69.77 0.17 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.601 0.239 . . . . 0.0 110.388 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 7.1 p -106.85 60.83 0.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.757 0.313 . . . . 0.0 110.317 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -177.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.252 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -84.46 67.4 9.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.763 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 14.4 t 75.06 -67.22 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.745 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.57 150.28 47.35 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.725 0.298 . . . . 0.0 110.922 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.415 ' CD1' HD13 ' A' ' 116' ' ' ILE . 43.3 p90 -149.22 130.37 14.51 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.248 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.439 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -96.66 175.23 31.31 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.122 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.4 m -145.76 136.67 19.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 117.05 0.425 . . . . 0.0 111.529 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 167.5 21.0 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.4 m -73.07 152.77 7.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.407 ' CB ' ' OG ' ' A' ' 255' ' ' SER . 2.8 mp -59.37 159.57 15.85 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 120.627 1.558 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.73 -159.81 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.959 2.44 . . . . 0.0 112.433 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 17.3 p -121.15 177.51 5.12 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 249' ' ' THR . 56.8 m-85 -165.64 110.33 0.86 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.234 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.3 mttp 60.88 34.55 19.56 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.714 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.15 43.32 21.57 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.301 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -156.48 148.82 17.72 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.515 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 95.8 Cg_endo -84.31 -169.59 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.17 2.58 . . . . 0.0 111.628 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.432 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 75.3 p -111.85 148.99 32.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.248 0.547 . . . . 0.0 112.244 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 3.1 ttpm? -85.32 109.24 19.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.725 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.586 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 2.7 Cg_exo -78.88 145.7 20.09 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.347 2.698 . . . . 0.0 112.466 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 1.6 m-85 -102.12 94.13 5.59 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.513 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.505 ' CG1' ' HA ' ' A' ' 324' ' ' ALA . 35.5 m -94.35 106.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.757 0.313 . . . . 0.0 111.82 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.403 ' HA2' ' CE ' ' A' ' 330' ' ' MET . . . -86.2 160.52 33.49 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 119.637 -1.268 . . . . 0.0 112.606 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -111.59 111.15 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.643 ' O ' ' N ' ' A' ' 108' ' ' ILE . 3.8 tp -84.4 107.04 16.45 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 117.502 -1.679 . . . . 0.0 107.071 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 63.9 p -133.36 141.94 48.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.46 ' HB1' ' CD2' ' A' ' 106' ' ' TYR . . . -73.73 132.99 43.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.169 -0.332 . . . . 0.0 110.289 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.17 136.33 11.17 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.74 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.462 ' HA ' HG23 ' A' ' 59' ' ' ILE . 7.0 mt -88.0 119.78 35.99 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 CA-C-N 118.425 1.113 . . . . 0.0 108.245 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.561 ' HA ' ' HZ ' ' A' ' 47' ' ' PHE . 44.5 t-20 -59.27 137.55 57.94 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -53.86 -22.34 9.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.711 0.687 . . . . 0.0 110.468 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 270' ' ' SER . . . -55.77 -27.34 50.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.723 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 269' ' ' ALA . 0.9 OUTLIER 93.22 91.29 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 122.602 0.361 . . . . 0.0 111.191 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.417 ' CD ' ' CG2' ' A' ' 266' ' ' ILE . 47.6 Cg_endo -91.14 81.11 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.279 2.653 . . . . 0.0 112.939 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 37.23 82.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.721 0.296 . . . . 0.0 111.142 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 7.9 mmtt -51.58 -54.2 30.1 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -66.9 -57.4 7.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.8 mt -63.74 -53.75 46.24 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.19 18.4 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -58.97 -32.59 69.79 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.32 -53.03 8.77 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 283' ' ' TYR . 85.9 t80 -56.37 -54.66 42.97 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.85 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 284' ' ' LEU . 1.0 OUTLIER -53.9 -43.5 69.75 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.566 0.698 . . . . 0.0 111.402 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.405 ' HG2' ' CD2' ' A' ' 85' ' ' PHE . 90.0 mt-10 -73.45 -34.36 65.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.787 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -93.15 -13.96 27.78 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.537 ' O ' HG22 ' A' ' 286' ' ' THR . 2.5 t80 -106.21 -65.72 1.05 Allowed 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 280' ' ' LEU . 1.5 tp -36.48 -33.04 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.732 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 283' ' ' TYR . 26.2 mt -89.8 42.09 1.08 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.637 0.255 . . . . 0.0 111.665 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 283' ' ' TYR . 10.1 t -145.72 160.55 41.56 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 9.3 m-20 -63.81 -12.72 38.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.549 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 9.9 mt-10 -77.85 -46.94 20.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.598 0.636 . . . . 0.0 111.012 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.419 ' H ' HG22 ' A' ' 286' ' ' THR . . . -83.86 -54.99 2.91 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 286' ' ' THR . 2.2 tp -48.86 -49.8 37.78 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 1.8 tt0 -78.65 -26.38 45.11 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.174 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -71.85 -35.12 69.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 119.838 1.199 . . . . 0.0 108.129 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 66.1 t -65.77 -41.95 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.036 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.602 ' O ' ' HB2' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -91.2 -33.88 15.22 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.632 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -46.27 85.98 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.437 ' HB3' ' HA3' ' A' ' 19' ' ' GLY . 1.2 p30 -61.49 -44.73 96.56 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.602 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 5.1 mttp -43.45 163.86 0.15 Allowed Pre-proline 0 N--CA 1.476 0.833 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.245 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -93.96 49.19 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.217 2.612 . . . . 0.0 114.699 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.2 mt 60.75 69.5 0.68 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.902 0.382 . . . . 0.0 111.533 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 301' ' ' ALA . . . 159.99 125.29 0.78 Allowed Glycine 0 C--O 1.231 -0.087 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.606 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . 159.61 -177.07 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.272 0.536 . . . . 0.0 111.571 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.99 83.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 304' ' ' LEU . . . -84.67 58.22 4.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.271 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.506 ' CB ' ' O ' ' A' ' 303' ' ' ALA . 0.3 OUTLIER 87.84 149.4 0.05 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -30.19 0.66 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 65.5 m -79.91 -47.24 15.38 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.064 0.935 . . . . 0.0 111.059 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.453 ' CG ' ' HB1' ' A' ' 303' ' ' ALA . 5.9 t80 -70.74 -19.2 62.76 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.607 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -42.24 62.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -56.81 -55.85 29.06 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.195 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.34 -42.99 99.84 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.942 0.401 . . . . 0.0 110.18 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.439 ' HG ' ' CD2' ' A' ' 307' ' ' TYR . 10.7 mt -59.93 -44.84 94.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.804 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -46.63 -33.61 4.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.6 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -57.38 -36.5 71.33 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.582 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.53 164.57 5.16 Favored Pre-proline 0 N--CA 1.462 0.139 0 CA-C-O 120.684 0.278 . . . . 0.0 110.714 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.21 -57.2 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.131 2.554 . . . . 0.0 113.48 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.7 mtt85 -58.89 -59.46 5.42 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.423 HD12 ' CG1' ' A' ' 110' ' ' VAL . 1.7 tp -52.26 -54.31 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.71 -51.86 11.81 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.269 0.486 . . . . 0.0 111.623 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -50.71 -48.4 58.84 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.318 1.056 . . . . 0.0 108.748 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.453 ' CG2' ' HA ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -60.95 -36.9 80.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 113.248 -1.797 . . . . 0.0 110.58 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -73.96 -42.83 59.92 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.95 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.31 -57.5 12.37 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.753 0.311 . . . . 0.0 110.377 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.36 -29.36 68.88 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.263 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.505 ' HA ' ' CG1' ' A' ' 259' ' ' VAL . . . -51.99 -53.05 46.15 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.734 0.302 . . . . 0.0 111.031 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -52.94 -32.85 47.96 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.203 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -98.64 13.2 32.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.586 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -93.9 160.0 23.98 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.865 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -97.76 131.93 43.83 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.2 pp -68.96 101.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 120.425 1.466 . . . . 0.0 107.875 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.578 ' CG ' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -36.07 144.84 0.24 Allowed Pre-proline 0 C--N 1.347 0.495 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -44.81 169.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.175 2.583 . . . . 0.0 112.297 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -128.4 -14.27 4.78 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.419 ' HB ' ' CD ' ' A' ' 334' ' ' PRO . 11.8 pt -78.94 165.89 46.06 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 118.77 0.714 . . . . 0.0 111.956 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.419 ' CD ' ' HB ' ' A' ' 333' ' ' ILE . 12.5 Cg_exo -70.55 -26.29 24.01 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.353 2.702 . . . . 0.0 113.402 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.418 ' CG ' HD11 ' A' ' 333' ' ' ILE . 84.1 mm-40 -42.01 -21.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.8 mmt -45.24 -32.17 1.81 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.234 0.47 . . . . 0.0 111.431 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -43.28 99.19 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.5 -34.81 78.6 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.09 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.406 ' CE2' HG23 ' A' ' 183' ' ' VAL . 4.3 m-85 -75.46 -52.28 11.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.542 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.434 ' CZ2' ' HG3' ' A' ' 154' ' ' PRO . 0.7 OUTLIER -53.45 -40.83 65.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.345 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -52.44 16.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.95 -44.49 69.43 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.478 ' HA ' HG22 ' A' ' 347' ' ' VAL . 47.9 t -64.72 -50.36 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.803 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.417 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 9.0 tpt180 -53.42 -56.99 12.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.987 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 6.3 m -56.77 -58.22 9.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.05 -60.75 2.09 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 343' ' ' VAL . 51.7 t -51.95 -47.47 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 0.4 OUTLIER -69.93 -45.27 77.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.893 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -69.12 -51.8 34.77 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 355' ' ' GLN . . . -73.12 -26.62 61.29 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 347' ' ' VAL . . . -51.86 -10.56 0.12 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 1.4 m -110.47 35.26 3.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.568 0.622 . . . . 0.0 111.059 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 88.64 -4.77 85.08 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 118.713 -1.708 . . . . 0.0 114.511 176.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -87.67 34.97 0.71 Allowed 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 115.683 -2.103 . . . . 0.0 107.903 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.515 ' HA ' ' CB ' ' A' ' 350' ' ' ALA . 2.0 mt-30 -71.14 -175.86 1.29 Allowed 'General case' 0 CA--C 1.547 0.838 1 N-CA-C 126.255 5.65 . . . . 0.0 126.255 -157.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 158.26 41.38 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 110.074 -3.239 . . . . 0.0 104.876 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 355' ' ' GLN . 53.2 t -72.43 -54.61 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.84 -174.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 6.7 t70 -46.23 -45.66 17.19 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.702 0.763 . . . . 0.0 111.269 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -77.4 -56.14 4.8 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.71 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -54.68 -44.32 73.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.209 1.004 . . . . 0.0 112.72 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 364' ' ' ALA . 32.7 mt -75.62 -33.93 60.55 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.787 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 12.1 tttt -67.81 -56.06 10.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.172 0.987 . . . . 0.0 109.903 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.22 -30.72 71.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.146 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 361' ' ' LEU . . . -53.87 -53.72 48.66 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.69 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.441 ' HB2' ' CG2' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -58.5 -36.43 73.79 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.893 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.425 ' N ' ' HG3' ' A' ' 365' ' ' GLN . 5.9 m -52.16 -41.24 62.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.409 0.623 . . . . 0.0 109.588 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -73.73 -42.77 60.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.938 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.413 ' CG2' HD12 ' A' ' 178' ' ' ILE . 21.8 mm -66.12 -34.68 71.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 6.6 p -94.5 -14.19 25.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.985 179.963 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.73 0.3 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -149.09 135.23 19.13 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.14 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -108.89 67.47 0.22 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.379 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.93 156.25 44.36 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.55 118.59 13.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.98 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -114.45 120.79 65.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.716 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 2.7 mp -121.67 130.79 74.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.123 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.433 ' CZ2' HG22 ' A' ' 50' ' ' VAL . 29.8 m95 -107.94 121.13 44.15 Favored 'General case' 0 CA--C 1.527 0.058 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.3 pt -150.96 142.3 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.406 ' HA ' ' CD1' ' A' ' 43' ' ' LEU . 2.8 t30 -79.8 67.51 5.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.102 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.71 66.28 2.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.525 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 4.1 m-20 -80.59 -34.55 35.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.291 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 6.7 mttp 105.99 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.34 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 297' ' ' LYS . . . -74.36 58.21 2.41 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' CE2' ' CG2' ' A' ' 37' ' ' VAL . 3.3 m-85 -78.24 -42.14 32.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.751 0.31 . . . . 0.0 110.277 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 4.1 m120 -58.03 -48.37 80.28 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.986 0.422 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.78 -47.86 30.92 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.357 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.48 -51.31 70.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.382 0.591 . . . . 0.0 110.535 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.79 81.75 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.859 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 4.0 tm-20 -65.56 -36.53 84.06 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG12 ' CE2' ' A' ' 283' ' ' TYR . 84.3 t -66.93 -61.3 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' CA ' HG21 ' A' ' 33' ' ' ILE . . . -49.09 -33.64 14.84 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.649 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -50.03 70.14 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.1 -41.46 62.46 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 112.809 -1.996 . . . . 0.0 107.902 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.562 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.17 -35.11 79.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.72 0.772 . . . . 0.0 110.865 178.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.713 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 18.4 tt0 -72.4 -52.46 15.88 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.223 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -53.05 -25.66 13.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.614 1.196 . . . . 0.0 110.244 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.51 ' O ' ' CG2' ' A' ' 31' ' ' THR . 9.1 t70 -89.04 -40.43 12.98 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.296 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER 169.67 38.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 173.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.36 39.53 0.02 OUTLIER Glycine 0 N--CA 1.466 0.671 0 C-N-CA 114.892 -3.528 . . . . 0.0 119.796 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.713 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 3.1 mm -139.7 137.55 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 122.32 3.06 . . . . 0.0 118.152 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -142.55 104.33 4.37 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.4 130.53 42.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 -171.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.1 m -119.21 145.14 46.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.675 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 2.1 m -131.09 122.94 52.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 122.057 -0.402 . . . . 0.0 110.683 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.48 130.78 55.48 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.518 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 1.3 p80 -150.57 71.22 8.99 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.36 178.77 5.97 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.462 2.108 . . . . 0.0 112.219 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -66.01 -40.05 90.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.962 0.411 . . . . 0.0 110.369 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 44' ' ' GLU . 11.1 mptt -84.72 1.05 48.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.096 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 47' ' ' PHE . 7.0 tt -19.33 -46.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 1.069 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -68.48 -54.61 15.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.711 0.291 . . . . 0.0 110.857 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.491 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -70.09 -37.59 75.45 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -60.2 -56.59 19.72 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.846 0.832 . . . . 0.0 109.861 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -41.76 -60.7 1.79 Allowed Pre-proline 0 C--N 1.352 0.693 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.31 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 1.069 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 29.2 Cg_exo -63.16 -25.18 72.73 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 121.617 1.544 . . . . 0.0 113.426 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -82.17 -35.57 28.23 Favored 'General case' 0 C--O 1.255 1.37 0 CA-C-O 122.171 0.986 . . . . 0.0 111.08 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.433 HG22 ' CZ2' ' A' ' 10' ' ' TRP . 29.2 m -77.78 -39.71 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.504 0 CA-C-O 122.04 0.924 . . . . 0.0 109.089 178.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.429 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -49.38 -37.82 26.35 Favored 'General case' 0 C--N 1.373 1.615 0 C-N-CA 126.048 1.739 . . . . 0.0 110.85 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.95 -42.4 21.33 Favored 'General case' 0 C--N 1.371 1.512 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.967 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 55' ' ' ASP . 1.2 m -73.69 145.93 44.87 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.578 1.081 . . . . 0.0 108.893 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 64.97 -78.35 0.07 OUTLIER Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 1.4 t0 85.39 56.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 117.613 0.707 . . . . 0.0 111.672 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.561 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . -156.07 47.4 0.49 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 119.967 -1.111 . . . . 0.0 114.449 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 56' ' ' GLY . 43.1 Cg_endo -100.15 -169.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.184 2.589 . . . . 0.0 112.093 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.98 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 4.1 t70 -88.24 -135.52 0.09 Allowed 'General case' 0 N--CA 1.414 -2.242 0 C-N-CA 123.123 0.569 . . . . 0.0 110.543 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' A' ' 266' ' ' ILE . 20.8 tt -103.08 163.67 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 265' ' ' GLY . 10.3 pt -130.17 128.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.427 ' CE2' ' HB1' ' A' ' 264' ' ' ALA . 4.0 m-85 -107.17 124.33 49.55 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.454 ' CZ3' ' CB ' ' A' ' 66' ' ' ARG . 8.3 t90 -167.44 161.38 13.93 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -49.09 160.8 0.18 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.137 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.577 ' HB2' ' HB ' ' A' ' 261' ' ' VAL . 22.1 t-80 -77.56 -28.69 51.84 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.82 -58.85 3.82 Favored 'General case' 0 C--O 1.251 1.173 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.454 ' CB ' ' CZ3' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -75.49 -30.46 59.88 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.32 0.581 . . . . 0.0 110.038 179.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 2.2 m-30 -62.52 -27.08 68.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 174.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -60.82 -66.21 2.83 Favored Glycine 0 CA--C 1.49 -1.496 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.15 -53.66 43.84 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 113.218 -1.491 . . . . 0.0 111.256 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.9 m-30 -51.4 -42.84 61.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -54.58 -39.33 67.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.74 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -78.79 -43.14 26.08 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 111.666 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -70.22 -14.86 62.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.91 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.6 29.62 8.63 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.656 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.1 mp -106.69 39.89 1.75 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.995 0.426 . . . . 0.0 110.424 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.37 145.4 0.25 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.366 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.1 115.3 27.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.969 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -47.68 129.68 13.96 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.652 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 14.6 mt -95.95 110.21 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.752 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.8 p -88.82 101.41 2.85 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.964 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 83.3 Cg_endo -101.24 -170.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.61 2.873 . . . . 0.0 113.161 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.19 -169.9 2.75 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.257 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.71 -44.08 7.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.532 0.206 . . . . 0.0 111.454 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -74.83 -23.54 58.47 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.423 ' CE1' HD23 ' A' ' 285' ' ' LEU . 6.5 t80 -64.62 -59.22 4.53 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.506 ' HG3' ' CG ' ' A' ' 94' ' ' TRP . 3.0 tt0 -70.13 -29.49 66.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.808 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.82 -12.88 60.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.9 OUTLIER -87.81 -7.66 56.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 304' ' ' LEU . 3.3 mp -100.91 -101.23 0.25 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.158 0.89 . . . . 0.0 111.584 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.415 ' CE1' ' HE3' ' A' ' 321' ' ' MET . 0.2 OUTLIER -145.19 133.18 10.56 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 122.102 -0.374 . . . . 0.0 111.056 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.0 -52.97 7.61 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.66 2.24 . . . . 0.0 112.934 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 325' ' ' GLN . 45.2 t80 -55.53 -44.53 76.79 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.704 0.288 . . . . 0.0 111.08 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 107' ' ' PRO . 29.8 m -61.27 -29.04 69.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.506 ' CG ' ' HG3' ' A' ' 86' ' ' GLN . 86.3 m95 -92.97 -24.1 18.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.508 0.67 . . . . 0.0 112.136 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -73.82 -24.09 59.74 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.433 ' CB ' ' CG2' ' A' ' 261' ' ' VAL . . . -65.76 -21.66 66.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.271 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.472 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 6.7 p -125.28 58.03 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 102' ' ' LYS . 26.6 ttt180 -124.84 100.93 6.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -89.07 90.9 8.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.169 0.44 . . . . 0.0 110.426 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 42.72 66.35 0.78 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.709 0.29 . . . . 0.0 110.87 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.22 38.98 58.67 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.593 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 103' ' ' LEU . 4.7 mmtt -139.84 -177.61 5.05 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 119.446 -0.312 . . . . 0.0 110.792 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 97' ' ' VAL . 0.3 OUTLIER 175.34 107.85 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.601 0.637 . . . . 0.0 109.661 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.43 ' CG2' ' HB1' ' A' ' 71' ' ' ALA . 3.6 tt -100.96 37.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.441 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 264' ' ' ALA . . . 170.21 149.14 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.511 ' O ' ' N ' ' A' ' 264' ' ' ALA . 12.7 m-30 -88.2 120.3 70.53 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.491 ' HB3' ' CG1' ' A' ' 261' ' ' VAL . 2.9 Cg_endo -78.94 155.28 26.36 Favored 'Trans proline' 0 CA--C 1.514 -0.478 0 C-N-CA 121.917 1.745 . . . . 0.0 112.847 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 262' ' ' LEU . 0.5 OUTLIER -157.11 38.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.142 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.676 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . . . 170.23 134.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.937 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.518 HG23 HG21 ' A' ' 320' ' ' THR . 17.2 m -114.8 133.74 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.936 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.595 ' HB2' ' HA3' ' A' ' 260' ' ' GLY . 0.6 OUTLIER -99.57 136.1 40.0 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 320' ' ' THR . . . -167.97 -173.68 2.15 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 123.411 1.577 . . . . 0.0 110.307 -167.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 156' ' ' PHE . 0.1 OUTLIER -146.12 135.57 23.02 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 110.598 -3.001 . . . . 0.0 116.246 -176.068 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.09 165.17 23.84 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.051 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.421 HD12 ' CH2' ' A' ' 129' ' ' TRP . 6.2 tp -93.21 130.79 38.78 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.424 ' CG2' ' CG2' ' A' ' 225' ' ' THR . 0.0 OUTLIER -115.25 136.16 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.169 -179.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.412 ' CE2' ' OG1' ' A' ' 245' ' ' THR . 14.1 m-85 -121.48 140.83 51.67 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -86.1 122.0 29.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -106.2 29.06 7.1 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.956 0.407 . . . . 0.0 111.515 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -131.43 -51.05 1.0 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.23 -136.89 0.02 OUTLIER 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.249 -1.796 . . . . 0.0 107.685 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.413 ' O ' ' CB ' ' A' ' 223' ' ' ALA . 2.0 mt -84.45 128.93 59.62 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -56.28 161.78 8.68 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.374 2.716 . . . . 0.0 110.997 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.44 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 8.4 p-10 -106.36 158.21 33.15 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.631 0.253 . . . . 0.0 111.042 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 19.9 Cg_endo -60.26 164.4 12.77 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.4 2.066 . . . . 0.0 111.833 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.404 ' HB2' ' HG3' ' A' ' 127' ' ' LYS . 4.0 Cg_exo -77.39 -42.35 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.801 2.334 . . . . 0.0 112.726 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 126' ' ' PRO . 2.8 mttp -153.49 -10.72 0.15 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' A' ' 130' ' ' GLU . 6.1 t -119.45 139.56 51.86 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.802 1.183 . . . . 0.0 112.961 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.447 ' O ' ' CG1' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -69.25 -23.76 63.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 172.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.486 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -44.82 -23.89 0.17 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.83 -26.4 66.91 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.575 HG13 ' CD ' ' A' ' 133' ' ' PRO . 0.2 OUTLIER -40.47 -53.06 5.76 Favored Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.804 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 6.6 Cg_endo -48.82 -43.83 33.59 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 120.699 0.933 . . . . 0.0 110.049 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.68 -58.6 3.19 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.424 ' O ' HD13 ' A' ' 139' ' ' LEU . 32.7 tp -66.32 -40.41 89.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.208 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 3.3 m-20 -70.74 -35.7 72.79 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.804 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -47.69 -50.23 25.52 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.455 176.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.87 -40.48 95.52 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.337 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 145' ' ' SER . 0.4 OUTLIER -61.79 -48.44 80.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -48.07 -43.9 30.94 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.02 -27.8 1.02 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -58.95 1.83 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.285 0.564 . . . . 0.0 110.239 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.81 40.19 0.02 OUTLIER Glycine 0 CA--C 1.519 0.319 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.299 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.48 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -152.83 -171.81 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 119.298 1.549 . . . . 0.0 111.501 -175.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.482 ' N ' HD22 ' A' ' 139' ' ' LEU . 5.0 m -138.76 158.24 44.6 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 139' ' ' LEU . . . -73.35 -33.34 65.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 224' ' ' MET . 3.1 pp -135.38 129.23 33.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.4 ' N ' ' CG2' ' A' ' 222' ' ' THR . 0.0 OUTLIER -133.4 134.91 44.25 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.092 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 150' ' ' ASN . 21.4 p90 -172.31 177.18 3.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.511 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -36.53 164.93 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.366 0.416 . . . . 0.0 111.485 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 208' ' ' THR . 2.8 tm? -114.03 -57.71 2.24 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -104.47 34.59 3.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 116.166 -2.213 . . . . 0.0 114.693 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.802 ' O ' ' OG1' ' A' ' 157' ' ' THR . 0.0 OUTLIER -79.81 140.32 54.52 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 121.279 1.854 . . . . 0.0 113.391 -176.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.957 ' O ' ' N ' ' A' ' 156' ' ' PHE . 84.5 Cg_endo -77.88 -135.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.376 3.384 . . . . 0.0 104.322 175.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 1.152 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 1.4 m-85 28.93 -59.95 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.038 1.29 . . . . 0.0 113.643 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.957 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -85.41 -61.85 1.67 Allowed 'General case' 0 C--O 1.258 1.544 0 CA-C-N 118.777 0.717 . . . . 0.0 112.534 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.802 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 8.5 p -59.2 -40.67 86.48 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.181 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.695 ' O ' HG13 ' A' ' 161' ' ' ILE . 1.1 m95 -51.24 -55.53 27.86 Favored Pre-proline 0 C--N 1.353 0.733 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 1.152 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 78.1 Cg_exo -43.38 -44.31 10.46 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.598 2.199 . . . . 0.0 113.201 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 255' ' ' SER . 7.3 mp -63.6 -56.69 13.94 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.002 0.819 . . . . 0.0 110.388 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.695 HG13 ' O ' ' A' ' 158' ' ' TRP . 2.4 pp -53.72 -19.33 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.296 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.409 ' CB ' ' HB2' ' A' ' 256' ' ' LYS . . . -78.61 -22.03 47.63 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.254 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -41.87 -59.26 1.75 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.438 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 45.7 t0 -64.35 -14.26 55.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -175.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 134.06 20.26 0.85 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 118.73 -1.7 . . . . 0.0 116.525 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.51 160.14 41.38 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 119.064 1.432 . . . . 0.0 111.423 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -145.61 136.0 24.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.336 0.568 . . . . 0.0 110.374 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.418 ' HB2' ' CD1' ' A' ' 169' ' ' PHE . . . -54.2 -80.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.358 0.599 . . . . 0.0 111.765 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.614 ' HB2' ' CG ' ' A' ' 176' ' ' TYR . 14.5 m-85 -113.13 173.8 6.21 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.576 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 1.184 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 6.5 mmtt -100.48 103.75 15.11 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.485 ' CD2' ' CE1' ' A' ' 176' ' ' TYR . 0.4 OUTLIER -85.04 115.25 22.75 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.586 176.262 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.886 ' O ' ' N ' ' A' ' 174' ' ' GLY . 1.1 tp10 -137.28 101.67 4.59 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.056 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.0 m120 44.42 -66.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 O-C-N 123.619 0.575 . . . . 0.0 110.656 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.886 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -70.66 -73.35 0.79 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 115.664 -0.698 . . . . 0.0 114.346 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -174.66 158.04 2.64 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 117.994 0.897 . . . . 0.0 110.677 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 1.184 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -56.29 -33.66 65.73 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.33 1.062 . . . . 0.0 108.256 177.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 1.0 OUTLIER 67.94 -85.71 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.862 179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 6.7 tp 175.02 -41.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -10.55 44.6 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.43 ' CB ' ' HB2' ' A' ' 170' ' ' LYS . 2.1 m-20 -124.56 93.75 3.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.58 121.54 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -123.23 39.72 2.16 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.698 -1.239 . . . . 0.0 113.959 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 188' ' ' ALA . 12.8 p -80.2 -44.14 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.028 0.442 . . . . 0.0 109.982 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.551 ' CB ' ' HB2' ' A' ' 361' ' ' LEU . 9.4 t70 -81.27 59.08 3.8 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.758 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -104.76 173.2 6.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.464 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.19 -28.11 62.54 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.352 0.596 . . . . 0.0 111.571 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -71.31 -45.97 44.79 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.09 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -60.41 -44.79 95.37 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -57.8 -60.01 4.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.325 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.37 -40.94 50.88 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.088 0.947 . . . . 0.0 112.017 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -62.88 -60.65 7.39 Favored Glycine 0 C--O 1.24 0.485 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.086 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.6 tp -59.49 -25.05 64.12 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 99.0 m -60.74 -50.2 74.42 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.499 ' CZ ' ' CE1' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -59.85 -37.26 78.76 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 tp -63.28 -47.58 81.75 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.631 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 44.6 t -57.68 -28.76 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.508 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.11 -45.62 80.49 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.855 0.836 . . . . 0.0 111.039 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.3 tt -59.46 -51.95 67.67 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.851 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 204' ' ' MET . 6.6 mt -66.62 -40.25 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.96 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -52.68 -36.91 57.94 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.626 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -113.18 -34.57 5.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 121.157 3.762 . . . . 0.0 121.157 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -63.73 -80.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.967 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.08 -9.67 27.58 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 4.8 ptt? 42.15 36.24 0.68 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 206' ' ' ALA . 0.7 OUTLIER -145.16 -73.34 0.25 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . 84.41 37.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -97.74 -3.08 39.79 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.566 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 34.8 p -55.08 117.19 3.25 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.97 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.91 -173.64 4.17 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.3 p90 -70.63 -45.28 65.49 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 1.7 t -73.72 -32.73 64.03 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.711 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.75 -48.66 23.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.74 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.01 -32.19 70.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.06 -45.36 92.57 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.75 -40.73 84.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.959 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.21 -57.09 10.72 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.09 -29.52 69.87 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.69 -37.45 58.93 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.443 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -74.24 -23.89 59.22 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.04 53.63 5.65 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 114.7 0.64 . . . . 0.0 114.7 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -124.5 37.64 4.36 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.35 1.075 . . . . 0.0 111.609 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 145' ' ' SER . 2.2 m -142.22 140.9 32.45 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 122' ' ' LEU . . . -113.13 38.79 2.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.618 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.699 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER 178.85 126.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 177.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.424 ' CG2' ' CG2' ' A' ' 116' ' ' ILE . 1.8 t -147.16 165.99 28.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.433 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.485 ' CG2' ' CE1' ' A' ' 156' ' ' PHE . 0.1 OUTLIER -100.49 146.02 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 172.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -146.4 166.33 26.68 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.182 1.355 . . . . 0.0 109.953 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 112' ' ' ALA . . . -176.11 130.41 1.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.294 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.67 -29.66 3.59 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.846 2.364 . . . . 0.0 113.219 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.41 ' HA ' ' CG ' ' A' ' 111' ' ' GLU . 29.7 t-105 -33.66 -72.87 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.94 -41.9 8.18 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.24 166.53 18.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.907 0.384 . . . . 0.0 111.714 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 t -124.49 -62.07 1.28 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.52 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -99.32 139.69 34.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.691 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 242' ' ' TYR . 25.4 pt -84.07 173.7 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.283 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.17 176.15 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.722 0.296 . . . . 0.0 110.995 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.05 83.43 0.33 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.965 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' SER . . . . . 0.405 ' O ' ' CE1' ' A' ' 242' ' ' TYR . 41.2 t -129.77 70.51 1.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.786 0.327 . . . . 0.0 110.682 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.429 ' O ' ' CZ ' ' A' ' 242' ' ' TYR . 0.0 OUTLIER 65.83 109.72 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.607 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.43 ' O ' ' CD2' ' A' ' 242' ' ' TYR . 58.4 t -45.29 -34.66 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.854 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -79.76 107.23 12.37 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.69 0.281 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 240' ' ' VAL . 48.0 m-85 -118.46 134.04 55.39 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.245 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.96 105.25 2.3 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.202 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.0 t -90.96 111.59 23.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.412 ' OG1' ' CE2' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -129.78 167.41 18.12 Favored 'General case' 0 CA--C 1.527 0.067 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.1 m -73.36 153.66 7.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.26 159.04 16.74 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 119.784 1.175 . . . . 0.0 111.414 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.419 ' HD3' ' CD1' ' A' ' 115' ' ' LEU . 90.4 Cg_endo -79.51 -165.08 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.035 2.49 . . . . 0.0 112.496 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -119.27 175.58 5.73 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.929 0.395 . . . . 0.0 111.763 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.499 ' CE1' ' CZ ' ' A' ' 194' ' ' PHE . 98.0 m-85 -166.13 111.05 0.82 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.957 0.884 . . . . 0.0 108.811 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 7.8 mttp 62.43 31.09 17.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.809 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.0 31.14 40.12 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.302 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -156.59 153.03 23.84 Favored Pre-proline 0 N--CA 1.463 0.179 0 CA-C-N 117.381 0.59 . . . . 0.0 112.251 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -87.88 170.36 6.25 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.209 2.606 . . . . 0.0 112.189 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -91.03 144.34 25.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.803 0.335 . . . . 0.0 111.411 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 2.2 mttt -86.58 108.3 17.42 Favored Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.066 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 255' ' ' SER . 88.2 Cg_endo -79.55 153.35 23.5 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.273 1.982 . . . . 0.0 112.717 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 2.5 t80 -79.19 164.39 24.24 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.42 ' CB ' HG21 ' A' ' 329' ' ' ILE . 15.5 t -121.8 127.56 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 111' ' ' GLU . . . -123.69 117.79 3.28 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 119.257 -1.449 . . . . 0.0 115.871 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -103.87 115.31 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.527 179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.676 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 1.5 mm? -94.22 93.63 7.87 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -111.28 -177.71 3.27 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -172.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 105' ' ' ALA . . . -108.67 128.31 54.74 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 60' ' ' ILE . . . -122.87 127.8 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.82 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.501 ' HA ' HG13 ' A' ' 59' ' ' ILE . 24.7 mt -87.84 121.48 38.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.65 142.9 56.88 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.35 -26.46 61.02 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.149 -0.345 . . . . 0.0 110.78 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.482 ' CB ' ' CD ' ' A' ' 57' ' ' PRO . . . -50.82 -59.89 3.64 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.921 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 19.2 p -135.64 154.11 77.95 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.728 0.299 . . . . 0.0 111.413 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -88.58 -66.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.054 2.503 . . . . 0.0 112.735 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 55.4 45.77 24.67 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 110.125 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 2.0 ttpt -60.32 -54.19 48.7 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.782 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 24.6 tp10 -50.2 -57.6 7.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.902 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.411 HD13 ' CD2' ' A' ' 27' ' ' PHE . 10.0 tp -64.93 -58.09 7.06 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.98 -56.69 5.65 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.2 OUTLIER -54.22 -38.55 65.83 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 1.9 tp10 -76.34 -53.14 8.6 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -56.17 -56.36 21.91 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.611 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.499 ' O ' ' CB ' ' A' ' 284' ' ' LEU . 7.2 tt -52.32 -43.91 64.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.675 0.75 . . . . 0.0 111.67 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -73.2 -34.27 65.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.651 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -91.57 -14.71 29.82 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.625 ' O ' HG22 ' A' ' 286' ' ' THR . 0.2 OUTLIER -102.45 -65.49 0.99 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.707 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 6.3 tp -43.2 -22.7 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.601 -0.44 . . . . 0.0 112.097 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 85' ' ' PHE . 3.8 mm? -101.37 37.38 1.8 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.002 -0.436 . . . . 0.0 110.721 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 283' ' ' TYR . 11.3 t -145.01 158.72 43.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 4.4 p30 -65.97 -11.66 49.3 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.603 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 5.5 tp10 -77.89 -47.12 19.47 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 109.993 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 293' ' ' VAL . . . -82.64 -49.49 5.11 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 284' ' ' LEU . 8.4 mt -61.75 -51.24 69.17 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.631 0.254 . . . . 0.0 111.383 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.509 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 2.9 tp10 -76.08 -27.9 57.37 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.059 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.603 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -71.57 -27.73 63.35 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.713 ' HA ' ' CB ' ' A' ' 297' ' ' LYS . 1.1 t -65.72 -61.0 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.798 175.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.505 ' N ' HG12 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -35.02 -50.31 0.49 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.313 1.445 . . . . 0.0 112.323 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 296' ' ' ASP . 20.2 ttpt -48.79 -43.9 38.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.254 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 295' ' ' LYS . 2.6 m-20 154.41 68.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.721 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.831 ' H ' ' HD2' ' A' ' 298' ' ' PRO . 0.5 OUTLIER -120.75 -37.95 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.023 171.293 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.831 ' HD2' ' H ' ' A' ' 297' ' ' LYS . 0.1 OUTLIER -91.61 -120.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 124.761 3.641 . . . . 0.0 113.283 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.448 ' CB ' ' HG ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -160.78 -41.38 0.05 OUTLIER 'General case' 0 C--N 1.356 0.883 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.559 ' N ' ' HB2' ' A' ' 109' ' ' ALA . . . -129.08 -155.59 8.6 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.56 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.551 ' O ' HG13 ' A' ' 317' ' ' ILE . . . -133.25 48.15 2.42 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.115 0.958 . . . . 0.0 112.46 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.483 ' CG2' HG22 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -140.78 92.26 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.686 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 304' ' ' LEU . . . 177.69 48.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER 158.48 99.11 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.314 0.246 . . . . 0.0 111.42 178.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -38.37 -32.64 0.08 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 20.0 m -78.66 -44.22 24.25 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.473 1.13 . . . . 0.0 109.572 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.584 ' CZ ' HD12 ' A' ' 311' ' ' LEU . 19.6 t80 -70.57 -20.03 62.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 112.87 -1.968 . . . . 0.0 110.249 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 312' ' ' ALA . 7.9 tp10 -76.28 -43.14 43.02 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.0 -58.6 5.67 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.724 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -54.09 -52.9 59.49 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.246 0.546 . . . . 0.0 110.5 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.584 HD12 ' CZ ' ' A' ' 307' ' ' TYR . 2.3 tt -70.91 -28.04 64.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.932 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 313' ' ' LYS . . . -45.92 -20.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -34.19 -42.67 0.13 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.543 0.61 . . . . 0.0 109.704 178.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -88.76 121.7 69.7 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.58 9.51 1.87 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.591 2.194 . . . . 0.0 115.467 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.446 ' O ' ' OG1' ' A' ' 320' ' ' THR . 5.6 mtm-85 -60.23 -59.82 4.81 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.706 0.684 . . . . 0.0 111.256 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.561 ' HA ' ' HB ' ' A' ' 320' ' ' THR . 5.2 mm -49.76 -55.35 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.68 -52.05 11.43 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.38 0.536 . . . . 0.0 111.757 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -71.66 -33.42 68.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.543 0.687 . . . . 0.0 109.351 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.671 ' HA ' ' HB1' ' A' ' 112' ' ' ALA . 94.6 m -62.02 -37.06 83.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.387 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.426 ' HG2' ' CD2' ' A' ' 92' ' ' PHE . 5.6 ttm -79.03 -44.93 21.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.693 0.282 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -54.0 -45.91 71.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.221 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.3 -51.95 9.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.226 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.416 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . . . -48.64 -33.82 10.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.694 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . 0.454 ' HA ' ' CE1' ' A' ' 92' ' ' PHE . 0.2 OUTLIER -63.33 -39.94 95.94 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.51 0.195 . . . . 0.0 110.998 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -104.74 60.67 0.7 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.595 0.236 . . . . 0.0 111.08 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -140.71 -147.18 4.91 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.12 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -127.32 111.77 14.29 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.42 HG21 ' CB ' ' A' ' 259' ' ' VAL . 1.8 pp -87.15 134.11 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.432 ' HG2' ' CE2' ' A' ' 258' ' ' PHE . 0.0 OUTLIER -41.03 105.33 0.38 Allowed Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.413 ' HD2' ' CE ' ' A' ' 330' ' ' MET . 96.2 Cg_exo -43.9 -34.89 6.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.676 2.251 . . . . 0.0 112.603 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.5 m120 79.06 51.3 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.478 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 4.0 pt -133.82 156.65 79.19 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.804 0.335 . . . . 0.0 111.143 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.71 -31.51 39.8 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.636 2.224 . . . . 0.0 112.76 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 338' ' ' ALA . 8.9 mm100 -59.85 -21.83 61.48 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 12.0 tpp -45.56 -36.7 4.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.589 0.233 . . . . 0.0 111.372 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 2.1 p -58.1 -38.88 77.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.698 0.285 . . . . 0.0 110.348 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . 0.422 ' CB ' ' CD1' ' A' ' 368' ' ' ILE . . . -55.6 -33.37 63.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.962 0.411 . . . . 0.0 111.307 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.51 -55.83 4.91 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.499 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.41 ' CE3' ' HA ' ' A' ' 340' ' ' TRP . 0.1 OUTLIER -44.33 -43.0 7.18 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.795 0.331 . . . . 0.0 111.025 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.99 -42.77 56.89 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.692 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.27 -45.84 72.03 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.471 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 9.9 p -69.62 -42.06 80.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.439 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.414 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -58.55 -59.29 5.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.698 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 9.8 m -56.39 -56.7 17.84 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -69.83 -60.83 2.06 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 48.5 t -54.56 -53.45 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 349' ' ' ASN . 1.9 tt -62.31 -46.68 95.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.031 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.419 ' N ' ' CG2' ' A' ' 348' ' ' ILE . 64.8 t-20 -64.64 -47.7 77.56 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 355' ' ' GLN . . . -73.37 -26.65 61.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -53.22 -11.26 0.26 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.3 p -110.46 36.77 2.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.585 0.63 . . . . 0.0 110.088 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.53 -3.42 87.06 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 118.711 -1.709 . . . . 0.0 113.691 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -87.3 34.92 0.69 Allowed 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 115.65 -2.119 . . . . 0.0 107.886 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.569 ' HA ' ' CB ' ' A' ' 350' ' ' ALA . 2.9 pp0? -71.17 -173.71 0.89 Allowed 'General case' 0 C--N 1.348 0.543 1 N-CA-C 123.34 4.57 . . . . 0.0 123.34 -159.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.498 ' HB ' ' CB ' ' A' ' 359' ' ' GLU . 0.0 OUTLIER -179.62 46.8 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.54 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.415 ' CG1' ' OD2' ' A' ' 184' ' ' ASP . 84.3 t -42.27 -49.85 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.863 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.615 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -61.33 -35.04 76.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 119.948 1.249 . . . . 0.0 109.611 178.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.498 ' CB ' ' HB ' ' A' ' 356' ' ' THR . 1.5 mm-40 -79.18 -26.97 42.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.441 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 356' ' ' THR . . . -66.8 -53.26 34.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 122.085 0.945 . . . . 0.0 111.824 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 184' ' ' ASP . 0.2 OUTLIER -82.24 -50.48 8.94 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.787 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 2.3 mmpt? -45.18 -53.04 8.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -65.13 -41.42 94.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.402 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.5 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -66.52 -58.19 5.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.611 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.505 ' HB2' HD12 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -62.16 -44.32 96.87 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.984 -0.447 . . . . 0.0 111.969 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 362' ' ' LYS . 52.7 p -56.24 -59.79 4.43 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -51.57 25.65 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.511 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 364' ' ' ALA . 32.8 mm -60.47 -42.84 92.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 369' ' ' THR . 1.3 p -114.15 55.63 0.73 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.917 0.389 . . . . 0.0 111.103 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.828 179.759 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.67 0.271 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -145.01 173.91 11.48 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.91 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -111.31 68.3 0.22 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.493 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.0 159.04 44.58 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -156.12 118.37 4.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.52 ' HB ' ' HA ' ' A' ' 58' ' ' ASP . 15.3 t -108.72 140.47 27.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 118.771 -1.172 . . . . 0.0 110.003 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 10.3 tt -136.51 124.74 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.402 0.62 . . . . 0.0 111.122 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CZ2' ' HB2' ' A' ' 43' ' ' LEU . 30.7 t90 -101.46 133.32 46.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.226 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -149.18 165.09 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.488 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 9.4 p30 -91.85 61.64 4.17 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.543 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.75 41.47 57.84 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.059 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 58.4 t0 -50.35 -31.66 15.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 111.438 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 105.15 -18.06 0.02 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.246 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.421 ' HA2' ' CG ' ' A' ' 296' ' ' ASP . . . -75.48 56.42 2.9 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 115.921 1.129 . . . . 0.0 115.921 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -75.96 -31.8 59.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.495 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 1.4 t30 -67.98 -47.14 69.37 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.152 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.14 -49.16 22.5 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.739 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.548 ' O ' HG13 ' A' ' 23' ' ' VAL . 20.7 mt -60.02 -51.03 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.394 0.597 . . . . 0.0 110.202 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.37 -37.08 84.48 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.591 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 9.6 tt0 -67.02 -37.44 84.14 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.449 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 20' ' ' LEU . 2.7 p -68.0 -61.03 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.14 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' HA3' ' CG1' ' A' ' 35' ' ' VAL . . . -49.12 -33.03 13.59 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.803 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -50.5 72.68 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 122.481 1.134 . . . . 0.0 108.418 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 21.8 mttt -51.81 -41.2 61.56 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 112.865 -1.971 . . . . 0.0 108.202 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.689 ' HB3' ' CB ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.84 -35.9 81.97 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.915 0.864 . . . . 0.0 111.052 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.768 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 5.1 tt0 -69.78 -50.63 41.31 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.331 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -51.23 -30.27 16.93 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 124.909 1.381 . . . . 0.0 111.25 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.641 ' O ' ' CG2' ' A' ' 31' ' ' THR . 1.5 t70 -82.72 -39.15 22.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 116.921 -1.514 . . . . 0.0 108.872 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.641 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 162.29 37.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 116.616 -2.033 . . . . 0.0 116.35 170.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.521 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 155.5 38.58 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 115.428 -3.273 . . . . 0.0 117.354 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.768 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 4.1 mp -139.31 100.94 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 121.09 2.445 . . . . 0.0 114.86 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -107.21 105.24 15.12 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 7.8 m -97.14 132.75 40.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.05 146.67 45.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.315 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -133.22 122.74 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 122.199 -0.313 . . . . 0.0 110.687 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -107.19 137.24 45.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.945 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.488 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -71.56 -177.9 0.54 Allowed Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.392 0.677 . . . . 0.0 111.912 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 30.7 Cg_endo -91.96 -172.67 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.302 2.668 . . . . 0.0 113.757 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 40' ' ' PRO . 9.8 t70 144.81 -72.29 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.862 0.865 . . . . 0.0 109.39 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -108.4 1.05 21.46 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.716 178.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 2.2 tp -19.37 -56.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.996 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 2.1 tm-20 -60.42 -55.11 37.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.53 -55.46 5.65 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.581 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -55.49 -57.96 9.74 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.923 -178.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.615 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -49.62 -57.72 11.28 Favored Pre-proline 0 C--N 1.353 0.76 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.25 -177.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.996 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 24.6 Cg_exo -62.76 -21.2 72.81 Favored 'Trans proline' 0 C--O 1.252 1.2 0 CA-C-N 121.6 1.607 . . . . 0.0 112.325 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -81.97 -39.72 23.25 Favored 'General case' 0 C--O 1.258 1.529 0 CA-C-O 122.561 1.172 . . . . 0.0 111.711 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 47' ' ' PHE . 17.1 m -77.93 -40.71 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.552 0 CA-C-O 122.247 1.023 . . . . 0.0 110.536 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.502 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -49.68 -37.88 30.56 Favored 'General case' 0 C--N 1.378 1.831 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.438 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.18 -33.57 32.92 Favored 'General case' 0 C--N 1.368 1.403 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.437 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.0 p -65.62 -41.06 93.15 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.186 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 55' ' ' ASP . . . -114.69 -70.73 0.51 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.458 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 5.8 m-20 89.02 47.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.851 0.826 . . . . 0.0 109.888 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.11 175.94 21.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 120.531 -0.842 . . . . 0.0 114.642 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 58' ' ' ASP . 82.4 Cg_exo -43.86 131.98 8.05 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.567 2.845 . . . . 0.0 111.909 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 2.0 p30 158.2 125.96 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' A' ' 265' ' ' GLY . 1.8 pt -117.15 178.38 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.506 HG22 ' HB3' ' A' ' 10' ' ' TRP . 2.7 pt -149.29 136.7 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.443 ' CG ' ' O ' ' A' ' 263' ' ' SER . 4.7 t80 -109.99 122.76 48.31 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.469 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 23.2 t-105 -166.75 166.37 15.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -45.35 158.73 0.07 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.63 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.595 ' CG ' ' CG1' ' A' ' 97' ' ' VAL . 4.5 t-80 -77.27 -27.09 53.02 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.467 ' HA ' ' HG3' ' A' ' 331' ' ' PRO . 9.9 p30 -53.34 -52.99 57.43 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-O 121.808 0.813 . . . . 0.0 111.893 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.604 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 18.9 mmm180 -73.4 -31.77 64.07 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.446 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.539 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 6.2 m-30 -60.26 -32.72 71.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 174.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -54.69 -66.87 2.5 Favored Glycine 0 C--O 1.25 1.152 0 CA-C-O 123.038 1.355 . . . . 0.0 111.616 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 70' ' ' TYR . . . -78.54 -55.67 3.86 Favored Glycine 0 C--N 1.357 1.73 0 CA-C-N 113.095 -1.553 . . . . 0.0 112.734 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.999 ' O ' ' N ' ' A' ' 75' ' ' LEU . 6.9 m-30 -42.01 -37.37 1.34 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.639 ' CB ' ' HB3' ' A' ' 76' ' ' LEU . . . -73.37 -58.76 3.09 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 117.852 -1.539 . . . . 0.0 112.432 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -46.96 68.35 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.434 1.016 . . . . 0.0 112.72 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 p -114.58 25.72 10.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.2 -87.48 0.06 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 118.539 -1.791 . . . . 0.0 114.909 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.999 ' N ' ' O ' ' A' ' 70' ' ' TYR . 1.2 tp -155.32 97.22 1.88 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.639 ' HB3' ' CB ' ' A' ' 71' ' ' ALA . 1.2 tp 179.33 144.36 0.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.068 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.608 ' O ' ' CD1' ' A' ' 266' ' ' ILE . . . -95.68 109.42 21.7 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.475 ' HA ' HG12 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -49.07 103.27 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -61.91 173.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.128 0.489 . . . . 0.0 111.193 -179.047 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.404 ' CB ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -88.06 175.38 4.22 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.086 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 80' ' ' THR . 79.1 Cg_endo -79.55 133.18 10.38 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.336 2.024 . . . . 0.0 113.629 -178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -152.87 68.06 0.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.323 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -47.36 -32.27 4.71 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -47.71 -29.03 2.75 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.462 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 1.3 m-85 -74.71 -59.32 2.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.805 0.335 . . . . 0.0 111.19 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.476 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 8.2 tm0? -70.36 -24.48 62.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -76.04 -43.89 41.76 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -11.07 59.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.426 HD22 ' CE3' ' A' ' 94' ' ' TRP . 0.3 OUTLIER -105.57 -170.61 1.77 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.976 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -78.19 145.96 69.99 Favored Pre-proline 0 C--O 1.232 0.154 0 CA-C-O 120.649 0.261 . . . . 0.0 110.543 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 95' ' ' ASP . 53.1 Cg_endo -69.75 -39.74 6.17 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.479 2.119 . . . . 0.0 112.596 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.415 ' CD1' ' HB2' ' A' ' 325' ' ' GLN . 1.9 m-85 -59.74 -57.34 13.35 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -28.06 68.81 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.476 ' CE3' ' HA ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -93.68 -22.86 18.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 91' ' ' PRO . 15.8 t0 -71.64 -24.69 61.91 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.949 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.476 ' HA ' HG12 ' A' ' 329' ' ' ILE . . . -69.0 -23.38 64.09 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.595 ' CG1' ' CG ' ' A' ' 64' ' ' HIS . 22.9 m -122.37 48.76 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.159 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -125.51 100.41 6.46 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 101' ' ' GLY . 3.6 m-85 -87.43 90.97 8.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.288 0.494 . . . . 0.0 110.197 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 48.14 -86.88 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.882 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . -132.67 42.15 1.41 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -145.48 -177.58 5.64 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 119.519 -0.277 . . . . 0.0 111.193 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.4 ' CG ' ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER 167.82 112.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.624 0.647 . . . . 0.0 110.617 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.587 ' CD1' ' O ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -98.67 38.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.479 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . 166.01 174.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -129.64 129.47 23.14 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.071 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' A' ' 263' ' ' SER . 3.6 Cg_exo -79.72 162.26 24.31 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.866 2.377 . . . . 0.0 112.416 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 262' ' ' LEU . 1.1 pt -156.15 38.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.092 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.774 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.614 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . . . -176.21 145.38 0.61 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.724 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.445 ' CG2' ' CB ' ' A' ' 324' ' ' ALA . 14.0 p -128.73 114.03 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.418 ' HG3' ' CD2' ' A' ' 230' ' ' TRP . 17.4 mm-40 -102.99 161.79 13.46 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.279 0.561 . . . . 0.0 109.749 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 320' ' ' THR . . . -165.25 147.24 7.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.758 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.485 ' CD1' ' HB2' ' A' ' 156' ' ' PHE . 3.0 tt -79.06 129.3 34.3 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.4 OUTLIER -135.12 159.65 40.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.412 ' CD2' ' CE2' ' A' ' 117' ' ' TYR . 7.2 tt -92.61 131.18 37.94 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.82 137.6 47.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.412 ' CE2' ' CD2' ' A' ' 115' ' ' LEU . 13.5 m-85 -106.07 133.38 50.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.62 ' HB3' ' CD2' ' A' ' 122' ' ' LEU . 14.8 m120 -88.58 125.9 35.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.559 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.33 -59.25 2.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.43 0.559 . . . . 0.0 112.209 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -38.31 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 122.426 1.108 . . . . 0.0 111.203 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.548 ' CD1' ' O ' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -102.82 42.42 1.15 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 112.739 -2.028 . . . . 0.0 112.442 -175.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.73 ' HG ' ' HA ' ' A' ' 223' ' ' ALA . 1.7 mm? -147.5 140.25 14.64 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 118.847 -1.141 . . . . 0.0 113.068 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.533 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 50.9 Cg_endo -90.97 163.51 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.789 1 C-N-CA 125.492 4.128 . . . . 0.0 113.493 -179.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -61.42 106.07 0.73 Allowed Pre-proline 0 N--CA 1.465 0.296 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.773 -174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 95.3 Cg_endo -99.0 168.27 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 124.882 3.721 . . . . 0.0 114.808 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 146' ' ' ALA . 35.8 Cg_exo -27.5 153.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 125.276 3.984 . . . . 0.0 116.19 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -135.81 -21.33 1.48 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.895 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.52 154.47 51.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -59.9 -53.93 52.13 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.137 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 133' ' ' PRO . 13.5 tt0 -45.45 -24.22 0.29 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -73.61 -28.2 61.69 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.574 ' O ' ' CB ' ' A' ' 136' ' ' ASP . 47.5 mt -42.11 -56.02 5.74 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 121.374 0.607 . . . . 0.0 112.215 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.582 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 2.7 Cg_endo -46.48 -38.61 21.47 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 120.565 0.843 . . . . 0.0 109.95 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.84 -59.99 2.51 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 1.4 mt -69.17 -33.12 72.9 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.212 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 1.038 ' HA ' ' CD1' ' A' ' 139' ' ' LEU . 10.0 t70 -68.32 -43.89 76.58 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -46.18 -49.2 17.24 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 118.208 -1.397 . . . . 0.0 110.079 177.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -63.73 -43.28 96.98 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.784 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 1.038 ' CD1' ' HA ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -52.94 -56.13 18.27 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -49.52 -44.01 46.04 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.704 0.764 . . . . 0.0 108.962 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -45.86 -26.0 0.61 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.29 -1.323 . . . . 0.0 114.343 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.21 -62.38 1.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.526 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.41 53.76 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.771 ' O ' ' CB ' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -172.44 -174.23 1.17 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.885 1.343 . . . . 0.0 109.769 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.768 ' HA ' HD12 ' A' ' 139' ' ' LEU . 8.6 t -144.81 150.27 36.88 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.786 0.435 . . . . 0.0 110.42 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.527 ' CB ' ' HD2' ' A' ' 126' ' ' PRO . . . -68.93 -22.99 64.12 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.509 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 224' ' ' MET . 0.7 OUTLIER -142.92 129.4 20.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -176.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.538 ' HB2' ' CG2' ' A' ' 222' ' ' THR . 0.3 OUTLIER -132.53 139.93 48.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.521 -0.871 . . . . 0.0 111.726 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 227' ' ' ASN . 3.7 t80 -172.48 175.57 3.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.698 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 149' ' ' PHE . 2.6 m-80 -38.76 161.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.931 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 208' ' ' THR . 3.2 mt -115.06 -50.35 2.76 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.19 34.48 3.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 116.04 -2.264 . . . . 0.0 113.897 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.724 ' O ' ' HB ' ' A' ' 157' ' ' THR . 17.9 mm-40 -79.49 145.75 64.2 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 121.6 2.0 . . . . 0.0 114.488 -175.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.993 ' O ' ' N ' ' A' ' 156' ' ' PHE . 5.8 Cg_exo -78.05 -135.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 1 C-N-CA 125.55 4.167 . . . . 0.0 106.242 176.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 1.117 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 36.0 m-85 16.15 -49.75 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.993 ' N ' ' O ' ' A' ' 154' ' ' PRO . 10.4 t80 -84.44 -60.03 2.2 Favored 'General case' 0 C--O 1.258 1.511 0 CA-C-N 119.406 1.003 . . . . 0.0 111.903 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.724 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -56.83 -42.61 79.94 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.458 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 2.3 m95 -51.61 -55.81 26.42 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 1.117 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 79.3 Cg_exo -43.19 -47.87 8.4 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.892 2.395 . . . . 0.0 113.065 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.9 mt -62.48 -56.81 14.59 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.072 0.851 . . . . 0.0 109.968 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 158' ' ' TRP . 20.6 pt -53.91 -18.01 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.904 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.06 -24.7 47.63 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.598 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -41.85 -56.71 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.539 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 1.8 m-20 -64.1 -39.34 93.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 119.211 0.914 . . . . 0.0 112.896 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 156.92 24.23 0.03 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 117.872 -2.109 . . . . 0.0 117.632 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.05 89.64 0.72 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-N 119.375 1.587 . . . . 0.0 112.633 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.493 ' O ' HG11 ' A' ' 183' ' ' VAL . 6.2 m-85 -73.68 158.58 34.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.29 0.545 . . . . 0.0 110.898 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.545 ' O ' HG11 ' A' ' 183' ' ' VAL . . . -61.28 -80.59 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.956 0.884 . . . . 0.0 111.604 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.767 ' HB2' ' CG ' ' A' ' 176' ' ' TYR . 58.5 m-85 -113.86 173.66 6.32 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.792 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 1.173 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -106.49 116.28 31.66 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.974 1.261 . . . . 0.0 107.729 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -78.75 113.22 16.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.456 176.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 1.4 tt0 -137.29 113.61 10.05 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.778 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 1.9 t-20 82.48 -32.33 0.09 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.848 0.356 . . . . 0.0 111.112 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 157.81 15.48 0.04 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.648 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.461 ' HA ' ' CE1' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -173.29 142.02 0.97 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.863 1.332 . . . . 0.0 110.391 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 1.173 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.6 m-85 -66.84 -25.11 66.27 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.506 1.146 . . . . 0.0 109.961 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.412 ' O ' ' CG2' ' A' ' 178' ' ' ILE . 18.6 t70 62.09 -85.7 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 112.793 -2.003 . . . . 0.0 111.51 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.412 ' CG2' ' O ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER 179.18 -54.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.426 ' HA ' ' HB ' ' A' ' 369' ' ' THR . 0.0 OUTLIER -51.17 -17.37 0.65 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.45 ' CB ' ' CB ' ' A' ' 170' ' ' LYS . 5.5 m-20 -117.27 94.99 4.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 119.68 1.127 . . . . 0.0 109.332 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.426 ' CG2' ' CG ' ' A' ' 365' ' ' GLN . 3.3 m -116.73 112.45 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -117.74 39.96 2.47 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.586 -1.292 . . . . 0.0 113.806 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.545 HG11 ' O ' ' A' ' 168' ' ' ALA . 1.8 m -79.09 -46.06 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.452 ' N ' ' CG2' ' A' ' 183' ' ' VAL . 18.5 t0 -81.49 57.25 3.22 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.08 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -102.77 177.93 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.345 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.48 -31.56 35.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.462 0.648 . . . . 0.0 111.429 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -74.91 -40.2 36.57 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.523 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 183' ' ' VAL . . . -61.38 -46.09 91.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 174.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.61 -60.62 3.52 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.08 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.23 -41.62 50.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.09 0.948 . . . . 0.0 111.768 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -65.9 -60.6 6.32 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.535 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -24.28 62.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.471 ' O ' HG13 ' A' ' 196' ' ' VAL . 23.5 m -63.99 -48.33 76.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 3.0 p90 -60.6 -35.22 75.58 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' A' ' 194' ' ' PHE . 4.5 mt -64.66 -47.64 77.73 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 193' ' ' THR . 0.5 OUTLIER -58.53 -28.33 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.18 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 196' ' ' VAL . 0.5 OUTLIER -63.77 -46.3 85.88 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.302 0.572 . . . . 0.0 110.229 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.409 ' CD1' HG23 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -62.93 -59.32 4.99 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.039 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 204' ' ' MET . 15.0 pt -54.14 -43.91 61.82 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -61.52 -34.26 75.21 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -89.95 2.31 55.24 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.96 -84.32 0.66 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.583 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.411 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.4 OUTLIER -120.73 -23.61 5.94 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 199' ' ' ILE . 0.3 OUTLIER 74.5 16.46 3.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.891 0.314 . . . . 0.0 110.645 -178.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -158.56 82.97 0.82 Allowed 'General case' 0 C--N 1.34 0.187 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.462 ' CA ' HD13 ' A' ' 151' ' ' LEU . . . -76.0 84.82 2.9 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -97.9 -2.77 39.97 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.272 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 89.4 m -56.66 121.1 8.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.95 -175.39 3.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -69.05 -45.36 70.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.138 0.495 . . . . 0.0 110.139 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.2 m -77.33 -25.53 51.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.613 0.72 . . . . 0.0 111.281 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -81.15 -50.82 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.801 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -53.46 -36.56 61.74 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.77 -46.16 89.32 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.05 -39.47 69.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.128 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.65 -56.98 13.98 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -60.52 -28.46 68.42 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.38 -43.41 75.13 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.286 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -23.98 59.18 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.71 45.09 78.43 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -109.44 37.19 2.68 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.86 1.33 . . . . 0.0 110.496 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.538 ' CG2' ' HB2' ' A' ' 148' ' ' MET . 0.6 OUTLIER -141.96 141.85 32.95 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.966 0.889 . . . . 0.0 109.166 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.73 ' HA ' ' HG ' ' A' ' 122' ' ' LEU . . . -103.16 38.66 1.71 Allowed 'General case' 0 C--N 1.345 0.391 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER 168.7 138.45 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.41 ' HB ' ' CD1' ' A' ' 149' ' ' PHE . 5.2 p -148.06 159.78 43.55 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 156' ' ' PHE . 3.1 mp -116.48 112.44 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 114' ' ' SER . 2.2 p-10 -147.53 165.09 31.37 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 118.94 -0.553 . . . . 0.0 112.15 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -129.3 149.7 18.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.799 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.49 69.75 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.557 2.171 . . . . 0.0 112.298 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.418 ' CD2' ' HG3' ' A' ' 111' ' ' GLU . 9.2 t-105 -159.02 -74.07 0.08 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.299 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.39 58.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.713 0.292 . . . . 0.0 110.997 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -152.07 95.7 2.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.256 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.9 m 53.2 176.28 0.02 OUTLIER 'General case' 0 C--O 1.231 0.079 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.339 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -109.24 94.99 5.33 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.632 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 12.6 tt -45.7 155.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.106 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.23 -171.29 0.09 Allowed 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.582 0.23 . . . . 0.0 110.501 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.9 m 67.02 35.55 4.59 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.707 0.289 . . . . 0.0 110.767 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 10.5 t -148.69 -62.06 0.24 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.544 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 14.9 mmtt -131.53 -85.97 0.49 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.402 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 2.7 p 158.38 -45.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -92.38 117.73 30.21 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.666 0.27 . . . . 0.0 111.266 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -149.29 129.86 13.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.428 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.99 176.21 54.74 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.668 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.3 t -146.55 113.16 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.557 0.678 . . . . 0.0 112.442 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.95 167.11 17.9 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -172.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.7 153.96 7.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.208 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.73 159.88 11.86 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 119.515 1.052 . . . . 0.0 110.996 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.49 -163.45 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 111.957 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -120.79 177.58 5.03 Favored 'General case' 0 CA--C 1.526 0.052 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 194' ' ' PHE . 46.4 m-85 -162.35 110.42 1.36 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.534 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.86 33.08 17.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.379 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.28 41.34 21.63 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.524 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.74 151.57 20.9 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.594 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 86.0 Cg_endo -86.51 -172.32 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.321 2.68 . . . . 0.0 111.891 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.422 ' HB2' ' CB ' ' A' ' 159' ' ' PRO . 10.2 p -108.57 148.33 30.47 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.4 OUTLIER -85.62 109.31 21.01 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.421 -178.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.489 ' HG2' ' O ' ' A' ' 323' ' ' ASN . 2.7 Cg_exo -79.36 149.45 21.7 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.305 2.67 . . . . 0.0 113.174 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.401 ' CB ' ' CD1' ' A' ' 155' ' ' TYR . 25.5 p90 -79.01 132.63 36.71 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 175.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.6 p -89.85 130.09 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -120.12 121.86 5.05 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 119.271 -1.442 . . . . 0.0 115.355 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -113.01 109.51 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.614 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 2.4 mm? -89.72 99.78 12.72 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 118.27 -1.372 . . . . 0.0 107.706 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.617 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -110.16 177.16 4.79 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -173.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -116.2 124.06 49.33 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -127.4 164.33 20.91 Favored Glycine 0 CA--C 1.547 2.033 0 C-N-CA 119.062 -1.542 . . . . 0.0 112.776 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.608 ' CD1' ' O ' ' A' ' 77' ' ' ALA . 33.8 pt -81.93 -179.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 2 C-N-CA 139.311 7.044 . . . . 0.0 92.25 172.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.48 ' ND2' ' CE1' ' A' ' 47' ' ' PHE . 12.1 t30 -151.89 168.73 24.21 Favored 'General case' 0 CA--C 1.547 0.831 2 CA-C-N 133.603 7.456 . . . . 0.0 103.403 177.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.459 ' N ' ' HA ' ' A' ' 76' ' ' LEU . . . -56.88 -52.27 65.78 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.203 0.911 . . . . 0.0 111.304 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 55' ' ' ASP . . . -33.93 -64.16 0.24 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.96 127.88 2.82 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.596 0.236 . . . . 0.0 111.036 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.423 ' HA ' ' HB ' ' A' ' 266' ' ' ILE . 81.0 Cg_endo -80.64 -41.3 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.359 2.04 . . . . 0.0 113.397 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 55.65 72.81 0.46 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.595 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 18.6 mtpt -56.64 -54.27 48.03 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 278' ' ' GLU . 4.2 mt-10 -55.65 -58.16 8.98 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.982 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.9 mt -69.46 -57.91 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.88 -55.74 17.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.595 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -57.53 -42.49 82.98 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 274' ' ' GLU . 5.3 mt-10 -76.25 -53.88 7.6 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.444 ' HB2' ' CE2' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -55.6 -56.36 21.22 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.661 179.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.2 mt -54.37 -43.4 71.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.359 0.599 . . . . 0.0 111.768 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -75.4 -33.24 60.97 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.214 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -97.14 -13.57 22.05 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.523 ' O ' HG22 ' A' ' 286' ' ' THR . 17.2 m-85 -114.32 -54.5 2.58 Favored 'General case' 0 CA--C 1.512 -0.513 0 O-C-N 122.008 -0.433 . . . . 0.0 110.659 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.6 tp -45.28 -25.46 0.39 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.93 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.93 43.39 1.09 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-O 120.832 0.349 . . . . 0.0 111.47 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 283' ' ' TYR . 13.2 t -143.7 156.93 44.69 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.532 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 49.4 p30 -66.13 -12.16 53.9 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.472 0.578 . . . . 0.0 110.55 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.593 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 10.9 tt0 -77.58 -47.48 19.31 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.029 -0.419 . . . . 0.0 111.054 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -84.71 -57.07 2.36 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 286' ' ' THR . 0.4 OUTLIER -48.29 -48.75 35.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.265 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -78.96 -26.77 43.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.077 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.593 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -65.8 -41.79 91.49 Favored 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 121.459 -0.776 . . . . 0.0 108.937 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.0 t -71.02 -64.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 116.704 -1.998 . . . . 0.0 105.856 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -51.43 3.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 129.119 2.967 . . . . 0.0 115.064 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -110.94 -57.0 2.29 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.421 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 57.6 m-20 -52.97 -36.85 60.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -111.61 98.19 39.88 Favored Pre-proline 0 C--N 1.35 0.593 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.939 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -95.25 76.08 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.416 2.744 . . . . 0.0 112.091 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 mt -101.55 -74.83 0.61 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.449 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 311' ' ' LEU . . . -142.62 -142.68 4.06 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.522 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.433 ' N ' ' CG2' ' A' ' 317' ' ' ILE . . . -79.79 178.42 8.2 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.741 0.305 . . . . 0.0 111.457 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.403 ' CG1' ' CD2' ' A' ' 290' ' ' LEU . 0.0 OUTLIER -126.83 -171.76 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.929 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.419 ' CB ' ' CD2' ' A' ' 89' ' ' LEU . . . -106.98 66.37 0.68 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.479 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 308' ' ' GLU . 10.4 tp -159.95 108.89 1.76 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.763 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.61 -60.36 0.71 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.78 -48.03 63.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.022 0.915 . . . . 0.0 111.529 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.401 ' OH ' ' CG ' ' A' ' 291' ' ' GLU . 1.9 t80 -70.07 -19.73 63.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.128 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 304' ' ' LEU . 3.0 tp10 -65.55 -39.95 92.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.82 -57.27 5.29 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.435 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -51.07 -57.21 9.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.248 0.547 . . . . 0.0 109.802 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 300' ' ' GLY . 1.2 tt -61.93 -38.68 89.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.241 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 317' ' ' ILE . . . -46.32 -29.11 1.51 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -40.31 -39.17 0.91 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.809 0.337 . . . . 0.0 110.241 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -78.53 118.34 71.75 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.09 -20.36 37.32 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.681 2.254 . . . . 0.0 114.287 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -59.15 5.61 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 312' ' ' ALA . 2.4 pp -50.04 -53.44 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.435 ' N ' ' CD1' ' A' ' 317' ' ' ILE . . . -45.77 -44.95 14.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.448 0.567 . . . . 0.0 111.518 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.52 -40.09 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.551 0.691 . . . . 0.0 110.242 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER -62.0 -56.6 17.37 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.528 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 9.0 ttp -53.1 -42.68 66.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.701 0.286 . . . . 0.0 110.691 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.18 -39.26 81.97 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.93 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 257' ' ' PRO . 7.3 m-80 -78.31 -48.11 16.36 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.659 0.266 . . . . 0.0 111.161 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.445 ' CB ' ' CG2' ' A' ' 110' ' ' VAL . . . -48.53 -40.79 28.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.621 0.248 . . . . 0.0 111.576 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 92' ' ' PHE . 5.3 pt20 -67.08 -28.43 68.18 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.607 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -76.54 -10.46 59.41 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 257' ' ' PRO . . . -79.91 161.2 45.55 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.815 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -96.6 139.62 32.41 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 96' ' ' ALA . 9.7 mt -51.58 102.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 119.891 1.223 . . . . 0.0 111.235 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.509 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 32.9 mtm -47.95 -48.33 62.4 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 330' ' ' MET . 57.9 Cg_endo -72.19 121.7 7.75 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.279 1.986 . . . . 0.0 113.218 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.404 ' C ' HG13 ' A' ' 333' ' ' ILE . 0.1 OUTLIER -160.69 -70.28 0.07 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.473 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.485 ' CG2' ' HD2' ' A' ' 334' ' ' PRO . 0.3 OUTLIER -137.32 140.42 30.71 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.001 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.485 ' HD2' ' CG2' ' A' ' 333' ' ' ILE . 10.9 Cg_endo -53.38 -18.27 10.64 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.881 2.388 . . . . 0.0 113.037 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.456 ' CG ' ' CG2' ' A' ' 368' ' ' ILE . 1.4 mp0 -44.07 -24.67 0.16 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.45 ' HE1' ' CZ ' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -45.71 -35.26 4.09 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.039 0.381 . . . . 0.0 111.372 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' SER . . . . . 0.482 ' HA ' ' CD2' ' A' ' 340' ' ' TRP . 3.0 t -56.26 -53.17 60.45 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 110.241 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 368' ' ' ILE . . . -52.13 -27.23 13.52 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.172 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.432 ' O ' HG22 ' A' ' 343' ' ' VAL . 25.2 m-85 -78.09 -55.74 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.344 -0.543 . . . . 0.0 112.459 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 341' ' ' TYR . 1.2 p90 -54.95 -31.93 60.98 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.26 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 340' ' ' TRP . 0.1 OUTLIER -75.57 -52.16 11.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.024 0.44 . . . . 0.0 110.994 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.33 88.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.731 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.489 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 4.8 m -69.17 -42.3 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.375 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.471 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 30.2 mtt-85 -57.79 -55.4 35.42 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.882 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -58.2 9.49 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.34 -60.69 2.13 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 42.7 t -53.03 -49.78 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 36.3 mt -67.87 -49.56 67.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.57 -55.06 19.71 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 355' ' ' GLN . . . -63.63 -26.55 68.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.905 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.48 -10.27 32.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.49 0.586 . . . . 0.0 112.327 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.3 p -110.77 14.8 22.18 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 122.059 -0.401 . . . . 0.0 110.785 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 97.73 29.74 7.58 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 116.815 -2.612 . . . . 0.0 116.08 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.46 35.65 4.36 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 116.252 -1.833 . . . . 0.0 106.328 174.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.458 ' HA ' ' CB ' ' A' ' 350' ' ' ALA . 3.9 pt20 -70.98 -174.77 1.0 Allowed 'General case' 0 CA--C 1.549 0.912 1 N-CA-C 125.704 5.446 . . . . 0.0 125.704 -157.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 158.34 41.78 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.415 -3.084 . . . . 0.0 104.538 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.3 p -72.36 -51.62 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.569 ' O ' ' HB3' ' A' ' 362' ' ' LYS . 10.0 t0 -47.77 -45.36 29.14 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.772 0.796 . . . . 0.0 111.31 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.6 ' HA ' ' HG2' ' A' ' 362' ' ' LYS . 8.1 mp0 -77.14 -56.32 4.67 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 113.885 -1.507 . . . . 0.0 113.62 -174.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -54.45 -43.09 71.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.416 1.103 . . . . 0.0 112.645 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.492 ' HA ' ' HB1' ' A' ' 364' ' ' ALA . 0.1 OUTLIER -76.17 -45.75 31.83 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.087 -1.87 . . . . 0.0 111.358 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.6 ' HG2' ' HA ' ' A' ' 359' ' ' GLU . 43.3 pttt -58.01 -54.89 41.79 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 121.961 0.886 . . . . 0.0 110.419 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 362' ' ' LYS . 9.0 m-20 -58.75 -36.15 73.89 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 114.611 -1.177 . . . . 0.0 107.832 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 361' ' ' LEU . . . -49.66 -45.54 48.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.426 ' CG ' ' CG2' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -58.93 -44.77 91.43 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.6 m -52.09 -42.54 63.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.112 0.482 . . . . 0.0 109.864 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.15 -37.06 85.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.909 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.456 ' CG2' ' CG ' ' A' ' 335' ' ' GLN . 4.2 mm -71.64 -35.29 55.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.934 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.426 ' HB ' ' HA ' ' A' ' 179' ' ' LYS . 7.4 p -118.64 51.35 1.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.936 0.398 . . . . 0.0 111.843 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.3 tptp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.195 179.79 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.626 0.251 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 63.3 68.49 0.61 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.063 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.46 -112.11 2.31 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.219 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HG3' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -118.21 -171.18 2.02 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 114.143 -1.028 . . . . 0.0 109.919 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.475 ' CD2' ' CZ ' ' A' ' 279' ' ' PHE . 0.1 OUTLIER -127.42 120.41 28.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 1.039 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -116.24 117.14 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.341 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' CG1' ' CG1' ' A' ' 37' ' ' VAL . 1.7 pp -123.51 129.88 74.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.691 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.518 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 8.5 m95 -107.58 122.44 46.69 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.6 tt -159.23 139.02 3.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.7 113.29 20.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.624 0.249 . . . . 0.0 111.111 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.29 -9.15 15.36 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.755 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 39.0 t0 -72.59 -82.11 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.853 0.827 . . . . 0.0 111.057 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 5.8 tmtm? 100.84 -2.75 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.531 0.733 . . . . 0.0 110.313 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 296' ' ' ASP . . . -76.72 66.01 2.8 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 115.271 0.868 . . . . 0.0 115.271 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CZ ' HG22 ' A' ' 37' ' ' VAL . 4.3 m-85 -77.39 -39.23 47.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.139 -0.531 . . . . 0.0 110.682 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 1.7 m120 -61.48 -47.0 87.66 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.058 0.456 . . . . 0.0 111.052 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.408 ' O ' ' CG2' ' A' ' 23' ' ' VAL . . . -71.37 -47.51 35.43 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.054 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.99 -49.6 77.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.381 0.59 . . . . 0.0 110.153 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.79 -38.46 80.01 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 2.1 tp10 -65.67 -36.93 85.08 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.063 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' A' ' 283' ' ' TYR . 61.0 t -66.82 -61.1 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.498 ' HA3' ' CG2' ' A' ' 35' ' ' VAL . . . -48.95 -32.42 11.68 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 119.685 -1.245 . . . . 0.0 111.491 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -55.29 -50.18 70.23 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.4 mttt -53.03 -41.72 65.0 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-N 112.862 -1.972 . . . . 0.0 108.374 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.585 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 47.4 m-85 -65.49 -34.31 77.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.777 0.799 . . . . 0.0 110.78 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.749 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 1.1 tm-20 -69.08 -51.26 40.65 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.963 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttp -50.99 -30.14 14.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 125.133 1.521 . . . . 0.0 110.867 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.636 ' O ' ' CG2' ' A' ' 31' ' ' THR . 0.4 OUTLIER -83.62 -38.2 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.428 179.085 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.636 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.75 37.71 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 171.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.09 38.58 0.02 OUTLIER Glycine 0 N--CA 1.468 0.805 0 C-N-CA 115.071 -3.443 . . . . 0.0 119.035 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.749 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 2.0 mp -140.02 136.8 38.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 121.861 2.831 . . . . 0.0 116.417 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.409 ' CD ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -142.42 105.13 4.52 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.498 ' CG2' ' HA3' ' A' ' 24' ' ' GLY . 42.6 t -86.89 131.61 34.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -174.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.8 p -117.3 145.1 44.21 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.44 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.441 HG22 ' CZ ' ' A' ' 17' ' ' TYR . 16.0 m -129.08 120.6 52.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -110.36 130.7 55.5 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -119.75 71.18 14.39 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.307 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.554 ' HG2' ' CB ' ' A' ' 43' ' ' LEU . 7.8 Cg_endo -94.93 -170.2 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.514 2.809 . . . . 0.0 112.857 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -109.74 -40.32 4.85 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.42 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB3' ' CG ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -86.23 0.32 54.02 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.589 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -31.68 -39.27 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 1.02 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 73.7 mt-10 -62.86 -54.61 36.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.467 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 11.9 pt-20 -74.2 -38.36 63.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -60.12 -57.53 12.42 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.705 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.597 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.1 t80 -42.94 -59.16 3.24 Favored Pre-proline 0 C--N 1.352 0.694 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.516 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 1.02 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 26.8 Cg_exo -62.66 -22.65 74.16 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 120.948 1.099 . . . . 0.0 113.171 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -82.23 -36.93 26.7 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 122.28 1.038 . . . . 0.0 111.271 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.3 m -78.59 -39.81 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.506 0 CA-C-O 122.254 1.026 . . . . 0.0 109.863 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.406 ' N ' HG21 ' A' ' 50' ' ' VAL . . . -50.56 -37.46 39.76 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 125.957 1.703 . . . . 0.0 110.906 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.411 ' O ' ' CG2' ' A' ' 53' ' ' THR . . . -81.52 -40.1 23.69 Favored 'General case' 0 C--N 1.372 1.567 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.701 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 52' ' ' ALA . 33.6 p -159.56 51.52 0.35 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.054 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -160.02 48.87 0.39 Allowed Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.333 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t0 70.67 104.24 0.06 Allowed 'General case' 0 C--O 1.23 0.077 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.07 112.15 4.73 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.836 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.492 ' CG ' ' CE1' ' A' ' 47' ' ' PHE . 86.1 Cg_endo -79.85 -164.68 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.956 2.437 . . . . 0.0 113.444 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 1.039 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 6.7 t0 -79.96 -135.57 0.03 OUTLIER 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 123.946 0.898 . . . . 0.0 110.521 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' A' ' 266' ' ' ILE . 1.3 mp -101.7 165.17 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.539 HG21 ' CE2' ' A' ' 47' ' ' PHE . 1.2 pt -127.16 130.69 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.5 OUTLIER -115.34 117.57 30.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.49 ' CD1' ' O ' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -167.26 165.38 15.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 62' ' ' TRP . . . -37.45 152.46 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.557 ' CB ' ' HB ' ' A' ' 261' ' ' VAL . 10.7 t-160 -77.35 -28.62 53.05 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -49.19 -58.29 5.25 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-O 121.979 0.895 . . . . 0.0 112.279 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.537 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -73.9 -30.59 62.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.546 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.487 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -63.35 -25.43 68.29 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -62.04 -65.37 3.24 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.62 -47.85 89.15 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 113.616 -1.292 . . . . 0.0 110.309 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.69 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 23.2 t80 -48.02 -46.56 33.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HA ' ' CB ' ' A' ' 76' ' ' LEU . . . -57.87 -37.43 73.92 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.299 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -78.94 -54.72 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.303 . . . . 0.0 111.764 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -113.34 -26.15 8.5 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' TYR . . . -65.41 -85.37 0.07 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.178 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 165.58 71.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.142 0.496 . . . . 0.0 109.726 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.519 HD13 ' HB ' ' A' ' 104' ' ' ILE . 2.5 tt -112.64 133.22 54.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.273 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 79' ' ' ILE . . . -86.45 91.92 8.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.631 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -56.3 85.49 0.01 OUTLIER 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.568 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 2.0 pp -49.24 119.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.224 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.7 p -105.84 82.79 0.91 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.365 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 42.8 Cg_endo -89.44 -168.58 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.122 2.548 . . . . 0.0 112.422 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -172.89 4.42 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.638 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -35.66 21.0 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.3 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.44 -23.64 58.04 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.93 -59.21 2.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -60.99 -24.74 66.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.389 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -75.8 -35.39 60.07 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.58 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -19.68 64.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.547 ' CD1' ' CG ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER -97.4 -179.57 4.53 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -94.58 143.32 26.06 Favored Pre-proline 0 C--N 1.343 0.304 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 31.8 Cg_exo -58.92 -50.58 8.66 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.422 2.081 . . . . 0.0 113.513 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' ' CG ' ' A' ' 325' ' ' GLN . 6.8 m-85 -56.76 -62.78 1.5 Allowed 'General case' 0 C--O 1.246 0.878 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.583 ' O ' ' HG3' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -62.85 -25.25 68.18 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.547 ' CG ' ' CD1' ' A' ' 89' ' ' LEU . 31.6 m95 -93.86 -23.39 18.14 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 14.7 t70 -72.65 -22.2 60.97 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.476 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.412 ' HB3' ' CG2' ' A' ' 261' ' ' VAL . . . -53.29 -45.53 68.96 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.444 ' HA ' ' CE1' ' A' ' 64' ' ' HIS . 20.2 m -113.93 39.25 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.407 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.438 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 12.0 ttp180 -104.94 138.96 40.37 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.289 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -124.15 90.99 3.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 119.172 0.896 . . . . 0.0 110.052 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.5 m120 51.73 -91.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.208 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.1 44.73 1.21 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.79 -177.03 5.37 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.486 0.314 . . . . 0.0 110.484 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.66 126.68 5.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.391 0.541 . . . . 0.0 110.742 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.521 ' O ' ' CB ' ' A' ' 105' ' ' ALA . 1.4 pp -128.25 39.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.55 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . 159.61 162.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 263' ' ' SER . 23.2 m-85 -124.7 119.81 25.78 Favored Pre-proline 0 C--O 1.223 -0.32 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.583 ' HG3' ' O ' ' A' ' 93' ' ' THR . 66.9 Cg_endo -79.14 162.48 25.83 Favored 'Trans proline' 0 N--CA 1.474 0.333 0 C-N-CA 122.284 1.989 . . . . 0.0 114.776 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.644 ' N ' ' O ' ' A' ' 262' ' ' LEU . 0.8 OUTLIER -171.82 38.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.502 ' CB ' ' CB ' ' A' ' 262' ' ' LEU . . . -179.56 137.58 0.13 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -124.09 119.48 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 259' ' ' VAL . 5.4 tt0 -99.03 135.04 41.0 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -168.06 -174.67 2.41 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 123.366 1.555 . . . . 0.0 110.204 -167.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.456 ' CD1' ' CZ2' ' A' ' 232' ' ' TRP . 2.7 tt -147.3 135.44 21.49 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 110.995 -2.821 . . . . 0.0 115.846 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.4 OUTLIER -130.31 168.42 16.93 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.893 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.8 tp -92.45 132.41 36.81 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 121.877 -0.514 . . . . 0.0 110.267 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 242' ' ' TYR . 0.5 OUTLIER -116.41 134.51 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.669 0.747 . . . . 0.0 111.175 -178.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.455 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 8.3 m-85 -93.23 -174.32 3.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.05 2.54 . . . . 0.0 110.037 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.468 ' HB3' ' H ' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -93.05 -135.43 0.17 Allowed 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 126.625 1.97 . . . . 0.0 113.615 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.468 ' H ' ' HB3' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -152.46 -108.26 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.085 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -67.94 -26.55 66.01 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.499 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -104.89 51.47 0.76 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.164 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 122' ' ' LEU . 1.2 pp -118.83 73.22 11.82 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 121.439 0.638 . . . . 0.0 109.788 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.536 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 12.5 Cg_exo -70.16 160.82 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.407 2.071 . . . . 0.0 112.508 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -61.56 108.19 1.44 Allowed Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.417 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 57.2 Cg_endo -69.63 167.94 22.82 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 124.094 3.196 . . . . 0.0 113.574 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -76.16 -162.0 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.762 2.308 . . . . 0.0 113.592 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -126.23 -93.03 0.49 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.6 t -45.0 152.99 0.2 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.352 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.481 ' HB2' ' CE1' ' A' ' 250' ' ' PHE . 13.9 t-105 -69.96 -26.51 64.14 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 174.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.423 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 62.5 mt-10 -44.55 -23.72 0.14 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 134' ' ' ALA . 22.1 mt-10 -73.5 -26.2 60.78 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.561 HG13 ' HD3' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -40.44 -52.81 5.84 Favored Pre-proline 0 N--CA 1.487 1.385 0 CA-C-N 119.122 0.874 . . . . 0.0 112.288 -178.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.58 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 53.1 Cg_exo -46.33 -39.94 21.95 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 120.699 0.933 . . . . 0.0 109.892 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.38 -58.92 2.99 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -68.14 -36.65 80.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.159 -178.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.445 ' HA ' HD11 ' A' ' 139' ' ' LEU . 1.9 m-20 -73.51 -41.09 63.51 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -48.22 -43.88 32.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.69 177.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -37.48 85.34 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.598 ' HB3' ' C ' ' A' ' 144' ' ' LYS . 0.7 OUTLIER -65.55 -46.47 79.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -48.91 -43.26 39.14 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.12 -22.93 0.26 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.296 -177.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -115.79 -60.31 1.89 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.774 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.62 56.85 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.598 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 24.2 pttt -169.08 -173.43 1.77 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.829 1.815 . . . . 0.0 110.246 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.429 ' O ' HD22 ' A' ' 139' ' ' LEU . 38.5 m -142.65 164.82 29.08 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.56 ' CA ' HD13 ' A' ' 139' ' ' LEU . . . -81.84 -23.01 36.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.931 0.395 . . . . 0.0 111.919 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 224' ' ' MET . 3.3 pp -144.82 128.76 17.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.2 mmm -132.41 141.59 48.93 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.702 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.459 ' HB3' HG22 ' A' ' 225' ' ' THR . 52.6 p90 -172.55 174.94 3.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.742 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -37.54 158.42 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.013 178.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 206' ' ' ALA . 3.3 mt -110.65 -51.66 2.85 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.17 34.35 3.1 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 115.752 -2.379 . . . . 0.0 113.765 -175.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.665 ' O ' ' OG1' ' A' ' 157' ' ' THR . 0.5 OUTLIER -79.63 142.32 57.26 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 121.067 1.758 . . . . 0.0 114.087 -176.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.968 ' O ' ' N ' ' A' ' 156' ' ' PHE . 67.3 Cg_endo -78.18 -134.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 1 C-N-CA 125.336 4.024 . . . . 0.0 105.2 175.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 1.167 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 12.3 m-85 21.13 -55.63 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.883 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.968 ' N ' ' O ' ' A' ' 154' ' ' PRO . 15.1 t80 -84.72 -55.81 3.92 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-N 119.561 1.073 . . . . 0.0 112.641 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.665 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 20.6 p -58.04 -39.77 79.25 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 117.913 -1.515 . . . . 0.0 107.336 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.424 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 24.2 m95 -53.0 -55.7 30.93 Favored Pre-proline 0 C--N 1.352 0.702 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.825 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 1.167 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 67.5 Cg_exo -43.04 -48.91 7.41 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.187 2.591 . . . . 0.0 112.425 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.466 ' CD2' ' CE2' ' A' ' 250' ' ' PHE . 0.1 OUTLIER -58.19 -53.55 57.03 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 119.361 0.982 . . . . 0.0 109.411 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.7 mt -55.42 -20.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.001 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.5 ' CB ' ' HB2' ' A' ' 256' ' ' LYS . . . -78.9 -25.16 43.77 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.445 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -42.85 -56.02 3.43 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.466 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 7.1 m-20 -64.54 -11.18 31.6 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.172 0.896 . . . . 0.0 112.777 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.91 27.76 0.7 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 119.545 -1.312 . . . . 0.0 115.561 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.85 162.06 38.82 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 118.557 1.178 . . . . 0.0 111.847 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.673 ' O ' ' N ' ' A' ' 169' ' ' PHE . 25.9 m-85 -151.28 30.18 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.992 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.447 ' HB1' ' CD1' ' A' ' 169' ' ' PHE . . . 50.04 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.024 0.916 . . . . 0.0 111.411 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.673 ' N ' ' O ' ' A' ' 167' ' ' TYR . 12.4 m-85 -112.88 170.72 8.0 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.423 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.927 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -108.01 114.74 28.88 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.49 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 5.9 t80 -79.23 114.03 17.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 113.473 -1.694 . . . . 0.0 110.36 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 174' ' ' GLY . 44.9 tp10 -137.54 124.53 21.43 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.202 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 t30 76.77 -31.69 0.18 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.872 -0.149 . . . . 0.0 111.109 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.49 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 163.83 11.77 0.03 OUTLIER Glycine 0 CA--C 1.532 1.123 0 C-N-CA 120.17 -1.014 . . . . 0.0 114.626 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -173.93 150.6 1.65 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.962 1.381 . . . . 0.0 110.031 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.927 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 7.0 m-85 -66.57 -26.32 67.06 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.151 0.977 . . . . 0.0 109.579 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.64 -103.98 0.08 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.403 -1.726 . . . . 0.0 112.163 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.3 tp -173.38 -46.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.42 -15.6 60.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.718 0.294 . . . . 0.0 110.872 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 170' ' ' LYS . 3.2 p-10 -129.19 94.3 3.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 169' ' ' PHE . 20.3 m -122.03 140.79 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.387 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.69 55.5 4.17 Favored Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.185 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 361' ' ' LEU . 30.4 m -87.03 -13.31 10.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.525 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 7.3 p-10 -124.62 62.68 1.13 Allowed 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.774 0.321 . . . . 0.0 110.844 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -116.93 135.1 53.98 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.282 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -39.25 -40.31 0.74 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.424 0.63 . . . . 0.0 112.264 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -76.78 -35.94 38.54 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 114.955 -1.02 . . . . 0.0 114.113 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.43 69.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.426 ' CE ' ' CD2' ' A' ' 361' ' ' LEU . 9.2 mttt -58.16 -60.45 3.73 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.651 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.404 ' O ' ' OG1' ' A' ' 193' ' ' THR . . . -50.36 -42.03 52.55 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.835 0.826 . . . . 0.0 111.959 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.46 -60.51 5.41 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.146 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.98 -28.32 62.22 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 122.841 -0.211 . . . . 0.0 110.48 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 190' ' ' ALA . 7.6 p -69.65 -42.37 74.34 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.666 0.27 . . . . 0.0 111.375 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 129' ' ' TRP . 86.7 t80 -61.68 -34.27 75.45 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.345 0.593 . . . . 0.0 109.606 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.67 -47.76 79.93 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.88 -31.64 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.467 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.11 -44.87 87.37 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.797 0.808 . . . . 0.0 111.508 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.439 HD12 ' CD1' ' A' ' 129' ' ' TRP . 13.0 mt -58.59 -55.39 35.64 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.657 ' O ' ' HA ' ' A' ' 204' ' ' MET . 26.9 pt -64.06 -39.82 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.102 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -52.67 -37.32 58.52 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.695 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.26 -34.53 5.62 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 121.141 3.756 . . . . 0.0 121.141 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -60.72 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.773 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -105.19 -1.94 24.79 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 9.0 mtm 43.39 36.02 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.773 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.09 159.36 42.34 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 151' ' ' LEU . . . -149.38 30.1 0.77 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -100.6 -3.51 30.34 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 151' ' ' LEU . 5.3 m -57.45 119.82 7.16 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -95.5 -174.24 3.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.875 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 211' ' ' SER . 53.5 p90 -68.05 -45.5 73.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.421 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -76.67 -25.49 53.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.588 0.709 . . . . 0.0 111.382 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 4.5 mt -81.63 -50.91 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.063 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.37 56.98 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.479 ' HA ' ' CD2' ' A' ' 217' ' ' PHE . 2.7 tt0 -60.17 -46.89 88.17 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.9 -36.24 69.91 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.481 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.55 -57.34 13.11 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 214' ' ' GLU . 0.4 OUTLIER -63.08 -28.32 70.0 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -55.14 -41.12 71.35 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.558 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.98 59.14 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.2 41.27 69.9 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -109.64 37.13 2.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.034 1.417 . . . . 0.0 110.822 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.6 m -140.44 140.75 35.46 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -105.09 38.42 1.94 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.349 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 2.7 ttm 171.6 135.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 149' ' ' PHE . 90.4 m -148.19 157.58 43.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.153 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.436 ' HB ' ' CZ ' ' A' ' 156' ' ' PHE . 2.7 mp -115.84 111.41 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.427 173.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 114' ' ' SER . 10.1 p30 -149.18 164.72 33.93 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 122.095 -0.378 . . . . 0.0 111.837 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -80.76 -172.82 46.25 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.124 -1.513 . . . . 0.0 109.784 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.425 ' CB ' ' HB3' ' A' ' 316' ' ' ARG . 57.5 Cg_endo -73.51 -40.7 1.43 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 121.759 1.639 . . . . 0.0 112.522 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.503 ' CZ2' ' HA3' ' A' ' 300' ' ' GLY . 0.3 OUTLIER -137.49 23.87 2.93 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.479 ' CB ' ' CE3' ' A' ' 232' ' ' TRP . . . -96.48 -33.79 11.73 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.479 ' CE3' ' CB ' ' A' ' 231' ' ' ALA . 1.7 m-90 -105.21 79.96 1.54 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.1 m 62.59 -175.69 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.91 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -83.0 129.5 35.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.813 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.405 HG13 ' CE2' ' A' ' 242' ' ' TYR . 8.4 tp -87.61 -32.55 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.368 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -46.2 -38.66 8.63 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.603 0.24 . . . . 0.0 111.294 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.0 t -87.05 65.2 8.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.702 0.287 . . . . 0.0 110.814 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 39.1 p -116.44 -60.3 1.87 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.812 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.48 -67.51 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.301 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 22.1 t -154.43 -60.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.526 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -136.74 157.46 46.7 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.876 0.37 . . . . 0.0 111.317 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.413 ' HB2' ' CD1' ' A' ' 116' ' ' ILE . 6.2 p90 -149.31 156.68 42.47 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.632 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 117' ' ' TYR . . . -107.34 172.82 18.22 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.42 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.0 t -146.51 119.98 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.139 0.469 . . . . 0.0 111.976 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.406 ' OG1' ' CE2' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -134.55 167.52 20.64 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -173.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.2 m -73.01 153.22 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.425 ' CD1' HG22 ' A' ' 226' ' ' ILE . 2.8 mm? -59.03 159.15 14.72 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-N 120.396 1.453 . . . . 0.0 111.885 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.11 -156.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.461 2.774 . . . . 0.0 112.242 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -128.51 172.99 10.63 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.913 -178.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 129' ' ' TRP . 97.4 m-85 -164.15 110.47 1.06 Allowed 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 121.791 0.805 . . . . 0.0 109.402 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt 61.16 33.0 19.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.678 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.01 36.64 35.12 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.118 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -156.83 155.17 28.07 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -92.14 157.88 3.22 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.598 2.865 . . . . 0.0 111.986 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.4 p -79.73 153.41 29.27 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.5 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 3.2 mmmm -85.4 110.82 32.18 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.391 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.479 ' HB2' ' CA ' ' A' ' 327' ' ' GLY . 6.2 Cg_exo -79.23 147.83 20.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.928 2.419 . . . . 0.0 112.39 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 155' ' ' TYR . 3.2 p90 -105.09 133.93 49.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.474 ' CG2' ' HA ' ' A' ' 324' ' ' ALA . 30.9 t -140.68 108.41 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.25 163.88 43.47 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.152 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.557 ' HB ' ' CB ' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -104.3 113.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 122.893 -0.181 . . . . 0.0 111.342 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.644 ' O ' ' N ' ' A' ' 108' ' ' ILE . 1.7 tt -89.04 99.67 12.6 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 117.502 -1.679 . . . . 0.0 106.68 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 23.3 p -134.85 142.06 46.52 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -172.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . -73.88 131.59 41.64 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.827 0.451 . . . . 0.0 110.061 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 60' ' ' ILE . . . -122.01 135.51 10.41 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.005 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.541 ' HA ' HG22 ' A' ' 59' ' ' ILE . 4.4 tp -89.98 123.6 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -64.43 145.37 56.18 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.74 -22.86 58.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.995 0.426 . . . . 0.0 111.436 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -61.5 -61.15 2.73 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.704 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.7 m -127.13 102.11 24.67 Favored Pre-proline 0 C--N 1.333 -0.13 0 CA-C-O 120.619 0.247 . . . . 0.0 111.29 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.25 -42.72 1.83 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.336 2.024 . . . . 0.0 112.276 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.5 m120 45.73 80.12 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -75.06 -54.12 7.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.626 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -57.28 11.58 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.652 0.263 . . . . 0.0 111.68 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.14 -57.95 10.38 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.213 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.59 -25.0 64.24 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.592 ' O ' ' CB ' ' A' ' 281' ' ' GLU . 24.0 tttt -69.95 -58.09 4.26 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 121.325 0.583 . . . . 0.0 111.687 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 13.4 pt-20 -69.97 -35.44 74.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.328 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.571 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 12.1 t80 -73.95 -61.13 1.95 Allowed 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.195 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.59 -44.45 64.44 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.179 -1.008 . . . . 0.0 113.175 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.592 ' CB ' ' O ' ' A' ' 277' ' ' LYS . 4.0 tt0 -75.45 -34.77 60.98 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.527 -1.215 . . . . 0.0 113.428 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 1.7 t-20 -92.15 -16.74 25.88 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 0.5 OUTLIER -108.78 -66.53 1.04 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -39.54 -32.89 0.14 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.944 0.793 . . . . 0.0 111.203 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 20.4 mt -91.05 42.03 1.09 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.79 0.328 . . . . 0.0 111.383 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.446 HG23 ' HA ' ' A' ' 283' ' ' TYR . 6.3 t -145.06 158.01 43.94 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 0.8 OUTLIER -66.23 -11.02 47.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.617 0.644 . . . . 0.0 110.297 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -77.4 -47.09 20.69 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 118.175 0.443 . . . . 0.0 111.157 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.422 ' H ' HG22 ' A' ' 286' ' ' THR . . . -83.74 -57.34 2.45 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.43 HD12 ' CG ' ' A' ' 307' ' ' TYR . 0.2 OUTLIER -50.8 -49.06 59.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.589 -0.305 . . . . 0.0 110.586 178.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.1 OUTLIER -79.28 -26.39 42.35 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.104 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.611 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -68.04 -39.61 83.03 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.34 -62.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.545 ' HA ' ' HB2' ' A' ' 297' ' ' LYS . 9.3 m-80 -44.59 -47.79 10.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.78 1.232 . . . . 0.0 112.427 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -57.93 -54.97 40.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.44 ' HB3' ' CA ' ' A' ' 16' ' ' GLY . 32.8 m-20 -53.6 -44.75 69.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 294' ' ' ASN . 0.7 OUTLIER -49.7 165.83 0.28 Allowed Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.866 -178.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 299' ' ' LEU . 6.6 Cg_exo -73.09 -8.78 22.66 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.241 2.628 . . . . 0.0 113.547 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 298' ' ' PRO . 6.7 tp 90.38 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.924 0.392 . . . . 0.0 111.66 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.503 ' HA3' ' CZ2' ' A' ' 230' ' ' TRP . . . -152.98 -156.67 7.68 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.947 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.45 ' HA ' ' CG1' ' A' ' 317' ' ' ILE . . . -79.97 164.47 23.45 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.44 0.62 . . . . 0.0 110.7 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 16.5 m -153.81 -151.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.492 ' HA ' ' CG2' ' A' ' 93' ' ' THR . . . -116.1 -138.75 0.37 Allowed 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 308' ' ' GLU . 13.5 tp 48.24 101.41 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.712 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -41.9 -58.44 2.04 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.5 p -53.39 -49.35 67.42 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.734 0.778 . . . . 0.0 112.073 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.43 ' CG ' HD12 ' A' ' 290' ' ' LEU . 9.1 t80 -69.48 -19.42 63.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.171 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -63.1 -39.02 93.48 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -70.63 -57.8 4.34 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.539 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -56.49 12.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.458 0.647 . . . . 0.0 109.279 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.443 ' O ' HG22 ' A' ' 317' ' ' ILE . 0.8 OUTLIER -59.09 -40.32 84.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.277 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 317' ' ' ILE . . . -46.96 -34.39 5.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.524 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.52 -38.39 6.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.518 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 14.3 m-20 -67.55 146.19 98.53 Favored Pre-proline 0 N--CA 1.462 0.132 0 CA-C-O 120.616 0.246 . . . . 0.0 110.667 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 17.3 Cg_exo -67.15 -42.81 7.25 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.665 2.243 . . . . 0.0 113.054 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.425 ' HB3' ' CB ' ' A' ' 229' ' ' PRO . 7.8 mtt85 -58.79 -59.73 4.97 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.45 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 0.0 OUTLIER -51.45 -54.13 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.417 ' N ' HD11 ' A' ' 317' ' ' ILE . . . -46.05 -51.91 12.88 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.419 0.554 . . . . 0.0 111.584 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.62 -46.72 70.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.217 1.008 . . . . 0.0 109.032 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -40.51 82.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 113.472 -1.694 . . . . 0.0 109.786 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.1 ttp -66.46 -50.25 63.98 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.646 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -53.17 -57.6 9.92 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 327' ' ' GLY . 22.4 m120 -64.55 -30.24 71.27 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.364 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.474 ' HA ' ' CG2' ' A' ' 259' ' ' VAL . . . -60.08 -53.13 61.4 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . 0.449 ' CG ' ' CZ ' ' A' ' 92' ' ' PHE . 2.4 tt0 -67.42 -30.06 69.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.39 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.28 -17.98 40.68 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.496 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.479 ' CA ' ' HB2' ' A' ' 257' ' ' PRO . . . -79.9 169.23 52.98 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.199 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -96.46 137.4 35.58 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.472 ' O ' ' C ' ' A' ' 330' ' ' MET . 4.6 mp -83.88 113.67 23.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 119.595 1.089 . . . . 0.0 110.301 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.472 ' C ' ' O ' ' A' ' 329' ' ' ILE . 0.0 OUTLIER -25.93 137.55 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 332' ' ' ASN . 36.3 Cg_endo -64.93 -38.44 29.28 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.629 2.22 . . . . 0.0 112.528 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 331' ' ' PRO . 1.5 m-20 71.49 57.14 0.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.661 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.98 160.34 68.18 Favored Pre-proline 0 C--N 1.326 -0.415 0 O-C-N 121.945 -0.472 . . . . 0.0 111.593 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.13 -42.29 8.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.644 2.229 . . . . 0.0 112.476 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -47.83 -25.2 1.2 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 32.0 tpp -45.72 -35.55 4.33 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 122.357 -0.214 . . . . 0.0 111.181 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.2 m -57.31 -42.51 81.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.761 0.315 . . . . 0.0 110.455 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -57.27 -31.51 65.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.04 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -78.1 -48.62 15.61 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.34 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -47.01 68.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.619 0.247 . . . . 0.0 111.474 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -74.33 -50.87 16.97 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.62 -43.68 79.84 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.437 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 0.3 OUTLIER -70.74 -41.42 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.42 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 0.8 OUTLIER -58.67 -59.56 5.22 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.458 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 53.0 p -54.36 -57.86 9.65 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.51 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.09 -60.56 2.89 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 44.1 t -59.08 -45.74 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 1.7 tt -68.5 -52.7 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.603 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 348' ' ' ILE . 29.6 m-20 -66.26 -53.39 37.39 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 354' ' ' ARG . . . -63.54 -26.42 68.69 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.356 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -54.53 -17.92 3.78 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.574 0.625 . . . . 0.0 111.503 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 13.2 p -106.73 24.08 13.26 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 171.1 -57.21 0.18 Allowed Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 119.697 -1.239 . . . . 0.0 113.254 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . 0.549 ' HG2' ' HA ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -103.17 34.05 3.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 113.792 -3.163 . . . . 0.0 116.971 -174.222 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.415 ' O ' ' OE1' ' A' ' 355' ' ' GLN . 0.8 OUTLIER -95.77 54.58 1.54 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.13 167.32 11.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.96 -49.34 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.533 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.549 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 62.2 m-20 -64.84 -49.3 71.11 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.72 -33.7 46.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 111.975 -177.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.46 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -61.44 -53.27 58.66 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.961 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.525 ' HG ' ' HA ' ' A' ' 184' ' ' ASP . 0.2 OUTLIER -78.91 -47.18 16.94 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.746 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.558 ' O ' ' CG2' ' A' ' 366' ' ' THR . 6.3 mmtp -50.35 -56.01 13.16 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.71 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.66 -53.3 14.05 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.435 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -58.76 -57.25 13.85 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.119 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.0 -54.86 39.77 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.558 ' CG2' ' O ' ' A' ' 362' ' ' LYS . 64.0 p -51.11 -52.71 41.07 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -66.4 -38.04 86.59 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 12.5 pt -79.42 -30.1 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.9 p -94.84 -18.91 20.76 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 366' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.252 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.623 0.249 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -155.1 156.37 35.71 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -125.36 75.32 0.4 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.227 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -158.39 163.9 36.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.496 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -169.21 124.28 0.86 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.912 ' H ' ' CB ' ' A' ' 58' ' ' ASP . 4.9 p -124.7 112.26 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.399 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -96.82 143.56 12.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.887 -175.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.459 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -104.29 127.21 51.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.635 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 39' ' ' HIS . 10.8 tt -158.55 164.89 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.016 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -132.65 39.99 3.3 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.08 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.71 -15.46 58.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.482 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER 61.18 65.18 1.01 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.054 0.427 . . . . 0.0 109.921 -179.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 2.3 mtmt 162.63 -170.78 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' CA ' ' HB3' ' A' ' 296' ' ' ASP . . . 75.96 24.34 69.55 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CE1' HG21 ' A' ' 37' ' ' VAL . 38.8 m-85 -76.2 -36.71 58.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.793 0.797 . . . . 0.0 111.03 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 2.7 m120 -64.75 -49.37 71.04 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.27 -49.73 19.57 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.673 -0.775 . . . . 0.0 114.212 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.569 ' O ' HG22 ' A' ' 23' ' ' VAL . 3.5 mm? -59.22 -51.16 71.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.75 0.775 . . . . 0.0 110.193 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -66.0 -37.7 86.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 111.973 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -67.16 -37.5 83.88 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.747 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 20' ' ' LEU . 4.5 m -68.1 -61.18 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 121.76 -0.588 . . . . 0.0 110.087 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -49.09 -34.16 16.0 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.374 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -50.43 69.42 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.447 1.117 . . . . 0.0 108.444 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -52.26 -42.31 63.56 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 112.874 -1.966 . . . . 0.0 108.677 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.606 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 71.7 m-85 -65.98 -32.22 73.57 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.756 0.789 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.754 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 7.2 tt0 -70.09 -51.8 28.88 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.022 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -52.07 -29.7 22.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 125.327 1.642 . . . . 0.0 111.254 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.746 ' O ' ' HB ' ' A' ' 31' ' ' THR . 3.5 m-20 -84.29 -38.07 20.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.187 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.746 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 4.5 t 159.79 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 156.38 38.7 0.02 OUTLIER Glycine 0 N--CA 1.466 0.658 0 C-N-CA 114.968 -3.491 . . . . 0.0 118.914 174.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.754 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 2.1 mp -140.16 130.25 29.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 121.513 2.657 . . . . 0.0 115.65 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -137.16 105.16 5.64 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 34.2 m -99.74 133.21 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.0 147.19 45.09 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.532 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG21 ' CE1' ' A' ' 17' ' ' TYR . 17.9 m -133.34 123.32 46.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 122.164 -0.335 . . . . 0.0 110.404 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -111.59 139.8 46.74 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.496 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.1 78.95 25.75 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-O 120.841 0.353 . . . . 0.0 110.739 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HG2' ' HB2' ' A' ' 43' ' ' LEU . 60.7 Cg_endo -92.69 163.11 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.261 2.64 . . . . 0.0 113.307 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -90.72 -35.45 14.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -82.76 0.49 43.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.482 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' A' ' 10' ' ' TRP . 54.1 tp -19.78 -49.31 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 1.081 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 mt-10 -67.29 -54.51 20.18 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.556 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.74 -43.62 62.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.905 0.383 . . . . 0.0 110.324 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.11 -56.13 23.27 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.955 0.883 . . . . 0.0 109.764 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.714 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 9.1 t80 -48.17 -60.95 3.59 Favored Pre-proline 0 C--O 1.219 -0.525 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.919 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 1.081 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 32.2 Cg_exo -60.22 -26.53 82.82 Favored 'Trans proline' 0 C--O 1.25 1.114 0 C-N-CA 121.278 1.318 . . . . 0.0 113.679 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -81.82 -38.76 25.03 Favored 'General case' 0 C--O 1.256 1.443 0 CA-C-O 122.161 0.981 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 54' ' ' GLY . 17.9 m -75.09 -39.26 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 CA-C-O 121.849 0.833 . . . . 0.0 109.832 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.402 ' HB1' ' CE1' ' A' ' 47' ' ' PHE . . . -50.16 -39.78 44.61 Favored 'General case' 0 C--N 1.372 1.553 0 C-N-CA 127.748 2.419 . . . . 0.0 111.593 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.46 -40.2 26.7 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.011 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -83.5 -7.23 59.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 77.82 -74.51 1.97 Allowed Glycine 0 C--N 1.352 1.45 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.184 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 t70 72.05 13.14 5.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.167 -1.016 . . . . 0.0 110.265 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.451 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . 57.72 59.38 10.93 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.094 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -101.39 171.36 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.38 2.72 . . . . 0.0 114.213 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.912 ' CB ' ' H ' ' A' ' 8' ' ' VAL . 25.1 m-20 -94.28 -133.12 0.17 Allowed 'General case' 0 N--CA 1.414 -2.257 0 C-N-CA 125.098 1.359 . . . . 0.0 109.137 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.613 HG13 ' HA ' ' A' ' 266' ' ' ILE . 9.6 tt -99.73 168.11 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 124.089 0.955 . . . . 0.0 112.477 -177.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.476 HD13 ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -134.31 126.35 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.452 ' CZ ' ' CB ' ' A' ' 264' ' ' ALA . 3.2 m-85 -108.15 125.4 51.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.603 ' CH2' ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -166.81 166.77 15.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.586 0.354 . . . . 0.0 110.062 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 62' ' ' TRP . . . -45.35 158.32 0.07 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.518 0.599 . . . . 0.0 112.519 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -77.5 -29.27 52.44 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -47.82 -53.72 14.64 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.825 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.39 -26.08 42.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.043 0.449 . . . . 0.0 110.098 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.603 ' CE1' ' CH2' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -57.44 -34.33 68.85 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 171.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -55.2 -69.65 1.2 Allowed Glycine 0 C--N 1.357 1.74 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 177.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.87 -54.16 23.39 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-N 112.996 -1.602 . . . . 0.0 111.363 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.465 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.4 m-30 -50.56 -40.53 52.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.501 ' CB ' HG23 ' A' ' 104' ' ' ILE . . . -48.63 -48.36 39.58 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.61 -31.08 46.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.138 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.26 -26.77 63.98 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.561 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.25 23.28 44.91 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.574 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.402 ' O ' HD23 ' A' ' 76' ' ' LEU . 4.0 mt -106.16 54.58 0.69 Allowed 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.911 0.386 . . . . 0.0 110.392 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.499 HD11 ' O ' ' A' ' 266' ' ' ILE . 0.2 OUTLIER -179.13 145.13 0.25 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.877 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB3' ' CG2' ' A' ' 266' ' ' ILE . . . -72.2 74.65 0.97 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.208 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -53.0 125.1 16.09 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.8 0.333 . . . . 0.0 110.495 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mm -70.88 173.38 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.856 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.95 175.54 4.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.2 101.49 1.43 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.052 1.835 . . . . 0.0 113.031 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -145.46 107.76 4.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.251 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.18 0.22 52.47 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.19 -32.99 25.44 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.579 0.228 . . . . 0.0 111.579 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.47 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 22.7 m-85 -79.31 -59.06 2.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.882 0.372 . . . . 0.0 110.075 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.45 -27.92 40.71 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.544 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -76.32 -47.01 25.08 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.664 0.269 . . . . 0.0 110.833 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -67.86 -20.41 65.13 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.521 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.447 HD23 ' HB3' ' A' ' 304' ' ' LEU . 5.1 mp -112.82 -163.46 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 121.454 -0.098 . . . . 0.0 110.879 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.439 ' CG ' ' HD2' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -84.68 146.78 47.41 Favored Pre-proline 0 C--N 1.34 0.175 0 O-C-N 121.992 -0.442 . . . . 0.0 111.641 -178.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 95' ' ' ASP . 61.0 Cg_endo -73.32 -35.03 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.234 1.956 . . . . 0.0 111.703 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 325' ' ' GLN . 63.2 m-85 -57.81 -62.43 1.81 Allowed 'General case' 0 C--O 1.246 0.872 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 94' ' ' TRP . 1.8 t -62.58 -24.68 67.67 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.47 ' CZ3' ' HB3' ' A' ' 85' ' ' PHE . 36.5 m95 -93.43 -24.45 18.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.145 0.498 . . . . 0.0 111.877 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 91' ' ' PRO . 8.3 m-20 -71.08 -23.49 62.13 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.711 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.452 ' O ' ' CD2' ' A' ' 64' ' ' HIS . . . -71.91 -43.21 65.7 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 64' ' ' HIS . 27.2 m -102.54 43.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.45 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -128.81 139.47 52.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.507 ' O ' ' N ' ' A' ' 101' ' ' GLY . 3.2 t80 -118.48 90.74 3.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 119.262 0.937 . . . . 0.0 109.874 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.6 t30 48.29 -86.72 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . -127.63 39.2 1.97 Allowed Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.66 -177.34 5.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.48 0.312 . . . . 0.0 111.225 -178.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 168.71 128.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.399 0.545 . . . . 0.0 110.032 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.663 ' CG1' ' O ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -114.24 38.01 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.315 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . 168.81 169.67 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.07 132.88 23.78 Favored Pre-proline 0 CA--C 1.528 0.122 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.277 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.585 ' HA ' ' HB3' ' A' ' 263' ' ' SER . 90.8 Cg_endo -79.61 166.91 21.4 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.463 2.109 . . . . 0.0 113.211 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.654 ' N ' ' O ' ' A' ' 262' ' ' LEU . 0.6 OUTLIER -162.31 38.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.364 178.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . . . -179.8 136.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.166 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' A' ' 320' ' ' THR . 21.7 t -123.58 105.89 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -116.68 131.16 57.02 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 -178.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.45 ' N ' ' HG3' ' A' ' 229' ' ' PRO . . . -158.19 143.26 16.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.468 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.482 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 6.5 mp -77.89 143.43 37.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.936 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.8 m -133.3 169.46 16.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.76 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.16 128.41 36.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.406 ' CD1' HG21 ' A' ' 244' ' ' VAL . 8.0 tp -116.95 140.43 39.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -153.63 161.44 42.16 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.396 0.279 . . . . 0.0 111.554 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.409 ' CB ' ' HB3' ' A' ' 121' ' ' LEU . 18.7 m120 -97.52 139.03 34.04 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -109.9 -4.84 15.73 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-N 113.096 -1.865 . . . . 0.0 111.23 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -43.56 6.78 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 124.781 2.229 . . . . 0.0 105.455 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -76.35 -135.45 0.02 OUTLIER 'General case' 0 N--CA 1.396 -3.169 1 CA-C-N 107.678 -4.328 . . . . 0.0 113.216 -170.548 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.422 ' N ' HD23 ' A' ' 121' ' ' LEU . 1.6 mt -82.66 148.26 57.61 Favored Pre-proline 0 C--N 1.287 -2.132 0 N-CA-C 119.98 3.326 . . . . 0.0 119.98 -167.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -27.33 166.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 1 C-N-CA 130.354 7.369 . . . . 0.0 120.34 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -62.03 111.81 5.19 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.365 -172.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.96 167.78 25.45 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 124.055 3.17 . . . . 0.0 112.904 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -49.66 111.13 0.45 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 123.324 2.683 . . . . 0.0 115.573 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -76.45 -25.64 54.58 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.084 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.91 147.31 43.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.489 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.467 ' NE1' ' CE2' ' A' ' 250' ' ' PHE . 65.3 m95 -67.92 -37.89 82.23 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 175.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.451 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.9 mp0 -58.82 -23.84 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.563 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 0.5 OUTLIER -87.03 -16.14 36.55 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.578 ' CG1' ' HD3' ' A' ' 133' ' ' PRO . 4.0 pt -52.37 -37.98 50.33 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 118.683 0.674 . . . . 0.0 111.417 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.871 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 52.3 Cg_exo -52.93 -33.26 61.1 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 N-CA-C 109.549 -0.981 . . . . 0.0 109.549 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.99 -58.59 3.19 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.21 -42.28 80.06 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.653 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.7 OUTLIER -69.21 -32.41 71.65 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.871 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -47.92 -50.14 27.84 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.061 176.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.35 -43.5 98.68 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.924 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.517 ' HB3' ' C ' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -60.36 -49.4 77.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -47.9 -44.11 29.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.04 -27.35 0.91 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.507 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -60.03 1.69 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.288 0.566 . . . . 0.0 109.891 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.84 42.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 118.934 -0.925 . . . . 0.0 111.073 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.517 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 9.0 ptpt -154.27 -171.88 4.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 119.514 1.657 . . . . 0.0 111.419 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.424 ' N ' HD21 ' A' ' 139' ' ' LEU . 2.5 m -141.56 161.8 37.04 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.43 ' N ' HD11 ' A' ' 139' ' ' LEU . . . -75.47 -28.91 59.43 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.508 ' HG ' ' HB3' ' A' ' 224' ' ' MET . 5.7 mp -123.74 127.16 47.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.419 ' HG2' ' CB ' ' A' ' 216' ' ' ALA . 8.8 tpt -134.1 127.9 33.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 120.039 1.29 . . . . 0.0 109.845 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.968 ' O ' ' O ' ' A' ' 150' ' ' ASN . 37.3 p90 -170.4 177.22 4.15 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.968 ' O ' ' O ' ' A' ' 149' ' ' PHE . 2.9 t-20 -28.42 -156.79 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' A' ' 208' ' ' THR . 1.0 OUTLIER -178.15 40.58 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 120.992 -1.068 . . . . 0.0 111.055 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' A' ' 151' ' ' LEU . 1.9 pp0? 172.86 32.92 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 168.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 157' ' ' THR . 0.2 OUTLIER -103.87 114.45 64.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 119.991 1.269 . . . . 0.0 107.585 177.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.808 ' HA ' ' OG1' ' A' ' 157' ' ' THR . 5.8 Cg_exo -79.77 36.98 0.64 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 119.265 0.773 . . . . 0.0 113.706 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 1.227 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 3.7 m-85 -97.79 -52.01 3.89 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 172.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.663 ' HA ' ' HG2' ' A' ' 159' ' ' PRO . 42.5 t80 -74.66 -42.63 58.16 Favored 'General case' 0 C--O 1.251 1.141 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.808 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 1.5 p -58.05 -57.03 14.63 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.487 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.546 ' HA ' HG12 ' A' ' 161' ' ' ILE . 7.5 m0 -49.54 -52.51 49.55 Favored Pre-proline 0 C--N 1.351 0.648 0 CA-C-O 120.78 0.324 . . . . 0.0 110.75 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 1.227 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 51.5 Cg_exo -44.44 -50.05 8.42 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.625 2.217 . . . . 0.0 113.171 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.451 ' HG ' ' CZ ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -60.4 -56.84 16.55 Favored 'General case' 0 CA--C 1.51 -0.567 0 O-C-N 122.026 -0.421 . . . . 0.0 109.908 -179.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' A' ' 158' ' ' TRP . 14.1 pt -53.94 -22.6 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.831 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.23 -24.5 51.23 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.895 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 253' ' ' GLN . . . -41.19 -58.83 1.68 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.84 -58.06 7.96 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.345 -0.847 . . . . 0.0 112.6 -175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.69 21.38 0.03 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 117.648 -2.215 . . . . 0.0 116.823 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.12 160.13 40.15 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 119.086 1.443 . . . . 0.0 111.573 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -139.49 122.56 16.81 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.429 0.615 . . . . 0.0 109.743 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.424 ' O ' ' CG1' ' A' ' 183' ' ' VAL . . . -38.49 -78.54 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.291 0.567 . . . . 0.0 111.971 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.707 ' HB3' ' CB ' ' A' ' 176' ' ' TYR . 9.8 m-85 -113.64 176.07 5.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 1.135 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -101.54 102.1 12.78 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.05 114.51 18.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.53 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 23.9 tt0 -137.22 109.36 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.517 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 1.4 m-20 84.1 -32.38 0.07 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.862 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 160.28 13.9 0.03 OUTLIER Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.036 -0.869 . . . . 0.0 114.072 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -174.0 143.12 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.577 1.689 . . . . 0.0 110.943 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 1.135 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 37.0 p90 -64.98 -25.45 67.87 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.193 0.997 . . . . 0.0 110.805 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.465 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 55.8 m-20 72.37 -106.91 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.743 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 177' ' ' ASP . 38.0 mm -159.16 -48.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -70.83 -4.01 21.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.72 95.56 3.5 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.276 -0.569 . . . . 0.0 112.12 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 18.9 t -117.98 131.04 71.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.434 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . -121.4 39.73 2.3 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 119.47 -1.348 . . . . 0.0 114.092 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 168' ' ' ALA . 6.4 m -79.1 -40.78 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.414 ' HB2' HD23 ' A' ' 361' ' ' LEU . 58.8 t0 -69.9 58.61 0.15 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.899 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 182' ' ' GLY . 5.9 p30 -110.33 175.94 5.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.982 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -80.45 -19.57 45.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.835 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.64 -48.84 40.58 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.3 98.6 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -59.4 5.12 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.215 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 193' ' ' THR . . . -50.43 -41.66 52.87 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.253 1.025 . . . . 0.0 112.051 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -70.45 -60.51 4.67 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.659 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 9.2 tt -56.05 -29.26 60.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 190' ' ' ALA . 14.8 p -66.87 -41.09 87.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 194' ' ' PHE . 0.0 OUTLIER -59.48 -37.74 79.02 Favored 'General case' 0 C--N 1.349 0.563 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.72 -47.56 83.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.782 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 43.6 t -58.22 -29.88 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.28 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.18 -45.4 85.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.732 0.777 . . . . 0.0 110.969 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.2 mp -57.34 -57.02 14.47 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.77 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.406 ' HA ' ' HB3' ' A' ' 203' ' ' HIS . 3.8 mt -65.16 -32.33 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.969 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -38.61 71.73 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 118.56 -0.734 . . . . 0.0 111.042 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -113.41 -34.97 5.43 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 121.086 3.735 . . . . 0.0 121.086 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.67 -66.1 1.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 199' ' ' ILE . 0.2 OUTLIER -36.45 -34.54 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 203' ' ' HIS . 2.2 ttp -36.0 97.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.707 0.289 . . . . 0.0 111.63 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.95 -173.19 3.83 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.064 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -85.61 58.66 5.17 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.5 ' HA ' ' CD2' ' A' ' 151' ' ' LEU . 2.3 p30 37.85 74.13 0.09 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 30.8 p -55.18 121.4 8.74 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.59 -173.65 4.43 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.0 p90 -69.49 -45.39 69.05 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 1.7 m -70.18 -35.93 74.3 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.89 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.17 -48.44 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.745 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.0 -30.93 71.97 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -47.66 85.03 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.54 77.65 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.276 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.419 ' CB ' ' HG2' ' A' ' 148' ' ' MET . . . -54.27 -57.68 10.29 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.947 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.419 ' CD2' HD13 ' A' ' 235' ' ' ILE . 2.6 t80 -58.57 -29.6 66.53 Favored 'General case' 0 C--O 1.23 0.071 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -53.79 -40.41 66.27 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -74.66 -23.92 58.73 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 65.66 54.79 23.65 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.419 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -116.03 37.2 3.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.452 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.416 ' CG2' ' HB2' ' A' ' 148' ' ' MET . 82.8 p -144.56 143.53 30.86 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.773 0.796 . . . . 0.0 110.213 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -102.08 38.3 1.69 Allowed 'General case' 0 C--N 1.352 0.674 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.508 ' HB3' ' HG ' ' A' ' 147' ' ' LEU . 36.1 ttm 177.24 147.06 0.12 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.43 170.26 16.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.701 0.762 . . . . 0.0 111.558 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.476 HD12 HG22 ' A' ' 226' ' ' ILE . 24.8 mm -120.68 130.34 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 172.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -147.31 166.69 26.33 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 123.759 0.823 . . . . 0.0 110.474 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -108.15 -162.88 21.02 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.47 -0.395 . . . . 0.0 112.741 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.494 ' HG3' ' HG2' ' A' ' 111' ' ' GLU . 56.2 Cg_endo -87.54 -20.72 2.01 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.128 2.552 . . . . 0.0 114.081 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.451 ' N ' ' CD1' ' A' ' 230' ' ' TRP . 0.2 OUTLIER -178.65 -42.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.65 62.37 6.46 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.803 0.335 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -107.7 -63.06 1.35 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.781 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 169.2 -176.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.658 0.266 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.83 58.85 2.31 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.795 0.331 . . . . 0.0 110.72 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.419 HD13 ' CD2' ' A' ' 217' ' ' PHE . 14.6 tt -86.69 145.47 7.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.174 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -100.67 123.5 44.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.5 p -61.3 137.72 58.24 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.871 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -43.94 84.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.45 159.74 41.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.771 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.2 m -55.9 -40.02 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.648 0.261 . . . . 0.0 111.372 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 137.26 37.2 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.651 0.262 . . . . 0.0 110.741 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -149.23 137.31 20.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 111.323 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -95.0 133.4 11.52 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.007 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 116' ' ' ILE . 1.7 t -115.16 133.87 60.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.867 0.334 . . . . 0.0 111.268 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.76 167.56 17.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -170.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 45.9 t -73.29 154.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 113.893 -1.503 . . . . 0.0 107.871 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.8 mt -57.61 159.29 9.69 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.627 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -78.26 -157.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.926 2.417 . . . . 0.0 112.906 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 253' ' ' GLN . 11.0 p -125.29 169.47 12.26 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.467 ' CE2' ' NE1' ' A' ' 129' ' ' TRP . 0.2 OUTLIER -162.59 110.57 1.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.075 178.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.34 32.08 17.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.421 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.69 38.41 24.1 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.033 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.514 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 3.7 mt-30 -156.54 153.94 25.88 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 74.8 Cg_endo -86.37 -171.19 0.78 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.444 2.763 . . . . 0.0 113.263 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -109.28 141.02 42.19 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.988 0.423 . . . . 0.0 111.812 -179.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.517 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 5.5 ttmm -88.17 121.41 70.49 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.072 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.448 ' O ' ' HA2' ' A' ' 327' ' ' GLY . 55.1 Cg_endo -91.61 152.6 3.51 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.538 2.825 . . . . 0.0 114.417 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -78.12 157.28 29.52 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.56 121.82 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -125.11 119.52 3.63 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 118.673 -1.727 . . . . 0.0 117.069 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.511 HG22 ' CG ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -114.38 108.53 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.654 ' O ' ' N ' ' A' ' 108' ' ' ILE . 1.6 tp -83.41 109.12 17.05 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.585 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -113.05 -178.12 3.3 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.452 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . . . -111.01 128.81 55.97 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 67' ' ' PHE . . . -123.27 122.62 5.01 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.932 -1.128 . . . . 0.0 115.022 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.613 ' HA ' HG13 ' A' ' 59' ' ' ILE . 4.6 tp -90.86 122.47 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.438 ' HB2' HD13 ' A' ' 60' ' ' ILE . 62.7 t30 -61.82 141.89 57.66 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.23 -23.42 47.86 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.948 -0.47 . . . . 0.0 111.105 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -98.5 49.07 0.98 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.36 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 38.8 t -171.9 89.5 0.43 Allowed Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 272' ' ' ASN . 72.7 Cg_endo -76.42 164.19 31.12 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.625 2.217 . . . . 0.0 111.906 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 271' ' ' PRO . 0.2 OUTLIER 165.69 57.24 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.709 0.29 . . . . 0.0 110.938 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -56.3 -54.1 49.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.452 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -56.68 7.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.16 -48.58 79.43 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.78 -56.84 4.25 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.1 OUTLIER -55.67 -41.02 73.09 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.513 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -53.17 8.62 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 27' ' ' PHE . 2.4 t80 -55.09 -59.44 4.75 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.59 -43.19 35.78 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.815 0.817 . . . . 0.0 111.245 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 51.9 mt-10 -73.8 -35.36 64.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.37 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.414 ' O ' ' CG2' ' A' ' 286' ' ' THR . 3.6 m-20 -89.99 -16.39 29.94 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.479 ' O ' ' CG2' ' A' ' 286' ' ' THR . 28.0 t80 -103.72 -74.36 0.64 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.08 -27.57 0.98 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.07 39.41 1.48 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 283' ' ' TYR . 0.0 OUTLIER -140.72 152.83 45.6 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 175.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.792 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -62.93 -42.37 99.78 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -75.36 -19.39 59.61 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.548 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.456 ' HA3' HG22 ' A' ' 286' ' ' THR . . . -82.54 -55.13 3.09 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.433 HD12 ' CE2' ' A' ' 307' ' ' TYR . 0.2 OUTLIER -68.23 -28.46 67.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.792 ' HB2' ' O ' ' A' ' 287' ' ' ASP . 32.0 mt-10 -71.91 -32.39 67.34 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.453 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.39 80.37 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 296' ' ' ASP . 61.0 t -67.64 -61.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 297' ' ' LYS . 36.9 t-20 -46.41 -46.8 18.85 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.713 1.205 . . . . 0.0 112.545 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -48.87 79.49 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.788 ' O ' ' HD3' ' A' ' 298' ' ' PRO . 76.7 m-20 -58.04 -47.02 84.36 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 294' ' ' ASN . 0.9 OUTLIER -96.37 91.05 0.8 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.623 -178.101 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.788 ' HD3' ' O ' ' A' ' 296' ' ' ASP . 75.9 Cg_endo -106.83 93.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 124.318 3.346 . . . . 0.0 112.752 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 230' ' ' TRP . 1.5 mp -161.1 -80.72 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.103 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.431 ' C ' HD11 ' A' ' 317' ' ' ILE . . . -108.39 -160.28 20.16 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.573 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.531 ' HB1' HD13 ' A' ' 317' ' ' ILE . . . -79.17 74.32 5.73 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.074 0.464 . . . . 0.0 111.613 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 53.7 t -97.22 76.13 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.873 ' O ' ' O ' ' A' ' 304' ' ' LEU . . . -177.28 107.51 0.06 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.718 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 303' ' ' ALA . 5.9 mp -22.84 179.68 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.08 -55.47 30.7 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 83.2 p -57.09 -47.95 79.79 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-O 121.479 0.657 . . . . 0.0 111.761 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.433 ' CE2' HD12 ' A' ' 290' ' ' LEU . 88.7 m-85 -67.42 -54.57 19.19 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.158 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 312' ' ' ALA . 4.4 mt-10 -61.11 -36.83 80.75 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.717 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -48.12 -49.66 31.3 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.889 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -71.36 -41.27 69.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.087 0.946 . . . . 0.0 109.529 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.97 -16.63 5.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.036 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 308' ' ' GLU . . . -46.22 -30.46 2.0 Allowed 'General case' 0 C--N 1.342 0.271 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.455 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -48.38 -34.79 11.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.53 158.26 11.71 Favored Pre-proline 0 N--CA 1.462 0.145 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.489 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -85.85 -46.67 0.04 OUTLIER 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.485 2.124 . . . . 0.0 114.521 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -58.9 6.24 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.531 HD13 ' HB1' ' A' ' 301' ' ' ALA . 1.3 mm -49.67 -56.24 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.81 -51.87 12.16 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.356 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.01 92.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.725 0.774 . . . . 0.0 109.812 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 110' ' ' VAL . 29.8 m -58.81 -42.83 90.09 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.49 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.5 ttp -63.64 -53.21 55.11 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -39.0 58.46 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.156 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -74.94 -44.23 49.72 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.017 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -48.76 -45.39 39.74 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 110.333 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . 0.437 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 10.6 mt-30 -63.68 -39.06 93.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.952 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -69.7 -20.04 63.55 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.389 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 257' ' ' PRO . . . -79.85 155.7 39.29 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.131 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.23 138.23 34.13 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 23.5 mm -61.85 106.16 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 119.525 1.057 . . . . 0.0 110.904 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.14 107.03 0.73 Allowed Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 120.548 0.214 . . . . 0.0 111.14 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.15 -30.6 32.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.365 2.044 . . . . 0.0 112.141 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 68.2 91.56 0.09 Allowed 'General case' 0 C--N 1.339 0.12 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.295 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 335' ' ' GLN . 1.0 OUTLIER -133.91 144.91 53.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.195 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.36 -27.86 60.15 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.55 2.166 . . . . 0.0 111.979 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' A' ' 333' ' ' ILE . 2.1 mp0 -61.1 -25.21 66.8 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.136 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.2 mmt -46.13 -41.0 11.85 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.687 0.279 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.99 -39.27 65.92 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . 0.414 ' CB ' HG21 ' A' ' 368' ' ' ILE . . . -55.07 -29.42 57.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.319 0.58 . . . . 0.0 110.8 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -78.77 -55.73 4.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.048 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 35.4 t-105 -42.88 -44.69 4.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.842 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -76.57 -38.52 54.8 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.52 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.08 -44.55 76.04 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.441 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 17.8 m -73.13 -42.23 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.347 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -55.38 -57.14 13.1 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.006 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 1.1 m -58.1 -55.63 32.41 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.06 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -73.34 -60.96 2.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 48.7 t -51.73 -47.05 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.1 mt -72.27 -47.91 51.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.911 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 345' ' ' THR . 76.6 m-20 -67.57 -43.28 81.0 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 355' ' ' GLN . . . -78.38 -26.57 46.61 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -58.6 -10.12 2.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 23.2 t -110.63 31.24 6.12 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 91.21 33.15 8.3 Favored Glycine 0 N--CA 1.417 -2.595 0 C-N-CA 116.844 -2.598 . . . . 0.0 114.779 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -127.8 35.12 4.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.568 ' HA ' ' CB ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -70.01 -174.48 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 1 N-CA-C 122.295 4.183 . . . . 0.0 122.295 -159.352 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.542 ' HB ' ' CB ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER 173.9 57.7 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.347 179.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 79.1 t -46.28 -41.85 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 3.0 t0 -63.13 -38.5 91.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 118.902 0.774 . . . . 0.0 110.395 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.542 ' CB ' ' HB ' ' A' ' 356' ' ' THR . 0.4 OUTLIER -80.14 -29.59 38.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.634 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -67.05 -54.02 25.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.919 0.866 . . . . 0.0 112.507 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' A' ' 184' ' ' ASP . 0.8 OUTLIER -82.64 -36.4 26.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.758 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 23.1 tttp -59.75 -51.97 67.47 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.823 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -44.77 65.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.239 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 368' ' ' ILE . . . -72.54 -57.81 3.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.422 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.475 ' HA ' ' CG1' ' A' ' 368' ' ' ILE . 28.0 tt0 -55.94 -42.25 75.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.9 m -65.25 -48.09 74.46 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.654 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -73.78 -44.37 56.22 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.019 -0.425 . . . . 0.0 111.154 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.498 HG22 ' O ' ' A' ' 364' ' ' ALA . 2.1 pp -62.13 -32.95 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.507 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.46 61.49 1.64 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.908 0.385 . . . . 0.0 111.154 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 56.7 tptt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.849 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.613 0.244 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -154.24 139.98 18.04 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.062 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 32' ' ' GLY . . . -129.61 47.39 1.02 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.545 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -140.78 162.09 36.26 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.421 ' CD2' ' CZ ' ' A' ' 279' ' ' PHE . 0.0 OUTLIER -132.4 122.56 25.18 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.839 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 1.015 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -116.47 115.52 49.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.737 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 7.8 mt -120.74 131.11 73.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.935 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.515 ' CH2' ' CD1' ' A' ' 47' ' ' PHE . 3.3 m0 -107.38 123.44 48.37 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' CG1' HG23 ' A' ' 9' ' ' ILE . 3.4 mt -155.67 166.12 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.846 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.671 ' O ' ' N ' ' A' ' 14' ' ' ASP . 3.5 m120 -78.84 48.84 0.86 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 120.014 1.279 . . . . 0.0 111.255 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.524 ' HA3' ' HB3' ' A' ' 39' ' ' HIS . . . -8.28 59.78 0.0 OUTLIER Glycine 0 C--N 1.348 1.202 0 C-N-CA 124.843 1.211 . . . . 0.0 115.923 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.671 ' N ' ' O ' ' A' ' 12' ' ' ASN . 72.2 m-20 -100.0 3.77 44.42 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.017 0.437 . . . . 0.0 110.177 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 162.99 -164.62 0.0 OUTLIER 'General case' 0 C--N 1.347 0.491 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.863 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 296' ' ' ASP . . . 70.66 34.3 66.99 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 117.038 1.575 . . . . 0.0 117.038 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.18 -59.72 2.54 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 11.5 p-10 -46.35 -42.39 14.8 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.055 0.455 . . . . 0.0 111.945 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' HG21 ' A' ' 23' ' ' VAL . . . -70.34 -45.41 55.01 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.578 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.553 ' O ' HG21 ' A' ' 23' ' ' VAL . 18.7 mt -60.77 -49.69 76.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.446 0.623 . . . . 0.0 111.081 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.05 -39.49 63.47 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 3.1 mm-40 -64.52 -36.08 83.05 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.762 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 20' ' ' LEU . 23.2 m -67.87 -57.19 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.663 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 35' ' ' VAL . . . -49.58 -45.84 37.9 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.111 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 -50.41 41.21 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.263 1.03 . . . . 0.0 109.7 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -41.9 60.13 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.155 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.617 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.65 -25.94 67.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.088 0.947 . . . . 0.0 111.084 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.726 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 7.9 tt0 -73.2 -52.05 15.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.654 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -52.73 -28.54 22.58 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 124.514 1.134 . . . . 0.0 110.576 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.638 ' O ' ' CG2' ' A' ' 31' ' ' THR . 0.5 OUTLIER -84.09 -37.68 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 117.626 -1.178 . . . . 0.0 108.844 178.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.638 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.85 37.79 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 171.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' CA ' ' A' ' 5' ' ' GLY . . . 156.26 38.57 0.02 OUTLIER Glycine 0 N--CA 1.463 0.494 0 C-N-CA 114.989 -3.482 . . . . 0.0 119.299 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.726 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.8 mp -139.89 139.0 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 122.243 3.021 . . . . 0.0 117.005 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -142.36 104.51 4.43 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.473 ' CG2' ' HA3' ' A' ' 24' ' ' GLY . 38.1 t -82.8 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.9 p -117.5 137.43 52.55 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.008 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 6.9 m -130.69 121.55 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 O-C-N 122.231 -0.293 . . . . 0.0 110.507 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -111.83 133.83 53.79 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.524 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . 46.1 p-80 -106.08 71.29 0.25 Allowed Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 120.682 0.277 . . . . 0.0 111.462 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.517 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 86.6 Cg_endo -78.07 -171.68 1.27 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.274 2.649 . . . . 0.0 113.627 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -125.22 -60.24 1.35 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 0.57 34.12 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.045 0.45 . . . . 0.0 110.92 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.517 ' HB3' ' HG2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -32.91 -45.68 0.13 Allowed 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 1.014 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 3.6 tm-20 -47.11 -54.93 9.35 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.042 -0.411 . . . . 0.0 112.104 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.12 -48.8 21.98 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.785 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 50' ' ' VAL . 24.5 mtpt -63.51 -56.81 13.07 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.167 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.767 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.9 t80 -45.42 -58.44 5.89 Favored Pre-proline 0 C--O 1.225 -0.191 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 1.014 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 38.9 Cg_exo -65.78 -36.38 32.25 Favored 'Trans proline' 0 C--O 1.249 1.031 0 C-N-CA 121.088 1.192 . . . . 0.0 114.628 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -52.18 46.93 Favored 'General case' 0 C--O 1.259 1.588 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 175.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.533 ' O ' HG21 ' A' ' 53' ' ' THR . 12.0 m -61.56 -21.22 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 122.231 1.015 . . . . 0.0 111.637 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 48' ' ' PRO . . . -60.85 -29.31 69.45 Favored 'General case' 0 C--N 1.393 2.459 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.643 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.46 -26.8 32.33 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.411 1.484 . . . . 0.0 112.946 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 50' ' ' VAL . 13.1 t -92.47 95.79 9.85 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.083 -0.647 . . . . 0.0 112.073 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 102.27 -71.24 0.33 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.487 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 21.2 m-20 94.77 107.03 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.115 1.457 . . . . 0.0 110.461 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 57' ' ' PRO . . . -163.41 -59.05 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.388 -0.91 . . . . 0.0 114.039 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.525 ' O ' ' O ' ' A' ' 56' ' ' GLY . 59.0 Cg_exo -22.9 157.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.797 3.665 . . . . 0.0 115.937 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 1.015 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 5.1 t70 -79.95 -133.86 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.822 0 C-N-CA 125.241 1.416 . . . . 0.0 112.286 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 265' ' ' GLY . 5.5 mm -105.77 159.31 5.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.442 HG23 HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -128.52 136.01 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.45 -178.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -117.97 113.85 22.31 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 34.6 t-105 -166.48 165.14 17.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.988 0.515 . . . . 0.0 109.846 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -37.74 154.48 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.822 0.737 . . . . 0.0 112.11 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.605 ' CB ' ' HB ' ' A' ' 261' ' ' VAL . 9.1 t-80 -77.24 -28.3 53.62 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -50.46 -51.49 46.45 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.984 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -77.85 -27.3 49.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.303 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 4.6 m-85 -64.73 -28.62 69.71 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 174.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -60.48 -63.89 4.6 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 332' ' ' ASN . . . -54.9 -52.29 47.49 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 113.471 -1.365 . . . . 0.0 111.656 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 66' ' ' ARG . 4.8 m-30 -54.52 -45.87 73.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.738 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . . . -50.84 -40.7 56.59 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.852 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.22 -60.33 2.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 m -113.78 -26.76 8.05 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 75' ' ' LEU . . . -56.78 -86.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.078 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER 167.98 66.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.738 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . 1.7 mt -110.54 136.37 49.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 110.926 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.425 ' N ' HD13 ' A' ' 104' ' ' ILE . . . -102.23 106.33 17.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.456 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.423 ' HA ' HG12 ' A' ' 104' ' ' ILE . 77.7 mt-10 -47.75 154.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.927 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 105' ' ' ALA . 20.1 mt -109.41 136.81 44.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.053 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 m -112.97 82.74 5.46 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.834 0.349 . . . . 0.0 110.764 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.05 -173.86 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.738 2.292 . . . . 0.0 112.229 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -88.49 117.91 27.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.593 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -33.24 4.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.462 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -57.55 -27.12 62.36 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.429 ' CE2' HD23 ' A' ' 285' ' ' LEU . 11.6 t80 -79.23 -59.22 2.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.832 0.349 . . . . 0.0 110.314 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.47 ' HG2' ' CD1' ' A' ' 94' ' ' TRP . 1.3 tt0 -60.94 -33.25 72.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.966 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -76.68 -31.9 57.56 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.972 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 7.1 mtpm? -80.34 -1.6 41.79 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.71 -171.25 2.24 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.323 0.51 . . . . 0.0 110.994 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.23 117.24 52.69 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.667 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.55 -41.51 67.71 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.581 2.187 . . . . 0.0 112.671 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -50.03 -45.3 51.91 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.726 0.298 . . . . 0.0 111.323 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.41 ' O ' ' CG ' ' A' ' 107' ' ' PRO . 2.4 m -61.17 -28.23 68.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.47 ' CD1' ' HG2' ' A' ' 86' ' ' GLN . 17.8 m95 -92.95 -24.72 18.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.317 0.58 . . . . 0.0 111.985 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -73.91 -22.65 59.61 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.842 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.443 ' CB ' ' CG1' ' A' ' 261' ' ' VAL . . . -53.19 -48.16 68.3 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.498 ' CG2' ' CG1' ' A' ' 261' ' ' VAL . 3.8 t -103.09 39.6 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 134.58 40.31 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.4 OUTLIER -113.84 91.06 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.806 0.73 . . . . 0.0 110.751 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 31.5 t30 69.62 -70.2 0.15 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.085 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.96 -41.65 0.98 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.281 -0.962 . . . . 0.0 114.207 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -125.96 -178.28 4.24 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.369 0.584 . . . . 0.0 109.869 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -116.82 139.26 50.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.683 ' O ' ' HB1' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -96.13 38.0 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.977 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.683 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . 160.72 -179.67 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 264' ' ' ALA . 20.6 p90 -118.94 127.5 26.49 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.68 ' HB3' HG13 ' A' ' 261' ' ' VAL . 72.6 Cg_endo -79.58 165.66 22.57 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 C-N-CA 122.265 1.977 . . . . 0.0 112.731 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 262' ' ' LEU . 1.7 pt -160.89 38.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.807 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . . . 178.56 110.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.833 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 302' ' ' VAL . 17.0 t -98.43 111.26 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -103.15 163.12 12.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.624 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 320' ' ' THR . . . -164.88 150.29 9.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.537 0.684 . . . . 0.0 111.981 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 156' ' ' PHE . 4.6 pp -79.19 127.66 32.32 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 175.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.56 166.77 19.91 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.22 136.44 45.92 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 243' ' ' GLY . 1.8 mp -112.93 129.65 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.501 0.667 . . . . 0.0 111.764 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.551 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 24.6 p90 -94.33 -174.22 3.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.864 2.466 . . . . 0.0 110.156 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.577 ' CB ' ' HB2' ' A' ' 122' ' ' LEU . 0.4 OUTLIER -154.0 130.82 10.84 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.991 0.814 . . . . 0.0 110.002 177.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 43.15 1.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.151 0.887 . . . . 0.0 111.421 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.67 -71.76 0.34 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 110.474 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.35 38.48 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.406 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.577 ' HB2' ' CB ' ' A' ' 118' ' ' ASN . 71.2 mt -157.97 72.91 4.1 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.647 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.36 133.28 25.89 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.445 2.097 . . . . 0.0 113.398 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.522 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 1.8 p-10 -71.22 159.98 83.9 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 67.7 Cg_endo -72.97 167.84 26.28 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.551 2.834 . . . . 0.0 111.946 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.63 -139.56 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.662 2.241 . . . . 0.0 113.312 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -17.62 35.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.91 0.777 . . . . 0.0 112.518 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.13 142.17 47.71 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.457 ' CZ2' ' CD2' ' A' ' 147' ' ' LEU . 6.3 t-105 -71.23 -28.39 64.15 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 173.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.547 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -44.49 -23.49 0.12 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.61 -21.25 62.67 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 2.1 tp -45.94 -47.28 41.88 Favored Pre-proline 0 N--CA 1.475 0.782 0 CA-C-N 118.579 0.627 . . . . 0.0 112.297 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 11.9 Cg_endo -52.48 -42.2 62.89 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 109.398 -1.039 . . . . 0.0 109.398 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.3 -58.7 3.12 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.453 ' O ' HD12 ' A' ' 139' ' ' LEU . 3.1 mm? -67.79 -35.51 78.79 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.689 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 132' ' ' ILE . 20.0 t0 -74.97 -41.55 59.35 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -49.86 -42.17 46.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.806 177.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.59 -36.26 80.54 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.509 ' HB3' ' C ' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -65.21 -46.68 79.68 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.78 -44.1 38.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -45.97 -23.48 0.3 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.645 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -113.06 -58.75 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.446 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.78 53.41 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.509 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -167.01 -172.99 2.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 120.15 1.975 . . . . 0.0 110.013 -177.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.482 ' N ' HD21 ' A' ' 139' ' ' LEU . 54.5 m -144.27 165.13 28.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.455 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -79.51 -20.34 47.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.457 ' CD2' ' CZ2' ' A' ' 129' ' ' TRP . 4.4 pp -152.48 178.26 9.74 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.509 ' HB2' ' CG2' ' A' ' 222' ' ' THR . 0.0 OUTLIER -179.21 143.34 0.2 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.336 178.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.486 ' O ' ' O ' ' A' ' 150' ' ' ASN . 26.4 p90 -172.85 175.93 3.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.746 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 149' ' ' PHE . 3.0 m120 -37.01 164.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.767 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 208' ' ' THR . 1.0 OUTLIER -110.51 -58.69 2.05 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -102.71 35.59 2.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 116.92 -1.912 . . . . 0.0 114.035 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.787 ' O ' ' HB ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -79.63 144.23 60.41 Favored Pre-proline 0 C--O 1.221 -0.42 0 CA-C-N 121.957 2.162 . . . . 0.0 114.932 -175.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.941 ' O ' ' N ' ' A' ' 156' ' ' PHE . 6.3 Cg_exo -78.07 -135.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 1 C-N-CA 125.72 4.28 . . . . 0.0 106.945 177.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 1.123 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 1.8 m-85 16.96 -51.87 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.941 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.2 OUTLIER -84.61 -55.92 3.87 Favored 'General case' 0 C--O 1.259 1.562 0 C-N-CA 124.452 1.101 . . . . 0.0 112.129 -178.324 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.787 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 95.9 m -57.71 -42.53 83.97 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.486 ' CE3' ' HA ' ' A' ' 154' ' ' PRO . 0.7 OUTLIER -51.16 -55.71 26.1 Favored Pre-proline 0 C--N 1.349 0.564 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 1.123 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 40.1 Cg_exo -43.13 -50.65 6.25 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.166 2.578 . . . . 0.0 113.284 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mt -61.83 -56.75 16.11 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 119.925 1.238 . . . . 0.0 109.832 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.6 mm -52.85 -18.74 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.153 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.03 -25.88 48.09 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -43.09 -58.61 2.38 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.497 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 9.3 t0 -65.0 -28.64 69.64 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.406 ' N ' ' HA3' ' A' ' 187' ' ' GLY . . . 147.32 23.44 0.09 OUTLIER Glycine 0 CA--C 1.526 0.721 0 C-N-CA 118.516 -1.802 . . . . 0.0 116.946 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -104.2 86.77 0.53 Allowed Glycine 0 C--N 1.335 0.503 0 CA-C-N 119.021 1.411 . . . . 0.0 113.225 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -104.74 -179.46 3.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.007 0.403 . . . . 0.0 110.04 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.407 ' HB2' ' CD2' ' A' ' 169' ' ' PHE . . . -97.71 -78.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.152 0.501 . . . . 0.0 111.013 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.631 ' HB3' ' CD1' ' A' ' 176' ' ' TYR . 1.1 m-85 -125.89 172.78 9.61 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.041 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 1.217 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.8 OUTLIER -112.57 139.3 48.27 Favored 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -174.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.97 116.56 29.13 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.641 ' O ' ' C ' ' A' ' 173' ' ' ASN . 2.7 mm-40 -137.44 178.66 6.93 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.147 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.641 ' C ' ' O ' ' A' ' 172' ' ' GLU . 4.8 m120 -20.05 -64.4 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -80.79 -71.9 1.25 Allowed Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -174.57 170.02 3.55 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.891 1.346 . . . . 0.0 107.439 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 1.217 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 1.3 p90 -49.95 -33.43 17.59 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 123.102 1.43 . . . . 0.0 109.908 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.435 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 12.9 m-20 65.2 -76.84 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.463 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.436 ' CD1' ' HB ' ' A' ' 369' ' ' THR . 0.0 OUTLIER 174.7 -51.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -51.78 -47.73 64.07 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.478 ' CB ' ' HD3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -77.96 91.66 4.24 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.825 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 178' ' ' ILE . 4.2 t -112.54 152.41 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.536 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -115.09 40.11 2.56 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 114.84 -1.073 . . . . 0.0 114.579 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 184' ' ' ASP . 35.4 m -90.17 -32.41 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.812 0.306 . . . . 0.0 111.135 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.419 ' N ' HG23 ' A' ' 183' ' ' VAL . 40.6 t0 -100.67 59.39 0.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.274 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -115.72 145.89 42.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.643 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.54 -25.64 67.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.173 0.511 . . . . 0.0 111.69 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -77.29 -33.58 43.81 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-O 119.093 -0.837 . . . . 0.0 114.938 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.99 -56.51 21.04 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -57.53 -60.15 4.1 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.002 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -50.47 -41.85 53.59 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.685 0.755 . . . . 0.0 112.035 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -62.27 -60.66 7.59 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.412 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -24.41 59.41 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 122.539 -0.389 . . . . 0.0 110.175 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 32.3 m -66.83 -49.26 66.34 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 2.7 p90 -61.59 -34.41 75.57 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 194' ' ' PHE . 0.7 OUTLIER -63.93 -47.94 78.5 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.59 -29.89 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.223 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.85 -46.92 82.81 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.599 0.714 . . . . 0.0 110.905 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.1 tp -61.07 -53.65 54.49 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.1 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 204' ' ' MET . 3.6 mt -62.37 -44.54 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.806 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -52.32 -36.93 54.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.907 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -113.18 -34.51 5.65 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 121.051 3.722 . . . . 0.0 121.051 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -62.22 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.863 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -5.4 26.92 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 6.1 ptm 41.7 37.6 0.78 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -139.56 162.07 35.98 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -147.93 24.03 1.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.45 -3.06 34.5 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -56.19 117.92 4.22 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -95.71 -174.15 3.07 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.735 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -67.27 -47.09 71.74 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.017 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -77.2 -25.38 51.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.572 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 3.7 mt -81.62 -52.08 14.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.691 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 150' ' ' ASN . . . -52.4 -38.07 58.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -61.61 -44.94 96.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.61 -38.38 71.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.186 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.63 -56.82 15.85 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -66.54 -28.45 68.55 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -58.52 -34.33 70.85 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.174 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.19 -23.73 59.26 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.96 28.51 58.6 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 119.204 -0.776 . . . . 0.0 114.829 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -107.67 37.19 2.49 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.914 1.357 . . . . 0.0 111.082 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 148' ' ' MET . 82.4 p -138.81 139.38 38.19 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -104.87 38.55 1.89 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.446 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.557 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.9 OUTLIER 170.54 134.59 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 86.3 m -147.88 158.89 44.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.74 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.457 ' O ' ' CE2' ' A' ' 156' ' ' PHE . 12.0 pt -115.7 112.87 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -147.76 165.3 30.95 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.969 -0.457 . . . . 0.0 112.141 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -136.39 -163.98 10.05 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 119.42 1.009 . . . . 0.0 111.297 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -98.99 5.97 0.99 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.346 2.698 . . . . 0.0 114.129 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 232' ' ' TRP . 36.7 t-105 -85.58 -80.99 0.21 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.302 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.98 42.84 1.68 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.693 0.282 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.505 ' CZ2' ' CD1' ' A' ' 156' ' ' PHE . 5.1 m-90 -149.07 59.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.891 0.377 . . . . 0.0 110.961 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 p -57.82 -43.02 85.45 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -67.26 74.19 0.13 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.731 0.3 . . . . 0.0 110.575 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 12.8 tt -147.02 153.98 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.11 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.437 ' HB3' ' CG ' ' A' ' 242' ' ' TYR . 83.6 m-20 61.86 41.59 11.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.637 0.256 . . . . 0.0 110.858 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.0 t -142.09 48.37 1.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.771 0.32 . . . . 0.0 110.983 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.96 -65.08 1.05 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.732 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.68 -62.47 1.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.735 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -168.73 -52.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.616 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.62 95.06 10.1 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.625 0.25 . . . . 0.0 111.079 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.437 ' CG ' ' HB3' ' A' ' 236' ' ' ASP . 44.1 p90 -98.99 146.68 25.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.466 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.551 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -130.44 160.25 23.03 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.112 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.3 m -135.78 134.54 51.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.764 0.282 . . . . 0.0 110.889 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.04 167.57 21.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.839 0.855 . . . . 0.0 110.506 -174.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.76 152.24 7.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.71 159.4 44.17 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 120.513 1.506 . . . . 0.0 111.204 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.32 -164.49 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.598 2.198 . . . . 0.0 111.532 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.463 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -116.34 177.62 4.62 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.501 -178.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 249' ' ' THR . 55.1 m-85 -164.57 110.05 0.98 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.847 0.832 . . . . 0.0 109.749 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.91 33.43 21.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.956 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.72 39.03 30.24 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.747 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.78 147.59 17.16 Favored Pre-proline 0 N--CA 1.464 0.255 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -91.15 125.73 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.466 2.777 . . . . 0.0 111.89 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 12.2 t -47.02 150.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 159' ' ' PRO . 6.7 tppt? -85.21 108.97 17.71 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.013 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.594 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 5.4 Cg_exo -79.29 142.53 16.86 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.144 2.562 . . . . 0.0 112.737 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -79.91 154.61 28.21 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 329' ' ' ILE . 54.6 t -113.08 135.59 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -123.51 118.41 3.5 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 118.873 -1.632 . . . . 0.0 115.912 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.68 HG13 ' HB3' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -110.63 111.9 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.597 ' O ' ' N ' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -88.73 99.68 12.54 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 117.659 -1.616 . . . . 0.0 107.518 177.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.513 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 43.7 p -136.55 135.44 38.46 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 118.878 2.918 . . . . 0.0 118.878 -173.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . -88.48 112.86 23.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.467 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -102.86 162.83 16.2 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.45 ' HA ' HG21 ' A' ' 59' ' ' ILE . 87.0 mt -88.2 123.58 40.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 118.929 1.364 . . . . 0.0 107.726 176.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -65.51 146.22 55.13 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.2 -23.47 55.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.162 0.437 . . . . 0.0 111.284 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.05 -59.1 4.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.573 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.3 m -143.23 127.87 9.68 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.607 0.242 . . . . 0.0 111.231 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -78.88 -39.64 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.541 2.16 . . . . 0.0 112.96 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 276' ' ' ALA . 2.7 m120 55.54 85.05 0.07 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-O 120.62 0.248 . . . . 0.0 110.519 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.1 OUTLIER -72.24 -54.17 10.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -75.41 -57.34 3.95 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 5.9 mt -53.52 -49.09 68.33 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 272' ' ' ASN . . . -71.09 -51.85 22.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 273' ' ' LYS . 9.8 mtpp -48.84 -53.22 20.23 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.306 0.574 . . . . 0.0 112.277 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 47.4 mm-40 -68.73 -30.2 68.78 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.944 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.484 ' CD2' ' CE2' ' A' ' 27' ' ' PHE . 14.8 t80 -73.71 -40.33 63.68 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.427 HD22 ' CE1' ' A' ' 106' ' ' TYR . 5.7 mp -81.69 -43.89 17.87 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.94 0.876 . . . . 0.0 112.654 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 285' ' ' LEU . 13.5 mt-10 -70.45 -43.53 69.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 113.912 -1.494 . . . . 0.0 112.643 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 3.7 t-20 -80.89 -32.23 34.9 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.996 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.493 ' CE1' ' CE2' ' A' ' 27' ' ' PHE . 4.3 m-85 -101.89 -82.34 0.48 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.411 HD23 ' CE2' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -39.38 -33.98 0.18 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.528 ' HB2' ' HA ' ' A' ' 281' ' ' GLU . 0.4 OUTLIER -94.45 39.98 1.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.647 HG21 ' H ' ' A' ' 289' ' ' GLY . 11.3 t -146.62 161.91 39.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 1.2 m-20 -62.49 -13.07 26.35 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.049 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 41.2 mt-10 -77.94 -46.65 20.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.662 0.664 . . . . 0.0 111.22 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.647 ' H ' HG21 ' A' ' 286' ' ' THR . . . -87.02 -41.79 6.54 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.451 ' O ' HG22 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -59.9 -46.55 88.98 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 287' ' ' ASP . 3.4 mm-40 -79.0 -26.66 43.26 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -71.33 -37.54 71.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.671 1.123 . . . . 0.0 109.159 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 290' ' ' LEU . 33.1 m -67.5 -40.03 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.439 ' N ' HG21 ' A' ' 293' ' ' VAL . 16.3 t-20 -80.22 -39.39 29.19 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 123.838 0.855 . . . . 0.0 113.003 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -64.78 -40.17 94.8 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.543 ' CA ' ' HA2' ' A' ' 16' ' ' GLY . 10.9 m-20 -59.99 -64.43 0.95 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 103.52 35.84 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.758 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -95.99 90.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.621 2.88 . . . . 0.0 112.424 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.24 -74.74 0.32 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -98.71 156.08 20.16 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.165 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.42 ' O ' HG12 ' A' ' 317' ' ' ILE . . . -121.47 52.73 1.21 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 117.046 0.423 . . . . 0.0 111.62 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.422 ' CG1' ' CG2' ' A' ' 110' ' ' VAL . 10.8 p -136.4 84.12 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.888 0.375 . . . . 0.0 111.521 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 304' ' ' LEU . . . -166.33 95.23 0.55 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.845 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 307' ' ' TYR . 8.4 tp 93.76 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.94 0.496 . . . . 0.0 112.015 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -32.63 -35.07 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.784 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -44.83 47.09 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.961 0.886 . . . . 0.0 110.257 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.538 ' HB3' ' HB3' ' A' ' 304' ' ' LEU . 1.2 t80 -76.65 -23.26 53.28 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.016 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -76.6 -42.84 40.96 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.08 -43.8 86.3 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.963 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -67.32 -53.4 29.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.919 0.39 . . . . 0.0 110.624 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 307' ' ' TYR . 1.1 tt -67.06 -41.24 86.76 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.291 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 313' ' ' LYS . . . -46.59 -15.5 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 312' ' ' ALA . 8.8 tttp -31.04 -43.48 0.05 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.512 0.596 . . . . 0.0 110.433 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 3.6 t0 -87.73 139.17 31.25 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 3.0 Cg_exo -75.48 3.89 5.46 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.659 2.239 . . . . 0.0 114.578 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -59.22 5.75 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 301' ' ' ALA . 2.8 tp -49.78 -55.61 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.62 -50.35 13.38 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.375 0.534 . . . . 0.0 111.758 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.6 -44.29 85.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.858 0.837 . . . . 0.0 110.026 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -65.55 -32.61 74.3 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.896 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -46.35 18.5 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.723 0.296 . . . . 0.0 110.437 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.67 -42.51 79.12 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.444 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -78.4 -38.62 41.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.637 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.412 ' CB ' ' CG1' ' A' ' 110' ' ' VAL . . . -51.88 -52.74 47.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.26 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -58.19 -29.64 65.81 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.858 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -12.67 60.08 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.381 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.594 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -79.79 163.81 48.1 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.936 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.35 139.69 32.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.546 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.0 mt -91.47 110.26 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 119.572 1.078 . . . . 0.0 110.5 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.436 ' HA ' ' HD2' ' A' ' 331' ' ' PRO . 1.4 ptp -45.2 101.88 0.28 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.132 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.456 ' HG3' ' CD2' ' A' ' 176' ' ' TYR . 4.4 Cg_endo -46.49 -35.67 16.85 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.025 2.483 . . . . 0.0 112.14 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 331' ' ' PRO . 0.6 OUTLIER 85.56 83.33 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.2 158.2 76.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 118.338 0.517 . . . . 0.0 111.758 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.2 -50.72 5.47 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.963 2.442 . . . . 0.0 112.693 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 368' ' ' ILE . 79.2 mm-40 -53.22 -21.82 5.84 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 3.6 tpt -45.49 -35.07 3.57 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 122.222 -0.299 . . . . 0.0 111.323 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 14.9 p -59.77 -40.21 87.43 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.615 0.245 . . . . 0.0 110.542 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -58.11 -32.03 67.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.112 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.505 ' CE1' ' CG2' ' A' ' 343' ' ' VAL . 2.3 t80 -77.96 -55.66 5.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.448 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.456 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 6.6 t-105 -46.98 -42.83 18.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.862 0.363 . . . . 0.0 110.913 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.96 -49.92 40.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.658 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.15 -44.63 87.99 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.505 ' CG2' ' CE1' ' A' ' 339' ' ' PHE . 19.6 t -71.13 -29.68 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.723 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -74.82 -43.9 52.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 348' ' ' ILE . 1.7 p -64.48 -58.32 6.76 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.94 -38.65 4.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.637 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.1 t -58.82 -48.59 85.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.462 HG22 HD13 ' A' ' 348' ' ' ILE . 58.5 mt -64.41 -27.97 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 346' ' ' ALA . 6.0 m120 -64.43 -36.9 85.68 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.459 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.766 ' HA ' ' HG3' ' A' ' 355' ' ' GLN . . . -78.78 -26.59 44.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.56 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.94 -14.36 62.91 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 354' ' ' ARG . 2.5 t -110.66 16.96 21.13 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.56 5.91 1.4 Allowed Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 119.71 1.141 . . . . 0.0 112.382 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 352' ' ' SER . 26.4 ttt85 -93.63 35.75 1.11 Allowed 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 115.522 -2.18 . . . . 0.0 107.812 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.766 ' HG3' ' HA ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -66.98 -170.42 0.11 Allowed 'General case' 0 CA--C 1.547 0.843 1 N-CA-C 123.881 4.771 . . . . 0.0 123.881 -156.917 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 159.59 39.95 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 112.47 -2.15 . . . . 0.0 108.174 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.418 ' HB ' ' OE1' ' A' ' 355' ' ' GLN . 7.5 p -57.67 -48.84 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.757 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 1.2 m-20 -52.21 -43.85 64.46 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.388 0.613 . . . . 0.0 110.986 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -75.8 -53.83 7.87 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 114.784 -1.098 . . . . 0.0 113.025 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -54.32 -44.31 71.94 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.956 0.884 . . . . 0.0 112.791 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 364' ' ' ALA . 79.7 mt -77.82 -37.13 49.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.681 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 1.2 tmtm? -63.88 -56.34 16.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.977 0.894 . . . . 0.0 109.631 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.07 -32.24 70.75 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.252 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 361' ' ' LEU . . . -58.14 -42.43 85.87 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.829 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 366' ' ' THR . 0.7 OUTLIER -64.4 -36.12 83.13 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.477 ' N ' ' HG3' ' A' ' 365' ' ' GLN . 87.7 m -57.93 -34.57 70.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -71.1 -35.58 71.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.08 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.406 ' CD1' ' HB3' ' A' ' 335' ' ' GLN . 4.2 mm -75.83 -39.53 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.675 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.436 ' HB ' ' CD1' ' A' ' 178' ' ' ILE . 13.9 p -88.01 -20.93 25.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.022 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 366' ' ' THR . 2.0 mtmp? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.989 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.738 0.304 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -177.12 154.74 1.09 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.244 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -128.66 63.17 0.62 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.469 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.29 160.77 42.79 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -155.25 122.62 5.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.189 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.65 ' HB ' ' CB ' ' A' ' 57' ' ' PRO . 24.0 t -116.94 124.95 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.482 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 59' ' ' ILE . 3.1 mp -123.7 130.47 74.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.475 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 73.3 m95 -102.66 128.67 49.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.024 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.45 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 1.5 tt -158.49 137.84 3.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 O-C-N 122.163 -0.336 . . . . 0.0 111.298 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -114.18 39.98 2.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.749 0.309 . . . . 0.0 111.081 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.1 -11.55 58.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.604 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.3 m-20 65.54 60.92 0.71 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.022 0.411 . . . . 0.0 110.743 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 1.2 mtpt 162.69 -173.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.183 0.516 . . . . 0.0 111.917 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.38 23.46 70.7 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 20.9 p90 -80.83 -34.46 33.85 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.78 0.79 . . . . 0.0 111.378 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 1.2 t-20 -66.69 -50.66 62.13 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.769 0.319 . . . . 0.0 111.742 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.57 -48.79 27.62 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.841 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.51 ' O ' HG12 ' A' ' 23' ' ' VAL . 10.3 mp -58.9 -49.19 78.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.845 0.823 . . . . 0.0 110.055 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.416 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -67.47 -37.72 83.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -67.19 -37.6 83.95 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.634 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 20' ' ' LEU . 3.7 p -67.65 -58.72 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.636 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.518 ' HA3' HG13 ' A' ' 35' ' ' VAL . . . -49.12 -34.18 16.26 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.246 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -50.47 67.62 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.51 1.148 . . . . 0.0 107.907 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -42.23 63.61 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-N 112.793 -2.003 . . . . 0.0 108.543 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.579 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 22.0 m-85 -65.75 -35.71 81.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.657 0.741 . . . . 0.0 111.083 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.772 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -70.85 -51.35 27.06 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.407 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -52.36 -28.56 19.99 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 125.076 1.485 . . . . 0.0 111.365 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.609 ' O ' ' CG2' ' A' ' 31' ' ' THR . 20.6 t70 -85.78 -38.71 17.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.581 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.609 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 162.88 38.05 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 172.222 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.458 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 156.43 38.7 0.02 OUTLIER Glycine 0 N--CA 1.466 0.682 0 C-N-CA 114.986 -3.483 . . . . 0.0 118.837 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.772 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.8 mp -139.89 107.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 121.532 2.666 . . . . 0.0 116.022 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.14 104.72 12.4 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.518 HG13 ' HA3' ' A' ' 24' ' ' GLY . 33.6 m -100.95 133.9 42.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -174.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -119.12 146.8 44.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.05 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 4.7 m -132.98 122.15 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.692 0.282 . . . . 0.0 110.302 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.51 134.03 48.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.263 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.423 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 9.1 p80 -139.7 71.03 37.25 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-O 120.927 0.394 . . . . 0.0 111.172 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HG2' ' CA ' ' A' ' 43' ' ' LEU . 58.2 Cg_endo -87.99 -177.73 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.218 2.612 . . . . 0.0 112.362 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.37 -40.14 14.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.67 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 43' ' ' LEU . 68.8 mmtt -86.47 0.68 53.68 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.312 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.51 ' CA ' ' HG2' ' A' ' 40' ' ' PRO . 10.2 tt -19.53 -62.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 1.059 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -46.52 -50.86 16.54 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -178.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 3.1 tt0 -71.98 -44.04 64.17 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.936 0.398 . . . . 0.0 110.782 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -56.62 -56.02 26.59 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.129 0.966 . . . . 0.0 110.496 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.677 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.8 t80 -45.37 -60.75 2.93 Favored Pre-proline 0 C--N 1.346 0.414 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.0 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 1.059 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 35.2 Cg_exo -61.91 -28.08 80.68 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 121.327 1.351 . . . . 0.0 113.858 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -80.98 -37.29 29.56 Favored 'General case' 0 C--O 1.256 1.416 0 CA-C-O 122.365 1.078 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.87 ' O ' ' N ' ' A' ' 54' ' ' GLY . 18.5 m -75.69 -40.51 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 CA-C-O 121.996 0.903 . . . . 0.0 109.686 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.404 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -48.38 -38.65 19.97 Favored 'General case' 0 C--N 1.365 1.261 0 C-N-CA 125.945 1.698 . . . . 0.0 111.275 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.94 -37.32 29.72 Favored 'General case' 0 C--N 1.37 1.465 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.974 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -118.09 17.48 14.04 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.911 0.778 . . . . 0.0 109.035 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.87 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -137.81 62.82 0.57 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -82.0 38.69 0.54 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.751 0.776 . . . . 0.0 112.731 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 57' ' ' PRO . . . -93.78 -39.85 4.83 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.602 -0.809 . . . . 0.0 114.451 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.65 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 34.0 Cg_endo -91.94 157.86 3.35 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.49 2.793 . . . . 0.0 112.953 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.07 35.43 4.12 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 117.663 -1.615 . . . . 0.0 114.823 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 1.9 mt -152.45 127.91 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 118.181 -1.408 . . . . 0.0 114.443 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.464 HG12 ' CE1' ' A' ' 47' ' ' PHE . 3.9 mp -139.27 122.83 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.613 0.244 . . . . 0.0 111.629 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 35.9 t80 -113.88 121.29 43.53 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.977 0.417 . . . . 0.0 110.151 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.425 ' CZ2' HD11 ' A' ' 76' ' ' LEU . 3.1 p90 -166.43 167.29 15.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.995 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -45.66 160.13 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.956 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.706 ' CB ' ' HB ' ' A' ' 261' ' ' VAL . 23.0 t-80 -77.63 -29.45 51.76 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -48.91 -54.13 16.74 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.629 0.728 . . . . 0.0 112.398 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -78.37 -30.73 48.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.181 0.515 . . . . 0.0 109.968 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.634 ' HB3' ' HA ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -56.37 -33.08 65.37 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -55.58 -68.0 1.92 Allowed Glycine 0 C--N 1.354 1.558 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.03 -54.49 31.07 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 112.451 -1.875 . . . . 0.0 111.218 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.445 ' HB3' ' CB ' ' A' ' 75' ' ' LEU . 16.5 m-85 -48.66 -41.19 30.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -51.8 -44.78 63.6 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -42.75 25.58 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 p -69.94 -26.65 64.23 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.97 4.02 10.51 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 119.968 -1.11 . . . . 0.0 114.283 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.472 ' CD1' ' CZ ' ' A' ' 47' ' ' PHE . 1.1 mm? -96.9 45.86 1.05 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.271 1.036 . . . . 0.0 110.738 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.498 ' CD1' ' CD2' ' A' ' 67' ' ' PHE . 0.5 OUTLIER 176.88 138.04 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 113.273 -1.785 . . . . 0.0 106.571 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.6 ' HB1' ' H ' ' A' ' 268' ' ' ALA . . . -135.16 138.78 44.02 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 118.391 -1.323 . . . . 0.0 111.585 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -47.42 137.07 9.0 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.554 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.509 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 7.8 mt -122.46 162.3 22.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.115 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.9 p -106.18 82.87 1.0 Allowed Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.399 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 67.0 Cg_endo -84.48 -171.51 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.949 2.433 . . . . 0.0 112.345 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -105.46 156.06 18.56 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.822 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -92.26 -38.88 11.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.364 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.5 -23.25 57.53 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.455 ' CE2' ' CD2' ' A' ' 285' ' ' LEU . 10.2 t80 -69.09 -59.3 3.12 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.904 0.383 . . . . 0.0 110.05 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 94' ' ' TRP . 1.3 mt-30 -66.48 -24.63 66.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.677 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.62 -34.04 62.72 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -76.46 -10.01 59.07 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.463 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -125.15 -159.76 0.91 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.28 -179.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -80.0 119.23 75.96 Favored Pre-proline 0 C--N 1.339 0.151 0 O-C-N 122.292 -0.255 . . . . 0.0 111.574 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.32 -32.93 97.14 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.369 2.046 . . . . 0.0 112.206 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 325' ' ' GLN . 17.3 m-85 -52.99 -53.69 46.23 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.158 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.51 ' O ' ' HG2' ' A' ' 107' ' ' PRO . 10.0 t -62.62 -23.38 67.04 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.463 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 6.1 m95 -93.18 -25.6 17.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.054 0.454 . . . . 0.0 111.798 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -75.41 -20.78 58.7 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.66 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.45 ' CB ' ' CG1' ' A' ' 261' ' ' VAL . . . -56.03 -50.41 71.0 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.469 ' HA ' ' CD2' ' A' ' 64' ' ' HIS . 9.1 p -100.42 41.38 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.431 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -97.82 135.77 39.11 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.668 -0.645 . . . . 0.0 109.872 178.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.4 t80 -99.94 174.86 5.99 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.02 -0.425 . . . . 0.0 110.081 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -64.87 73.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.674 0.273 . . . . 0.0 110.703 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 138.57 -47.8 0.91 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.051 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -145.99 175.57 10.35 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 117.179 0.49 . . . . 0.0 110.926 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -118.89 119.69 35.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 105' ' ' ALA . 3.3 mp -94.99 39.38 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.7 ' HB3' ' HA2' ' A' ' 265' ' ' GLY . . . 167.14 -178.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.458 ' CE2' ' CD1' ' A' ' 280' ' ' LEU . 48.3 p90 -132.97 121.5 16.94 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.015 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.713 ' HA ' ' CB ' ' A' ' 263' ' ' SER . 6.3 Cg_exo -79.41 172.39 14.61 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.177 2.585 . . . . 0.0 113.727 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 262' ' ' LEU . 2.2 tt -168.9 39.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 119.586 -0.846 . . . . 0.0 112.713 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 262' ' ' LEU . . . -174.92 110.4 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.905 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.5 m -96.89 117.14 40.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.599 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.452 ' CG ' ' CH2' ' A' ' 230' ' ' TRP . 33.1 mt-10 -102.89 146.85 27.67 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.552 0.691 . . . . 0.0 110.766 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -165.26 139.05 4.72 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.385 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.579 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 0.4 OUTLIER -77.94 137.74 38.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.642 -179.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.15 163.5 28.38 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 tt -93.63 130.11 39.67 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.1 tt -115.62 138.74 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.619 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.446 ' CD1' HD22 ' A' ' 122' ' ' LEU . 3.9 m-85 -117.2 138.58 51.6 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -85.17 119.78 25.93 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -90.82 60.83 4.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.899 0.38 . . . . 0.0 111.421 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.89 -51.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.86 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' CB ' ' A' ' 223' ' ' ALA . 5.6 mt -118.96 38.4 3.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.43 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.579 ' HB2' ' CB ' ' A' ' 223' ' ' ALA . 0.4 OUTLIER -157.69 108.06 1.8 Allowed Pre-proline 0 CA--C 1.521 -0.15 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.687 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 9.2 Cg_endo -90.51 130.3 1.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.302 2.001 . . . . 0.0 112.443 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 81.4 m-20 -64.4 127.13 91.85 Favored Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -172.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 124' ' ' ASN . 55.5 Cg_endo -93.42 167.62 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 124.038 3.159 . . . . 0.0 109.66 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.49 -51.14 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 121.806 1.671 . . . . 0.0 114.246 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.64 -3.48 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 49.5 p -118.03 139.35 51.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 121.252 1.842 . . . . 0.0 114.287 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -23.27 63.47 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 171.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.588 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 24.3 mt-10 -44.13 -23.61 0.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.359 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -75.91 -19.16 59.03 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.525 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 96.7 mt -46.59 -50.61 40.97 Favored Pre-proline 0 N--CA 1.479 0.994 0 CA-C-O 121.709 0.766 . . . . 0.0 111.346 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.603 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 58.7 Cg_exo -46.4 -36.26 17.47 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 120.826 1.017 . . . . 0.0 109.57 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 137' ' ' LYS . . . -75.36 -59.03 2.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.435 ' O ' ' CG ' ' A' ' 138' ' ' GLU . 64.3 mt -68.75 -37.34 79.32 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.881 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 132' ' ' ILE . 42.2 t0 -72.1 -40.65 68.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.603 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 3.4 tptm -47.48 -49.0 26.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.81 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 139' ' ' LEU . 1.2 pt-20 -62.83 -37.23 85.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.59 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.481 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 0.3 OUTLIER -58.89 -51.03 71.77 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -47.69 -45.68 28.62 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.03 -27.58 0.97 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.09 -56.66 2.16 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.244 0.545 . . . . 0.0 110.671 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.96 39.87 0.02 OUTLIER Glycine 0 CA--C 1.52 0.351 0 CA-C-O 119.029 -0.873 . . . . 0.0 111.216 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.42 -172.06 4.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 119.183 1.492 . . . . 0.0 111.629 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.471 ' N ' HD21 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -143.72 127.12 16.81 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -41.52 -33.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 224' ' ' MET . 0.6 OUTLIER -141.3 130.26 23.18 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 -176.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.432 ' HB2' ' CB ' ' A' ' 222' ' ' THR . 0.0 OUTLIER -132.22 138.75 48.06 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.739 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.934 ' O ' ' O ' ' A' ' 150' ' ' ASN . 17.3 p90 -171.92 174.73 4.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.693 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.934 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -27.86 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.757 0.661 . . . . 0.0 112.17 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 152' ' ' GLN . 0.1 OUTLIER -160.66 39.0 0.16 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.261 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER 171.68 33.09 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.998 169.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.657 ' O ' ' HB ' ' A' ' 157' ' ' THR . 3.3 mt-10 -79.96 152.52 74.42 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 121.986 2.175 . . . . 0.0 115.833 -174.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.975 ' O ' ' N ' ' A' ' 156' ' ' PHE . 67.0 Cg_endo -78.67 -135.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.802 1 C-N-CA 125.559 4.172 . . . . 0.0 107.095 176.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 1.12 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 4.7 p90 3.01 -39.82 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.975 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -86.14 -55.48 3.91 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-N 120.262 1.392 . . . . 0.0 111.55 -179.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 61.6 m -56.6 -43.82 80.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.42 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 2.6 m0 -51.26 -55.73 26.18 Favored Pre-proline 0 C--N 1.346 0.416 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.735 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 1.12 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 89.4 Cg_exo -43.11 -50.3 6.48 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.081 2.521 . . . . 0.0 113.026 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.45 -53.82 49.15 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 119.671 1.123 . . . . 0.0 108.645 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 1.5 mp -51.86 -25.82 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.421 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.59 -22.67 46.73 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.668 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -41.86 -58.35 2.06 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -64.37 5.57 0.26 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.303 1.224 . . . . 0.0 114.303 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.59 22.69 5.34 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 119.588 -1.291 . . . . 0.0 115.262 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.9 163.41 41.83 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.707 -1.235 . . . . 0.0 111.447 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -146.09 120.94 9.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.126 0.463 . . . . 0.0 109.967 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.424 ' HB1' ' CE1' ' A' ' 169' ' ' PHE . . . -39.14 -79.01 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.675 0.75 . . . . 0.0 111.148 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.587 ' HB3' ' CB ' ' A' ' 176' ' ' TYR . 1.7 m-85 -113.43 172.73 6.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.768 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 1.201 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -101.88 106.87 17.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.08 114.42 18.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.053 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 28.2 tt0 -136.66 102.04 4.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.259 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 0.2 OUTLIER 90.28 -31.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.379 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 154.77 17.04 0.05 OUTLIER Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.151 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -174.18 127.73 0.36 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.175 1.487 . . . . 0.0 111.257 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 1.201 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 47.9 p90 -55.47 -24.45 31.22 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 122.181 0.991 . . . . 0.0 110.987 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 78.8 m-20 76.74 -78.57 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.008 -1.905 . . . . 0.0 111.773 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 369' ' ' THR . 0.8 OUTLIER 168.88 -41.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.497 ' HA ' HG23 ' A' ' 369' ' ' THR . 9.6 tttm -72.75 -5.66 39.33 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.401 ' CB ' ' CB ' ' A' ' 170' ' ' LYS . 4.4 m-20 -120.24 94.14 4.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.253 0.933 . . . . 0.0 109.634 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.406 HG11 ' CE1' ' A' ' 339' ' ' PHE . 6.4 t -115.78 111.29 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.433 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . -119.76 39.91 2.36 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.852 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 168' ' ' ALA . 31.0 t -80.41 -44.72 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-O 121.275 0.56 . . . . 0.0 109.865 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -83.83 61.28 6.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.984 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 182' ' ' GLY . 7.4 p30 -110.94 173.92 6.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.712 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.58 -26.43 65.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.274 0.559 . . . . 0.0 111.28 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.95 -46.79 42.5 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.675 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -56.93 -51.4 69.28 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 175.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -56.06 18.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.979 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -50.07 -41.18 47.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.006 0.908 . . . . 0.0 112.096 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -66.76 -60.65 5.95 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.715 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.427 ' HB2' HG12 ' A' ' 161' ' ' ILE . 0.5 OUTLIER -56.54 -27.62 58.03 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.161 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 42.2 m -62.36 -47.62 83.41 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.816 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.531 ' CZ ' ' CZ ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -60.71 -36.7 79.48 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-O 121.542 0.687 . . . . 0.0 109.54 177.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.77 -51.02 71.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.983 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.29 -31.5 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.562 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 2.6 t0 -57.03 -49.9 74.38 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 121.286 0.565 . . . . 0.0 110.717 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.9 tp -61.97 -59.24 5.4 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.285 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 39.4 mm -56.93 -41.13 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.83 -31.73 72.54 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.49 178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 6.0 m-80 -107.54 13.12 27.09 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -173.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.406 ' HG2' ' N ' ' A' ' 203' ' ' HIS . 1.4 ttmp? -121.92 -91.87 0.55 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.946 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.415 ' O ' ' N ' ' A' ' 205' ' ' ASN . 0.5 OUTLIER -122.02 -10.82 8.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -178.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.35 -71.69 0.12 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 203' ' ' HIS . 3.0 m120 64.43 162.49 0.12 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.26 78.88 3.1 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.603 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.424 ' HA ' HD22 ' A' ' 151' ' ' LEU . 33.8 m-20 39.46 70.75 0.2 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.476 ' CG2' HG22 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -55.05 124.19 16.02 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 213' ' ' ALA . 0.4 OUTLIER -92.13 -174.65 3.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -69.92 -45.55 67.31 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.3 m -75.18 -30.01 60.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.502 0.668 . . . . 0.0 111.024 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.476 HG22 ' CG2' ' A' ' 208' ' ' THR . 1.2 mp -79.33 -49.74 19.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.207 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -57.61 -34.05 68.88 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -60.02 -48.24 82.53 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.91 -36.59 67.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.247 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.77 -57.6 11.74 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.963 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.522 ' CE1' ' HA ' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -60.09 -30.04 68.98 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -53.18 -42.03 65.81 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.396 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.84 59.12 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.74 57.96 7.44 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.672 -0.695 . . . . 0.0 114.588 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -125.29 37.29 4.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.378 1.089 . . . . 0.0 111.037 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.432 ' CB ' ' HB2' ' A' ' 148' ' ' MET . 12.2 t -142.5 140.48 31.86 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.608 ' CB ' ' O ' ' A' ' 121' ' ' LEU . . . -114.45 38.5 3.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.064 -1.426 . . . . 0.0 113.328 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 25.8 ttm -178.08 129.22 0.13 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.77 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 148' ' ' MET . 69.1 p -145.51 169.32 18.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.566 0.698 . . . . 0.0 111.534 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.462 ' CD1' ' CE1' ' A' ' 156' ' ' PHE . 21.9 mt -109.06 145.44 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -146.86 167.05 24.89 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.849 0.86 . . . . 0.0 111.232 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -110.4 -159.8 17.26 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.446 -0.406 . . . . 0.0 112.782 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.441 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 11.7 Cg_endo -55.49 -59.44 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.82 2.346 . . . . 0.0 112.451 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.452 ' CH2' ' CG ' ' A' ' 111' ' ' GLU . 18.6 p90 -173.34 -43.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.474 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.28 70.99 1.2 Allowed 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.786 0.326 . . . . 0.0 110.803 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.423 ' O ' ' N ' ' A' ' 234' ' ' ASN . 1.5 m95 -125.72 39.77 3.88 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 11.3 t 64.87 -72.74 0.06 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.544 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 232' ' ' TRP . 4.6 t-20 -145.64 85.12 1.69 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.575 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.406 ' O ' ' N ' ' A' ' 237' ' ' THR . 18.1 tt -44.55 154.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.434 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -47.9 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.707 0.289 . . . . 0.0 111.242 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 235' ' ' ILE . 19.7 m -121.4 39.37 3.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.744 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 83.0 p -63.2 -43.62 97.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.689 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.57 -174.91 2.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.816 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.0 -57.26 4.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.193 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.02 126.32 35.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -144.44 164.22 31.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.167 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.4 122.14 5.85 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.425 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 34.7 m -91.58 115.31 30.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.743 0.271 . . . . 0.0 111.384 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.6 p -127.62 167.18 16.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.47 153.91 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.4 ' CD1' ' CD1' ' A' ' 113' ' ' LEU . 58.5 mt -58.29 158.67 13.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 120.31 1.414 . . . . 0.0 110.092 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.21 -174.65 2.37 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.453 2.102 . . . . 0.0 113.144 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.449 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -105.3 171.16 7.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.091 0.472 . . . . 0.0 111.488 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.531 ' CZ ' ' CZ ' ' A' ' 194' ' ' PHE . 35.6 m-85 -167.31 111.08 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 62.72 31.71 16.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.637 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.94 33.58 36.45 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.318 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 13.8 mp0 -156.75 154.43 26.65 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.459 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 68.7 Cg_endo -90.61 162.91 4.28 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.592 2.861 . . . . 0.0 112.213 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.41 148.71 26.45 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.1 OUTLIER -86.0 109.81 25.69 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.531 -178.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.407 ' HA ' ' CD2' ' A' ' 113' ' ' LEU . 6.2 Cg_exo -79.84 149.38 20.48 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.998 2.465 . . . . 0.0 112.89 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 155' ' ' TYR . 23.2 p90 -78.86 146.35 33.68 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.475 ' HB ' ' HA ' ' A' ' 329' ' ' ILE . 15.6 t -103.53 122.83 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -118.02 123.45 5.74 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.135 -1.507 . . . . 0.0 114.771 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.706 ' HB ' ' CB ' ' A' ' 64' ' ' HIS . 15.7 t -109.09 110.06 30.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.453 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 1.7 tp -89.85 99.15 12.21 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 117.881 -1.528 . . . . 0.0 107.257 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.713 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 32.8 p -134.46 141.17 46.69 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 118.501 2.778 . . . . 0.0 118.501 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.543 ' O ' ' CB ' ' A' ' 105' ' ' ALA . . . -74.04 132.71 42.61 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.025 -0.422 . . . . 0.0 110.292 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.7 ' HA2' ' HB3' ' A' ' 105' ' ' ALA . . . -122.18 139.59 12.88 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.652 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.39 127.16 71.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.713 ' C ' ' H ' ' A' ' 269' ' ' ALA . 96.1 m-20 -61.07 126.38 27.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.6 ' H ' ' HB1' ' A' ' 77' ' ' ALA . . . -51.6 5.11 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 119.883 1.219 . . . . 0.0 113.177 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.713 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -81.99 -38.1 25.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.854 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 75.5 m -133.89 69.4 75.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.91 0.386 . . . . 0.0 110.925 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.97 -36.21 3.67 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.842 2.362 . . . . 0.0 112.734 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 50.64 68.17 0.81 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 6.5 mttt -48.98 -54.44 15.6 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 2.9 mt-10 -62.98 -57.94 9.03 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.282 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.6 mt -68.01 -58.0 5.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.45 -51.97 31.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 1.1 tpmp? -64.98 -35.76 82.23 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 12.4 tt0 -76.49 -53.09 8.58 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -56.23 -52.01 66.0 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.787 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.475 ' N ' ' CG ' ' A' ' 279' ' ' PHE . 8.2 tt -57.41 -43.42 83.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.524 0.678 . . . . 0.0 111.777 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -73.77 -34.3 64.63 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.558 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -94.16 -13.54 26.59 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.457 ' CE2' ' CG2' ' A' ' 23' ' ' VAL . 1.6 t80 -109.41 -62.2 1.52 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 119.241 -0.409 . . . . 0.0 109.936 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 280' ' ' LEU . 1.7 tt -40.19 -33.57 0.24 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.809 0.731 . . . . 0.0 110.87 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.455 ' CD2' ' CE2' ' A' ' 85' ' ' PHE . 80.5 mt -86.59 42.21 0.99 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.959 0.409 . . . . 0.0 110.257 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 283' ' ' TYR . 17.4 p -145.21 155.93 43.55 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 44.1 m-20 -62.7 -15.04 50.87 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 0.9 OUTLIER -78.27 -47.38 18.02 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.882 -0.511 . . . . 0.0 110.922 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -79.96 -55.58 3.51 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.291 -0.957 . . . . 0.0 110.972 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.41 ' CD1' ' CD1' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -55.26 -46.14 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.226 . . . . 0.0 111.066 179.415 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -79.05 -26.32 43.12 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.707 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -68.33 -41.55 80.64 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 119.441 1.019 . . . . 0.0 109.117 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.4 -61.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 297' ' ' LYS . 0.6 OUTLIER -50.14 -45.14 52.84 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.682 1.193 . . . . 0.0 112.546 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -59.33 -50.36 74.27 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.528 ' O ' ' HD3' ' A' ' 298' ' ' PRO . 42.0 m-20 -56.17 -47.86 77.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 176.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 294' ' ' ASN . 0.0 OUTLIER -69.04 104.67 0.78 Allowed Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.951 -178.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 296' ' ' ASP . 93.1 Cg_endo -99.64 54.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.322 2.681 . . . . 0.0 112.675 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 230' ' ' TRP . 0.4 OUTLIER -138.88 -67.83 0.45 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.57 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 301' ' ' ALA . . . -172.91 -166.31 31.21 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.853 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 300' ' ' GLY . . . 160.0 177.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.579 0.228 . . . . 0.0 111.141 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 301' ' ' ALA . 5.8 p 174.52 62.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 304' ' ' LEU . . . -113.78 -138.6 0.37 Allowed 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' A' ' 303' ' ' ALA . 0.4 OUTLIER -4.51 110.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.38 1.072 . . . . 0.0 113.803 -179.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -34.22 -60.88 0.39 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.099 0.476 . . . . 0.0 112.085 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.14 -47.1 54.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.988 0.899 . . . . 0.0 111.272 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.407 ' CZ ' ' OE2' ' A' ' 291' ' ' GLU . 2.4 t80 -73.0 -20.12 61.08 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.319 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 312' ' ' ALA . 12.0 tt0 -66.64 -39.88 88.45 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.46 -51.85 38.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.335 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -56.83 -56.31 23.23 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.012 0.434 . . . . 0.0 110.174 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -41.02 98.06 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.776 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 308' ' ' GLU . . . -46.23 -26.77 0.85 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 312' ' ' ALA . 10.5 mtpp -37.76 -40.04 0.4 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.753 0.311 . . . . 0.0 110.599 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -82.82 124.35 77.14 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.903 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.21 -13.51 40.19 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.637 2.225 . . . . 0.0 114.214 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 -62.08 -58.89 6.12 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.441 ' HA ' ' OG1' ' A' ' 320' ' ' THR . 10.3 pt -50.12 -52.36 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.78 -45.14 14.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.84 0.291 . . . . 0.0 111.71 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.73 -38.96 73.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.299 0.571 . . . . 0.0 110.322 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 19.9 p -65.17 -33.61 76.42 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -49.19 16.23 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.603 0.24 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -43.52 84.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.307 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -71.58 -41.56 68.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.584 0.231 . . . . 0.0 111.17 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -23.08 67.16 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . 0.438 ' HG3' ' CE1' ' A' ' 92' ' ' PHE . 3.0 tm0? -85.27 -34.09 22.02 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -101.48 62.74 0.95 Allowed 'General case' 0 C--O 1.232 0.151 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.478 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -154.96 -140.79 3.09 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.681 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -128.32 118.84 23.94 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.475 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.5 mm -75.34 131.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.77 133.08 2.96 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.725 0.297 . . . . 0.0 111.326 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.545 ' HB3' ' CE2' ' A' ' 176' ' ' TYR . 12.6 Cg_endo -56.05 -161.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.092 2.528 . . . . 0.0 111.975 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -159.21 40.78 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.543 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 5.1 pt -136.55 170.78 9.99 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.893 -0.139 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 87.5 Cg_endo -84.83 -20.51 3.63 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.628 2.219 . . . . 0.0 113.927 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -56.13 -21.04 20.15 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.481 ' HE2' ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -44.72 -33.36 1.84 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 23.2 m -57.16 -33.17 67.16 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.649 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.0 78.08 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.928 0.394 . . . . 0.0 111.92 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.406 ' CE1' HG11 ' A' ' 181' ' ' VAL . 0.1 OUTLIER -78.35 -55.66 5.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.772 -178.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.414 ' HA ' ' CE3' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -44.0 -44.73 7.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.045 -179.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -74.79 -44.01 51.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.972 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.21 76.48 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.427 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 5.5 m -71.94 -41.31 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.034 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.381 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 348' ' ' ILE . 6.7 mmp_? -56.34 -55.29 35.25 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.212 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 43.9 p -59.45 -56.23 24.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.064 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.62 -60.67 2.17 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 48.3 t -51.17 -50.52 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 344' ' ' ARG . 2.1 tt -69.88 -46.14 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.837 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 345' ' ' THR . 3.5 t30 -66.35 -53.97 30.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 355' ' ' GLN . . . -66.21 -26.55 67.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.07 -12.31 2.06 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.0 p -110.42 26.75 10.34 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.48 0.582 . . . . 0.0 111.424 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 89.41 -5.72 83.78 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 118.463 -1.827 . . . . 0.0 114.482 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 34.98 0.72 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 116.199 -2.2 . . . . 0.0 107.956 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.45 ' HA ' ' CB ' ' A' ' 350' ' ' ALA . 1.0 OUTLIER -72.15 -174.81 1.34 Allowed 'General case' 0 CA--C 1.548 0.868 1 N-CA-C 126.385 5.698 . . . . 0.0 126.385 -158.057 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 158.22 40.48 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 109.833 -3.349 . . . . 0.0 104.283 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.8 p -72.56 -52.58 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 13.4 t0 -47.34 -45.64 24.85 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.596 0.712 . . . . 0.0 111.28 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -77.07 -56.34 4.66 Favored 'General case' 0 C--N 1.353 0.74 0 CA-C-N 114.073 -1.421 . . . . 0.0 113.733 -175.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -51.49 -41.72 61.15 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 122.583 1.182 . . . . 0.0 112.253 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.7 mt -79.03 -34.95 43.4 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 112.745 -2.025 . . . . 0.0 110.494 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 5.2 mmmt -65.75 -56.6 11.17 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.391 1.091 . . . . 0.0 109.599 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -59.46 -36.03 75.21 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.372 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -52.18 -44.01 64.45 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 362' ' ' LYS . 4.2 tt0 -60.21 -46.42 89.8 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 370' ' ' LYS . 53.1 m -51.03 -42.88 60.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.09 0.471 . . . . 0.0 110.138 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 10.3 ttm105 -59.12 -52.57 65.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.122 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 368' ' ' ILE . 15.7 tt -73.55 -30.31 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 178' ' ' ILE . 80.9 p -82.52 -30.24 29.91 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 366' ' ' THR . 8.2 tptt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.962 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.527 0.203 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -156.08 160.24 39.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.784 0.326 . . . . 0.0 111.213 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . 90.88 25.56 24.54 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.415 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.34 152.79 42.04 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -129.76 121.27 26.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 1.128 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -117.04 118.23 58.07 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 24.4 mt -123.04 130.07 74.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.435 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.44 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 8.6 m95 -108.99 122.29 46.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.443 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -145.74 143.07 21.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 122.881 0.473 . . . . 0.0 109.813 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -79.8 72.62 6.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 119.014 0.824 . . . . 0.0 112.015 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.64 65.88 2.9 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.098 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.804 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -87.11 -32.82 19.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.804 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 102.12 -156.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -177.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 71.39 52.56 12.59 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 116.089 1.196 . . . . 0.0 116.089 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -58.71 2.92 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 2.0 t-20 -46.18 -43.33 15.08 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.122 0.487 . . . . 0.0 111.127 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.12 -45.54 49.22 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.302 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.13 -51.47 68.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.944 0.372 . . . . 0.0 110.678 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.17 74.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 34.8 tt0 -65.3 -36.09 82.99 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.754 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 27' ' ' PHE . 74.8 t -67.7 -61.27 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 27' ' ' PHE . . . -49.22 -34.22 17.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.205 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.41 -50.38 67.74 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 177.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -41.63 62.77 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 112.826 -1.988 . . . . 0.0 108.593 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.561 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 21.7 m-30 -66.91 -34.32 77.53 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.128 0.966 . . . . 0.0 111.367 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.703 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -72.6 -51.96 17.48 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.914 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tpmp? -53.1 -27.55 21.04 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 124.807 1.317 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.632 ' O ' ' CG2' ' A' ' 31' ' ' THR . 3.7 m-20 -86.03 -37.42 18.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 117.732 -1.128 . . . . 0.0 108.97 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.632 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.92 38.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 172.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.598 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 156.88 39.25 0.02 OUTLIER Glycine 0 N--CA 1.465 0.582 0 C-N-CA 114.537 -3.697 . . . . 0.0 119.337 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.703 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.5 mp -139.46 136.27 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 121.961 2.88 . . . . 0.0 116.637 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -142.32 104.46 4.43 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.423 ' HA ' ' CB ' ' A' ' 7' ' ' LEU . 37.4 t -88.48 128.97 40.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 m -118.51 140.11 50.39 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.645 -1.162 . . . . 0.0 110.853 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 15.2 m -129.85 122.47 54.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 O-C-N 122.133 -0.354 . . . . 0.0 110.703 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 3.0 tp10 -113.4 134.03 54.86 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER -117.98 74.83 10.29 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 122.355 0.262 . . . . 0.0 111.208 178.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 43' ' ' LEU . 6.0 Cg_endo -89.18 -167.47 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.546 2.831 . . . . 0.0 113.262 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -109.42 -54.85 2.5 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.347 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -78.03 0.12 25.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.41 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 2.0 tt -26.08 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 1.062 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 3.5 mt-10 -70.59 -55.02 9.81 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -68.34 -50.06 55.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.113 0.482 . . . . 0.0 111.454 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -61.82 -56.27 21.21 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.668 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 73.4 t80 -47.03 -55.01 16.73 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 1.062 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 30.8 Cg_exo -66.96 -39.69 13.54 Favored 'Trans proline' 0 C--O 1.25 1.12 0 C-N-CA 121.478 1.452 . . . . 0.0 115.196 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -67.54 -51.15 54.22 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 47' ' ' PHE . 9.0 m -61.37 -22.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.114 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 47' ' ' PHE . . . -59.05 -30.03 67.74 Favored 'General case' 0 C--N 1.394 2.535 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.058 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.38 -28.94 31.18 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.227 1.411 . . . . 0.0 113.029 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 t -88.3 129.66 35.32 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.126 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.93 -67.95 0.05 OUTLIER Glycine 0 C--N 1.337 0.587 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.396 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.29 -84.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.417 1.609 . . . . 0.0 111.427 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.03 142.86 4.34 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.517 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.18 -146.6 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.84 2.36 . . . . 0.0 112.767 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 1.128 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -79.99 -135.65 0.03 OUTLIER 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 123.744 0.818 . . . . 0.0 110.069 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.41 HD12 ' CZ ' ' A' ' 61' ' ' PHE . 16.6 pt -104.48 166.89 2.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 1.7 tt -127.69 134.87 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.548 ' CD2' ' HB1' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -110.69 120.08 41.25 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.477 ' CZ3' ' CG2' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -166.99 162.91 15.88 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.393 0.542 . . . . 0.0 110.437 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -38.34 154.84 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.506 ' HB3' HG11 ' A' ' 261' ' ' VAL . 16.6 t-160 -77.29 -30.04 54.02 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.99 -36.96 75.77 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.693 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.29 -33.11 24.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.933 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.555 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 4.5 t80 -59.94 -30.35 69.01 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -57.07 -68.51 1.66 Allowed Glycine 0 C--N 1.353 1.502 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.99 45.08 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.555 ' HB2' ' HA ' ' A' ' 67' ' ' PHE . 1.2 m-85 -48.03 -46.35 33.03 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 68' ' ' GLY . . . -51.08 -48.83 61.53 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.884 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -63.87 -16.89 62.47 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 m -69.36 -26.88 64.9 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.936 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.69 28.94 33.73 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.697 -0.763 . . . . 0.0 114.996 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.45 38.5 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.502 1.151 . . . . 0.0 111.99 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . 3.2 mm? -110.15 131.61 54.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.93 0.395 . . . . 0.0 111.306 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.68 121.64 37.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.645 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -82.78 133.15 35.15 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.974 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.5 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 18.6 tt -78.29 159.63 4.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.119 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.5 p -108.61 82.76 1.79 Allowed Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 48.1 Cg_endo -90.08 -169.9 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.126 2.55 . . . . 0.0 112.244 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -127.94 156.2 43.02 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.557 0.218 . . . . 0.0 110.921 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -57.52 -45.62 84.77 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.672 0.272 . . . . 0.0 110.946 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.6 -23.13 64.45 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.637 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.477 ' CE2' ' CH2' ' A' ' 94' ' ' TRP . 8.6 t80 -79.23 -59.19 2.87 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.501 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 23.2 tt0 -55.65 -38.2 69.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.705 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -76.71 -34.58 58.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.682 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.87 -31.8 1.37 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.427 HD11 ' CE2' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -126.21 -90.1 0.55 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.123 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.451 ' O ' ' CD1' ' A' ' 94' ' ' TRP . 2.4 m-85 -136.26 111.24 9.97 Favored Pre-proline 0 CA--C 1.53 0.192 0 O-C-N 122.005 -0.434 . . . . 0.0 111.686 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 90' ' ' TYR . 19.3 Cg_endo -57.45 -22.34 50.03 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.592 2.195 . . . . 0.0 112.504 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -56.94 -53.81 53.82 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.578 0.228 . . . . 0.0 111.589 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.41 ' CB ' ' HG3' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -62.19 -45.51 93.05 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 110.267 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.501 ' CE2' ' HA ' ' A' ' 86' ' ' GLN . 71.7 m95 -60.26 -40.39 90.18 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 121.7 0.762 . . . . 0.0 109.861 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.78 -22.08 61.63 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.953 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.43 ' O ' ' CE1' ' A' ' 64' ' ' HIS . . . -75.59 -17.67 59.96 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 105' ' ' ALA . 13.1 m -121.74 46.22 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -128.92 139.54 52.08 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.42 0.554 . . . . 0.0 109.533 178.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -142.55 114.37 8.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 119.178 0.899 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 78.21 25.96 0.59 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.74 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.48 -27.98 17.96 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.998 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -102.34 163.85 12.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.561 0.681 . . . . 0.0 111.226 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -91.08 137.99 31.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.83 0.348 . . . . 0.0 110.616 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 15.6 tt -137.57 48.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.344 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HA ' ' HA2' ' A' ' 265' ' ' GLY . . . 159.61 -177.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 264' ' ' ALA . 49.5 m-85 -142.29 122.82 8.31 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.633 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.524 ' HA ' ' CB ' ' A' ' 263' ' ' SER . 88.5 Cg_endo -79.48 166.13 22.38 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.271 1.98 . . . . 0.0 112.37 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.61 ' N ' ' O ' ' A' ' 262' ' ' LEU . 3.1 tt -168.61 39.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.136 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.599 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' A' ' 301' ' ' ALA . . . 176.08 122.37 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.443 ' HB ' ' CG1' ' A' ' 302' ' ' VAL . 11.3 p -113.7 105.62 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.514 ' HA ' ' CG2' ' A' ' 320' ' ' THR . 2.0 mp0 -103.08 162.91 12.56 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.672 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -164.86 150.1 9.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.591 0.71 . . . . 0.0 112.131 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.467 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 2.6 pp -79.51 126.9 31.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.3 171.72 11.24 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 122.178 -0.326 . . . . 0.0 111.118 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.443 HD22 ' O ' ' A' ' 225' ' ' THR . 1.3 tt -110.99 136.29 50.22 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' A' ' 116' ' ' ILE . 3.3 mp -112.11 128.8 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.456 ' CD2' ' OG1' ' A' ' 245' ' ' THR . 22.6 m-30 -110.36 134.87 51.88 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -84.41 119.12 24.75 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -109.54 29.21 7.78 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.715 0.293 . . . . 0.0 111.675 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.1 -54.0 1.12 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -136.74 0.02 OUTLIER 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.406 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -84.27 128.96 59.96 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 41.4 Cg_exo -55.91 161.45 8.39 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.411 2.74 . . . . 0.0 111.604 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.504 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 4.9 p-10 -101.38 169.25 7.98 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.858 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 50.1 Cg_exo -53.84 167.55 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.675 2.25 . . . . 0.0 111.915 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -92.53 -118.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 122.816 2.344 . . . . 0.0 112.868 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.38 -18.17 36.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.309 0.959 . . . . 0.0 111.747 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.75 141.25 48.61 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -69.71 -25.82 64.04 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 173.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.525 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.4 OUTLIER -44.83 -23.9 0.17 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.989 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.78 -23.48 62.4 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.43 ' HA ' ' OD1' ' A' ' 136' ' ' ASP . 1.5 mp -40.44 -60.23 1.62 Allowed Pre-proline 0 N--CA 1.477 0.906 0 CA-C-O 121.446 0.641 . . . . 0.0 111.425 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 67.5 Cg_exo -46.45 -40.87 23.23 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 120.891 1.06 . . . . 0.0 109.861 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.3 -58.84 3.03 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.03 -36.79 80.52 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.393 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' ' 132' ' ' ILE . 1.3 m-20 -74.16 -40.53 62.52 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 3.0 ttpt -49.87 -46.78 51.86 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 118.949 -1.1 . . . . 0.0 109.29 177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.59 -37.1 84.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.194 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.581 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 0.2 OUTLIER -62.43 -47.86 82.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -47.59 -45.14 27.05 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.06 -24.43 0.43 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -99.01 -57.63 2.13 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.04 39.57 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.717 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.673 ' HB2' ' O ' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -174.04 177.28 2.38 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.703 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.424 ' O ' ' CD2' ' A' ' 139' ' ' LEU . 0.4 OUTLIER -107.1 177.66 4.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.754 ' O ' ' C ' ' A' ' 223' ' ' ALA . . . -86.84 -14.25 42.65 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 224' ' ' MET . 2.5 pp -138.95 128.68 24.78 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.4 ' O ' ' CG2' ' A' ' 225' ' ' THR . 2.1 tpt -132.47 136.29 46.6 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.471 ' O ' ' C ' ' A' ' 150' ' ' ASN . 6.2 t80 -171.63 173.66 4.59 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.948 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.548 ' O ' ' O ' ' A' ' 208' ' ' THR . 2.5 m120 -23.08 -70.34 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 0.1 OUTLIER 97.53 38.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.88 0.872 . . . . 0.0 109.226 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.404 ' HB3' ' O ' ' A' ' 151' ' ' LEU . 4.2 pt20 172.36 34.73 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 117.637 -1.173 . . . . 0.0 114.113 170.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' OG1' ' A' ' 157' ' ' THR . 13.5 mt-10 -102.59 151.04 38.19 Favored Pre-proline 0 C--O 1.218 -0.589 0 CA-C-N 122.349 2.34 . . . . 0.0 116.025 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.923 ' O ' ' N ' ' A' ' 156' ' ' PHE . 65.9 Cg_endo -78.14 -134.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 1 C-N-CA 125.922 4.415 . . . . 0.0 106.285 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 1.149 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 12.9 m-85 26.08 -60.33 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 119.335 0.97 . . . . 0.0 113.431 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.923 ' N ' ' O ' ' A' ' 154' ' ' PRO . 56.1 m-85 -83.48 -56.6 3.65 Favored 'General case' 0 C--O 1.257 1.471 0 C-N-CA 123.65 0.78 . . . . 0.0 112.097 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.859 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 27.8 p -59.33 -40.5 86.51 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.215 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.486 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 29.4 m0 -52.41 -55.48 31.45 Favored Pre-proline 0 C--N 1.352 0.703 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 1.149 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 86.2 Cg_exo -43.39 -49.26 7.68 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.68 2.253 . . . . 0.0 112.241 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mt -56.91 -56.89 15.88 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 119.514 1.052 . . . . 0.0 109.341 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.436 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 4.4 mt -51.57 -20.94 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.095 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 256' ' ' LYS . . . -83.97 -19.45 34.57 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.045 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.495 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -46.79 -47.11 20.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.532 ' CB ' ' CA ' ' A' ' 187' ' ' GLY . 6.6 m-20 -65.29 -58.32 6.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 120.744 1.611 . . . . 0.0 112.831 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.78 31.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.085 -1.531 . . . . 0.0 115.181 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.3 100.36 1.63 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.111 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.416 ' O ' ' CA ' ' A' ' 183' ' ' VAL . 60.9 m-85 -77.72 151.09 34.32 Favored 'General case' 0 C--N 1.337 0.048 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.15 -72.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.556 ' HB3' ' CD2' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -111.99 169.83 8.57 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.903 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 1.167 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.5 OUTLIER -102.25 111.48 23.78 Favored 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.424 ' CE1' ' HG2' ' A' ' 328' ' ' GLU . 28.6 m-85 -84.26 115.03 22.25 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.914 -1.494 . . . . 0.0 108.616 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.928 ' O ' ' N ' ' A' ' 174' ' ' GLY . 5.4 mm-40 -137.1 101.59 4.6 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.52 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 41.54 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 123.93 0.769 . . . . 0.0 110.475 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.928 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -75.2 -73.35 0.97 Allowed Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -175.87 143.51 0.58 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.768 1.284 . . . . 0.0 111.154 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 1.167 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 21.8 p90 -45.4 -32.51 2.13 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.061 0.934 . . . . 0.0 109.609 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 40.8 t0 59.38 -98.3 0.08 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.773 -1.558 . . . . 0.0 111.592 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.409 ' O ' HG13 ' A' ' 178' ' ' ILE . 7.4 tp -176.77 32.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -132.54 -18.5 2.48 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.079 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 3.7 m-20 -121.87 93.02 3.86 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.445 ' CG2' ' CD1' ' A' ' 368' ' ' ILE . 29.0 m -116.72 116.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.85 39.77 2.39 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.617 -1.277 . . . . 0.0 113.494 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 188' ' ' ALA . 11.5 p -79.92 -46.13 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -75.59 54.49 0.77 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.751 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.6 -171.79 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -49.82 -37.33 30.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.773 0.797 . . . . 0.0 111.807 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.532 ' CA ' ' CB ' ' A' ' 164' ' ' ASP . . . -75.38 -37.14 42.41 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.583 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 183' ' ' VAL . . . -64.17 -42.9 96.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -50.3 -40.26 48.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.094 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 194' ' ' PHE . . . -69.59 -47.64 62.86 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -66.7 -60.47 6.14 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.189 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.8 tt -50.04 -39.37 41.56 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 98.8 m -75.78 -42.33 50.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.431 ' HB3' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -60.17 -35.66 75.84 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -47.04 78.58 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.7 t -56.38 -30.6 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.968 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -62.62 -47.57 83.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.827 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.0 mt -62.75 -59.1 5.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.663 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 33.5 mm -52.01 -47.96 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.651 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -59.69 -34.56 73.04 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.91 0.77 52.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -120.33 -80.77 0.63 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.722 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -120.19 -26.54 5.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 75.91 14.03 2.69 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.81 0.277 . . . . 0.0 111.369 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -144.39 -59.56 0.38 Allowed 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 67.09 81.08 0.2 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.39 -2.7 35.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.42 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.548 ' O ' ' O ' ' A' ' 150' ' ' ASN . 27.5 m -56.88 127.05 29.79 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 213' ' ' ALA . 2.8 p-10 -101.65 -175.67 2.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.632 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.5 p90 -69.35 -45.28 69.78 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.208 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.422 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -77.12 -26.72 53.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.428 0.633 . . . . 0.0 111.133 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.463 HD13 HG22 ' A' ' 212' ' ' ILE . 5.7 mt -81.56 -51.53 15.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.857 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -54.82 -33.7 61.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -48.89 76.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.75 65.67 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.065 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.31 -55.95 20.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.103 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -60.25 -31.41 70.18 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.01 -39.87 69.53 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -23.78 58.89 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.18 61.0 3.87 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 11.7 pt-20 -123.55 37.92 4.31 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 123.049 1.404 . . . . 0.0 111.534 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.467 ' O ' ' CB ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER -92.56 -166.06 1.47 Allowed 'General case' 0 N--CA 1.424 -1.751 2 C-N-CA 135.562 5.545 . . . . 0.0 121.939 -170.204 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.767 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . 158.7 34.58 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.14 1 CA-C-N 104.421 -5.808 . . . . 0.0 112.062 168.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.767 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 158.38 131.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 174.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.443 ' O ' HD22 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -148.57 155.45 41.13 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.42 ' CG2' ' HG ' ' A' ' 115' ' ' LEU . 10.3 pt -115.88 112.47 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.809 1.186 . . . . 0.0 108.503 174.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 2.2 p-10 -147.93 165.23 31.31 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-O 118.95 -0.548 . . . . 0.0 112.411 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -122.85 -176.36 14.88 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.575 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 74.7 Cg_exo -47.43 -32.4 15.13 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.533 2.156 . . . . 0.0 112.354 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -47.14 -43.15 20.55 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.26 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.62 41.15 3.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.639 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.424 ' HA ' ' CE3' ' A' ' 232' ' ' TRP . 0.0 OUTLIER -93.04 -44.03 8.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.801 0.334 . . . . 0.0 110.758 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.8 m -69.6 -33.53 72.82 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.229 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.54 -42.06 6.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.618 0.247 . . . . 0.0 111.419 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.4 -60.77 2.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.954 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 44.91 42.37 6.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.575 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.62 -71.89 0.34 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.93 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.92 42.02 11.63 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.377 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.0 -72.11 0.09 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.017 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.56 -53.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -126.84 119.5 26.97 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.638 0.256 . . . . 0.0 111.0 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -108.46 155.36 20.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.83 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -122.36 111.52 1.8 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.671 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.1 t -91.04 135.28 27.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.685 0.242 . . . . 0.0 110.46 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.456 ' OG1' ' CD2' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -137.17 167.28 21.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.914 0.485 . . . . 0.0 111.798 -173.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.06 152.68 7.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.48 159.66 16.3 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 121.279 1.854 . . . . 0.0 110.132 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.94 -165.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.47 2.114 . . . . 0.0 112.069 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.484 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -112.95 175.72 5.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.813 0.339 . . . . 0.0 111.68 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.495 ' HB2' ' CB ' ' A' ' 163' ' ' ALA . 97.3 m-85 -164.13 110.38 1.06 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.364 0.602 . . . . 0.0 109.384 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt 61.18 34.19 18.97 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.521 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.05 40.63 34.4 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.899 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -156.99 158.68 31.34 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.486 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 79.9 Cg_endo -93.98 160.81 2.18 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.887 3.058 . . . . 0.0 111.776 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 1.3 p -84.43 156.05 21.96 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 162' ' ' ALA . 6.1 tmmm? -85.93 112.95 48.89 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.181 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.474 ' HG2' ' CA ' ' A' ' 327' ' ' GLY . 71.6 Cg_endo -84.59 145.0 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.829 2.353 . . . . 0.0 112.417 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.458 ' CD2' ' HA ' ' A' ' 155' ' ' TYR . 1.3 m-85 -79.64 148.79 31.51 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.6 ' CG2' ' HA ' ' A' ' 329' ' ' ILE . 1.9 m -104.8 139.69 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -176.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -125.25 118.85 3.38 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 118.787 -1.673 . . . . 0.0 116.985 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -129.87 97.62 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 176.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.61 ' O ' ' N ' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -78.19 115.3 17.82 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.524 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 53.6 p -133.87 138.59 45.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 60' ' ' ILE . . . -89.74 109.65 20.61 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 105' ' ' ALA . . . -97.75 165.42 22.2 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 176.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 10.4 mt -91.13 123.3 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 118.495 1.148 . . . . 0.0 108.022 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -61.97 138.19 58.34 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.987 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -51.13 -18.42 0.86 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.705 1.139 . . . . 0.0 110.892 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -56.5 -37.79 70.89 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.49 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 78.8 82.74 0.1 OUTLIER Pre-proline 0 N--CA 1.463 0.221 0 CA-C-O 120.769 0.319 . . . . 0.0 110.9 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -91.65 99.76 0.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.24 2.627 . . . . 0.0 112.612 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 47.83 73.44 0.2 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.797 0.332 . . . . 0.0 110.629 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 5.4 mttm -53.1 -54.05 41.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.656 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 13.5 mm-40 -63.28 -57.4 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 9.0 tt -65.66 -57.93 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.44 ' HA ' ' CE2' ' A' ' 279' ' ' PHE . . . -60.45 -56.73 17.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 7.3 ttpp -60.69 -30.31 69.86 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 2.4 tt0 -76.41 -52.82 9.13 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.532 ' CD1' ' CE2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -57.2 -50.0 74.23 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.781 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 279' ' ' PHE . 2.1 tp -56.94 -43.08 81.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.622 0.725 . . . . 0.0 111.227 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -73.42 -34.78 65.64 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.664 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -93.88 -14.02 26.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.416 ' N ' ' O ' ' A' ' 279' ' ' PHE . 26.1 t80 -109.13 -63.14 1.39 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 283' ' ' TYR . 0.2 OUTLIER -39.92 -31.82 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.983 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.01 42.53 1.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.737 0.303 . . . . 0.0 111.131 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.9 p -144.18 155.1 43.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 1.0 OUTLIER -64.42 -13.57 51.99 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.586 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 1.1 mp0 -77.91 -47.47 18.59 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 117.999 0.363 . . . . 0.0 110.149 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.407 ' O ' HG11 ' A' ' 293' ' ' VAL . . . -84.23 -55.03 2.84 Favored Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 304' ' ' LEU . 10.7 tp -47.42 -51.57 19.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.538 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 8.6 tt0 -79.23 -26.21 42.54 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.616 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -68.54 -40.15 80.83 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 290' ' ' LEU . 3.0 p -67.97 -61.45 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.436 ' O ' ' CG ' ' A' ' 297' ' ' LYS . 16.5 t30 -37.57 -50.91 1.16 Allowed 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.408 1.483 . . . . 0.0 112.289 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -60.08 -45.69 92.06 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.4 OUTLIER -57.87 -52.59 64.84 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -42.48 162.49 0.16 Allowed Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.359 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.07 -72.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.0 2.467 . . . . 0.0 113.405 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.448 ' N ' ' HD2' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -157.78 -62.99 0.09 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.536 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.488 ' HA2' HG13 ' A' ' 317' ' ' ILE . . . -79.87 138.83 20.66 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.951 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . 168.56 -172.95 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.443 ' CG1' ' HB ' ' A' ' 110' ' ' VAL . 8.3 p -178.04 137.38 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.22 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 304' ' ' LEU . . . 167.59 96.04 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 307' ' ' TYR . 5.9 tp 96.59 116.73 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.234 0.614 . . . . 0.0 110.752 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 304' ' ' LEU . 13.9 ttmt -26.54 -64.44 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.569 0.543 . . . . 0.0 111.12 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.2 m -48.3 -40.82 26.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.8 0.809 . . . . 0.0 110.277 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.586 ' N ' ' O ' ' A' ' 304' ' ' LEU . 42.5 t80 -75.85 -33.58 60.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.005 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 305' ' ' LYS . 7.0 pt-20 -72.51 -41.31 66.06 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 120.561 -0.456 . . . . 0.0 109.987 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.65 -56.93 6.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.14 -57.38 8.87 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.722 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.532 HD22 ' CE2' ' A' ' 307' ' ' TYR . 2.7 pp -61.52 -43.0 99.65 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.154 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 313' ' ' LYS . . . -46.78 -29.67 2.05 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -35.54 -41.52 0.2 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.719 0.295 . . . . 0.0 110.886 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.05 127.89 85.92 Favored Pre-proline 0 CA--C 1.528 0.126 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.38 -22.69 34.85 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.614 2.209 . . . . 0.0 113.714 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.401 ' O ' ' OG1' ' A' ' 320' ' ' THR . 18.2 mtm180 -60.7 -59.12 5.89 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.488 HG13 ' HA2' ' A' ' 300' ' ' GLY . 2.6 mp -49.82 -55.8 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.89 -52.0 12.18 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.08 0.4 . . . . 0.0 111.659 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.15 -41.48 92.86 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.843 0.83 . . . . 0.0 109.738 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 111' ' ' GLU . 1.5 m -60.9 -41.94 97.07 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.614 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -77.13 -39.43 49.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.69 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.08 -41.73 79.37 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.852 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.404 ' CB ' ' HB2' ' A' ' 112' ' ' ALA . 2.8 m120 -75.58 -42.01 53.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.715 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.73 -42.43 91.04 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.852 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.1 -31.84 53.19 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.278 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -100.61 41.59 1.17 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.592 0.234 . . . . 0.0 111.15 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.474 ' CA ' ' HG2' ' A' ' 257' ' ' PRO . . . -120.85 172.11 15.0 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.992 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . 0.424 ' HG2' ' CE1' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -94.46 138.38 32.46 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 175.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.6 ' HA ' ' CG2' ' A' ' 259' ' ' VAL . 1.3 pp -83.62 109.56 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 119.105 0.866 . . . . 0.0 112.226 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.422 ' CE ' ' HA ' ' A' ' 330' ' ' MET . 0.0 OUTLIER -44.14 98.48 0.18 Allowed Pre-proline 0 C--N 1.344 0.348 0 CA-C-O 120.791 0.329 . . . . 0.0 110.802 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.647 ' HG2' ' CE1' ' A' ' 176' ' ' TYR . 32.5 Cg_exo -60.79 -42.48 38.08 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.002 2.468 . . . . 0.0 112.045 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 331' ' ' PRO . 3.0 t30 86.34 93.08 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.457 HG12 ' CE2' ' A' ' 176' ' ' TYR . 1.9 pp -133.82 146.69 61.24 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 118.457 0.571 . . . . 0.0 110.833 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.64 -48.19 16.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.782 2.321 . . . . 0.0 113.319 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -54.2 -21.43 8.9 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 12.5 mtt -45.49 -35.63 3.95 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.892 0.315 . . . . 0.0 111.459 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 m -58.29 -34.17 70.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 110.482 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.49 82.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.065 0.459 . . . . 0.0 111.709 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.456 ' CE2' ' CD1' ' A' ' 368' ' ' ILE . 0.1 OUTLIER -78.4 -55.69 5.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.614 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -44.67 -45.14 9.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.327 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -76.01 -43.47 44.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.27 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.49 90.86 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 347' ' ' VAL . 13.9 p -76.85 -29.92 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.555 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -46.76 57.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.556 ' HA ' HG22 ' A' ' 348' ' ' ILE . 29.9 p -62.77 -57.82 9.6 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.79 -38.87 4.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.63 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 343' ' ' VAL . 24.8 t -60.76 -57.2 13.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.556 HG22 ' HA ' ' A' ' 345' ' ' THR . 3.5 tt -60.06 -27.85 39.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.8 OUTLIER -63.84 -30.13 71.25 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.423 ' HA ' ' CG ' ' A' ' 355' ' ' GLN . . . -75.52 -46.14 33.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -84.18 -9.8 58.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 348' ' ' ILE . 86.7 p -97.8 -49.76 4.69 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 147.52 -2.92 0.82 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 117.923 -2.084 . . . . 0.0 117.404 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.74 34.3 4.66 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 115.328 -2.549 . . . . 0.0 115.818 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.475 ' HB3' ' C ' ' A' ' 349' ' ' ASN . 1.0 OUTLIER -72.12 -130.01 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 129.855 3.262 . . . . 0.0 106.476 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.652 ' N ' ' HB1' ' A' ' 360' ' ' ALA . 0.0 OUTLIER 153.12 86.57 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.249 1 N-CA-C 94.539 -6.097 . . . . 0.0 94.539 177.091 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.565 ' C ' ' O ' ' A' ' 356' ' ' THR . 1.3 p -40.26 -60.72 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.46 0 CA-C-N 122.833 2.56 . . . . 0.0 112.491 -166.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -72.9 -44.48 61.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.48 -38.92 62.76 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.02 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.652 ' HB1' ' N ' ' A' ' 356' ' ' THR . . . -62.18 -50.34 72.19 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.25 -36.27 69.02 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.564 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -56.07 15.17 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.254 1.026 . . . . 0.0 110.059 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.434 ' O ' ' HB ' ' A' ' 366' ' ' THR . 13.5 t0 -62.63 -36.01 81.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.522 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -49.78 -43.07 48.05 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -43.16 98.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.359 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 363' ' ' ASP . 23.6 m -50.46 -42.58 54.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.322 0.582 . . . . 0.0 110.193 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -60.17 3.49 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.098 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.46 HD11 HG21 ' A' ' 368' ' ' ILE . 17.8 pt -58.4 -27.01 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.993 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.403 HG22 HG23 ' A' ' 181' ' ' VAL . 77.4 p -118.26 48.26 1.45 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.825 0.345 . . . . 0.0 110.513 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.3 mttm . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.664 0.269 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.95 103.63 5.44 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.907 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -120.04 146.37 45.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.32 179.81 6.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -137.07 47.56 0.95 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.413 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -149.6 155.34 40.11 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -152.12 117.64 5.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 58' ' ' ASP . 47.6 t -111.61 135.94 49.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.127 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 37' ' ' VAL . 11.7 tt -132.3 127.45 57.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.329 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.616 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -103.53 126.77 50.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.407 178.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.515 HG22 HD13 ' A' ' 11' ' ' ILE . 4.6 mm -146.35 139.19 20.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -112.84 39.79 2.44 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.816 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.47 -11.43 35.86 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.636 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.9 t70 65.92 68.82 0.45 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.15 0.475 . . . . 0.0 110.395 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 162.64 -172.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.167 0.508 . . . . 0.0 111.74 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.06 22.73 67.84 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 116.26 1.264 . . . . 0.0 116.26 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -35.33 33.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.972 0.886 . . . . 0.0 111.205 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 11.3 t30 -65.54 -52.57 51.49 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 111.786 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.61 -48.96 26.52 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.83 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.413 ' O ' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -59.5 -50.51 73.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.904 0.852 . . . . 0.0 110.331 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.97 -37.87 87.1 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 56.7 mt-10 -66.28 -36.84 84.01 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.46 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 283' ' ' TYR . 41.0 t -68.03 -61.61 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.96 -0.462 . . . . 0.0 110.46 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -49.22 -35.16 19.28 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.288 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -50.14 67.42 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 122.515 1.15 . . . . 0.0 108.479 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -52.1 -43.21 63.8 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.32 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.594 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.5 m-30 -65.77 -29.71 70.25 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.762 0.791 . . . . 0.0 111.013 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.728 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 1.1 tm-20 -71.14 -52.54 18.69 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.029 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -52.36 -28.42 19.42 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 125.159 1.537 . . . . 0.0 111.245 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.711 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -86.07 -37.5 18.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.188 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.711 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 3.5 t 160.0 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.462 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 156.75 38.55 0.02 OUTLIER Glycine 0 N--CA 1.465 0.581 0 C-N-CA 114.712 -3.613 . . . . 0.0 119.318 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.728 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.6 mp -139.92 134.98 37.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 121.576 2.688 . . . . 0.0 115.422 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -140.89 104.76 4.75 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 9.4 p -103.7 134.1 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.5 p -118.33 146.82 44.07 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.136 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.668 ' HA ' HG22 ' A' ' 9' ' ' ILE . 9.5 t -130.9 120.79 48.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.511 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 30.8 tt0 -112.99 144.44 42.57 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -131.79 73.9 78.2 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.724 0.297 . . . . 0.0 111.236 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 43' ' ' LEU . 43.0 Cg_endo -89.98 -173.75 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.057 2.505 . . . . 0.0 112.82 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -96.01 -40.31 9.33 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -85.38 0.35 52.42 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.619 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HG ' ' CD1' ' A' ' 10' ' ' TRP . 4.9 tt -21.57 -45.97 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 1.062 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 1.5 pp20? -68.68 -54.16 17.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.399 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 3.5 tt0 -69.66 -41.22 75.83 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.055 0.455 . . . . 0.0 109.797 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -56.28 -56.24 23.49 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.011 0.91 . . . . 0.0 109.834 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.581 ' CG ' HG12 ' A' ' 60' ' ' ILE . 1.3 t80 -44.15 -61.26 2.14 Favored Pre-proline 0 C--N 1.349 0.556 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.127 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 1.062 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 37.0 Cg_exo -61.5 -25.36 79.55 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 121.347 1.365 . . . . 0.0 113.341 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -81.58 -37.1 28.22 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 122.143 0.973 . . . . 0.0 111.034 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.461 HG21 ' N ' ' A' ' 51' ' ' ALA . 19.2 m -77.28 -40.0 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.59 0 CA-C-O 122.001 0.905 . . . . 0.0 109.797 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.461 ' N ' HG21 ' A' ' 50' ' ' VAL . . . -49.78 -37.98 32.26 Favored 'General case' 0 C--N 1.374 1.666 0 C-N-CA 126.074 1.75 . . . . 0.0 110.999 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.25 -40.64 23.45 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-N 114.144 -1.389 . . . . 0.0 113.519 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -63.22 1.15 Allowed 'General case' 0 C--N 1.346 0.429 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.015 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.08 69.39 0.05 OUTLIER Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.216 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -96.37 -64.94 1.0 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.8 -120.78 5.58 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.661 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 72.4 Cg_exo -49.83 109.56 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.187 1.925 . . . . 0.0 110.978 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.572 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 15.6 t0 159.27 113.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.608 0.363 . . . . 0.0 110.77 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.616 ' O ' ' HB2' ' A' ' 10' ' ' TRP . 0.7 OUTLIER -98.5 173.24 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.957 -177.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.788 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -131.06 130.08 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.697 -177.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 70.2 t80 -121.8 112.21 18.08 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -166.84 161.94 15.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' N ' ' CD1' ' A' ' 62' ' ' TRP . . . -34.95 151.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.626 ' HB3' HG23 ' A' ' 261' ' ' VAL . 2.7 t60 -77.26 -28.94 53.69 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -47.37 -59.29 3.31 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.6 mtp85 -78.51 -26.95 45.99 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.712 -0.617 . . . . 0.0 109.648 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.478 ' CE2' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.64 -28.69 70.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.52 ' O ' ' HB1' ' A' ' 71' ' ' ALA . . . -61.97 -58.74 11.47 Favored Glycine 0 CA--C 1.49 -1.495 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 177.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.29 -60.43 8.84 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 111.848 -2.176 . . . . 0.0 111.598 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.598 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 22.2 m-85 -48.81 -37.56 19.62 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.959 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . . . -56.5 -38.95 72.47 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.338 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -78.51 -56.3 4.54 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.342 -0.224 . . . . 0.0 111.556 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 m -113.91 -27.19 7.83 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 70' ' ' TYR . . . -63.41 -89.7 0.03 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.861 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.57 ' C ' ' CB ' ' A' ' 268' ' ' ALA . 0.2 OUTLIER -179.02 63.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.959 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -116.36 140.11 49.68 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 173.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.959 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . -90.33 88.13 7.08 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.763 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.499 ' HA ' ' CG1' ' A' ' 104' ' ' ILE . 1.2 mt-10 -47.36 100.09 0.02 OUTLIER 'General case' 0 C--O 1.23 0.076 0 CA-C-O 120.821 0.343 . . . . 0.0 110.434 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mt -47.66 159.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.554 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.424 ' CG2' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -88.26 175.15 4.37 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.424 ' HD2' ' CG2' ' A' ' 80' ' ' THR . 76.1 Cg_endo -79.76 133.56 10.38 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.344 2.029 . . . . 0.0 113.399 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.71 -170.11 2.15 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.809 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 -78.18 0.59 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.237 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.03 -23.02 67.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -62.12 -59.31 5.24 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.77 0.319 . . . . 0.0 110.236 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -77.08 -28.43 54.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.71 -10.84 59.67 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -92.26 -18.19 23.75 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -90.59 -176.84 4.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.277 0.49 . . . . 0.0 111.297 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.557 ' CB ' ' CZ3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -94.49 165.72 16.81 Favored Pre-proline 0 C--N 1.341 0.238 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.581 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 6.3 Cg_exo -75.4 -24.09 12.53 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.826 2.351 . . . . 0.0 115.248 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CE1' ' NE2' ' A' ' 325' ' ' GLN . 4.2 m-85 -87.31 -63.5 1.3 Allowed 'General case' 0 C--O 1.245 0.832 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.467 ' HB ' ' CE3' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -63.19 -24.68 67.99 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.557 ' CZ3' ' CB ' ' A' ' 90' ' ' TYR . 5.9 m-90 -93.75 -24.31 17.86 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.48 0.712 . . . . 0.0 111.345 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 8.1 t0 -73.63 -23.53 59.89 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.653 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.419 ' CB ' ' CG1' ' A' ' 261' ' ' VAL . . . -62.91 -42.95 99.96 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 261' ' ' VAL . 44.5 t -108.62 54.13 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.424 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . 0.9 OUTLIER -130.85 140.28 50.23 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.03 -0.419 . . . . 0.0 110.786 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 101' ' ' GLY . 57.0 m-85 -112.34 174.72 5.75 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -48.05 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 56.16 38.14 75.65 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.268 -0.968 . . . . 0.0 110.752 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 -177.27 5.5 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 168.34 130.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.617 ' CD1' ' O ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -115.67 38.86 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . 165.22 175.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 263' ' ' SER . 5.3 p90 -117.51 133.41 23.26 Favored Pre-proline 0 C--N 1.343 0.288 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.985 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.642 ' HA ' ' HB3' ' A' ' 263' ' ' SER . 96.0 Cg_endo -79.37 149.76 21.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.433 2.088 . . . . 0.0 113.315 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 262' ' ' LEU . 1.3 mm -149.32 38.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.009 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . . . 177.33 124.65 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.399 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.424 ' O ' ' CG2' ' A' ' 320' ' ' THR . 4.1 p -107.01 114.99 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.325 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -99.36 132.79 44.44 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 320' ' ' THR . . . -168.3 -174.13 2.18 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.493 1.517 . . . . 0.0 110.077 -167.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.486 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 2.0 tp -146.65 136.98 23.73 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 111.542 -2.572 . . . . 0.0 116.35 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.427 ' C ' ' CD1' ' A' ' 226' ' ' ILE . 0.2 OUTLIER -131.42 164.74 25.05 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.59 -178.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.439 ' HA ' HD11 ' A' ' 226' ' ' ILE . 0.9 OUTLIER -92.6 132.17 37.09 Favored 'General case' 0 C--N 1.342 0.257 0 O-C-N 121.972 -0.455 . . . . 0.0 110.289 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.451 ' CD1' ' CD2' ' A' ' 242' ' ' TYR . 19.1 tt -113.88 131.19 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.258 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.411 ' CE2' ' OG1' ' A' ' 245' ' ' THR . 17.8 m-85 -104.24 132.64 50.27 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.744 ' O ' ' O ' ' A' ' 122' ' ' LEU . 45.8 m-80 -87.29 123.98 32.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.203 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -98.03 -87.98 0.32 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 119' ' ' LYS . 26.4 t0 -19.72 -63.67 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.5 pp -125.87 38.9 4.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.744 ' O ' ' O ' ' A' ' 118' ' ' ASN . 90.9 mt -158.41 113.22 1.7 Allowed Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.101 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -92.63 124.17 0.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.196 1.264 . . . . 0.0 111.45 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.547 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 11.9 p-10 -97.47 161.64 25.28 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 81.5 Cg_endo -77.1 167.86 24.25 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.676 2.917 . . . . 0.0 112.315 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.34 -47.94 0.08 OUTLIER 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.084 2.522 . . . . 0.0 113.654 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.63 -10.06 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.4 p -117.2 140.21 49.82 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.218 0.917 . . . . 0.0 113.278 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -71.14 -27.73 63.77 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 172.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.498 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.5 OUTLIER -44.61 -24.0 0.16 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.19 -23.3 67.37 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.509 ' O ' ' CB ' ' A' ' 136' ' ' ASP . 5.8 mt -40.52 -59.73 1.86 Allowed Pre-proline 0 N--CA 1.477 0.924 0 CA-C-O 121.11 0.481 . . . . 0.0 112.147 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 4.6 Cg_endo -46.63 -45.39 19.87 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 121.251 1.301 . . . . 0.0 110.701 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.13 -58.91 2.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 139' ' ' LEU . 36.9 mt -67.37 -36.84 82.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.68 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.511 ' HA ' ' CD1' ' A' ' 139' ' ' LEU . 7.7 t0 -73.43 -41.41 63.27 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 5.2 tttt -48.77 -41.94 34.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.123 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.37 -38.1 84.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.189 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.578 ' HB3' ' C ' ' A' ' 144' ' ' LYS . 1.2 mt -63.18 -47.96 80.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.87 -44.6 29.55 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.05 -24.25 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.601 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -111.7 -60.56 1.83 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.62 46.76 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 CA-C-O 118.777 -1.013 . . . . 0.0 111.379 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.578 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.1 OUTLIER -157.04 -172.41 4.02 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.939 1.87 . . . . 0.0 111.128 -176.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 222' ' ' THR . 49.3 m -139.82 167.17 22.72 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.56 ' N ' HD11 ' A' ' 139' ' ' LEU . . . -83.57 -30.57 26.91 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 224' ' ' MET . 0.8 OUTLIER -137.54 127.94 26.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -176.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -132.21 137.87 47.74 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.975 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 1.026 ' O ' ' O ' ' A' ' 150' ' ' ASN . 7.1 p90 -171.33 174.72 4.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.53 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 1.026 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -20.45 -169.77 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 206' ' ' ALA . 0.1 OUTLIER -168.64 33.58 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.351 -0.843 . . . . 0.0 110.544 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.455 ' CB ' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER 172.05 33.99 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 169.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.883 ' O ' ' OG1' ' A' ' 157' ' ' THR . 14.1 pt-20 -115.16 152.74 47.03 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 121.125 1.784 . . . . 0.0 114.376 -176.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.815 ' O ' ' N ' ' A' ' 156' ' ' PHE . 5.1 Cg_exo -77.27 -136.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 124.643 3.562 . . . . 0.0 105.044 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 1.189 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 20.1 m-85 40.88 -68.37 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 120.51 1.505 . . . . 0.0 112.991 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.815 ' N ' ' O ' ' A' ' 154' ' ' PRO . 2.2 t80 -88.51 -58.63 2.48 Favored 'General case' 0 C--O 1.26 1.616 0 CA-C-N 118.705 0.684 . . . . 0.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.883 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 7.0 p -60.16 -42.92 95.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 118.276 -1.37 . . . . 0.0 107.854 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.438 ' HA ' ' CE3' ' A' ' 158' ' ' TRP . 0.0 OUTLIER -49.65 -55.75 21.04 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 1.189 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 84.0 Cg_exo -43.7 -47.26 9.81 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.025 2.483 . . . . 0.0 113.493 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 mp -60.84 -56.38 21.91 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.07 0.85 . . . . 0.0 109.094 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 188' ' ' ALA . 3.7 mt -51.73 -23.6 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.388 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.428 ' CB ' ' HB2' ' A' ' 256' ' ' LYS . . . -79.83 -22.4 43.04 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.047 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 253' ' ' GLN . . . -42.03 -55.81 3.04 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.515 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 1.3 m-20 -64.19 -51.89 61.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 119.449 1.022 . . . . 0.0 112.393 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 169.34 26.14 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 117.924 -2.084 . . . . 0.0 117.117 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.59 89.65 0.7 Allowed Glycine 0 CA--C 1.522 0.526 0 CA-C-N 119.157 1.479 . . . . 0.0 112.66 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -75.11 157.75 34.21 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.184 0.492 . . . . 0.0 111.061 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.523 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.82 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 111.352 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.839 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 4.9 m-85 -112.98 171.87 7.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.215 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 1.19 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER -101.21 107.96 19.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.13 115.42 23.7 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.577 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.877 ' O ' ' N ' ' A' ' 174' ' ' GLY . 19.7 mt-10 -136.35 101.53 4.7 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.449 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 53.0 t30 44.28 -64.31 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 123.796 0.685 . . . . 0.0 111.079 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.877 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -71.64 -73.35 0.83 Allowed Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 116.016 -0.538 . . . . 0.0 114.172 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -175.19 158.12 2.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.797 0.799 . . . . 0.0 109.688 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 1.19 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 17.4 p90 -44.37 -35.89 2.59 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.006 1.384 . . . . 0.0 109.068 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.575 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 0.9 OUTLIER 72.92 -79.48 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.778 -2.465 . . . . 0.0 110.839 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 8.1 tp 168.66 -41.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -8.15 51.93 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.72 93.84 4.2 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.357 0.98 . . . . 0.0 109.36 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.435 HG12 ' CE2' ' A' ' 339' ' ' PHE . 2.6 t -116.33 112.41 39.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -118.48 40.05 2.4 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.745 -1.217 . . . . 0.0 113.553 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -79.97 -47.52 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -81.43 57.26 3.21 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.149 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -102.06 179.52 4.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.244 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.09 -30.49 36.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.486 0.66 . . . . 0.0 111.559 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.515 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -74.71 -40.69 36.83 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.39 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 161' ' ' ILE . . . -59.69 -48.93 79.74 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -59.62 -60.27 4.11 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.551 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.38 -40.69 50.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.972 0.891 . . . . 0.0 112.004 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -64.86 -60.61 6.69 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.431 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.6 tp -58.97 -25.79 63.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 3.1 m -61.94 -49.56 75.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.448 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 1.3 p90 -61.28 -35.52 77.55 Favored 'General case' 0 C--N 1.345 0.413 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.88 -46.84 83.09 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 44.8 t -57.78 -31.42 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.454 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -45.72 89.35 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.725 0.774 . . . . 0.0 110.841 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.85 -54.37 47.63 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.903 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.415 ' HA ' ' CB ' ' A' ' 203' ' ' HIS . 10.8 tt -65.98 -35.13 74.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.387 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.07 -38.58 70.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.148 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -113.03 -34.85 5.59 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 120.785 3.624 . . . . 0.0 120.785 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.72 -70.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CE1' HD12 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -47.8 -37.11 12.88 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.22 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.1 mtp 61.68 -77.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 203' ' ' HIS . 4.9 t-20 -86.38 -178.75 6.53 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.464 ' HA ' HD22 ' A' ' 151' ' ' LEU . . . -155.24 36.44 0.38 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -97.24 -2.81 41.96 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.444 ' HB ' ' CD1' ' A' ' 151' ' ' LEU . 29.5 m -55.2 118.98 4.83 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.53 -174.28 4.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -70.12 -45.45 66.86 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.69 -33.63 66.63 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.829 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.406 HG21 ' CG2' ' A' ' 208' ' ' THR . 1.4 mp -77.38 -48.71 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.881 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.41 68.07 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.538 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 2.5 tp10 -60.58 -46.3 90.73 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.16 -36.11 74.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.641 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.13 -57.79 11.31 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.538 ' CE2' ' HA ' ' A' ' 214' ' ' GLU . 0.0 OUTLIER -61.12 -28.35 69.04 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -53.45 -45.49 69.51 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -23.96 58.96 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.89 53.63 22.23 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.404 -0.817 . . . . 0.0 115.009 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -109.33 37.01 2.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.516 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 145' ' ' SER . 14.3 t -140.33 140.02 35.53 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.592 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -104.11 38.53 1.83 Allowed 'General case' 0 C--N 1.349 0.559 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -176.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.592 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 3.0 tmm? 167.69 137.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 89.1 m -147.78 159.92 43.3 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.674 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.526 HD13 ' HG ' ' A' ' 247' ' ' LEU . 2.3 tp -115.68 112.13 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.473 ' HB2' ' CD1' ' A' ' 232' ' ' TRP . 1.7 p30 -148.07 165.01 32.09 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.877 -0.514 . . . . 0.0 112.152 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 113' ' ' LEU . . . -160.23 -177.75 33.61 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 119.905 -1.14 . . . . 0.0 111.092 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.93 69.73 0.11 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.225 1.95 . . . . 0.0 111.979 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.473 ' N ' ' O ' ' A' ' 228' ' ' GLY . 9.2 t90 -157.93 -59.6 0.08 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.455 ' CB ' ' CE3' ' A' ' 230' ' ' TRP . . . -89.69 -34.68 16.15 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.777 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.473 ' CD1' ' HB2' ' A' ' 227' ' ' ASN . 0.3 OUTLIER -124.56 79.93 1.8 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.716 0.293 . . . . 0.0 111.287 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.3 m -71.04 -43.89 66.93 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.316 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -100.5 77.22 1.9 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.476 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 tt -45.7 136.94 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.605 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.09 -172.93 3.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.594 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.49 78.42 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.658 0.266 . . . . 0.0 110.937 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.0 m -113.14 52.58 0.79 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.403 ' CD ' HD12 ' A' ' 122' ' ' LEU . 0.9 OUTLIER 61.63 112.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.705 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.2 m -52.9 -40.11 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.533 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -83.36 104.3 13.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.716 0.293 . . . . 0.0 110.727 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.451 ' CD2' ' CD1' ' A' ' 116' ' ' ILE . 47.7 p90 -148.55 142.54 25.87 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.336 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -85.53 162.7 36.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.075 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.8 106.49 13.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.911 0.356 . . . . 0.0 111.524 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.411 ' OG1' ' CE2' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -126.56 166.9 16.43 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -172.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.8 154.21 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.169 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 226' ' ' ILE . 0.1 OUTLIER -58.23 156.17 22.51 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 120.327 1.421 . . . . 0.0 110.256 -178.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.45 ' HD2' ' HG ' ' A' ' 247' ' ' LEU . 72.2 Cg_endo -79.44 -165.97 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.532 2.155 . . . . 0.0 112.466 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 40.8 p -106.3 168.16 9.34 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.308 0.575 . . . . 0.0 111.444 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' A' ' 253' ' ' GLN . 0.5 OUTLIER -166.05 126.44 1.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.851 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 36.93 31.11 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.992 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.36 27.49 48.05 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.612 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.476 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 23.7 mm100 -156.6 151.17 20.34 Favored Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 117.479 0.639 . . . . 0.0 112.661 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -91.89 138.88 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.392 2.728 . . . . 0.0 112.093 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.405 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 52.6 m -57.85 142.7 45.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.201 0.524 . . . . 0.0 112.176 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -86.16 108.91 19.24 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.981 -178.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.442 ' HD2' ' HA3' ' A' ' 327' ' ' GLY . 4.8 Cg_exo -79.82 147.2 19.12 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.984 2.456 . . . . 0.0 112.501 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 1.1 m-85 -79.78 136.51 36.75 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 329' ' ' ILE . 27.2 t -92.09 124.46 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -117.59 125.78 6.64 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.196 -1.478 . . . . 0.0 114.764 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.626 HG23 ' HB3' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -121.89 103.5 13.57 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.588 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 69.7 mt -86.11 103.84 15.14 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.563 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.642 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 68.9 p -133.05 139.68 47.31 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 118.142 2.645 . . . . 0.0 118.142 -172.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.788 ' HA ' ' O ' ' A' ' 60' ' ' ILE . . . -95.06 113.36 25.05 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.472 ' CA ' ' HB2' ' A' ' 105' ' ' ALA . . . -102.55 163.26 16.51 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.367 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.624 ' O ' ' O ' ' A' ' 267' ' ' ASN . 0.8 OUTLIER -89.78 134.49 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 176.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.959 ' O ' ' N ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -13.52 -167.38 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.956 1 C-N-CA 132.156 4.183 . . . . 0.0 117.165 -171.525 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.642 ' HA ' ' N ' ' A' ' 77' ' ' ALA . . . -107.39 119.91 40.71 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 110.651 -2.977 . . . . 0.0 104.143 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 268' ' ' ALA . . . 104.94 -65.8 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.217 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 269' ' ' ALA . 2.4 p 155.46 103.07 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.476 ' O ' ' C ' ' A' ' 272' ' ' ASN . 15.5 Cg_endo -99.38 102.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.457 2.772 . . . . 0.0 113.446 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 271' ' ' PRO . 91.1 m-20 26.76 74.19 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.946 0.403 . . . . 0.0 111.646 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -64.67 -31.61 72.9 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 277' ' ' LYS . 0.7 OUTLIER -53.48 -57.5 10.44 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.875 -0.515 . . . . 0.0 112.366 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.91 -53.48 49.71 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.59 94.15 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -63.29 -40.59 97.8 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 -54.15 7.19 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.438 ' CZ ' HG12 ' A' ' 23' ' ' VAL . 8.8 t80 -55.52 -58.72 6.61 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.71 -43.17 37.02 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.776 0.798 . . . . 0.0 111.065 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -74.27 -34.56 63.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.095 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -93.6 -15.89 24.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.462 ' CE2' ' CG1' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -112.5 -60.2 1.9 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.463 0.574 . . . . 0.0 110.594 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 290' ' ' LEU . 1.1 tp -43.12 -33.01 0.79 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.862 0.755 . . . . 0.0 109.798 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.5 mp -86.29 42.24 0.98 Allowed 'General case' 0 C--N 1.342 0.239 0 CA-C-O 120.92 0.391 . . . . 0.0 110.481 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' TYR . 12.9 p -144.47 154.58 43.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 1.7 m-20 -63.8 -13.98 49.0 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.586 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 2.0 tp10 -77.86 -48.24 16.92 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 121.719 -0.613 . . . . 0.0 110.986 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.66 -61.81 2.84 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.627 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 303' ' ' ALA . 0.1 OUTLIER -57.39 -47.74 80.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.0 OUTLIER -79.42 -26.39 41.85 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -68.36 -38.41 81.4 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.458 ' HA ' ' OD2' ' A' ' 296' ' ' ASP . 61.3 t -66.07 -61.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.638 ' HB2' ' CE1' ' A' ' 307' ' ' TYR . 57.8 t30 -33.53 -52.33 0.39 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.738 1.215 . . . . 0.0 112.516 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -58.41 -49.62 76.62 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER -57.19 -45.7 83.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -47.57 169.06 0.13 Allowed Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.28 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -90.67 -72.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.549 2.833 . . . . 0.0 112.853 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.31 -69.14 0.11 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.644 0.259 . . . . 0.0 110.482 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 301' ' ' ALA . . . -79.9 139.25 21.15 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . 159.98 -174.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.242 0.521 . . . . 0.0 110.861 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 108' ' ' ILE . 0.3 OUTLIER -149.91 175.07 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.421 179.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 307' ' ' TYR . . . 172.02 70.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.429 ' CB ' ' O ' ' A' ' 303' ' ' ALA . 3.1 tp 82.26 142.56 0.07 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -48.07 -55.95 8.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -177.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.7 t -53.67 -48.93 69.0 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.879 0.847 . . . . 0.0 111.549 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.638 ' CE1' ' HB2' ' A' ' 294' ' ' ASN . 33.0 t80 -70.46 -19.66 62.94 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.282 176.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 309' ' ' GLU . 0.0 OUTLIER -65.14 -38.15 89.68 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.424 ' N ' ' HG3' ' A' ' 308' ' ' GLU . 3.4 tt0 -66.19 -54.62 23.01 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.838 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.4 -51.23 70.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.244 0.545 . . . . 0.0 109.614 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.457 HD23 HG13 ' A' ' 317' ' ' ILE . 0.2 OUTLIER -59.79 -41.87 92.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.628 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 313' ' ' LYS . . . -47.22 -29.83 2.61 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 312' ' ' ALA . 5.2 ttpt -31.16 -42.96 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.637 0.256 . . . . 0.0 111.506 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.34 135.82 69.02 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.384 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.26 -20.66 56.39 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.529 2.153 . . . . 0.0 113.575 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.556 ' O ' ' OG1' ' A' ' 320' ' ' THR . 7.3 mmt180 -61.42 -58.91 6.28 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.457 HG13 HD23 ' A' ' 311' ' ' LEU . 3.3 mm -49.3 -55.35 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.48 -45.4 13.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.791 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.34 -35.64 63.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.397 0.618 . . . . 0.0 110.267 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 316' ' ' ARG . 0.2 OUTLIER -59.44 -42.69 92.49 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.249 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 60.1 mtm -76.31 -42.01 46.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.143 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -46.96 60.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.446 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -78.28 -41.96 32.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.486 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.54 -36.7 24.35 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.422 ' NE2' ' CE1' ' A' ' 92' ' ' PHE . 2.1 tt0 -85.28 -34.03 22.0 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -93.41 60.68 3.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 111.028 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' ' 257' ' ' PRO . . . -160.67 -139.57 2.69 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.338 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -128.84 117.27 20.77 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.5 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 34.5 mt -83.88 124.09 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.51 ' O ' ' O ' ' A' ' 331' ' ' PRO . 10.9 mtm -42.53 132.43 2.84 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.855 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 176' ' ' TYR . 75.8 Cg_exo -50.28 -156.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.052 2.502 . . . . 0.0 112.605 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -146.65 40.32 1.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.954 0.407 . . . . 0.0 111.158 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.2 160.4 64.27 Favored Pre-proline 0 C--N 1.34 0.185 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.714 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.11 -13.56 23.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.626 2.217 . . . . 0.0 113.515 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.56 -21.17 62.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.17 -34.58 2.78 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.144 -0.347 . . . . 0.0 111.827 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.43 -35.31 71.9 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.834 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.24 72.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.919 0.39 . . . . 0.0 111.723 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.438 ' CZ ' ' CG2' ' A' ' 183' ' ' VAL . 0.2 OUTLIER -78.39 -55.75 4.99 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.79 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -43.42 -45.28 6.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.061 0.458 . . . . 0.0 110.177 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.464 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 34.7 t80 -70.72 -41.08 72.37 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.662 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.412 ' CB ' ' CD2' ' A' ' 361' ' ' LEU . . . -69.68 -46.05 66.94 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.411 ' O ' ' CG2' ' A' ' 347' ' ' VAL . 31.7 t -70.51 -35.03 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.15 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 341' ' ' TYR . 0.0 OUTLIER -69.73 -36.73 76.12 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 349' ' ' ASN . 95.0 m -66.71 -58.52 4.94 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -49.58 -50.39 42.69 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.394 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 343' ' ' VAL . 63.0 t -50.99 -56.93 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 24.8 mt -59.03 -27.39 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.575 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.6 OUTLIER -64.47 -38.68 91.87 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.297 0.57 . . . . 0.0 111.242 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -80.13 -26.58 39.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.359 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.18 -16.88 51.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 2.9 p -111.26 -6.68 14.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.561 1.073 . . . . 0.0 113.376 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 85.61 -2.65 87.88 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.604 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -88.58 35.18 0.76 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 115.808 -2.044 . . . . 0.0 107.605 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -70.82 -174.53 0.94 Allowed 'General case' 0 CA--C 1.547 0.838 1 N-CA-C 125.303 5.297 . . . . 0.0 125.303 -158.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.421 ' N ' ' OD1' ' A' ' 349' ' ' ASN . 4.5 t 159.84 44.76 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 110.365 -3.107 . . . . 0.0 104.252 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' A' ' 346' ' ' ALA . 7.7 p -72.44 -56.4 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.516 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 1.6 m-20 -48.78 -45.06 39.49 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.563 0.697 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.19 -55.78 5.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.938 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -52.37 -44.71 65.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 122.413 1.101 . . . . 0.0 112.65 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.412 ' CD2' ' CB ' ' A' ' 342' ' ' ALA . 1.7 tm? -77.28 -41.56 40.38 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.052 -1.885 . . . . 0.0 110.594 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.607 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 5.2 tttt -60.19 -56.42 21.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.083 0.944 . . . . 0.0 109.129 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -53.05 -37.21 61.4 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.596 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 361' ' ' LEU . . . -49.96 -48.12 52.25 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.479 ' HA ' ' CG2' ' A' ' 368' ' ' ILE . 41.5 tt0 -54.3 -44.89 72.37 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.5 m -57.16 -43.33 82.43 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.495 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -71.2 -57.47 4.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.025 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 368' ' ' ILE . 0.0 OUTLIER -54.45 -33.21 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.265 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.537 ' HA ' ' CG1' ' A' ' 178' ' ' ILE . 41.2 p -94.86 -15.91 23.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.651 0.262 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.56 146.66 44.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.786 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.27 152.85 22.98 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.949 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -142.93 136.86 29.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.954 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.82 -101.72 0.65 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.28 -170.9 1.94 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.319 -0.94 . . . . 0.0 110.01 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.478 ' CD1' ' CE1' ' A' ' 279' ' ' PHE . 0.0 OUTLIER -119.59 123.25 43.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 1.7 t -121.88 111.94 32.89 Favored 'Isoleucine or valine' 0 C--O 1.26 1.62 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 4.0 mt -133.52 126.79 52.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.544 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.538 ' CD1' ' HA ' ' A' ' 60' ' ' ILE . 1.9 p-90 -98.72 135.29 40.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.611 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 10' ' ' TRP . 1.5 mp -154.27 137.59 7.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 O-C-N 122.102 -0.374 . . . . 0.0 110.763 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -120.73 125.74 48.39 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.782 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.44 29.37 14.31 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.882 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 58.8 t0 -102.03 -80.23 0.51 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.166 0.483 . . . . 0.0 110.436 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 6.2 mttm 101.42 -5.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.898 0.879 . . . . 0.0 111.162 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' HA3' ' CB ' ' A' ' 296' ' ' ASP . . . -76.38 64.76 2.82 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 115.359 0.904 . . . . 0.0 115.359 -176.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -78.72 -32.49 46.84 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.348 -0.426 . . . . 0.0 111.284 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 3.3 t-20 -68.47 -46.79 68.81 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 111.347 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.514 ' HA2' ' HG2' ' A' ' 22' ' ' GLU . . . -70.67 -47.52 40.48 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.983 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.583 ' O ' HG21 ' A' ' 23' ' ' VAL . 1.2 mt -59.56 -50.78 72.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.434 0.617 . . . . 0.0 110.336 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -68.76 -39.27 80.33 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.514 ' HG2' ' HA2' ' A' ' 19' ' ' GLY . 11.0 pt-20 -66.21 -35.91 81.66 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.244 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.583 HG21 ' O ' ' A' ' 20' ' ' LEU . 11.3 m -68.63 -60.34 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.464 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' HA3' HG13 ' A' ' 35' ' ' VAL . . . -49.54 -34.19 19.49 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.736 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -57.77 -50.14 74.26 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 122.442 1.115 . . . . 0.0 109.005 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.67 -43.59 62.77 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 112.977 -1.92 . . . . 0.0 109.787 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.711 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -66.36 -26.05 67.09 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.096 -1.003 . . . . 0.0 111.151 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.686 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -73.15 -52.01 15.78 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.304 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -52.76 -28.01 20.41 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 124.683 1.24 . . . . 0.0 110.478 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.638 ' O ' ' CG2' ' A' ' 31' ' ' THR . 1.2 m-20 -84.64 -37.93 20.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 117.634 -1.174 . . . . 0.0 108.819 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.638 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.89 37.74 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 171.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.35 38.62 0.02 OUTLIER Glycine 0 N--CA 1.465 0.633 0 C-N-CA 114.796 -3.573 . . . . 0.0 119.545 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.711 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 22.3 mm -140.05 138.73 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 122.157 2.979 . . . . 0.0 116.956 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -142.36 104.4 4.42 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 20' ' ' LEU . 28.6 m -89.35 130.34 38.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -174.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 p -116.51 140.47 49.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.135 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 6.2 m -130.05 119.68 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -110.43 134.82 51.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.63 71.26 3.55 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 120.829 0.347 . . . . 0.0 111.617 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 39.1 Cg_endo -95.12 -160.95 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.931 3.088 . . . . 0.0 112.72 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.91 -62.63 1.11 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 0.15 34.45 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.602 ' HB3' ' HG2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -56.8 -28.37 61.29 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.218 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 1.047 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -47.32 -54.26 11.5 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.547 -0.721 . . . . 0.0 110.25 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mt-10 -71.85 -50.16 31.93 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.279 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' O ' HG22 ' A' ' 50' ' ' VAL . 32.7 mtmt -59.71 -56.36 22.87 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.122 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.67 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 7.2 t80 -44.38 -57.92 5.8 Favored Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 1.047 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 25.6 Cg_exo -66.03 -35.91 32.15 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 120.977 1.118 . . . . 0.0 114.251 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -66.63 -52.24 47.24 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 123.038 1.399 . . . . 0.0 107.549 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 47' ' ' PHE . 14.7 m -61.22 -21.85 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.555 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' A' ' 48' ' ' PRO . . . -59.84 -29.47 68.29 Favored 'General case' 0 C--N 1.395 2.563 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.644 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.16 -24.59 34.93 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 124.991 1.316 . . . . 0.0 112.008 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.5 m -47.89 -30.96 4.57 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 167.93 -19.09 0.08 OUTLIER Glycine 0 CA--C 1.526 0.724 0 C-N-CA 119.891 -1.147 . . . . 0.0 114.644 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER 155.77 -71.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.719 1.26 . . . . 0.0 111.561 179.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 40.44 -158.46 0.03 OUTLIER Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.031 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.674 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 10.9 Cg_exo -35.81 143.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.887 3.058 . . . . 0.0 112.78 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -123.51 35.44 4.85 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 117.478 -1.689 . . . . 0.0 113.877 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.46 HG23 HD12 ' A' ' 59' ' ' ILE . 2.8 mt -150.57 127.92 2.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 119.662 1.119 . . . . 0.0 113.692 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.538 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -139.4 123.29 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 118.872 0.76 . . . . 0.0 110.034 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.523 ' O ' ' CZ2' ' A' ' 10' ' ' TRP . 2.6 m-85 -104.62 128.53 52.68 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.13 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.567 ' CZ3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -166.0 166.67 17.17 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 119.188 0.904 . . . . 0.0 109.723 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.11 165.99 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 120.479 1.49 . . . . 0.0 110.319 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 67' ' ' PHE . 2.7 p80 -77.05 -29.3 55.1 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.477 0.656 . . . . 0.0 112.059 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -58.46 -36.08 73.15 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.425 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -85.43 -35.26 21.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 3.2 t80 -54.85 -32.82 61.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 172.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.441 ' HA2' ' CD1' ' A' ' 99' ' ' TYR . . . -58.19 -65.35 3.58 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.32 -41.44 16.46 Favored Glycine 0 C--N 1.355 1.639 0 CA-C-N 113.268 -1.466 . . . . 0.0 110.609 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.426 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.3 m-85 -59.49 -46.46 88.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.473 ' CB ' ' CD1' ' A' ' 99' ' ' TYR . . . -50.35 -51.32 46.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.843 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -78.25 -27.15 47.49 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 t -71.63 -17.67 62.25 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.85 11.34 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.231 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.409 ' CD1' ' CB ' ' A' ' 48' ' ' PRO . 3.6 mm? -121.76 57.15 1.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.941 0.4 . . . . 0.0 111.533 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.433 ' CD2' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -179.07 142.01 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.401 0.62 . . . . 0.0 112.127 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.569 ' O ' ' CG2' ' A' ' 104' ' ' ILE . . . -59.94 176.98 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.527 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -139.74 80.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.375 0.27 . . . . 0.0 110.489 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.0 pt -70.99 162.19 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.108 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.92 118.35 69.17 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.875 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -79.87 146.79 18.75 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.571 2.181 . . . . 0.0 112.158 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -136.0 163.67 29.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.863 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -49.06 78.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.631 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.73 -23.64 63.36 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.822 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.5 ' CE2' ' CZ2' ' A' ' 94' ' ' TRP . 19.3 t80 -68.74 -58.65 3.91 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.916 0.389 . . . . 0.0 110.352 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -77.12 -24.7 51.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -76.36 -45.24 32.87 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 89' ' ' LEU . 3.9 pttp -51.54 -41.71 61.27 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.495 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.431 ' N ' ' HG3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -103.92 -175.14 2.71 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.6 0.238 . . . . 0.0 110.663 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CG ' ' CE2' ' A' ' 92' ' ' PHE . 0.9 OUTLIER -69.5 131.0 90.19 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.693 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.44 -38.0 82.52 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.515 2.143 . . . . 0.0 112.711 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.452 ' CE2' ' CG ' ' A' ' 90' ' ' TYR . 45.1 p90 -73.22 -43.61 60.97 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 120.549 0.214 . . . . 0.0 111.275 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.435 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 45.0 m -62.14 -25.42 67.73 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.5 ' CZ2' ' CE2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -92.45 -26.49 17.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.216 0.531 . . . . 0.0 111.202 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -21.29 60.07 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.813 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.08 -50.17 65.04 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.685 0.278 . . . . 0.0 110.722 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 107' ' ' PRO . 11.7 p -94.7 60.11 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.01 138.83 48.39 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.063 -1.023 . . . . 0.0 109.753 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 101' ' ' GLY . 31.5 t80 -107.64 138.68 43.43 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.344 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -59.11 78.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.811 0.339 . . . . 0.0 110.108 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 133.11 -18.23 4.49 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.36 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.441 ' CG ' ' HB3' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.7 123.75 12.83 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.125 0.962 . . . . 0.0 111.843 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.82 74.68 1.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.569 ' CG2' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -129.46 91.3 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 121.668 0.747 . . . . 0.0 112.634 -177.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . 159.54 -177.22 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.502 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -136.63 142.86 40.68 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.16 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.441 ' HB3' HG11 ' A' ' 97' ' ' VAL . 84.4 Cg_endo -82.02 156.88 17.77 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.499 2.132 . . . . 0.0 112.437 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.651 ' N ' ' O ' ' A' ' 262' ' ' LEU . 28.2 mt -119.44 -135.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.501 ' H ' ' CG2' ' A' ' 108' ' ' ILE . . . -79.48 157.44 27.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 302' ' ' VAL . 4.2 m -110.02 114.41 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.817 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -101.9 164.94 11.46 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.154 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.8 146.72 8.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.848 0.832 . . . . 0.0 111.267 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HB2' ' CD2' ' A' ' 156' ' ' PHE . 3.2 pp -79.02 128.06 32.78 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.101 -1.408 . . . . 0.0 107.482 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 227' ' ' ASN . 24.8 p -131.35 165.85 22.55 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 tp -99.2 135.13 41.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.99 133.84 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.418 ' CD2' HG21 ' A' ' 245' ' ' THR . 12.1 p90 -122.08 142.02 50.79 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.842 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 1.4 t-20 -89.29 126.91 35.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.488 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.34 -3.61 28.5 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.064 -0.398 . . . . 0.0 110.37 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.22 -62.76 1.19 Allowed 'General case' 0 C--N 1.34 0.177 0 CA-C-O 121.252 0.548 . . . . 0.0 110.498 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 39.82 2.31 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.644 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.842 ' HB3' ' O ' ' A' ' 118' ' ' ASN . 1.3 tp -131.68 89.72 38.83 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.354 0.597 . . . . 0.0 110.65 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.433 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 81.0 Cg_exo -44.5 162.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.465 2.777 . . . . 0.0 112.571 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 23.0 m-20 -60.12 110.7 3.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 122.449 1.119 . . . . 0.0 111.793 -170.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 58.9 Cg_endo -69.88 168.31 22.09 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 125.238 3.959 . . . . 0.0 114.14 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.415 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 56.9 Cg_endo -92.34 -154.05 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 123.34 2.693 . . . . 0.0 115.501 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -125.52 -91.7 0.52 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 t -46.4 155.53 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.058 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.433 ' CZ2' ' CD2' ' A' ' 147' ' ' LEU . 10.0 t-105 -69.67 -33.49 72.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 174.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 133' ' ' PRO . 1.9 mm-40 -44.98 -24.17 0.2 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.731 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -72.67 -26.51 61.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.484 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 25.6 mm -40.64 -57.33 3.19 Favored Pre-proline 0 N--CA 1.478 0.974 0 CA-C-O 121.29 0.567 . . . . 0.0 111.982 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 6.0 Cg_endo -48.27 -39.09 34.76 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 N-CA-C 109.399 -1.039 . . . . 0.0 109.399 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.35 -58.56 3.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.415 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 0.3 OUTLIER -68.65 -36.34 78.44 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.039 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.482 ' HA ' HD11 ' A' ' 139' ' ' LEU . 21.6 t0 -72.85 -40.15 65.95 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -46.82 -47.37 21.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.402 176.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.74 -39.6 94.69 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.405 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -60.81 -49.84 75.87 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -44.52 29.67 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -45.89 -26.3 0.67 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -108.04 -58.57 1.96 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.058 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.8 43.93 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 CA-C-O 118.824 -0.986 . . . . 0.0 111.036 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.492 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 4.0 mttt -155.34 -172.22 4.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.636 1.718 . . . . 0.0 111.086 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.449 ' N ' HD22 ' A' ' 139' ' ' LEU . 47.9 m -142.4 160.71 39.74 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -75.15 -28.67 60.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.433 ' CD2' ' CZ2' ' A' ' 129' ' ' TRP . 0.7 OUTLIER -152.6 133.05 13.74 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -176.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.421 ' HB2' ' CB ' ' A' ' 222' ' ' THR . 7.9 tpt -132.3 140.72 48.7 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.907 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 150' ' ' ASN . 34.8 p90 -172.7 175.21 3.48 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.665 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 149' ' ' PHE . 45.2 m-80 -37.74 170.69 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.683 0.615 . . . . 0.0 110.828 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.449 ' CB ' ' O ' ' A' ' 208' ' ' THR . 2.1 tm? -114.64 -59.66 1.99 Allowed 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -102.75 36.01 2.32 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 116.788 -1.965 . . . . 0.0 114.862 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.675 ' O ' ' HB ' ' A' ' 157' ' ' THR . 4.6 mm-40 -88.3 144.35 33.95 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 121.18 1.809 . . . . 0.0 114.61 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.934 ' O ' ' N ' ' A' ' 156' ' ' PHE . 6.0 Cg_exo -77.71 -135.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.285 1 C-N-CA 125.787 4.325 . . . . 0.0 106.04 176.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 1.149 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 1.2 m-85 27.17 -54.88 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.934 ' N ' ' O ' ' A' ' 154' ' ' PRO . 14.9 m-85 -87.88 -58.8 2.44 Favored 'General case' 0 C--O 1.26 1.625 0 C-N-CA 124.486 1.114 . . . . 0.0 110.761 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.675 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 24.1 m -57.24 -44.6 83.99 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.491 ' CZ2' ' CG2' ' A' ' 343' ' ' VAL . 4.8 m95 -52.31 -55.02 35.51 Favored Pre-proline 0 C--N 1.348 0.521 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.534 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 1.149 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 87.5 Cg_exo -43.4 -49.53 7.47 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.387 2.058 . . . . 0.0 114.124 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.509 ' HB3' ' CE2' ' A' ' 250' ' ' PHE . 1.5 pp -79.18 -56.95 3.98 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 120.529 -1.357 . . . . 0.0 113.241 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.627 ' CA ' ' HA3' ' A' ' 191' ' ' GLY . 1.1 pt -61.19 -13.17 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 164' ' ' ASP . . . -124.95 -46.4 1.83 Allowed 'General case' 0 N--CA 1.471 0.622 1 N-CA-C 124.147 4.869 . . . . 0.0 124.147 -178.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.84 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . . . -54.58 49.72 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -176.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 162' ' ' ALA . 10.2 m-20 -122.1 -58.83 1.7 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.727 0.694 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.68 1.68 2.09 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.23 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.12 95.79 1.09 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.104 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -67.08 139.55 57.57 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.026 0.413 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.486 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . . . -43.6 -74.65 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.742 0.782 . . . . 0.0 111.643 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.576 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 32.3 m-85 -112.33 173.9 6.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.708 ' O ' ' O ' ' A' ' 175' ' ' LYS . 6.3 ttmt -100.68 108.06 19.83 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.933 ' HA ' ' O ' ' A' ' 175' ' ' LYS . 27.5 m-85 -84.05 111.33 19.2 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.134 176.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 173' ' ' ASN . 18.0 mt-10 -104.89 101.17 10.77 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.597 ' C ' ' O ' ' A' ' 172' ' ' GLU . 8.8 m120 34.8 73.52 0.08 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 65.67 70.69 1.04 Allowed Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.171 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.933 ' O ' ' HA ' ' A' ' 171' ' ' TYR . 3.8 tptp -177.67 122.75 0.12 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.522 1.161 . . . . 0.0 112.98 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.608 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -114.63 -19.8 10.96 Favored 'General case' 0 N--CA 1.512 2.653 0 CA-C-O 122.907 1.337 . . . . 0.0 109.14 175.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 6.5 m-20 38.84 -85.8 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 111.523 -2.58 . . . . 0.0 111.725 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 7.3 tp 171.86 -41.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -65.9 -12.7 56.62 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 71.9 m-20 -120.59 93.53 4.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.994 0.816 . . . . 0.0 109.127 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.407 ' CG2' ' CG ' ' A' ' 365' ' ' GLN . 32.2 m -115.95 112.55 40.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.69 39.79 2.39 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.736 -1.221 . . . . 0.0 114.065 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 168' ' ' ALA . 2.1 t -78.27 -43.54 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.506 ' HA ' ' CB ' ' A' ' 188' ' ' ALA . 5.8 p-10 -66.22 57.01 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.458 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 183' ' ' VAL . 0.7 OUTLIER -102.98 -172.34 2.1 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.37 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.689 ' O ' ' HG3' ' A' ' 189' ' ' LYS . . . -38.79 -48.59 1.54 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.244 0.545 . . . . 0.0 112.346 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.13 -32.3 52.89 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-O 118.975 -0.903 . . . . 0.0 113.053 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.506 ' CB ' ' HA ' ' A' ' 184' ' ' ASP . . . -60.07 -54.96 39.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.33 1.565 . . . . 0.0 107.301 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -52.64 -39.42 61.77 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.31 76.29 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 111.954 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.627 ' HA3' ' CA ' ' A' ' 161' ' ' ILE . . . -56.48 -60.59 8.7 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.711 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -59.76 -30.93 69.2 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.194 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.5 m -74.94 -53.7 8.53 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.477 ' CD2' ' HA2' ' A' ' 191' ' ' GLY . 0.1 OUTLIER -62.09 -33.62 74.78 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.863 0.364 . . . . 0.0 110.16 178.149 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.92 -48.32 77.04 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 192' ' ' LEU . 76.1 t -56.48 -30.66 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.11 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -46.65 84.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.569 0.699 . . . . 0.0 111.006 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -51.42 68.27 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.151 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 204' ' ' MET . 46.3 mm -63.41 -45.97 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.686 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.19 -36.71 52.67 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 118.437 -0.792 . . . . 0.0 112.02 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -113.0 -34.61 5.68 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 120.962 3.69 . . . . 0.0 120.962 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -79.41 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.702 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -101.47 -6.01 24.51 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 8.4 ttt 45.18 35.44 1.72 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.597 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -146.52 165.96 27.88 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -152.35 32.57 0.52 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -99.0 -3.45 34.88 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -55.18 120.27 6.76 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 119.757 -0.777 . . . . 0.0 108.92 178.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 213' ' ' ALA . 8.5 m-20 -94.77 -175.29 3.53 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.158 -0.339 . . . . 0.0 111.621 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -70.71 -45.26 65.27 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.136 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.95 -25.54 48.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.449 0.642 . . . . 0.0 110.771 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.7 mt -81.47 -52.01 14.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -51.11 -36.81 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.46 -45.55 86.9 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.26 -39.38 69.73 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.795 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.54 -56.06 25.98 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.97 -28.69 70.26 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -55.79 -41.56 74.27 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.512 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -23.9 59.13 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.12 42.71 58.02 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.405 ' HB3' ' HG3' ' A' ' 144' ' ' LYS . 1.4 mp0 -110.57 37.09 2.86 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.94 1.37 . . . . 0.0 110.794 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.421 ' CB ' ' HB2' ' A' ' 148' ' ' MET . 8.9 t -139.2 138.62 37.04 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 224' ' ' MET . . . -92.93 38.2 1.03 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -177.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 162.4 149.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 87.0 m -147.89 160.05 43.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.137 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.2 pt -116.5 113.26 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -146.85 165.48 29.6 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.283 -177.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 232' ' ' TRP . . . -79.82 -154.4 9.18 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 119.341 -1.409 . . . . 0.0 113.495 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.71 -50.91 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.816 2.344 . . . . 0.0 114.115 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.449 ' CZ2' ' HB3' ' A' ' 299' ' ' LEU . 12.7 p-90 -135.78 -54.72 0.77 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.42 ' HB2' ' CE3' ' A' ' 230' ' ' TRP . . . -135.11 46.37 2.43 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.408 ' CB ' ' HA3' ' A' ' 228' ' ' GLY . 6.0 t-105 -91.64 -44.4 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.665 0.269 . . . . 0.0 110.432 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -114.42 38.14 3.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.045 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 54.07 87.92 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.634 0.254 . . . . 0.0 111.105 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 237' ' ' THR . 0.2 OUTLIER -155.08 -43.82 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.401 ' N ' HG12 ' A' ' 235' ' ' ILE . 0.0 OUTLIER 45.09 -84.88 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 235' ' ' ILE . 15.6 p -67.18 138.0 56.66 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.651 0.262 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 22.1 p -134.51 158.87 42.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.898 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.85 176.62 0.07 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.984 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.64 -60.86 2.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.024 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -108.99 99.9 9.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.722 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -117.46 127.59 54.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.075 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 117' ' ' TYR . . . -96.71 114.13 4.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.205 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.72 137.01 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.579 -0.365 . . . . 0.0 110.829 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.418 HG21 ' CD2' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -141.18 167.93 21.0 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.071 0.548 . . . . 0.0 111.613 -172.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.6 m -72.75 152.23 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 248' ' ' PRO . 1.9 mp -58.73 159.54 12.64 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 119.903 1.229 . . . . 0.0 110.682 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 247' ' ' LEU . 72.4 Cg_endo -78.66 -162.67 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.552 2.168 . . . . 0.0 113.063 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.4 p -94.91 144.31 25.77 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 160' ' ' LEU . 62.2 m-85 -144.61 111.2 5.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.96 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.04 31.98 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.196 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 105.78 29.98 4.75 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.423 ' OE1' ' HD2' ' A' ' 254' ' ' PRO . 0.1 OUTLIER -156.68 167.1 15.14 Favored Pre-proline 0 N--CA 1.467 0.375 0 CA-C-N 119.1 1.45 . . . . 0.0 112.302 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.423 ' HD2' ' OE1' ' A' ' 253' ' ' GLN . 67.7 Cg_endo -93.08 23.73 0.5 Allowed 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.43 2.753 . . . . 0.0 114.48 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 0.7 OUTLIER 72.21 133.61 0.04 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 178.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.84 ' HB2' ' HB2' ' A' ' 163' ' ' ALA . 10.5 mttt -86.38 106.39 10.11 Favored Pre-proline 0 CA--C 1.512 -0.499 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.795 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.723 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 94.8 Cg_endo -78.9 143.87 18.62 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.201 1.267 . . . . 0.0 109.719 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -89.19 119.32 29.58 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 324' ' ' ALA . 6.2 m -115.2 99.86 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 118.247 0.476 . . . . 0.0 112.148 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -90.86 156.69 24.7 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.782 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.473 HG13 ' CG ' ' A' ' 64' ' ' HIS . 2.1 p -118.19 106.49 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -72.3 129.61 38.82 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 117.54 -1.664 . . . . 0.0 107.115 178.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.486 ' HA ' HG13 ' A' ' 108' ' ' ILE . 2.9 p -140.85 130.0 23.48 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 118.624 2.824 . . . . 0.0 118.624 -172.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.516 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . . . -88.88 111.98 22.72 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 105' ' ' ALA . . . -100.78 164.27 18.64 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.475 ' HB ' HD11 ' A' ' 104' ' ' ILE . 3.7 mt -88.21 123.05 40.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 118.723 1.262 . . . . 0.0 107.617 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -64.59 145.73 55.71 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.73 -25.5 60.48 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.132 -0.355 . . . . 0.0 110.947 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -49.5 -60.0 3.25 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.471 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.94 131.77 8.87 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.652 0.263 . . . . 0.0 111.279 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.37 -42.57 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.497 2.131 . . . . 0.0 112.999 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 276' ' ' ALA . 4.2 m-20 47.8 81.08 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.533 0.206 . . . . 0.0 110.787 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.12 -54.07 7.77 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -58.48 -57.29 13.58 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 8.3 tt -59.72 -42.88 94.08 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.658 0.266 . . . . 0.0 111.472 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.519 ' HB3' HD13 ' A' ' 280' ' ' LEU . . . -72.9 -33.41 65.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.612 ' O ' ' CB ' ' A' ' 281' ' ' GLU . 1.1 tmtt? -63.58 -58.7 6.13 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 121.413 0.625 . . . . 0.0 112.165 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.508 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 3.6 tp10 -68.06 -34.55 76.66 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.699 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.486 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 54.9 t80 -74.04 -60.02 2.45 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.963 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 276' ' ' ALA . 5.8 mp -75.01 -43.13 55.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 118.373 -1.331 . . . . 0.0 113.05 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.612 ' CB ' ' O ' ' A' ' 277' ' ' LYS . 0.2 OUTLIER -73.65 -37.73 65.21 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.518 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 3.9 t30 -87.99 -20.61 25.61 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 285' ' ' LEU . 0.2 OUTLIER -104.06 -74.45 0.64 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 177.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.493 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 0.5 OUTLIER -36.22 -30.63 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 281' ' ' GLU . 3.2 mm? -98.35 43.49 1.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.896 0.316 . . . . 0.0 111.792 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.5 p -144.89 157.78 44.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 11.2 m-20 -61.18 -15.17 31.15 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 2.3 mm-40 -78.32 -46.91 18.92 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.316 0.507 . . . . 0.0 110.498 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -81.06 -53.46 3.92 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 284' ' ' LEU . 17.6 mt -50.07 -49.24 51.97 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.452 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 1.4 tp10 -78.14 -27.41 48.2 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.912 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -71.92 -38.06 69.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 119.776 1.171 . . . . 0.0 108.405 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 290' ' ' LEU . 14.7 p -65.92 -38.03 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.441 ' N ' HG11 ' A' ' 293' ' ' VAL . 24.5 t30 -74.95 -41.88 58.75 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.458 1.103 . . . . 0.0 113.374 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -65.09 -42.74 93.76 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.482 ' CB ' ' HA3' ' A' ' 16' ' ' GLY . 33.4 m-20 -56.68 -64.53 0.84 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -97.63 105.24 25.12 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.814 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -100.18 93.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.62 2.88 . . . . 0.0 112.305 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.449 ' HB3' ' CZ2' ' A' ' 230' ' ' TRP . 0.0 OUTLIER -143.33 -74.29 0.27 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.526 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -144.0 173.6 24.71 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.084 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 311' ' ' LEU . . . -129.93 131.24 45.93 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 110' ' ' VAL . 10.9 p -179.8 39.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.085 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.431 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . -111.06 -138.21 0.37 Allowed 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 285' ' ' LEU . 22.0 tp -39.63 121.24 1.2 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -30.33 -63.15 0.14 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.514 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 95.7 p -48.88 -44.73 40.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.966 0.889 . . . . 0.0 110.933 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.479 ' CG ' ' HB3' ' A' ' 290' ' ' LEU . 3.1 t80 -75.87 -25.05 55.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.909 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -68.54 -39.78 80.99 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -68.66 -61.33 1.87 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.288 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -46.78 -56.61 5.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.872 0.368 . . . . 0.0 111.169 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.461 ' HB3' ' CB ' ' A' ' 301' ' ' ALA . 0.3 OUTLIER -64.43 -45.58 86.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.641 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 308' ' ' GLU . . . -46.84 -28.7 1.65 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -31.22 -42.21 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.19 137.12 84.33 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.784 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.72 -21.8 70.94 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.631 2.22 . . . . 0.0 113.252 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -59.71 -59.14 5.9 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.646 0.26 . . . . 0.0 111.559 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.438 HG23 ' HB3' ' A' ' 301' ' ' ALA . 3.0 mp -50.91 -55.6 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.91 -39.07 8.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.163 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.08 -52.74 64.43 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 122.058 0.932 . . . . 0.0 108.837 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.41 ' OG1' HG22 ' A' ' 110' ' ' VAL . 3.2 p -56.84 -37.57 71.43 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 113.625 -1.625 . . . . 0.0 109.85 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.4 ttp -70.93 -44.59 65.86 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -58.56 -57.38 13.21 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' A' ' 327' ' ' GLY . 6.5 m-20 -50.45 -38.71 45.0 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.44 ' HA ' ' CG1' ' A' ' 259' ' ' VAL . . . -57.35 -43.19 83.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.603 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -57.33 -42.06 81.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.228 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -106.19 26.41 9.81 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.887 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.723 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -114.66 157.64 14.85 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.618 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.86 135.66 36.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 330' ' ' MET . 39.0 mt -86.45 115.43 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 118.906 0.775 . . . . 0.0 110.87 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.492 ' C ' ' O ' ' A' ' 329' ' ' ILE . 0.0 OUTLIER -28.27 130.84 0.2 Allowed Pre-proline 0 N--CA 1.47 0.568 0 N-CA-C 111.412 0.153 . . . . 0.0 111.412 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.426 ' HG2' ' CE1' ' A' ' 169' ' ' PHE . 62.4 Cg_exo -51.79 -164.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.893 2.395 . . . . 0.0 113.152 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -150.73 39.29 0.71 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.343 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.421 HG13 ' CE1' ' A' ' 176' ' ' TYR . 1.2 pp -132.58 163.23 52.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.026 0.441 . . . . 0.0 111.911 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.21 -37.86 7.56 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.046 2.497 . . . . 0.0 112.403 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -45.98 -21.79 0.16 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 4.0 tpp -45.49 -35.61 3.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.956 0.344 . . . . 0.0 110.978 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.5 t -61.12 -40.33 93.36 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.78 0.324 . . . . 0.0 110.19 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.12 -37.61 85.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.764 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.457 ' CD2' HD13 ' A' ' 368' ' ' ILE . 23.4 t80 -74.04 -55.74 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.624 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 344' ' ' ARG . 2.3 t-105 -49.91 -43.61 49.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.494 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.79 -52.2 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.9 -44.17 81.5 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.491 ' CG2' ' CZ2' ' A' ' 158' ' ' TRP . 5.0 p -71.7 -29.42 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -75.03 -49.18 20.63 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 349' ' ' ASN . 69.9 p -57.33 -57.94 10.42 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.683 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.79 -41.22 6.76 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.861 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 343' ' ' VAL . 54.9 t -59.04 -47.69 89.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 6.7 mt -66.97 -28.24 42.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.8 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.683 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.9 OUTLIER -67.94 -27.63 66.78 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.66 0.267 . . . . 0.0 110.913 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.51 -44.76 23.62 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.54 -9.39 59.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 9.4 t -101.72 -46.03 5.06 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 142.1 0.77 1.4 Allowed Glycine 0 N--CA 1.464 0.504 0 C-N-CA 117.054 -2.498 . . . . 0.0 118.074 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.46 32.38 4.66 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 113.232 -3.387 . . . . 0.0 114.916 173.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.542 ' HB3' ' CB ' ' A' ' 360' ' ' ALA . 0.0 OUTLIER -158.24 119.22 3.43 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 34.3 p -78.73 146.88 33.65 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.5 p -41.97 -45.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 16.0 m-20 -71.58 -49.67 38.26 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.01 -46.38 57.39 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.475 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 355' ' ' GLN . . . -54.16 -49.47 69.21 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.282 1.039 . . . . 0.0 113.593 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 47.3 mt -74.71 -36.69 62.7 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.283 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 365' ' ' GLN . 14.7 tttm -65.13 -56.7 11.41 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 122.351 1.072 . . . . 0.0 110.581 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.34 -37.45 83.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.749 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -49.61 -43.98 46.87 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 362' ' ' LYS . 0.0 OUTLIER -60.62 -44.74 95.97 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.57 -44.15 56.57 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.34 0.591 . . . . 0.0 110.168 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.08 -46.22 90.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.269 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.457 HD13 ' CD2' ' A' ' 339' ' ' PHE . 6.7 pt -81.19 -5.65 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.837 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 10.8 p -135.28 42.81 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.619 0.247 . . . . 0.0 110.616 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.248 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.667 0.27 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.7 p -137.21 111.53 8.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.847 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -131.81 117.96 19.25 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -138.95 -179.45 5.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.98 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.7 66.04 0.55 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HA ' HG12 ' A' ' 33' ' ' ILE . 2.3 tttp -153.18 157.49 40.36 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.465 ' HB2' HD11 ' A' ' 33' ' ' ILE . 24.7 tp -146.48 124.75 12.24 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.79 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' A' ' 58' ' ' ASP . 99.3 t -111.74 132.9 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.488 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.706 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 5.4 mp -135.21 125.15 43.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.063 0.459 . . . . 0.0 111.412 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.458 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -106.04 121.04 43.31 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 15.3 mt -158.09 137.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.063 0.458 . . . . 0.0 111.252 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -156.07 41.98 0.39 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.59 -35.21 0.57 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.698 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 3.3 m-20 -90.05 -105.51 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER 161.91 -172.6 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.03 0.919 . . . . 0.0 113.204 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.66 100.58 0.32 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 113.733 -1.576 . . . . 0.0 115.423 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -36.33 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.984 -0.608 . . . . 0.0 111.167 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 12.1 t-20 -64.84 -43.94 91.4 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 296' ' ' ASP . . . -71.99 -49.01 23.99 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.631 -0.795 . . . . 0.0 114.043 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -50.18 74.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.789 0.795 . . . . 0.0 110.371 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.29 82.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 53.9 tt0 -65.8 -36.98 85.02 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.42 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.6 -61.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 122.063 -0.398 . . . . 0.0 110.377 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -49.31 -32.49 14.32 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.278 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -58.37 -50.84 72.23 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 122.503 1.144 . . . . 0.0 109.183 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -42.81 61.96 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 113.05 -1.886 . . . . 0.0 109.515 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.6 ' O ' ' HB ' ' A' ' 31' ' ' THR . 10.8 t80 -64.26 -32.23 73.74 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.316 0.579 . . . . 0.0 110.691 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 32' ' ' GLY . 26.8 tt0 -68.78 -46.62 68.25 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.897 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -25.6 54.27 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -176.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.7 -33.61 21.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 27' ' ' PHE . 1.8 m -95.75 -133.5 0.2 Allowed 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 111.115 -2.766 . . . . 0.0 104.792 173.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 28' ' ' GLU . . . -173.59 42.71 0.15 Allowed Glycine 0 C--N 1.291 -1.94 0 N-CA-C 106.869 -2.492 . . . . 0.0 106.869 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.501 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -113.95 152.14 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -105.71 105.78 15.98 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.655 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 ' CG2' ' CD1' ' A' ' 9' ' ' ILE . 10.7 p -84.49 131.32 34.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.0 p -116.71 141.24 48.46 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.379 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 27.0 m -136.74 119.97 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 1.7 mp0 -109.42 141.87 41.2 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -113.65 81.27 5.47 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 120.638 0.256 . . . . 0.0 111.483 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.475 ' CG ' ' HG ' ' A' ' 43' ' ' LEU . 38.1 Cg_endo -90.83 -172.55 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.31 2.673 . . . . 0.0 113.005 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -114.05 -44.97 3.1 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.622 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -81.03 0.61 35.01 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.475 ' HG ' ' CG ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -19.77 -39.81 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 1.05 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -63.49 -55.06 27.06 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.273 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mp0 -74.07 -41.75 61.25 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.154 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -57.97 -57.82 11.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.24 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.699 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 34.7 t80 -41.73 -60.99 1.61 Allowed Pre-proline 0 C--N 1.355 0.828 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.26 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 1.05 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 25.0 Cg_exo -62.4 -19.83 68.51 Favored 'Trans proline' 0 C--O 1.25 1.106 0 CA-C-N 120.17 1.096 . . . . 0.0 111.704 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -81.07 -34.13 32.93 Favored 'General case' 0 C--O 1.259 1.599 0 CA-C-O 122.644 1.211 . . . . 0.0 110.683 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 47' ' ' PHE . 2.7 m -80.13 -40.86 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 CA-C-O 122.287 1.041 . . . . 0.0 110.308 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.06 -37.21 20.36 Favored 'General case' 0 C--N 1.381 1.958 0 CA-C-N 113.226 -1.806 . . . . 0.0 110.096 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.27 -35.74 30.77 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.555 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -172.49 64.57 0.03 OUTLIER 'General case' 0 C--N 1.34 0.169 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.606 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . -167.12 44.18 0.25 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 119.566 -1.302 . . . . 0.0 115.008 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 3.5 m-20 155.75 -86.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.74 -106.16 0.9 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 18.6 Cg_endo -57.11 132.99 54.77 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.938 1.759 . . . . 0.0 108.316 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.766 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 20.7 t0 157.97 126.9 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 118.717 0.69 . . . . 0.0 112.855 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.462 HG23 ' HA ' ' A' ' 266' ' ' ILE . 9.5 mt -107.87 162.85 5.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.547 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 6.3 tt -138.16 127.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.706 ' O ' ' HE3' ' A' ' 62' ' ' TRP . 3.1 m-85 -85.94 148.07 25.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.706 ' HE3' ' O ' ' A' ' 61' ' ' PHE . 1.6 t-105 -168.54 153.38 6.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 120.119 1.327 . . . . 0.0 108.518 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 67' ' ' PHE . . . -77.21 -175.51 3.68 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.73 1.15 . . . . 0.0 108.746 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.573 ' HB2' ' HB ' ' A' ' 261' ' ' VAL . 22.4 t-80 -77.9 -44.89 25.71 Favored 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.578 ' HB3' ' CG ' ' A' ' 330' ' ' MET . 0.8 OUTLIER -52.91 -59.44 4.52 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 1.6 mtt85 -70.6 -29.86 66.37 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.541 ' CB ' ' O ' ' A' ' 63' ' ' ALA . 7.3 t80 -62.46 -39.7 94.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 72' ' ' GLN . . . -46.99 -67.62 1.4 Allowed Glycine 0 CA--C 1.488 -1.652 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.886 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 73' ' ' SER . . . -76.44 -71.84 1.15 Allowed Glycine 0 C--N 1.341 0.839 0 CA-C-N 114.485 -0.857 . . . . 0.0 112.612 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.709 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 12.7 m-30 -41.82 -57.5 2.33 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.423 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 67' ' ' PHE . . . -75.61 -56.63 4.51 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.625 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 4.8 tm0? -63.8 -12.9 39.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.621 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 48.4 t -82.84 -26.75 31.36 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.119 -0.363 . . . . 0.0 111.78 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 166.99 -32.09 0.2 Allowed Glycine 0 C--N 1.339 0.735 0 C-N-CA 119.414 -1.374 . . . . 0.0 114.772 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.709 ' HG ' ' O ' ' A' ' 70' ' ' TYR . 1.8 pp -86.72 61.8 7.03 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 118.195 0.998 . . . . 0.0 111.743 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.19 143.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.238 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.96 115.13 29.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.716 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.58 ' HA ' HG13 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -53.99 151.44 6.77 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.2 pt -90.96 155.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.276 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.25 175.31 4.25 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.097 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.52 139.46 14.41 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.776 2.318 . . . . 0.0 112.952 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.21 -162.19 1.26 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.303 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.404 ' N ' ' HD3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -117.07 -58.6 2.04 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.318 -0.239 . . . . 0.0 111.237 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.69 70.18 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.634 0.254 . . . . 0.0 111.417 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.405 ' CD2' ' HG2' ' A' ' 281' ' ' GLU . 0.1 OUTLIER -73.75 -59.08 2.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.464 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -56.93 -27.33 60.86 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.3 -31.07 57.99 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.8 29.62 2.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.567 ' HA ' ' CD1' ' A' ' 94' ' ' TRP . 19.7 mt -104.8 107.8 18.95 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.173 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -89.1 -179.19 1.19 Allowed Pre-proline 0 N--CA 1.452 -0.361 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 7.4 Cg_exo -74.08 -39.0 1.86 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.326 2.017 . . . . 0.0 115.603 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -87.65 -63.61 1.28 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.586 ' OG1' ' CE3' ' A' ' 94' ' ' TRP . 1.2 p -64.78 -26.99 68.59 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -175.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.586 ' CE3' ' OG1' ' A' ' 93' ' ' THR . 5.2 m-90 -89.2 -24.93 22.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.015 0.926 . . . . 0.0 111.001 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 2.5 t70 -72.97 -26.81 61.49 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.125 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.442 ' CB ' ' CG2' ' A' ' 261' ' ' VAL . . . -71.72 -38.63 70.47 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 105' ' ' ALA . 40.7 t -100.02 44.74 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.03 140.21 51.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 119.16 -0.448 . . . . 0.0 109.9 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.9 t80 -109.3 174.7 5.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.529 1.059 . . . . 0.0 109.433 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -61.32 75.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.724 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 138.97 -55.69 0.66 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.173 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -145.93 -178.29 6.04 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 117.126 0.463 . . . . 0.0 111.316 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.36 146.28 42.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.226 0.536 . . . . 0.0 112.39 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.695 HG12 ' O ' ' A' ' 104' ' ' ILE . 4.1 tt -122.32 58.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.131 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . 159.03 176.04 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' CD2' ' HB1' ' A' ' 264' ' ' ALA . 0.0 OUTLIER -139.02 127.91 14.0 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 115.542 -0.754 . . . . 0.0 108.974 177.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.549 ' HA ' ' HB3' ' A' ' 263' ' ' SER . 86.3 Cg_endo -79.6 162.06 24.71 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 122.886 2.391 . . . . 0.0 113.479 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.643 ' N ' ' O ' ' A' ' 262' ' ' LEU . 1.4 pp -167.99 38.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.256 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -178.11 119.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.319 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.423 ' CG1' HD12 ' A' ' 317' ' ' ILE . 14.4 p -110.7 105.5 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.861 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.453 ' HA ' ' CG2' ' A' ' 320' ' ' THR . 1.9 pt-20 -102.46 161.8 13.42 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.788 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.68 146.87 8.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.741 0.781 . . . . 0.0 111.614 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.604 ' HB2' ' CE2' ' A' ' 156' ' ' PHE . 2.1 pp -79.75 125.27 29.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.1 OUTLIER -135.09 160.5 38.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -176.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 226' ' ' ILE . 8.2 tt -92.55 132.07 37.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.438 HG22 HD12 ' A' ' 116' ' ' ILE . 4.1 tt -114.48 133.69 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.439 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 9.8 p90 -118.46 140.05 50.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 0.7 OUTLIER -89.25 128.08 35.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.611 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.06 -43.82 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.223 -0.298 . . . . 0.0 110.59 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -65.21 0.71 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.638 0.733 . . . . 0.0 110.84 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 tt -110.24 64.99 0.61 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.98 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.764 ' HB3' ' O ' ' A' ' 118' ' ' ASN . 2.1 tp -157.18 88.68 2.59 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 119.976 -0.689 . . . . 0.0 112.638 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.619 ' O ' HD11 ' A' ' 122' ' ' LEU . 9.1 Cg_endo -48.26 162.98 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.192 2.594 . . . . 0.0 110.176 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -59.48 108.38 1.35 Allowed Pre-proline 0 N--CA 1.468 0.436 0 C-N-CA 118.186 -1.406 . . . . 0.0 109.686 -172.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 58.2 Cg_endo -93.31 168.6 2.28 Favored 'Trans proline' 0 C--N 1.369 1.627 1 C-N-CA 125.812 4.341 . . . . 0.0 115.868 -175.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 135' ' ' LEU . 4.7 Cg_exo -39.94 156.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.618 3.546 . . . . 0.0 115.572 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -136.07 -20.88 1.45 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.28 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.7 m -133.82 155.23 50.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -59.47 -54.32 48.03 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.406 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -24.25 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.577 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 134' ' ' ALA . 6.8 mt-10 -79.17 -27.92 42.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.63 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 7.2 mt -43.99 -54.25 11.57 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 121.385 0.612 . . . . 0.0 111.368 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 51.9 Cg_exo -49.07 -39.22 41.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 N-CA-C 109.511 -0.996 . . . . 0.0 109.511 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.11 -58.57 3.2 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.601 ' HB3' ' HD3' ' A' ' 126' ' ' PRO . 0.2 OUTLIER -69.07 -37.09 78.3 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.171 -178.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 49.0 t0 -73.09 -40.77 64.73 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -47.52 -45.11 26.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 118.599 -1.24 . . . . 0.0 108.949 177.001 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -64.28 -39.81 94.68 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.698 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.739 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -61.22 -49.17 78.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.75 -44.62 28.27 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.04 -25.19 0.53 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.497 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -100.01 -63.68 1.11 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.73 39.39 0.02 OUTLIER Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.014 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.739 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 0.5 OUTLIER -173.77 176.18 2.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.516 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.8 m -109.26 166.97 10.46 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.474 ' CB ' ' CD1' ' A' ' 139' ' ' LEU . . . -73.31 -16.1 61.38 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 224' ' ' MET . 1.6 pt? -148.74 133.07 17.49 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 117.633 2.457 . . . . 0.0 117.633 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.451 ' N ' ' O ' ' A' ' 224' ' ' MET . 28.3 mmt -132.34 138.89 47.94 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.671 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.975 ' O ' ' O ' ' A' ' 150' ' ' ASN . 2.3 p90 -172.48 175.28 3.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.65 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.975 ' O ' ' O ' ' A' ' 149' ' ' PHE . 1.3 m120 -28.68 -147.74 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 123.897 0.748 . . . . 0.0 112.201 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.447 ' HB2' HG22 ' A' ' 208' ' ' THR . 2.8 mt 169.66 41.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.824 -1.172 . . . . 0.0 110.615 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER 173.11 34.05 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 169.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.666 ' O ' ' HB ' ' A' ' 157' ' ' THR . 4.1 mp0 -119.46 155.13 54.38 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 121.113 1.779 . . . . 0.0 114.405 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.859 ' O ' ' N ' ' A' ' 156' ' ' PHE . 86.1 Cg_endo -77.59 -135.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 125.201 3.934 . . . . 0.0 105.466 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 1.182 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 4.0 m-85 39.83 -65.19 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 120.312 1.415 . . . . 0.0 113.073 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.859 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -89.5 -59.89 2.09 Favored 'General case' 0 C--O 1.259 1.593 0 C-N-CA 124.483 1.113 . . . . 0.0 111.36 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 5.9 m -58.88 -43.29 90.89 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.441 ' HA ' HG12 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -51.54 -55.34 30.31 Favored Pre-proline 0 C--N 1.35 0.612 0 C-N-CA 120.299 -0.561 . . . . 0.0 109.96 177.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 1.182 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 87.6 Cg_exo -43.48 -50.62 6.7 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.596 2.197 . . . . 0.0 113.349 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.5 mp -64.06 -56.8 12.34 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 119.571 1.078 . . . . 0.0 109.972 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 158' ' ' TRP . 42.3 pt -54.31 -17.32 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.707 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.38 -25.75 51.2 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.7 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -42.13 -59.31 1.81 Allowed 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.481 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 6.3 t70 -64.35 -17.45 63.72 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 136.61 23.0 0.53 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 118.722 -1.704 . . . . 0.0 117.146 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.5 160.25 41.51 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 119.331 1.565 . . . . 0.0 111.779 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -163.08 168.1 21.39 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.504 0.652 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.47 -79.31 0.42 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.614 0.721 . . . . 0.0 111.343 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.668 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 14.3 m-85 -112.15 168.73 9.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.87 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 1.258 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -103.94 115.8 31.1 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.434 ' CE1' ' CD2' ' A' ' 176' ' ' TYR . 0.2 OUTLIER -86.48 114.38 23.18 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.378 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 173' ' ' ASN . 1.2 tt0 -106.47 100.71 10.22 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 172' ' ' GLU . 35.7 m-80 39.03 78.63 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.32 6.52 80.43 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.86 124.37 5.91 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 121.44 2.62 . . . . 0.0 113.388 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 1.258 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.2 p90 -96.92 -23.12 16.48 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.599 1.19 . . . . 0.0 109.724 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 2.8 m-20 65.82 -82.43 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.911 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 7.1 tp 172.21 -43.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -16.62 17.11 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 119.167 -0.444 . . . . 0.0 111.769 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 170' ' ' LYS . 4.0 m-20 -112.92 93.93 4.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 365' ' ' GLN . 15.4 m -118.06 120.12 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.314 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.42 52.57 3.81 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 119.479 -1.344 . . . . 0.0 112.86 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.406 HG23 ' CE2' ' A' ' 339' ' ' PHE . 14.5 t -90.93 -17.84 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.409 -0.895 . . . . 0.0 109.366 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.72 52.24 0.72 Allowed 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.858 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.56 160.65 16.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.375 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.75 -25.92 59.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.383 0.611 . . . . 0.0 111.706 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -76.4 -36.43 39.08 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.866 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.17 66.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -60.44 3.85 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.544 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.31 -41.04 50.43 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.829 0.823 . . . . 0.0 111.609 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.469 ' HA2' ' CE2' ' A' ' 194' ' ' PHE . . . -58.89 -60.7 8.42 Favored Glycine 0 C--O 1.237 0.338 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.839 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.2 mt -61.32 -23.93 66.07 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.577 -0.367 . . . . 0.0 110.092 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.447 ' O ' ' CG1' ' A' ' 196' ' ' VAL . 98.1 m -62.69 -53.46 54.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.658 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.469 ' CE2' ' HA2' ' A' ' 191' ' ' GLY . 4.3 p90 -61.83 -33.88 74.95 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.42 HD21 ' CE1' ' A' ' 194' ' ' PHE . 0.2 OUTLIER -61.33 -51.2 69.84 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.671 178.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 193' ' ' THR . 7.8 p -58.66 -28.75 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.958 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.417 ' N ' HG13 ' A' ' 196' ' ' VAL . 3.0 t0 -57.87 -49.36 76.96 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 121.399 0.618 . . . . 0.0 109.779 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.4 tt -62.33 -59.14 5.42 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.748 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 204' ' ' MET . 4.3 mt -53.8 -45.16 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -61.71 -34.14 75.27 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -91.09 3.35 55.0 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.4 -81.11 0.63 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.72 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.48 -24.07 5.94 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.418 ' N ' ' O ' ' A' ' 199' ' ' ILE . 1.4 ptm 74.44 13.42 3.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.948 0.34 . . . . 0.0 110.8 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -148.88 104.96 3.5 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 151' ' ' LEU . . . -99.16 72.01 1.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.22 -4.27 27.48 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.593 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.447 HG22 ' HB2' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -57.24 123.9 16.95 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.1 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 213' ' ' ALA . 0.5 OUTLIER -94.48 -174.74 3.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.6 p90 -70.18 -45.1 67.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.239 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.432 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.4 OUTLIER -77.87 -25.53 48.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.943 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.45 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 2.9 mp -81.68 -51.76 14.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -50.39 -37.35 37.03 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.61 -45.62 86.15 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.77 -38.8 67.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.874 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.01 -56.7 18.3 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -61.46 -29.13 69.76 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.8 -40.54 76.11 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.572 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.23 -23.93 59.24 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.4 33.12 61.63 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 115.3 0.88 . . . . 0.0 115.3 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -109.02 36.9 2.71 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.147 1.474 . . . . 0.0 111.4 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 148' ' ' MET . 0.5 OUTLIER -140.23 137.91 34.66 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 178.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -104.58 38.18 1.95 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.573 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 170.55 138.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.0 t -148.17 159.37 44.01 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.533 ' HB ' ' CE1' ' A' ' 156' ' ' PHE . 8.5 pt -116.05 111.92 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.755 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.584 ' HA ' ' HE2' ' A' ' 156' ' ' PHE . 89.6 m-20 -148.67 164.78 33.31 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 121.874 -0.516 . . . . 0.0 111.939 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 230' ' ' TRP . . . -86.57 114.89 4.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.413 -1.375 . . . . 0.0 109.861 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.663 ' O ' ' HB3' ' A' ' 230' ' ' TRP . 75.2 Cg_exo -50.15 72.94 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.974 2.45 . . . . 0.0 114.548 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.663 ' HB3' ' O ' ' A' ' 229' ' ' PRO . 0.4 OUTLIER 150.96 -30.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 177.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.32 -85.91 0.55 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -52.22 -31.89 34.18 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.346 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -54.47 3.48 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.585 0.231 . . . . 0.0 111.172 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.6 m120 65.91 -74.48 0.06 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.219 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 5.8 mt 65.72 -68.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 74.76 -69.77 0.17 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.601 0.239 . . . . 0.0 110.388 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 7.1 p -106.85 60.83 0.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.757 0.313 . . . . 0.0 110.317 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -177.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.252 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -84.46 67.4 9.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.763 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 14.4 t 75.06 -67.22 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.745 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.57 150.28 47.35 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.725 0.298 . . . . 0.0 110.922 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.415 ' CD1' HD13 ' A' ' 116' ' ' ILE . 43.3 p90 -149.22 130.37 14.51 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.248 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.439 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -96.66 175.23 31.31 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.122 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.4 m -145.76 136.67 19.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 117.05 0.425 . . . . 0.0 111.529 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 167.5 21.0 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.4 m -73.07 152.77 7.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.407 ' CB ' ' OG ' ' A' ' 255' ' ' SER . 2.8 mp -59.37 159.57 15.85 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 120.627 1.558 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.73 -159.81 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.959 2.44 . . . . 0.0 112.433 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 17.3 p -121.15 177.51 5.12 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 249' ' ' THR . 56.8 m-85 -165.64 110.33 0.86 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.234 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.3 mttp 60.88 34.55 19.56 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.714 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.15 43.32 21.57 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.301 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -156.48 148.82 17.72 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.515 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 95.8 Cg_endo -84.31 -169.59 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.17 2.58 . . . . 0.0 111.628 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.432 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 75.3 p -111.85 148.99 32.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.248 0.547 . . . . 0.0 112.244 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 3.1 ttpm? -85.32 109.24 19.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.725 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.586 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 2.7 Cg_exo -78.88 145.7 20.09 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.347 2.698 . . . . 0.0 112.466 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 1.6 m-85 -102.12 94.13 5.59 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.513 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.505 ' CG1' ' HA ' ' A' ' 324' ' ' ALA . 35.5 m -94.35 106.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.757 0.313 . . . . 0.0 111.82 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.403 ' HA2' ' CE ' ' A' ' 330' ' ' MET . . . -86.2 160.52 33.49 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 119.637 -1.268 . . . . 0.0 112.606 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -111.59 111.15 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.643 ' O ' ' N ' ' A' ' 108' ' ' ILE . 3.8 tp -84.4 107.04 16.45 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 117.502 -1.679 . . . . 0.0 107.071 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 63.9 p -133.36 141.94 48.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.46 ' HB1' ' CD2' ' A' ' 106' ' ' TYR . . . -73.73 132.99 43.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.169 -0.332 . . . . 0.0 110.289 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.17 136.33 11.17 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.74 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.462 ' HA ' HG23 ' A' ' 59' ' ' ILE . 7.0 mt -88.0 119.78 35.99 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 CA-C-N 118.425 1.113 . . . . 0.0 108.245 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.561 ' HA ' ' HZ ' ' A' ' 47' ' ' PHE . 44.5 t-20 -59.27 137.55 57.94 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -53.86 -22.34 9.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.711 0.687 . . . . 0.0 110.468 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 270' ' ' SER . . . -55.77 -27.34 50.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.723 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 269' ' ' ALA . 0.9 OUTLIER 93.22 91.29 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 122.602 0.361 . . . . 0.0 111.191 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.417 ' CD ' ' CG2' ' A' ' 266' ' ' ILE . 47.6 Cg_endo -91.14 81.11 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.279 2.653 . . . . 0.0 112.939 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 37.23 82.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.721 0.296 . . . . 0.0 111.142 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 7.9 mmtt -51.58 -54.2 30.1 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -66.9 -57.4 7.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.8 mt -63.74 -53.75 46.24 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.19 18.4 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -58.97 -32.59 69.79 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.32 -53.03 8.77 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 283' ' ' TYR . 85.9 t80 -56.37 -54.66 42.97 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.85 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 284' ' ' LEU . 1.0 OUTLIER -53.9 -43.5 69.75 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.566 0.698 . . . . 0.0 111.402 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.405 ' HG2' ' CD2' ' A' ' 85' ' ' PHE . 90.0 mt-10 -73.45 -34.36 65.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.787 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -93.15 -13.96 27.78 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.537 ' O ' HG22 ' A' ' 286' ' ' THR . 2.5 t80 -106.21 -65.72 1.05 Allowed 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 280' ' ' LEU . 1.5 tp -36.48 -33.04 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.732 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 283' ' ' TYR . 26.2 mt -89.8 42.09 1.08 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.637 0.255 . . . . 0.0 111.665 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 283' ' ' TYR . 10.1 t -145.72 160.55 41.56 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 9.3 m-20 -63.81 -12.72 38.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.549 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 9.9 mt-10 -77.85 -46.94 20.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.598 0.636 . . . . 0.0 111.012 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.419 ' H ' HG22 ' A' ' 286' ' ' THR . . . -83.86 -54.99 2.91 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 286' ' ' THR . 2.2 tp -48.86 -49.8 37.78 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 1.8 tt0 -78.65 -26.38 45.11 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.174 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -71.85 -35.12 69.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 119.838 1.199 . . . . 0.0 108.129 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 66.1 t -65.77 -41.95 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.036 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.602 ' O ' ' HB2' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -91.2 -33.88 15.22 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.632 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -46.27 85.98 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.437 ' HB3' ' HA3' ' A' ' 19' ' ' GLY . 1.2 p30 -61.49 -44.73 96.56 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.602 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 5.1 mttp -43.45 163.86 0.15 Allowed Pre-proline 0 N--CA 1.476 0.833 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.245 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -93.96 49.19 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.217 2.612 . . . . 0.0 114.699 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.2 mt 60.75 69.5 0.68 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.902 0.382 . . . . 0.0 111.533 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 301' ' ' ALA . . . 159.99 125.29 0.78 Allowed Glycine 0 C--O 1.231 -0.087 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.606 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . 159.61 -177.07 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.272 0.536 . . . . 0.0 111.571 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.99 83.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 304' ' ' LEU . . . -84.67 58.22 4.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.271 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.506 ' CB ' ' O ' ' A' ' 303' ' ' ALA . 0.3 OUTLIER 87.84 149.4 0.05 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -30.19 0.66 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 65.5 m -79.91 -47.24 15.38 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.064 0.935 . . . . 0.0 111.059 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.453 ' CG ' ' HB1' ' A' ' 303' ' ' ALA . 5.9 t80 -70.74 -19.2 62.76 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.607 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -42.24 62.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -56.81 -55.85 29.06 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.195 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.34 -42.99 99.84 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.942 0.401 . . . . 0.0 110.18 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.439 ' HG ' ' CD2' ' A' ' 307' ' ' TYR . 10.7 mt -59.93 -44.84 94.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.804 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -46.63 -33.61 4.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.6 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -57.38 -36.5 71.33 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.582 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.53 164.57 5.16 Favored Pre-proline 0 N--CA 1.462 0.139 0 CA-C-O 120.684 0.278 . . . . 0.0 110.714 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.21 -57.2 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.131 2.554 . . . . 0.0 113.48 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.7 mtt85 -58.89 -59.46 5.42 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.423 HD12 ' CG1' ' A' ' 110' ' ' VAL . 1.7 tp -52.26 -54.31 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.71 -51.86 11.81 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.269 0.486 . . . . 0.0 111.623 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -50.71 -48.4 58.84 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.318 1.056 . . . . 0.0 108.748 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.453 ' CG2' ' HA ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -60.95 -36.9 80.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 113.248 -1.797 . . . . 0.0 110.58 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -73.96 -42.83 59.92 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.95 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.31 -57.5 12.37 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.753 0.311 . . . . 0.0 110.377 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.36 -29.36 68.88 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.263 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.505 ' HA ' ' CG1' ' A' ' 259' ' ' VAL . . . -51.99 -53.05 46.15 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.734 0.302 . . . . 0.0 111.031 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -52.94 -32.85 47.96 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.203 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -98.64 13.2 32.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.586 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -93.9 160.0 23.98 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.865 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -97.76 131.93 43.83 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.2 pp -68.96 101.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 120.425 1.466 . . . . 0.0 107.875 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.578 ' CG ' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -36.07 144.84 0.24 Allowed Pre-proline 0 C--N 1.347 0.495 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -44.81 169.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.175 2.583 . . . . 0.0 112.297 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -128.4 -14.27 4.78 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.419 ' HB ' ' CD ' ' A' ' 334' ' ' PRO . 11.8 pt -78.94 165.89 46.06 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 118.77 0.714 . . . . 0.0 111.956 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.419 ' CD ' ' HB ' ' A' ' 333' ' ' ILE . 12.5 Cg_exo -70.55 -26.29 24.01 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.353 2.702 . . . . 0.0 113.402 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.418 ' CG ' HD11 ' A' ' 333' ' ' ILE . 84.1 mm-40 -42.01 -21.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.8 mmt -45.24 -32.17 1.81 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.234 0.47 . . . . 0.0 111.431 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -43.28 99.19 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.5 -34.81 78.6 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.09 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.406 ' CE2' HG23 ' A' ' 183' ' ' VAL . 4.3 m-85 -75.46 -52.28 11.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.542 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.434 ' CZ2' ' HG3' ' A' ' 154' ' ' PRO . 0.7 OUTLIER -53.45 -40.83 65.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.345 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -52.44 16.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.95 -44.49 69.43 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.478 ' HA ' HG22 ' A' ' 347' ' ' VAL . 47.9 t -64.72 -50.36 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.803 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.417 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 9.0 tpt180 -53.42 -56.99 12.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.987 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 6.3 m -56.77 -58.22 9.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.05 -60.75 2.09 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 343' ' ' VAL . 51.7 t -51.95 -47.47 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 0.4 OUTLIER -69.93 -45.27 77.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.893 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -69.12 -51.8 34.77 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 355' ' ' GLN . . . -73.12 -26.62 61.29 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 347' ' ' VAL . . . -51.86 -10.56 0.12 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 1.4 m -110.47 35.26 3.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.568 0.622 . . . . 0.0 111.059 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 88.64 -4.77 85.08 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 118.713 -1.708 . . . . 0.0 114.511 176.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -87.67 34.97 0.71 Allowed 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 115.683 -2.103 . . . . 0.0 107.903 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.515 ' HA ' ' CB ' ' A' ' 350' ' ' ALA . 2.0 mt-30 -71.14 -175.86 1.29 Allowed 'General case' 0 CA--C 1.547 0.838 1 N-CA-C 126.255 5.65 . . . . 0.0 126.255 -157.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 158.26 41.38 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 110.074 -3.239 . . . . 0.0 104.876 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 355' ' ' GLN . 53.2 t -72.43 -54.61 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.84 -174.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 6.7 t70 -46.23 -45.66 17.19 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.702 0.763 . . . . 0.0 111.269 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -77.4 -56.14 4.8 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.71 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -54.68 -44.32 73.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.209 1.004 . . . . 0.0 112.72 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 364' ' ' ALA . 32.7 mt -75.62 -33.93 60.55 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.787 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 12.1 tttt -67.81 -56.06 10.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.172 0.987 . . . . 0.0 109.903 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.22 -30.72 71.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.146 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 361' ' ' LEU . . . -53.87 -53.72 48.66 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.69 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.441 ' HB2' ' CG2' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -58.5 -36.43 73.79 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.893 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.425 ' N ' ' HG3' ' A' ' 365' ' ' GLN . 5.9 m -52.16 -41.24 62.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.409 0.623 . . . . 0.0 109.588 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -73.73 -42.77 60.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.938 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.413 ' CG2' HD12 ' A' ' 178' ' ' ILE . 21.8 mm -66.12 -34.68 71.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 6.6 p -94.5 -14.19 25.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.985 179.963 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.664 0.269 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 t -128.46 108.2 10.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.739 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.97 111.03 9.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.89 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -149.09 135.23 19.13 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.14 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -108.89 67.47 0.22 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.379 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.93 156.25 44.36 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.55 118.59 13.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.98 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -114.45 120.79 65.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.716 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 2.7 mp -121.67 130.79 74.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.123 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.433 ' CZ2' HG22 ' A' ' 50' ' ' VAL . 29.8 m95 -107.94 121.13 44.15 Favored 'General case' 0 CA--C 1.527 0.058 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.3 pt -150.96 142.3 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.406 ' HA ' ' CD1' ' A' ' 43' ' ' LEU . 2.8 t30 -79.8 67.51 5.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.102 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.71 66.28 2.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.525 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 4.1 m-20 -80.59 -34.55 35.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.291 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 6.7 mttp 105.99 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.34 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 297' ' ' LYS . . . -74.36 58.21 2.41 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' CE2' ' CG2' ' A' ' 37' ' ' VAL . 3.3 m-85 -78.24 -42.14 32.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.751 0.31 . . . . 0.0 110.277 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 4.1 m120 -58.03 -48.37 80.28 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.986 0.422 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.78 -47.86 30.92 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.357 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.48 -51.31 70.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.382 0.591 . . . . 0.0 110.535 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.79 81.75 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.859 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 4.0 tm-20 -65.56 -36.53 84.06 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG12 ' CE2' ' A' ' 283' ' ' TYR . 84.3 t -66.93 -61.3 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' CA ' HG21 ' A' ' 33' ' ' ILE . . . -49.09 -33.64 14.84 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.649 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -50.03 70.14 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.1 -41.46 62.46 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 112.809 -1.996 . . . . 0.0 107.902 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.562 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.17 -35.11 79.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.72 0.772 . . . . 0.0 110.865 178.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.713 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 18.4 tt0 -72.4 -52.46 15.88 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.223 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -53.05 -25.66 13.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.614 1.196 . . . . 0.0 110.244 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.51 ' O ' ' CG2' ' A' ' 31' ' ' THR . 9.1 t70 -89.04 -40.43 12.98 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.296 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER 169.67 38.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 173.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.36 39.53 0.02 OUTLIER Glycine 0 N--CA 1.466 0.671 0 C-N-CA 114.892 -3.528 . . . . 0.0 119.796 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.713 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 3.1 mm -139.7 137.55 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 122.32 3.06 . . . . 0.0 118.152 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -142.55 104.33 4.37 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.4 130.53 42.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 -171.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.1 m -119.21 145.14 46.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.675 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 2.1 m -131.09 122.94 52.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 122.057 -0.402 . . . . 0.0 110.683 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.48 130.78 55.48 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.518 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 1.3 p80 -150.57 71.22 8.99 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.36 178.77 5.97 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.462 2.108 . . . . 0.0 112.219 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -66.01 -40.05 90.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.962 0.411 . . . . 0.0 110.369 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 44' ' ' GLU . 11.1 mptt -84.72 1.05 48.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.096 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 47' ' ' PHE . 7.0 tt -19.33 -46.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 1.069 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -68.48 -54.61 15.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.711 0.291 . . . . 0.0 110.857 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.491 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -70.09 -37.59 75.45 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -60.2 -56.59 19.72 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.846 0.832 . . . . 0.0 109.861 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -41.76 -60.7 1.79 Allowed Pre-proline 0 C--N 1.352 0.693 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.31 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 1.069 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 29.2 Cg_exo -63.16 -25.18 72.73 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 121.617 1.544 . . . . 0.0 113.426 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -82.17 -35.57 28.23 Favored 'General case' 0 C--O 1.255 1.37 0 CA-C-O 122.171 0.986 . . . . 0.0 111.08 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.433 HG22 ' CZ2' ' A' ' 10' ' ' TRP . 29.2 m -77.78 -39.71 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.504 0 CA-C-O 122.04 0.924 . . . . 0.0 109.089 178.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.429 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -49.38 -37.82 26.35 Favored 'General case' 0 C--N 1.373 1.615 0 C-N-CA 126.048 1.739 . . . . 0.0 110.85 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.95 -42.4 21.33 Favored 'General case' 0 C--N 1.371 1.512 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.967 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 55' ' ' ASP . 1.2 m -73.69 145.93 44.87 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.578 1.081 . . . . 0.0 108.893 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 64.97 -78.35 0.07 OUTLIER Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 1.4 t0 85.39 56.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 117.613 0.707 . . . . 0.0 111.672 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.561 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . -156.07 47.4 0.49 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 119.967 -1.111 . . . . 0.0 114.449 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 56' ' ' GLY . 43.1 Cg_endo -100.15 -169.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.184 2.589 . . . . 0.0 112.093 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.98 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 4.1 t70 -88.24 -135.52 0.09 Allowed 'General case' 0 N--CA 1.414 -2.242 0 C-N-CA 123.123 0.569 . . . . 0.0 110.543 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' A' ' 266' ' ' ILE . 20.8 tt -103.08 163.67 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 265' ' ' GLY . 10.3 pt -130.17 128.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.427 ' CE2' ' HB1' ' A' ' 264' ' ' ALA . 4.0 m-85 -107.17 124.33 49.55 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.454 ' CZ3' ' CB ' ' A' ' 66' ' ' ARG . 8.3 t90 -167.44 161.38 13.93 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -49.09 160.8 0.18 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.137 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.577 ' HB2' ' HB ' ' A' ' 261' ' ' VAL . 22.1 t-80 -77.56 -28.69 51.84 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.82 -58.85 3.82 Favored 'General case' 0 C--O 1.251 1.173 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.454 ' CB ' ' CZ3' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -75.49 -30.46 59.88 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.32 0.581 . . . . 0.0 110.038 179.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 2.2 m-30 -62.52 -27.08 68.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 174.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -60.82 -66.21 2.83 Favored Glycine 0 CA--C 1.49 -1.496 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.15 -53.66 43.84 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 113.218 -1.491 . . . . 0.0 111.256 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.9 m-30 -51.4 -42.84 61.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -54.58 -39.33 67.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.74 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -78.79 -43.14 26.08 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 111.666 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -70.22 -14.86 62.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.91 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.6 29.62 8.63 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.656 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.1 mp -106.69 39.89 1.75 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.995 0.426 . . . . 0.0 110.424 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.37 145.4 0.25 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.366 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.1 115.3 27.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.969 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -47.68 129.68 13.96 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.652 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 14.6 mt -95.95 110.21 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.752 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.8 p -88.82 101.41 2.85 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.964 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 83.3 Cg_endo -101.24 -170.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.61 2.873 . . . . 0.0 113.161 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.19 -169.9 2.75 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.257 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.71 -44.08 7.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.532 0.206 . . . . 0.0 111.454 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -74.83 -23.54 58.47 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.423 ' CE1' HD23 ' A' ' 285' ' ' LEU . 6.5 t80 -64.62 -59.22 4.53 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.506 ' HG3' ' CG ' ' A' ' 94' ' ' TRP . 3.0 tt0 -70.13 -29.49 66.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.808 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.82 -12.88 60.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.9 OUTLIER -87.81 -7.66 56.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 304' ' ' LEU . 3.3 mp -100.91 -101.23 0.25 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.158 0.89 . . . . 0.0 111.584 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.415 ' CE1' ' HE3' ' A' ' 321' ' ' MET . 0.2 OUTLIER -145.19 133.18 10.56 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 122.102 -0.374 . . . . 0.0 111.056 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.0 -52.97 7.61 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.66 2.24 . . . . 0.0 112.934 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 325' ' ' GLN . 45.2 t80 -55.53 -44.53 76.79 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.704 0.288 . . . . 0.0 111.08 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 107' ' ' PRO . 29.8 m -61.27 -29.04 69.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.506 ' CG ' ' HG3' ' A' ' 86' ' ' GLN . 86.3 m95 -92.97 -24.1 18.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.508 0.67 . . . . 0.0 112.136 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -73.82 -24.09 59.74 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.433 ' CB ' ' CG2' ' A' ' 261' ' ' VAL . . . -65.76 -21.66 66.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.271 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.472 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 6.7 p -125.28 58.03 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 102' ' ' LYS . 26.6 ttt180 -124.84 100.93 6.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -89.07 90.9 8.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.169 0.44 . . . . 0.0 110.426 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 42.72 66.35 0.78 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.709 0.29 . . . . 0.0 110.87 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.22 38.98 58.67 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.593 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 103' ' ' LEU . 4.7 mmtt -139.84 -177.61 5.05 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 119.446 -0.312 . . . . 0.0 110.792 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 97' ' ' VAL . 0.3 OUTLIER 175.34 107.85 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.601 0.637 . . . . 0.0 109.661 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.43 ' CG2' ' HB1' ' A' ' 71' ' ' ALA . 3.6 tt -100.96 37.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.441 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 264' ' ' ALA . . . 170.21 149.14 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.511 ' O ' ' N ' ' A' ' 264' ' ' ALA . 12.7 m-30 -88.2 120.3 70.53 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.491 ' HB3' ' CG1' ' A' ' 261' ' ' VAL . 2.9 Cg_endo -78.94 155.28 26.36 Favored 'Trans proline' 0 CA--C 1.514 -0.478 0 C-N-CA 121.917 1.745 . . . . 0.0 112.847 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 262' ' ' LEU . 0.5 OUTLIER -157.11 38.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.142 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.676 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . . . 170.23 134.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.937 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.518 HG23 HG21 ' A' ' 320' ' ' THR . 17.2 m -114.8 133.74 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.936 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.595 ' HB2' ' HA3' ' A' ' 260' ' ' GLY . 0.6 OUTLIER -99.57 136.1 40.0 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 320' ' ' THR . . . -167.97 -173.68 2.15 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 123.411 1.577 . . . . 0.0 110.307 -167.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 156' ' ' PHE . 0.1 OUTLIER -146.12 135.57 23.02 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 110.598 -3.001 . . . . 0.0 116.246 -176.068 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.09 165.17 23.84 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.051 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.421 HD12 ' CH2' ' A' ' 129' ' ' TRP . 6.2 tp -93.21 130.79 38.78 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.424 ' CG2' ' CG2' ' A' ' 225' ' ' THR . 0.0 OUTLIER -115.25 136.16 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.169 -179.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.412 ' CE2' ' OG1' ' A' ' 245' ' ' THR . 14.1 m-85 -121.48 140.83 51.67 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -86.1 122.0 29.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -106.2 29.06 7.1 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.956 0.407 . . . . 0.0 111.515 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -131.43 -51.05 1.0 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.23 -136.89 0.02 OUTLIER 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.249 -1.796 . . . . 0.0 107.685 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.413 ' O ' ' CB ' ' A' ' 223' ' ' ALA . 2.0 mt -84.45 128.93 59.62 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -56.28 161.78 8.68 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.374 2.716 . . . . 0.0 110.997 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.44 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 8.4 p-10 -106.36 158.21 33.15 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.631 0.253 . . . . 0.0 111.042 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 19.9 Cg_endo -60.26 164.4 12.77 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.4 2.066 . . . . 0.0 111.833 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.404 ' HB2' ' HG3' ' A' ' 127' ' ' LYS . 4.0 Cg_exo -77.39 -42.35 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.801 2.334 . . . . 0.0 112.726 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 126' ' ' PRO . 2.8 mttp -153.49 -10.72 0.15 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' A' ' 130' ' ' GLU . 6.1 t -119.45 139.56 51.86 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.802 1.183 . . . . 0.0 112.961 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.447 ' O ' ' CG1' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -69.25 -23.76 63.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 172.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.486 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -44.82 -23.89 0.17 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.83 -26.4 66.91 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.575 HG13 ' CD ' ' A' ' 133' ' ' PRO . 0.2 OUTLIER -40.47 -53.06 5.76 Favored Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.804 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 6.6 Cg_endo -48.82 -43.83 33.59 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 120.699 0.933 . . . . 0.0 110.049 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.68 -58.6 3.19 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.424 ' O ' HD13 ' A' ' 139' ' ' LEU . 32.7 tp -66.32 -40.41 89.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.208 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 3.3 m-20 -70.74 -35.7 72.79 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.804 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -47.69 -50.23 25.52 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.455 176.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.87 -40.48 95.52 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.337 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 145' ' ' SER . 0.4 OUTLIER -61.79 -48.44 80.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -48.07 -43.9 30.94 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.02 -27.8 1.02 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -58.95 1.83 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.285 0.564 . . . . 0.0 110.239 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.81 40.19 0.02 OUTLIER Glycine 0 CA--C 1.519 0.319 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.299 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.48 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -152.83 -171.81 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 119.298 1.549 . . . . 0.0 111.501 -175.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.482 ' N ' HD22 ' A' ' 139' ' ' LEU . 5.0 m -138.76 158.24 44.6 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 139' ' ' LEU . . . -73.35 -33.34 65.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 224' ' ' MET . 3.1 pp -135.38 129.23 33.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.4 ' N ' ' CG2' ' A' ' 222' ' ' THR . 0.0 OUTLIER -133.4 134.91 44.25 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.092 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 150' ' ' ASN . 21.4 p90 -172.31 177.18 3.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.511 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -36.53 164.93 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.366 0.416 . . . . 0.0 111.485 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 208' ' ' THR . 2.8 tm? -114.03 -57.71 2.24 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -104.47 34.59 3.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 116.166 -2.213 . . . . 0.0 114.693 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.802 ' O ' ' OG1' ' A' ' 157' ' ' THR . 0.0 OUTLIER -79.81 140.32 54.52 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 121.279 1.854 . . . . 0.0 113.391 -176.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.957 ' O ' ' N ' ' A' ' 156' ' ' PHE . 84.5 Cg_endo -77.88 -135.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.376 3.384 . . . . 0.0 104.322 175.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 1.152 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 1.4 m-85 28.93 -59.95 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.038 1.29 . . . . 0.0 113.643 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.957 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -85.41 -61.85 1.67 Allowed 'General case' 0 C--O 1.258 1.544 0 CA-C-N 118.777 0.717 . . . . 0.0 112.534 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.802 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 8.5 p -59.2 -40.67 86.48 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.181 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.695 ' O ' HG13 ' A' ' 161' ' ' ILE . 1.1 m95 -51.24 -55.53 27.86 Favored Pre-proline 0 C--N 1.353 0.733 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 1.152 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 78.1 Cg_exo -43.38 -44.31 10.46 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.598 2.199 . . . . 0.0 113.201 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 255' ' ' SER . 7.3 mp -63.6 -56.69 13.94 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.002 0.819 . . . . 0.0 110.388 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.695 HG13 ' O ' ' A' ' 158' ' ' TRP . 2.4 pp -53.72 -19.33 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.296 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.409 ' CB ' ' HB2' ' A' ' 256' ' ' LYS . . . -78.61 -22.03 47.63 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.254 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -41.87 -59.26 1.75 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.438 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 45.7 t0 -64.35 -14.26 55.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -175.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 134.06 20.26 0.85 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 118.73 -1.7 . . . . 0.0 116.525 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.51 160.14 41.38 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 119.064 1.432 . . . . 0.0 111.423 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -145.61 136.0 24.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.336 0.568 . . . . 0.0 110.374 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.418 ' HB2' ' CD1' ' A' ' 169' ' ' PHE . . . -54.2 -80.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.358 0.599 . . . . 0.0 111.765 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.614 ' HB2' ' CG ' ' A' ' 176' ' ' TYR . 14.5 m-85 -113.13 173.8 6.21 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.576 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 1.184 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 6.5 mmtt -100.48 103.75 15.11 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.485 ' CD2' ' CE1' ' A' ' 176' ' ' TYR . 0.4 OUTLIER -85.04 115.25 22.75 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.586 176.262 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.886 ' O ' ' N ' ' A' ' 174' ' ' GLY . 1.1 tp10 -137.28 101.67 4.59 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.056 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.0 m120 44.42 -66.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 O-C-N 123.619 0.575 . . . . 0.0 110.656 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.886 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -70.66 -73.35 0.79 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 115.664 -0.698 . . . . 0.0 114.346 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -174.66 158.04 2.64 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 117.994 0.897 . . . . 0.0 110.677 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 1.184 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -56.29 -33.66 65.73 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.33 1.062 . . . . 0.0 108.256 177.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 1.0 OUTLIER 67.94 -85.71 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.862 179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 6.7 tp 175.02 -41.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -10.55 44.6 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.43 ' CB ' ' HB2' ' A' ' 170' ' ' LYS . 2.1 m-20 -124.56 93.75 3.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.58 121.54 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -123.23 39.72 2.16 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.698 -1.239 . . . . 0.0 113.959 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 188' ' ' ALA . 12.8 p -80.2 -44.14 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.028 0.442 . . . . 0.0 109.982 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.551 ' CB ' ' HB2' ' A' ' 361' ' ' LEU . 9.4 t70 -81.27 59.08 3.8 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.758 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -104.76 173.2 6.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.464 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.19 -28.11 62.54 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.352 0.596 . . . . 0.0 111.571 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -71.31 -45.97 44.79 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.09 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -60.41 -44.79 95.37 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -57.8 -60.01 4.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.325 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.37 -40.94 50.88 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.088 0.947 . . . . 0.0 112.017 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -62.88 -60.65 7.39 Favored Glycine 0 C--O 1.24 0.485 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.086 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.6 tp -59.49 -25.05 64.12 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 99.0 m -60.74 -50.2 74.42 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.499 ' CZ ' ' CE1' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -59.85 -37.26 78.76 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 tp -63.28 -47.58 81.75 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.631 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 44.6 t -57.68 -28.76 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.508 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.11 -45.62 80.49 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.855 0.836 . . . . 0.0 111.039 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.3 tt -59.46 -51.95 67.67 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.851 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 204' ' ' MET . 6.6 mt -66.62 -40.25 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.96 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -52.68 -36.91 57.94 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.626 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -113.18 -34.57 5.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 121.157 3.762 . . . . 0.0 121.157 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -63.73 -80.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.967 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.08 -9.67 27.58 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 4.8 ptt? 42.15 36.24 0.68 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 206' ' ' ALA . 0.7 OUTLIER -145.16 -73.34 0.25 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . 84.41 37.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -97.74 -3.08 39.79 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.566 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 34.8 p -55.08 117.19 3.25 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.97 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.91 -173.64 4.17 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.3 p90 -70.63 -45.28 65.49 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 1.7 t -73.72 -32.73 64.03 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.711 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.75 -48.66 23.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.74 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.01 -32.19 70.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.06 -45.36 92.57 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.75 -40.73 84.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.959 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.21 -57.09 10.72 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.09 -29.52 69.87 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.69 -37.45 58.93 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.443 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -74.24 -23.89 59.22 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.04 53.63 5.65 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 114.7 0.64 . . . . 0.0 114.7 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -124.5 37.64 4.36 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.35 1.075 . . . . 0.0 111.609 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 145' ' ' SER . 2.2 m -142.22 140.9 32.45 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 122' ' ' LEU . . . -113.13 38.79 2.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.618 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.699 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER 178.85 126.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 177.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.424 ' CG2' ' CG2' ' A' ' 116' ' ' ILE . 1.8 t -147.16 165.99 28.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.433 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.485 ' CG2' ' CE1' ' A' ' 156' ' ' PHE . 0.1 OUTLIER -100.49 146.02 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 172.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -146.4 166.33 26.68 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.182 1.355 . . . . 0.0 109.953 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 112' ' ' ALA . . . -176.11 130.41 1.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.294 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.67 -29.66 3.59 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.846 2.364 . . . . 0.0 113.219 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.41 ' HA ' ' CG ' ' A' ' 111' ' ' GLU . 29.7 t-105 -33.66 -72.87 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.94 -41.9 8.18 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.24 166.53 18.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.907 0.384 . . . . 0.0 111.714 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 t -124.49 -62.07 1.28 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.52 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -99.32 139.69 34.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.691 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 242' ' ' TYR . 25.4 pt -84.07 173.7 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.283 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.17 176.15 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.722 0.296 . . . . 0.0 110.995 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.05 83.43 0.33 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.965 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.405 ' O ' ' CE1' ' A' ' 242' ' ' TYR . 41.2 t -129.77 70.51 1.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.786 0.327 . . . . 0.0 110.682 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.429 ' O ' ' CZ ' ' A' ' 242' ' ' TYR . 0.0 OUTLIER 65.83 109.72 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.607 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.43 ' O ' ' CD2' ' A' ' 242' ' ' TYR . 58.4 t -45.29 -34.66 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.854 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -79.76 107.23 12.37 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.69 0.281 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 240' ' ' VAL . 48.0 m-85 -118.46 134.04 55.39 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.245 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.96 105.25 2.3 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.202 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.0 t -90.96 111.59 23.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.412 ' OG1' ' CE2' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -129.78 167.41 18.12 Favored 'General case' 0 CA--C 1.527 0.067 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.1 m -73.36 153.66 7.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.26 159.04 16.74 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 119.784 1.175 . . . . 0.0 111.414 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.419 ' HD3' ' CD1' ' A' ' 115' ' ' LEU . 90.4 Cg_endo -79.51 -165.08 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.035 2.49 . . . . 0.0 112.496 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -119.27 175.58 5.73 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.929 0.395 . . . . 0.0 111.763 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.499 ' CE1' ' CZ ' ' A' ' 194' ' ' PHE . 98.0 m-85 -166.13 111.05 0.82 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.957 0.884 . . . . 0.0 108.811 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 7.8 mttp 62.43 31.09 17.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.809 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.0 31.14 40.12 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.302 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -156.59 153.03 23.84 Favored Pre-proline 0 N--CA 1.463 0.179 0 CA-C-N 117.381 0.59 . . . . 0.0 112.251 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -87.88 170.36 6.25 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.209 2.606 . . . . 0.0 112.189 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -91.03 144.34 25.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.803 0.335 . . . . 0.0 111.411 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 2.2 mttt -86.58 108.3 17.42 Favored Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.066 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 255' ' ' SER . 88.2 Cg_endo -79.55 153.35 23.5 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.273 1.982 . . . . 0.0 112.717 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 2.5 t80 -79.19 164.39 24.24 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.42 ' CB ' HG21 ' A' ' 329' ' ' ILE . 15.5 t -121.8 127.56 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 111' ' ' GLU . . . -123.69 117.79 3.28 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 119.257 -1.449 . . . . 0.0 115.871 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -103.87 115.31 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.527 179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.676 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 1.5 mm? -94.22 93.63 7.87 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -111.28 -177.71 3.27 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -172.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 105' ' ' ALA . . . -108.67 128.31 54.74 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 60' ' ' ILE . . . -122.87 127.8 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.82 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.501 ' HA ' HG13 ' A' ' 59' ' ' ILE . 24.7 mt -87.84 121.48 38.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.65 142.9 56.88 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.35 -26.46 61.02 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.149 -0.345 . . . . 0.0 110.78 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.482 ' CB ' ' CD ' ' A' ' 57' ' ' PRO . . . -50.82 -59.89 3.64 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.921 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 19.2 p -135.64 154.11 77.95 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.728 0.299 . . . . 0.0 111.413 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -88.58 -66.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.054 2.503 . . . . 0.0 112.735 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 55.4 45.77 24.67 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 110.125 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 2.0 ttpt -60.32 -54.19 48.7 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.782 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 24.6 tp10 -50.2 -57.6 7.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.902 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.411 HD13 ' CD2' ' A' ' 27' ' ' PHE . 10.0 tp -64.93 -58.09 7.06 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.98 -56.69 5.65 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.2 OUTLIER -54.22 -38.55 65.83 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 1.9 tp10 -76.34 -53.14 8.6 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -56.17 -56.36 21.91 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.611 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.499 ' O ' ' CB ' ' A' ' 284' ' ' LEU . 7.2 tt -52.32 -43.91 64.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.675 0.75 . . . . 0.0 111.67 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -73.2 -34.27 65.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.651 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -91.57 -14.71 29.82 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.625 ' O ' HG22 ' A' ' 286' ' ' THR . 0.2 OUTLIER -102.45 -65.49 0.99 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.707 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 6.3 tp -43.2 -22.7 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.601 -0.44 . . . . 0.0 112.097 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 85' ' ' PHE . 3.8 mm? -101.37 37.38 1.8 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.002 -0.436 . . . . 0.0 110.721 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 283' ' ' TYR . 11.3 t -145.01 158.72 43.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 4.4 p30 -65.97 -11.66 49.3 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.603 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 5.5 tp10 -77.89 -47.12 19.47 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 109.993 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 293' ' ' VAL . . . -82.64 -49.49 5.11 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 284' ' ' LEU . 8.4 mt -61.75 -51.24 69.17 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.631 0.254 . . . . 0.0 111.383 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.509 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 2.9 tp10 -76.08 -27.9 57.37 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.059 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.603 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -71.57 -27.73 63.35 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.713 ' HA ' ' CB ' ' A' ' 297' ' ' LYS . 1.1 t -65.72 -61.0 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.798 175.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.505 ' N ' HG12 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -35.02 -50.31 0.49 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.313 1.445 . . . . 0.0 112.323 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 296' ' ' ASP . 20.2 ttpt -48.79 -43.9 38.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.254 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 295' ' ' LYS . 2.6 m-20 154.41 68.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.721 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.831 ' H ' ' HD2' ' A' ' 298' ' ' PRO . 0.5 OUTLIER -120.75 -37.95 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.023 171.293 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.831 ' HD2' ' H ' ' A' ' 297' ' ' LYS . 0.1 OUTLIER -91.61 -120.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 124.761 3.641 . . . . 0.0 113.283 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.448 ' CB ' ' HG ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -160.78 -41.38 0.05 OUTLIER 'General case' 0 C--N 1.356 0.883 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.559 ' N ' ' HB2' ' A' ' 109' ' ' ALA . . . -129.08 -155.59 8.6 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.56 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.551 ' O ' HG13 ' A' ' 317' ' ' ILE . . . -133.25 48.15 2.42 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.115 0.958 . . . . 0.0 112.46 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.483 ' CG2' HG22 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -140.78 92.26 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.686 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 304' ' ' LEU . . . 177.69 48.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER 158.48 99.11 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.314 0.246 . . . . 0.0 111.42 178.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -38.37 -32.64 0.08 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 20.0 m -78.66 -44.22 24.25 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.473 1.13 . . . . 0.0 109.572 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.584 ' CZ ' HD12 ' A' ' 311' ' ' LEU . 19.6 t80 -70.57 -20.03 62.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 112.87 -1.968 . . . . 0.0 110.249 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 312' ' ' ALA . 7.9 tp10 -76.28 -43.14 43.02 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.0 -58.6 5.67 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.724 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -54.09 -52.9 59.49 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.246 0.546 . . . . 0.0 110.5 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.584 HD12 ' CZ ' ' A' ' 307' ' ' TYR . 2.3 tt -70.91 -28.04 64.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.932 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 313' ' ' LYS . . . -45.92 -20.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -34.19 -42.67 0.13 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.543 0.61 . . . . 0.0 109.704 178.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -88.76 121.7 69.7 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.58 9.51 1.87 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.591 2.194 . . . . 0.0 115.467 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.446 ' O ' ' OG1' ' A' ' 320' ' ' THR . 5.6 mtm-85 -60.23 -59.82 4.81 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.706 0.684 . . . . 0.0 111.256 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.561 ' HA ' ' HB ' ' A' ' 320' ' ' THR . 5.2 mm -49.76 -55.35 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.68 -52.05 11.43 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.38 0.536 . . . . 0.0 111.757 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -71.66 -33.42 68.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.543 0.687 . . . . 0.0 109.351 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.671 ' HA ' ' HB1' ' A' ' 112' ' ' ALA . 94.6 m -62.02 -37.06 83.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.387 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.426 ' HG2' ' CD2' ' A' ' 92' ' ' PHE . 5.6 ttm -79.03 -44.93 21.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.693 0.282 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -54.0 -45.91 71.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.221 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.3 -51.95 9.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.226 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.416 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . . . -48.64 -33.82 10.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.694 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.454 ' HA ' ' CE1' ' A' ' 92' ' ' PHE . 0.2 OUTLIER -63.33 -39.94 95.94 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.51 0.195 . . . . 0.0 110.998 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -104.74 60.67 0.7 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.595 0.236 . . . . 0.0 111.08 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -140.71 -147.18 4.91 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.12 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -127.32 111.77 14.29 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.42 HG21 ' CB ' ' A' ' 259' ' ' VAL . 1.8 pp -87.15 134.11 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.432 ' HG2' ' CE2' ' A' ' 258' ' ' PHE . 0.0 OUTLIER -41.03 105.33 0.38 Allowed Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.413 ' HD2' ' CE ' ' A' ' 330' ' ' MET . 96.2 Cg_exo -43.9 -34.89 6.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.676 2.251 . . . . 0.0 112.603 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.5 m120 79.06 51.3 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.478 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 4.0 pt -133.82 156.65 79.19 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.804 0.335 . . . . 0.0 111.143 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.71 -31.51 39.8 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.636 2.224 . . . . 0.0 112.76 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 338' ' ' ALA . 8.9 mm100 -59.85 -21.83 61.48 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 12.0 tpp -45.56 -36.7 4.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.589 0.233 . . . . 0.0 111.372 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 2.1 p -58.1 -38.88 77.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.698 0.285 . . . . 0.0 110.348 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . 0.422 ' CB ' ' CD1' ' A' ' 368' ' ' ILE . . . -55.6 -33.37 63.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.962 0.411 . . . . 0.0 111.307 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.51 -55.83 4.91 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.499 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.41 ' CE3' ' HA ' ' A' ' 340' ' ' TRP . 0.1 OUTLIER -44.33 -43.0 7.18 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.795 0.331 . . . . 0.0 111.025 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.99 -42.77 56.89 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.692 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.27 -45.84 72.03 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.471 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 9.9 p -69.62 -42.06 80.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.439 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.414 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -58.55 -59.29 5.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.698 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 9.8 m -56.39 -56.7 17.84 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -69.83 -60.83 2.06 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 48.5 t -54.56 -53.45 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 349' ' ' ASN . 1.9 tt -62.31 -46.68 95.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.031 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.419 ' N ' ' CG2' ' A' ' 348' ' ' ILE . 64.8 t-20 -64.64 -47.7 77.56 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 355' ' ' GLN . . . -73.37 -26.65 61.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -53.22 -11.26 0.26 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.3 p -110.46 36.77 2.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.585 0.63 . . . . 0.0 110.088 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.53 -3.42 87.06 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 118.711 -1.709 . . . . 0.0 113.691 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -87.3 34.92 0.69 Allowed 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 115.65 -2.119 . . . . 0.0 107.886 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.569 ' HA ' ' CB ' ' A' ' 350' ' ' ALA . 2.9 pp0? -71.17 -173.71 0.89 Allowed 'General case' 0 C--N 1.348 0.543 1 N-CA-C 123.34 4.57 . . . . 0.0 123.34 -159.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.498 ' HB ' ' CB ' ' A' ' 359' ' ' GLU . 0.0 OUTLIER -179.62 46.8 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.54 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.415 ' CG1' ' OD2' ' A' ' 184' ' ' ASP . 84.3 t -42.27 -49.85 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.863 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.615 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -61.33 -35.04 76.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 119.948 1.249 . . . . 0.0 109.611 178.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.498 ' CB ' ' HB ' ' A' ' 356' ' ' THR . 1.5 mm-40 -79.18 -26.97 42.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.441 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 356' ' ' THR . . . -66.8 -53.26 34.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 122.085 0.945 . . . . 0.0 111.824 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 184' ' ' ASP . 0.2 OUTLIER -82.24 -50.48 8.94 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.787 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 2.3 mmpt? -45.18 -53.04 8.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -65.13 -41.42 94.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.402 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.5 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -66.52 -58.19 5.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.611 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.505 ' HB2' HD12 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -62.16 -44.32 96.87 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.984 -0.447 . . . . 0.0 111.969 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 362' ' ' LYS . 52.7 p -56.24 -59.79 4.43 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -51.57 25.65 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.511 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 364' ' ' ALA . 32.8 mm -60.47 -42.84 92.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 369' ' ' THR . 1.3 p -114.15 55.63 0.73 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.917 0.389 . . . . 0.0 111.103 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.828 179.759 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 tptp . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.637 0.256 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 p -112.64 134.69 54.04 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.873 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -134.96 111.02 9.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -145.01 173.91 11.48 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.91 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -111.31 68.3 0.22 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.493 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.0 159.04 44.58 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -156.12 118.37 4.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.52 ' HB ' ' HA ' ' A' ' 58' ' ' ASP . 15.3 t -108.72 140.47 27.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 118.771 -1.172 . . . . 0.0 110.003 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 10.3 tt -136.51 124.74 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.402 0.62 . . . . 0.0 111.122 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CZ2' ' HB2' ' A' ' 43' ' ' LEU . 30.7 t90 -101.46 133.32 46.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.226 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -149.18 165.09 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.488 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 9.4 p30 -91.85 61.64 4.17 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.543 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.75 41.47 57.84 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.059 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 58.4 t0 -50.35 -31.66 15.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 111.438 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 105.15 -18.06 0.02 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.246 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.421 ' HA2' ' CG ' ' A' ' 296' ' ' ASP . . . -75.48 56.42 2.9 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 115.921 1.129 . . . . 0.0 115.921 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -75.96 -31.8 59.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.495 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 1.4 t30 -67.98 -47.14 69.37 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.152 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.14 -49.16 22.5 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.739 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.548 ' O ' HG13 ' A' ' 23' ' ' VAL . 20.7 mt -60.02 -51.03 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.394 0.597 . . . . 0.0 110.202 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.37 -37.08 84.48 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.591 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 9.6 tt0 -67.02 -37.44 84.14 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.449 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 20' ' ' LEU . 2.7 p -68.0 -61.03 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.14 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' HA3' ' CG1' ' A' ' 35' ' ' VAL . . . -49.12 -33.03 13.59 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.803 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -50.5 72.68 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 122.481 1.134 . . . . 0.0 108.418 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 21.8 mttt -51.81 -41.2 61.56 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 112.865 -1.971 . . . . 0.0 108.202 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.689 ' HB3' ' CB ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.84 -35.9 81.97 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.915 0.864 . . . . 0.0 111.052 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.768 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 5.1 tt0 -69.78 -50.63 41.31 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.331 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -51.23 -30.27 16.93 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 124.909 1.381 . . . . 0.0 111.25 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.641 ' O ' ' CG2' ' A' ' 31' ' ' THR . 1.5 t70 -82.72 -39.15 22.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 116.921 -1.514 . . . . 0.0 108.872 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.641 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 162.29 37.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 116.616 -2.033 . . . . 0.0 116.35 170.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.521 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 155.5 38.58 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 115.428 -3.273 . . . . 0.0 117.354 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.768 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 4.1 mp -139.31 100.94 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 121.09 2.445 . . . . 0.0 114.86 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -107.21 105.24 15.12 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 7.8 m -97.14 132.75 40.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.05 146.67 45.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.315 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -133.22 122.74 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 122.199 -0.313 . . . . 0.0 110.687 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -107.19 137.24 45.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.945 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.488 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -71.56 -177.9 0.54 Allowed Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.392 0.677 . . . . 0.0 111.912 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 30.7 Cg_endo -91.96 -172.67 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.302 2.668 . . . . 0.0 113.757 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 40' ' ' PRO . 9.8 t70 144.81 -72.29 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.862 0.865 . . . . 0.0 109.39 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -108.4 1.05 21.46 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.716 178.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 2.2 tp -19.37 -56.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.996 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 2.1 tm-20 -60.42 -55.11 37.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.53 -55.46 5.65 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.581 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -55.49 -57.96 9.74 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.923 -178.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.615 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -49.62 -57.72 11.28 Favored Pre-proline 0 C--N 1.353 0.76 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.25 -177.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.996 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 24.6 Cg_exo -62.76 -21.2 72.81 Favored 'Trans proline' 0 C--O 1.252 1.2 0 CA-C-N 121.6 1.607 . . . . 0.0 112.325 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -81.97 -39.72 23.25 Favored 'General case' 0 C--O 1.258 1.529 0 CA-C-O 122.561 1.172 . . . . 0.0 111.711 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 47' ' ' PHE . 17.1 m -77.93 -40.71 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.552 0 CA-C-O 122.247 1.023 . . . . 0.0 110.536 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.502 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -49.68 -37.88 30.56 Favored 'General case' 0 C--N 1.378 1.831 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.438 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.18 -33.57 32.92 Favored 'General case' 0 C--N 1.368 1.403 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.437 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.0 p -65.62 -41.06 93.15 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.186 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 55' ' ' ASP . . . -114.69 -70.73 0.51 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.458 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 5.8 m-20 89.02 47.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.851 0.826 . . . . 0.0 109.888 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.11 175.94 21.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 120.531 -0.842 . . . . 0.0 114.642 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 58' ' ' ASP . 82.4 Cg_exo -43.86 131.98 8.05 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.567 2.845 . . . . 0.0 111.909 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 2.0 p30 158.2 125.96 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' A' ' 265' ' ' GLY . 1.8 pt -117.15 178.38 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.506 HG22 ' HB3' ' A' ' 10' ' ' TRP . 2.7 pt -149.29 136.7 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.443 ' CG ' ' O ' ' A' ' 263' ' ' SER . 4.7 t80 -109.99 122.76 48.31 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.469 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 23.2 t-105 -166.75 166.37 15.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -45.35 158.73 0.07 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.63 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.595 ' CG ' ' CG1' ' A' ' 97' ' ' VAL . 4.5 t-80 -77.27 -27.09 53.02 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.467 ' HA ' ' HG3' ' A' ' 331' ' ' PRO . 9.9 p30 -53.34 -52.99 57.43 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-O 121.808 0.813 . . . . 0.0 111.893 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.604 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 18.9 mmm180 -73.4 -31.77 64.07 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.446 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.539 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 6.2 m-30 -60.26 -32.72 71.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 174.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -54.69 -66.87 2.5 Favored Glycine 0 C--O 1.25 1.152 0 CA-C-O 123.038 1.355 . . . . 0.0 111.616 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 70' ' ' TYR . . . -78.54 -55.67 3.86 Favored Glycine 0 C--N 1.357 1.73 0 CA-C-N 113.095 -1.553 . . . . 0.0 112.734 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.999 ' O ' ' N ' ' A' ' 75' ' ' LEU . 6.9 m-30 -42.01 -37.37 1.34 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.639 ' CB ' ' HB3' ' A' ' 76' ' ' LEU . . . -73.37 -58.76 3.09 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 117.852 -1.539 . . . . 0.0 112.432 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -46.96 68.35 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.434 1.016 . . . . 0.0 112.72 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 p -114.58 25.72 10.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.2 -87.48 0.06 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 118.539 -1.791 . . . . 0.0 114.909 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.999 ' N ' ' O ' ' A' ' 70' ' ' TYR . 1.2 tp -155.32 97.22 1.88 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.639 ' HB3' ' CB ' ' A' ' 71' ' ' ALA . 1.2 tp 179.33 144.36 0.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.068 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.608 ' O ' ' CD1' ' A' ' 266' ' ' ILE . . . -95.68 109.42 21.7 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.475 ' HA ' HG12 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -49.07 103.27 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -61.91 173.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.128 0.489 . . . . 0.0 111.193 -179.047 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.404 ' CB ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -88.06 175.38 4.22 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.086 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 80' ' ' THR . 79.1 Cg_endo -79.55 133.18 10.38 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.336 2.024 . . . . 0.0 113.629 -178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -152.87 68.06 0.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.323 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -47.36 -32.27 4.71 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -47.71 -29.03 2.75 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.462 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 1.3 m-85 -74.71 -59.32 2.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.805 0.335 . . . . 0.0 111.19 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.476 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 8.2 tm0? -70.36 -24.48 62.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -76.04 -43.89 41.76 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -11.07 59.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.426 HD22 ' CE3' ' A' ' 94' ' ' TRP . 0.3 OUTLIER -105.57 -170.61 1.77 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.976 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -78.19 145.96 69.99 Favored Pre-proline 0 C--O 1.232 0.154 0 CA-C-O 120.649 0.261 . . . . 0.0 110.543 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 95' ' ' ASP . 53.1 Cg_endo -69.75 -39.74 6.17 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.479 2.119 . . . . 0.0 112.596 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.415 ' CD1' ' HB2' ' A' ' 325' ' ' GLN . 1.9 m-85 -59.74 -57.34 13.35 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -28.06 68.81 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.476 ' CE3' ' HA ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -93.68 -22.86 18.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 91' ' ' PRO . 15.8 t0 -71.64 -24.69 61.91 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.949 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.476 ' HA ' HG12 ' A' ' 329' ' ' ILE . . . -69.0 -23.38 64.09 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.595 ' CG1' ' CG ' ' A' ' 64' ' ' HIS . 22.9 m -122.37 48.76 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.159 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -125.51 100.41 6.46 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 101' ' ' GLY . 3.6 m-85 -87.43 90.97 8.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.288 0.494 . . . . 0.0 110.197 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 48.14 -86.88 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.882 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . -132.67 42.15 1.41 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -145.48 -177.58 5.64 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 119.519 -0.277 . . . . 0.0 111.193 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.4 ' CG ' ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER 167.82 112.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.624 0.647 . . . . 0.0 110.617 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.587 ' CD1' ' O ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -98.67 38.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.479 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . 166.01 174.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -129.64 129.47 23.14 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.071 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' A' ' 263' ' ' SER . 3.6 Cg_exo -79.72 162.26 24.31 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.866 2.377 . . . . 0.0 112.416 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 262' ' ' LEU . 1.1 pt -156.15 38.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.092 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.774 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.614 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . . . -176.21 145.38 0.61 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.724 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.445 ' CG2' ' CB ' ' A' ' 324' ' ' ALA . 14.0 p -128.73 114.03 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.418 ' HG3' ' CD2' ' A' ' 230' ' ' TRP . 17.4 mm-40 -102.99 161.79 13.46 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.279 0.561 . . . . 0.0 109.749 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 320' ' ' THR . . . -165.25 147.24 7.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.758 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.485 ' CD1' ' HB2' ' A' ' 156' ' ' PHE . 3.0 tt -79.06 129.3 34.3 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.4 OUTLIER -135.12 159.65 40.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.412 ' CD2' ' CE2' ' A' ' 117' ' ' TYR . 7.2 tt -92.61 131.18 37.94 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.82 137.6 47.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.412 ' CE2' ' CD2' ' A' ' 115' ' ' LEU . 13.5 m-85 -106.07 133.38 50.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.62 ' HB3' ' CD2' ' A' ' 122' ' ' LEU . 14.8 m120 -88.58 125.9 35.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.559 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.33 -59.25 2.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.43 0.559 . . . . 0.0 112.209 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -38.31 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 122.426 1.108 . . . . 0.0 111.203 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.548 ' CD1' ' O ' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -102.82 42.42 1.15 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 112.739 -2.028 . . . . 0.0 112.442 -175.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.73 ' HG ' ' HA ' ' A' ' 223' ' ' ALA . 1.7 mm? -147.5 140.25 14.64 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 118.847 -1.141 . . . . 0.0 113.068 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.533 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 50.9 Cg_endo -90.97 163.51 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.789 1 C-N-CA 125.492 4.128 . . . . 0.0 113.493 -179.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -61.42 106.07 0.73 Allowed Pre-proline 0 N--CA 1.465 0.296 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.773 -174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 95.3 Cg_endo -99.0 168.27 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 124.882 3.721 . . . . 0.0 114.808 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 146' ' ' ALA . 35.8 Cg_exo -27.5 153.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 125.276 3.984 . . . . 0.0 116.19 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -135.81 -21.33 1.48 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.895 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.52 154.47 51.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -59.9 -53.93 52.13 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.137 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 133' ' ' PRO . 13.5 tt0 -45.45 -24.22 0.29 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -73.61 -28.2 61.69 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.574 ' O ' ' CB ' ' A' ' 136' ' ' ASP . 47.5 mt -42.11 -56.02 5.74 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 121.374 0.607 . . . . 0.0 112.215 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.582 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 2.7 Cg_endo -46.48 -38.61 21.47 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 120.565 0.843 . . . . 0.0 109.95 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.84 -59.99 2.51 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 1.4 mt -69.17 -33.12 72.9 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.212 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 1.038 ' HA ' ' CD1' ' A' ' 139' ' ' LEU . 10.0 t70 -68.32 -43.89 76.58 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -46.18 -49.2 17.24 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 118.208 -1.397 . . . . 0.0 110.079 177.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -63.73 -43.28 96.98 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.784 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 1.038 ' CD1' ' HA ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -52.94 -56.13 18.27 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -49.52 -44.01 46.04 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.704 0.764 . . . . 0.0 108.962 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -45.86 -26.0 0.61 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.29 -1.323 . . . . 0.0 114.343 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.21 -62.38 1.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.526 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.41 53.76 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.771 ' O ' ' CB ' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -172.44 -174.23 1.17 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.885 1.343 . . . . 0.0 109.769 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.768 ' HA ' HD12 ' A' ' 139' ' ' LEU . 8.6 t -144.81 150.27 36.88 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.786 0.435 . . . . 0.0 110.42 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.527 ' CB ' ' HD2' ' A' ' 126' ' ' PRO . . . -68.93 -22.99 64.12 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.509 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 224' ' ' MET . 0.7 OUTLIER -142.92 129.4 20.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -176.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.538 ' HB2' ' CG2' ' A' ' 222' ' ' THR . 0.3 OUTLIER -132.53 139.93 48.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.521 -0.871 . . . . 0.0 111.726 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 227' ' ' ASN . 3.7 t80 -172.48 175.57 3.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.698 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 149' ' ' PHE . 2.6 m-80 -38.76 161.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.931 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 208' ' ' THR . 3.2 mt -115.06 -50.35 2.76 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.19 34.48 3.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 116.04 -2.264 . . . . 0.0 113.897 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.724 ' O ' ' HB ' ' A' ' 157' ' ' THR . 17.9 mm-40 -79.49 145.75 64.2 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 121.6 2.0 . . . . 0.0 114.488 -175.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.993 ' O ' ' N ' ' A' ' 156' ' ' PHE . 5.8 Cg_exo -78.05 -135.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 1 C-N-CA 125.55 4.167 . . . . 0.0 106.242 176.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 1.117 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 36.0 m-85 16.15 -49.75 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.993 ' N ' ' O ' ' A' ' 154' ' ' PRO . 10.4 t80 -84.44 -60.03 2.2 Favored 'General case' 0 C--O 1.258 1.511 0 CA-C-N 119.406 1.003 . . . . 0.0 111.903 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.724 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -56.83 -42.61 79.94 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.458 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 2.3 m95 -51.61 -55.81 26.42 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 1.117 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 79.3 Cg_exo -43.19 -47.87 8.4 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.892 2.395 . . . . 0.0 113.065 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.9 mt -62.48 -56.81 14.59 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.072 0.851 . . . . 0.0 109.968 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 158' ' ' TRP . 20.6 pt -53.91 -18.01 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.904 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.06 -24.7 47.63 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.598 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -41.85 -56.71 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.539 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 1.8 m-20 -64.1 -39.34 93.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 119.211 0.914 . . . . 0.0 112.896 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 156.92 24.23 0.03 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 117.872 -2.109 . . . . 0.0 117.632 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.05 89.64 0.72 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-N 119.375 1.587 . . . . 0.0 112.633 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.493 ' O ' HG11 ' A' ' 183' ' ' VAL . 6.2 m-85 -73.68 158.58 34.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.29 0.545 . . . . 0.0 110.898 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.545 ' O ' HG11 ' A' ' 183' ' ' VAL . . . -61.28 -80.59 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.956 0.884 . . . . 0.0 111.604 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.767 ' HB2' ' CG ' ' A' ' 176' ' ' TYR . 58.5 m-85 -113.86 173.66 6.32 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.792 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 1.173 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -106.49 116.28 31.66 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.974 1.261 . . . . 0.0 107.729 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -78.75 113.22 16.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.456 176.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 1.4 tt0 -137.29 113.61 10.05 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.778 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 1.9 t-20 82.48 -32.33 0.09 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.848 0.356 . . . . 0.0 111.112 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 157.81 15.48 0.04 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.648 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.461 ' HA ' ' CE1' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -173.29 142.02 0.97 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.863 1.332 . . . . 0.0 110.391 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 1.173 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.6 m-85 -66.84 -25.11 66.27 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.506 1.146 . . . . 0.0 109.961 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.412 ' O ' ' CG2' ' A' ' 178' ' ' ILE . 18.6 t70 62.09 -85.7 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 112.793 -2.003 . . . . 0.0 111.51 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.412 ' CG2' ' O ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER 179.18 -54.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.426 ' HA ' ' HB ' ' A' ' 369' ' ' THR . 0.0 OUTLIER -51.17 -17.37 0.65 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.45 ' CB ' ' CB ' ' A' ' 170' ' ' LYS . 5.5 m-20 -117.27 94.99 4.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 119.68 1.127 . . . . 0.0 109.332 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.426 ' CG2' ' CG ' ' A' ' 365' ' ' GLN . 3.3 m -116.73 112.45 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -117.74 39.96 2.47 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.586 -1.292 . . . . 0.0 113.806 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.545 HG11 ' O ' ' A' ' 168' ' ' ALA . 1.8 m -79.09 -46.06 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.452 ' N ' ' CG2' ' A' ' 183' ' ' VAL . 18.5 t0 -81.49 57.25 3.22 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.08 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -102.77 177.93 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.345 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.48 -31.56 35.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.462 0.648 . . . . 0.0 111.429 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -74.91 -40.2 36.57 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.523 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 183' ' ' VAL . . . -61.38 -46.09 91.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 174.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.61 -60.62 3.52 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.08 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.23 -41.62 50.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.09 0.948 . . . . 0.0 111.768 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -65.9 -60.6 6.32 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.535 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -24.28 62.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.471 ' O ' HG13 ' A' ' 196' ' ' VAL . 23.5 m -63.99 -48.33 76.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 3.0 p90 -60.6 -35.22 75.58 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' A' ' 194' ' ' PHE . 4.5 mt -64.66 -47.64 77.73 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 193' ' ' THR . 0.5 OUTLIER -58.53 -28.33 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.18 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 196' ' ' VAL . 0.5 OUTLIER -63.77 -46.3 85.88 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.302 0.572 . . . . 0.0 110.229 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.409 ' CD1' HG23 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -62.93 -59.32 4.99 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.039 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 204' ' ' MET . 15.0 pt -54.14 -43.91 61.82 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -61.52 -34.26 75.21 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -89.95 2.31 55.24 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.96 -84.32 0.66 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.583 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.411 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.4 OUTLIER -120.73 -23.61 5.94 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 199' ' ' ILE . 0.3 OUTLIER 74.5 16.46 3.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.891 0.314 . . . . 0.0 110.645 -178.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -158.56 82.97 0.82 Allowed 'General case' 0 C--N 1.34 0.187 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.462 ' CA ' HD13 ' A' ' 151' ' ' LEU . . . -76.0 84.82 2.9 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -97.9 -2.77 39.97 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.272 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 89.4 m -56.66 121.1 8.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.95 -175.39 3.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -69.05 -45.36 70.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.138 0.495 . . . . 0.0 110.139 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.2 m -77.33 -25.53 51.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.613 0.72 . . . . 0.0 111.281 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -81.15 -50.82 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.801 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -53.46 -36.56 61.74 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.77 -46.16 89.32 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.05 -39.47 69.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.128 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.65 -56.98 13.98 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -60.52 -28.46 68.42 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.38 -43.41 75.13 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.286 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -23.98 59.18 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.71 45.09 78.43 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -109.44 37.19 2.68 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.86 1.33 . . . . 0.0 110.496 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.538 ' CG2' ' HB2' ' A' ' 148' ' ' MET . 0.6 OUTLIER -141.96 141.85 32.95 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.966 0.889 . . . . 0.0 109.166 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.73 ' HA ' ' HG ' ' A' ' 122' ' ' LEU . . . -103.16 38.66 1.71 Allowed 'General case' 0 C--N 1.345 0.391 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER 168.7 138.45 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.41 ' HB ' ' CD1' ' A' ' 149' ' ' PHE . 5.2 p -148.06 159.78 43.55 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 156' ' ' PHE . 3.1 mp -116.48 112.44 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 114' ' ' SER . 2.2 p-10 -147.53 165.09 31.37 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 118.94 -0.553 . . . . 0.0 112.15 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -129.3 149.7 18.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.799 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.49 69.75 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.557 2.171 . . . . 0.0 112.298 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.418 ' CD2' ' HG3' ' A' ' 111' ' ' GLU . 9.2 t-105 -159.02 -74.07 0.08 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.299 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.39 58.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.713 0.292 . . . . 0.0 110.997 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -152.07 95.7 2.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.256 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.9 m 53.2 176.28 0.02 OUTLIER 'General case' 0 C--O 1.231 0.079 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.339 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -109.24 94.99 5.33 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.632 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 12.6 tt -45.7 155.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.106 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.23 -171.29 0.09 Allowed 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.582 0.23 . . . . 0.0 110.501 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.9 m 67.02 35.55 4.59 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.707 0.289 . . . . 0.0 110.767 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 10.5 t -148.69 -62.06 0.24 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.544 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 14.9 mmtt -131.53 -85.97 0.49 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.402 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 2.7 p 158.38 -45.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -92.38 117.73 30.21 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.666 0.27 . . . . 0.0 111.266 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -149.29 129.86 13.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.428 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.99 176.21 54.74 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.668 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.3 t -146.55 113.16 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.557 0.678 . . . . 0.0 112.442 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.95 167.11 17.9 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -172.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.7 153.96 7.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.208 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.73 159.88 11.86 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 119.515 1.052 . . . . 0.0 110.996 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.49 -163.45 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 111.957 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -120.79 177.58 5.03 Favored 'General case' 0 CA--C 1.526 0.052 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 194' ' ' PHE . 46.4 m-85 -162.35 110.42 1.36 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.534 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.86 33.08 17.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.379 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.28 41.34 21.63 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.524 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.74 151.57 20.9 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.594 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 86.0 Cg_endo -86.51 -172.32 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.321 2.68 . . . . 0.0 111.891 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.422 ' HB2' ' CB ' ' A' ' 159' ' ' PRO . 10.2 p -108.57 148.33 30.47 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.4 OUTLIER -85.62 109.31 21.01 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.421 -178.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.489 ' HG2' ' O ' ' A' ' 323' ' ' ASN . 2.7 Cg_exo -79.36 149.45 21.7 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.305 2.67 . . . . 0.0 113.174 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.401 ' CB ' ' CD1' ' A' ' 155' ' ' TYR . 25.5 p90 -79.01 132.63 36.71 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 175.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.6 p -89.85 130.09 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -120.12 121.86 5.05 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 119.271 -1.442 . . . . 0.0 115.355 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -113.01 109.51 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.614 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 2.4 mm? -89.72 99.78 12.72 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 118.27 -1.372 . . . . 0.0 107.706 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.617 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -110.16 177.16 4.79 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -173.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -116.2 124.06 49.33 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -127.4 164.33 20.91 Favored Glycine 0 CA--C 1.547 2.033 0 C-N-CA 119.062 -1.542 . . . . 0.0 112.776 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.608 ' CD1' ' O ' ' A' ' 77' ' ' ALA . 33.8 pt -81.93 -179.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 2 C-N-CA 139.311 7.044 . . . . 0.0 92.25 172.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.48 ' ND2' ' CE1' ' A' ' 47' ' ' PHE . 12.1 t30 -151.89 168.73 24.21 Favored 'General case' 0 CA--C 1.547 0.831 2 CA-C-N 133.603 7.456 . . . . 0.0 103.403 177.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.459 ' N ' ' HA ' ' A' ' 76' ' ' LEU . . . -56.88 -52.27 65.78 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.203 0.911 . . . . 0.0 111.304 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 55' ' ' ASP . . . -33.93 -64.16 0.24 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.96 127.88 2.82 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.596 0.236 . . . . 0.0 111.036 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.423 ' HA ' ' HB ' ' A' ' 266' ' ' ILE . 81.0 Cg_endo -80.64 -41.3 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.359 2.04 . . . . 0.0 113.397 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 55.65 72.81 0.46 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.595 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 18.6 mtpt -56.64 -54.27 48.03 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 278' ' ' GLU . 4.2 mt-10 -55.65 -58.16 8.98 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.982 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.9 mt -69.46 -57.91 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.88 -55.74 17.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.595 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -57.53 -42.49 82.98 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 274' ' ' GLU . 5.3 mt-10 -76.25 -53.88 7.6 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.444 ' HB2' ' CE2' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -55.6 -56.36 21.22 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.661 179.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.2 mt -54.37 -43.4 71.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.359 0.599 . . . . 0.0 111.768 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -75.4 -33.24 60.97 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.214 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -97.14 -13.57 22.05 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.523 ' O ' HG22 ' A' ' 286' ' ' THR . 17.2 m-85 -114.32 -54.5 2.58 Favored 'General case' 0 CA--C 1.512 -0.513 0 O-C-N 122.008 -0.433 . . . . 0.0 110.659 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.6 tp -45.28 -25.46 0.39 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.93 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.93 43.39 1.09 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-O 120.832 0.349 . . . . 0.0 111.47 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 283' ' ' TYR . 13.2 t -143.7 156.93 44.69 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.532 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 49.4 p30 -66.13 -12.16 53.9 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.472 0.578 . . . . 0.0 110.55 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.593 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 10.9 tt0 -77.58 -47.48 19.31 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.029 -0.419 . . . . 0.0 111.054 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -84.71 -57.07 2.36 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 286' ' ' THR . 0.4 OUTLIER -48.29 -48.75 35.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.265 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -78.96 -26.77 43.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.077 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.593 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -65.8 -41.79 91.49 Favored 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 121.459 -0.776 . . . . 0.0 108.937 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.0 t -71.02 -64.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 116.704 -1.998 . . . . 0.0 105.856 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -51.43 3.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 129.119 2.967 . . . . 0.0 115.064 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -110.94 -57.0 2.29 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.421 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 57.6 m-20 -52.97 -36.85 60.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -111.61 98.19 39.88 Favored Pre-proline 0 C--N 1.35 0.593 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.939 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -95.25 76.08 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.416 2.744 . . . . 0.0 112.091 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 mt -101.55 -74.83 0.61 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.449 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 311' ' ' LEU . . . -142.62 -142.68 4.06 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.522 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.433 ' N ' ' CG2' ' A' ' 317' ' ' ILE . . . -79.79 178.42 8.2 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.741 0.305 . . . . 0.0 111.457 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.403 ' CG1' ' CD2' ' A' ' 290' ' ' LEU . 0.0 OUTLIER -126.83 -171.76 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.929 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.419 ' CB ' ' CD2' ' A' ' 89' ' ' LEU . . . -106.98 66.37 0.68 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.479 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 308' ' ' GLU . 10.4 tp -159.95 108.89 1.76 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.763 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.61 -60.36 0.71 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.78 -48.03 63.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.022 0.915 . . . . 0.0 111.529 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.401 ' OH ' ' CG ' ' A' ' 291' ' ' GLU . 1.9 t80 -70.07 -19.73 63.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.128 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 304' ' ' LEU . 3.0 tp10 -65.55 -39.95 92.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.82 -57.27 5.29 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.435 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -51.07 -57.21 9.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.248 0.547 . . . . 0.0 109.802 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 300' ' ' GLY . 1.2 tt -61.93 -38.68 89.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.241 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 317' ' ' ILE . . . -46.32 -29.11 1.51 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -40.31 -39.17 0.91 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.809 0.337 . . . . 0.0 110.241 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -78.53 118.34 71.75 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.09 -20.36 37.32 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.681 2.254 . . . . 0.0 114.287 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -59.15 5.61 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 312' ' ' ALA . 2.4 pp -50.04 -53.44 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.435 ' N ' ' CD1' ' A' ' 317' ' ' ILE . . . -45.77 -44.95 14.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.448 0.567 . . . . 0.0 111.518 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.52 -40.09 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.551 0.691 . . . . 0.0 110.242 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER -62.0 -56.6 17.37 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.528 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 9.0 ttp -53.1 -42.68 66.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.701 0.286 . . . . 0.0 110.691 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.18 -39.26 81.97 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.93 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 257' ' ' PRO . 7.3 m-80 -78.31 -48.11 16.36 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.659 0.266 . . . . 0.0 111.161 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.445 ' CB ' ' CG2' ' A' ' 110' ' ' VAL . . . -48.53 -40.79 28.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.621 0.248 . . . . 0.0 111.576 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 92' ' ' PHE . 5.3 pt20 -67.08 -28.43 68.18 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.607 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -76.54 -10.46 59.41 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 257' ' ' PRO . . . -79.91 161.2 45.55 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.815 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -96.6 139.62 32.41 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 96' ' ' ALA . 9.7 mt -51.58 102.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 119.891 1.223 . . . . 0.0 111.235 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.509 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 32.9 mtm -47.95 -48.33 62.4 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 330' ' ' MET . 57.9 Cg_endo -72.19 121.7 7.75 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.279 1.986 . . . . 0.0 113.218 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.404 ' C ' HG13 ' A' ' 333' ' ' ILE . 0.1 OUTLIER -160.69 -70.28 0.07 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.473 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.485 ' CG2' ' HD2' ' A' ' 334' ' ' PRO . 0.3 OUTLIER -137.32 140.42 30.71 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.001 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.485 ' HD2' ' CG2' ' A' ' 333' ' ' ILE . 10.9 Cg_endo -53.38 -18.27 10.64 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.881 2.388 . . . . 0.0 113.037 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.456 ' CG ' ' CG2' ' A' ' 368' ' ' ILE . 1.4 mp0 -44.07 -24.67 0.16 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.45 ' HE1' ' CZ ' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -45.71 -35.26 4.09 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.039 0.381 . . . . 0.0 111.372 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' SER . . . . . 0.482 ' HA ' ' CD2' ' A' ' 340' ' ' TRP . 3.0 t -56.26 -53.17 60.45 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 110.241 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 368' ' ' ILE . . . -52.13 -27.23 13.52 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.172 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.432 ' O ' HG22 ' A' ' 343' ' ' VAL . 25.2 m-85 -78.09 -55.74 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.344 -0.543 . . . . 0.0 112.459 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 341' ' ' TYR . 1.2 p90 -54.95 -31.93 60.98 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.26 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 340' ' ' TRP . 0.1 OUTLIER -75.57 -52.16 11.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.024 0.44 . . . . 0.0 110.994 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.33 88.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.731 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.489 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 4.8 m -69.17 -42.3 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.375 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.471 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 30.2 mtt-85 -57.79 -55.4 35.42 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.882 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -58.2 9.49 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.34 -60.69 2.13 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 42.7 t -53.03 -49.78 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 36.3 mt -67.87 -49.56 67.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.57 -55.06 19.71 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 355' ' ' GLN . . . -63.63 -26.55 68.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.905 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.48 -10.27 32.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.49 0.586 . . . . 0.0 112.327 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.3 p -110.77 14.8 22.18 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 122.059 -0.401 . . . . 0.0 110.785 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 97.73 29.74 7.58 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 116.815 -2.612 . . . . 0.0 116.08 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.46 35.65 4.36 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 116.252 -1.833 . . . . 0.0 106.328 174.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.458 ' HA ' ' CB ' ' A' ' 350' ' ' ALA . 3.9 pt20 -70.98 -174.77 1.0 Allowed 'General case' 0 CA--C 1.549 0.912 1 N-CA-C 125.704 5.446 . . . . 0.0 125.704 -157.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 158.34 41.78 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.415 -3.084 . . . . 0.0 104.538 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.3 p -72.36 -51.62 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.569 ' O ' ' HB3' ' A' ' 362' ' ' LYS . 10.0 t0 -47.77 -45.36 29.14 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.772 0.796 . . . . 0.0 111.31 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.6 ' HA ' ' HG2' ' A' ' 362' ' ' LYS . 8.1 mp0 -77.14 -56.32 4.67 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 113.885 -1.507 . . . . 0.0 113.62 -174.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -54.45 -43.09 71.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.416 1.103 . . . . 0.0 112.645 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.492 ' HA ' ' HB1' ' A' ' 364' ' ' ALA . 0.1 OUTLIER -76.17 -45.75 31.83 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.087 -1.87 . . . . 0.0 111.358 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.6 ' HG2' ' HA ' ' A' ' 359' ' ' GLU . 43.3 pttt -58.01 -54.89 41.79 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 121.961 0.886 . . . . 0.0 110.419 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 362' ' ' LYS . 9.0 m-20 -58.75 -36.15 73.89 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 114.611 -1.177 . . . . 0.0 107.832 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 361' ' ' LEU . . . -49.66 -45.54 48.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.426 ' CG ' ' CG2' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -58.93 -44.77 91.43 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.6 m -52.09 -42.54 63.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.112 0.482 . . . . 0.0 109.864 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.15 -37.06 85.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.909 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.456 ' CG2' ' CG ' ' A' ' 335' ' ' GLN . 4.2 mm -71.64 -35.29 55.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.934 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.426 ' HB ' ' HA ' ' A' ' 179' ' ' LYS . 7.4 p -118.64 51.35 1.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.936 0.398 . . . . 0.0 111.843 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.3 tptp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.195 179.79 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.663 0.268 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.78 107.84 10.22 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -112.8 146.37 38.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 63.3 68.49 0.61 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.063 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.46 -112.11 2.31 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.219 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HG3' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -118.21 -171.18 2.02 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 114.143 -1.028 . . . . 0.0 109.919 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.475 ' CD2' ' CZ ' ' A' ' 279' ' ' PHE . 0.1 OUTLIER -127.42 120.41 28.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 1.039 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -116.24 117.14 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.341 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.421 ' CG1' ' CG1' ' A' ' 37' ' ' VAL . 1.7 pp -123.51 129.88 74.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.691 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.518 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 8.5 m95 -107.58 122.44 46.69 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.6 tt -159.23 139.02 3.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.7 113.29 20.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.624 0.249 . . . . 0.0 111.111 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.29 -9.15 15.36 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.755 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 39.0 t0 -72.59 -82.11 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.853 0.827 . . . . 0.0 111.057 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 5.8 tmtm? 100.84 -2.75 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.531 0.733 . . . . 0.0 110.313 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 296' ' ' ASP . . . -76.72 66.01 2.8 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 115.271 0.868 . . . . 0.0 115.271 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CZ ' HG22 ' A' ' 37' ' ' VAL . 4.3 m-85 -77.39 -39.23 47.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.139 -0.531 . . . . 0.0 110.682 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 1.7 m120 -61.48 -47.0 87.66 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.058 0.456 . . . . 0.0 111.052 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.408 ' O ' ' CG2' ' A' ' 23' ' ' VAL . . . -71.37 -47.51 35.43 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.054 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.99 -49.6 77.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.381 0.59 . . . . 0.0 110.153 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.79 -38.46 80.01 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 2.1 tp10 -65.67 -36.93 85.08 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.063 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' A' ' 283' ' ' TYR . 61.0 t -66.82 -61.1 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.498 ' HA3' ' CG2' ' A' ' 35' ' ' VAL . . . -48.95 -32.42 11.68 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 119.685 -1.245 . . . . 0.0 111.491 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -55.29 -50.18 70.23 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.4 mttt -53.03 -41.72 65.0 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-N 112.862 -1.972 . . . . 0.0 108.374 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.585 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 47.4 m-85 -65.49 -34.31 77.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.777 0.799 . . . . 0.0 110.78 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.749 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 1.1 tm-20 -69.08 -51.26 40.65 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.963 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttp -50.99 -30.14 14.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 125.133 1.521 . . . . 0.0 110.867 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.636 ' O ' ' CG2' ' A' ' 31' ' ' THR . 0.4 OUTLIER -83.62 -38.2 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.428 179.085 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.636 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.75 37.71 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 171.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.09 38.58 0.02 OUTLIER Glycine 0 N--CA 1.468 0.805 0 C-N-CA 115.071 -3.443 . . . . 0.0 119.035 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.749 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 2.0 mp -140.02 136.8 38.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 121.861 2.831 . . . . 0.0 116.417 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' CD ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -142.42 105.13 4.52 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.498 ' CG2' ' HA3' ' A' ' 24' ' ' GLY . 42.6 t -86.89 131.61 34.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -174.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.8 p -117.3 145.1 44.21 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.44 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.441 HG22 ' CZ ' ' A' ' 17' ' ' TYR . 16.0 m -129.08 120.6 52.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -110.36 130.7 55.5 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -119.75 71.18 14.39 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.307 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.554 ' HG2' ' CB ' ' A' ' 43' ' ' LEU . 7.8 Cg_endo -94.93 -170.2 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.514 2.809 . . . . 0.0 112.857 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -109.74 -40.32 4.85 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.42 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB3' ' CG ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -86.23 0.32 54.02 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.589 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -31.68 -39.27 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 1.02 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 73.7 mt-10 -62.86 -54.61 36.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.467 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.514 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 11.9 pt-20 -74.2 -38.36 63.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -60.12 -57.53 12.42 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.705 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.597 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.1 t80 -42.94 -59.16 3.24 Favored Pre-proline 0 C--N 1.352 0.694 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.516 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 1.02 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 26.8 Cg_exo -62.66 -22.65 74.16 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 120.948 1.099 . . . . 0.0 113.171 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -82.23 -36.93 26.7 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 122.28 1.038 . . . . 0.0 111.271 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.3 m -78.59 -39.81 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.506 0 CA-C-O 122.254 1.026 . . . . 0.0 109.863 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.406 ' N ' HG21 ' A' ' 50' ' ' VAL . . . -50.56 -37.46 39.76 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 125.957 1.703 . . . . 0.0 110.906 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.411 ' O ' ' CG2' ' A' ' 53' ' ' THR . . . -81.52 -40.1 23.69 Favored 'General case' 0 C--N 1.372 1.567 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.701 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 52' ' ' ALA . 33.6 p -159.56 51.52 0.35 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.054 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -160.02 48.87 0.39 Allowed Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.333 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t0 70.67 104.24 0.06 Allowed 'General case' 0 C--O 1.23 0.077 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.07 112.15 4.73 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.836 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.492 ' CG ' ' CE1' ' A' ' 47' ' ' PHE . 86.1 Cg_endo -79.85 -164.68 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.956 2.437 . . . . 0.0 113.444 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 1.039 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 6.7 t0 -79.96 -135.57 0.03 OUTLIER 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 123.946 0.898 . . . . 0.0 110.521 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' A' ' 266' ' ' ILE . 1.3 mp -101.7 165.17 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.539 HG21 ' CE2' ' A' ' 47' ' ' PHE . 1.2 pt -127.16 130.69 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.5 OUTLIER -115.34 117.57 30.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.49 ' CD1' ' O ' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -167.26 165.38 15.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 62' ' ' TRP . . . -37.45 152.46 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.557 ' CB ' ' HB ' ' A' ' 261' ' ' VAL . 10.7 t-160 -77.35 -28.62 53.05 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -49.19 -58.29 5.25 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-O 121.979 0.895 . . . . 0.0 112.279 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.537 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -73.9 -30.59 62.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.546 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.487 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -63.35 -25.43 68.29 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -62.04 -65.37 3.24 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.62 -47.85 89.15 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 113.616 -1.292 . . . . 0.0 110.309 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.69 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 23.2 t80 -48.02 -46.56 33.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HA ' ' CB ' ' A' ' 76' ' ' LEU . . . -57.87 -37.43 73.92 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.299 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -78.94 -54.72 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.303 . . . . 0.0 111.764 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -113.34 -26.15 8.5 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' TYR . . . -65.41 -85.37 0.07 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.178 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 165.58 71.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.142 0.496 . . . . 0.0 109.726 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.519 HD13 ' HB ' ' A' ' 104' ' ' ILE . 2.5 tt -112.64 133.22 54.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.273 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 79' ' ' ILE . . . -86.45 91.92 8.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.631 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -56.3 85.49 0.01 OUTLIER 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.568 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 2.0 pp -49.24 119.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.224 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.7 p -105.84 82.79 0.91 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.365 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 42.8 Cg_endo -89.44 -168.58 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.122 2.548 . . . . 0.0 112.422 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -172.89 4.42 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.638 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -35.66 21.0 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.3 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.44 -23.64 58.04 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.93 -59.21 2.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -60.99 -24.74 66.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.389 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -75.8 -35.39 60.07 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.58 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -19.68 64.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.547 ' CD1' ' CG ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER -97.4 -179.57 4.53 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -94.58 143.32 26.06 Favored Pre-proline 0 C--N 1.343 0.304 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 31.8 Cg_exo -58.92 -50.58 8.66 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.422 2.081 . . . . 0.0 113.513 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' ' CG ' ' A' ' 325' ' ' GLN . 6.8 m-85 -56.76 -62.78 1.5 Allowed 'General case' 0 C--O 1.246 0.878 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.583 ' O ' ' HG3' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -62.85 -25.25 68.18 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.547 ' CG ' ' CD1' ' A' ' 89' ' ' LEU . 31.6 m95 -93.86 -23.39 18.14 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 14.7 t70 -72.65 -22.2 60.97 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.476 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' HB3' ' CG2' ' A' ' 261' ' ' VAL . . . -53.29 -45.53 68.96 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.444 ' HA ' ' CE1' ' A' ' 64' ' ' HIS . 20.2 m -113.93 39.25 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.407 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.438 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 12.0 ttp180 -104.94 138.96 40.37 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.289 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -124.15 90.99 3.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 119.172 0.896 . . . . 0.0 110.052 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.5 m120 51.73 -91.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.208 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.1 44.73 1.21 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.79 -177.03 5.37 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.486 0.314 . . . . 0.0 110.484 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.66 126.68 5.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.391 0.541 . . . . 0.0 110.742 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.521 ' O ' ' CB ' ' A' ' 105' ' ' ALA . 1.4 pp -128.25 39.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.55 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . 159.61 162.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 263' ' ' SER . 23.2 m-85 -124.7 119.81 25.78 Favored Pre-proline 0 C--O 1.223 -0.32 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.583 ' HG3' ' O ' ' A' ' 93' ' ' THR . 66.9 Cg_endo -79.14 162.48 25.83 Favored 'Trans proline' 0 N--CA 1.474 0.333 0 C-N-CA 122.284 1.989 . . . . 0.0 114.776 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.644 ' N ' ' O ' ' A' ' 262' ' ' LEU . 0.8 OUTLIER -171.82 38.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.502 ' CB ' ' CB ' ' A' ' 262' ' ' LEU . . . -179.56 137.58 0.13 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -124.09 119.48 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 259' ' ' VAL . 5.4 tt0 -99.03 135.04 41.0 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -168.06 -174.67 2.41 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 123.366 1.555 . . . . 0.0 110.204 -167.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.456 ' CD1' ' CZ2' ' A' ' 232' ' ' TRP . 2.7 tt -147.3 135.44 21.49 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 110.995 -2.821 . . . . 0.0 115.846 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.4 OUTLIER -130.31 168.42 16.93 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.893 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.8 tp -92.45 132.41 36.81 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 121.877 -0.514 . . . . 0.0 110.267 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 242' ' ' TYR . 0.5 OUTLIER -116.41 134.51 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.669 0.747 . . . . 0.0 111.175 -178.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.455 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 8.3 m-85 -93.23 -174.32 3.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.05 2.54 . . . . 0.0 110.037 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.468 ' HB3' ' H ' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -93.05 -135.43 0.17 Allowed 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 126.625 1.97 . . . . 0.0 113.615 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.468 ' H ' ' HB3' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -152.46 -108.26 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.085 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -67.94 -26.55 66.01 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.499 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -104.89 51.47 0.76 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.164 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 122' ' ' LEU . 1.2 pp -118.83 73.22 11.82 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 121.439 0.638 . . . . 0.0 109.788 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.536 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 12.5 Cg_exo -70.16 160.82 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.407 2.071 . . . . 0.0 112.508 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -61.56 108.19 1.44 Allowed Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.417 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 57.2 Cg_endo -69.63 167.94 22.82 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 124.094 3.196 . . . . 0.0 113.574 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -76.16 -162.0 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.762 2.308 . . . . 0.0 113.592 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -126.23 -93.03 0.49 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.6 t -45.0 152.99 0.2 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.352 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.481 ' HB2' ' CE1' ' A' ' 250' ' ' PHE . 13.9 t-105 -69.96 -26.51 64.14 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 174.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.423 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 62.5 mt-10 -44.55 -23.72 0.14 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 134' ' ' ALA . 22.1 mt-10 -73.5 -26.2 60.78 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.561 HG13 ' HD3' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -40.44 -52.81 5.84 Favored Pre-proline 0 N--CA 1.487 1.385 0 CA-C-N 119.122 0.874 . . . . 0.0 112.288 -178.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.58 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 53.1 Cg_exo -46.33 -39.94 21.95 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 120.699 0.933 . . . . 0.0 109.892 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.38 -58.92 2.99 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -68.14 -36.65 80.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.159 -178.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.445 ' HA ' HD11 ' A' ' 139' ' ' LEU . 1.9 m-20 -73.51 -41.09 63.51 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -48.22 -43.88 32.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.69 177.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -37.48 85.34 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.598 ' HB3' ' C ' ' A' ' 144' ' ' LYS . 0.7 OUTLIER -65.55 -46.47 79.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -48.91 -43.26 39.14 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.12 -22.93 0.26 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.296 -177.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -115.79 -60.31 1.89 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.774 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.62 56.85 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.598 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 24.2 pttt -169.08 -173.43 1.77 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.829 1.815 . . . . 0.0 110.246 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.429 ' O ' HD22 ' A' ' 139' ' ' LEU . 38.5 m -142.65 164.82 29.08 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.56 ' CA ' HD13 ' A' ' 139' ' ' LEU . . . -81.84 -23.01 36.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.931 0.395 . . . . 0.0 111.919 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 224' ' ' MET . 3.3 pp -144.82 128.76 17.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.2 mmm -132.41 141.59 48.93 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.702 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.459 ' HB3' HG22 ' A' ' 225' ' ' THR . 52.6 p90 -172.55 174.94 3.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.742 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -37.54 158.42 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.013 178.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 206' ' ' ALA . 3.3 mt -110.65 -51.66 2.85 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.17 34.35 3.1 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 115.752 -2.379 . . . . 0.0 113.765 -175.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.665 ' O ' ' OG1' ' A' ' 157' ' ' THR . 0.5 OUTLIER -79.63 142.32 57.26 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 121.067 1.758 . . . . 0.0 114.087 -176.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.968 ' O ' ' N ' ' A' ' 156' ' ' PHE . 67.3 Cg_endo -78.18 -134.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 1 C-N-CA 125.336 4.024 . . . . 0.0 105.2 175.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 1.167 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 12.3 m-85 21.13 -55.63 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.883 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.968 ' N ' ' O ' ' A' ' 154' ' ' PRO . 15.1 t80 -84.72 -55.81 3.92 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-N 119.561 1.073 . . . . 0.0 112.641 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.665 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 20.6 p -58.04 -39.77 79.25 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 117.913 -1.515 . . . . 0.0 107.336 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.424 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 24.2 m95 -53.0 -55.7 30.93 Favored Pre-proline 0 C--N 1.352 0.702 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.825 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 1.167 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 67.5 Cg_exo -43.04 -48.91 7.41 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.187 2.591 . . . . 0.0 112.425 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.466 ' CD2' ' CE2' ' A' ' 250' ' ' PHE . 0.1 OUTLIER -58.19 -53.55 57.03 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 119.361 0.982 . . . . 0.0 109.411 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.7 mt -55.42 -20.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.001 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.5 ' CB ' ' HB2' ' A' ' 256' ' ' LYS . . . -78.9 -25.16 43.77 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.445 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -42.85 -56.02 3.43 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.466 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 7.1 m-20 -64.54 -11.18 31.6 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.172 0.896 . . . . 0.0 112.777 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.91 27.76 0.7 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 119.545 -1.312 . . . . 0.0 115.561 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.85 162.06 38.82 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 118.557 1.178 . . . . 0.0 111.847 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.673 ' O ' ' N ' ' A' ' 169' ' ' PHE . 25.9 m-85 -151.28 30.18 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.992 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.447 ' HB1' ' CD1' ' A' ' 169' ' ' PHE . . . 50.04 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.024 0.916 . . . . 0.0 111.411 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.673 ' N ' ' O ' ' A' ' 167' ' ' TYR . 12.4 m-85 -112.88 170.72 8.0 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.423 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.927 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -108.01 114.74 28.88 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.49 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 5.9 t80 -79.23 114.03 17.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 113.473 -1.694 . . . . 0.0 110.36 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 174' ' ' GLY . 44.9 tp10 -137.54 124.53 21.43 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.202 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 t30 76.77 -31.69 0.18 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.872 -0.149 . . . . 0.0 111.109 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.49 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 163.83 11.77 0.03 OUTLIER Glycine 0 CA--C 1.532 1.123 0 C-N-CA 120.17 -1.014 . . . . 0.0 114.626 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -173.93 150.6 1.65 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.962 1.381 . . . . 0.0 110.031 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.927 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 7.0 m-85 -66.57 -26.32 67.06 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.151 0.977 . . . . 0.0 109.579 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.64 -103.98 0.08 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.403 -1.726 . . . . 0.0 112.163 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.3 tp -173.38 -46.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.42 -15.6 60.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.718 0.294 . . . . 0.0 110.872 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 170' ' ' LYS . 3.2 p-10 -129.19 94.3 3.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 169' ' ' PHE . 20.3 m -122.03 140.79 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.387 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.69 55.5 4.17 Favored Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.185 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 361' ' ' LEU . 30.4 m -87.03 -13.31 10.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.525 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 7.3 p-10 -124.62 62.68 1.13 Allowed 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.774 0.321 . . . . 0.0 110.844 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -116.93 135.1 53.98 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.282 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -39.25 -40.31 0.74 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.424 0.63 . . . . 0.0 112.264 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -76.78 -35.94 38.54 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 114.955 -1.02 . . . . 0.0 114.113 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.43 69.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.426 ' CE ' ' CD2' ' A' ' 361' ' ' LEU . 9.2 mttt -58.16 -60.45 3.73 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.651 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.404 ' O ' ' OG1' ' A' ' 193' ' ' THR . . . -50.36 -42.03 52.55 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.835 0.826 . . . . 0.0 111.959 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.46 -60.51 5.41 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.146 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.98 -28.32 62.22 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 122.841 -0.211 . . . . 0.0 110.48 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 190' ' ' ALA . 7.6 p -69.65 -42.37 74.34 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.666 0.27 . . . . 0.0 111.375 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 129' ' ' TRP . 86.7 t80 -61.68 -34.27 75.45 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.345 0.593 . . . . 0.0 109.606 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.67 -47.76 79.93 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.88 -31.64 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.467 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.11 -44.87 87.37 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.797 0.808 . . . . 0.0 111.508 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.439 HD12 ' CD1' ' A' ' 129' ' ' TRP . 13.0 mt -58.59 -55.39 35.64 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.657 ' O ' ' HA ' ' A' ' 204' ' ' MET . 26.9 pt -64.06 -39.82 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.102 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -52.67 -37.32 58.52 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.695 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.26 -34.53 5.62 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 121.141 3.756 . . . . 0.0 121.141 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -60.72 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.773 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -105.19 -1.94 24.79 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 9.0 mtm 43.39 36.02 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.773 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.09 159.36 42.34 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 151' ' ' LEU . . . -149.38 30.1 0.77 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -100.6 -3.51 30.34 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 151' ' ' LEU . 5.3 m -57.45 119.82 7.16 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -95.5 -174.24 3.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.875 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 211' ' ' SER . 53.5 p90 -68.05 -45.5 73.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.421 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -76.67 -25.49 53.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.588 0.709 . . . . 0.0 111.382 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 4.5 mt -81.63 -50.91 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.063 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.37 56.98 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.479 ' HA ' ' CD2' ' A' ' 217' ' ' PHE . 2.7 tt0 -60.17 -46.89 88.17 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.9 -36.24 69.91 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.481 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.55 -57.34 13.11 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 214' ' ' GLU . 0.4 OUTLIER -63.08 -28.32 70.0 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -55.14 -41.12 71.35 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.558 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.98 59.14 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.2 41.27 69.9 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -109.64 37.13 2.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.034 1.417 . . . . 0.0 110.822 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.6 m -140.44 140.75 35.46 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -105.09 38.42 1.94 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.349 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 2.7 ttm 171.6 135.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 149' ' ' PHE . 90.4 m -148.19 157.58 43.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.153 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.436 ' HB ' ' CZ ' ' A' ' 156' ' ' PHE . 2.7 mp -115.84 111.41 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.427 173.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 114' ' ' SER . 10.1 p30 -149.18 164.72 33.93 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 122.095 -0.378 . . . . 0.0 111.837 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -80.76 -172.82 46.25 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.124 -1.513 . . . . 0.0 109.784 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.425 ' CB ' ' HB3' ' A' ' 316' ' ' ARG . 57.5 Cg_endo -73.51 -40.7 1.43 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 121.759 1.639 . . . . 0.0 112.522 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.503 ' CZ2' ' HA3' ' A' ' 300' ' ' GLY . 0.3 OUTLIER -137.49 23.87 2.93 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.479 ' CB ' ' CE3' ' A' ' 232' ' ' TRP . . . -96.48 -33.79 11.73 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.479 ' CE3' ' CB ' ' A' ' 231' ' ' ALA . 1.7 m-90 -105.21 79.96 1.54 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.1 m 62.59 -175.69 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.91 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -83.0 129.5 35.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.813 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.405 HG13 ' CE2' ' A' ' 242' ' ' TYR . 8.4 tp -87.61 -32.55 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.368 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -46.2 -38.66 8.63 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.603 0.24 . . . . 0.0 111.294 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.0 t -87.05 65.2 8.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.702 0.287 . . . . 0.0 110.814 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 39.1 p -116.44 -60.3 1.87 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.812 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.48 -67.51 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.301 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 22.1 t -154.43 -60.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.526 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -136.74 157.46 46.7 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.876 0.37 . . . . 0.0 111.317 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.413 ' HB2' ' CD1' ' A' ' 116' ' ' ILE . 6.2 p90 -149.31 156.68 42.47 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.632 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 117' ' ' TYR . . . -107.34 172.82 18.22 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.42 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.0 t -146.51 119.98 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.139 0.469 . . . . 0.0 111.976 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.406 ' OG1' ' CE2' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -134.55 167.52 20.64 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -173.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.2 m -73.01 153.22 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.425 ' CD1' HG22 ' A' ' 226' ' ' ILE . 2.8 mm? -59.03 159.15 14.72 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-N 120.396 1.453 . . . . 0.0 111.885 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.11 -156.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.461 2.774 . . . . 0.0 112.242 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -128.51 172.99 10.63 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.913 -178.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 129' ' ' TRP . 97.4 m-85 -164.15 110.47 1.06 Allowed 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 121.791 0.805 . . . . 0.0 109.402 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt 61.16 33.0 19.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.678 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.01 36.64 35.12 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.118 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -156.83 155.17 28.07 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -92.14 157.88 3.22 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.598 2.865 . . . . 0.0 111.986 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.4 p -79.73 153.41 29.27 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.5 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 3.2 mmmm -85.4 110.82 32.18 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.391 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.479 ' HB2' ' CA ' ' A' ' 327' ' ' GLY . 6.2 Cg_exo -79.23 147.83 20.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.928 2.419 . . . . 0.0 112.39 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 155' ' ' TYR . 3.2 p90 -105.09 133.93 49.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.474 ' CG2' ' HA ' ' A' ' 324' ' ' ALA . 30.9 t -140.68 108.41 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.25 163.88 43.47 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.152 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.557 ' HB ' ' CB ' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -104.3 113.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 122.893 -0.181 . . . . 0.0 111.342 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.644 ' O ' ' N ' ' A' ' 108' ' ' ILE . 1.7 tt -89.04 99.67 12.6 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 117.502 -1.679 . . . . 0.0 106.68 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 23.3 p -134.85 142.06 46.52 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -172.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . -73.88 131.59 41.64 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.827 0.451 . . . . 0.0 110.061 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 60' ' ' ILE . . . -122.01 135.51 10.41 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.005 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.541 ' HA ' HG22 ' A' ' 59' ' ' ILE . 4.4 tp -89.98 123.6 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -64.43 145.37 56.18 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.74 -22.86 58.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.995 0.426 . . . . 0.0 111.436 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -61.5 -61.15 2.73 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.704 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.7 m -127.13 102.11 24.67 Favored Pre-proline 0 C--N 1.333 -0.13 0 CA-C-O 120.619 0.247 . . . . 0.0 111.29 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.25 -42.72 1.83 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.336 2.024 . . . . 0.0 112.276 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.5 m120 45.73 80.12 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -75.06 -54.12 7.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.626 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -57.28 11.58 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.652 0.263 . . . . 0.0 111.68 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.14 -57.95 10.38 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.213 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.59 -25.0 64.24 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.592 ' O ' ' CB ' ' A' ' 281' ' ' GLU . 24.0 tttt -69.95 -58.09 4.26 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 121.325 0.583 . . . . 0.0 111.687 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 13.4 pt-20 -69.97 -35.44 74.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.328 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.571 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 12.1 t80 -73.95 -61.13 1.95 Allowed 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.195 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.59 -44.45 64.44 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.179 -1.008 . . . . 0.0 113.175 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.592 ' CB ' ' O ' ' A' ' 277' ' ' LYS . 4.0 tt0 -75.45 -34.77 60.98 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.527 -1.215 . . . . 0.0 113.428 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 1.7 t-20 -92.15 -16.74 25.88 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 0.5 OUTLIER -108.78 -66.53 1.04 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -39.54 -32.89 0.14 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.944 0.793 . . . . 0.0 111.203 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 20.4 mt -91.05 42.03 1.09 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.79 0.328 . . . . 0.0 111.383 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.446 HG23 ' HA ' ' A' ' 283' ' ' TYR . 6.3 t -145.06 158.01 43.94 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 0.8 OUTLIER -66.23 -11.02 47.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.617 0.644 . . . . 0.0 110.297 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -77.4 -47.09 20.69 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 118.175 0.443 . . . . 0.0 111.157 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.422 ' H ' HG22 ' A' ' 286' ' ' THR . . . -83.74 -57.34 2.45 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.43 HD12 ' CG ' ' A' ' 307' ' ' TYR . 0.2 OUTLIER -50.8 -49.06 59.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.589 -0.305 . . . . 0.0 110.586 178.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.1 OUTLIER -79.28 -26.39 42.35 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.104 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.611 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -68.04 -39.61 83.03 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.34 -62.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.545 ' HA ' ' HB2' ' A' ' 297' ' ' LYS . 9.3 m-80 -44.59 -47.79 10.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.78 1.232 . . . . 0.0 112.427 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -57.93 -54.97 40.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.44 ' HB3' ' CA ' ' A' ' 16' ' ' GLY . 32.8 m-20 -53.6 -44.75 69.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 294' ' ' ASN . 0.7 OUTLIER -49.7 165.83 0.28 Allowed Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.866 -178.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 299' ' ' LEU . 6.6 Cg_exo -73.09 -8.78 22.66 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.241 2.628 . . . . 0.0 113.547 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 298' ' ' PRO . 6.7 tp 90.38 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.924 0.392 . . . . 0.0 111.66 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.503 ' HA3' ' CZ2' ' A' ' 230' ' ' TRP . . . -152.98 -156.67 7.68 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.947 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.45 ' HA ' ' CG1' ' A' ' 317' ' ' ILE . . . -79.97 164.47 23.45 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.44 0.62 . . . . 0.0 110.7 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 16.5 m -153.81 -151.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.492 ' HA ' ' CG2' ' A' ' 93' ' ' THR . . . -116.1 -138.75 0.37 Allowed 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 308' ' ' GLU . 13.5 tp 48.24 101.41 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.712 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -41.9 -58.44 2.04 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.5 p -53.39 -49.35 67.42 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.734 0.778 . . . . 0.0 112.073 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.43 ' CG ' HD12 ' A' ' 290' ' ' LEU . 9.1 t80 -69.48 -19.42 63.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.171 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -63.1 -39.02 93.48 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -70.63 -57.8 4.34 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.539 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -56.49 12.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.458 0.647 . . . . 0.0 109.279 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.443 ' O ' HG22 ' A' ' 317' ' ' ILE . 0.8 OUTLIER -59.09 -40.32 84.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.277 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 317' ' ' ILE . . . -46.96 -34.39 5.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.524 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.52 -38.39 6.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.518 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 14.3 m-20 -67.55 146.19 98.53 Favored Pre-proline 0 N--CA 1.462 0.132 0 CA-C-O 120.616 0.246 . . . . 0.0 110.667 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 17.3 Cg_exo -67.15 -42.81 7.25 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.665 2.243 . . . . 0.0 113.054 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.425 ' HB3' ' CB ' ' A' ' 229' ' ' PRO . 7.8 mtt85 -58.79 -59.73 4.97 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.45 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 0.0 OUTLIER -51.45 -54.13 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.417 ' N ' HD11 ' A' ' 317' ' ' ILE . . . -46.05 -51.91 12.88 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.419 0.554 . . . . 0.0 111.584 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.62 -46.72 70.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.217 1.008 . . . . 0.0 109.032 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -40.51 82.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 113.472 -1.694 . . . . 0.0 109.786 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.1 ttp -66.46 -50.25 63.98 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.646 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -53.17 -57.6 9.92 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 327' ' ' GLY . 22.4 m120 -64.55 -30.24 71.27 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.364 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.474 ' HA ' ' CG2' ' A' ' 259' ' ' VAL . . . -60.08 -53.13 61.4 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.449 ' CG ' ' CZ ' ' A' ' 92' ' ' PHE . 2.4 tt0 -67.42 -30.06 69.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.39 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.28 -17.98 40.68 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.496 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.479 ' CA ' ' HB2' ' A' ' 257' ' ' PRO . . . -79.9 169.23 52.98 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.199 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -96.46 137.4 35.58 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.472 ' O ' ' C ' ' A' ' 330' ' ' MET . 4.6 mp -83.88 113.67 23.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 119.595 1.089 . . . . 0.0 110.301 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.472 ' C ' ' O ' ' A' ' 329' ' ' ILE . 0.0 OUTLIER -25.93 137.55 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 332' ' ' ASN . 36.3 Cg_endo -64.93 -38.44 29.28 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.629 2.22 . . . . 0.0 112.528 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 331' ' ' PRO . 1.5 m-20 71.49 57.14 0.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.661 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.98 160.34 68.18 Favored Pre-proline 0 C--N 1.326 -0.415 0 O-C-N 121.945 -0.472 . . . . 0.0 111.593 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.13 -42.29 8.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.644 2.229 . . . . 0.0 112.476 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -47.83 -25.2 1.2 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 32.0 tpp -45.72 -35.55 4.33 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 122.357 -0.214 . . . . 0.0 111.181 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.2 m -57.31 -42.51 81.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.761 0.315 . . . . 0.0 110.455 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -57.27 -31.51 65.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.04 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -78.1 -48.62 15.61 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.34 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -47.01 68.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.619 0.247 . . . . 0.0 111.474 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -74.33 -50.87 16.97 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.62 -43.68 79.84 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.437 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 0.3 OUTLIER -70.74 -41.42 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.42 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 0.8 OUTLIER -58.67 -59.56 5.22 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.458 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 53.0 p -54.36 -57.86 9.65 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.51 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.09 -60.56 2.89 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 44.1 t -59.08 -45.74 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 1.7 tt -68.5 -52.7 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.603 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 348' ' ' ILE . 29.6 m-20 -66.26 -53.39 37.39 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 354' ' ' ARG . . . -63.54 -26.42 68.69 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.356 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -54.53 -17.92 3.78 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.574 0.625 . . . . 0.0 111.503 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 13.2 p -106.73 24.08 13.26 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 171.1 -57.21 0.18 Allowed Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 119.697 -1.239 . . . . 0.0 113.254 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . 0.549 ' HG2' ' HA ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -103.17 34.05 3.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 113.792 -3.163 . . . . 0.0 116.971 -174.222 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.415 ' O ' ' OE1' ' A' ' 355' ' ' GLN . 0.8 OUTLIER -95.77 54.58 1.54 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.13 167.32 11.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.96 -49.34 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.533 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.549 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 62.2 m-20 -64.84 -49.3 71.11 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.72 -33.7 46.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 111.975 -177.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.46 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -61.44 -53.27 58.66 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.961 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.525 ' HG ' ' HA ' ' A' ' 184' ' ' ASP . 0.2 OUTLIER -78.91 -47.18 16.94 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.746 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.558 ' O ' ' CG2' ' A' ' 366' ' ' THR . 6.3 mmtp -50.35 -56.01 13.16 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.71 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.66 -53.3 14.05 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.435 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -58.76 -57.25 13.85 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.119 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.0 -54.86 39.77 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.558 ' CG2' ' O ' ' A' ' 362' ' ' LYS . 64.0 p -51.11 -52.71 41.07 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -66.4 -38.04 86.59 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 12.5 pt -79.42 -30.1 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.9 p -94.84 -18.91 20.76 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 366' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.252 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.643 0.259 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -137.72 96.84 3.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -135.0 119.68 18.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.951 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -155.1 156.37 35.71 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -125.36 75.32 0.4 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.227 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -158.39 163.9 36.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.496 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -169.21 124.28 0.86 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.912 ' H ' ' CB ' ' A' ' 58' ' ' ASP . 4.9 p -124.7 112.26 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.399 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -96.82 143.56 12.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.887 -175.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.459 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -104.29 127.21 51.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.635 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 39' ' ' HIS . 10.8 tt -158.55 164.89 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.016 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -132.65 39.99 3.3 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.08 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.71 -15.46 58.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.482 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER 61.18 65.18 1.01 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.054 0.427 . . . . 0.0 109.921 -179.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 2.3 mtmt 162.63 -170.78 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' CA ' ' HB3' ' A' ' 296' ' ' ASP . . . 75.96 24.34 69.55 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CE1' HG21 ' A' ' 37' ' ' VAL . 38.8 m-85 -76.2 -36.71 58.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.793 0.797 . . . . 0.0 111.03 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 2.7 m120 -64.75 -49.37 71.04 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.27 -49.73 19.57 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.673 -0.775 . . . . 0.0 114.212 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.569 ' O ' HG22 ' A' ' 23' ' ' VAL . 3.5 mm? -59.22 -51.16 71.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.75 0.775 . . . . 0.0 110.193 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -66.0 -37.7 86.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 111.973 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -67.16 -37.5 83.88 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.747 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 20' ' ' LEU . 4.5 m -68.1 -61.18 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 121.76 -0.588 . . . . 0.0 110.087 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -49.09 -34.16 16.0 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.374 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -50.43 69.42 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.447 1.117 . . . . 0.0 108.444 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -52.26 -42.31 63.56 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 112.874 -1.966 . . . . 0.0 108.677 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.606 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 71.7 m-85 -65.98 -32.22 73.57 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.756 0.789 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.754 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 7.2 tt0 -70.09 -51.8 28.88 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.022 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -52.07 -29.7 22.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 125.327 1.642 . . . . 0.0 111.254 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.746 ' O ' ' HB ' ' A' ' 31' ' ' THR . 3.5 m-20 -84.29 -38.07 20.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.187 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.746 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 4.5 t 159.79 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 156.38 38.7 0.02 OUTLIER Glycine 0 N--CA 1.466 0.658 0 C-N-CA 114.968 -3.491 . . . . 0.0 118.914 174.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.754 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 2.1 mp -140.16 130.25 29.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 121.513 2.657 . . . . 0.0 115.65 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -137.16 105.16 5.64 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 34.2 m -99.74 133.21 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.0 147.19 45.09 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.532 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG21 ' CE1' ' A' ' 17' ' ' TYR . 17.9 m -133.34 123.32 46.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 122.164 -0.335 . . . . 0.0 110.404 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -111.59 139.8 46.74 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.496 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.1 78.95 25.75 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-O 120.841 0.353 . . . . 0.0 110.739 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HG2' ' HB2' ' A' ' 43' ' ' LEU . 60.7 Cg_endo -92.69 163.11 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.261 2.64 . . . . 0.0 113.307 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -90.72 -35.45 14.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -82.76 0.49 43.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.482 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' A' ' 10' ' ' TRP . 54.1 tp -19.78 -49.31 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 1.081 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 mt-10 -67.29 -54.51 20.18 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.556 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.74 -43.62 62.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.905 0.383 . . . . 0.0 110.324 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.11 -56.13 23.27 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.955 0.883 . . . . 0.0 109.764 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.714 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 9.1 t80 -48.17 -60.95 3.59 Favored Pre-proline 0 C--O 1.219 -0.525 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.919 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 1.081 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 32.2 Cg_exo -60.22 -26.53 82.82 Favored 'Trans proline' 0 C--O 1.25 1.114 0 C-N-CA 121.278 1.318 . . . . 0.0 113.679 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -81.82 -38.76 25.03 Favored 'General case' 0 C--O 1.256 1.443 0 CA-C-O 122.161 0.981 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 54' ' ' GLY . 17.9 m -75.09 -39.26 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 CA-C-O 121.849 0.833 . . . . 0.0 109.832 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.402 ' HB1' ' CE1' ' A' ' 47' ' ' PHE . . . -50.16 -39.78 44.61 Favored 'General case' 0 C--N 1.372 1.553 0 C-N-CA 127.748 2.419 . . . . 0.0 111.593 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.46 -40.2 26.7 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.011 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -83.5 -7.23 59.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 77.82 -74.51 1.97 Allowed Glycine 0 C--N 1.352 1.45 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.184 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 t70 72.05 13.14 5.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.167 -1.016 . . . . 0.0 110.265 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.451 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . 57.72 59.38 10.93 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.094 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -101.39 171.36 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.38 2.72 . . . . 0.0 114.213 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.912 ' CB ' ' H ' ' A' ' 8' ' ' VAL . 25.1 m-20 -94.28 -133.12 0.17 Allowed 'General case' 0 N--CA 1.414 -2.257 0 C-N-CA 125.098 1.359 . . . . 0.0 109.137 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.613 HG13 ' HA ' ' A' ' 266' ' ' ILE . 9.6 tt -99.73 168.11 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 124.089 0.955 . . . . 0.0 112.477 -177.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.476 HD13 ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -134.31 126.35 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.452 ' CZ ' ' CB ' ' A' ' 264' ' ' ALA . 3.2 m-85 -108.15 125.4 51.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.603 ' CH2' ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -166.81 166.77 15.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.586 0.354 . . . . 0.0 110.062 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 62' ' ' TRP . . . -45.35 158.32 0.07 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.518 0.599 . . . . 0.0 112.519 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -77.5 -29.27 52.44 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -47.82 -53.72 14.64 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.825 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.39 -26.08 42.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.043 0.449 . . . . 0.0 110.098 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.603 ' CE1' ' CH2' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -57.44 -34.33 68.85 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 171.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -55.2 -69.65 1.2 Allowed Glycine 0 C--N 1.357 1.74 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 177.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.87 -54.16 23.39 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-N 112.996 -1.602 . . . . 0.0 111.363 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.465 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.4 m-30 -50.56 -40.53 52.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.501 ' CB ' HG23 ' A' ' 104' ' ' ILE . . . -48.63 -48.36 39.58 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.61 -31.08 46.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.138 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.26 -26.77 63.98 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.561 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.25 23.28 44.91 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.574 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.402 ' O ' HD23 ' A' ' 76' ' ' LEU . 4.0 mt -106.16 54.58 0.69 Allowed 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.911 0.386 . . . . 0.0 110.392 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.499 HD11 ' O ' ' A' ' 266' ' ' ILE . 0.2 OUTLIER -179.13 145.13 0.25 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.877 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB3' ' CG2' ' A' ' 266' ' ' ILE . . . -72.2 74.65 0.97 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.208 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -53.0 125.1 16.09 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.8 0.333 . . . . 0.0 110.495 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mm -70.88 173.38 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.856 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.95 175.54 4.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.2 101.49 1.43 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.052 1.835 . . . . 0.0 113.031 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -145.46 107.76 4.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.251 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.18 0.22 52.47 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.19 -32.99 25.44 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.579 0.228 . . . . 0.0 111.579 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.47 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 22.7 m-85 -79.31 -59.06 2.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.882 0.372 . . . . 0.0 110.075 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.45 -27.92 40.71 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.544 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -76.32 -47.01 25.08 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.664 0.269 . . . . 0.0 110.833 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -67.86 -20.41 65.13 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.521 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.447 HD23 ' HB3' ' A' ' 304' ' ' LEU . 5.1 mp -112.82 -163.46 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 121.454 -0.098 . . . . 0.0 110.879 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.439 ' CG ' ' HD2' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -84.68 146.78 47.41 Favored Pre-proline 0 C--N 1.34 0.175 0 O-C-N 121.992 -0.442 . . . . 0.0 111.641 -178.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 95' ' ' ASP . 61.0 Cg_endo -73.32 -35.03 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.234 1.956 . . . . 0.0 111.703 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 325' ' ' GLN . 63.2 m-85 -57.81 -62.43 1.81 Allowed 'General case' 0 C--O 1.246 0.872 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 94' ' ' TRP . 1.8 t -62.58 -24.68 67.67 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.47 ' CZ3' ' HB3' ' A' ' 85' ' ' PHE . 36.5 m95 -93.43 -24.45 18.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.145 0.498 . . . . 0.0 111.877 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 91' ' ' PRO . 8.3 m-20 -71.08 -23.49 62.13 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.711 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.452 ' O ' ' CD2' ' A' ' 64' ' ' HIS . . . -71.91 -43.21 65.7 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 64' ' ' HIS . 27.2 m -102.54 43.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.45 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -128.81 139.47 52.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.507 ' O ' ' N ' ' A' ' 101' ' ' GLY . 3.2 t80 -118.48 90.74 3.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 119.262 0.937 . . . . 0.0 109.874 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.6 t30 48.29 -86.72 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . -127.63 39.2 1.97 Allowed Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.66 -177.34 5.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.48 0.312 . . . . 0.0 111.225 -178.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 168.71 128.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.399 0.545 . . . . 0.0 110.032 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.663 ' CG1' ' O ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -114.24 38.01 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.315 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . 168.81 169.67 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.07 132.88 23.78 Favored Pre-proline 0 CA--C 1.528 0.122 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.277 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.585 ' HA ' ' HB3' ' A' ' 263' ' ' SER . 90.8 Cg_endo -79.61 166.91 21.4 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.463 2.109 . . . . 0.0 113.211 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.654 ' N ' ' O ' ' A' ' 262' ' ' LEU . 0.6 OUTLIER -162.31 38.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.364 178.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . . . -179.8 136.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.166 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' A' ' 320' ' ' THR . 21.7 t -123.58 105.89 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -116.68 131.16 57.02 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 -178.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.45 ' N ' ' HG3' ' A' ' 229' ' ' PRO . . . -158.19 143.26 16.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.468 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.482 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 6.5 mp -77.89 143.43 37.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.936 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.8 m -133.3 169.46 16.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.76 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.16 128.41 36.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.406 ' CD1' HG21 ' A' ' 244' ' ' VAL . 8.0 tp -116.95 140.43 39.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -153.63 161.44 42.16 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.396 0.279 . . . . 0.0 111.554 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.409 ' CB ' ' HB3' ' A' ' 121' ' ' LEU . 18.7 m120 -97.52 139.03 34.04 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -109.9 -4.84 15.73 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-N 113.096 -1.865 . . . . 0.0 111.23 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -43.56 6.78 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 124.781 2.229 . . . . 0.0 105.455 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -76.35 -135.45 0.02 OUTLIER 'General case' 0 N--CA 1.396 -3.169 1 CA-C-N 107.678 -4.328 . . . . 0.0 113.216 -170.548 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.422 ' N ' HD23 ' A' ' 121' ' ' LEU . 1.6 mt -82.66 148.26 57.61 Favored Pre-proline 0 C--N 1.287 -2.132 0 N-CA-C 119.98 3.326 . . . . 0.0 119.98 -167.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -27.33 166.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 1 C-N-CA 130.354 7.369 . . . . 0.0 120.34 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -62.03 111.81 5.19 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.365 -172.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.96 167.78 25.45 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 124.055 3.17 . . . . 0.0 112.904 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -49.66 111.13 0.45 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 123.324 2.683 . . . . 0.0 115.573 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -76.45 -25.64 54.58 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.084 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.91 147.31 43.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.489 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.467 ' NE1' ' CE2' ' A' ' 250' ' ' PHE . 65.3 m95 -67.92 -37.89 82.23 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 175.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.451 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.9 mp0 -58.82 -23.84 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.563 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 0.5 OUTLIER -87.03 -16.14 36.55 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.578 ' CG1' ' HD3' ' A' ' 133' ' ' PRO . 4.0 pt -52.37 -37.98 50.33 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 118.683 0.674 . . . . 0.0 111.417 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.871 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 52.3 Cg_exo -52.93 -33.26 61.1 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 N-CA-C 109.549 -0.981 . . . . 0.0 109.549 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.99 -58.59 3.19 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.21 -42.28 80.06 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.653 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.7 OUTLIER -69.21 -32.41 71.65 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.871 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -47.92 -50.14 27.84 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.061 176.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.35 -43.5 98.68 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.924 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.517 ' HB3' ' C ' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -60.36 -49.4 77.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -47.9 -44.11 29.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.04 -27.35 0.91 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.507 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -60.03 1.69 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.288 0.566 . . . . 0.0 109.891 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.84 42.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 118.934 -0.925 . . . . 0.0 111.073 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.517 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 9.0 ptpt -154.27 -171.88 4.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 119.514 1.657 . . . . 0.0 111.419 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.424 ' N ' HD21 ' A' ' 139' ' ' LEU . 2.5 m -141.56 161.8 37.04 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.43 ' N ' HD11 ' A' ' 139' ' ' LEU . . . -75.47 -28.91 59.43 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.508 ' HG ' ' HB3' ' A' ' 224' ' ' MET . 5.7 mp -123.74 127.16 47.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.419 ' HG2' ' CB ' ' A' ' 216' ' ' ALA . 8.8 tpt -134.1 127.9 33.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 120.039 1.29 . . . . 0.0 109.845 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.968 ' O ' ' O ' ' A' ' 150' ' ' ASN . 37.3 p90 -170.4 177.22 4.15 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.968 ' O ' ' O ' ' A' ' 149' ' ' PHE . 2.9 t-20 -28.42 -156.79 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' A' ' 208' ' ' THR . 1.0 OUTLIER -178.15 40.58 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 120.992 -1.068 . . . . 0.0 111.055 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' A' ' 151' ' ' LEU . 1.9 pp0? 172.86 32.92 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 168.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 157' ' ' THR . 0.2 OUTLIER -103.87 114.45 64.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 119.991 1.269 . . . . 0.0 107.585 177.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.808 ' HA ' ' OG1' ' A' ' 157' ' ' THR . 5.8 Cg_exo -79.77 36.98 0.64 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 119.265 0.773 . . . . 0.0 113.706 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 1.227 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 3.7 m-85 -97.79 -52.01 3.89 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 172.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.663 ' HA ' ' HG2' ' A' ' 159' ' ' PRO . 42.5 t80 -74.66 -42.63 58.16 Favored 'General case' 0 C--O 1.251 1.141 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.808 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 1.5 p -58.05 -57.03 14.63 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.487 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.546 ' HA ' HG12 ' A' ' 161' ' ' ILE . 7.5 m0 -49.54 -52.51 49.55 Favored Pre-proline 0 C--N 1.351 0.648 0 CA-C-O 120.78 0.324 . . . . 0.0 110.75 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 1.227 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 51.5 Cg_exo -44.44 -50.05 8.42 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.625 2.217 . . . . 0.0 113.171 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.451 ' HG ' ' CZ ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -60.4 -56.84 16.55 Favored 'General case' 0 CA--C 1.51 -0.567 0 O-C-N 122.026 -0.421 . . . . 0.0 109.908 -179.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' A' ' 158' ' ' TRP . 14.1 pt -53.94 -22.6 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.831 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.23 -24.5 51.23 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.895 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 253' ' ' GLN . . . -41.19 -58.83 1.68 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.84 -58.06 7.96 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.345 -0.847 . . . . 0.0 112.6 -175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.69 21.38 0.03 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 117.648 -2.215 . . . . 0.0 116.823 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.12 160.13 40.15 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 119.086 1.443 . . . . 0.0 111.573 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -139.49 122.56 16.81 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.429 0.615 . . . . 0.0 109.743 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.424 ' O ' ' CG1' ' A' ' 183' ' ' VAL . . . -38.49 -78.54 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.291 0.567 . . . . 0.0 111.971 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.707 ' HB3' ' CB ' ' A' ' 176' ' ' TYR . 9.8 m-85 -113.64 176.07 5.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 1.135 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -101.54 102.1 12.78 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.05 114.51 18.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.53 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 23.9 tt0 -137.22 109.36 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.517 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 1.4 m-20 84.1 -32.38 0.07 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.862 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 160.28 13.9 0.03 OUTLIER Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.036 -0.869 . . . . 0.0 114.072 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -174.0 143.12 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.577 1.689 . . . . 0.0 110.943 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 1.135 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 37.0 p90 -64.98 -25.45 67.87 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.193 0.997 . . . . 0.0 110.805 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.465 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 55.8 m-20 72.37 -106.91 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.743 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 177' ' ' ASP . 38.0 mm -159.16 -48.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -70.83 -4.01 21.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.72 95.56 3.5 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.276 -0.569 . . . . 0.0 112.12 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 18.9 t -117.98 131.04 71.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.434 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . -121.4 39.73 2.3 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 119.47 -1.348 . . . . 0.0 114.092 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 168' ' ' ALA . 6.4 m -79.1 -40.78 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.414 ' HB2' HD23 ' A' ' 361' ' ' LEU . 58.8 t0 -69.9 58.61 0.15 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.899 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 182' ' ' GLY . 5.9 p30 -110.33 175.94 5.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.982 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -80.45 -19.57 45.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.835 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.64 -48.84 40.58 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.3 98.6 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -59.4 5.12 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.215 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 193' ' ' THR . . . -50.43 -41.66 52.87 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.253 1.025 . . . . 0.0 112.051 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -70.45 -60.51 4.67 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.659 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 9.2 tt -56.05 -29.26 60.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 190' ' ' ALA . 14.8 p -66.87 -41.09 87.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 194' ' ' PHE . 0.0 OUTLIER -59.48 -37.74 79.02 Favored 'General case' 0 C--N 1.349 0.563 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.72 -47.56 83.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.782 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 43.6 t -58.22 -29.88 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.28 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.18 -45.4 85.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.732 0.777 . . . . 0.0 110.969 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.2 mp -57.34 -57.02 14.47 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.77 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.406 ' HA ' ' HB3' ' A' ' 203' ' ' HIS . 3.8 mt -65.16 -32.33 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.969 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -38.61 71.73 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 118.56 -0.734 . . . . 0.0 111.042 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -113.41 -34.97 5.43 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 121.086 3.735 . . . . 0.0 121.086 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.67 -66.1 1.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 199' ' ' ILE . 0.2 OUTLIER -36.45 -34.54 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 203' ' ' HIS . 2.2 ttp -36.0 97.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.707 0.289 . . . . 0.0 111.63 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.95 -173.19 3.83 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.064 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -85.61 58.66 5.17 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.5 ' HA ' ' CD2' ' A' ' 151' ' ' LEU . 2.3 p30 37.85 74.13 0.09 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 30.8 p -55.18 121.4 8.74 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.59 -173.65 4.43 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.0 p90 -69.49 -45.39 69.05 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 1.7 m -70.18 -35.93 74.3 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.89 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.17 -48.44 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.745 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.0 -30.93 71.97 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -47.66 85.03 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.54 77.65 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.276 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.419 ' CB ' ' HG2' ' A' ' 148' ' ' MET . . . -54.27 -57.68 10.29 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.947 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.419 ' CD2' HD13 ' A' ' 235' ' ' ILE . 2.6 t80 -58.57 -29.6 66.53 Favored 'General case' 0 C--O 1.23 0.071 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -53.79 -40.41 66.27 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -74.66 -23.92 58.73 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 65.66 54.79 23.65 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.419 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -116.03 37.2 3.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.452 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.416 ' CG2' ' HB2' ' A' ' 148' ' ' MET . 82.8 p -144.56 143.53 30.86 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.773 0.796 . . . . 0.0 110.213 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -102.08 38.3 1.69 Allowed 'General case' 0 C--N 1.352 0.674 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.508 ' HB3' ' HG ' ' A' ' 147' ' ' LEU . 36.1 ttm 177.24 147.06 0.12 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.43 170.26 16.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.701 0.762 . . . . 0.0 111.558 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.476 HD12 HG22 ' A' ' 226' ' ' ILE . 24.8 mm -120.68 130.34 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 172.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -147.31 166.69 26.33 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 123.759 0.823 . . . . 0.0 110.474 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -108.15 -162.88 21.02 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.47 -0.395 . . . . 0.0 112.741 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.494 ' HG3' ' HG2' ' A' ' 111' ' ' GLU . 56.2 Cg_endo -87.54 -20.72 2.01 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.128 2.552 . . . . 0.0 114.081 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.451 ' N ' ' CD1' ' A' ' 230' ' ' TRP . 0.2 OUTLIER -178.65 -42.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.65 62.37 6.46 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.803 0.335 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -107.7 -63.06 1.35 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.781 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 169.2 -176.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.658 0.266 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.83 58.85 2.31 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.795 0.331 . . . . 0.0 110.72 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.419 HD13 ' CD2' ' A' ' 217' ' ' PHE . 14.6 tt -86.69 145.47 7.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.174 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -100.67 123.5 44.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.5 p -61.3 137.72 58.24 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.871 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -43.94 84.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.45 159.74 41.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.771 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.2 m -55.9 -40.02 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.648 0.261 . . . . 0.0 111.372 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 137.26 37.2 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.651 0.262 . . . . 0.0 110.741 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -149.23 137.31 20.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 111.323 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -95.0 133.4 11.52 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.007 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 116' ' ' ILE . 1.7 t -115.16 133.87 60.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.867 0.334 . . . . 0.0 111.268 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.76 167.56 17.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -170.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 45.9 t -73.29 154.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 113.893 -1.503 . . . . 0.0 107.871 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.8 mt -57.61 159.29 9.69 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.627 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -78.26 -157.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.926 2.417 . . . . 0.0 112.906 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 253' ' ' GLN . 11.0 p -125.29 169.47 12.26 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.467 ' CE2' ' NE1' ' A' ' 129' ' ' TRP . 0.2 OUTLIER -162.59 110.57 1.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.075 178.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.34 32.08 17.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.421 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.69 38.41 24.1 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.033 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.514 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 3.7 mt-30 -156.54 153.94 25.88 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 74.8 Cg_endo -86.37 -171.19 0.78 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.444 2.763 . . . . 0.0 113.263 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -109.28 141.02 42.19 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.988 0.423 . . . . 0.0 111.812 -179.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.517 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 5.5 ttmm -88.17 121.41 70.49 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.072 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.448 ' O ' ' HA2' ' A' ' 327' ' ' GLY . 55.1 Cg_endo -91.61 152.6 3.51 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.538 2.825 . . . . 0.0 114.417 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -78.12 157.28 29.52 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.56 121.82 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -125.11 119.52 3.63 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 118.673 -1.727 . . . . 0.0 117.069 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.511 HG22 ' CG ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -114.38 108.53 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.654 ' O ' ' N ' ' A' ' 108' ' ' ILE . 1.6 tp -83.41 109.12 17.05 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.585 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -113.05 -178.12 3.3 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.452 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . . . -111.01 128.81 55.97 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 67' ' ' PHE . . . -123.27 122.62 5.01 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.932 -1.128 . . . . 0.0 115.022 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.613 ' HA ' HG13 ' A' ' 59' ' ' ILE . 4.6 tp -90.86 122.47 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.438 ' HB2' HD13 ' A' ' 60' ' ' ILE . 62.7 t30 -61.82 141.89 57.66 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.23 -23.42 47.86 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.948 -0.47 . . . . 0.0 111.105 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -98.5 49.07 0.98 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.36 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 38.8 t -171.9 89.5 0.43 Allowed Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 272' ' ' ASN . 72.7 Cg_endo -76.42 164.19 31.12 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.625 2.217 . . . . 0.0 111.906 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 271' ' ' PRO . 0.2 OUTLIER 165.69 57.24 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.709 0.29 . . . . 0.0 110.938 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -56.3 -54.1 49.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.452 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -56.68 7.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.16 -48.58 79.43 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.78 -56.84 4.25 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.1 OUTLIER -55.67 -41.02 73.09 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.513 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -53.17 8.62 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 27' ' ' PHE . 2.4 t80 -55.09 -59.44 4.75 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.59 -43.19 35.78 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.815 0.817 . . . . 0.0 111.245 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 51.9 mt-10 -73.8 -35.36 64.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.37 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.414 ' O ' ' CG2' ' A' ' 286' ' ' THR . 3.6 m-20 -89.99 -16.39 29.94 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.479 ' O ' ' CG2' ' A' ' 286' ' ' THR . 28.0 t80 -103.72 -74.36 0.64 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.08 -27.57 0.98 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.07 39.41 1.48 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 283' ' ' TYR . 0.0 OUTLIER -140.72 152.83 45.6 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 175.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.792 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -62.93 -42.37 99.78 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -75.36 -19.39 59.61 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.548 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.456 ' HA3' HG22 ' A' ' 286' ' ' THR . . . -82.54 -55.13 3.09 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.433 HD12 ' CE2' ' A' ' 307' ' ' TYR . 0.2 OUTLIER -68.23 -28.46 67.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.792 ' HB2' ' O ' ' A' ' 287' ' ' ASP . 32.0 mt-10 -71.91 -32.39 67.34 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.453 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.39 80.37 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 296' ' ' ASP . 61.0 t -67.64 -61.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 297' ' ' LYS . 36.9 t-20 -46.41 -46.8 18.85 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.713 1.205 . . . . 0.0 112.545 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -48.87 79.49 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.788 ' O ' ' HD3' ' A' ' 298' ' ' PRO . 76.7 m-20 -58.04 -47.02 84.36 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 294' ' ' ASN . 0.9 OUTLIER -96.37 91.05 0.8 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.623 -178.101 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.788 ' HD3' ' O ' ' A' ' 296' ' ' ASP . 75.9 Cg_endo -106.83 93.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 124.318 3.346 . . . . 0.0 112.752 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 230' ' ' TRP . 1.5 mp -161.1 -80.72 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.103 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.431 ' C ' HD11 ' A' ' 317' ' ' ILE . . . -108.39 -160.28 20.16 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.573 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.531 ' HB1' HD13 ' A' ' 317' ' ' ILE . . . -79.17 74.32 5.73 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.074 0.464 . . . . 0.0 111.613 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 53.7 t -97.22 76.13 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.873 ' O ' ' O ' ' A' ' 304' ' ' LEU . . . -177.28 107.51 0.06 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.718 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 303' ' ' ALA . 5.9 mp -22.84 179.68 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.08 -55.47 30.7 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 83.2 p -57.09 -47.95 79.79 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-O 121.479 0.657 . . . . 0.0 111.761 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.433 ' CE2' HD12 ' A' ' 290' ' ' LEU . 88.7 m-85 -67.42 -54.57 19.19 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.158 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 312' ' ' ALA . 4.4 mt-10 -61.11 -36.83 80.75 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.717 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -48.12 -49.66 31.3 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.889 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -71.36 -41.27 69.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.087 0.946 . . . . 0.0 109.529 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.97 -16.63 5.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.036 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 308' ' ' GLU . . . -46.22 -30.46 2.0 Allowed 'General case' 0 C--N 1.342 0.271 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.455 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -48.38 -34.79 11.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.53 158.26 11.71 Favored Pre-proline 0 N--CA 1.462 0.145 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.489 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -85.85 -46.67 0.04 OUTLIER 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.485 2.124 . . . . 0.0 114.521 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -58.9 6.24 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.531 HD13 ' HB1' ' A' ' 301' ' ' ALA . 1.3 mm -49.67 -56.24 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.81 -51.87 12.16 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.356 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.01 92.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.725 0.774 . . . . 0.0 109.812 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 110' ' ' VAL . 29.8 m -58.81 -42.83 90.09 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.49 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.5 ttp -63.64 -53.21 55.11 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -39.0 58.46 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.156 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -74.94 -44.23 49.72 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.017 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -48.76 -45.39 39.74 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 110.333 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.437 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 10.6 mt-30 -63.68 -39.06 93.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.952 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -69.7 -20.04 63.55 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.389 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 257' ' ' PRO . . . -79.85 155.7 39.29 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.131 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.23 138.23 34.13 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 23.5 mm -61.85 106.16 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 119.525 1.057 . . . . 0.0 110.904 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.14 107.03 0.73 Allowed Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 120.548 0.214 . . . . 0.0 111.14 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.15 -30.6 32.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.365 2.044 . . . . 0.0 112.141 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 68.2 91.56 0.09 Allowed 'General case' 0 C--N 1.339 0.12 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.295 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 335' ' ' GLN . 1.0 OUTLIER -133.91 144.91 53.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.195 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.36 -27.86 60.15 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.55 2.166 . . . . 0.0 111.979 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' A' ' 333' ' ' ILE . 2.1 mp0 -61.1 -25.21 66.8 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.136 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.2 mmt -46.13 -41.0 11.85 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.687 0.279 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.99 -39.27 65.92 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . 0.414 ' CB ' HG21 ' A' ' 368' ' ' ILE . . . -55.07 -29.42 57.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.319 0.58 . . . . 0.0 110.8 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -78.77 -55.73 4.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.048 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 35.4 t-105 -42.88 -44.69 4.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.842 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -76.57 -38.52 54.8 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.52 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.08 -44.55 76.04 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.441 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 17.8 m -73.13 -42.23 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.347 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -55.38 -57.14 13.1 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.006 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 1.1 m -58.1 -55.63 32.41 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.06 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -73.34 -60.96 2.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 48.7 t -51.73 -47.05 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.1 mt -72.27 -47.91 51.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.911 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 345' ' ' THR . 76.6 m-20 -67.57 -43.28 81.0 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 355' ' ' GLN . . . -78.38 -26.57 46.61 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -58.6 -10.12 2.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 23.2 t -110.63 31.24 6.12 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 91.21 33.15 8.3 Favored Glycine 0 N--CA 1.417 -2.595 0 C-N-CA 116.844 -2.598 . . . . 0.0 114.779 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -127.8 35.12 4.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.568 ' HA ' ' CB ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -70.01 -174.48 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 1 N-CA-C 122.295 4.183 . . . . 0.0 122.295 -159.352 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.542 ' HB ' ' CB ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER 173.9 57.7 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.347 179.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 79.1 t -46.28 -41.85 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 3.0 t0 -63.13 -38.5 91.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 118.902 0.774 . . . . 0.0 110.395 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.542 ' CB ' ' HB ' ' A' ' 356' ' ' THR . 0.4 OUTLIER -80.14 -29.59 38.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.634 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -67.05 -54.02 25.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.919 0.866 . . . . 0.0 112.507 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' A' ' 184' ' ' ASP . 0.8 OUTLIER -82.64 -36.4 26.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.758 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 23.1 tttp -59.75 -51.97 67.47 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.823 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -44.77 65.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.239 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 368' ' ' ILE . . . -72.54 -57.81 3.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.422 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.475 ' HA ' ' CG1' ' A' ' 368' ' ' ILE . 28.0 tt0 -55.94 -42.25 75.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.9 m -65.25 -48.09 74.46 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.654 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -73.78 -44.37 56.22 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.019 -0.425 . . . . 0.0 111.154 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.498 HG22 ' O ' ' A' ' 364' ' ' ALA . 2.1 pp -62.13 -32.95 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.507 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.46 61.49 1.64 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.908 0.385 . . . . 0.0 111.154 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 56.7 tptt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.849 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.659 0.266 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.5 p -103.29 156.84 17.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.53 110.96 19.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -154.24 139.98 18.04 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.062 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 32' ' ' GLY . . . -129.61 47.39 1.02 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.545 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -140.78 162.09 36.26 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.421 ' CD2' ' CZ ' ' A' ' 279' ' ' PHE . 0.0 OUTLIER -132.4 122.56 25.18 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.839 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 1.015 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -116.47 115.52 49.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.737 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 7.8 mt -120.74 131.11 73.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.935 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.515 ' CH2' ' CD1' ' A' ' 47' ' ' PHE . 3.3 m0 -107.38 123.44 48.37 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.401 ' CG1' HG23 ' A' ' 9' ' ' ILE . 3.4 mt -155.67 166.12 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.846 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.671 ' O ' ' N ' ' A' ' 14' ' ' ASP . 3.5 m120 -78.84 48.84 0.86 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 120.014 1.279 . . . . 0.0 111.255 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.524 ' HA3' ' HB3' ' A' ' 39' ' ' HIS . . . -8.28 59.78 0.0 OUTLIER Glycine 0 C--N 1.348 1.202 0 C-N-CA 124.843 1.211 . . . . 0.0 115.923 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.671 ' N ' ' O ' ' A' ' 12' ' ' ASN . 72.2 m-20 -100.0 3.77 44.42 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.017 0.437 . . . . 0.0 110.177 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 162.99 -164.62 0.0 OUTLIER 'General case' 0 C--N 1.347 0.491 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.863 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 296' ' ' ASP . . . 70.66 34.3 66.99 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 117.038 1.575 . . . . 0.0 117.038 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.18 -59.72 2.54 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 11.5 p-10 -46.35 -42.39 14.8 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.055 0.455 . . . . 0.0 111.945 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' HG21 ' A' ' 23' ' ' VAL . . . -70.34 -45.41 55.01 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.578 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.553 ' O ' HG21 ' A' ' 23' ' ' VAL . 18.7 mt -60.77 -49.69 76.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.446 0.623 . . . . 0.0 111.081 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.05 -39.49 63.47 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 3.1 mm-40 -64.52 -36.08 83.05 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.762 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 20' ' ' LEU . 23.2 m -67.87 -57.19 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.663 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 35' ' ' VAL . . . -49.58 -45.84 37.9 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.111 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 -50.41 41.21 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.263 1.03 . . . . 0.0 109.7 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -41.9 60.13 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.155 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.617 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.65 -25.94 67.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.088 0.947 . . . . 0.0 111.084 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.726 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 7.9 tt0 -73.2 -52.05 15.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.654 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -52.73 -28.54 22.58 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 124.514 1.134 . . . . 0.0 110.576 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.638 ' O ' ' CG2' ' A' ' 31' ' ' THR . 0.5 OUTLIER -84.09 -37.68 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 117.626 -1.178 . . . . 0.0 108.844 178.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.638 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.85 37.79 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 171.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' CA ' ' A' ' 5' ' ' GLY . . . 156.26 38.57 0.02 OUTLIER Glycine 0 N--CA 1.463 0.494 0 C-N-CA 114.989 -3.482 . . . . 0.0 119.299 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.726 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.8 mp -139.89 139.0 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 122.243 3.021 . . . . 0.0 117.005 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -142.36 104.51 4.43 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.473 ' CG2' ' HA3' ' A' ' 24' ' ' GLY . 38.1 t -82.8 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.9 p -117.5 137.43 52.55 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.008 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 6.9 m -130.69 121.55 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 O-C-N 122.231 -0.293 . . . . 0.0 110.507 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -111.83 133.83 53.79 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.524 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . 46.1 p-80 -106.08 71.29 0.25 Allowed Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 120.682 0.277 . . . . 0.0 111.462 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.517 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 86.6 Cg_endo -78.07 -171.68 1.27 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.274 2.649 . . . . 0.0 113.627 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -125.22 -60.24 1.35 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 0.57 34.12 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.045 0.45 . . . . 0.0 110.92 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.517 ' HB3' ' HG2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -32.91 -45.68 0.13 Allowed 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 1.014 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 3.6 tm-20 -47.11 -54.93 9.35 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.042 -0.411 . . . . 0.0 112.104 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.12 -48.8 21.98 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.785 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 50' ' ' VAL . 24.5 mtpt -63.51 -56.81 13.07 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.167 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.767 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.9 t80 -45.42 -58.44 5.89 Favored Pre-proline 0 C--O 1.225 -0.191 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 1.014 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 38.9 Cg_exo -65.78 -36.38 32.25 Favored 'Trans proline' 0 C--O 1.249 1.031 0 C-N-CA 121.088 1.192 . . . . 0.0 114.628 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -52.18 46.93 Favored 'General case' 0 C--O 1.259 1.588 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 175.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.533 ' O ' HG21 ' A' ' 53' ' ' THR . 12.0 m -61.56 -21.22 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 122.231 1.015 . . . . 0.0 111.637 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 48' ' ' PRO . . . -60.85 -29.31 69.45 Favored 'General case' 0 C--N 1.393 2.459 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.643 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.46 -26.8 32.33 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.411 1.484 . . . . 0.0 112.946 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 50' ' ' VAL . 13.1 t -92.47 95.79 9.85 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.083 -0.647 . . . . 0.0 112.073 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 102.27 -71.24 0.33 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.487 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 21.2 m-20 94.77 107.03 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.115 1.457 . . . . 0.0 110.461 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 57' ' ' PRO . . . -163.41 -59.05 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.388 -0.91 . . . . 0.0 114.039 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.525 ' O ' ' O ' ' A' ' 56' ' ' GLY . 59.0 Cg_exo -22.9 157.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.797 3.665 . . . . 0.0 115.937 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 1.015 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 5.1 t70 -79.95 -133.86 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.822 0 C-N-CA 125.241 1.416 . . . . 0.0 112.286 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 265' ' ' GLY . 5.5 mm -105.77 159.31 5.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.442 HG23 HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -128.52 136.01 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.45 -178.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -117.97 113.85 22.31 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 34.6 t-105 -166.48 165.14 17.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.988 0.515 . . . . 0.0 109.846 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -37.74 154.48 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.822 0.737 . . . . 0.0 112.11 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.605 ' CB ' ' HB ' ' A' ' 261' ' ' VAL . 9.1 t-80 -77.24 -28.3 53.62 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -50.46 -51.49 46.45 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.984 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -77.85 -27.3 49.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.303 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 4.6 m-85 -64.73 -28.62 69.71 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 174.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -60.48 -63.89 4.6 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 332' ' ' ASN . . . -54.9 -52.29 47.49 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 113.471 -1.365 . . . . 0.0 111.656 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 66' ' ' ARG . 4.8 m-30 -54.52 -45.87 73.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.738 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . . . -50.84 -40.7 56.59 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.852 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.22 -60.33 2.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 m -113.78 -26.76 8.05 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 75' ' ' LEU . . . -56.78 -86.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.078 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER 167.98 66.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.738 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . 1.7 mt -110.54 136.37 49.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 110.926 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' N ' HD13 ' A' ' 104' ' ' ILE . . . -102.23 106.33 17.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.456 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.423 ' HA ' HG12 ' A' ' 104' ' ' ILE . 77.7 mt-10 -47.75 154.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.927 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 105' ' ' ALA . 20.1 mt -109.41 136.81 44.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.053 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 m -112.97 82.74 5.46 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.834 0.349 . . . . 0.0 110.764 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.05 -173.86 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.738 2.292 . . . . 0.0 112.229 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -88.49 117.91 27.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.593 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -33.24 4.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.462 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -57.55 -27.12 62.36 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.429 ' CE2' HD23 ' A' ' 285' ' ' LEU . 11.6 t80 -79.23 -59.22 2.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.832 0.349 . . . . 0.0 110.314 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.47 ' HG2' ' CD1' ' A' ' 94' ' ' TRP . 1.3 tt0 -60.94 -33.25 72.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.966 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -76.68 -31.9 57.56 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.972 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 7.1 mtpm? -80.34 -1.6 41.79 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.71 -171.25 2.24 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.323 0.51 . . . . 0.0 110.994 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.23 117.24 52.69 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.667 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.55 -41.51 67.71 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.581 2.187 . . . . 0.0 112.671 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -50.03 -45.3 51.91 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.726 0.298 . . . . 0.0 111.323 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.41 ' O ' ' CG ' ' A' ' 107' ' ' PRO . 2.4 m -61.17 -28.23 68.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.47 ' CD1' ' HG2' ' A' ' 86' ' ' GLN . 17.8 m95 -92.95 -24.72 18.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.317 0.58 . . . . 0.0 111.985 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -73.91 -22.65 59.61 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.842 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.443 ' CB ' ' CG1' ' A' ' 261' ' ' VAL . . . -53.19 -48.16 68.3 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.498 ' CG2' ' CG1' ' A' ' 261' ' ' VAL . 3.8 t -103.09 39.6 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 134.58 40.31 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.4 OUTLIER -113.84 91.06 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.806 0.73 . . . . 0.0 110.751 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 31.5 t30 69.62 -70.2 0.15 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.085 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.96 -41.65 0.98 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.281 -0.962 . . . . 0.0 114.207 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -125.96 -178.28 4.24 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.369 0.584 . . . . 0.0 109.869 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -116.82 139.26 50.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.683 ' O ' ' HB1' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -96.13 38.0 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.977 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.683 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . 160.72 -179.67 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 264' ' ' ALA . 20.6 p90 -118.94 127.5 26.49 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.68 ' HB3' HG13 ' A' ' 261' ' ' VAL . 72.6 Cg_endo -79.58 165.66 22.57 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 C-N-CA 122.265 1.977 . . . . 0.0 112.731 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 262' ' ' LEU . 1.7 pt -160.89 38.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.807 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . . . 178.56 110.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.833 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 302' ' ' VAL . 17.0 t -98.43 111.26 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -103.15 163.12 12.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.624 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 320' ' ' THR . . . -164.88 150.29 9.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.537 0.684 . . . . 0.0 111.981 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 156' ' ' PHE . 4.6 pp -79.19 127.66 32.32 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 175.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.56 166.77 19.91 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.22 136.44 45.92 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 243' ' ' GLY . 1.8 mp -112.93 129.65 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.501 0.667 . . . . 0.0 111.764 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.551 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 24.6 p90 -94.33 -174.22 3.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.864 2.466 . . . . 0.0 110.156 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.577 ' CB ' ' HB2' ' A' ' 122' ' ' LEU . 0.4 OUTLIER -154.0 130.82 10.84 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.991 0.814 . . . . 0.0 110.002 177.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 43.15 1.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.151 0.887 . . . . 0.0 111.421 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.67 -71.76 0.34 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 110.474 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.35 38.48 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.406 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.577 ' HB2' ' CB ' ' A' ' 118' ' ' ASN . 71.2 mt -157.97 72.91 4.1 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.647 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.36 133.28 25.89 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.445 2.097 . . . . 0.0 113.398 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.522 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 1.8 p-10 -71.22 159.98 83.9 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 67.7 Cg_endo -72.97 167.84 26.28 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.551 2.834 . . . . 0.0 111.946 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.63 -139.56 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.662 2.241 . . . . 0.0 113.312 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -17.62 35.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.91 0.777 . . . . 0.0 112.518 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.13 142.17 47.71 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.457 ' CZ2' ' CD2' ' A' ' 147' ' ' LEU . 6.3 t-105 -71.23 -28.39 64.15 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 173.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.547 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -44.49 -23.49 0.12 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.61 -21.25 62.67 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 2.1 tp -45.94 -47.28 41.88 Favored Pre-proline 0 N--CA 1.475 0.782 0 CA-C-N 118.579 0.627 . . . . 0.0 112.297 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 11.9 Cg_endo -52.48 -42.2 62.89 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 109.398 -1.039 . . . . 0.0 109.398 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.3 -58.7 3.12 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.453 ' O ' HD12 ' A' ' 139' ' ' LEU . 3.1 mm? -67.79 -35.51 78.79 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.689 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 132' ' ' ILE . 20.0 t0 -74.97 -41.55 59.35 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -49.86 -42.17 46.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.806 177.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.59 -36.26 80.54 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.509 ' HB3' ' C ' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -65.21 -46.68 79.68 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.78 -44.1 38.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -45.97 -23.48 0.3 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.645 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -113.06 -58.75 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.446 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.78 53.41 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.509 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -167.01 -172.99 2.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 120.15 1.975 . . . . 0.0 110.013 -177.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.482 ' N ' HD21 ' A' ' 139' ' ' LEU . 54.5 m -144.27 165.13 28.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.455 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -79.51 -20.34 47.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.457 ' CD2' ' CZ2' ' A' ' 129' ' ' TRP . 4.4 pp -152.48 178.26 9.74 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.509 ' HB2' ' CG2' ' A' ' 222' ' ' THR . 0.0 OUTLIER -179.21 143.34 0.2 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.336 178.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.486 ' O ' ' O ' ' A' ' 150' ' ' ASN . 26.4 p90 -172.85 175.93 3.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.746 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 149' ' ' PHE . 3.0 m120 -37.01 164.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.767 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 208' ' ' THR . 1.0 OUTLIER -110.51 -58.69 2.05 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -102.71 35.59 2.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 116.92 -1.912 . . . . 0.0 114.035 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.787 ' O ' ' HB ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -79.63 144.23 60.41 Favored Pre-proline 0 C--O 1.221 -0.42 0 CA-C-N 121.957 2.162 . . . . 0.0 114.932 -175.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.941 ' O ' ' N ' ' A' ' 156' ' ' PHE . 6.3 Cg_exo -78.07 -135.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 1 C-N-CA 125.72 4.28 . . . . 0.0 106.945 177.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 1.123 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 1.8 m-85 16.96 -51.87 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.941 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.2 OUTLIER -84.61 -55.92 3.87 Favored 'General case' 0 C--O 1.259 1.562 0 C-N-CA 124.452 1.101 . . . . 0.0 112.129 -178.324 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.787 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 95.9 m -57.71 -42.53 83.97 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.486 ' CE3' ' HA ' ' A' ' 154' ' ' PRO . 0.7 OUTLIER -51.16 -55.71 26.1 Favored Pre-proline 0 C--N 1.349 0.564 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 1.123 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 40.1 Cg_exo -43.13 -50.65 6.25 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.166 2.578 . . . . 0.0 113.284 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mt -61.83 -56.75 16.11 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 119.925 1.238 . . . . 0.0 109.832 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.6 mm -52.85 -18.74 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.153 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.03 -25.88 48.09 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -43.09 -58.61 2.38 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.497 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 9.3 t0 -65.0 -28.64 69.64 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.406 ' N ' ' HA3' ' A' ' 187' ' ' GLY . . . 147.32 23.44 0.09 OUTLIER Glycine 0 CA--C 1.526 0.721 0 C-N-CA 118.516 -1.802 . . . . 0.0 116.946 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -104.2 86.77 0.53 Allowed Glycine 0 C--N 1.335 0.503 0 CA-C-N 119.021 1.411 . . . . 0.0 113.225 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -104.74 -179.46 3.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.007 0.403 . . . . 0.0 110.04 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.407 ' HB2' ' CD2' ' A' ' 169' ' ' PHE . . . -97.71 -78.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.152 0.501 . . . . 0.0 111.013 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.631 ' HB3' ' CD1' ' A' ' 176' ' ' TYR . 1.1 m-85 -125.89 172.78 9.61 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.041 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 1.217 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.8 OUTLIER -112.57 139.3 48.27 Favored 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -174.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.97 116.56 29.13 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.641 ' O ' ' C ' ' A' ' 173' ' ' ASN . 2.7 mm-40 -137.44 178.66 6.93 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.147 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.641 ' C ' ' O ' ' A' ' 172' ' ' GLU . 4.8 m120 -20.05 -64.4 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -80.79 -71.9 1.25 Allowed Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -174.57 170.02 3.55 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.891 1.346 . . . . 0.0 107.439 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 1.217 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 1.3 p90 -49.95 -33.43 17.59 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 123.102 1.43 . . . . 0.0 109.908 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.435 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 12.9 m-20 65.2 -76.84 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.463 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.436 ' CD1' ' HB ' ' A' ' 369' ' ' THR . 0.0 OUTLIER 174.7 -51.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -51.78 -47.73 64.07 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.478 ' CB ' ' HD3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -77.96 91.66 4.24 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.825 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 178' ' ' ILE . 4.2 t -112.54 152.41 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.536 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -115.09 40.11 2.56 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 114.84 -1.073 . . . . 0.0 114.579 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 184' ' ' ASP . 35.4 m -90.17 -32.41 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.812 0.306 . . . . 0.0 111.135 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.419 ' N ' HG23 ' A' ' 183' ' ' VAL . 40.6 t0 -100.67 59.39 0.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.274 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -115.72 145.89 42.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.643 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.54 -25.64 67.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.173 0.511 . . . . 0.0 111.69 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -77.29 -33.58 43.81 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-O 119.093 -0.837 . . . . 0.0 114.938 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.99 -56.51 21.04 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -57.53 -60.15 4.1 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.002 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -50.47 -41.85 53.59 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.685 0.755 . . . . 0.0 112.035 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -62.27 -60.66 7.59 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.412 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -24.41 59.41 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 122.539 -0.389 . . . . 0.0 110.175 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 32.3 m -66.83 -49.26 66.34 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 2.7 p90 -61.59 -34.41 75.57 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 194' ' ' PHE . 0.7 OUTLIER -63.93 -47.94 78.5 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.59 -29.89 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.223 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.85 -46.92 82.81 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.599 0.714 . . . . 0.0 110.905 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.1 tp -61.07 -53.65 54.49 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.1 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 204' ' ' MET . 3.6 mt -62.37 -44.54 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.806 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -52.32 -36.93 54.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.907 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -113.18 -34.51 5.65 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 121.051 3.722 . . . . 0.0 121.051 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -62.22 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.863 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -5.4 26.92 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 6.1 ptm 41.7 37.6 0.78 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -139.56 162.07 35.98 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -147.93 24.03 1.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.45 -3.06 34.5 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -56.19 117.92 4.22 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -95.71 -174.15 3.07 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.735 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -67.27 -47.09 71.74 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.017 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -77.2 -25.38 51.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.572 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 3.7 mt -81.62 -52.08 14.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.691 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 150' ' ' ASN . . . -52.4 -38.07 58.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -61.61 -44.94 96.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.61 -38.38 71.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.186 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.63 -56.82 15.85 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -66.54 -28.45 68.55 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -58.52 -34.33 70.85 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.174 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.19 -23.73 59.26 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.96 28.51 58.6 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 119.204 -0.776 . . . . 0.0 114.829 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -107.67 37.19 2.49 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.914 1.357 . . . . 0.0 111.082 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 148' ' ' MET . 82.4 p -138.81 139.38 38.19 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -104.87 38.55 1.89 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.446 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.557 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.9 OUTLIER 170.54 134.59 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 86.3 m -147.88 158.89 44.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.74 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.457 ' O ' ' CE2' ' A' ' 156' ' ' PHE . 12.0 pt -115.7 112.87 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -147.76 165.3 30.95 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.969 -0.457 . . . . 0.0 112.141 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -136.39 -163.98 10.05 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 119.42 1.009 . . . . 0.0 111.297 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -98.99 5.97 0.99 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.346 2.698 . . . . 0.0 114.129 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 232' ' ' TRP . 36.7 t-105 -85.58 -80.99 0.21 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.302 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.98 42.84 1.68 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.693 0.282 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.505 ' CZ2' ' CD1' ' A' ' 156' ' ' PHE . 5.1 m-90 -149.07 59.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.891 0.377 . . . . 0.0 110.961 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 p -57.82 -43.02 85.45 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -67.26 74.19 0.13 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.731 0.3 . . . . 0.0 110.575 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 12.8 tt -147.02 153.98 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.11 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.437 ' HB3' ' CG ' ' A' ' 242' ' ' TYR . 83.6 m-20 61.86 41.59 11.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.637 0.256 . . . . 0.0 110.858 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.0 t -142.09 48.37 1.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.771 0.32 . . . . 0.0 110.983 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.96 -65.08 1.05 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.732 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.68 -62.47 1.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.735 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -168.73 -52.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.616 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.62 95.06 10.1 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.625 0.25 . . . . 0.0 111.079 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.437 ' CG ' ' HB3' ' A' ' 236' ' ' ASP . 44.1 p90 -98.99 146.68 25.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.466 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.551 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -130.44 160.25 23.03 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.112 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.3 m -135.78 134.54 51.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.764 0.282 . . . . 0.0 110.889 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.04 167.57 21.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.839 0.855 . . . . 0.0 110.506 -174.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.76 152.24 7.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.71 159.4 44.17 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 120.513 1.506 . . . . 0.0 111.204 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.32 -164.49 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.598 2.198 . . . . 0.0 111.532 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.463 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -116.34 177.62 4.62 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.501 -178.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 249' ' ' THR . 55.1 m-85 -164.57 110.05 0.98 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.847 0.832 . . . . 0.0 109.749 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.91 33.43 21.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.956 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.72 39.03 30.24 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.747 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.78 147.59 17.16 Favored Pre-proline 0 N--CA 1.464 0.255 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -91.15 125.73 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.466 2.777 . . . . 0.0 111.89 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 12.2 t -47.02 150.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 159' ' ' PRO . 6.7 tppt? -85.21 108.97 17.71 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.013 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.594 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 5.4 Cg_exo -79.29 142.53 16.86 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.144 2.562 . . . . 0.0 112.737 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -79.91 154.61 28.21 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 329' ' ' ILE . 54.6 t -113.08 135.59 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -123.51 118.41 3.5 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 118.873 -1.632 . . . . 0.0 115.912 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.68 HG13 ' HB3' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -110.63 111.9 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.597 ' O ' ' N ' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -88.73 99.68 12.54 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 117.659 -1.616 . . . . 0.0 107.518 177.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.513 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 43.7 p -136.55 135.44 38.46 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 118.878 2.918 . . . . 0.0 118.878 -173.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . -88.48 112.86 23.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.467 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -102.86 162.83 16.2 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.45 ' HA ' HG21 ' A' ' 59' ' ' ILE . 87.0 mt -88.2 123.58 40.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 118.929 1.364 . . . . 0.0 107.726 176.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -65.51 146.22 55.13 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -58.2 -23.47 55.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.162 0.437 . . . . 0.0 111.284 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.05 -59.1 4.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.573 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.3 m -143.23 127.87 9.68 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.607 0.242 . . . . 0.0 111.231 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -78.88 -39.64 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.541 2.16 . . . . 0.0 112.96 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 276' ' ' ALA . 2.7 m120 55.54 85.05 0.07 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-O 120.62 0.248 . . . . 0.0 110.519 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.1 OUTLIER -72.24 -54.17 10.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -75.41 -57.34 3.95 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 5.9 mt -53.52 -49.09 68.33 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 272' ' ' ASN . . . -71.09 -51.85 22.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 273' ' ' LYS . 9.8 mtpp -48.84 -53.22 20.23 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.306 0.574 . . . . 0.0 112.277 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 47.4 mm-40 -68.73 -30.2 68.78 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.944 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.484 ' CD2' ' CE2' ' A' ' 27' ' ' PHE . 14.8 t80 -73.71 -40.33 63.68 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.427 HD22 ' CE1' ' A' ' 106' ' ' TYR . 5.7 mp -81.69 -43.89 17.87 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.94 0.876 . . . . 0.0 112.654 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 285' ' ' LEU . 13.5 mt-10 -70.45 -43.53 69.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 113.912 -1.494 . . . . 0.0 112.643 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 3.7 t-20 -80.89 -32.23 34.9 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.996 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.493 ' CE1' ' CE2' ' A' ' 27' ' ' PHE . 4.3 m-85 -101.89 -82.34 0.48 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.411 HD23 ' CE2' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -39.38 -33.98 0.18 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.528 ' HB2' ' HA ' ' A' ' 281' ' ' GLU . 0.4 OUTLIER -94.45 39.98 1.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.647 HG21 ' H ' ' A' ' 289' ' ' GLY . 11.3 t -146.62 161.91 39.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 1.2 m-20 -62.49 -13.07 26.35 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.049 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 41.2 mt-10 -77.94 -46.65 20.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.662 0.664 . . . . 0.0 111.22 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.647 ' H ' HG21 ' A' ' 286' ' ' THR . . . -87.02 -41.79 6.54 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.451 ' O ' HG22 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -59.9 -46.55 88.98 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 287' ' ' ASP . 3.4 mm-40 -79.0 -26.66 43.26 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -71.33 -37.54 71.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.671 1.123 . . . . 0.0 109.159 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 290' ' ' LEU . 33.1 m -67.5 -40.03 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.439 ' N ' HG21 ' A' ' 293' ' ' VAL . 16.3 t-20 -80.22 -39.39 29.19 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 123.838 0.855 . . . . 0.0 113.003 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -64.78 -40.17 94.8 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.543 ' CA ' ' HA2' ' A' ' 16' ' ' GLY . 10.9 m-20 -59.99 -64.43 0.95 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 103.52 35.84 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.758 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -95.99 90.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.621 2.88 . . . . 0.0 112.424 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.24 -74.74 0.32 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -98.71 156.08 20.16 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.165 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.42 ' O ' HG12 ' A' ' 317' ' ' ILE . . . -121.47 52.73 1.21 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 117.046 0.423 . . . . 0.0 111.62 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.422 ' CG1' ' CG2' ' A' ' 110' ' ' VAL . 10.8 p -136.4 84.12 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.888 0.375 . . . . 0.0 111.521 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 304' ' ' LEU . . . -166.33 95.23 0.55 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.845 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 307' ' ' TYR . 8.4 tp 93.76 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.94 0.496 . . . . 0.0 112.015 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -32.63 -35.07 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.784 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -44.83 47.09 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.961 0.886 . . . . 0.0 110.257 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.538 ' HB3' ' HB3' ' A' ' 304' ' ' LEU . 1.2 t80 -76.65 -23.26 53.28 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.016 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -76.6 -42.84 40.96 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.08 -43.8 86.3 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.963 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -67.32 -53.4 29.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.919 0.39 . . . . 0.0 110.624 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 307' ' ' TYR . 1.1 tt -67.06 -41.24 86.76 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.291 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 313' ' ' LYS . . . -46.59 -15.5 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 312' ' ' ALA . 8.8 tttp -31.04 -43.48 0.05 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.512 0.596 . . . . 0.0 110.433 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 3.6 t0 -87.73 139.17 31.25 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 3.0 Cg_exo -75.48 3.89 5.46 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.659 2.239 . . . . 0.0 114.578 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -59.22 5.75 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 301' ' ' ALA . 2.8 tp -49.78 -55.61 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.62 -50.35 13.38 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.375 0.534 . . . . 0.0 111.758 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.6 -44.29 85.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.858 0.837 . . . . 0.0 110.026 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -65.55 -32.61 74.3 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.896 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -46.35 18.5 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.723 0.296 . . . . 0.0 110.437 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.67 -42.51 79.12 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.444 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -78.4 -38.62 41.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.637 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.412 ' CB ' ' CG1' ' A' ' 110' ' ' VAL . . . -51.88 -52.74 47.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.26 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -58.19 -29.64 65.81 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.858 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -12.67 60.08 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.381 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.594 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -79.79 163.81 48.1 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.936 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.35 139.69 32.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.546 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.0 mt -91.47 110.26 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 119.572 1.078 . . . . 0.0 110.5 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.436 ' HA ' ' HD2' ' A' ' 331' ' ' PRO . 1.4 ptp -45.2 101.88 0.28 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.132 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.456 ' HG3' ' CD2' ' A' ' 176' ' ' TYR . 4.4 Cg_endo -46.49 -35.67 16.85 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.025 2.483 . . . . 0.0 112.14 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 331' ' ' PRO . 0.6 OUTLIER 85.56 83.33 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.2 158.2 76.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 118.338 0.517 . . . . 0.0 111.758 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.2 -50.72 5.47 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.963 2.442 . . . . 0.0 112.693 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 368' ' ' ILE . 79.2 mm-40 -53.22 -21.82 5.84 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 3.6 tpt -45.49 -35.07 3.57 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 122.222 -0.299 . . . . 0.0 111.323 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 14.9 p -59.77 -40.21 87.43 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.615 0.245 . . . . 0.0 110.542 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -58.11 -32.03 67.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.112 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.505 ' CE1' ' CG2' ' A' ' 343' ' ' VAL . 2.3 t80 -77.96 -55.66 5.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.448 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.456 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 6.6 t-105 -46.98 -42.83 18.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.862 0.363 . . . . 0.0 110.913 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.96 -49.92 40.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.658 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.15 -44.63 87.99 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.505 ' CG2' ' CE1' ' A' ' 339' ' ' PHE . 19.6 t -71.13 -29.68 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.723 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -74.82 -43.9 52.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 348' ' ' ILE . 1.7 p -64.48 -58.32 6.76 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.94 -38.65 4.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.637 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.1 t -58.82 -48.59 85.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.462 HG22 HD13 ' A' ' 348' ' ' ILE . 58.5 mt -64.41 -27.97 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 346' ' ' ALA . 6.0 m120 -64.43 -36.9 85.68 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.459 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.766 ' HA ' ' HG3' ' A' ' 355' ' ' GLN . . . -78.78 -26.59 44.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.56 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.94 -14.36 62.91 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 354' ' ' ARG . 2.5 t -110.66 16.96 21.13 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.56 5.91 1.4 Allowed Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 119.71 1.141 . . . . 0.0 112.382 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 352' ' ' SER . 26.4 ttt85 -93.63 35.75 1.11 Allowed 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 115.522 -2.18 . . . . 0.0 107.812 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.766 ' HG3' ' HA ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -66.98 -170.42 0.11 Allowed 'General case' 0 CA--C 1.547 0.843 1 N-CA-C 123.881 4.771 . . . . 0.0 123.881 -156.917 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 159.59 39.95 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 112.47 -2.15 . . . . 0.0 108.174 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.418 ' HB ' ' OE1' ' A' ' 355' ' ' GLN . 7.5 p -57.67 -48.84 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.757 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 1.2 m-20 -52.21 -43.85 64.46 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.388 0.613 . . . . 0.0 110.986 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -75.8 -53.83 7.87 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 114.784 -1.098 . . . . 0.0 113.025 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -54.32 -44.31 71.94 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.956 0.884 . . . . 0.0 112.791 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 364' ' ' ALA . 79.7 mt -77.82 -37.13 49.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.681 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 1.2 tmtm? -63.88 -56.34 16.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.977 0.894 . . . . 0.0 109.631 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.07 -32.24 70.75 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.252 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 361' ' ' LEU . . . -58.14 -42.43 85.87 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.829 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 366' ' ' THR . 0.7 OUTLIER -64.4 -36.12 83.13 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.477 ' N ' ' HG3' ' A' ' 365' ' ' GLN . 87.7 m -57.93 -34.57 70.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -71.1 -35.58 71.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.08 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.406 ' CD1' ' HB3' ' A' ' 335' ' ' GLN . 4.2 mm -75.83 -39.53 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.675 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.436 ' HB ' ' CD1' ' A' ' 178' ' ' ILE . 13.9 p -88.01 -20.93 25.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.022 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 366' ' ' THR . 2.0 mtmp? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.989 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.0 mtmm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.7 0.286 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.6 m -138.36 84.4 2.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.977 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.99 136.12 41.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.738 0.304 . . . . 0.0 110.945 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -177.12 154.74 1.09 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.244 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -128.66 63.17 0.62 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.469 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.29 160.77 42.79 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -155.25 122.62 5.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.189 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.65 ' HB ' ' CB ' ' A' ' 57' ' ' PRO . 24.0 t -116.94 124.95 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.482 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 59' ' ' ILE . 3.1 mp -123.7 130.47 74.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.475 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 73.3 m95 -102.66 128.67 49.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.024 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.45 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 1.5 tt -158.49 137.84 3.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 O-C-N 122.163 -0.336 . . . . 0.0 111.298 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -114.18 39.98 2.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.749 0.309 . . . . 0.0 111.081 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.1 -11.55 58.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.604 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.3 m-20 65.54 60.92 0.71 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.022 0.411 . . . . 0.0 110.743 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 1.2 mtpt 162.69 -173.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.183 0.516 . . . . 0.0 111.917 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.38 23.46 70.7 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 20.9 p90 -80.83 -34.46 33.85 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.78 0.79 . . . . 0.0 111.378 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 1.2 t-20 -66.69 -50.66 62.13 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.769 0.319 . . . . 0.0 111.742 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.57 -48.79 27.62 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.841 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.51 ' O ' HG12 ' A' ' 23' ' ' VAL . 10.3 mp -58.9 -49.19 78.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.845 0.823 . . . . 0.0 110.055 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -67.47 -37.72 83.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -67.19 -37.6 83.95 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.634 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 20' ' ' LEU . 3.7 p -67.65 -58.72 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.636 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.518 ' HA3' HG13 ' A' ' 35' ' ' VAL . . . -49.12 -34.18 16.26 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.246 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -50.47 67.62 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.51 1.148 . . . . 0.0 107.907 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -42.23 63.61 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-N 112.793 -2.003 . . . . 0.0 108.543 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.579 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 22.0 m-85 -65.75 -35.71 81.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.657 0.741 . . . . 0.0 111.083 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.772 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -70.85 -51.35 27.06 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.407 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -52.36 -28.56 19.99 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 125.076 1.485 . . . . 0.0 111.365 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.609 ' O ' ' CG2' ' A' ' 31' ' ' THR . 20.6 t70 -85.78 -38.71 17.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.581 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.609 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 162.88 38.05 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 172.222 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.458 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 156.43 38.7 0.02 OUTLIER Glycine 0 N--CA 1.466 0.682 0 C-N-CA 114.986 -3.483 . . . . 0.0 118.837 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.772 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.8 mp -139.89 107.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 121.532 2.666 . . . . 0.0 116.022 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.14 104.72 12.4 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.518 HG13 ' HA3' ' A' ' 24' ' ' GLY . 33.6 m -100.95 133.9 42.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -174.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -119.12 146.8 44.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.05 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 4.7 m -132.98 122.15 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.692 0.282 . . . . 0.0 110.302 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.51 134.03 48.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.263 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.423 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 9.1 p80 -139.7 71.03 37.25 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-O 120.927 0.394 . . . . 0.0 111.172 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HG2' ' CA ' ' A' ' 43' ' ' LEU . 58.2 Cg_endo -87.99 -177.73 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.218 2.612 . . . . 0.0 112.362 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.37 -40.14 14.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.67 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 43' ' ' LEU . 68.8 mmtt -86.47 0.68 53.68 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.312 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.51 ' CA ' ' HG2' ' A' ' 40' ' ' PRO . 10.2 tt -19.53 -62.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 1.059 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -46.52 -50.86 16.54 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -178.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 3.1 tt0 -71.98 -44.04 64.17 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.936 0.398 . . . . 0.0 110.782 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -56.62 -56.02 26.59 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.129 0.966 . . . . 0.0 110.496 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.677 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.8 t80 -45.37 -60.75 2.93 Favored Pre-proline 0 C--N 1.346 0.414 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.0 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 1.059 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 35.2 Cg_exo -61.91 -28.08 80.68 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 121.327 1.351 . . . . 0.0 113.858 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -80.98 -37.29 29.56 Favored 'General case' 0 C--O 1.256 1.416 0 CA-C-O 122.365 1.078 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.87 ' O ' ' N ' ' A' ' 54' ' ' GLY . 18.5 m -75.69 -40.51 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 CA-C-O 121.996 0.903 . . . . 0.0 109.686 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.404 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -48.38 -38.65 19.97 Favored 'General case' 0 C--N 1.365 1.261 0 C-N-CA 125.945 1.698 . . . . 0.0 111.275 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.94 -37.32 29.72 Favored 'General case' 0 C--N 1.37 1.465 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.974 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -118.09 17.48 14.04 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.911 0.778 . . . . 0.0 109.035 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.87 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -137.81 62.82 0.57 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -82.0 38.69 0.54 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.751 0.776 . . . . 0.0 112.731 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 57' ' ' PRO . . . -93.78 -39.85 4.83 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.602 -0.809 . . . . 0.0 114.451 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.65 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 34.0 Cg_endo -91.94 157.86 3.35 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.49 2.793 . . . . 0.0 112.953 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.07 35.43 4.12 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 117.663 -1.615 . . . . 0.0 114.823 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 1.9 mt -152.45 127.91 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 118.181 -1.408 . . . . 0.0 114.443 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.464 HG12 ' CE1' ' A' ' 47' ' ' PHE . 3.9 mp -139.27 122.83 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.613 0.244 . . . . 0.0 111.629 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 35.9 t80 -113.88 121.29 43.53 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.977 0.417 . . . . 0.0 110.151 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.425 ' CZ2' HD11 ' A' ' 76' ' ' LEU . 3.1 p90 -166.43 167.29 15.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.995 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -45.66 160.13 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.956 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.706 ' CB ' ' HB ' ' A' ' 261' ' ' VAL . 23.0 t-80 -77.63 -29.45 51.76 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -48.91 -54.13 16.74 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.629 0.728 . . . . 0.0 112.398 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -78.37 -30.73 48.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.181 0.515 . . . . 0.0 109.968 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.634 ' HB3' ' HA ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -56.37 -33.08 65.37 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -55.58 -68.0 1.92 Allowed Glycine 0 C--N 1.354 1.558 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.03 -54.49 31.07 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 112.451 -1.875 . . . . 0.0 111.218 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.445 ' HB3' ' CB ' ' A' ' 75' ' ' LEU . 16.5 m-85 -48.66 -41.19 30.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -51.8 -44.78 63.6 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -42.75 25.58 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 p -69.94 -26.65 64.23 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.97 4.02 10.51 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 119.968 -1.11 . . . . 0.0 114.283 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.472 ' CD1' ' CZ ' ' A' ' 47' ' ' PHE . 1.1 mm? -96.9 45.86 1.05 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.271 1.036 . . . . 0.0 110.738 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.498 ' CD1' ' CD2' ' A' ' 67' ' ' PHE . 0.5 OUTLIER 176.88 138.04 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 113.273 -1.785 . . . . 0.0 106.571 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.6 ' HB1' ' H ' ' A' ' 268' ' ' ALA . . . -135.16 138.78 44.02 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 118.391 -1.323 . . . . 0.0 111.585 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -47.42 137.07 9.0 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.554 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.509 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 7.8 mt -122.46 162.3 22.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.115 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.9 p -106.18 82.87 1.0 Allowed Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.399 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 67.0 Cg_endo -84.48 -171.51 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.949 2.433 . . . . 0.0 112.345 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -105.46 156.06 18.56 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.822 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -92.26 -38.88 11.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.364 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.5 -23.25 57.53 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.455 ' CE2' ' CD2' ' A' ' 285' ' ' LEU . 10.2 t80 -69.09 -59.3 3.12 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.904 0.383 . . . . 0.0 110.05 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 94' ' ' TRP . 1.3 mt-30 -66.48 -24.63 66.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.677 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.62 -34.04 62.72 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -76.46 -10.01 59.07 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.463 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -125.15 -159.76 0.91 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.28 -179.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -80.0 119.23 75.96 Favored Pre-proline 0 C--N 1.339 0.151 0 O-C-N 122.292 -0.255 . . . . 0.0 111.574 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.32 -32.93 97.14 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.369 2.046 . . . . 0.0 112.206 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 325' ' ' GLN . 17.3 m-85 -52.99 -53.69 46.23 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.158 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.51 ' O ' ' HG2' ' A' ' 107' ' ' PRO . 10.0 t -62.62 -23.38 67.04 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.463 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 6.1 m95 -93.18 -25.6 17.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.054 0.454 . . . . 0.0 111.798 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -75.41 -20.78 58.7 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.66 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.45 ' CB ' ' CG1' ' A' ' 261' ' ' VAL . . . -56.03 -50.41 71.0 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.469 ' HA ' ' CD2' ' A' ' 64' ' ' HIS . 9.1 p -100.42 41.38 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.431 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -97.82 135.77 39.11 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.668 -0.645 . . . . 0.0 109.872 178.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.4 t80 -99.94 174.86 5.99 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.02 -0.425 . . . . 0.0 110.081 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -64.87 73.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.674 0.273 . . . . 0.0 110.703 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 138.57 -47.8 0.91 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.051 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -145.99 175.57 10.35 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 117.179 0.49 . . . . 0.0 110.926 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -118.89 119.69 35.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 105' ' ' ALA . 3.3 mp -94.99 39.38 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.7 ' HB3' ' HA2' ' A' ' 265' ' ' GLY . . . 167.14 -178.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.458 ' CE2' ' CD1' ' A' ' 280' ' ' LEU . 48.3 p90 -132.97 121.5 16.94 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.015 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.713 ' HA ' ' CB ' ' A' ' 263' ' ' SER . 6.3 Cg_exo -79.41 172.39 14.61 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.177 2.585 . . . . 0.0 113.727 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 262' ' ' LEU . 2.2 tt -168.9 39.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 119.586 -0.846 . . . . 0.0 112.713 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 262' ' ' LEU . . . -174.92 110.4 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.905 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.5 m -96.89 117.14 40.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.599 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.452 ' CG ' ' CH2' ' A' ' 230' ' ' TRP . 33.1 mt-10 -102.89 146.85 27.67 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.552 0.691 . . . . 0.0 110.766 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -165.26 139.05 4.72 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.385 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.579 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 0.4 OUTLIER -77.94 137.74 38.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.642 -179.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.15 163.5 28.38 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 tt -93.63 130.11 39.67 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.1 tt -115.62 138.74 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.619 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.446 ' CD1' HD22 ' A' ' 122' ' ' LEU . 3.9 m-85 -117.2 138.58 51.6 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -85.17 119.78 25.93 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -90.82 60.83 4.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.899 0.38 . . . . 0.0 111.421 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.89 -51.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.86 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' CB ' ' A' ' 223' ' ' ALA . 5.6 mt -118.96 38.4 3.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.43 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.579 ' HB2' ' CB ' ' A' ' 223' ' ' ALA . 0.4 OUTLIER -157.69 108.06 1.8 Allowed Pre-proline 0 CA--C 1.521 -0.15 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.687 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 9.2 Cg_endo -90.51 130.3 1.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.302 2.001 . . . . 0.0 112.443 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 81.4 m-20 -64.4 127.13 91.85 Favored Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -172.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 124' ' ' ASN . 55.5 Cg_endo -93.42 167.62 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 124.038 3.159 . . . . 0.0 109.66 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.49 -51.14 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 121.806 1.671 . . . . 0.0 114.246 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.64 -3.48 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 49.5 p -118.03 139.35 51.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 121.252 1.842 . . . . 0.0 114.287 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -23.27 63.47 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 171.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.588 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 24.3 mt-10 -44.13 -23.61 0.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.359 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -75.91 -19.16 59.03 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.525 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 96.7 mt -46.59 -50.61 40.97 Favored Pre-proline 0 N--CA 1.479 0.994 0 CA-C-O 121.709 0.766 . . . . 0.0 111.346 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.603 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 58.7 Cg_exo -46.4 -36.26 17.47 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 120.826 1.017 . . . . 0.0 109.57 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 137' ' ' LYS . . . -75.36 -59.03 2.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.435 ' O ' ' CG ' ' A' ' 138' ' ' GLU . 64.3 mt -68.75 -37.34 79.32 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.881 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 132' ' ' ILE . 42.2 t0 -72.1 -40.65 68.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.603 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 3.4 tptm -47.48 -49.0 26.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.81 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 139' ' ' LEU . 1.2 pt-20 -62.83 -37.23 85.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.59 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.481 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 0.3 OUTLIER -58.89 -51.03 71.77 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -47.69 -45.68 28.62 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.03 -27.58 0.97 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.09 -56.66 2.16 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.244 0.545 . . . . 0.0 110.671 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.96 39.87 0.02 OUTLIER Glycine 0 CA--C 1.52 0.351 0 CA-C-O 119.029 -0.873 . . . . 0.0 111.216 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.42 -172.06 4.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 119.183 1.492 . . . . 0.0 111.629 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.471 ' N ' HD21 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -143.72 127.12 16.81 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -41.52 -33.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 224' ' ' MET . 0.6 OUTLIER -141.3 130.26 23.18 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 -176.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.432 ' HB2' ' CB ' ' A' ' 222' ' ' THR . 0.0 OUTLIER -132.22 138.75 48.06 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.739 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.934 ' O ' ' O ' ' A' ' 150' ' ' ASN . 17.3 p90 -171.92 174.73 4.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.693 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.934 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -27.86 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.757 0.661 . . . . 0.0 112.17 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 152' ' ' GLN . 0.1 OUTLIER -160.66 39.0 0.16 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.261 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER 171.68 33.09 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.998 169.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.657 ' O ' ' HB ' ' A' ' 157' ' ' THR . 3.3 mt-10 -79.96 152.52 74.42 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 121.986 2.175 . . . . 0.0 115.833 -174.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.975 ' O ' ' N ' ' A' ' 156' ' ' PHE . 67.0 Cg_endo -78.67 -135.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.802 1 C-N-CA 125.559 4.172 . . . . 0.0 107.095 176.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 1.12 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 4.7 p90 3.01 -39.82 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.975 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -86.14 -55.48 3.91 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-N 120.262 1.392 . . . . 0.0 111.55 -179.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 61.6 m -56.6 -43.82 80.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.42 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 2.6 m0 -51.26 -55.73 26.18 Favored Pre-proline 0 C--N 1.346 0.416 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.735 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 1.12 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 89.4 Cg_exo -43.11 -50.3 6.48 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.081 2.521 . . . . 0.0 113.026 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.45 -53.82 49.15 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 119.671 1.123 . . . . 0.0 108.645 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 1.5 mp -51.86 -25.82 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.421 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.59 -22.67 46.73 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.668 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -41.86 -58.35 2.06 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -64.37 5.57 0.26 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.303 1.224 . . . . 0.0 114.303 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.59 22.69 5.34 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 119.588 -1.291 . . . . 0.0 115.262 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.9 163.41 41.83 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.707 -1.235 . . . . 0.0 111.447 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -146.09 120.94 9.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.126 0.463 . . . . 0.0 109.967 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.424 ' HB1' ' CE1' ' A' ' 169' ' ' PHE . . . -39.14 -79.01 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.675 0.75 . . . . 0.0 111.148 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.587 ' HB3' ' CB ' ' A' ' 176' ' ' TYR . 1.7 m-85 -113.43 172.73 6.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.768 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 1.201 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -101.88 106.87 17.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.08 114.42 18.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.053 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 28.2 tt0 -136.66 102.04 4.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.259 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 0.2 OUTLIER 90.28 -31.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.379 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 154.77 17.04 0.05 OUTLIER Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.151 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -174.18 127.73 0.36 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.175 1.487 . . . . 0.0 111.257 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 1.201 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 47.9 p90 -55.47 -24.45 31.22 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 122.181 0.991 . . . . 0.0 110.987 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 78.8 m-20 76.74 -78.57 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.008 -1.905 . . . . 0.0 111.773 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 369' ' ' THR . 0.8 OUTLIER 168.88 -41.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.497 ' HA ' HG23 ' A' ' 369' ' ' THR . 9.6 tttm -72.75 -5.66 39.33 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.401 ' CB ' ' CB ' ' A' ' 170' ' ' LYS . 4.4 m-20 -120.24 94.14 4.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.253 0.933 . . . . 0.0 109.634 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.406 HG11 ' CE1' ' A' ' 339' ' ' PHE . 6.4 t -115.78 111.29 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.433 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . -119.76 39.91 2.36 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.852 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 168' ' ' ALA . 31.0 t -80.41 -44.72 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-O 121.275 0.56 . . . . 0.0 109.865 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -83.83 61.28 6.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.984 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 182' ' ' GLY . 7.4 p30 -110.94 173.92 6.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.712 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.58 -26.43 65.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.274 0.559 . . . . 0.0 111.28 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.95 -46.79 42.5 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.675 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -56.93 -51.4 69.28 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 175.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -56.06 18.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.979 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -50.07 -41.18 47.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.006 0.908 . . . . 0.0 112.096 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -66.76 -60.65 5.95 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.715 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.427 ' HB2' HG12 ' A' ' 161' ' ' ILE . 0.5 OUTLIER -56.54 -27.62 58.03 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.161 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 42.2 m -62.36 -47.62 83.41 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.816 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.531 ' CZ ' ' CZ ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -60.71 -36.7 79.48 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-O 121.542 0.687 . . . . 0.0 109.54 177.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.77 -51.02 71.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.983 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.29 -31.5 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.562 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 2.6 t0 -57.03 -49.9 74.38 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 121.286 0.565 . . . . 0.0 110.717 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.9 tp -61.97 -59.24 5.4 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.285 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 39.4 mm -56.93 -41.13 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.83 -31.73 72.54 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.49 178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 6.0 m-80 -107.54 13.12 27.09 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -173.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.406 ' HG2' ' N ' ' A' ' 203' ' ' HIS . 1.4 ttmp? -121.92 -91.87 0.55 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.946 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.415 ' O ' ' N ' ' A' ' 205' ' ' ASN . 0.5 OUTLIER -122.02 -10.82 8.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -178.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.35 -71.69 0.12 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 203' ' ' HIS . 3.0 m120 64.43 162.49 0.12 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.26 78.88 3.1 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.603 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.424 ' HA ' HD22 ' A' ' 151' ' ' LEU . 33.8 m-20 39.46 70.75 0.2 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.476 ' CG2' HG22 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -55.05 124.19 16.02 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 213' ' ' ALA . 0.4 OUTLIER -92.13 -174.65 3.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -69.92 -45.55 67.31 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.3 m -75.18 -30.01 60.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.502 0.668 . . . . 0.0 111.024 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.476 HG22 ' CG2' ' A' ' 208' ' ' THR . 1.2 mp -79.33 -49.74 19.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.207 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -57.61 -34.05 68.88 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -60.02 -48.24 82.53 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.91 -36.59 67.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.247 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.77 -57.6 11.74 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.963 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.522 ' CE1' ' HA ' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -60.09 -30.04 68.98 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -53.18 -42.03 65.81 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.396 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.84 59.12 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.74 57.96 7.44 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.672 -0.695 . . . . 0.0 114.588 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -125.29 37.29 4.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.378 1.089 . . . . 0.0 111.037 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.432 ' CB ' ' HB2' ' A' ' 148' ' ' MET . 12.2 t -142.5 140.48 31.86 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.608 ' CB ' ' O ' ' A' ' 121' ' ' LEU . . . -114.45 38.5 3.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.064 -1.426 . . . . 0.0 113.328 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 25.8 ttm -178.08 129.22 0.13 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.77 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 148' ' ' MET . 69.1 p -145.51 169.32 18.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.566 0.698 . . . . 0.0 111.534 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.462 ' CD1' ' CE1' ' A' ' 156' ' ' PHE . 21.9 mt -109.06 145.44 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -146.86 167.05 24.89 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.849 0.86 . . . . 0.0 111.232 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -110.4 -159.8 17.26 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.446 -0.406 . . . . 0.0 112.782 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.441 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 11.7 Cg_endo -55.49 -59.44 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.82 2.346 . . . . 0.0 112.451 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.452 ' CH2' ' CG ' ' A' ' 111' ' ' GLU . 18.6 p90 -173.34 -43.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.474 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.28 70.99 1.2 Allowed 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.786 0.326 . . . . 0.0 110.803 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.423 ' O ' ' N ' ' A' ' 234' ' ' ASN . 1.5 m95 -125.72 39.77 3.88 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 11.3 t 64.87 -72.74 0.06 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.544 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 232' ' ' TRP . 4.6 t-20 -145.64 85.12 1.69 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.575 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.406 ' O ' ' N ' ' A' ' 237' ' ' THR . 18.1 tt -44.55 154.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.434 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -47.9 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.707 0.289 . . . . 0.0 111.242 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 235' ' ' ILE . 19.7 m -121.4 39.37 3.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.744 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 83.0 p -63.2 -43.62 97.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.689 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.57 -174.91 2.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.816 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.0 -57.26 4.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.193 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.02 126.32 35.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -144.44 164.22 31.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.167 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.4 122.14 5.85 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.425 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 34.7 m -91.58 115.31 30.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.743 0.271 . . . . 0.0 111.384 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.6 p -127.62 167.18 16.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.47 153.91 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.4 ' CD1' ' CD1' ' A' ' 113' ' ' LEU . 58.5 mt -58.29 158.67 13.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 120.31 1.414 . . . . 0.0 110.092 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.21 -174.65 2.37 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.453 2.102 . . . . 0.0 113.144 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.449 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -105.3 171.16 7.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.091 0.472 . . . . 0.0 111.488 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.531 ' CZ ' ' CZ ' ' A' ' 194' ' ' PHE . 35.6 m-85 -167.31 111.08 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 62.72 31.71 16.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.637 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.94 33.58 36.45 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.318 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 13.8 mp0 -156.75 154.43 26.65 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.459 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 68.7 Cg_endo -90.61 162.91 4.28 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.592 2.861 . . . . 0.0 112.213 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.41 148.71 26.45 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.1 OUTLIER -86.0 109.81 25.69 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.531 -178.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.407 ' HA ' ' CD2' ' A' ' 113' ' ' LEU . 6.2 Cg_exo -79.84 149.38 20.48 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.998 2.465 . . . . 0.0 112.89 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 155' ' ' TYR . 23.2 p90 -78.86 146.35 33.68 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.475 ' HB ' ' HA ' ' A' ' 329' ' ' ILE . 15.6 t -103.53 122.83 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -118.02 123.45 5.74 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.135 -1.507 . . . . 0.0 114.771 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.706 ' HB ' ' CB ' ' A' ' 64' ' ' HIS . 15.7 t -109.09 110.06 30.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.453 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 1.7 tp -89.85 99.15 12.21 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 117.881 -1.528 . . . . 0.0 107.257 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.713 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 32.8 p -134.46 141.17 46.69 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 118.501 2.778 . . . . 0.0 118.501 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.543 ' O ' ' CB ' ' A' ' 105' ' ' ALA . . . -74.04 132.71 42.61 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.025 -0.422 . . . . 0.0 110.292 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.7 ' HA2' ' HB3' ' A' ' 105' ' ' ALA . . . -122.18 139.59 12.88 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.652 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.39 127.16 71.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.713 ' C ' ' H ' ' A' ' 269' ' ' ALA . 96.1 m-20 -61.07 126.38 27.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.6 ' H ' ' HB1' ' A' ' 77' ' ' ALA . . . -51.6 5.11 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 119.883 1.219 . . . . 0.0 113.177 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.713 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -81.99 -38.1 25.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.854 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 75.5 m -133.89 69.4 75.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.91 0.386 . . . . 0.0 110.925 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.97 -36.21 3.67 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.842 2.362 . . . . 0.0 112.734 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 50.64 68.17 0.81 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 6.5 mttt -48.98 -54.44 15.6 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 2.9 mt-10 -62.98 -57.94 9.03 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.282 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.6 mt -68.01 -58.0 5.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.45 -51.97 31.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 1.1 tpmp? -64.98 -35.76 82.23 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 12.4 tt0 -76.49 -53.09 8.58 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -56.23 -52.01 66.0 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.787 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.475 ' N ' ' CG ' ' A' ' 279' ' ' PHE . 8.2 tt -57.41 -43.42 83.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.524 0.678 . . . . 0.0 111.777 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -73.77 -34.3 64.63 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.558 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -94.16 -13.54 26.59 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.457 ' CE2' ' CG2' ' A' ' 23' ' ' VAL . 1.6 t80 -109.41 -62.2 1.52 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 119.241 -0.409 . . . . 0.0 109.936 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 280' ' ' LEU . 1.7 tt -40.19 -33.57 0.24 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.809 0.731 . . . . 0.0 110.87 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.455 ' CD2' ' CE2' ' A' ' 85' ' ' PHE . 80.5 mt -86.59 42.21 0.99 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.959 0.409 . . . . 0.0 110.257 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 283' ' ' TYR . 17.4 p -145.21 155.93 43.55 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 44.1 m-20 -62.7 -15.04 50.87 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 0.9 OUTLIER -78.27 -47.38 18.02 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.882 -0.511 . . . . 0.0 110.922 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -79.96 -55.58 3.51 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.291 -0.957 . . . . 0.0 110.972 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.41 ' CD1' ' CD1' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -55.26 -46.14 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.226 . . . . 0.0 111.066 179.415 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -79.05 -26.32 43.12 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.707 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -68.33 -41.55 80.64 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 119.441 1.019 . . . . 0.0 109.117 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.4 -61.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 297' ' ' LYS . 0.6 OUTLIER -50.14 -45.14 52.84 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.682 1.193 . . . . 0.0 112.546 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -59.33 -50.36 74.27 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.528 ' O ' ' HD3' ' A' ' 298' ' ' PRO . 42.0 m-20 -56.17 -47.86 77.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 176.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 294' ' ' ASN . 0.0 OUTLIER -69.04 104.67 0.78 Allowed Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.951 -178.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 296' ' ' ASP . 93.1 Cg_endo -99.64 54.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.322 2.681 . . . . 0.0 112.675 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 230' ' ' TRP . 0.4 OUTLIER -138.88 -67.83 0.45 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.57 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 301' ' ' ALA . . . -172.91 -166.31 31.21 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.853 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 300' ' ' GLY . . . 160.0 177.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.579 0.228 . . . . 0.0 111.141 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 301' ' ' ALA . 5.8 p 174.52 62.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 304' ' ' LEU . . . -113.78 -138.6 0.37 Allowed 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' A' ' 303' ' ' ALA . 0.4 OUTLIER -4.51 110.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.38 1.072 . . . . 0.0 113.803 -179.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -34.22 -60.88 0.39 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.099 0.476 . . . . 0.0 112.085 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.14 -47.1 54.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.988 0.899 . . . . 0.0 111.272 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.407 ' CZ ' ' OE2' ' A' ' 291' ' ' GLU . 2.4 t80 -73.0 -20.12 61.08 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.319 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 312' ' ' ALA . 12.0 tt0 -66.64 -39.88 88.45 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.46 -51.85 38.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.335 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -56.83 -56.31 23.23 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.012 0.434 . . . . 0.0 110.174 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -41.02 98.06 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.776 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 308' ' ' GLU . . . -46.23 -26.77 0.85 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 312' ' ' ALA . 10.5 mtpp -37.76 -40.04 0.4 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.753 0.311 . . . . 0.0 110.599 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -82.82 124.35 77.14 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.903 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.21 -13.51 40.19 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.637 2.225 . . . . 0.0 114.214 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 -62.08 -58.89 6.12 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.441 ' HA ' ' OG1' ' A' ' 320' ' ' THR . 10.3 pt -50.12 -52.36 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.78 -45.14 14.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.84 0.291 . . . . 0.0 111.71 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.73 -38.96 73.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.299 0.571 . . . . 0.0 110.322 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 19.9 p -65.17 -33.61 76.42 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -49.19 16.23 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.603 0.24 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -43.52 84.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.307 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -71.58 -41.56 68.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.584 0.231 . . . . 0.0 111.17 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -23.08 67.16 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.438 ' HG3' ' CE1' ' A' ' 92' ' ' PHE . 3.0 tm0? -85.27 -34.09 22.02 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -101.48 62.74 0.95 Allowed 'General case' 0 C--O 1.232 0.151 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.478 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -154.96 -140.79 3.09 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.681 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -128.32 118.84 23.94 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.475 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.5 mm -75.34 131.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.77 133.08 2.96 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.725 0.297 . . . . 0.0 111.326 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.545 ' HB3' ' CE2' ' A' ' 176' ' ' TYR . 12.6 Cg_endo -56.05 -161.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.092 2.528 . . . . 0.0 111.975 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -159.21 40.78 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.543 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 5.1 pt -136.55 170.78 9.99 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.893 -0.139 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 87.5 Cg_endo -84.83 -20.51 3.63 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.628 2.219 . . . . 0.0 113.927 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -56.13 -21.04 20.15 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.481 ' HE2' ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -44.72 -33.36 1.84 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 23.2 m -57.16 -33.17 67.16 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.649 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.0 78.08 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.928 0.394 . . . . 0.0 111.92 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.406 ' CE1' HG11 ' A' ' 181' ' ' VAL . 0.1 OUTLIER -78.35 -55.66 5.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.772 -178.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.414 ' HA ' ' CE3' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -44.0 -44.73 7.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.045 -179.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -74.79 -44.01 51.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.972 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.21 76.48 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.427 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 5.5 m -71.94 -41.31 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.034 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.381 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 348' ' ' ILE . 6.7 mmp_? -56.34 -55.29 35.25 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.212 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 43.9 p -59.45 -56.23 24.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.064 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.62 -60.67 2.17 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 48.3 t -51.17 -50.52 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 344' ' ' ARG . 2.1 tt -69.88 -46.14 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.837 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 345' ' ' THR . 3.5 t30 -66.35 -53.97 30.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 355' ' ' GLN . . . -66.21 -26.55 67.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.07 -12.31 2.06 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.0 p -110.42 26.75 10.34 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.48 0.582 . . . . 0.0 111.424 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 89.41 -5.72 83.78 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 118.463 -1.827 . . . . 0.0 114.482 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 34.98 0.72 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 116.199 -2.2 . . . . 0.0 107.956 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.45 ' HA ' ' CB ' ' A' ' 350' ' ' ALA . 1.0 OUTLIER -72.15 -174.81 1.34 Allowed 'General case' 0 CA--C 1.548 0.868 1 N-CA-C 126.385 5.698 . . . . 0.0 126.385 -158.057 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 158.22 40.48 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 109.833 -3.349 . . . . 0.0 104.283 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.8 p -72.56 -52.58 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 13.4 t0 -47.34 -45.64 24.85 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.596 0.712 . . . . 0.0 111.28 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -77.07 -56.34 4.66 Favored 'General case' 0 C--N 1.353 0.74 0 CA-C-N 114.073 -1.421 . . . . 0.0 113.733 -175.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -51.49 -41.72 61.15 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 122.583 1.182 . . . . 0.0 112.253 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.7 mt -79.03 -34.95 43.4 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 112.745 -2.025 . . . . 0.0 110.494 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 5.2 mmmt -65.75 -56.6 11.17 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.391 1.091 . . . . 0.0 109.599 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -59.46 -36.03 75.21 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.372 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -52.18 -44.01 64.45 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 362' ' ' LYS . 4.2 tt0 -60.21 -46.42 89.8 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 370' ' ' LYS . 53.1 m -51.03 -42.88 60.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.09 0.471 . . . . 0.0 110.138 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 10.3 ttm105 -59.12 -52.57 65.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.122 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 368' ' ' ILE . 15.7 tt -73.55 -30.31 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 178' ' ' ILE . 80.9 p -82.52 -30.24 29.91 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 366' ' ' THR . 8.2 tptt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.962 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.1 mttp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.622 0.249 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.2 p -137.51 179.68 6.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -80.4 123.41 28.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.777 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -156.08 160.24 39.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.784 0.326 . . . . 0.0 111.213 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . 90.88 25.56 24.54 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.415 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.34 152.79 42.04 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -129.76 121.27 26.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 1.128 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -117.04 118.23 58.07 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 24.4 mt -123.04 130.07 74.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.435 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.44 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 8.6 m95 -108.99 122.29 46.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.443 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -145.74 143.07 21.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 122.881 0.473 . . . . 0.0 109.813 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -79.8 72.62 6.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 119.014 0.824 . . . . 0.0 112.015 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.64 65.88 2.9 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.098 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.804 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -87.11 -32.82 19.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.804 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 102.12 -156.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -177.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 71.39 52.56 12.59 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 116.089 1.196 . . . . 0.0 116.089 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -58.71 2.92 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 2.0 t-20 -46.18 -43.33 15.08 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.122 0.487 . . . . 0.0 111.127 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.12 -45.54 49.22 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.302 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.13 -51.47 68.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.944 0.372 . . . . 0.0 110.678 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.17 74.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 34.8 tt0 -65.3 -36.09 82.99 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.754 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 27' ' ' PHE . 74.8 t -67.7 -61.27 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 27' ' ' PHE . . . -49.22 -34.22 17.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.205 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.41 -50.38 67.74 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 177.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -41.63 62.77 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 112.826 -1.988 . . . . 0.0 108.593 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.561 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 21.7 m-30 -66.91 -34.32 77.53 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.128 0.966 . . . . 0.0 111.367 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.703 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -72.6 -51.96 17.48 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.914 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tpmp? -53.1 -27.55 21.04 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 124.807 1.317 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.632 ' O ' ' CG2' ' A' ' 31' ' ' THR . 3.7 m-20 -86.03 -37.42 18.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 117.732 -1.128 . . . . 0.0 108.97 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.632 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.92 38.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 172.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.598 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 156.88 39.25 0.02 OUTLIER Glycine 0 N--CA 1.465 0.582 0 C-N-CA 114.537 -3.697 . . . . 0.0 119.337 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.703 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.5 mp -139.46 136.27 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 121.961 2.88 . . . . 0.0 116.637 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -142.32 104.46 4.43 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.423 ' HA ' ' CB ' ' A' ' 7' ' ' LEU . 37.4 t -88.48 128.97 40.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 m -118.51 140.11 50.39 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.645 -1.162 . . . . 0.0 110.853 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 15.2 m -129.85 122.47 54.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 O-C-N 122.133 -0.354 . . . . 0.0 110.703 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 3.0 tp10 -113.4 134.03 54.86 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER -117.98 74.83 10.29 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 122.355 0.262 . . . . 0.0 111.208 178.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 43' ' ' LEU . 6.0 Cg_endo -89.18 -167.47 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.546 2.831 . . . . 0.0 113.262 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -109.42 -54.85 2.5 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.347 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -78.03 0.12 25.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.41 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 2.0 tt -26.08 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 1.062 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 3.5 mt-10 -70.59 -55.02 9.81 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -68.34 -50.06 55.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.113 0.482 . . . . 0.0 111.454 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -61.82 -56.27 21.21 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.668 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 73.4 t80 -47.03 -55.01 16.73 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 1.062 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 30.8 Cg_exo -66.96 -39.69 13.54 Favored 'Trans proline' 0 C--O 1.25 1.12 0 C-N-CA 121.478 1.452 . . . . 0.0 115.196 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -67.54 -51.15 54.22 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 47' ' ' PHE . 9.0 m -61.37 -22.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.114 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 47' ' ' PHE . . . -59.05 -30.03 67.74 Favored 'General case' 0 C--N 1.394 2.535 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.058 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.38 -28.94 31.18 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.227 1.411 . . . . 0.0 113.029 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 t -88.3 129.66 35.32 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.126 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.93 -67.95 0.05 OUTLIER Glycine 0 C--N 1.337 0.587 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.396 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.29 -84.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.417 1.609 . . . . 0.0 111.427 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.03 142.86 4.34 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.517 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.18 -146.6 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.84 2.36 . . . . 0.0 112.767 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 1.128 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -79.99 -135.65 0.03 OUTLIER 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 123.744 0.818 . . . . 0.0 110.069 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.41 HD12 ' CZ ' ' A' ' 61' ' ' PHE . 16.6 pt -104.48 166.89 2.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 1.7 tt -127.69 134.87 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.548 ' CD2' ' HB1' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -110.69 120.08 41.25 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.477 ' CZ3' ' CG2' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -166.99 162.91 15.88 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.393 0.542 . . . . 0.0 110.437 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -38.34 154.84 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.506 ' HB3' HG11 ' A' ' 261' ' ' VAL . 16.6 t-160 -77.29 -30.04 54.02 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.99 -36.96 75.77 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.693 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.29 -33.11 24.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.933 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.555 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 4.5 t80 -59.94 -30.35 69.01 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -57.07 -68.51 1.66 Allowed Glycine 0 C--N 1.353 1.502 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.99 45.08 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.555 ' HB2' ' HA ' ' A' ' 67' ' ' PHE . 1.2 m-85 -48.03 -46.35 33.03 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 68' ' ' GLY . . . -51.08 -48.83 61.53 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.884 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -63.87 -16.89 62.47 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 m -69.36 -26.88 64.9 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.936 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.69 28.94 33.73 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.697 -0.763 . . . . 0.0 114.996 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.45 38.5 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.502 1.151 . . . . 0.0 111.99 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . 3.2 mm? -110.15 131.61 54.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.93 0.395 . . . . 0.0 111.306 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.68 121.64 37.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.645 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -82.78 133.15 35.15 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.974 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.5 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 18.6 tt -78.29 159.63 4.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.119 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.5 p -108.61 82.76 1.79 Allowed Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 48.1 Cg_endo -90.08 -169.9 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.126 2.55 . . . . 0.0 112.244 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -127.94 156.2 43.02 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.557 0.218 . . . . 0.0 110.921 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -57.52 -45.62 84.77 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.672 0.272 . . . . 0.0 110.946 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.6 -23.13 64.45 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.637 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.477 ' CE2' ' CH2' ' A' ' 94' ' ' TRP . 8.6 t80 -79.23 -59.19 2.87 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.501 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 23.2 tt0 -55.65 -38.2 69.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.705 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -76.71 -34.58 58.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.682 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.87 -31.8 1.37 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.427 HD11 ' CE2' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -126.21 -90.1 0.55 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.123 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.451 ' O ' ' CD1' ' A' ' 94' ' ' TRP . 2.4 m-85 -136.26 111.24 9.97 Favored Pre-proline 0 CA--C 1.53 0.192 0 O-C-N 122.005 -0.434 . . . . 0.0 111.686 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 90' ' ' TYR . 19.3 Cg_endo -57.45 -22.34 50.03 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.592 2.195 . . . . 0.0 112.504 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -56.94 -53.81 53.82 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.578 0.228 . . . . 0.0 111.589 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.41 ' CB ' ' HG3' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -62.19 -45.51 93.05 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 110.267 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.501 ' CE2' ' HA ' ' A' ' 86' ' ' GLN . 71.7 m95 -60.26 -40.39 90.18 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 121.7 0.762 . . . . 0.0 109.861 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.78 -22.08 61.63 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.953 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.43 ' O ' ' CE1' ' A' ' 64' ' ' HIS . . . -75.59 -17.67 59.96 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 105' ' ' ALA . 13.1 m -121.74 46.22 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -128.92 139.54 52.08 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.42 0.554 . . . . 0.0 109.533 178.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -142.55 114.37 8.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 119.178 0.899 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 78.21 25.96 0.59 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.74 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.48 -27.98 17.96 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.998 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -102.34 163.85 12.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.561 0.681 . . . . 0.0 111.226 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -91.08 137.99 31.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.83 0.348 . . . . 0.0 110.616 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 15.6 tt -137.57 48.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.344 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HA ' ' HA2' ' A' ' 265' ' ' GLY . . . 159.61 -177.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 264' ' ' ALA . 49.5 m-85 -142.29 122.82 8.31 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.633 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.524 ' HA ' ' CB ' ' A' ' 263' ' ' SER . 88.5 Cg_endo -79.48 166.13 22.38 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.271 1.98 . . . . 0.0 112.37 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.61 ' N ' ' O ' ' A' ' 262' ' ' LEU . 3.1 tt -168.61 39.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.136 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.599 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' A' ' 301' ' ' ALA . . . 176.08 122.37 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.443 ' HB ' ' CG1' ' A' ' 302' ' ' VAL . 11.3 p -113.7 105.62 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.514 ' HA ' ' CG2' ' A' ' 320' ' ' THR . 2.0 mp0 -103.08 162.91 12.56 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.672 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -164.86 150.1 9.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.591 0.71 . . . . 0.0 112.131 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.467 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 2.6 pp -79.51 126.9 31.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.3 171.72 11.24 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 122.178 -0.326 . . . . 0.0 111.118 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.443 HD22 ' O ' ' A' ' 225' ' ' THR . 1.3 tt -110.99 136.29 50.22 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' A' ' 116' ' ' ILE . 3.3 mp -112.11 128.8 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.456 ' CD2' ' OG1' ' A' ' 245' ' ' THR . 22.6 m-30 -110.36 134.87 51.88 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -84.41 119.12 24.75 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -109.54 29.21 7.78 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.715 0.293 . . . . 0.0 111.675 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.1 -54.0 1.12 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -136.74 0.02 OUTLIER 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.406 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -84.27 128.96 59.96 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 41.4 Cg_exo -55.91 161.45 8.39 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.411 2.74 . . . . 0.0 111.604 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.504 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 4.9 p-10 -101.38 169.25 7.98 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.858 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 50.1 Cg_exo -53.84 167.55 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.675 2.25 . . . . 0.0 111.915 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -92.53 -118.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 122.816 2.344 . . . . 0.0 112.868 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.38 -18.17 36.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.309 0.959 . . . . 0.0 111.747 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.75 141.25 48.61 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -69.71 -25.82 64.04 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 173.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.525 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.4 OUTLIER -44.83 -23.9 0.17 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.989 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.78 -23.48 62.4 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.43 ' HA ' ' OD1' ' A' ' 136' ' ' ASP . 1.5 mp -40.44 -60.23 1.62 Allowed Pre-proline 0 N--CA 1.477 0.906 0 CA-C-O 121.446 0.641 . . . . 0.0 111.425 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 67.5 Cg_exo -46.45 -40.87 23.23 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 120.891 1.06 . . . . 0.0 109.861 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.3 -58.84 3.03 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.03 -36.79 80.52 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.393 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' ' 132' ' ' ILE . 1.3 m-20 -74.16 -40.53 62.52 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 3.0 ttpt -49.87 -46.78 51.86 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 118.949 -1.1 . . . . 0.0 109.29 177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.59 -37.1 84.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.194 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.581 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 0.2 OUTLIER -62.43 -47.86 82.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -47.59 -45.14 27.05 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -46.06 -24.43 0.43 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -99.01 -57.63 2.13 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.04 39.57 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.717 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.673 ' HB2' ' O ' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -174.04 177.28 2.38 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.703 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.424 ' O ' ' CD2' ' A' ' 139' ' ' LEU . 0.4 OUTLIER -107.1 177.66 4.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.754 ' O ' ' C ' ' A' ' 223' ' ' ALA . . . -86.84 -14.25 42.65 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 224' ' ' MET . 2.5 pp -138.95 128.68 24.78 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.4 ' O ' ' CG2' ' A' ' 225' ' ' THR . 2.1 tpt -132.47 136.29 46.6 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.471 ' O ' ' C ' ' A' ' 150' ' ' ASN . 6.2 t80 -171.63 173.66 4.59 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.948 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.548 ' O ' ' O ' ' A' ' 208' ' ' THR . 2.5 m120 -23.08 -70.34 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 0.1 OUTLIER 97.53 38.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.88 0.872 . . . . 0.0 109.226 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.404 ' HB3' ' O ' ' A' ' 151' ' ' LEU . 4.2 pt20 172.36 34.73 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 117.637 -1.173 . . . . 0.0 114.113 170.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' OG1' ' A' ' 157' ' ' THR . 13.5 mt-10 -102.59 151.04 38.19 Favored Pre-proline 0 C--O 1.218 -0.589 0 CA-C-N 122.349 2.34 . . . . 0.0 116.025 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.923 ' O ' ' N ' ' A' ' 156' ' ' PHE . 65.9 Cg_endo -78.14 -134.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 1 C-N-CA 125.922 4.415 . . . . 0.0 106.285 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 1.149 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 12.9 m-85 26.08 -60.33 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 119.335 0.97 . . . . 0.0 113.431 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.923 ' N ' ' O ' ' A' ' 154' ' ' PRO . 56.1 m-85 -83.48 -56.6 3.65 Favored 'General case' 0 C--O 1.257 1.471 0 C-N-CA 123.65 0.78 . . . . 0.0 112.097 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.859 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 27.8 p -59.33 -40.5 86.51 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.215 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.486 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 29.4 m0 -52.41 -55.48 31.45 Favored Pre-proline 0 C--N 1.352 0.703 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 1.149 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 86.2 Cg_exo -43.39 -49.26 7.68 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.68 2.253 . . . . 0.0 112.241 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mt -56.91 -56.89 15.88 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 119.514 1.052 . . . . 0.0 109.341 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.436 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 4.4 mt -51.57 -20.94 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.095 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 256' ' ' LYS . . . -83.97 -19.45 34.57 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.045 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.495 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -46.79 -47.11 20.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.532 ' CB ' ' CA ' ' A' ' 187' ' ' GLY . 6.6 m-20 -65.29 -58.32 6.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 120.744 1.611 . . . . 0.0 112.831 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.78 31.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.085 -1.531 . . . . 0.0 115.181 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.3 100.36 1.63 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.111 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.416 ' O ' ' CA ' ' A' ' 183' ' ' VAL . 60.9 m-85 -77.72 151.09 34.32 Favored 'General case' 0 C--N 1.337 0.048 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.15 -72.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.556 ' HB3' ' CD2' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -111.99 169.83 8.57 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.903 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 1.167 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.5 OUTLIER -102.25 111.48 23.78 Favored 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.424 ' CE1' ' HG2' ' A' ' 328' ' ' GLU . 28.6 m-85 -84.26 115.03 22.25 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.914 -1.494 . . . . 0.0 108.616 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.928 ' O ' ' N ' ' A' ' 174' ' ' GLY . 5.4 mm-40 -137.1 101.59 4.6 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.52 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 41.54 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 123.93 0.769 . . . . 0.0 110.475 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.928 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -75.2 -73.35 0.97 Allowed Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -175.87 143.51 0.58 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.768 1.284 . . . . 0.0 111.154 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 1.167 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 21.8 p90 -45.4 -32.51 2.13 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.061 0.934 . . . . 0.0 109.609 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 40.8 t0 59.38 -98.3 0.08 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.773 -1.558 . . . . 0.0 111.592 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.409 ' O ' HG13 ' A' ' 178' ' ' ILE . 7.4 tp -176.77 32.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -132.54 -18.5 2.48 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.079 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 3.7 m-20 -121.87 93.02 3.86 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.445 ' CG2' ' CD1' ' A' ' 368' ' ' ILE . 29.0 m -116.72 116.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.85 39.77 2.39 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.617 -1.277 . . . . 0.0 113.494 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 188' ' ' ALA . 11.5 p -79.92 -46.13 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -75.59 54.49 0.77 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.751 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.6 -171.79 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -49.82 -37.33 30.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.773 0.797 . . . . 0.0 111.807 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.532 ' CA ' ' CB ' ' A' ' 164' ' ' ASP . . . -75.38 -37.14 42.41 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.583 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 183' ' ' VAL . . . -64.17 -42.9 96.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -50.3 -40.26 48.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.094 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 194' ' ' PHE . . . -69.59 -47.64 62.86 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -66.7 -60.47 6.14 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.189 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.8 tt -50.04 -39.37 41.56 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 98.8 m -75.78 -42.33 50.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.431 ' HB3' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -60.17 -35.66 75.84 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -47.04 78.58 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.7 t -56.38 -30.6 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.968 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -62.62 -47.57 83.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.827 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.0 mt -62.75 -59.1 5.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.663 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 33.5 mm -52.01 -47.96 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.651 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -59.69 -34.56 73.04 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.91 0.77 52.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -120.33 -80.77 0.63 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.722 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -120.19 -26.54 5.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 75.91 14.03 2.69 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.81 0.277 . . . . 0.0 111.369 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -144.39 -59.56 0.38 Allowed 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 67.09 81.08 0.2 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.39 -2.7 35.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.42 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.548 ' O ' ' O ' ' A' ' 150' ' ' ASN . 27.5 m -56.88 127.05 29.79 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 213' ' ' ALA . 2.8 p-10 -101.65 -175.67 2.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.632 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.5 p90 -69.35 -45.28 69.78 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.208 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.422 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -77.12 -26.72 53.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.428 0.633 . . . . 0.0 111.133 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.463 HD13 HG22 ' A' ' 212' ' ' ILE . 5.7 mt -81.56 -51.53 15.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.857 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -54.82 -33.7 61.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -48.89 76.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.75 65.67 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.065 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.31 -55.95 20.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.103 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -60.25 -31.41 70.18 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.01 -39.87 69.53 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -23.78 58.89 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.18 61.0 3.87 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 11.7 pt-20 -123.55 37.92 4.31 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 123.049 1.404 . . . . 0.0 111.534 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.467 ' O ' ' CB ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER -92.56 -166.06 1.47 Allowed 'General case' 0 N--CA 1.424 -1.751 2 C-N-CA 135.562 5.545 . . . . 0.0 121.939 -170.204 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.767 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . 158.7 34.58 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.14 1 CA-C-N 104.421 -5.808 . . . . 0.0 112.062 168.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.767 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 158.38 131.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 174.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.443 ' O ' HD22 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -148.57 155.45 41.13 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.42 ' CG2' ' HG ' ' A' ' 115' ' ' LEU . 10.3 pt -115.88 112.47 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.809 1.186 . . . . 0.0 108.503 174.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 2.2 p-10 -147.93 165.23 31.31 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-O 118.95 -0.548 . . . . 0.0 112.411 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -122.85 -176.36 14.88 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.575 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 74.7 Cg_exo -47.43 -32.4 15.13 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.533 2.156 . . . . 0.0 112.354 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -47.14 -43.15 20.55 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.26 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.62 41.15 3.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.639 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.424 ' HA ' ' CE3' ' A' ' 232' ' ' TRP . 0.0 OUTLIER -93.04 -44.03 8.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.801 0.334 . . . . 0.0 110.758 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.8 m -69.6 -33.53 72.82 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.229 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.54 -42.06 6.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.618 0.247 . . . . 0.0 111.419 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.4 -60.77 2.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.954 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 44.91 42.37 6.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.575 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.62 -71.89 0.34 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.93 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.92 42.02 11.63 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.377 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.0 -72.11 0.09 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.017 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.56 -53.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -126.84 119.5 26.97 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.638 0.256 . . . . 0.0 111.0 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -108.46 155.36 20.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.83 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -122.36 111.52 1.8 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.671 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.1 t -91.04 135.28 27.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.685 0.242 . . . . 0.0 110.46 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.456 ' OG1' ' CD2' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -137.17 167.28 21.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.914 0.485 . . . . 0.0 111.798 -173.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.06 152.68 7.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.48 159.66 16.3 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 121.279 1.854 . . . . 0.0 110.132 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.94 -165.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.47 2.114 . . . . 0.0 112.069 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.484 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -112.95 175.72 5.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.813 0.339 . . . . 0.0 111.68 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.495 ' HB2' ' CB ' ' A' ' 163' ' ' ALA . 97.3 m-85 -164.13 110.38 1.06 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.364 0.602 . . . . 0.0 109.384 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt 61.18 34.19 18.97 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.521 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.05 40.63 34.4 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.899 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -156.99 158.68 31.34 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.486 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 79.9 Cg_endo -93.98 160.81 2.18 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.887 3.058 . . . . 0.0 111.776 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 1.3 p -84.43 156.05 21.96 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 162' ' ' ALA . 6.1 tmmm? -85.93 112.95 48.89 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.181 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.474 ' HG2' ' CA ' ' A' ' 327' ' ' GLY . 71.6 Cg_endo -84.59 145.0 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.829 2.353 . . . . 0.0 112.417 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.458 ' CD2' ' HA ' ' A' ' 155' ' ' TYR . 1.3 m-85 -79.64 148.79 31.51 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.6 ' CG2' ' HA ' ' A' ' 329' ' ' ILE . 1.9 m -104.8 139.69 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -176.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -125.25 118.85 3.38 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 118.787 -1.673 . . . . 0.0 116.985 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -129.87 97.62 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 176.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.61 ' O ' ' N ' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -78.19 115.3 17.82 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.524 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 53.6 p -133.87 138.59 45.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 60' ' ' ILE . . . -89.74 109.65 20.61 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 105' ' ' ALA . . . -97.75 165.42 22.2 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 176.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 10.4 mt -91.13 123.3 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 118.495 1.148 . . . . 0.0 108.022 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -61.97 138.19 58.34 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.987 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -51.13 -18.42 0.86 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.705 1.139 . . . . 0.0 110.892 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -56.5 -37.79 70.89 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.49 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 78.8 82.74 0.1 OUTLIER Pre-proline 0 N--CA 1.463 0.221 0 CA-C-O 120.769 0.319 . . . . 0.0 110.9 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -91.65 99.76 0.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.24 2.627 . . . . 0.0 112.612 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 47.83 73.44 0.2 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.797 0.332 . . . . 0.0 110.629 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 5.4 mttm -53.1 -54.05 41.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.656 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 13.5 mm-40 -63.28 -57.4 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 9.0 tt -65.66 -57.93 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.44 ' HA ' ' CE2' ' A' ' 279' ' ' PHE . . . -60.45 -56.73 17.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 7.3 ttpp -60.69 -30.31 69.86 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 2.4 tt0 -76.41 -52.82 9.13 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.532 ' CD1' ' CE2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -57.2 -50.0 74.23 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.781 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 279' ' ' PHE . 2.1 tp -56.94 -43.08 81.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.622 0.725 . . . . 0.0 111.227 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -73.42 -34.78 65.64 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.664 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -93.88 -14.02 26.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.416 ' N ' ' O ' ' A' ' 279' ' ' PHE . 26.1 t80 -109.13 -63.14 1.39 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 283' ' ' TYR . 0.2 OUTLIER -39.92 -31.82 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.983 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.01 42.53 1.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.737 0.303 . . . . 0.0 111.131 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.9 p -144.18 155.1 43.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 1.0 OUTLIER -64.42 -13.57 51.99 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.586 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 1.1 mp0 -77.91 -47.47 18.59 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 117.999 0.363 . . . . 0.0 110.149 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.407 ' O ' HG11 ' A' ' 293' ' ' VAL . . . -84.23 -55.03 2.84 Favored Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 304' ' ' LEU . 10.7 tp -47.42 -51.57 19.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.538 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 8.6 tt0 -79.23 -26.21 42.54 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.616 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -68.54 -40.15 80.83 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 290' ' ' LEU . 3.0 p -67.97 -61.45 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.436 ' O ' ' CG ' ' A' ' 297' ' ' LYS . 16.5 t30 -37.57 -50.91 1.16 Allowed 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.408 1.483 . . . . 0.0 112.289 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -60.08 -45.69 92.06 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.4 OUTLIER -57.87 -52.59 64.84 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -42.48 162.49 0.16 Allowed Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.359 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.07 -72.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.0 2.467 . . . . 0.0 113.405 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.448 ' N ' ' HD2' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -157.78 -62.99 0.09 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.536 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.488 ' HA2' HG13 ' A' ' 317' ' ' ILE . . . -79.87 138.83 20.66 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.951 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . 168.56 -172.95 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.443 ' CG1' ' HB ' ' A' ' 110' ' ' VAL . 8.3 p -178.04 137.38 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.22 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 304' ' ' LEU . . . 167.59 96.04 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 307' ' ' TYR . 5.9 tp 96.59 116.73 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.234 0.614 . . . . 0.0 110.752 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 304' ' ' LEU . 13.9 ttmt -26.54 -64.44 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.569 0.543 . . . . 0.0 111.12 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.2 m -48.3 -40.82 26.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.8 0.809 . . . . 0.0 110.277 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.586 ' N ' ' O ' ' A' ' 304' ' ' LEU . 42.5 t80 -75.85 -33.58 60.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.005 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 305' ' ' LYS . 7.0 pt-20 -72.51 -41.31 66.06 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 120.561 -0.456 . . . . 0.0 109.987 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.65 -56.93 6.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.14 -57.38 8.87 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.722 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.532 HD22 ' CE2' ' A' ' 307' ' ' TYR . 2.7 pp -61.52 -43.0 99.65 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.154 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 313' ' ' LYS . . . -46.78 -29.67 2.05 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -35.54 -41.52 0.2 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.719 0.295 . . . . 0.0 110.886 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.05 127.89 85.92 Favored Pre-proline 0 CA--C 1.528 0.126 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.38 -22.69 34.85 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.614 2.209 . . . . 0.0 113.714 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.401 ' O ' ' OG1' ' A' ' 320' ' ' THR . 18.2 mtm180 -60.7 -59.12 5.89 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.488 HG13 ' HA2' ' A' ' 300' ' ' GLY . 2.6 mp -49.82 -55.8 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.89 -52.0 12.18 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.08 0.4 . . . . 0.0 111.659 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.15 -41.48 92.86 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.843 0.83 . . . . 0.0 109.738 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 111' ' ' GLU . 1.5 m -60.9 -41.94 97.07 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.614 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -77.13 -39.43 49.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.69 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.08 -41.73 79.37 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.852 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.404 ' CB ' ' HB2' ' A' ' 112' ' ' ALA . 2.8 m120 -75.58 -42.01 53.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.715 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.73 -42.43 91.04 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.852 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.1 -31.84 53.19 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.278 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -100.61 41.59 1.17 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.592 0.234 . . . . 0.0 111.15 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.474 ' CA ' ' HG2' ' A' ' 257' ' ' PRO . . . -120.85 172.11 15.0 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.992 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.424 ' HG2' ' CE1' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -94.46 138.38 32.46 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 175.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.6 ' HA ' ' CG2' ' A' ' 259' ' ' VAL . 1.3 pp -83.62 109.56 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 119.105 0.866 . . . . 0.0 112.226 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.422 ' CE ' ' HA ' ' A' ' 330' ' ' MET . 0.0 OUTLIER -44.14 98.48 0.18 Allowed Pre-proline 0 C--N 1.344 0.348 0 CA-C-O 120.791 0.329 . . . . 0.0 110.802 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.647 ' HG2' ' CE1' ' A' ' 176' ' ' TYR . 32.5 Cg_exo -60.79 -42.48 38.08 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.002 2.468 . . . . 0.0 112.045 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 331' ' ' PRO . 3.0 t30 86.34 93.08 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.457 HG12 ' CE2' ' A' ' 176' ' ' TYR . 1.9 pp -133.82 146.69 61.24 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 118.457 0.571 . . . . 0.0 110.833 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.64 -48.19 16.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.782 2.321 . . . . 0.0 113.319 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -54.2 -21.43 8.9 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 12.5 mtt -45.49 -35.63 3.95 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.892 0.315 . . . . 0.0 111.459 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 m -58.29 -34.17 70.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 110.482 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.49 82.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.065 0.459 . . . . 0.0 111.709 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.456 ' CE2' ' CD1' ' A' ' 368' ' ' ILE . 0.1 OUTLIER -78.4 -55.69 5.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.614 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -44.67 -45.14 9.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.327 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -76.01 -43.47 44.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.27 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.49 90.86 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 347' ' ' VAL . 13.9 p -76.85 -29.92 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.555 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -46.76 57.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.556 ' HA ' HG22 ' A' ' 348' ' ' ILE . 29.9 p -62.77 -57.82 9.6 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.79 -38.87 4.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.63 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 343' ' ' VAL . 24.8 t -60.76 -57.2 13.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.556 HG22 ' HA ' ' A' ' 345' ' ' THR . 3.5 tt -60.06 -27.85 39.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.8 OUTLIER -63.84 -30.13 71.25 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.423 ' HA ' ' CG ' ' A' ' 355' ' ' GLN . . . -75.52 -46.14 33.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -84.18 -9.8 58.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 348' ' ' ILE . 86.7 p -97.8 -49.76 4.69 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 147.52 -2.92 0.82 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 117.923 -2.084 . . . . 0.0 117.404 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.74 34.3 4.66 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 115.328 -2.549 . . . . 0.0 115.818 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.475 ' HB3' ' C ' ' A' ' 349' ' ' ASN . 1.0 OUTLIER -72.12 -130.01 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 129.855 3.262 . . . . 0.0 106.476 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.652 ' N ' ' HB1' ' A' ' 360' ' ' ALA . 0.0 OUTLIER 153.12 86.57 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.249 1 N-CA-C 94.539 -6.097 . . . . 0.0 94.539 177.091 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.565 ' C ' ' O ' ' A' ' 356' ' ' THR . 1.3 p -40.26 -60.72 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.46 0 CA-C-N 122.833 2.56 . . . . 0.0 112.491 -166.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -72.9 -44.48 61.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.48 -38.92 62.76 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.02 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.652 ' HB1' ' N ' ' A' ' 356' ' ' THR . . . -62.18 -50.34 72.19 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.25 -36.27 69.02 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.564 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -56.07 15.17 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.254 1.026 . . . . 0.0 110.059 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.434 ' O ' ' HB ' ' A' ' 366' ' ' THR . 13.5 t0 -62.63 -36.01 81.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.522 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -49.78 -43.07 48.05 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -43.16 98.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.359 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 363' ' ' ASP . 23.6 m -50.46 -42.58 54.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.322 0.582 . . . . 0.0 110.193 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -60.17 3.49 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.098 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.46 HD11 HG21 ' A' ' 368' ' ' ILE . 17.8 pt -58.4 -27.01 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.993 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.403 HG22 HG23 ' A' ' 181' ' ' VAL . 77.4 p -118.26 48.26 1.45 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.825 0.345 . . . . 0.0 110.513 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.693 0.282 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.32 179.81 6.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -137.07 47.56 0.95 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.413 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -149.6 155.34 40.11 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -152.12 117.64 5.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 58' ' ' ASP . 47.6 t -111.61 135.94 49.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.127 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.993 HG23 HG13 ' A' ' 37' ' ' VAL . 11.7 tt -132.3 127.45 57.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.329 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.712 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -103.53 126.77 50.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.407 178.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.896 HD13 ' HB3' ' A' ' 61' ' ' PHE . 4.6 mm -146.35 139.19 20.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 12' ' ' ASN . 2.0 p-10 -112.84 39.79 2.44 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.816 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.47 -11.43 35.86 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.636 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.9 t70 65.92 68.82 0.45 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.15 0.475 . . . . 0.0 110.395 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 162.64 -172.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.167 0.508 . . . . 0.0 111.74 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.06 22.73 67.84 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 116.26 1.264 . . . . 0.0 116.26 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -35.33 33.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.972 0.886 . . . . 0.0 111.205 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 11.3 t30 -65.54 -52.57 51.49 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 111.786 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.919 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.61 -48.96 26.52 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.83 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.763 ' CD1' HG21 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -59.5 -50.51 73.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.904 0.852 . . . . 0.0 110.331 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.97 -37.87 87.1 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 56.7 mt-10 -66.28 -36.84 84.01 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.46 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 19' ' ' GLY . 41.0 t -68.03 -61.61 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.96 -0.462 . . . . 0.0 110.46 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . -49.22 -35.16 19.28 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.288 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -50.14 67.42 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 122.515 1.15 . . . . 0.0 108.479 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -52.1 -43.21 63.8 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.32 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.783 ' HB3' HD13 ' A' ' 33' ' ' ILE . 1.5 m-30 -65.77 -29.71 70.25 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.762 0.791 . . . . 0.0 111.013 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.797 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 1.1 tm-20 -71.14 -52.54 18.69 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.029 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -52.36 -28.42 19.42 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 125.159 1.537 . . . . 0.0 111.245 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.78 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -86.07 -37.5 18.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.188 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.78 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 3.5 t 160.0 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.801 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.75 38.55 0.02 OUTLIER Glycine 0 N--CA 1.465 0.581 0 C-N-CA 114.712 -3.613 . . . . 0.0 119.318 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.801 HD12 ' C ' ' A' ' 32' ' ' GLY . 1.6 mp -139.92 134.98 37.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 121.576 2.688 . . . . 0.0 115.422 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -140.89 104.76 4.75 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.763 HG21 ' CD1' ' A' ' 20' ' ' LEU . 9.4 p -103.7 134.1 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.473 ' OG1' HG22 ' A' ' 8' ' ' VAL . 34.5 p -118.33 146.82 44.07 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.136 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.993 HG13 HG23 ' A' ' 9' ' ' ILE . 9.5 t -130.9 120.79 48.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.517 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 30.8 tt0 -112.99 144.44 42.57 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -131.79 73.9 78.2 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.724 0.297 . . . . 0.0 111.236 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.786 ' HD2' HD12 ' A' ' 43' ' ' LEU . 43.0 Cg_endo -89.98 -173.75 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.057 2.505 . . . . 0.0 112.82 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -96.01 -40.31 9.33 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -85.38 0.35 52.42 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.619 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.786 HD12 ' HD2' ' A' ' 40' ' ' PRO . 4.9 tt -21.57 -45.97 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 1.062 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 1.5 pp20? -68.68 -54.16 17.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.399 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 3.5 tt0 -69.66 -41.22 75.83 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.055 0.455 . . . . 0.0 109.797 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' O ' HG13 ' A' ' 50' ' ' VAL . 9.5 mtpt -56.28 -56.24 23.49 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.011 0.91 . . . . 0.0 109.834 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.612 ' CG ' HG12 ' A' ' 60' ' ' ILE . 1.3 t80 -44.15 -61.26 2.14 Favored Pre-proline 0 C--N 1.349 0.556 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.127 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 1.062 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 37.0 Cg_exo -61.5 -25.36 79.55 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 121.347 1.365 . . . . 0.0 113.341 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -81.58 -37.1 28.22 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 122.143 0.973 . . . . 0.0 111.034 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 46' ' ' LYS . 19.2 m -77.28 -40.0 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.59 0 CA-C-O 122.001 0.905 . . . . 0.0 109.797 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.78 -37.98 32.26 Favored 'General case' 0 C--N 1.374 1.666 0 C-N-CA 126.074 1.75 . . . . 0.0 110.999 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.25 -40.64 23.45 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-N 114.144 -1.389 . . . . 0.0 113.519 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -63.22 1.15 Allowed 'General case' 0 C--N 1.346 0.429 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.015 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.08 69.39 0.05 OUTLIER Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.216 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -96.37 -64.94 1.0 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.8 -120.78 5.58 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.661 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 72.4 Cg_exo -49.83 109.56 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.187 1.925 . . . . 0.0 110.978 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 15.6 t0 159.27 113.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.608 0.363 . . . . 0.0 110.77 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 265' ' ' GLY . 0.7 OUTLIER -98.5 173.24 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.957 -177.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.815 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -131.06 130.08 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.697 -177.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.896 ' HB3' HD13 ' A' ' 11' ' ' ILE . 70.2 t80 -121.8 112.21 18.08 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -166.84 161.94 15.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HA ' HD23 ' A' ' 262' ' ' LEU . . . -34.95 151.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.791 ' HB3' HG23 ' A' ' 261' ' ' VAL . 2.7 t60 -77.26 -28.94 53.69 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD2' ' HE1' ' A' ' 330' ' ' MET . 33.5 m-20 -47.37 -59.29 3.31 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.6 mtp85 -78.51 -26.95 45.99 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.712 -0.617 . . . . 0.0 109.648 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.946 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.64 -28.69 70.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -61.97 -58.74 11.47 Favored Glycine 0 CA--C 1.49 -1.495 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.29 -60.43 8.84 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 111.848 -2.176 . . . . 0.0 111.598 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.642 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 22.2 m-85 -48.81 -37.56 19.62 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.007 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . . . -56.5 -38.95 72.47 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.338 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -78.51 -56.3 4.54 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.342 -0.224 . . . . 0.0 111.556 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 m -113.91 -27.19 7.83 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.642 ' HA3' ' HA ' ' A' ' 70' ' ' TYR . . . -63.41 -89.7 0.03 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.861 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.094 ' C ' ' HB2' ' A' ' 268' ' ' ALA . 0.2 OUTLIER -179.02 63.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.007 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -116.36 140.11 49.68 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 173.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.959 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . -90.33 88.13 7.08 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.763 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HA ' ' CG1' ' A' ' 104' ' ' ILE . 1.2 mt-10 -47.36 100.09 0.02 OUTLIER 'General case' 0 C--O 1.23 0.076 0 CA-C-O 120.821 0.343 . . . . 0.0 110.434 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 104' ' ' ILE . 4.4 mt -47.66 159.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.554 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.586 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -88.26 175.15 4.37 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 80' ' ' THR . 76.1 Cg_endo -79.76 133.56 10.38 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.344 2.029 . . . . 0.0 113.399 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.71 -170.11 2.15 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.809 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 -78.18 0.59 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.237 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.03 -23.02 67.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -62.12 -59.31 5.24 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.77 0.319 . . . . 0.0 110.236 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -77.08 -28.43 54.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.71 -10.84 59.67 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -92.26 -18.19 23.75 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.754 HD22 ' CD1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -90.59 -176.84 4.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.277 0.49 . . . . 0.0 111.297 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.557 ' CB ' ' CZ3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -94.49 165.72 16.81 Favored Pre-proline 0 C--N 1.341 0.238 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.581 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 6.3 Cg_exo -75.4 -24.09 12.53 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.826 2.351 . . . . 0.0 115.248 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CE1' ' NE2' ' A' ' 325' ' ' GLN . 4.2 m-85 -87.31 -63.5 1.3 Allowed 'General case' 0 C--O 1.245 0.832 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.925 HG21 HG21 ' A' ' 302' ' ' VAL . 0.2 OUTLIER -63.19 -24.68 67.99 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.02 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.754 ' CD1' HD22 ' A' ' 89' ' ' LEU . 5.9 m-90 -93.75 -24.31 17.86 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.48 0.712 . . . . 0.0 111.345 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 8.1 t0 -73.63 -23.53 59.89 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.653 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.641 ' HB3' HG11 ' A' ' 261' ' ' VAL . . . -62.91 -42.95 99.96 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.904 HG23 HG11 ' A' ' 261' ' ' VAL . 44.5 t -108.62 54.13 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . 0.9 OUTLIER -130.85 140.28 50.23 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.03 -0.419 . . . . 0.0 110.786 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 101' ' ' GLY . 57.0 m-85 -112.34 174.72 5.75 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -48.05 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 56.16 38.14 75.65 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.268 -0.968 . . . . 0.0 110.752 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 -177.27 5.5 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 97' ' ' VAL . 0.7 OUTLIER 168.34 130.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.913 ' CD1' HD12 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -115.67 38.86 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.426 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 165.22 175.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.767 ' CE1' ' HB3' ' A' ' 264' ' ' ALA . 5.3 p90 -117.51 133.41 23.26 Favored Pre-proline 0 C--N 1.343 0.288 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.985 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.855 ' O ' HD13 ' A' ' 108' ' ' ILE . 96.0 Cg_endo -79.37 149.76 21.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.433 2.088 . . . . 0.0 113.315 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 107' ' ' PRO . 1.3 mm -149.32 38.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.009 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.913 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 177.33 124.65 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.399 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.6 HG22 HG22 ' A' ' 320' ' ' THR . 4.1 p -107.01 114.99 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.325 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 229' ' ' PRO . 18.6 mt-10 -99.36 132.79 44.44 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.641 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -168.3 -174.13 2.18 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.493 1.517 . . . . 0.0 110.077 -167.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.569 HD23 HG13 ' A' ' 226' ' ' ILE . 2.0 tp -146.65 136.98 23.73 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 111.542 -2.572 . . . . 0.0 116.35 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.874 ' O ' HD12 ' A' ' 226' ' ' ILE . 0.2 OUTLIER -131.42 164.74 25.05 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.59 -178.648 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.497 HD12 ' HD3' ' A' ' 248' ' ' PRO . 0.9 OUTLIER -92.6 132.17 37.09 Favored 'General case' 0 C--N 1.342 0.257 0 O-C-N 121.972 -0.455 . . . . 0.0 110.289 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.792 HD11 ' CD2' ' A' ' 242' ' ' TYR . 19.1 tt -113.88 131.19 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.258 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -104.24 132.64 50.27 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.753 ' CB ' ' HB2' ' A' ' 122' ' ' LEU . 45.8 m-80 -87.29 123.98 32.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.203 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -98.03 -87.98 0.32 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 119' ' ' LYS . 26.4 t0 -19.72 -63.67 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.776 HD12 ' HG ' ' A' ' 122' ' ' LEU . 2.5 pp -125.87 38.9 4.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.776 ' HG ' HD12 ' A' ' 121' ' ' LEU . 90.9 mt -158.41 113.22 1.7 Allowed Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.101 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -92.63 124.17 0.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.196 1.264 . . . . 0.0 111.45 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.575 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 11.9 p-10 -97.47 161.64 25.28 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 81.5 Cg_endo -77.1 167.86 24.25 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.676 2.917 . . . . 0.0 112.315 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.34 -47.94 0.08 OUTLIER 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.084 2.522 . . . . 0.0 113.654 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.663 ' CE ' HG23 ' A' ' 128' ' ' THR . 0.4 OUTLIER -155.63 -10.06 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -178.127 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.663 HG23 ' CE ' ' A' ' 127' ' ' LYS . 1.4 p -117.2 140.21 49.82 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.218 0.917 . . . . 0.0 113.278 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.604 ' O ' HD12 ' A' ' 132' ' ' ILE . 1.8 m0 -71.14 -27.73 63.77 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.486 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.5 OUTLIER -44.61 -24.0 0.16 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.682 ' HB3' HD12 ' A' ' 135' ' ' LEU . 3.4 mp0 -63.19 -23.3 67.37 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.778 HD13 HD11 ' A' ' 198' ' ' LEU . 5.8 mt -40.52 -59.73 1.86 Allowed Pre-proline 0 N--CA 1.477 0.924 0 CA-C-O 121.11 0.481 . . . . 0.0 112.147 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 4.6 Cg_endo -46.63 -45.39 19.87 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 121.251 1.301 . . . . 0.0 110.701 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.13 -58.91 2.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 131' ' ' GLU . 36.9 mt -67.37 -36.84 82.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.68 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.751 ' HA ' HD12 ' A' ' 139' ' ' LEU . 7.7 t0 -73.43 -41.41 63.27 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 5.2 tttt -48.77 -41.94 34.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.123 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 4.0 tm-20 -67.37 -38.1 84.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.189 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.916 HD13 ' N ' ' A' ' 146' ' ' ALA . 1.2 mt -63.18 -47.96 80.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.87 -44.6 29.55 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.05 -24.25 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.601 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -111.7 -60.56 1.83 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.62 46.76 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 CA-C-O 118.777 -1.013 . . . . 0.0 111.379 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.607 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.1 OUTLIER -157.04 -172.41 4.02 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.939 1.87 . . . . 0.0 111.128 -176.149 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.876 ' C ' HD13 ' A' ' 139' ' ' LEU . 49.3 m -139.82 167.17 22.72 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.916 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -83.57 -30.57 26.91 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.695 HD21 ' CG1' ' A' ' 132' ' ' ILE . 0.8 OUTLIER -137.54 127.94 26.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -176.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.852 ' HB3' HG21 ' A' ' 222' ' ' THR . 0.4 OUTLIER -132.21 137.87 47.74 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.975 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 1.026 ' O ' ' O ' ' A' ' 150' ' ' ASN . 7.1 p90 -171.33 174.72 4.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.53 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 1.026 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -20.45 -169.77 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 150' ' ' ASN . 0.1 OUTLIER -168.64 33.58 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.351 -0.843 . . . . 0.0 110.544 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.455 ' CB ' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER 172.05 33.99 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 169.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.879 ' O ' ' OG1' ' A' ' 157' ' ' THR . 14.1 pt-20 -115.16 152.74 47.03 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 121.125 1.784 . . . . 0.0 114.376 -176.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.815 ' O ' ' N ' ' A' ' 156' ' ' PHE . 5.1 Cg_exo -77.27 -136.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 124.643 3.562 . . . . 0.0 105.044 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 1.189 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 20.1 m-85 40.88 -68.37 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 120.51 1.505 . . . . 0.0 112.991 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.815 ' N ' ' O ' ' A' ' 154' ' ' PRO . 2.2 t80 -88.51 -58.63 2.48 Favored 'General case' 0 C--O 1.26 1.616 0 CA-C-N 118.705 0.684 . . . . 0.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.879 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 7.0 p -60.16 -42.92 95.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 118.276 -1.37 . . . . 0.0 107.854 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.453 ' CE3' ' HA ' ' A' ' 158' ' ' TRP . 0.0 OUTLIER -49.65 -55.75 21.04 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 1.189 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 84.0 Cg_exo -43.7 -47.26 9.81 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.025 2.483 . . . . 0.0 113.493 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.672 HD12 ' OG ' ' A' ' 255' ' ' SER . 4.9 mp -60.84 -56.38 21.91 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.07 0.85 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.669 HG22 ' HA ' ' A' ' 188' ' ' ALA . 3.7 mt -51.73 -23.6 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.388 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.452 ' CB ' ' HB2' ' A' ' 256' ' ' LYS . . . -79.83 -22.4 43.04 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.047 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 253' ' ' GLN . . . -42.03 -55.81 3.04 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.543 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 1.3 m-20 -64.19 -51.89 61.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 119.449 1.022 . . . . 0.0 112.393 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 169.34 26.14 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 117.924 -2.084 . . . . 0.0 117.117 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.59 89.65 0.7 Allowed Glycine 0 CA--C 1.522 0.526 0 CA-C-N 119.157 1.479 . . . . 0.0 112.66 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 27.1 m-85 -75.11 157.75 34.21 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.184 0.492 . . . . 0.0 111.061 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.674 ' HA ' HG13 ' A' ' 183' ' ' VAL . . . -61.82 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 111.352 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.893 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 4.9 m-85 -112.98 171.87 7.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.215 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 1.208 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER -101.21 107.96 19.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.13 115.42 23.7 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.577 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.877 ' O ' ' N ' ' A' ' 174' ' ' GLY . 19.7 mt-10 -136.35 101.53 4.7 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.449 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 53.0 t30 44.28 -64.31 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 123.796 0.685 . . . . 0.0 111.079 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.877 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -71.64 -73.35 0.83 Allowed Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 116.016 -0.538 . . . . 0.0 114.172 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -175.19 158.12 2.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.797 0.799 . . . . 0.0 109.688 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 1.208 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 17.4 p90 -44.37 -35.89 2.59 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.006 1.384 . . . . 0.0 109.068 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.577 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 0.9 OUTLIER 72.92 -79.48 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.778 -2.465 . . . . 0.0 110.839 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.743 HD11 HD13 ' A' ' 368' ' ' ILE . 8.1 tp 168.66 -41.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -8.15 51.93 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 4.6 m-20 -119.72 93.84 4.2 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.357 0.98 . . . . 0.0 109.36 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.495 HG11 ' CZ ' ' A' ' 339' ' ' PHE . 2.6 t -116.33 112.41 39.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -118.48 40.05 2.4 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.745 -1.217 . . . . 0.0 113.553 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.708 ' O ' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -79.97 -47.52 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -81.43 57.26 3.21 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.149 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -102.06 179.52 4.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.244 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.09 -30.49 36.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.486 0.66 . . . . 0.0 111.559 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.543 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -74.71 -40.69 36.83 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.39 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -59.69 -48.93 79.74 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -59.62 -60.27 4.11 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.551 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.38 -40.69 50.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.972 0.891 . . . . 0.0 112.004 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -64.86 -60.61 6.69 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.431 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 196' ' ' VAL . 5.6 tp -58.97 -25.79 63.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 3.1 m -61.94 -49.56 75.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.448 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 1.3 p90 -61.28 -35.52 77.55 Favored 'General case' 0 C--N 1.345 0.413 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.88 -46.84 83.09 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 192' ' ' LEU . 44.8 t -57.78 -31.42 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.454 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -45.72 89.35 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.725 0.774 . . . . 0.0 110.841 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.778 HD11 HD13 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -57.85 -54.37 47.63 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.903 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.667 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 10.8 tt -65.98 -35.13 74.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.387 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.07 -38.58 70.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.148 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -113.03 -34.85 5.59 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 120.785 3.624 . . . . 0.0 120.785 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.72 -70.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.514 ' NE2' HD11 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -47.8 -37.11 12.88 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.22 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.1 mtp 61.68 -77.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 203' ' ' HIS . 4.9 t-20 -86.38 -178.75 6.53 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.667 ' HB2' ' CD1' ' A' ' 199' ' ' ILE . . . -155.24 36.44 0.38 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -97.24 -2.81 41.96 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.762 HG22 ' HB2' ' A' ' 213' ' ' ALA . 29.5 m -55.2 118.98 4.83 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.53 -174.28 4.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -70.12 -45.45 66.86 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.69 -33.63 66.63 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.829 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.686 HG22 HG23 ' A' ' 208' ' ' THR . 1.4 mp -77.38 -48.71 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.881 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.762 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -58.1 -32.41 68.07 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.534 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 2.5 tp10 -60.58 -46.3 90.73 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.16 -36.11 74.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.641 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.13 -57.79 11.31 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -61.12 -28.35 69.04 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -53.45 -45.49 69.51 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -23.96 58.96 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.89 53.63 22.23 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.404 -0.817 . . . . 0.0 115.009 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -109.33 37.01 2.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.516 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.852 HG21 ' HB3' ' A' ' 148' ' ' MET . 14.3 t -140.33 140.02 35.53 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.736 ' HA ' HD13 ' A' ' 122' ' ' LEU . . . -104.11 38.53 1.83 Allowed 'General case' 0 C--N 1.349 0.559 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -176.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.613 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 3.0 tmm? 167.69 137.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.597 HG23 ' HB3' ' A' ' 149' ' ' PHE . 89.1 m -147.78 159.92 43.3 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.674 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.874 HD12 ' O ' ' A' ' 114' ' ' SER . 2.3 tp -115.68 112.13 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 232' ' ' TRP . 1.7 p30 -148.07 165.01 32.09 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.877 -0.514 . . . . 0.0 112.152 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 113' ' ' LEU . . . -160.23 -177.75 33.61 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 119.905 -1.14 . . . . 0.0 111.092 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 36.7 Cg_exo -61.93 69.73 0.11 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.225 1.95 . . . . 0.0 111.979 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.86 ' CZ3' ' HB2' ' A' ' 231' ' ' ALA . 9.2 t90 -157.93 -59.6 0.08 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.86 ' HB2' ' CZ3' ' A' ' 230' ' ' TRP . . . -89.69 -34.68 16.15 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.777 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.501 ' CD1' ' HB2' ' A' ' 227' ' ' ASN . 0.3 OUTLIER -124.56 79.93 1.8 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.716 0.293 . . . . 0.0 111.287 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.3 m -71.04 -43.89 66.93 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.316 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -100.5 77.22 1.9 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.476 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 tt -45.7 136.94 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.605 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.09 -172.93 3.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.594 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.49 78.42 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.658 0.266 . . . . 0.0 110.937 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.0 m -113.14 52.58 0.79 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 61.63 112.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.705 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.2 m -52.9 -40.11 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.533 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -83.36 104.3 13.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.716 0.293 . . . . 0.0 110.727 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.792 ' CD2' HD11 ' A' ' 116' ' ' ILE . 47.7 p90 -148.55 142.54 25.87 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.336 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -85.53 162.7 36.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.075 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.8 106.49 13.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.911 0.356 . . . . 0.0 111.524 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.56 166.9 16.43 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -172.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.8 154.21 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.169 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.849 HD12 HD11 ' A' ' 226' ' ' ILE . 0.1 OUTLIER -58.23 156.17 22.51 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 120.327 1.421 . . . . 0.0 110.256 -178.29 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.497 ' HD3' HD12 ' A' ' 115' ' ' LEU . 72.2 Cg_endo -79.44 -165.97 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.532 2.155 . . . . 0.0 112.466 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 40.8 p -106.3 168.16 9.34 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.308 0.575 . . . . 0.0 111.444 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' A' ' 253' ' ' GLN . 0.5 OUTLIER -166.05 126.44 1.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.851 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 36.93 31.11 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.992 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.447 ' O ' ' NE2' ' A' ' 253' ' ' GLN . . . 81.36 27.49 48.05 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.612 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.476 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 60.5 mm-40 -156.6 151.17 20.34 Favored Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 117.479 0.639 . . . . 0.0 112.661 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -91.89 138.88 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.392 2.728 . . . . 0.0 112.093 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.672 ' OG ' HD12 ' A' ' 160' ' ' LEU . 52.6 m -57.85 142.7 45.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.201 0.524 . . . . 0.0 112.176 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -86.16 108.91 19.24 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.981 -178.104 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.46 ' HD2' ' HA3' ' A' ' 327' ' ' GLY . 4.8 Cg_exo -79.82 147.2 19.12 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.984 2.456 . . . . 0.0 112.501 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 1.1 m-85 -79.78 136.51 36.75 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.653 HG21 HG13 ' A' ' 329' ' ' ILE . 27.2 t -92.09 124.46 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -117.59 125.78 6.64 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.196 -1.478 . . . . 0.0 114.764 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.904 HG11 HG23 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.89 103.5 13.57 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.913 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 69.7 mt -86.11 103.84 15.14 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.563 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.641 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 68.9 p -133.05 139.68 47.31 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 118.142 2.645 . . . . 0.0 118.142 -172.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.873 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . . . -95.06 113.36 25.05 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.677 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -102.55 163.26 16.51 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.367 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.624 ' O ' ' O ' ' A' ' 267' ' ' ASN . 0.8 OUTLIER -89.78 134.49 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 176.028 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.959 ' O ' ' N ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -13.52 -167.38 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.956 1 C-N-CA 132.156 4.183 . . . . 0.0 117.165 -171.525 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 1.094 ' HB2' ' C ' ' A' ' 75' ' ' LEU . . . -107.39 119.91 40.71 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 110.651 -2.977 . . . . 0.0 104.143 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 268' ' ' ALA . . . 104.94 -65.8 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.217 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 269' ' ' ALA . 2.4 p 155.46 103.07 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.476 ' O ' ' C ' ' A' ' 272' ' ' ASN . 15.5 Cg_endo -99.38 102.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.457 2.772 . . . . 0.0 113.446 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 271' ' ' PRO . 91.1 m-20 26.76 74.19 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.946 0.403 . . . . 0.0 111.646 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -64.67 -31.61 72.9 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 277' ' ' LYS . 0.7 OUTLIER -53.48 -57.5 10.44 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.875 -0.515 . . . . 0.0 112.366 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.91 -53.48 49.71 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.59 94.15 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -63.29 -40.59 97.8 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.566 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 -54.15 7.19 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.553 ' HE2' HG12 ' A' ' 23' ' ' VAL . 8.8 t80 -55.52 -58.72 6.61 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.714 HD11 HD22 ' A' ' 284' ' ' LEU . 0.9 OUTLIER -48.71 -43.17 37.02 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.776 0.798 . . . . 0.0 111.065 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -74.27 -34.56 63.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.095 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -93.6 -15.89 24.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.622 ' CZ ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -112.5 -60.2 1.9 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.463 0.574 . . . . 0.0 110.594 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.743 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.1 tp -43.12 -33.01 0.79 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.862 0.755 . . . . 0.0 109.798 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 285' ' ' LEU . 6.5 mp -86.29 42.24 0.98 Allowed 'General case' 0 C--N 1.342 0.239 0 CA-C-O 120.92 0.391 . . . . 0.0 110.481 178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 283' ' ' TYR . 12.9 p -144.47 154.58 43.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 1.7 m-20 -63.8 -13.98 49.0 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.586 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 2.0 tp10 -77.86 -48.24 16.92 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 121.719 -0.613 . . . . 0.0 110.986 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.669 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -75.66 -61.81 2.84 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.627 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER -57.39 -47.74 80.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.0 OUTLIER -79.42 -26.39 41.85 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.314 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -68.36 -38.41 81.4 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.823 HG12 ' CD ' ' A' ' 297' ' ' LYS . 61.3 t -66.07 -61.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.645 ' HB2' ' CE1' ' A' ' 307' ' ' TYR . 57.8 t30 -33.53 -52.33 0.39 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.738 1.215 . . . . 0.0 112.516 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -58.41 -49.62 76.62 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER -57.19 -45.7 83.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.429 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.823 ' CD ' HG12 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -47.57 169.06 0.13 Allowed Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.28 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.407 ' HD3' ' HG3' ' A' ' 297' ' ' LYS . 11.0 Cg_endo -90.67 -72.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.549 2.833 . . . . 0.0 112.853 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.616 HD11 ' CG ' ' A' ' 314' ' ' ASP . 0.4 OUTLIER -156.31 -69.14 0.11 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.644 0.259 . . . . 0.0 110.482 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.663 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . -79.9 139.25 21.15 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . 159.98 -174.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.242 0.521 . . . . 0.0 110.861 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.925 HG21 HG21 ' A' ' 93' ' ' THR . 0.3 OUTLIER -149.91 175.07 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.421 179.419 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.964 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . 172.02 70.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.709 ' HB3' HD21 ' A' ' 290' ' ' LEU . 3.1 tp 82.26 142.56 0.07 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -48.07 -55.95 8.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -177.154 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.7 t -53.67 -48.93 69.0 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.879 0.847 . . . . 0.0 111.549 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.964 ' CD2' ' HB3' ' A' ' 303' ' ' ALA . 33.0 t80 -70.46 -19.66 62.94 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.282 176.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -65.14 -38.15 89.68 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.276 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' A' ' 308' ' ' GLU . 3.4 tt0 -66.19 -54.62 23.01 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.838 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.4 -51.23 70.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.244 0.545 . . . . 0.0 109.614 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.589 HD22 HG13 ' A' ' 317' ' ' ILE . 0.2 OUTLIER -59.79 -41.87 92.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.628 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 313' ' ' LYS . . . -47.22 -29.83 2.61 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 312' ' ' ALA . 5.2 ttpt -31.16 -42.96 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.637 0.256 . . . . 0.0 111.506 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.616 ' CG ' HD11 ' A' ' 299' ' ' LEU . 1.1 t70 -76.34 135.82 69.02 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.384 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 31.1 Cg_exo -59.26 -20.66 56.39 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.529 2.153 . . . . 0.0 113.575 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.553 ' O ' ' OG1' ' A' ' 320' ' ' THR . 7.3 mmt180 -61.42 -58.91 6.28 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.589 HG13 HD22 ' A' ' 311' ' ' LEU . 3.3 mm -49.3 -55.35 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.48 -45.4 13.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.791 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.34 -35.64 63.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.397 0.618 . . . . 0.0 110.267 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.641 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -59.44 -42.69 92.49 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.249 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.45 ' CE ' HG22 ' A' ' 317' ' ' ILE . 60.1 mtm -76.31 -42.01 46.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.143 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -46.96 60.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.446 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.28 -41.96 32.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.486 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.508 ' O ' HG22 ' A' ' 259' ' ' VAL . . . -49.54 -36.7 24.35 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLN . . . . . 0.422 ' NE2' ' CE1' ' A' ' 92' ' ' PHE . 2.1 tt0 -85.28 -34.03 22.0 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -93.41 60.68 3.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 111.028 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.46 ' HA3' ' HD2' ' A' ' 257' ' ' PRO . . . -160.67 -139.57 2.69 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.338 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -128.84 117.27 20.77 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.653 HG13 HG21 ' A' ' 259' ' ' VAL . 34.5 mt -83.88 124.09 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.51 ' O ' ' O ' ' A' ' 331' ' ' PRO . 10.9 mtm -42.53 132.43 2.84 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.855 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 176' ' ' TYR . 75.8 Cg_exo -50.28 -156.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.052 2.502 . . . . 0.0 112.605 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.475 ' CG ' ' HH ' ' A' ' 176' ' ' TYR . 8.8 p-10 -146.65 40.32 1.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.954 0.407 . . . . 0.0 111.158 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 335' ' ' GLN . 1.8 pp -138.2 160.4 64.27 Favored Pre-proline 0 C--N 1.34 0.185 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.714 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.11 -13.56 23.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.626 2.217 . . . . 0.0 113.515 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.698 ' HB2' HD13 ' A' ' 333' ' ' ILE . 0.9 OUTLIER -60.56 -21.17 62.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.17 -34.58 2.78 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.144 -0.347 . . . . 0.0 111.827 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.43 -35.31 71.9 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.834 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.429 ' HB3' ' CG1' ' A' ' 368' ' ' ILE . . . -58.09 -36.24 72.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.919 0.39 . . . . 0.0 111.723 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.564 ' CZ ' HG21 ' A' ' 183' ' ' VAL . 0.2 OUTLIER -78.39 -55.75 4.99 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.79 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -43.42 -45.28 6.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.061 0.458 . . . . 0.0 110.177 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 0.476 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 34.7 t80 -70.72 -41.08 72.37 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.662 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.78 ' HB1' HD22 ' A' ' 361' ' ' LEU . . . -69.68 -46.05 66.94 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.813 ' O ' HG23 ' A' ' 347' ' ' VAL . 31.7 t -70.51 -35.03 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.15 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 341' ' ' TYR . 0.0 OUTLIER -69.73 -36.73 76.12 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 349' ' ' ASN . 95.0 m -66.71 -58.52 4.94 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.969 ' HB1' HG23 ' A' ' 357' ' ' VAL . . . -49.58 -50.39 42.69 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.394 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 343' ' ' VAL . 63.0 t -50.99 -56.93 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 24.8 mt -59.03 -27.39 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.627 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.6 OUTLIER -64.47 -38.68 91.87 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.297 0.57 . . . . 0.0 111.242 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -80.13 -26.58 39.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.359 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.18 -16.88 51.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 2.9 p -111.26 -6.68 14.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.561 1.073 . . . . 0.0 113.376 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 85.61 -2.65 87.88 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.604 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -88.58 35.18 0.76 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 115.808 -2.044 . . . . 0.0 107.605 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -70.82 -174.53 0.94 Allowed 'General case' 0 CA--C 1.547 0.838 1 N-CA-C 125.303 5.297 . . . . 0.0 125.303 -158.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.421 ' N ' ' OD1' ' A' ' 349' ' ' ASN . 4.5 t 159.84 44.76 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 110.365 -3.107 . . . . 0.0 104.252 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.969 HG23 ' HB1' ' A' ' 346' ' ' ALA . 7.7 p -72.44 -56.4 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.516 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 1.6 m-20 -48.78 -45.06 39.49 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.563 0.697 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.19 -55.78 5.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.938 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -52.37 -44.71 65.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 122.413 1.101 . . . . 0.0 112.65 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.78 HD22 ' HB1' ' A' ' 342' ' ' ALA . 1.7 tm? -77.28 -41.56 40.38 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.052 -1.885 . . . . 0.0 110.594 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.607 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 5.2 tttt -60.19 -56.42 21.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.083 0.944 . . . . 0.0 109.129 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -53.05 -37.21 61.4 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.596 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 361' ' ' LEU . . . -49.96 -48.12 52.25 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.524 ' HA ' HG22 ' A' ' 368' ' ' ILE . 41.5 tt0 -54.3 -44.89 72.37 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.5 m -57.16 -43.33 82.43 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.495 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -71.2 -57.47 4.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.025 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 368' ' ' ILE . 0.0 OUTLIER -54.45 -33.21 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.265 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.538 HG23 HG23 ' A' ' 368' ' ' ILE . 41.2 p -94.86 -15.91 23.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.664 0.269 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.657 ' CG ' HD12 ' A' ' 275' ' ' LEU . 2.4 tm-20 -142.93 136.86 29.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.954 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.82 -101.72 0.65 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.28 -170.9 1.94 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.319 -0.94 . . . . 0.0 110.01 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.928 HD12 HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -119.59 123.25 43.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.922 HG11 ' HG3' ' A' ' 57' ' ' PRO . 1.7 t -121.88 111.94 32.89 Favored 'Isoleucine or valine' 0 C--O 1.26 1.62 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.71 ' CG1' HD12 ' A' ' 59' ' ' ILE . 4.0 mt -133.52 126.79 52.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.544 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.686 ' HD1' HG22 ' A' ' 60' ' ' ILE . 1.9 p-90 -98.72 135.29 40.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.611 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 11' ' ' ILE . 1.5 mp -154.27 137.59 7.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 O-C-N 122.102 -0.374 . . . . 0.0 110.763 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -120.73 125.74 48.39 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.782 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.44 29.37 14.31 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.882 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 58.8 t0 -102.03 -80.23 0.51 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.166 0.483 . . . . 0.0 110.436 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 6.2 mttm 101.42 -5.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.898 0.879 . . . . 0.0 111.162 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.667 ' O ' HD12 ' A' ' 20' ' ' LEU . . . -76.38 64.76 2.82 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 115.359 0.904 . . . . 0.0 115.359 -176.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -78.72 -32.49 46.84 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.348 -0.426 . . . . 0.0 111.284 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 3.3 t-20 -68.47 -46.79 68.81 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 111.347 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.692 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -70.67 -47.52 40.48 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.983 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.036 HD13 HG11 ' A' ' 37' ' ' VAL . 1.2 mt -59.56 -50.78 72.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.434 0.617 . . . . 0.0 110.336 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -68.76 -39.27 80.33 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.516 ' HG2' ' HA2' ' A' ' 19' ' ' GLY . 11.0 pt-20 -66.21 -35.91 81.66 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.244 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 19' ' ' GLY . 11.3 m -68.63 -60.34 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.464 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.614 ' HA3' HG13 ' A' ' 35' ' ' VAL . . . -49.54 -34.19 19.49 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.736 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -57.77 -50.14 74.26 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 122.442 1.115 . . . . 0.0 109.005 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.67 -43.59 62.77 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 112.977 -1.92 . . . . 0.0 109.787 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.749 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -66.36 -26.05 67.09 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.096 -1.003 . . . . 0.0 111.151 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.748 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -73.15 -52.01 15.78 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.304 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -52.76 -28.01 20.41 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 124.683 1.24 . . . . 0.0 110.478 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.842 ' O ' HG23 ' A' ' 31' ' ' THR . 1.2 m-20 -84.64 -37.93 20.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 117.634 -1.174 . . . . 0.0 108.819 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.89 37.74 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 171.602 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.35 38.62 0.02 OUTLIER Glycine 0 N--CA 1.465 0.633 0 C-N-CA 114.796 -3.573 . . . . 0.0 119.545 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.928 HD12 HD12 ' A' ' 7' ' ' LEU . 22.3 mm -140.05 138.73 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 122.157 2.979 . . . . 0.0 116.956 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -142.36 104.4 4.42 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.965 HG21 ' O ' ' A' ' 20' ' ' LEU . 28.6 m -89.35 130.34 38.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -174.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 p -116.51 140.47 49.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.135 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.036 HG11 HD13 ' A' ' 20' ' ' LEU . 6.2 m -130.05 119.68 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.522 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -110.43 134.82 51.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.63 71.26 3.55 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 120.829 0.347 . . . . 0.0 111.617 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.873 ' CG ' HD13 ' A' ' 43' ' ' LEU . 39.1 Cg_endo -95.12 -160.95 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.931 3.088 . . . . 0.0 112.72 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.91 -62.63 1.11 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 0.15 34.45 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.873 HD13 ' CG ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -56.8 -28.37 61.29 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.218 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 1.047 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -47.32 -54.26 11.5 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.547 -0.721 . . . . 0.0 110.25 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mt-10 -71.85 -50.16 31.93 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.279 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 50' ' ' VAL . 32.7 mtmt -59.71 -56.36 22.87 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.122 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.688 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 7.2 t80 -44.38 -57.92 5.8 Favored Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 1.047 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 25.6 Cg_exo -66.03 -35.91 32.15 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 120.977 1.118 . . . . 0.0 114.251 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 17.0 mt-30 -66.63 -52.24 47.24 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 123.038 1.399 . . . . 0.0 107.549 175.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 46' ' ' LYS . 14.7 m -61.22 -21.85 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.555 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 48' ' ' PRO . . . -59.84 -29.47 68.29 Favored 'General case' 0 C--N 1.395 2.563 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.644 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -82.16 -24.59 34.93 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 124.991 1.316 . . . . 0.0 112.008 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.5 m -47.89 -30.96 4.57 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 167.93 -19.09 0.08 OUTLIER Glycine 0 CA--C 1.526 0.724 0 C-N-CA 119.891 -1.147 . . . . 0.0 114.644 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.629 ' O ' ' HB1' ' A' ' 269' ' ' ALA . 1.0 OUTLIER 155.77 -71.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.719 1.26 . . . . 0.0 111.561 179.393 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 40.44 -158.46 0.03 OUTLIER Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.031 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.922 ' HG3' HG11 ' A' ' 8' ' ' VAL . 10.9 Cg_exo -35.81 143.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.887 3.058 . . . . 0.0 112.78 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 59' ' ' ILE . 30.7 m-20 -123.51 35.44 4.85 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 117.478 -1.689 . . . . 0.0 113.877 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.71 HD12 ' CG1' ' A' ' 9' ' ' ILE . 2.8 mt -150.57 127.92 2.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 119.662 1.119 . . . . 0.0 113.692 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.686 HG22 ' HD1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -139.4 123.29 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 118.872 0.76 . . . . 0.0 110.034 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.523 ' O ' ' CZ2' ' A' ' 10' ' ' TRP . 2.6 m-85 -104.62 128.53 52.68 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.13 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -166.0 166.67 17.17 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 119.188 0.904 . . . . 0.0 109.723 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.11 165.99 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 120.479 1.49 . . . . 0.0 110.319 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.858 ' HB3' HG13 ' A' ' 261' ' ' VAL . 12.8 p-80 -77.05 -29.3 55.1 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.477 0.656 . . . . 0.0 112.059 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -58.46 -36.08 73.15 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.425 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -85.43 -35.26 21.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.644 ' CE1' HD22 ' A' ' 76' ' ' LEU . 3.2 t80 -54.85 -32.82 61.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 172.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -58.19 -65.35 3.58 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.32 -41.44 16.46 Favored Glycine 0 C--N 1.355 1.639 0 CA-C-N 113.268 -1.466 . . . . 0.0 110.609 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.57 ' HB3' HD12 ' A' ' 76' ' ' LEU . 5.3 m-85 -59.49 -46.46 88.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.684 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . . . -50.35 -51.32 46.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.843 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -78.25 -27.15 47.49 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.641 ' HB3' HD23 ' A' ' 75' ' ' LEU . 1.7 t -71.63 -17.67 62.25 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.739 ' C ' HD22 ' A' ' 75' ' ' LEU . . . 83.69 37.85 11.34 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.231 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.739 HD22 ' C ' ' A' ' 74' ' ' GLY . 3.6 mm? -121.76 57.15 1.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.941 0.4 . . . . 0.0 111.533 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.829 HD23 ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -179.07 142.01 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.401 0.62 . . . . 0.0 112.127 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.982 ' O ' HG21 ' A' ' 104' ' ' ILE . . . -59.94 176.98 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.527 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.43 ' HA ' ' HB ' ' A' ' 104' ' ' ILE . 2.6 tm-20 -139.74 80.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.375 0.27 . . . . 0.0 110.489 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.0 pt -70.99 162.19 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.108 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.92 118.35 69.17 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.875 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.576 ' HB3' HD13 ' A' ' 103' ' ' LEU . 2.7 Cg_endo -79.87 146.79 18.75 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.571 2.181 . . . . 0.0 112.158 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -136.0 163.67 29.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.863 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -49.06 78.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.631 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.73 -23.64 63.36 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.822 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.5 ' CE2' ' CZ2' ' A' ' 94' ' ' TRP . 19.3 t80 -68.74 -58.65 3.91 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.916 0.389 . . . . 0.0 110.352 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -77.12 -24.7 51.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -76.36 -45.24 32.87 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 89' ' ' LEU . 3.9 pttp -51.54 -41.71 61.27 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.495 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.445 ' N ' ' HG3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -103.92 -175.14 2.71 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.6 0.238 . . . . 0.0 110.663 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CG ' ' CE2' ' A' ' 92' ' ' PHE . 0.9 OUTLIER -69.5 131.0 90.19 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.693 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.44 -38.0 82.52 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.515 2.143 . . . . 0.0 112.711 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.452 ' CE2' ' CG ' ' A' ' 90' ' ' TYR . 45.1 p90 -73.22 -43.61 60.97 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 120.549 0.214 . . . . 0.0 111.275 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 302' ' ' VAL . 45.0 m -62.14 -25.42 67.73 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.5 ' CZ2' ' CE2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -92.45 -26.49 17.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.216 0.531 . . . . 0.0 111.202 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -21.29 60.07 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.813 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.644 ' HB1' ' HB ' ' A' ' 261' ' ' VAL . . . -66.08 -50.17 65.04 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.685 0.278 . . . . 0.0 110.722 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.688 HG11 ' HD3' ' A' ' 107' ' ' PRO . 11.7 p -94.7 60.11 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.01 138.83 48.39 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.063 -1.023 . . . . 0.0 109.753 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.684 ' CE1' ' HB3' ' A' ' 71' ' ' ALA . 31.5 t80 -107.64 138.68 43.43 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.344 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -59.11 78.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.811 0.339 . . . . 0.0 110.108 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 133.11 -18.23 4.49 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.36 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.526 ' HD3' ' HB1' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -144.7 123.75 12.83 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.125 0.962 . . . . 0.0 111.843 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.576 HD13 ' HB3' ' A' ' 81' ' ' PRO . 0.5 OUTLIER -105.82 74.68 1.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.778 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.982 HG21 ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -129.46 91.3 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 121.668 0.747 . . . . 0.0 112.634 -177.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 159.54 -177.22 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.502 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -136.63 142.86 40.68 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.16 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.688 ' HD3' HG11 ' A' ' 97' ' ' VAL . 84.4 Cg_endo -82.02 156.88 17.77 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.499 2.132 . . . . 0.0 112.437 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.697 HG22 ' H ' ' A' ' 109' ' ' ALA . 28.2 mt -119.44 -135.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.697 ' H ' HG22 ' A' ' 108' ' ' ILE . . . -79.48 157.44 27.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.007 ' CG1' HG11 ' A' ' 302' ' ' VAL . 4.2 m -110.02 114.41 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.817 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -101.9 164.94 11.46 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.154 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.8 146.72 8.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.848 0.832 . . . . 0.0 111.267 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.868 ' CD1' HD21 ' A' ' 247' ' ' LEU . 3.2 pp -79.02 128.06 32.78 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.101 -1.408 . . . . 0.0 107.482 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 227' ' ' ASN . 24.8 p -131.35 165.85 22.55 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.513 HD12 ' CG2' ' A' ' 226' ' ' ILE . 4.3 tp -99.2 135.13 41.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.408 HD13 ' C ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -114.99 133.84 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.296 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.541 ' HE2' HG23 ' A' ' 245' ' ' THR . 12.1 p90 -122.08 142.02 50.79 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.855 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 1.4 t-20 -89.29 126.91 35.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.488 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.34 -3.61 28.5 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.064 -0.398 . . . . 0.0 110.37 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.22 -62.76 1.19 Allowed 'General case' 0 C--N 1.34 0.177 0 CA-C-O 121.252 0.548 . . . . 0.0 110.498 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 39.82 2.31 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.644 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.993 HD13 ' HB1' ' A' ' 223' ' ' ALA . 1.3 tp -131.68 89.72 38.83 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.354 0.597 . . . . 0.0 110.65 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.435 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 81.0 Cg_exo -44.5 162.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.465 2.777 . . . . 0.0 112.571 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 23.0 m-20 -60.12 110.7 3.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 122.449 1.119 . . . . 0.0 111.793 -170.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.9 Cg_endo -69.88 168.31 22.09 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 125.238 3.959 . . . . 0.0 114.14 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.668 ' HD3' HD22 ' A' ' 135' ' ' LEU . 56.9 Cg_endo -92.34 -154.05 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 123.34 2.693 . . . . 0.0 115.501 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -125.52 -91.7 0.52 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 t -46.4 155.53 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.058 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.642 ' CZ2' HD22 ' A' ' 147' ' ' LEU . 10.0 t-105 -69.67 -33.49 72.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 174.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 133' ' ' PRO . 1.9 mm-40 -44.98 -24.17 0.2 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.731 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -72.67 -26.51 61.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.494 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 25.6 mm -40.64 -57.33 3.19 Favored Pre-proline 0 N--CA 1.478 0.974 0 CA-C-O 121.29 0.567 . . . . 0.0 111.982 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 6.0 Cg_endo -48.27 -39.09 34.76 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 N-CA-C 109.399 -1.039 . . . . 0.0 109.399 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.35 -58.56 3.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.668 HD22 ' HD3' ' A' ' 126' ' ' PRO . 0.3 OUTLIER -68.65 -36.34 78.44 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.039 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 132' ' ' ILE . 21.6 t0 -72.85 -40.15 65.95 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -46.82 -47.37 21.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.402 176.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -63.74 -39.6 94.69 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.405 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.833 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -60.81 -49.84 75.87 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -44.52 29.67 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -45.89 -26.3 0.67 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -108.04 -58.57 1.96 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.058 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.8 43.93 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 CA-C-O 118.824 -0.986 . . . . 0.0 111.036 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.512 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 4.0 mttt -155.34 -172.22 4.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.636 1.718 . . . . 0.0 111.086 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.606 ' O ' HD22 ' A' ' 139' ' ' LEU . 47.9 m -142.4 160.71 39.74 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.833 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -75.15 -28.67 60.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.642 HD22 ' CZ2' ' A' ' 129' ' ' TRP . 0.7 OUTLIER -152.6 133.05 13.74 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -176.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.968 ' HB3' HG21 ' A' ' 222' ' ' THR . 7.9 tpt -132.3 140.72 48.7 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.907 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 150' ' ' ASN . 34.8 p90 -172.7 175.21 3.48 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.665 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 149' ' ' PHE . 45.2 m-80 -37.74 170.69 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.683 0.615 . . . . 0.0 110.828 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.569 HD11 ' HB1' ' A' ' 206' ' ' ALA . 2.1 tm? -114.64 -59.66 1.99 Allowed 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.404 ' HB3' ' NH2' ' A' ' 344' ' ' ARG . 2.0 mt-30 -102.75 36.01 2.32 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 116.788 -1.965 . . . . 0.0 114.862 -174.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.662 ' O ' ' HB ' ' A' ' 157' ' ' THR . 4.6 mm-40 -88.3 144.35 33.95 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 121.18 1.809 . . . . 0.0 114.61 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.934 ' O ' ' N ' ' A' ' 156' ' ' PHE . 6.0 Cg_exo -77.71 -135.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.285 1 C-N-CA 125.787 4.325 . . . . 0.0 106.04 176.621 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 1.149 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 1.2 m-85 27.17 -54.88 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.934 ' N ' ' O ' ' A' ' 154' ' ' PRO . 14.9 m-85 -87.88 -58.8 2.44 Favored 'General case' 0 C--O 1.26 1.625 0 C-N-CA 124.486 1.114 . . . . 0.0 110.761 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 24.1 m -57.24 -44.6 83.99 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.83 ' CE3' HD11 ' A' ' 161' ' ' ILE . 4.8 m95 -52.31 -55.02 35.51 Favored Pre-proline 0 C--N 1.348 0.521 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.534 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 1.149 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 87.5 Cg_exo -43.4 -49.53 7.47 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.387 2.058 . . . . 0.0 114.124 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.708 HD12 HG23 ' A' ' 161' ' ' ILE . 1.5 pp -79.18 -56.95 3.98 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 120.529 -1.357 . . . . 0.0 113.241 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.83 HD11 ' CE3' ' A' ' 158' ' ' TRP . 1.1 pt -61.19 -13.17 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 158' ' ' TRP . . . -124.95 -46.4 1.83 Allowed 'General case' 0 N--CA 1.471 0.622 1 N-CA-C 124.147 4.869 . . . . 0.0 124.147 -178.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.07 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . . . -54.58 49.72 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -176.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 162' ' ' ALA . 10.2 m-20 -122.1 -58.83 1.7 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.727 0.694 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.68 1.68 2.09 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.23 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.12 95.79 1.09 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.104 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -67.08 139.55 57.57 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.026 0.413 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.749 ' HA ' HG22 ' A' ' 183' ' ' VAL . . . -43.6 -74.65 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.742 0.782 . . . . 0.0 111.643 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.632 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 32.3 m-85 -112.33 173.9 6.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.708 ' O ' ' O ' ' A' ' 175' ' ' LYS . 6.3 ttmt -100.68 108.06 19.83 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.949 ' HA ' ' O ' ' A' ' 175' ' ' LYS . 27.5 m-85 -84.05 111.33 19.2 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.134 176.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 173' ' ' ASN . 18.0 mt-10 -104.89 101.17 10.77 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.597 ' C ' ' O ' ' A' ' 172' ' ' GLU . 8.8 m120 34.8 73.52 0.08 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 65.67 70.69 1.04 Allowed Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.171 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.949 ' O ' ' HA ' ' A' ' 171' ' ' TYR . 3.8 tptp -177.67 122.75 0.12 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.522 1.161 . . . . 0.0 112.98 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.632 ' HB2' ' HB3' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -114.63 -19.8 10.96 Favored 'General case' 0 N--CA 1.512 2.653 0 CA-C-O 122.907 1.337 . . . . 0.0 109.14 175.328 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.487 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 6.5 m-20 38.84 -85.8 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 111.523 -2.58 . . . . 0.0 111.725 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.739 HD13 ' HB3' ' A' ' 335' ' ' GLN . 7.3 tp 171.86 -41.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -65.9 -12.7 56.62 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 71.9 m-20 -120.59 93.53 4.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.994 0.816 . . . . 0.0 109.127 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.859 HG11 HD12 ' A' ' 368' ' ' ILE . 32.2 m -115.95 112.55 40.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.69 39.79 2.39 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.736 -1.221 . . . . 0.0 114.065 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.749 HG22 ' HA ' ' A' ' 168' ' ' ALA . 2.1 t -78.27 -43.54 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.524 ' HA ' ' CB ' ' A' ' 188' ' ' ALA . 5.8 p-10 -66.22 57.01 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.458 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 183' ' ' VAL . 0.7 OUTLIER -102.98 -172.34 2.1 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.37 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.696 ' O ' ' HG3' ' A' ' 189' ' ' LYS . . . -38.79 -48.59 1.54 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.244 0.545 . . . . 0.0 112.346 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.13 -32.3 52.89 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-O 118.975 -0.903 . . . . 0.0 113.053 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -60.07 -54.96 39.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.33 1.565 . . . . 0.0 107.301 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -52.64 -39.42 61.77 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.481 ' HB2' ' HD2' ' A' ' 251' ' ' LYS . . . -69.1 -42.31 76.29 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 111.954 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 161' ' ' ILE . . . -56.48 -60.59 8.7 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.711 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.893 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.6 OUTLIER -59.76 -30.93 69.2 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.194 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.5 m -74.94 -53.7 8.53 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.489 ' CD2' ' HA2' ' A' ' 191' ' ' GLY . 0.1 OUTLIER -62.09 -33.62 74.78 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.863 0.364 . . . . 0.0 110.16 178.149 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.92 -48.32 77.04 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 192' ' ' LEU . 76.1 t -56.48 -30.66 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.11 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -46.65 84.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.569 0.699 . . . . 0.0 111.006 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -51.42 68.27 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.151 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.71 HG23 ' O ' ' A' ' 205' ' ' ASN . 46.3 mm -63.41 -45.97 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.686 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.19 -36.71 52.67 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 118.437 -0.792 . . . . 0.0 112.02 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -113.0 -34.61 5.68 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 120.962 3.69 . . . . 0.0 120.962 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -79.41 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.702 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -101.47 -6.01 24.51 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.564 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 8.4 ttt 45.18 35.44 1.72 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.597 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.71 ' O ' HG23 ' A' ' 199' ' ' ILE . 19.8 m-20 -146.52 165.96 27.88 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 151' ' ' LEU . . . -152.35 32.57 0.52 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -99.0 -3.45 34.88 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -55.18 120.27 6.76 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 119.757 -0.777 . . . . 0.0 108.92 178.432 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.63 ' OD2' HD12 ' A' ' 212' ' ' ILE . 8.5 m-20 -94.77 -175.29 3.53 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.158 -0.339 . . . . 0.0 111.621 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -70.71 -45.26 65.27 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.136 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.95 -25.54 48.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.449 0.642 . . . . 0.0 110.771 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.63 HD12 ' OD2' ' A' ' 209' ' ' ASP . 1.7 mt -81.47 -52.01 14.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -51.11 -36.81 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.46 -45.55 86.9 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.26 -39.38 69.73 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.795 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.54 -56.06 25.98 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.97 -28.69 70.26 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -55.79 -41.56 74.27 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.512 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -23.9 59.13 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.12 42.71 58.02 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.445 ' HB3' ' HG3' ' A' ' 144' ' ' LYS . 1.4 mp0 -110.57 37.09 2.86 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.94 1.37 . . . . 0.0 110.794 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.968 HG21 ' HB3' ' A' ' 148' ' ' MET . 8.9 t -139.2 138.62 37.04 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.993 ' HB1' HD13 ' A' ' 122' ' ' LEU . . . -92.93 38.2 1.03 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -177.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 162.4 149.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.412 HG22 ' OD1' ' A' ' 227' ' ' ASN . 87.0 m -147.89 160.05 43.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.137 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 156' ' ' PHE . 2.2 pt -116.5 113.26 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -146.85 165.48 29.6 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.283 -177.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 232' ' ' TRP . . . -79.82 -154.4 9.18 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 119.341 -1.409 . . . . 0.0 113.495 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.71 -50.91 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.816 2.344 . . . . 0.0 114.115 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.456 ' CZ2' ' HB3' ' A' ' 299' ' ' LEU . 12.7 p-90 -135.78 -54.72 0.77 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.11 46.37 2.43 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.413 ' CB ' ' HA3' ' A' ' 228' ' ' GLY . 6.0 t-105 -91.64 -44.4 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.665 0.269 . . . . 0.0 110.432 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -114.42 38.14 3.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.045 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 54.07 87.92 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.634 0.254 . . . . 0.0 111.105 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 235' ' ' ILE . 0.2 OUTLIER -155.08 -43.82 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.402 ' N ' HG12 ' A' ' 235' ' ' ILE . 0.0 OUTLIER 45.09 -84.88 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 235' ' ' ILE . 15.6 p -67.18 138.0 56.66 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.651 0.262 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 22.1 p -134.51 158.87 42.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.898 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.85 176.62 0.07 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.984 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.64 -60.86 2.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.024 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -108.99 99.9 9.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.722 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -117.46 127.59 54.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.075 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 117' ' ' TYR . . . -96.71 114.13 4.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.205 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.72 137.01 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.579 -0.365 . . . . 0.0 110.829 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.541 HG23 ' HE2' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -141.18 167.93 21.0 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.071 0.548 . . . . 0.0 111.613 -172.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.6 m -72.75 152.23 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.868 HD21 ' CD1' ' A' ' 113' ' ' LEU . 1.9 mp -58.73 159.54 12.64 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 119.903 1.229 . . . . 0.0 110.682 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 247' ' ' LEU . 72.4 Cg_endo -78.66 -162.67 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.552 2.168 . . . . 0.0 113.063 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.4 p -94.91 144.31 25.77 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 160' ' ' LEU . 62.2 m-85 -144.61 111.2 5.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.96 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 190' ' ' ALA . 0.0 OUTLIER 37.04 31.98 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.196 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 105.78 29.98 4.75 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 254' ' ' PRO . 0.1 OUTLIER -156.68 167.1 15.14 Favored Pre-proline 0 N--CA 1.467 0.375 0 CA-C-N 119.1 1.45 . . . . 0.0 112.302 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 253' ' ' GLN . 67.7 Cg_endo -93.08 23.73 0.5 Allowed 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.43 2.753 . . . . 0.0 114.48 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.659 ' HB2' HD13 ' A' ' 247' ' ' LEU . 0.7 OUTLIER 72.21 133.61 0.04 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 178.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 1.07 ' HB2' ' HB2' ' A' ' 163' ' ' ALA . 10.5 mttt -86.38 106.39 10.11 Favored Pre-proline 0 CA--C 1.512 -0.499 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.795 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.745 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 94.8 Cg_endo -78.9 143.87 18.62 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.201 1.267 . . . . 0.0 109.719 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -89.19 119.32 29.58 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.898 HG11 ' HA ' ' A' ' 324' ' ' ALA . 6.2 m -115.2 99.86 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 118.247 0.476 . . . . 0.0 112.148 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -90.86 156.69 24.7 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.782 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.858 HG13 ' HB3' ' A' ' 64' ' ' HIS . 2.1 p -118.19 106.49 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -72.3 129.61 38.82 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 117.54 -1.664 . . . . 0.0 107.115 178.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.542 ' HA ' HG13 ' A' ' 108' ' ' ILE . 2.9 p -140.85 130.0 23.48 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 118.624 2.824 . . . . 0.0 118.624 -172.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.516 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . . . -88.88 111.98 22.72 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.643 ' HA3' HD21 ' A' ' 76' ' ' LEU . . . -100.78 164.27 18.64 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.543 ' HB ' HD11 ' A' ' 104' ' ' ILE . 3.7 mt -88.21 123.05 40.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 118.723 1.262 . . . . 0.0 107.617 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -64.59 145.73 55.71 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.515 ' HB2' ' H ' ' A' ' 76' ' ' LEU . . . -57.73 -25.5 60.48 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.132 -0.355 . . . . 0.0 110.947 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 55' ' ' ASP . . . -49.5 -60.0 3.25 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.471 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.94 131.77 8.87 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.652 0.263 . . . . 0.0 111.279 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.37 -42.57 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.497 2.131 . . . . 0.0 112.999 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 4.2 m-20 47.8 81.08 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.533 0.206 . . . . 0.0 110.787 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.12 -54.07 7.77 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -58.48 -57.29 13.58 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.657 HD12 ' CG ' ' A' ' 4' ' ' GLU . 8.3 tt -59.72 -42.88 94.08 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.658 0.266 . . . . 0.0 111.472 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.596 ' HB1' HD13 ' A' ' 280' ' ' LEU . . . -72.9 -33.41 65.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.612 ' O ' ' CB ' ' A' ' 281' ' ' GLU . 1.1 tmtt? -63.58 -58.7 6.13 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 121.413 0.625 . . . . 0.0 112.165 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.508 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 3.6 tp10 -68.06 -34.55 76.66 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.699 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.494 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 54.9 t80 -74.04 -60.02 2.45 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.963 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.596 HD13 ' HB1' ' A' ' 276' ' ' ALA . 5.8 mp -75.01 -43.13 55.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 118.373 -1.331 . . . . 0.0 113.05 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.826 ' HA ' HD23 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -73.65 -37.73 65.21 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.518 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 3.9 t30 -87.99 -20.61 25.61 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.639 ' CE1' HG12 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -104.06 -74.45 0.64 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 177.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.501 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 0.5 OUTLIER -36.22 -30.63 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.841 HD12 HD13 ' A' ' 304' ' ' LEU . 3.2 mm? -98.35 43.49 1.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.896 0.316 . . . . 0.0 111.792 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.5 p -144.89 157.78 44.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 11.2 m-20 -61.18 -15.17 31.15 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 2.3 mm-40 -78.32 -46.91 18.92 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.316 0.507 . . . . 0.0 110.498 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -81.06 -53.46 3.92 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.922 HD11 HD23 ' A' ' 304' ' ' LEU . 17.6 mt -50.07 -49.24 51.97 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.452 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 1.4 tp10 -78.14 -27.41 48.2 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.912 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -71.92 -38.06 69.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 119.776 1.171 . . . . 0.0 108.405 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 290' ' ' LEU . 14.7 p -65.92 -38.03 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -74.95 -41.88 58.75 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.458 1.103 . . . . 0.0 113.374 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -65.09 -42.74 93.76 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.499 ' CB ' ' HA3' ' A' ' 16' ' ' GLY . 33.4 m-20 -56.68 -64.53 0.84 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.48 ' HB3' HD11 ' A' ' 299' ' ' LEU . 17.4 mtmm -97.63 105.24 25.12 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.814 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -100.18 93.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.62 2.88 . . . . 0.0 112.305 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -143.33 -74.29 0.27 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.526 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -144.0 173.6 24.71 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.084 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 1.019 ' HB2' HD13 ' A' ' 311' ' ' LEU . . . -129.93 131.24 45.93 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 1.007 HG11 ' CG1' ' A' ' 110' ' ' VAL . 10.9 p -179.8 39.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.085 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.465 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . -111.06 -138.21 0.37 Allowed 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.922 HD23 HD11 ' A' ' 290' ' ' LEU . 22.0 tp -39.63 121.24 1.2 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -30.33 -63.15 0.14 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.514 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 95.7 p -48.88 -44.73 40.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.966 0.889 . . . . 0.0 110.933 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.906 ' CE1' HD12 ' A' ' 311' ' ' LEU . 3.1 t80 -75.87 -25.05 55.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.909 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -68.54 -39.78 80.99 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -68.66 -61.33 1.87 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.288 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -46.78 -56.61 5.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.872 0.368 . . . . 0.0 111.169 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 1.019 HD13 ' HB2' ' A' ' 301' ' ' ALA . 0.3 OUTLIER -64.43 -45.58 86.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.641 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -46.84 -28.7 1.65 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -31.22 -42.21 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.477 ' HB2' HD12 ' A' ' 317' ' ' ILE . 28.6 m-20 -71.19 137.12 84.33 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.784 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.72 -21.8 70.94 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.631 2.22 . . . . 0.0 113.252 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -59.71 -59.14 5.9 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.646 0.26 . . . . 0.0 111.559 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 301' ' ' ALA . 3.0 mp -50.91 -55.6 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.91 -39.07 8.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.163 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.08 -52.74 64.43 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 122.058 0.932 . . . . 0.0 108.837 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.4 ' OG1' HG23 ' A' ' 110' ' ' VAL . 3.2 p -56.84 -37.57 71.43 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 113.625 -1.625 . . . . 0.0 109.85 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.414 ' O ' ' HB3' ' A' ' 324' ' ' ALA . 1.4 ttp -70.93 -44.59 65.86 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -58.56 -57.38 13.21 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' A' ' 327' ' ' GLY . 6.5 m-20 -50.45 -38.71 45.0 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.898 ' HA ' HG11 ' A' ' 259' ' ' VAL . . . -57.35 -43.19 83.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.603 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -57.33 -42.06 81.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.228 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -106.19 26.41 9.81 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.887 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.745 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -114.66 157.64 14.85 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.618 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.86 135.66 36.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 330' ' ' MET . 39.0 mt -86.45 115.43 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 118.906 0.775 . . . . 0.0 110.87 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.535 ' HE3' ' HE1' ' A' ' 336' ' ' MET . 0.0 OUTLIER -28.27 130.84 0.2 Allowed Pre-proline 0 N--CA 1.47 0.568 0 N-CA-C 111.412 0.153 . . . . 0.0 111.412 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.459 ' HG2' ' CE1' ' A' ' 169' ' ' PHE . 62.4 Cg_exo -51.79 -164.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.893 2.395 . . . . 0.0 113.152 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -150.73 39.29 0.71 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.343 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.448 HG13 ' CE1' ' A' ' 176' ' ' TYR . 1.2 pp -132.58 163.23 52.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.026 0.441 . . . . 0.0 111.911 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.21 -37.86 7.56 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.046 2.497 . . . . 0.0 112.403 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.739 ' HB3' HD13 ' A' ' 178' ' ' ILE . 8.8 mp0 -45.98 -21.79 0.16 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.535 ' HE1' ' HE3' ' A' ' 330' ' ' MET . 4.0 tpp -45.49 -35.61 3.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.956 0.344 . . . . 0.0 110.978 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.5 t -61.12 -40.33 93.36 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.78 0.324 . . . . 0.0 110.19 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.12 -37.61 85.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.764 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.724 ' O ' HG12 ' A' ' 343' ' ' VAL . 23.4 t80 -74.04 -55.74 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.624 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 344' ' ' ARG . 2.3 t-105 -49.91 -43.61 49.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.494 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 0.722 ' O ' HG23 ' A' ' 345' ' ' THR . 0.9 OUTLIER -69.79 -52.2 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.9 -44.17 81.5 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.939 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.0 p -71.7 -29.42 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -75.03 -49.18 20.63 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 341' ' ' TYR . 69.9 p -57.33 -57.94 10.42 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.729 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.79 -41.22 6.76 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.861 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 343' ' ' VAL . 54.9 t -59.04 -47.69 89.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 345' ' ' THR . 6.7 mt -66.97 -28.24 42.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.8 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.729 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.1 OUTLIER -67.94 -27.63 66.78 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.66 0.267 . . . . 0.0 110.913 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.51 -44.76 23.62 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.54 -9.39 59.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 9.4 t -101.72 -46.03 5.06 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 142.1 0.77 1.4 Allowed Glycine 0 N--CA 1.464 0.504 0 C-N-CA 117.054 -2.498 . . . . 0.0 118.074 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.46 32.38 4.66 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 113.232 -3.387 . . . . 0.0 114.916 173.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.804 ' HB3' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER -158.24 119.22 3.43 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 34.3 p -78.73 146.88 33.65 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 358' ' ' ASP . 12.5 p -41.97 -45.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.433 ' N ' HG13 ' A' ' 357' ' ' VAL . 16.0 m-20 -71.58 -49.67 38.26 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.01 -46.38 57.39 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.475 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.804 ' HB2' ' HB3' ' A' ' 355' ' ' GLN . . . -54.16 -49.47 69.21 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.282 1.039 . . . . 0.0 113.593 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 47.3 mt -74.71 -36.69 62.7 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.283 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 365' ' ' GLN . 14.7 tttm -65.13 -56.7 11.41 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 122.351 1.072 . . . . 0.0 110.581 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.34 -37.45 83.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.749 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -49.61 -43.98 46.87 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.698 ' HG3' HG23 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -60.62 -44.74 95.97 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.57 -44.15 56.57 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.34 0.591 . . . . 0.0 110.168 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.08 -46.22 90.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.269 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.859 HD12 HG11 ' A' ' 181' ' ' VAL . 6.7 pt -81.19 -5.65 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.837 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.757 ' CG2' HG22 ' A' ' 181' ' ' VAL . 10.8 p -135.28 42.81 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.619 0.247 . . . . 0.0 110.616 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.248 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.665 0.269 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -138.95 -179.45 5.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.98 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.7 66.04 0.55 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HA ' HG12 ' A' ' 33' ' ' ILE . 2.3 tttp -153.18 157.49 40.36 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.658 ' HG ' HD11 ' A' ' 9' ' ' ILE . 24.7 tp -146.48 124.75 12.24 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.79 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.773 ' O ' ' HA ' ' A' ' 58' ' ' ASP . 99.3 t -111.74 132.9 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.488 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.831 ' HB ' HG12 ' A' ' 37' ' ' VAL . 5.4 mp -135.21 125.15 43.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.063 0.459 . . . . 0.0 111.412 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.573 ' CH2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -106.04 121.04 43.31 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.802 HG23 ' HB2' ' A' ' 61' ' ' PHE . 15.3 mt -158.09 137.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.063 0.458 . . . . 0.0 111.252 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -156.07 41.98 0.39 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.59 -35.21 0.57 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.698 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 3.3 m-20 -90.05 -105.51 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER 161.91 -172.6 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.03 0.919 . . . . 0.0 113.204 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.66 100.58 0.32 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 113.733 -1.576 . . . . 0.0 115.423 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -36.33 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.984 -0.608 . . . . 0.0 111.167 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 12.1 t-20 -64.84 -43.94 91.4 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.87 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.99 -49.01 23.99 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.631 -0.795 . . . . 0.0 114.043 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.63 ' CD1' HG11 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -59.85 -50.18 74.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.789 0.795 . . . . 0.0 110.371 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.29 82.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 53.9 tt0 -65.8 -36.98 85.02 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.42 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 19' ' ' GLY . 57.5 t -68.6 -61.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 122.063 -0.398 . . . . 0.0 110.377 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.923 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -49.31 -32.49 14.32 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.278 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 8.7 tmtm? -58.37 -50.84 72.23 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 122.503 1.144 . . . . 0.0 109.183 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -42.81 61.96 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 113.05 -1.886 . . . . 0.0 109.515 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.599 ' O ' ' CB ' ' A' ' 31' ' ' THR . 10.8 t80 -64.26 -32.23 73.74 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.316 0.579 . . . . 0.0 110.691 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.592 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 26.8 tt0 -68.78 -46.62 68.25 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.897 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -25.6 54.27 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -176.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.7 -33.61 21.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.599 ' CB ' ' O ' ' A' ' 27' ' ' PHE . 1.8 m -95.75 -133.5 0.2 Allowed 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 111.115 -2.766 . . . . 0.0 104.792 173.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 28' ' ' GLU . . . -173.59 42.71 0.15 Allowed Glycine 0 C--N 1.291 -1.94 0 N-CA-C 106.869 -2.492 . . . . 0.0 106.869 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.608 HD11 ' N ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -113.95 152.14 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.583 ' N ' HD13 ' A' ' 33' ' ' ILE . 5.2 mtpt -105.71 105.78 15.98 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.655 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.923 HG11 ' HA3' ' A' ' 24' ' ' GLY . 10.7 p -84.49 131.32 34.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.0 p -116.71 141.24 48.46 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.379 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.831 HG12 ' HB ' ' A' ' 9' ' ' ILE . 27.0 m -136.74 119.97 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 1.7 mp0 -109.42 141.87 41.2 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -113.65 81.27 5.47 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 120.638 0.256 . . . . 0.0 111.483 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.492 ' CG ' ' HG ' ' A' ' 43' ' ' LEU . 38.1 Cg_endo -90.83 -172.55 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.31 2.673 . . . . 0.0 113.005 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -114.05 -44.97 3.1 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.622 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -81.03 0.61 35.01 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.667 HD22 HD11 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -19.77 -39.81 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 1.05 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -63.49 -55.06 27.06 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.273 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mp0 -74.07 -41.75 61.25 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.154 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.642 ' O ' HG13 ' A' ' 50' ' ' VAL . 23.4 mtpt -57.97 -57.82 11.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.24 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.716 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 34.7 t80 -41.73 -60.99 1.61 Allowed Pre-proline 0 C--N 1.355 0.828 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.26 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 1.05 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 25.0 Cg_exo -62.4 -19.83 68.51 Favored 'Trans proline' 0 C--O 1.25 1.106 0 CA-C-N 120.17 1.096 . . . . 0.0 111.704 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -81.07 -34.13 32.93 Favored 'General case' 0 C--O 1.259 1.599 0 CA-C-O 122.644 1.211 . . . . 0.0 110.683 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 46' ' ' LYS . 2.7 m -80.13 -40.86 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 CA-C-O 122.287 1.041 . . . . 0.0 110.308 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.06 -37.21 20.36 Favored 'General case' 0 C--N 1.381 1.958 0 CA-C-N 113.226 -1.806 . . . . 0.0 110.096 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 53' ' ' THR . . . -81.27 -35.74 30.77 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.555 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -172.49 64.57 0.03 OUTLIER 'General case' 0 C--N 1.34 0.169 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.606 179.064 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . -167.12 44.18 0.25 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 119.566 -1.302 . . . . 0.0 115.008 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 3.5 m-20 155.75 -86.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.74 -106.16 0.9 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.618 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 18.6 Cg_endo -57.11 132.99 54.77 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.938 1.759 . . . . 0.0 108.316 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.773 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 20.7 t0 157.97 126.9 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 118.717 0.69 . . . . 0.0 112.855 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.5 HG23 ' HA ' ' A' ' 266' ' ' ILE . 9.5 mt -107.87 162.85 5.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.667 HD11 HD22 ' A' ' 43' ' ' LEU . 6.3 tt -138.16 127.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.802 ' HB2' HG23 ' A' ' 11' ' ' ILE . 3.1 m-85 -85.94 148.07 25.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.717 ' HE3' ' O ' ' A' ' 61' ' ' PHE . 1.6 t-105 -168.54 153.38 6.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 120.119 1.327 . . . . 0.0 108.518 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 67' ' ' PHE . . . -77.21 -175.51 3.68 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.73 1.15 . . . . 0.0 108.746 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.687 ' HB3' HG23 ' A' ' 261' ' ' VAL . 22.4 t-80 -77.9 -44.89 25.71 Favored 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.59 ' HB3' ' CG ' ' A' ' 330' ' ' MET . 0.8 OUTLIER -52.91 -59.44 4.52 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 1.6 mtt85 -70.6 -29.86 66.37 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.796 ' HZ ' HG23 ' A' ' 104' ' ' ILE . 7.3 t80 -62.46 -39.7 94.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 72' ' ' GLN . . . -46.99 -67.62 1.4 Allowed Glycine 0 CA--C 1.488 -1.652 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.886 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 73' ' ' SER . . . -76.44 -71.84 1.15 Allowed Glycine 0 C--N 1.341 0.839 0 CA-C-N 114.485 -0.857 . . . . 0.0 112.612 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.761 ' HB3' HD21 ' A' ' 75' ' ' LEU . 12.7 m-30 -41.82 -57.5 2.33 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.423 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.731 ' HB1' ' HG ' ' A' ' 76' ' ' LEU . . . -75.61 -56.63 4.51 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.625 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 4.8 tm0? -63.8 -12.9 39.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.621 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 48.4 t -82.84 -26.75 31.36 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.119 -0.363 . . . . 0.0 111.78 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 166.99 -32.09 0.2 Allowed Glycine 0 C--N 1.339 0.735 0 C-N-CA 119.414 -1.374 . . . . 0.0 114.772 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.835 HD13 ' HG3' ' A' ' 48' ' ' PRO . 1.8 pp -86.72 61.8 7.03 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 118.195 0.998 . . . . 0.0 111.743 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.827 HD12 ' CG1' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.19 143.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.238 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.86 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -107.96 115.13 29.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.716 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -53.99 151.44 6.77 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.2 pt -90.96 155.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.276 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.43 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -88.25 175.31 4.25 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.097 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.43 ' CD ' ' HB ' ' A' ' 80' ' ' THR . 5.9 Cg_exo -79.52 139.46 14.41 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.776 2.318 . . . . 0.0 112.952 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.21 -162.19 1.26 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.303 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.07 -58.6 2.04 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.318 -0.239 . . . . 0.0 111.237 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.69 70.18 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.634 0.254 . . . . 0.0 111.417 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.419 ' CD2' ' HG2' ' A' ' 281' ' ' GLU . 0.1 OUTLIER -73.75 -59.08 2.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.473 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -56.93 -27.33 60.86 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.405 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.3 -31.07 57.99 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.886 ' HG3' HD21 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -93.8 29.62 2.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.578 ' HA ' ' CD1' ' A' ' 94' ' ' TRP . 19.7 mt -104.8 107.8 18.95 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.173 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -89.1 -179.19 1.19 Allowed Pre-proline 0 N--CA 1.452 -0.361 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HD3' ' CG ' ' A' ' 90' ' ' TYR . 7.4 Cg_exo -74.08 -39.0 1.86 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.326 2.017 . . . . 0.0 115.603 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.576 ' HZ ' HG21 ' A' ' 259' ' ' VAL . 31.1 t80 -87.65 -63.61 1.28 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.648 HG21 HG21 ' A' ' 302' ' ' VAL . 1.2 p -64.78 -26.99 68.59 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -175.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.578 ' CD1' ' HA ' ' A' ' 89' ' ' LEU . 5.2 m-90 -89.2 -24.93 22.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.015 0.926 . . . . 0.0 111.001 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 2.5 t70 -72.97 -26.81 61.49 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.125 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.922 ' HB1' HG21 ' A' ' 261' ' ' VAL . . . -71.72 -38.63 70.47 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.778 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 40.7 t -100.02 44.74 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.03 140.21 51.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 119.16 -0.448 . . . . 0.0 109.9 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.9 t80 -109.3 174.7 5.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.529 1.059 . . . . 0.0 109.433 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -61.32 75.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.724 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 138.97 -55.69 0.66 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.173 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -145.93 -178.29 6.04 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 117.126 0.463 . . . . 0.0 111.316 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.36 146.28 42.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.226 0.536 . . . . 0.0 112.39 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.827 ' CG1' HD12 ' A' ' 76' ' ' LEU . 4.1 tt -122.32 58.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.131 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.778 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . . . 159.03 176.04 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.819 ' CD2' ' HB3' ' A' ' 264' ' ' ALA . 0.0 OUTLIER -139.02 127.91 14.0 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 115.542 -0.754 . . . . 0.0 108.974 177.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.765 ' O ' HG23 ' A' ' 108' ' ' ILE . 86.3 Cg_endo -79.6 162.06 24.71 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 122.886 2.391 . . . . 0.0 113.479 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 107' ' ' PRO . 1.4 pp -167.99 38.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.256 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.904 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -178.11 119.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.319 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 110' ' ' VAL . 14.4 p -110.7 105.5 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.861 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.513 ' HA ' HG21 ' A' ' 320' ' ' THR . 1.9 pt-20 -102.46 161.8 13.42 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.788 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.68 146.87 8.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.741 0.781 . . . . 0.0 111.614 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.735 HD13 ' CD1' ' A' ' 156' ' ' PHE . 2.1 pp -79.75 125.27 29.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.1 OUTLIER -135.09 160.5 38.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -176.262 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 226' ' ' ILE . 8.2 tt -92.55 132.07 37.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 242' ' ' TYR . 4.1 tt -114.48 133.69 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.45 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 9.8 p90 -118.46 140.05 50.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.781 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 0.7 OUTLIER -89.25 128.08 35.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.611 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.06 -43.82 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.223 -0.298 . . . . 0.0 110.59 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -65.21 0.71 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.638 0.733 . . . . 0.0 110.84 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 121' ' ' LEU . 1.1 tt -110.24 64.99 0.61 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.98 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.911 HD13 ' HB1' ' A' ' 223' ' ' ALA . 2.1 tp -157.18 88.68 2.59 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 119.976 -0.689 . . . . 0.0 112.638 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.539 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 9.1 Cg_endo -48.26 162.98 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.192 2.594 . . . . 0.0 110.176 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -59.48 108.38 1.35 Allowed Pre-proline 0 N--CA 1.468 0.436 0 C-N-CA 118.186 -1.406 . . . . 0.0 109.686 -172.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.88 ' HB3' HD11 ' A' ' 122' ' ' LEU . 58.2 Cg_endo -93.31 168.6 2.28 Favored 'Trans proline' 0 C--N 1.369 1.627 1 C-N-CA 125.812 4.341 . . . . 0.0 115.868 -175.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 135' ' ' LEU . 4.7 Cg_exo -39.94 156.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.618 3.546 . . . . 0.0 115.572 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -136.07 -20.88 1.45 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.28 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.7 m -133.82 155.23 50.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -59.47 -54.32 48.03 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.406 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -24.25 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.577 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 134' ' ' ALA . 6.8 mt-10 -79.17 -27.92 42.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.651 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 7.2 mt -43.99 -54.25 11.57 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 121.385 0.612 . . . . 0.0 111.368 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 51.9 Cg_exo -49.07 -39.22 41.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 N-CA-C 109.511 -0.996 . . . . 0.0 109.511 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.11 -58.57 3.2 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.596 ' HB3' ' HD3' ' A' ' 126' ' ' PRO . 0.2 OUTLIER -69.07 -37.09 78.3 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.171 -178.742 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 49.0 t0 -73.09 -40.77 64.73 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -47.52 -45.11 26.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 118.599 -1.24 . . . . 0.0 108.949 177.001 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 75.0 mm-40 -64.28 -39.81 94.68 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.698 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.774 ' CD1' ' HB2' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -61.22 -49.17 78.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.75 -44.62 28.27 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.04 -25.19 0.53 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.497 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -100.01 -63.68 1.11 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.73 39.39 0.02 OUTLIER Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.014 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.76 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 0.5 OUTLIER -173.77 176.18 2.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.516 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.767 ' O ' HD22 ' A' ' 139' ' ' LEU . 9.8 m -109.26 166.97 10.46 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.774 ' HB2' ' CD1' ' A' ' 139' ' ' LEU . . . -73.31 -16.1 61.38 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.658 HD12 ' CE2' ' A' ' 149' ' ' PHE . 1.6 pt? -148.74 133.07 17.49 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 117.633 2.457 . . . . 0.0 117.633 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.56 ' HB2' HG21 ' A' ' 222' ' ' THR . 28.3 mmt -132.34 138.89 47.94 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.671 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.975 ' O ' ' O ' ' A' ' 150' ' ' ASN . 2.3 p90 -172.48 175.28 3.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.65 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.975 ' O ' ' O ' ' A' ' 149' ' ' PHE . 1.3 m120 -28.68 -147.74 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 123.897 0.748 . . . . 0.0 112.201 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.064 HD22 ' HB1' ' A' ' 206' ' ' ALA . 2.8 mt 169.66 41.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.824 -1.172 . . . . 0.0 110.615 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.742 ' OE1' HD11 ' A' ' 348' ' ' ILE . 0.0 OUTLIER 173.11 34.05 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 169.454 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.66 ' O ' ' HB ' ' A' ' 157' ' ' THR . 4.1 mp0 -119.46 155.13 54.38 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 121.113 1.779 . . . . 0.0 114.405 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.859 ' O ' ' N ' ' A' ' 156' ' ' PHE . 86.1 Cg_endo -77.59 -135.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 125.201 3.934 . . . . 0.0 105.466 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 1.182 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 4.0 m-85 39.83 -65.19 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 120.312 1.415 . . . . 0.0 113.073 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.859 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -89.5 -59.89 2.09 Favored 'General case' 0 C--O 1.259 1.593 0 C-N-CA 124.483 1.113 . . . . 0.0 111.36 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.66 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 5.9 m -58.88 -43.29 90.89 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.43 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.54 -55.34 30.31 Favored Pre-proline 0 C--N 1.35 0.612 0 C-N-CA 120.299 -0.561 . . . . 0.0 109.96 177.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 1.182 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 87.6 Cg_exo -43.48 -50.62 6.7 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.596 2.197 . . . . 0.0 113.349 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.502 HD23 ' CZ ' ' A' ' 250' ' ' PHE . 9.5 mp -64.06 -56.8 12.34 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 119.571 1.078 . . . . 0.0 109.972 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 158' ' ' TRP . 42.3 pt -54.31 -17.32 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.707 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -77.38 -25.75 51.2 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.7 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -42.13 -59.31 1.81 Allowed 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.491 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 6.3 t70 -64.35 -17.45 63.72 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 136.61 23.0 0.53 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 118.722 -1.704 . . . . 0.0 117.146 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.5 160.25 41.51 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 119.331 1.565 . . . . 0.0 111.779 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -163.08 168.1 21.39 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.504 0.652 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.47 -79.31 0.42 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.614 0.721 . . . . 0.0 111.343 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 14.3 m-85 -112.15 168.73 9.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.87 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 1.271 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -103.94 115.8 31.1 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.267 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.434 ' CE1' ' CD2' ' A' ' 176' ' ' TYR . 0.2 OUTLIER -86.48 114.38 23.18 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.378 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 173' ' ' ASN . 1.2 tt0 -106.47 100.71 10.22 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 172' ' ' GLU . 35.7 m-80 39.03 78.63 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.32 6.52 80.43 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.86 124.37 5.91 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 121.44 2.62 . . . . 0.0 113.388 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 1.271 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.2 p90 -96.92 -23.12 16.48 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.599 1.19 . . . . 0.0 109.724 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.497 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 2.8 m-20 65.82 -82.43 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.911 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.893 HD11 HG22 ' A' ' 368' ' ' ILE . 7.1 tp 172.21 -43.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.419 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.3 OUTLIER -58.67 -16.62 17.11 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 119.167 -0.444 . . . . 0.0 111.769 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 4.0 m-20 -112.92 93.93 4.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 178' ' ' ILE . 15.4 m -118.06 120.12 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.314 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.42 52.57 3.81 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 119.479 -1.344 . . . . 0.0 112.86 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.601 HG12 ' HB3' ' A' ' 361' ' ' LEU . 14.5 t -90.93 -17.84 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.409 -0.895 . . . . 0.0 109.366 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.72 52.24 0.72 Allowed 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.858 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.56 160.65 16.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.375 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.75 -25.92 59.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.383 0.611 . . . . 0.0 111.706 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -76.4 -36.43 39.08 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.866 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.17 66.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -60.44 3.85 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.544 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.31 -41.04 50.43 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.829 0.823 . . . . 0.0 111.609 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.48 ' HA2' ' CE2' ' A' ' 194' ' ' PHE . . . -58.89 -60.7 8.42 Favored Glycine 0 C--O 1.237 0.338 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.839 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.561 HD13 HG13 ' A' ' 347' ' ' VAL . 4.2 mt -61.32 -23.93 66.07 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.577 -0.367 . . . . 0.0 110.092 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.824 ' O ' HG12 ' A' ' 196' ' ' VAL . 98.1 m -62.69 -53.46 54.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.658 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.48 ' CE2' ' HA2' ' A' ' 191' ' ' GLY . 4.3 p90 -61.83 -33.88 74.95 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.638 ' CD1' HD11 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -61.33 -51.2 69.84 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.671 178.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 193' ' ' THR . 7.8 p -58.66 -28.75 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.958 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -57.87 -49.36 76.96 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 121.399 0.618 . . . . 0.0 109.779 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.4 tt -62.33 -59.14 5.42 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.748 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 195' ' ' LEU . 4.3 mt -53.8 -45.16 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -61.71 -34.14 75.27 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -91.09 3.35 55.0 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.4 -81.11 0.63 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.72 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.48 -24.07 5.94 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 199' ' ' ILE . 1.4 ptm 74.44 13.42 3.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.948 0.34 . . . . 0.0 110.8 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -148.88 104.96 3.5 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 1.064 ' HB1' HD22 ' A' ' 151' ' ' LEU . . . -99.16 72.01 1.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.22 -4.27 27.48 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.593 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.912 HG22 ' HB2' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -57.24 123.9 16.95 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.1 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.671 ' HB2' HD13 ' A' ' 212' ' ' ILE . 0.5 OUTLIER -94.48 -174.74 3.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.275 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.6 p90 -70.18 -45.1 67.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.239 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.432 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.4 OUTLIER -77.87 -25.53 48.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.943 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.671 HD13 ' HB2' ' A' ' 209' ' ' ASP . 2.9 mp -81.68 -51.76 14.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.568 ' HB2' HG23 ' A' ' 208' ' ' THR . . . -50.39 -37.35 37.03 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.61 -45.62 86.15 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.77 -38.8 67.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.874 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.01 -56.7 18.3 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -61.46 -29.13 69.76 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.8 -40.54 76.11 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.572 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.23 -23.93 59.24 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.4 33.12 61.63 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 115.3 0.88 . . . . 0.0 115.3 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -109.02 36.9 2.71 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.147 1.474 . . . . 0.0 111.4 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.56 HG21 ' HB2' ' A' ' 148' ' ' MET . 0.5 OUTLIER -140.23 137.91 34.66 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 178.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 122' ' ' LEU . . . -104.58 38.18 1.95 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.578 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 170.55 138.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.562 HG23 HG22 ' A' ' 116' ' ' ILE . 9.0 t -148.17 159.37 44.01 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.564 ' HB ' ' CE1' ' A' ' 156' ' ' PHE . 8.5 pt -116.05 111.92 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.755 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.618 ' HA ' ' HE2' ' A' ' 156' ' ' PHE . 89.6 m-20 -148.67 164.78 33.31 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 121.874 -0.516 . . . . 0.0 111.939 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 230' ' ' TRP . . . -86.57 114.89 4.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.413 -1.375 . . . . 0.0 109.861 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.668 ' O ' ' HB3' ' A' ' 230' ' ' TRP . 75.2 Cg_exo -50.15 72.94 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.974 2.45 . . . . 0.0 114.548 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.668 ' HB3' ' O ' ' A' ' 229' ' ' PRO . 0.4 OUTLIER 150.96 -30.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 177.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.32 -85.91 0.55 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -52.22 -31.89 34.18 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.346 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -54.47 3.48 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.585 0.231 . . . . 0.0 111.172 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.6 m120 65.91 -74.48 0.06 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.219 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.575 HG21 ' CB ' ' A' ' 238' ' ' SER . 5.8 mt 65.72 -68.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 74.76 -69.77 0.17 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.601 0.239 . . . . 0.0 110.388 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 7.1 p -106.85 60.83 0.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.757 0.313 . . . . 0.0 110.317 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' SER . . . . . 0.575 ' CB ' HG21 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -52.93 -177.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.252 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -84.46 67.4 9.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.763 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 14.4 t 75.06 -67.22 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.745 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.57 150.28 47.35 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.725 0.298 . . . . 0.0 110.922 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.568 ' HB2' HD11 ' A' ' 116' ' ' ILE . 43.3 p90 -149.22 130.37 14.51 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.248 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.45 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -96.66 175.23 31.31 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.122 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.445 HG11 ' CG ' ' A' ' 229' ' ' PRO . 19.4 m -145.76 136.67 19.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 117.05 0.425 . . . . 0.0 111.529 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 167.5 21.0 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.4 m -73.07 152.77 7.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.713 HD22 ' OG ' ' A' ' 255' ' ' SER . 2.8 mp -59.37 159.57 15.85 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 120.627 1.558 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.73 -159.81 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.959 2.44 . . . . 0.0 112.433 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 17.3 p -121.15 177.51 5.12 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 249' ' ' THR . 56.8 m-85 -165.64 110.33 0.86 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.234 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.3 mttp 60.88 34.55 19.56 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.714 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.15 43.32 21.57 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.301 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -156.48 148.82 17.72 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.494 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 95.8 Cg_endo -84.31 -169.59 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.17 2.58 . . . . 0.0 111.628 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.713 ' OG ' HD22 ' A' ' 247' ' ' LEU . 75.3 p -111.85 148.99 32.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.248 0.547 . . . . 0.0 112.244 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 3.1 ttpm? -85.32 109.24 19.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.725 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.578 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 2.7 Cg_exo -78.88 145.7 20.09 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.347 2.698 . . . . 0.0 112.466 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 1.6 m-85 -102.12 94.13 5.59 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.513 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.657 HG13 ' HA3' ' A' ' 327' ' ' GLY . 35.5 m -94.35 106.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.757 0.313 . . . . 0.0 111.82 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.424 ' HA2' ' CE ' ' A' ' 330' ' ' MET . . . -86.2 160.52 33.49 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 119.637 -1.268 . . . . 0.0 112.606 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.922 HG21 ' HB1' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -111.59 111.15 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.904 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 3.8 tp -84.4 107.04 16.45 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 117.502 -1.679 . . . . 0.0 107.071 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 63.9 p -133.36 141.94 48.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.819 ' HB3' ' CD2' ' A' ' 106' ' ' TYR . . . -73.73 132.99 43.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.169 -0.332 . . . . 0.0 110.289 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.17 136.33 11.17 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.74 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.955 HG23 ' CG ' ' A' ' 271' ' ' PRO . 7.0 mt -88.0 119.78 35.99 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 CA-C-N 118.425 1.113 . . . . 0.0 108.245 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.545 ' HA ' ' HZ ' ' A' ' 47' ' ' PHE . 44.5 t-20 -59.27 137.55 57.94 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.86 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -53.86 -22.34 9.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.711 0.687 . . . . 0.0 110.468 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 270' ' ' SER . . . -55.77 -27.34 50.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.723 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 269' ' ' ALA . 0.9 OUTLIER 93.22 91.29 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 122.602 0.361 . . . . 0.0 111.191 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.955 ' CG ' HG23 ' A' ' 266' ' ' ILE . 47.6 Cg_endo -91.14 81.11 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.279 2.653 . . . . 0.0 112.939 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 6.6 m-80 37.23 82.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.721 0.296 . . . . 0.0 111.142 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 7.9 mmtt -51.58 -54.2 30.1 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -66.9 -57.4 7.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.8 mt -63.74 -53.75 46.24 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -65.83 -55.19 18.4 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -58.97 -32.59 69.79 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.32 -53.03 8.77 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.421 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 85.9 t80 -56.37 -54.66 42.97 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.85 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 284' ' ' LEU . 1.0 OUTLIER -53.9 -43.5 69.75 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.566 0.698 . . . . 0.0 111.402 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.706 ' O ' HD12 ' A' ' 285' ' ' LEU . 90.0 mt-10 -73.45 -34.36 65.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.787 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -93.15 -13.96 27.78 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 1.003 ' O ' HG22 ' A' ' 286' ' ' THR . 2.5 t80 -106.21 -65.72 1.05 Allowed 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.759 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.5 tp -36.48 -33.04 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.732 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.706 HD12 ' O ' ' A' ' 281' ' ' GLU . 26.2 mt -89.8 42.09 1.08 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.637 0.255 . . . . 0.0 111.665 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . 1.003 HG22 ' O ' ' A' ' 283' ' ' TYR . 10.1 t -145.72 160.55 41.56 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 9.3 m-20 -63.81 -12.72 38.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.549 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.591 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 9.9 mt-10 -77.85 -46.94 20.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.598 0.636 . . . . 0.0 111.012 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.861 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -83.86 -54.99 2.91 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 284' ' ' LEU . 2.2 tp -48.86 -49.8 37.78 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 1.8 tt0 -78.65 -26.38 45.11 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.174 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -71.85 -35.12 69.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 119.838 1.199 . . . . 0.0 108.129 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 289' ' ' GLY . 66.1 t -65.77 -41.95 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.036 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -91.2 -33.88 15.22 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.632 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -46.27 85.98 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.471 ' HB3' ' HA3' ' A' ' 19' ' ' GLY . 1.2 p30 -61.49 -44.73 96.56 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 5.1 mttp -43.45 163.86 0.15 Allowed Pre-proline 0 N--CA 1.476 0.833 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.245 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -93.96 49.19 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.217 2.612 . . . . 0.0 114.699 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.2 mt 60.75 69.5 0.68 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.902 0.382 . . . . 0.0 111.533 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.673 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . 159.99 125.29 0.78 Allowed Glycine 0 C--O 1.231 -0.087 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.606 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . 159.61 -177.07 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.272 0.536 . . . . 0.0 111.571 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.648 HG21 HG21 ' A' ' 93' ' ' THR . 6.5 p -141.99 83.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.563 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . -84.67 58.22 4.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.271 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.886 HD21 ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER 87.84 149.4 0.05 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -30.19 0.66 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 65.5 m -79.91 -47.24 15.38 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.064 0.935 . . . . 0.0 111.059 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.563 ' CD2' ' HB3' ' A' ' 303' ' ' ALA . 5.9 t80 -70.74 -19.2 62.76 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.607 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -42.24 62.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -56.81 -55.85 29.06 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.195 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.34 -42.99 99.84 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.942 0.401 . . . . 0.0 110.18 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.479 ' O ' HG21 ' A' ' 317' ' ' ILE . 10.7 mt -59.93 -44.84 94.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.804 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.642 ' O ' ' HB2' ' A' ' 318' ' ' ALA . . . -46.63 -33.61 4.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.6 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -57.38 -36.5 71.33 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.582 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.53 164.57 5.16 Favored Pre-proline 0 N--CA 1.462 0.139 0 CA-C-O 120.684 0.278 . . . . 0.0 110.714 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.21 -57.2 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.131 2.554 . . . . 0.0 113.48 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.7 mtt85 -58.89 -59.46 5.42 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.49 HD11 ' CG1' ' A' ' 110' ' ' VAL . 1.7 tp -52.26 -54.31 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 312' ' ' ALA . . . -45.71 -51.86 11.81 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.269 0.486 . . . . 0.0 111.623 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -50.71 -48.4 58.84 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.318 1.056 . . . . 0.0 108.748 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.689 ' O ' ' HB2' ' A' ' 324' ' ' ALA . 0.3 OUTLIER -60.95 -36.9 80.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 113.248 -1.797 . . . . 0.0 110.58 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -73.96 -42.83 59.92 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.95 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.31 -57.5 12.37 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.753 0.311 . . . . 0.0 110.377 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -29.36 68.88 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.263 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -51.99 -53.05 46.15 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.734 0.302 . . . . 0.0 111.031 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -52.94 -32.85 47.96 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.203 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -98.64 13.2 32.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.657 ' HA3' HG13 ' A' ' 259' ' ' VAL . . . -93.9 160.0 23.98 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.865 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -97.76 131.93 43.83 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.2 pp -68.96 101.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 120.425 1.466 . . . . 0.0 107.875 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.59 ' CG ' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -36.07 144.84 0.24 Allowed Pre-proline 0 C--N 1.347 0.495 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -44.81 169.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.175 2.583 . . . . 0.0 112.297 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.404 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 9.3 p30 -128.4 -14.27 4.78 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.596 HD12 ' CG ' ' A' ' 335' ' ' GLN . 11.8 pt -78.94 165.89 46.06 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 118.77 0.714 . . . . 0.0 111.956 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.417 ' CD ' ' HB ' ' A' ' 333' ' ' ILE . 12.5 Cg_exo -70.55 -26.29 24.01 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.353 2.702 . . . . 0.0 113.402 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.699 ' OE1' HG23 ' A' ' 368' ' ' ILE . 84.1 mm-40 -42.01 -21.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.8 mmt -45.24 -32.17 1.81 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.234 0.47 . . . . 0.0 111.431 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -43.28 99.19 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 368' ' ' ILE . . . -63.5 -34.81 78.6 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.09 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.609 ' O ' HG23 ' A' ' 343' ' ' VAL . 4.3 m-85 -75.46 -52.28 11.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.542 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.459 ' CZ2' ' HG3' ' A' ' 154' ' ' PRO . 0.7 OUTLIER -53.45 -40.83 65.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.345 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -52.44 16.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.95 -44.49 69.43 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 1.037 HG13 HG21 ' A' ' 347' ' ' VAL . 47.9 t -64.72 -50.36 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.803 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.456 ' O ' HG22 ' A' ' 348' ' ' ILE . 9.0 tpt180 -53.42 -56.99 12.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.987 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 6.3 m -56.77 -58.22 9.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.05 -60.75 2.09 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 1.037 HG21 HG13 ' A' ' 343' ' ' VAL . 51.7 t -51.95 -47.47 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.742 HD11 ' OE1' ' A' ' 152' ' ' GLN . 0.4 OUTLIER -69.93 -45.27 77.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.893 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -69.12 -51.8 34.77 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.692 ' HB1' ' HA ' ' A' ' 355' ' ' GLN . . . -73.12 -26.62 61.29 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -51.86 -10.56 0.12 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 1.4 m -110.47 35.26 3.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.568 0.622 . . . . 0.0 111.059 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 88.64 -4.77 85.08 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 118.713 -1.708 . . . . 0.0 114.511 176.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -87.67 34.97 0.71 Allowed 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 115.683 -2.103 . . . . 0.0 107.903 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.971 ' HG2' HG23 ' A' ' 357' ' ' VAL . 2.0 mt-30 -71.14 -175.86 1.29 Allowed 'General case' 0 CA--C 1.547 0.838 1 N-CA-C 126.255 5.65 . . . . 0.0 126.255 -157.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.7 OUTLIER 158.26 41.38 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 110.074 -3.239 . . . . 0.0 104.876 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.971 HG23 ' HG2' ' A' ' 355' ' ' GLN . 53.2 t -72.43 -54.61 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.84 -174.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 6.7 t70 -46.23 -45.66 17.19 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.702 0.763 . . . . 0.0 111.269 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -77.4 -56.14 4.8 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.71 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -54.68 -44.32 73.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.209 1.004 . . . . 0.0 112.72 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.601 ' HB3' HG12 ' A' ' 183' ' ' VAL . 32.7 mt -75.62 -33.93 60.55 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.787 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 12.1 tttt -67.81 -56.06 10.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.172 0.987 . . . . 0.0 109.903 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.22 -30.72 71.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.146 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -53.87 -53.72 48.66 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.69 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.571 ' O ' HG23 ' A' ' 369' ' ' THR . 1.0 OUTLIER -58.5 -36.43 73.79 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.893 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.43 ' N ' ' HG3' ' A' ' 365' ' ' GLN . 5.9 m -52.16 -41.24 62.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.409 0.623 . . . . 0.0 109.588 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -73.73 -42.77 60.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.938 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.893 HG22 HD11 ' A' ' 178' ' ' ILE . 21.8 mm -66.12 -34.68 71.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 365' ' ' GLN . 6.6 p -94.5 -14.19 25.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.985 179.963 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.73 0.3 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -149.09 135.23 19.13 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.14 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -108.89 67.47 0.22 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.379 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.93 156.25 44.36 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.007 HD22 HD11 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -138.55 118.59 13.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.001 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -114.45 120.79 65.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.716 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.007 HD11 HD22 ' A' ' 7' ' ' LEU . 2.7 mp -121.67 130.79 74.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.123 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.886 ' HB2' HG22 ' A' ' 60' ' ' ILE . 29.8 m95 -107.94 121.13 44.15 Favored 'General case' 0 CA--C 1.527 0.058 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.3 pt -150.96 142.3 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.707 ' HA ' HD13 ' A' ' 43' ' ' LEU . 2.8 t30 -79.8 67.51 5.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.102 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.71 66.28 2.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.525 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 4.1 m-20 -80.59 -34.55 35.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.291 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 6.7 mttp 105.99 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.34 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 297' ' ' LYS . . . -74.36 58.21 2.41 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CZ ' HG21 ' A' ' 37' ' ' VAL . 3.3 m-85 -78.24 -42.14 32.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.751 0.31 . . . . 0.0 110.277 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 4.1 m120 -58.03 -48.37 80.28 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.986 0.422 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.883 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.78 -47.86 30.92 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.357 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.908 HD11 HG21 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -60.48 -51.31 70.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.382 0.591 . . . . 0.0 110.535 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.79 81.75 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.859 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 4.0 tm-20 -65.56 -36.53 84.06 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 19' ' ' GLY . 84.3 t -66.93 -61.3 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.605 ' CA ' HG21 ' A' ' 33' ' ' ILE . . . -49.09 -33.64 14.84 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.649 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -50.03 70.14 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.1 -41.46 62.46 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 112.809 -1.996 . . . . 0.0 107.902 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.574 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.17 -35.11 79.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.72 0.772 . . . . 0.0 110.865 178.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.716 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 18.4 tt0 -72.4 -52.46 15.88 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.223 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -53.05 -25.66 13.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.614 1.196 . . . . 0.0 110.244 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.728 ' O ' HG23 ' A' ' 31' ' ' THR . 9.1 t70 -89.04 -40.43 12.98 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.296 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER 169.67 38.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 173.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 157.36 39.53 0.02 OUTLIER Glycine 0 N--CA 1.466 0.671 0 C-N-CA 114.892 -3.528 . . . . 0.0 119.796 175.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 3.1 mm -139.7 137.55 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 122.32 3.06 . . . . 0.0 118.152 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -142.55 104.33 4.37 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.651 HG11 HD22 ' A' ' 20' ' ' LEU . 6.4 t -93.4 130.53 42.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 -171.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.1 m -119.21 145.14 46.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.675 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.683 HG12 ' HB ' ' A' ' 9' ' ' ILE . 2.1 m -131.09 122.94 52.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 122.057 -0.402 . . . . 0.0 110.683 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.48 130.78 55.48 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.964 ' HA ' HD12 ' A' ' 43' ' ' LEU . 1.3 p80 -150.57 71.22 8.99 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.36 178.77 5.97 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.462 2.108 . . . . 0.0 112.219 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -66.01 -40.05 90.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.962 0.411 . . . . 0.0 110.369 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 44' ' ' GLU . 11.1 mptt -84.72 1.05 48.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.096 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 39' ' ' HIS . 7.0 tt -19.33 -46.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 1.069 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -68.48 -54.61 15.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.711 0.291 . . . . 0.0 110.857 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.505 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -70.09 -37.59 75.45 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -60.2 -56.59 19.72 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.846 0.832 . . . . 0.0 109.861 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.7 ' CZ ' HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -41.76 -60.7 1.79 Allowed Pre-proline 0 C--N 1.352 0.693 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.31 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 1.069 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 29.2 Cg_exo -63.16 -25.18 72.73 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 121.617 1.544 . . . . 0.0 113.426 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -82.17 -35.57 28.23 Favored 'General case' 0 C--O 1.255 1.37 0 CA-C-O 122.171 0.986 . . . . 0.0 111.08 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.463 HG21 ' CZ2' ' A' ' 10' ' ' TRP . 29.2 m -77.78 -39.71 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.504 0 CA-C-O 122.04 0.924 . . . . 0.0 109.089 178.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.38 -37.82 26.35 Favored 'General case' 0 C--N 1.373 1.615 0 C-N-CA 126.048 1.739 . . . . 0.0 110.85 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.95 -42.4 21.33 Favored 'General case' 0 C--N 1.371 1.512 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.967 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 55' ' ' ASP . 1.2 m -73.69 145.93 44.87 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.578 1.081 . . . . 0.0 108.893 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 64.97 -78.35 0.07 OUTLIER Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.741 ' C ' ' HB1' ' A' ' 269' ' ' ALA . 1.4 t0 85.39 56.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 117.613 0.707 . . . . 0.0 111.672 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.581 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . -156.07 47.4 0.49 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 119.967 -1.111 . . . . 0.0 114.449 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.749 ' HD2' ' HB3' ' A' ' 269' ' ' ALA . 43.1 Cg_endo -100.15 -169.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.184 2.589 . . . . 0.0 112.093 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 1.001 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 4.1 t70 -88.24 -135.52 0.09 Allowed 'General case' 0 N--CA 1.414 -2.242 0 C-N-CA 123.123 0.569 . . . . 0.0 110.543 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.514 HG13 ' HA ' ' A' ' 266' ' ' ILE . 20.8 tt -103.08 163.67 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.886 HG22 ' HB2' ' A' ' 10' ' ' TRP . 10.3 pt -130.17 128.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 4.0 m-85 -107.17 124.33 49.55 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.471 ' CZ2' ' HG2' ' A' ' 44' ' ' GLU . 8.3 t90 -167.44 161.38 13.93 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -49.09 160.8 0.18 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.137 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.645 ' CD2' HG23 ' A' ' 97' ' ' VAL . 22.1 t-80 -77.56 -28.69 51.84 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.82 -58.85 3.82 Favored 'General case' 0 C--O 1.251 1.173 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.454 ' CB ' ' CZ3' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -75.49 -30.46 59.88 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.32 0.581 . . . . 0.0 110.038 179.555 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.58 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 2.2 m-30 -62.52 -27.08 68.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 174.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -60.82 -66.21 2.83 Favored Glycine 0 CA--C 1.49 -1.496 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.15 -53.66 43.84 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 113.218 -1.491 . . . . 0.0 111.256 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.476 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.9 m-30 -51.4 -42.84 61.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.729 ' HB2' HG21 ' A' ' 104' ' ' ILE . . . -54.58 -39.33 67.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.74 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -78.79 -43.14 26.08 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 111.666 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -70.22 -14.86 62.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.91 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.6 29.62 8.63 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.656 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 48' ' ' PRO . 8.1 mp -106.69 39.89 1.75 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.995 0.426 . . . . 0.0 110.424 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.736 ' C ' HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.37 145.4 0.25 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.366 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.868 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -96.1 115.3 27.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.969 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -47.68 129.68 13.96 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.806 HD12 ' HA ' ' A' ' 105' ' ' ALA . 14.6 mt -95.95 110.21 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.752 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.8 p -88.82 101.41 2.85 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.964 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 83.3 Cg_endo -101.24 -170.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.61 2.873 . . . . 0.0 113.161 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.19 -169.9 2.75 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.257 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.71 -44.08 7.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.532 0.206 . . . . 0.0 111.454 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -74.83 -23.54 58.47 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.725 ' HE1' HD21 ' A' ' 285' ' ' LEU . 6.5 t80 -64.62 -59.22 4.53 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.507 ' HG3' ' CG ' ' A' ' 94' ' ' TRP . 3.0 tt0 -70.13 -29.49 66.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.808 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 84' ' ' ALA . 12.6 t70 -76.82 -12.88 60.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.9 OUTLIER -87.81 -7.66 56.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.705 HD23 ' HB1' ' A' ' 303' ' ' ALA . 3.3 mp -100.91 -101.23 0.25 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.158 0.89 . . . . 0.0 111.584 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.19 133.18 10.56 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 122.102 -0.374 . . . . 0.0 111.056 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.0 -52.97 7.61 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.66 2.24 . . . . 0.0 112.934 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.462 ' CE1' ' HA ' ' A' ' 325' ' ' GLN . 45.2 t80 -55.53 -44.53 76.79 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.704 0.288 . . . . 0.0 111.08 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 302' ' ' VAL . 29.8 m -61.27 -29.04 69.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.507 ' CG ' ' HG3' ' A' ' 86' ' ' GLN . 86.3 m95 -92.97 -24.1 18.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.508 0.67 . . . . 0.0 112.136 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -73.82 -24.09 59.74 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.759 ' HB1' HG22 ' A' ' 261' ' ' VAL . . . -65.76 -21.66 66.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.271 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.645 HG23 ' CD2' ' A' ' 64' ' ' HIS . 6.7 p -125.28 58.03 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 102' ' ' LYS . 26.6 ttt180 -124.84 100.93 6.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.433 ' HH ' ' CG ' ' A' ' 332' ' ' ASN . 4.4 m-85 -89.07 90.9 8.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.169 0.44 . . . . 0.0 110.426 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 42.72 66.35 0.78 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.709 0.29 . . . . 0.0 110.87 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.22 38.98 58.67 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.593 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 4.7 mmtt -139.84 -177.61 5.05 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 119.446 -0.312 . . . . 0.0 110.792 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 97' ' ' VAL . 0.3 OUTLIER 175.34 107.85 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.601 0.637 . . . . 0.0 109.661 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.736 HD11 ' C ' ' A' ' 76' ' ' LEU . 3.6 tt -100.96 37.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.441 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.806 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . 170.21 149.14 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.544 ' CZ ' HG21 ' A' ' 79' ' ' ILE . 12.7 m-30 -88.2 120.3 70.53 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.617 ' HB3' HG12 ' A' ' 261' ' ' VAL . 2.9 Cg_endo -78.94 155.28 26.36 Favored 'Trans proline' 0 CA--C 1.514 -0.478 0 C-N-CA 121.917 1.745 . . . . 0.0 112.847 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 262' ' ' LEU . 0.5 OUTLIER -157.11 38.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.142 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 1.015 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 170.23 134.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.937 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.031 HG22 HG21 ' A' ' 302' ' ' VAL . 17.2 m -114.8 133.74 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.936 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.6 ' HB2' ' HA3' ' A' ' 260' ' ' GLY . 0.6 OUTLIER -99.57 136.1 40.0 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 1.038 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -167.97 -173.68 2.15 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 123.411 1.577 . . . . 0.0 110.307 -167.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.73 HD13 ' CD1' ' A' ' 156' ' ' PHE . 0.1 OUTLIER -146.12 135.57 23.02 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 110.598 -3.001 . . . . 0.0 116.246 -176.068 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.46 ' HA ' HD12 ' A' ' 247' ' ' LEU . 0.9 OUTLIER -131.09 165.17 23.84 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.051 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.906 HD23 ' OH ' ' A' ' 117' ' ' TYR . 6.2 tp -93.21 130.79 38.78 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.848 HD13 ' N ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -115.25 136.16 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.169 -179.497 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.906 ' OH ' HD23 ' A' ' 115' ' ' LEU . 14.1 m-85 -121.48 140.83 51.67 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -86.1 122.0 29.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -106.2 29.06 7.1 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.956 0.407 . . . . 0.0 111.515 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -131.43 -51.05 1.0 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.23 -136.89 0.02 OUTLIER 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.249 -1.796 . . . . 0.0 107.685 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.768 HD23 ' HD2' ' A' ' 123' ' ' PRO . 2.0 mt -84.45 128.93 59.62 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.768 ' HD2' HD23 ' A' ' 122' ' ' LEU . 33.5 Cg_exo -56.28 161.78 8.68 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.374 2.716 . . . . 0.0 110.997 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 8.4 p-10 -106.36 158.21 33.15 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.631 0.253 . . . . 0.0 111.042 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 19.9 Cg_endo -60.26 164.4 12.77 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.4 2.066 . . . . 0.0 111.833 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.423 ' HB2' ' HG3' ' A' ' 127' ' ' LYS . 4.0 Cg_exo -77.39 -42.35 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.801 2.334 . . . . 0.0 112.726 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.423 ' HG3' ' HB2' ' A' ' 126' ' ' PRO . 2.8 mttp -153.49 -10.72 0.15 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -119.45 139.56 51.86 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.802 1.183 . . . . 0.0 112.961 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.707 ' CH2' HD21 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -69.25 -23.76 63.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 172.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -44.82 -23.89 0.17 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.248 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.458 ' OE2' ' HB3' ' A' ' 134' ' ' ALA . 5.3 tp10 -66.83 -26.4 66.91 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.593 HG13 ' HD2' ' A' ' 133' ' ' PRO . 0.2 OUTLIER -40.47 -53.06 5.76 Favored Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.378 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.813 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 6.6 Cg_endo -48.82 -43.83 33.59 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 120.699 0.933 . . . . 0.0 110.049 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.458 ' HB3' ' OE2' ' A' ' 131' ' ' GLU . . . -74.68 -58.6 3.19 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 139' ' ' LEU . 32.7 tp -66.32 -40.41 89.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.208 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.636 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 3.3 m-20 -70.74 -35.7 72.79 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -47.69 -50.23 25.52 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.455 176.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 4.3 mp0 -61.87 -40.48 95.52 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.337 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.835 HD22 ' O ' ' A' ' 145' ' ' SER . 0.4 OUTLIER -61.79 -48.44 80.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -48.07 -43.9 30.94 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.02 -27.8 1.02 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -58.95 1.83 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.285 0.564 . . . . 0.0 110.239 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.81 40.19 0.02 OUTLIER Glycine 0 CA--C 1.519 0.319 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.299 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.501 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -152.83 -171.81 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 119.298 1.549 . . . . 0.0 111.501 -175.157 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.835 ' O ' HD22 ' A' ' 139' ' ' LEU . 5.0 m -138.76 158.24 44.6 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.731 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -73.35 -33.34 65.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.1 pp -135.38 129.23 33.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.83 ' N ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -133.4 134.91 44.25 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.092 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.68 ' CE2' HD13 ' A' ' 147' ' ' LEU . 21.4 p90 -172.31 177.18 3.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.511 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -36.53 164.93 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.366 0.416 . . . . 0.0 111.485 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.743 HD11 ' HB1' ' A' ' 206' ' ' ALA . 2.8 tm? -114.03 -57.71 2.24 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.415 ' OE1' HD11 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -104.47 34.59 3.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 116.166 -2.213 . . . . 0.0 114.693 -174.17 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.792 ' O ' ' OG1' ' A' ' 157' ' ' THR . 0.0 OUTLIER -79.81 140.32 54.52 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 121.279 1.854 . . . . 0.0 113.391 -176.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.957 ' O ' ' N ' ' A' ' 156' ' ' PHE . 84.5 Cg_endo -77.88 -135.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.376 3.384 . . . . 0.0 104.322 175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 1.152 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 1.4 m-85 28.93 -59.95 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.038 1.29 . . . . 0.0 113.643 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.957 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -85.41 -61.85 1.67 Allowed 'General case' 0 C--O 1.258 1.544 0 CA-C-N 118.777 0.717 . . . . 0.0 112.534 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.792 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 8.5 p -59.2 -40.67 86.48 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.181 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.692 ' O ' HG13 ' A' ' 161' ' ' ILE . 1.1 m95 -51.24 -55.53 27.86 Favored Pre-proline 0 C--N 1.353 0.733 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 1.152 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 78.1 Cg_exo -43.38 -44.31 10.46 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.598 2.199 . . . . 0.0 113.201 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 255' ' ' SER . 7.3 mp -63.6 -56.69 13.94 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.002 0.819 . . . . 0.0 110.388 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.692 HG13 ' O ' ' A' ' 158' ' ' TRP . 2.4 pp -53.72 -19.33 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.296 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.666 ' N ' HD12 ' A' ' 161' ' ' ILE . . . -78.61 -22.03 47.63 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.254 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -41.87 -59.26 1.75 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' A' ' 190' ' ' ALA . 45.7 t0 -64.35 -14.26 55.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -175.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 134.06 20.26 0.85 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 118.73 -1.7 . . . . 0.0 116.525 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.51 160.14 41.38 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 119.064 1.432 . . . . 0.0 111.423 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -145.61 136.0 24.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.336 0.568 . . . . 0.0 110.374 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.2 -80.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.358 0.599 . . . . 0.0 111.765 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.637 ' HB2' ' CG ' ' A' ' 176' ' ' TYR . 14.5 m-85 -113.13 173.8 6.21 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.576 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 1.194 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 6.5 mmtt -100.48 103.75 15.11 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.485 ' CD2' ' CE1' ' A' ' 176' ' ' TYR . 0.4 OUTLIER -85.04 115.25 22.75 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.586 176.262 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.886 ' O ' ' N ' ' A' ' 174' ' ' GLY . 1.1 tp10 -137.28 101.67 4.59 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.056 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.0 m120 44.42 -66.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 O-C-N 123.619 0.575 . . . . 0.0 110.656 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.886 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -70.66 -73.35 0.79 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 115.664 -0.698 . . . . 0.0 114.346 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -174.66 158.04 2.64 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 117.994 0.897 . . . . 0.0 110.677 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 1.194 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -56.29 -33.66 65.73 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.33 1.062 . . . . 0.0 108.256 177.005 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 1.0 OUTLIER 67.94 -85.71 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.862 179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 6.7 tp 175.02 -41.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.0 OUTLIER -66.38 -10.55 44.6 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.441 ' CB ' ' HB2' ' A' ' 170' ' ' LYS . 2.1 m-20 -124.56 93.75 3.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.58 121.54 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -123.23 39.72 2.16 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.698 -1.239 . . . . 0.0 113.959 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 184' ' ' ASP . 12.8 p -80.2 -44.14 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.028 0.442 . . . . 0.0 109.982 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.923 ' HB2' HD23 ' A' ' 361' ' ' LEU . 9.4 t70 -81.27 59.08 3.8 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.758 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -104.76 173.2 6.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.464 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.19 -28.11 62.54 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.352 0.596 . . . . 0.0 111.571 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -71.31 -45.97 44.79 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.09 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -60.41 -44.79 95.37 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HG3' HG21 ' A' ' 357' ' ' VAL . 5.5 tttp -57.8 -60.01 4.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.325 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.37 -40.94 50.88 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.088 0.947 . . . . 0.0 112.017 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -62.88 -60.65 7.39 Favored Glycine 0 C--O 1.24 0.485 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.086 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 196' ' ' VAL . 5.6 tp -59.49 -25.05 64.12 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 99.0 m -60.74 -50.2 74.42 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.499 ' CZ ' ' CE1' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -59.85 -37.26 78.76 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 tp -63.28 -47.58 81.75 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.631 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 192' ' ' LEU . 44.6 t -57.68 -28.76 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.508 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.11 -45.62 80.49 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.855 0.836 . . . . 0.0 111.039 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.458 ' HG ' HD13 ' A' ' 132' ' ' ILE . 4.3 tt -59.46 -51.95 67.67 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.851 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 204' ' ' MET . 6.6 mt -66.62 -40.25 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.96 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 4.9 tppt? -52.68 -36.91 57.94 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.626 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -113.18 -34.57 5.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 121.157 3.762 . . . . 0.0 121.157 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -63.73 -80.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.967 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.08 -9.67 27.58 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.563 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 4.8 ptt? 42.15 36.24 0.68 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.611 ' O ' ' HB3' ' A' ' 206' ' ' ALA . 0.7 OUTLIER -145.16 -73.34 0.25 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.743 ' HB1' HD11 ' A' ' 151' ' ' LEU . . . 84.41 37.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -97.74 -3.08 39.79 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 34.8 p -55.08 117.19 3.25 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.97 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.91 -173.64 4.17 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.3 p90 -70.63 -45.28 65.49 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 1.7 t -73.72 -32.73 64.03 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.711 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.75 -48.66 23.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.74 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.01 -32.19 70.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.06 -45.36 92.57 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 218' ' ' ASN . . . -58.75 -40.73 84.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.959 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.21 -57.09 10.72 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.09 -29.52 69.87 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.419 ' HB2' ' HA ' ' A' ' 215' ' ' ALA . 0.7 OUTLIER -52.69 -37.45 58.93 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.443 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -74.24 -23.89 59.22 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.04 53.63 5.65 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 114.7 0.64 . . . . 0.0 114.7 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -124.5 37.64 4.36 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.35 1.075 . . . . 0.0 111.609 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.83 HG21 ' N ' ' A' ' 148' ' ' MET . 2.2 m -142.22 140.9 32.45 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.731 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -113.13 38.79 2.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.618 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.658 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER 178.85 126.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 177.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.746 HG23 ' CG2' ' A' ' 116' ' ' ILE . 1.8 t -147.16 165.99 28.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.433 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.533 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 0.1 OUTLIER -100.49 146.02 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 172.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 114' ' ' SER . 2.3 t-20 -146.4 166.33 26.68 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.182 1.355 . . . . 0.0 109.953 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 112' ' ' ALA . . . -176.11 130.41 1.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.294 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.67 -29.66 3.59 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.846 2.364 . . . . 0.0 113.219 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.421 ' HA ' ' CG ' ' A' ' 111' ' ' GLU . 29.7 t-105 -33.66 -72.87 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.94 -41.9 8.18 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.24 166.53 18.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.907 0.384 . . . . 0.0 111.714 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 t -124.49 -62.07 1.28 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.52 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -99.32 139.69 34.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.691 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.8 HD11 ' CE1' ' A' ' 242' ' ' TYR . 25.4 pt -84.07 173.7 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.283 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.17 176.15 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.722 0.296 . . . . 0.0 110.995 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.05 83.43 0.33 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.965 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' SER . . . . . 0.405 ' O ' ' CE1' ' A' ' 242' ' ' TYR . 41.2 t -129.77 70.51 1.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.786 0.327 . . . . 0.0 110.682 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.429 ' O ' ' CZ ' ' A' ' 242' ' ' TYR . 0.0 OUTLIER 65.83 109.72 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.607 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.43 ' O ' ' CD2' ' A' ' 242' ' ' TYR . 58.4 t -45.29 -34.66 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.854 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -79.76 107.23 12.37 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.69 0.281 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.8 ' CE1' HD11 ' A' ' 235' ' ' ILE . 48.0 m-85 -118.46 134.04 55.39 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.245 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.96 105.25 2.3 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.202 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.0 t -90.96 111.59 23.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.78 167.41 18.12 Favored 'General case' 0 CA--C 1.527 0.067 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.1 m -73.36 153.66 7.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.522 HD23 ' OG ' ' A' ' 255' ' ' SER . 0.3 OUTLIER -59.26 159.04 16.74 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 119.784 1.175 . . . . 0.0 111.414 -178.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.706 ' HD3' HD13 ' A' ' 115' ' ' LEU . 90.4 Cg_endo -79.51 -165.08 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.035 2.49 . . . . 0.0 112.496 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -119.27 175.58 5.73 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.929 0.395 . . . . 0.0 111.763 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.499 ' CE1' ' CZ ' ' A' ' 194' ' ' PHE . 98.0 m-85 -166.13 111.05 0.82 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.957 0.884 . . . . 0.0 108.811 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 7.8 mttp 62.43 31.09 17.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.809 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.0 31.14 40.12 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.302 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.405 ' N ' HG22 ' A' ' 249' ' ' THR . 1.1 mm-40 -156.59 153.03 23.84 Favored Pre-proline 0 N--CA 1.463 0.179 0 CA-C-N 117.381 0.59 . . . . 0.0 112.251 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -87.88 170.36 6.25 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.209 2.606 . . . . 0.0 112.189 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.522 ' OG ' HD23 ' A' ' 247' ' ' LEU . 0.0 OUTLIER -91.03 144.34 25.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.803 0.335 . . . . 0.0 111.411 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 2.2 mttt -86.58 108.3 17.42 Favored Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.066 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.642 ' CB ' HD21 ' A' ' 113' ' ' LEU . 88.2 Cg_endo -79.55 153.35 23.5 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.273 1.982 . . . . 0.0 112.717 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 2.5 t80 -79.19 164.39 24.24 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.767 ' CB ' HG22 ' A' ' 329' ' ' ILE . 15.5 t -121.8 127.56 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.6 ' HA3' ' HB2' ' A' ' 111' ' ' GLU . . . -123.69 117.79 3.28 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 119.257 -1.449 . . . . 0.0 115.871 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.759 HG22 ' HB1' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -103.87 115.31 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.527 179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 1.015 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.5 mm? -94.22 93.63 7.87 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -111.28 -177.71 3.27 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -172.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.631 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -108.67 128.31 54.74 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 60' ' ' ILE . . . -122.87 127.8 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.82 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.639 HD12 HG12 ' A' ' 79' ' ' ILE . 24.7 mt -87.84 121.48 38.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.65 142.9 56.88 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.868 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -57.35 -26.46 61.02 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.149 -0.345 . . . . 0.0 110.78 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.749 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . . . -50.82 -59.89 3.64 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.921 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 271' ' ' PRO . 19.2 p -135.64 154.11 77.95 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.728 0.299 . . . . 0.0 111.413 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 270' ' ' SER . 15.3 Cg_endo -88.58 -66.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.054 2.503 . . . . 0.0 112.735 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 55.4 45.77 24.67 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 110.125 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 2.0 ttpt -60.32 -54.19 48.7 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.782 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 24.6 tp10 -50.2 -57.6 7.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.902 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.667 HD21 HD11 ' A' ' 33' ' ' ILE . 10.0 tp -64.93 -58.09 7.06 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.98 -56.69 5.65 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.2 OUTLIER -54.22 -38.55 65.83 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 1.9 tp10 -76.34 -53.14 8.6 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -56.17 -56.36 21.91 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.611 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.733 HD21 HD22 ' A' ' 284' ' ' LEU . 7.2 tt -52.32 -43.91 64.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.675 0.75 . . . . 0.0 111.67 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.698 ' O ' HD23 ' A' ' 285' ' ' LEU . 31.0 tt0 -73.2 -34.27 65.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.651 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -91.57 -14.71 29.82 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.874 ' O ' HG22 ' A' ' 286' ' ' THR . 0.2 OUTLIER -102.45 -65.49 0.99 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.237 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.733 HD22 HD21 ' A' ' 280' ' ' LEU . 6.3 tp -43.2 -22.7 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.601 -0.44 . . . . 0.0 112.097 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 1.067 HD13 HD11 ' A' ' 304' ' ' LEU . 3.8 mm? -101.37 37.38 1.8 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.002 -0.436 . . . . 0.0 110.721 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.874 HG22 ' O ' ' A' ' 283' ' ' TYR . 11.3 t -145.01 158.72 43.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 4.4 p30 -65.97 -11.66 49.3 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.603 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 5.5 tp10 -77.89 -47.12 19.47 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 109.993 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.607 ' O ' ' HB ' ' A' ' 293' ' ' VAL . . . -82.64 -49.49 5.11 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 1.027 HD11 HD13 ' A' ' 304' ' ' LEU . 8.4 mt -61.75 -51.24 69.17 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.631 0.254 . . . . 0.0 111.383 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.509 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 2.9 tp10 -76.08 -27.9 57.37 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.059 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.603 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -71.57 -27.73 63.35 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.957 HG13 ' HG3' ' A' ' 298' ' ' PRO . 1.1 t -65.72 -61.0 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.798 175.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.571 ' N ' HG12 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -35.02 -50.31 0.49 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.313 1.445 . . . . 0.0 112.323 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 296' ' ' ASP . 20.2 ttpt -48.79 -43.9 38.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.254 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 295' ' ' LYS . 2.6 m-20 154.41 68.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.721 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.841 ' H ' ' HD2' ' A' ' 298' ' ' PRO . 0.5 OUTLIER -120.75 -37.95 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.023 171.293 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.957 ' HG3' HG13 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -91.61 -120.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 124.761 3.641 . . . . 0.0 113.283 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.847 HD13 ' CD1' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -160.78 -41.38 0.05 OUTLIER 'General case' 0 C--N 1.356 0.883 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -129.08 -155.59 8.6 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.56 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.898 ' HB3' ' CG1' ' A' ' 317' ' ' ILE . . . -133.25 48.15 2.42 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.115 0.958 . . . . 0.0 112.46 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 1.031 HG21 HG22 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -140.78 92.26 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.686 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.801 ' O ' HD12 ' A' ' 304' ' ' LEU . . . 177.69 48.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 1.067 HD11 HD13 ' A' ' 285' ' ' LEU . 0.0 OUTLIER 158.48 99.11 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.314 0.246 . . . . 0.0 111.42 178.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -38.37 -32.64 0.08 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 20.0 m -78.66 -44.22 24.25 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.473 1.13 . . . . 0.0 109.572 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.908 ' CD2' HD22 ' A' ' 290' ' ' LEU . 19.6 t80 -70.57 -20.03 62.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 112.87 -1.968 . . . . 0.0 110.249 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.777 ' OE2' HG21 ' A' ' 317' ' ' ILE . 7.9 tp10 -76.28 -43.14 43.02 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.0 -58.6 5.67 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.724 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -54.09 -52.9 59.49 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.246 0.546 . . . . 0.0 110.5 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.76 ' O ' HD23 ' A' ' 311' ' ' LEU . 2.3 tt -70.91 -28.04 64.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.932 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -45.92 -20.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -34.19 -42.67 0.13 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.543 0.61 . . . . 0.0 109.704 178.432 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -88.76 121.7 69.7 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.58 9.51 1.87 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.591 2.194 . . . . 0.0 115.467 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.404 ' O ' ' OG1' ' A' ' 320' ' ' THR . 5.6 mtm-85 -60.23 -59.82 4.81 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.706 0.684 . . . . 0.0 111.256 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.898 ' CG1' ' HB3' ' A' ' 301' ' ' ALA . 5.2 mm -49.76 -55.35 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.68 -52.05 11.43 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.38 0.536 . . . . 0.0 111.757 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -71.66 -33.42 68.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.543 0.687 . . . . 0.0 109.351 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' THR . . . . . 1.038 HG23 ' HB3' ' A' ' 112' ' ' ALA . 94.6 m -62.02 -37.06 83.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.387 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.451 ' HG2' ' CD2' ' A' ' 92' ' ' PHE . 5.6 ttm -79.03 -44.93 21.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.693 0.282 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -54.0 -45.91 71.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.221 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.512 ' ND2' HD13 ' A' ' 247' ' ' LEU . 2.8 t-20 -78.3 -51.95 9.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.226 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . . . -48.64 -33.82 10.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.694 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' GLN . . . . . 0.462 ' HA ' ' CE1' ' A' ' 92' ' ' PHE . 0.9 OUTLIER -63.33 -39.94 95.94 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.51 0.195 . . . . 0.0 110.998 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -104.74 60.67 0.7 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.595 0.236 . . . . 0.0 111.08 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 257' ' ' PRO . . . -140.71 -147.18 4.91 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.12 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -127.32 111.77 14.29 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.767 HG22 ' CB ' ' A' ' 259' ' ' VAL . 1.8 pp -87.15 134.11 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.455 ' HG2' ' CE2' ' A' ' 258' ' ' PHE . 0.0 OUTLIER -41.03 105.33 0.38 Allowed Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.428 ' HD2' ' CE ' ' A' ' 330' ' ' MET . 96.2 Cg_exo -43.9 -34.89 6.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.676 2.251 . . . . 0.0 112.603 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.433 ' CG ' ' HH ' ' A' ' 99' ' ' TYR . 9.5 m120 79.06 51.3 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.478 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 335' ' ' GLN . 4.0 pt -133.82 156.65 79.19 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.804 0.335 . . . . 0.0 111.143 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.71 -31.51 39.8 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.636 2.224 . . . . 0.0 112.76 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.732 ' HB2' HD12 ' A' ' 333' ' ' ILE . 8.9 mm100 -59.85 -21.83 61.48 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.421 ' HG2' ' HE3' ' A' ' 330' ' ' MET . 12.0 tpp -45.56 -36.7 4.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.589 0.233 . . . . 0.0 111.372 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 2.1 p -58.1 -38.88 77.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.698 0.285 . . . . 0.0 110.348 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.948 ' HB1' ' CD1' ' A' ' 368' ' ' ILE . . . -55.6 -33.37 63.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.962 0.411 . . . . 0.0 111.307 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 343' ' ' VAL . 0.2 OUTLIER -78.51 -55.83 4.91 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.499 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.412 ' CE3' ' HA ' ' A' ' 340' ' ' TRP . 0.1 OUTLIER -44.33 -43.0 7.18 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.795 0.331 . . . . 0.0 111.025 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.99 -42.77 56.89 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.692 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.27 -45.84 72.03 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.706 ' CG2' HG21 ' A' ' 347' ' ' VAL . 9.9 p -69.62 -42.06 80.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.439 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -58.55 -59.29 5.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.698 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 9.8 m -56.39 -56.7 17.84 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.83 -60.83 2.06 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.706 HG21 ' CG2' ' A' ' 343' ' ' VAL . 48.5 t -54.56 -53.45 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 344' ' ' ARG . 1.9 tt -62.31 -46.68 95.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.031 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.419 ' N ' ' CG2' ' A' ' 348' ' ' ILE . 64.8 t-20 -64.64 -47.7 77.56 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' A' ' 355' ' ' GLN . . . -73.37 -26.65 61.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -53.22 -11.26 0.26 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.3 p -110.46 36.77 2.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.585 0.63 . . . . 0.0 110.088 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.53 -3.42 87.06 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 118.711 -1.709 . . . . 0.0 113.691 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -87.3 34.92 0.69 Allowed 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 115.65 -2.119 . . . . 0.0 107.886 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.685 ' HA ' ' HB1' ' A' ' 350' ' ' ALA . 2.9 pp0? -71.17 -173.71 0.89 Allowed 'General case' 0 C--N 1.348 0.543 1 N-CA-C 123.34 4.57 . . . . 0.0 123.34 -159.425 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.504 ' HB ' ' CB ' ' A' ' 359' ' ' GLU . 0.0 OUTLIER -179.62 46.8 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.54 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.557 HG23 ' OE1' ' A' ' 355' ' ' GLN . 84.3 t -42.27 -49.85 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.863 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -61.33 -35.04 76.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 119.948 1.249 . . . . 0.0 109.611 178.403 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.504 ' CB ' ' HB ' ' A' ' 356' ' ' THR . 1.5 mm-40 -79.18 -26.97 42.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.441 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 356' ' ' THR . . . -66.8 -53.26 34.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 122.085 0.945 . . . . 0.0 111.824 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.923 HD23 ' HB2' ' A' ' 184' ' ' ASP . 0.2 OUTLIER -82.24 -50.48 8.94 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.787 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.654 ' O ' HG23 ' A' ' 366' ' ' THR . 2.3 mmpt? -45.18 -53.04 8.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -65.13 -41.42 94.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.402 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.525 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -66.52 -58.19 5.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.611 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.525 ' HB2' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -62.16 -44.32 96.87 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.984 -0.447 . . . . 0.0 111.969 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 362' ' ' LYS . 52.7 p -56.24 -59.79 4.43 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -51.57 25.65 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.511 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.948 ' CD1' ' HB1' ' A' ' 338' ' ' ALA . 32.8 mm -60.47 -42.84 92.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 369' ' ' THR . 1.3 p -114.15 55.63 0.73 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.917 0.389 . . . . 0.0 111.103 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.828 179.759 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.67 0.271 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -145.01 173.91 11.48 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.91 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -111.31 68.3 0.22 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.493 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.0 159.04 44.58 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -156.12 118.37 4.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 58' ' ' ASP . 15.3 t -108.72 140.47 27.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 118.771 -1.172 . . . . 0.0 110.003 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.804 HD12 HD11 ' A' ' 59' ' ' ILE . 10.3 tt -136.51 124.74 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.402 0.62 . . . . 0.0 111.122 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 1.002 ' CH2' HD22 ' A' ' 43' ' ' LEU . 30.7 t90 -101.46 133.32 46.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.226 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.686 HD11 HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -149.18 165.09 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 12' ' ' ASN . 3.2 p-10 -91.85 61.64 4.17 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.543 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.75 41.47 57.84 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.059 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 58.4 t0 -50.35 -31.66 15.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 111.438 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 105.15 -18.06 0.02 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.246 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.444 ' HA2' ' CG ' ' A' ' 296' ' ' ASP . . . -75.48 56.42 2.9 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 115.921 1.129 . . . . 0.0 115.921 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -75.96 -31.8 59.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.495 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 1.4 t30 -67.98 -47.14 69.37 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.152 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.569 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -72.14 -49.16 22.5 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.739 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.7 mt -60.02 -51.03 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.394 0.597 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.37 -37.08 84.48 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.591 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 9.6 tt0 -67.02 -37.44 84.14 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.449 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 19' ' ' GLY . 2.7 p -68.0 -61.03 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.14 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' H ' HG13 ' A' ' 23' ' ' VAL . . . -49.12 -33.03 13.59 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.803 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -50.5 72.68 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 122.481 1.134 . . . . 0.0 108.418 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 21.8 mttt -51.81 -41.2 61.56 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 112.865 -1.971 . . . . 0.0 108.202 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.732 ' HB3' ' CB ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.84 -35.9 81.97 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.915 0.864 . . . . 0.0 111.052 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.784 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 5.1 tt0 -69.78 -50.63 41.31 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.331 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -51.23 -30.27 16.93 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 124.909 1.381 . . . . 0.0 111.25 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.84 ' O ' HG23 ' A' ' 31' ' ' THR . 1.5 t70 -82.72 -39.15 22.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 116.921 -1.514 . . . . 0.0 108.872 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.84 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 162.29 37.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 116.616 -2.033 . . . . 0.0 116.35 170.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.694 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 155.5 38.58 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 115.428 -3.273 . . . . 0.0 117.354 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.784 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 4.1 mp -139.31 100.94 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 121.09 2.445 . . . . 0.0 114.86 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -107.21 105.24 15.12 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 7.8 m -97.14 132.75 40.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.05 146.67 45.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.315 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.794 HG12 ' CG2' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -133.22 122.74 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 122.199 -0.313 . . . . 0.0 110.687 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -107.19 137.24 45.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.945 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.488 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -71.56 -177.9 0.54 Allowed Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.392 0.677 . . . . 0.0 111.912 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 30.7 Cg_endo -91.96 -172.67 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.302 2.668 . . . . 0.0 113.757 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 40' ' ' PRO . 9.8 t70 144.81 -72.29 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.862 0.865 . . . . 0.0 109.39 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -108.4 1.05 21.46 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.716 178.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.002 HD22 ' CH2' ' A' ' 10' ' ' TRP . 2.2 tp -19.37 -56.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.996 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 2.1 tm-20 -60.42 -55.11 37.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -75.53 -55.46 5.65 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.581 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -55.49 -57.96 9.74 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.923 -178.011 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -49.62 -57.72 11.28 Favored Pre-proline 0 C--N 1.353 0.76 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.25 -177.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 1.097 ' HA ' HD13 ' A' ' 75' ' ' LEU . 24.6 Cg_exo -62.76 -21.2 72.81 Favored 'Trans proline' 0 C--O 1.252 1.2 0 CA-C-N 121.6 1.607 . . . . 0.0 112.325 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.68 ' O ' HG23 ' A' ' 53' ' ' THR . 61.1 tt0 -81.97 -39.72 23.25 Favored 'General case' 0 C--O 1.258 1.529 0 CA-C-O 122.561 1.172 . . . . 0.0 111.711 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 47' ' ' PHE . 17.1 m -77.93 -40.71 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.552 0 CA-C-O 122.247 1.023 . . . . 0.0 110.536 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.678 ' CB ' ' HB2' ' A' ' 269' ' ' ALA . . . -49.68 -37.88 30.56 Favored 'General case' 0 C--N 1.378 1.831 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.438 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.18 -33.57 32.92 Favored 'General case' 0 C--N 1.368 1.403 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.437 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 49' ' ' GLN . 19.0 p -65.62 -41.06 93.15 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.186 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 55' ' ' ASP . . . -114.69 -70.73 0.51 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.458 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 5.8 m-20 89.02 47.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.851 0.826 . . . . 0.0 109.888 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.11 175.94 21.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 120.531 -0.842 . . . . 0.0 114.642 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 58' ' ' ASP . 82.4 Cg_exo -43.86 131.98 8.05 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.567 2.845 . . . . 0.0 111.909 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.569 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 2.0 p30 158.2 125.96 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.804 HD11 HD12 ' A' ' 9' ' ' ILE . 1.8 pt -117.15 178.38 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 76' ' ' LEU . 2.7 pt -149.29 136.7 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.505 ' CZ ' HD11 ' A' ' 108' ' ' ILE . 4.7 t80 -109.99 122.76 48.31 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 23.2 t-105 -166.75 166.37 15.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -45.35 158.73 0.07 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.63 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.595 ' CG ' ' CG1' ' A' ' 97' ' ' VAL . 4.5 t-80 -77.27 -27.09 53.02 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 331' ' ' PRO . 9.9 p30 -53.34 -52.99 57.43 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-O 121.808 0.813 . . . . 0.0 111.893 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 18.9 mmm180 -73.4 -31.77 64.07 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.446 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.671 ' HA ' HD22 ' A' ' 76' ' ' LEU . 6.2 m-30 -60.26 -32.72 71.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 174.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -54.69 -66.87 2.5 Favored Glycine 0 C--O 1.25 1.152 0 CA-C-O 123.038 1.355 . . . . 0.0 111.616 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 70' ' ' TYR . . . -78.54 -55.67 3.86 Favored Glycine 0 C--N 1.357 1.73 0 CA-C-N 113.095 -1.553 . . . . 0.0 112.734 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.999 ' O ' ' N ' ' A' ' 75' ' ' LEU . 6.9 m-30 -42.01 -37.37 1.34 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.992 ' CB ' HG21 ' A' ' 104' ' ' ILE . . . -73.37 -58.76 3.09 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 117.852 -1.539 . . . . 0.0 112.432 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -46.96 68.35 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.434 1.016 . . . . 0.0 112.72 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 p -114.58 25.72 10.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.2 -87.48 0.06 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 118.539 -1.791 . . . . 0.0 114.909 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.097 HD13 ' HA ' ' A' ' 48' ' ' PRO . 1.2 tp -155.32 97.22 1.88 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.79 HD12 ' HA ' ' A' ' 267' ' ' ASN . 1.2 tp 179.33 144.36 0.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.068 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 1.02 ' O ' HD11 ' A' ' 266' ' ' ILE . . . -95.68 109.42 21.7 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.504 ' HA ' HG12 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -49.07 103.27 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.181 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.963 HG23 HD13 ' A' ' 266' ' ' ILE . 0.0 OUTLIER -61.91 173.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.128 0.489 . . . . 0.0 111.193 -179.047 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.487 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -88.06 175.38 4.22 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.086 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 80' ' ' THR . 79.1 Cg_endo -79.55 133.18 10.38 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.336 2.024 . . . . 0.0 113.629 -178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -152.87 68.06 0.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.323 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -47.36 -32.27 4.71 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -47.71 -29.03 2.75 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.489 ' CE1' HD21 ' A' ' 285' ' ' LEU . 1.3 m-85 -74.71 -59.32 2.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.805 0.335 . . . . 0.0 111.19 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.486 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 8.2 tm0? -70.36 -24.48 62.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -76.04 -43.89 41.76 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -11.07 59.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.88 ' CD2' ' HB1' ' A' ' 303' ' ' ALA . 0.3 OUTLIER -105.57 -170.61 1.77 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.976 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -78.19 145.96 69.99 Favored Pre-proline 0 C--O 1.232 0.154 0 CA-C-O 120.649 0.261 . . . . 0.0 110.543 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 95' ' ' ASP . 53.1 Cg_endo -69.75 -39.74 6.17 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.479 2.119 . . . . 0.0 112.596 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 325' ' ' GLN . 1.9 m-85 -59.74 -57.34 13.35 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -28.06 68.81 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.799 ' CZ3' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -93.68 -22.86 18.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.735 ' O ' HD11 ' A' ' 329' ' ' ILE . 15.8 t0 -71.64 -24.69 61.91 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.949 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 329' ' ' ILE . . . -69.0 -23.38 64.09 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.882 HG13 HG11 ' A' ' 261' ' ' VAL . 22.9 m -122.37 48.76 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.159 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' ' CD1' ' A' ' 103' ' ' LEU . 6.8 tmm_? -125.51 100.41 6.46 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 101' ' ' GLY . 3.6 m-85 -87.43 90.97 8.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.288 0.494 . . . . 0.0 110.197 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 48.14 -86.88 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.882 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . -132.67 42.15 1.41 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -145.48 -177.58 5.64 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 119.519 -0.277 . . . . 0.0 111.193 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.58 HD21 ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER 167.82 112.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.624 0.647 . . . . 0.0 110.617 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.992 HG21 ' CB ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -98.67 38.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.479 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.755 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . 166.01 174.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.582 ' OH ' HD13 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -129.64 129.47 23.14 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.071 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.675 ' HG3' HG21 ' A' ' 97' ' ' VAL . 3.6 Cg_exo -79.72 162.26 24.31 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.866 2.377 . . . . 0.0 112.416 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 262' ' ' LEU . 1.1 pt -156.15 38.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.092 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.774 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 1.066 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -176.21 145.38 0.61 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.724 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 110' ' ' VAL . 14.0 p -128.73 114.03 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 324' ' ' ALA . 17.4 mm-40 -102.99 161.79 13.46 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.279 0.561 . . . . 0.0 109.749 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -165.25 147.24 7.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.758 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 HD11 ' A' ' 247' ' ' LEU . 3.0 tt -79.06 129.3 34.3 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.4 OUTLIER -135.12 159.65 40.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.511 HD11 ' HE1' ' A' ' 224' ' ' MET . 7.2 tt -92.61 131.18 37.94 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.749 HD12 HG22 ' A' ' 244' ' ' VAL . 0.9 OUTLIER -114.82 137.6 47.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.412 ' CE2' ' CD2' ' A' ' 115' ' ' LEU . 13.5 m-85 -106.07 133.38 50.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.916 ' HB3' HD23 ' A' ' 122' ' ' LEU . 14.8 m120 -88.58 125.9 35.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.559 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.33 -59.25 2.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.43 0.559 . . . . 0.0 112.209 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.5 ' OD2' HG13 ' A' ' 240' ' ' VAL . 0.4 OUTLIER -38.31 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 122.426 1.108 . . . . 0.0 111.203 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.84 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -102.82 42.42 1.15 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 112.739 -2.028 . . . . 0.0 112.442 -175.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.093 HD12 ' HB2' ' A' ' 223' ' ' ALA . 1.7 mm? -147.5 140.25 14.64 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 118.847 -1.141 . . . . 0.0 113.068 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 223' ' ' ALA . 50.9 Cg_endo -90.97 163.51 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.789 1 C-N-CA 125.492 4.128 . . . . 0.0 113.493 -179.158 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -61.42 106.07 0.73 Allowed Pre-proline 0 N--CA 1.465 0.296 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.773 -174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 95.3 Cg_endo -99.0 168.27 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 124.882 3.721 . . . . 0.0 114.808 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.794 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 35.8 Cg_exo -27.5 153.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 125.276 3.984 . . . . 0.0 116.19 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -135.81 -21.33 1.48 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.895 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.52 154.47 51.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -59.9 -53.93 52.13 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.137 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 133' ' ' PRO . 13.5 tt0 -45.45 -24.22 0.29 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.479 ' HG2' HD12 ' A' ' 135' ' ' LEU . 2.7 tt0 -73.61 -28.2 61.69 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.802 HG21 HD21 ' A' ' 198' ' ' LEU . 47.5 mt -42.11 -56.02 5.74 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 121.374 0.607 . . . . 0.0 112.215 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.582 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 2.7 Cg_endo -46.48 -38.61 21.47 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 120.565 0.843 . . . . 0.0 109.95 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.84 -59.99 2.51 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.785 HD13 ' CD ' ' A' ' 126' ' ' PRO . 1.4 mt -69.17 -33.12 72.9 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.212 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 1.075 ' HA ' ' CD1' ' A' ' 139' ' ' LEU . 10.0 t70 -68.32 -43.89 76.58 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -46.18 -49.2 17.24 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 118.208 -1.397 . . . . 0.0 110.079 177.34 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.677 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 3.1 tm-20 -63.73 -43.28 96.98 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.784 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 1.075 ' CD1' ' HA ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -52.94 -56.13 18.27 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -49.52 -44.01 46.04 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.704 0.764 . . . . 0.0 108.962 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -45.86 -26.0 0.61 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.29 -1.323 . . . . 0.0 114.343 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.21 -62.38 1.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.526 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.41 53.76 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -172.44 -174.23 1.17 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.885 1.343 . . . . 0.0 109.769 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.8 ' HA ' ' HB3' ' A' ' 139' ' ' LEU . 8.6 t -144.81 150.27 36.88 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.786 0.435 . . . . 0.0 110.42 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.794 ' HB1' ' HD2' ' A' ' 126' ' ' PRO . . . -68.93 -22.99 64.12 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.509 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 224' ' ' MET . 0.7 OUTLIER -142.92 129.4 20.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -176.394 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.755 ' HB2' HG21 ' A' ' 222' ' ' THR . 0.3 OUTLIER -132.53 139.93 48.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.521 -0.871 . . . . 0.0 111.726 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 227' ' ' ASN . 3.7 t80 -172.48 175.57 3.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.698 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 149' ' ' PHE . 2.6 m-80 -38.76 161.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.931 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.862 HD13 ' CB ' ' A' ' 206' ' ' ALA . 3.2 mt -115.06 -50.35 2.76 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.19 34.48 3.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 116.04 -2.264 . . . . 0.0 113.897 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.777 ' O ' ' HB ' ' A' ' 157' ' ' THR . 17.9 mm-40 -79.49 145.75 64.2 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 121.6 2.0 . . . . 0.0 114.488 -175.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.993 ' O ' ' N ' ' A' ' 156' ' ' PHE . 5.8 Cg_exo -78.05 -135.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 1 C-N-CA 125.55 4.167 . . . . 0.0 106.242 176.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 1.117 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 36.0 m-85 16.15 -49.75 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.993 ' N ' ' O ' ' A' ' 154' ' ' PRO . 10.4 t80 -84.44 -60.03 2.2 Favored 'General case' 0 C--O 1.258 1.511 0 CA-C-N 119.406 1.003 . . . . 0.0 111.903 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.777 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -56.83 -42.61 79.94 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.469 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 2.3 m95 -51.61 -55.81 26.42 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 1.117 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 79.3 Cg_exo -43.19 -47.87 8.4 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.892 2.395 . . . . 0.0 113.065 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 250' ' ' PHE . 49.9 mt -62.48 -56.81 14.59 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.072 0.851 . . . . 0.0 109.968 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.722 HG21 HD12 ' A' ' 192' ' ' LEU . 20.6 pt -53.91 -18.01 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.904 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -78.06 -24.7 47.63 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.598 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -41.85 -56.71 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.57 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 1.8 m-20 -64.1 -39.34 93.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 119.211 0.914 . . . . 0.0 112.896 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 156.92 24.23 0.03 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 117.872 -2.109 . . . . 0.0 117.632 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.05 89.64 0.72 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-N 119.375 1.587 . . . . 0.0 112.633 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -73.68 158.58 34.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.29 0.545 . . . . 0.0 110.898 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.829 ' HA ' HG12 ' A' ' 183' ' ' VAL . . . -61.28 -80.59 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.956 0.884 . . . . 0.0 111.604 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.796 ' HB2' ' CG ' ' A' ' 176' ' ' TYR . 58.5 m-85 -113.86 173.66 6.32 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.792 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 1.209 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -106.49 116.28 31.66 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.974 1.261 . . . . 0.0 107.729 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.463 ' CE1' ' HA ' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -78.75 113.22 16.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.456 176.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 1.4 tt0 -137.29 113.61 10.05 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.778 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 1.9 t-20 82.48 -32.33 0.09 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.848 0.356 . . . . 0.0 111.112 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 157.81 15.48 0.04 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.648 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.463 ' HA ' ' CE1' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -173.29 142.02 0.97 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.863 1.332 . . . . 0.0 110.391 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 1.209 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.6 m-85 -66.84 -25.11 66.27 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.506 1.146 . . . . 0.0 109.961 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.757 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.6 t70 62.09 -85.7 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 112.793 -2.003 . . . . 0.0 111.51 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER 179.18 -54.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HA ' ' CG2' ' A' ' 369' ' ' THR . 0.0 OUTLIER -51.17 -17.37 0.65 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 5.5 m-20 -117.27 94.99 4.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 119.68 1.127 . . . . 0.0 109.332 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.426 ' CG2' ' CG ' ' A' ' 365' ' ' GLN . 3.3 m -116.73 112.45 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -117.74 39.96 2.47 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.586 -1.292 . . . . 0.0 113.806 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.829 HG12 ' HA ' ' A' ' 168' ' ' ALA . 1.8 m -79.09 -46.06 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.452 ' N ' ' CG2' ' A' ' 183' ' ' VAL . 18.5 t0 -81.49 57.25 3.22 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.08 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -102.77 177.93 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.345 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.48 -31.56 35.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.462 0.648 . . . . 0.0 111.429 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.57 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -74.91 -40.2 36.57 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.523 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -61.38 -46.09 91.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 174.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.61 -60.62 3.52 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.08 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.23 -41.62 50.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.09 0.948 . . . . 0.0 111.768 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -65.9 -60.6 6.32 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.535 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.722 HD12 HG21 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -58.91 -24.28 62.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.086 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.876 ' O ' HG12 ' A' ' 196' ' ' VAL . 23.5 m -63.99 -48.33 76.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 3.0 p90 -60.6 -35.22 75.58 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' A' ' 194' ' ' PHE . 4.5 mt -64.66 -47.64 77.73 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.876 HG12 ' O ' ' A' ' 193' ' ' THR . 0.5 OUTLIER -58.53 -28.33 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.18 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.77 -46.3 85.88 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.302 0.572 . . . . 0.0 110.229 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.802 HD21 HG21 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -62.93 -59.32 4.99 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.039 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 204' ' ' MET . 15.0 pt -54.14 -43.91 61.82 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -61.52 -34.26 75.21 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -89.95 2.31 55.24 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.96 -84.32 0.66 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.583 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.401 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.4 OUTLIER -120.73 -23.61 5.94 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 199' ' ' ILE . 0.3 OUTLIER 74.5 16.46 3.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.891 0.314 . . . . 0.0 110.645 -178.438 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -158.56 82.97 0.82 Allowed 'General case' 0 C--N 1.34 0.187 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.862 ' CB ' HD13 ' A' ' 151' ' ' LEU . . . -76.0 84.82 2.9 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -97.9 -2.77 39.97 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.272 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.672 HG22 ' HB2' ' A' ' 213' ' ' ALA . 89.4 m -56.66 121.1 8.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.95 -175.39 3.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -69.05 -45.36 70.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.138 0.495 . . . . 0.0 110.139 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.2 m -77.33 -25.53 51.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.613 0.72 . . . . 0.0 111.281 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.648 HG22 HG23 ' A' ' 208' ' ' THR . 0.9 OUTLIER -81.15 -50.82 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.801 178.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -53.46 -36.56 61.74 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.77 -46.16 89.32 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.05 -39.47 69.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.128 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.65 -56.98 13.98 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.407 ' CD2' HG21 ' A' ' 225' ' ' THR . 35.1 t80 -60.52 -28.46 68.42 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.38 -43.41 75.13 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.286 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -23.98 59.18 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.71 45.09 78.43 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -109.44 37.19 2.68 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.86 1.33 . . . . 0.0 110.496 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.755 HG21 ' HB2' ' A' ' 148' ' ' MET . 0.6 OUTLIER -141.96 141.85 32.95 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.966 0.889 . . . . 0.0 109.166 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 1.093 ' HB2' HD12 ' A' ' 122' ' ' LEU . . . -103.16 38.66 1.71 Allowed 'General case' 0 C--N 1.345 0.391 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.511 ' HE1' HD11 ' A' ' 115' ' ' LEU . 0.9 OUTLIER 168.7 138.45 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 148' ' ' MET . 5.2 p -148.06 159.78 43.55 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 226' ' ' ILE . 3.1 mp -116.48 112.44 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 114' ' ' SER . 2.2 p-10 -147.53 165.09 31.37 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 118.94 -0.553 . . . . 0.0 112.15 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -129.3 149.7 18.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.799 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.49 69.75 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.557 2.171 . . . . 0.0 112.298 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.689 ' CZ3' HD11 ' A' ' 262' ' ' LEU . 9.2 t-105 -159.02 -74.07 0.08 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.299 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.39 58.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.713 0.292 . . . . 0.0 110.997 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -152.07 95.7 2.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.256 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.9 m 53.2 176.28 0.02 OUTLIER 'General case' 0 C--O 1.231 0.079 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.339 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -109.24 94.99 5.33 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.632 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 12.6 tt -45.7 155.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.106 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.23 -171.29 0.09 Allowed 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.582 0.23 . . . . 0.0 110.501 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.9 m 67.02 35.55 4.59 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.707 0.289 . . . . 0.0 110.767 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 10.5 t -148.69 -62.06 0.24 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.544 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 14.9 mmtt -131.53 -85.97 0.49 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.402 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 2.7 p 158.38 -45.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -92.38 117.73 30.21 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.666 0.27 . . . . 0.0 111.266 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.637 ' CD1' HD11 ' A' ' 116' ' ' ILE . 7.8 p90 -149.29 129.86 13.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.428 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.99 176.21 54.74 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.668 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.749 HG22 HD12 ' A' ' 116' ' ' ILE . 19.3 t -146.55 113.16 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.557 0.678 . . . . 0.0 112.442 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.95 167.11 17.9 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -172.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.7 153.96 7.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.208 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.653 HD11 HD23 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -58.73 159.88 11.86 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 119.515 1.052 . . . . 0.0 110.996 -179.25 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.49 -163.45 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 111.957 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -120.79 177.58 5.03 Favored 'General case' 0 CA--C 1.526 0.052 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.269 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 160' ' ' LEU . 46.4 m-85 -162.35 110.42 1.36 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.534 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.86 33.08 17.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.379 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.28 41.34 21.63 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.524 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.434 ' C ' HG22 ' A' ' 249' ' ' THR . 0.0 OUTLIER -156.74 151.57 20.9 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.559 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 86.0 Cg_endo -86.51 -172.32 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.321 2.68 . . . . 0.0 111.891 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.513 ' OG ' HD22 ' A' ' 247' ' ' LEU . 10.2 p -108.57 148.33 30.47 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.4 OUTLIER -85.62 109.31 21.01 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.421 -178.148 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.491 ' HG2' ' O ' ' A' ' 323' ' ' ASN . 2.7 Cg_exo -79.36 149.45 21.7 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.305 2.67 . . . . 0.0 113.174 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.401 ' CB ' ' CD1' ' A' ' 155' ' ' TYR . 25.5 p90 -79.01 132.63 36.71 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 175.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.589 HG11 ' HA ' ' A' ' 329' ' ' ILE . 12.6 p -89.85 130.09 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -120.12 121.86 5.05 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 119.271 -1.442 . . . . 0.0 115.355 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.882 HG11 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -113.01 109.51 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 1.066 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 2.4 mm? -89.72 99.78 12.72 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 118.27 -1.372 . . . . 0.0 107.706 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.603 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -110.16 177.16 4.79 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -173.295 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.449 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . . . -116.2 124.06 49.33 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.666 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -127.4 164.33 20.91 Favored Glycine 0 CA--C 1.547 2.033 0 C-N-CA 119.062 -1.542 . . . . 0.0 112.776 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 1.02 HD11 ' O ' ' A' ' 77' ' ' ALA . 33.8 pt -81.93 -179.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 2 C-N-CA 139.311 7.044 . . . . 0.0 92.25 172.568 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.79 ' HA ' HD12 ' A' ' 76' ' ' LEU . 12.1 t30 -151.89 168.73 24.21 Favored 'General case' 0 CA--C 1.547 0.831 2 CA-C-N 133.603 7.456 . . . . 0.0 103.403 177.058 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 1.062 ' HB3' HD12 ' A' ' 75' ' ' LEU . . . -56.88 -52.27 65.78 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.203 0.911 . . . . 0.0 111.304 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.678 ' HB2' ' CB ' ' A' ' 51' ' ' ALA . . . -33.93 -64.16 0.24 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.96 127.88 2.82 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.596 0.236 . . . . 0.0 111.036 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -80.64 -41.3 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.359 2.04 . . . . 0.0 113.397 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.6 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 1.9 m-80 55.65 72.81 0.46 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.595 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 18.6 mtpt -56.64 -54.27 48.03 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 278' ' ' GLU . 4.2 mt-10 -55.65 -58.16 8.98 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.982 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.9 mt -69.46 -57.91 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.764 ' O ' HD12 ' A' ' 280' ' ' LEU . . . -64.88 -55.74 17.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.595 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -57.53 -42.49 82.98 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 274' ' ' GLU . 5.3 mt-10 -76.25 -53.88 7.6 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.445 ' HB2' ' CE2' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -55.6 -56.36 21.22 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.661 179.352 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 276' ' ' ALA . 1.2 mt -54.37 -43.4 71.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.359 0.599 . . . . 0.0 111.768 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.893 ' O ' HD23 ' A' ' 285' ' ' LEU . 17.8 tt0 -75.4 -33.24 60.97 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.214 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.14 -13.57 22.05 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 1.007 ' O ' HG22 ' A' ' 286' ' ' THR . 17.2 m-85 -114.32 -54.5 2.58 Favored 'General case' 0 CA--C 1.512 -0.513 0 O-C-N 122.008 -0.433 . . . . 0.0 110.659 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 284' ' ' LEU . 9.6 tp -45.28 -25.46 0.39 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.93 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.893 HD23 ' O ' ' A' ' 281' ' ' GLU . 2.6 mm? -94.93 43.39 1.09 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-O 120.832 0.349 . . . . 0.0 111.47 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . 1.007 HG22 ' O ' ' A' ' 283' ' ' TYR . 13.2 t -143.7 156.93 44.69 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.532 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 49.4 p30 -66.13 -12.16 53.9 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.472 0.578 . . . . 0.0 110.55 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.764 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 10.9 tt0 -77.58 -47.48 19.31 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.029 -0.419 . . . . 0.0 111.054 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 286' ' ' THR . . . -84.71 -57.07 2.36 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.795 ' CD2' HG11 ' A' ' 302' ' ' VAL . 0.4 OUTLIER -48.29 -48.75 35.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.265 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -78.96 -26.77 43.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.077 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.764 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -65.8 -41.79 91.49 Favored 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 121.459 -0.776 . . . . 0.0 108.937 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.0 t -71.02 -64.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 116.704 -1.998 . . . . 0.0 105.856 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -51.43 3.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 129.119 2.967 . . . . 0.0 115.064 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -110.94 -57.0 2.29 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.208 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.444 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 57.6 m-20 -52.97 -36.85 60.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.868 ' HE3' HD12 ' A' ' 299' ' ' LEU . 16.7 ttpt -111.61 98.19 39.88 Favored Pre-proline 0 C--N 1.35 0.593 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.939 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -95.25 76.08 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.416 2.744 . . . . 0.0 112.091 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.868 HD12 ' HE3' ' A' ' 297' ' ' LYS . 16.3 mt -101.55 -74.83 0.61 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.449 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -142.62 -142.68 4.06 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.522 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.903 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . . . -79.79 178.42 8.2 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.741 0.305 . . . . 0.0 111.457 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.795 HG11 ' CD2' ' A' ' 290' ' ' LEU . 0.0 OUTLIER -126.83 -171.76 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.929 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.88 ' HB1' ' CD2' ' A' ' 89' ' ' LEU . . . -106.98 66.37 0.68 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.479 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.812 HD23 ' HB2' ' A' ' 307' ' ' TYR . 10.4 tp -159.95 108.89 1.76 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.763 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.61 -60.36 0.71 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.78 -48.03 63.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.022 0.915 . . . . 0.0 111.529 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.812 ' HB2' HD23 ' A' ' 304' ' ' LEU . 1.9 t80 -70.07 -19.73 63.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.128 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 3.0 tp10 -65.55 -39.95 92.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.82 -57.27 5.29 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.435 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -51.07 -57.21 9.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.248 0.547 . . . . 0.0 109.802 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.897 HD22 HG21 ' A' ' 317' ' ' ILE . 1.2 tt -61.93 -38.68 89.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.241 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.771 ' HA ' HD11 ' A' ' 317' ' ' ILE . . . -46.32 -29.11 1.51 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -40.31 -39.17 0.91 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.809 0.337 . . . . 0.0 110.241 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -78.53 118.34 71.75 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.09 -20.36 37.32 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.681 2.254 . . . . 0.0 114.287 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -59.15 5.61 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.903 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 2.4 pp -50.04 -53.44 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 317' ' ' ILE . . . -45.77 -44.95 14.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.448 0.567 . . . . 0.0 111.518 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.52 -40.09 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.551 0.691 . . . . 0.0 110.242 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.836 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER -62.0 -56.6 17.37 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.528 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 9.0 ttp -53.1 -42.68 66.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.701 0.286 . . . . 0.0 110.691 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.18 -39.26 81.97 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.93 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.743 ' CB ' ' HB1' ' A' ' 112' ' ' ALA . 7.3 m-80 -78.31 -48.11 16.36 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.659 0.266 . . . . 0.0 111.161 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 111' ' ' GLU . . . -48.53 -40.79 28.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.621 0.248 . . . . 0.0 111.576 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' GLN . . . . . 0.433 ' HB2' ' CD1' ' A' ' 92' ' ' PHE . 5.3 pt20 -67.08 -28.43 68.18 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.607 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -76.54 -10.46 59.41 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 257' ' ' PRO . . . -79.91 161.2 45.55 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.815 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -96.6 139.62 32.41 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.735 HD11 ' O ' ' A' ' 95' ' ' ASP . 9.7 mt -51.58 102.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 119.891 1.223 . . . . 0.0 111.235 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.529 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 32.9 mtm -47.95 -48.33 62.4 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 330' ' ' MET . 57.9 Cg_endo -72.19 121.7 7.75 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.279 1.986 . . . . 0.0 113.218 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.578 HD22 HD12 ' A' ' 333' ' ' ILE . 0.1 OUTLIER -160.69 -70.28 0.07 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.473 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.578 HD12 HD22 ' A' ' 332' ' ' ASN . 0.3 OUTLIER -137.32 140.42 30.71 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.001 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.561 ' HD2' HG22 ' A' ' 333' ' ' ILE . 10.9 Cg_endo -53.38 -18.27 10.64 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.881 2.388 . . . . 0.0 113.037 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.652 ' HG2' HG22 ' A' ' 178' ' ' ILE . 1.4 mp0 -44.07 -24.67 0.16 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.606 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -45.71 -35.26 4.09 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.039 0.381 . . . . 0.0 111.372 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 337' ' ' SER . . . . . 0.494 ' HA ' ' CD2' ' A' ' 340' ' ' TRP . 3.0 t -56.26 -53.17 60.45 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 110.241 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.6 ' HB1' HD11 ' A' ' 368' ' ' ILE . . . -52.13 -27.23 13.52 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.172 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.744 ' O ' HG13 ' A' ' 343' ' ' VAL . 25.2 m-85 -78.09 -55.74 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.344 -0.543 . . . . 0.0 112.459 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.494 ' CD2' ' HA ' ' A' ' 337' ' ' SER . 1.2 p90 -54.95 -31.93 60.98 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.26 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 340' ' ' TRP . 0.1 OUTLIER -75.57 -52.16 11.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.024 0.44 . . . . 0.0 110.994 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.33 88.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.731 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 339' ' ' PHE . 4.8 m -69.17 -42.3 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.375 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 30.2 mtt-85 -57.79 -55.4 35.42 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.882 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -58.2 9.49 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.34 -60.69 2.13 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.582 HG11 HD11 ' A' ' 192' ' ' LEU . 42.7 t -53.03 -49.78 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 36.3 mt -67.87 -49.56 67.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.57 -55.06 19.71 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.552 ' HB1' ' HB2' ' A' ' 355' ' ' GLN . . . -63.63 -26.55 68.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.905 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -65.48 -10.27 32.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.49 0.586 . . . . 0.0 112.327 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.3 p -110.77 14.8 22.18 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 122.059 -0.401 . . . . 0.0 110.785 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 97.73 29.74 7.58 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 116.815 -2.612 . . . . 0.0 116.08 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.46 35.65 4.36 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 116.252 -1.833 . . . . 0.0 106.328 174.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.608 ' O ' HG23 ' A' ' 356' ' ' THR . 3.9 pt20 -70.98 -174.77 1.0 Allowed 'General case' 0 CA--C 1.549 0.912 1 N-CA-C 125.704 5.446 . . . . 0.0 125.704 -157.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.7 OUTLIER 158.34 41.78 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.415 -3.084 . . . . 0.0 104.538 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 358' ' ' ASP . 12.3 p -72.36 -51.62 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.57 ' O ' ' HB3' ' A' ' 362' ' ' LYS . 10.0 t0 -47.77 -45.36 29.14 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.772 0.796 . . . . 0.0 111.31 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.644 ' HA ' ' HG2' ' A' ' 362' ' ' LYS . 8.1 mp0 -77.14 -56.32 4.67 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 113.885 -1.507 . . . . 0.0 113.62 -174.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -54.45 -43.09 71.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.416 1.103 . . . . 0.0 112.645 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.669 ' O ' ' HB3' ' A' ' 364' ' ' ALA . 0.1 OUTLIER -76.17 -45.75 31.83 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.087 -1.87 . . . . 0.0 111.358 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.644 ' HG2' ' HA ' ' A' ' 359' ' ' GLU . 43.3 pttt -58.01 -54.89 41.79 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 121.961 0.886 . . . . 0.0 110.419 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 362' ' ' LYS . 9.0 m-20 -58.75 -36.15 73.89 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 114.611 -1.177 . . . . 0.0 107.832 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 361' ' ' LEU . . . -49.66 -45.54 48.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.426 ' CG ' ' CG2' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -58.93 -44.77 91.43 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.6 m -52.09 -42.54 63.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.112 0.482 . . . . 0.0 109.864 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.15 -37.06 85.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.909 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.648 HG23 ' HG3' ' A' ' 335' ' ' GLN . 4.2 mm -71.64 -35.29 55.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.934 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.446 ' CG2' ' HA ' ' A' ' 179' ' ' LYS . 7.4 p -118.64 51.35 1.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.936 0.398 . . . . 0.0 111.843 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.3 tptp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.195 179.79 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.626 0.251 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 63.3 68.49 0.61 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.063 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.46 -112.11 2.31 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.219 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HG3' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -118.21 -171.18 2.02 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 114.143 -1.028 . . . . 0.0 109.919 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.96 HD21 ' CZ ' ' A' ' 279' ' ' PHE . 0.1 OUTLIER -127.42 120.41 28.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.062 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -116.24 117.14 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.341 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.952 ' CG1' HG12 ' A' ' 37' ' ' VAL . 1.7 pp -123.51 129.88 74.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.691 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.997 ' HB2' HG22 ' A' ' 60' ' ' ILE . 8.5 m95 -107.58 122.44 46.69 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.407 HG22 ' CD1' ' A' ' 9' ' ' ILE . 2.6 tt -159.23 139.02 3.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.7 113.29 20.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.624 0.249 . . . . 0.0 111.111 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.29 -9.15 15.36 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.755 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 39.0 t0 -72.59 -82.11 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.853 0.827 . . . . 0.0 111.057 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 5.8 tmtm? 100.84 -2.75 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.531 0.733 . . . . 0.0 110.313 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.559 ' O ' HD23 ' A' ' 20' ' ' LEU . . . -76.72 66.01 2.8 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 115.271 0.868 . . . . 0.0 115.271 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -77.39 -39.23 47.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.139 -0.531 . . . . 0.0 110.682 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 1.7 m120 -61.48 -47.0 87.66 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.058 0.456 . . . . 0.0 111.052 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.899 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.37 -47.51 35.43 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.054 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 16' ' ' GLY . 4.2 mm? -59.99 -49.6 77.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.381 0.59 . . . . 0.0 110.153 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.79 -38.46 80.01 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 2.1 tp10 -65.67 -36.93 85.08 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.063 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.899 HG23 ' O ' ' A' ' 19' ' ' GLY . 61.0 t -66.82 -61.1 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.851 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . -48.95 -32.42 11.68 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 119.685 -1.245 . . . . 0.0 111.491 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -55.29 -50.18 70.23 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.4 mttt -53.03 -41.72 65.0 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-N 112.862 -1.972 . . . . 0.0 108.374 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.762 ' HB3' HD13 ' A' ' 33' ' ' ILE . 47.4 m-85 -65.49 -34.31 77.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.777 0.799 . . . . 0.0 110.78 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.781 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 1.1 tm-20 -69.08 -51.26 40.65 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.963 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttp -50.99 -30.14 14.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 125.133 1.521 . . . . 0.0 110.867 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.841 ' O ' HG23 ' A' ' 31' ' ' THR . 0.4 OUTLIER -83.62 -38.2 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.428 179.085 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.75 37.71 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 171.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.822 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.09 38.58 0.02 OUTLIER Glycine 0 N--CA 1.468 0.805 0 C-N-CA 115.071 -3.443 . . . . 0.0 119.035 174.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.822 HD12 ' C ' ' A' ' 32' ' ' GLY . 2.0 mp -140.02 136.8 38.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 121.861 2.831 . . . . 0.0 116.417 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' CD ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -142.42 105.13 4.52 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.89 HG22 ' CB ' ' A' ' 7' ' ' LEU . 42.6 t -86.89 131.61 34.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -174.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.8 p -117.3 145.1 44.21 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.44 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.952 HG12 ' CG1' ' A' ' 9' ' ' ILE . 16.0 m -129.08 120.6 52.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 5.8 mt-10 -110.36 130.7 55.5 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -119.75 71.18 14.39 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.307 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 43' ' ' LEU . 7.8 Cg_endo -94.93 -170.2 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.514 2.809 . . . . 0.0 112.857 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -109.74 -40.32 4.85 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.42 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.406 ' HB3' ' CG ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -86.23 0.32 54.02 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.921 HD23 ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -31.68 -39.27 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 1.02 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 73.7 mt-10 -62.86 -54.61 36.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.467 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 11.9 pt-20 -74.2 -38.36 63.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -60.12 -57.53 12.42 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.705 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.743 ' CD2' HD13 ' A' ' 60' ' ' ILE . 1.1 t80 -42.94 -59.16 3.24 Favored Pre-proline 0 C--N 1.352 0.694 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.516 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 1.02 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 26.8 Cg_exo -62.66 -22.65 74.16 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 120.948 1.099 . . . . 0.0 113.171 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -82.23 -36.93 26.7 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 122.28 1.038 . . . . 0.0 111.271 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.3 m -78.59 -39.81 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.506 0 CA-C-O 122.254 1.026 . . . . 0.0 109.863 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 269' ' ' ALA . . . -50.56 -37.46 39.76 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 125.957 1.703 . . . . 0.0 110.906 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 53' ' ' THR . . . -81.52 -40.1 23.69 Favored 'General case' 0 C--N 1.372 1.567 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.701 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 52' ' ' ALA . 33.6 p -159.56 51.52 0.35 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.054 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -160.02 48.87 0.39 Allowed Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.333 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t0 70.67 104.24 0.06 Allowed 'General case' 0 C--O 1.23 0.077 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.07 112.15 4.73 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.836 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.492 ' CG ' ' CE1' ' A' ' 47' ' ' PHE . 86.1 Cg_endo -79.85 -164.68 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.956 2.437 . . . . 0.0 113.444 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 1.062 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 6.7 t0 -79.96 -135.57 0.03 OUTLIER 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 123.946 0.898 . . . . 0.0 110.521 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.682 HD12 ' OD2' ' A' ' 58' ' ' ASP . 1.3 mp -101.7 165.17 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.997 HG22 ' HB2' ' A' ' 10' ' ' TRP . 1.2 pt -127.16 130.69 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.5 OUTLIER -115.34 117.57 30.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.71 ' CZ3' HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -167.26 165.38 15.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 62' ' ' TRP . . . -37.45 152.46 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.809 ' CG ' HG12 ' A' ' 97' ' ' VAL . 10.7 t-160 -77.35 -28.62 53.05 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.408 ' HA ' ' ND2' ' A' ' 332' ' ' ASN . 3.4 m-20 -49.19 -58.29 5.25 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-O 121.979 0.895 . . . . 0.0 112.279 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.57 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -73.9 -30.59 62.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.546 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.571 ' CD1' HD12 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -63.35 -25.43 68.29 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -62.04 -65.37 3.24 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.62 -47.85 89.15 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 113.616 -1.292 . . . . 0.0 110.309 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.724 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 23.2 t80 -48.02 -46.56 33.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.525 ' HA ' ' CB ' ' A' ' 76' ' ' LEU . . . -57.87 -37.43 73.92 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.299 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -78.94 -54.72 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.303 . . . . 0.0 111.764 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -113.34 -26.15 8.5 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' TYR . . . -65.41 -85.37 0.07 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.178 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.983 HD23 ' HB3' ' A' ' 268' ' ' ALA . 0.2 OUTLIER 165.58 71.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.142 0.496 . . . . 0.0 109.726 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 77' ' ' ALA . 2.5 tt -112.64 133.22 54.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.273 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 1.056 ' HB3' HG23 ' A' ' 266' ' ' ILE . . . -86.45 91.92 8.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.631 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -56.3 85.49 0.01 OUTLIER 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.881 HD12 ' HD3' ' A' ' 81' ' ' PRO . 2.0 pp -49.24 119.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.224 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.7 p -105.84 82.79 0.91 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.365 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.881 ' HD3' HD12 ' A' ' 79' ' ' ILE . 42.8 Cg_endo -89.44 -168.58 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.122 2.548 . . . . 0.0 112.422 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -172.89 4.42 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.638 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -35.66 21.0 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.3 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.44 -23.64 58.04 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.93 -59.21 2.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.576 ' HA ' HD21 ' A' ' 89' ' ' LEU . 10.0 tt0 -60.99 -24.74 66.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.389 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -75.8 -35.39 60.07 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.58 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -19.68 64.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.092 HD13 ' CG ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER -97.4 -179.57 4.53 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -94.58 143.32 26.06 Favored Pre-proline 0 C--N 1.343 0.304 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 31.8 Cg_exo -58.92 -50.58 8.66 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.422 2.081 . . . . 0.0 113.513 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' ' CG ' ' A' ' 325' ' ' GLN . 6.8 m-85 -56.76 -62.78 1.5 Allowed 'General case' 0 C--O 1.246 0.878 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.748 HG21 ' HA ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -62.85 -25.25 68.18 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.24 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 1.092 ' CG ' HD13 ' A' ' 89' ' ' LEU . 31.6 m95 -93.86 -23.39 18.14 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 14.7 t70 -72.65 -22.2 60.97 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.476 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.597 ' HB1' HG22 ' A' ' 261' ' ' VAL . . . -53.29 -45.53 68.96 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 1.073 HG13 HG11 ' A' ' 261' ' ' VAL . 20.2 m -113.93 39.25 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.407 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.437 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 12.0 ttp180 -104.94 138.96 40.37 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.289 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -124.15 90.99 3.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 119.172 0.896 . . . . 0.0 110.052 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.5 m120 51.73 -91.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.208 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.1 44.73 1.21 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.79 -177.03 5.37 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.486 0.314 . . . . 0.0 110.484 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.765 ' CD2' HD11 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -158.66 126.68 5.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.391 0.541 . . . . 0.0 110.742 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.702 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 1.4 pp -128.25 39.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.55 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 159.61 162.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.569 ' OH ' HD13 ' A' ' 79' ' ' ILE . 23.2 m-85 -124.7 119.81 25.78 Favored Pre-proline 0 C--O 1.223 -0.32 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.803 ' O ' HG23 ' A' ' 108' ' ' ILE . 66.9 Cg_endo -79.14 162.48 25.83 Favored 'Trans proline' 0 N--CA 1.474 0.333 0 C-N-CA 122.284 1.989 . . . . 0.0 114.776 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -171.82 38.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 1.043 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -179.56 137.58 0.13 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.916 HG12 ' HB3' ' A' ' 301' ' ' ALA . 0.3 OUTLIER -124.09 119.48 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 259' ' ' VAL . 5.4 tt0 -99.03 135.04 41.0 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 323' ' ' ASN . . . -168.06 -174.67 2.41 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 123.366 1.555 . . . . 0.0 110.204 -167.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.862 HD21 HG22 ' A' ' 226' ' ' ILE . 2.7 tt -147.3 135.44 21.49 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 110.995 -2.821 . . . . 0.0 115.846 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.4 OUTLIER -130.31 168.42 16.93 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.893 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.669 HD12 HG13 ' A' ' 226' ' ' ILE . 6.8 tp -92.45 132.41 36.81 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 121.877 -0.514 . . . . 0.0 110.267 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.695 HD11 ' HB2' ' A' ' 242' ' ' TYR . 0.5 OUTLIER -116.41 134.51 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.669 0.747 . . . . 0.0 111.175 -178.112 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.46 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 8.3 m-85 -93.23 -174.32 3.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.05 2.54 . . . . 0.0 110.037 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -93.05 -135.43 0.17 Allowed 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 126.625 1.97 . . . . 0.0 113.615 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.919 ' O ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -152.46 -108.26 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.085 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -67.94 -26.55 66.01 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.513 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -104.89 51.47 0.76 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.164 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.919 HD23 ' O ' ' A' ' 119' ' ' LYS . 1.2 pp -118.83 73.22 11.82 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 121.439 0.638 . . . . 0.0 109.788 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.548 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 12.5 Cg_exo -70.16 160.82 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.407 2.071 . . . . 0.0 112.508 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 49.7 t30 -61.56 108.19 1.44 Allowed Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.417 -173.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 57.2 Cg_endo -69.63 167.94 22.82 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 124.094 3.196 . . . . 0.0 113.574 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -76.16 -162.0 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.762 2.308 . . . . 0.0 113.592 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -126.23 -93.03 0.49 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.6 t -45.0 152.99 0.2 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.352 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.523 ' HH2' HD11 ' A' ' 226' ' ' ILE . 13.9 t-105 -69.96 -26.51 64.14 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 174.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.425 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 62.5 mt-10 -44.55 -23.72 0.14 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 134' ' ' ALA . 22.1 mt-10 -73.5 -26.2 60.78 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.886 ' CD1' HD22 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -40.44 -52.81 5.84 Favored Pre-proline 0 N--CA 1.487 1.385 0 CA-C-N 119.122 0.874 . . . . 0.0 112.288 -178.284 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.587 ' HD3' HG13 ' A' ' 132' ' ' ILE . 53.1 Cg_exo -46.33 -39.94 21.95 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 120.699 0.933 . . . . 0.0 109.892 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.38 -58.92 2.99 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -68.14 -36.65 80.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.159 -178.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.537 ' OD2' HG22 ' A' ' 132' ' ' ILE . 1.9 m-20 -73.51 -41.09 63.51 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -48.22 -43.88 32.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.69 177.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 0.2 OUTLIER -66.4 -37.48 85.34 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.7 OUTLIER -65.55 -46.47 79.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -48.91 -43.26 39.14 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.12 -22.93 0.26 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.296 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -115.79 -60.31 1.89 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.774 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.62 56.85 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.659 ' HG3' HD23 ' A' ' 139' ' ' LEU . 24.2 pttt -169.08 -173.43 1.77 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.829 1.815 . . . . 0.0 110.246 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.721 ' C ' HD22 ' A' ' 139' ' ' LEU . 38.5 m -142.65 164.82 29.08 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.965 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -81.84 -23.01 36.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.931 0.395 . . . . 0.0 111.919 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.681 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.3 pp -144.82 128.76 17.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.78 ' N ' HG21 ' A' ' 222' ' ' THR . 11.2 mmm -132.41 141.59 48.93 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.702 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.497 ' HB3' HG23 ' A' ' 225' ' ' THR . 52.6 p90 -172.55 174.94 3.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.742 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -37.54 158.42 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.013 178.326 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.006 HD13 ' HA ' ' A' ' 206' ' ' ALA . 3.3 mt -110.65 -51.66 2.85 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.17 34.35 3.1 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 115.752 -2.379 . . . . 0.0 113.765 -175.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.751 ' O ' HG23 ' A' ' 157' ' ' THR . 0.5 OUTLIER -79.63 142.32 57.26 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 121.067 1.758 . . . . 0.0 114.087 -176.34 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.968 ' O ' ' N ' ' A' ' 156' ' ' PHE . 67.3 Cg_endo -78.18 -134.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 1 C-N-CA 125.336 4.024 . . . . 0.0 105.2 175.858 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 1.167 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 12.3 m-85 21.13 -55.63 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.883 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.968 ' N ' ' O ' ' A' ' 154' ' ' PRO . 15.1 t80 -84.72 -55.81 3.92 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-N 119.561 1.073 . . . . 0.0 112.641 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 153' ' ' GLU . 20.6 p -58.04 -39.77 79.25 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 117.913 -1.515 . . . . 0.0 107.336 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.543 ' HZ2' HG21 ' A' ' 343' ' ' VAL . 24.2 m95 -53.0 -55.7 30.93 Favored Pre-proline 0 C--N 1.352 0.702 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.825 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 1.167 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 67.5 Cg_exo -43.04 -48.91 7.41 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.187 2.591 . . . . 0.0 112.425 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.699 HD21 ' CZ ' ' A' ' 250' ' ' PHE . 0.1 OUTLIER -58.19 -53.55 57.03 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 119.361 0.982 . . . . 0.0 109.411 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.625 HG22 ' HA ' ' A' ' 188' ' ' ALA . 4.7 mt -55.42 -20.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.001 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.718 ' HB1' ' HG3' ' A' ' 256' ' ' LYS . . . -78.9 -25.16 43.77 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -42.85 -56.02 3.43 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.492 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 7.1 m-20 -64.54 -11.18 31.6 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.172 0.896 . . . . 0.0 112.777 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.91 27.76 0.7 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 119.545 -1.312 . . . . 0.0 115.561 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.85 162.06 38.82 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 118.557 1.178 . . . . 0.0 111.847 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.673 ' O ' ' N ' ' A' ' 169' ' ' PHE . 25.9 m-85 -151.28 30.18 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.992 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 50.04 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.024 0.916 . . . . 0.0 111.411 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.691 ' CB ' ' HB3' ' A' ' 176' ' ' TYR . 12.4 m-85 -112.88 170.72 8.0 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.423 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.957 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -108.01 114.74 28.88 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.487 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 5.9 t80 -79.23 114.03 17.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 113.473 -1.694 . . . . 0.0 110.36 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -137.54 124.53 21.43 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.202 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 t30 76.77 -31.69 0.18 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.872 -0.149 . . . . 0.0 111.109 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.487 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 163.83 11.77 0.03 OUTLIER Glycine 0 CA--C 1.532 1.123 0 C-N-CA 120.17 -1.014 . . . . 0.0 114.626 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.402 ' C ' ' HA ' ' A' ' 171' ' ' TYR . 3.4 mtmt -173.93 150.6 1.65 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.962 1.381 . . . . 0.0 110.031 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.957 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 7.0 m-85 -66.57 -26.32 67.06 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.151 0.977 . . . . 0.0 109.579 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.64 -103.98 0.08 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.403 -1.726 . . . . 0.0 112.163 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 179' ' ' LYS . 8.3 tp -173.38 -46.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.43 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.1 OUTLIER -64.42 -15.6 60.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.718 0.294 . . . . 0.0 110.872 179.273 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 170' ' ' LYS . 3.2 p-10 -129.19 94.3 3.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 169' ' ' PHE . 20.3 m -122.03 140.79 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.387 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.69 55.5 4.17 Favored Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.185 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.799 HG11 HD11 ' A' ' 368' ' ' ILE . 30.4 m -87.03 -13.31 10.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.526 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 7.3 p-10 -124.62 62.68 1.13 Allowed 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.774 0.321 . . . . 0.0 110.844 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -116.93 135.1 53.98 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.282 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 189' ' ' LYS . . . -39.25 -40.31 0.74 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.424 0.63 . . . . 0.0 112.264 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.492 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -76.78 -35.94 38.54 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 114.955 -1.02 . . . . 0.0 114.113 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.625 ' HA ' HG22 ' A' ' 161' ' ' ILE . . . -60.0 -51.43 69.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.771 ' HE3' HD21 ' A' ' 361' ' ' LEU . 9.2 mttt -58.16 -60.45 3.73 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.651 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -50.36 -42.03 52.55 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.835 0.826 . . . . 0.0 111.959 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.46 -60.51 5.41 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.146 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.5 OUTLIER -56.98 -28.32 62.22 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 122.841 -0.211 . . . . 0.0 110.48 179.204 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 189' ' ' LYS . 7.6 p -69.65 -42.37 74.34 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.666 0.27 . . . . 0.0 111.375 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.48 ' CZ ' HD21 ' A' ' 198' ' ' LEU . 86.7 t80 -61.68 -34.27 75.45 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.345 0.593 . . . . 0.0 109.606 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.67 -47.76 79.93 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.892 HG21 ' OE1' ' A' ' 355' ' ' GLN . 43.8 t -56.88 -31.64 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.467 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.11 -44.87 87.37 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.797 0.808 . . . . 0.0 111.508 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.886 HD22 ' CD1' ' A' ' 132' ' ' ILE . 13.0 mt -58.59 -55.39 35.64 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 204' ' ' MET . 26.9 pt -64.06 -39.82 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.102 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 2.9 tttt -52.67 -37.32 58.52 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.695 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.26 -34.53 5.62 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 121.141 3.756 . . . . 0.0 121.141 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -60.72 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.773 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -105.19 -1.94 24.79 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.668 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 9.0 mtm 43.39 36.02 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.773 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.09 159.36 42.34 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 1.006 ' HA ' HD13 ' A' ' 151' ' ' LEU . . . -149.38 30.1 0.77 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -100.6 -3.51 30.34 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 213' ' ' ALA . 5.3 m -57.45 119.82 7.16 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.563 ' OD2' HD12 ' A' ' 212' ' ' ILE . 3.5 p30 -95.5 -174.24 3.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.875 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 211' ' ' SER . 53.5 p90 -68.05 -45.5 73.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.421 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -76.67 -25.49 53.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.588 0.709 . . . . 0.0 111.382 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.563 HD12 ' OD2' ' A' ' 209' ' ' ASP . 4.5 mt -81.63 -50.91 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.063 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -52.47 -37.37 56.98 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.482 ' HA ' ' CD2' ' A' ' 217' ' ' PHE . 2.7 tt0 -60.17 -46.89 88.17 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.9 -36.24 69.91 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.481 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.55 -57.34 13.11 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.482 ' CD2' ' HA ' ' A' ' 214' ' ' GLU . 0.4 OUTLIER -63.08 -28.32 70.0 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -55.14 -41.12 71.35 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.558 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.98 59.14 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.2 41.27 69.9 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -109.64 37.13 2.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.034 1.417 . . . . 0.0 110.822 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.78 HG21 ' N ' ' A' ' 148' ' ' MET . 1.6 m -140.44 140.75 35.46 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -105.09 38.42 1.94 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.349 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 2.7 ttm 171.6 135.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.497 HG23 ' HB3' ' A' ' 149' ' ' PHE . 90.4 m -148.19 157.58 43.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.153 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.862 HG22 HD21 ' A' ' 113' ' ' LEU . 2.7 mp -115.84 111.41 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.427 173.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 114' ' ' SER . 10.1 p30 -149.18 164.72 33.93 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 122.095 -0.378 . . . . 0.0 111.837 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -80.76 -172.82 46.25 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.124 -1.513 . . . . 0.0 109.784 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.435 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 57.5 Cg_endo -73.51 -40.7 1.43 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 121.759 1.639 . . . . 0.0 112.522 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.508 ' CZ2' ' HA3' ' A' ' 300' ' ' GLY . 0.3 OUTLIER -137.49 23.87 2.93 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.631 ' HB3' ' CE3' ' A' ' 232' ' ' TRP . . . -96.48 -33.79 11.73 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.631 ' CE3' ' HB3' ' A' ' 231' ' ' ALA . 1.7 m-90 -105.21 79.96 1.54 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.1 m 62.59 -175.69 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.91 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -83.0 129.5 35.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.813 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.427 HG13 ' CE2' ' A' ' 242' ' ' TYR . 8.4 tp -87.61 -32.55 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.368 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -46.2 -38.66 8.63 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.603 0.24 . . . . 0.0 111.294 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 237' ' ' THR . 9.0 t -87.05 65.2 8.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.702 0.287 . . . . 0.0 110.814 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 39.1 p -116.44 -60.3 1.87 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.812 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.48 -67.51 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.301 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.41 ' HB ' ' HD3' ' A' ' 119' ' ' LYS . 22.1 t -154.43 -60.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.526 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -136.74 157.46 46.7 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.876 0.37 . . . . 0.0 111.317 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.695 ' HB2' HD11 ' A' ' 116' ' ' ILE . 6.2 p90 -149.31 156.68 42.47 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.632 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.485 ' O ' HD12 ' A' ' 116' ' ' ILE . . . -107.34 172.82 18.22 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.42 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.0 t -146.51 119.98 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.139 0.469 . . . . 0.0 111.976 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.55 167.52 20.64 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -173.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.2 m -73.01 153.22 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.646 ' CD1' HG21 ' A' ' 226' ' ' ILE . 2.8 mm? -59.03 159.15 14.72 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-N 120.396 1.453 . . . . 0.0 111.885 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.11 -156.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.461 2.774 . . . . 0.0 112.242 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -128.51 172.99 10.63 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.913 -178.789 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.699 ' CZ ' HD21 ' A' ' 160' ' ' LEU . 97.4 m-85 -164.15 110.47 1.06 Allowed 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 121.791 0.805 . . . . 0.0 109.402 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt 61.16 33.0 19.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.678 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.01 36.64 35.12 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.118 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 163' ' ' ALA . 1.4 mt-30 -156.83 155.17 28.07 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -92.14 157.88 3.22 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.598 2.865 . . . . 0.0 111.986 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.4 p -79.73 153.41 29.27 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.718 ' HG3' ' HB1' ' A' ' 162' ' ' ALA . 3.2 mmmm -85.4 110.82 32.18 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.391 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.477 ' HB2' ' CA ' ' A' ' 327' ' ' GLY . 6.2 Cg_exo -79.23 147.83 20.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.928 2.419 . . . . 0.0 112.39 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 155' ' ' TYR . 3.2 p90 -105.09 133.93 49.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' A' ' 324' ' ' ALA . 30.9 t -140.68 108.41 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.25 163.88 43.47 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.152 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 1.073 HG11 HG13 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -104.3 113.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 122.893 -0.181 . . . . 0.0 111.342 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 1.043 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 1.7 tt -89.04 99.67 12.6 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 117.502 -1.679 . . . . 0.0 106.68 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.552 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 23.3 p -134.85 142.06 46.52 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -172.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . -73.88 131.59 41.64 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.827 0.451 . . . . 0.0 110.061 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.513 ' O ' HG13 ' A' ' 60' ' ' ILE . . . -122.01 135.51 10.41 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.005 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 1.056 HG23 ' HB3' ' A' ' 77' ' ' ALA . 4.4 tp -89.98 123.6 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -64.43 145.37 56.18 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.983 ' HB3' HD23 ' A' ' 75' ' ' LEU . . . -58.74 -22.86 58.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.995 0.426 . . . . 0.0 111.436 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.425 ' HB2' ' HB1' ' A' ' 51' ' ' ALA . . . -61.5 -61.15 2.73 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.704 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' SER . . . . . 0.845 ' O ' HD11 ' A' ' 266' ' ' ILE . 5.7 m -127.13 102.11 24.67 Favored Pre-proline 0 C--N 1.333 -0.13 0 CA-C-O 120.619 0.247 . . . . 0.0 111.29 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.439 ' HA ' ' CG1' ' A' ' 266' ' ' ILE . 55.4 Cg_endo -71.25 -42.72 1.83 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.336 2.024 . . . . 0.0 112.276 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.53 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 2.5 m120 45.73 80.12 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.97 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 10.1 ttmt -75.06 -54.12 7.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.626 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -57.28 11.58 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.652 0.263 . . . . 0.0 111.68 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.14 -57.95 10.38 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.213 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -59.59 -25.0 64.24 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.592 ' O ' ' CB ' ' A' ' 281' ' ' GLU . 24.0 tttt -69.95 -58.09 4.26 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 121.325 0.583 . . . . 0.0 111.687 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 13.4 pt-20 -69.97 -35.44 74.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.328 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.96 ' CZ ' HD21 ' A' ' 7' ' ' LEU . 12.1 t80 -73.95 -61.13 1.95 Allowed 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.195 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.59 -44.45 64.44 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.179 -1.008 . . . . 0.0 113.175 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.761 ' O ' HD12 ' A' ' 285' ' ' LEU . 4.0 tt0 -75.45 -34.77 60.98 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.527 -1.215 . . . . 0.0 113.428 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 1.7 t-20 -92.15 -16.74 25.88 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.935 ' O ' HG22 ' A' ' 286' ' ' THR . 0.5 OUTLIER -108.78 -66.53 1.04 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 290' ' ' LEU . 0.1 OUTLIER -39.54 -32.89 0.14 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.944 0.793 . . . . 0.0 111.203 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 281' ' ' GLU . 20.4 mt -91.05 42.03 1.09 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.79 0.328 . . . . 0.0 111.383 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.935 HG22 ' O ' ' A' ' 283' ' ' TYR . 6.3 t -145.06 158.01 43.94 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 0.8 OUTLIER -66.23 -11.02 47.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.617 0.644 . . . . 0.0 110.297 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.706 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -77.4 -47.09 20.69 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 118.175 0.443 . . . . 0.0 111.157 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -83.74 -57.34 2.45 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.654 HD12 ' CD2' ' A' ' 307' ' ' TYR . 0.2 OUTLIER -50.8 -49.06 59.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.589 -0.305 . . . . 0.0 110.586 178.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.1 OUTLIER -79.28 -26.39 42.35 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.104 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -68.04 -39.61 83.03 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 289' ' ' GLY . 58.3 t -68.34 -62.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 297' ' ' LYS . 9.3 m-80 -44.59 -47.79 10.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.78 1.232 . . . . 0.0 112.427 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -57.93 -54.97 40.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.44 ' HB3' ' CA ' ' A' ' 16' ' ' GLY . 32.8 m-20 -53.6 -44.75 69.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 294' ' ' ASN . 0.7 OUTLIER -49.7 165.83 0.28 Allowed Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.866 -178.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 299' ' ' LEU . 6.6 Cg_exo -73.09 -8.78 22.66 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.241 2.628 . . . . 0.0 113.547 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 298' ' ' PRO . 6.7 tp 90.38 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.924 0.392 . . . . 0.0 111.66 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.508 ' HA3' ' CZ2' ' A' ' 230' ' ' TRP . . . -152.98 -156.67 7.68 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.947 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.916 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -79.97 164.47 23.45 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.44 0.62 . . . . 0.0 110.7 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.553 HG22 ' CD1' ' A' ' 311' ' ' LEU . 16.5 m -153.81 -151.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.748 ' HA ' HG21 ' A' ' 93' ' ' THR . . . -116.1 -138.75 0.37 Allowed 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.552 HD23 ' HG ' ' A' ' 290' ' ' LEU . 13.5 tp 48.24 101.41 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.712 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -41.9 -58.44 2.04 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.5 p -53.39 -49.35 67.42 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.734 0.778 . . . . 0.0 112.073 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.654 ' CD2' HD12 ' A' ' 290' ' ' LEU . 9.1 t80 -69.48 -19.42 63.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.171 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.3 OUTLIER -63.1 -39.02 93.48 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.028 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 9.1 mt-10 -70.63 -57.8 4.34 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.539 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -56.49 12.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.458 0.647 . . . . 0.0 109.279 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.768 ' O ' HG21 ' A' ' 317' ' ' ILE . 0.8 OUTLIER -59.09 -40.32 84.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.277 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 317' ' ' ILE . . . -46.96 -34.39 5.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.524 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.52 -38.39 6.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.518 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.72 ' HB2' HG22 ' A' ' 317' ' ' ILE . 14.3 m-20 -67.55 146.19 98.53 Favored Pre-proline 0 N--CA 1.462 0.132 0 CA-C-O 120.616 0.246 . . . . 0.0 110.667 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 17.3 Cg_exo -67.15 -42.81 7.25 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.665 2.243 . . . . 0.0 113.054 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 229' ' ' PRO . 7.8 mtt85 -58.79 -59.73 4.97 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -51.45 -54.13 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.432 ' N ' HD13 ' A' ' 317' ' ' ILE . . . -46.05 -51.91 12.88 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.419 0.554 . . . . 0.0 111.584 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.62 -46.72 70.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.217 1.008 . . . . 0.0 109.032 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.767 HG22 HG13 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -58.38 -40.51 82.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 113.472 -1.694 . . . . 0.0 109.786 178.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.1 ttp -66.46 -50.25 63.98 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.646 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -53.17 -57.6 9.92 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.571 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 22.4 m120 -64.55 -30.24 71.27 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.364 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.727 ' HB1' HG21 ' A' ' 110' ' ' VAL . . . -60.08 -53.13 61.4 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' GLN . . . . . 0.449 ' CG ' ' CZ ' ' A' ' 92' ' ' PHE . 2.4 tt0 -67.42 -30.06 69.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.39 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.28 -17.98 40.68 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.496 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.689 ' HA3' HG23 ' A' ' 259' ' ' VAL . . . -79.9 169.23 52.98 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.199 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 257' ' ' PRO . 1.9 mm-40 -96.46 137.4 35.58 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 96' ' ' ALA . 4.6 mp -83.88 113.67 23.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 119.595 1.089 . . . . 0.0 110.301 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.472 ' C ' ' O ' ' A' ' 329' ' ' ILE . 0.0 OUTLIER -25.93 137.55 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 332' ' ' ASN . 36.3 Cg_endo -64.93 -38.44 29.28 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.629 2.22 . . . . 0.0 112.528 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 65' ' ' ASP . 1.5 m-20 71.49 57.14 0.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.661 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.98 160.34 68.18 Favored Pre-proline 0 C--N 1.326 -0.415 0 O-C-N 121.945 -0.472 . . . . 0.0 111.593 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.13 -42.29 8.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.644 2.229 . . . . 0.0 112.476 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.417 ' HB3' HD13 ' A' ' 178' ' ' ILE . 6.3 mm100 -47.83 -25.2 1.2 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 32.0 tpp -45.72 -35.55 4.33 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 122.357 -0.214 . . . . 0.0 111.181 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.2 m -57.31 -42.51 81.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.761 0.315 . . . . 0.0 110.455 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -57.27 -31.51 65.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.04 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.414 ' O ' HG12 ' A' ' 343' ' ' VAL . 2.9 t80 -78.1 -48.62 15.61 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.34 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -47.01 68.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.619 0.247 . . . . 0.0 111.474 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -74.33 -50.87 16.97 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.497 ' CB ' HG22 ' A' ' 368' ' ' ILE . . . -67.62 -43.68 79.84 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.984 HG22 HG21 ' A' ' 347' ' ' VAL . 0.3 OUTLIER -70.74 -41.42 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.42 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.484 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 0.8 OUTLIER -58.67 -59.56 5.22 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.458 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 53.0 p -54.36 -57.86 9.65 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.51 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -65.09 -60.56 2.89 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.984 HG21 HG22 ' A' ' 343' ' ' VAL . 44.1 t -59.08 -45.74 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 1.7 tt -68.5 -52.7 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.603 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 348' ' ' ILE . 29.6 m-20 -66.26 -53.39 37.39 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.554 ' HA ' ' HG2' ' A' ' 354' ' ' ARG . . . -63.54 -26.42 68.69 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.356 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -54.53 -17.92 3.78 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.574 0.625 . . . . 0.0 111.503 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 13.2 p -106.73 24.08 13.26 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 171.1 -57.21 0.18 Allowed Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 119.697 -1.239 . . . . 0.0 113.254 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ARG . . . . . 0.554 ' HG2' ' HA ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -103.17 34.05 3.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 113.792 -3.163 . . . . 0.0 116.971 -174.222 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.892 ' OE1' HG21 ' A' ' 196' ' ' VAL . 0.8 OUTLIER -95.77 54.58 1.54 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.13 167.32 11.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.645 HG23 ' HG2' ' A' ' 189' ' ' LYS . 7.1 p -48.96 -49.34 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.533 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 62.2 m-20 -64.84 -49.3 71.11 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.72 -33.7 46.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 111.975 -177.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 364' ' ' ALA . . . -61.44 -53.27 58.66 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.961 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.771 HD21 ' HE3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -78.91 -47.18 16.94 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.746 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.704 ' O ' HG23 ' A' ' 366' ' ' THR . 6.3 mmtp -50.35 -56.01 13.16 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.71 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.66 -53.3 14.05 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.435 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 368' ' ' ILE . . . -58.76 -57.25 13.85 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.119 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.411 ' HG2' HG21 ' A' ' 369' ' ' THR . 0.8 OUTLIER -61.0 -54.86 39.77 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 362' ' ' LYS . 64.0 p -51.11 -52.71 41.07 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -66.4 -38.04 86.59 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.799 HD11 HG11 ' A' ' 183' ' ' VAL . 12.5 pt -79.42 -30.1 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.411 HG21 ' HG2' ' A' ' 365' ' ' GLN . 63.9 p -94.84 -18.91 20.76 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 366' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.252 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.623 0.249 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -155.1 156.37 35.71 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -125.36 75.32 0.4 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.227 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -158.39 163.9 36.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.496 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -169.21 124.28 0.86 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.96 ' H ' ' CB ' ' A' ' 58' ' ' ASP . 4.9 p -124.7 112.26 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.399 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.475 HG23 HG23 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -96.82 143.56 12.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.887 -175.494 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.824 ' HB3' HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -104.29 127.21 51.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.635 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 39' ' ' HIS . 10.8 tt -158.55 164.89 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.016 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -132.65 39.99 3.3 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.08 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.71 -15.46 58.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.482 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER 61.18 65.18 1.01 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.054 0.427 . . . . 0.0 109.921 -179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 2.3 mtmt 162.63 -170.78 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 296' ' ' ASP . . . 75.96 24.34 69.55 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CE1' HG23 ' A' ' 37' ' ' VAL . 38.8 m-85 -76.2 -36.71 58.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.793 0.797 . . . . 0.0 111.03 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 2.7 m120 -64.75 -49.37 71.04 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.637 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -72.27 -49.73 19.57 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.673 -0.775 . . . . 0.0 114.212 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.726 ' O ' HG21 ' A' ' 35' ' ' VAL . 3.5 mm? -59.22 -51.16 71.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.75 0.775 . . . . 0.0 110.193 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.443 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -66.0 -37.7 86.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 111.973 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -67.16 -37.5 83.88 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.747 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 19' ' ' GLY . 4.5 m -68.1 -61.18 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 121.76 -0.588 . . . . 0.0 110.087 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.511 ' H ' HG23 ' A' ' 23' ' ' VAL . . . -49.09 -34.16 16.0 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.374 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -50.43 69.42 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.447 1.117 . . . . 0.0 108.444 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -52.26 -42.31 63.56 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 112.874 -1.966 . . . . 0.0 108.677 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.823 ' HB3' HD13 ' A' ' 33' ' ' ILE . 71.7 m-85 -65.98 -32.22 73.57 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.756 0.789 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.791 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 7.2 tt0 -70.09 -51.8 28.88 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.022 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -52.07 -29.7 22.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 125.327 1.642 . . . . 0.0 111.254 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.804 ' O ' ' HB ' ' A' ' 31' ' ' THR . 3.5 m-20 -84.29 -38.07 20.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.187 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.804 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 4.5 t 159.79 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.84 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.38 38.7 0.02 OUTLIER Glycine 0 N--CA 1.466 0.658 0 C-N-CA 114.968 -3.491 . . . . 0.0 118.914 174.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.84 HD12 ' C ' ' A' ' 32' ' ' GLY . 2.1 mp -140.16 130.25 29.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 121.513 2.657 . . . . 0.0 115.65 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -137.16 105.16 5.64 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.726 HG21 ' O ' ' A' ' 20' ' ' LEU . 34.2 m -99.74 133.21 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.847 ' HB ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.0 147.19 45.09 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.532 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.445 HG23 ' CE1' ' A' ' 17' ' ' TYR . 17.9 m -133.34 123.32 46.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 122.164 -0.335 . . . . 0.0 110.404 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -111.59 139.8 46.74 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.1 78.95 25.75 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-O 120.841 0.353 . . . . 0.0 110.739 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 43' ' ' LEU . 60.7 Cg_endo -92.69 163.11 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.261 2.64 . . . . 0.0 113.307 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -90.72 -35.45 14.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -82.76 0.49 43.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.482 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 10' ' ' TRP . 54.1 tp -19.78 -49.31 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 1.081 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 mt-10 -67.29 -54.51 20.18 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.556 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.74 -43.62 62.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.905 0.383 . . . . 0.0 110.324 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.616 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.11 -56.13 23.27 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.955 0.883 . . . . 0.0 109.764 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.728 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 9.1 t80 -48.17 -60.95 3.59 Favored Pre-proline 0 C--O 1.219 -0.525 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.919 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 1.081 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 32.2 Cg_exo -60.22 -26.53 82.82 Favored 'Trans proline' 0 C--O 1.25 1.114 0 C-N-CA 121.278 1.318 . . . . 0.0 113.679 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -81.82 -38.76 25.03 Favored 'General case' 0 C--O 1.256 1.443 0 CA-C-O 122.161 0.981 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 54' ' ' GLY . 17.9 m -75.09 -39.26 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 CA-C-O 121.849 0.833 . . . . 0.0 109.832 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB1' ' OD1' ' A' ' 267' ' ' ASN . . . -50.16 -39.78 44.61 Favored 'General case' 0 C--N 1.372 1.553 0 C-N-CA 127.748 2.419 . . . . 0.0 111.593 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.46 -40.2 26.7 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.011 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -83.5 -7.23 59.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 77.82 -74.51 1.97 Allowed Glycine 0 C--N 1.352 1.45 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.184 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 t70 72.05 13.14 5.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.167 -1.016 . . . . 0.0 110.265 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . 57.72 59.38 10.93 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.094 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -101.39 171.36 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.38 2.72 . . . . 0.0 114.213 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.96 ' CB ' ' H ' ' A' ' 8' ' ' VAL . 25.1 m-20 -94.28 -133.12 0.17 Allowed 'General case' 0 N--CA 1.414 -2.257 0 C-N-CA 125.098 1.359 . . . . 0.0 109.137 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.64 HG13 ' HA ' ' A' ' 266' ' ' ILE . 9.6 tt -99.73 168.11 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 124.089 0.955 . . . . 0.0 112.477 -177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.804 HG23 ' HB2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -134.31 126.35 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 3.2 m-85 -108.15 125.4 51.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.603 ' CH2' ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -166.81 166.77 15.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.586 0.354 . . . . 0.0 110.062 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 62' ' ' TRP . . . -45.35 158.32 0.07 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.518 0.599 . . . . 0.0 112.519 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.942 ' HB2' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -77.5 -29.27 52.44 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -47.82 -53.72 14.64 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.825 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.39 -26.08 42.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.043 0.449 . . . . 0.0 110.098 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.609 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -57.44 -34.33 68.85 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 171.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.762 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -55.2 -69.65 1.2 Allowed Glycine 0 C--N 1.357 1.74 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 177.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.87 -54.16 23.39 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-N 112.996 -1.602 . . . . 0.0 111.363 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.493 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.4 m-30 -50.56 -40.53 52.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -48.63 -48.36 39.58 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.61 -31.08 46.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.138 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -70.26 -26.77 63.98 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.561 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.25 23.28 44.91 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.574 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 48' ' ' PRO . 4.0 mt -106.16 54.58 0.69 Allowed 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.911 0.386 . . . . 0.0 110.392 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.813 ' CG ' HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.13 145.13 0.25 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.877 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.966 ' HB3' HG23 ' A' ' 266' ' ' ILE . . . -72.2 74.65 0.97 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.208 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 1.7 pm0 -53.0 125.1 16.09 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.8 0.333 . . . . 0.0 110.495 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.642 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.1 mm -70.88 173.38 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.856 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.582 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -87.95 175.54 4.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 80' ' ' THR . 72.2 Cg_endo -79.2 101.49 1.43 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.052 1.835 . . . . 0.0 113.031 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 84' ' ' ALA . 18.1 t70 -145.46 107.76 4.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.251 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.18 0.22 52.47 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.499 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . . . -51.19 -32.99 25.44 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.579 0.228 . . . . 0.0 111.579 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.509 ' O ' HD12 ' A' ' 89' ' ' LEU . 22.7 m-85 -79.31 -59.06 2.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.882 0.372 . . . . 0.0 110.075 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.45 -27.92 40.71 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.544 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -76.32 -47.01 25.08 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.664 0.269 . . . . 0.0 110.833 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -67.86 -20.41 65.13 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.521 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.75 HD22 ' HZ2' ' A' ' 94' ' ' TRP . 5.1 mp -112.82 -163.46 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 121.454 -0.098 . . . . 0.0 110.879 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.458 ' CG ' ' HD2' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -84.68 146.78 47.41 Favored Pre-proline 0 C--N 1.34 0.175 0 O-C-N 121.992 -0.442 . . . . 0.0 111.641 -178.629 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 95' ' ' ASP . 61.0 Cg_endo -73.32 -35.03 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.234 1.956 . . . . 0.0 111.703 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CD2' ' HG2' ' A' ' 325' ' ' GLN . 63.2 m-85 -57.81 -62.43 1.81 Allowed 'General case' 0 C--O 1.246 0.872 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.884 HG23 ' CD1' ' A' ' 94' ' ' TRP . 1.8 t -62.58 -24.68 67.67 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.884 ' CD1' HG23 ' A' ' 93' ' ' THR . 36.5 m95 -93.43 -24.45 18.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.145 0.498 . . . . 0.0 111.877 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 91' ' ' PRO . 8.3 m-20 -71.08 -23.49 62.13 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.711 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.651 ' HA ' HD12 ' A' ' 329' ' ' ILE . . . -71.91 -43.21 65.7 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.942 HG12 ' HB2' ' A' ' 64' ' ' HIS . 27.2 m -102.54 43.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.45 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -128.81 139.47 52.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.637 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.507 ' O ' ' N ' ' A' ' 101' ' ' GLY . 3.2 t80 -118.48 90.74 3.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 119.262 0.937 . . . . 0.0 109.874 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.6 t30 48.29 -86.72 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . -127.63 39.2 1.97 Allowed Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.66 -177.34 5.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.48 0.312 . . . . 0.0 111.225 -178.32 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 97' ' ' VAL . 0.7 OUTLIER 168.71 128.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.399 0.545 . . . . 0.0 110.032 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.813 HD11 ' CG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -114.24 38.01 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.315 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 168.81 169.67 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.07 132.88 23.78 Favored Pre-proline 0 CA--C 1.528 0.122 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.277 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.768 ' HD3' HG21 ' A' ' 97' ' ' VAL . 90.8 Cg_endo -79.61 166.91 21.4 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.463 2.109 . . . . 0.0 113.211 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.822 ' O ' HG13 ' A' ' 302' ' ' VAL . 0.6 OUTLIER -162.31 38.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.364 178.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.729 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -179.8 136.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.166 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.708 ' O ' HG21 ' A' ' 320' ' ' THR . 21.7 t -123.58 105.89 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.541 ' HG2' ' HG3' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -116.68 131.16 57.02 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 -178.191 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.456 ' N ' HG23 ' A' ' 320' ' ' THR . . . -158.19 143.26 16.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.468 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.509 HD21 ' OE1' ' A' ' 153' ' ' GLU . 6.5 mp -77.89 143.43 37.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.936 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.409 ' OG ' ' HB1' ' A' ' 319' ' ' ALA . 1.8 m -133.3 169.46 16.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.76 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -91.16 128.41 36.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 1.021 HG23 HG23 ' A' ' 225' ' ' THR . 8.0 tp -116.95 140.43 39.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -153.63 161.44 42.16 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.396 0.279 . . . . 0.0 111.554 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.408 ' CB ' ' HB3' ' A' ' 121' ' ' LEU . 18.7 m120 -97.52 139.03 34.04 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -109.9 -4.84 15.73 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-N 113.096 -1.865 . . . . 0.0 111.23 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -43.56 6.78 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 124.781 2.229 . . . . 0.0 105.455 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.592 HD13 HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -76.35 -135.45 0.02 OUTLIER 'General case' 0 N--CA 1.396 -3.169 1 CA-C-N 107.678 -4.328 . . . . 0.0 113.216 -170.548 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.635 HD23 ' HD2' ' A' ' 123' ' ' PRO . 1.6 mt -82.66 148.26 57.61 Favored Pre-proline 0 C--N 1.287 -2.132 0 N-CA-C 119.98 3.326 . . . . 0.0 119.98 -167.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.635 ' HD2' HD23 ' A' ' 122' ' ' LEU . 1.4 Cg_exo -27.33 166.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 1 C-N-CA 130.354 7.369 . . . . 0.0 120.34 176.307 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.808 ' O ' HD11 ' A' ' 135' ' ' LEU . 18.8 m-80 -62.03 111.81 5.19 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.365 -172.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.96 167.78 25.45 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 124.055 3.17 . . . . 0.0 112.904 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.49 ' HD2' HD11 ' A' ' 147' ' ' LEU . 77.4 Cg_exo -49.66 111.13 0.45 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 123.324 2.683 . . . . 0.0 115.573 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -76.45 -25.64 54.58 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.084 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.91 147.31 43.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.489 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.579 ' HE3' HD21 ' A' ' 198' ' ' LEU . 65.3 m95 -67.92 -37.89 82.23 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 175.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.461 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.9 mp0 -58.82 -23.84 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.563 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 0.5 OUTLIER -87.03 -16.14 36.55 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.379 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.579 ' CG1' ' HD3' ' A' ' 133' ' ' PRO . 4.0 pt -52.37 -37.98 50.33 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 118.683 0.674 . . . . 0.0 111.417 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.881 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 52.3 Cg_exo -52.93 -33.26 61.1 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 N-CA-C 109.549 -0.981 . . . . 0.0 109.549 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.99 -58.59 3.19 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.808 HD11 ' O ' ' A' ' 124' ' ' ASN . 0.2 OUTLIER -68.21 -42.28 80.06 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.653 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.7 OUTLIER -69.21 -32.41 71.65 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.153 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.881 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -47.92 -50.14 27.84 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.061 176.104 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 35.3 mt-10 -62.35 -43.5 98.68 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.924 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.828 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.6 OUTLIER -60.36 -49.4 77.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -47.9 -44.11 29.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.04 -27.35 0.91 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.507 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -60.03 1.69 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.288 0.566 . . . . 0.0 109.891 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.84 42.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 118.934 -0.925 . . . . 0.0 111.073 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.687 ' HG3' HD23 ' A' ' 139' ' ' LEU . 9.0 ptpt -154.27 -171.88 4.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 119.514 1.657 . . . . 0.0 111.419 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.779 ' C ' HD22 ' A' ' 139' ' ' LEU . 2.5 m -141.56 161.8 37.04 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.828 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -75.47 -28.91 59.43 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.755 HD12 ' C ' ' A' ' 146' ' ' ALA . 5.7 mp -123.74 127.16 47.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.911 ' HB2' HG21 ' A' ' 222' ' ' THR . 8.8 tpt -134.1 127.9 33.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 120.039 1.29 . . . . 0.0 109.845 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.968 ' O ' ' O ' ' A' ' 150' ' ' ASN . 37.3 p90 -170.4 177.22 4.15 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.968 ' O ' ' O ' ' A' ' 149' ' ' PHE . 2.9 t-20 -28.42 -156.79 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 208' ' ' THR . 1.0 OUTLIER -178.15 40.58 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 120.992 -1.068 . . . . 0.0 111.055 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 151' ' ' LEU . 1.9 pp0? 172.86 32.92 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 168.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 157' ' ' THR . 0.2 OUTLIER -103.87 114.45 64.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 119.991 1.269 . . . . 0.0 107.585 177.458 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.787 ' HA ' ' OG1' ' A' ' 157' ' ' THR . 5.8 Cg_exo -79.77 36.98 0.64 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 119.265 0.773 . . . . 0.0 113.706 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 1.227 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 3.7 m-85 -97.79 -52.01 3.89 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 172.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.731 ' CZ ' HD12 ' A' ' 226' ' ' ILE . 42.5 t80 -74.66 -42.63 58.16 Favored 'General case' 0 C--O 1.251 1.141 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 153' ' ' GLU . 1.5 p -58.05 -57.03 14.63 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.487 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.559 ' HA ' HG12 ' A' ' 161' ' ' ILE . 7.5 m0 -49.54 -52.51 49.55 Favored Pre-proline 0 C--N 1.351 0.648 0 CA-C-O 120.78 0.324 . . . . 0.0 110.75 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 1.227 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 51.5 Cg_exo -44.44 -50.05 8.42 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.625 2.217 . . . . 0.0 113.171 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.48 ' HG ' ' CZ ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -60.4 -56.84 16.55 Favored 'General case' 0 CA--C 1.51 -0.567 0 O-C-N 122.026 -0.421 . . . . 0.0 109.908 -179.573 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 158' ' ' TRP . 14.1 pt -53.94 -22.6 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.831 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -77.23 -24.5 51.23 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.895 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 253' ' ' GLN . . . -41.19 -58.83 1.68 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.403 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 13.1 t70 -63.84 -58.06 7.96 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.345 -0.847 . . . . 0.0 112.6 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.69 21.38 0.03 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 117.648 -2.215 . . . . 0.0 116.823 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.12 160.13 40.15 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 119.086 1.443 . . . . 0.0 111.573 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -139.49 122.56 16.81 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.429 0.615 . . . . 0.0 109.743 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.878 ' O ' HG13 ' A' ' 183' ' ' VAL . . . -38.49 -78.54 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.291 0.567 . . . . 0.0 111.971 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.753 ' HB3' ' CB ' ' A' ' 176' ' ' TYR . 9.8 m-85 -113.64 176.07 5.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 1.159 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -101.54 102.1 12.78 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.05 114.51 18.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.53 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 23.9 tt0 -137.22 109.36 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.517 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 1.4 m-20 84.1 -32.38 0.07 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.862 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 160.28 13.9 0.03 OUTLIER Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.036 -0.869 . . . . 0.0 114.072 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -174.0 143.12 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.577 1.689 . . . . 0.0 110.943 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 1.159 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 37.0 p90 -64.98 -25.45 67.87 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.193 0.997 . . . . 0.0 110.805 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.471 ' O ' HD13 ' A' ' 178' ' ' ILE . 55.8 m-20 72.37 -106.91 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.743 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 177' ' ' ASP . 38.0 mm -159.16 -48.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -70.83 -4.01 21.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.72 95.56 3.5 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.276 -0.569 . . . . 0.0 112.12 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 18.9 t -117.98 131.04 71.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.434 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . -121.4 39.73 2.3 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 119.47 -1.348 . . . . 0.0 114.092 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 168' ' ' ALA . 6.4 m -79.1 -40.78 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.848 ' OD1' HD13 ' A' ' 361' ' ' LEU . 58.8 t0 -69.9 58.61 0.15 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.899 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 182' ' ' GLY . 5.9 p30 -110.33 175.94 5.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.982 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -80.45 -19.57 45.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.835 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -69.64 -48.84 40.58 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.3 98.6 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 193' ' ' THR . 0.0 OUTLIER -56.99 -59.4 5.12 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.215 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 193' ' ' THR . . . -50.43 -41.66 52.87 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.253 1.025 . . . . 0.0 112.051 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -70.45 -60.51 4.67 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.659 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.628 ' O ' HG23 ' A' ' 196' ' ' VAL . 9.2 tt -56.05 -29.26 60.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 189' ' ' LYS . 14.8 p -66.87 -41.09 87.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 194' ' ' PHE . 0.0 OUTLIER -59.48 -37.74 79.02 Favored 'General case' 0 C--N 1.349 0.563 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.125 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.512 HD23 HD11 ' A' ' 199' ' ' ILE . 0.4 OUTLIER -62.72 -47.56 83.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.782 178.278 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 192' ' ' LEU . 43.6 t -58.22 -29.88 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.28 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.18 -45.4 85.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.732 0.777 . . . . 0.0 110.969 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.579 HD21 ' HE3' ' A' ' 129' ' ' TRP . 11.2 mp -57.34 -57.02 14.47 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.77 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.512 HD11 HD23 ' A' ' 195' ' ' LEU . 3.8 mt -65.16 -32.33 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.969 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -56.4 -38.61 71.73 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 118.56 -0.734 . . . . 0.0 111.042 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -113.41 -34.97 5.43 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 121.086 3.735 . . . . 0.0 121.086 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.67 -66.1 1.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 199' ' ' ILE . 0.2 OUTLIER -36.45 -34.54 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 203' ' ' HIS . 2.2 ttp -36.0 97.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.707 0.289 . . . . 0.0 111.63 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.95 -173.19 3.83 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.064 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -85.61 58.66 5.17 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.626 ' HA ' HD23 ' A' ' 151' ' ' LEU . 2.3 p30 37.85 74.13 0.09 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 30.8 p -55.18 121.4 8.74 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.59 -173.65 4.43 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.0 p90 -69.49 -45.39 69.05 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 1.7 m -70.18 -35.93 74.3 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.89 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.17 -48.44 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.745 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.0 -30.93 71.97 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -47.66 85.03 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.54 77.65 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.276 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.44 ' CB ' ' HG2' ' A' ' 148' ' ' MET . . . -54.27 -57.68 10.29 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.947 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.787 ' CB ' HD11 ' A' ' 235' ' ' ILE . 2.6 t80 -58.57 -29.6 66.53 Favored 'General case' 0 C--O 1.23 0.071 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -53.79 -40.41 66.27 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -74.66 -23.92 58.73 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 65.66 54.79 23.65 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.419 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -116.03 37.2 3.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.452 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.911 HG21 ' HB2' ' A' ' 148' ' ' MET . 82.8 p -144.56 143.53 30.86 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.773 0.796 . . . . 0.0 110.213 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -102.08 38.3 1.69 Allowed 'General case' 0 C--N 1.352 0.674 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 36.1 ttm 177.24 147.06 0.12 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' THR . . . . . 1.021 HG23 HG23 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -142.43 170.26 16.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.701 0.762 . . . . 0.0 111.558 -176.106 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.731 HD12 ' CZ ' ' A' ' 156' ' ' PHE . 24.8 mm -120.68 130.34 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 172.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -147.31 166.69 26.33 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 123.759 0.823 . . . . 0.0 110.474 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -108.15 -162.88 21.02 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.47 -0.395 . . . . 0.0 112.741 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.541 ' HG3' ' HG2' ' A' ' 111' ' ' GLU . 56.2 Cg_endo -87.54 -20.72 2.01 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.128 2.552 . . . . 0.0 114.081 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.464 ' CB ' ' HB3' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -178.65 -42.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.65 62.37 6.46 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.803 0.335 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -107.7 -63.06 1.35 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.781 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 169.2 -176.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.658 0.266 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.83 58.85 2.31 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.795 0.331 . . . . 0.0 110.72 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.787 HD11 ' CB ' ' A' ' 217' ' ' PHE . 14.6 tt -86.69 145.47 7.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.174 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -100.67 123.5 44.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.5 p -61.3 137.72 58.24 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.871 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -43.94 84.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.45 159.74 41.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.771 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.2 m -55.9 -40.02 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.648 0.261 . . . . 0.0 111.372 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 137.26 37.2 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.651 0.262 . . . . 0.0 110.741 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.413 ' CD1' HD11 ' A' ' 116' ' ' ILE . 10.5 p90 -149.23 137.31 20.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 111.323 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.531 ' O ' HD12 ' A' ' 116' ' ' ILE . . . -95.0 133.4 11.52 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.007 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.967 HG22 HD13 ' A' ' 116' ' ' ILE . 1.7 t -115.16 133.87 60.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.867 0.334 . . . . 0.0 111.268 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.76 167.56 17.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -170.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 45.9 t -73.29 154.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 113.893 -1.503 . . . . 0.0 107.871 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.8 mt -57.61 159.29 9.69 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.627 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -78.26 -157.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.926 2.417 . . . . 0.0 112.906 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 253' ' ' GLN . 11.0 p -125.29 169.47 12.26 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.48 ' CZ ' ' HG ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -162.59 110.57 1.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.075 178.533 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.34 32.08 17.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.421 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.69 38.41 24.1 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.033 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.514 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 3.7 mt-30 -156.54 153.94 25.88 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 74.8 Cg_endo -86.37 -171.19 0.78 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.444 2.763 . . . . 0.0 113.263 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -109.28 141.02 42.19 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.988 0.423 . . . . 0.0 111.812 -179.229 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 5.5 ttmm -88.17 121.41 70.49 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.072 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.476 ' O ' ' HA2' ' A' ' 327' ' ' GLY . 55.1 Cg_endo -91.61 152.6 3.51 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.538 2.825 . . . . 0.0 114.417 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' A' ' 155' ' ' TYR . 5.9 m-85 -78.12 157.28 29.52 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 329' ' ' ILE . 20.8 t -110.56 121.82 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -125.11 119.52 3.63 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 118.673 -1.727 . . . . 0.0 117.069 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.769 HG21 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -114.38 108.53 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.729 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 1.6 tp -83.41 109.12 17.05 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.585 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -113.05 -178.12 3.3 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.509 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -111.01 128.81 55.97 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.743 ' O ' HD12 ' A' ' 60' ' ' ILE . . . -123.27 122.62 5.01 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.932 -1.128 . . . . 0.0 115.022 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.966 HG23 ' HB3' ' A' ' 77' ' ' ALA . 4.6 tp -90.86 122.47 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.596 ' HB2' HD11 ' A' ' 60' ' ' ILE . 62.7 t30 -61.82 141.89 57.66 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.23 -23.42 47.86 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.948 -0.47 . . . . 0.0 111.105 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.439 ' HB3' ' ND2' ' A' ' 267' ' ' ASN . . . -98.5 49.07 0.98 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.36 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 38.8 t -171.9 89.5 0.43 Allowed Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 272' ' ' ASN . 72.7 Cg_endo -76.42 164.19 31.12 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.625 2.217 . . . . 0.0 111.906 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.612 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 0.2 OUTLIER 165.69 57.24 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.709 0.29 . . . . 0.0 110.938 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -56.3 -54.1 49.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.452 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -56.68 7.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.16 -48.58 79.43 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -76.78 -56.84 4.25 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.1 OUTLIER -55.67 -41.02 73.09 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.513 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -53.17 8.62 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 27' ' ' PHE . 2.4 t80 -55.09 -59.44 4.75 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.59 -43.19 35.78 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.815 0.817 . . . . 0.0 111.245 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 285' ' ' LEU . 51.9 mt-10 -73.8 -35.36 64.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.37 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.414 ' O ' ' CG2' ' A' ' 286' ' ' THR . 3.6 m-20 -89.99 -16.39 29.94 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.479 ' O ' ' CG2' ' A' ' 286' ' ' THR . 28.0 t80 -103.72 -74.36 0.64 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 290' ' ' LEU . 0.1 OUTLIER -46.08 -27.57 0.98 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -102.07 39.41 1.48 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 283' ' ' TYR . 0.0 OUTLIER -140.72 152.83 45.6 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 175.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.795 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -62.93 -42.37 99.78 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -75.36 -19.39 59.61 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.548 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.463 ' HA3' HG23 ' A' ' 286' ' ' THR . . . -82.54 -55.13 3.09 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.897 HD21 ' HA ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -68.23 -28.46 67.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.795 ' HB2' ' O ' ' A' ' 287' ' ' ASP . 32.0 mt-10 -71.91 -32.39 67.34 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.453 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.39 80.37 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 296' ' ' ASP . 61.0 t -67.64 -61.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 297' ' ' LYS . 36.9 t-20 -46.41 -46.8 18.85 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.713 1.205 . . . . 0.0 112.545 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -48.87 79.49 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.8 ' O ' ' HD3' ' A' ' 298' ' ' PRO . 76.7 m-20 -58.04 -47.02 84.36 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 294' ' ' ASN . 0.9 OUTLIER -96.37 91.05 0.8 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.623 -178.101 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.8 ' HD3' ' O ' ' A' ' 296' ' ' ASP . 75.9 Cg_endo -106.83 93.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 124.318 3.346 . . . . 0.0 112.752 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.584 HD12 ' HD2' ' A' ' 298' ' ' PRO . 1.5 mp -161.1 -80.72 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.103 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -108.39 -160.28 20.16 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.573 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.795 ' HB2' HG23 ' A' ' 317' ' ' ILE . . . -79.17 74.32 5.73 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.074 0.464 . . . . 0.0 111.613 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.822 HG13 ' O ' ' A' ' 108' ' ' ILE . 53.7 t -97.22 76.13 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.897 ' HA ' HD21 ' A' ' 290' ' ' LEU . . . -177.28 107.51 0.06 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.718 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 303' ' ' ALA . 5.9 mp -22.84 179.68 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.627 ' H ' HD23 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -55.08 -55.47 30.7 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -177.694 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 83.2 p -57.09 -47.95 79.79 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-O 121.479 0.657 . . . . 0.0 111.761 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.642 ' CD2' HD13 ' A' ' 290' ' ' LEU . 88.7 m-85 -67.42 -54.57 19.19 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.158 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.735 ' CD ' ' HB1' ' A' ' 301' ' ' ALA . 4.4 mt-10 -61.11 -36.83 80.75 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.717 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.406 ' HG3' ' CD ' ' A' ' 305' ' ' LYS . 2.7 mm-40 -48.12 -49.66 31.3 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.889 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -71.36 -41.27 69.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.087 0.946 . . . . 0.0 109.529 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.454 ' O ' HD23 ' A' ' 311' ' ' LEU . 0.9 OUTLIER -55.97 -16.63 5.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.036 176.256 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 308' ' ' GLU . . . -46.22 -30.46 2.0 Allowed 'General case' 0 C--N 1.342 0.271 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.455 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -48.38 -34.79 11.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.53 158.26 11.71 Favored Pre-proline 0 N--CA 1.462 0.145 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.489 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -85.85 -46.67 0.04 OUTLIER 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.485 2.124 . . . . 0.0 114.521 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -58.9 6.24 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' A' ' 301' ' ' ALA . 1.3 mm -49.67 -56.24 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.81 -51.87 12.16 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.356 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.409 ' HB1' ' OG ' ' A' ' 114' ' ' SER . . . -65.15 -39.01 92.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.725 0.774 . . . . 0.0 109.812 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.708 HG21 ' O ' ' A' ' 110' ' ' VAL . 29.8 m -58.81 -42.83 90.09 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.49 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.5 ttp -63.64 -53.21 55.11 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -39.0 58.46 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.156 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -44.23 49.72 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.017 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -48.76 -45.39 39.74 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 110.333 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' GLN . . . . . 0.449 ' HG2' ' CD2' ' A' ' 92' ' ' PHE . 10.6 mt-30 -63.68 -39.06 93.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.952 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -69.7 -20.04 63.55 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.389 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 257' ' ' PRO . . . -79.85 155.7 39.29 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.131 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 259' ' ' VAL . 0.6 OUTLIER -96.23 138.23 34.13 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.017 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 96' ' ' ALA . 23.5 mm -61.85 106.16 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 119.525 1.057 . . . . 0.0 110.904 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.14 107.03 0.73 Allowed Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 120.548 0.214 . . . . 0.0 111.14 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.15 -30.6 32.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.365 2.044 . . . . 0.0 112.141 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 68.2 91.56 0.09 Allowed 'General case' 0 C--N 1.339 0.12 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.295 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 335' ' ' GLN . 1.0 OUTLIER -133.91 144.91 53.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.195 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.36 -27.86 60.15 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.55 2.166 . . . . 0.0 111.979 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.755 ' HB2' HD12 ' A' ' 333' ' ' ILE . 2.1 mp0 -61.1 -25.21 66.8 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.136 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.2 mmt -46.13 -41.0 11.85 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.687 0.279 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.99 -39.27 65.92 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 1.074 ' HB1' HG22 ' A' ' 368' ' ' ILE . . . -55.07 -29.42 57.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.319 0.58 . . . . 0.0 110.8 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 343' ' ' VAL . 2.2 m-85 -78.77 -55.73 4.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.048 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -42.88 -44.69 4.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.842 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -76.57 -38.52 54.8 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.52 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.538 ' HB1' ' CB ' ' A' ' 364' ' ' ALA . . . -68.08 -44.55 76.04 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 17.8 m -73.13 -42.23 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.347 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.406 ' N ' HG23 ' A' ' 343' ' ' VAL . 0.0 OUTLIER -55.38 -57.14 13.1 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.006 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 1.1 m -58.1 -55.63 32.41 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.06 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.34 -60.96 2.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 351' ' ' ALA . 48.7 t -51.73 -47.05 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.1 mt -72.27 -47.91 51.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.911 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 345' ' ' THR . 76.6 m-20 -67.57 -43.28 81.0 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.836 ' HB1' ' HA ' ' A' ' 355' ' ' GLN . . . -78.38 -26.57 46.61 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -58.6 -10.12 2.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 23.2 t -110.63 31.24 6.12 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 91.21 33.15 8.3 Favored Glycine 0 N--CA 1.417 -2.595 0 C-N-CA 116.844 -2.598 . . . . 0.0 114.779 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -127.8 35.12 4.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.836 ' HA ' ' HB1' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -70.01 -174.48 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 1 N-CA-C 122.295 4.183 . . . . 0.0 122.295 -159.352 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.1 OUTLIER 173.9 57.7 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.347 179.375 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.829 ' O ' HD12 ' A' ' 361' ' ' LEU . 79.1 t -46.28 -41.85 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 3.0 t0 -63.13 -38.5 91.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 118.902 0.774 . . . . 0.0 110.395 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.537 ' CB ' ' HB ' ' A' ' 356' ' ' THR . 0.4 OUTLIER -80.14 -29.59 38.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.634 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -67.05 -54.02 25.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.919 0.866 . . . . 0.0 112.507 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.848 HD13 ' OD1' ' A' ' 184' ' ' ASP . 0.8 OUTLIER -82.64 -36.4 26.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.758 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 23.1 tttp -59.75 -51.97 67.47 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.823 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -44.77 65.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.239 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 368' ' ' ILE . . . -72.54 -57.81 3.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.422 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.493 ' HA ' ' CG1' ' A' ' 368' ' ' ILE . 9.3 tt0 -55.94 -42.25 75.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.9 m -65.25 -48.09 74.46 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.654 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -73.78 -44.37 56.22 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.019 -0.425 . . . . 0.0 111.154 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 1.074 HG22 ' HB1' ' A' ' 338' ' ' ALA . 2.1 pp -62.13 -32.95 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.507 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.651 HG23 HD12 ' A' ' 368' ' ' ILE . 0.6 OUTLIER -131.46 61.49 1.64 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.908 0.385 . . . . 0.0 111.154 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 56.7 tptt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.849 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.613 0.244 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -154.24 139.98 18.04 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.062 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -129.61 47.39 1.02 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.545 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -140.78 162.09 36.26 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.718 ' CB ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -132.4 122.56 25.18 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.839 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.037 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -116.47 115.52 49.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.737 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.949 HD12 HD22 ' A' ' 20' ' ' LEU . 7.8 mt -120.74 131.11 73.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.935 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.868 ' HE3' HD12 ' A' ' 43' ' ' LEU . 3.3 m0 -107.38 123.44 48.37 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.48 HD11 HG21 ' A' ' 9' ' ' ILE . 3.4 mt -155.67 166.12 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.846 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.671 ' O ' ' N ' ' A' ' 14' ' ' ASP . 3.5 m120 -78.84 48.84 0.86 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 120.014 1.279 . . . . 0.0 111.255 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.541 ' HA3' ' HB3' ' A' ' 39' ' ' HIS . . . -8.28 59.78 0.0 OUTLIER Glycine 0 C--N 1.348 1.202 0 C-N-CA 124.843 1.211 . . . . 0.0 115.923 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.671 ' N ' ' O ' ' A' ' 12' ' ' ASN . 72.2 m-20 -100.0 3.77 44.42 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.017 0.437 . . . . 0.0 110.177 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 162.99 -164.62 0.0 OUTLIER 'General case' 0 C--N 1.347 0.491 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.863 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.682 ' O ' HD12 ' A' ' 20' ' ' LEU . . . 70.66 34.3 66.99 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 117.038 1.575 . . . . 0.0 117.038 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.18 -59.72 2.54 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 11.5 p-10 -46.35 -42.39 14.8 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.055 0.455 . . . . 0.0 111.945 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.637 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -70.34 -45.41 55.01 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.578 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.956 HD13 HG11 ' A' ' 37' ' ' VAL . 18.7 mt -60.77 -49.69 76.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.446 0.623 . . . . 0.0 111.081 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.05 -39.49 63.47 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 3.1 mm-40 -64.52 -36.08 83.05 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.762 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 19' ' ' GLY . 23.2 m -67.87 -57.19 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.663 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.678 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . -49.58 -45.84 37.9 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.111 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 -50.41 41.21 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.263 1.03 . . . . 0.0 109.7 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -41.9 60.13 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.155 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.665 ' HB3' HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.65 -25.94 67.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.088 0.947 . . . . 0.0 111.084 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.773 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 7.9 tt0 -73.2 -52.05 15.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.654 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -52.73 -28.54 22.58 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 124.514 1.134 . . . . 0.0 110.576 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.838 ' O ' HG23 ' A' ' 31' ' ' THR . 0.5 OUTLIER -84.09 -37.68 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 117.626 -1.178 . . . . 0.0 108.844 178.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.85 37.79 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 171.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.811 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.26 38.57 0.02 OUTLIER Glycine 0 N--CA 1.463 0.494 0 C-N-CA 114.989 -3.482 . . . . 0.0 119.299 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.811 HD12 ' C ' ' A' ' 32' ' ' GLY . 1.8 mp -139.89 139.0 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 122.243 3.021 . . . . 0.0 117.005 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -142.36 104.51 4.43 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.718 HG22 ' CB ' ' A' ' 7' ' ' LEU . 38.1 t -82.8 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.9 p -117.5 137.43 52.55 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.008 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.956 HG11 HD13 ' A' ' 20' ' ' LEU . 6.9 m -130.69 121.55 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 O-C-N 122.231 -0.293 . . . . 0.0 110.507 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.435 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 2.5 tt0 -111.83 133.83 53.79 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.541 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . 46.1 p-80 -106.08 71.29 0.25 Allowed Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 120.682 0.277 . . . . 0.0 111.462 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.551 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 86.6 Cg_endo -78.07 -171.68 1.27 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.274 2.649 . . . . 0.0 113.627 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -125.22 -60.24 1.35 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 0.57 34.12 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.045 0.45 . . . . 0.0 110.92 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.868 HD12 ' HE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -32.91 -45.68 0.13 Allowed 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 1.014 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 3.6 tm-20 -47.11 -54.93 9.35 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.042 -0.411 . . . . 0.0 112.104 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.12 -48.8 21.98 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.785 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 50' ' ' VAL . 24.5 mtpt -63.51 -56.81 13.07 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.167 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.78 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.9 t80 -45.42 -58.44 5.89 Favored Pre-proline 0 C--O 1.225 -0.191 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 1.014 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 38.9 Cg_exo -65.78 -36.38 32.25 Favored 'Trans proline' 0 C--O 1.249 1.031 0 C-N-CA 121.088 1.192 . . . . 0.0 114.628 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -66.81 -52.18 46.93 Favored 'General case' 0 C--O 1.259 1.588 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 175.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 46' ' ' LYS . 12.0 m -61.56 -21.22 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 122.231 1.015 . . . . 0.0 111.637 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 48' ' ' PRO . . . -60.85 -29.31 69.45 Favored 'General case' 0 C--N 1.393 2.459 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.643 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -82.46 -26.8 32.33 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.411 1.484 . . . . 0.0 112.946 -178.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.61 ' O ' HG23 ' A' ' 53' ' ' THR . 13.1 t -92.47 95.79 9.85 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.083 -0.647 . . . . 0.0 112.073 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 102.27 -71.24 0.33 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.487 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 21.2 m-20 94.77 107.03 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.115 1.457 . . . . 0.0 110.461 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 57' ' ' PRO . . . -163.41 -59.05 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.388 -0.91 . . . . 0.0 114.039 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.525 ' O ' ' O ' ' A' ' 56' ' ' GLY . 59.0 Cg_exo -22.9 157.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.797 3.665 . . . . 0.0 115.937 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 1.037 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 5.1 t70 -79.95 -133.86 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.822 0 C-N-CA 125.241 1.416 . . . . 0.0 112.286 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 265' ' ' GLY . 5.5 mm -105.77 159.31 5.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.857 HG23 ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -128.52 136.01 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.45 -178.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.936 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -117.97 113.85 22.31 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.477 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 34.6 t-105 -166.48 165.14 17.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.988 0.515 . . . . 0.0 109.846 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -37.74 154.48 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.822 0.737 . . . . 0.0 112.11 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.635 ' CB ' ' HB ' ' A' ' 261' ' ' VAL . 14.9 t60 -77.24 -28.3 53.62 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.436 ' OD2' ' HB1' ' A' ' 63' ' ' ALA . 1.3 p30 -50.46 -51.49 46.45 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.984 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -77.85 -27.3 49.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.303 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.857 ' CZ ' HG23 ' A' ' 60' ' ' ILE . 4.6 m-85 -64.73 -28.62 69.71 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 174.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.48 -63.89 4.6 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 332' ' ' ASN . . . -54.9 -52.29 47.49 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 113.471 -1.365 . . . . 0.0 111.656 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HB2' HD12 ' A' ' 76' ' ' LEU . 4.8 m-30 -54.52 -45.87 73.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.786 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . . . -50.84 -40.7 56.59 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.852 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.22 -60.33 2.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 m -113.78 -26.76 8.05 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' LEU . . . -56.78 -86.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.078 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.999 HD23 ' HB3' ' A' ' 268' ' ' ALA . 0.0 OUTLIER 167.98 66.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.007 HD22 HD12 ' A' ' 104' ' ' ILE . 1.7 mt -110.54 136.37 49.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 110.926 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -102.23 106.33 17.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.456 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.437 ' CG ' HG12 ' A' ' 104' ' ' ILE . 77.7 mt-10 -47.75 154.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.927 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 105' ' ' ALA . 20.1 mt -109.41 136.81 44.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.053 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 m -112.97 82.74 5.46 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.834 0.349 . . . . 0.0 110.764 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.05 -173.86 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.738 2.292 . . . . 0.0 112.229 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -88.49 117.91 27.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.593 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -33.24 4.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.462 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -57.55 -27.12 62.36 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.879 ' CE1' HD11 ' A' ' 285' ' ' LEU . 11.6 t80 -79.23 -59.22 2.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.832 0.349 . . . . 0.0 110.314 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.492 ' HG2' ' CD1' ' A' ' 94' ' ' TRP . 1.3 tt0 -60.94 -33.25 72.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.966 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -76.68 -31.9 57.56 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.972 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 7.1 mtpm? -80.34 -1.6 41.79 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.456 HD21 ' N ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -122.71 -171.25 2.24 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.323 0.51 . . . . 0.0 110.994 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.23 117.24 52.69 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.667 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.55 -41.51 67.71 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.581 2.187 . . . . 0.0 112.671 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -50.03 -45.3 51.91 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.726 0.298 . . . . 0.0 111.323 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.708 ' CG2' HG22 ' A' ' 302' ' ' VAL . 2.4 m -61.17 -28.23 68.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.492 ' CD1' ' HG2' ' A' ' 86' ' ' GLN . 17.8 m95 -92.95 -24.72 18.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.317 0.58 . . . . 0.0 111.985 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -73.91 -22.65 59.61 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.842 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.82 ' HB1' HG13 ' A' ' 261' ' ' VAL . . . -53.19 -48.16 68.3 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.671 HG22 HG11 ' A' ' 261' ' ' VAL . 3.8 t -103.09 39.6 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 134.58 40.31 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.4 OUTLIER -113.84 91.06 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.806 0.73 . . . . 0.0 110.751 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 99' ' ' TYR . 31.5 t30 69.62 -70.2 0.15 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.085 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.96 -41.65 0.98 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.281 -0.962 . . . . 0.0 114.207 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -125.96 -178.28 4.24 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.369 0.584 . . . . 0.0 109.869 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 103' ' ' LEU . 0.5 OUTLIER -116.82 139.26 50.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.605 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.007 HD12 HD22 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -96.13 38.0 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.977 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 160.72 -179.67 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 264' ' ' ALA . 20.6 p90 -118.94 127.5 26.49 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.708 ' HB3' HG12 ' A' ' 261' ' ' VAL . 72.6 Cg_endo -79.58 165.66 22.57 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 C-N-CA 122.265 1.977 . . . . 0.0 112.731 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 107' ' ' PRO . 1.7 pt -160.89 38.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.807 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.929 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . 178.56 110.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.833 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.037 HG23 HG11 ' A' ' 302' ' ' VAL . 17.0 t -98.43 111.26 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -103.15 163.12 12.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.624 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.676 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -164.88 150.29 9.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.537 0.684 . . . . 0.0 111.981 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.814 ' O ' HD12 ' A' ' 113' ' ' LEU . 4.6 pp -79.19 127.66 32.32 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.407 ' HA ' ' CD2' ' A' ' 247' ' ' LEU . 0.3 OUTLIER -130.56 166.77 19.91 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 116' ' ' ILE . 6.7 tt -106.22 136.44 45.92 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.801 ' CD1' HD11 ' A' ' 235' ' ' ILE . 1.8 mp -112.93 129.65 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.501 0.667 . . . . 0.0 111.764 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.578 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 24.6 p90 -94.33 -174.22 3.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.864 2.466 . . . . 0.0 110.156 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.597 ' CB ' ' HB2' ' A' ' 122' ' ' LEU . 0.4 OUTLIER -154.0 130.82 10.84 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.991 0.814 . . . . 0.0 110.002 177.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 43.15 1.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.151 0.887 . . . . 0.0 111.421 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.67 -71.76 0.34 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 110.474 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -142.35 38.48 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.406 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.597 ' HB2' ' CB ' ' A' ' 118' ' ' ASN . 71.2 mt -157.97 72.91 4.1 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.647 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.36 133.28 25.89 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.445 2.097 . . . . 0.0 113.398 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.547 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 1.8 p-10 -71.22 159.98 83.9 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 67.7 Cg_endo -72.97 167.84 26.28 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.551 2.834 . . . . 0.0 111.946 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.63 -139.56 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.662 2.241 . . . . 0.0 113.312 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 128' ' ' THR . 0.0 OUTLIER -85.5 -17.62 35.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.91 0.777 . . . . 0.0 112.518 -179.028 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.473 HG22 ' HG2' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -118.13 142.17 47.71 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.567 ' CZ2' HD22 ' A' ' 147' ' ' LEU . 6.3 t-105 -71.23 -28.39 64.15 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 173.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.539 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -44.49 -23.49 0.12 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.61 -21.25 62.67 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.834 HG23 ' HD3' ' A' ' 133' ' ' PRO . 2.1 tp -45.94 -47.28 41.88 Favored Pre-proline 0 N--CA 1.475 0.782 0 CA-C-N 118.579 0.627 . . . . 0.0 112.297 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.834 ' HD3' HG23 ' A' ' 132' ' ' ILE . 11.9 Cg_endo -52.48 -42.2 62.89 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 109.398 -1.039 . . . . 0.0 109.398 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.3 -58.7 3.12 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 139' ' ' LEU . 3.1 mm? -67.79 -35.51 78.79 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.689 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 132' ' ' ILE . 20.0 t0 -74.97 -41.55 59.35 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -49.86 -42.17 46.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.806 177.493 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.2 mm-40 -67.59 -36.26 80.54 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.906 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -65.21 -46.68 79.68 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.78 -44.1 38.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -45.97 -23.48 0.3 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.645 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -113.06 -58.75 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.446 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.78 53.41 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.75 ' HG3' HD23 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -167.01 -172.99 2.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 120.15 1.975 . . . . 0.0 110.013 -177.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.804 ' O ' HD22 ' A' ' 139' ' ' LEU . 54.5 m -144.27 165.13 28.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.906 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -79.51 -20.34 47.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.567 HD22 ' CZ2' ' A' ' 129' ' ' TRP . 4.4 pp -152.48 178.26 9.74 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.871 ' HB2' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -179.21 143.34 0.2 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.336 178.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.486 ' O ' ' O ' ' A' ' 150' ' ' ASN . 26.4 p90 -172.85 175.93 3.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.746 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 149' ' ' PHE . 3.0 m120 -37.01 164.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.767 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 208' ' ' THR . 1.0 OUTLIER -110.51 -58.69 2.05 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -102.71 35.59 2.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 116.92 -1.912 . . . . 0.0 114.035 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.766 ' O ' ' HB ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -79.63 144.23 60.41 Favored Pre-proline 0 C--O 1.221 -0.42 0 CA-C-N 121.957 2.162 . . . . 0.0 114.932 -175.05 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.941 ' O ' ' N ' ' A' ' 156' ' ' PHE . 6.3 Cg_exo -78.07 -135.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 1 C-N-CA 125.72 4.28 . . . . 0.0 106.945 177.09 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 1.123 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 1.8 m-85 16.96 -51.87 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.941 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.2 OUTLIER -84.61 -55.92 3.87 Favored 'General case' 0 C--O 1.259 1.562 0 C-N-CA 124.452 1.101 . . . . 0.0 112.129 -178.324 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.766 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 95.9 m -57.71 -42.53 83.97 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.51 ' CE3' ' HA ' ' A' ' 154' ' ' PRO . 0.7 OUTLIER -51.16 -55.71 26.1 Favored Pre-proline 0 C--N 1.349 0.564 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 1.123 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 40.1 Cg_exo -43.13 -50.65 6.25 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.166 2.578 . . . . 0.0 113.284 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mt -61.83 -56.75 16.11 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 119.925 1.238 . . . . 0.0 109.832 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 192' ' ' LEU . 4.6 mm -52.85 -18.74 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.153 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -78.03 -25.88 48.09 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -43.09 -58.61 2.38 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.51 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 9.3 t0 -65.0 -28.64 69.64 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.416 ' N ' ' HA3' ' A' ' 187' ' ' GLY . . . 147.32 23.44 0.09 OUTLIER Glycine 0 CA--C 1.526 0.721 0 C-N-CA 118.516 -1.802 . . . . 0.0 116.946 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -104.2 86.77 0.53 Allowed Glycine 0 C--N 1.335 0.503 0 CA-C-N 119.021 1.411 . . . . 0.0 113.225 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -104.74 -179.46 3.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.007 0.403 . . . . 0.0 110.04 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.71 -78.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.152 0.501 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.645 ' HB3' ' CD1' ' A' ' 176' ' ' TYR . 1.1 m-85 -125.89 172.78 9.61 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.041 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 1.226 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.8 OUTLIER -112.57 139.3 48.27 Favored 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -174.352 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.97 116.56 29.13 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.641 ' O ' ' C ' ' A' ' 173' ' ' ASN . 2.7 mm-40 -137.44 178.66 6.93 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.147 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.641 ' C ' ' O ' ' A' ' 172' ' ' GLU . 4.8 m120 -20.05 -64.4 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -80.79 -71.9 1.25 Allowed Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -174.57 170.02 3.55 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.891 1.346 . . . . 0.0 107.439 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 1.226 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 1.3 p90 -49.95 -33.43 17.59 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 123.102 1.43 . . . . 0.0 109.908 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.556 ' C ' HG22 ' A' ' 178' ' ' ILE . 12.9 m-20 65.2 -76.84 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.463 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 1.0 HD11 ' HB ' ' A' ' 369' ' ' THR . 0.0 OUTLIER 174.7 -51.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.834 ' N ' HD13 ' A' ' 178' ' ' ILE . 6.6 mmtt -51.78 -47.73 64.07 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.502 ' CB ' ' HD3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -77.96 91.66 4.24 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.825 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.477 HG12 HG13 ' A' ' 183' ' ' VAL . 4.2 t -112.54 152.41 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.536 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -115.09 40.11 2.56 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 114.84 -1.073 . . . . 0.0 114.579 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.72 HG12 ' CE1' ' A' ' 339' ' ' PHE . 35.4 m -90.17 -32.41 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.812 0.306 . . . . 0.0 111.135 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -100.67 59.39 0.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.274 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -115.72 145.89 42.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.643 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.54 -25.64 67.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.173 0.511 . . . . 0.0 111.69 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -77.29 -33.58 43.81 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-O 119.093 -0.837 . . . . 0.0 114.938 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.99 -56.51 21.04 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -57.53 -60.15 4.1 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.002 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.47 -41.85 53.59 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.685 0.755 . . . . 0.0 112.035 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -62.27 -60.66 7.59 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.412 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.92 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -58.29 -24.41 59.41 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 122.539 -0.389 . . . . 0.0 110.175 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 32.3 m -66.83 -49.26 66.34 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 2.7 p90 -61.59 -34.41 75.57 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 199' ' ' ILE . 0.7 OUTLIER -63.93 -47.94 78.5 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 192' ' ' LEU . 48.5 t -56.59 -29.89 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.223 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.85 -46.92 82.81 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.599 0.714 . . . . 0.0 110.905 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.587 ' CD1' HG21 ' A' ' 132' ' ' ILE . 7.1 tp -61.07 -53.65 54.49 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.1 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 204' ' ' MET . 3.6 mt -62.37 -44.54 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.806 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -52.32 -36.93 54.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.907 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -113.18 -34.51 5.65 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 121.051 3.722 . . . . 0.0 121.051 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -62.22 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.863 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -5.4 26.92 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.565 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 6.1 ptm 41.7 37.6 0.78 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.533 ' O ' HG23 ' A' ' 199' ' ' ILE . 4.5 m120 -139.56 162.07 35.98 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.427 ' HA ' ' HG ' ' A' ' 151' ' ' LEU . . . -147.93 24.03 1.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.45 -3.06 34.5 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -56.19 117.92 4.22 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.544 ' OD2' HD12 ' A' ' 212' ' ' ILE . 2.7 p30 -95.71 -174.15 3.07 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.735 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -67.27 -47.09 71.74 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.017 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -77.2 -25.38 51.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.572 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.544 HD12 ' OD2' ' A' ' 209' ' ' ASP . 3.7 mt -81.62 -52.08 14.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.691 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 150' ' ' ASN . . . -52.4 -38.07 58.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -61.61 -44.94 96.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.61 -38.38 71.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.186 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.63 -56.82 15.85 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -66.54 -28.45 68.55 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -58.52 -34.33 70.85 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.174 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.19 -23.73 59.26 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.96 28.51 58.6 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 119.204 -0.776 . . . . 0.0 114.829 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -107.67 37.19 2.49 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.914 1.357 . . . . 0.0 111.082 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.871 HG21 ' HB2' ' A' ' 148' ' ' MET . 82.4 p -138.81 139.38 38.19 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.576 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -104.87 38.55 1.89 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.446 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.9 OUTLIER 170.54 134.59 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 86.3 m -147.88 158.89 44.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.74 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.457 ' O ' ' CE2' ' A' ' 156' ' ' PHE . 12.0 pt -115.7 112.87 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.765 ' CB ' HD12 ' A' ' 235' ' ' ILE . 37.1 m-20 -147.76 165.3 30.95 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.969 -0.457 . . . . 0.0 112.141 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -136.39 -163.98 10.05 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 119.42 1.009 . . . . 0.0 111.297 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.538 ' HG3' HG21 ' A' ' 320' ' ' THR . 77.2 Cg_endo -98.99 5.97 0.99 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.346 2.698 . . . . 0.0 114.129 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 232' ' ' TRP . 36.7 t-105 -85.58 -80.99 0.21 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.302 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.98 42.84 1.68 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.693 0.282 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.512 ' CZ3' ' HB3' ' A' ' 230' ' ' TRP . 5.1 m-90 -149.07 59.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.891 0.377 . . . . 0.0 110.961 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 p -57.82 -43.02 85.45 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -67.26 74.19 0.13 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.731 0.3 . . . . 0.0 110.575 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.801 HD11 ' CD1' ' A' ' 116' ' ' ILE . 12.8 tt -147.02 153.98 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.11 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.425 ' HB3' ' CG ' ' A' ' 242' ' ' TYR . 83.6 m-20 61.86 41.59 11.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.637 0.256 . . . . 0.0 110.858 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.0 t -142.09 48.37 1.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.771 0.32 . . . . 0.0 110.983 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.96 -65.08 1.05 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.732 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.742 ' O ' HG13 ' A' ' 240' ' ' VAL . 0.3 OUTLIER -125.68 -62.47 1.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.735 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 239' ' ' LYS . 0.2 OUTLIER -168.73 -52.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.616 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.62 95.06 10.1 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.625 0.25 . . . . 0.0 111.079 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.425 ' CG ' ' HB3' ' A' ' 236' ' ' ASP . 44.1 p90 -98.99 146.68 25.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.466 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 116' ' ' ILE . . . -130.44 160.25 23.03 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.112 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.604 HG12 HG13 ' A' ' 116' ' ' ILE . 29.3 m -135.78 134.54 51.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.764 0.282 . . . . 0.0 110.889 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.04 167.57 21.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.839 0.855 . . . . 0.0 110.506 -174.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.76 152.24 7.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.501 ' CD2' HD12 ' A' ' 113' ' ' LEU . 4.3 mm? -62.71 159.4 44.17 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 120.513 1.506 . . . . 0.0 111.204 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.45 ' HD2' HD12 ' A' ' 247' ' ' LEU . 93.2 Cg_endo -79.32 -164.49 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.598 2.198 . . . . 0.0 111.532 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.463 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -116.34 177.62 4.62 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.501 -178.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 249' ' ' THR . 55.1 m-85 -164.57 110.05 0.98 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.847 0.832 . . . . 0.0 109.749 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.91 33.43 21.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.956 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.72 39.03 30.24 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.747 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.78 147.59 17.16 Favored Pre-proline 0 N--CA 1.464 0.255 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -91.15 125.73 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.466 2.777 . . . . 0.0 111.89 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.429 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 12.2 t -47.02 150.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 159' ' ' PRO . 6.7 tppt? -85.21 108.97 17.71 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.013 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.577 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 5.4 Cg_exo -79.29 142.53 16.86 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.144 2.562 . . . . 0.0 112.737 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.91 154.61 28.21 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.695 HG11 HG12 ' A' ' 329' ' ' ILE . 54.6 t -113.08 135.59 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -123.51 118.41 3.5 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 118.873 -1.632 . . . . 0.0 115.912 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.82 HG13 ' HB1' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -110.63 111.9 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.929 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -88.73 99.68 12.54 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 117.659 -1.616 . . . . 0.0 107.518 177.306 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.549 ' CB ' HG21 ' A' ' 97' ' ' VAL . 43.7 p -136.55 135.44 38.46 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 118.878 2.918 . . . . 0.0 118.878 -173.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.936 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -88.48 112.86 23.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.551 ' CA ' ' HB2' ' A' ' 105' ' ' ALA . . . -102.86 162.83 16.2 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.508 HG21 ' HA ' ' A' ' 271' ' ' PRO . 87.0 mt -88.2 123.58 40.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 118.929 1.364 . . . . 0.0 107.726 176.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -65.51 146.22 55.13 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.999 ' HB3' HD23 ' A' ' 75' ' ' LEU . . . -58.2 -23.47 55.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.162 0.437 . . . . 0.0 111.284 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.514 ' HB1' ' H ' ' A' ' 56' ' ' GLY . . . -53.05 -59.1 4.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.573 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.3 m -143.23 127.87 9.68 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.607 0.242 . . . . 0.0 111.231 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.508 ' HA ' HG21 ' A' ' 266' ' ' ILE . 76.1 Cg_endo -78.88 -39.64 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.541 2.16 . . . . 0.0 112.96 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.788 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 2.7 m120 55.54 85.05 0.07 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-O 120.62 0.248 . . . . 0.0 110.519 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.1 OUTLIER -72.24 -54.17 10.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -75.41 -57.34 3.95 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 5.9 mt -53.52 -49.09 68.33 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.788 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -71.09 -51.85 22.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 273' ' ' LYS . 9.8 mtpp -48.84 -53.22 20.23 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.306 0.574 . . . . 0.0 112.277 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 47.4 mm-40 -68.73 -30.2 68.78 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.944 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.631 ' CZ ' HD21 ' A' ' 7' ' ' LEU . 14.8 t80 -73.71 -40.33 63.68 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.575 HD12 ' HD1' ' A' ' 279' ' ' PHE . 5.7 mp -81.69 -43.89 17.87 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.94 0.876 . . . . 0.0 112.654 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 285' ' ' LEU . 13.5 mt-10 -70.45 -43.53 69.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 113.912 -1.494 . . . . 0.0 112.643 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 3.7 t-20 -80.89 -32.23 34.9 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.996 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.897 ' O ' HG22 ' A' ' 286' ' ' THR . 4.3 m-85 -101.89 -82.34 0.48 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -39.38 -33.98 0.18 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.879 HD11 ' CE1' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -94.45 39.98 1.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.897 HG22 ' O ' ' A' ' 283' ' ' TYR . 11.3 t -146.62 161.91 39.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 1.2 m-20 -62.49 -13.07 26.35 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.049 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 41.2 mt-10 -77.94 -46.65 20.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.662 0.664 . . . . 0.0 111.22 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.723 ' O ' HG13 ' A' ' 293' ' ' VAL . . . -87.02 -41.79 6.54 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.741 HD12 ' CD2' ' A' ' 307' ' ' TYR . 0.1 OUTLIER -59.9 -46.55 88.98 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 287' ' ' ASP . 3.4 mm-40 -79.0 -26.66 43.26 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -71.33 -37.54 71.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.671 1.123 . . . . 0.0 109.159 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 289' ' ' GLY . 33.1 m -67.5 -40.03 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -80.22 -39.39 29.19 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 123.838 0.855 . . . . 0.0 113.003 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -64.78 -40.17 94.8 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.571 ' CA ' ' HA2' ' A' ' 16' ' ' GLY . 10.9 m-20 -59.99 -64.43 0.95 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.616 ' CG ' HD21 ' A' ' 299' ' ' LEU . 0.0 OUTLIER -103.38 103.52 35.84 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.758 -177.654 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.488 ' C ' HD23 ' A' ' 299' ' ' LEU . 45.6 Cg_endo -95.99 90.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.621 2.88 . . . . 0.0 112.424 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.616 HD21 ' CG ' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -141.24 -74.74 0.32 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.153 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -98.71 156.08 20.16 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.165 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.852 ' HB3' ' HB ' ' A' ' 317' ' ' ILE . . . -121.47 52.73 1.21 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 117.046 0.423 . . . . 0.0 111.62 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 1.037 HG11 HG23 ' A' ' 110' ' ' VAL . 10.8 p -136.4 84.12 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.888 0.375 . . . . 0.0 111.521 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 304' ' ' LEU . . . -166.33 95.23 0.55 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.845 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 307' ' ' TYR . 8.4 tp 93.76 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.94 0.496 . . . . 0.0 112.015 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.456 ' N ' HD21 ' A' ' 89' ' ' LEU . 3.3 tmtm? -32.63 -35.07 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.784 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -44.83 47.09 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.961 0.886 . . . . 0.0 110.257 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.828 ' CZ ' HD12 ' A' ' 311' ' ' LEU . 1.2 t80 -76.65 -23.26 53.28 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.016 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -76.6 -42.84 40.96 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.717 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.08 -43.8 86.3 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.963 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -67.32 -53.4 29.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.919 0.39 . . . . 0.0 110.624 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.828 HD12 ' CZ ' ' A' ' 307' ' ' TYR . 1.1 tt -67.06 -41.24 86.76 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.291 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -46.59 -15.5 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 312' ' ' ALA . 8.8 tttp -31.04 -43.48 0.05 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.512 0.596 . . . . 0.0 110.433 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 3.6 t0 -87.73 139.17 31.25 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 3.0 Cg_exo -75.48 3.89 5.46 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.659 2.239 . . . . 0.0 114.578 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -59.22 5.75 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.852 ' HB ' ' HB3' ' A' ' 301' ' ' ALA . 2.8 tp -49.78 -55.61 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.62 -50.35 13.38 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.375 0.534 . . . . 0.0 111.758 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.6 -44.29 85.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.858 0.837 . . . . 0.0 110.026 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.676 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -65.55 -32.61 74.3 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.896 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.619 ' HA ' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -78.95 -46.35 18.5 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.723 0.296 . . . . 0.0 110.437 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.67 -42.51 79.12 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.444 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.538 ' HB3' ' HB1' ' A' ' 112' ' ' ALA . 27.3 t-20 -78.4 -38.62 41.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.637 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -51.88 -52.74 47.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.26 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -58.19 -29.64 65.81 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.858 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -12.67 60.08 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.381 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.577 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -79.79 163.81 48.1 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.936 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.35 139.69 32.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.695 HG12 HG11 ' A' ' 259' ' ' VAL . 5.0 mt -91.47 110.26 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 119.572 1.078 . . . . 0.0 110.5 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.467 ' HA ' ' HD2' ' A' ' 331' ' ' PRO . 1.4 ptp -45.2 101.88 0.28 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.132 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.468 ' HG3' ' CD2' ' A' ' 176' ' ' TYR . 4.4 Cg_endo -46.49 -35.67 16.85 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.025 2.483 . . . . 0.0 112.14 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 331' ' ' PRO . 0.6 OUTLIER 85.56 83.33 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.768 HG21 ' OH ' ' A' ' 176' ' ' TYR . 1.0 OUTLIER -132.2 158.2 76.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 118.338 0.517 . . . . 0.0 111.758 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.2 -50.72 5.47 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.963 2.442 . . . . 0.0 112.693 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.768 ' HB3' HG23 ' A' ' 368' ' ' ILE . 79.2 mm-40 -53.22 -21.82 5.84 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 3.6 tpt -45.49 -35.07 3.57 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 122.222 -0.299 . . . . 0.0 111.323 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 14.9 p -59.77 -40.21 87.43 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.615 0.245 . . . . 0.0 110.542 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.836 ' HB3' ' CD1' ' A' ' 368' ' ' ILE . . . -58.11 -32.03 67.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.112 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.72 ' CE1' HG12 ' A' ' 183' ' ' VAL . 2.3 t80 -77.96 -55.66 5.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.448 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.456 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 6.6 t-105 -46.98 -42.83 18.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.862 0.363 . . . . 0.0 110.913 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.96 -49.92 40.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.658 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.15 -44.63 87.99 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.909 HG22 HD22 ' A' ' 361' ' ' LEU . 19.6 t -71.13 -29.68 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.723 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -74.82 -43.9 52.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 348' ' ' ILE . 1.7 p -64.48 -58.32 6.76 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.94 -38.65 4.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.637 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.1 t -58.82 -48.59 85.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 345' ' ' THR . 58.5 mt -64.41 -27.97 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 346' ' ' ALA . 6.0 m120 -64.43 -36.9 85.68 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.459 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.82 ' HA ' ' HG3' ' A' ' 355' ' ' GLN . . . -78.78 -26.59 44.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.56 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.94 -14.36 62.91 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 354' ' ' ARG . 2.5 t -110.66 16.96 21.13 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.56 5.91 1.4 Allowed Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 119.71 1.141 . . . . 0.0 112.382 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 352' ' ' SER . 26.4 ttt85 -93.63 35.75 1.11 Allowed 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 115.522 -2.18 . . . . 0.0 107.812 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.82 ' HG3' ' HA ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -66.98 -170.42 0.11 Allowed 'General case' 0 CA--C 1.547 0.843 1 N-CA-C 123.881 4.771 . . . . 0.0 123.881 -156.917 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.6 OUTLIER 159.59 39.95 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 112.47 -2.15 . . . . 0.0 108.174 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.62 HG22 HD12 ' A' ' 361' ' ' LEU . 7.5 p -57.67 -48.84 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.757 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 1.2 m-20 -52.21 -43.85 64.46 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.388 0.613 . . . . 0.0 110.986 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -75.8 -53.83 7.87 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 114.784 -1.098 . . . . 0.0 113.025 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -54.32 -44.31 71.94 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.956 0.884 . . . . 0.0 112.791 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.909 HD22 HG22 ' A' ' 343' ' ' VAL . 79.7 mt -77.82 -37.13 49.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.681 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 1.2 tmtm? -63.88 -56.34 16.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.977 0.894 . . . . 0.0 109.631 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.07 -32.24 70.75 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.252 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -58.14 -42.43 85.87 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.829 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.619 ' HB3' HG21 ' A' ' 183' ' ' VAL . 0.7 OUTLIER -64.4 -36.12 83.13 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.482 ' N ' ' HG3' ' A' ' 365' ' ' GLN . 87.7 m -57.93 -34.57 70.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -71.1 -35.58 71.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.08 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.836 ' CD1' ' HB3' ' A' ' 338' ' ' ALA . 4.2 mm -75.83 -39.53 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.675 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' THR . . . . . 1.0 ' HB ' HD11 ' A' ' 178' ' ' ILE . 13.9 p -88.01 -20.93 25.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.022 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 366' ' ' THR . 2.0 mtmp? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.989 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.738 0.304 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -177.12 154.74 1.09 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.244 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -128.66 63.17 0.62 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.469 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.477 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -153.29 160.77 42.79 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.921 ' CB ' HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -155.25 122.62 5.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.189 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.735 HG11 ' HB3' ' A' ' 57' ' ' PRO . 24.0 t -116.94 124.95 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.482 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.722 HG13 HD12 ' A' ' 59' ' ' ILE . 3.1 mp -123.7 130.47 74.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.63 ' HB2' HG23 ' A' ' 60' ' ' ILE . 73.3 m95 -102.66 128.67 49.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.024 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.767 HD12 ' CD1' ' A' ' 61' ' ' PHE . 1.5 tt -158.49 137.84 3.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 O-C-N 122.163 -0.336 . . . . 0.0 111.298 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -114.18 39.98 2.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.749 0.309 . . . . 0.0 111.081 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.1 -11.55 58.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.604 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.3 m-20 65.54 60.92 0.71 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.022 0.411 . . . . 0.0 110.743 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 1.2 mtpt 162.69 -173.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.183 0.516 . . . . 0.0 111.917 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 296' ' ' ASP . . . 76.38 23.46 70.7 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 20.9 p90 -80.83 -34.46 33.85 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.78 0.79 . . . . 0.0 111.378 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 1.2 t-20 -66.69 -50.66 62.13 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.769 0.319 . . . . 0.0 111.742 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.515 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -71.57 -48.79 27.62 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.841 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.9 -49.19 78.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.845 0.823 . . . . 0.0 110.055 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -67.47 -37.72 83.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -67.19 -37.6 83.95 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.634 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.748 HG23 ' CE2' ' A' ' 283' ' ' TYR . 3.7 p -67.65 -58.72 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.636 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.483 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . -49.12 -34.18 16.26 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.246 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -50.47 67.62 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.51 1.148 . . . . 0.0 107.907 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -42.23 63.61 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-N 112.793 -2.003 . . . . 0.0 108.543 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.785 ' HB3' HD13 ' A' ' 33' ' ' ILE . 22.0 m-85 -65.75 -35.71 81.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.657 0.741 . . . . 0.0 111.083 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.817 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -70.85 -51.35 27.06 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.407 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -52.36 -28.56 19.99 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 125.076 1.485 . . . . 0.0 111.365 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.814 ' O ' HG23 ' A' ' 31' ' ' THR . 20.6 t70 -85.78 -38.71 17.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.581 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 162.88 38.05 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 172.222 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.837 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.43 38.7 0.02 OUTLIER Glycine 0 N--CA 1.466 0.682 0 C-N-CA 114.986 -3.483 . . . . 0.0 118.837 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.837 HD12 ' C ' ' A' ' 32' ' ' GLY . 1.8 mp -139.89 107.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 121.532 2.666 . . . . 0.0 116.022 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.14 104.72 12.4 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.921 HG12 ' CB ' ' A' ' 7' ' ' LEU . 33.6 m -100.95 133.9 42.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -174.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -119.12 146.8 44.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.05 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.686 HG12 ' HB ' ' A' ' 9' ' ' ILE . 4.7 m -132.98 122.15 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.692 0.282 . . . . 0.0 110.302 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.51 134.03 48.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.263 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 9.1 p80 -139.7 71.03 37.25 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-O 120.927 0.394 . . . . 0.0 111.172 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.794 ' HD2' HD12 ' A' ' 43' ' ' LEU . 58.2 Cg_endo -87.99 -177.73 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.218 2.612 . . . . 0.0 112.362 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.37 -40.14 14.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.67 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 43' ' ' LEU . 68.8 mmtt -86.47 0.68 53.68 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.312 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.794 HD12 ' HD2' ' A' ' 40' ' ' PRO . 10.2 tt -19.53 -62.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 1.059 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -46.52 -50.86 16.54 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -178.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.471 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 3.1 tt0 -71.98 -44.04 64.17 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.936 0.398 . . . . 0.0 110.782 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.6 ' O ' HG13 ' A' ' 50' ' ' VAL . 6.6 mttp -56.62 -56.02 26.59 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.129 0.966 . . . . 0.0 110.496 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.864 ' CZ ' HD12 ' A' ' 75' ' ' LEU . 1.8 t80 -45.37 -60.75 2.93 Favored Pre-proline 0 C--N 1.346 0.414 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.0 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 1.059 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 35.2 Cg_exo -61.91 -28.08 80.68 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 121.327 1.351 . . . . 0.0 113.858 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -80.98 -37.29 29.56 Favored 'General case' 0 C--O 1.256 1.416 0 CA-C-O 122.365 1.078 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.87 ' O ' ' N ' ' A' ' 54' ' ' GLY . 18.5 m -75.69 -40.51 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 CA-C-O 121.996 0.903 . . . . 0.0 109.686 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.38 -38.65 19.97 Favored 'General case' 0 C--N 1.365 1.261 0 C-N-CA 125.945 1.698 . . . . 0.0 111.275 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.94 -37.32 29.72 Favored 'General case' 0 C--N 1.37 1.465 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.974 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -118.09 17.48 14.04 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.911 0.778 . . . . 0.0 109.035 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.87 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -137.81 62.82 0.57 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -82.0 38.69 0.54 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.751 0.776 . . . . 0.0 112.731 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 57' ' ' PRO . . . -93.78 -39.85 4.83 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.602 -0.809 . . . . 0.0 114.451 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.735 ' HB3' HG11 ' A' ' 8' ' ' VAL . 34.0 Cg_endo -91.94 157.86 3.35 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.49 2.793 . . . . 0.0 112.953 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 266' ' ' ILE . 0.4 OUTLIER -130.07 35.43 4.12 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 117.663 -1.615 . . . . 0.0 114.823 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.774 HD11 ' HG ' ' A' ' 7' ' ' LEU . 1.9 mt -152.45 127.91 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 118.181 -1.408 . . . . 0.0 114.443 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.772 HG22 ' CE3' ' A' ' 62' ' ' TRP . 3.9 mp -139.27 122.83 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.613 0.244 . . . . 0.0 111.629 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.767 ' CD1' HD12 ' A' ' 11' ' ' ILE . 35.9 t80 -113.88 121.29 43.53 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.977 0.417 . . . . 0.0 110.151 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.772 ' CE3' HG22 ' A' ' 60' ' ' ILE . 3.1 p90 -166.43 167.29 15.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.995 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -45.66 160.13 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.956 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.73 ' CB ' ' HB ' ' A' ' 261' ' ' VAL . 65.2 t60 -77.63 -29.45 51.76 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -48.91 -54.13 16.74 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.629 0.728 . . . . 0.0 112.398 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -78.37 -30.73 48.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.181 0.515 . . . . 0.0 109.968 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.663 ' HB3' ' HA ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -56.37 -33.08 65.37 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.711 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -55.58 -68.0 1.92 Allowed Glycine 0 C--N 1.354 1.558 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.03 -54.49 31.07 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 112.451 -1.875 . . . . 0.0 111.218 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.436 ' HB3' ' CB ' ' A' ' 75' ' ' LEU . 16.5 m-85 -48.66 -41.19 30.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -51.8 -44.78 63.6 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -42.75 25.58 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 p -69.94 -26.65 64.23 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.97 4.02 10.51 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 119.968 -1.11 . . . . 0.0 114.283 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.864 HD12 ' CZ ' ' A' ' 47' ' ' PHE . 1.1 mm? -96.9 45.86 1.05 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.271 1.036 . . . . 0.0 110.738 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 67' ' ' PHE . 0.5 OUTLIER 176.88 138.04 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 113.273 -1.785 . . . . 0.0 106.571 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.726 ' CB ' ' HB3' ' A' ' 268' ' ' ALA . . . -135.16 138.78 44.02 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 118.391 -1.323 . . . . 0.0 111.585 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -47.42 137.07 9.0 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.554 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.546 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 7.8 mt -122.46 162.3 22.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.115 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.9 p -106.18 82.87 1.0 Allowed Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.399 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 67.0 Cg_endo -84.48 -171.51 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.949 2.433 . . . . 0.0 112.345 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -105.46 156.06 18.56 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.822 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -92.26 -38.88 11.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.364 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.5 -23.25 57.53 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.87 ' CZ ' HD21 ' A' ' 285' ' ' LEU . 10.2 t80 -69.09 -59.3 3.12 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.904 0.383 . . . . 0.0 110.05 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.435 ' HB3' ' CD1' ' A' ' 94' ' ' TRP . 1.3 mt-30 -66.48 -24.63 66.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.677 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.62 -34.04 62.72 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -76.46 -10.01 59.07 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.813 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -125.15 -159.76 0.91 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.28 -179.563 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.657 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -80.0 119.23 75.96 Favored Pre-proline 0 C--N 1.339 0.151 0 O-C-N 122.292 -0.255 . . . . 0.0 111.574 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.32 -32.93 97.14 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.369 2.046 . . . . 0.0 112.206 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.465 ' CE1' ' HG3' ' A' ' 325' ' ' GLN . 17.3 m-85 -52.99 -53.69 46.23 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.158 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.773 HG23 ' CD2' ' A' ' 94' ' ' TRP . 10.0 t -62.62 -23.38 67.04 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.813 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 6.1 m95 -93.18 -25.6 17.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.054 0.454 . . . . 0.0 111.798 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -75.41 -20.78 58.7 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.66 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.739 ' HB1' HG13 ' A' ' 261' ' ' VAL . . . -56.03 -50.41 71.0 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 105' ' ' ALA . 9.1 p -100.42 41.38 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -97.82 135.77 39.11 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.668 -0.645 . . . . 0.0 109.872 178.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.4 t80 -99.94 174.86 5.99 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.02 -0.425 . . . . 0.0 110.081 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -64.87 73.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.674 0.273 . . . . 0.0 110.703 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 138.57 -47.8 0.91 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.051 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -145.99 175.57 10.35 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 117.179 0.49 . . . . 0.0 110.926 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.689 ' O ' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -118.89 119.69 35.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.654 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 3.3 mp -94.99 39.38 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.93 ' HB1' ' O ' ' A' ' 264' ' ' ALA . . . 167.14 -178.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.804 ' CE2' HD11 ' A' ' 280' ' ' LEU . 48.3 p90 -132.97 121.5 16.94 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.015 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.679 ' HA ' ' CB ' ' A' ' 263' ' ' SER . 6.3 Cg_exo -79.41 172.39 14.61 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.177 2.585 . . . . 0.0 113.727 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.519 HG22 ' CE2' ' A' ' 61' ' ' PHE . 2.2 tt -168.9 39.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 119.586 -0.846 . . . . 0.0 112.713 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.957 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -174.92 110.4 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.905 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.554 HG23 ' OG1' ' A' ' 320' ' ' THR . 15.5 m -96.89 117.14 40.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.599 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.452 ' CG ' ' CH2' ' A' ' 230' ' ' TRP . 33.1 mt-10 -102.89 146.85 27.67 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.552 0.691 . . . . 0.0 110.766 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.894 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -165.26 139.05 4.72 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.385 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.838 HD21 ' HA ' ' A' ' 257' ' ' PRO . 0.4 OUTLIER -77.94 137.74 38.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.642 -179.634 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.15 163.5 28.38 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 116' ' ' ILE . 1.5 tt -93.63 130.11 39.67 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.585 ' N ' HD23 ' A' ' 115' ' ' LEU . 12.1 tt -115.62 138.74 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.619 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.729 ' CD1' HD21 ' A' ' 122' ' ' LEU . 3.9 m-85 -117.2 138.58 51.6 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -85.17 119.78 25.93 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -90.82 60.83 4.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.899 0.38 . . . . 0.0 111.421 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.89 -51.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.86 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' CB ' ' A' ' 223' ' ' ALA . 5.6 mt -118.96 38.4 3.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.43 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 224' ' ' MET . 0.4 OUTLIER -157.69 108.06 1.8 Allowed Pre-proline 0 CA--C 1.521 -0.15 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.687 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 9.2 Cg_endo -90.51 130.3 1.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.302 2.001 . . . . 0.0 112.443 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.485 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 81.4 m-20 -64.4 127.13 91.85 Favored Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -172.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 124' ' ' ASN . 55.5 Cg_endo -93.42 167.62 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 124.038 3.159 . . . . 0.0 109.66 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.49 -51.14 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 121.806 1.671 . . . . 0.0 114.246 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.64 -3.48 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 49.5 p -118.03 139.35 51.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 121.252 1.842 . . . . 0.0 114.287 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.521 ' CD2' HD11 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -69.63 -23.27 63.47 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 171.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.591 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 24.3 mt-10 -44.13 -23.61 0.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.359 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 40.4 mm-40 -75.91 -19.16 59.03 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.77 ' CG2' HD21 ' A' ' 147' ' ' LEU . 96.7 mt -46.59 -50.61 40.97 Favored Pre-proline 0 N--CA 1.479 0.994 0 CA-C-O 121.709 0.766 . . . . 0.0 111.346 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.603 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 58.7 Cg_exo -46.4 -36.26 17.47 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 120.826 1.017 . . . . 0.0 109.57 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 137' ' ' LYS . . . -75.36 -59.03 2.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 139' ' ' LEU . 64.3 mt -68.75 -37.34 79.32 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.881 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.1 -40.65 68.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.603 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 3.4 tptm -47.48 -49.0 26.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.81 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 139' ' ' LEU . 1.2 pt-20 -62.83 -37.23 85.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.59 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.84 HD23 ' CG ' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -58.89 -51.03 71.77 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -47.69 -45.68 28.62 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.03 -27.58 0.97 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.09 -56.66 2.16 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.244 0.545 . . . . 0.0 110.671 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.96 39.87 0.02 OUTLIER Glycine 0 CA--C 1.52 0.351 0 CA-C-O 119.029 -0.873 . . . . 0.0 111.216 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.84 ' CG ' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -149.42 -172.06 4.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 119.183 1.492 . . . . 0.0 111.629 -175.104 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.828 ' C ' HD22 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -143.72 127.12 16.81 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.644 ' CA ' HD13 ' A' ' 139' ' ' LEU . . . -41.52 -33.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.77 HD21 ' CG2' ' A' ' 132' ' ' ILE . 0.6 OUTLIER -141.3 130.26 23.18 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 -176.269 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.86 ' O ' HG22 ' A' ' 225' ' ' THR . 0.0 OUTLIER -132.22 138.75 48.06 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.739 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.934 ' O ' ' O ' ' A' ' 150' ' ' ASN . 17.3 p90 -171.92 174.73 4.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.693 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.934 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -27.86 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.757 0.661 . . . . 0.0 112.17 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.965 HD13 ' OG1' ' A' ' 208' ' ' THR . 0.1 OUTLIER -160.66 39.0 0.16 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.261 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.527 ' OE1' HD11 ' A' ' 348' ' ' ILE . 0.0 OUTLIER 171.68 33.09 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.998 169.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.634 ' O ' ' HB ' ' A' ' 157' ' ' THR . 3.3 mt-10 -79.96 152.52 74.42 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 121.986 2.175 . . . . 0.0 115.833 -174.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.975 ' O ' ' N ' ' A' ' 156' ' ' PHE . 67.0 Cg_endo -78.67 -135.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.802 1 C-N-CA 125.559 4.172 . . . . 0.0 107.095 176.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 1.12 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 4.7 p90 3.01 -39.82 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.975 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -86.14 -55.48 3.91 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-N 120.262 1.392 . . . . 0.0 111.55 -179.207 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.845 HG22 ' CD1' ' A' ' 161' ' ' ILE . 61.6 m -56.6 -43.82 80.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.427 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 2.6 m0 -51.26 -55.73 26.18 Favored Pre-proline 0 C--N 1.346 0.416 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.735 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 1.12 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 89.4 Cg_exo -43.11 -50.3 6.48 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.081 2.521 . . . . 0.0 113.026 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.461 HD11 ' HE1' ' A' ' 156' ' ' PHE . 81.3 mt -62.45 -53.82 49.15 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 119.671 1.123 . . . . 0.0 108.645 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.845 ' CD1' HG22 ' A' ' 157' ' ' THR . 1.5 mp -51.86 -25.82 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.421 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -78.59 -22.67 46.73 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.668 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -41.86 -58.35 2.06 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -64.37 5.57 0.26 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.303 1.224 . . . . 0.0 114.303 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.59 22.69 5.34 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 119.588 -1.291 . . . . 0.0 115.262 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.9 163.41 41.83 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.707 -1.235 . . . . 0.0 111.447 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -146.09 120.94 9.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.126 0.463 . . . . 0.0 109.967 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.674 ' HA ' HG22 ' A' ' 183' ' ' VAL . . . -39.14 -79.01 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.675 0.75 . . . . 0.0 111.148 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.633 ' HB3' ' CB ' ' A' ' 176' ' ' TYR . 1.7 m-85 -113.43 172.73 6.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.768 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 1.22 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -101.88 106.87 17.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.08 114.42 18.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.053 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 28.2 tt0 -136.66 102.04 4.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.259 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 0.2 OUTLIER 90.28 -31.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.379 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 154.77 17.04 0.05 OUTLIER Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.151 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -174.18 127.73 0.36 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.175 1.487 . . . . 0.0 111.257 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 1.22 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 47.9 p90 -55.47 -24.45 31.22 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 122.181 0.991 . . . . 0.0 110.987 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 78.8 m-20 76.74 -78.57 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.008 -1.905 . . . . 0.0 111.773 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 369' ' ' THR . 0.8 OUTLIER 168.88 -41.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.498 ' HA ' HG22 ' A' ' 369' ' ' THR . 9.6 tttm -72.75 -5.66 39.33 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 4.4 m-20 -120.24 94.14 4.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.253 0.933 . . . . 0.0 109.634 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.617 HG11 ' CE1' ' A' ' 339' ' ' PHE . 6.4 t -115.78 111.29 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.433 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . -119.76 39.91 2.36 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.852 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.674 HG22 ' HA ' ' A' ' 168' ' ' ALA . 31.0 t -80.41 -44.72 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-O 121.275 0.56 . . . . 0.0 109.865 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -83.83 61.28 6.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.984 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 182' ' ' GLY . 7.4 p30 -110.94 173.92 6.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.712 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.58 -26.43 65.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.274 0.559 . . . . 0.0 111.28 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.95 -46.79 42.5 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.675 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.612 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -56.93 -51.4 69.28 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 175.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -56.06 18.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.979 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.765 ' HB1' ' HE3' ' A' ' 251' ' ' LYS . . . -50.07 -41.18 47.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.006 0.908 . . . . 0.0 112.096 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -66.76 -60.65 5.95 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.715 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.537 HD12 HG12 ' A' ' 161' ' ' ILE . 0.5 OUTLIER -56.54 -27.62 58.03 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.161 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 42.2 m -62.36 -47.62 83.41 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.816 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.531 ' CZ ' ' CZ ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -60.71 -36.7 79.48 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-O 121.542 0.687 . . . . 0.0 109.54 177.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.77 -51.02 71.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.983 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 192' ' ' LEU . 43.1 t -57.29 -31.5 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.562 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 2.6 t0 -57.03 -49.9 74.38 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 121.286 0.565 . . . . 0.0 110.717 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.9 tp -61.97 -59.24 5.4 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.285 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.583 HG22 ' HA ' ' A' ' 204' ' ' MET . 39.4 mm -56.93 -41.13 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.83 -31.73 72.54 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.49 178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 6.0 m-80 -107.54 13.12 27.09 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -173.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 203' ' ' HIS . 1.4 ttmp? -121.92 -91.87 0.55 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.946 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' A' ' 205' ' ' ASN . 0.5 OUTLIER -122.02 -10.82 8.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -178.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.583 ' HA ' HG22 ' A' ' 199' ' ' ILE . 0.0 OUTLIER 69.35 -71.69 0.12 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -176.281 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 203' ' ' HIS . 3.0 m120 64.43 162.49 0.12 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.26 78.88 3.1 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.603 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 39.46 70.75 0.2 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.965 ' OG1' HD13 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -55.05 124.19 16.02 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 213' ' ' ALA . 0.4 OUTLIER -92.13 -174.65 3.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -69.92 -45.55 67.31 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.3 m -75.18 -30.01 60.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.502 0.668 . . . . 0.0 111.024 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.743 HG22 HG22 ' A' ' 208' ' ' THR . 1.2 mp -79.33 -49.74 19.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.207 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -57.61 -34.05 68.88 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -60.02 -48.24 82.53 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.91 -36.59 67.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.247 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.77 -57.6 11.74 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.963 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.538 ' CE1' ' HA ' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -60.09 -30.04 68.98 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -53.18 -42.03 65.81 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.396 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.84 59.12 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.74 57.96 7.44 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.672 -0.695 . . . . 0.0 114.588 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -125.29 37.29 4.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.378 1.089 . . . . 0.0 111.037 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.45 ' CB ' ' HB2' ' A' ' 148' ' ' MET . 12.2 t -142.5 140.48 31.86 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -114.45 38.5 3.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.064 -1.426 . . . . 0.0 113.328 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.789 ' HB2' HD13 ' A' ' 122' ' ' LEU . 25.8 ttm -178.08 129.22 0.13 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.77 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 148' ' ' MET . 69.1 p -145.51 169.32 18.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.566 0.698 . . . . 0.0 111.534 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.566 HD12 ' CZ ' ' A' ' 156' ' ' PHE . 21.9 mt -109.06 145.44 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -146.86 167.05 24.89 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.849 0.86 . . . . 0.0 111.232 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -110.4 -159.8 17.26 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.446 -0.406 . . . . 0.0 112.782 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.429 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 11.7 Cg_endo -55.49 -59.44 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.82 2.346 . . . . 0.0 112.451 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.452 ' CH2' ' CG ' ' A' ' 111' ' ' GLU . 18.6 p90 -173.34 -43.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.474 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.28 70.99 1.2 Allowed 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.786 0.326 . . . . 0.0 110.803 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.423 ' O ' ' N ' ' A' ' 234' ' ' ASN . 1.5 m95 -125.72 39.77 3.88 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 11.3 t 64.87 -72.74 0.06 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.544 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 232' ' ' TRP . 4.6 t-20 -145.64 85.12 1.69 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.575 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.406 ' O ' ' N ' ' A' ' 237' ' ' THR . 18.1 tt -44.55 154.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.434 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.511 ' OD1' HG21 ' A' ' 225' ' ' THR . 37.2 t70 -47.9 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.707 0.289 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 237' ' ' THR . 19.7 m -121.4 39.37 3.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.744 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 83.0 p -63.2 -43.62 97.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.689 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.57 -174.91 2.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.816 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.0 -57.26 4.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.193 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.02 126.32 35.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.543 ' CG ' HD11 ' A' ' 116' ' ' ILE . 9.8 p90 -144.44 164.22 31.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.167 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.4 122.14 5.85 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.425 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 244' ' ' VAL . 34.7 m -91.58 115.31 30.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.743 0.271 . . . . 0.0 111.384 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.6 p -127.62 167.18 16.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.47 153.91 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.807 HD11 ' CD1' ' A' ' 113' ' ' LEU . 58.5 mt -58.29 158.67 13.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 120.31 1.414 . . . . 0.0 110.092 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.437 ' HD3' HD12 ' A' ' 115' ' ' LEU . 72.7 Cg_endo -79.21 -174.65 2.37 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.453 2.102 . . . . 0.0 113.144 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.449 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -105.3 171.16 7.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.091 0.472 . . . . 0.0 111.488 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.531 ' CZ ' ' CZ ' ' A' ' 194' ' ' PHE . 35.6 m-85 -167.31 111.08 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.765 ' HE3' ' HB1' ' A' ' 190' ' ' ALA . 13.2 mttt 62.72 31.71 16.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.637 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.94 33.58 36.45 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.318 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 13.8 mp0 -156.75 154.43 26.65 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 68.7 Cg_endo -90.61 162.91 4.28 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.592 2.861 . . . . 0.0 112.213 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.569 ' OG ' HD13 ' A' ' 247' ' ' LEU . 1.0 OUTLIER -84.41 148.71 26.45 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.1 OUTLIER -86.0 109.81 25.69 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.531 -178.381 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.838 ' HA ' HD21 ' A' ' 113' ' ' LEU . 6.2 Cg_exo -79.84 149.38 20.48 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.998 2.465 . . . . 0.0 112.89 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 155' ' ' TYR . 23.2 p90 -78.86 146.35 33.68 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.979 HG21 HD13 ' A' ' 329' ' ' ILE . 15.6 t -103.53 122.83 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -118.02 123.45 5.74 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.135 -1.507 . . . . 0.0 114.771 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.739 HG13 ' HB1' ' A' ' 96' ' ' ALA . 15.7 t -109.09 110.06 30.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.957 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.7 tp -89.85 99.15 12.21 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 117.881 -1.528 . . . . 0.0 107.257 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.679 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 32.8 p -134.46 141.17 46.69 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 118.501 2.778 . . . . 0.0 118.501 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.93 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -74.04 132.71 42.61 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.025 -0.422 . . . . 0.0 110.292 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -122.18 139.59 12.88 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.652 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 58' ' ' ASP . 3.7 mp -114.39 127.16 71.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.646 ' C ' ' H ' ' A' ' 269' ' ' ALA . 96.1 m-20 -61.07 126.38 27.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.726 ' HB3' ' CB ' ' A' ' 77' ' ' ALA . . . -51.6 5.11 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 119.883 1.219 . . . . 0.0 113.177 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.646 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -81.99 -38.1 25.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.854 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 75.5 m -133.89 69.4 75.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.91 0.386 . . . . 0.0 110.925 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.655 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 6.4 Cg_exo -73.97 -36.21 3.67 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.842 2.362 . . . . 0.0 112.734 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.472 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 23.2 m-20 50.64 68.17 0.81 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 6.5 mttt -48.98 -54.44 15.6 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 2.9 mt-10 -62.98 -57.94 9.03 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.282 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.6 mt -68.01 -58.0 5.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 271' ' ' PRO . . . -69.45 -51.97 31.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 1.1 tpmp? -64.98 -35.76 82.23 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 12.4 tt0 -76.49 -53.09 8.58 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -56.23 -52.01 66.0 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.787 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.804 HD11 ' CE2' ' A' ' 106' ' ' TYR . 8.2 tt -57.41 -43.42 83.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.524 0.678 . . . . 0.0 111.777 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -73.77 -34.3 64.63 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.558 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -94.16 -13.54 26.59 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.748 ' CE2' HG23 ' A' ' 23' ' ' VAL . 1.6 t80 -109.41 -62.2 1.52 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 119.241 -0.409 . . . . 0.0 109.936 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.636 ' O ' HD23 ' A' ' 284' ' ' LEU . 1.7 tt -40.19 -33.57 0.24 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.809 0.731 . . . . 0.0 110.87 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.87 HD21 ' CZ ' ' A' ' 85' ' ' PHE . 80.5 mt -86.59 42.21 0.99 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.959 0.409 . . . . 0.0 110.257 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 283' ' ' TYR . 17.4 p -145.21 155.93 43.55 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 44.1 m-20 -62.7 -15.04 50.87 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.611 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 0.9 OUTLIER -78.27 -47.38 18.02 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.882 -0.511 . . . . 0.0 110.922 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.531 ' O ' HG12 ' A' ' 293' ' ' VAL . . . -79.96 -55.58 3.51 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.291 -0.957 . . . . 0.0 110.972 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.835 ' CD1' HD13 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -55.26 -46.14 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.226 . . . . 0.0 111.066 179.415 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -79.05 -26.32 43.12 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.707 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -68.33 -41.55 80.64 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 119.441 1.019 . . . . 0.0 109.117 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 289' ' ' GLY . 2.7 p -68.4 -61.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.502 ' H ' HG13 ' A' ' 293' ' ' VAL . 0.6 OUTLIER -50.14 -45.14 52.84 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.682 1.193 . . . . 0.0 112.546 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -59.33 -50.36 74.27 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.515 ' O ' ' HD3' ' A' ' 298' ' ' PRO . 42.0 m-20 -56.17 -47.86 77.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 176.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 294' ' ' ASN . 0.0 OUTLIER -69.04 104.67 0.78 Allowed Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.951 -178.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.697 ' O ' HD23 ' A' ' 299' ' ' LEU . 93.1 Cg_endo -99.64 54.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.322 2.681 . . . . 0.0 112.675 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 298' ' ' PRO . 0.4 OUTLIER -138.88 -67.83 0.45 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.57 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.63 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . -172.91 -166.31 31.21 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.853 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.725 ' HB3' ' CD1' ' A' ' 311' ' ' LEU . . . 160.0 177.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.579 0.228 . . . . 0.0 111.141 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 302' ' ' VAL . 5.8 p 174.52 62.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.486 ' HA ' HG21 ' A' ' 93' ' ' THR . . . -113.78 -138.6 0.37 Allowed 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.835 HD13 ' CD1' ' A' ' 290' ' ' LEU . 0.4 OUTLIER -4.51 110.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.38 1.072 . . . . 0.0 113.803 -179.307 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -34.22 -60.88 0.39 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.099 0.476 . . . . 0.0 112.085 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.14 -47.1 54.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.988 0.899 . . . . 0.0 111.272 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.817 ' CG ' HD22 ' A' ' 290' ' ' LEU . 2.4 t80 -73.0 -20.12 61.08 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.319 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 12.0 tt0 -66.64 -39.88 88.45 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.46 -51.85 38.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.335 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -56.83 -56.31 23.23 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.012 0.434 . . . . 0.0 110.174 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.845 HD22 HD13 ' A' ' 317' ' ' ILE . 0.9 OUTLIER -63.76 -41.02 98.06 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.776 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.908 ' HA ' HD11 ' A' ' 317' ' ' ILE . . . -46.23 -26.77 0.85 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 312' ' ' ALA . 10.5 mtpp -37.76 -40.04 0.4 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.753 0.311 . . . . 0.0 110.599 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -82.82 124.35 77.14 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.903 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.21 -13.51 40.19 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.637 2.225 . . . . 0.0 114.214 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.8 ' O ' HG23 ' A' ' 320' ' ' THR . 5.3 mtp85 -62.08 -58.89 6.12 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.908 HD11 ' HA ' ' A' ' 312' ' ' ALA . 10.3 pt -50.12 -52.36 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.78 -45.14 14.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.84 0.291 . . . . 0.0 111.71 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.73 -38.96 73.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.299 0.571 . . . . 0.0 110.322 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.894 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 19.9 p -65.17 -33.61 76.42 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.408 ' HG3' HG21 ' A' ' 302' ' ' VAL . 0.0 OUTLIER -76.89 -49.19 16.23 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.603 0.24 . . . . 0.0 111.04 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -43.52 84.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.307 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.667 ' CB ' ' HB1' ' A' ' 112' ' ' ALA . 16.2 m-80 -71.58 -41.56 68.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.584 0.231 . . . . 0.0 111.17 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -23.08 67.16 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' GLN . . . . . 0.465 ' HG3' ' CE1' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -85.27 -34.09 22.02 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -101.48 62.74 0.95 Allowed 'General case' 0 C--O 1.232 0.151 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.478 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -154.96 -140.79 3.09 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.681 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -128.32 118.84 23.94 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.979 HD13 HG21 ' A' ' 259' ' ' VAL . 3.5 mm -75.34 131.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.77 133.08 2.96 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.725 0.297 . . . . 0.0 111.326 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.556 ' HB3' ' CE2' ' A' ' 176' ' ' TYR . 12.6 Cg_endo -56.05 -161.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.092 2.528 . . . . 0.0 111.975 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -159.21 40.78 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.589 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 5.1 pt -136.55 170.78 9.99 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.893 -0.139 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 87.5 Cg_endo -84.83 -20.51 3.63 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.628 2.219 . . . . 0.0 113.927 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 368' ' ' ILE . 14.6 mm-40 -56.13 -21.04 20.15 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.482 ' HE1' ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -44.72 -33.36 1.84 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.516 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 23.2 m -57.16 -33.17 67.16 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.649 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.0 78.08 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.928 0.394 . . . . 0.0 111.92 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.617 ' CE1' HG11 ' A' ' 181' ' ' VAL . 0.1 OUTLIER -78.35 -55.66 5.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.772 -178.799 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.419 ' HA ' ' CE3' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -44.0 -44.73 7.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.045 -179.372 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 345' ' ' THR . 7.0 m-85 -74.79 -44.01 51.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.972 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.21 76.48 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.987 HG12 HD21 ' A' ' 361' ' ' LEU . 5.5 m -71.94 -41.31 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.034 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.381 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 348' ' ' ILE . 6.7 mmp_? -56.34 -55.29 35.25 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.212 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 341' ' ' TYR . 43.9 p -59.45 -56.23 24.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.064 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.62 -60.67 2.17 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.596 ' CG2' HD11 ' A' ' 361' ' ' LEU . 48.3 t -51.17 -50.52 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.527 HD11 ' OE1' ' A' ' 152' ' ' GLN . 2.1 tt -69.88 -46.14 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.837 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 345' ' ' THR . 19.6 t-20 -66.35 -53.97 30.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 355' ' ' GLN . . . -66.21 -26.55 67.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -57.07 -12.31 2.06 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.0 p -110.42 26.75 10.34 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.48 0.582 . . . . 0.0 111.424 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 89.41 -5.72 83.78 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 118.463 -1.827 . . . . 0.0 114.482 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 34.98 0.72 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 116.199 -2.2 . . . . 0.0 107.956 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 356' ' ' THR . 1.0 OUTLIER -72.15 -174.81 1.34 Allowed 'General case' 0 CA--C 1.548 0.868 1 N-CA-C 126.385 5.698 . . . . 0.0 126.385 -158.057 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.6 OUTLIER 158.22 40.48 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 109.833 -3.349 . . . . 0.0 104.283 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.689 ' CG2' HD12 ' A' ' 361' ' ' LEU . 12.8 p -72.56 -52.58 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -174.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 13.4 t0 -47.34 -45.64 24.85 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.596 0.712 . . . . 0.0 111.28 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -77.07 -56.34 4.66 Favored 'General case' 0 C--N 1.353 0.74 0 CA-C-N 114.073 -1.421 . . . . 0.0 113.733 -175.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -51.49 -41.72 61.15 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 122.583 1.182 . . . . 0.0 112.253 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.987 HD21 HG12 ' A' ' 343' ' ' VAL . 5.7 mt -79.03 -34.95 43.4 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 112.745 -2.025 . . . . 0.0 110.494 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 5.2 mmmt -65.75 -56.6 11.17 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.391 1.091 . . . . 0.0 109.599 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 366' ' ' THR . 1.4 t70 -59.46 -36.03 75.21 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.372 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -52.18 -44.01 64.45 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 369' ' ' THR . 15.0 tt0 -60.21 -46.42 89.8 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 363' ' ' ASP . 53.1 m -51.03 -42.88 60.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.09 0.471 . . . . 0.0 110.138 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 10.3 ttm105 -59.12 -52.57 65.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.122 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 178' ' ' ILE . 15.7 tt -73.55 -30.31 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 178' ' ' ILE . 80.9 p -82.52 -30.24 29.91 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 8.2 tptt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.962 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.527 0.203 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -156.08 160.24 39.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.784 0.326 . . . . 0.0 111.213 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . 90.88 25.56 24.54 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.415 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.34 152.79 42.04 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.585 HD13 HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -129.76 121.27 26.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.152 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -117.04 118.23 58.07 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.849 HG23 ' CE1' ' A' ' 61' ' ' PHE . 24.4 mt -123.04 130.07 74.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.435 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.609 ' HB3' HD11 ' A' ' 43' ' ' LEU . 8.6 m95 -108.99 122.29 46.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -145.74 143.07 21.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 122.881 0.473 . . . . 0.0 109.813 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -79.8 72.62 6.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 119.014 0.824 . . . . 0.0 112.015 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.64 65.88 2.9 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.098 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.814 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -87.11 -32.82 19.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.814 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 102.12 -156.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -177.309 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.756 ' O ' HD23 ' A' ' 20' ' ' LEU . . . 71.39 52.56 12.59 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 116.089 1.196 . . . . 0.0 116.089 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -58.71 2.92 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 2.0 t-20 -46.18 -43.33 15.08 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.122 0.487 . . . . 0.0 111.127 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.782 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.12 -45.54 49.22 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.302 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 16' ' ' GLY . 3.5 mm? -61.13 -51.47 68.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.944 0.372 . . . . 0.0 110.678 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.17 74.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 34.8 tt0 -65.3 -36.09 82.99 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.754 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 19' ' ' GLY . 74.8 t -67.7 -61.27 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.54 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . -49.22 -34.22 17.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.205 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.41 -50.38 67.74 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 177.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -41.63 62.77 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 112.826 -1.988 . . . . 0.0 108.593 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.785 ' HB3' HD13 ' A' ' 33' ' ' ILE . 21.7 m-30 -66.91 -34.32 77.53 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.128 0.966 . . . . 0.0 111.367 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.76 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -72.6 -51.96 17.48 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.914 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tpmp? -53.1 -27.55 21.04 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 124.807 1.317 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 31' ' ' THR . 3.7 m-20 -86.03 -37.42 18.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 117.732 -1.128 . . . . 0.0 108.97 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.829 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.92 38.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 172.253 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.808 ' O ' HD12 ' A' ' 33' ' ' ILE . . . 156.88 39.25 0.02 OUTLIER Glycine 0 N--CA 1.465 0.582 0 C-N-CA 114.537 -3.697 . . . . 0.0 119.337 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.083 HD11 HD21 ' A' ' 275' ' ' LEU . 1.5 mp -139.46 136.27 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 121.961 2.88 . . . . 0.0 116.637 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -142.32 104.46 4.43 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.585 HG22 HD13 ' A' ' 7' ' ' LEU . 37.4 t -88.48 128.97 40.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 m -118.51 140.11 50.39 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.645 -1.162 . . . . 0.0 110.853 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.694 HG12 ' HB ' ' A' ' 9' ' ' ILE . 15.2 m -129.85 122.47 54.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 O-C-N 122.133 -0.354 . . . . 0.0 110.703 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.425 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 3.0 tp10 -113.4 134.03 54.86 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.98 74.83 10.29 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 122.355 0.262 . . . . 0.0 111.208 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 38' ' ' GLU . 6.0 Cg_endo -89.18 -167.47 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.546 2.831 . . . . 0.0 113.262 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -109.42 -54.85 2.5 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.347 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -78.03 0.12 25.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.41 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.996 HD21 HD11 ' A' ' 60' ' ' ILE . 2.0 tt -26.08 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 1.062 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 3.5 mt-10 -70.59 -55.02 9.81 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -68.34 -50.06 55.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.113 0.482 . . . . 0.0 111.454 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.665 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.4 mmtm -61.82 -56.27 21.21 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.682 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 73.4 t80 -47.03 -55.01 16.73 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 1.062 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 30.8 Cg_exo -66.96 -39.69 13.54 Favored 'Trans proline' 0 C--O 1.25 1.12 0 C-N-CA 121.478 1.452 . . . . 0.0 115.196 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.44 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 34.4 tt0 -67.54 -51.15 54.22 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 46' ' ' LYS . 9.0 m -61.37 -22.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.114 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 48' ' ' PRO . . . -59.05 -30.03 67.74 Favored 'General case' 0 C--N 1.394 2.535 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.058 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -82.38 -28.94 31.18 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.227 1.411 . . . . 0.0 113.029 -178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 50' ' ' VAL . 5.7 t -88.3 129.66 35.32 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.126 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.93 -67.95 0.05 OUTLIER Glycine 0 C--N 1.337 0.587 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.396 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -165.29 -84.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.417 1.609 . . . . 0.0 111.427 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.03 142.86 4.34 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.517 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.18 -146.6 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.84 2.36 . . . . 0.0 112.767 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 1.152 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -79.99 -135.65 0.03 OUTLIER 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 123.744 0.818 . . . . 0.0 110.069 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.639 HD12 ' HB1' ' A' ' 264' ' ' ALA . 16.6 pt -104.48 166.89 2.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.996 HD11 HD21 ' A' ' 43' ' ' LEU . 1.7 tt -127.69 134.87 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 1.026 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -110.69 120.08 41.25 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.973 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -166.99 162.91 15.88 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.393 0.542 . . . . 0.0 110.437 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.515 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . . . -38.34 154.84 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.831 ' HB3' HG13 ' A' ' 261' ' ' VAL . 2.6 t60 -77.29 -30.04 54.02 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.99 -36.96 75.77 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.693 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.515 ' HD3' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -84.29 -33.11 24.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.933 178.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.606 ' HZ ' HG23 ' A' ' 104' ' ' ILE . 4.5 t80 -59.94 -30.35 69.01 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.07 -68.51 1.66 Allowed Glycine 0 C--N 1.353 1.502 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.99 45.08 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.541 ' CZ ' ' HG3' ' A' ' 48' ' ' PRO . 1.2 m-85 -48.03 -46.35 33.03 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -51.08 -48.83 61.53 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.884 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -63.87 -16.89 62.47 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 m -69.36 -26.88 64.9 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.936 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.759 ' O ' HD22 ' A' ' 75' ' ' LEU . . . 83.69 28.94 33.73 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.697 -0.763 . . . . 0.0 114.996 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.759 HD22 ' O ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -139.45 38.5 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.502 1.151 . . . . 0.0 111.99 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.711 ' HB3' HD11 ' A' ' 104' ' ' ILE . 3.2 mm? -110.15 131.61 54.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.93 0.395 . . . . 0.0 111.306 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.825 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -95.68 121.64 37.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.645 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.911 ' HG3' HD12 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -82.78 133.15 35.15 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.974 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.535 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 18.6 tt -78.29 159.63 4.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.119 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.5 p -108.61 82.76 1.79 Allowed Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 48.1 Cg_endo -90.08 -169.9 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.126 2.55 . . . . 0.0 112.244 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -127.94 156.2 43.02 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.557 0.218 . . . . 0.0 110.921 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -57.52 -45.62 84.77 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.672 0.272 . . . . 0.0 110.946 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.6 -23.13 64.45 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.637 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.477 ' CE2' ' CH2' ' A' ' 94' ' ' TRP . 8.6 t80 -79.23 -59.19 2.87 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 23.2 tt0 -55.65 -38.2 69.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.705 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -76.71 -34.58 58.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.682 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.87 -31.8 1.37 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.914 HD13 ' HA ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -126.21 -90.1 0.55 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.123 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.47 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 2.4 m-85 -136.26 111.24 9.97 Favored Pre-proline 0 CA--C 1.53 0.192 0 O-C-N 122.005 -0.434 . . . . 0.0 111.686 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 90' ' ' TYR . 19.3 Cg_endo -57.45 -22.34 50.03 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.592 2.195 . . . . 0.0 112.504 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -56.94 -53.81 53.82 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.578 0.228 . . . . 0.0 111.589 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.542 HG22 ' CG ' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -62.19 -45.51 93.05 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 110.267 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.78 ' CZ2' HD11 ' A' ' 89' ' ' LEU . 71.7 m95 -60.26 -40.39 90.18 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 121.7 0.762 . . . . 0.0 109.861 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.78 -22.08 61.63 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.953 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.496 ' HB1' HG21 ' A' ' 261' ' ' VAL . . . -75.59 -17.67 59.96 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.657 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 13.1 m -121.74 46.22 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -128.92 139.54 52.08 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.42 0.554 . . . . 0.0 109.533 178.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -142.55 114.37 8.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 119.178 0.899 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 78.21 25.96 0.59 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.74 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.48 -27.98 17.96 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.998 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -102.34 163.85 12.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.561 0.681 . . . . 0.0 111.226 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -91.08 137.99 31.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.83 0.348 . . . . 0.0 110.616 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.911 HD12 ' HG3' ' A' ' 78' ' ' GLU . 15.6 tt -137.57 48.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.344 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 159.61 -177.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 264' ' ' ALA . 49.5 m-85 -142.29 122.82 8.31 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.633 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.64 ' HB3' HG23 ' A' ' 261' ' ' VAL . 88.5 Cg_endo -79.48 166.13 22.38 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.271 1.98 . . . . 0.0 112.37 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.699 ' HA ' ' HB2' ' A' ' 303' ' ' ALA . 3.1 tt -168.61 39.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.136 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.599 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.849 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 176.08 122.37 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 110' ' ' VAL . 11.3 p -113.7 105.62 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.525 ' HA ' ' CG2' ' A' ' 320' ' ' THR . 2.0 mp0 -103.08 162.91 12.56 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.672 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -164.86 150.1 9.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.591 0.71 . . . . 0.0 112.131 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.883 HD11 HD11 ' A' ' 247' ' ' LEU . 2.6 pp -79.51 126.9 31.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.3 171.72 11.24 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 122.178 -0.326 . . . . 0.0 111.118 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.811 HD22 ' CE1' ' A' ' 117' ' ' TYR . 1.3 tt -110.99 136.29 50.22 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.716 HD13 ' OD1' ' A' ' 227' ' ' ASN . 3.3 mp -112.11 128.8 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.811 ' CE1' HD22 ' A' ' 115' ' ' LEU . 22.6 m-30 -110.36 134.87 51.88 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -84.41 119.12 24.75 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -109.54 29.21 7.78 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.715 0.293 . . . . 0.0 111.675 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.1 -54.0 1.12 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -136.74 0.02 OUTLIER 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.406 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.917 HD22 HD11 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -84.27 128.96 59.96 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.023 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 41.4 Cg_exo -55.91 161.45 8.39 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.411 2.74 . . . . 0.0 111.604 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.539 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 4.9 p-10 -101.38 169.25 7.98 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.858 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 50.1 Cg_exo -53.84 167.55 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.675 2.25 . . . . 0.0 111.915 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -92.53 -118.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 122.816 2.344 . . . . 0.0 112.868 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.769 ' HD2' HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -84.38 -18.17 36.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.309 0.959 . . . . 0.0 111.747 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.769 HG23 ' HD2' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -117.75 141.25 48.61 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.552 ' CH2' HD22 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -69.71 -25.82 64.04 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 173.039 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.533 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.4 OUTLIER -44.83 -23.9 0.17 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.989 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.416 ' CD ' HD23 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -70.78 -23.48 62.4 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.774 HG21 ' CD2' ' A' ' 198' ' ' LEU . 1.5 mp -40.44 -60.23 1.62 Allowed Pre-proline 0 N--CA 1.477 0.906 0 CA-C-O 121.446 0.641 . . . . 0.0 111.425 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 67.5 Cg_exo -46.45 -40.87 23.23 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 120.891 1.06 . . . . 0.0 109.861 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.3 -58.84 3.03 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 139' ' ' LEU . 4.0 mm? -68.03 -36.79 80.52 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.393 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.71 ' OD2' HG23 ' A' ' 132' ' ' ILE . 1.3 m-20 -74.16 -40.53 62.52 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 3.0 ttpt -49.87 -46.78 51.86 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 118.949 -1.1 . . . . 0.0 109.29 177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.5 mm-40 -62.59 -37.1 84.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.194 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.972 HD22 ' O ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -62.43 -47.86 82.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.038 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -47.59 -45.14 27.05 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.06 -24.43 0.43 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -99.01 -57.63 2.13 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.04 39.57 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.717 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.684 ' HB2' ' O ' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -174.04 177.28 2.38 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.703 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.972 ' O ' HD22 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -107.1 177.66 4.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.754 ' O ' ' C ' ' A' ' 223' ' ' ALA . . . -86.84 -14.25 42.65 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.552 HD22 ' CH2' ' A' ' 129' ' ' TRP . 2.5 pp -138.95 128.68 24.78 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.602 ' O ' HG22 ' A' ' 225' ' ' THR . 2.1 tpt -132.47 136.29 46.6 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 227' ' ' ASN . 6.2 t80 -171.63 173.66 4.59 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.948 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.548 ' O ' ' O ' ' A' ' 208' ' ' THR . 2.5 m120 -23.08 -70.34 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.726 HD22 ' HB1' ' A' ' 206' ' ' ALA . 0.1 OUTLIER 97.53 38.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.88 0.872 . . . . 0.0 109.226 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 172.36 34.73 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 117.637 -1.173 . . . . 0.0 114.113 170.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' OG1' ' A' ' 157' ' ' THR . 13.5 mt-10 -102.59 151.04 38.19 Favored Pre-proline 0 C--O 1.218 -0.589 0 CA-C-N 122.349 2.34 . . . . 0.0 116.025 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.923 ' O ' ' N ' ' A' ' 156' ' ' PHE . 65.9 Cg_endo -78.14 -134.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 1 C-N-CA 125.922 4.415 . . . . 0.0 106.285 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 1.149 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 12.9 m-85 26.08 -60.33 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 119.335 0.97 . . . . 0.0 113.431 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.923 ' N ' ' O ' ' A' ' 154' ' ' PRO . 56.1 m-85 -83.48 -56.6 3.65 Favored 'General case' 0 C--O 1.257 1.471 0 C-N-CA 123.65 0.78 . . . . 0.0 112.097 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.859 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 27.8 p -59.33 -40.5 86.51 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.215 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.539 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 29.4 m0 -52.41 -55.48 31.45 Favored Pre-proline 0 C--N 1.352 0.703 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 1.149 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 86.2 Cg_exo -43.39 -49.26 7.68 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.68 2.253 . . . . 0.0 112.241 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.718 HD11 HD13 ' A' ' 226' ' ' ILE . 5.7 mt -56.91 -56.89 15.88 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 119.514 1.052 . . . . 0.0 109.341 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.452 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 4.4 mt -51.57 -20.94 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.095 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.493 ' HB3' ' H ' ' A' ' 256' ' ' LYS . . . -83.97 -19.45 34.57 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.045 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 250' ' ' PHE . . . -46.79 -47.11 20.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.532 ' CB ' ' CA ' ' A' ' 187' ' ' GLY . 6.6 m-20 -65.29 -58.32 6.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 120.744 1.611 . . . . 0.0 112.831 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.78 31.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.085 -1.531 . . . . 0.0 115.181 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -106.3 100.36 1.63 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.111 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.416 ' O ' ' CA ' ' A' ' 183' ' ' VAL . 60.9 m-85 -77.72 151.09 34.32 Favored 'General case' 0 C--N 1.337 0.048 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.15 -72.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.575 ' HB3' ' CD2' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -111.99 169.83 8.57 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.903 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 1.19 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.5 OUTLIER -102.25 111.48 23.78 Favored 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 328' ' ' GLU . 28.6 m-85 -84.26 115.03 22.25 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.914 -1.494 . . . . 0.0 108.616 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.928 ' O ' ' N ' ' A' ' 174' ' ' GLY . 5.4 mm-40 -137.1 101.59 4.6 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.52 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 41.54 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 123.93 0.769 . . . . 0.0 110.475 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.928 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -75.2 -73.35 0.97 Allowed Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -175.87 143.51 0.58 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.768 1.284 . . . . 0.0 111.154 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 1.19 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 21.8 p90 -45.4 -32.51 2.13 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.061 0.934 . . . . 0.0 109.609 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 40.8 t0 59.38 -98.3 0.08 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.773 -1.558 . . . . 0.0 111.592 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 178' ' ' ILE . 7.4 tp -176.77 32.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -132.54 -18.5 2.48 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.079 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 3.7 m-20 -121.87 93.02 3.86 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.962 HG21 ' CD1' ' A' ' 368' ' ' ILE . 29.0 m -116.72 116.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.85 39.77 2.39 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.617 -1.277 . . . . 0.0 113.494 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.781 ' O ' ' HB2' ' A' ' 188' ' ' ALA . 11.5 p -79.92 -46.13 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.451 ' N ' HG13 ' A' ' 183' ' ' VAL . 13.5 p-10 -75.59 54.49 0.77 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.751 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.6 -171.79 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -49.82 -37.33 30.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.773 0.797 . . . . 0.0 111.807 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.532 ' CA ' ' CB ' ' A' ' 164' ' ' ASP . . . -75.38 -37.14 42.41 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.583 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -64.17 -42.9 96.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -50.3 -40.26 48.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.094 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 194' ' ' PHE . . . -69.59 -47.64 62.86 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -66.7 -60.47 6.14 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.189 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.842 ' O ' HG23 ' A' ' 196' ' ' VAL . 3.8 tt -50.04 -39.37 41.56 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 98.8 m -75.78 -42.33 50.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -60.17 -35.66 75.84 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.112 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -47.04 78.58 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 192' ' ' LEU . 46.7 t -56.38 -30.6 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.968 177.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -62.62 -47.57 83.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.827 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.774 ' CD2' HG21 ' A' ' 132' ' ' ILE . 2.0 mt -62.75 -59.1 5.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.663 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 206' ' ' ALA . 33.5 mm -52.01 -47.96 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.651 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -59.69 -34.56 73.04 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.91 0.77 52.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -120.33 -80.77 0.63 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.722 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -120.19 -26.54 5.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.461 ' HA ' HG22 ' A' ' 199' ' ' ILE . 0.0 OUTLIER 75.91 14.03 2.69 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.81 0.277 . . . . 0.0 111.369 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -144.39 -59.56 0.38 Allowed 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.726 ' HB1' HD22 ' A' ' 151' ' ' LEU . . . 67.09 81.08 0.2 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.39 -2.7 35.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.42 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.822 HG22 ' HB2' ' A' ' 213' ' ' ALA . 27.5 m -56.88 127.05 29.79 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.613 ' OD1' HD12 ' A' ' 212' ' ' ILE . 2.8 p-10 -101.65 -175.67 2.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.632 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.5 p90 -69.35 -45.28 69.78 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.208 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.422 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -77.12 -26.72 53.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.428 0.633 . . . . 0.0 111.133 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.613 HD12 ' OD1' ' A' ' 209' ' ' ASP . 5.7 mt -81.56 -51.53 15.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.857 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.822 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -54.82 -33.7 61.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -48.89 76.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 218' ' ' ASN . . . -52.91 -42.75 65.67 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.065 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.518 ' HB3' ' HG2' ' A' ' 148' ' ' MET . . . -53.31 -55.95 20.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.103 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.597 ' CD2' HG21 ' A' ' 222' ' ' THR . 30.0 t80 -60.25 -31.41 70.18 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 215' ' ' ALA . 1.3 t30 -55.01 -39.87 69.53 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -23.78 58.89 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.18 61.0 3.87 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.684 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 11.7 pt-20 -123.55 37.92 4.31 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 123.049 1.404 . . . . 0.0 111.534 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.636 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 0.0 OUTLIER -92.56 -166.06 1.47 Allowed 'General case' 0 N--CA 1.424 -1.751 2 C-N-CA 135.562 5.545 . . . . 0.0 121.939 -170.204 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.786 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . 158.7 34.58 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.14 1 CA-C-N 104.421 -5.808 . . . . 0.0 112.062 168.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.786 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 158.38 131.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 174.716 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 148' ' ' MET . 0.9 OUTLIER -148.57 155.45 41.13 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.018 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.718 HD13 HD11 ' A' ' 160' ' ' LEU . 10.3 pt -115.88 112.47 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.809 1.186 . . . . 0.0 108.503 174.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.716 ' OD1' HD13 ' A' ' 116' ' ' ILE . 2.2 p-10 -147.93 165.23 31.31 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-O 118.95 -0.548 . . . . 0.0 112.411 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -122.85 -176.36 14.88 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.575 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' A' ' 232' ' ' TRP . 74.7 Cg_exo -47.43 -32.4 15.13 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.533 2.156 . . . . 0.0 112.354 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -47.14 -43.15 20.55 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.26 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.62 41.15 3.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.639 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.556 ' HZ2' HG22 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -93.04 -44.03 8.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.801 0.334 . . . . 0.0 110.758 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.8 m -69.6 -33.53 72.82 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.229 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.54 -42.06 6.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.618 0.247 . . . . 0.0 111.419 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.4 -60.77 2.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.954 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 44.91 42.37 6.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.575 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.62 -71.89 0.34 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.93 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.92 42.02 11.63 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.377 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.491 ' O ' HG13 ' A' ' 240' ' ' VAL . 0.0 OUTLIER 67.0 -72.11 0.09 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.017 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 239' ' ' LYS . 0.7 OUTLIER -157.56 -53.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -126.84 119.5 26.97 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.638 0.256 . . . . 0.0 111.0 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -108.46 155.36 20.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.83 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -122.36 111.52 1.8 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.671 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.556 HG22 ' HZ2' ' A' ' 232' ' ' TRP . 13.1 t -91.04 135.28 27.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.685 0.242 . . . . 0.0 110.46 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.403 HG21 ' HE2' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -137.17 167.28 21.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.914 0.485 . . . . 0.0 111.798 -173.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.06 152.68 7.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.883 HD11 HD11 ' A' ' 113' ' ' LEU . 7.1 mt -59.48 159.66 16.3 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 121.279 1.854 . . . . 0.0 110.132 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.794 ' HD3' HD12 ' A' ' 115' ' ' LEU . 5.8 Cg_exo -78.94 -165.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.47 2.114 . . . . 0.0 112.069 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.484 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -112.95 175.72 5.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.813 0.339 . . . . 0.0 111.68 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.514 ' HB2' ' HB1' ' A' ' 163' ' ' ALA . 97.3 m-85 -164.13 110.38 1.06 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.364 0.602 . . . . 0.0 109.384 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt 61.18 34.19 18.97 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.521 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.05 40.63 34.4 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.899 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.423 ' HB3' ' O ' ' A' ' 163' ' ' ALA . 7.8 mt-30 -156.99 158.68 31.34 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.506 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 79.9 Cg_endo -93.98 160.81 2.18 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.887 3.058 . . . . 0.0 111.776 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 247' ' ' LEU . 1.3 p -84.43 156.05 21.96 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.493 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 6.1 tmmm? -85.93 112.95 48.89 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.181 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.477 ' HG2' ' CA ' ' A' ' 327' ' ' GLY . 71.6 Cg_endo -84.59 145.0 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.829 2.353 . . . . 0.0 112.417 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 155' ' ' TYR . 1.3 m-85 -79.64 148.79 31.51 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 328' ' ' GLU . 1.9 m -104.8 139.69 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -176.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -125.25 118.85 3.38 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 118.787 -1.673 . . . . 0.0 116.985 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.831 HG13 ' HB3' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -129.87 97.62 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 176.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.849 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -78.19 115.3 17.82 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.507 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 53.6 p -133.87 138.59 45.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 1.026 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -89.74 109.65 20.61 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 105' ' ' ALA . . . -97.75 165.42 22.2 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 176.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 59' ' ' ILE . 10.4 mt -91.13 123.3 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 118.495 1.148 . . . . 0.0 108.022 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.493 ' ND2' ' HB3' ' A' ' 269' ' ' ALA . 11.5 p-10 -61.97 138.19 58.34 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.987 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.825 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -51.13 -18.42 0.86 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.705 1.139 . . . . 0.0 110.892 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 55' ' ' ASP . . . -56.5 -37.79 70.89 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.49 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 78.8 82.74 0.1 OUTLIER Pre-proline 0 N--CA 1.463 0.221 0 CA-C-O 120.769 0.319 . . . . 0.0 110.9 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -91.65 99.76 0.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.24 2.627 . . . . 0.0 112.612 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.551 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 1.6 m-20 47.83 73.44 0.2 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.797 0.332 . . . . 0.0 110.629 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 5.4 mttm -53.1 -54.05 41.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.656 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 13.5 mm-40 -63.28 -57.4 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 1.083 HD21 HD11 ' A' ' 33' ' ' ILE . 9.0 tt -65.66 -57.93 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -60.45 -56.73 17.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 7.3 ttpp -60.69 -30.31 69.86 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 2.4 tt0 -76.41 -52.82 9.13 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.532 ' CD1' ' CE2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -57.2 -50.0 74.23 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.781 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 279' ' ' PHE . 2.1 tp -56.94 -43.08 81.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.622 0.725 . . . . 0.0 111.227 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -73.42 -34.78 65.64 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.664 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -93.88 -14.02 26.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.486 ' CE2' HG13 ' A' ' 23' ' ' VAL . 26.1 t80 -109.13 -63.14 1.39 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 284' ' ' LEU . 0.2 OUTLIER -39.92 -31.82 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.983 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.774 HD13 HD21 ' A' ' 304' ' ' LEU . 3.5 mm? -90.01 42.53 1.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.737 0.303 . . . . 0.0 111.131 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.9 p -144.18 155.1 43.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 1.0 OUTLIER -64.42 -13.57 51.99 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.461 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.721 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 1.1 mp0 -77.91 -47.47 18.59 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 117.999 0.363 . . . . 0.0 110.149 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.576 ' O ' HG12 ' A' ' 293' ' ' VAL . . . -84.23 -55.03 2.84 Favored Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.953 HD22 HD23 ' A' ' 304' ' ' LEU . 10.7 tp -47.42 -51.57 19.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.538 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 8.6 tt0 -79.23 -26.21 42.54 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.616 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -68.54 -40.15 80.83 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 289' ' ' GLY . 3.0 p -67.97 -61.45 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.508 ' H ' HG13 ' A' ' 293' ' ' VAL . 16.5 t30 -37.57 -50.91 1.16 Allowed 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.408 1.483 . . . . 0.0 112.289 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -60.08 -45.69 92.06 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.4 OUTLIER -57.87 -52.59 64.84 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.422 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.804 ' HZ1' ' HB3' ' A' ' 301' ' ' ALA . 0.0 OUTLIER -42.48 162.49 0.16 Allowed Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.359 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.07 -72.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.0 2.467 . . . . 0.0 113.405 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.462 ' N ' ' HD2' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -157.78 -62.99 0.09 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.536 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.603 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . -79.87 138.83 20.66 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.951 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.804 ' HB3' ' HZ1' ' A' ' 297' ' ' LYS . . . 168.56 -172.95 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.612 ' HA ' HD21 ' A' ' 311' ' ' LEU . 8.3 p -178.04 137.38 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.22 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' A' ' 108' ' ' ILE . . . 167.59 96.04 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.953 HD23 HD22 ' A' ' 290' ' ' LEU . 5.9 tp 96.59 116.73 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.234 0.614 . . . . 0.0 110.752 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 304' ' ' LEU . 13.9 ttmt -26.54 -64.44 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.569 0.543 . . . . 0.0 111.12 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.2 m -48.3 -40.82 26.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.8 0.809 . . . . 0.0 110.277 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.717 ' CD2' HD23 ' A' ' 311' ' ' LEU . 42.5 t80 -75.85 -33.58 60.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.005 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.565 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 7.0 pt-20 -72.51 -41.31 66.06 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 120.561 -0.456 . . . . 0.0 109.987 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.65 -56.93 6.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.14 -57.38 8.87 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.722 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.939 HD11 HG21 ' A' ' 317' ' ' ILE . 2.7 pp -61.52 -43.0 99.65 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.154 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.726 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -46.78 -29.67 2.05 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -35.54 -41.52 0.2 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.719 0.295 . . . . 0.0 110.886 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.05 127.89 85.92 Favored Pre-proline 0 CA--C 1.528 0.126 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.38 -22.69 34.85 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.614 2.209 . . . . 0.0 113.714 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -60.7 -59.12 5.89 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.939 HG21 HD11 ' A' ' 311' ' ' LEU . 2.6 mp -49.82 -55.8 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.89 -52.0 12.18 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.08 0.4 . . . . 0.0 111.659 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.15 -41.48 92.86 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.843 0.83 . . . . 0.0 109.738 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 111' ' ' GLU . 1.5 m -60.9 -41.94 97.07 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.614 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.459 ' HG2' HG21 ' A' ' 110' ' ' VAL . 1.7 tmm? -77.13 -39.43 49.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.69 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.08 -41.73 79.37 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.852 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.477 ' HB3' ' HB1' ' A' ' 112' ' ' ALA . 8.9 m-80 -75.58 -42.01 53.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.715 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 111' ' ' GLU . . . -65.73 -42.43 91.04 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.852 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.1 -31.84 53.19 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.278 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -100.61 41.59 1.17 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.592 0.234 . . . . 0.0 111.15 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.477 ' CA ' ' HG2' ' A' ' 257' ' ' PRO . . . -120.85 172.11 15.0 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.992 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.697 ' O ' HG13 ' A' ' 259' ' ' VAL . 0.6 OUTLIER -94.46 138.38 32.46 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 175.085 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.611 ' HA ' ' CG2' ' A' ' 259' ' ' VAL . 1.3 pp -83.62 109.56 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 119.105 0.866 . . . . 0.0 112.226 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.454 ' HA ' ' HE2' ' A' ' 330' ' ' MET . 0.0 OUTLIER -44.14 98.48 0.18 Allowed Pre-proline 0 C--N 1.344 0.348 0 CA-C-O 120.791 0.329 . . . . 0.0 110.802 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.648 ' HG2' ' CE1' ' A' ' 176' ' ' TYR . 32.5 Cg_exo -60.79 -42.48 38.08 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.002 2.468 . . . . 0.0 112.045 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 331' ' ' PRO . 3.0 t30 86.34 93.08 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.611 HD12 ' H ' ' A' ' 336' ' ' MET . 1.9 pp -133.82 146.69 61.24 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 118.457 0.571 . . . . 0.0 110.833 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.64 -48.19 16.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.782 2.321 . . . . 0.0 113.319 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.445 ' HB2' HD13 ' A' ' 333' ' ' ILE . 4.0 mp0 -54.2 -21.43 8.9 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.611 ' H ' HD12 ' A' ' 333' ' ' ILE . 12.5 mtt -45.49 -35.63 3.95 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.892 0.315 . . . . 0.0 111.459 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 m -58.29 -34.17 70.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 110.482 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.49 82.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.065 0.459 . . . . 0.0 111.709 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.76 ' O ' HG12 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -78.4 -55.69 5.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.614 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -44.67 -45.14 9.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.327 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 0.465 ' O ' HG23 ' A' ' 345' ' ' THR . 8.8 m-85 -76.01 -43.47 44.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.27 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.49 90.86 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.878 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.9 p -76.85 -29.92 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.555 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -46.76 57.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.653 ' O ' HG22 ' A' ' 348' ' ' ILE . 29.9 p -62.77 -57.82 9.6 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.79 -38.87 4.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.63 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 343' ' ' VAL . 24.8 t -60.76 -57.2 13.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 345' ' ' THR . 3.5 tt -60.06 -27.85 39.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.8 OUTLIER -63.84 -30.13 71.25 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 355' ' ' GLN . . . -75.52 -46.14 33.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -84.18 -9.8 58.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 348' ' ' ILE . 86.7 p -97.8 -49.76 4.69 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 147.52 -2.92 0.82 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 117.923 -2.084 . . . . 0.0 117.404 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.74 34.3 4.66 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 115.328 -2.549 . . . . 0.0 115.818 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.595 ' C ' ' HB2' ' A' ' 360' ' ' ALA . 1.0 OUTLIER -72.12 -130.01 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 129.855 3.262 . . . . 0.0 106.476 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.76 ' OG1' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER 153.12 86.57 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.249 1 N-CA-C 94.539 -6.097 . . . . 0.0 94.539 177.091 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.565 ' C ' ' O ' ' A' ' 356' ' ' THR . 1.3 p -40.26 -60.72 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.46 0 CA-C-N 122.833 2.56 . . . . 0.0 112.491 -166.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.473 ' H ' HG13 ' A' ' 357' ' ' VAL . 35.8 t0 -72.9 -44.48 61.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.48 -38.92 62.76 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.02 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.76 ' HB2' ' OG1' ' A' ' 356' ' ' THR . . . -62.18 -50.34 72.19 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.834 HD11 HD13 ' A' ' 192' ' ' LEU . 13.3 mt -72.25 -36.27 69.02 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.564 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -56.07 15.17 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.254 1.026 . . . . 0.0 110.059 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 366' ' ' THR . 13.5 t0 -62.63 -36.01 81.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.522 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -49.78 -43.07 48.05 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' A' ' 181' ' ' VAL . 0.2 OUTLIER -63.33 -43.16 98.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.359 177.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 363' ' ' ASP . 23.6 m -50.46 -42.58 54.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.322 0.582 . . . . 0.0 110.193 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -60.17 3.49 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.098 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.962 ' CD1' HG21 ' A' ' 181' ' ' VAL . 17.8 pt -58.4 -27.01 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.993 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.71 ' CG2' HG22 ' A' ' 181' ' ' VAL . 77.4 p -118.26 48.26 1.45 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.825 0.345 . . . . 0.0 110.513 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.3 mttm . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.664 0.269 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.95 103.63 5.44 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.907 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -120.04 146.37 45.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.32 179.81 6.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -137.07 47.56 0.95 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.413 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -149.6 155.34 40.11 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -152.12 117.64 5.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 58' ' ' ASP . 47.6 t -111.61 135.94 49.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.127 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.993 HG23 HG13 ' A' ' 37' ' ' VAL . 11.7 tt -132.3 127.45 57.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.329 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.712 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -103.53 126.77 50.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.407 178.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.896 HD13 ' HB3' ' A' ' 61' ' ' PHE . 4.6 mm -146.35 139.19 20.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 12' ' ' ASN . 2.0 p-10 -112.84 39.79 2.44 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.816 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.47 -11.43 35.86 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.636 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.9 t70 65.92 68.82 0.45 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.15 0.475 . . . . 0.0 110.395 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 162.64 -172.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.167 0.508 . . . . 0.0 111.74 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.06 22.73 67.84 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 116.26 1.264 . . . . 0.0 116.26 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -35.33 33.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.972 0.886 . . . . 0.0 111.205 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 11.3 t30 -65.54 -52.57 51.49 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 111.786 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.919 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.61 -48.96 26.52 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.83 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.763 ' CD1' HG21 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -59.5 -50.51 73.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.904 0.852 . . . . 0.0 110.331 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.97 -37.87 87.1 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 56.7 mt-10 -66.28 -36.84 84.01 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.46 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 19' ' ' GLY . 41.0 t -68.03 -61.61 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.96 -0.462 . . . . 0.0 110.46 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . -49.22 -35.16 19.28 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.288 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -50.14 67.42 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 122.515 1.15 . . . . 0.0 108.479 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -52.1 -43.21 63.8 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.32 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.783 ' HB3' HD13 ' A' ' 33' ' ' ILE . 1.5 m-30 -65.77 -29.71 70.25 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.762 0.791 . . . . 0.0 111.013 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.797 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 1.1 tm-20 -71.14 -52.54 18.69 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.029 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -52.36 -28.42 19.42 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 125.159 1.537 . . . . 0.0 111.245 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.78 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -86.07 -37.5 18.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.188 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.78 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 3.5 t 160.0 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.801 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.75 38.55 0.02 OUTLIER Glycine 0 N--CA 1.465 0.581 0 C-N-CA 114.712 -3.613 . . . . 0.0 119.318 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.801 HD12 ' C ' ' A' ' 32' ' ' GLY . 1.6 mp -139.92 134.98 37.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 121.576 2.688 . . . . 0.0 115.422 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -140.89 104.76 4.75 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.763 HG21 ' CD1' ' A' ' 20' ' ' LEU . 9.4 p -103.7 134.1 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.473 ' OG1' HG22 ' A' ' 8' ' ' VAL . 34.5 p -118.33 146.82 44.07 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.136 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.993 HG13 HG23 ' A' ' 9' ' ' ILE . 9.5 t -130.9 120.79 48.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.517 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 30.8 tt0 -112.99 144.44 42.57 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -131.79 73.9 78.2 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.724 0.297 . . . . 0.0 111.236 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.786 ' HD2' HD12 ' A' ' 43' ' ' LEU . 43.0 Cg_endo -89.98 -173.75 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.057 2.505 . . . . 0.0 112.82 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -96.01 -40.31 9.33 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -85.38 0.35 52.42 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.619 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.786 HD12 ' HD2' ' A' ' 40' ' ' PRO . 4.9 tt -21.57 -45.97 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 1.062 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 1.5 pp20? -68.68 -54.16 17.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.399 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 3.5 tt0 -69.66 -41.22 75.83 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.055 0.455 . . . . 0.0 109.797 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' O ' HG13 ' A' ' 50' ' ' VAL . 9.5 mtpt -56.28 -56.24 23.49 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.011 0.91 . . . . 0.0 109.834 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.612 ' CG ' HG12 ' A' ' 60' ' ' ILE . 1.3 t80 -44.15 -61.26 2.14 Favored Pre-proline 0 C--N 1.349 0.556 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.127 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 1.062 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 37.0 Cg_exo -61.5 -25.36 79.55 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 121.347 1.365 . . . . 0.0 113.341 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -81.58 -37.1 28.22 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 122.143 0.973 . . . . 0.0 111.034 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 46' ' ' LYS . 19.2 m -77.28 -40.0 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.59 0 CA-C-O 122.001 0.905 . . . . 0.0 109.797 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.78 -37.98 32.26 Favored 'General case' 0 C--N 1.374 1.666 0 C-N-CA 126.074 1.75 . . . . 0.0 110.999 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.25 -40.64 23.45 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-N 114.144 -1.389 . . . . 0.0 113.519 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -63.22 1.15 Allowed 'General case' 0 C--N 1.346 0.429 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.015 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.08 69.39 0.05 OUTLIER Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.216 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -96.37 -64.94 1.0 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.8 -120.78 5.58 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.661 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 72.4 Cg_exo -49.83 109.56 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.187 1.925 . . . . 0.0 110.978 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 15.6 t0 159.27 113.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.608 0.363 . . . . 0.0 110.77 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 265' ' ' GLY . 0.7 OUTLIER -98.5 173.24 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.957 -177.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.815 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -131.06 130.08 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.697 -177.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.896 ' HB3' HD13 ' A' ' 11' ' ' ILE . 70.2 t80 -121.8 112.21 18.08 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -166.84 161.94 15.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HA ' HD23 ' A' ' 262' ' ' LEU . . . -34.95 151.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.791 ' HB3' HG23 ' A' ' 261' ' ' VAL . 2.7 t60 -77.26 -28.94 53.69 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD2' ' HE1' ' A' ' 330' ' ' MET . 33.5 m-20 -47.37 -59.29 3.31 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.6 mtp85 -78.51 -26.95 45.99 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.712 -0.617 . . . . 0.0 109.648 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.946 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.64 -28.69 70.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -61.97 -58.74 11.47 Favored Glycine 0 CA--C 1.49 -1.495 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.29 -60.43 8.84 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 111.848 -2.176 . . . . 0.0 111.598 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.642 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 22.2 m-85 -48.81 -37.56 19.62 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.007 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . . . -56.5 -38.95 72.47 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.338 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -78.51 -56.3 4.54 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.342 -0.224 . . . . 0.0 111.556 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 m -113.91 -27.19 7.83 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.642 ' HA3' ' HA ' ' A' ' 70' ' ' TYR . . . -63.41 -89.7 0.03 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.861 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.094 ' C ' ' HB2' ' A' ' 268' ' ' ALA . 0.2 OUTLIER -179.02 63.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.007 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -116.36 140.11 49.68 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 173.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.959 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . -90.33 88.13 7.08 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.763 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HA ' ' CG1' ' A' ' 104' ' ' ILE . 1.2 mt-10 -47.36 100.09 0.02 OUTLIER 'General case' 0 C--O 1.23 0.076 0 CA-C-O 120.821 0.343 . . . . 0.0 110.434 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 104' ' ' ILE . 4.4 mt -47.66 159.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.554 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.586 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -88.26 175.15 4.37 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 80' ' ' THR . 76.1 Cg_endo -79.76 133.56 10.38 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.344 2.029 . . . . 0.0 113.399 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.71 -170.11 2.15 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.809 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 -78.18 0.59 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.237 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.03 -23.02 67.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -62.12 -59.31 5.24 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.77 0.319 . . . . 0.0 110.236 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -77.08 -28.43 54.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.71 -10.84 59.67 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -92.26 -18.19 23.75 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.754 HD22 ' CD1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -90.59 -176.84 4.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.277 0.49 . . . . 0.0 111.297 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.557 ' CB ' ' CZ3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -94.49 165.72 16.81 Favored Pre-proline 0 C--N 1.341 0.238 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.581 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 6.3 Cg_exo -75.4 -24.09 12.53 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.826 2.351 . . . . 0.0 115.248 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CE1' ' NE2' ' A' ' 325' ' ' GLN . 4.2 m-85 -87.31 -63.5 1.3 Allowed 'General case' 0 C--O 1.245 0.832 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.925 HG21 HG21 ' A' ' 302' ' ' VAL . 0.2 OUTLIER -63.19 -24.68 67.99 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.02 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.754 ' CD1' HD22 ' A' ' 89' ' ' LEU . 5.9 m-90 -93.75 -24.31 17.86 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.48 0.712 . . . . 0.0 111.345 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 8.1 t0 -73.63 -23.53 59.89 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.653 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.641 ' HB3' HG11 ' A' ' 261' ' ' VAL . . . -62.91 -42.95 99.96 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.904 HG23 HG11 ' A' ' 261' ' ' VAL . 44.5 t -108.62 54.13 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . 0.9 OUTLIER -130.85 140.28 50.23 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.03 -0.419 . . . . 0.0 110.786 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 101' ' ' GLY . 57.0 m-85 -112.34 174.72 5.75 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -48.05 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 56.16 38.14 75.65 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.268 -0.968 . . . . 0.0 110.752 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 -177.27 5.5 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 97' ' ' VAL . 0.7 OUTLIER 168.34 130.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.913 ' CD1' HD12 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -115.67 38.86 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.426 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 165.22 175.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.767 ' CE1' ' HB3' ' A' ' 264' ' ' ALA . 5.3 p90 -117.51 133.41 23.26 Favored Pre-proline 0 C--N 1.343 0.288 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.985 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.855 ' O ' HD13 ' A' ' 108' ' ' ILE . 96.0 Cg_endo -79.37 149.76 21.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.433 2.088 . . . . 0.0 113.315 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 107' ' ' PRO . 1.3 mm -149.32 38.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.009 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.913 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 177.33 124.65 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.399 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.6 HG22 HG22 ' A' ' 320' ' ' THR . 4.1 p -107.01 114.99 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.325 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 229' ' ' PRO . 18.6 mt-10 -99.36 132.79 44.44 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.641 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -168.3 -174.13 2.18 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.493 1.517 . . . . 0.0 110.077 -167.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.569 HD23 HG13 ' A' ' 226' ' ' ILE . 2.0 tp -146.65 136.98 23.73 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 111.542 -2.572 . . . . 0.0 116.35 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.874 ' O ' HD12 ' A' ' 226' ' ' ILE . 0.2 OUTLIER -131.42 164.74 25.05 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.59 -178.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.497 HD12 ' HD3' ' A' ' 248' ' ' PRO . 0.9 OUTLIER -92.6 132.17 37.09 Favored 'General case' 0 C--N 1.342 0.257 0 O-C-N 121.972 -0.455 . . . . 0.0 110.289 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.792 HD11 ' CD2' ' A' ' 242' ' ' TYR . 19.1 tt -113.88 131.19 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.258 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -104.24 132.64 50.27 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.753 ' CB ' ' HB2' ' A' ' 122' ' ' LEU . 45.8 m-80 -87.29 123.98 32.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.203 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -98.03 -87.98 0.32 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 119' ' ' LYS . 26.4 t0 -19.72 -63.67 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.776 HD12 ' HG ' ' A' ' 122' ' ' LEU . 2.5 pp -125.87 38.9 4.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.776 ' HG ' HD12 ' A' ' 121' ' ' LEU . 90.9 mt -158.41 113.22 1.7 Allowed Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.101 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -92.63 124.17 0.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.196 1.264 . . . . 0.0 111.45 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.575 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 11.9 p-10 -97.47 161.64 25.28 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 81.5 Cg_endo -77.1 167.86 24.25 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.676 2.917 . . . . 0.0 112.315 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.34 -47.94 0.08 OUTLIER 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.084 2.522 . . . . 0.0 113.654 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.663 ' CE ' HG23 ' A' ' 128' ' ' THR . 0.4 OUTLIER -155.63 -10.06 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -178.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.663 HG23 ' CE ' ' A' ' 127' ' ' LYS . 1.4 p -117.2 140.21 49.82 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.218 0.917 . . . . 0.0 113.278 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.604 ' O ' HD12 ' A' ' 132' ' ' ILE . 1.8 m0 -71.14 -27.73 63.77 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.486 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.5 OUTLIER -44.61 -24.0 0.16 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.682 ' HB3' HD12 ' A' ' 135' ' ' LEU . 3.4 mp0 -63.19 -23.3 67.37 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.778 HD13 HD11 ' A' ' 198' ' ' LEU . 5.8 mt -40.52 -59.73 1.86 Allowed Pre-proline 0 N--CA 1.477 0.924 0 CA-C-O 121.11 0.481 . . . . 0.0 112.147 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 4.6 Cg_endo -46.63 -45.39 19.87 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 121.251 1.301 . . . . 0.0 110.701 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.13 -58.91 2.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 131' ' ' GLU . 36.9 mt -67.37 -36.84 82.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.68 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.751 ' HA ' HD12 ' A' ' 139' ' ' LEU . 7.7 t0 -73.43 -41.41 63.27 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 5.2 tttt -48.77 -41.94 34.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.123 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 4.0 tm-20 -67.37 -38.1 84.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.189 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.916 HD13 ' N ' ' A' ' 146' ' ' ALA . 1.2 mt -63.18 -47.96 80.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.87 -44.6 29.55 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.05 -24.25 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.601 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -111.7 -60.56 1.83 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.62 46.76 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 CA-C-O 118.777 -1.013 . . . . 0.0 111.379 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.607 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.1 OUTLIER -157.04 -172.41 4.02 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.939 1.87 . . . . 0.0 111.128 -176.149 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.876 ' C ' HD13 ' A' ' 139' ' ' LEU . 49.3 m -139.82 167.17 22.72 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.916 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -83.57 -30.57 26.91 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.695 HD21 ' CG1' ' A' ' 132' ' ' ILE . 0.8 OUTLIER -137.54 127.94 26.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -176.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.852 ' HB3' HG21 ' A' ' 222' ' ' THR . 0.4 OUTLIER -132.21 137.87 47.74 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.975 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 1.026 ' O ' ' O ' ' A' ' 150' ' ' ASN . 7.1 p90 -171.33 174.72 4.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.53 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 1.026 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -20.45 -169.77 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 150' ' ' ASN . 0.1 OUTLIER -168.64 33.58 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.351 -0.843 . . . . 0.0 110.544 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.455 ' CB ' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER 172.05 33.99 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 169.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.879 ' O ' ' OG1' ' A' ' 157' ' ' THR . 14.1 pt-20 -115.16 152.74 47.03 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 121.125 1.784 . . . . 0.0 114.376 -176.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.815 ' O ' ' N ' ' A' ' 156' ' ' PHE . 5.1 Cg_exo -77.27 -136.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 124.643 3.562 . . . . 0.0 105.044 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 1.189 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 20.1 m-85 40.88 -68.37 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 120.51 1.505 . . . . 0.0 112.991 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.815 ' N ' ' O ' ' A' ' 154' ' ' PRO . 2.2 t80 -88.51 -58.63 2.48 Favored 'General case' 0 C--O 1.26 1.616 0 CA-C-N 118.705 0.684 . . . . 0.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.879 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 7.0 p -60.16 -42.92 95.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 118.276 -1.37 . . . . 0.0 107.854 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.453 ' CE3' ' HA ' ' A' ' 158' ' ' TRP . 0.0 OUTLIER -49.65 -55.75 21.04 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 1.189 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 84.0 Cg_exo -43.7 -47.26 9.81 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.025 2.483 . . . . 0.0 113.493 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.672 HD12 ' OG ' ' A' ' 255' ' ' SER . 4.9 mp -60.84 -56.38 21.91 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.07 0.85 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.669 HG22 ' HA ' ' A' ' 188' ' ' ALA . 3.7 mt -51.73 -23.6 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.388 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.452 ' CB ' ' HB2' ' A' ' 256' ' ' LYS . . . -79.83 -22.4 43.04 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.047 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 253' ' ' GLN . . . -42.03 -55.81 3.04 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.543 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 1.3 m-20 -64.19 -51.89 61.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 119.449 1.022 . . . . 0.0 112.393 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 169.34 26.14 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 117.924 -2.084 . . . . 0.0 117.117 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.59 89.65 0.7 Allowed Glycine 0 CA--C 1.522 0.526 0 CA-C-N 119.157 1.479 . . . . 0.0 112.66 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 27.1 m-85 -75.11 157.75 34.21 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.184 0.492 . . . . 0.0 111.061 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.674 ' HA ' HG13 ' A' ' 183' ' ' VAL . . . -61.82 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 111.352 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.893 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 4.9 m-85 -112.98 171.87 7.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.215 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 1.208 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER -101.21 107.96 19.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.13 115.42 23.7 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.577 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.877 ' O ' ' N ' ' A' ' 174' ' ' GLY . 19.7 mt-10 -136.35 101.53 4.7 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.449 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 53.0 t30 44.28 -64.31 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 123.796 0.685 . . . . 0.0 111.079 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.877 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -71.64 -73.35 0.83 Allowed Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 116.016 -0.538 . . . . 0.0 114.172 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -175.19 158.12 2.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.797 0.799 . . . . 0.0 109.688 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 1.208 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 17.4 p90 -44.37 -35.89 2.59 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.006 1.384 . . . . 0.0 109.068 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.577 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 0.9 OUTLIER 72.92 -79.48 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.778 -2.465 . . . . 0.0 110.839 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.743 HD11 HD13 ' A' ' 368' ' ' ILE . 8.1 tp 168.66 -41.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -8.15 51.93 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 4.6 m-20 -119.72 93.84 4.2 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.357 0.98 . . . . 0.0 109.36 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.495 HG11 ' CZ ' ' A' ' 339' ' ' PHE . 2.6 t -116.33 112.41 39.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -118.48 40.05 2.4 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.745 -1.217 . . . . 0.0 113.553 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.708 ' O ' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -79.97 -47.52 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -81.43 57.26 3.21 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.149 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -102.06 179.52 4.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.244 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.09 -30.49 36.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.486 0.66 . . . . 0.0 111.559 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.543 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -74.71 -40.69 36.83 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.39 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -59.69 -48.93 79.74 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -59.62 -60.27 4.11 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.551 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.38 -40.69 50.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.972 0.891 . . . . 0.0 112.004 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -64.86 -60.61 6.69 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.431 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 196' ' ' VAL . 5.6 tp -58.97 -25.79 63.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 3.1 m -61.94 -49.56 75.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.448 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 1.3 p90 -61.28 -35.52 77.55 Favored 'General case' 0 C--N 1.345 0.413 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.88 -46.84 83.09 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 192' ' ' LEU . 44.8 t -57.78 -31.42 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.454 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -45.72 89.35 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.725 0.774 . . . . 0.0 110.841 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.778 HD11 HD13 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -57.85 -54.37 47.63 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.903 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.667 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 10.8 tt -65.98 -35.13 74.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.387 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.07 -38.58 70.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.148 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -113.03 -34.85 5.59 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 120.785 3.624 . . . . 0.0 120.785 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.72 -70.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.514 ' NE2' HD11 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -47.8 -37.11 12.88 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.22 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.1 mtp 61.68 -77.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 203' ' ' HIS . 4.9 t-20 -86.38 -178.75 6.53 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.667 ' HB2' ' CD1' ' A' ' 199' ' ' ILE . . . -155.24 36.44 0.38 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -97.24 -2.81 41.96 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.762 HG22 ' HB2' ' A' ' 213' ' ' ALA . 29.5 m -55.2 118.98 4.83 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.53 -174.28 4.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -70.12 -45.45 66.86 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.69 -33.63 66.63 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.829 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.686 HG22 HG23 ' A' ' 208' ' ' THR . 1.4 mp -77.38 -48.71 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.881 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.762 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -58.1 -32.41 68.07 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.534 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 2.5 tp10 -60.58 -46.3 90.73 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.16 -36.11 74.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.641 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.13 -57.79 11.31 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -61.12 -28.35 69.04 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -53.45 -45.49 69.51 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -23.96 58.96 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.89 53.63 22.23 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.404 -0.817 . . . . 0.0 115.009 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -109.33 37.01 2.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.516 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.852 HG21 ' HB3' ' A' ' 148' ' ' MET . 14.3 t -140.33 140.02 35.53 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.736 ' HA ' HD13 ' A' ' 122' ' ' LEU . . . -104.11 38.53 1.83 Allowed 'General case' 0 C--N 1.349 0.559 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -176.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.613 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 3.0 tmm? 167.69 137.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.597 HG23 ' HB3' ' A' ' 149' ' ' PHE . 89.1 m -147.78 159.92 43.3 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.674 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.874 HD12 ' O ' ' A' ' 114' ' ' SER . 2.3 tp -115.68 112.13 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 232' ' ' TRP . 1.7 p30 -148.07 165.01 32.09 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.877 -0.514 . . . . 0.0 112.152 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 113' ' ' LEU . . . -160.23 -177.75 33.61 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 119.905 -1.14 . . . . 0.0 111.092 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 36.7 Cg_exo -61.93 69.73 0.11 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.225 1.95 . . . . 0.0 111.979 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.86 ' CZ3' ' HB2' ' A' ' 231' ' ' ALA . 9.2 t90 -157.93 -59.6 0.08 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.86 ' HB2' ' CZ3' ' A' ' 230' ' ' TRP . . . -89.69 -34.68 16.15 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.777 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.501 ' CD1' ' HB2' ' A' ' 227' ' ' ASN . 0.3 OUTLIER -124.56 79.93 1.8 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.716 0.293 . . . . 0.0 111.287 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.3 m -71.04 -43.89 66.93 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.316 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -100.5 77.22 1.9 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.476 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 tt -45.7 136.94 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.605 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.09 -172.93 3.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.594 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.49 78.42 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.658 0.266 . . . . 0.0 110.937 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.0 m -113.14 52.58 0.79 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 61.63 112.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.705 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.2 m -52.9 -40.11 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.533 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -83.36 104.3 13.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.716 0.293 . . . . 0.0 110.727 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.792 ' CD2' HD11 ' A' ' 116' ' ' ILE . 47.7 p90 -148.55 142.54 25.87 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.336 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -85.53 162.7 36.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.075 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.8 106.49 13.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.911 0.356 . . . . 0.0 111.524 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.56 166.9 16.43 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -172.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.8 154.21 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.169 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.849 HD12 HD11 ' A' ' 226' ' ' ILE . 0.1 OUTLIER -58.23 156.17 22.51 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 120.327 1.421 . . . . 0.0 110.256 -178.29 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.497 ' HD3' HD12 ' A' ' 115' ' ' LEU . 72.2 Cg_endo -79.44 -165.97 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.532 2.155 . . . . 0.0 112.466 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 40.8 p -106.3 168.16 9.34 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.308 0.575 . . . . 0.0 111.444 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' A' ' 253' ' ' GLN . 0.5 OUTLIER -166.05 126.44 1.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.851 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 36.93 31.11 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.992 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.447 ' O ' ' NE2' ' A' ' 253' ' ' GLN . . . 81.36 27.49 48.05 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.612 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.476 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 60.5 mm-40 -156.6 151.17 20.34 Favored Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 117.479 0.639 . . . . 0.0 112.661 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -91.89 138.88 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.392 2.728 . . . . 0.0 112.093 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.672 ' OG ' HD12 ' A' ' 160' ' ' LEU . 52.6 m -57.85 142.7 45.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.201 0.524 . . . . 0.0 112.176 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -86.16 108.91 19.24 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.981 -178.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.46 ' HD2' ' HA3' ' A' ' 327' ' ' GLY . 4.8 Cg_exo -79.82 147.2 19.12 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.984 2.456 . . . . 0.0 112.501 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 1.1 m-85 -79.78 136.51 36.75 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.653 HG21 HG13 ' A' ' 329' ' ' ILE . 27.2 t -92.09 124.46 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -117.59 125.78 6.64 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.196 -1.478 . . . . 0.0 114.764 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.904 HG11 HG23 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.89 103.5 13.57 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.913 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 69.7 mt -86.11 103.84 15.14 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.563 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.641 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 68.9 p -133.05 139.68 47.31 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 118.142 2.645 . . . . 0.0 118.142 -172.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.873 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . . . -95.06 113.36 25.05 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.677 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -102.55 163.26 16.51 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.367 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.624 ' O ' ' O ' ' A' ' 267' ' ' ASN . 0.8 OUTLIER -89.78 134.49 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 176.028 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.959 ' O ' ' N ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -13.52 -167.38 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.956 1 C-N-CA 132.156 4.183 . . . . 0.0 117.165 -171.525 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 1.094 ' HB2' ' C ' ' A' ' 75' ' ' LEU . . . -107.39 119.91 40.71 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 110.651 -2.977 . . . . 0.0 104.143 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 268' ' ' ALA . . . 104.94 -65.8 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.217 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 269' ' ' ALA . 2.4 p 155.46 103.07 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.476 ' O ' ' C ' ' A' ' 272' ' ' ASN . 15.5 Cg_endo -99.38 102.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.457 2.772 . . . . 0.0 113.446 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 271' ' ' PRO . 91.1 m-20 26.76 74.19 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.946 0.403 . . . . 0.0 111.646 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -64.67 -31.61 72.9 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 277' ' ' LYS . 0.7 OUTLIER -53.48 -57.5 10.44 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.875 -0.515 . . . . 0.0 112.366 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.91 -53.48 49.71 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.59 94.15 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -63.29 -40.59 97.8 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 -54.15 7.19 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.553 ' HE2' HG12 ' A' ' 23' ' ' VAL . 8.8 t80 -55.52 -58.72 6.61 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.714 HD11 HD22 ' A' ' 284' ' ' LEU . 0.9 OUTLIER -48.71 -43.17 37.02 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.776 0.798 . . . . 0.0 111.065 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -74.27 -34.56 63.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.095 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -93.6 -15.89 24.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.622 ' CZ ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -112.5 -60.2 1.9 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.463 0.574 . . . . 0.0 110.594 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.743 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.1 tp -43.12 -33.01 0.79 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.862 0.755 . . . . 0.0 109.798 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 285' ' ' LEU . 6.5 mp -86.29 42.24 0.98 Allowed 'General case' 0 C--N 1.342 0.239 0 CA-C-O 120.92 0.391 . . . . 0.0 110.481 178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 283' ' ' TYR . 12.9 p -144.47 154.58 43.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 1.7 m-20 -63.8 -13.98 49.0 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.586 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 2.0 tp10 -77.86 -48.24 16.92 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 121.719 -0.613 . . . . 0.0 110.986 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.669 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -75.66 -61.81 2.84 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.627 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER -57.39 -47.74 80.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.0 OUTLIER -79.42 -26.39 41.85 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -68.36 -38.41 81.4 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.823 HG12 ' CD ' ' A' ' 297' ' ' LYS . 61.3 t -66.07 -61.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.645 ' HB2' ' CE1' ' A' ' 307' ' ' TYR . 57.8 t30 -33.53 -52.33 0.39 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.738 1.215 . . . . 0.0 112.516 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -58.41 -49.62 76.62 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER -57.19 -45.7 83.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.429 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.823 ' CD ' HG12 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -47.57 169.06 0.13 Allowed Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.28 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.407 ' HD3' ' HG3' ' A' ' 297' ' ' LYS . 11.0 Cg_endo -90.67 -72.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.549 2.833 . . . . 0.0 112.853 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.616 HD11 ' CG ' ' A' ' 314' ' ' ASP . 0.4 OUTLIER -156.31 -69.14 0.11 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.644 0.259 . . . . 0.0 110.482 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.663 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . -79.9 139.25 21.15 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . 159.98 -174.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.242 0.521 . . . . 0.0 110.861 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.925 HG21 HG21 ' A' ' 93' ' ' THR . 0.3 OUTLIER -149.91 175.07 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.421 179.419 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.964 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . 172.02 70.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.709 ' HB3' HD21 ' A' ' 290' ' ' LEU . 3.1 tp 82.26 142.56 0.07 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -48.07 -55.95 8.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -177.154 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.7 t -53.67 -48.93 69.0 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.879 0.847 . . . . 0.0 111.549 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.964 ' CD2' ' HB3' ' A' ' 303' ' ' ALA . 33.0 t80 -70.46 -19.66 62.94 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.282 176.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -65.14 -38.15 89.68 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.276 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' A' ' 308' ' ' GLU . 3.4 tt0 -66.19 -54.62 23.01 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.838 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.4 -51.23 70.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.244 0.545 . . . . 0.0 109.614 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.589 HD22 HG13 ' A' ' 317' ' ' ILE . 0.2 OUTLIER -59.79 -41.87 92.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.628 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 313' ' ' LYS . . . -47.22 -29.83 2.61 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 312' ' ' ALA . 5.2 ttpt -31.16 -42.96 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.637 0.256 . . . . 0.0 111.506 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.616 ' CG ' HD11 ' A' ' 299' ' ' LEU . 1.1 t70 -76.34 135.82 69.02 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.384 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 31.1 Cg_exo -59.26 -20.66 56.39 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.529 2.153 . . . . 0.0 113.575 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.553 ' O ' ' OG1' ' A' ' 320' ' ' THR . 7.3 mmt180 -61.42 -58.91 6.28 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.589 HG13 HD22 ' A' ' 311' ' ' LEU . 3.3 mm -49.3 -55.35 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.48 -45.4 13.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.791 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.34 -35.64 63.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.397 0.618 . . . . 0.0 110.267 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.641 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -59.44 -42.69 92.49 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.249 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.45 ' CE ' HG22 ' A' ' 317' ' ' ILE . 60.1 mtm -76.31 -42.01 46.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.143 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -46.96 60.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.446 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.28 -41.96 32.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.486 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.508 ' O ' HG22 ' A' ' 259' ' ' VAL . . . -49.54 -36.7 24.35 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.422 ' NE2' ' CE1' ' A' ' 92' ' ' PHE . 2.1 tt0 -85.28 -34.03 22.0 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -93.41 60.68 3.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 111.028 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.46 ' HA3' ' HD2' ' A' ' 257' ' ' PRO . . . -160.67 -139.57 2.69 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.338 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -128.84 117.27 20.77 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.653 HG13 HG21 ' A' ' 259' ' ' VAL . 34.5 mt -83.88 124.09 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.51 ' O ' ' O ' ' A' ' 331' ' ' PRO . 10.9 mtm -42.53 132.43 2.84 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.855 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 176' ' ' TYR . 75.8 Cg_exo -50.28 -156.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.052 2.502 . . . . 0.0 112.605 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.475 ' CG ' ' HH ' ' A' ' 176' ' ' TYR . 8.8 p-10 -146.65 40.32 1.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.954 0.407 . . . . 0.0 111.158 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 335' ' ' GLN . 1.8 pp -138.2 160.4 64.27 Favored Pre-proline 0 C--N 1.34 0.185 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.714 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.11 -13.56 23.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.626 2.217 . . . . 0.0 113.515 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.698 ' HB2' HD13 ' A' ' 333' ' ' ILE . 0.9 OUTLIER -60.56 -21.17 62.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.17 -34.58 2.78 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.144 -0.347 . . . . 0.0 111.827 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.43 -35.31 71.9 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.834 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.429 ' HB3' ' CG1' ' A' ' 368' ' ' ILE . . . -58.09 -36.24 72.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.919 0.39 . . . . 0.0 111.723 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.564 ' CZ ' HG21 ' A' ' 183' ' ' VAL . 0.2 OUTLIER -78.39 -55.75 4.99 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.79 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -43.42 -45.28 6.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.061 0.458 . . . . 0.0 110.177 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 0.476 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 34.7 t80 -70.72 -41.08 72.37 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.662 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.78 ' HB1' HD22 ' A' ' 361' ' ' LEU . . . -69.68 -46.05 66.94 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.813 ' O ' HG23 ' A' ' 347' ' ' VAL . 31.7 t -70.51 -35.03 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.15 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 341' ' ' TYR . 0.0 OUTLIER -69.73 -36.73 76.12 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 349' ' ' ASN . 95.0 m -66.71 -58.52 4.94 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.969 ' HB1' HG23 ' A' ' 357' ' ' VAL . . . -49.58 -50.39 42.69 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.394 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 343' ' ' VAL . 63.0 t -50.99 -56.93 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 24.8 mt -59.03 -27.39 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.627 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.6 OUTLIER -64.47 -38.68 91.87 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.297 0.57 . . . . 0.0 111.242 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -80.13 -26.58 39.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.359 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.18 -16.88 51.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 2.9 p -111.26 -6.68 14.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.561 1.073 . . . . 0.0 113.376 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 85.61 -2.65 87.88 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.604 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -88.58 35.18 0.76 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 115.808 -2.044 . . . . 0.0 107.605 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -70.82 -174.53 0.94 Allowed 'General case' 0 CA--C 1.547 0.838 1 N-CA-C 125.303 5.297 . . . . 0.0 125.303 -158.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.421 ' N ' ' OD1' ' A' ' 349' ' ' ASN . 4.5 t 159.84 44.76 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 110.365 -3.107 . . . . 0.0 104.252 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.969 HG23 ' HB1' ' A' ' 346' ' ' ALA . 7.7 p -72.44 -56.4 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.516 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 1.6 m-20 -48.78 -45.06 39.49 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.563 0.697 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.19 -55.78 5.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.938 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -52.37 -44.71 65.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 122.413 1.101 . . . . 0.0 112.65 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.78 HD22 ' HB1' ' A' ' 342' ' ' ALA . 1.7 tm? -77.28 -41.56 40.38 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.052 -1.885 . . . . 0.0 110.594 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.607 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 5.2 tttt -60.19 -56.42 21.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.083 0.944 . . . . 0.0 109.129 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -53.05 -37.21 61.4 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.596 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 361' ' ' LEU . . . -49.96 -48.12 52.25 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.524 ' HA ' HG22 ' A' ' 368' ' ' ILE . 41.5 tt0 -54.3 -44.89 72.37 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.5 m -57.16 -43.33 82.43 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.495 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -71.2 -57.47 4.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.025 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 368' ' ' ILE . 0.0 OUTLIER -54.45 -33.21 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.265 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.538 HG23 HG23 ' A' ' 368' ' ' ILE . 41.2 p -94.86 -15.91 23.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.651 0.262 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.56 146.66 44.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.786 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.27 152.85 22.98 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.949 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.657 ' CG ' HD12 ' A' ' 275' ' ' LEU . 2.4 tm-20 -142.93 136.86 29.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.954 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.82 -101.72 0.65 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.28 -170.9 1.94 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.319 -0.94 . . . . 0.0 110.01 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.928 HD12 HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -119.59 123.25 43.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.922 HG11 ' HG3' ' A' ' 57' ' ' PRO . 1.7 t -121.88 111.94 32.89 Favored 'Isoleucine or valine' 0 C--O 1.26 1.62 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.71 ' CG1' HD12 ' A' ' 59' ' ' ILE . 4.0 mt -133.52 126.79 52.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.544 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.686 ' HD1' HG22 ' A' ' 60' ' ' ILE . 1.9 p-90 -98.72 135.29 40.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.611 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 11' ' ' ILE . 1.5 mp -154.27 137.59 7.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 O-C-N 122.102 -0.374 . . . . 0.0 110.763 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -120.73 125.74 48.39 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.782 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.44 29.37 14.31 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.882 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 58.8 t0 -102.03 -80.23 0.51 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.166 0.483 . . . . 0.0 110.436 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 6.2 mttm 101.42 -5.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.898 0.879 . . . . 0.0 111.162 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.667 ' O ' HD12 ' A' ' 20' ' ' LEU . . . -76.38 64.76 2.82 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 115.359 0.904 . . . . 0.0 115.359 -176.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -78.72 -32.49 46.84 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.348 -0.426 . . . . 0.0 111.284 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 3.3 t-20 -68.47 -46.79 68.81 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 111.347 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.692 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -70.67 -47.52 40.48 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.983 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.036 HD13 HG11 ' A' ' 37' ' ' VAL . 1.2 mt -59.56 -50.78 72.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.434 0.617 . . . . 0.0 110.336 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -68.76 -39.27 80.33 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.516 ' HG2' ' HA2' ' A' ' 19' ' ' GLY . 11.0 pt-20 -66.21 -35.91 81.66 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.244 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 19' ' ' GLY . 11.3 m -68.63 -60.34 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.464 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.614 ' HA3' HG13 ' A' ' 35' ' ' VAL . . . -49.54 -34.19 19.49 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.736 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -57.77 -50.14 74.26 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 122.442 1.115 . . . . 0.0 109.005 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.67 -43.59 62.77 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 112.977 -1.92 . . . . 0.0 109.787 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.749 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -66.36 -26.05 67.09 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.096 -1.003 . . . . 0.0 111.151 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.748 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -73.15 -52.01 15.78 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.304 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -52.76 -28.01 20.41 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 124.683 1.24 . . . . 0.0 110.478 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.842 ' O ' HG23 ' A' ' 31' ' ' THR . 1.2 m-20 -84.64 -37.93 20.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 117.634 -1.174 . . . . 0.0 108.819 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.89 37.74 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 171.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.35 38.62 0.02 OUTLIER Glycine 0 N--CA 1.465 0.633 0 C-N-CA 114.796 -3.573 . . . . 0.0 119.545 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.928 HD12 HD12 ' A' ' 7' ' ' LEU . 22.3 mm -140.05 138.73 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 122.157 2.979 . . . . 0.0 116.956 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -142.36 104.4 4.42 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.965 HG21 ' O ' ' A' ' 20' ' ' LEU . 28.6 m -89.35 130.34 38.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -174.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 p -116.51 140.47 49.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.135 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.036 HG11 HD13 ' A' ' 20' ' ' LEU . 6.2 m -130.05 119.68 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.522 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -110.43 134.82 51.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.63 71.26 3.55 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 120.829 0.347 . . . . 0.0 111.617 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.873 ' CG ' HD13 ' A' ' 43' ' ' LEU . 39.1 Cg_endo -95.12 -160.95 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.931 3.088 . . . . 0.0 112.72 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.91 -62.63 1.11 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 0.15 34.45 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.873 HD13 ' CG ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -56.8 -28.37 61.29 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.218 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 1.047 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -47.32 -54.26 11.5 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.547 -0.721 . . . . 0.0 110.25 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mt-10 -71.85 -50.16 31.93 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.279 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 50' ' ' VAL . 32.7 mtmt -59.71 -56.36 22.87 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.122 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.688 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 7.2 t80 -44.38 -57.92 5.8 Favored Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 1.047 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 25.6 Cg_exo -66.03 -35.91 32.15 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 120.977 1.118 . . . . 0.0 114.251 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 17.0 mt-30 -66.63 -52.24 47.24 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 123.038 1.399 . . . . 0.0 107.549 175.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 46' ' ' LYS . 14.7 m -61.22 -21.85 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.555 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 48' ' ' PRO . . . -59.84 -29.47 68.29 Favored 'General case' 0 C--N 1.395 2.563 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.644 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -82.16 -24.59 34.93 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 124.991 1.316 . . . . 0.0 112.008 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.5 m -47.89 -30.96 4.57 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 167.93 -19.09 0.08 OUTLIER Glycine 0 CA--C 1.526 0.724 0 C-N-CA 119.891 -1.147 . . . . 0.0 114.644 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.629 ' O ' ' HB1' ' A' ' 269' ' ' ALA . 1.0 OUTLIER 155.77 -71.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.719 1.26 . . . . 0.0 111.561 179.393 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 40.44 -158.46 0.03 OUTLIER Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.031 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.922 ' HG3' HG11 ' A' ' 8' ' ' VAL . 10.9 Cg_exo -35.81 143.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.887 3.058 . . . . 0.0 112.78 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 59' ' ' ILE . 30.7 m-20 -123.51 35.44 4.85 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 117.478 -1.689 . . . . 0.0 113.877 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.71 HD12 ' CG1' ' A' ' 9' ' ' ILE . 2.8 mt -150.57 127.92 2.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 119.662 1.119 . . . . 0.0 113.692 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.686 HG22 ' HD1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -139.4 123.29 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 118.872 0.76 . . . . 0.0 110.034 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.523 ' O ' ' CZ2' ' A' ' 10' ' ' TRP . 2.6 m-85 -104.62 128.53 52.68 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.13 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -166.0 166.67 17.17 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 119.188 0.904 . . . . 0.0 109.723 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.11 165.99 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 120.479 1.49 . . . . 0.0 110.319 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.858 ' HB3' HG13 ' A' ' 261' ' ' VAL . 12.8 p-80 -77.05 -29.3 55.1 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.477 0.656 . . . . 0.0 112.059 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -58.46 -36.08 73.15 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.425 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -85.43 -35.26 21.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.644 ' CE1' HD22 ' A' ' 76' ' ' LEU . 3.2 t80 -54.85 -32.82 61.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 172.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -58.19 -65.35 3.58 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.32 -41.44 16.46 Favored Glycine 0 C--N 1.355 1.639 0 CA-C-N 113.268 -1.466 . . . . 0.0 110.609 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.57 ' HB3' HD12 ' A' ' 76' ' ' LEU . 5.3 m-85 -59.49 -46.46 88.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.684 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . . . -50.35 -51.32 46.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.843 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -78.25 -27.15 47.49 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.641 ' HB3' HD23 ' A' ' 75' ' ' LEU . 1.7 t -71.63 -17.67 62.25 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.739 ' C ' HD22 ' A' ' 75' ' ' LEU . . . 83.69 37.85 11.34 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.231 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.739 HD22 ' C ' ' A' ' 74' ' ' GLY . 3.6 mm? -121.76 57.15 1.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.941 0.4 . . . . 0.0 111.533 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.829 HD23 ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -179.07 142.01 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.401 0.62 . . . . 0.0 112.127 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.982 ' O ' HG21 ' A' ' 104' ' ' ILE . . . -59.94 176.98 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.527 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' HA ' ' HB ' ' A' ' 104' ' ' ILE . 2.6 tm-20 -139.74 80.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.375 0.27 . . . . 0.0 110.489 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.0 pt -70.99 162.19 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.108 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.92 118.35 69.17 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.875 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.576 ' HB3' HD13 ' A' ' 103' ' ' LEU . 2.7 Cg_endo -79.87 146.79 18.75 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.571 2.181 . . . . 0.0 112.158 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -136.0 163.67 29.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.863 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -49.06 78.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.631 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.73 -23.64 63.36 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.822 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.5 ' CE2' ' CZ2' ' A' ' 94' ' ' TRP . 19.3 t80 -68.74 -58.65 3.91 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.916 0.389 . . . . 0.0 110.352 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -77.12 -24.7 51.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -76.36 -45.24 32.87 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 89' ' ' LEU . 3.9 pttp -51.54 -41.71 61.27 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.495 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.445 ' N ' ' HG3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -103.92 -175.14 2.71 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.6 0.238 . . . . 0.0 110.663 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CG ' ' CE2' ' A' ' 92' ' ' PHE . 0.9 OUTLIER -69.5 131.0 90.19 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.693 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.44 -38.0 82.52 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.515 2.143 . . . . 0.0 112.711 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.452 ' CE2' ' CG ' ' A' ' 90' ' ' TYR . 45.1 p90 -73.22 -43.61 60.97 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 120.549 0.214 . . . . 0.0 111.275 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 302' ' ' VAL . 45.0 m -62.14 -25.42 67.73 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.5 ' CZ2' ' CE2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -92.45 -26.49 17.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.216 0.531 . . . . 0.0 111.202 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -21.29 60.07 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.813 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.644 ' HB1' ' HB ' ' A' ' 261' ' ' VAL . . . -66.08 -50.17 65.04 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.685 0.278 . . . . 0.0 110.722 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.688 HG11 ' HD3' ' A' ' 107' ' ' PRO . 11.7 p -94.7 60.11 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.01 138.83 48.39 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.063 -1.023 . . . . 0.0 109.753 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.684 ' CE1' ' HB3' ' A' ' 71' ' ' ALA . 31.5 t80 -107.64 138.68 43.43 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.344 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -59.11 78.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.811 0.339 . . . . 0.0 110.108 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 133.11 -18.23 4.49 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.36 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.526 ' HD3' ' HB1' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -144.7 123.75 12.83 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.125 0.962 . . . . 0.0 111.843 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.576 HD13 ' HB3' ' A' ' 81' ' ' PRO . 0.5 OUTLIER -105.82 74.68 1.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.982 HG21 ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -129.46 91.3 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 121.668 0.747 . . . . 0.0 112.634 -177.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 159.54 -177.22 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.502 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -136.63 142.86 40.68 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.16 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.688 ' HD3' HG11 ' A' ' 97' ' ' VAL . 84.4 Cg_endo -82.02 156.88 17.77 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.499 2.132 . . . . 0.0 112.437 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.697 HG22 ' H ' ' A' ' 109' ' ' ALA . 28.2 mt -119.44 -135.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.697 ' H ' HG22 ' A' ' 108' ' ' ILE . . . -79.48 157.44 27.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.007 ' CG1' HG11 ' A' ' 302' ' ' VAL . 4.2 m -110.02 114.41 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.817 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -101.9 164.94 11.46 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.154 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.8 146.72 8.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.848 0.832 . . . . 0.0 111.267 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.868 ' CD1' HD21 ' A' ' 247' ' ' LEU . 3.2 pp -79.02 128.06 32.78 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.101 -1.408 . . . . 0.0 107.482 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 227' ' ' ASN . 24.8 p -131.35 165.85 22.55 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.513 HD12 ' CG2' ' A' ' 226' ' ' ILE . 4.3 tp -99.2 135.13 41.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.408 HD13 ' C ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -114.99 133.84 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.296 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.541 ' HE2' HG23 ' A' ' 245' ' ' THR . 12.1 p90 -122.08 142.02 50.79 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.855 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 1.4 t-20 -89.29 126.91 35.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.488 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.34 -3.61 28.5 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.064 -0.398 . . . . 0.0 110.37 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.22 -62.76 1.19 Allowed 'General case' 0 C--N 1.34 0.177 0 CA-C-O 121.252 0.548 . . . . 0.0 110.498 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 39.82 2.31 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.644 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.993 HD13 ' HB1' ' A' ' 223' ' ' ALA . 1.3 tp -131.68 89.72 38.83 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.354 0.597 . . . . 0.0 110.65 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.435 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 81.0 Cg_exo -44.5 162.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.465 2.777 . . . . 0.0 112.571 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 23.0 m-20 -60.12 110.7 3.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 122.449 1.119 . . . . 0.0 111.793 -170.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.9 Cg_endo -69.88 168.31 22.09 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 125.238 3.959 . . . . 0.0 114.14 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.668 ' HD3' HD22 ' A' ' 135' ' ' LEU . 56.9 Cg_endo -92.34 -154.05 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 123.34 2.693 . . . . 0.0 115.501 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -125.52 -91.7 0.52 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 t -46.4 155.53 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.058 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.642 ' CZ2' HD22 ' A' ' 147' ' ' LEU . 10.0 t-105 -69.67 -33.49 72.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 174.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 133' ' ' PRO . 1.9 mm-40 -44.98 -24.17 0.2 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.731 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -72.67 -26.51 61.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.494 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 25.6 mm -40.64 -57.33 3.19 Favored Pre-proline 0 N--CA 1.478 0.974 0 CA-C-O 121.29 0.567 . . . . 0.0 111.982 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 6.0 Cg_endo -48.27 -39.09 34.76 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 N-CA-C 109.399 -1.039 . . . . 0.0 109.399 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.35 -58.56 3.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.668 HD22 ' HD3' ' A' ' 126' ' ' PRO . 0.3 OUTLIER -68.65 -36.34 78.44 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.039 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 132' ' ' ILE . 21.6 t0 -72.85 -40.15 65.95 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -46.82 -47.37 21.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.402 176.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -63.74 -39.6 94.69 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.405 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.833 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -60.81 -49.84 75.87 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -44.52 29.67 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -45.89 -26.3 0.67 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -108.04 -58.57 1.96 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.058 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.8 43.93 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 CA-C-O 118.824 -0.986 . . . . 0.0 111.036 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.512 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 4.0 mttt -155.34 -172.22 4.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.636 1.718 . . . . 0.0 111.086 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.606 ' O ' HD22 ' A' ' 139' ' ' LEU . 47.9 m -142.4 160.71 39.74 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.833 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -75.15 -28.67 60.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.642 HD22 ' CZ2' ' A' ' 129' ' ' TRP . 0.7 OUTLIER -152.6 133.05 13.74 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -176.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.968 ' HB3' HG21 ' A' ' 222' ' ' THR . 7.9 tpt -132.3 140.72 48.7 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.907 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 150' ' ' ASN . 34.8 p90 -172.7 175.21 3.48 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.665 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 149' ' ' PHE . 45.2 m-80 -37.74 170.69 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.683 0.615 . . . . 0.0 110.828 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.569 HD11 ' HB1' ' A' ' 206' ' ' ALA . 2.1 tm? -114.64 -59.66 1.99 Allowed 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.404 ' HB3' ' NH2' ' A' ' 344' ' ' ARG . 2.0 mt-30 -102.75 36.01 2.32 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 116.788 -1.965 . . . . 0.0 114.862 -174.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.662 ' O ' ' HB ' ' A' ' 157' ' ' THR . 4.6 mm-40 -88.3 144.35 33.95 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 121.18 1.809 . . . . 0.0 114.61 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.934 ' O ' ' N ' ' A' ' 156' ' ' PHE . 6.0 Cg_exo -77.71 -135.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.285 1 C-N-CA 125.787 4.325 . . . . 0.0 106.04 176.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 1.149 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 1.2 m-85 27.17 -54.88 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.934 ' N ' ' O ' ' A' ' 154' ' ' PRO . 14.9 m-85 -87.88 -58.8 2.44 Favored 'General case' 0 C--O 1.26 1.625 0 C-N-CA 124.486 1.114 . . . . 0.0 110.761 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 24.1 m -57.24 -44.6 83.99 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.83 ' CE3' HD11 ' A' ' 161' ' ' ILE . 4.8 m95 -52.31 -55.02 35.51 Favored Pre-proline 0 C--N 1.348 0.521 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.534 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 1.149 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 87.5 Cg_exo -43.4 -49.53 7.47 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.387 2.058 . . . . 0.0 114.124 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.708 HD12 HG23 ' A' ' 161' ' ' ILE . 1.5 pp -79.18 -56.95 3.98 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 120.529 -1.357 . . . . 0.0 113.241 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.83 HD11 ' CE3' ' A' ' 158' ' ' TRP . 1.1 pt -61.19 -13.17 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 158' ' ' TRP . . . -124.95 -46.4 1.83 Allowed 'General case' 0 N--CA 1.471 0.622 1 N-CA-C 124.147 4.869 . . . . 0.0 124.147 -178.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.07 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . . . -54.58 49.72 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -176.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 162' ' ' ALA . 10.2 m-20 -122.1 -58.83 1.7 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.727 0.694 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.68 1.68 2.09 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.23 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.12 95.79 1.09 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.104 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -67.08 139.55 57.57 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.026 0.413 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.749 ' HA ' HG22 ' A' ' 183' ' ' VAL . . . -43.6 -74.65 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.742 0.782 . . . . 0.0 111.643 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.632 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 32.3 m-85 -112.33 173.9 6.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.708 ' O ' ' O ' ' A' ' 175' ' ' LYS . 6.3 ttmt -100.68 108.06 19.83 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.949 ' HA ' ' O ' ' A' ' 175' ' ' LYS . 27.5 m-85 -84.05 111.33 19.2 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.134 176.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 173' ' ' ASN . 18.0 mt-10 -104.89 101.17 10.77 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.597 ' C ' ' O ' ' A' ' 172' ' ' GLU . 8.8 m120 34.8 73.52 0.08 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 65.67 70.69 1.04 Allowed Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.171 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.949 ' O ' ' HA ' ' A' ' 171' ' ' TYR . 3.8 tptp -177.67 122.75 0.12 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.522 1.161 . . . . 0.0 112.98 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.632 ' HB2' ' HB3' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -114.63 -19.8 10.96 Favored 'General case' 0 N--CA 1.512 2.653 0 CA-C-O 122.907 1.337 . . . . 0.0 109.14 175.328 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.487 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 6.5 m-20 38.84 -85.8 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 111.523 -2.58 . . . . 0.0 111.725 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.739 HD13 ' HB3' ' A' ' 335' ' ' GLN . 7.3 tp 171.86 -41.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -65.9 -12.7 56.62 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 71.9 m-20 -120.59 93.53 4.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.994 0.816 . . . . 0.0 109.127 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.859 HG11 HD12 ' A' ' 368' ' ' ILE . 32.2 m -115.95 112.55 40.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.69 39.79 2.39 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.736 -1.221 . . . . 0.0 114.065 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.749 HG22 ' HA ' ' A' ' 168' ' ' ALA . 2.1 t -78.27 -43.54 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.524 ' HA ' ' CB ' ' A' ' 188' ' ' ALA . 5.8 p-10 -66.22 57.01 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.458 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 183' ' ' VAL . 0.7 OUTLIER -102.98 -172.34 2.1 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.37 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.696 ' O ' ' HG3' ' A' ' 189' ' ' LYS . . . -38.79 -48.59 1.54 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.244 0.545 . . . . 0.0 112.346 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.13 -32.3 52.89 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-O 118.975 -0.903 . . . . 0.0 113.053 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -60.07 -54.96 39.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.33 1.565 . . . . 0.0 107.301 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -52.64 -39.42 61.77 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.481 ' HB2' ' HD2' ' A' ' 251' ' ' LYS . . . -69.1 -42.31 76.29 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 111.954 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 161' ' ' ILE . . . -56.48 -60.59 8.7 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.711 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.893 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.6 OUTLIER -59.76 -30.93 69.2 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.194 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.5 m -74.94 -53.7 8.53 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.489 ' CD2' ' HA2' ' A' ' 191' ' ' GLY . 0.1 OUTLIER -62.09 -33.62 74.78 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.863 0.364 . . . . 0.0 110.16 178.149 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.92 -48.32 77.04 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 192' ' ' LEU . 76.1 t -56.48 -30.66 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.11 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -46.65 84.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.569 0.699 . . . . 0.0 111.006 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -51.42 68.27 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.151 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.71 HG23 ' O ' ' A' ' 205' ' ' ASN . 46.3 mm -63.41 -45.97 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.686 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.19 -36.71 52.67 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 118.437 -0.792 . . . . 0.0 112.02 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -113.0 -34.61 5.68 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 120.962 3.69 . . . . 0.0 120.962 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -79.41 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.702 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -101.47 -6.01 24.51 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.564 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 8.4 ttt 45.18 35.44 1.72 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.597 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.71 ' O ' HG23 ' A' ' 199' ' ' ILE . 19.8 m-20 -146.52 165.96 27.88 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 151' ' ' LEU . . . -152.35 32.57 0.52 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -99.0 -3.45 34.88 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -55.18 120.27 6.76 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 119.757 -0.777 . . . . 0.0 108.92 178.432 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.63 ' OD2' HD12 ' A' ' 212' ' ' ILE . 8.5 m-20 -94.77 -175.29 3.53 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.158 -0.339 . . . . 0.0 111.621 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -70.71 -45.26 65.27 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.136 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.95 -25.54 48.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.449 0.642 . . . . 0.0 110.771 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.63 HD12 ' OD2' ' A' ' 209' ' ' ASP . 1.7 mt -81.47 -52.01 14.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -51.11 -36.81 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.46 -45.55 86.9 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.26 -39.38 69.73 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.795 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.54 -56.06 25.98 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.97 -28.69 70.26 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -55.79 -41.56 74.27 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.512 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -23.9 59.13 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.12 42.71 58.02 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.445 ' HB3' ' HG3' ' A' ' 144' ' ' LYS . 1.4 mp0 -110.57 37.09 2.86 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.94 1.37 . . . . 0.0 110.794 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.968 HG21 ' HB3' ' A' ' 148' ' ' MET . 8.9 t -139.2 138.62 37.04 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.993 ' HB1' HD13 ' A' ' 122' ' ' LEU . . . -92.93 38.2 1.03 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -177.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 162.4 149.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.412 HG22 ' OD1' ' A' ' 227' ' ' ASN . 87.0 m -147.89 160.05 43.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.137 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 156' ' ' PHE . 2.2 pt -116.5 113.26 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -146.85 165.48 29.6 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.283 -177.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 232' ' ' TRP . . . -79.82 -154.4 9.18 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 119.341 -1.409 . . . . 0.0 113.495 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.71 -50.91 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.816 2.344 . . . . 0.0 114.115 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.456 ' CZ2' ' HB3' ' A' ' 299' ' ' LEU . 12.7 p-90 -135.78 -54.72 0.77 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.11 46.37 2.43 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.413 ' CB ' ' HA3' ' A' ' 228' ' ' GLY . 6.0 t-105 -91.64 -44.4 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.665 0.269 . . . . 0.0 110.432 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -114.42 38.14 3.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.045 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 54.07 87.92 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.634 0.254 . . . . 0.0 111.105 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 235' ' ' ILE . 0.2 OUTLIER -155.08 -43.82 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.402 ' N ' HG12 ' A' ' 235' ' ' ILE . 0.0 OUTLIER 45.09 -84.88 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 235' ' ' ILE . 15.6 p -67.18 138.0 56.66 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.651 0.262 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 22.1 p -134.51 158.87 42.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.898 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.85 176.62 0.07 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.984 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.64 -60.86 2.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.024 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -108.99 99.9 9.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.722 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -117.46 127.59 54.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.075 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 117' ' ' TYR . . . -96.71 114.13 4.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.205 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.72 137.01 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.579 -0.365 . . . . 0.0 110.829 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.541 HG23 ' HE2' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -141.18 167.93 21.0 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.071 0.548 . . . . 0.0 111.613 -172.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.6 m -72.75 152.23 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.868 HD21 ' CD1' ' A' ' 113' ' ' LEU . 1.9 mp -58.73 159.54 12.64 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 119.903 1.229 . . . . 0.0 110.682 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 247' ' ' LEU . 72.4 Cg_endo -78.66 -162.67 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.552 2.168 . . . . 0.0 113.063 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.4 p -94.91 144.31 25.77 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 160' ' ' LEU . 62.2 m-85 -144.61 111.2 5.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.96 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 190' ' ' ALA . 0.0 OUTLIER 37.04 31.98 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.196 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 105.78 29.98 4.75 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 254' ' ' PRO . 0.1 OUTLIER -156.68 167.1 15.14 Favored Pre-proline 0 N--CA 1.467 0.375 0 CA-C-N 119.1 1.45 . . . . 0.0 112.302 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 253' ' ' GLN . 67.7 Cg_endo -93.08 23.73 0.5 Allowed 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.43 2.753 . . . . 0.0 114.48 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.659 ' HB2' HD13 ' A' ' 247' ' ' LEU . 0.7 OUTLIER 72.21 133.61 0.04 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 178.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 1.07 ' HB2' ' HB2' ' A' ' 163' ' ' ALA . 10.5 mttt -86.38 106.39 10.11 Favored Pre-proline 0 CA--C 1.512 -0.499 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.795 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.745 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 94.8 Cg_endo -78.9 143.87 18.62 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.201 1.267 . . . . 0.0 109.719 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -89.19 119.32 29.58 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.898 HG11 ' HA ' ' A' ' 324' ' ' ALA . 6.2 m -115.2 99.86 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 118.247 0.476 . . . . 0.0 112.148 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -90.86 156.69 24.7 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.782 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.858 HG13 ' HB3' ' A' ' 64' ' ' HIS . 2.1 p -118.19 106.49 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -72.3 129.61 38.82 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 117.54 -1.664 . . . . 0.0 107.115 178.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.542 ' HA ' HG13 ' A' ' 108' ' ' ILE . 2.9 p -140.85 130.0 23.48 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 118.624 2.824 . . . . 0.0 118.624 -172.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.516 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . . . -88.88 111.98 22.72 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.643 ' HA3' HD21 ' A' ' 76' ' ' LEU . . . -100.78 164.27 18.64 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.543 ' HB ' HD11 ' A' ' 104' ' ' ILE . 3.7 mt -88.21 123.05 40.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 118.723 1.262 . . . . 0.0 107.617 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -64.59 145.73 55.71 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.515 ' HB2' ' H ' ' A' ' 76' ' ' LEU . . . -57.73 -25.5 60.48 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.132 -0.355 . . . . 0.0 110.947 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 55' ' ' ASP . . . -49.5 -60.0 3.25 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.471 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.94 131.77 8.87 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.652 0.263 . . . . 0.0 111.279 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.37 -42.57 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.497 2.131 . . . . 0.0 112.999 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 4.2 m-20 47.8 81.08 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.533 0.206 . . . . 0.0 110.787 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.12 -54.07 7.77 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -58.48 -57.29 13.58 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.657 HD12 ' CG ' ' A' ' 4' ' ' GLU . 8.3 tt -59.72 -42.88 94.08 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.658 0.266 . . . . 0.0 111.472 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.596 ' HB1' HD13 ' A' ' 280' ' ' LEU . . . -72.9 -33.41 65.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.612 ' O ' ' CB ' ' A' ' 281' ' ' GLU . 1.1 tmtt? -63.58 -58.7 6.13 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 121.413 0.625 . . . . 0.0 112.165 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.508 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 3.6 tp10 -68.06 -34.55 76.66 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.699 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.494 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 54.9 t80 -74.04 -60.02 2.45 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.963 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.596 HD13 ' HB1' ' A' ' 276' ' ' ALA . 5.8 mp -75.01 -43.13 55.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 118.373 -1.331 . . . . 0.0 113.05 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.826 ' HA ' HD23 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -73.65 -37.73 65.21 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.518 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 3.9 t30 -87.99 -20.61 25.61 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.639 ' CE1' HG12 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -104.06 -74.45 0.64 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 177.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.501 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 0.5 OUTLIER -36.22 -30.63 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.841 HD12 HD13 ' A' ' 304' ' ' LEU . 3.2 mm? -98.35 43.49 1.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.896 0.316 . . . . 0.0 111.792 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.5 p -144.89 157.78 44.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 11.2 m-20 -61.18 -15.17 31.15 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 2.3 mm-40 -78.32 -46.91 18.92 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.316 0.507 . . . . 0.0 110.498 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -81.06 -53.46 3.92 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.922 HD11 HD23 ' A' ' 304' ' ' LEU . 17.6 mt -50.07 -49.24 51.97 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.452 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 1.4 tp10 -78.14 -27.41 48.2 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.912 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -71.92 -38.06 69.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 119.776 1.171 . . . . 0.0 108.405 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 290' ' ' LEU . 14.7 p -65.92 -38.03 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -74.95 -41.88 58.75 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.458 1.103 . . . . 0.0 113.374 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -65.09 -42.74 93.76 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.499 ' CB ' ' HA3' ' A' ' 16' ' ' GLY . 33.4 m-20 -56.68 -64.53 0.84 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.48 ' HB3' HD11 ' A' ' 299' ' ' LEU . 17.4 mtmm -97.63 105.24 25.12 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.814 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -100.18 93.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.62 2.88 . . . . 0.0 112.305 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -143.33 -74.29 0.27 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.526 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -144.0 173.6 24.71 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.084 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 1.019 ' HB2' HD13 ' A' ' 311' ' ' LEU . . . -129.93 131.24 45.93 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 1.007 HG11 ' CG1' ' A' ' 110' ' ' VAL . 10.9 p -179.8 39.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.085 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.465 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . -111.06 -138.21 0.37 Allowed 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.922 HD23 HD11 ' A' ' 290' ' ' LEU . 22.0 tp -39.63 121.24 1.2 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -30.33 -63.15 0.14 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.514 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 95.7 p -48.88 -44.73 40.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.966 0.889 . . . . 0.0 110.933 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.906 ' CE1' HD12 ' A' ' 311' ' ' LEU . 3.1 t80 -75.87 -25.05 55.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.909 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -68.54 -39.78 80.99 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -68.66 -61.33 1.87 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.288 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -46.78 -56.61 5.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.872 0.368 . . . . 0.0 111.169 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 1.019 HD13 ' HB2' ' A' ' 301' ' ' ALA . 0.3 OUTLIER -64.43 -45.58 86.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.641 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -46.84 -28.7 1.65 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -31.22 -42.21 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.477 ' HB2' HD12 ' A' ' 317' ' ' ILE . 28.6 m-20 -71.19 137.12 84.33 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.784 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.72 -21.8 70.94 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.631 2.22 . . . . 0.0 113.252 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -59.71 -59.14 5.9 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.646 0.26 . . . . 0.0 111.559 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 301' ' ' ALA . 3.0 mp -50.91 -55.6 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.91 -39.07 8.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.163 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.08 -52.74 64.43 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 122.058 0.932 . . . . 0.0 108.837 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.4 ' OG1' HG23 ' A' ' 110' ' ' VAL . 3.2 p -56.84 -37.57 71.43 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 113.625 -1.625 . . . . 0.0 109.85 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.414 ' O ' ' HB3' ' A' ' 324' ' ' ALA . 1.4 ttp -70.93 -44.59 65.86 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -58.56 -57.38 13.21 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' A' ' 327' ' ' GLY . 6.5 m-20 -50.45 -38.71 45.0 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.898 ' HA ' HG11 ' A' ' 259' ' ' VAL . . . -57.35 -43.19 83.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.603 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -57.33 -42.06 81.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.228 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -106.19 26.41 9.81 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.887 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.745 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -114.66 157.64 14.85 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.618 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.86 135.66 36.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 330' ' ' MET . 39.0 mt -86.45 115.43 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 118.906 0.775 . . . . 0.0 110.87 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.535 ' HE3' ' HE1' ' A' ' 336' ' ' MET . 0.0 OUTLIER -28.27 130.84 0.2 Allowed Pre-proline 0 N--CA 1.47 0.568 0 N-CA-C 111.412 0.153 . . . . 0.0 111.412 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.459 ' HG2' ' CE1' ' A' ' 169' ' ' PHE . 62.4 Cg_exo -51.79 -164.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.893 2.395 . . . . 0.0 113.152 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -150.73 39.29 0.71 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.343 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.448 HG13 ' CE1' ' A' ' 176' ' ' TYR . 1.2 pp -132.58 163.23 52.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.026 0.441 . . . . 0.0 111.911 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.21 -37.86 7.56 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.046 2.497 . . . . 0.0 112.403 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.739 ' HB3' HD13 ' A' ' 178' ' ' ILE . 8.8 mp0 -45.98 -21.79 0.16 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.535 ' HE1' ' HE3' ' A' ' 330' ' ' MET . 4.0 tpp -45.49 -35.61 3.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.956 0.344 . . . . 0.0 110.978 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.5 t -61.12 -40.33 93.36 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.78 0.324 . . . . 0.0 110.19 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.12 -37.61 85.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.764 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.724 ' O ' HG12 ' A' ' 343' ' ' VAL . 23.4 t80 -74.04 -55.74 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.624 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 344' ' ' ARG . 2.3 t-105 -49.91 -43.61 49.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.494 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 0.722 ' O ' HG23 ' A' ' 345' ' ' THR . 0.9 OUTLIER -69.79 -52.2 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.9 -44.17 81.5 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.939 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.0 p -71.7 -29.42 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -75.03 -49.18 20.63 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 341' ' ' TYR . 69.9 p -57.33 -57.94 10.42 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.729 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.79 -41.22 6.76 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.861 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 343' ' ' VAL . 54.9 t -59.04 -47.69 89.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 345' ' ' THR . 6.7 mt -66.97 -28.24 42.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.8 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.729 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.1 OUTLIER -67.94 -27.63 66.78 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.66 0.267 . . . . 0.0 110.913 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.51 -44.76 23.62 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.54 -9.39 59.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 9.4 t -101.72 -46.03 5.06 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 142.1 0.77 1.4 Allowed Glycine 0 N--CA 1.464 0.504 0 C-N-CA 117.054 -2.498 . . . . 0.0 118.074 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.46 32.38 4.66 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 113.232 -3.387 . . . . 0.0 114.916 173.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.804 ' HB3' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER -158.24 119.22 3.43 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 34.3 p -78.73 146.88 33.65 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 358' ' ' ASP . 12.5 p -41.97 -45.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.433 ' N ' HG13 ' A' ' 357' ' ' VAL . 16.0 m-20 -71.58 -49.67 38.26 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.01 -46.38 57.39 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.475 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.804 ' HB2' ' HB3' ' A' ' 355' ' ' GLN . . . -54.16 -49.47 69.21 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.282 1.039 . . . . 0.0 113.593 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 47.3 mt -74.71 -36.69 62.7 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.283 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 365' ' ' GLN . 14.7 tttm -65.13 -56.7 11.41 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 122.351 1.072 . . . . 0.0 110.581 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.34 -37.45 83.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.749 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -49.61 -43.98 46.87 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.698 ' HG3' HG23 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -60.62 -44.74 95.97 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.57 -44.15 56.57 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.34 0.591 . . . . 0.0 110.168 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.08 -46.22 90.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.269 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.859 HD12 HG11 ' A' ' 181' ' ' VAL . 6.7 pt -81.19 -5.65 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.837 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.757 ' CG2' HG22 ' A' ' 181' ' ' VAL . 10.8 p -135.28 42.81 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.619 0.247 . . . . 0.0 110.616 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.248 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.667 0.27 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.7 p -137.21 111.53 8.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.847 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -131.81 117.96 19.25 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -138.95 -179.45 5.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.98 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.7 66.04 0.55 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HA ' HG12 ' A' ' 33' ' ' ILE . 2.3 tttp -153.18 157.49 40.36 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.658 ' HG ' HD11 ' A' ' 9' ' ' ILE . 24.7 tp -146.48 124.75 12.24 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.79 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.773 ' O ' ' HA ' ' A' ' 58' ' ' ASP . 99.3 t -111.74 132.9 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.488 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.831 ' HB ' HG12 ' A' ' 37' ' ' VAL . 5.4 mp -135.21 125.15 43.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.063 0.459 . . . . 0.0 111.412 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.573 ' CH2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -106.04 121.04 43.31 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.802 HG23 ' HB2' ' A' ' 61' ' ' PHE . 15.3 mt -158.09 137.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.063 0.458 . . . . 0.0 111.252 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -156.07 41.98 0.39 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.59 -35.21 0.57 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.698 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 3.3 m-20 -90.05 -105.51 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER 161.91 -172.6 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.03 0.919 . . . . 0.0 113.204 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.66 100.58 0.32 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 113.733 -1.576 . . . . 0.0 115.423 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -36.33 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.984 -0.608 . . . . 0.0 111.167 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 12.1 t-20 -64.84 -43.94 91.4 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.87 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.99 -49.01 23.99 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.631 -0.795 . . . . 0.0 114.043 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.63 ' CD1' HG11 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -59.85 -50.18 74.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.789 0.795 . . . . 0.0 110.371 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.29 82.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 53.9 tt0 -65.8 -36.98 85.02 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.42 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 19' ' ' GLY . 57.5 t -68.6 -61.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 122.063 -0.398 . . . . 0.0 110.377 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.923 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -49.31 -32.49 14.32 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.278 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 8.7 tmtm? -58.37 -50.84 72.23 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 122.503 1.144 . . . . 0.0 109.183 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -42.81 61.96 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 113.05 -1.886 . . . . 0.0 109.515 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.599 ' O ' ' CB ' ' A' ' 31' ' ' THR . 10.8 t80 -64.26 -32.23 73.74 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.316 0.579 . . . . 0.0 110.691 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.592 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 26.8 tt0 -68.78 -46.62 68.25 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.897 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -25.6 54.27 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -176.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.7 -33.61 21.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.599 ' CB ' ' O ' ' A' ' 27' ' ' PHE . 1.8 m -95.75 -133.5 0.2 Allowed 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 111.115 -2.766 . . . . 0.0 104.792 173.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 28' ' ' GLU . . . -173.59 42.71 0.15 Allowed Glycine 0 C--N 1.291 -1.94 0 N-CA-C 106.869 -2.492 . . . . 0.0 106.869 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.608 HD11 ' N ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -113.95 152.14 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.583 ' N ' HD13 ' A' ' 33' ' ' ILE . 5.2 mtpt -105.71 105.78 15.98 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.655 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.923 HG11 ' HA3' ' A' ' 24' ' ' GLY . 10.7 p -84.49 131.32 34.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.0 p -116.71 141.24 48.46 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.379 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.831 HG12 ' HB ' ' A' ' 9' ' ' ILE . 27.0 m -136.74 119.97 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 1.7 mp0 -109.42 141.87 41.2 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -113.65 81.27 5.47 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 120.638 0.256 . . . . 0.0 111.483 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.492 ' CG ' ' HG ' ' A' ' 43' ' ' LEU . 38.1 Cg_endo -90.83 -172.55 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.31 2.673 . . . . 0.0 113.005 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -114.05 -44.97 3.1 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.622 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -81.03 0.61 35.01 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.667 HD22 HD11 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -19.77 -39.81 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 1.05 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -63.49 -55.06 27.06 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.273 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mp0 -74.07 -41.75 61.25 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.154 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.642 ' O ' HG13 ' A' ' 50' ' ' VAL . 23.4 mtpt -57.97 -57.82 11.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.24 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.716 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 34.7 t80 -41.73 -60.99 1.61 Allowed Pre-proline 0 C--N 1.355 0.828 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.26 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 1.05 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 25.0 Cg_exo -62.4 -19.83 68.51 Favored 'Trans proline' 0 C--O 1.25 1.106 0 CA-C-N 120.17 1.096 . . . . 0.0 111.704 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -81.07 -34.13 32.93 Favored 'General case' 0 C--O 1.259 1.599 0 CA-C-O 122.644 1.211 . . . . 0.0 110.683 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 46' ' ' LYS . 2.7 m -80.13 -40.86 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 CA-C-O 122.287 1.041 . . . . 0.0 110.308 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.06 -37.21 20.36 Favored 'General case' 0 C--N 1.381 1.958 0 CA-C-N 113.226 -1.806 . . . . 0.0 110.096 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 53' ' ' THR . . . -81.27 -35.74 30.77 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.555 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -172.49 64.57 0.03 OUTLIER 'General case' 0 C--N 1.34 0.169 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.606 179.064 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . -167.12 44.18 0.25 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 119.566 -1.302 . . . . 0.0 115.008 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 3.5 m-20 155.75 -86.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.74 -106.16 0.9 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.618 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 18.6 Cg_endo -57.11 132.99 54.77 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.938 1.759 . . . . 0.0 108.316 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.773 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 20.7 t0 157.97 126.9 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 118.717 0.69 . . . . 0.0 112.855 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.5 HG23 ' HA ' ' A' ' 266' ' ' ILE . 9.5 mt -107.87 162.85 5.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.667 HD11 HD22 ' A' ' 43' ' ' LEU . 6.3 tt -138.16 127.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.802 ' HB2' HG23 ' A' ' 11' ' ' ILE . 3.1 m-85 -85.94 148.07 25.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.717 ' HE3' ' O ' ' A' ' 61' ' ' PHE . 1.6 t-105 -168.54 153.38 6.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 120.119 1.327 . . . . 0.0 108.518 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 67' ' ' PHE . . . -77.21 -175.51 3.68 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.73 1.15 . . . . 0.0 108.746 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.687 ' HB3' HG23 ' A' ' 261' ' ' VAL . 22.4 t-80 -77.9 -44.89 25.71 Favored 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.59 ' HB3' ' CG ' ' A' ' 330' ' ' MET . 0.8 OUTLIER -52.91 -59.44 4.52 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 1.6 mtt85 -70.6 -29.86 66.37 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.796 ' HZ ' HG23 ' A' ' 104' ' ' ILE . 7.3 t80 -62.46 -39.7 94.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 72' ' ' GLN . . . -46.99 -67.62 1.4 Allowed Glycine 0 CA--C 1.488 -1.652 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.886 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 73' ' ' SER . . . -76.44 -71.84 1.15 Allowed Glycine 0 C--N 1.341 0.839 0 CA-C-N 114.485 -0.857 . . . . 0.0 112.612 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.761 ' HB3' HD21 ' A' ' 75' ' ' LEU . 12.7 m-30 -41.82 -57.5 2.33 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.423 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.731 ' HB1' ' HG ' ' A' ' 76' ' ' LEU . . . -75.61 -56.63 4.51 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.625 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 4.8 tm0? -63.8 -12.9 39.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.621 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 48.4 t -82.84 -26.75 31.36 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.119 -0.363 . . . . 0.0 111.78 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 166.99 -32.09 0.2 Allowed Glycine 0 C--N 1.339 0.735 0 C-N-CA 119.414 -1.374 . . . . 0.0 114.772 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.835 HD13 ' HG3' ' A' ' 48' ' ' PRO . 1.8 pp -86.72 61.8 7.03 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 118.195 0.998 . . . . 0.0 111.743 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.827 HD12 ' CG1' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.19 143.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.238 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.86 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -107.96 115.13 29.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.716 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -53.99 151.44 6.77 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.2 pt -90.96 155.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.276 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.43 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -88.25 175.31 4.25 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.097 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.43 ' CD ' ' HB ' ' A' ' 80' ' ' THR . 5.9 Cg_exo -79.52 139.46 14.41 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.776 2.318 . . . . 0.0 112.952 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.21 -162.19 1.26 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.303 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.07 -58.6 2.04 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.318 -0.239 . . . . 0.0 111.237 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.69 70.18 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.634 0.254 . . . . 0.0 111.417 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.419 ' CD2' ' HG2' ' A' ' 281' ' ' GLU . 0.1 OUTLIER -73.75 -59.08 2.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.473 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -56.93 -27.33 60.86 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.405 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.3 -31.07 57.99 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.886 ' HG3' HD21 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -93.8 29.62 2.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.578 ' HA ' ' CD1' ' A' ' 94' ' ' TRP . 19.7 mt -104.8 107.8 18.95 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.173 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -89.1 -179.19 1.19 Allowed Pre-proline 0 N--CA 1.452 -0.361 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HD3' ' CG ' ' A' ' 90' ' ' TYR . 7.4 Cg_exo -74.08 -39.0 1.86 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.326 2.017 . . . . 0.0 115.603 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.576 ' HZ ' HG21 ' A' ' 259' ' ' VAL . 31.1 t80 -87.65 -63.61 1.28 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.648 HG21 HG21 ' A' ' 302' ' ' VAL . 1.2 p -64.78 -26.99 68.59 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -175.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.578 ' CD1' ' HA ' ' A' ' 89' ' ' LEU . 5.2 m-90 -89.2 -24.93 22.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.015 0.926 . . . . 0.0 111.001 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 2.5 t70 -72.97 -26.81 61.49 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.125 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.922 ' HB1' HG21 ' A' ' 261' ' ' VAL . . . -71.72 -38.63 70.47 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.778 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 40.7 t -100.02 44.74 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.03 140.21 51.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 119.16 -0.448 . . . . 0.0 109.9 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.9 t80 -109.3 174.7 5.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.529 1.059 . . . . 0.0 109.433 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -61.32 75.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.724 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 138.97 -55.69 0.66 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.173 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -145.93 -178.29 6.04 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 117.126 0.463 . . . . 0.0 111.316 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.36 146.28 42.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.226 0.536 . . . . 0.0 112.39 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.827 ' CG1' HD12 ' A' ' 76' ' ' LEU . 4.1 tt -122.32 58.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.131 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.778 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . . . 159.03 176.04 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.819 ' CD2' ' HB3' ' A' ' 264' ' ' ALA . 0.0 OUTLIER -139.02 127.91 14.0 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 115.542 -0.754 . . . . 0.0 108.974 177.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.765 ' O ' HG23 ' A' ' 108' ' ' ILE . 86.3 Cg_endo -79.6 162.06 24.71 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 122.886 2.391 . . . . 0.0 113.479 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 107' ' ' PRO . 1.4 pp -167.99 38.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.256 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.904 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -178.11 119.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.319 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 110' ' ' VAL . 14.4 p -110.7 105.5 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.861 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.513 ' HA ' HG21 ' A' ' 320' ' ' THR . 1.9 pt-20 -102.46 161.8 13.42 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.788 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.68 146.87 8.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.741 0.781 . . . . 0.0 111.614 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.735 HD13 ' CD1' ' A' ' 156' ' ' PHE . 2.1 pp -79.75 125.27 29.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.1 OUTLIER -135.09 160.5 38.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -176.262 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 226' ' ' ILE . 8.2 tt -92.55 132.07 37.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 242' ' ' TYR . 4.1 tt -114.48 133.69 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.45 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 9.8 p90 -118.46 140.05 50.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.781 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 0.7 OUTLIER -89.25 128.08 35.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.611 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.06 -43.82 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.223 -0.298 . . . . 0.0 110.59 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -65.21 0.71 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.638 0.733 . . . . 0.0 110.84 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 121' ' ' LEU . 1.1 tt -110.24 64.99 0.61 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.98 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.911 HD13 ' HB1' ' A' ' 223' ' ' ALA . 2.1 tp -157.18 88.68 2.59 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 119.976 -0.689 . . . . 0.0 112.638 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.539 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 9.1 Cg_endo -48.26 162.98 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.192 2.594 . . . . 0.0 110.176 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -59.48 108.38 1.35 Allowed Pre-proline 0 N--CA 1.468 0.436 0 C-N-CA 118.186 -1.406 . . . . 0.0 109.686 -172.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.88 ' HB3' HD11 ' A' ' 122' ' ' LEU . 58.2 Cg_endo -93.31 168.6 2.28 Favored 'Trans proline' 0 C--N 1.369 1.627 1 C-N-CA 125.812 4.341 . . . . 0.0 115.868 -175.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 135' ' ' LEU . 4.7 Cg_exo -39.94 156.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.618 3.546 . . . . 0.0 115.572 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -136.07 -20.88 1.45 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.28 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.7 m -133.82 155.23 50.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -59.47 -54.32 48.03 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.406 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -24.25 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.577 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 134' ' ' ALA . 6.8 mt-10 -79.17 -27.92 42.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.651 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 7.2 mt -43.99 -54.25 11.57 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 121.385 0.612 . . . . 0.0 111.368 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 51.9 Cg_exo -49.07 -39.22 41.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 N-CA-C 109.511 -0.996 . . . . 0.0 109.511 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.11 -58.57 3.2 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.596 ' HB3' ' HD3' ' A' ' 126' ' ' PRO . 0.2 OUTLIER -69.07 -37.09 78.3 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.171 -178.742 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 49.0 t0 -73.09 -40.77 64.73 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -47.52 -45.11 26.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 118.599 -1.24 . . . . 0.0 108.949 177.001 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 75.0 mm-40 -64.28 -39.81 94.68 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.698 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.774 ' CD1' ' HB2' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -61.22 -49.17 78.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.75 -44.62 28.27 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.04 -25.19 0.53 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.497 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -100.01 -63.68 1.11 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.73 39.39 0.02 OUTLIER Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.014 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.76 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 0.5 OUTLIER -173.77 176.18 2.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.516 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.767 ' O ' HD22 ' A' ' 139' ' ' LEU . 9.8 m -109.26 166.97 10.46 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.774 ' HB2' ' CD1' ' A' ' 139' ' ' LEU . . . -73.31 -16.1 61.38 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.658 HD12 ' CE2' ' A' ' 149' ' ' PHE . 1.6 pt? -148.74 133.07 17.49 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 117.633 2.457 . . . . 0.0 117.633 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.56 ' HB2' HG21 ' A' ' 222' ' ' THR . 28.3 mmt -132.34 138.89 47.94 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.671 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.975 ' O ' ' O ' ' A' ' 150' ' ' ASN . 2.3 p90 -172.48 175.28 3.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.65 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.975 ' O ' ' O ' ' A' ' 149' ' ' PHE . 1.3 m120 -28.68 -147.74 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 123.897 0.748 . . . . 0.0 112.201 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.064 HD22 ' HB1' ' A' ' 206' ' ' ALA . 2.8 mt 169.66 41.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.824 -1.172 . . . . 0.0 110.615 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.742 ' OE1' HD11 ' A' ' 348' ' ' ILE . 0.0 OUTLIER 173.11 34.05 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 169.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.66 ' O ' ' HB ' ' A' ' 157' ' ' THR . 4.1 mp0 -119.46 155.13 54.38 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 121.113 1.779 . . . . 0.0 114.405 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.859 ' O ' ' N ' ' A' ' 156' ' ' PHE . 86.1 Cg_endo -77.59 -135.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 125.201 3.934 . . . . 0.0 105.466 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 1.182 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 4.0 m-85 39.83 -65.19 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 120.312 1.415 . . . . 0.0 113.073 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.859 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -89.5 -59.89 2.09 Favored 'General case' 0 C--O 1.259 1.593 0 C-N-CA 124.483 1.113 . . . . 0.0 111.36 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.66 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 5.9 m -58.88 -43.29 90.89 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.43 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.54 -55.34 30.31 Favored Pre-proline 0 C--N 1.35 0.612 0 C-N-CA 120.299 -0.561 . . . . 0.0 109.96 177.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 1.182 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 87.6 Cg_exo -43.48 -50.62 6.7 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.596 2.197 . . . . 0.0 113.349 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.502 HD23 ' CZ ' ' A' ' 250' ' ' PHE . 9.5 mp -64.06 -56.8 12.34 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 119.571 1.078 . . . . 0.0 109.972 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 158' ' ' TRP . 42.3 pt -54.31 -17.32 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.707 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -77.38 -25.75 51.2 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.7 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -42.13 -59.31 1.81 Allowed 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.491 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 6.3 t70 -64.35 -17.45 63.72 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 136.61 23.0 0.53 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 118.722 -1.704 . . . . 0.0 117.146 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.5 160.25 41.51 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 119.331 1.565 . . . . 0.0 111.779 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -163.08 168.1 21.39 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.504 0.652 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.47 -79.31 0.42 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.614 0.721 . . . . 0.0 111.343 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 14.3 m-85 -112.15 168.73 9.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.87 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 1.271 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -103.94 115.8 31.1 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.267 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.434 ' CE1' ' CD2' ' A' ' 176' ' ' TYR . 0.2 OUTLIER -86.48 114.38 23.18 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.378 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 173' ' ' ASN . 1.2 tt0 -106.47 100.71 10.22 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 172' ' ' GLU . 35.7 m-80 39.03 78.63 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.32 6.52 80.43 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.86 124.37 5.91 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 121.44 2.62 . . . . 0.0 113.388 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 1.271 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.2 p90 -96.92 -23.12 16.48 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.599 1.19 . . . . 0.0 109.724 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.497 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 2.8 m-20 65.82 -82.43 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.911 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.893 HD11 HG22 ' A' ' 368' ' ' ILE . 7.1 tp 172.21 -43.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.419 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.3 OUTLIER -58.67 -16.62 17.11 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 119.167 -0.444 . . . . 0.0 111.769 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 4.0 m-20 -112.92 93.93 4.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 178' ' ' ILE . 15.4 m -118.06 120.12 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.314 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.42 52.57 3.81 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 119.479 -1.344 . . . . 0.0 112.86 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.601 HG12 ' HB3' ' A' ' 361' ' ' LEU . 14.5 t -90.93 -17.84 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.409 -0.895 . . . . 0.0 109.366 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.72 52.24 0.72 Allowed 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.858 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.56 160.65 16.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.375 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.75 -25.92 59.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.383 0.611 . . . . 0.0 111.706 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -76.4 -36.43 39.08 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.866 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.17 66.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -60.44 3.85 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.544 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.31 -41.04 50.43 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.829 0.823 . . . . 0.0 111.609 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.48 ' HA2' ' CE2' ' A' ' 194' ' ' PHE . . . -58.89 -60.7 8.42 Favored Glycine 0 C--O 1.237 0.338 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.839 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.561 HD13 HG13 ' A' ' 347' ' ' VAL . 4.2 mt -61.32 -23.93 66.07 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.577 -0.367 . . . . 0.0 110.092 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.824 ' O ' HG12 ' A' ' 196' ' ' VAL . 98.1 m -62.69 -53.46 54.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.658 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.48 ' CE2' ' HA2' ' A' ' 191' ' ' GLY . 4.3 p90 -61.83 -33.88 74.95 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.638 ' CD1' HD11 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -61.33 -51.2 69.84 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.671 178.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 193' ' ' THR . 7.8 p -58.66 -28.75 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.958 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -57.87 -49.36 76.96 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 121.399 0.618 . . . . 0.0 109.779 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.4 tt -62.33 -59.14 5.42 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.748 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 195' ' ' LEU . 4.3 mt -53.8 -45.16 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -61.71 -34.14 75.27 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -91.09 3.35 55.0 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.4 -81.11 0.63 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.72 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.48 -24.07 5.94 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 199' ' ' ILE . 1.4 ptm 74.44 13.42 3.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.948 0.34 . . . . 0.0 110.8 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -148.88 104.96 3.5 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 1.064 ' HB1' HD22 ' A' ' 151' ' ' LEU . . . -99.16 72.01 1.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.22 -4.27 27.48 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.593 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.912 HG22 ' HB2' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -57.24 123.9 16.95 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.1 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.671 ' HB2' HD13 ' A' ' 212' ' ' ILE . 0.5 OUTLIER -94.48 -174.74 3.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.275 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.6 p90 -70.18 -45.1 67.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.239 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.432 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.4 OUTLIER -77.87 -25.53 48.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.943 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.671 HD13 ' HB2' ' A' ' 209' ' ' ASP . 2.9 mp -81.68 -51.76 14.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.568 ' HB2' HG23 ' A' ' 208' ' ' THR . . . -50.39 -37.35 37.03 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.61 -45.62 86.15 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.77 -38.8 67.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.874 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.01 -56.7 18.3 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -61.46 -29.13 69.76 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.8 -40.54 76.11 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.572 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.23 -23.93 59.24 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.4 33.12 61.63 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 115.3 0.88 . . . . 0.0 115.3 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -109.02 36.9 2.71 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.147 1.474 . . . . 0.0 111.4 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.56 HG21 ' HB2' ' A' ' 148' ' ' MET . 0.5 OUTLIER -140.23 137.91 34.66 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 178.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 122' ' ' LEU . . . -104.58 38.18 1.95 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.578 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 170.55 138.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.562 HG23 HG22 ' A' ' 116' ' ' ILE . 9.0 t -148.17 159.37 44.01 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.564 ' HB ' ' CE1' ' A' ' 156' ' ' PHE . 8.5 pt -116.05 111.92 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.755 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.618 ' HA ' ' HE2' ' A' ' 156' ' ' PHE . 89.6 m-20 -148.67 164.78 33.31 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 121.874 -0.516 . . . . 0.0 111.939 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 230' ' ' TRP . . . -86.57 114.89 4.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.413 -1.375 . . . . 0.0 109.861 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.668 ' O ' ' HB3' ' A' ' 230' ' ' TRP . 75.2 Cg_exo -50.15 72.94 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.974 2.45 . . . . 0.0 114.548 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.668 ' HB3' ' O ' ' A' ' 229' ' ' PRO . 0.4 OUTLIER 150.96 -30.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 177.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.32 -85.91 0.55 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -52.22 -31.89 34.18 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.346 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -54.47 3.48 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.585 0.231 . . . . 0.0 111.172 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.6 m120 65.91 -74.48 0.06 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.219 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.575 HG21 ' CB ' ' A' ' 238' ' ' SER . 5.8 mt 65.72 -68.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 74.76 -69.77 0.17 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.601 0.239 . . . . 0.0 110.388 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 7.1 p -106.85 60.83 0.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.757 0.313 . . . . 0.0 110.317 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.575 ' CB ' HG21 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -52.93 -177.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.252 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -84.46 67.4 9.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.763 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 14.4 t 75.06 -67.22 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.745 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.57 150.28 47.35 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.725 0.298 . . . . 0.0 110.922 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.568 ' HB2' HD11 ' A' ' 116' ' ' ILE . 43.3 p90 -149.22 130.37 14.51 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.248 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.45 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -96.66 175.23 31.31 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.122 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.445 HG11 ' CG ' ' A' ' 229' ' ' PRO . 19.4 m -145.76 136.67 19.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 117.05 0.425 . . . . 0.0 111.529 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 167.5 21.0 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.4 m -73.07 152.77 7.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.713 HD22 ' OG ' ' A' ' 255' ' ' SER . 2.8 mp -59.37 159.57 15.85 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 120.627 1.558 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.73 -159.81 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.959 2.44 . . . . 0.0 112.433 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 17.3 p -121.15 177.51 5.12 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 249' ' ' THR . 56.8 m-85 -165.64 110.33 0.86 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.234 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.3 mttp 60.88 34.55 19.56 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.714 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.15 43.32 21.57 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.301 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -156.48 148.82 17.72 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.494 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 95.8 Cg_endo -84.31 -169.59 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.17 2.58 . . . . 0.0 111.628 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.713 ' OG ' HD22 ' A' ' 247' ' ' LEU . 75.3 p -111.85 148.99 32.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.248 0.547 . . . . 0.0 112.244 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 3.1 ttpm? -85.32 109.24 19.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.725 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.578 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 2.7 Cg_exo -78.88 145.7 20.09 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.347 2.698 . . . . 0.0 112.466 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 1.6 m-85 -102.12 94.13 5.59 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.513 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.657 HG13 ' HA3' ' A' ' 327' ' ' GLY . 35.5 m -94.35 106.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.757 0.313 . . . . 0.0 111.82 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.424 ' HA2' ' CE ' ' A' ' 330' ' ' MET . . . -86.2 160.52 33.49 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 119.637 -1.268 . . . . 0.0 112.606 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.922 HG21 ' HB1' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -111.59 111.15 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.904 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 3.8 tp -84.4 107.04 16.45 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 117.502 -1.679 . . . . 0.0 107.071 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 63.9 p -133.36 141.94 48.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.819 ' HB3' ' CD2' ' A' ' 106' ' ' TYR . . . -73.73 132.99 43.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.169 -0.332 . . . . 0.0 110.289 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.17 136.33 11.17 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.74 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.955 HG23 ' CG ' ' A' ' 271' ' ' PRO . 7.0 mt -88.0 119.78 35.99 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 CA-C-N 118.425 1.113 . . . . 0.0 108.245 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.545 ' HA ' ' HZ ' ' A' ' 47' ' ' PHE . 44.5 t-20 -59.27 137.55 57.94 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.86 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -53.86 -22.34 9.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.711 0.687 . . . . 0.0 110.468 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 270' ' ' SER . . . -55.77 -27.34 50.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.723 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 269' ' ' ALA . 0.9 OUTLIER 93.22 91.29 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 122.602 0.361 . . . . 0.0 111.191 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.955 ' CG ' HG23 ' A' ' 266' ' ' ILE . 47.6 Cg_endo -91.14 81.11 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.279 2.653 . . . . 0.0 112.939 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 6.6 m-80 37.23 82.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.721 0.296 . . . . 0.0 111.142 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 7.9 mmtt -51.58 -54.2 30.1 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -66.9 -57.4 7.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.8 mt -63.74 -53.75 46.24 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -65.83 -55.19 18.4 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -58.97 -32.59 69.79 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.32 -53.03 8.77 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.421 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 85.9 t80 -56.37 -54.66 42.97 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.85 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 284' ' ' LEU . 1.0 OUTLIER -53.9 -43.5 69.75 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.566 0.698 . . . . 0.0 111.402 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.706 ' O ' HD12 ' A' ' 285' ' ' LEU . 90.0 mt-10 -73.45 -34.36 65.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.787 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -93.15 -13.96 27.78 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 1.003 ' O ' HG22 ' A' ' 286' ' ' THR . 2.5 t80 -106.21 -65.72 1.05 Allowed 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.759 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.5 tp -36.48 -33.04 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.732 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.706 HD12 ' O ' ' A' ' 281' ' ' GLU . 26.2 mt -89.8 42.09 1.08 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.637 0.255 . . . . 0.0 111.665 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . 1.003 HG22 ' O ' ' A' ' 283' ' ' TYR . 10.1 t -145.72 160.55 41.56 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 9.3 m-20 -63.81 -12.72 38.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.549 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.591 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 9.9 mt-10 -77.85 -46.94 20.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.598 0.636 . . . . 0.0 111.012 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.861 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -83.86 -54.99 2.91 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 284' ' ' LEU . 2.2 tp -48.86 -49.8 37.78 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 1.8 tt0 -78.65 -26.38 45.11 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.174 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -71.85 -35.12 69.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 119.838 1.199 . . . . 0.0 108.129 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 289' ' ' GLY . 66.1 t -65.77 -41.95 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.036 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -91.2 -33.88 15.22 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.632 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -46.27 85.98 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.471 ' HB3' ' HA3' ' A' ' 19' ' ' GLY . 1.2 p30 -61.49 -44.73 96.56 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 5.1 mttp -43.45 163.86 0.15 Allowed Pre-proline 0 N--CA 1.476 0.833 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.245 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -93.96 49.19 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.217 2.612 . . . . 0.0 114.699 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.2 mt 60.75 69.5 0.68 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.902 0.382 . . . . 0.0 111.533 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.673 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . 159.99 125.29 0.78 Allowed Glycine 0 C--O 1.231 -0.087 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.606 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . 159.61 -177.07 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.272 0.536 . . . . 0.0 111.571 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.648 HG21 HG21 ' A' ' 93' ' ' THR . 6.5 p -141.99 83.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.563 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . -84.67 58.22 4.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.271 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.886 HD21 ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER 87.84 149.4 0.05 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -30.19 0.66 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 65.5 m -79.91 -47.24 15.38 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.064 0.935 . . . . 0.0 111.059 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.563 ' CD2' ' HB3' ' A' ' 303' ' ' ALA . 5.9 t80 -70.74 -19.2 62.76 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.607 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -42.24 62.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -56.81 -55.85 29.06 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.195 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.34 -42.99 99.84 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.942 0.401 . . . . 0.0 110.18 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.479 ' O ' HG21 ' A' ' 317' ' ' ILE . 10.7 mt -59.93 -44.84 94.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.804 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.642 ' O ' ' HB2' ' A' ' 318' ' ' ALA . . . -46.63 -33.61 4.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.6 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -57.38 -36.5 71.33 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.582 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.53 164.57 5.16 Favored Pre-proline 0 N--CA 1.462 0.139 0 CA-C-O 120.684 0.278 . . . . 0.0 110.714 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.21 -57.2 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.131 2.554 . . . . 0.0 113.48 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.7 mtt85 -58.89 -59.46 5.42 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.49 HD11 ' CG1' ' A' ' 110' ' ' VAL . 1.7 tp -52.26 -54.31 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 312' ' ' ALA . . . -45.71 -51.86 11.81 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.269 0.486 . . . . 0.0 111.623 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -50.71 -48.4 58.84 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.318 1.056 . . . . 0.0 108.748 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.689 ' O ' ' HB2' ' A' ' 324' ' ' ALA . 0.3 OUTLIER -60.95 -36.9 80.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 113.248 -1.797 . . . . 0.0 110.58 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -73.96 -42.83 59.92 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.95 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.31 -57.5 12.37 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.753 0.311 . . . . 0.0 110.377 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -29.36 68.88 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.263 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -51.99 -53.05 46.15 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.734 0.302 . . . . 0.0 111.031 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -52.94 -32.85 47.96 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.203 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -98.64 13.2 32.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.657 ' HA3' HG13 ' A' ' 259' ' ' VAL . . . -93.9 160.0 23.98 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.865 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -97.76 131.93 43.83 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.2 pp -68.96 101.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 120.425 1.466 . . . . 0.0 107.875 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.59 ' CG ' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -36.07 144.84 0.24 Allowed Pre-proline 0 C--N 1.347 0.495 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -44.81 169.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.175 2.583 . . . . 0.0 112.297 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.404 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 9.3 p30 -128.4 -14.27 4.78 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.596 HD12 ' CG ' ' A' ' 335' ' ' GLN . 11.8 pt -78.94 165.89 46.06 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 118.77 0.714 . . . . 0.0 111.956 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.417 ' CD ' ' HB ' ' A' ' 333' ' ' ILE . 12.5 Cg_exo -70.55 -26.29 24.01 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.353 2.702 . . . . 0.0 113.402 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.699 ' OE1' HG23 ' A' ' 368' ' ' ILE . 84.1 mm-40 -42.01 -21.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.8 mmt -45.24 -32.17 1.81 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.234 0.47 . . . . 0.0 111.431 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -43.28 99.19 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 368' ' ' ILE . . . -63.5 -34.81 78.6 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.09 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.609 ' O ' HG23 ' A' ' 343' ' ' VAL . 4.3 m-85 -75.46 -52.28 11.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.542 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.459 ' CZ2' ' HG3' ' A' ' 154' ' ' PRO . 0.7 OUTLIER -53.45 -40.83 65.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.345 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -52.44 16.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.95 -44.49 69.43 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 1.037 HG13 HG21 ' A' ' 347' ' ' VAL . 47.9 t -64.72 -50.36 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.803 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.456 ' O ' HG22 ' A' ' 348' ' ' ILE . 9.0 tpt180 -53.42 -56.99 12.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.987 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 6.3 m -56.77 -58.22 9.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.05 -60.75 2.09 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 1.037 HG21 HG13 ' A' ' 343' ' ' VAL . 51.7 t -51.95 -47.47 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.742 HD11 ' OE1' ' A' ' 152' ' ' GLN . 0.4 OUTLIER -69.93 -45.27 77.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.893 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -69.12 -51.8 34.77 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.692 ' HB1' ' HA ' ' A' ' 355' ' ' GLN . . . -73.12 -26.62 61.29 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -51.86 -10.56 0.12 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 1.4 m -110.47 35.26 3.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.568 0.622 . . . . 0.0 111.059 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 88.64 -4.77 85.08 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 118.713 -1.708 . . . . 0.0 114.511 176.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -87.67 34.97 0.71 Allowed 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 115.683 -2.103 . . . . 0.0 107.903 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.971 ' HG2' HG23 ' A' ' 357' ' ' VAL . 2.0 mt-30 -71.14 -175.86 1.29 Allowed 'General case' 0 CA--C 1.547 0.838 1 N-CA-C 126.255 5.65 . . . . 0.0 126.255 -157.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.7 OUTLIER 158.26 41.38 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 110.074 -3.239 . . . . 0.0 104.876 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.971 HG23 ' HG2' ' A' ' 355' ' ' GLN . 53.2 t -72.43 -54.61 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.84 -174.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 6.7 t70 -46.23 -45.66 17.19 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.702 0.763 . . . . 0.0 111.269 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -77.4 -56.14 4.8 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.71 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -54.68 -44.32 73.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.209 1.004 . . . . 0.0 112.72 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.601 ' HB3' HG12 ' A' ' 183' ' ' VAL . 32.7 mt -75.62 -33.93 60.55 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.787 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 12.1 tttt -67.81 -56.06 10.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.172 0.987 . . . . 0.0 109.903 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.22 -30.72 71.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.146 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -53.87 -53.72 48.66 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.69 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.571 ' O ' HG23 ' A' ' 369' ' ' THR . 1.0 OUTLIER -58.5 -36.43 73.79 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.893 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.43 ' N ' ' HG3' ' A' ' 365' ' ' GLN . 5.9 m -52.16 -41.24 62.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.409 0.623 . . . . 0.0 109.588 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -73.73 -42.77 60.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.938 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.893 HG22 HD11 ' A' ' 178' ' ' ILE . 21.8 mm -66.12 -34.68 71.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 365' ' ' GLN . 6.6 p -94.5 -14.19 25.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.985 179.963 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.664 0.269 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.558 ' O ' HG23 ' A' ' 2' ' ' THR . 15.1 t -128.46 108.2 10.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.739 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.97 111.03 9.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.89 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -149.09 135.23 19.13 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.14 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -108.89 67.47 0.22 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.379 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.93 156.25 44.36 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.007 HD22 HD11 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -138.55 118.59 13.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.001 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -114.45 120.79 65.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.716 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.007 HD11 HD22 ' A' ' 7' ' ' LEU . 2.7 mp -121.67 130.79 74.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.123 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.886 ' HB2' HG22 ' A' ' 60' ' ' ILE . 29.8 m95 -107.94 121.13 44.15 Favored 'General case' 0 CA--C 1.527 0.058 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.3 pt -150.96 142.3 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.707 ' HA ' HD13 ' A' ' 43' ' ' LEU . 2.8 t30 -79.8 67.51 5.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.102 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.71 66.28 2.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.525 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 4.1 m-20 -80.59 -34.55 35.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.291 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 6.7 mttp 105.99 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.34 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 297' ' ' LYS . . . -74.36 58.21 2.41 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CZ ' HG21 ' A' ' 37' ' ' VAL . 3.3 m-85 -78.24 -42.14 32.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.751 0.31 . . . . 0.0 110.277 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 4.1 m120 -58.03 -48.37 80.28 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.986 0.422 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.883 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.78 -47.86 30.92 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.357 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.908 HD11 HG21 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -60.48 -51.31 70.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.382 0.591 . . . . 0.0 110.535 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.79 81.75 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.859 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 4.0 tm-20 -65.56 -36.53 84.06 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 19' ' ' GLY . 84.3 t -66.93 -61.3 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.605 ' CA ' HG21 ' A' ' 33' ' ' ILE . . . -49.09 -33.64 14.84 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.649 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -50.03 70.14 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.1 -41.46 62.46 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 112.809 -1.996 . . . . 0.0 107.902 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.574 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.17 -35.11 79.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.72 0.772 . . . . 0.0 110.865 178.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.716 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 18.4 tt0 -72.4 -52.46 15.88 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.223 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -53.05 -25.66 13.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.614 1.196 . . . . 0.0 110.244 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.728 ' O ' HG23 ' A' ' 31' ' ' THR . 9.1 t70 -89.04 -40.43 12.98 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.296 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER 169.67 38.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 173.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 157.36 39.53 0.02 OUTLIER Glycine 0 N--CA 1.466 0.671 0 C-N-CA 114.892 -3.528 . . . . 0.0 119.796 175.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 3.1 mm -139.7 137.55 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 122.32 3.06 . . . . 0.0 118.152 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -142.55 104.33 4.37 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.651 HG11 HD22 ' A' ' 20' ' ' LEU . 6.4 t -93.4 130.53 42.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 -171.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.1 m -119.21 145.14 46.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.675 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.683 HG12 ' HB ' ' A' ' 9' ' ' ILE . 2.1 m -131.09 122.94 52.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 122.057 -0.402 . . . . 0.0 110.683 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.48 130.78 55.48 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.964 ' HA ' HD12 ' A' ' 43' ' ' LEU . 1.3 p80 -150.57 71.22 8.99 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.36 178.77 5.97 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.462 2.108 . . . . 0.0 112.219 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -66.01 -40.05 90.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.962 0.411 . . . . 0.0 110.369 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 44' ' ' GLU . 11.1 mptt -84.72 1.05 48.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.096 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 39' ' ' HIS . 7.0 tt -19.33 -46.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 1.069 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -68.48 -54.61 15.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.711 0.291 . . . . 0.0 110.857 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.505 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -70.09 -37.59 75.45 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -60.2 -56.59 19.72 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.846 0.832 . . . . 0.0 109.861 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.7 ' CZ ' HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -41.76 -60.7 1.79 Allowed Pre-proline 0 C--N 1.352 0.693 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.31 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 1.069 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 29.2 Cg_exo -63.16 -25.18 72.73 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 121.617 1.544 . . . . 0.0 113.426 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -82.17 -35.57 28.23 Favored 'General case' 0 C--O 1.255 1.37 0 CA-C-O 122.171 0.986 . . . . 0.0 111.08 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.463 HG21 ' CZ2' ' A' ' 10' ' ' TRP . 29.2 m -77.78 -39.71 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.504 0 CA-C-O 122.04 0.924 . . . . 0.0 109.089 178.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.38 -37.82 26.35 Favored 'General case' 0 C--N 1.373 1.615 0 C-N-CA 126.048 1.739 . . . . 0.0 110.85 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.95 -42.4 21.33 Favored 'General case' 0 C--N 1.371 1.512 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.967 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 55' ' ' ASP . 1.2 m -73.69 145.93 44.87 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.578 1.081 . . . . 0.0 108.893 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 64.97 -78.35 0.07 OUTLIER Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.741 ' C ' ' HB1' ' A' ' 269' ' ' ALA . 1.4 t0 85.39 56.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 117.613 0.707 . . . . 0.0 111.672 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.581 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . -156.07 47.4 0.49 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 119.967 -1.111 . . . . 0.0 114.449 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.749 ' HD2' ' HB3' ' A' ' 269' ' ' ALA . 43.1 Cg_endo -100.15 -169.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.184 2.589 . . . . 0.0 112.093 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 1.001 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 4.1 t70 -88.24 -135.52 0.09 Allowed 'General case' 0 N--CA 1.414 -2.242 0 C-N-CA 123.123 0.569 . . . . 0.0 110.543 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.514 HG13 ' HA ' ' A' ' 266' ' ' ILE . 20.8 tt -103.08 163.67 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.886 HG22 ' HB2' ' A' ' 10' ' ' TRP . 10.3 pt -130.17 128.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 4.0 m-85 -107.17 124.33 49.55 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.471 ' CZ2' ' HG2' ' A' ' 44' ' ' GLU . 8.3 t90 -167.44 161.38 13.93 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -49.09 160.8 0.18 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.137 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.645 ' CD2' HG23 ' A' ' 97' ' ' VAL . 22.1 t-80 -77.56 -28.69 51.84 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.82 -58.85 3.82 Favored 'General case' 0 C--O 1.251 1.173 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.454 ' CB ' ' CZ3' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -75.49 -30.46 59.88 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.32 0.581 . . . . 0.0 110.038 179.555 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.58 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 2.2 m-30 -62.52 -27.08 68.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 174.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -60.82 -66.21 2.83 Favored Glycine 0 CA--C 1.49 -1.496 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.15 -53.66 43.84 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 113.218 -1.491 . . . . 0.0 111.256 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.476 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.9 m-30 -51.4 -42.84 61.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.729 ' HB2' HG21 ' A' ' 104' ' ' ILE . . . -54.58 -39.33 67.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.74 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -78.79 -43.14 26.08 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 111.666 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -70.22 -14.86 62.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.91 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.6 29.62 8.63 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.656 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 48' ' ' PRO . 8.1 mp -106.69 39.89 1.75 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.995 0.426 . . . . 0.0 110.424 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.736 ' C ' HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.37 145.4 0.25 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.366 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.868 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -96.1 115.3 27.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.969 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -47.68 129.68 13.96 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.806 HD12 ' HA ' ' A' ' 105' ' ' ALA . 14.6 mt -95.95 110.21 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.752 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.8 p -88.82 101.41 2.85 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.964 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 83.3 Cg_endo -101.24 -170.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.61 2.873 . . . . 0.0 113.161 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.19 -169.9 2.75 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.257 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.71 -44.08 7.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.532 0.206 . . . . 0.0 111.454 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -74.83 -23.54 58.47 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.725 ' HE1' HD21 ' A' ' 285' ' ' LEU . 6.5 t80 -64.62 -59.22 4.53 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.507 ' HG3' ' CG ' ' A' ' 94' ' ' TRP . 3.0 tt0 -70.13 -29.49 66.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.808 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 84' ' ' ALA . 12.6 t70 -76.82 -12.88 60.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.9 OUTLIER -87.81 -7.66 56.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.705 HD23 ' HB1' ' A' ' 303' ' ' ALA . 3.3 mp -100.91 -101.23 0.25 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.158 0.89 . . . . 0.0 111.584 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.19 133.18 10.56 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 122.102 -0.374 . . . . 0.0 111.056 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.0 -52.97 7.61 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.66 2.24 . . . . 0.0 112.934 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.462 ' CE1' ' HA ' ' A' ' 325' ' ' GLN . 45.2 t80 -55.53 -44.53 76.79 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.704 0.288 . . . . 0.0 111.08 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 302' ' ' VAL . 29.8 m -61.27 -29.04 69.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.507 ' CG ' ' HG3' ' A' ' 86' ' ' GLN . 86.3 m95 -92.97 -24.1 18.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.508 0.67 . . . . 0.0 112.136 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -73.82 -24.09 59.74 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.759 ' HB1' HG22 ' A' ' 261' ' ' VAL . . . -65.76 -21.66 66.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.271 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.645 HG23 ' CD2' ' A' ' 64' ' ' HIS . 6.7 p -125.28 58.03 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 102' ' ' LYS . 26.6 ttt180 -124.84 100.93 6.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.433 ' HH ' ' CG ' ' A' ' 332' ' ' ASN . 4.4 m-85 -89.07 90.9 8.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.169 0.44 . . . . 0.0 110.426 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 42.72 66.35 0.78 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.709 0.29 . . . . 0.0 110.87 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.22 38.98 58.67 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.593 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 4.7 mmtt -139.84 -177.61 5.05 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 119.446 -0.312 . . . . 0.0 110.792 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 97' ' ' VAL . 0.3 OUTLIER 175.34 107.85 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.601 0.637 . . . . 0.0 109.661 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.736 HD11 ' C ' ' A' ' 76' ' ' LEU . 3.6 tt -100.96 37.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.441 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.806 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . 170.21 149.14 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.544 ' CZ ' HG21 ' A' ' 79' ' ' ILE . 12.7 m-30 -88.2 120.3 70.53 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.617 ' HB3' HG12 ' A' ' 261' ' ' VAL . 2.9 Cg_endo -78.94 155.28 26.36 Favored 'Trans proline' 0 CA--C 1.514 -0.478 0 C-N-CA 121.917 1.745 . . . . 0.0 112.847 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 262' ' ' LEU . 0.5 OUTLIER -157.11 38.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.142 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 1.015 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 170.23 134.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.937 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.031 HG22 HG21 ' A' ' 302' ' ' VAL . 17.2 m -114.8 133.74 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.936 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.6 ' HB2' ' HA3' ' A' ' 260' ' ' GLY . 0.6 OUTLIER -99.57 136.1 40.0 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 1.038 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -167.97 -173.68 2.15 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 123.411 1.577 . . . . 0.0 110.307 -167.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.73 HD13 ' CD1' ' A' ' 156' ' ' PHE . 0.1 OUTLIER -146.12 135.57 23.02 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 110.598 -3.001 . . . . 0.0 116.246 -176.068 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.46 ' HA ' HD12 ' A' ' 247' ' ' LEU . 0.9 OUTLIER -131.09 165.17 23.84 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.051 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.906 HD23 ' OH ' ' A' ' 117' ' ' TYR . 6.2 tp -93.21 130.79 38.78 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.848 HD13 ' N ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -115.25 136.16 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.169 -179.497 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.906 ' OH ' HD23 ' A' ' 115' ' ' LEU . 14.1 m-85 -121.48 140.83 51.67 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -86.1 122.0 29.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -106.2 29.06 7.1 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.956 0.407 . . . . 0.0 111.515 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -131.43 -51.05 1.0 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.23 -136.89 0.02 OUTLIER 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.249 -1.796 . . . . 0.0 107.685 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.768 HD23 ' HD2' ' A' ' 123' ' ' PRO . 2.0 mt -84.45 128.93 59.62 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.768 ' HD2' HD23 ' A' ' 122' ' ' LEU . 33.5 Cg_exo -56.28 161.78 8.68 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.374 2.716 . . . . 0.0 110.997 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 8.4 p-10 -106.36 158.21 33.15 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.631 0.253 . . . . 0.0 111.042 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 19.9 Cg_endo -60.26 164.4 12.77 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.4 2.066 . . . . 0.0 111.833 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.423 ' HB2' ' HG3' ' A' ' 127' ' ' LYS . 4.0 Cg_exo -77.39 -42.35 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.801 2.334 . . . . 0.0 112.726 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.423 ' HG3' ' HB2' ' A' ' 126' ' ' PRO . 2.8 mttp -153.49 -10.72 0.15 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -119.45 139.56 51.86 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.802 1.183 . . . . 0.0 112.961 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.707 ' CH2' HD21 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -69.25 -23.76 63.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 172.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -44.82 -23.89 0.17 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.248 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.458 ' OE2' ' HB3' ' A' ' 134' ' ' ALA . 5.3 tp10 -66.83 -26.4 66.91 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.593 HG13 ' HD2' ' A' ' 133' ' ' PRO . 0.2 OUTLIER -40.47 -53.06 5.76 Favored Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.378 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.813 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 6.6 Cg_endo -48.82 -43.83 33.59 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 120.699 0.933 . . . . 0.0 110.049 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.458 ' HB3' ' OE2' ' A' ' 131' ' ' GLU . . . -74.68 -58.6 3.19 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 139' ' ' LEU . 32.7 tp -66.32 -40.41 89.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.208 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.636 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 3.3 m-20 -70.74 -35.7 72.79 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -47.69 -50.23 25.52 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.455 176.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 4.3 mp0 -61.87 -40.48 95.52 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.337 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.835 HD22 ' O ' ' A' ' 145' ' ' SER . 0.4 OUTLIER -61.79 -48.44 80.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -48.07 -43.9 30.94 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.02 -27.8 1.02 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -58.95 1.83 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.285 0.564 . . . . 0.0 110.239 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.81 40.19 0.02 OUTLIER Glycine 0 CA--C 1.519 0.319 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.299 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.501 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -152.83 -171.81 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 119.298 1.549 . . . . 0.0 111.501 -175.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.835 ' O ' HD22 ' A' ' 139' ' ' LEU . 5.0 m -138.76 158.24 44.6 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.731 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -73.35 -33.34 65.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.1 pp -135.38 129.23 33.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.83 ' N ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -133.4 134.91 44.25 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.092 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.68 ' CE2' HD13 ' A' ' 147' ' ' LEU . 21.4 p90 -172.31 177.18 3.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.511 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -36.53 164.93 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.366 0.416 . . . . 0.0 111.485 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.743 HD11 ' HB1' ' A' ' 206' ' ' ALA . 2.8 tm? -114.03 -57.71 2.24 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.415 ' OE1' HD11 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -104.47 34.59 3.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 116.166 -2.213 . . . . 0.0 114.693 -174.17 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.792 ' O ' ' OG1' ' A' ' 157' ' ' THR . 0.0 OUTLIER -79.81 140.32 54.52 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 121.279 1.854 . . . . 0.0 113.391 -176.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.957 ' O ' ' N ' ' A' ' 156' ' ' PHE . 84.5 Cg_endo -77.88 -135.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.376 3.384 . . . . 0.0 104.322 175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 1.152 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 1.4 m-85 28.93 -59.95 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.038 1.29 . . . . 0.0 113.643 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.957 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -85.41 -61.85 1.67 Allowed 'General case' 0 C--O 1.258 1.544 0 CA-C-N 118.777 0.717 . . . . 0.0 112.534 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.792 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 8.5 p -59.2 -40.67 86.48 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.181 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.692 ' O ' HG13 ' A' ' 161' ' ' ILE . 1.1 m95 -51.24 -55.53 27.86 Favored Pre-proline 0 C--N 1.353 0.733 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 1.152 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 78.1 Cg_exo -43.38 -44.31 10.46 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.598 2.199 . . . . 0.0 113.201 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 255' ' ' SER . 7.3 mp -63.6 -56.69 13.94 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.002 0.819 . . . . 0.0 110.388 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.692 HG13 ' O ' ' A' ' 158' ' ' TRP . 2.4 pp -53.72 -19.33 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.296 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.666 ' N ' HD12 ' A' ' 161' ' ' ILE . . . -78.61 -22.03 47.63 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.254 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -41.87 -59.26 1.75 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' A' ' 190' ' ' ALA . 45.7 t0 -64.35 -14.26 55.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -175.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 134.06 20.26 0.85 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 118.73 -1.7 . . . . 0.0 116.525 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.51 160.14 41.38 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 119.064 1.432 . . . . 0.0 111.423 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -145.61 136.0 24.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.336 0.568 . . . . 0.0 110.374 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.2 -80.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.358 0.599 . . . . 0.0 111.765 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.637 ' HB2' ' CG ' ' A' ' 176' ' ' TYR . 14.5 m-85 -113.13 173.8 6.21 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.576 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 1.194 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 6.5 mmtt -100.48 103.75 15.11 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.485 ' CD2' ' CE1' ' A' ' 176' ' ' TYR . 0.4 OUTLIER -85.04 115.25 22.75 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.586 176.262 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.886 ' O ' ' N ' ' A' ' 174' ' ' GLY . 1.1 tp10 -137.28 101.67 4.59 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.056 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.0 m120 44.42 -66.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 O-C-N 123.619 0.575 . . . . 0.0 110.656 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.886 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -70.66 -73.35 0.79 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 115.664 -0.698 . . . . 0.0 114.346 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -174.66 158.04 2.64 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 117.994 0.897 . . . . 0.0 110.677 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 1.194 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -56.29 -33.66 65.73 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.33 1.062 . . . . 0.0 108.256 177.005 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 1.0 OUTLIER 67.94 -85.71 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.862 179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 6.7 tp 175.02 -41.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.0 OUTLIER -66.38 -10.55 44.6 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.441 ' CB ' ' HB2' ' A' ' 170' ' ' LYS . 2.1 m-20 -124.56 93.75 3.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.58 121.54 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -123.23 39.72 2.16 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.698 -1.239 . . . . 0.0 113.959 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 184' ' ' ASP . 12.8 p -80.2 -44.14 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.028 0.442 . . . . 0.0 109.982 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.923 ' HB2' HD23 ' A' ' 361' ' ' LEU . 9.4 t70 -81.27 59.08 3.8 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.758 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -104.76 173.2 6.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.464 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.19 -28.11 62.54 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.352 0.596 . . . . 0.0 111.571 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -71.31 -45.97 44.79 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.09 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -60.41 -44.79 95.37 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HG3' HG21 ' A' ' 357' ' ' VAL . 5.5 tttp -57.8 -60.01 4.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.325 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.37 -40.94 50.88 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.088 0.947 . . . . 0.0 112.017 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -62.88 -60.65 7.39 Favored Glycine 0 C--O 1.24 0.485 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.086 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 196' ' ' VAL . 5.6 tp -59.49 -25.05 64.12 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 99.0 m -60.74 -50.2 74.42 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.499 ' CZ ' ' CE1' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -59.85 -37.26 78.76 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 tp -63.28 -47.58 81.75 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.631 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 192' ' ' LEU . 44.6 t -57.68 -28.76 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.508 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.11 -45.62 80.49 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.855 0.836 . . . . 0.0 111.039 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.458 ' HG ' HD13 ' A' ' 132' ' ' ILE . 4.3 tt -59.46 -51.95 67.67 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.851 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 204' ' ' MET . 6.6 mt -66.62 -40.25 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.96 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 4.9 tppt? -52.68 -36.91 57.94 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.626 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -113.18 -34.57 5.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 121.157 3.762 . . . . 0.0 121.157 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -63.73 -80.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.967 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.08 -9.67 27.58 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.563 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 4.8 ptt? 42.15 36.24 0.68 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.611 ' O ' ' HB3' ' A' ' 206' ' ' ALA . 0.7 OUTLIER -145.16 -73.34 0.25 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.743 ' HB1' HD11 ' A' ' 151' ' ' LEU . . . 84.41 37.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -97.74 -3.08 39.79 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 34.8 p -55.08 117.19 3.25 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.97 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.91 -173.64 4.17 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.3 p90 -70.63 -45.28 65.49 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 1.7 t -73.72 -32.73 64.03 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.711 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.75 -48.66 23.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.74 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.01 -32.19 70.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.06 -45.36 92.57 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 218' ' ' ASN . . . -58.75 -40.73 84.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.959 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.21 -57.09 10.72 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.09 -29.52 69.87 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.419 ' HB2' ' HA ' ' A' ' 215' ' ' ALA . 0.7 OUTLIER -52.69 -37.45 58.93 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.443 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -74.24 -23.89 59.22 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.04 53.63 5.65 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 114.7 0.64 . . . . 0.0 114.7 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -124.5 37.64 4.36 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.35 1.075 . . . . 0.0 111.609 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.83 HG21 ' N ' ' A' ' 148' ' ' MET . 2.2 m -142.22 140.9 32.45 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.731 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -113.13 38.79 2.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.618 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.658 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER 178.85 126.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 177.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.746 HG23 ' CG2' ' A' ' 116' ' ' ILE . 1.8 t -147.16 165.99 28.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.433 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.533 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 0.1 OUTLIER -100.49 146.02 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 172.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 114' ' ' SER . 2.3 t-20 -146.4 166.33 26.68 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.182 1.355 . . . . 0.0 109.953 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 112' ' ' ALA . . . -176.11 130.41 1.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.294 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.67 -29.66 3.59 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.846 2.364 . . . . 0.0 113.219 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.421 ' HA ' ' CG ' ' A' ' 111' ' ' GLU . 29.7 t-105 -33.66 -72.87 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.94 -41.9 8.18 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.24 166.53 18.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.907 0.384 . . . . 0.0 111.714 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 t -124.49 -62.07 1.28 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.52 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -99.32 139.69 34.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.691 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.8 HD11 ' CE1' ' A' ' 242' ' ' TYR . 25.4 pt -84.07 173.7 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.283 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.17 176.15 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.722 0.296 . . . . 0.0 110.995 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.05 83.43 0.33 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.965 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.405 ' O ' ' CE1' ' A' ' 242' ' ' TYR . 41.2 t -129.77 70.51 1.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.786 0.327 . . . . 0.0 110.682 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.429 ' O ' ' CZ ' ' A' ' 242' ' ' TYR . 0.0 OUTLIER 65.83 109.72 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.607 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.43 ' O ' ' CD2' ' A' ' 242' ' ' TYR . 58.4 t -45.29 -34.66 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.854 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -79.76 107.23 12.37 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.69 0.281 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.8 ' CE1' HD11 ' A' ' 235' ' ' ILE . 48.0 m-85 -118.46 134.04 55.39 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.245 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.96 105.25 2.3 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.202 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.0 t -90.96 111.59 23.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.78 167.41 18.12 Favored 'General case' 0 CA--C 1.527 0.067 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.1 m -73.36 153.66 7.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.522 HD23 ' OG ' ' A' ' 255' ' ' SER . 0.3 OUTLIER -59.26 159.04 16.74 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 119.784 1.175 . . . . 0.0 111.414 -178.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.706 ' HD3' HD13 ' A' ' 115' ' ' LEU . 90.4 Cg_endo -79.51 -165.08 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.035 2.49 . . . . 0.0 112.496 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -119.27 175.58 5.73 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.929 0.395 . . . . 0.0 111.763 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.499 ' CE1' ' CZ ' ' A' ' 194' ' ' PHE . 98.0 m-85 -166.13 111.05 0.82 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.957 0.884 . . . . 0.0 108.811 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 7.8 mttp 62.43 31.09 17.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.809 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.0 31.14 40.12 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.302 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.405 ' N ' HG22 ' A' ' 249' ' ' THR . 1.1 mm-40 -156.59 153.03 23.84 Favored Pre-proline 0 N--CA 1.463 0.179 0 CA-C-N 117.381 0.59 . . . . 0.0 112.251 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -87.88 170.36 6.25 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.209 2.606 . . . . 0.0 112.189 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.522 ' OG ' HD23 ' A' ' 247' ' ' LEU . 0.0 OUTLIER -91.03 144.34 25.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.803 0.335 . . . . 0.0 111.411 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 2.2 mttt -86.58 108.3 17.42 Favored Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.066 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.642 ' CB ' HD21 ' A' ' 113' ' ' LEU . 88.2 Cg_endo -79.55 153.35 23.5 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.273 1.982 . . . . 0.0 112.717 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 2.5 t80 -79.19 164.39 24.24 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.767 ' CB ' HG22 ' A' ' 329' ' ' ILE . 15.5 t -121.8 127.56 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.6 ' HA3' ' HB2' ' A' ' 111' ' ' GLU . . . -123.69 117.79 3.28 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 119.257 -1.449 . . . . 0.0 115.871 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.759 HG22 ' HB1' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -103.87 115.31 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.527 179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 1.015 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.5 mm? -94.22 93.63 7.87 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -111.28 -177.71 3.27 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -172.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.631 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -108.67 128.31 54.74 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 60' ' ' ILE . . . -122.87 127.8 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.82 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.639 HD12 HG12 ' A' ' 79' ' ' ILE . 24.7 mt -87.84 121.48 38.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.65 142.9 56.88 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.868 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -57.35 -26.46 61.02 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.149 -0.345 . . . . 0.0 110.78 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.749 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . . . -50.82 -59.89 3.64 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.921 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 271' ' ' PRO . 19.2 p -135.64 154.11 77.95 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.728 0.299 . . . . 0.0 111.413 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 270' ' ' SER . 15.3 Cg_endo -88.58 -66.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.054 2.503 . . . . 0.0 112.735 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 55.4 45.77 24.67 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 110.125 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 2.0 ttpt -60.32 -54.19 48.7 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.782 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 24.6 tp10 -50.2 -57.6 7.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.902 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.667 HD21 HD11 ' A' ' 33' ' ' ILE . 10.0 tp -64.93 -58.09 7.06 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.98 -56.69 5.65 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.2 OUTLIER -54.22 -38.55 65.83 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 1.9 tp10 -76.34 -53.14 8.6 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -56.17 -56.36 21.91 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.611 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.733 HD21 HD22 ' A' ' 284' ' ' LEU . 7.2 tt -52.32 -43.91 64.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.675 0.75 . . . . 0.0 111.67 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.698 ' O ' HD23 ' A' ' 285' ' ' LEU . 31.0 tt0 -73.2 -34.27 65.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.651 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -91.57 -14.71 29.82 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.874 ' O ' HG22 ' A' ' 286' ' ' THR . 0.2 OUTLIER -102.45 -65.49 0.99 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.237 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.733 HD22 HD21 ' A' ' 280' ' ' LEU . 6.3 tp -43.2 -22.7 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.601 -0.44 . . . . 0.0 112.097 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 1.067 HD13 HD11 ' A' ' 304' ' ' LEU . 3.8 mm? -101.37 37.38 1.8 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.002 -0.436 . . . . 0.0 110.721 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.874 HG22 ' O ' ' A' ' 283' ' ' TYR . 11.3 t -145.01 158.72 43.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 4.4 p30 -65.97 -11.66 49.3 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.603 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 5.5 tp10 -77.89 -47.12 19.47 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 109.993 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.607 ' O ' ' HB ' ' A' ' 293' ' ' VAL . . . -82.64 -49.49 5.11 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 1.027 HD11 HD13 ' A' ' 304' ' ' LEU . 8.4 mt -61.75 -51.24 69.17 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.631 0.254 . . . . 0.0 111.383 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.509 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 2.9 tp10 -76.08 -27.9 57.37 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.059 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.603 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -71.57 -27.73 63.35 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.957 HG13 ' HG3' ' A' ' 298' ' ' PRO . 1.1 t -65.72 -61.0 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.798 175.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.571 ' N ' HG12 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -35.02 -50.31 0.49 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.313 1.445 . . . . 0.0 112.323 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 296' ' ' ASP . 20.2 ttpt -48.79 -43.9 38.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.254 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 295' ' ' LYS . 2.6 m-20 154.41 68.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.721 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.841 ' H ' ' HD2' ' A' ' 298' ' ' PRO . 0.5 OUTLIER -120.75 -37.95 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.023 171.293 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.957 ' HG3' HG13 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -91.61 -120.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 124.761 3.641 . . . . 0.0 113.283 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.847 HD13 ' CD1' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -160.78 -41.38 0.05 OUTLIER 'General case' 0 C--N 1.356 0.883 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -129.08 -155.59 8.6 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.56 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.898 ' HB3' ' CG1' ' A' ' 317' ' ' ILE . . . -133.25 48.15 2.42 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.115 0.958 . . . . 0.0 112.46 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 1.031 HG21 HG22 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -140.78 92.26 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.686 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.801 ' O ' HD12 ' A' ' 304' ' ' LEU . . . 177.69 48.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 1.067 HD11 HD13 ' A' ' 285' ' ' LEU . 0.0 OUTLIER 158.48 99.11 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.314 0.246 . . . . 0.0 111.42 178.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -38.37 -32.64 0.08 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 20.0 m -78.66 -44.22 24.25 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.473 1.13 . . . . 0.0 109.572 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.908 ' CD2' HD22 ' A' ' 290' ' ' LEU . 19.6 t80 -70.57 -20.03 62.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 112.87 -1.968 . . . . 0.0 110.249 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.777 ' OE2' HG21 ' A' ' 317' ' ' ILE . 7.9 tp10 -76.28 -43.14 43.02 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.0 -58.6 5.67 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.724 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -54.09 -52.9 59.49 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.246 0.546 . . . . 0.0 110.5 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.76 ' O ' HD23 ' A' ' 311' ' ' LEU . 2.3 tt -70.91 -28.04 64.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.932 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -45.92 -20.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -34.19 -42.67 0.13 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.543 0.61 . . . . 0.0 109.704 178.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -88.76 121.7 69.7 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.58 9.51 1.87 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.591 2.194 . . . . 0.0 115.467 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.404 ' O ' ' OG1' ' A' ' 320' ' ' THR . 5.6 mtm-85 -60.23 -59.82 4.81 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.706 0.684 . . . . 0.0 111.256 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.898 ' CG1' ' HB3' ' A' ' 301' ' ' ALA . 5.2 mm -49.76 -55.35 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.68 -52.05 11.43 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.38 0.536 . . . . 0.0 111.757 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -71.66 -33.42 68.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.543 0.687 . . . . 0.0 109.351 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' THR . . . . . 1.038 HG23 ' HB3' ' A' ' 112' ' ' ALA . 94.6 m -62.02 -37.06 83.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.387 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.451 ' HG2' ' CD2' ' A' ' 92' ' ' PHE . 5.6 ttm -79.03 -44.93 21.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.693 0.282 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -54.0 -45.91 71.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.221 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.512 ' ND2' HD13 ' A' ' 247' ' ' LEU . 2.8 t-20 -78.3 -51.95 9.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.226 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . . . -48.64 -33.82 10.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.694 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.462 ' HA ' ' CE1' ' A' ' 92' ' ' PHE . 0.9 OUTLIER -63.33 -39.94 95.94 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.51 0.195 . . . . 0.0 110.998 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -104.74 60.67 0.7 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.595 0.236 . . . . 0.0 111.08 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 257' ' ' PRO . . . -140.71 -147.18 4.91 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.12 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -127.32 111.77 14.29 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.767 HG22 ' CB ' ' A' ' 259' ' ' VAL . 1.8 pp -87.15 134.11 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.455 ' HG2' ' CE2' ' A' ' 258' ' ' PHE . 0.0 OUTLIER -41.03 105.33 0.38 Allowed Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.428 ' HD2' ' CE ' ' A' ' 330' ' ' MET . 96.2 Cg_exo -43.9 -34.89 6.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.676 2.251 . . . . 0.0 112.603 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.433 ' CG ' ' HH ' ' A' ' 99' ' ' TYR . 9.5 m120 79.06 51.3 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.478 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 335' ' ' GLN . 4.0 pt -133.82 156.65 79.19 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.804 0.335 . . . . 0.0 111.143 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.71 -31.51 39.8 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.636 2.224 . . . . 0.0 112.76 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.732 ' HB2' HD12 ' A' ' 333' ' ' ILE . 8.9 mm100 -59.85 -21.83 61.48 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.421 ' HG2' ' HE3' ' A' ' 330' ' ' MET . 12.0 tpp -45.56 -36.7 4.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.589 0.233 . . . . 0.0 111.372 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 2.1 p -58.1 -38.88 77.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.698 0.285 . . . . 0.0 110.348 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.948 ' HB1' ' CD1' ' A' ' 368' ' ' ILE . . . -55.6 -33.37 63.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.962 0.411 . . . . 0.0 111.307 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 343' ' ' VAL . 0.2 OUTLIER -78.51 -55.83 4.91 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.499 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.412 ' CE3' ' HA ' ' A' ' 340' ' ' TRP . 0.1 OUTLIER -44.33 -43.0 7.18 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.795 0.331 . . . . 0.0 111.025 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.99 -42.77 56.89 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.692 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.27 -45.84 72.03 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.706 ' CG2' HG21 ' A' ' 347' ' ' VAL . 9.9 p -69.62 -42.06 80.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.439 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -58.55 -59.29 5.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.698 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 9.8 m -56.39 -56.7 17.84 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.83 -60.83 2.06 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.706 HG21 ' CG2' ' A' ' 343' ' ' VAL . 48.5 t -54.56 -53.45 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 344' ' ' ARG . 1.9 tt -62.31 -46.68 95.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.031 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.419 ' N ' ' CG2' ' A' ' 348' ' ' ILE . 64.8 t-20 -64.64 -47.7 77.56 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' A' ' 355' ' ' GLN . . . -73.37 -26.65 61.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -53.22 -11.26 0.26 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.3 p -110.46 36.77 2.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.585 0.63 . . . . 0.0 110.088 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.53 -3.42 87.06 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 118.711 -1.709 . . . . 0.0 113.691 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -87.3 34.92 0.69 Allowed 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 115.65 -2.119 . . . . 0.0 107.886 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.685 ' HA ' ' HB1' ' A' ' 350' ' ' ALA . 2.9 pp0? -71.17 -173.71 0.89 Allowed 'General case' 0 C--N 1.348 0.543 1 N-CA-C 123.34 4.57 . . . . 0.0 123.34 -159.425 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.504 ' HB ' ' CB ' ' A' ' 359' ' ' GLU . 0.0 OUTLIER -179.62 46.8 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.54 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.557 HG23 ' OE1' ' A' ' 355' ' ' GLN . 84.3 t -42.27 -49.85 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.863 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -61.33 -35.04 76.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 119.948 1.249 . . . . 0.0 109.611 178.403 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.504 ' CB ' ' HB ' ' A' ' 356' ' ' THR . 1.5 mm-40 -79.18 -26.97 42.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.441 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 356' ' ' THR . . . -66.8 -53.26 34.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 122.085 0.945 . . . . 0.0 111.824 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.923 HD23 ' HB2' ' A' ' 184' ' ' ASP . 0.2 OUTLIER -82.24 -50.48 8.94 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.787 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.654 ' O ' HG23 ' A' ' 366' ' ' THR . 2.3 mmpt? -45.18 -53.04 8.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -65.13 -41.42 94.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.402 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.525 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -66.52 -58.19 5.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.611 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.525 ' HB2' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -62.16 -44.32 96.87 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.984 -0.447 . . . . 0.0 111.969 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 362' ' ' LYS . 52.7 p -56.24 -59.79 4.43 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -51.57 25.65 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.511 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.948 ' CD1' ' HB1' ' A' ' 338' ' ' ALA . 32.8 mm -60.47 -42.84 92.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 369' ' ' THR . 1.3 p -114.15 55.63 0.73 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.917 0.389 . . . . 0.0 111.103 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.828 179.759 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 tptp . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.637 0.256 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 p -112.64 134.69 54.04 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.873 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -134.96 111.02 9.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -145.01 173.91 11.48 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.91 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -111.31 68.3 0.22 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.493 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.0 159.04 44.58 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -156.12 118.37 4.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 58' ' ' ASP . 15.3 t -108.72 140.47 27.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 118.771 -1.172 . . . . 0.0 110.003 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.804 HD12 HD11 ' A' ' 59' ' ' ILE . 10.3 tt -136.51 124.74 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.402 0.62 . . . . 0.0 111.122 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 1.002 ' CH2' HD22 ' A' ' 43' ' ' LEU . 30.7 t90 -101.46 133.32 46.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.226 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.686 HD11 HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -149.18 165.09 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 12' ' ' ASN . 3.2 p-10 -91.85 61.64 4.17 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.543 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.75 41.47 57.84 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.059 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 58.4 t0 -50.35 -31.66 15.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 111.438 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 105.15 -18.06 0.02 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.246 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.444 ' HA2' ' CG ' ' A' ' 296' ' ' ASP . . . -75.48 56.42 2.9 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 115.921 1.129 . . . . 0.0 115.921 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -75.96 -31.8 59.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.495 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 1.4 t30 -67.98 -47.14 69.37 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.152 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.569 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -72.14 -49.16 22.5 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.739 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.7 mt -60.02 -51.03 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.394 0.597 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.37 -37.08 84.48 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.591 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 9.6 tt0 -67.02 -37.44 84.14 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.449 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 19' ' ' GLY . 2.7 p -68.0 -61.03 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.14 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' H ' HG13 ' A' ' 23' ' ' VAL . . . -49.12 -33.03 13.59 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.803 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -50.5 72.68 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 122.481 1.134 . . . . 0.0 108.418 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 21.8 mttt -51.81 -41.2 61.56 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 112.865 -1.971 . . . . 0.0 108.202 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.732 ' HB3' ' CB ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.84 -35.9 81.97 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.915 0.864 . . . . 0.0 111.052 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.784 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 5.1 tt0 -69.78 -50.63 41.31 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.331 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -51.23 -30.27 16.93 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 124.909 1.381 . . . . 0.0 111.25 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.84 ' O ' HG23 ' A' ' 31' ' ' THR . 1.5 t70 -82.72 -39.15 22.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 116.921 -1.514 . . . . 0.0 108.872 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.84 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 162.29 37.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 116.616 -2.033 . . . . 0.0 116.35 170.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.694 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 155.5 38.58 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 115.428 -3.273 . . . . 0.0 117.354 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.784 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 4.1 mp -139.31 100.94 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 121.09 2.445 . . . . 0.0 114.86 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -107.21 105.24 15.12 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 7.8 m -97.14 132.75 40.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.05 146.67 45.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.315 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.794 HG12 ' CG2' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -133.22 122.74 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 122.199 -0.313 . . . . 0.0 110.687 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -107.19 137.24 45.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.945 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.488 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -71.56 -177.9 0.54 Allowed Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.392 0.677 . . . . 0.0 111.912 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 30.7 Cg_endo -91.96 -172.67 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.302 2.668 . . . . 0.0 113.757 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 40' ' ' PRO . 9.8 t70 144.81 -72.29 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.862 0.865 . . . . 0.0 109.39 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -108.4 1.05 21.46 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.716 178.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.002 HD22 ' CH2' ' A' ' 10' ' ' TRP . 2.2 tp -19.37 -56.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.996 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 2.1 tm-20 -60.42 -55.11 37.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -75.53 -55.46 5.65 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.581 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -55.49 -57.96 9.74 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.923 -178.011 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -49.62 -57.72 11.28 Favored Pre-proline 0 C--N 1.353 0.76 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.25 -177.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 1.097 ' HA ' HD13 ' A' ' 75' ' ' LEU . 24.6 Cg_exo -62.76 -21.2 72.81 Favored 'Trans proline' 0 C--O 1.252 1.2 0 CA-C-N 121.6 1.607 . . . . 0.0 112.325 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.68 ' O ' HG23 ' A' ' 53' ' ' THR . 61.1 tt0 -81.97 -39.72 23.25 Favored 'General case' 0 C--O 1.258 1.529 0 CA-C-O 122.561 1.172 . . . . 0.0 111.711 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 47' ' ' PHE . 17.1 m -77.93 -40.71 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.552 0 CA-C-O 122.247 1.023 . . . . 0.0 110.536 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.678 ' CB ' ' HB2' ' A' ' 269' ' ' ALA . . . -49.68 -37.88 30.56 Favored 'General case' 0 C--N 1.378 1.831 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.438 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.18 -33.57 32.92 Favored 'General case' 0 C--N 1.368 1.403 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.437 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 49' ' ' GLN . 19.0 p -65.62 -41.06 93.15 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.186 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 55' ' ' ASP . . . -114.69 -70.73 0.51 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.458 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 5.8 m-20 89.02 47.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.851 0.826 . . . . 0.0 109.888 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.11 175.94 21.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 120.531 -0.842 . . . . 0.0 114.642 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 58' ' ' ASP . 82.4 Cg_exo -43.86 131.98 8.05 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.567 2.845 . . . . 0.0 111.909 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.569 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 2.0 p30 158.2 125.96 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.804 HD11 HD12 ' A' ' 9' ' ' ILE . 1.8 pt -117.15 178.38 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 76' ' ' LEU . 2.7 pt -149.29 136.7 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.505 ' CZ ' HD11 ' A' ' 108' ' ' ILE . 4.7 t80 -109.99 122.76 48.31 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 23.2 t-105 -166.75 166.37 15.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -45.35 158.73 0.07 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.63 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.595 ' CG ' ' CG1' ' A' ' 97' ' ' VAL . 4.5 t-80 -77.27 -27.09 53.02 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 331' ' ' PRO . 9.9 p30 -53.34 -52.99 57.43 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-O 121.808 0.813 . . . . 0.0 111.893 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 18.9 mmm180 -73.4 -31.77 64.07 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.446 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.671 ' HA ' HD22 ' A' ' 76' ' ' LEU . 6.2 m-30 -60.26 -32.72 71.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 174.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -54.69 -66.87 2.5 Favored Glycine 0 C--O 1.25 1.152 0 CA-C-O 123.038 1.355 . . . . 0.0 111.616 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 70' ' ' TYR . . . -78.54 -55.67 3.86 Favored Glycine 0 C--N 1.357 1.73 0 CA-C-N 113.095 -1.553 . . . . 0.0 112.734 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.999 ' O ' ' N ' ' A' ' 75' ' ' LEU . 6.9 m-30 -42.01 -37.37 1.34 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.992 ' CB ' HG21 ' A' ' 104' ' ' ILE . . . -73.37 -58.76 3.09 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 117.852 -1.539 . . . . 0.0 112.432 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -46.96 68.35 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.434 1.016 . . . . 0.0 112.72 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 p -114.58 25.72 10.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.2 -87.48 0.06 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 118.539 -1.791 . . . . 0.0 114.909 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.097 HD13 ' HA ' ' A' ' 48' ' ' PRO . 1.2 tp -155.32 97.22 1.88 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.79 HD12 ' HA ' ' A' ' 267' ' ' ASN . 1.2 tp 179.33 144.36 0.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.068 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 1.02 ' O ' HD11 ' A' ' 266' ' ' ILE . . . -95.68 109.42 21.7 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.504 ' HA ' HG12 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -49.07 103.27 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.181 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.963 HG23 HD13 ' A' ' 266' ' ' ILE . 0.0 OUTLIER -61.91 173.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.128 0.489 . . . . 0.0 111.193 -179.047 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.487 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -88.06 175.38 4.22 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.086 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 80' ' ' THR . 79.1 Cg_endo -79.55 133.18 10.38 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.336 2.024 . . . . 0.0 113.629 -178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -152.87 68.06 0.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.323 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -47.36 -32.27 4.71 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -47.71 -29.03 2.75 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.489 ' CE1' HD21 ' A' ' 285' ' ' LEU . 1.3 m-85 -74.71 -59.32 2.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.805 0.335 . . . . 0.0 111.19 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.486 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 8.2 tm0? -70.36 -24.48 62.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -76.04 -43.89 41.76 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -11.07 59.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.88 ' CD2' ' HB1' ' A' ' 303' ' ' ALA . 0.3 OUTLIER -105.57 -170.61 1.77 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.976 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -78.19 145.96 69.99 Favored Pre-proline 0 C--O 1.232 0.154 0 CA-C-O 120.649 0.261 . . . . 0.0 110.543 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 95' ' ' ASP . 53.1 Cg_endo -69.75 -39.74 6.17 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.479 2.119 . . . . 0.0 112.596 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 325' ' ' GLN . 1.9 m-85 -59.74 -57.34 13.35 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -28.06 68.81 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.799 ' CZ3' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -93.68 -22.86 18.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.735 ' O ' HD11 ' A' ' 329' ' ' ILE . 15.8 t0 -71.64 -24.69 61.91 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.949 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 329' ' ' ILE . . . -69.0 -23.38 64.09 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.882 HG13 HG11 ' A' ' 261' ' ' VAL . 22.9 m -122.37 48.76 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.159 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' ' CD1' ' A' ' 103' ' ' LEU . 6.8 tmm_? -125.51 100.41 6.46 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 101' ' ' GLY . 3.6 m-85 -87.43 90.97 8.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.288 0.494 . . . . 0.0 110.197 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 48.14 -86.88 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.882 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . -132.67 42.15 1.41 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -145.48 -177.58 5.64 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 119.519 -0.277 . . . . 0.0 111.193 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.58 HD21 ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER 167.82 112.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.624 0.647 . . . . 0.0 110.617 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.992 HG21 ' CB ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -98.67 38.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.479 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.755 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . 166.01 174.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.582 ' OH ' HD13 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -129.64 129.47 23.14 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.071 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.675 ' HG3' HG21 ' A' ' 97' ' ' VAL . 3.6 Cg_exo -79.72 162.26 24.31 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.866 2.377 . . . . 0.0 112.416 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 262' ' ' LEU . 1.1 pt -156.15 38.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.092 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.774 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 1.066 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -176.21 145.38 0.61 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.724 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 110' ' ' VAL . 14.0 p -128.73 114.03 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 324' ' ' ALA . 17.4 mm-40 -102.99 161.79 13.46 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.279 0.561 . . . . 0.0 109.749 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -165.25 147.24 7.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.758 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 HD11 ' A' ' 247' ' ' LEU . 3.0 tt -79.06 129.3 34.3 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.4 OUTLIER -135.12 159.65 40.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.511 HD11 ' HE1' ' A' ' 224' ' ' MET . 7.2 tt -92.61 131.18 37.94 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.749 HD12 HG22 ' A' ' 244' ' ' VAL . 0.9 OUTLIER -114.82 137.6 47.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.412 ' CE2' ' CD2' ' A' ' 115' ' ' LEU . 13.5 m-85 -106.07 133.38 50.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.916 ' HB3' HD23 ' A' ' 122' ' ' LEU . 14.8 m120 -88.58 125.9 35.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.559 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.33 -59.25 2.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.43 0.559 . . . . 0.0 112.209 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.5 ' OD2' HG13 ' A' ' 240' ' ' VAL . 0.4 OUTLIER -38.31 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 122.426 1.108 . . . . 0.0 111.203 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.84 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -102.82 42.42 1.15 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 112.739 -2.028 . . . . 0.0 112.442 -175.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.093 HD12 ' HB2' ' A' ' 223' ' ' ALA . 1.7 mm? -147.5 140.25 14.64 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 118.847 -1.141 . . . . 0.0 113.068 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 223' ' ' ALA . 50.9 Cg_endo -90.97 163.51 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.789 1 C-N-CA 125.492 4.128 . . . . 0.0 113.493 -179.158 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -61.42 106.07 0.73 Allowed Pre-proline 0 N--CA 1.465 0.296 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.773 -174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 95.3 Cg_endo -99.0 168.27 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 124.882 3.721 . . . . 0.0 114.808 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.794 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 35.8 Cg_exo -27.5 153.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 125.276 3.984 . . . . 0.0 116.19 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -135.81 -21.33 1.48 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.895 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.52 154.47 51.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -59.9 -53.93 52.13 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.137 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 133' ' ' PRO . 13.5 tt0 -45.45 -24.22 0.29 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.479 ' HG2' HD12 ' A' ' 135' ' ' LEU . 2.7 tt0 -73.61 -28.2 61.69 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.802 HG21 HD21 ' A' ' 198' ' ' LEU . 47.5 mt -42.11 -56.02 5.74 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 121.374 0.607 . . . . 0.0 112.215 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.582 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 2.7 Cg_endo -46.48 -38.61 21.47 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 120.565 0.843 . . . . 0.0 109.95 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.84 -59.99 2.51 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.785 HD13 ' CD ' ' A' ' 126' ' ' PRO . 1.4 mt -69.17 -33.12 72.9 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.212 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 1.075 ' HA ' ' CD1' ' A' ' 139' ' ' LEU . 10.0 t70 -68.32 -43.89 76.58 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -46.18 -49.2 17.24 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 118.208 -1.397 . . . . 0.0 110.079 177.34 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.677 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 3.1 tm-20 -63.73 -43.28 96.98 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.784 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 1.075 ' CD1' ' HA ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -52.94 -56.13 18.27 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -49.52 -44.01 46.04 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.704 0.764 . . . . 0.0 108.962 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -45.86 -26.0 0.61 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.29 -1.323 . . . . 0.0 114.343 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.21 -62.38 1.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.526 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.41 53.76 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -172.44 -174.23 1.17 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.885 1.343 . . . . 0.0 109.769 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.8 ' HA ' ' HB3' ' A' ' 139' ' ' LEU . 8.6 t -144.81 150.27 36.88 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.786 0.435 . . . . 0.0 110.42 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.794 ' HB1' ' HD2' ' A' ' 126' ' ' PRO . . . -68.93 -22.99 64.12 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.509 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 224' ' ' MET . 0.7 OUTLIER -142.92 129.4 20.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -176.394 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.755 ' HB2' HG21 ' A' ' 222' ' ' THR . 0.3 OUTLIER -132.53 139.93 48.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.521 -0.871 . . . . 0.0 111.726 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 227' ' ' ASN . 3.7 t80 -172.48 175.57 3.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.698 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 149' ' ' PHE . 2.6 m-80 -38.76 161.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.931 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.862 HD13 ' CB ' ' A' ' 206' ' ' ALA . 3.2 mt -115.06 -50.35 2.76 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.19 34.48 3.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 116.04 -2.264 . . . . 0.0 113.897 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.777 ' O ' ' HB ' ' A' ' 157' ' ' THR . 17.9 mm-40 -79.49 145.75 64.2 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 121.6 2.0 . . . . 0.0 114.488 -175.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.993 ' O ' ' N ' ' A' ' 156' ' ' PHE . 5.8 Cg_exo -78.05 -135.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 1 C-N-CA 125.55 4.167 . . . . 0.0 106.242 176.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 1.117 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 36.0 m-85 16.15 -49.75 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.993 ' N ' ' O ' ' A' ' 154' ' ' PRO . 10.4 t80 -84.44 -60.03 2.2 Favored 'General case' 0 C--O 1.258 1.511 0 CA-C-N 119.406 1.003 . . . . 0.0 111.903 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.777 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -56.83 -42.61 79.94 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.469 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 2.3 m95 -51.61 -55.81 26.42 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 1.117 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 79.3 Cg_exo -43.19 -47.87 8.4 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.892 2.395 . . . . 0.0 113.065 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 250' ' ' PHE . 49.9 mt -62.48 -56.81 14.59 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.072 0.851 . . . . 0.0 109.968 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.722 HG21 HD12 ' A' ' 192' ' ' LEU . 20.6 pt -53.91 -18.01 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.904 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -78.06 -24.7 47.63 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.598 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -41.85 -56.71 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.57 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 1.8 m-20 -64.1 -39.34 93.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 119.211 0.914 . . . . 0.0 112.896 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 156.92 24.23 0.03 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 117.872 -2.109 . . . . 0.0 117.632 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.05 89.64 0.72 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-N 119.375 1.587 . . . . 0.0 112.633 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -73.68 158.58 34.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.29 0.545 . . . . 0.0 110.898 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.829 ' HA ' HG12 ' A' ' 183' ' ' VAL . . . -61.28 -80.59 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.956 0.884 . . . . 0.0 111.604 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.796 ' HB2' ' CG ' ' A' ' 176' ' ' TYR . 58.5 m-85 -113.86 173.66 6.32 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.792 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 1.209 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -106.49 116.28 31.66 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.974 1.261 . . . . 0.0 107.729 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.463 ' CE1' ' HA ' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -78.75 113.22 16.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.456 176.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 1.4 tt0 -137.29 113.61 10.05 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.778 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 1.9 t-20 82.48 -32.33 0.09 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.848 0.356 . . . . 0.0 111.112 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 157.81 15.48 0.04 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.648 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.463 ' HA ' ' CE1' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -173.29 142.02 0.97 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.863 1.332 . . . . 0.0 110.391 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 1.209 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.6 m-85 -66.84 -25.11 66.27 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.506 1.146 . . . . 0.0 109.961 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.757 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.6 t70 62.09 -85.7 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 112.793 -2.003 . . . . 0.0 111.51 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER 179.18 -54.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HA ' ' CG2' ' A' ' 369' ' ' THR . 0.0 OUTLIER -51.17 -17.37 0.65 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 5.5 m-20 -117.27 94.99 4.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 119.68 1.127 . . . . 0.0 109.332 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.426 ' CG2' ' CG ' ' A' ' 365' ' ' GLN . 3.3 m -116.73 112.45 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -117.74 39.96 2.47 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.586 -1.292 . . . . 0.0 113.806 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.829 HG12 ' HA ' ' A' ' 168' ' ' ALA . 1.8 m -79.09 -46.06 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.452 ' N ' ' CG2' ' A' ' 183' ' ' VAL . 18.5 t0 -81.49 57.25 3.22 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.08 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -102.77 177.93 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.345 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.48 -31.56 35.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.462 0.648 . . . . 0.0 111.429 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.57 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -74.91 -40.2 36.57 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.523 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -61.38 -46.09 91.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 174.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.61 -60.62 3.52 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.08 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.23 -41.62 50.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.09 0.948 . . . . 0.0 111.768 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -65.9 -60.6 6.32 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.535 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.722 HD12 HG21 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -58.91 -24.28 62.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.086 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.876 ' O ' HG12 ' A' ' 196' ' ' VAL . 23.5 m -63.99 -48.33 76.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 3.0 p90 -60.6 -35.22 75.58 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' A' ' 194' ' ' PHE . 4.5 mt -64.66 -47.64 77.73 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.876 HG12 ' O ' ' A' ' 193' ' ' THR . 0.5 OUTLIER -58.53 -28.33 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.18 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.77 -46.3 85.88 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.302 0.572 . . . . 0.0 110.229 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.802 HD21 HG21 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -62.93 -59.32 4.99 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.039 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 204' ' ' MET . 15.0 pt -54.14 -43.91 61.82 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -61.52 -34.26 75.21 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -89.95 2.31 55.24 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.96 -84.32 0.66 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.583 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.401 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.4 OUTLIER -120.73 -23.61 5.94 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 199' ' ' ILE . 0.3 OUTLIER 74.5 16.46 3.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.891 0.314 . . . . 0.0 110.645 -178.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -158.56 82.97 0.82 Allowed 'General case' 0 C--N 1.34 0.187 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.862 ' CB ' HD13 ' A' ' 151' ' ' LEU . . . -76.0 84.82 2.9 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -97.9 -2.77 39.97 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.272 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.672 HG22 ' HB2' ' A' ' 213' ' ' ALA . 89.4 m -56.66 121.1 8.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.95 -175.39 3.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -69.05 -45.36 70.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.138 0.495 . . . . 0.0 110.139 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.2 m -77.33 -25.53 51.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.613 0.72 . . . . 0.0 111.281 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.648 HG22 HG23 ' A' ' 208' ' ' THR . 0.9 OUTLIER -81.15 -50.82 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.801 178.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -53.46 -36.56 61.74 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.77 -46.16 89.32 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.05 -39.47 69.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.128 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.65 -56.98 13.98 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.407 ' CD2' HG21 ' A' ' 225' ' ' THR . 35.1 t80 -60.52 -28.46 68.42 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.38 -43.41 75.13 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.286 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -23.98 59.18 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.71 45.09 78.43 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -109.44 37.19 2.68 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.86 1.33 . . . . 0.0 110.496 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.755 HG21 ' HB2' ' A' ' 148' ' ' MET . 0.6 OUTLIER -141.96 141.85 32.95 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.966 0.889 . . . . 0.0 109.166 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 1.093 ' HB2' HD12 ' A' ' 122' ' ' LEU . . . -103.16 38.66 1.71 Allowed 'General case' 0 C--N 1.345 0.391 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.511 ' HE1' HD11 ' A' ' 115' ' ' LEU . 0.9 OUTLIER 168.7 138.45 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 148' ' ' MET . 5.2 p -148.06 159.78 43.55 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 226' ' ' ILE . 3.1 mp -116.48 112.44 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 114' ' ' SER . 2.2 p-10 -147.53 165.09 31.37 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 118.94 -0.553 . . . . 0.0 112.15 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -129.3 149.7 18.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.799 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.49 69.75 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.557 2.171 . . . . 0.0 112.298 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.689 ' CZ3' HD11 ' A' ' 262' ' ' LEU . 9.2 t-105 -159.02 -74.07 0.08 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.299 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.39 58.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.713 0.292 . . . . 0.0 110.997 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -152.07 95.7 2.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.256 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.9 m 53.2 176.28 0.02 OUTLIER 'General case' 0 C--O 1.231 0.079 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.339 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -109.24 94.99 5.33 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.632 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 12.6 tt -45.7 155.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.106 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.23 -171.29 0.09 Allowed 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.582 0.23 . . . . 0.0 110.501 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.9 m 67.02 35.55 4.59 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.707 0.289 . . . . 0.0 110.767 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 10.5 t -148.69 -62.06 0.24 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.544 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 14.9 mmtt -131.53 -85.97 0.49 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.402 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 2.7 p 158.38 -45.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -92.38 117.73 30.21 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.666 0.27 . . . . 0.0 111.266 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.637 ' CD1' HD11 ' A' ' 116' ' ' ILE . 7.8 p90 -149.29 129.86 13.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.428 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.99 176.21 54.74 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.668 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.749 HG22 HD12 ' A' ' 116' ' ' ILE . 19.3 t -146.55 113.16 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.557 0.678 . . . . 0.0 112.442 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.95 167.11 17.9 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -172.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.7 153.96 7.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.208 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.653 HD11 HD23 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -58.73 159.88 11.86 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 119.515 1.052 . . . . 0.0 110.996 -179.25 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.49 -163.45 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 111.957 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -120.79 177.58 5.03 Favored 'General case' 0 CA--C 1.526 0.052 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.269 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 160' ' ' LEU . 46.4 m-85 -162.35 110.42 1.36 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.534 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.86 33.08 17.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.379 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.28 41.34 21.63 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.524 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.434 ' C ' HG22 ' A' ' 249' ' ' THR . 0.0 OUTLIER -156.74 151.57 20.9 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.559 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 86.0 Cg_endo -86.51 -172.32 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.321 2.68 . . . . 0.0 111.891 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.513 ' OG ' HD22 ' A' ' 247' ' ' LEU . 10.2 p -108.57 148.33 30.47 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.4 OUTLIER -85.62 109.31 21.01 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.421 -178.148 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.491 ' HG2' ' O ' ' A' ' 323' ' ' ASN . 2.7 Cg_exo -79.36 149.45 21.7 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.305 2.67 . . . . 0.0 113.174 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.401 ' CB ' ' CD1' ' A' ' 155' ' ' TYR . 25.5 p90 -79.01 132.63 36.71 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 175.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.589 HG11 ' HA ' ' A' ' 329' ' ' ILE . 12.6 p -89.85 130.09 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -120.12 121.86 5.05 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 119.271 -1.442 . . . . 0.0 115.355 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.882 HG11 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -113.01 109.51 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 1.066 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 2.4 mm? -89.72 99.78 12.72 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 118.27 -1.372 . . . . 0.0 107.706 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.603 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -110.16 177.16 4.79 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -173.295 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.449 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . . . -116.2 124.06 49.33 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.666 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -127.4 164.33 20.91 Favored Glycine 0 CA--C 1.547 2.033 0 C-N-CA 119.062 -1.542 . . . . 0.0 112.776 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 1.02 HD11 ' O ' ' A' ' 77' ' ' ALA . 33.8 pt -81.93 -179.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 2 C-N-CA 139.311 7.044 . . . . 0.0 92.25 172.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.79 ' HA ' HD12 ' A' ' 76' ' ' LEU . 12.1 t30 -151.89 168.73 24.21 Favored 'General case' 0 CA--C 1.547 0.831 2 CA-C-N 133.603 7.456 . . . . 0.0 103.403 177.058 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 1.062 ' HB3' HD12 ' A' ' 75' ' ' LEU . . . -56.88 -52.27 65.78 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.203 0.911 . . . . 0.0 111.304 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.678 ' HB2' ' CB ' ' A' ' 51' ' ' ALA . . . -33.93 -64.16 0.24 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.96 127.88 2.82 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.596 0.236 . . . . 0.0 111.036 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -80.64 -41.3 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.359 2.04 . . . . 0.0 113.397 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.6 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 1.9 m-80 55.65 72.81 0.46 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.595 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 18.6 mtpt -56.64 -54.27 48.03 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 278' ' ' GLU . 4.2 mt-10 -55.65 -58.16 8.98 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.982 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.9 mt -69.46 -57.91 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.764 ' O ' HD12 ' A' ' 280' ' ' LEU . . . -64.88 -55.74 17.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.595 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -57.53 -42.49 82.98 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 274' ' ' GLU . 5.3 mt-10 -76.25 -53.88 7.6 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.445 ' HB2' ' CE2' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -55.6 -56.36 21.22 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.661 179.352 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 276' ' ' ALA . 1.2 mt -54.37 -43.4 71.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.359 0.599 . . . . 0.0 111.768 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.893 ' O ' HD23 ' A' ' 285' ' ' LEU . 17.8 tt0 -75.4 -33.24 60.97 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.214 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.14 -13.57 22.05 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 1.007 ' O ' HG22 ' A' ' 286' ' ' THR . 17.2 m-85 -114.32 -54.5 2.58 Favored 'General case' 0 CA--C 1.512 -0.513 0 O-C-N 122.008 -0.433 . . . . 0.0 110.659 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 284' ' ' LEU . 9.6 tp -45.28 -25.46 0.39 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.93 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.893 HD23 ' O ' ' A' ' 281' ' ' GLU . 2.6 mm? -94.93 43.39 1.09 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-O 120.832 0.349 . . . . 0.0 111.47 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . 1.007 HG22 ' O ' ' A' ' 283' ' ' TYR . 13.2 t -143.7 156.93 44.69 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.532 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 49.4 p30 -66.13 -12.16 53.9 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.472 0.578 . . . . 0.0 110.55 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.764 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 10.9 tt0 -77.58 -47.48 19.31 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.029 -0.419 . . . . 0.0 111.054 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 286' ' ' THR . . . -84.71 -57.07 2.36 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.795 ' CD2' HG11 ' A' ' 302' ' ' VAL . 0.4 OUTLIER -48.29 -48.75 35.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.265 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -78.96 -26.77 43.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.077 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.764 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -65.8 -41.79 91.49 Favored 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 121.459 -0.776 . . . . 0.0 108.937 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.0 t -71.02 -64.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 116.704 -1.998 . . . . 0.0 105.856 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -51.43 3.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 129.119 2.967 . . . . 0.0 115.064 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -110.94 -57.0 2.29 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.208 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.444 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 57.6 m-20 -52.97 -36.85 60.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.868 ' HE3' HD12 ' A' ' 299' ' ' LEU . 16.7 ttpt -111.61 98.19 39.88 Favored Pre-proline 0 C--N 1.35 0.593 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.939 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -95.25 76.08 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.416 2.744 . . . . 0.0 112.091 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.868 HD12 ' HE3' ' A' ' 297' ' ' LYS . 16.3 mt -101.55 -74.83 0.61 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.449 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -142.62 -142.68 4.06 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.522 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.903 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . . . -79.79 178.42 8.2 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.741 0.305 . . . . 0.0 111.457 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.795 HG11 ' CD2' ' A' ' 290' ' ' LEU . 0.0 OUTLIER -126.83 -171.76 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.929 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.88 ' HB1' ' CD2' ' A' ' 89' ' ' LEU . . . -106.98 66.37 0.68 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.479 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.812 HD23 ' HB2' ' A' ' 307' ' ' TYR . 10.4 tp -159.95 108.89 1.76 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.763 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.61 -60.36 0.71 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.78 -48.03 63.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.022 0.915 . . . . 0.0 111.529 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.812 ' HB2' HD23 ' A' ' 304' ' ' LEU . 1.9 t80 -70.07 -19.73 63.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.128 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 3.0 tp10 -65.55 -39.95 92.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.82 -57.27 5.29 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.435 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -51.07 -57.21 9.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.248 0.547 . . . . 0.0 109.802 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.897 HD22 HG21 ' A' ' 317' ' ' ILE . 1.2 tt -61.93 -38.68 89.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.241 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.771 ' HA ' HD11 ' A' ' 317' ' ' ILE . . . -46.32 -29.11 1.51 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -40.31 -39.17 0.91 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.809 0.337 . . . . 0.0 110.241 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -78.53 118.34 71.75 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.09 -20.36 37.32 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.681 2.254 . . . . 0.0 114.287 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -59.15 5.61 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.903 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 2.4 pp -50.04 -53.44 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 317' ' ' ILE . . . -45.77 -44.95 14.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.448 0.567 . . . . 0.0 111.518 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.52 -40.09 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.551 0.691 . . . . 0.0 110.242 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.836 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER -62.0 -56.6 17.37 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.528 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 9.0 ttp -53.1 -42.68 66.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.701 0.286 . . . . 0.0 110.691 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.18 -39.26 81.97 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.93 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.743 ' CB ' ' HB1' ' A' ' 112' ' ' ALA . 7.3 m-80 -78.31 -48.11 16.36 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.659 0.266 . . . . 0.0 111.161 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 111' ' ' GLU . . . -48.53 -40.79 28.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.621 0.248 . . . . 0.0 111.576 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.433 ' HB2' ' CD1' ' A' ' 92' ' ' PHE . 5.3 pt20 -67.08 -28.43 68.18 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.607 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -76.54 -10.46 59.41 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 257' ' ' PRO . . . -79.91 161.2 45.55 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.815 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -96.6 139.62 32.41 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.735 HD11 ' O ' ' A' ' 95' ' ' ASP . 9.7 mt -51.58 102.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 119.891 1.223 . . . . 0.0 111.235 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.529 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 32.9 mtm -47.95 -48.33 62.4 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 330' ' ' MET . 57.9 Cg_endo -72.19 121.7 7.75 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.279 1.986 . . . . 0.0 113.218 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.578 HD22 HD12 ' A' ' 333' ' ' ILE . 0.1 OUTLIER -160.69 -70.28 0.07 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.473 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.578 HD12 HD22 ' A' ' 332' ' ' ASN . 0.3 OUTLIER -137.32 140.42 30.71 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.001 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.561 ' HD2' HG22 ' A' ' 333' ' ' ILE . 10.9 Cg_endo -53.38 -18.27 10.64 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.881 2.388 . . . . 0.0 113.037 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.652 ' HG2' HG22 ' A' ' 178' ' ' ILE . 1.4 mp0 -44.07 -24.67 0.16 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.606 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -45.71 -35.26 4.09 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.039 0.381 . . . . 0.0 111.372 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 337' ' ' SER . . . . . 0.494 ' HA ' ' CD2' ' A' ' 340' ' ' TRP . 3.0 t -56.26 -53.17 60.45 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 110.241 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.6 ' HB1' HD11 ' A' ' 368' ' ' ILE . . . -52.13 -27.23 13.52 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.172 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.744 ' O ' HG13 ' A' ' 343' ' ' VAL . 25.2 m-85 -78.09 -55.74 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.344 -0.543 . . . . 0.0 112.459 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.494 ' CD2' ' HA ' ' A' ' 337' ' ' SER . 1.2 p90 -54.95 -31.93 60.98 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.26 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 340' ' ' TRP . 0.1 OUTLIER -75.57 -52.16 11.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.024 0.44 . . . . 0.0 110.994 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.33 88.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.731 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 339' ' ' PHE . 4.8 m -69.17 -42.3 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.375 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 30.2 mtt-85 -57.79 -55.4 35.42 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.882 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -58.2 9.49 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.34 -60.69 2.13 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.582 HG11 HD11 ' A' ' 192' ' ' LEU . 42.7 t -53.03 -49.78 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 36.3 mt -67.87 -49.56 67.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.57 -55.06 19.71 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.552 ' HB1' ' HB2' ' A' ' 355' ' ' GLN . . . -63.63 -26.55 68.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.905 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -65.48 -10.27 32.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.49 0.586 . . . . 0.0 112.327 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.3 p -110.77 14.8 22.18 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 122.059 -0.401 . . . . 0.0 110.785 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 97.73 29.74 7.58 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 116.815 -2.612 . . . . 0.0 116.08 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.46 35.65 4.36 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 116.252 -1.833 . . . . 0.0 106.328 174.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.608 ' O ' HG23 ' A' ' 356' ' ' THR . 3.9 pt20 -70.98 -174.77 1.0 Allowed 'General case' 0 CA--C 1.549 0.912 1 N-CA-C 125.704 5.446 . . . . 0.0 125.704 -157.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.7 OUTLIER 158.34 41.78 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.415 -3.084 . . . . 0.0 104.538 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 358' ' ' ASP . 12.3 p -72.36 -51.62 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.57 ' O ' ' HB3' ' A' ' 362' ' ' LYS . 10.0 t0 -47.77 -45.36 29.14 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.772 0.796 . . . . 0.0 111.31 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.644 ' HA ' ' HG2' ' A' ' 362' ' ' LYS . 8.1 mp0 -77.14 -56.32 4.67 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 113.885 -1.507 . . . . 0.0 113.62 -174.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -54.45 -43.09 71.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.416 1.103 . . . . 0.0 112.645 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.669 ' O ' ' HB3' ' A' ' 364' ' ' ALA . 0.1 OUTLIER -76.17 -45.75 31.83 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.087 -1.87 . . . . 0.0 111.358 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.644 ' HG2' ' HA ' ' A' ' 359' ' ' GLU . 43.3 pttt -58.01 -54.89 41.79 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 121.961 0.886 . . . . 0.0 110.419 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 362' ' ' LYS . 9.0 m-20 -58.75 -36.15 73.89 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 114.611 -1.177 . . . . 0.0 107.832 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 361' ' ' LEU . . . -49.66 -45.54 48.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.426 ' CG ' ' CG2' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -58.93 -44.77 91.43 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.6 m -52.09 -42.54 63.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.112 0.482 . . . . 0.0 109.864 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.15 -37.06 85.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.909 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.648 HG23 ' HG3' ' A' ' 335' ' ' GLN . 4.2 mm -71.64 -35.29 55.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.934 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.446 ' CG2' ' HA ' ' A' ' 179' ' ' LYS . 7.4 p -118.64 51.35 1.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.936 0.398 . . . . 0.0 111.843 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.3 tptp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.195 179.79 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.663 0.268 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.78 107.84 10.22 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -112.8 146.37 38.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 63.3 68.49 0.61 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.063 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.46 -112.11 2.31 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.219 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HG3' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -118.21 -171.18 2.02 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 114.143 -1.028 . . . . 0.0 109.919 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.96 HD21 ' CZ ' ' A' ' 279' ' ' PHE . 0.1 OUTLIER -127.42 120.41 28.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.062 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -116.24 117.14 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.341 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.952 ' CG1' HG12 ' A' ' 37' ' ' VAL . 1.7 pp -123.51 129.88 74.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.691 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.997 ' HB2' HG22 ' A' ' 60' ' ' ILE . 8.5 m95 -107.58 122.44 46.69 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.407 HG22 ' CD1' ' A' ' 9' ' ' ILE . 2.6 tt -159.23 139.02 3.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.7 113.29 20.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.624 0.249 . . . . 0.0 111.111 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.29 -9.15 15.36 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.755 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 39.0 t0 -72.59 -82.11 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.853 0.827 . . . . 0.0 111.057 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 5.8 tmtm? 100.84 -2.75 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.531 0.733 . . . . 0.0 110.313 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.559 ' O ' HD23 ' A' ' 20' ' ' LEU . . . -76.72 66.01 2.8 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 115.271 0.868 . . . . 0.0 115.271 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -77.39 -39.23 47.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.139 -0.531 . . . . 0.0 110.682 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 1.7 m120 -61.48 -47.0 87.66 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.058 0.456 . . . . 0.0 111.052 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.899 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.37 -47.51 35.43 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.054 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 16' ' ' GLY . 4.2 mm? -59.99 -49.6 77.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.381 0.59 . . . . 0.0 110.153 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.79 -38.46 80.01 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 2.1 tp10 -65.67 -36.93 85.08 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.063 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.899 HG23 ' O ' ' A' ' 19' ' ' GLY . 61.0 t -66.82 -61.1 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.851 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . -48.95 -32.42 11.68 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 119.685 -1.245 . . . . 0.0 111.491 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -55.29 -50.18 70.23 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.4 mttt -53.03 -41.72 65.0 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-N 112.862 -1.972 . . . . 0.0 108.374 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.762 ' HB3' HD13 ' A' ' 33' ' ' ILE . 47.4 m-85 -65.49 -34.31 77.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.777 0.799 . . . . 0.0 110.78 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.781 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 1.1 tm-20 -69.08 -51.26 40.65 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.963 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttp -50.99 -30.14 14.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 125.133 1.521 . . . . 0.0 110.867 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.841 ' O ' HG23 ' A' ' 31' ' ' THR . 0.4 OUTLIER -83.62 -38.2 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.428 179.085 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.75 37.71 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 171.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.822 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.09 38.58 0.02 OUTLIER Glycine 0 N--CA 1.468 0.805 0 C-N-CA 115.071 -3.443 . . . . 0.0 119.035 174.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.822 HD12 ' C ' ' A' ' 32' ' ' GLY . 2.0 mp -140.02 136.8 38.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 121.861 2.831 . . . . 0.0 116.417 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' CD ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -142.42 105.13 4.52 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.89 HG22 ' CB ' ' A' ' 7' ' ' LEU . 42.6 t -86.89 131.61 34.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -174.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.8 p -117.3 145.1 44.21 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.44 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.952 HG12 ' CG1' ' A' ' 9' ' ' ILE . 16.0 m -129.08 120.6 52.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 5.8 mt-10 -110.36 130.7 55.5 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -119.75 71.18 14.39 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.307 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 43' ' ' LEU . 7.8 Cg_endo -94.93 -170.2 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.514 2.809 . . . . 0.0 112.857 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -109.74 -40.32 4.85 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.42 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.406 ' HB3' ' CG ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -86.23 0.32 54.02 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.921 HD23 ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -31.68 -39.27 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 1.02 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 73.7 mt-10 -62.86 -54.61 36.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.467 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 11.9 pt-20 -74.2 -38.36 63.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -60.12 -57.53 12.42 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.705 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.743 ' CD2' HD13 ' A' ' 60' ' ' ILE . 1.1 t80 -42.94 -59.16 3.24 Favored Pre-proline 0 C--N 1.352 0.694 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.516 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 1.02 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 26.8 Cg_exo -62.66 -22.65 74.16 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 120.948 1.099 . . . . 0.0 113.171 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -82.23 -36.93 26.7 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 122.28 1.038 . . . . 0.0 111.271 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.3 m -78.59 -39.81 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.506 0 CA-C-O 122.254 1.026 . . . . 0.0 109.863 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 269' ' ' ALA . . . -50.56 -37.46 39.76 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 125.957 1.703 . . . . 0.0 110.906 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 53' ' ' THR . . . -81.52 -40.1 23.69 Favored 'General case' 0 C--N 1.372 1.567 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.701 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 52' ' ' ALA . 33.6 p -159.56 51.52 0.35 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.054 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -160.02 48.87 0.39 Allowed Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.333 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t0 70.67 104.24 0.06 Allowed 'General case' 0 C--O 1.23 0.077 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.07 112.15 4.73 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.836 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.492 ' CG ' ' CE1' ' A' ' 47' ' ' PHE . 86.1 Cg_endo -79.85 -164.68 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.956 2.437 . . . . 0.0 113.444 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 1.062 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 6.7 t0 -79.96 -135.57 0.03 OUTLIER 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 123.946 0.898 . . . . 0.0 110.521 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.682 HD12 ' OD2' ' A' ' 58' ' ' ASP . 1.3 mp -101.7 165.17 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.997 HG22 ' HB2' ' A' ' 10' ' ' TRP . 1.2 pt -127.16 130.69 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.5 OUTLIER -115.34 117.57 30.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.71 ' CZ3' HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -167.26 165.38 15.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 62' ' ' TRP . . . -37.45 152.46 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.809 ' CG ' HG12 ' A' ' 97' ' ' VAL . 10.7 t-160 -77.35 -28.62 53.05 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.408 ' HA ' ' ND2' ' A' ' 332' ' ' ASN . 3.4 m-20 -49.19 -58.29 5.25 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-O 121.979 0.895 . . . . 0.0 112.279 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.57 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -73.9 -30.59 62.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.546 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.571 ' CD1' HD12 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -63.35 -25.43 68.29 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -62.04 -65.37 3.24 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.62 -47.85 89.15 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 113.616 -1.292 . . . . 0.0 110.309 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.724 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 23.2 t80 -48.02 -46.56 33.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.525 ' HA ' ' CB ' ' A' ' 76' ' ' LEU . . . -57.87 -37.43 73.92 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.299 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -78.94 -54.72 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.303 . . . . 0.0 111.764 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -113.34 -26.15 8.5 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' TYR . . . -65.41 -85.37 0.07 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.178 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.983 HD23 ' HB3' ' A' ' 268' ' ' ALA . 0.2 OUTLIER 165.58 71.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.142 0.496 . . . . 0.0 109.726 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 77' ' ' ALA . 2.5 tt -112.64 133.22 54.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.273 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 1.056 ' HB3' HG23 ' A' ' 266' ' ' ILE . . . -86.45 91.92 8.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.631 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -56.3 85.49 0.01 OUTLIER 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.881 HD12 ' HD3' ' A' ' 81' ' ' PRO . 2.0 pp -49.24 119.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.224 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.7 p -105.84 82.79 0.91 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.365 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.881 ' HD3' HD12 ' A' ' 79' ' ' ILE . 42.8 Cg_endo -89.44 -168.58 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.122 2.548 . . . . 0.0 112.422 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -172.89 4.42 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.638 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -35.66 21.0 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.3 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.44 -23.64 58.04 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.93 -59.21 2.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.576 ' HA ' HD21 ' A' ' 89' ' ' LEU . 10.0 tt0 -60.99 -24.74 66.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.389 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -75.8 -35.39 60.07 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.58 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -19.68 64.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.092 HD13 ' CG ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER -97.4 -179.57 4.53 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -94.58 143.32 26.06 Favored Pre-proline 0 C--N 1.343 0.304 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 31.8 Cg_exo -58.92 -50.58 8.66 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.422 2.081 . . . . 0.0 113.513 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' ' CG ' ' A' ' 325' ' ' GLN . 6.8 m-85 -56.76 -62.78 1.5 Allowed 'General case' 0 C--O 1.246 0.878 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.748 HG21 ' HA ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -62.85 -25.25 68.18 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.24 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 1.092 ' CG ' HD13 ' A' ' 89' ' ' LEU . 31.6 m95 -93.86 -23.39 18.14 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 14.7 t70 -72.65 -22.2 60.97 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.476 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.597 ' HB1' HG22 ' A' ' 261' ' ' VAL . . . -53.29 -45.53 68.96 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.073 HG13 HG11 ' A' ' 261' ' ' VAL . 20.2 m -113.93 39.25 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.407 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.437 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 12.0 ttp180 -104.94 138.96 40.37 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.289 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -124.15 90.99 3.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 119.172 0.896 . . . . 0.0 110.052 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.5 m120 51.73 -91.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.208 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.1 44.73 1.21 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.79 -177.03 5.37 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.486 0.314 . . . . 0.0 110.484 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.765 ' CD2' HD11 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -158.66 126.68 5.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.391 0.541 . . . . 0.0 110.742 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.702 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 1.4 pp -128.25 39.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.55 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 159.61 162.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.569 ' OH ' HD13 ' A' ' 79' ' ' ILE . 23.2 m-85 -124.7 119.81 25.78 Favored Pre-proline 0 C--O 1.223 -0.32 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.803 ' O ' HG23 ' A' ' 108' ' ' ILE . 66.9 Cg_endo -79.14 162.48 25.83 Favored 'Trans proline' 0 N--CA 1.474 0.333 0 C-N-CA 122.284 1.989 . . . . 0.0 114.776 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -171.82 38.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 1.043 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -179.56 137.58 0.13 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.916 HG12 ' HB3' ' A' ' 301' ' ' ALA . 0.3 OUTLIER -124.09 119.48 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 259' ' ' VAL . 5.4 tt0 -99.03 135.04 41.0 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 323' ' ' ASN . . . -168.06 -174.67 2.41 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 123.366 1.555 . . . . 0.0 110.204 -167.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.862 HD21 HG22 ' A' ' 226' ' ' ILE . 2.7 tt -147.3 135.44 21.49 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 110.995 -2.821 . . . . 0.0 115.846 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.4 OUTLIER -130.31 168.42 16.93 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.893 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.669 HD12 HG13 ' A' ' 226' ' ' ILE . 6.8 tp -92.45 132.41 36.81 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 121.877 -0.514 . . . . 0.0 110.267 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.695 HD11 ' HB2' ' A' ' 242' ' ' TYR . 0.5 OUTLIER -116.41 134.51 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.669 0.747 . . . . 0.0 111.175 -178.112 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.46 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 8.3 m-85 -93.23 -174.32 3.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.05 2.54 . . . . 0.0 110.037 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -93.05 -135.43 0.17 Allowed 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 126.625 1.97 . . . . 0.0 113.615 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.919 ' O ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -152.46 -108.26 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.085 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -67.94 -26.55 66.01 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.513 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -104.89 51.47 0.76 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.164 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.919 HD23 ' O ' ' A' ' 119' ' ' LYS . 1.2 pp -118.83 73.22 11.82 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 121.439 0.638 . . . . 0.0 109.788 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.548 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 12.5 Cg_exo -70.16 160.82 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.407 2.071 . . . . 0.0 112.508 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 49.7 t30 -61.56 108.19 1.44 Allowed Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.417 -173.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 57.2 Cg_endo -69.63 167.94 22.82 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 124.094 3.196 . . . . 0.0 113.574 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -76.16 -162.0 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.762 2.308 . . . . 0.0 113.592 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -126.23 -93.03 0.49 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.6 t -45.0 152.99 0.2 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.352 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.523 ' HH2' HD11 ' A' ' 226' ' ' ILE . 13.9 t-105 -69.96 -26.51 64.14 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 174.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.425 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 62.5 mt-10 -44.55 -23.72 0.14 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 134' ' ' ALA . 22.1 mt-10 -73.5 -26.2 60.78 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.886 ' CD1' HD22 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -40.44 -52.81 5.84 Favored Pre-proline 0 N--CA 1.487 1.385 0 CA-C-N 119.122 0.874 . . . . 0.0 112.288 -178.284 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.587 ' HD3' HG13 ' A' ' 132' ' ' ILE . 53.1 Cg_exo -46.33 -39.94 21.95 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 120.699 0.933 . . . . 0.0 109.892 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.38 -58.92 2.99 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -68.14 -36.65 80.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.159 -178.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.537 ' OD2' HG22 ' A' ' 132' ' ' ILE . 1.9 m-20 -73.51 -41.09 63.51 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -48.22 -43.88 32.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.69 177.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 0.2 OUTLIER -66.4 -37.48 85.34 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.7 OUTLIER -65.55 -46.47 79.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -48.91 -43.26 39.14 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.12 -22.93 0.26 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.296 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -115.79 -60.31 1.89 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.774 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.62 56.85 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.659 ' HG3' HD23 ' A' ' 139' ' ' LEU . 24.2 pttt -169.08 -173.43 1.77 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.829 1.815 . . . . 0.0 110.246 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.721 ' C ' HD22 ' A' ' 139' ' ' LEU . 38.5 m -142.65 164.82 29.08 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.965 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -81.84 -23.01 36.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.931 0.395 . . . . 0.0 111.919 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.681 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.3 pp -144.82 128.76 17.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.78 ' N ' HG21 ' A' ' 222' ' ' THR . 11.2 mmm -132.41 141.59 48.93 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.702 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.497 ' HB3' HG23 ' A' ' 225' ' ' THR . 52.6 p90 -172.55 174.94 3.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.742 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -37.54 158.42 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.013 178.326 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.006 HD13 ' HA ' ' A' ' 206' ' ' ALA . 3.3 mt -110.65 -51.66 2.85 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.17 34.35 3.1 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 115.752 -2.379 . . . . 0.0 113.765 -175.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.751 ' O ' HG23 ' A' ' 157' ' ' THR . 0.5 OUTLIER -79.63 142.32 57.26 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 121.067 1.758 . . . . 0.0 114.087 -176.34 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.968 ' O ' ' N ' ' A' ' 156' ' ' PHE . 67.3 Cg_endo -78.18 -134.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 1 C-N-CA 125.336 4.024 . . . . 0.0 105.2 175.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 1.167 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 12.3 m-85 21.13 -55.63 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.883 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.968 ' N ' ' O ' ' A' ' 154' ' ' PRO . 15.1 t80 -84.72 -55.81 3.92 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-N 119.561 1.073 . . . . 0.0 112.641 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 153' ' ' GLU . 20.6 p -58.04 -39.77 79.25 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 117.913 -1.515 . . . . 0.0 107.336 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.543 ' HZ2' HG21 ' A' ' 343' ' ' VAL . 24.2 m95 -53.0 -55.7 30.93 Favored Pre-proline 0 C--N 1.352 0.702 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.825 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 1.167 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 67.5 Cg_exo -43.04 -48.91 7.41 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.187 2.591 . . . . 0.0 112.425 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.699 HD21 ' CZ ' ' A' ' 250' ' ' PHE . 0.1 OUTLIER -58.19 -53.55 57.03 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 119.361 0.982 . . . . 0.0 109.411 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.625 HG22 ' HA ' ' A' ' 188' ' ' ALA . 4.7 mt -55.42 -20.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.001 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.718 ' HB1' ' HG3' ' A' ' 256' ' ' LYS . . . -78.9 -25.16 43.77 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -42.85 -56.02 3.43 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.492 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 7.1 m-20 -64.54 -11.18 31.6 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.172 0.896 . . . . 0.0 112.777 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.91 27.76 0.7 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 119.545 -1.312 . . . . 0.0 115.561 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.85 162.06 38.82 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 118.557 1.178 . . . . 0.0 111.847 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.673 ' O ' ' N ' ' A' ' 169' ' ' PHE . 25.9 m-85 -151.28 30.18 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.992 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 50.04 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.024 0.916 . . . . 0.0 111.411 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.691 ' CB ' ' HB3' ' A' ' 176' ' ' TYR . 12.4 m-85 -112.88 170.72 8.0 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.423 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.957 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -108.01 114.74 28.88 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.487 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 5.9 t80 -79.23 114.03 17.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 113.473 -1.694 . . . . 0.0 110.36 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -137.54 124.53 21.43 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.202 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 t30 76.77 -31.69 0.18 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.872 -0.149 . . . . 0.0 111.109 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.487 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 163.83 11.77 0.03 OUTLIER Glycine 0 CA--C 1.532 1.123 0 C-N-CA 120.17 -1.014 . . . . 0.0 114.626 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.402 ' C ' ' HA ' ' A' ' 171' ' ' TYR . 3.4 mtmt -173.93 150.6 1.65 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.962 1.381 . . . . 0.0 110.031 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.957 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 7.0 m-85 -66.57 -26.32 67.06 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.151 0.977 . . . . 0.0 109.579 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.64 -103.98 0.08 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.403 -1.726 . . . . 0.0 112.163 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 179' ' ' LYS . 8.3 tp -173.38 -46.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.43 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.1 OUTLIER -64.42 -15.6 60.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.718 0.294 . . . . 0.0 110.872 179.273 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 170' ' ' LYS . 3.2 p-10 -129.19 94.3 3.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 169' ' ' PHE . 20.3 m -122.03 140.79 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.387 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.69 55.5 4.17 Favored Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.185 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.799 HG11 HD11 ' A' ' 368' ' ' ILE . 30.4 m -87.03 -13.31 10.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.526 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 7.3 p-10 -124.62 62.68 1.13 Allowed 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.774 0.321 . . . . 0.0 110.844 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -116.93 135.1 53.98 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.282 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 189' ' ' LYS . . . -39.25 -40.31 0.74 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.424 0.63 . . . . 0.0 112.264 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.492 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -76.78 -35.94 38.54 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 114.955 -1.02 . . . . 0.0 114.113 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.625 ' HA ' HG22 ' A' ' 161' ' ' ILE . . . -60.0 -51.43 69.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.771 ' HE3' HD21 ' A' ' 361' ' ' LEU . 9.2 mttt -58.16 -60.45 3.73 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.651 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -50.36 -42.03 52.55 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.835 0.826 . . . . 0.0 111.959 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.46 -60.51 5.41 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.146 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.5 OUTLIER -56.98 -28.32 62.22 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 122.841 -0.211 . . . . 0.0 110.48 179.204 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 189' ' ' LYS . 7.6 p -69.65 -42.37 74.34 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.666 0.27 . . . . 0.0 111.375 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.48 ' CZ ' HD21 ' A' ' 198' ' ' LEU . 86.7 t80 -61.68 -34.27 75.45 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.345 0.593 . . . . 0.0 109.606 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.67 -47.76 79.93 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.892 HG21 ' OE1' ' A' ' 355' ' ' GLN . 43.8 t -56.88 -31.64 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.467 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.11 -44.87 87.37 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.797 0.808 . . . . 0.0 111.508 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.886 HD22 ' CD1' ' A' ' 132' ' ' ILE . 13.0 mt -58.59 -55.39 35.64 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 204' ' ' MET . 26.9 pt -64.06 -39.82 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.102 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 2.9 tttt -52.67 -37.32 58.52 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.695 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.26 -34.53 5.62 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 121.141 3.756 . . . . 0.0 121.141 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -60.72 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.773 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -105.19 -1.94 24.79 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.668 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 9.0 mtm 43.39 36.02 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.773 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.09 159.36 42.34 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 1.006 ' HA ' HD13 ' A' ' 151' ' ' LEU . . . -149.38 30.1 0.77 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -100.6 -3.51 30.34 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 213' ' ' ALA . 5.3 m -57.45 119.82 7.16 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.563 ' OD2' HD12 ' A' ' 212' ' ' ILE . 3.5 p30 -95.5 -174.24 3.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.875 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 211' ' ' SER . 53.5 p90 -68.05 -45.5 73.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.421 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -76.67 -25.49 53.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.588 0.709 . . . . 0.0 111.382 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.563 HD12 ' OD2' ' A' ' 209' ' ' ASP . 4.5 mt -81.63 -50.91 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.063 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -52.47 -37.37 56.98 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.482 ' HA ' ' CD2' ' A' ' 217' ' ' PHE . 2.7 tt0 -60.17 -46.89 88.17 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.9 -36.24 69.91 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.481 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.55 -57.34 13.11 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.482 ' CD2' ' HA ' ' A' ' 214' ' ' GLU . 0.4 OUTLIER -63.08 -28.32 70.0 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -55.14 -41.12 71.35 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.558 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.98 59.14 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.2 41.27 69.9 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -109.64 37.13 2.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.034 1.417 . . . . 0.0 110.822 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.78 HG21 ' N ' ' A' ' 148' ' ' MET . 1.6 m -140.44 140.75 35.46 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -105.09 38.42 1.94 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.349 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 2.7 ttm 171.6 135.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.497 HG23 ' HB3' ' A' ' 149' ' ' PHE . 90.4 m -148.19 157.58 43.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.153 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.862 HG22 HD21 ' A' ' 113' ' ' LEU . 2.7 mp -115.84 111.41 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.427 173.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 114' ' ' SER . 10.1 p30 -149.18 164.72 33.93 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 122.095 -0.378 . . . . 0.0 111.837 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -80.76 -172.82 46.25 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.124 -1.513 . . . . 0.0 109.784 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.435 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 57.5 Cg_endo -73.51 -40.7 1.43 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 121.759 1.639 . . . . 0.0 112.522 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.508 ' CZ2' ' HA3' ' A' ' 300' ' ' GLY . 0.3 OUTLIER -137.49 23.87 2.93 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.631 ' HB3' ' CE3' ' A' ' 232' ' ' TRP . . . -96.48 -33.79 11.73 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.631 ' CE3' ' HB3' ' A' ' 231' ' ' ALA . 1.7 m-90 -105.21 79.96 1.54 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.1 m 62.59 -175.69 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.91 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -83.0 129.5 35.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.813 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.427 HG13 ' CE2' ' A' ' 242' ' ' TYR . 8.4 tp -87.61 -32.55 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.368 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -46.2 -38.66 8.63 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.603 0.24 . . . . 0.0 111.294 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 237' ' ' THR . 9.0 t -87.05 65.2 8.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.702 0.287 . . . . 0.0 110.814 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 39.1 p -116.44 -60.3 1.87 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.812 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.48 -67.51 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.301 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.41 ' HB ' ' HD3' ' A' ' 119' ' ' LYS . 22.1 t -154.43 -60.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.526 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -136.74 157.46 46.7 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.876 0.37 . . . . 0.0 111.317 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.695 ' HB2' HD11 ' A' ' 116' ' ' ILE . 6.2 p90 -149.31 156.68 42.47 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.632 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.485 ' O ' HD12 ' A' ' 116' ' ' ILE . . . -107.34 172.82 18.22 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.42 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.0 t -146.51 119.98 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.139 0.469 . . . . 0.0 111.976 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.55 167.52 20.64 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -173.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.2 m -73.01 153.22 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.646 ' CD1' HG21 ' A' ' 226' ' ' ILE . 2.8 mm? -59.03 159.15 14.72 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-N 120.396 1.453 . . . . 0.0 111.885 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.11 -156.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.461 2.774 . . . . 0.0 112.242 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -128.51 172.99 10.63 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.913 -178.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.699 ' CZ ' HD21 ' A' ' 160' ' ' LEU . 97.4 m-85 -164.15 110.47 1.06 Allowed 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 121.791 0.805 . . . . 0.0 109.402 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt 61.16 33.0 19.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.678 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.01 36.64 35.12 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.118 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 163' ' ' ALA . 1.4 mt-30 -156.83 155.17 28.07 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -92.14 157.88 3.22 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.598 2.865 . . . . 0.0 111.986 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.4 p -79.73 153.41 29.27 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.718 ' HG3' ' HB1' ' A' ' 162' ' ' ALA . 3.2 mmmm -85.4 110.82 32.18 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.391 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.477 ' HB2' ' CA ' ' A' ' 327' ' ' GLY . 6.2 Cg_exo -79.23 147.83 20.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.928 2.419 . . . . 0.0 112.39 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 155' ' ' TYR . 3.2 p90 -105.09 133.93 49.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' A' ' 324' ' ' ALA . 30.9 t -140.68 108.41 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.25 163.88 43.47 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.152 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 1.073 HG11 HG13 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -104.3 113.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 122.893 -0.181 . . . . 0.0 111.342 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 1.043 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 1.7 tt -89.04 99.67 12.6 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 117.502 -1.679 . . . . 0.0 106.68 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.552 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 23.3 p -134.85 142.06 46.52 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -172.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . -73.88 131.59 41.64 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.827 0.451 . . . . 0.0 110.061 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.513 ' O ' HG13 ' A' ' 60' ' ' ILE . . . -122.01 135.51 10.41 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.005 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 1.056 HG23 ' HB3' ' A' ' 77' ' ' ALA . 4.4 tp -89.98 123.6 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -64.43 145.37 56.18 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.983 ' HB3' HD23 ' A' ' 75' ' ' LEU . . . -58.74 -22.86 58.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.995 0.426 . . . . 0.0 111.436 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.425 ' HB2' ' HB1' ' A' ' 51' ' ' ALA . . . -61.5 -61.15 2.73 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.704 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.845 ' O ' HD11 ' A' ' 266' ' ' ILE . 5.7 m -127.13 102.11 24.67 Favored Pre-proline 0 C--N 1.333 -0.13 0 CA-C-O 120.619 0.247 . . . . 0.0 111.29 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.439 ' HA ' ' CG1' ' A' ' 266' ' ' ILE . 55.4 Cg_endo -71.25 -42.72 1.83 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.336 2.024 . . . . 0.0 112.276 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.53 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 2.5 m120 45.73 80.12 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.97 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 10.1 ttmt -75.06 -54.12 7.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.626 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -57.28 11.58 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.652 0.263 . . . . 0.0 111.68 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.14 -57.95 10.38 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.213 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -59.59 -25.0 64.24 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.592 ' O ' ' CB ' ' A' ' 281' ' ' GLU . 24.0 tttt -69.95 -58.09 4.26 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 121.325 0.583 . . . . 0.0 111.687 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 13.4 pt-20 -69.97 -35.44 74.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.328 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.96 ' CZ ' HD21 ' A' ' 7' ' ' LEU . 12.1 t80 -73.95 -61.13 1.95 Allowed 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.195 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.59 -44.45 64.44 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.179 -1.008 . . . . 0.0 113.175 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.761 ' O ' HD12 ' A' ' 285' ' ' LEU . 4.0 tt0 -75.45 -34.77 60.98 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.527 -1.215 . . . . 0.0 113.428 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 1.7 t-20 -92.15 -16.74 25.88 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.935 ' O ' HG22 ' A' ' 286' ' ' THR . 0.5 OUTLIER -108.78 -66.53 1.04 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 290' ' ' LEU . 0.1 OUTLIER -39.54 -32.89 0.14 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.944 0.793 . . . . 0.0 111.203 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 281' ' ' GLU . 20.4 mt -91.05 42.03 1.09 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.79 0.328 . . . . 0.0 111.383 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.935 HG22 ' O ' ' A' ' 283' ' ' TYR . 6.3 t -145.06 158.01 43.94 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 0.8 OUTLIER -66.23 -11.02 47.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.617 0.644 . . . . 0.0 110.297 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.706 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -77.4 -47.09 20.69 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 118.175 0.443 . . . . 0.0 111.157 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -83.74 -57.34 2.45 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.654 HD12 ' CD2' ' A' ' 307' ' ' TYR . 0.2 OUTLIER -50.8 -49.06 59.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.589 -0.305 . . . . 0.0 110.586 178.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.1 OUTLIER -79.28 -26.39 42.35 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.104 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -68.04 -39.61 83.03 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 289' ' ' GLY . 58.3 t -68.34 -62.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 297' ' ' LYS . 9.3 m-80 -44.59 -47.79 10.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.78 1.232 . . . . 0.0 112.427 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -57.93 -54.97 40.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.44 ' HB3' ' CA ' ' A' ' 16' ' ' GLY . 32.8 m-20 -53.6 -44.75 69.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 294' ' ' ASN . 0.7 OUTLIER -49.7 165.83 0.28 Allowed Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.866 -178.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 299' ' ' LEU . 6.6 Cg_exo -73.09 -8.78 22.66 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.241 2.628 . . . . 0.0 113.547 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 298' ' ' PRO . 6.7 tp 90.38 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.924 0.392 . . . . 0.0 111.66 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.508 ' HA3' ' CZ2' ' A' ' 230' ' ' TRP . . . -152.98 -156.67 7.68 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.947 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.916 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -79.97 164.47 23.45 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.44 0.62 . . . . 0.0 110.7 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.553 HG22 ' CD1' ' A' ' 311' ' ' LEU . 16.5 m -153.81 -151.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.748 ' HA ' HG21 ' A' ' 93' ' ' THR . . . -116.1 -138.75 0.37 Allowed 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.552 HD23 ' HG ' ' A' ' 290' ' ' LEU . 13.5 tp 48.24 101.41 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.712 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -41.9 -58.44 2.04 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.5 p -53.39 -49.35 67.42 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.734 0.778 . . . . 0.0 112.073 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.654 ' CD2' HD12 ' A' ' 290' ' ' LEU . 9.1 t80 -69.48 -19.42 63.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.171 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.3 OUTLIER -63.1 -39.02 93.48 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 9.1 mt-10 -70.63 -57.8 4.34 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.539 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -56.49 12.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.458 0.647 . . . . 0.0 109.279 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.768 ' O ' HG21 ' A' ' 317' ' ' ILE . 0.8 OUTLIER -59.09 -40.32 84.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.277 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 317' ' ' ILE . . . -46.96 -34.39 5.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.524 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.52 -38.39 6.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.518 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.72 ' HB2' HG22 ' A' ' 317' ' ' ILE . 14.3 m-20 -67.55 146.19 98.53 Favored Pre-proline 0 N--CA 1.462 0.132 0 CA-C-O 120.616 0.246 . . . . 0.0 110.667 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 17.3 Cg_exo -67.15 -42.81 7.25 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.665 2.243 . . . . 0.0 113.054 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 229' ' ' PRO . 7.8 mtt85 -58.79 -59.73 4.97 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -51.45 -54.13 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.432 ' N ' HD13 ' A' ' 317' ' ' ILE . . . -46.05 -51.91 12.88 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.419 0.554 . . . . 0.0 111.584 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.62 -46.72 70.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.217 1.008 . . . . 0.0 109.032 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.767 HG22 HG13 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -58.38 -40.51 82.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 113.472 -1.694 . . . . 0.0 109.786 178.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.1 ttp -66.46 -50.25 63.98 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.646 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -53.17 -57.6 9.92 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.571 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 22.4 m120 -64.55 -30.24 71.27 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.364 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.727 ' HB1' HG21 ' A' ' 110' ' ' VAL . . . -60.08 -53.13 61.4 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.449 ' CG ' ' CZ ' ' A' ' 92' ' ' PHE . 2.4 tt0 -67.42 -30.06 69.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.39 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.28 -17.98 40.68 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.496 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.689 ' HA3' HG23 ' A' ' 259' ' ' VAL . . . -79.9 169.23 52.98 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.199 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 257' ' ' PRO . 1.9 mm-40 -96.46 137.4 35.58 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 96' ' ' ALA . 4.6 mp -83.88 113.67 23.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 119.595 1.089 . . . . 0.0 110.301 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.472 ' C ' ' O ' ' A' ' 329' ' ' ILE . 0.0 OUTLIER -25.93 137.55 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 332' ' ' ASN . 36.3 Cg_endo -64.93 -38.44 29.28 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.629 2.22 . . . . 0.0 112.528 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 65' ' ' ASP . 1.5 m-20 71.49 57.14 0.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.661 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.98 160.34 68.18 Favored Pre-proline 0 C--N 1.326 -0.415 0 O-C-N 121.945 -0.472 . . . . 0.0 111.593 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.13 -42.29 8.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.644 2.229 . . . . 0.0 112.476 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.417 ' HB3' HD13 ' A' ' 178' ' ' ILE . 6.3 mm100 -47.83 -25.2 1.2 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 32.0 tpp -45.72 -35.55 4.33 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 122.357 -0.214 . . . . 0.0 111.181 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.2 m -57.31 -42.51 81.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.761 0.315 . . . . 0.0 110.455 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -57.27 -31.51 65.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.04 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.414 ' O ' HG12 ' A' ' 343' ' ' VAL . 2.9 t80 -78.1 -48.62 15.61 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.34 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -47.01 68.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.619 0.247 . . . . 0.0 111.474 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -74.33 -50.87 16.97 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.497 ' CB ' HG22 ' A' ' 368' ' ' ILE . . . -67.62 -43.68 79.84 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.984 HG22 HG21 ' A' ' 347' ' ' VAL . 0.3 OUTLIER -70.74 -41.42 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.42 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.484 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 0.8 OUTLIER -58.67 -59.56 5.22 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.458 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 53.0 p -54.36 -57.86 9.65 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.51 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -65.09 -60.56 2.89 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.984 HG21 HG22 ' A' ' 343' ' ' VAL . 44.1 t -59.08 -45.74 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 1.7 tt -68.5 -52.7 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.603 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 348' ' ' ILE . 29.6 m-20 -66.26 -53.39 37.39 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.554 ' HA ' ' HG2' ' A' ' 354' ' ' ARG . . . -63.54 -26.42 68.69 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.356 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -54.53 -17.92 3.78 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.574 0.625 . . . . 0.0 111.503 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 13.2 p -106.73 24.08 13.26 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 171.1 -57.21 0.18 Allowed Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 119.697 -1.239 . . . . 0.0 113.254 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ARG . . . . . 0.554 ' HG2' ' HA ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -103.17 34.05 3.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 113.792 -3.163 . . . . 0.0 116.971 -174.222 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.892 ' OE1' HG21 ' A' ' 196' ' ' VAL . 0.8 OUTLIER -95.77 54.58 1.54 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.13 167.32 11.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.645 HG23 ' HG2' ' A' ' 189' ' ' LYS . 7.1 p -48.96 -49.34 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.533 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 62.2 m-20 -64.84 -49.3 71.11 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.72 -33.7 46.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 111.975 -177.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 364' ' ' ALA . . . -61.44 -53.27 58.66 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.961 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.771 HD21 ' HE3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -78.91 -47.18 16.94 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.746 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.704 ' O ' HG23 ' A' ' 366' ' ' THR . 6.3 mmtp -50.35 -56.01 13.16 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.71 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.66 -53.3 14.05 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.435 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 368' ' ' ILE . . . -58.76 -57.25 13.85 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.119 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.411 ' HG2' HG21 ' A' ' 369' ' ' THR . 0.8 OUTLIER -61.0 -54.86 39.77 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 362' ' ' LYS . 64.0 p -51.11 -52.71 41.07 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -66.4 -38.04 86.59 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.799 HD11 HG11 ' A' ' 183' ' ' VAL . 12.5 pt -79.42 -30.1 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.411 HG21 ' HG2' ' A' ' 365' ' ' GLN . 63.9 p -94.84 -18.91 20.76 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 366' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.252 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.643 0.259 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -137.72 96.84 3.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -135.0 119.68 18.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.951 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -155.1 156.37 35.71 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -125.36 75.32 0.4 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.227 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -158.39 163.9 36.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.496 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -169.21 124.28 0.86 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.96 ' H ' ' CB ' ' A' ' 58' ' ' ASP . 4.9 p -124.7 112.26 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.399 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.475 HG23 HG23 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -96.82 143.56 12.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.887 -175.494 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.824 ' HB3' HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -104.29 127.21 51.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.635 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 39' ' ' HIS . 10.8 tt -158.55 164.89 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.016 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -132.65 39.99 3.3 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.08 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.71 -15.46 58.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.482 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER 61.18 65.18 1.01 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.054 0.427 . . . . 0.0 109.921 -179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 2.3 mtmt 162.63 -170.78 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 296' ' ' ASP . . . 75.96 24.34 69.55 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CE1' HG23 ' A' ' 37' ' ' VAL . 38.8 m-85 -76.2 -36.71 58.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.793 0.797 . . . . 0.0 111.03 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 2.7 m120 -64.75 -49.37 71.04 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.637 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -72.27 -49.73 19.57 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.673 -0.775 . . . . 0.0 114.212 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.726 ' O ' HG21 ' A' ' 35' ' ' VAL . 3.5 mm? -59.22 -51.16 71.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.75 0.775 . . . . 0.0 110.193 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.443 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -66.0 -37.7 86.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 111.973 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -67.16 -37.5 83.88 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.747 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 19' ' ' GLY . 4.5 m -68.1 -61.18 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 121.76 -0.588 . . . . 0.0 110.087 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.511 ' H ' HG23 ' A' ' 23' ' ' VAL . . . -49.09 -34.16 16.0 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.374 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -50.43 69.42 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.447 1.117 . . . . 0.0 108.444 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -52.26 -42.31 63.56 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 112.874 -1.966 . . . . 0.0 108.677 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.823 ' HB3' HD13 ' A' ' 33' ' ' ILE . 71.7 m-85 -65.98 -32.22 73.57 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.756 0.789 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.791 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 7.2 tt0 -70.09 -51.8 28.88 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.022 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -52.07 -29.7 22.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 125.327 1.642 . . . . 0.0 111.254 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.804 ' O ' ' HB ' ' A' ' 31' ' ' THR . 3.5 m-20 -84.29 -38.07 20.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.187 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.804 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 4.5 t 159.79 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.84 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.38 38.7 0.02 OUTLIER Glycine 0 N--CA 1.466 0.658 0 C-N-CA 114.968 -3.491 . . . . 0.0 118.914 174.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.84 HD12 ' C ' ' A' ' 32' ' ' GLY . 2.1 mp -140.16 130.25 29.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 121.513 2.657 . . . . 0.0 115.65 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -137.16 105.16 5.64 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.726 HG21 ' O ' ' A' ' 20' ' ' LEU . 34.2 m -99.74 133.21 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.847 ' HB ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.0 147.19 45.09 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.532 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.445 HG23 ' CE1' ' A' ' 17' ' ' TYR . 17.9 m -133.34 123.32 46.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 122.164 -0.335 . . . . 0.0 110.404 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -111.59 139.8 46.74 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.1 78.95 25.75 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-O 120.841 0.353 . . . . 0.0 110.739 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 43' ' ' LEU . 60.7 Cg_endo -92.69 163.11 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.261 2.64 . . . . 0.0 113.307 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -90.72 -35.45 14.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -82.76 0.49 43.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.482 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 10' ' ' TRP . 54.1 tp -19.78 -49.31 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 1.081 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 mt-10 -67.29 -54.51 20.18 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.556 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.74 -43.62 62.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.905 0.383 . . . . 0.0 110.324 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.616 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.11 -56.13 23.27 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.955 0.883 . . . . 0.0 109.764 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.728 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 9.1 t80 -48.17 -60.95 3.59 Favored Pre-proline 0 C--O 1.219 -0.525 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.919 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 1.081 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 32.2 Cg_exo -60.22 -26.53 82.82 Favored 'Trans proline' 0 C--O 1.25 1.114 0 C-N-CA 121.278 1.318 . . . . 0.0 113.679 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -81.82 -38.76 25.03 Favored 'General case' 0 C--O 1.256 1.443 0 CA-C-O 122.161 0.981 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 54' ' ' GLY . 17.9 m -75.09 -39.26 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 CA-C-O 121.849 0.833 . . . . 0.0 109.832 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB1' ' OD1' ' A' ' 267' ' ' ASN . . . -50.16 -39.78 44.61 Favored 'General case' 0 C--N 1.372 1.553 0 C-N-CA 127.748 2.419 . . . . 0.0 111.593 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.46 -40.2 26.7 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.011 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -83.5 -7.23 59.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 77.82 -74.51 1.97 Allowed Glycine 0 C--N 1.352 1.45 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.184 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 t70 72.05 13.14 5.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.167 -1.016 . . . . 0.0 110.265 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . 57.72 59.38 10.93 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.094 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -101.39 171.36 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.38 2.72 . . . . 0.0 114.213 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.96 ' CB ' ' H ' ' A' ' 8' ' ' VAL . 25.1 m-20 -94.28 -133.12 0.17 Allowed 'General case' 0 N--CA 1.414 -2.257 0 C-N-CA 125.098 1.359 . . . . 0.0 109.137 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.64 HG13 ' HA ' ' A' ' 266' ' ' ILE . 9.6 tt -99.73 168.11 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 124.089 0.955 . . . . 0.0 112.477 -177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.804 HG23 ' HB2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -134.31 126.35 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 3.2 m-85 -108.15 125.4 51.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.603 ' CH2' ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -166.81 166.77 15.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.586 0.354 . . . . 0.0 110.062 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 62' ' ' TRP . . . -45.35 158.32 0.07 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.518 0.599 . . . . 0.0 112.519 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.942 ' HB2' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -77.5 -29.27 52.44 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -47.82 -53.72 14.64 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.825 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.39 -26.08 42.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.043 0.449 . . . . 0.0 110.098 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.609 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -57.44 -34.33 68.85 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 171.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.762 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -55.2 -69.65 1.2 Allowed Glycine 0 C--N 1.357 1.74 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 177.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.87 -54.16 23.39 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-N 112.996 -1.602 . . . . 0.0 111.363 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.493 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.4 m-30 -50.56 -40.53 52.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -48.63 -48.36 39.58 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.61 -31.08 46.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.138 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -70.26 -26.77 63.98 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.561 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.25 23.28 44.91 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.574 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 48' ' ' PRO . 4.0 mt -106.16 54.58 0.69 Allowed 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.911 0.386 . . . . 0.0 110.392 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.813 ' CG ' HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.13 145.13 0.25 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.877 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.966 ' HB3' HG23 ' A' ' 266' ' ' ILE . . . -72.2 74.65 0.97 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.208 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 1.7 pm0 -53.0 125.1 16.09 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.8 0.333 . . . . 0.0 110.495 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.642 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.1 mm -70.88 173.38 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.856 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.582 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -87.95 175.54 4.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 80' ' ' THR . 72.2 Cg_endo -79.2 101.49 1.43 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.052 1.835 . . . . 0.0 113.031 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 84' ' ' ALA . 18.1 t70 -145.46 107.76 4.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.251 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.18 0.22 52.47 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.499 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . . . -51.19 -32.99 25.44 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.579 0.228 . . . . 0.0 111.579 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.509 ' O ' HD12 ' A' ' 89' ' ' LEU . 22.7 m-85 -79.31 -59.06 2.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.882 0.372 . . . . 0.0 110.075 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.45 -27.92 40.71 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.544 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -76.32 -47.01 25.08 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.664 0.269 . . . . 0.0 110.833 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -67.86 -20.41 65.13 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.521 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.75 HD22 ' HZ2' ' A' ' 94' ' ' TRP . 5.1 mp -112.82 -163.46 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 121.454 -0.098 . . . . 0.0 110.879 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.458 ' CG ' ' HD2' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -84.68 146.78 47.41 Favored Pre-proline 0 C--N 1.34 0.175 0 O-C-N 121.992 -0.442 . . . . 0.0 111.641 -178.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 95' ' ' ASP . 61.0 Cg_endo -73.32 -35.03 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.234 1.956 . . . . 0.0 111.703 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CD2' ' HG2' ' A' ' 325' ' ' GLN . 63.2 m-85 -57.81 -62.43 1.81 Allowed 'General case' 0 C--O 1.246 0.872 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.884 HG23 ' CD1' ' A' ' 94' ' ' TRP . 1.8 t -62.58 -24.68 67.67 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.884 ' CD1' HG23 ' A' ' 93' ' ' THR . 36.5 m95 -93.43 -24.45 18.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.145 0.498 . . . . 0.0 111.877 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 91' ' ' PRO . 8.3 m-20 -71.08 -23.49 62.13 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.711 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.651 ' HA ' HD12 ' A' ' 329' ' ' ILE . . . -71.91 -43.21 65.7 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.942 HG12 ' HB2' ' A' ' 64' ' ' HIS . 27.2 m -102.54 43.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.45 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -128.81 139.47 52.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.507 ' O ' ' N ' ' A' ' 101' ' ' GLY . 3.2 t80 -118.48 90.74 3.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 119.262 0.937 . . . . 0.0 109.874 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.6 t30 48.29 -86.72 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . -127.63 39.2 1.97 Allowed Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.66 -177.34 5.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.48 0.312 . . . . 0.0 111.225 -178.32 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 97' ' ' VAL . 0.7 OUTLIER 168.71 128.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.399 0.545 . . . . 0.0 110.032 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.813 HD11 ' CG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -114.24 38.01 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.315 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 168.81 169.67 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.07 132.88 23.78 Favored Pre-proline 0 CA--C 1.528 0.122 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.277 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.768 ' HD3' HG21 ' A' ' 97' ' ' VAL . 90.8 Cg_endo -79.61 166.91 21.4 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.463 2.109 . . . . 0.0 113.211 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.822 ' O ' HG13 ' A' ' 302' ' ' VAL . 0.6 OUTLIER -162.31 38.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.364 178.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.729 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -179.8 136.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.166 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.708 ' O ' HG21 ' A' ' 320' ' ' THR . 21.7 t -123.58 105.89 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.541 ' HG2' ' HG3' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -116.68 131.16 57.02 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 -178.191 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.456 ' N ' HG23 ' A' ' 320' ' ' THR . . . -158.19 143.26 16.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.468 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.509 HD21 ' OE1' ' A' ' 153' ' ' GLU . 6.5 mp -77.89 143.43 37.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.936 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.409 ' OG ' ' HB1' ' A' ' 319' ' ' ALA . 1.8 m -133.3 169.46 16.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.76 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -91.16 128.41 36.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 1.021 HG23 HG23 ' A' ' 225' ' ' THR . 8.0 tp -116.95 140.43 39.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -153.63 161.44 42.16 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.396 0.279 . . . . 0.0 111.554 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.408 ' CB ' ' HB3' ' A' ' 121' ' ' LEU . 18.7 m120 -97.52 139.03 34.04 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -109.9 -4.84 15.73 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-N 113.096 -1.865 . . . . 0.0 111.23 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -43.56 6.78 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 124.781 2.229 . . . . 0.0 105.455 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.592 HD13 HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -76.35 -135.45 0.02 OUTLIER 'General case' 0 N--CA 1.396 -3.169 1 CA-C-N 107.678 -4.328 . . . . 0.0 113.216 -170.548 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.635 HD23 ' HD2' ' A' ' 123' ' ' PRO . 1.6 mt -82.66 148.26 57.61 Favored Pre-proline 0 C--N 1.287 -2.132 0 N-CA-C 119.98 3.326 . . . . 0.0 119.98 -167.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.635 ' HD2' HD23 ' A' ' 122' ' ' LEU . 1.4 Cg_exo -27.33 166.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 1 C-N-CA 130.354 7.369 . . . . 0.0 120.34 176.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.808 ' O ' HD11 ' A' ' 135' ' ' LEU . 18.8 m-80 -62.03 111.81 5.19 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.365 -172.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.96 167.78 25.45 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 124.055 3.17 . . . . 0.0 112.904 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.49 ' HD2' HD11 ' A' ' 147' ' ' LEU . 77.4 Cg_exo -49.66 111.13 0.45 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 123.324 2.683 . . . . 0.0 115.573 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -76.45 -25.64 54.58 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.084 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.91 147.31 43.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.489 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.579 ' HE3' HD21 ' A' ' 198' ' ' LEU . 65.3 m95 -67.92 -37.89 82.23 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 175.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.461 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.9 mp0 -58.82 -23.84 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.563 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 0.5 OUTLIER -87.03 -16.14 36.55 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.379 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.579 ' CG1' ' HD3' ' A' ' 133' ' ' PRO . 4.0 pt -52.37 -37.98 50.33 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 118.683 0.674 . . . . 0.0 111.417 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.881 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 52.3 Cg_exo -52.93 -33.26 61.1 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 N-CA-C 109.549 -0.981 . . . . 0.0 109.549 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.99 -58.59 3.19 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.808 HD11 ' O ' ' A' ' 124' ' ' ASN . 0.2 OUTLIER -68.21 -42.28 80.06 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.653 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.7 OUTLIER -69.21 -32.41 71.65 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.881 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -47.92 -50.14 27.84 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.061 176.104 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 35.3 mt-10 -62.35 -43.5 98.68 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.924 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.828 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.6 OUTLIER -60.36 -49.4 77.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -47.9 -44.11 29.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.04 -27.35 0.91 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.507 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -60.03 1.69 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.288 0.566 . . . . 0.0 109.891 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.84 42.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 118.934 -0.925 . . . . 0.0 111.073 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.687 ' HG3' HD23 ' A' ' 139' ' ' LEU . 9.0 ptpt -154.27 -171.88 4.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 119.514 1.657 . . . . 0.0 111.419 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.779 ' C ' HD22 ' A' ' 139' ' ' LEU . 2.5 m -141.56 161.8 37.04 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.828 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -75.47 -28.91 59.43 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.755 HD12 ' C ' ' A' ' 146' ' ' ALA . 5.7 mp -123.74 127.16 47.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.911 ' HB2' HG21 ' A' ' 222' ' ' THR . 8.8 tpt -134.1 127.9 33.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 120.039 1.29 . . . . 0.0 109.845 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.968 ' O ' ' O ' ' A' ' 150' ' ' ASN . 37.3 p90 -170.4 177.22 4.15 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.968 ' O ' ' O ' ' A' ' 149' ' ' PHE . 2.9 t-20 -28.42 -156.79 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 208' ' ' THR . 1.0 OUTLIER -178.15 40.58 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 120.992 -1.068 . . . . 0.0 111.055 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 151' ' ' LEU . 1.9 pp0? 172.86 32.92 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 168.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 157' ' ' THR . 0.2 OUTLIER -103.87 114.45 64.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 119.991 1.269 . . . . 0.0 107.585 177.458 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.787 ' HA ' ' OG1' ' A' ' 157' ' ' THR . 5.8 Cg_exo -79.77 36.98 0.64 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 119.265 0.773 . . . . 0.0 113.706 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 1.227 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 3.7 m-85 -97.79 -52.01 3.89 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 172.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.731 ' CZ ' HD12 ' A' ' 226' ' ' ILE . 42.5 t80 -74.66 -42.63 58.16 Favored 'General case' 0 C--O 1.251 1.141 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 153' ' ' GLU . 1.5 p -58.05 -57.03 14.63 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.487 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.559 ' HA ' HG12 ' A' ' 161' ' ' ILE . 7.5 m0 -49.54 -52.51 49.55 Favored Pre-proline 0 C--N 1.351 0.648 0 CA-C-O 120.78 0.324 . . . . 0.0 110.75 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 1.227 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 51.5 Cg_exo -44.44 -50.05 8.42 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.625 2.217 . . . . 0.0 113.171 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.48 ' HG ' ' CZ ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -60.4 -56.84 16.55 Favored 'General case' 0 CA--C 1.51 -0.567 0 O-C-N 122.026 -0.421 . . . . 0.0 109.908 -179.573 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 158' ' ' TRP . 14.1 pt -53.94 -22.6 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.831 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -77.23 -24.5 51.23 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.895 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 253' ' ' GLN . . . -41.19 -58.83 1.68 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.403 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 13.1 t70 -63.84 -58.06 7.96 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.345 -0.847 . . . . 0.0 112.6 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.69 21.38 0.03 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 117.648 -2.215 . . . . 0.0 116.823 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.12 160.13 40.15 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 119.086 1.443 . . . . 0.0 111.573 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -139.49 122.56 16.81 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.429 0.615 . . . . 0.0 109.743 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.878 ' O ' HG13 ' A' ' 183' ' ' VAL . . . -38.49 -78.54 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.291 0.567 . . . . 0.0 111.971 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.753 ' HB3' ' CB ' ' A' ' 176' ' ' TYR . 9.8 m-85 -113.64 176.07 5.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 1.159 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -101.54 102.1 12.78 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.05 114.51 18.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.53 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 23.9 tt0 -137.22 109.36 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.517 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 1.4 m-20 84.1 -32.38 0.07 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.862 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 160.28 13.9 0.03 OUTLIER Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.036 -0.869 . . . . 0.0 114.072 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -174.0 143.12 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.577 1.689 . . . . 0.0 110.943 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 1.159 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 37.0 p90 -64.98 -25.45 67.87 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.193 0.997 . . . . 0.0 110.805 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.471 ' O ' HD13 ' A' ' 178' ' ' ILE . 55.8 m-20 72.37 -106.91 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.743 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 177' ' ' ASP . 38.0 mm -159.16 -48.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -70.83 -4.01 21.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.72 95.56 3.5 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.276 -0.569 . . . . 0.0 112.12 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 18.9 t -117.98 131.04 71.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.434 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . -121.4 39.73 2.3 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 119.47 -1.348 . . . . 0.0 114.092 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 168' ' ' ALA . 6.4 m -79.1 -40.78 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.848 ' OD1' HD13 ' A' ' 361' ' ' LEU . 58.8 t0 -69.9 58.61 0.15 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.899 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 182' ' ' GLY . 5.9 p30 -110.33 175.94 5.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.982 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -80.45 -19.57 45.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.835 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -69.64 -48.84 40.58 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.3 98.6 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 193' ' ' THR . 0.0 OUTLIER -56.99 -59.4 5.12 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.215 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 193' ' ' THR . . . -50.43 -41.66 52.87 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.253 1.025 . . . . 0.0 112.051 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -70.45 -60.51 4.67 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.659 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.628 ' O ' HG23 ' A' ' 196' ' ' VAL . 9.2 tt -56.05 -29.26 60.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 189' ' ' LYS . 14.8 p -66.87 -41.09 87.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 194' ' ' PHE . 0.0 OUTLIER -59.48 -37.74 79.02 Favored 'General case' 0 C--N 1.349 0.563 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.125 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.512 HD23 HD11 ' A' ' 199' ' ' ILE . 0.4 OUTLIER -62.72 -47.56 83.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.782 178.278 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 192' ' ' LEU . 43.6 t -58.22 -29.88 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.28 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.18 -45.4 85.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.732 0.777 . . . . 0.0 110.969 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.579 HD21 ' HE3' ' A' ' 129' ' ' TRP . 11.2 mp -57.34 -57.02 14.47 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.77 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.512 HD11 HD23 ' A' ' 195' ' ' LEU . 3.8 mt -65.16 -32.33 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.969 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -56.4 -38.61 71.73 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 118.56 -0.734 . . . . 0.0 111.042 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -113.41 -34.97 5.43 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 121.086 3.735 . . . . 0.0 121.086 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.67 -66.1 1.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 199' ' ' ILE . 0.2 OUTLIER -36.45 -34.54 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 203' ' ' HIS . 2.2 ttp -36.0 97.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.707 0.289 . . . . 0.0 111.63 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.95 -173.19 3.83 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.064 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -85.61 58.66 5.17 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.626 ' HA ' HD23 ' A' ' 151' ' ' LEU . 2.3 p30 37.85 74.13 0.09 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 30.8 p -55.18 121.4 8.74 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.59 -173.65 4.43 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.0 p90 -69.49 -45.39 69.05 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 1.7 m -70.18 -35.93 74.3 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.89 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.17 -48.44 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.745 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.0 -30.93 71.97 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -47.66 85.03 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.54 77.65 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.276 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.44 ' CB ' ' HG2' ' A' ' 148' ' ' MET . . . -54.27 -57.68 10.29 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.947 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.787 ' CB ' HD11 ' A' ' 235' ' ' ILE . 2.6 t80 -58.57 -29.6 66.53 Favored 'General case' 0 C--O 1.23 0.071 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -53.79 -40.41 66.27 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -74.66 -23.92 58.73 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 65.66 54.79 23.65 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.419 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -116.03 37.2 3.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.452 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.911 HG21 ' HB2' ' A' ' 148' ' ' MET . 82.8 p -144.56 143.53 30.86 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.773 0.796 . . . . 0.0 110.213 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -102.08 38.3 1.69 Allowed 'General case' 0 C--N 1.352 0.674 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 36.1 ttm 177.24 147.06 0.12 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' THR . . . . . 1.021 HG23 HG23 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -142.43 170.26 16.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.701 0.762 . . . . 0.0 111.558 -176.106 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.731 HD12 ' CZ ' ' A' ' 156' ' ' PHE . 24.8 mm -120.68 130.34 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 172.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -147.31 166.69 26.33 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 123.759 0.823 . . . . 0.0 110.474 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -108.15 -162.88 21.02 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.47 -0.395 . . . . 0.0 112.741 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.541 ' HG3' ' HG2' ' A' ' 111' ' ' GLU . 56.2 Cg_endo -87.54 -20.72 2.01 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.128 2.552 . . . . 0.0 114.081 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.464 ' CB ' ' HB3' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -178.65 -42.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.65 62.37 6.46 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.803 0.335 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -107.7 -63.06 1.35 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.781 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 169.2 -176.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.658 0.266 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.83 58.85 2.31 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.795 0.331 . . . . 0.0 110.72 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.787 HD11 ' CB ' ' A' ' 217' ' ' PHE . 14.6 tt -86.69 145.47 7.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.174 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -100.67 123.5 44.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.5 p -61.3 137.72 58.24 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.871 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -43.94 84.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.45 159.74 41.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.771 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.2 m -55.9 -40.02 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.648 0.261 . . . . 0.0 111.372 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 137.26 37.2 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.651 0.262 . . . . 0.0 110.741 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.413 ' CD1' HD11 ' A' ' 116' ' ' ILE . 10.5 p90 -149.23 137.31 20.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 111.323 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.531 ' O ' HD12 ' A' ' 116' ' ' ILE . . . -95.0 133.4 11.52 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.007 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.967 HG22 HD13 ' A' ' 116' ' ' ILE . 1.7 t -115.16 133.87 60.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.867 0.334 . . . . 0.0 111.268 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.76 167.56 17.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -170.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 45.9 t -73.29 154.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 113.893 -1.503 . . . . 0.0 107.871 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.8 mt -57.61 159.29 9.69 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.627 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -78.26 -157.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.926 2.417 . . . . 0.0 112.906 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 253' ' ' GLN . 11.0 p -125.29 169.47 12.26 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.48 ' CZ ' ' HG ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -162.59 110.57 1.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.075 178.533 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.34 32.08 17.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.421 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.69 38.41 24.1 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.033 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.514 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 3.7 mt-30 -156.54 153.94 25.88 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 74.8 Cg_endo -86.37 -171.19 0.78 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.444 2.763 . . . . 0.0 113.263 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -109.28 141.02 42.19 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.988 0.423 . . . . 0.0 111.812 -179.229 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 5.5 ttmm -88.17 121.41 70.49 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.072 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.476 ' O ' ' HA2' ' A' ' 327' ' ' GLY . 55.1 Cg_endo -91.61 152.6 3.51 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.538 2.825 . . . . 0.0 114.417 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' A' ' 155' ' ' TYR . 5.9 m-85 -78.12 157.28 29.52 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 329' ' ' ILE . 20.8 t -110.56 121.82 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -125.11 119.52 3.63 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 118.673 -1.727 . . . . 0.0 117.069 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.769 HG21 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -114.38 108.53 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.729 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 1.6 tp -83.41 109.12 17.05 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.585 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -113.05 -178.12 3.3 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.509 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -111.01 128.81 55.97 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.743 ' O ' HD12 ' A' ' 60' ' ' ILE . . . -123.27 122.62 5.01 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.932 -1.128 . . . . 0.0 115.022 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.966 HG23 ' HB3' ' A' ' 77' ' ' ALA . 4.6 tp -90.86 122.47 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.596 ' HB2' HD11 ' A' ' 60' ' ' ILE . 62.7 t30 -61.82 141.89 57.66 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.23 -23.42 47.86 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.948 -0.47 . . . . 0.0 111.105 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.439 ' HB3' ' ND2' ' A' ' 267' ' ' ASN . . . -98.5 49.07 0.98 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.36 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 38.8 t -171.9 89.5 0.43 Allowed Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 272' ' ' ASN . 72.7 Cg_endo -76.42 164.19 31.12 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.625 2.217 . . . . 0.0 111.906 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.612 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 0.2 OUTLIER 165.69 57.24 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.709 0.29 . . . . 0.0 110.938 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -56.3 -54.1 49.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.452 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -56.68 7.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.16 -48.58 79.43 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -76.78 -56.84 4.25 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.1 OUTLIER -55.67 -41.02 73.09 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.513 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -53.17 8.62 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 27' ' ' PHE . 2.4 t80 -55.09 -59.44 4.75 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.59 -43.19 35.78 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.815 0.817 . . . . 0.0 111.245 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 285' ' ' LEU . 51.9 mt-10 -73.8 -35.36 64.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.37 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.414 ' O ' ' CG2' ' A' ' 286' ' ' THR . 3.6 m-20 -89.99 -16.39 29.94 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.479 ' O ' ' CG2' ' A' ' 286' ' ' THR . 28.0 t80 -103.72 -74.36 0.64 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 290' ' ' LEU . 0.1 OUTLIER -46.08 -27.57 0.98 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -102.07 39.41 1.48 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 283' ' ' TYR . 0.0 OUTLIER -140.72 152.83 45.6 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 175.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.795 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -62.93 -42.37 99.78 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -75.36 -19.39 59.61 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.548 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.463 ' HA3' HG23 ' A' ' 286' ' ' THR . . . -82.54 -55.13 3.09 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.897 HD21 ' HA ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -68.23 -28.46 67.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.795 ' HB2' ' O ' ' A' ' 287' ' ' ASP . 32.0 mt-10 -71.91 -32.39 67.34 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.453 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.39 80.37 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 296' ' ' ASP . 61.0 t -67.64 -61.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 297' ' ' LYS . 36.9 t-20 -46.41 -46.8 18.85 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.713 1.205 . . . . 0.0 112.545 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -48.87 79.49 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.8 ' O ' ' HD3' ' A' ' 298' ' ' PRO . 76.7 m-20 -58.04 -47.02 84.36 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 294' ' ' ASN . 0.9 OUTLIER -96.37 91.05 0.8 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.623 -178.101 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.8 ' HD3' ' O ' ' A' ' 296' ' ' ASP . 75.9 Cg_endo -106.83 93.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 124.318 3.346 . . . . 0.0 112.752 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.584 HD12 ' HD2' ' A' ' 298' ' ' PRO . 1.5 mp -161.1 -80.72 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.103 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -108.39 -160.28 20.16 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.573 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.795 ' HB2' HG23 ' A' ' 317' ' ' ILE . . . -79.17 74.32 5.73 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.074 0.464 . . . . 0.0 111.613 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.822 HG13 ' O ' ' A' ' 108' ' ' ILE . 53.7 t -97.22 76.13 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.897 ' HA ' HD21 ' A' ' 290' ' ' LEU . . . -177.28 107.51 0.06 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.718 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 303' ' ' ALA . 5.9 mp -22.84 179.68 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.627 ' H ' HD23 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -55.08 -55.47 30.7 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -177.694 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 83.2 p -57.09 -47.95 79.79 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-O 121.479 0.657 . . . . 0.0 111.761 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.642 ' CD2' HD13 ' A' ' 290' ' ' LEU . 88.7 m-85 -67.42 -54.57 19.19 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.158 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.735 ' CD ' ' HB1' ' A' ' 301' ' ' ALA . 4.4 mt-10 -61.11 -36.83 80.75 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.717 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.406 ' HG3' ' CD ' ' A' ' 305' ' ' LYS . 2.7 mm-40 -48.12 -49.66 31.3 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.889 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -71.36 -41.27 69.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.087 0.946 . . . . 0.0 109.529 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.454 ' O ' HD23 ' A' ' 311' ' ' LEU . 0.9 OUTLIER -55.97 -16.63 5.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.036 176.256 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 308' ' ' GLU . . . -46.22 -30.46 2.0 Allowed 'General case' 0 C--N 1.342 0.271 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.455 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -48.38 -34.79 11.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.53 158.26 11.71 Favored Pre-proline 0 N--CA 1.462 0.145 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.489 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -85.85 -46.67 0.04 OUTLIER 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.485 2.124 . . . . 0.0 114.521 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -58.9 6.24 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' A' ' 301' ' ' ALA . 1.3 mm -49.67 -56.24 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.81 -51.87 12.16 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.356 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.409 ' HB1' ' OG ' ' A' ' 114' ' ' SER . . . -65.15 -39.01 92.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.725 0.774 . . . . 0.0 109.812 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.708 HG21 ' O ' ' A' ' 110' ' ' VAL . 29.8 m -58.81 -42.83 90.09 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.49 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.5 ttp -63.64 -53.21 55.11 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -39.0 58.46 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.156 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -44.23 49.72 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.017 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -48.76 -45.39 39.74 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 110.333 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.449 ' HG2' ' CD2' ' A' ' 92' ' ' PHE . 10.6 mt-30 -63.68 -39.06 93.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.952 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -69.7 -20.04 63.55 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.389 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 257' ' ' PRO . . . -79.85 155.7 39.29 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.131 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 259' ' ' VAL . 0.6 OUTLIER -96.23 138.23 34.13 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.017 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 96' ' ' ALA . 23.5 mm -61.85 106.16 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 119.525 1.057 . . . . 0.0 110.904 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.14 107.03 0.73 Allowed Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 120.548 0.214 . . . . 0.0 111.14 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.15 -30.6 32.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.365 2.044 . . . . 0.0 112.141 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 68.2 91.56 0.09 Allowed 'General case' 0 C--N 1.339 0.12 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.295 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 335' ' ' GLN . 1.0 OUTLIER -133.91 144.91 53.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.195 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.36 -27.86 60.15 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.55 2.166 . . . . 0.0 111.979 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.755 ' HB2' HD12 ' A' ' 333' ' ' ILE . 2.1 mp0 -61.1 -25.21 66.8 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.136 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.2 mmt -46.13 -41.0 11.85 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.687 0.279 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.99 -39.27 65.92 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 1.074 ' HB1' HG22 ' A' ' 368' ' ' ILE . . . -55.07 -29.42 57.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.319 0.58 . . . . 0.0 110.8 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 343' ' ' VAL . 2.2 m-85 -78.77 -55.73 4.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.048 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -42.88 -44.69 4.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.842 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -76.57 -38.52 54.8 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.52 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.538 ' HB1' ' CB ' ' A' ' 364' ' ' ALA . . . -68.08 -44.55 76.04 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 17.8 m -73.13 -42.23 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.347 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.406 ' N ' HG23 ' A' ' 343' ' ' VAL . 0.0 OUTLIER -55.38 -57.14 13.1 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.006 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 1.1 m -58.1 -55.63 32.41 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.06 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.34 -60.96 2.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 351' ' ' ALA . 48.7 t -51.73 -47.05 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.1 mt -72.27 -47.91 51.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.911 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 345' ' ' THR . 76.6 m-20 -67.57 -43.28 81.0 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.836 ' HB1' ' HA ' ' A' ' 355' ' ' GLN . . . -78.38 -26.57 46.61 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -58.6 -10.12 2.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 23.2 t -110.63 31.24 6.12 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 91.21 33.15 8.3 Favored Glycine 0 N--CA 1.417 -2.595 0 C-N-CA 116.844 -2.598 . . . . 0.0 114.779 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -127.8 35.12 4.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.836 ' HA ' ' HB1' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -70.01 -174.48 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 1 N-CA-C 122.295 4.183 . . . . 0.0 122.295 -159.352 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.1 OUTLIER 173.9 57.7 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.347 179.375 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.829 ' O ' HD12 ' A' ' 361' ' ' LEU . 79.1 t -46.28 -41.85 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 3.0 t0 -63.13 -38.5 91.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 118.902 0.774 . . . . 0.0 110.395 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.537 ' CB ' ' HB ' ' A' ' 356' ' ' THR . 0.4 OUTLIER -80.14 -29.59 38.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.634 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -67.05 -54.02 25.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.919 0.866 . . . . 0.0 112.507 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.848 HD13 ' OD1' ' A' ' 184' ' ' ASP . 0.8 OUTLIER -82.64 -36.4 26.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.758 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 23.1 tttp -59.75 -51.97 67.47 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.823 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -44.77 65.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.239 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 368' ' ' ILE . . . -72.54 -57.81 3.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.422 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.493 ' HA ' ' CG1' ' A' ' 368' ' ' ILE . 9.3 tt0 -55.94 -42.25 75.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.9 m -65.25 -48.09 74.46 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.654 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -73.78 -44.37 56.22 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.019 -0.425 . . . . 0.0 111.154 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 1.074 HG22 ' HB1' ' A' ' 338' ' ' ALA . 2.1 pp -62.13 -32.95 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.507 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.651 HG23 HD12 ' A' ' 368' ' ' ILE . 0.6 OUTLIER -131.46 61.49 1.64 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.908 0.385 . . . . 0.0 111.154 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 56.7 tptt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.849 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.659 0.266 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.5 p -103.29 156.84 17.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.53 110.96 19.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -154.24 139.98 18.04 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.062 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -129.61 47.39 1.02 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.545 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -140.78 162.09 36.26 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.718 ' CB ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -132.4 122.56 25.18 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.839 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.037 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -116.47 115.52 49.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.737 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.949 HD12 HD22 ' A' ' 20' ' ' LEU . 7.8 mt -120.74 131.11 73.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.935 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.868 ' HE3' HD12 ' A' ' 43' ' ' LEU . 3.3 m0 -107.38 123.44 48.37 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.48 HD11 HG21 ' A' ' 9' ' ' ILE . 3.4 mt -155.67 166.12 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.846 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.671 ' O ' ' N ' ' A' ' 14' ' ' ASP . 3.5 m120 -78.84 48.84 0.86 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 120.014 1.279 . . . . 0.0 111.255 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.541 ' HA3' ' HB3' ' A' ' 39' ' ' HIS . . . -8.28 59.78 0.0 OUTLIER Glycine 0 C--N 1.348 1.202 0 C-N-CA 124.843 1.211 . . . . 0.0 115.923 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.671 ' N ' ' O ' ' A' ' 12' ' ' ASN . 72.2 m-20 -100.0 3.77 44.42 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.017 0.437 . . . . 0.0 110.177 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 162.99 -164.62 0.0 OUTLIER 'General case' 0 C--N 1.347 0.491 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.863 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.682 ' O ' HD12 ' A' ' 20' ' ' LEU . . . 70.66 34.3 66.99 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 117.038 1.575 . . . . 0.0 117.038 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.18 -59.72 2.54 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 11.5 p-10 -46.35 -42.39 14.8 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.055 0.455 . . . . 0.0 111.945 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.637 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -70.34 -45.41 55.01 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.578 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.956 HD13 HG11 ' A' ' 37' ' ' VAL . 18.7 mt -60.77 -49.69 76.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.446 0.623 . . . . 0.0 111.081 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.05 -39.49 63.47 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 3.1 mm-40 -64.52 -36.08 83.05 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.762 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 19' ' ' GLY . 23.2 m -67.87 -57.19 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.663 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.678 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . -49.58 -45.84 37.9 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.111 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 -50.41 41.21 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.263 1.03 . . . . 0.0 109.7 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -41.9 60.13 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.155 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.665 ' HB3' HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.65 -25.94 67.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.088 0.947 . . . . 0.0 111.084 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.773 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 7.9 tt0 -73.2 -52.05 15.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.654 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -52.73 -28.54 22.58 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 124.514 1.134 . . . . 0.0 110.576 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.838 ' O ' HG23 ' A' ' 31' ' ' THR . 0.5 OUTLIER -84.09 -37.68 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 117.626 -1.178 . . . . 0.0 108.844 178.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.85 37.79 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 171.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.811 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.26 38.57 0.02 OUTLIER Glycine 0 N--CA 1.463 0.494 0 C-N-CA 114.989 -3.482 . . . . 0.0 119.299 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.811 HD12 ' C ' ' A' ' 32' ' ' GLY . 1.8 mp -139.89 139.0 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 122.243 3.021 . . . . 0.0 117.005 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -142.36 104.51 4.43 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.718 HG22 ' CB ' ' A' ' 7' ' ' LEU . 38.1 t -82.8 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.9 p -117.5 137.43 52.55 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.008 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.956 HG11 HD13 ' A' ' 20' ' ' LEU . 6.9 m -130.69 121.55 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 O-C-N 122.231 -0.293 . . . . 0.0 110.507 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.435 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 2.5 tt0 -111.83 133.83 53.79 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.541 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . 46.1 p-80 -106.08 71.29 0.25 Allowed Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 120.682 0.277 . . . . 0.0 111.462 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.551 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 86.6 Cg_endo -78.07 -171.68 1.27 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.274 2.649 . . . . 0.0 113.627 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -125.22 -60.24 1.35 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 0.57 34.12 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.045 0.45 . . . . 0.0 110.92 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.868 HD12 ' HE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -32.91 -45.68 0.13 Allowed 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 1.014 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 3.6 tm-20 -47.11 -54.93 9.35 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.042 -0.411 . . . . 0.0 112.104 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.12 -48.8 21.98 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.785 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 50' ' ' VAL . 24.5 mtpt -63.51 -56.81 13.07 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.167 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.78 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.9 t80 -45.42 -58.44 5.89 Favored Pre-proline 0 C--O 1.225 -0.191 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 1.014 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 38.9 Cg_exo -65.78 -36.38 32.25 Favored 'Trans proline' 0 C--O 1.249 1.031 0 C-N-CA 121.088 1.192 . . . . 0.0 114.628 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -66.81 -52.18 46.93 Favored 'General case' 0 C--O 1.259 1.588 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 175.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 46' ' ' LYS . 12.0 m -61.56 -21.22 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 122.231 1.015 . . . . 0.0 111.637 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 48' ' ' PRO . . . -60.85 -29.31 69.45 Favored 'General case' 0 C--N 1.393 2.459 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.643 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -82.46 -26.8 32.33 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.411 1.484 . . . . 0.0 112.946 -178.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.61 ' O ' HG23 ' A' ' 53' ' ' THR . 13.1 t -92.47 95.79 9.85 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.083 -0.647 . . . . 0.0 112.073 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 102.27 -71.24 0.33 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.487 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 21.2 m-20 94.77 107.03 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.115 1.457 . . . . 0.0 110.461 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 57' ' ' PRO . . . -163.41 -59.05 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.388 -0.91 . . . . 0.0 114.039 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.525 ' O ' ' O ' ' A' ' 56' ' ' GLY . 59.0 Cg_exo -22.9 157.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.797 3.665 . . . . 0.0 115.937 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 1.037 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 5.1 t70 -79.95 -133.86 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.822 0 C-N-CA 125.241 1.416 . . . . 0.0 112.286 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 265' ' ' GLY . 5.5 mm -105.77 159.31 5.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.857 HG23 ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -128.52 136.01 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.45 -178.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.936 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -117.97 113.85 22.31 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.477 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 34.6 t-105 -166.48 165.14 17.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.988 0.515 . . . . 0.0 109.846 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -37.74 154.48 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.822 0.737 . . . . 0.0 112.11 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.635 ' CB ' ' HB ' ' A' ' 261' ' ' VAL . 14.9 t60 -77.24 -28.3 53.62 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' OD2' ' HB1' ' A' ' 63' ' ' ALA . 1.3 p30 -50.46 -51.49 46.45 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.984 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -77.85 -27.3 49.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.303 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.857 ' CZ ' HG23 ' A' ' 60' ' ' ILE . 4.6 m-85 -64.73 -28.62 69.71 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 174.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.48 -63.89 4.6 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 332' ' ' ASN . . . -54.9 -52.29 47.49 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 113.471 -1.365 . . . . 0.0 111.656 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HB2' HD12 ' A' ' 76' ' ' LEU . 4.8 m-30 -54.52 -45.87 73.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.786 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . . . -50.84 -40.7 56.59 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.852 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.22 -60.33 2.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 m -113.78 -26.76 8.05 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' LEU . . . -56.78 -86.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.078 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.999 HD23 ' HB3' ' A' ' 268' ' ' ALA . 0.0 OUTLIER 167.98 66.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.007 HD22 HD12 ' A' ' 104' ' ' ILE . 1.7 mt -110.54 136.37 49.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 110.926 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -102.23 106.33 17.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.456 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.437 ' CG ' HG12 ' A' ' 104' ' ' ILE . 77.7 mt-10 -47.75 154.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.927 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 105' ' ' ALA . 20.1 mt -109.41 136.81 44.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.053 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 m -112.97 82.74 5.46 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.834 0.349 . . . . 0.0 110.764 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.05 -173.86 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.738 2.292 . . . . 0.0 112.229 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -88.49 117.91 27.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.593 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -33.24 4.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.462 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -57.55 -27.12 62.36 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.879 ' CE1' HD11 ' A' ' 285' ' ' LEU . 11.6 t80 -79.23 -59.22 2.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.832 0.349 . . . . 0.0 110.314 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.492 ' HG2' ' CD1' ' A' ' 94' ' ' TRP . 1.3 tt0 -60.94 -33.25 72.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.966 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -76.68 -31.9 57.56 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.972 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 7.1 mtpm? -80.34 -1.6 41.79 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.456 HD21 ' N ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -122.71 -171.25 2.24 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.323 0.51 . . . . 0.0 110.994 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.23 117.24 52.69 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.667 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.55 -41.51 67.71 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.581 2.187 . . . . 0.0 112.671 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -50.03 -45.3 51.91 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.726 0.298 . . . . 0.0 111.323 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.708 ' CG2' HG22 ' A' ' 302' ' ' VAL . 2.4 m -61.17 -28.23 68.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.492 ' CD1' ' HG2' ' A' ' 86' ' ' GLN . 17.8 m95 -92.95 -24.72 18.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.317 0.58 . . . . 0.0 111.985 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -73.91 -22.65 59.61 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.842 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.82 ' HB1' HG13 ' A' ' 261' ' ' VAL . . . -53.19 -48.16 68.3 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.671 HG22 HG11 ' A' ' 261' ' ' VAL . 3.8 t -103.09 39.6 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 134.58 40.31 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.4 OUTLIER -113.84 91.06 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.806 0.73 . . . . 0.0 110.751 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 99' ' ' TYR . 31.5 t30 69.62 -70.2 0.15 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.085 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.96 -41.65 0.98 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.281 -0.962 . . . . 0.0 114.207 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -125.96 -178.28 4.24 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.369 0.584 . . . . 0.0 109.869 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 103' ' ' LEU . 0.5 OUTLIER -116.82 139.26 50.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.007 HD12 HD22 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -96.13 38.0 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.977 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 160.72 -179.67 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 264' ' ' ALA . 20.6 p90 -118.94 127.5 26.49 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.708 ' HB3' HG12 ' A' ' 261' ' ' VAL . 72.6 Cg_endo -79.58 165.66 22.57 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 C-N-CA 122.265 1.977 . . . . 0.0 112.731 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 107' ' ' PRO . 1.7 pt -160.89 38.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.807 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.929 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . 178.56 110.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.833 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.037 HG23 HG11 ' A' ' 302' ' ' VAL . 17.0 t -98.43 111.26 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -103.15 163.12 12.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.624 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.676 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -164.88 150.29 9.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.537 0.684 . . . . 0.0 111.981 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.814 ' O ' HD12 ' A' ' 113' ' ' LEU . 4.6 pp -79.19 127.66 32.32 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.407 ' HA ' ' CD2' ' A' ' 247' ' ' LEU . 0.3 OUTLIER -130.56 166.77 19.91 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 116' ' ' ILE . 6.7 tt -106.22 136.44 45.92 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.801 ' CD1' HD11 ' A' ' 235' ' ' ILE . 1.8 mp -112.93 129.65 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.501 0.667 . . . . 0.0 111.764 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.578 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 24.6 p90 -94.33 -174.22 3.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.864 2.466 . . . . 0.0 110.156 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.597 ' CB ' ' HB2' ' A' ' 122' ' ' LEU . 0.4 OUTLIER -154.0 130.82 10.84 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.991 0.814 . . . . 0.0 110.002 177.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 43.15 1.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.151 0.887 . . . . 0.0 111.421 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.67 -71.76 0.34 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 110.474 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -142.35 38.48 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.406 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.597 ' HB2' ' CB ' ' A' ' 118' ' ' ASN . 71.2 mt -157.97 72.91 4.1 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.647 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.36 133.28 25.89 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.445 2.097 . . . . 0.0 113.398 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.547 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 1.8 p-10 -71.22 159.98 83.9 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 67.7 Cg_endo -72.97 167.84 26.28 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.551 2.834 . . . . 0.0 111.946 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.63 -139.56 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.662 2.241 . . . . 0.0 113.312 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 128' ' ' THR . 0.0 OUTLIER -85.5 -17.62 35.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.91 0.777 . . . . 0.0 112.518 -179.028 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.473 HG22 ' HG2' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -118.13 142.17 47.71 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.567 ' CZ2' HD22 ' A' ' 147' ' ' LEU . 6.3 t-105 -71.23 -28.39 64.15 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 173.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.539 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -44.49 -23.49 0.12 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.61 -21.25 62.67 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.834 HG23 ' HD3' ' A' ' 133' ' ' PRO . 2.1 tp -45.94 -47.28 41.88 Favored Pre-proline 0 N--CA 1.475 0.782 0 CA-C-N 118.579 0.627 . . . . 0.0 112.297 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.834 ' HD3' HG23 ' A' ' 132' ' ' ILE . 11.9 Cg_endo -52.48 -42.2 62.89 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 109.398 -1.039 . . . . 0.0 109.398 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.3 -58.7 3.12 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 139' ' ' LEU . 3.1 mm? -67.79 -35.51 78.79 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.689 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 132' ' ' ILE . 20.0 t0 -74.97 -41.55 59.35 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -49.86 -42.17 46.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.806 177.493 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.2 mm-40 -67.59 -36.26 80.54 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.906 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -65.21 -46.68 79.68 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.78 -44.1 38.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -45.97 -23.48 0.3 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.645 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -113.06 -58.75 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.446 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.78 53.41 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.75 ' HG3' HD23 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -167.01 -172.99 2.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 120.15 1.975 . . . . 0.0 110.013 -177.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.804 ' O ' HD22 ' A' ' 139' ' ' LEU . 54.5 m -144.27 165.13 28.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.906 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -79.51 -20.34 47.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.567 HD22 ' CZ2' ' A' ' 129' ' ' TRP . 4.4 pp -152.48 178.26 9.74 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.871 ' HB2' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -179.21 143.34 0.2 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.336 178.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.486 ' O ' ' O ' ' A' ' 150' ' ' ASN . 26.4 p90 -172.85 175.93 3.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.746 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 149' ' ' PHE . 3.0 m120 -37.01 164.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.767 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 208' ' ' THR . 1.0 OUTLIER -110.51 -58.69 2.05 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -102.71 35.59 2.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 116.92 -1.912 . . . . 0.0 114.035 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.766 ' O ' ' HB ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -79.63 144.23 60.41 Favored Pre-proline 0 C--O 1.221 -0.42 0 CA-C-N 121.957 2.162 . . . . 0.0 114.932 -175.05 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.941 ' O ' ' N ' ' A' ' 156' ' ' PHE . 6.3 Cg_exo -78.07 -135.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 1 C-N-CA 125.72 4.28 . . . . 0.0 106.945 177.09 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 1.123 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 1.8 m-85 16.96 -51.87 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.941 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.2 OUTLIER -84.61 -55.92 3.87 Favored 'General case' 0 C--O 1.259 1.562 0 C-N-CA 124.452 1.101 . . . . 0.0 112.129 -178.324 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.766 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 95.9 m -57.71 -42.53 83.97 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.51 ' CE3' ' HA ' ' A' ' 154' ' ' PRO . 0.7 OUTLIER -51.16 -55.71 26.1 Favored Pre-proline 0 C--N 1.349 0.564 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 1.123 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 40.1 Cg_exo -43.13 -50.65 6.25 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.166 2.578 . . . . 0.0 113.284 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mt -61.83 -56.75 16.11 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 119.925 1.238 . . . . 0.0 109.832 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 192' ' ' LEU . 4.6 mm -52.85 -18.74 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.153 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -78.03 -25.88 48.09 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -43.09 -58.61 2.38 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.51 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 9.3 t0 -65.0 -28.64 69.64 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.416 ' N ' ' HA3' ' A' ' 187' ' ' GLY . . . 147.32 23.44 0.09 OUTLIER Glycine 0 CA--C 1.526 0.721 0 C-N-CA 118.516 -1.802 . . . . 0.0 116.946 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -104.2 86.77 0.53 Allowed Glycine 0 C--N 1.335 0.503 0 CA-C-N 119.021 1.411 . . . . 0.0 113.225 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -104.74 -179.46 3.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.007 0.403 . . . . 0.0 110.04 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.71 -78.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.152 0.501 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.645 ' HB3' ' CD1' ' A' ' 176' ' ' TYR . 1.1 m-85 -125.89 172.78 9.61 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.041 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 1.226 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.8 OUTLIER -112.57 139.3 48.27 Favored 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -174.352 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.97 116.56 29.13 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.641 ' O ' ' C ' ' A' ' 173' ' ' ASN . 2.7 mm-40 -137.44 178.66 6.93 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.147 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.641 ' C ' ' O ' ' A' ' 172' ' ' GLU . 4.8 m120 -20.05 -64.4 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -80.79 -71.9 1.25 Allowed Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -174.57 170.02 3.55 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.891 1.346 . . . . 0.0 107.439 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 1.226 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 1.3 p90 -49.95 -33.43 17.59 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 123.102 1.43 . . . . 0.0 109.908 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.556 ' C ' HG22 ' A' ' 178' ' ' ILE . 12.9 m-20 65.2 -76.84 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.463 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 1.0 HD11 ' HB ' ' A' ' 369' ' ' THR . 0.0 OUTLIER 174.7 -51.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.834 ' N ' HD13 ' A' ' 178' ' ' ILE . 6.6 mmtt -51.78 -47.73 64.07 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.502 ' CB ' ' HD3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -77.96 91.66 4.24 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.825 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.477 HG12 HG13 ' A' ' 183' ' ' VAL . 4.2 t -112.54 152.41 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.536 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -115.09 40.11 2.56 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 114.84 -1.073 . . . . 0.0 114.579 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.72 HG12 ' CE1' ' A' ' 339' ' ' PHE . 35.4 m -90.17 -32.41 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.812 0.306 . . . . 0.0 111.135 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -100.67 59.39 0.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.274 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -115.72 145.89 42.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.643 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.54 -25.64 67.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.173 0.511 . . . . 0.0 111.69 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -77.29 -33.58 43.81 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-O 119.093 -0.837 . . . . 0.0 114.938 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.99 -56.51 21.04 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -57.53 -60.15 4.1 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.002 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.47 -41.85 53.59 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.685 0.755 . . . . 0.0 112.035 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -62.27 -60.66 7.59 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.412 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.92 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -58.29 -24.41 59.41 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 122.539 -0.389 . . . . 0.0 110.175 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 32.3 m -66.83 -49.26 66.34 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 2.7 p90 -61.59 -34.41 75.57 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 199' ' ' ILE . 0.7 OUTLIER -63.93 -47.94 78.5 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 192' ' ' LEU . 48.5 t -56.59 -29.89 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.223 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.85 -46.92 82.81 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.599 0.714 . . . . 0.0 110.905 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.587 ' CD1' HG21 ' A' ' 132' ' ' ILE . 7.1 tp -61.07 -53.65 54.49 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.1 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 204' ' ' MET . 3.6 mt -62.37 -44.54 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.806 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -52.32 -36.93 54.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.907 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -113.18 -34.51 5.65 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 121.051 3.722 . . . . 0.0 121.051 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -62.22 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.863 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -5.4 26.92 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.565 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 6.1 ptm 41.7 37.6 0.78 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.533 ' O ' HG23 ' A' ' 199' ' ' ILE . 4.5 m120 -139.56 162.07 35.98 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.427 ' HA ' ' HG ' ' A' ' 151' ' ' LEU . . . -147.93 24.03 1.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.45 -3.06 34.5 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -56.19 117.92 4.22 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.544 ' OD2' HD12 ' A' ' 212' ' ' ILE . 2.7 p30 -95.71 -174.15 3.07 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.735 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -67.27 -47.09 71.74 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.017 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -77.2 -25.38 51.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.572 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.544 HD12 ' OD2' ' A' ' 209' ' ' ASP . 3.7 mt -81.62 -52.08 14.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.691 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 150' ' ' ASN . . . -52.4 -38.07 58.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -61.61 -44.94 96.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.61 -38.38 71.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.186 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.63 -56.82 15.85 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -66.54 -28.45 68.55 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -58.52 -34.33 70.85 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.174 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.19 -23.73 59.26 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.96 28.51 58.6 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 119.204 -0.776 . . . . 0.0 114.829 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -107.67 37.19 2.49 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.914 1.357 . . . . 0.0 111.082 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.871 HG21 ' HB2' ' A' ' 148' ' ' MET . 82.4 p -138.81 139.38 38.19 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.576 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -104.87 38.55 1.89 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.446 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.9 OUTLIER 170.54 134.59 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 86.3 m -147.88 158.89 44.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.74 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.457 ' O ' ' CE2' ' A' ' 156' ' ' PHE . 12.0 pt -115.7 112.87 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.765 ' CB ' HD12 ' A' ' 235' ' ' ILE . 37.1 m-20 -147.76 165.3 30.95 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.969 -0.457 . . . . 0.0 112.141 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -136.39 -163.98 10.05 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 119.42 1.009 . . . . 0.0 111.297 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.538 ' HG3' HG21 ' A' ' 320' ' ' THR . 77.2 Cg_endo -98.99 5.97 0.99 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.346 2.698 . . . . 0.0 114.129 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 232' ' ' TRP . 36.7 t-105 -85.58 -80.99 0.21 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.302 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.98 42.84 1.68 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.693 0.282 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.512 ' CZ3' ' HB3' ' A' ' 230' ' ' TRP . 5.1 m-90 -149.07 59.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.891 0.377 . . . . 0.0 110.961 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 p -57.82 -43.02 85.45 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -67.26 74.19 0.13 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.731 0.3 . . . . 0.0 110.575 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.801 HD11 ' CD1' ' A' ' 116' ' ' ILE . 12.8 tt -147.02 153.98 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.11 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.425 ' HB3' ' CG ' ' A' ' 242' ' ' TYR . 83.6 m-20 61.86 41.59 11.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.637 0.256 . . . . 0.0 110.858 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.0 t -142.09 48.37 1.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.771 0.32 . . . . 0.0 110.983 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.96 -65.08 1.05 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.732 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.742 ' O ' HG13 ' A' ' 240' ' ' VAL . 0.3 OUTLIER -125.68 -62.47 1.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.735 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 239' ' ' LYS . 0.2 OUTLIER -168.73 -52.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.616 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.62 95.06 10.1 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.625 0.25 . . . . 0.0 111.079 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.425 ' CG ' ' HB3' ' A' ' 236' ' ' ASP . 44.1 p90 -98.99 146.68 25.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.466 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 116' ' ' ILE . . . -130.44 160.25 23.03 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.112 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.604 HG12 HG13 ' A' ' 116' ' ' ILE . 29.3 m -135.78 134.54 51.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.764 0.282 . . . . 0.0 110.889 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.04 167.57 21.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.839 0.855 . . . . 0.0 110.506 -174.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.76 152.24 7.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.501 ' CD2' HD12 ' A' ' 113' ' ' LEU . 4.3 mm? -62.71 159.4 44.17 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 120.513 1.506 . . . . 0.0 111.204 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.45 ' HD2' HD12 ' A' ' 247' ' ' LEU . 93.2 Cg_endo -79.32 -164.49 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.598 2.198 . . . . 0.0 111.532 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.463 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -116.34 177.62 4.62 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.501 -178.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 249' ' ' THR . 55.1 m-85 -164.57 110.05 0.98 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.847 0.832 . . . . 0.0 109.749 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.91 33.43 21.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.956 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.72 39.03 30.24 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.747 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.78 147.59 17.16 Favored Pre-proline 0 N--CA 1.464 0.255 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -91.15 125.73 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.466 2.777 . . . . 0.0 111.89 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.429 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 12.2 t -47.02 150.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 159' ' ' PRO . 6.7 tppt? -85.21 108.97 17.71 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.013 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.577 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 5.4 Cg_exo -79.29 142.53 16.86 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.144 2.562 . . . . 0.0 112.737 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.91 154.61 28.21 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.695 HG11 HG12 ' A' ' 329' ' ' ILE . 54.6 t -113.08 135.59 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -123.51 118.41 3.5 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 118.873 -1.632 . . . . 0.0 115.912 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.82 HG13 ' HB1' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -110.63 111.9 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.929 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -88.73 99.68 12.54 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 117.659 -1.616 . . . . 0.0 107.518 177.306 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.549 ' CB ' HG21 ' A' ' 97' ' ' VAL . 43.7 p -136.55 135.44 38.46 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 118.878 2.918 . . . . 0.0 118.878 -173.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.936 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -88.48 112.86 23.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.551 ' CA ' ' HB2' ' A' ' 105' ' ' ALA . . . -102.86 162.83 16.2 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.508 HG21 ' HA ' ' A' ' 271' ' ' PRO . 87.0 mt -88.2 123.58 40.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 118.929 1.364 . . . . 0.0 107.726 176.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -65.51 146.22 55.13 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.999 ' HB3' HD23 ' A' ' 75' ' ' LEU . . . -58.2 -23.47 55.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.162 0.437 . . . . 0.0 111.284 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.514 ' HB1' ' H ' ' A' ' 56' ' ' GLY . . . -53.05 -59.1 4.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.573 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.3 m -143.23 127.87 9.68 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.607 0.242 . . . . 0.0 111.231 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.508 ' HA ' HG21 ' A' ' 266' ' ' ILE . 76.1 Cg_endo -78.88 -39.64 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.541 2.16 . . . . 0.0 112.96 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.788 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 2.7 m120 55.54 85.05 0.07 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-O 120.62 0.248 . . . . 0.0 110.519 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.1 OUTLIER -72.24 -54.17 10.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -75.41 -57.34 3.95 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 5.9 mt -53.52 -49.09 68.33 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.788 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -71.09 -51.85 22.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 273' ' ' LYS . 9.8 mtpp -48.84 -53.22 20.23 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.306 0.574 . . . . 0.0 112.277 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 47.4 mm-40 -68.73 -30.2 68.78 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.944 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.631 ' CZ ' HD21 ' A' ' 7' ' ' LEU . 14.8 t80 -73.71 -40.33 63.68 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.575 HD12 ' HD1' ' A' ' 279' ' ' PHE . 5.7 mp -81.69 -43.89 17.87 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.94 0.876 . . . . 0.0 112.654 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 285' ' ' LEU . 13.5 mt-10 -70.45 -43.53 69.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 113.912 -1.494 . . . . 0.0 112.643 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 3.7 t-20 -80.89 -32.23 34.9 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.996 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.897 ' O ' HG22 ' A' ' 286' ' ' THR . 4.3 m-85 -101.89 -82.34 0.48 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -39.38 -33.98 0.18 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.879 HD11 ' CE1' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -94.45 39.98 1.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.897 HG22 ' O ' ' A' ' 283' ' ' TYR . 11.3 t -146.62 161.91 39.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 1.2 m-20 -62.49 -13.07 26.35 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.049 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 41.2 mt-10 -77.94 -46.65 20.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.662 0.664 . . . . 0.0 111.22 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.723 ' O ' HG13 ' A' ' 293' ' ' VAL . . . -87.02 -41.79 6.54 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.741 HD12 ' CD2' ' A' ' 307' ' ' TYR . 0.1 OUTLIER -59.9 -46.55 88.98 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 287' ' ' ASP . 3.4 mm-40 -79.0 -26.66 43.26 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -71.33 -37.54 71.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.671 1.123 . . . . 0.0 109.159 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 289' ' ' GLY . 33.1 m -67.5 -40.03 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -80.22 -39.39 29.19 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 123.838 0.855 . . . . 0.0 113.003 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -64.78 -40.17 94.8 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.571 ' CA ' ' HA2' ' A' ' 16' ' ' GLY . 10.9 m-20 -59.99 -64.43 0.95 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.616 ' CG ' HD21 ' A' ' 299' ' ' LEU . 0.0 OUTLIER -103.38 103.52 35.84 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.758 -177.654 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.488 ' C ' HD23 ' A' ' 299' ' ' LEU . 45.6 Cg_endo -95.99 90.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.621 2.88 . . . . 0.0 112.424 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.616 HD21 ' CG ' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -141.24 -74.74 0.32 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.153 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -98.71 156.08 20.16 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.165 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.852 ' HB3' ' HB ' ' A' ' 317' ' ' ILE . . . -121.47 52.73 1.21 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 117.046 0.423 . . . . 0.0 111.62 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 1.037 HG11 HG23 ' A' ' 110' ' ' VAL . 10.8 p -136.4 84.12 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.888 0.375 . . . . 0.0 111.521 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 304' ' ' LEU . . . -166.33 95.23 0.55 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.845 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 307' ' ' TYR . 8.4 tp 93.76 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.94 0.496 . . . . 0.0 112.015 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.456 ' N ' HD21 ' A' ' 89' ' ' LEU . 3.3 tmtm? -32.63 -35.07 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.784 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -44.83 47.09 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.961 0.886 . . . . 0.0 110.257 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.828 ' CZ ' HD12 ' A' ' 311' ' ' LEU . 1.2 t80 -76.65 -23.26 53.28 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.016 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -76.6 -42.84 40.96 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.08 -43.8 86.3 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.963 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -67.32 -53.4 29.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.919 0.39 . . . . 0.0 110.624 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.828 HD12 ' CZ ' ' A' ' 307' ' ' TYR . 1.1 tt -67.06 -41.24 86.76 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.291 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -46.59 -15.5 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 312' ' ' ALA . 8.8 tttp -31.04 -43.48 0.05 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.512 0.596 . . . . 0.0 110.433 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 3.6 t0 -87.73 139.17 31.25 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 3.0 Cg_exo -75.48 3.89 5.46 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.659 2.239 . . . . 0.0 114.578 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -59.22 5.75 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.852 ' HB ' ' HB3' ' A' ' 301' ' ' ALA . 2.8 tp -49.78 -55.61 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.62 -50.35 13.38 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.375 0.534 . . . . 0.0 111.758 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.6 -44.29 85.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.858 0.837 . . . . 0.0 110.026 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.676 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -65.55 -32.61 74.3 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.896 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.619 ' HA ' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -78.95 -46.35 18.5 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.723 0.296 . . . . 0.0 110.437 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.67 -42.51 79.12 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.444 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.538 ' HB3' ' HB1' ' A' ' 112' ' ' ALA . 27.3 t-20 -78.4 -38.62 41.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.637 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -51.88 -52.74 47.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.26 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -58.19 -29.64 65.81 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.858 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -12.67 60.08 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.381 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.577 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -79.79 163.81 48.1 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.936 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.35 139.69 32.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.695 HG12 HG11 ' A' ' 259' ' ' VAL . 5.0 mt -91.47 110.26 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 119.572 1.078 . . . . 0.0 110.5 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.467 ' HA ' ' HD2' ' A' ' 331' ' ' PRO . 1.4 ptp -45.2 101.88 0.28 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.132 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.468 ' HG3' ' CD2' ' A' ' 176' ' ' TYR . 4.4 Cg_endo -46.49 -35.67 16.85 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.025 2.483 . . . . 0.0 112.14 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 331' ' ' PRO . 0.6 OUTLIER 85.56 83.33 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.768 HG21 ' OH ' ' A' ' 176' ' ' TYR . 1.0 OUTLIER -132.2 158.2 76.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 118.338 0.517 . . . . 0.0 111.758 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.2 -50.72 5.47 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.963 2.442 . . . . 0.0 112.693 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.768 ' HB3' HG23 ' A' ' 368' ' ' ILE . 79.2 mm-40 -53.22 -21.82 5.84 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 3.6 tpt -45.49 -35.07 3.57 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 122.222 -0.299 . . . . 0.0 111.323 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 14.9 p -59.77 -40.21 87.43 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.615 0.245 . . . . 0.0 110.542 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.836 ' HB3' ' CD1' ' A' ' 368' ' ' ILE . . . -58.11 -32.03 67.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.112 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.72 ' CE1' HG12 ' A' ' 183' ' ' VAL . 2.3 t80 -77.96 -55.66 5.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.448 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.456 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 6.6 t-105 -46.98 -42.83 18.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.862 0.363 . . . . 0.0 110.913 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.96 -49.92 40.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.658 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.15 -44.63 87.99 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.909 HG22 HD22 ' A' ' 361' ' ' LEU . 19.6 t -71.13 -29.68 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.723 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -74.82 -43.9 52.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 348' ' ' ILE . 1.7 p -64.48 -58.32 6.76 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.94 -38.65 4.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.637 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.1 t -58.82 -48.59 85.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 345' ' ' THR . 58.5 mt -64.41 -27.97 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 346' ' ' ALA . 6.0 m120 -64.43 -36.9 85.68 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.459 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.82 ' HA ' ' HG3' ' A' ' 355' ' ' GLN . . . -78.78 -26.59 44.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.56 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.94 -14.36 62.91 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 354' ' ' ARG . 2.5 t -110.66 16.96 21.13 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.56 5.91 1.4 Allowed Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 119.71 1.141 . . . . 0.0 112.382 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 352' ' ' SER . 26.4 ttt85 -93.63 35.75 1.11 Allowed 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 115.522 -2.18 . . . . 0.0 107.812 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.82 ' HG3' ' HA ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -66.98 -170.42 0.11 Allowed 'General case' 0 CA--C 1.547 0.843 1 N-CA-C 123.881 4.771 . . . . 0.0 123.881 -156.917 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.6 OUTLIER 159.59 39.95 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 112.47 -2.15 . . . . 0.0 108.174 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.62 HG22 HD12 ' A' ' 361' ' ' LEU . 7.5 p -57.67 -48.84 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.757 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 1.2 m-20 -52.21 -43.85 64.46 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.388 0.613 . . . . 0.0 110.986 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -75.8 -53.83 7.87 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 114.784 -1.098 . . . . 0.0 113.025 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -54.32 -44.31 71.94 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.956 0.884 . . . . 0.0 112.791 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.909 HD22 HG22 ' A' ' 343' ' ' VAL . 79.7 mt -77.82 -37.13 49.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.681 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 1.2 tmtm? -63.88 -56.34 16.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.977 0.894 . . . . 0.0 109.631 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.07 -32.24 70.75 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.252 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -58.14 -42.43 85.87 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.829 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.619 ' HB3' HG21 ' A' ' 183' ' ' VAL . 0.7 OUTLIER -64.4 -36.12 83.13 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.482 ' N ' ' HG3' ' A' ' 365' ' ' GLN . 87.7 m -57.93 -34.57 70.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -71.1 -35.58 71.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.08 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.836 ' CD1' ' HB3' ' A' ' 338' ' ' ALA . 4.2 mm -75.83 -39.53 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.675 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' THR . . . . . 1.0 ' HB ' HD11 ' A' ' 178' ' ' ILE . 13.9 p -88.01 -20.93 25.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.022 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 366' ' ' THR . 2.0 mtmp? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.989 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.0 mtmm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.7 0.286 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.6 m -138.36 84.4 2.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.977 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.99 136.12 41.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.738 0.304 . . . . 0.0 110.945 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -177.12 154.74 1.09 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.244 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -128.66 63.17 0.62 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.469 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.477 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -153.29 160.77 42.79 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.921 ' CB ' HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -155.25 122.62 5.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.189 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.735 HG11 ' HB3' ' A' ' 57' ' ' PRO . 24.0 t -116.94 124.95 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.482 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.722 HG13 HD12 ' A' ' 59' ' ' ILE . 3.1 mp -123.7 130.47 74.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.63 ' HB2' HG23 ' A' ' 60' ' ' ILE . 73.3 m95 -102.66 128.67 49.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.024 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.767 HD12 ' CD1' ' A' ' 61' ' ' PHE . 1.5 tt -158.49 137.84 3.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 O-C-N 122.163 -0.336 . . . . 0.0 111.298 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -114.18 39.98 2.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.749 0.309 . . . . 0.0 111.081 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.1 -11.55 58.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.604 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.3 m-20 65.54 60.92 0.71 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.022 0.411 . . . . 0.0 110.743 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 1.2 mtpt 162.69 -173.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.183 0.516 . . . . 0.0 111.917 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 296' ' ' ASP . . . 76.38 23.46 70.7 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 20.9 p90 -80.83 -34.46 33.85 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.78 0.79 . . . . 0.0 111.378 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 1.2 t-20 -66.69 -50.66 62.13 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.769 0.319 . . . . 0.0 111.742 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.515 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -71.57 -48.79 27.62 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.841 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.9 -49.19 78.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.845 0.823 . . . . 0.0 110.055 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -67.47 -37.72 83.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -67.19 -37.6 83.95 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.634 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.748 HG23 ' CE2' ' A' ' 283' ' ' TYR . 3.7 p -67.65 -58.72 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.636 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.483 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . -49.12 -34.18 16.26 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.246 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -50.47 67.62 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.51 1.148 . . . . 0.0 107.907 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -42.23 63.61 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-N 112.793 -2.003 . . . . 0.0 108.543 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.785 ' HB3' HD13 ' A' ' 33' ' ' ILE . 22.0 m-85 -65.75 -35.71 81.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.657 0.741 . . . . 0.0 111.083 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.817 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -70.85 -51.35 27.06 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.407 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -52.36 -28.56 19.99 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 125.076 1.485 . . . . 0.0 111.365 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.814 ' O ' HG23 ' A' ' 31' ' ' THR . 20.6 t70 -85.78 -38.71 17.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.581 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 162.88 38.05 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 172.222 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.837 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.43 38.7 0.02 OUTLIER Glycine 0 N--CA 1.466 0.682 0 C-N-CA 114.986 -3.483 . . . . 0.0 118.837 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.837 HD12 ' C ' ' A' ' 32' ' ' GLY . 1.8 mp -139.89 107.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 121.532 2.666 . . . . 0.0 116.022 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.14 104.72 12.4 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.921 HG12 ' CB ' ' A' ' 7' ' ' LEU . 33.6 m -100.95 133.9 42.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -174.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -119.12 146.8 44.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.05 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.686 HG12 ' HB ' ' A' ' 9' ' ' ILE . 4.7 m -132.98 122.15 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.692 0.282 . . . . 0.0 110.302 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.51 134.03 48.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.263 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 9.1 p80 -139.7 71.03 37.25 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-O 120.927 0.394 . . . . 0.0 111.172 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.794 ' HD2' HD12 ' A' ' 43' ' ' LEU . 58.2 Cg_endo -87.99 -177.73 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.218 2.612 . . . . 0.0 112.362 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.37 -40.14 14.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.67 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 43' ' ' LEU . 68.8 mmtt -86.47 0.68 53.68 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.312 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.794 HD12 ' HD2' ' A' ' 40' ' ' PRO . 10.2 tt -19.53 -62.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 1.059 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -46.52 -50.86 16.54 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -178.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 3.1 tt0 -71.98 -44.04 64.17 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.936 0.398 . . . . 0.0 110.782 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.6 ' O ' HG13 ' A' ' 50' ' ' VAL . 6.6 mttp -56.62 -56.02 26.59 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.129 0.966 . . . . 0.0 110.496 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.864 ' CZ ' HD12 ' A' ' 75' ' ' LEU . 1.8 t80 -45.37 -60.75 2.93 Favored Pre-proline 0 C--N 1.346 0.414 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.0 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 1.059 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 35.2 Cg_exo -61.91 -28.08 80.68 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 121.327 1.351 . . . . 0.0 113.858 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -80.98 -37.29 29.56 Favored 'General case' 0 C--O 1.256 1.416 0 CA-C-O 122.365 1.078 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.87 ' O ' ' N ' ' A' ' 54' ' ' GLY . 18.5 m -75.69 -40.51 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 CA-C-O 121.996 0.903 . . . . 0.0 109.686 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.38 -38.65 19.97 Favored 'General case' 0 C--N 1.365 1.261 0 C-N-CA 125.945 1.698 . . . . 0.0 111.275 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.94 -37.32 29.72 Favored 'General case' 0 C--N 1.37 1.465 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.974 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -118.09 17.48 14.04 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.911 0.778 . . . . 0.0 109.035 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.87 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -137.81 62.82 0.57 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -82.0 38.69 0.54 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.751 0.776 . . . . 0.0 112.731 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 57' ' ' PRO . . . -93.78 -39.85 4.83 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.602 -0.809 . . . . 0.0 114.451 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.735 ' HB3' HG11 ' A' ' 8' ' ' VAL . 34.0 Cg_endo -91.94 157.86 3.35 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.49 2.793 . . . . 0.0 112.953 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 266' ' ' ILE . 0.4 OUTLIER -130.07 35.43 4.12 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 117.663 -1.615 . . . . 0.0 114.823 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.774 HD11 ' HG ' ' A' ' 7' ' ' LEU . 1.9 mt -152.45 127.91 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 118.181 -1.408 . . . . 0.0 114.443 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.772 HG22 ' CE3' ' A' ' 62' ' ' TRP . 3.9 mp -139.27 122.83 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.613 0.244 . . . . 0.0 111.629 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.767 ' CD1' HD12 ' A' ' 11' ' ' ILE . 35.9 t80 -113.88 121.29 43.53 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.977 0.417 . . . . 0.0 110.151 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.772 ' CE3' HG22 ' A' ' 60' ' ' ILE . 3.1 p90 -166.43 167.29 15.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.995 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -45.66 160.13 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.956 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.73 ' CB ' ' HB ' ' A' ' 261' ' ' VAL . 65.2 t60 -77.63 -29.45 51.76 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -48.91 -54.13 16.74 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.629 0.728 . . . . 0.0 112.398 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -78.37 -30.73 48.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.181 0.515 . . . . 0.0 109.968 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.663 ' HB3' ' HA ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -56.37 -33.08 65.37 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.711 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -55.58 -68.0 1.92 Allowed Glycine 0 C--N 1.354 1.558 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.03 -54.49 31.07 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 112.451 -1.875 . . . . 0.0 111.218 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.436 ' HB3' ' CB ' ' A' ' 75' ' ' LEU . 16.5 m-85 -48.66 -41.19 30.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -51.8 -44.78 63.6 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -42.75 25.58 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 p -69.94 -26.65 64.23 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.97 4.02 10.51 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 119.968 -1.11 . . . . 0.0 114.283 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.864 HD12 ' CZ ' ' A' ' 47' ' ' PHE . 1.1 mm? -96.9 45.86 1.05 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.271 1.036 . . . . 0.0 110.738 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 67' ' ' PHE . 0.5 OUTLIER 176.88 138.04 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 113.273 -1.785 . . . . 0.0 106.571 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.726 ' CB ' ' HB3' ' A' ' 268' ' ' ALA . . . -135.16 138.78 44.02 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 118.391 -1.323 . . . . 0.0 111.585 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -47.42 137.07 9.0 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.554 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.546 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 7.8 mt -122.46 162.3 22.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.115 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.9 p -106.18 82.87 1.0 Allowed Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.399 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 67.0 Cg_endo -84.48 -171.51 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.949 2.433 . . . . 0.0 112.345 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -105.46 156.06 18.56 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.822 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -92.26 -38.88 11.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.364 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.5 -23.25 57.53 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.87 ' CZ ' HD21 ' A' ' 285' ' ' LEU . 10.2 t80 -69.09 -59.3 3.12 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.904 0.383 . . . . 0.0 110.05 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.435 ' HB3' ' CD1' ' A' ' 94' ' ' TRP . 1.3 mt-30 -66.48 -24.63 66.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.677 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.62 -34.04 62.72 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -76.46 -10.01 59.07 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.813 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -125.15 -159.76 0.91 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.28 -179.563 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.657 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -80.0 119.23 75.96 Favored Pre-proline 0 C--N 1.339 0.151 0 O-C-N 122.292 -0.255 . . . . 0.0 111.574 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.32 -32.93 97.14 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.369 2.046 . . . . 0.0 112.206 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.465 ' CE1' ' HG3' ' A' ' 325' ' ' GLN . 17.3 m-85 -52.99 -53.69 46.23 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.158 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.773 HG23 ' CD2' ' A' ' 94' ' ' TRP . 10.0 t -62.62 -23.38 67.04 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.813 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 6.1 m95 -93.18 -25.6 17.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.054 0.454 . . . . 0.0 111.798 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -75.41 -20.78 58.7 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.66 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.739 ' HB1' HG13 ' A' ' 261' ' ' VAL . . . -56.03 -50.41 71.0 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 105' ' ' ALA . 9.1 p -100.42 41.38 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -97.82 135.77 39.11 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.668 -0.645 . . . . 0.0 109.872 178.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.4 t80 -99.94 174.86 5.99 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.02 -0.425 . . . . 0.0 110.081 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -64.87 73.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.674 0.273 . . . . 0.0 110.703 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 138.57 -47.8 0.91 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.051 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -145.99 175.57 10.35 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 117.179 0.49 . . . . 0.0 110.926 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.689 ' O ' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -118.89 119.69 35.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.654 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 3.3 mp -94.99 39.38 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.93 ' HB1' ' O ' ' A' ' 264' ' ' ALA . . . 167.14 -178.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.804 ' CE2' HD11 ' A' ' 280' ' ' LEU . 48.3 p90 -132.97 121.5 16.94 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.015 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.679 ' HA ' ' CB ' ' A' ' 263' ' ' SER . 6.3 Cg_exo -79.41 172.39 14.61 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.177 2.585 . . . . 0.0 113.727 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.519 HG22 ' CE2' ' A' ' 61' ' ' PHE . 2.2 tt -168.9 39.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 119.586 -0.846 . . . . 0.0 112.713 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.957 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -174.92 110.4 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.905 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.554 HG23 ' OG1' ' A' ' 320' ' ' THR . 15.5 m -96.89 117.14 40.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.599 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.452 ' CG ' ' CH2' ' A' ' 230' ' ' TRP . 33.1 mt-10 -102.89 146.85 27.67 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.552 0.691 . . . . 0.0 110.766 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.894 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -165.26 139.05 4.72 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.385 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.838 HD21 ' HA ' ' A' ' 257' ' ' PRO . 0.4 OUTLIER -77.94 137.74 38.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.642 -179.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.15 163.5 28.38 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 116' ' ' ILE . 1.5 tt -93.63 130.11 39.67 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.585 ' N ' HD23 ' A' ' 115' ' ' LEU . 12.1 tt -115.62 138.74 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.619 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.729 ' CD1' HD21 ' A' ' 122' ' ' LEU . 3.9 m-85 -117.2 138.58 51.6 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -85.17 119.78 25.93 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -90.82 60.83 4.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.899 0.38 . . . . 0.0 111.421 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.89 -51.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.86 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' CB ' ' A' ' 223' ' ' ALA . 5.6 mt -118.96 38.4 3.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.43 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 224' ' ' MET . 0.4 OUTLIER -157.69 108.06 1.8 Allowed Pre-proline 0 CA--C 1.521 -0.15 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.687 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 9.2 Cg_endo -90.51 130.3 1.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.302 2.001 . . . . 0.0 112.443 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.485 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 81.4 m-20 -64.4 127.13 91.85 Favored Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -172.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 124' ' ' ASN . 55.5 Cg_endo -93.42 167.62 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 124.038 3.159 . . . . 0.0 109.66 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.49 -51.14 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 121.806 1.671 . . . . 0.0 114.246 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.64 -3.48 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 49.5 p -118.03 139.35 51.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 121.252 1.842 . . . . 0.0 114.287 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.521 ' CD2' HD11 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -69.63 -23.27 63.47 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 171.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.591 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 24.3 mt-10 -44.13 -23.61 0.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.359 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 40.4 mm-40 -75.91 -19.16 59.03 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.77 ' CG2' HD21 ' A' ' 147' ' ' LEU . 96.7 mt -46.59 -50.61 40.97 Favored Pre-proline 0 N--CA 1.479 0.994 0 CA-C-O 121.709 0.766 . . . . 0.0 111.346 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.603 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 58.7 Cg_exo -46.4 -36.26 17.47 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 120.826 1.017 . . . . 0.0 109.57 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 137' ' ' LYS . . . -75.36 -59.03 2.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 139' ' ' LEU . 64.3 mt -68.75 -37.34 79.32 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.881 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.1 -40.65 68.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.603 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 3.4 tptm -47.48 -49.0 26.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.81 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 139' ' ' LEU . 1.2 pt-20 -62.83 -37.23 85.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.59 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.84 HD23 ' CG ' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -58.89 -51.03 71.77 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -47.69 -45.68 28.62 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.03 -27.58 0.97 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.09 -56.66 2.16 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.244 0.545 . . . . 0.0 110.671 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.96 39.87 0.02 OUTLIER Glycine 0 CA--C 1.52 0.351 0 CA-C-O 119.029 -0.873 . . . . 0.0 111.216 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.84 ' CG ' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -149.42 -172.06 4.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 119.183 1.492 . . . . 0.0 111.629 -175.104 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.828 ' C ' HD22 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -143.72 127.12 16.81 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.644 ' CA ' HD13 ' A' ' 139' ' ' LEU . . . -41.52 -33.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.77 HD21 ' CG2' ' A' ' 132' ' ' ILE . 0.6 OUTLIER -141.3 130.26 23.18 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 -176.269 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.86 ' O ' HG22 ' A' ' 225' ' ' THR . 0.0 OUTLIER -132.22 138.75 48.06 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.739 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.934 ' O ' ' O ' ' A' ' 150' ' ' ASN . 17.3 p90 -171.92 174.73 4.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.693 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.934 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -27.86 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.757 0.661 . . . . 0.0 112.17 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.965 HD13 ' OG1' ' A' ' 208' ' ' THR . 0.1 OUTLIER -160.66 39.0 0.16 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.261 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.527 ' OE1' HD11 ' A' ' 348' ' ' ILE . 0.0 OUTLIER 171.68 33.09 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.998 169.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.634 ' O ' ' HB ' ' A' ' 157' ' ' THR . 3.3 mt-10 -79.96 152.52 74.42 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 121.986 2.175 . . . . 0.0 115.833 -174.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.975 ' O ' ' N ' ' A' ' 156' ' ' PHE . 67.0 Cg_endo -78.67 -135.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.802 1 C-N-CA 125.559 4.172 . . . . 0.0 107.095 176.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 1.12 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 4.7 p90 3.01 -39.82 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.975 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -86.14 -55.48 3.91 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-N 120.262 1.392 . . . . 0.0 111.55 -179.207 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.845 HG22 ' CD1' ' A' ' 161' ' ' ILE . 61.6 m -56.6 -43.82 80.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.427 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 2.6 m0 -51.26 -55.73 26.18 Favored Pre-proline 0 C--N 1.346 0.416 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.735 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 1.12 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 89.4 Cg_exo -43.11 -50.3 6.48 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.081 2.521 . . . . 0.0 113.026 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.461 HD11 ' HE1' ' A' ' 156' ' ' PHE . 81.3 mt -62.45 -53.82 49.15 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 119.671 1.123 . . . . 0.0 108.645 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.845 ' CD1' HG22 ' A' ' 157' ' ' THR . 1.5 mp -51.86 -25.82 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.421 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -78.59 -22.67 46.73 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.668 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -41.86 -58.35 2.06 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -64.37 5.57 0.26 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.303 1.224 . . . . 0.0 114.303 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.59 22.69 5.34 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 119.588 -1.291 . . . . 0.0 115.262 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.9 163.41 41.83 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.707 -1.235 . . . . 0.0 111.447 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -146.09 120.94 9.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.126 0.463 . . . . 0.0 109.967 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.674 ' HA ' HG22 ' A' ' 183' ' ' VAL . . . -39.14 -79.01 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.675 0.75 . . . . 0.0 111.148 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.633 ' HB3' ' CB ' ' A' ' 176' ' ' TYR . 1.7 m-85 -113.43 172.73 6.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.768 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 1.22 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -101.88 106.87 17.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.08 114.42 18.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.053 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 28.2 tt0 -136.66 102.04 4.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.259 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 0.2 OUTLIER 90.28 -31.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.379 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 154.77 17.04 0.05 OUTLIER Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.151 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -174.18 127.73 0.36 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.175 1.487 . . . . 0.0 111.257 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 1.22 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 47.9 p90 -55.47 -24.45 31.22 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 122.181 0.991 . . . . 0.0 110.987 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 78.8 m-20 76.74 -78.57 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.008 -1.905 . . . . 0.0 111.773 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 369' ' ' THR . 0.8 OUTLIER 168.88 -41.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.498 ' HA ' HG22 ' A' ' 369' ' ' THR . 9.6 tttm -72.75 -5.66 39.33 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 4.4 m-20 -120.24 94.14 4.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.253 0.933 . . . . 0.0 109.634 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.617 HG11 ' CE1' ' A' ' 339' ' ' PHE . 6.4 t -115.78 111.29 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.433 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . -119.76 39.91 2.36 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.852 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.674 HG22 ' HA ' ' A' ' 168' ' ' ALA . 31.0 t -80.41 -44.72 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-O 121.275 0.56 . . . . 0.0 109.865 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -83.83 61.28 6.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.984 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 182' ' ' GLY . 7.4 p30 -110.94 173.92 6.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.712 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.58 -26.43 65.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.274 0.559 . . . . 0.0 111.28 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.95 -46.79 42.5 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.675 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.612 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -56.93 -51.4 69.28 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 175.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -56.06 18.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.979 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.765 ' HB1' ' HE3' ' A' ' 251' ' ' LYS . . . -50.07 -41.18 47.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.006 0.908 . . . . 0.0 112.096 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -66.76 -60.65 5.95 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.715 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.537 HD12 HG12 ' A' ' 161' ' ' ILE . 0.5 OUTLIER -56.54 -27.62 58.03 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.161 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 42.2 m -62.36 -47.62 83.41 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.816 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.531 ' CZ ' ' CZ ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -60.71 -36.7 79.48 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-O 121.542 0.687 . . . . 0.0 109.54 177.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.77 -51.02 71.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.983 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 192' ' ' LEU . 43.1 t -57.29 -31.5 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.562 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 2.6 t0 -57.03 -49.9 74.38 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 121.286 0.565 . . . . 0.0 110.717 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.9 tp -61.97 -59.24 5.4 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.285 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.583 HG22 ' HA ' ' A' ' 204' ' ' MET . 39.4 mm -56.93 -41.13 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.83 -31.73 72.54 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.49 178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 6.0 m-80 -107.54 13.12 27.09 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -173.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 203' ' ' HIS . 1.4 ttmp? -121.92 -91.87 0.55 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.946 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' A' ' 205' ' ' ASN . 0.5 OUTLIER -122.02 -10.82 8.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -178.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.583 ' HA ' HG22 ' A' ' 199' ' ' ILE . 0.0 OUTLIER 69.35 -71.69 0.12 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -176.281 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 203' ' ' HIS . 3.0 m120 64.43 162.49 0.12 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.26 78.88 3.1 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.603 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 39.46 70.75 0.2 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.965 ' OG1' HD13 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -55.05 124.19 16.02 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 213' ' ' ALA . 0.4 OUTLIER -92.13 -174.65 3.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -69.92 -45.55 67.31 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.3 m -75.18 -30.01 60.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.502 0.668 . . . . 0.0 111.024 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.743 HG22 HG22 ' A' ' 208' ' ' THR . 1.2 mp -79.33 -49.74 19.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.207 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -57.61 -34.05 68.88 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -60.02 -48.24 82.53 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.91 -36.59 67.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.247 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.77 -57.6 11.74 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.963 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.538 ' CE1' ' HA ' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -60.09 -30.04 68.98 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -53.18 -42.03 65.81 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.396 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.84 59.12 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.74 57.96 7.44 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.672 -0.695 . . . . 0.0 114.588 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -125.29 37.29 4.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.378 1.089 . . . . 0.0 111.037 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.45 ' CB ' ' HB2' ' A' ' 148' ' ' MET . 12.2 t -142.5 140.48 31.86 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -114.45 38.5 3.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.064 -1.426 . . . . 0.0 113.328 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.789 ' HB2' HD13 ' A' ' 122' ' ' LEU . 25.8 ttm -178.08 129.22 0.13 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.77 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 148' ' ' MET . 69.1 p -145.51 169.32 18.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.566 0.698 . . . . 0.0 111.534 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.566 HD12 ' CZ ' ' A' ' 156' ' ' PHE . 21.9 mt -109.06 145.44 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -146.86 167.05 24.89 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.849 0.86 . . . . 0.0 111.232 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -110.4 -159.8 17.26 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.446 -0.406 . . . . 0.0 112.782 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.429 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 11.7 Cg_endo -55.49 -59.44 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.82 2.346 . . . . 0.0 112.451 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.452 ' CH2' ' CG ' ' A' ' 111' ' ' GLU . 18.6 p90 -173.34 -43.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.474 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.28 70.99 1.2 Allowed 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.786 0.326 . . . . 0.0 110.803 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.423 ' O ' ' N ' ' A' ' 234' ' ' ASN . 1.5 m95 -125.72 39.77 3.88 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 11.3 t 64.87 -72.74 0.06 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.544 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 232' ' ' TRP . 4.6 t-20 -145.64 85.12 1.69 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.575 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.406 ' O ' ' N ' ' A' ' 237' ' ' THR . 18.1 tt -44.55 154.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.434 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.511 ' OD1' HG21 ' A' ' 225' ' ' THR . 37.2 t70 -47.9 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.707 0.289 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 237' ' ' THR . 19.7 m -121.4 39.37 3.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.744 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 83.0 p -63.2 -43.62 97.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.689 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.57 -174.91 2.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.816 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.0 -57.26 4.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.193 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.02 126.32 35.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.543 ' CG ' HD11 ' A' ' 116' ' ' ILE . 9.8 p90 -144.44 164.22 31.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.167 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.4 122.14 5.85 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.425 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 244' ' ' VAL . 34.7 m -91.58 115.31 30.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.743 0.271 . . . . 0.0 111.384 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.6 p -127.62 167.18 16.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.47 153.91 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.807 HD11 ' CD1' ' A' ' 113' ' ' LEU . 58.5 mt -58.29 158.67 13.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 120.31 1.414 . . . . 0.0 110.092 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.437 ' HD3' HD12 ' A' ' 115' ' ' LEU . 72.7 Cg_endo -79.21 -174.65 2.37 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.453 2.102 . . . . 0.0 113.144 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.449 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -105.3 171.16 7.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.091 0.472 . . . . 0.0 111.488 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.531 ' CZ ' ' CZ ' ' A' ' 194' ' ' PHE . 35.6 m-85 -167.31 111.08 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.765 ' HE3' ' HB1' ' A' ' 190' ' ' ALA . 13.2 mttt 62.72 31.71 16.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.637 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.94 33.58 36.45 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.318 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 13.8 mp0 -156.75 154.43 26.65 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 68.7 Cg_endo -90.61 162.91 4.28 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.592 2.861 . . . . 0.0 112.213 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.569 ' OG ' HD13 ' A' ' 247' ' ' LEU . 1.0 OUTLIER -84.41 148.71 26.45 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.1 OUTLIER -86.0 109.81 25.69 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.531 -178.381 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.838 ' HA ' HD21 ' A' ' 113' ' ' LEU . 6.2 Cg_exo -79.84 149.38 20.48 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.998 2.465 . . . . 0.0 112.89 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 155' ' ' TYR . 23.2 p90 -78.86 146.35 33.68 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.979 HG21 HD13 ' A' ' 329' ' ' ILE . 15.6 t -103.53 122.83 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -118.02 123.45 5.74 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.135 -1.507 . . . . 0.0 114.771 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.739 HG13 ' HB1' ' A' ' 96' ' ' ALA . 15.7 t -109.09 110.06 30.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.957 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.7 tp -89.85 99.15 12.21 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 117.881 -1.528 . . . . 0.0 107.257 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.679 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 32.8 p -134.46 141.17 46.69 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 118.501 2.778 . . . . 0.0 118.501 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.93 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -74.04 132.71 42.61 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.025 -0.422 . . . . 0.0 110.292 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -122.18 139.59 12.88 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.652 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 58' ' ' ASP . 3.7 mp -114.39 127.16 71.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.646 ' C ' ' H ' ' A' ' 269' ' ' ALA . 96.1 m-20 -61.07 126.38 27.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.726 ' HB3' ' CB ' ' A' ' 77' ' ' ALA . . . -51.6 5.11 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 119.883 1.219 . . . . 0.0 113.177 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.646 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -81.99 -38.1 25.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.854 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 75.5 m -133.89 69.4 75.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.91 0.386 . . . . 0.0 110.925 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.655 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 6.4 Cg_exo -73.97 -36.21 3.67 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.842 2.362 . . . . 0.0 112.734 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.472 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 23.2 m-20 50.64 68.17 0.81 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 6.5 mttt -48.98 -54.44 15.6 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 2.9 mt-10 -62.98 -57.94 9.03 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.282 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.6 mt -68.01 -58.0 5.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 271' ' ' PRO . . . -69.45 -51.97 31.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 1.1 tpmp? -64.98 -35.76 82.23 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 12.4 tt0 -76.49 -53.09 8.58 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -56.23 -52.01 66.0 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.787 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.804 HD11 ' CE2' ' A' ' 106' ' ' TYR . 8.2 tt -57.41 -43.42 83.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.524 0.678 . . . . 0.0 111.777 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -73.77 -34.3 64.63 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.558 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -94.16 -13.54 26.59 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.748 ' CE2' HG23 ' A' ' 23' ' ' VAL . 1.6 t80 -109.41 -62.2 1.52 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 119.241 -0.409 . . . . 0.0 109.936 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.636 ' O ' HD23 ' A' ' 284' ' ' LEU . 1.7 tt -40.19 -33.57 0.24 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.809 0.731 . . . . 0.0 110.87 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.87 HD21 ' CZ ' ' A' ' 85' ' ' PHE . 80.5 mt -86.59 42.21 0.99 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.959 0.409 . . . . 0.0 110.257 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 283' ' ' TYR . 17.4 p -145.21 155.93 43.55 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 44.1 m-20 -62.7 -15.04 50.87 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.611 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 0.9 OUTLIER -78.27 -47.38 18.02 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.882 -0.511 . . . . 0.0 110.922 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.531 ' O ' HG12 ' A' ' 293' ' ' VAL . . . -79.96 -55.58 3.51 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.291 -0.957 . . . . 0.0 110.972 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.835 ' CD1' HD13 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -55.26 -46.14 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.226 . . . . 0.0 111.066 179.415 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -79.05 -26.32 43.12 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.707 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -68.33 -41.55 80.64 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 119.441 1.019 . . . . 0.0 109.117 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 289' ' ' GLY . 2.7 p -68.4 -61.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.502 ' H ' HG13 ' A' ' 293' ' ' VAL . 0.6 OUTLIER -50.14 -45.14 52.84 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.682 1.193 . . . . 0.0 112.546 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -59.33 -50.36 74.27 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.515 ' O ' ' HD3' ' A' ' 298' ' ' PRO . 42.0 m-20 -56.17 -47.86 77.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 176.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 294' ' ' ASN . 0.0 OUTLIER -69.04 104.67 0.78 Allowed Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.951 -178.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.697 ' O ' HD23 ' A' ' 299' ' ' LEU . 93.1 Cg_endo -99.64 54.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.322 2.681 . . . . 0.0 112.675 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 298' ' ' PRO . 0.4 OUTLIER -138.88 -67.83 0.45 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.57 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.63 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . -172.91 -166.31 31.21 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.853 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.725 ' HB3' ' CD1' ' A' ' 311' ' ' LEU . . . 160.0 177.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.579 0.228 . . . . 0.0 111.141 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 302' ' ' VAL . 5.8 p 174.52 62.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.486 ' HA ' HG21 ' A' ' 93' ' ' THR . . . -113.78 -138.6 0.37 Allowed 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.835 HD13 ' CD1' ' A' ' 290' ' ' LEU . 0.4 OUTLIER -4.51 110.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.38 1.072 . . . . 0.0 113.803 -179.307 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -34.22 -60.88 0.39 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.099 0.476 . . . . 0.0 112.085 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.14 -47.1 54.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.988 0.899 . . . . 0.0 111.272 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.817 ' CG ' HD22 ' A' ' 290' ' ' LEU . 2.4 t80 -73.0 -20.12 61.08 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.319 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 12.0 tt0 -66.64 -39.88 88.45 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.46 -51.85 38.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.335 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -56.83 -56.31 23.23 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.012 0.434 . . . . 0.0 110.174 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.845 HD22 HD13 ' A' ' 317' ' ' ILE . 0.9 OUTLIER -63.76 -41.02 98.06 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.776 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.908 ' HA ' HD11 ' A' ' 317' ' ' ILE . . . -46.23 -26.77 0.85 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 312' ' ' ALA . 10.5 mtpp -37.76 -40.04 0.4 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.753 0.311 . . . . 0.0 110.599 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -82.82 124.35 77.14 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.903 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.21 -13.51 40.19 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.637 2.225 . . . . 0.0 114.214 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.8 ' O ' HG23 ' A' ' 320' ' ' THR . 5.3 mtp85 -62.08 -58.89 6.12 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.908 HD11 ' HA ' ' A' ' 312' ' ' ALA . 10.3 pt -50.12 -52.36 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.78 -45.14 14.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.84 0.291 . . . . 0.0 111.71 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.73 -38.96 73.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.299 0.571 . . . . 0.0 110.322 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.894 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 19.9 p -65.17 -33.61 76.42 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.408 ' HG3' HG21 ' A' ' 302' ' ' VAL . 0.0 OUTLIER -76.89 -49.19 16.23 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.603 0.24 . . . . 0.0 111.04 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -43.52 84.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.307 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.667 ' CB ' ' HB1' ' A' ' 112' ' ' ALA . 16.2 m-80 -71.58 -41.56 68.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.584 0.231 . . . . 0.0 111.17 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -23.08 67.16 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.465 ' HG3' ' CE1' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -85.27 -34.09 22.02 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -101.48 62.74 0.95 Allowed 'General case' 0 C--O 1.232 0.151 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.478 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -154.96 -140.79 3.09 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.681 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -128.32 118.84 23.94 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.979 HD13 HG21 ' A' ' 259' ' ' VAL . 3.5 mm -75.34 131.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.77 133.08 2.96 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.725 0.297 . . . . 0.0 111.326 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.556 ' HB3' ' CE2' ' A' ' 176' ' ' TYR . 12.6 Cg_endo -56.05 -161.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.092 2.528 . . . . 0.0 111.975 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -159.21 40.78 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.589 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 5.1 pt -136.55 170.78 9.99 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.893 -0.139 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 87.5 Cg_endo -84.83 -20.51 3.63 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.628 2.219 . . . . 0.0 113.927 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 368' ' ' ILE . 14.6 mm-40 -56.13 -21.04 20.15 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.482 ' HE1' ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -44.72 -33.36 1.84 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.516 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 23.2 m -57.16 -33.17 67.16 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.649 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.0 78.08 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.928 0.394 . . . . 0.0 111.92 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.617 ' CE1' HG11 ' A' ' 181' ' ' VAL . 0.1 OUTLIER -78.35 -55.66 5.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.772 -178.799 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.419 ' HA ' ' CE3' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -44.0 -44.73 7.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.045 -179.372 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 345' ' ' THR . 7.0 m-85 -74.79 -44.01 51.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.972 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.21 76.48 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.987 HG12 HD21 ' A' ' 361' ' ' LEU . 5.5 m -71.94 -41.31 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.034 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.381 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 348' ' ' ILE . 6.7 mmp_? -56.34 -55.29 35.25 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.212 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 341' ' ' TYR . 43.9 p -59.45 -56.23 24.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.064 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.62 -60.67 2.17 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.596 ' CG2' HD11 ' A' ' 361' ' ' LEU . 48.3 t -51.17 -50.52 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.527 HD11 ' OE1' ' A' ' 152' ' ' GLN . 2.1 tt -69.88 -46.14 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.837 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 345' ' ' THR . 19.6 t-20 -66.35 -53.97 30.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 355' ' ' GLN . . . -66.21 -26.55 67.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -57.07 -12.31 2.06 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.0 p -110.42 26.75 10.34 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.48 0.582 . . . . 0.0 111.424 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 89.41 -5.72 83.78 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 118.463 -1.827 . . . . 0.0 114.482 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 34.98 0.72 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 116.199 -2.2 . . . . 0.0 107.956 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 356' ' ' THR . 1.0 OUTLIER -72.15 -174.81 1.34 Allowed 'General case' 0 CA--C 1.548 0.868 1 N-CA-C 126.385 5.698 . . . . 0.0 126.385 -158.057 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.6 OUTLIER 158.22 40.48 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 109.833 -3.349 . . . . 0.0 104.283 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.689 ' CG2' HD12 ' A' ' 361' ' ' LEU . 12.8 p -72.56 -52.58 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -174.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 13.4 t0 -47.34 -45.64 24.85 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.596 0.712 . . . . 0.0 111.28 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -77.07 -56.34 4.66 Favored 'General case' 0 C--N 1.353 0.74 0 CA-C-N 114.073 -1.421 . . . . 0.0 113.733 -175.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -51.49 -41.72 61.15 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 122.583 1.182 . . . . 0.0 112.253 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.987 HD21 HG12 ' A' ' 343' ' ' VAL . 5.7 mt -79.03 -34.95 43.4 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 112.745 -2.025 . . . . 0.0 110.494 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 5.2 mmmt -65.75 -56.6 11.17 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.391 1.091 . . . . 0.0 109.599 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 366' ' ' THR . 1.4 t70 -59.46 -36.03 75.21 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.372 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -52.18 -44.01 64.45 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 369' ' ' THR . 15.0 tt0 -60.21 -46.42 89.8 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 363' ' ' ASP . 53.1 m -51.03 -42.88 60.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.09 0.471 . . . . 0.0 110.138 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 10.3 ttm105 -59.12 -52.57 65.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.122 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 178' ' ' ILE . 15.7 tt -73.55 -30.31 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 178' ' ' ILE . 80.9 p -82.52 -30.24 29.91 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 8.2 tptt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.962 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.1 mttp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.622 0.249 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.2 p -137.51 179.68 6.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -80.4 123.41 28.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.777 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -156.08 160.24 39.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.784 0.326 . . . . 0.0 111.213 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . 90.88 25.56 24.54 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.415 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.34 152.79 42.04 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.585 HD13 HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -129.76 121.27 26.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.152 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -117.04 118.23 58.07 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.849 HG23 ' CE1' ' A' ' 61' ' ' PHE . 24.4 mt -123.04 130.07 74.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.435 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.609 ' HB3' HD11 ' A' ' 43' ' ' LEU . 8.6 m95 -108.99 122.29 46.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -145.74 143.07 21.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 122.881 0.473 . . . . 0.0 109.813 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -79.8 72.62 6.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 119.014 0.824 . . . . 0.0 112.015 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.64 65.88 2.9 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.098 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.814 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -87.11 -32.82 19.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.814 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 102.12 -156.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -177.309 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.756 ' O ' HD23 ' A' ' 20' ' ' LEU . . . 71.39 52.56 12.59 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 116.089 1.196 . . . . 0.0 116.089 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -58.71 2.92 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 2.0 t-20 -46.18 -43.33 15.08 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.122 0.487 . . . . 0.0 111.127 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.782 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.12 -45.54 49.22 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.302 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 16' ' ' GLY . 3.5 mm? -61.13 -51.47 68.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.944 0.372 . . . . 0.0 110.678 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.17 74.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 34.8 tt0 -65.3 -36.09 82.99 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.754 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 19' ' ' GLY . 74.8 t -67.7 -61.27 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.54 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . -49.22 -34.22 17.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.205 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.41 -50.38 67.74 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 177.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -41.63 62.77 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 112.826 -1.988 . . . . 0.0 108.593 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.785 ' HB3' HD13 ' A' ' 33' ' ' ILE . 21.7 m-30 -66.91 -34.32 77.53 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.128 0.966 . . . . 0.0 111.367 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.76 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -72.6 -51.96 17.48 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.914 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tpmp? -53.1 -27.55 21.04 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 124.807 1.317 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 31' ' ' THR . 3.7 m-20 -86.03 -37.42 18.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 117.732 -1.128 . . . . 0.0 108.97 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.829 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.92 38.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 172.253 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.808 ' O ' HD12 ' A' ' 33' ' ' ILE . . . 156.88 39.25 0.02 OUTLIER Glycine 0 N--CA 1.465 0.582 0 C-N-CA 114.537 -3.697 . . . . 0.0 119.337 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.083 HD11 HD21 ' A' ' 275' ' ' LEU . 1.5 mp -139.46 136.27 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 121.961 2.88 . . . . 0.0 116.637 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -142.32 104.46 4.43 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.585 HG22 HD13 ' A' ' 7' ' ' LEU . 37.4 t -88.48 128.97 40.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 m -118.51 140.11 50.39 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.645 -1.162 . . . . 0.0 110.853 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.694 HG12 ' HB ' ' A' ' 9' ' ' ILE . 15.2 m -129.85 122.47 54.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 O-C-N 122.133 -0.354 . . . . 0.0 110.703 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 3.0 tp10 -113.4 134.03 54.86 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.98 74.83 10.29 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 122.355 0.262 . . . . 0.0 111.208 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 38' ' ' GLU . 6.0 Cg_endo -89.18 -167.47 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.546 2.831 . . . . 0.0 113.262 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -109.42 -54.85 2.5 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.347 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -78.03 0.12 25.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.41 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.996 HD21 HD11 ' A' ' 60' ' ' ILE . 2.0 tt -26.08 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 1.062 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 3.5 mt-10 -70.59 -55.02 9.81 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -68.34 -50.06 55.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.113 0.482 . . . . 0.0 111.454 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.665 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.4 mmtm -61.82 -56.27 21.21 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.682 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 73.4 t80 -47.03 -55.01 16.73 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 1.062 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 30.8 Cg_exo -66.96 -39.69 13.54 Favored 'Trans proline' 0 C--O 1.25 1.12 0 C-N-CA 121.478 1.452 . . . . 0.0 115.196 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.44 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 34.4 tt0 -67.54 -51.15 54.22 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 46' ' ' LYS . 9.0 m -61.37 -22.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.114 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 48' ' ' PRO . . . -59.05 -30.03 67.74 Favored 'General case' 0 C--N 1.394 2.535 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.058 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -82.38 -28.94 31.18 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.227 1.411 . . . . 0.0 113.029 -178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 50' ' ' VAL . 5.7 t -88.3 129.66 35.32 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.126 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.93 -67.95 0.05 OUTLIER Glycine 0 C--N 1.337 0.587 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.396 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -165.29 -84.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.417 1.609 . . . . 0.0 111.427 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.03 142.86 4.34 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.517 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.18 -146.6 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.84 2.36 . . . . 0.0 112.767 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 1.152 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -79.99 -135.65 0.03 OUTLIER 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 123.744 0.818 . . . . 0.0 110.069 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.639 HD12 ' HB1' ' A' ' 264' ' ' ALA . 16.6 pt -104.48 166.89 2.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.996 HD11 HD21 ' A' ' 43' ' ' LEU . 1.7 tt -127.69 134.87 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 1.026 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -110.69 120.08 41.25 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.973 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -166.99 162.91 15.88 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.393 0.542 . . . . 0.0 110.437 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.515 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . . . -38.34 154.84 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.831 ' HB3' HG13 ' A' ' 261' ' ' VAL . 2.6 t60 -77.29 -30.04 54.02 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.99 -36.96 75.77 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.693 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.515 ' HD3' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -84.29 -33.11 24.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.933 178.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.606 ' HZ ' HG23 ' A' ' 104' ' ' ILE . 4.5 t80 -59.94 -30.35 69.01 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.07 -68.51 1.66 Allowed Glycine 0 C--N 1.353 1.502 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.99 45.08 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.541 ' CZ ' ' HG3' ' A' ' 48' ' ' PRO . 1.2 m-85 -48.03 -46.35 33.03 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -51.08 -48.83 61.53 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.884 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -63.87 -16.89 62.47 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 m -69.36 -26.88 64.9 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.936 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.759 ' O ' HD22 ' A' ' 75' ' ' LEU . . . 83.69 28.94 33.73 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.697 -0.763 . . . . 0.0 114.996 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.759 HD22 ' O ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -139.45 38.5 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.502 1.151 . . . . 0.0 111.99 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.711 ' HB3' HD11 ' A' ' 104' ' ' ILE . 3.2 mm? -110.15 131.61 54.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.93 0.395 . . . . 0.0 111.306 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.825 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -95.68 121.64 37.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.645 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.911 ' HG3' HD12 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -82.78 133.15 35.15 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.974 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.535 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 18.6 tt -78.29 159.63 4.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.119 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.5 p -108.61 82.76 1.79 Allowed Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 48.1 Cg_endo -90.08 -169.9 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.126 2.55 . . . . 0.0 112.244 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -127.94 156.2 43.02 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.557 0.218 . . . . 0.0 110.921 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -57.52 -45.62 84.77 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.672 0.272 . . . . 0.0 110.946 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.6 -23.13 64.45 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.637 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.477 ' CE2' ' CH2' ' A' ' 94' ' ' TRP . 8.6 t80 -79.23 -59.19 2.87 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 23.2 tt0 -55.65 -38.2 69.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.705 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -76.71 -34.58 58.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.682 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.87 -31.8 1.37 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.914 HD13 ' HA ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -126.21 -90.1 0.55 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.123 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.47 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 2.4 m-85 -136.26 111.24 9.97 Favored Pre-proline 0 CA--C 1.53 0.192 0 O-C-N 122.005 -0.434 . . . . 0.0 111.686 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 90' ' ' TYR . 19.3 Cg_endo -57.45 -22.34 50.03 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.592 2.195 . . . . 0.0 112.504 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -56.94 -53.81 53.82 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.578 0.228 . . . . 0.0 111.589 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.542 HG22 ' CG ' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -62.19 -45.51 93.05 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 110.267 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.78 ' CZ2' HD11 ' A' ' 89' ' ' LEU . 71.7 m95 -60.26 -40.39 90.18 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 121.7 0.762 . . . . 0.0 109.861 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.78 -22.08 61.63 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.953 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.496 ' HB1' HG21 ' A' ' 261' ' ' VAL . . . -75.59 -17.67 59.96 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.657 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 13.1 m -121.74 46.22 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -128.92 139.54 52.08 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.42 0.554 . . . . 0.0 109.533 178.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -142.55 114.37 8.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 119.178 0.899 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 78.21 25.96 0.59 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.74 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.48 -27.98 17.96 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.998 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -102.34 163.85 12.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.561 0.681 . . . . 0.0 111.226 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -91.08 137.99 31.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.83 0.348 . . . . 0.0 110.616 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.911 HD12 ' HG3' ' A' ' 78' ' ' GLU . 15.6 tt -137.57 48.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.344 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 159.61 -177.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 264' ' ' ALA . 49.5 m-85 -142.29 122.82 8.31 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.633 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.64 ' HB3' HG23 ' A' ' 261' ' ' VAL . 88.5 Cg_endo -79.48 166.13 22.38 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.271 1.98 . . . . 0.0 112.37 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.699 ' HA ' ' HB2' ' A' ' 303' ' ' ALA . 3.1 tt -168.61 39.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.136 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.599 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.849 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 176.08 122.37 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 110' ' ' VAL . 11.3 p -113.7 105.62 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.525 ' HA ' ' CG2' ' A' ' 320' ' ' THR . 2.0 mp0 -103.08 162.91 12.56 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.672 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -164.86 150.1 9.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.591 0.71 . . . . 0.0 112.131 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.883 HD11 HD11 ' A' ' 247' ' ' LEU . 2.6 pp -79.51 126.9 31.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.3 171.72 11.24 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 122.178 -0.326 . . . . 0.0 111.118 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.811 HD22 ' CE1' ' A' ' 117' ' ' TYR . 1.3 tt -110.99 136.29 50.22 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.716 HD13 ' OD1' ' A' ' 227' ' ' ASN . 3.3 mp -112.11 128.8 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.811 ' CE1' HD22 ' A' ' 115' ' ' LEU . 22.6 m-30 -110.36 134.87 51.88 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -84.41 119.12 24.75 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -109.54 29.21 7.78 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.715 0.293 . . . . 0.0 111.675 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.1 -54.0 1.12 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -136.74 0.02 OUTLIER 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.406 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.917 HD22 HD11 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -84.27 128.96 59.96 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.023 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 41.4 Cg_exo -55.91 161.45 8.39 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.411 2.74 . . . . 0.0 111.604 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.539 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 4.9 p-10 -101.38 169.25 7.98 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.858 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 50.1 Cg_exo -53.84 167.55 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.675 2.25 . . . . 0.0 111.915 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -92.53 -118.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 122.816 2.344 . . . . 0.0 112.868 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.769 ' HD2' HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -84.38 -18.17 36.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.309 0.959 . . . . 0.0 111.747 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.769 HG23 ' HD2' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -117.75 141.25 48.61 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.552 ' CH2' HD22 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -69.71 -25.82 64.04 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 173.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.533 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.4 OUTLIER -44.83 -23.9 0.17 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.989 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.416 ' CD ' HD23 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -70.78 -23.48 62.4 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.774 HG21 ' CD2' ' A' ' 198' ' ' LEU . 1.5 mp -40.44 -60.23 1.62 Allowed Pre-proline 0 N--CA 1.477 0.906 0 CA-C-O 121.446 0.641 . . . . 0.0 111.425 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 67.5 Cg_exo -46.45 -40.87 23.23 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 120.891 1.06 . . . . 0.0 109.861 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.3 -58.84 3.03 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 139' ' ' LEU . 4.0 mm? -68.03 -36.79 80.52 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.393 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.71 ' OD2' HG23 ' A' ' 132' ' ' ILE . 1.3 m-20 -74.16 -40.53 62.52 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 3.0 ttpt -49.87 -46.78 51.86 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 118.949 -1.1 . . . . 0.0 109.29 177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.5 mm-40 -62.59 -37.1 84.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.194 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.972 HD22 ' O ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -62.43 -47.86 82.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.038 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -47.59 -45.14 27.05 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.06 -24.43 0.43 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -99.01 -57.63 2.13 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.04 39.57 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.717 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.684 ' HB2' ' O ' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -174.04 177.28 2.38 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.703 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.972 ' O ' HD22 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -107.1 177.66 4.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.754 ' O ' ' C ' ' A' ' 223' ' ' ALA . . . -86.84 -14.25 42.65 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.552 HD22 ' CH2' ' A' ' 129' ' ' TRP . 2.5 pp -138.95 128.68 24.78 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.602 ' O ' HG22 ' A' ' 225' ' ' THR . 2.1 tpt -132.47 136.29 46.6 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 227' ' ' ASN . 6.2 t80 -171.63 173.66 4.59 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.948 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.548 ' O ' ' O ' ' A' ' 208' ' ' THR . 2.5 m120 -23.08 -70.34 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.726 HD22 ' HB1' ' A' ' 206' ' ' ALA . 0.1 OUTLIER 97.53 38.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.88 0.872 . . . . 0.0 109.226 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 172.36 34.73 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 117.637 -1.173 . . . . 0.0 114.113 170.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' OG1' ' A' ' 157' ' ' THR . 13.5 mt-10 -102.59 151.04 38.19 Favored Pre-proline 0 C--O 1.218 -0.589 0 CA-C-N 122.349 2.34 . . . . 0.0 116.025 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.923 ' O ' ' N ' ' A' ' 156' ' ' PHE . 65.9 Cg_endo -78.14 -134.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 1 C-N-CA 125.922 4.415 . . . . 0.0 106.285 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 1.149 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 12.9 m-85 26.08 -60.33 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 119.335 0.97 . . . . 0.0 113.431 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.923 ' N ' ' O ' ' A' ' 154' ' ' PRO . 56.1 m-85 -83.48 -56.6 3.65 Favored 'General case' 0 C--O 1.257 1.471 0 C-N-CA 123.65 0.78 . . . . 0.0 112.097 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.859 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 27.8 p -59.33 -40.5 86.51 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.215 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.539 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 29.4 m0 -52.41 -55.48 31.45 Favored Pre-proline 0 C--N 1.352 0.703 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 1.149 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 86.2 Cg_exo -43.39 -49.26 7.68 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.68 2.253 . . . . 0.0 112.241 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.718 HD11 HD13 ' A' ' 226' ' ' ILE . 5.7 mt -56.91 -56.89 15.88 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 119.514 1.052 . . . . 0.0 109.341 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.452 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 4.4 mt -51.57 -20.94 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.095 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.493 ' HB3' ' H ' ' A' ' 256' ' ' LYS . . . -83.97 -19.45 34.57 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.045 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 250' ' ' PHE . . . -46.79 -47.11 20.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.532 ' CB ' ' CA ' ' A' ' 187' ' ' GLY . 6.6 m-20 -65.29 -58.32 6.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 120.744 1.611 . . . . 0.0 112.831 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.78 31.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.085 -1.531 . . . . 0.0 115.181 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -106.3 100.36 1.63 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.111 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.416 ' O ' ' CA ' ' A' ' 183' ' ' VAL . 60.9 m-85 -77.72 151.09 34.32 Favored 'General case' 0 C--N 1.337 0.048 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.15 -72.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.575 ' HB3' ' CD2' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -111.99 169.83 8.57 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.903 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 1.19 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.5 OUTLIER -102.25 111.48 23.78 Favored 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 328' ' ' GLU . 28.6 m-85 -84.26 115.03 22.25 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.914 -1.494 . . . . 0.0 108.616 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.928 ' O ' ' N ' ' A' ' 174' ' ' GLY . 5.4 mm-40 -137.1 101.59 4.6 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.52 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 41.54 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 123.93 0.769 . . . . 0.0 110.475 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.928 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -75.2 -73.35 0.97 Allowed Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -175.87 143.51 0.58 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.768 1.284 . . . . 0.0 111.154 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 1.19 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 21.8 p90 -45.4 -32.51 2.13 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.061 0.934 . . . . 0.0 109.609 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 40.8 t0 59.38 -98.3 0.08 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.773 -1.558 . . . . 0.0 111.592 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 178' ' ' ILE . 7.4 tp -176.77 32.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -132.54 -18.5 2.48 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.079 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 3.7 m-20 -121.87 93.02 3.86 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.962 HG21 ' CD1' ' A' ' 368' ' ' ILE . 29.0 m -116.72 116.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.85 39.77 2.39 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.617 -1.277 . . . . 0.0 113.494 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.781 ' O ' ' HB2' ' A' ' 188' ' ' ALA . 11.5 p -79.92 -46.13 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.451 ' N ' HG13 ' A' ' 183' ' ' VAL . 13.5 p-10 -75.59 54.49 0.77 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.751 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.6 -171.79 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -49.82 -37.33 30.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.773 0.797 . . . . 0.0 111.807 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.532 ' CA ' ' CB ' ' A' ' 164' ' ' ASP . . . -75.38 -37.14 42.41 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.583 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -64.17 -42.9 96.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -50.3 -40.26 48.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.094 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 194' ' ' PHE . . . -69.59 -47.64 62.86 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -66.7 -60.47 6.14 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.189 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.842 ' O ' HG23 ' A' ' 196' ' ' VAL . 3.8 tt -50.04 -39.37 41.56 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 98.8 m -75.78 -42.33 50.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -60.17 -35.66 75.84 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.112 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -47.04 78.58 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 192' ' ' LEU . 46.7 t -56.38 -30.6 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.968 177.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -62.62 -47.57 83.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.827 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.774 ' CD2' HG21 ' A' ' 132' ' ' ILE . 2.0 mt -62.75 -59.1 5.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.663 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 206' ' ' ALA . 33.5 mm -52.01 -47.96 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.651 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -59.69 -34.56 73.04 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.91 0.77 52.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -120.33 -80.77 0.63 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.722 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -120.19 -26.54 5.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.461 ' HA ' HG22 ' A' ' 199' ' ' ILE . 0.0 OUTLIER 75.91 14.03 2.69 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.81 0.277 . . . . 0.0 111.369 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -144.39 -59.56 0.38 Allowed 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.726 ' HB1' HD22 ' A' ' 151' ' ' LEU . . . 67.09 81.08 0.2 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.39 -2.7 35.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.42 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.822 HG22 ' HB2' ' A' ' 213' ' ' ALA . 27.5 m -56.88 127.05 29.79 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.613 ' OD1' HD12 ' A' ' 212' ' ' ILE . 2.8 p-10 -101.65 -175.67 2.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.632 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.5 p90 -69.35 -45.28 69.78 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.208 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.422 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -77.12 -26.72 53.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.428 0.633 . . . . 0.0 111.133 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.613 HD12 ' OD1' ' A' ' 209' ' ' ASP . 5.7 mt -81.56 -51.53 15.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.857 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.822 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -54.82 -33.7 61.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -48.89 76.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 218' ' ' ASN . . . -52.91 -42.75 65.67 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.065 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.518 ' HB3' ' HG2' ' A' ' 148' ' ' MET . . . -53.31 -55.95 20.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.103 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.597 ' CD2' HG21 ' A' ' 222' ' ' THR . 30.0 t80 -60.25 -31.41 70.18 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 215' ' ' ALA . 1.3 t30 -55.01 -39.87 69.53 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -23.78 58.89 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.18 61.0 3.87 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.684 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 11.7 pt-20 -123.55 37.92 4.31 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 123.049 1.404 . . . . 0.0 111.534 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.636 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 0.0 OUTLIER -92.56 -166.06 1.47 Allowed 'General case' 0 N--CA 1.424 -1.751 2 C-N-CA 135.562 5.545 . . . . 0.0 121.939 -170.204 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.786 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . 158.7 34.58 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.14 1 CA-C-N 104.421 -5.808 . . . . 0.0 112.062 168.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.786 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 158.38 131.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 174.716 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 148' ' ' MET . 0.9 OUTLIER -148.57 155.45 41.13 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.018 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.718 HD13 HD11 ' A' ' 160' ' ' LEU . 10.3 pt -115.88 112.47 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.809 1.186 . . . . 0.0 108.503 174.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.716 ' OD1' HD13 ' A' ' 116' ' ' ILE . 2.2 p-10 -147.93 165.23 31.31 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-O 118.95 -0.548 . . . . 0.0 112.411 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -122.85 -176.36 14.88 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.575 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' A' ' 232' ' ' TRP . 74.7 Cg_exo -47.43 -32.4 15.13 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.533 2.156 . . . . 0.0 112.354 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -47.14 -43.15 20.55 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.26 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.62 41.15 3.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.639 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.556 ' HZ2' HG22 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -93.04 -44.03 8.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.801 0.334 . . . . 0.0 110.758 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.8 m -69.6 -33.53 72.82 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.229 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.54 -42.06 6.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.618 0.247 . . . . 0.0 111.419 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.4 -60.77 2.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.954 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 44.91 42.37 6.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.575 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.62 -71.89 0.34 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.93 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.92 42.02 11.63 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.377 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.491 ' O ' HG13 ' A' ' 240' ' ' VAL . 0.0 OUTLIER 67.0 -72.11 0.09 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.017 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 239' ' ' LYS . 0.7 OUTLIER -157.56 -53.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -126.84 119.5 26.97 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.638 0.256 . . . . 0.0 111.0 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -108.46 155.36 20.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.83 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -122.36 111.52 1.8 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.671 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.556 HG22 ' HZ2' ' A' ' 232' ' ' TRP . 13.1 t -91.04 135.28 27.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.685 0.242 . . . . 0.0 110.46 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.403 HG21 ' HE2' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -137.17 167.28 21.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.914 0.485 . . . . 0.0 111.798 -173.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.06 152.68 7.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.883 HD11 HD11 ' A' ' 113' ' ' LEU . 7.1 mt -59.48 159.66 16.3 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 121.279 1.854 . . . . 0.0 110.132 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.794 ' HD3' HD12 ' A' ' 115' ' ' LEU . 5.8 Cg_exo -78.94 -165.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.47 2.114 . . . . 0.0 112.069 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.484 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -112.95 175.72 5.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.813 0.339 . . . . 0.0 111.68 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.514 ' HB2' ' HB1' ' A' ' 163' ' ' ALA . 97.3 m-85 -164.13 110.38 1.06 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.364 0.602 . . . . 0.0 109.384 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt 61.18 34.19 18.97 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.521 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.05 40.63 34.4 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.899 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.423 ' HB3' ' O ' ' A' ' 163' ' ' ALA . 7.8 mt-30 -156.99 158.68 31.34 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.506 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 79.9 Cg_endo -93.98 160.81 2.18 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.887 3.058 . . . . 0.0 111.776 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 247' ' ' LEU . 1.3 p -84.43 156.05 21.96 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.493 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 6.1 tmmm? -85.93 112.95 48.89 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.181 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.477 ' HG2' ' CA ' ' A' ' 327' ' ' GLY . 71.6 Cg_endo -84.59 145.0 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.829 2.353 . . . . 0.0 112.417 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 155' ' ' TYR . 1.3 m-85 -79.64 148.79 31.51 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 328' ' ' GLU . 1.9 m -104.8 139.69 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -176.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -125.25 118.85 3.38 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 118.787 -1.673 . . . . 0.0 116.985 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.831 HG13 ' HB3' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -129.87 97.62 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 176.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.849 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -78.19 115.3 17.82 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.507 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 53.6 p -133.87 138.59 45.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 1.026 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -89.74 109.65 20.61 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 105' ' ' ALA . . . -97.75 165.42 22.2 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 176.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 59' ' ' ILE . 10.4 mt -91.13 123.3 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 118.495 1.148 . . . . 0.0 108.022 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.493 ' ND2' ' HB3' ' A' ' 269' ' ' ALA . 11.5 p-10 -61.97 138.19 58.34 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.987 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.825 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -51.13 -18.42 0.86 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.705 1.139 . . . . 0.0 110.892 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 55' ' ' ASP . . . -56.5 -37.79 70.89 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.49 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 78.8 82.74 0.1 OUTLIER Pre-proline 0 N--CA 1.463 0.221 0 CA-C-O 120.769 0.319 . . . . 0.0 110.9 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -91.65 99.76 0.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.24 2.627 . . . . 0.0 112.612 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.551 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 1.6 m-20 47.83 73.44 0.2 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.797 0.332 . . . . 0.0 110.629 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 5.4 mttm -53.1 -54.05 41.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.656 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 13.5 mm-40 -63.28 -57.4 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 1.083 HD21 HD11 ' A' ' 33' ' ' ILE . 9.0 tt -65.66 -57.93 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -60.45 -56.73 17.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 7.3 ttpp -60.69 -30.31 69.86 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 2.4 tt0 -76.41 -52.82 9.13 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.532 ' CD1' ' CE2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -57.2 -50.0 74.23 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.781 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 279' ' ' PHE . 2.1 tp -56.94 -43.08 81.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.622 0.725 . . . . 0.0 111.227 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -73.42 -34.78 65.64 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.664 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -93.88 -14.02 26.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.486 ' CE2' HG13 ' A' ' 23' ' ' VAL . 26.1 t80 -109.13 -63.14 1.39 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 284' ' ' LEU . 0.2 OUTLIER -39.92 -31.82 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.983 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.774 HD13 HD21 ' A' ' 304' ' ' LEU . 3.5 mm? -90.01 42.53 1.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.737 0.303 . . . . 0.0 111.131 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.9 p -144.18 155.1 43.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 1.0 OUTLIER -64.42 -13.57 51.99 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.461 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.721 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 1.1 mp0 -77.91 -47.47 18.59 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 117.999 0.363 . . . . 0.0 110.149 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.576 ' O ' HG12 ' A' ' 293' ' ' VAL . . . -84.23 -55.03 2.84 Favored Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.953 HD22 HD23 ' A' ' 304' ' ' LEU . 10.7 tp -47.42 -51.57 19.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.538 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 8.6 tt0 -79.23 -26.21 42.54 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.616 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -68.54 -40.15 80.83 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 289' ' ' GLY . 3.0 p -67.97 -61.45 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.508 ' H ' HG13 ' A' ' 293' ' ' VAL . 16.5 t30 -37.57 -50.91 1.16 Allowed 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.408 1.483 . . . . 0.0 112.289 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -60.08 -45.69 92.06 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.4 OUTLIER -57.87 -52.59 64.84 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.422 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.804 ' HZ1' ' HB3' ' A' ' 301' ' ' ALA . 0.0 OUTLIER -42.48 162.49 0.16 Allowed Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.359 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.07 -72.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.0 2.467 . . . . 0.0 113.405 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.462 ' N ' ' HD2' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -157.78 -62.99 0.09 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.536 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.603 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . -79.87 138.83 20.66 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.951 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.804 ' HB3' ' HZ1' ' A' ' 297' ' ' LYS . . . 168.56 -172.95 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.612 ' HA ' HD21 ' A' ' 311' ' ' LEU . 8.3 p -178.04 137.38 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.22 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' A' ' 108' ' ' ILE . . . 167.59 96.04 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.953 HD23 HD22 ' A' ' 290' ' ' LEU . 5.9 tp 96.59 116.73 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.234 0.614 . . . . 0.0 110.752 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 304' ' ' LEU . 13.9 ttmt -26.54 -64.44 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.569 0.543 . . . . 0.0 111.12 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.2 m -48.3 -40.82 26.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.8 0.809 . . . . 0.0 110.277 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.717 ' CD2' HD23 ' A' ' 311' ' ' LEU . 42.5 t80 -75.85 -33.58 60.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.005 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.565 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 7.0 pt-20 -72.51 -41.31 66.06 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 120.561 -0.456 . . . . 0.0 109.987 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.65 -56.93 6.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.14 -57.38 8.87 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.722 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.939 HD11 HG21 ' A' ' 317' ' ' ILE . 2.7 pp -61.52 -43.0 99.65 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.154 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.726 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -46.78 -29.67 2.05 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -35.54 -41.52 0.2 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.719 0.295 . . . . 0.0 110.886 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.05 127.89 85.92 Favored Pre-proline 0 CA--C 1.528 0.126 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.38 -22.69 34.85 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.614 2.209 . . . . 0.0 113.714 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -60.7 -59.12 5.89 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.939 HG21 HD11 ' A' ' 311' ' ' LEU . 2.6 mp -49.82 -55.8 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.89 -52.0 12.18 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.08 0.4 . . . . 0.0 111.659 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.15 -41.48 92.86 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.843 0.83 . . . . 0.0 109.738 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 111' ' ' GLU . 1.5 m -60.9 -41.94 97.07 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.614 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.459 ' HG2' HG21 ' A' ' 110' ' ' VAL . 1.7 tmm? -77.13 -39.43 49.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.69 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.08 -41.73 79.37 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.852 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.477 ' HB3' ' HB1' ' A' ' 112' ' ' ALA . 8.9 m-80 -75.58 -42.01 53.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.715 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 111' ' ' GLU . . . -65.73 -42.43 91.04 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.852 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.1 -31.84 53.19 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.278 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -100.61 41.59 1.17 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.592 0.234 . . . . 0.0 111.15 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.477 ' CA ' ' HG2' ' A' ' 257' ' ' PRO . . . -120.85 172.11 15.0 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.992 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.697 ' O ' HG13 ' A' ' 259' ' ' VAL . 0.6 OUTLIER -94.46 138.38 32.46 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 175.085 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.611 ' HA ' ' CG2' ' A' ' 259' ' ' VAL . 1.3 pp -83.62 109.56 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 119.105 0.866 . . . . 0.0 112.226 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.454 ' HA ' ' HE2' ' A' ' 330' ' ' MET . 0.0 OUTLIER -44.14 98.48 0.18 Allowed Pre-proline 0 C--N 1.344 0.348 0 CA-C-O 120.791 0.329 . . . . 0.0 110.802 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.648 ' HG2' ' CE1' ' A' ' 176' ' ' TYR . 32.5 Cg_exo -60.79 -42.48 38.08 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.002 2.468 . . . . 0.0 112.045 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 331' ' ' PRO . 3.0 t30 86.34 93.08 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.611 HD12 ' H ' ' A' ' 336' ' ' MET . 1.9 pp -133.82 146.69 61.24 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 118.457 0.571 . . . . 0.0 110.833 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.64 -48.19 16.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.782 2.321 . . . . 0.0 113.319 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.445 ' HB2' HD13 ' A' ' 333' ' ' ILE . 4.0 mp0 -54.2 -21.43 8.9 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.611 ' H ' HD12 ' A' ' 333' ' ' ILE . 12.5 mtt -45.49 -35.63 3.95 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.892 0.315 . . . . 0.0 111.459 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 m -58.29 -34.17 70.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 110.482 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.49 82.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.065 0.459 . . . . 0.0 111.709 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.76 ' O ' HG12 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -78.4 -55.69 5.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.614 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -44.67 -45.14 9.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.327 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 0.465 ' O ' HG23 ' A' ' 345' ' ' THR . 8.8 m-85 -76.01 -43.47 44.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.27 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.49 90.86 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.878 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.9 p -76.85 -29.92 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.555 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -46.76 57.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.653 ' O ' HG22 ' A' ' 348' ' ' ILE . 29.9 p -62.77 -57.82 9.6 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.79 -38.87 4.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.63 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 343' ' ' VAL . 24.8 t -60.76 -57.2 13.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 345' ' ' THR . 3.5 tt -60.06 -27.85 39.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.8 OUTLIER -63.84 -30.13 71.25 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 355' ' ' GLN . . . -75.52 -46.14 33.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -84.18 -9.8 58.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 348' ' ' ILE . 86.7 p -97.8 -49.76 4.69 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 147.52 -2.92 0.82 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 117.923 -2.084 . . . . 0.0 117.404 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.74 34.3 4.66 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 115.328 -2.549 . . . . 0.0 115.818 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.595 ' C ' ' HB2' ' A' ' 360' ' ' ALA . 1.0 OUTLIER -72.12 -130.01 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 129.855 3.262 . . . . 0.0 106.476 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.76 ' OG1' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER 153.12 86.57 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.249 1 N-CA-C 94.539 -6.097 . . . . 0.0 94.539 177.091 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.565 ' C ' ' O ' ' A' ' 356' ' ' THR . 1.3 p -40.26 -60.72 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.46 0 CA-C-N 122.833 2.56 . . . . 0.0 112.491 -166.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.473 ' H ' HG13 ' A' ' 357' ' ' VAL . 35.8 t0 -72.9 -44.48 61.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.48 -38.92 62.76 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.02 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.76 ' HB2' ' OG1' ' A' ' 356' ' ' THR . . . -62.18 -50.34 72.19 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.834 HD11 HD13 ' A' ' 192' ' ' LEU . 13.3 mt -72.25 -36.27 69.02 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.564 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -56.07 15.17 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.254 1.026 . . . . 0.0 110.059 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 366' ' ' THR . 13.5 t0 -62.63 -36.01 81.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.522 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -49.78 -43.07 48.05 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' A' ' 181' ' ' VAL . 0.2 OUTLIER -63.33 -43.16 98.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.359 177.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 363' ' ' ASP . 23.6 m -50.46 -42.58 54.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.322 0.582 . . . . 0.0 110.193 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -60.17 3.49 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.098 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.962 ' CD1' HG21 ' A' ' 181' ' ' VAL . 17.8 pt -58.4 -27.01 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.993 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.71 ' CG2' HG22 ' A' ' 181' ' ' VAL . 77.4 p -118.26 48.26 1.45 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.825 0.345 . . . . 0.0 110.513 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.693 0.282 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.32 179.81 6.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -137.07 47.56 0.95 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.413 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -149.6 155.34 40.11 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -152.12 117.64 5.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 58' ' ' ASP . 47.6 t -111.61 135.94 49.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.127 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.993 HG23 HG13 ' A' ' 37' ' ' VAL . 11.7 tt -132.3 127.45 57.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.329 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.712 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -103.53 126.77 50.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.407 178.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.896 HD13 ' HB3' ' A' ' 61' ' ' PHE . 4.6 mm -146.35 139.19 20.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -112.84 39.79 2.44 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.816 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.47 -11.43 35.86 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.636 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.9 t70 65.92 68.82 0.45 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.15 0.475 . . . . 0.0 110.395 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 162.64 -172.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.167 0.508 . . . . 0.0 111.74 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.06 22.73 67.84 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 116.26 1.264 . . . . 0.0 116.26 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -35.33 33.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.972 0.886 . . . . 0.0 111.205 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 11.3 t30 -65.54 -52.57 51.49 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 111.786 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.919 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.61 -48.96 26.52 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.83 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.763 ' CD1' HG21 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -59.5 -50.51 73.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.904 0.852 . . . . 0.0 110.331 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.97 -37.87 87.1 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 56.7 mt-10 -66.28 -36.84 84.01 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.46 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 19' ' ' GLY . 41.0 t -68.03 -61.61 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.96 -0.462 . . . . 0.0 110.46 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . -49.22 -35.16 19.28 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.288 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -50.14 67.42 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 122.515 1.15 . . . . 0.0 108.479 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -52.1 -43.21 63.8 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.32 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.783 ' HB3' HD13 ' A' ' 33' ' ' ILE . 1.5 m-30 -65.77 -29.71 70.25 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.762 0.791 . . . . 0.0 111.013 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.797 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 1.1 tm-20 -71.14 -52.54 18.69 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.029 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -52.36 -28.42 19.42 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 125.159 1.537 . . . . 0.0 111.245 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.78 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -86.07 -37.5 18.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.188 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.78 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 3.5 t 160.0 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.801 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.75 38.55 0.02 OUTLIER Glycine 0 N--CA 1.465 0.581 0 C-N-CA 114.712 -3.613 . . . . 0.0 119.318 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.801 HD12 ' C ' ' A' ' 32' ' ' GLY . 1.6 mp -139.92 134.98 37.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 121.576 2.688 . . . . 0.0 115.422 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -140.89 104.76 4.75 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.763 HG21 ' CD1' ' A' ' 20' ' ' LEU . 9.4 p -103.7 134.1 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.473 ' OG1' HG22 ' A' ' 8' ' ' VAL . 34.5 p -118.33 146.82 44.07 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.136 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.993 HG13 HG23 ' A' ' 9' ' ' ILE . 9.5 t -130.9 120.79 48.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.517 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 30.8 tt0 -112.99 144.44 42.57 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -131.79 73.9 78.2 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.724 0.297 . . . . 0.0 111.236 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.786 ' HD2' HD12 ' A' ' 43' ' ' LEU . 43.0 Cg_endo -89.98 -173.75 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.057 2.505 . . . . 0.0 112.82 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -96.01 -40.31 9.33 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -85.38 0.35 52.42 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.619 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.786 HD12 ' HD2' ' A' ' 40' ' ' PRO . 4.9 tt -21.57 -45.97 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 1.062 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 1.5 pp20? -68.68 -54.16 17.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.399 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 3.5 tt0 -69.66 -41.22 75.83 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.055 0.455 . . . . 0.0 109.797 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' O ' HG13 ' A' ' 50' ' ' VAL . 9.5 mtpt -56.28 -56.24 23.49 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.011 0.91 . . . . 0.0 109.834 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.612 ' CG ' HG12 ' A' ' 60' ' ' ILE . 1.3 t80 -44.15 -61.26 2.14 Favored Pre-proline 0 C--N 1.349 0.556 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.127 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 1.062 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 37.0 Cg_exo -61.5 -25.36 79.55 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 121.347 1.365 . . . . 0.0 113.341 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -81.58 -37.1 28.22 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 122.143 0.973 . . . . 0.0 111.034 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 46' ' ' LYS . 19.2 m -77.28 -40.0 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.59 0 CA-C-O 122.001 0.905 . . . . 0.0 109.797 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.78 -37.98 32.26 Favored 'General case' 0 C--N 1.374 1.666 0 C-N-CA 126.074 1.75 . . . . 0.0 110.999 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.25 -40.64 23.45 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-N 114.144 -1.389 . . . . 0.0 113.519 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -63.22 1.15 Allowed 'General case' 0 C--N 1.346 0.429 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.015 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.08 69.39 0.05 OUTLIER Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.216 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -96.37 -64.94 1.0 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.8 -120.78 5.58 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.661 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 72.4 Cg_exo -49.83 109.56 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.187 1.925 . . . . 0.0 110.978 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 15.6 t0 159.27 113.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.608 0.363 . . . . 0.0 110.77 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 265' ' ' GLY . 0.7 OUTLIER -98.5 173.24 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.957 -177.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.815 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -131.06 130.08 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.697 -177.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.896 ' HB3' HD13 ' A' ' 11' ' ' ILE . 70.2 t80 -121.8 112.21 18.08 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -166.84 161.94 15.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HA ' HD23 ' A' ' 262' ' ' LEU . . . -34.95 151.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.791 ' HB3' HG23 ' A' ' 261' ' ' VAL . 2.7 t60 -77.26 -28.94 53.69 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD2' ' HE1' ' A' ' 330' ' ' MET . 33.5 m-20 -47.37 -59.29 3.31 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.6 mtp85 -78.51 -26.95 45.99 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.712 -0.617 . . . . 0.0 109.648 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.946 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.64 -28.69 70.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -61.97 -58.74 11.47 Favored Glycine 0 CA--C 1.49 -1.495 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.29 -60.43 8.84 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 111.848 -2.176 . . . . 0.0 111.598 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.642 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 22.2 m-85 -48.81 -37.56 19.62 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.007 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . . . -56.5 -38.95 72.47 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.338 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -78.51 -56.3 4.54 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.342 -0.224 . . . . 0.0 111.556 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 m -113.91 -27.19 7.83 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.642 ' HA3' ' HA ' ' A' ' 70' ' ' TYR . . . -63.41 -89.7 0.03 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.861 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.094 ' C ' ' HB2' ' A' ' 268' ' ' ALA . 0.2 OUTLIER -179.02 63.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.007 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -116.36 140.11 49.68 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 173.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.959 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . -90.33 88.13 7.08 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.763 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HA ' ' CG1' ' A' ' 104' ' ' ILE . 1.2 mt-10 -47.36 100.09 0.02 OUTLIER 'General case' 0 C--O 1.23 0.076 0 CA-C-O 120.821 0.343 . . . . 0.0 110.434 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 104' ' ' ILE . 4.4 mt -47.66 159.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.554 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.586 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -88.26 175.15 4.37 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 80' ' ' THR . 76.1 Cg_endo -79.76 133.56 10.38 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.344 2.029 . . . . 0.0 113.399 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.71 -170.11 2.15 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.809 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 -78.18 0.59 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.237 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.03 -23.02 67.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -62.12 -59.31 5.24 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.77 0.319 . . . . 0.0 110.236 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -77.08 -28.43 54.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.71 -10.84 59.67 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -92.26 -18.19 23.75 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.754 HD22 ' CD1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -90.59 -176.84 4.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.277 0.49 . . . . 0.0 111.297 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.557 ' CB ' ' CZ3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -94.49 165.72 16.81 Favored Pre-proline 0 C--N 1.341 0.238 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.581 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 6.3 Cg_exo -75.4 -24.09 12.53 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.826 2.351 . . . . 0.0 115.248 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CE1' ' NE2' ' A' ' 325' ' ' GLN . 4.2 m-85 -87.31 -63.5 1.3 Allowed 'General case' 0 C--O 1.245 0.832 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.925 HG21 HG21 ' A' ' 302' ' ' VAL . 0.2 OUTLIER -63.19 -24.68 67.99 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.754 ' CD1' HD22 ' A' ' 89' ' ' LEU . 5.9 m-90 -93.75 -24.31 17.86 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.48 0.712 . . . . 0.0 111.345 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 8.1 t0 -73.63 -23.53 59.89 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.653 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.641 ' HB3' HG11 ' A' ' 261' ' ' VAL . . . -62.91 -42.95 99.96 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.904 HG23 HG11 ' A' ' 261' ' ' VAL . 44.5 t -108.62 54.13 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . 0.9 OUTLIER -130.85 140.28 50.23 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.03 -0.419 . . . . 0.0 110.786 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 101' ' ' GLY . 57.0 m-85 -112.34 174.72 5.75 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -48.05 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 56.16 38.14 75.65 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.268 -0.968 . . . . 0.0 110.752 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 -177.27 5.5 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 97' ' ' VAL . 0.7 OUTLIER 168.34 130.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.913 ' CD1' HD12 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -115.67 38.86 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 165.22 175.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.767 ' CE1' ' HB3' ' A' ' 264' ' ' ALA . 5.3 p90 -117.51 133.41 23.26 Favored Pre-proline 0 C--N 1.343 0.288 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.985 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.855 ' O ' HD13 ' A' ' 108' ' ' ILE . 96.0 Cg_endo -79.37 149.76 21.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.433 2.088 . . . . 0.0 113.315 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 107' ' ' PRO . 1.3 mm -149.32 38.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.009 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.913 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 177.33 124.65 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.399 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.6 HG22 HG22 ' A' ' 320' ' ' THR . 4.1 p -107.01 114.99 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.325 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 229' ' ' PRO . 18.6 mt-10 -99.36 132.79 44.44 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.641 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -168.3 -174.13 2.18 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.493 1.517 . . . . 0.0 110.077 -167.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.569 HD23 HG13 ' A' ' 226' ' ' ILE . 2.0 tp -146.65 136.98 23.73 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 111.542 -2.572 . . . . 0.0 116.35 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.874 ' O ' HD12 ' A' ' 226' ' ' ILE . 0.2 OUTLIER -131.42 164.74 25.05 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.59 -178.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.497 HD12 ' HD3' ' A' ' 248' ' ' PRO . 0.9 OUTLIER -92.6 132.17 37.09 Favored 'General case' 0 C--N 1.342 0.257 0 O-C-N 121.972 -0.455 . . . . 0.0 110.289 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.792 HD11 ' CD2' ' A' ' 242' ' ' TYR . 19.1 tt -113.88 131.19 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.258 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -104.24 132.64 50.27 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.753 ' CB ' ' HB2' ' A' ' 122' ' ' LEU . 45.8 m-80 -87.29 123.98 32.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.203 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -98.03 -87.98 0.32 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 119' ' ' LYS . 26.4 t0 -19.72 -63.67 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.776 HD12 ' HG ' ' A' ' 122' ' ' LEU . 2.5 pp -125.87 38.9 4.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.776 ' HG ' HD12 ' A' ' 121' ' ' LEU . 90.9 mt -158.41 113.22 1.7 Allowed Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.101 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -92.63 124.17 0.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.196 1.264 . . . . 0.0 111.45 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.575 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 11.9 p-10 -97.47 161.64 25.28 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 81.5 Cg_endo -77.1 167.86 24.25 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.676 2.917 . . . . 0.0 112.315 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.34 -47.94 0.08 OUTLIER 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.084 2.522 . . . . 0.0 113.654 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.663 ' CE ' HG23 ' A' ' 128' ' ' THR . 0.4 OUTLIER -155.63 -10.06 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -178.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.663 HG23 ' CE ' ' A' ' 127' ' ' LYS . 1.4 p -117.2 140.21 49.82 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.218 0.917 . . . . 0.0 113.278 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.604 ' O ' HD12 ' A' ' 132' ' ' ILE . 1.8 m0 -71.14 -27.73 63.77 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.486 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.5 OUTLIER -44.61 -24.0 0.16 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.682 ' HB3' HD12 ' A' ' 135' ' ' LEU . 3.4 mp0 -63.19 -23.3 67.37 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.778 HD13 HD11 ' A' ' 198' ' ' LEU . 5.8 mt -40.52 -59.73 1.86 Allowed Pre-proline 0 N--CA 1.477 0.924 0 CA-C-O 121.11 0.481 . . . . 0.0 112.147 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 4.6 Cg_endo -46.63 -45.39 19.87 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 121.251 1.301 . . . . 0.0 110.701 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.13 -58.91 2.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 131' ' ' GLU . 36.9 mt -67.37 -36.84 82.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.68 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.751 ' HA ' HD12 ' A' ' 139' ' ' LEU . 7.7 t0 -73.43 -41.41 63.27 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 5.2 tttt -48.77 -41.94 34.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.123 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 4.0 tm-20 -67.37 -38.1 84.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.189 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.916 HD13 ' N ' ' A' ' 146' ' ' ALA . 1.2 mt -63.18 -47.96 80.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.87 -44.6 29.55 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.05 -24.25 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.601 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -111.7 -60.56 1.83 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.62 46.76 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 CA-C-O 118.777 -1.013 . . . . 0.0 111.379 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.607 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.1 OUTLIER -157.04 -172.41 4.02 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.939 1.87 . . . . 0.0 111.128 -176.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.876 ' C ' HD13 ' A' ' 139' ' ' LEU . 49.3 m -139.82 167.17 22.72 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.916 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -83.57 -30.57 26.91 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.695 HD21 ' CG1' ' A' ' 132' ' ' ILE . 0.8 OUTLIER -137.54 127.94 26.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -176.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.852 ' HB3' HG21 ' A' ' 222' ' ' THR . 0.4 OUTLIER -132.21 137.87 47.74 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.975 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 1.026 ' O ' ' O ' ' A' ' 150' ' ' ASN . 7.1 p90 -171.33 174.72 4.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.53 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 1.026 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -20.45 -169.77 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 150' ' ' ASN . 0.1 OUTLIER -168.64 33.58 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.351 -0.843 . . . . 0.0 110.544 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.455 ' CB ' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER 172.05 33.99 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 169.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.879 ' O ' ' OG1' ' A' ' 157' ' ' THR . 14.1 pt-20 -115.16 152.74 47.03 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 121.125 1.784 . . . . 0.0 114.376 -176.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.815 ' O ' ' N ' ' A' ' 156' ' ' PHE . 5.1 Cg_exo -77.27 -136.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 124.643 3.562 . . . . 0.0 105.044 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 1.189 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 20.1 m-85 40.88 -68.37 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 120.51 1.505 . . . . 0.0 112.991 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.815 ' N ' ' O ' ' A' ' 154' ' ' PRO . 2.2 t80 -88.51 -58.63 2.48 Favored 'General case' 0 C--O 1.26 1.616 0 CA-C-N 118.705 0.684 . . . . 0.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.879 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 7.0 p -60.16 -42.92 95.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 118.276 -1.37 . . . . 0.0 107.854 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.453 ' HA ' ' CE3' ' A' ' 158' ' ' TRP . 0.0 OUTLIER -49.65 -55.75 21.04 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 1.189 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 84.0 Cg_exo -43.7 -47.26 9.81 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.025 2.483 . . . . 0.0 113.493 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.672 HD12 ' OG ' ' A' ' 255' ' ' SER . 4.9 mp -60.84 -56.38 21.91 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.07 0.85 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.669 HG22 ' HA ' ' A' ' 188' ' ' ALA . 3.7 mt -51.73 -23.6 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.388 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.452 ' CB ' ' HB2' ' A' ' 256' ' ' LYS . . . -79.83 -22.4 43.04 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.047 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 253' ' ' GLN . . . -42.03 -55.81 3.04 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.543 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 1.3 m-20 -64.19 -51.89 61.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 119.449 1.022 . . . . 0.0 112.393 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 169.34 26.14 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 117.924 -2.084 . . . . 0.0 117.117 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.59 89.65 0.7 Allowed Glycine 0 CA--C 1.522 0.526 0 CA-C-N 119.157 1.479 . . . . 0.0 112.66 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 27.1 m-85 -75.11 157.75 34.21 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.184 0.492 . . . . 0.0 111.061 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.674 ' HA ' HG13 ' A' ' 183' ' ' VAL . . . -61.82 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 111.352 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.893 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 4.9 m-85 -112.98 171.87 7.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.215 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 1.208 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER -101.21 107.96 19.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.13 115.42 23.7 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.577 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.877 ' O ' ' N ' ' A' ' 174' ' ' GLY . 19.7 mt-10 -136.35 101.53 4.7 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.449 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 53.0 t30 44.28 -64.31 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 123.796 0.685 . . . . 0.0 111.079 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.877 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -71.64 -73.35 0.83 Allowed Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 116.016 -0.538 . . . . 0.0 114.172 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -175.19 158.12 2.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.797 0.799 . . . . 0.0 109.688 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 1.208 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 17.4 p90 -44.37 -35.89 2.59 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.006 1.384 . . . . 0.0 109.068 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.577 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 0.9 OUTLIER 72.92 -79.48 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.778 -2.465 . . . . 0.0 110.839 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.743 HD11 HD13 ' A' ' 368' ' ' ILE . 8.1 tp 168.66 -41.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -8.15 51.93 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 4.6 m-20 -119.72 93.84 4.2 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.357 0.98 . . . . 0.0 109.36 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.495 HG11 ' CZ ' ' A' ' 339' ' ' PHE . 2.6 t -116.33 112.41 39.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -118.48 40.05 2.4 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.745 -1.217 . . . . 0.0 113.553 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.708 ' O ' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -79.97 -47.52 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -81.43 57.26 3.21 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.149 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -102.06 179.52 4.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.244 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.09 -30.49 36.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.486 0.66 . . . . 0.0 111.559 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.543 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -74.71 -40.69 36.83 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.39 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -59.69 -48.93 79.74 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -59.62 -60.27 4.11 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.551 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.38 -40.69 50.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.972 0.891 . . . . 0.0 112.004 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -64.86 -60.61 6.69 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.431 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 196' ' ' VAL . 5.6 tp -58.97 -25.79 63.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 3.1 m -61.94 -49.56 75.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.448 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 1.3 p90 -61.28 -35.52 77.55 Favored 'General case' 0 C--N 1.345 0.413 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.88 -46.84 83.09 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 192' ' ' LEU . 44.8 t -57.78 -31.42 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.454 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -45.72 89.35 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.725 0.774 . . . . 0.0 110.841 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.778 HD11 HD13 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -57.85 -54.37 47.63 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.903 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.667 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 10.8 tt -65.98 -35.13 74.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.387 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.07 -38.58 70.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.148 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -113.03 -34.85 5.59 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 120.785 3.624 . . . . 0.0 120.785 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.72 -70.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.514 ' NE2' HD11 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -47.8 -37.11 12.88 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.22 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.1 mtp 61.68 -77.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 203' ' ' HIS . 4.9 t-20 -86.38 -178.75 6.53 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.667 ' HB2' ' CD1' ' A' ' 199' ' ' ILE . . . -155.24 36.44 0.38 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -97.24 -2.81 41.96 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.762 HG22 ' HB2' ' A' ' 213' ' ' ALA . 29.5 m -55.2 118.98 4.83 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.53 -174.28 4.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -70.12 -45.45 66.86 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.69 -33.63 66.63 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.829 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.686 HG22 HG23 ' A' ' 208' ' ' THR . 1.4 mp -77.38 -48.71 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.881 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.762 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -58.1 -32.41 68.07 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.534 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 2.5 tp10 -60.58 -46.3 90.73 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.16 -36.11 74.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.641 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.13 -57.79 11.31 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -61.12 -28.35 69.04 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -53.45 -45.49 69.51 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -23.96 58.96 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.89 53.63 22.23 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.404 -0.817 . . . . 0.0 115.009 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -109.33 37.01 2.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.516 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.852 HG21 ' HB3' ' A' ' 148' ' ' MET . 14.3 t -140.33 140.02 35.53 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.736 ' HA ' HD13 ' A' ' 122' ' ' LEU . . . -104.11 38.53 1.83 Allowed 'General case' 0 C--N 1.349 0.559 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -176.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.613 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 3.0 tmm? 167.69 137.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.597 HG23 ' HB3' ' A' ' 149' ' ' PHE . 89.1 m -147.78 159.92 43.3 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.674 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.874 HD12 ' O ' ' A' ' 114' ' ' SER . 2.3 tp -115.68 112.13 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 232' ' ' TRP . 1.7 p30 -148.07 165.01 32.09 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.877 -0.514 . . . . 0.0 112.152 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 113' ' ' LEU . . . -160.23 -177.75 33.61 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 119.905 -1.14 . . . . 0.0 111.092 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 36.7 Cg_exo -61.93 69.73 0.11 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.225 1.95 . . . . 0.0 111.979 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.86 ' CZ3' ' HB2' ' A' ' 231' ' ' ALA . 9.2 t90 -157.93 -59.6 0.08 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.86 ' HB2' ' CZ3' ' A' ' 230' ' ' TRP . . . -89.69 -34.68 16.15 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.777 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.501 ' CD1' ' HB2' ' A' ' 227' ' ' ASN . 0.3 OUTLIER -124.56 79.93 1.8 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.716 0.293 . . . . 0.0 111.287 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.3 m -71.04 -43.89 66.93 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.316 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -100.5 77.22 1.9 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.476 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 tt -45.7 136.94 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.605 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.09 -172.93 3.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.594 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.49 78.42 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.658 0.266 . . . . 0.0 110.937 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.0 m -113.14 52.58 0.79 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 61.63 112.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.705 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.2 m -52.9 -40.11 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.533 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -83.36 104.3 13.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.716 0.293 . . . . 0.0 110.727 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.792 ' CD2' HD11 ' A' ' 116' ' ' ILE . 47.7 p90 -148.55 142.54 25.87 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.336 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -85.53 162.7 36.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.075 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.8 106.49 13.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.911 0.356 . . . . 0.0 111.524 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.56 166.9 16.43 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -172.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.8 154.21 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.169 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.849 HD12 HD11 ' A' ' 226' ' ' ILE . 0.1 OUTLIER -58.23 156.17 22.51 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 120.327 1.421 . . . . 0.0 110.256 -178.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.497 ' HD3' HD12 ' A' ' 115' ' ' LEU . 72.2 Cg_endo -79.44 -165.97 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.532 2.155 . . . . 0.0 112.466 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 40.8 p -106.3 168.16 9.34 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.308 0.575 . . . . 0.0 111.444 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' A' ' 253' ' ' GLN . 0.5 OUTLIER -166.05 126.44 1.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.851 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 36.93 31.11 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.992 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.36 27.49 48.05 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.612 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.476 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 23.7 mm100 -156.6 151.17 20.34 Favored Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 117.479 0.639 . . . . 0.0 112.661 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -91.89 138.88 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.392 2.728 . . . . 0.0 112.093 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.672 ' OG ' HD12 ' A' ' 160' ' ' LEU . 52.6 m -57.85 142.7 45.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.201 0.524 . . . . 0.0 112.176 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -86.16 108.91 19.24 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.981 -178.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.46 ' HD2' ' HA3' ' A' ' 327' ' ' GLY . 4.8 Cg_exo -79.82 147.2 19.12 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.984 2.456 . . . . 0.0 112.501 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 1.1 m-85 -79.78 136.51 36.75 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.653 HG21 HG13 ' A' ' 329' ' ' ILE . 27.2 t -92.09 124.46 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -117.59 125.78 6.64 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.196 -1.478 . . . . 0.0 114.764 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.904 HG11 HG23 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.89 103.5 13.57 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.913 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 69.7 mt -86.11 103.84 15.14 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.563 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.641 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 68.9 p -133.05 139.68 47.31 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 118.142 2.645 . . . . 0.0 118.142 -172.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.873 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . . . -95.06 113.36 25.05 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.677 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -102.55 163.26 16.51 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.367 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.624 ' O ' ' O ' ' A' ' 267' ' ' ASN . 0.8 OUTLIER -89.78 134.49 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 176.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.959 ' O ' ' N ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -13.52 -167.38 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.956 1 C-N-CA 132.156 4.183 . . . . 0.0 117.165 -171.525 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 1.094 ' HB2' ' C ' ' A' ' 75' ' ' LEU . . . -107.39 119.91 40.71 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 110.651 -2.977 . . . . 0.0 104.143 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 268' ' ' ALA . . . 104.94 -65.8 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.217 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 269' ' ' ALA . 2.4 p 155.46 103.07 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.476 ' O ' ' C ' ' A' ' 272' ' ' ASN . 15.5 Cg_endo -99.38 102.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.457 2.772 . . . . 0.0 113.446 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 271' ' ' PRO . 91.1 m-20 26.76 74.19 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.946 0.403 . . . . 0.0 111.646 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -64.67 -31.61 72.9 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 277' ' ' LYS . 0.7 OUTLIER -53.48 -57.5 10.44 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.875 -0.515 . . . . 0.0 112.366 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.91 -53.48 49.71 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.59 94.15 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -63.29 -40.59 97.8 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 -54.15 7.19 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.553 ' HE2' HG12 ' A' ' 23' ' ' VAL . 8.8 t80 -55.52 -58.72 6.61 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.714 HD11 HD22 ' A' ' 284' ' ' LEU . 0.9 OUTLIER -48.71 -43.17 37.02 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.776 0.798 . . . . 0.0 111.065 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -74.27 -34.56 63.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.095 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -93.6 -15.89 24.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.622 ' CZ ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -112.5 -60.2 1.9 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.463 0.574 . . . . 0.0 110.594 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.743 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.1 tp -43.12 -33.01 0.79 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.862 0.755 . . . . 0.0 109.798 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 285' ' ' LEU . 6.5 mp -86.29 42.24 0.98 Allowed 'General case' 0 C--N 1.342 0.239 0 CA-C-O 120.92 0.391 . . . . 0.0 110.481 178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 283' ' ' TYR . 12.9 p -144.47 154.58 43.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 1.7 m-20 -63.8 -13.98 49.0 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.586 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 2.0 tp10 -77.86 -48.24 16.92 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 121.719 -0.613 . . . . 0.0 110.986 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.669 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -75.66 -61.81 2.84 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.627 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER -57.39 -47.74 80.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.0 OUTLIER -79.42 -26.39 41.85 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -68.36 -38.41 81.4 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.823 HG12 ' CD ' ' A' ' 297' ' ' LYS . 61.3 t -66.07 -61.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.645 ' HB2' ' CE1' ' A' ' 307' ' ' TYR . 57.8 t30 -33.53 -52.33 0.39 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.738 1.215 . . . . 0.0 112.516 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -58.41 -49.62 76.62 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER -57.19 -45.7 83.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.823 ' CD ' HG12 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -47.57 169.06 0.13 Allowed Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.28 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.407 ' HD3' ' HG3' ' A' ' 297' ' ' LYS . 11.0 Cg_endo -90.67 -72.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.549 2.833 . . . . 0.0 112.853 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.616 HD11 ' CG ' ' A' ' 314' ' ' ASP . 0.4 OUTLIER -156.31 -69.14 0.11 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.644 0.259 . . . . 0.0 110.482 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.663 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . -79.9 139.25 21.15 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . 159.98 -174.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.242 0.521 . . . . 0.0 110.861 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.925 HG21 HG21 ' A' ' 93' ' ' THR . 0.3 OUTLIER -149.91 175.07 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.421 179.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.964 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . 172.02 70.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.709 ' HB3' HD21 ' A' ' 290' ' ' LEU . 3.1 tp 82.26 142.56 0.07 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -48.07 -55.95 8.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -177.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.7 t -53.67 -48.93 69.0 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.879 0.847 . . . . 0.0 111.549 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.964 ' CD2' ' HB3' ' A' ' 303' ' ' ALA . 33.0 t80 -70.46 -19.66 62.94 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.282 176.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -65.14 -38.15 89.68 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' A' ' 308' ' ' GLU . 3.4 tt0 -66.19 -54.62 23.01 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.838 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.4 -51.23 70.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.244 0.545 . . . . 0.0 109.614 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.589 HD22 HG13 ' A' ' 317' ' ' ILE . 0.2 OUTLIER -59.79 -41.87 92.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.628 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 313' ' ' LYS . . . -47.22 -29.83 2.61 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 312' ' ' ALA . 5.2 ttpt -31.16 -42.96 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.637 0.256 . . . . 0.0 111.506 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.616 ' CG ' HD11 ' A' ' 299' ' ' LEU . 1.1 t70 -76.34 135.82 69.02 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.384 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 31.1 Cg_exo -59.26 -20.66 56.39 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.529 2.153 . . . . 0.0 113.575 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.553 ' O ' ' OG1' ' A' ' 320' ' ' THR . 7.3 mmt180 -61.42 -58.91 6.28 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.589 HG13 HD22 ' A' ' 311' ' ' LEU . 3.3 mm -49.3 -55.35 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.48 -45.4 13.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.791 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.34 -35.64 63.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.397 0.618 . . . . 0.0 110.267 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.641 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -59.44 -42.69 92.49 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.249 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.45 ' CE ' HG22 ' A' ' 317' ' ' ILE . 60.1 mtm -76.31 -42.01 46.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.143 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -46.96 60.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.446 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -78.28 -41.96 32.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.486 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.508 ' O ' HG22 ' A' ' 259' ' ' VAL . . . -49.54 -36.7 24.35 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . 0.422 ' NE2' ' CE1' ' A' ' 92' ' ' PHE . 2.1 tt0 -85.28 -34.03 22.0 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -93.41 60.68 3.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 111.028 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.46 ' HA3' ' HD2' ' A' ' 257' ' ' PRO . . . -160.67 -139.57 2.69 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.338 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -128.84 117.27 20.77 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.653 HG13 HG21 ' A' ' 259' ' ' VAL . 34.5 mt -83.88 124.09 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.51 ' O ' ' O ' ' A' ' 331' ' ' PRO . 10.9 mtm -42.53 132.43 2.84 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.855 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 176' ' ' TYR . 75.8 Cg_exo -50.28 -156.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.052 2.502 . . . . 0.0 112.605 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.475 ' CG ' ' HH ' ' A' ' 176' ' ' TYR . 8.8 p-10 -146.65 40.32 1.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.954 0.407 . . . . 0.0 111.158 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 335' ' ' GLN . 1.8 pp -138.2 160.4 64.27 Favored Pre-proline 0 C--N 1.34 0.185 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.714 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.11 -13.56 23.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.626 2.217 . . . . 0.0 113.515 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.698 ' HB2' HD13 ' A' ' 333' ' ' ILE . 0.9 OUTLIER -60.56 -21.17 62.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.17 -34.58 2.78 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.144 -0.347 . . . . 0.0 111.827 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.43 -35.31 71.9 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.834 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.429 ' HB3' ' CG1' ' A' ' 368' ' ' ILE . . . -58.09 -36.24 72.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.919 0.39 . . . . 0.0 111.723 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.564 ' CZ ' HG21 ' A' ' 183' ' ' VAL . 0.2 OUTLIER -78.39 -55.75 4.99 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.79 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -43.42 -45.28 6.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.061 0.458 . . . . 0.0 110.177 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.476 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 34.7 t80 -70.72 -41.08 72.37 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.662 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.78 ' HB1' HD22 ' A' ' 361' ' ' LEU . . . -69.68 -46.05 66.94 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.813 ' O ' HG23 ' A' ' 347' ' ' VAL . 31.7 t -70.51 -35.03 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.15 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 341' ' ' TYR . 0.0 OUTLIER -69.73 -36.73 76.12 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 349' ' ' ASN . 95.0 m -66.71 -58.52 4.94 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.969 ' HB1' HG23 ' A' ' 357' ' ' VAL . . . -49.58 -50.39 42.69 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.394 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 343' ' ' VAL . 63.0 t -50.99 -56.93 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 24.8 mt -59.03 -27.39 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.627 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.6 OUTLIER -64.47 -38.68 91.87 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.297 0.57 . . . . 0.0 111.242 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -80.13 -26.58 39.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.359 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.18 -16.88 51.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 2.9 p -111.26 -6.68 14.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.561 1.073 . . . . 0.0 113.376 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 85.61 -2.65 87.88 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.604 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -88.58 35.18 0.76 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 115.808 -2.044 . . . . 0.0 107.605 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -70.82 -174.53 0.94 Allowed 'General case' 0 CA--C 1.547 0.838 1 N-CA-C 125.303 5.297 . . . . 0.0 125.303 -158.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.421 ' N ' ' OD1' ' A' ' 349' ' ' ASN . 4.5 t 159.84 44.76 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 110.365 -3.107 . . . . 0.0 104.252 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.969 HG23 ' HB1' ' A' ' 346' ' ' ALA . 7.7 p -72.44 -56.4 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.516 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 1.6 m-20 -48.78 -45.06 39.49 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.563 0.697 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.19 -55.78 5.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.938 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -52.37 -44.71 65.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 122.413 1.101 . . . . 0.0 112.65 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.78 HD22 ' HB1' ' A' ' 342' ' ' ALA . 1.7 tm? -77.28 -41.56 40.38 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.052 -1.885 . . . . 0.0 110.594 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.607 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 5.2 tttt -60.19 -56.42 21.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.083 0.944 . . . . 0.0 109.129 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -53.05 -37.21 61.4 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.596 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 361' ' ' LEU . . . -49.96 -48.12 52.25 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.524 ' HA ' HG22 ' A' ' 368' ' ' ILE . 41.5 tt0 -54.3 -44.89 72.37 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.5 m -57.16 -43.33 82.43 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.495 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -71.2 -57.47 4.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.025 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 368' ' ' ILE . 0.0 OUTLIER -54.45 -33.21 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.265 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.538 HG23 HG23 ' A' ' 368' ' ' ILE . 41.2 p -94.86 -15.91 23.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.664 0.269 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.657 ' CG ' HD12 ' A' ' 275' ' ' LEU . 2.4 tm-20 -142.93 136.86 29.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.954 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.82 -101.72 0.65 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.28 -170.9 1.94 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.319 -0.94 . . . . 0.0 110.01 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.928 HD12 HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -119.59 123.25 43.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.922 HG11 ' HG3' ' A' ' 57' ' ' PRO . 1.7 t -121.88 111.94 32.89 Favored 'Isoleucine or valine' 0 C--O 1.26 1.62 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.71 ' CG1' HD12 ' A' ' 59' ' ' ILE . 4.0 mt -133.52 126.79 52.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.544 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.686 ' HD1' HG22 ' A' ' 60' ' ' ILE . 1.9 p-90 -98.72 135.29 40.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.611 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 11' ' ' ILE . 1.5 mp -154.27 137.59 7.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 O-C-N 122.102 -0.374 . . . . 0.0 110.763 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -120.73 125.74 48.39 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.782 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.44 29.37 14.31 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.882 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 58.8 t0 -102.03 -80.23 0.51 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.166 0.483 . . . . 0.0 110.436 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 6.2 mttm 101.42 -5.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.898 0.879 . . . . 0.0 111.162 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.667 ' O ' HD12 ' A' ' 20' ' ' LEU . . . -76.38 64.76 2.82 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 115.359 0.904 . . . . 0.0 115.359 -176.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -78.72 -32.49 46.84 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.348 -0.426 . . . . 0.0 111.284 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 3.3 t-20 -68.47 -46.79 68.81 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 111.347 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.692 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -70.67 -47.52 40.48 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.983 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.036 HD13 HG11 ' A' ' 37' ' ' VAL . 1.2 mt -59.56 -50.78 72.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.434 0.617 . . . . 0.0 110.336 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -68.76 -39.27 80.33 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.516 ' HG2' ' HA2' ' A' ' 19' ' ' GLY . 11.0 pt-20 -66.21 -35.91 81.66 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.244 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 19' ' ' GLY . 11.3 m -68.63 -60.34 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.464 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.614 ' HA3' HG13 ' A' ' 35' ' ' VAL . . . -49.54 -34.19 19.49 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.736 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -57.77 -50.14 74.26 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 122.442 1.115 . . . . 0.0 109.005 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.67 -43.59 62.77 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 112.977 -1.92 . . . . 0.0 109.787 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.749 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -66.36 -26.05 67.09 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.096 -1.003 . . . . 0.0 111.151 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.748 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -73.15 -52.01 15.78 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.304 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -52.76 -28.01 20.41 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 124.683 1.24 . . . . 0.0 110.478 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.842 ' O ' HG23 ' A' ' 31' ' ' THR . 1.2 m-20 -84.64 -37.93 20.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 117.634 -1.174 . . . . 0.0 108.819 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.89 37.74 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 171.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.35 38.62 0.02 OUTLIER Glycine 0 N--CA 1.465 0.633 0 C-N-CA 114.796 -3.573 . . . . 0.0 119.545 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.928 HD12 HD12 ' A' ' 7' ' ' LEU . 22.3 mm -140.05 138.73 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 122.157 2.979 . . . . 0.0 116.956 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -142.36 104.4 4.42 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.965 HG21 ' O ' ' A' ' 20' ' ' LEU . 28.6 m -89.35 130.34 38.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -174.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 p -116.51 140.47 49.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.135 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.036 HG11 HD13 ' A' ' 20' ' ' LEU . 6.2 m -130.05 119.68 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.522 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -110.43 134.82 51.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.63 71.26 3.55 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 120.829 0.347 . . . . 0.0 111.617 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.873 ' CG ' HD13 ' A' ' 43' ' ' LEU . 39.1 Cg_endo -95.12 -160.95 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.931 3.088 . . . . 0.0 112.72 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.91 -62.63 1.11 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 0.15 34.45 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.873 HD13 ' CG ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -56.8 -28.37 61.29 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.218 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 1.047 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -47.32 -54.26 11.5 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.547 -0.721 . . . . 0.0 110.25 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mt-10 -71.85 -50.16 31.93 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.279 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 50' ' ' VAL . 32.7 mtmt -59.71 -56.36 22.87 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.122 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.688 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 7.2 t80 -44.38 -57.92 5.8 Favored Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 1.047 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 25.6 Cg_exo -66.03 -35.91 32.15 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 120.977 1.118 . . . . 0.0 114.251 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 17.0 mt-30 -66.63 -52.24 47.24 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 123.038 1.399 . . . . 0.0 107.549 175.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 46' ' ' LYS . 14.7 m -61.22 -21.85 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.555 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 48' ' ' PRO . . . -59.84 -29.47 68.29 Favored 'General case' 0 C--N 1.395 2.563 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.644 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -82.16 -24.59 34.93 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 124.991 1.316 . . . . 0.0 112.008 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.5 m -47.89 -30.96 4.57 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 167.93 -19.09 0.08 OUTLIER Glycine 0 CA--C 1.526 0.724 0 C-N-CA 119.891 -1.147 . . . . 0.0 114.644 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.629 ' O ' ' HB1' ' A' ' 269' ' ' ALA . 1.0 OUTLIER 155.77 -71.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.719 1.26 . . . . 0.0 111.561 179.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 40.44 -158.46 0.03 OUTLIER Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.031 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.922 ' HG3' HG11 ' A' ' 8' ' ' VAL . 10.9 Cg_exo -35.81 143.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.887 3.058 . . . . 0.0 112.78 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 59' ' ' ILE . 30.7 m-20 -123.51 35.44 4.85 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 117.478 -1.689 . . . . 0.0 113.877 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.71 HD12 ' CG1' ' A' ' 9' ' ' ILE . 2.8 mt -150.57 127.92 2.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 119.662 1.119 . . . . 0.0 113.692 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.686 HG22 ' HD1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -139.4 123.29 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 118.872 0.76 . . . . 0.0 110.034 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.523 ' O ' ' CZ2' ' A' ' 10' ' ' TRP . 2.6 m-85 -104.62 128.53 52.68 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.13 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -166.0 166.67 17.17 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 119.188 0.904 . . . . 0.0 109.723 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.11 165.99 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 120.479 1.49 . . . . 0.0 110.319 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.858 ' HB3' HG13 ' A' ' 261' ' ' VAL . 2.7 p80 -77.05 -29.3 55.1 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.477 0.656 . . . . 0.0 112.059 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -58.46 -36.08 73.15 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.425 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -85.43 -35.26 21.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.644 ' CE1' HD22 ' A' ' 76' ' ' LEU . 3.2 t80 -54.85 -32.82 61.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 172.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -58.19 -65.35 3.58 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.32 -41.44 16.46 Favored Glycine 0 C--N 1.355 1.639 0 CA-C-N 113.268 -1.466 . . . . 0.0 110.609 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.57 ' HB3' HD12 ' A' ' 76' ' ' LEU . 5.3 m-85 -59.49 -46.46 88.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.684 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . . . -50.35 -51.32 46.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.843 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -78.25 -27.15 47.49 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.641 ' HB3' HD23 ' A' ' 75' ' ' LEU . 1.7 t -71.63 -17.67 62.25 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.739 ' C ' HD22 ' A' ' 75' ' ' LEU . . . 83.69 37.85 11.34 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.231 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.739 HD22 ' C ' ' A' ' 74' ' ' GLY . 3.6 mm? -121.76 57.15 1.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.941 0.4 . . . . 0.0 111.533 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.829 HD23 ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -179.07 142.01 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.401 0.62 . . . . 0.0 112.127 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.982 ' O ' HG21 ' A' ' 104' ' ' ILE . . . -59.94 176.98 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.527 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.43 ' HA ' ' HB ' ' A' ' 104' ' ' ILE . 2.6 tm-20 -139.74 80.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.375 0.27 . . . . 0.0 110.489 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.0 pt -70.99 162.19 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.108 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.92 118.35 69.17 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.875 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.576 ' HB3' HD13 ' A' ' 103' ' ' LEU . 2.7 Cg_endo -79.87 146.79 18.75 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.571 2.181 . . . . 0.0 112.158 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -136.0 163.67 29.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.863 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -49.06 78.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.631 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.73 -23.64 63.36 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.822 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.5 ' CE2' ' CZ2' ' A' ' 94' ' ' TRP . 19.3 t80 -68.74 -58.65 3.91 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.916 0.389 . . . . 0.0 110.352 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -77.12 -24.7 51.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -76.36 -45.24 32.87 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 89' ' ' LEU . 3.9 pttp -51.54 -41.71 61.27 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.495 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.445 ' N ' ' HG3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -103.92 -175.14 2.71 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.6 0.238 . . . . 0.0 110.663 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CG ' ' CE2' ' A' ' 92' ' ' PHE . 0.9 OUTLIER -69.5 131.0 90.19 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.693 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.44 -38.0 82.52 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.515 2.143 . . . . 0.0 112.711 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.452 ' CE2' ' CG ' ' A' ' 90' ' ' TYR . 45.1 p90 -73.22 -43.61 60.97 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 120.549 0.214 . . . . 0.0 111.275 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 302' ' ' VAL . 45.0 m -62.14 -25.42 67.73 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.5 ' CZ2' ' CE2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -92.45 -26.49 17.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.216 0.531 . . . . 0.0 111.202 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -21.29 60.07 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.813 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.644 ' HB1' ' HB ' ' A' ' 261' ' ' VAL . . . -66.08 -50.17 65.04 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.685 0.278 . . . . 0.0 110.722 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.688 HG11 ' HD3' ' A' ' 107' ' ' PRO . 11.7 p -94.7 60.11 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.01 138.83 48.39 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.063 -1.023 . . . . 0.0 109.753 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.684 ' CE1' ' HB3' ' A' ' 71' ' ' ALA . 31.5 t80 -107.64 138.68 43.43 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.344 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -59.11 78.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.811 0.339 . . . . 0.0 110.108 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 133.11 -18.23 4.49 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.36 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.526 ' HD3' ' HB1' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -144.7 123.75 12.83 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.125 0.962 . . . . 0.0 111.843 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.576 HD13 ' HB3' ' A' ' 81' ' ' PRO . 0.5 OUTLIER -105.82 74.68 1.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.982 HG21 ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -129.46 91.3 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 121.668 0.747 . . . . 0.0 112.634 -177.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 159.54 -177.22 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.502 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -136.63 142.86 40.68 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.16 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.688 ' HD3' HG11 ' A' ' 97' ' ' VAL . 84.4 Cg_endo -82.02 156.88 17.77 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.499 2.132 . . . . 0.0 112.437 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.697 HG22 ' H ' ' A' ' 109' ' ' ALA . 28.2 mt -119.44 -135.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.697 ' H ' HG22 ' A' ' 108' ' ' ILE . . . -79.48 157.44 27.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.007 ' CG1' HG11 ' A' ' 302' ' ' VAL . 4.2 m -110.02 114.41 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.817 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -101.9 164.94 11.46 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.154 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.8 146.72 8.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.848 0.832 . . . . 0.0 111.267 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.868 ' CD1' HD21 ' A' ' 247' ' ' LEU . 3.2 pp -79.02 128.06 32.78 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.101 -1.408 . . . . 0.0 107.482 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 227' ' ' ASN . 24.8 p -131.35 165.85 22.55 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.513 HD12 ' CG2' ' A' ' 226' ' ' ILE . 4.3 tp -99.2 135.13 41.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.408 HD13 ' C ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -114.99 133.84 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.541 ' HE2' HG23 ' A' ' 245' ' ' THR . 12.1 p90 -122.08 142.02 50.79 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.855 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 1.4 t-20 -89.29 126.91 35.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.488 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.34 -3.61 28.5 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.064 -0.398 . . . . 0.0 110.37 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.22 -62.76 1.19 Allowed 'General case' 0 C--N 1.34 0.177 0 CA-C-O 121.252 0.548 . . . . 0.0 110.498 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 39.82 2.31 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.644 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.993 HD13 ' HB1' ' A' ' 223' ' ' ALA . 1.3 tp -131.68 89.72 38.83 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.354 0.597 . . . . 0.0 110.65 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.435 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 81.0 Cg_exo -44.5 162.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.465 2.777 . . . . 0.0 112.571 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 23.0 m-20 -60.12 110.7 3.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 122.449 1.119 . . . . 0.0 111.793 -170.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.9 Cg_endo -69.88 168.31 22.09 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 125.238 3.959 . . . . 0.0 114.14 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.668 ' HD3' HD22 ' A' ' 135' ' ' LEU . 56.9 Cg_endo -92.34 -154.05 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 123.34 2.693 . . . . 0.0 115.501 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -125.52 -91.7 0.52 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 t -46.4 155.53 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.058 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.642 ' CZ2' HD22 ' A' ' 147' ' ' LEU . 10.0 t-105 -69.67 -33.49 72.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 174.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 133' ' ' PRO . 1.9 mm-40 -44.98 -24.17 0.2 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.731 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -72.67 -26.51 61.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.494 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 25.6 mm -40.64 -57.33 3.19 Favored Pre-proline 0 N--CA 1.478 0.974 0 CA-C-O 121.29 0.567 . . . . 0.0 111.982 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 6.0 Cg_endo -48.27 -39.09 34.76 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 N-CA-C 109.399 -1.039 . . . . 0.0 109.399 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.35 -58.56 3.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.668 HD22 ' HD3' ' A' ' 126' ' ' PRO . 0.3 OUTLIER -68.65 -36.34 78.44 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.039 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 132' ' ' ILE . 21.6 t0 -72.85 -40.15 65.95 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -46.82 -47.37 21.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.402 176.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -63.74 -39.6 94.69 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.405 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.833 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -60.81 -49.84 75.87 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -44.52 29.67 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -45.89 -26.3 0.67 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -108.04 -58.57 1.96 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.058 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.8 43.93 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 CA-C-O 118.824 -0.986 . . . . 0.0 111.036 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.512 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 4.0 mttt -155.34 -172.22 4.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.636 1.718 . . . . 0.0 111.086 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.606 ' O ' HD22 ' A' ' 139' ' ' LEU . 47.9 m -142.4 160.71 39.74 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.833 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -75.15 -28.67 60.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.642 HD22 ' CZ2' ' A' ' 129' ' ' TRP . 0.7 OUTLIER -152.6 133.05 13.74 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -176.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.968 ' HB3' HG21 ' A' ' 222' ' ' THR . 7.9 tpt -132.3 140.72 48.7 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.907 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 150' ' ' ASN . 34.8 p90 -172.7 175.21 3.48 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.665 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 149' ' ' PHE . 45.2 m-80 -37.74 170.69 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.683 0.615 . . . . 0.0 110.828 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.569 HD11 ' HB1' ' A' ' 206' ' ' ALA . 2.1 tm? -114.64 -59.66 1.99 Allowed 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.404 ' HB3' ' NH2' ' A' ' 344' ' ' ARG . 2.0 mt-30 -102.75 36.01 2.32 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 116.788 -1.965 . . . . 0.0 114.862 -174.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.662 ' O ' ' HB ' ' A' ' 157' ' ' THR . 4.6 mm-40 -88.3 144.35 33.95 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 121.18 1.809 . . . . 0.0 114.61 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.934 ' O ' ' N ' ' A' ' 156' ' ' PHE . 6.0 Cg_exo -77.71 -135.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.285 1 C-N-CA 125.787 4.325 . . . . 0.0 106.04 176.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 1.149 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 1.2 m-85 27.17 -54.88 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.934 ' N ' ' O ' ' A' ' 154' ' ' PRO . 14.9 m-85 -87.88 -58.8 2.44 Favored 'General case' 0 C--O 1.26 1.625 0 C-N-CA 124.486 1.114 . . . . 0.0 110.761 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 24.1 m -57.24 -44.6 83.99 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.83 ' CE3' HD11 ' A' ' 161' ' ' ILE . 4.8 m95 -52.31 -55.02 35.51 Favored Pre-proline 0 C--N 1.348 0.521 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.534 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 1.149 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 87.5 Cg_exo -43.4 -49.53 7.47 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.387 2.058 . . . . 0.0 114.124 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.708 HD12 HG23 ' A' ' 161' ' ' ILE . 1.5 pp -79.18 -56.95 3.98 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 120.529 -1.357 . . . . 0.0 113.241 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.83 HD11 ' CE3' ' A' ' 158' ' ' TRP . 1.1 pt -61.19 -13.17 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 158' ' ' TRP . . . -124.95 -46.4 1.83 Allowed 'General case' 0 N--CA 1.471 0.622 1 N-CA-C 124.147 4.869 . . . . 0.0 124.147 -178.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.07 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . . . -54.58 49.72 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -176.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 162' ' ' ALA . 10.2 m-20 -122.1 -58.83 1.7 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.727 0.694 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.68 1.68 2.09 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.23 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.12 95.79 1.09 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.104 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -67.08 139.55 57.57 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.026 0.413 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.749 ' HA ' HG22 ' A' ' 183' ' ' VAL . . . -43.6 -74.65 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.742 0.782 . . . . 0.0 111.643 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.632 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 32.3 m-85 -112.33 173.9 6.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.708 ' O ' ' O ' ' A' ' 175' ' ' LYS . 6.3 ttmt -100.68 108.06 19.83 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.949 ' HA ' ' O ' ' A' ' 175' ' ' LYS . 27.5 m-85 -84.05 111.33 19.2 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.134 176.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 173' ' ' ASN . 18.0 mt-10 -104.89 101.17 10.77 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.597 ' C ' ' O ' ' A' ' 172' ' ' GLU . 8.8 m120 34.8 73.52 0.08 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 65.67 70.69 1.04 Allowed Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.171 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.949 ' O ' ' HA ' ' A' ' 171' ' ' TYR . 3.8 tptp -177.67 122.75 0.12 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.522 1.161 . . . . 0.0 112.98 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.632 ' HB2' ' HB3' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -114.63 -19.8 10.96 Favored 'General case' 0 N--CA 1.512 2.653 0 CA-C-O 122.907 1.337 . . . . 0.0 109.14 175.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.487 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 6.5 m-20 38.84 -85.8 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 111.523 -2.58 . . . . 0.0 111.725 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.739 HD13 ' HB3' ' A' ' 335' ' ' GLN . 7.3 tp 171.86 -41.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -65.9 -12.7 56.62 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 71.9 m-20 -120.59 93.53 4.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.994 0.816 . . . . 0.0 109.127 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.859 HG11 HD12 ' A' ' 368' ' ' ILE . 32.2 m -115.95 112.55 40.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.69 39.79 2.39 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.736 -1.221 . . . . 0.0 114.065 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.749 HG22 ' HA ' ' A' ' 168' ' ' ALA . 2.1 t -78.27 -43.54 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.524 ' HA ' ' CB ' ' A' ' 188' ' ' ALA . 5.8 p-10 -66.22 57.01 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.458 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 183' ' ' VAL . 0.7 OUTLIER -102.98 -172.34 2.1 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.37 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.696 ' O ' ' HG3' ' A' ' 189' ' ' LYS . . . -38.79 -48.59 1.54 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.244 0.545 . . . . 0.0 112.346 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.13 -32.3 52.89 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-O 118.975 -0.903 . . . . 0.0 113.053 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -60.07 -54.96 39.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.33 1.565 . . . . 0.0 107.301 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -52.64 -39.42 61.77 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.481 ' HB2' ' HD2' ' A' ' 251' ' ' LYS . . . -69.1 -42.31 76.29 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 111.954 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 161' ' ' ILE . . . -56.48 -60.59 8.7 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.711 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.893 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.6 OUTLIER -59.76 -30.93 69.2 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.194 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.5 m -74.94 -53.7 8.53 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.489 ' CD2' ' HA2' ' A' ' 191' ' ' GLY . 0.1 OUTLIER -62.09 -33.62 74.78 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.863 0.364 . . . . 0.0 110.16 178.149 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.92 -48.32 77.04 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 192' ' ' LEU . 76.1 t -56.48 -30.66 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.11 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -46.65 84.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.569 0.699 . . . . 0.0 111.006 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -51.42 68.27 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.151 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.71 HG23 ' O ' ' A' ' 205' ' ' ASN . 46.3 mm -63.41 -45.97 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.686 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.19 -36.71 52.67 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 118.437 -0.792 . . . . 0.0 112.02 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -113.0 -34.61 5.68 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 120.962 3.69 . . . . 0.0 120.962 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -79.41 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.702 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -101.47 -6.01 24.51 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.564 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 8.4 ttt 45.18 35.44 1.72 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.597 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.71 ' O ' HG23 ' A' ' 199' ' ' ILE . 19.8 m-20 -146.52 165.96 27.88 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 151' ' ' LEU . . . -152.35 32.57 0.52 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -99.0 -3.45 34.88 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -55.18 120.27 6.76 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 119.757 -0.777 . . . . 0.0 108.92 178.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.63 ' OD2' HD12 ' A' ' 212' ' ' ILE . 8.5 m-20 -94.77 -175.29 3.53 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.158 -0.339 . . . . 0.0 111.621 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -70.71 -45.26 65.27 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.136 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.95 -25.54 48.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.449 0.642 . . . . 0.0 110.771 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.63 HD12 ' OD2' ' A' ' 209' ' ' ASP . 1.7 mt -81.47 -52.01 14.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -51.11 -36.81 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.46 -45.55 86.9 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.26 -39.38 69.73 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.795 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.54 -56.06 25.98 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.97 -28.69 70.26 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -55.79 -41.56 74.27 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.512 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -23.9 59.13 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.12 42.71 58.02 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.445 ' HB3' ' HG3' ' A' ' 144' ' ' LYS . 1.4 mp0 -110.57 37.09 2.86 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.94 1.37 . . . . 0.0 110.794 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.968 HG21 ' HB3' ' A' ' 148' ' ' MET . 8.9 t -139.2 138.62 37.04 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.993 ' HB1' HD13 ' A' ' 122' ' ' LEU . . . -92.93 38.2 1.03 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -177.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 162.4 149.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.412 HG22 ' OD1' ' A' ' 227' ' ' ASN . 87.0 m -147.89 160.05 43.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.137 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 156' ' ' PHE . 2.2 pt -116.5 113.26 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -146.85 165.48 29.6 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.283 -177.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 232' ' ' TRP . . . -79.82 -154.4 9.18 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 119.341 -1.409 . . . . 0.0 113.495 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.71 -50.91 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.816 2.344 . . . . 0.0 114.115 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.456 ' CZ2' ' HB3' ' A' ' 299' ' ' LEU . 12.7 p-90 -135.78 -54.72 0.77 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.11 46.37 2.43 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.413 ' CB ' ' HA3' ' A' ' 228' ' ' GLY . 6.0 t-105 -91.64 -44.4 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.665 0.269 . . . . 0.0 110.432 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -114.42 38.14 3.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.045 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 54.07 87.92 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.634 0.254 . . . . 0.0 111.105 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.649 ' N ' HD13 ' A' ' 235' ' ' ILE . 0.2 OUTLIER -155.08 -43.82 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.402 ' N ' HG12 ' A' ' 235' ' ' ILE . 0.0 OUTLIER 45.09 -84.88 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 235' ' ' ILE . 15.6 p -67.18 138.0 56.66 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.651 0.262 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 22.1 p -134.51 158.87 42.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.898 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.85 176.62 0.07 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.984 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.64 -60.86 2.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.024 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -108.99 99.9 9.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.722 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -117.46 127.59 54.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.075 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 117' ' ' TYR . . . -96.71 114.13 4.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.205 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.72 137.01 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.579 -0.365 . . . . 0.0 110.829 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.541 HG23 ' HE2' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -141.18 167.93 21.0 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.071 0.548 . . . . 0.0 111.613 -172.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.6 m -72.75 152.23 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.868 HD21 ' CD1' ' A' ' 113' ' ' LEU . 1.9 mp -58.73 159.54 12.64 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 119.903 1.229 . . . . 0.0 110.682 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 247' ' ' LEU . 72.4 Cg_endo -78.66 -162.67 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.552 2.168 . . . . 0.0 113.063 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.4 p -94.91 144.31 25.77 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 160' ' ' LEU . 62.2 m-85 -144.61 111.2 5.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.96 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 190' ' ' ALA . 0.0 OUTLIER 37.04 31.98 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.196 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 105.78 29.98 4.75 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 254' ' ' PRO . 0.1 OUTLIER -156.68 167.1 15.14 Favored Pre-proline 0 N--CA 1.467 0.375 0 CA-C-N 119.1 1.45 . . . . 0.0 112.302 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 253' ' ' GLN . 67.7 Cg_endo -93.08 23.73 0.5 Allowed 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.43 2.753 . . . . 0.0 114.48 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.659 ' HB2' HD13 ' A' ' 247' ' ' LEU . 0.7 OUTLIER 72.21 133.61 0.04 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 178.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 1.07 ' HB2' ' HB2' ' A' ' 163' ' ' ALA . 10.5 mttt -86.38 106.39 10.11 Favored Pre-proline 0 CA--C 1.512 -0.499 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.795 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.745 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 94.8 Cg_endo -78.9 143.87 18.62 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.201 1.267 . . . . 0.0 109.719 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -89.19 119.32 29.58 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.898 HG11 ' HA ' ' A' ' 324' ' ' ALA . 6.2 m -115.2 99.86 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 118.247 0.476 . . . . 0.0 112.148 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -90.86 156.69 24.7 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.782 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.858 HG13 ' HB3' ' A' ' 64' ' ' HIS . 2.1 p -118.19 106.49 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -72.3 129.61 38.82 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 117.54 -1.664 . . . . 0.0 107.115 178.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.542 ' HA ' HG13 ' A' ' 108' ' ' ILE . 2.9 p -140.85 130.0 23.48 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 118.624 2.824 . . . . 0.0 118.624 -172.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.516 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . . . -88.88 111.98 22.72 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.643 ' HA3' HD21 ' A' ' 76' ' ' LEU . . . -100.78 164.27 18.64 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.543 ' HB ' HD11 ' A' ' 104' ' ' ILE . 3.7 mt -88.21 123.05 40.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 118.723 1.262 . . . . 0.0 107.617 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -64.59 145.73 55.71 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.515 ' HB2' ' H ' ' A' ' 76' ' ' LEU . . . -57.73 -25.5 60.48 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.132 -0.355 . . . . 0.0 110.947 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 55' ' ' ASP . . . -49.5 -60.0 3.25 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.471 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.94 131.77 8.87 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.652 0.263 . . . . 0.0 111.279 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.37 -42.57 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.497 2.131 . . . . 0.0 112.999 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 4.2 m-20 47.8 81.08 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.533 0.206 . . . . 0.0 110.787 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.12 -54.07 7.77 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -58.48 -57.29 13.58 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.657 HD12 ' CG ' ' A' ' 4' ' ' GLU . 8.3 tt -59.72 -42.88 94.08 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.658 0.266 . . . . 0.0 111.472 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.596 ' HB1' HD13 ' A' ' 280' ' ' LEU . . . -72.9 -33.41 65.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.612 ' O ' ' CB ' ' A' ' 281' ' ' GLU . 1.1 tmtt? -63.58 -58.7 6.13 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 121.413 0.625 . . . . 0.0 112.165 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.508 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 3.6 tp10 -68.06 -34.55 76.66 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.699 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.494 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 54.9 t80 -74.04 -60.02 2.45 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.963 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.596 HD13 ' HB1' ' A' ' 276' ' ' ALA . 5.8 mp -75.01 -43.13 55.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 118.373 -1.331 . . . . 0.0 113.05 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.826 ' HA ' HD23 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -73.65 -37.73 65.21 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.518 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 3.9 t30 -87.99 -20.61 25.61 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.639 ' CE1' HG12 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -104.06 -74.45 0.64 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 177.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.501 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 0.5 OUTLIER -36.22 -30.63 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.841 HD12 HD13 ' A' ' 304' ' ' LEU . 3.2 mm? -98.35 43.49 1.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.896 0.316 . . . . 0.0 111.792 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.5 p -144.89 157.78 44.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 11.2 m-20 -61.18 -15.17 31.15 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 2.3 mm-40 -78.32 -46.91 18.92 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.316 0.507 . . . . 0.0 110.498 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -81.06 -53.46 3.92 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.922 HD11 HD23 ' A' ' 304' ' ' LEU . 17.6 mt -50.07 -49.24 51.97 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.452 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 1.4 tp10 -78.14 -27.41 48.2 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.912 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -71.92 -38.06 69.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 119.776 1.171 . . . . 0.0 108.405 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 290' ' ' LEU . 14.7 p -65.92 -38.03 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -74.95 -41.88 58.75 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.458 1.103 . . . . 0.0 113.374 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -65.09 -42.74 93.76 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.499 ' CB ' ' HA3' ' A' ' 16' ' ' GLY . 33.4 m-20 -56.68 -64.53 0.84 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.48 ' HB3' HD11 ' A' ' 299' ' ' LEU . 17.4 mtmm -97.63 105.24 25.12 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.814 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -100.18 93.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.62 2.88 . . . . 0.0 112.305 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -143.33 -74.29 0.27 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.526 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -144.0 173.6 24.71 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.084 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 1.019 ' HB2' HD13 ' A' ' 311' ' ' LEU . . . -129.93 131.24 45.93 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 1.007 HG11 ' CG1' ' A' ' 110' ' ' VAL . 10.9 p -179.8 39.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.085 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.465 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . -111.06 -138.21 0.37 Allowed 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.922 HD23 HD11 ' A' ' 290' ' ' LEU . 22.0 tp -39.63 121.24 1.2 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -30.33 -63.15 0.14 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.514 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 95.7 p -48.88 -44.73 40.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.966 0.889 . . . . 0.0 110.933 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.906 ' CE1' HD12 ' A' ' 311' ' ' LEU . 3.1 t80 -75.87 -25.05 55.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.909 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -68.54 -39.78 80.99 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -68.66 -61.33 1.87 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.288 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -46.78 -56.61 5.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.872 0.368 . . . . 0.0 111.169 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 1.019 HD13 ' HB2' ' A' ' 301' ' ' ALA . 0.3 OUTLIER -64.43 -45.58 86.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.641 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -46.84 -28.7 1.65 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -31.22 -42.21 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.477 ' HB2' HD12 ' A' ' 317' ' ' ILE . 28.6 m-20 -71.19 137.12 84.33 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.784 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.72 -21.8 70.94 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.631 2.22 . . . . 0.0 113.252 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -59.71 -59.14 5.9 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.646 0.26 . . . . 0.0 111.559 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 301' ' ' ALA . 3.0 mp -50.91 -55.6 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.91 -39.07 8.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.163 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.08 -52.74 64.43 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 122.058 0.932 . . . . 0.0 108.837 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.4 ' OG1' HG23 ' A' ' 110' ' ' VAL . 3.2 p -56.84 -37.57 71.43 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 113.625 -1.625 . . . . 0.0 109.85 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.414 ' O ' ' HB3' ' A' ' 324' ' ' ALA . 1.4 ttp -70.93 -44.59 65.86 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -58.56 -57.38 13.21 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' A' ' 327' ' ' GLY . 6.5 m-20 -50.45 -38.71 45.0 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.898 ' HA ' HG11 ' A' ' 259' ' ' VAL . . . -57.35 -43.19 83.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.603 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -57.33 -42.06 81.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.228 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -106.19 26.41 9.81 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.887 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.745 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -114.66 157.64 14.85 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.618 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.86 135.66 36.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 330' ' ' MET . 39.0 mt -86.45 115.43 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 118.906 0.775 . . . . 0.0 110.87 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.535 ' HE3' ' HE1' ' A' ' 336' ' ' MET . 0.0 OUTLIER -28.27 130.84 0.2 Allowed Pre-proline 0 N--CA 1.47 0.568 0 N-CA-C 111.412 0.153 . . . . 0.0 111.412 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.459 ' HG2' ' CE1' ' A' ' 169' ' ' PHE . 62.4 Cg_exo -51.79 -164.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.893 2.395 . . . . 0.0 113.152 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -150.73 39.29 0.71 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.343 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.448 HG13 ' CE1' ' A' ' 176' ' ' TYR . 1.2 pp -132.58 163.23 52.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.026 0.441 . . . . 0.0 111.911 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.21 -37.86 7.56 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.046 2.497 . . . . 0.0 112.403 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.739 ' HB3' HD13 ' A' ' 178' ' ' ILE . 8.8 mp0 -45.98 -21.79 0.16 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.535 ' HE1' ' HE3' ' A' ' 330' ' ' MET . 4.0 tpp -45.49 -35.61 3.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.956 0.344 . . . . 0.0 110.978 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.5 t -61.12 -40.33 93.36 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.78 0.324 . . . . 0.0 110.19 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.12 -37.61 85.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.764 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.724 ' O ' HG12 ' A' ' 343' ' ' VAL . 23.4 t80 -74.04 -55.74 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.624 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 344' ' ' ARG . 2.3 t-105 -49.91 -43.61 49.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.494 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.722 ' O ' HG23 ' A' ' 345' ' ' THR . 0.9 OUTLIER -69.79 -52.2 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.9 -44.17 81.5 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.939 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.0 p -71.7 -29.42 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -75.03 -49.18 20.63 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 341' ' ' TYR . 69.9 p -57.33 -57.94 10.42 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.729 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.79 -41.22 6.76 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.861 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 343' ' ' VAL . 54.9 t -59.04 -47.69 89.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 345' ' ' THR . 6.7 mt -66.97 -28.24 42.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.8 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.729 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.9 OUTLIER -67.94 -27.63 66.78 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.66 0.267 . . . . 0.0 110.913 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.51 -44.76 23.62 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.54 -9.39 59.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 9.4 t -101.72 -46.03 5.06 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 142.1 0.77 1.4 Allowed Glycine 0 N--CA 1.464 0.504 0 C-N-CA 117.054 -2.498 . . . . 0.0 118.074 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.46 32.38 4.66 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 113.232 -3.387 . . . . 0.0 114.916 173.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.804 ' HB3' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER -158.24 119.22 3.43 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 34.3 p -78.73 146.88 33.65 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 358' ' ' ASP . 12.5 p -41.97 -45.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.433 ' N ' HG13 ' A' ' 357' ' ' VAL . 16.0 m-20 -71.58 -49.67 38.26 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.01 -46.38 57.39 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.475 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.804 ' HB2' ' HB3' ' A' ' 355' ' ' GLN . . . -54.16 -49.47 69.21 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.282 1.039 . . . . 0.0 113.593 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 47.3 mt -74.71 -36.69 62.7 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.283 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 365' ' ' GLN . 14.7 tttm -65.13 -56.7 11.41 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 122.351 1.072 . . . . 0.0 110.581 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.34 -37.45 83.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.749 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -49.61 -43.98 46.87 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.698 ' HG3' HG23 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -60.62 -44.74 95.97 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.57 -44.15 56.57 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.34 0.591 . . . . 0.0 110.168 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.08 -46.22 90.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.269 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.859 HD12 HG11 ' A' ' 181' ' ' VAL . 6.7 pt -81.19 -5.65 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.837 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.757 ' CG2' HG22 ' A' ' 181' ' ' VAL . 10.8 p -135.28 42.81 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.619 0.247 . . . . 0.0 110.616 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.248 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.665 0.269 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -138.95 -179.45 5.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.98 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.7 66.04 0.55 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HA ' HG12 ' A' ' 33' ' ' ILE . 2.3 tttp -153.18 157.49 40.36 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.658 ' HG ' HD11 ' A' ' 9' ' ' ILE . 24.7 tp -146.48 124.75 12.24 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.79 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.773 ' O ' ' HA ' ' A' ' 58' ' ' ASP . 99.3 t -111.74 132.9 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.488 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.831 ' HB ' HG12 ' A' ' 37' ' ' VAL . 5.4 mp -135.21 125.15 43.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.063 0.459 . . . . 0.0 111.412 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.573 ' CH2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -106.04 121.04 43.31 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.802 HG23 ' HB2' ' A' ' 61' ' ' PHE . 15.3 mt -158.09 137.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.063 0.458 . . . . 0.0 111.252 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -156.07 41.98 0.39 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.59 -35.21 0.57 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.698 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 3.3 m-20 -90.05 -105.51 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER 161.91 -172.6 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.03 0.919 . . . . 0.0 113.204 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.66 100.58 0.32 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 113.733 -1.576 . . . . 0.0 115.423 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -36.33 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.984 -0.608 . . . . 0.0 111.167 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 12.1 t-20 -64.84 -43.94 91.4 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.87 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.99 -49.01 23.99 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.631 -0.795 . . . . 0.0 114.043 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.63 ' CD1' HG11 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -59.85 -50.18 74.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.789 0.795 . . . . 0.0 110.371 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.29 82.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 53.9 tt0 -65.8 -36.98 85.02 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.42 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 19' ' ' GLY . 57.5 t -68.6 -61.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 122.063 -0.398 . . . . 0.0 110.377 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.923 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -49.31 -32.49 14.32 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.278 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 8.7 tmtm? -58.37 -50.84 72.23 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 122.503 1.144 . . . . 0.0 109.183 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -42.81 61.96 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 113.05 -1.886 . . . . 0.0 109.515 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.599 ' O ' ' CB ' ' A' ' 31' ' ' THR . 10.8 t80 -64.26 -32.23 73.74 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.316 0.579 . . . . 0.0 110.691 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.592 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 26.8 tt0 -68.78 -46.62 68.25 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.897 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -25.6 54.27 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -176.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.7 -33.61 21.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.599 ' CB ' ' O ' ' A' ' 27' ' ' PHE . 1.8 m -95.75 -133.5 0.2 Allowed 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 111.115 -2.766 . . . . 0.0 104.792 173.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 28' ' ' GLU . . . -173.59 42.71 0.15 Allowed Glycine 0 C--N 1.291 -1.94 0 N-CA-C 106.869 -2.492 . . . . 0.0 106.869 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.608 HD11 ' N ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -113.95 152.14 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.583 ' N ' HD13 ' A' ' 33' ' ' ILE . 5.2 mtpt -105.71 105.78 15.98 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.655 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.923 HG11 ' HA3' ' A' ' 24' ' ' GLY . 10.7 p -84.49 131.32 34.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.0 p -116.71 141.24 48.46 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.379 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.831 HG12 ' HB ' ' A' ' 9' ' ' ILE . 27.0 m -136.74 119.97 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 1.7 mp0 -109.42 141.87 41.2 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -113.65 81.27 5.47 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 120.638 0.256 . . . . 0.0 111.483 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.492 ' CG ' ' HG ' ' A' ' 43' ' ' LEU . 38.1 Cg_endo -90.83 -172.55 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.31 2.673 . . . . 0.0 113.005 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -114.05 -44.97 3.1 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.622 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -81.03 0.61 35.01 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.667 HD22 HD11 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -19.77 -39.81 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 1.05 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -63.49 -55.06 27.06 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.273 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mp0 -74.07 -41.75 61.25 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.154 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.642 ' O ' HG13 ' A' ' 50' ' ' VAL . 23.4 mtpt -57.97 -57.82 11.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.24 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.716 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 34.7 t80 -41.73 -60.99 1.61 Allowed Pre-proline 0 C--N 1.355 0.828 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.26 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 1.05 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 25.0 Cg_exo -62.4 -19.83 68.51 Favored 'Trans proline' 0 C--O 1.25 1.106 0 CA-C-N 120.17 1.096 . . . . 0.0 111.704 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -81.07 -34.13 32.93 Favored 'General case' 0 C--O 1.259 1.599 0 CA-C-O 122.644 1.211 . . . . 0.0 110.683 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 46' ' ' LYS . 2.7 m -80.13 -40.86 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 CA-C-O 122.287 1.041 . . . . 0.0 110.308 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.06 -37.21 20.36 Favored 'General case' 0 C--N 1.381 1.958 0 CA-C-N 113.226 -1.806 . . . . 0.0 110.096 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 53' ' ' THR . . . -81.27 -35.74 30.77 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.555 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -172.49 64.57 0.03 OUTLIER 'General case' 0 C--N 1.34 0.169 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.606 179.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . -167.12 44.18 0.25 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 119.566 -1.302 . . . . 0.0 115.008 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 3.5 m-20 155.75 -86.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.74 -106.16 0.9 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.618 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 18.6 Cg_endo -57.11 132.99 54.77 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.938 1.759 . . . . 0.0 108.316 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.773 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 20.7 t0 157.97 126.9 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 118.717 0.69 . . . . 0.0 112.855 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.5 HG23 ' HA ' ' A' ' 266' ' ' ILE . 9.5 mt -107.87 162.85 5.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.667 HD11 HD22 ' A' ' 43' ' ' LEU . 6.3 tt -138.16 127.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.802 ' HB2' HG23 ' A' ' 11' ' ' ILE . 3.1 m-85 -85.94 148.07 25.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.717 ' HE3' ' O ' ' A' ' 61' ' ' PHE . 1.6 t-105 -168.54 153.38 6.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 120.119 1.327 . . . . 0.0 108.518 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 67' ' ' PHE . . . -77.21 -175.51 3.68 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.73 1.15 . . . . 0.0 108.746 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.687 ' HB3' HG23 ' A' ' 261' ' ' VAL . 22.4 t-80 -77.9 -44.89 25.71 Favored 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.59 ' HB3' ' CG ' ' A' ' 330' ' ' MET . 0.8 OUTLIER -52.91 -59.44 4.52 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 1.6 mtt85 -70.6 -29.86 66.37 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.796 ' HZ ' HG23 ' A' ' 104' ' ' ILE . 7.3 t80 -62.46 -39.7 94.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 72' ' ' GLN . . . -46.99 -67.62 1.4 Allowed Glycine 0 CA--C 1.488 -1.652 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.886 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 73' ' ' SER . . . -76.44 -71.84 1.15 Allowed Glycine 0 C--N 1.341 0.839 0 CA-C-N 114.485 -0.857 . . . . 0.0 112.612 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.761 ' HB3' HD21 ' A' ' 75' ' ' LEU . 12.7 m-30 -41.82 -57.5 2.33 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.423 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -75.61 -56.63 4.51 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.625 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 4.8 tm0? -63.8 -12.9 39.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.621 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 48.4 t -82.84 -26.75 31.36 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.119 -0.363 . . . . 0.0 111.78 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 166.99 -32.09 0.2 Allowed Glycine 0 C--N 1.339 0.735 0 C-N-CA 119.414 -1.374 . . . . 0.0 114.772 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.835 HD13 ' HG3' ' A' ' 48' ' ' PRO . 1.8 pp -86.72 61.8 7.03 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 118.195 0.998 . . . . 0.0 111.743 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.827 HD12 ' CG1' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.19 143.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.238 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.86 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -107.96 115.13 29.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.716 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -53.99 151.44 6.77 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.2 pt -90.96 155.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.276 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.43 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -88.25 175.31 4.25 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.097 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.43 ' CD ' ' HB ' ' A' ' 80' ' ' THR . 5.9 Cg_exo -79.52 139.46 14.41 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.776 2.318 . . . . 0.0 112.952 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.21 -162.19 1.26 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.303 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.07 -58.6 2.04 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.318 -0.239 . . . . 0.0 111.237 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.69 70.18 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.634 0.254 . . . . 0.0 111.417 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.419 ' CD2' ' HG2' ' A' ' 281' ' ' GLU . 0.1 OUTLIER -73.75 -59.08 2.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.473 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -56.93 -27.33 60.86 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.3 -31.07 57.99 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.886 ' HG3' HD21 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -93.8 29.62 2.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.578 ' HA ' ' CD1' ' A' ' 94' ' ' TRP . 19.7 mt -104.8 107.8 18.95 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.173 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -89.1 -179.19 1.19 Allowed Pre-proline 0 N--CA 1.452 -0.361 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HD3' ' CG ' ' A' ' 90' ' ' TYR . 7.4 Cg_exo -74.08 -39.0 1.86 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.326 2.017 . . . . 0.0 115.603 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.576 ' HZ ' HG21 ' A' ' 259' ' ' VAL . 31.1 t80 -87.65 -63.61 1.28 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.648 HG21 HG21 ' A' ' 302' ' ' VAL . 1.2 p -64.78 -26.99 68.59 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -175.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.578 ' CD1' ' HA ' ' A' ' 89' ' ' LEU . 5.2 m-90 -89.2 -24.93 22.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.015 0.926 . . . . 0.0 111.001 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 2.5 t70 -72.97 -26.81 61.49 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.125 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.922 ' HB1' HG21 ' A' ' 261' ' ' VAL . . . -71.72 -38.63 70.47 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.778 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 40.7 t -100.02 44.74 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.03 140.21 51.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 119.16 -0.448 . . . . 0.0 109.9 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.9 t80 -109.3 174.7 5.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.529 1.059 . . . . 0.0 109.433 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -61.32 75.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.724 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 138.97 -55.69 0.66 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.173 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -145.93 -178.29 6.04 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 117.126 0.463 . . . . 0.0 111.316 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.36 146.28 42.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.226 0.536 . . . . 0.0 112.39 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.827 ' CG1' HD12 ' A' ' 76' ' ' LEU . 4.1 tt -122.32 58.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.131 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.778 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . . . 159.03 176.04 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.819 ' CD2' ' HB3' ' A' ' 264' ' ' ALA . 0.0 OUTLIER -139.02 127.91 14.0 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 115.542 -0.754 . . . . 0.0 108.974 177.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.765 ' O ' HG23 ' A' ' 108' ' ' ILE . 86.3 Cg_endo -79.6 162.06 24.71 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 122.886 2.391 . . . . 0.0 113.479 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 107' ' ' PRO . 1.4 pp -167.99 38.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.256 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.904 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -178.11 119.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.319 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 110' ' ' VAL . 14.4 p -110.7 105.5 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.861 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.513 ' HA ' HG21 ' A' ' 320' ' ' THR . 1.9 pt-20 -102.46 161.8 13.42 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.788 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.68 146.87 8.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.741 0.781 . . . . 0.0 111.614 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.735 HD13 ' CD1' ' A' ' 156' ' ' PHE . 2.1 pp -79.75 125.27 29.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.1 OUTLIER -135.09 160.5 38.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -176.262 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 226' ' ' ILE . 8.2 tt -92.55 132.07 37.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 242' ' ' TYR . 4.1 tt -114.48 133.69 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.45 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 9.8 p90 -118.46 140.05 50.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.781 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 0.7 OUTLIER -89.25 128.08 35.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.611 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.06 -43.82 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.223 -0.298 . . . . 0.0 110.59 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -65.21 0.71 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.638 0.733 . . . . 0.0 110.84 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 121' ' ' LEU . 1.1 tt -110.24 64.99 0.61 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.98 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.911 HD13 ' HB1' ' A' ' 223' ' ' ALA . 2.1 tp -157.18 88.68 2.59 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 119.976 -0.689 . . . . 0.0 112.638 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.539 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 9.1 Cg_endo -48.26 162.98 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.192 2.594 . . . . 0.0 110.176 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -59.48 108.38 1.35 Allowed Pre-proline 0 N--CA 1.468 0.436 0 C-N-CA 118.186 -1.406 . . . . 0.0 109.686 -172.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.88 ' HB3' HD11 ' A' ' 122' ' ' LEU . 58.2 Cg_endo -93.31 168.6 2.28 Favored 'Trans proline' 0 C--N 1.369 1.627 1 C-N-CA 125.812 4.341 . . . . 0.0 115.868 -175.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 135' ' ' LEU . 4.7 Cg_exo -39.94 156.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.618 3.546 . . . . 0.0 115.572 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -136.07 -20.88 1.45 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.28 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.7 m -133.82 155.23 50.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -59.47 -54.32 48.03 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.406 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -24.25 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.577 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 134' ' ' ALA . 6.8 mt-10 -79.17 -27.92 42.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.651 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 7.2 mt -43.99 -54.25 11.57 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 121.385 0.612 . . . . 0.0 111.368 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 51.9 Cg_exo -49.07 -39.22 41.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 N-CA-C 109.511 -0.996 . . . . 0.0 109.511 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.11 -58.57 3.2 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.596 ' HB3' ' HD3' ' A' ' 126' ' ' PRO . 0.2 OUTLIER -69.07 -37.09 78.3 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.171 -178.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 49.0 t0 -73.09 -40.77 64.73 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -47.52 -45.11 26.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 118.599 -1.24 . . . . 0.0 108.949 177.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 75.0 mm-40 -64.28 -39.81 94.68 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.698 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.774 ' CD1' ' HB2' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -61.22 -49.17 78.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.75 -44.62 28.27 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.04 -25.19 0.53 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.497 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -100.01 -63.68 1.11 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.73 39.39 0.02 OUTLIER Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.014 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.76 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 0.5 OUTLIER -173.77 176.18 2.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.516 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.767 ' O ' HD22 ' A' ' 139' ' ' LEU . 9.8 m -109.26 166.97 10.46 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.774 ' HB2' ' CD1' ' A' ' 139' ' ' LEU . . . -73.31 -16.1 61.38 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.658 HD12 ' CE2' ' A' ' 149' ' ' PHE . 1.6 pt? -148.74 133.07 17.49 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 117.633 2.457 . . . . 0.0 117.633 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.56 ' HB2' HG21 ' A' ' 222' ' ' THR . 28.3 mmt -132.34 138.89 47.94 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.671 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.975 ' O ' ' O ' ' A' ' 150' ' ' ASN . 2.3 p90 -172.48 175.28 3.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.65 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.975 ' O ' ' O ' ' A' ' 149' ' ' PHE . 1.3 m120 -28.68 -147.74 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 123.897 0.748 . . . . 0.0 112.201 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.064 HD22 ' HB1' ' A' ' 206' ' ' ALA . 2.8 mt 169.66 41.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.824 -1.172 . . . . 0.0 110.615 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.892 ' NE2' HD11 ' A' ' 348' ' ' ILE . 0.0 OUTLIER 173.11 34.05 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 169.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.66 ' O ' ' HB ' ' A' ' 157' ' ' THR . 4.1 mp0 -119.46 155.13 54.38 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 121.113 1.779 . . . . 0.0 114.405 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.859 ' O ' ' N ' ' A' ' 156' ' ' PHE . 86.1 Cg_endo -77.59 -135.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 125.201 3.934 . . . . 0.0 105.466 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 1.182 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 4.0 m-85 39.83 -65.19 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 120.312 1.415 . . . . 0.0 113.073 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.859 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -89.5 -59.89 2.09 Favored 'General case' 0 C--O 1.259 1.593 0 C-N-CA 124.483 1.113 . . . . 0.0 111.36 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.66 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 5.9 m -58.88 -43.29 90.89 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.43 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.54 -55.34 30.31 Favored Pre-proline 0 C--N 1.35 0.612 0 C-N-CA 120.299 -0.561 . . . . 0.0 109.96 177.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 1.182 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 87.6 Cg_exo -43.48 -50.62 6.7 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.596 2.197 . . . . 0.0 113.349 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.502 HD23 ' CZ ' ' A' ' 250' ' ' PHE . 9.5 mp -64.06 -56.8 12.34 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 119.571 1.078 . . . . 0.0 109.972 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 158' ' ' TRP . 42.3 pt -54.31 -17.32 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.707 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -77.38 -25.75 51.2 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.7 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -42.13 -59.31 1.81 Allowed 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.491 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 6.3 t70 -64.35 -17.45 63.72 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 136.61 23.0 0.53 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 118.722 -1.704 . . . . 0.0 117.146 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.5 160.25 41.51 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 119.331 1.565 . . . . 0.0 111.779 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -163.08 168.1 21.39 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.504 0.652 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.47 -79.31 0.42 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.614 0.721 . . . . 0.0 111.343 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 14.3 m-85 -112.15 168.73 9.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.87 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 1.271 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -103.94 115.8 31.1 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.434 ' CE1' ' CD2' ' A' ' 176' ' ' TYR . 0.2 OUTLIER -86.48 114.38 23.18 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.378 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 173' ' ' ASN . 1.2 tt0 -106.47 100.71 10.22 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 172' ' ' GLU . 35.7 m-80 39.03 78.63 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.32 6.52 80.43 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.86 124.37 5.91 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 121.44 2.62 . . . . 0.0 113.388 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 1.271 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.2 p90 -96.92 -23.12 16.48 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.599 1.19 . . . . 0.0 109.724 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.497 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 2.8 m-20 65.82 -82.43 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.911 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.893 HD11 HG22 ' A' ' 368' ' ' ILE . 7.1 tp 172.21 -43.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.419 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.3 OUTLIER -58.67 -16.62 17.11 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 119.167 -0.444 . . . . 0.0 111.769 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 4.0 m-20 -112.92 93.93 4.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 178' ' ' ILE . 15.4 m -118.06 120.12 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.314 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.42 52.57 3.81 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 119.479 -1.344 . . . . 0.0 112.86 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.601 HG12 ' HB3' ' A' ' 361' ' ' LEU . 14.5 t -90.93 -17.84 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.409 -0.895 . . . . 0.0 109.366 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.72 52.24 0.72 Allowed 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.858 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.56 160.65 16.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.375 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.75 -25.92 59.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.383 0.611 . . . . 0.0 111.706 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -76.4 -36.43 39.08 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.866 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.17 66.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -60.44 3.85 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.544 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.31 -41.04 50.43 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.829 0.823 . . . . 0.0 111.609 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.48 ' HA2' ' CE2' ' A' ' 194' ' ' PHE . . . -58.89 -60.7 8.42 Favored Glycine 0 C--O 1.237 0.338 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.839 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.561 HD13 HG13 ' A' ' 347' ' ' VAL . 4.2 mt -61.32 -23.93 66.07 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.577 -0.367 . . . . 0.0 110.092 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.824 ' O ' HG12 ' A' ' 196' ' ' VAL . 98.1 m -62.69 -53.46 54.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.658 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.48 ' CE2' ' HA2' ' A' ' 191' ' ' GLY . 4.3 p90 -61.83 -33.88 74.95 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.638 ' CD1' HD11 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -61.33 -51.2 69.84 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.671 178.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 193' ' ' THR . 7.8 p -58.66 -28.75 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.958 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -57.87 -49.36 76.96 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 121.399 0.618 . . . . 0.0 109.779 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.4 tt -62.33 -59.14 5.42 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.748 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 195' ' ' LEU . 4.3 mt -53.8 -45.16 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -61.71 -34.14 75.27 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -91.09 3.35 55.0 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.4 -81.11 0.63 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.72 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.48 -24.07 5.94 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 199' ' ' ILE . 1.4 ptm 74.44 13.42 3.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.948 0.34 . . . . 0.0 110.8 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -148.88 104.96 3.5 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 1.064 ' HB1' HD22 ' A' ' 151' ' ' LEU . . . -99.16 72.01 1.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.22 -4.27 27.48 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.593 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.912 HG22 ' HB2' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -57.24 123.9 16.95 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.1 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.671 ' HB2' HD13 ' A' ' 212' ' ' ILE . 0.5 OUTLIER -94.48 -174.74 3.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.6 p90 -70.18 -45.1 67.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.239 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.432 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.4 OUTLIER -77.87 -25.53 48.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.943 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.671 HD13 ' HB2' ' A' ' 209' ' ' ASP . 2.9 mp -81.68 -51.76 14.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.568 ' HB2' HG23 ' A' ' 208' ' ' THR . . . -50.39 -37.35 37.03 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.61 -45.62 86.15 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.77 -38.8 67.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.874 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.01 -56.7 18.3 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -61.46 -29.13 69.76 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.8 -40.54 76.11 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.572 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.23 -23.93 59.24 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.4 33.12 61.63 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 115.3 0.88 . . . . 0.0 115.3 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -109.02 36.9 2.71 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.147 1.474 . . . . 0.0 111.4 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.56 HG21 ' HB2' ' A' ' 148' ' ' MET . 0.5 OUTLIER -140.23 137.91 34.66 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 178.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 122' ' ' LEU . . . -104.58 38.18 1.95 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.578 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 170.55 138.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.562 HG23 HG22 ' A' ' 116' ' ' ILE . 9.0 t -148.17 159.37 44.01 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.564 ' HB ' ' CE1' ' A' ' 156' ' ' PHE . 8.5 pt -116.05 111.92 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.755 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.618 ' HA ' ' HE2' ' A' ' 156' ' ' PHE . 89.6 m-20 -148.67 164.78 33.31 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 121.874 -0.516 . . . . 0.0 111.939 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 230' ' ' TRP . . . -86.57 114.89 4.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.413 -1.375 . . . . 0.0 109.861 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.668 ' O ' ' HB3' ' A' ' 230' ' ' TRP . 75.2 Cg_exo -50.15 72.94 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.974 2.45 . . . . 0.0 114.548 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.668 ' HB3' ' O ' ' A' ' 229' ' ' PRO . 0.4 OUTLIER 150.96 -30.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 177.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.32 -85.91 0.55 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -52.22 -31.89 34.18 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.346 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -54.47 3.48 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.585 0.231 . . . . 0.0 111.172 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.6 m120 65.91 -74.48 0.06 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.219 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.575 HG21 ' CB ' ' A' ' 238' ' ' SER . 5.8 mt 65.72 -68.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 74.76 -69.77 0.17 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.601 0.239 . . . . 0.0 110.388 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 7.1 p -106.85 60.83 0.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.757 0.313 . . . . 0.0 110.317 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . 0.575 ' CB ' HG21 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -52.93 -177.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.252 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -84.46 67.4 9.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.763 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 14.4 t 75.06 -67.22 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.745 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.57 150.28 47.35 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.725 0.298 . . . . 0.0 110.922 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.568 ' HB2' HD11 ' A' ' 116' ' ' ILE . 43.3 p90 -149.22 130.37 14.51 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.248 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.45 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -96.66 175.23 31.31 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.122 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.445 HG11 ' CG ' ' A' ' 229' ' ' PRO . 19.4 m -145.76 136.67 19.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 117.05 0.425 . . . . 0.0 111.529 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 167.5 21.0 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.4 m -73.07 152.77 7.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.713 HD22 ' OG ' ' A' ' 255' ' ' SER . 2.8 mp -59.37 159.57 15.85 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 120.627 1.558 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.73 -159.81 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.959 2.44 . . . . 0.0 112.433 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 17.3 p -121.15 177.51 5.12 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 249' ' ' THR . 56.8 m-85 -165.64 110.33 0.86 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.234 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.3 mttp 60.88 34.55 19.56 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.714 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.15 43.32 21.57 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.301 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -156.48 148.82 17.72 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.494 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 95.8 Cg_endo -84.31 -169.59 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.17 2.58 . . . . 0.0 111.628 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.713 ' OG ' HD22 ' A' ' 247' ' ' LEU . 75.3 p -111.85 148.99 32.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.248 0.547 . . . . 0.0 112.244 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 3.1 ttpm? -85.32 109.24 19.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.725 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.578 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 2.7 Cg_exo -78.88 145.7 20.09 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.347 2.698 . . . . 0.0 112.466 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 1.6 m-85 -102.12 94.13 5.59 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.513 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.657 HG13 ' HA3' ' A' ' 327' ' ' GLY . 35.5 m -94.35 106.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.757 0.313 . . . . 0.0 111.82 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.424 ' HA2' ' CE ' ' A' ' 330' ' ' MET . . . -86.2 160.52 33.49 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 119.637 -1.268 . . . . 0.0 112.606 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.922 HG21 ' HB1' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -111.59 111.15 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.904 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 3.8 tp -84.4 107.04 16.45 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 117.502 -1.679 . . . . 0.0 107.071 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 63.9 p -133.36 141.94 48.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.819 ' HB3' ' CD2' ' A' ' 106' ' ' TYR . . . -73.73 132.99 43.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.169 -0.332 . . . . 0.0 110.289 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.17 136.33 11.17 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.74 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.955 HG23 ' CG ' ' A' ' 271' ' ' PRO . 7.0 mt -88.0 119.78 35.99 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 CA-C-N 118.425 1.113 . . . . 0.0 108.245 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.545 ' HA ' ' HZ ' ' A' ' 47' ' ' PHE . 44.5 t-20 -59.27 137.55 57.94 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.86 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -53.86 -22.34 9.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.711 0.687 . . . . 0.0 110.468 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 270' ' ' SER . . . -55.77 -27.34 50.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.723 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 269' ' ' ALA . 0.9 OUTLIER 93.22 91.29 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 122.602 0.361 . . . . 0.0 111.191 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.955 ' CG ' HG23 ' A' ' 266' ' ' ILE . 47.6 Cg_endo -91.14 81.11 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.279 2.653 . . . . 0.0 112.939 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 6.6 m-80 37.23 82.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.721 0.296 . . . . 0.0 111.142 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 7.9 mmtt -51.58 -54.2 30.1 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -66.9 -57.4 7.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.8 mt -63.74 -53.75 46.24 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -65.83 -55.19 18.4 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -58.97 -32.59 69.79 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.32 -53.03 8.77 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.421 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 85.9 t80 -56.37 -54.66 42.97 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.85 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 284' ' ' LEU . 1.0 OUTLIER -53.9 -43.5 69.75 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.566 0.698 . . . . 0.0 111.402 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.706 ' O ' HD12 ' A' ' 285' ' ' LEU . 90.0 mt-10 -73.45 -34.36 65.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.787 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -93.15 -13.96 27.78 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 1.003 ' O ' HG22 ' A' ' 286' ' ' THR . 2.5 t80 -106.21 -65.72 1.05 Allowed 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.759 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.5 tp -36.48 -33.04 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.732 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.706 HD12 ' O ' ' A' ' 281' ' ' GLU . 26.2 mt -89.8 42.09 1.08 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.637 0.255 . . . . 0.0 111.665 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 1.003 HG22 ' O ' ' A' ' 283' ' ' TYR . 10.1 t -145.72 160.55 41.56 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 9.3 m-20 -63.81 -12.72 38.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.549 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.591 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 9.9 mt-10 -77.85 -46.94 20.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.598 0.636 . . . . 0.0 111.012 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.861 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -83.86 -54.99 2.91 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 284' ' ' LEU . 2.2 tp -48.86 -49.8 37.78 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 1.8 tt0 -78.65 -26.38 45.11 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.174 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -71.85 -35.12 69.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 119.838 1.199 . . . . 0.0 108.129 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 289' ' ' GLY . 66.1 t -65.77 -41.95 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.036 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -91.2 -33.88 15.22 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.632 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -46.27 85.98 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.471 ' HB3' ' HA3' ' A' ' 19' ' ' GLY . 1.2 p30 -61.49 -44.73 96.56 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 5.1 mttp -43.45 163.86 0.15 Allowed Pre-proline 0 N--CA 1.476 0.833 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.245 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -93.96 49.19 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.217 2.612 . . . . 0.0 114.699 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.2 mt 60.75 69.5 0.68 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.902 0.382 . . . . 0.0 111.533 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.673 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . 159.99 125.29 0.78 Allowed Glycine 0 C--O 1.231 -0.087 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.606 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . 159.61 -177.07 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.272 0.536 . . . . 0.0 111.571 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.648 HG21 HG21 ' A' ' 93' ' ' THR . 6.5 p -141.99 83.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.563 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . -84.67 58.22 4.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.271 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.886 HD21 ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER 87.84 149.4 0.05 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -30.19 0.66 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 65.5 m -79.91 -47.24 15.38 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.064 0.935 . . . . 0.0 111.059 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.563 ' CD2' ' HB3' ' A' ' 303' ' ' ALA . 5.9 t80 -70.74 -19.2 62.76 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.607 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -42.24 62.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -56.81 -55.85 29.06 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.195 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.34 -42.99 99.84 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.942 0.401 . . . . 0.0 110.18 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.479 ' O ' HG21 ' A' ' 317' ' ' ILE . 10.7 mt -59.93 -44.84 94.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.804 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.642 ' O ' ' HB2' ' A' ' 318' ' ' ALA . . . -46.63 -33.61 4.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.6 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -57.38 -36.5 71.33 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.582 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.53 164.57 5.16 Favored Pre-proline 0 N--CA 1.462 0.139 0 CA-C-O 120.684 0.278 . . . . 0.0 110.714 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.21 -57.2 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.131 2.554 . . . . 0.0 113.48 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.7 mtt85 -58.89 -59.46 5.42 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.49 HD11 ' CG1' ' A' ' 110' ' ' VAL . 1.7 tp -52.26 -54.31 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 312' ' ' ALA . . . -45.71 -51.86 11.81 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.269 0.486 . . . . 0.0 111.623 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -50.71 -48.4 58.84 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.318 1.056 . . . . 0.0 108.748 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.689 ' O ' ' HB2' ' A' ' 324' ' ' ALA . 0.3 OUTLIER -60.95 -36.9 80.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 113.248 -1.797 . . . . 0.0 110.58 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -73.96 -42.83 59.92 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.95 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.31 -57.5 12.37 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.753 0.311 . . . . 0.0 110.377 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.507 HD21 HD12 ' A' ' 247' ' ' LEU . 0.9 OUTLIER -67.36 -29.36 68.88 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.263 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -51.99 -53.05 46.15 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.734 0.302 . . . . 0.0 111.031 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -52.94 -32.85 47.96 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.203 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -98.64 13.2 32.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.657 ' HA3' HG13 ' A' ' 259' ' ' VAL . . . -93.9 160.0 23.98 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.865 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -97.76 131.93 43.83 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.2 pp -68.96 101.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 120.425 1.466 . . . . 0.0 107.875 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.59 ' CG ' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -36.07 144.84 0.24 Allowed Pre-proline 0 C--N 1.347 0.495 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -44.81 169.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.175 2.583 . . . . 0.0 112.297 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.404 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 9.3 p30 -128.4 -14.27 4.78 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.596 HD12 ' CG ' ' A' ' 335' ' ' GLN . 11.8 pt -78.94 165.89 46.06 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 118.77 0.714 . . . . 0.0 111.956 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.417 ' CD ' ' HB ' ' A' ' 333' ' ' ILE . 12.5 Cg_exo -70.55 -26.29 24.01 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.353 2.702 . . . . 0.0 113.402 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.699 ' OE1' HG23 ' A' ' 368' ' ' ILE . 84.1 mm-40 -42.01 -21.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.8 mmt -45.24 -32.17 1.81 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.234 0.47 . . . . 0.0 111.431 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -43.28 99.19 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 368' ' ' ILE . . . -63.5 -34.81 78.6 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.09 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.609 ' O ' HG23 ' A' ' 343' ' ' VAL . 4.3 m-85 -75.46 -52.28 11.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.542 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.459 ' CZ2' ' HG3' ' A' ' 154' ' ' PRO . 0.7 OUTLIER -53.45 -40.83 65.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.345 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -52.44 16.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.95 -44.49 69.43 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 1.037 HG13 HG21 ' A' ' 347' ' ' VAL . 47.9 t -64.72 -50.36 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.803 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.456 ' O ' HG22 ' A' ' 348' ' ' ILE . 9.0 tpt180 -53.42 -56.99 12.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.987 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 6.3 m -56.77 -58.22 9.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.05 -60.75 2.09 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 1.037 HG21 HG13 ' A' ' 343' ' ' VAL . 51.7 t -51.95 -47.47 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.892 HD11 ' NE2' ' A' ' 152' ' ' GLN . 0.4 OUTLIER -69.93 -45.27 77.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.893 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -69.12 -51.8 34.77 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.692 ' HB1' ' HA ' ' A' ' 355' ' ' GLN . . . -73.12 -26.62 61.29 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -51.86 -10.56 0.12 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 1.4 m -110.47 35.26 3.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.568 0.622 . . . . 0.0 111.059 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 88.64 -4.77 85.08 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 118.713 -1.708 . . . . 0.0 114.511 176.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -87.67 34.97 0.71 Allowed 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 115.683 -2.103 . . . . 0.0 107.903 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.971 ' HG2' HG23 ' A' ' 357' ' ' VAL . 2.0 mt-30 -71.14 -175.86 1.29 Allowed 'General case' 0 CA--C 1.547 0.838 1 N-CA-C 126.255 5.65 . . . . 0.0 126.255 -157.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.7 OUTLIER 158.26 41.38 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 110.074 -3.239 . . . . 0.0 104.876 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.971 HG23 ' HG2' ' A' ' 355' ' ' GLN . 53.2 t -72.43 -54.61 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.84 -174.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 6.7 t70 -46.23 -45.66 17.19 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.702 0.763 . . . . 0.0 111.269 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -77.4 -56.14 4.8 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.71 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -54.68 -44.32 73.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.209 1.004 . . . . 0.0 112.72 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.601 ' HB3' HG12 ' A' ' 183' ' ' VAL . 32.7 mt -75.62 -33.93 60.55 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.787 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 12.1 tttt -67.81 -56.06 10.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.172 0.987 . . . . 0.0 109.903 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.22 -30.72 71.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.146 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -53.87 -53.72 48.66 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.69 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.571 ' O ' HG23 ' A' ' 369' ' ' THR . 1.0 OUTLIER -58.5 -36.43 73.79 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.893 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.43 ' N ' ' HG3' ' A' ' 365' ' ' GLN . 5.9 m -52.16 -41.24 62.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.409 0.623 . . . . 0.0 109.588 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -73.73 -42.77 60.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.938 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.893 HG22 HD11 ' A' ' 178' ' ' ILE . 21.8 mm -66.12 -34.68 71.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 365' ' ' GLN . 6.6 p -94.5 -14.19 25.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.985 179.963 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.73 0.3 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -149.09 135.23 19.13 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.14 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -108.89 67.47 0.22 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.379 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.93 156.25 44.36 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.007 HD22 HD11 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -138.55 118.59 13.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.001 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -114.45 120.79 65.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.716 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.007 HD11 HD22 ' A' ' 7' ' ' LEU . 2.7 mp -121.67 130.79 74.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.123 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.886 ' HB2' HG22 ' A' ' 60' ' ' ILE . 29.8 m95 -107.94 121.13 44.15 Favored 'General case' 0 CA--C 1.527 0.058 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.3 pt -150.96 142.3 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.707 ' HA ' HD13 ' A' ' 43' ' ' LEU . 2.8 t30 -79.8 67.51 5.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.102 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.71 66.28 2.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.525 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 4.1 m-20 -80.59 -34.55 35.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.291 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 6.7 mttp 105.99 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.34 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 297' ' ' LYS . . . -74.36 58.21 2.41 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CZ ' HG21 ' A' ' 37' ' ' VAL . 3.3 m-85 -78.24 -42.14 32.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.751 0.31 . . . . 0.0 110.277 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 4.1 m120 -58.03 -48.37 80.28 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.986 0.422 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.883 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.78 -47.86 30.92 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.357 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.908 HD11 HG21 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -60.48 -51.31 70.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.382 0.591 . . . . 0.0 110.535 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.79 81.75 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.859 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 4.0 tm-20 -65.56 -36.53 84.06 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 19' ' ' GLY . 84.3 t -66.93 -61.3 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.605 ' CA ' HG21 ' A' ' 33' ' ' ILE . . . -49.09 -33.64 14.84 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.649 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -50.03 70.14 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.1 -41.46 62.46 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 112.809 -1.996 . . . . 0.0 107.902 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.574 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.17 -35.11 79.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.72 0.772 . . . . 0.0 110.865 178.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.716 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 18.4 tt0 -72.4 -52.46 15.88 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.223 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -53.05 -25.66 13.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.614 1.196 . . . . 0.0 110.244 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.728 ' O ' HG23 ' A' ' 31' ' ' THR . 9.1 t70 -89.04 -40.43 12.98 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.296 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER 169.67 38.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 173.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 157.36 39.53 0.02 OUTLIER Glycine 0 N--CA 1.466 0.671 0 C-N-CA 114.892 -3.528 . . . . 0.0 119.796 175.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 3.1 mm -139.7 137.55 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 122.32 3.06 . . . . 0.0 118.152 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -142.55 104.33 4.37 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.651 HG11 HD22 ' A' ' 20' ' ' LEU . 6.4 t -93.4 130.53 42.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 -171.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.1 m -119.21 145.14 46.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.675 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.683 HG12 ' HB ' ' A' ' 9' ' ' ILE . 2.1 m -131.09 122.94 52.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 122.057 -0.402 . . . . 0.0 110.683 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.48 130.78 55.48 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.964 ' HA ' HD12 ' A' ' 43' ' ' LEU . 1.3 p80 -150.57 71.22 8.99 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.36 178.77 5.97 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.462 2.108 . . . . 0.0 112.219 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -66.01 -40.05 90.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.962 0.411 . . . . 0.0 110.369 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 44' ' ' GLU . 11.1 mptt -84.72 1.05 48.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.096 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 39' ' ' HIS . 7.0 tt -19.33 -46.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 1.069 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -68.48 -54.61 15.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.711 0.291 . . . . 0.0 110.857 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.505 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -70.09 -37.59 75.45 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -60.2 -56.59 19.72 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.846 0.832 . . . . 0.0 109.861 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.7 ' CZ ' HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -41.76 -60.7 1.79 Allowed Pre-proline 0 C--N 1.352 0.693 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.31 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 1.069 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 29.2 Cg_exo -63.16 -25.18 72.73 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 121.617 1.544 . . . . 0.0 113.426 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -82.17 -35.57 28.23 Favored 'General case' 0 C--O 1.255 1.37 0 CA-C-O 122.171 0.986 . . . . 0.0 111.08 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.463 HG21 ' CZ2' ' A' ' 10' ' ' TRP . 29.2 m -77.78 -39.71 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.504 0 CA-C-O 122.04 0.924 . . . . 0.0 109.089 178.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.38 -37.82 26.35 Favored 'General case' 0 C--N 1.373 1.615 0 C-N-CA 126.048 1.739 . . . . 0.0 110.85 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.95 -42.4 21.33 Favored 'General case' 0 C--N 1.371 1.512 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.967 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 55' ' ' ASP . 1.2 m -73.69 145.93 44.87 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.578 1.081 . . . . 0.0 108.893 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 64.97 -78.35 0.07 OUTLIER Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.741 ' C ' ' HB1' ' A' ' 269' ' ' ALA . 1.4 t0 85.39 56.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 117.613 0.707 . . . . 0.0 111.672 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.581 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . -156.07 47.4 0.49 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 119.967 -1.111 . . . . 0.0 114.449 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.749 ' HD2' ' HB3' ' A' ' 269' ' ' ALA . 43.1 Cg_endo -100.15 -169.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.184 2.589 . . . . 0.0 112.093 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 1.001 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 4.1 t70 -88.24 -135.52 0.09 Allowed 'General case' 0 N--CA 1.414 -2.242 0 C-N-CA 123.123 0.569 . . . . 0.0 110.543 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.514 HG13 ' HA ' ' A' ' 266' ' ' ILE . 20.8 tt -103.08 163.67 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.886 HG22 ' HB2' ' A' ' 10' ' ' TRP . 10.3 pt -130.17 128.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 4.0 m-85 -107.17 124.33 49.55 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.471 ' CZ2' ' HG2' ' A' ' 44' ' ' GLU . 8.3 t90 -167.44 161.38 13.93 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -49.09 160.8 0.18 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.137 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.645 ' CD2' HG23 ' A' ' 97' ' ' VAL . 22.1 t-80 -77.56 -28.69 51.84 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.82 -58.85 3.82 Favored 'General case' 0 C--O 1.251 1.173 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.454 ' CB ' ' CZ3' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -75.49 -30.46 59.88 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.32 0.581 . . . . 0.0 110.038 179.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.58 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 2.2 m-30 -62.52 -27.08 68.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 174.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -60.82 -66.21 2.83 Favored Glycine 0 CA--C 1.49 -1.496 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.15 -53.66 43.84 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 113.218 -1.491 . . . . 0.0 111.256 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.476 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.9 m-30 -51.4 -42.84 61.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.729 ' HB2' HG21 ' A' ' 104' ' ' ILE . . . -54.58 -39.33 67.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.74 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -78.79 -43.14 26.08 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 111.666 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -70.22 -14.86 62.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.91 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.6 29.62 8.63 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.656 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 48' ' ' PRO . 8.1 mp -106.69 39.89 1.75 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.995 0.426 . . . . 0.0 110.424 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.736 ' C ' HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.37 145.4 0.25 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.366 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.868 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -96.1 115.3 27.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.969 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -47.68 129.68 13.96 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.806 HD12 ' HA ' ' A' ' 105' ' ' ALA . 14.6 mt -95.95 110.21 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.752 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.8 p -88.82 101.41 2.85 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.964 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 83.3 Cg_endo -101.24 -170.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.61 2.873 . . . . 0.0 113.161 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.19 -169.9 2.75 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.257 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.71 -44.08 7.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.532 0.206 . . . . 0.0 111.454 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -74.83 -23.54 58.47 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.725 ' HE1' HD21 ' A' ' 285' ' ' LEU . 6.5 t80 -64.62 -59.22 4.53 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.507 ' HG3' ' CG ' ' A' ' 94' ' ' TRP . 3.0 tt0 -70.13 -29.49 66.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.808 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 84' ' ' ALA . 12.6 t70 -76.82 -12.88 60.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.9 OUTLIER -87.81 -7.66 56.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.705 HD23 ' HB1' ' A' ' 303' ' ' ALA . 3.3 mp -100.91 -101.23 0.25 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.158 0.89 . . . . 0.0 111.584 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.19 133.18 10.56 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 122.102 -0.374 . . . . 0.0 111.056 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.0 -52.97 7.61 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.66 2.24 . . . . 0.0 112.934 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.462 ' CE1' ' HA ' ' A' ' 325' ' ' GLN . 45.2 t80 -55.53 -44.53 76.79 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.704 0.288 . . . . 0.0 111.08 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 302' ' ' VAL . 29.8 m -61.27 -29.04 69.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.507 ' CG ' ' HG3' ' A' ' 86' ' ' GLN . 86.3 m95 -92.97 -24.1 18.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.508 0.67 . . . . 0.0 112.136 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -73.82 -24.09 59.74 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.759 ' HB1' HG22 ' A' ' 261' ' ' VAL . . . -65.76 -21.66 66.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.271 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.645 HG23 ' CD2' ' A' ' 64' ' ' HIS . 6.7 p -125.28 58.03 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 102' ' ' LYS . 26.6 ttt180 -124.84 100.93 6.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.433 ' HH ' ' CG ' ' A' ' 332' ' ' ASN . 4.4 m-85 -89.07 90.9 8.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.169 0.44 . . . . 0.0 110.426 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 42.72 66.35 0.78 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.709 0.29 . . . . 0.0 110.87 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.22 38.98 58.67 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.593 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 4.7 mmtt -139.84 -177.61 5.05 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 119.446 -0.312 . . . . 0.0 110.792 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 97' ' ' VAL . 0.3 OUTLIER 175.34 107.85 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.601 0.637 . . . . 0.0 109.661 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.736 HD11 ' C ' ' A' ' 76' ' ' LEU . 3.6 tt -100.96 37.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.441 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.806 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . 170.21 149.14 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.544 ' CZ ' HG21 ' A' ' 79' ' ' ILE . 12.7 m-30 -88.2 120.3 70.53 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.617 ' HB3' HG12 ' A' ' 261' ' ' VAL . 2.9 Cg_endo -78.94 155.28 26.36 Favored 'Trans proline' 0 CA--C 1.514 -0.478 0 C-N-CA 121.917 1.745 . . . . 0.0 112.847 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 262' ' ' LEU . 0.5 OUTLIER -157.11 38.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.142 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 1.015 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 170.23 134.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.937 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.031 HG22 HG21 ' A' ' 302' ' ' VAL . 17.2 m -114.8 133.74 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.936 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.6 ' HB2' ' HA3' ' A' ' 260' ' ' GLY . 0.6 OUTLIER -99.57 136.1 40.0 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 1.038 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -167.97 -173.68 2.15 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 123.411 1.577 . . . . 0.0 110.307 -167.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.73 HD13 ' CD1' ' A' ' 156' ' ' PHE . 0.1 OUTLIER -146.12 135.57 23.02 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 110.598 -3.001 . . . . 0.0 116.246 -176.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.46 ' HA ' HD12 ' A' ' 247' ' ' LEU . 0.9 OUTLIER -131.09 165.17 23.84 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.051 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.906 HD23 ' OH ' ' A' ' 117' ' ' TYR . 6.2 tp -93.21 130.79 38.78 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.848 HD13 ' N ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -115.25 136.16 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.169 -179.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.906 ' OH ' HD23 ' A' ' 115' ' ' LEU . 14.1 m-85 -121.48 140.83 51.67 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -86.1 122.0 29.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -106.2 29.06 7.1 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.956 0.407 . . . . 0.0 111.515 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -131.43 -51.05 1.0 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.23 -136.89 0.02 OUTLIER 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.249 -1.796 . . . . 0.0 107.685 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.768 HD23 ' HD2' ' A' ' 123' ' ' PRO . 2.0 mt -84.45 128.93 59.62 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.768 ' HD2' HD23 ' A' ' 122' ' ' LEU . 33.5 Cg_exo -56.28 161.78 8.68 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.374 2.716 . . . . 0.0 110.997 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 8.4 p-10 -106.36 158.21 33.15 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.631 0.253 . . . . 0.0 111.042 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 19.9 Cg_endo -60.26 164.4 12.77 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.4 2.066 . . . . 0.0 111.833 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.423 ' HB2' ' HG3' ' A' ' 127' ' ' LYS . 4.0 Cg_exo -77.39 -42.35 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.801 2.334 . . . . 0.0 112.726 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.423 ' HG3' ' HB2' ' A' ' 126' ' ' PRO . 2.8 mttp -153.49 -10.72 0.15 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -119.45 139.56 51.86 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.802 1.183 . . . . 0.0 112.961 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.707 ' CH2' HD21 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -69.25 -23.76 63.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 172.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -44.82 -23.89 0.17 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.458 ' OE2' ' HB3' ' A' ' 134' ' ' ALA . 5.3 tp10 -66.83 -26.4 66.91 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.593 HG13 ' HD2' ' A' ' 133' ' ' PRO . 0.2 OUTLIER -40.47 -53.06 5.76 Favored Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.813 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 6.6 Cg_endo -48.82 -43.83 33.59 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 120.699 0.933 . . . . 0.0 110.049 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.458 ' HB3' ' OE2' ' A' ' 131' ' ' GLU . . . -74.68 -58.6 3.19 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 139' ' ' LEU . 32.7 tp -66.32 -40.41 89.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.208 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.636 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 3.3 m-20 -70.74 -35.7 72.79 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -47.69 -50.23 25.52 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.455 176.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 4.3 mp0 -61.87 -40.48 95.52 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.337 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.835 HD22 ' O ' ' A' ' 145' ' ' SER . 0.4 OUTLIER -61.79 -48.44 80.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -48.07 -43.9 30.94 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.02 -27.8 1.02 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -58.95 1.83 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.285 0.564 . . . . 0.0 110.239 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.81 40.19 0.02 OUTLIER Glycine 0 CA--C 1.519 0.319 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.299 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.501 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -152.83 -171.81 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 119.298 1.549 . . . . 0.0 111.501 -175.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.835 ' O ' HD22 ' A' ' 139' ' ' LEU . 5.0 m -138.76 158.24 44.6 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.731 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -73.35 -33.34 65.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.1 pp -135.38 129.23 33.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.83 ' N ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -133.4 134.91 44.25 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.092 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.68 ' CE2' HD13 ' A' ' 147' ' ' LEU . 21.4 p90 -172.31 177.18 3.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.511 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -36.53 164.93 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.366 0.416 . . . . 0.0 111.485 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.743 HD11 ' HB1' ' A' ' 206' ' ' ALA . 2.8 tm? -114.03 -57.71 2.24 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.57 ' NE2' HD11 ' A' ' 348' ' ' ILE . 1.1 pt20 -104.47 34.59 3.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 116.166 -2.213 . . . . 0.0 114.693 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.792 ' O ' ' OG1' ' A' ' 157' ' ' THR . 0.0 OUTLIER -79.81 140.32 54.52 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 121.279 1.854 . . . . 0.0 113.391 -176.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.957 ' O ' ' N ' ' A' ' 156' ' ' PHE . 84.5 Cg_endo -77.88 -135.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.376 3.384 . . . . 0.0 104.322 175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 1.152 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 1.4 m-85 28.93 -59.95 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.038 1.29 . . . . 0.0 113.643 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.957 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -85.41 -61.85 1.67 Allowed 'General case' 0 C--O 1.258 1.544 0 CA-C-N 118.777 0.717 . . . . 0.0 112.534 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.792 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 8.5 p -59.2 -40.67 86.48 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.181 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.692 ' O ' HG13 ' A' ' 161' ' ' ILE . 1.1 m95 -51.24 -55.53 27.86 Favored Pre-proline 0 C--N 1.353 0.733 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 1.152 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 78.1 Cg_exo -43.38 -44.31 10.46 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.598 2.199 . . . . 0.0 113.201 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 255' ' ' SER . 7.3 mp -63.6 -56.69 13.94 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.002 0.819 . . . . 0.0 110.388 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.692 HG13 ' O ' ' A' ' 158' ' ' TRP . 2.4 pp -53.72 -19.33 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.296 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.666 ' N ' HD12 ' A' ' 161' ' ' ILE . . . -78.61 -22.03 47.63 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.254 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -41.87 -59.26 1.75 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' A' ' 190' ' ' ALA . 45.7 t0 -64.35 -14.26 55.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -175.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 134.06 20.26 0.85 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 118.73 -1.7 . . . . 0.0 116.525 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.51 160.14 41.38 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 119.064 1.432 . . . . 0.0 111.423 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -145.61 136.0 24.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.336 0.568 . . . . 0.0 110.374 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.2 -80.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.358 0.599 . . . . 0.0 111.765 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.637 ' HB2' ' CG ' ' A' ' 176' ' ' TYR . 14.5 m-85 -113.13 173.8 6.21 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.576 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 1.194 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 6.5 mmtt -100.48 103.75 15.11 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.485 ' CD2' ' CE1' ' A' ' 176' ' ' TYR . 0.4 OUTLIER -85.04 115.25 22.75 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.586 176.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.886 ' O ' ' N ' ' A' ' 174' ' ' GLY . 1.1 tp10 -137.28 101.67 4.59 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.056 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.0 m120 44.42 -66.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 O-C-N 123.619 0.575 . . . . 0.0 110.656 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.886 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -70.66 -73.35 0.79 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 115.664 -0.698 . . . . 0.0 114.346 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -174.66 158.04 2.64 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 117.994 0.897 . . . . 0.0 110.677 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 1.194 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -56.29 -33.66 65.73 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.33 1.062 . . . . 0.0 108.256 177.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 1.0 OUTLIER 67.94 -85.71 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.862 179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 6.7 tp 175.02 -41.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.0 OUTLIER -66.38 -10.55 44.6 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.441 ' CB ' ' HB2' ' A' ' 170' ' ' LYS . 2.1 m-20 -124.56 93.75 3.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.58 121.54 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -123.23 39.72 2.16 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.698 -1.239 . . . . 0.0 113.959 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 184' ' ' ASP . 12.8 p -80.2 -44.14 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.028 0.442 . . . . 0.0 109.982 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.923 ' HB2' HD23 ' A' ' 361' ' ' LEU . 9.4 t70 -81.27 59.08 3.8 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.758 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -104.76 173.2 6.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.464 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.19 -28.11 62.54 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.352 0.596 . . . . 0.0 111.571 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -71.31 -45.97 44.79 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.09 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -60.41 -44.79 95.37 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HG3' HG21 ' A' ' 357' ' ' VAL . 5.5 tttp -57.8 -60.01 4.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.325 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.37 -40.94 50.88 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.088 0.947 . . . . 0.0 112.017 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -62.88 -60.65 7.39 Favored Glycine 0 C--O 1.24 0.485 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.086 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 196' ' ' VAL . 5.6 tp -59.49 -25.05 64.12 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 99.0 m -60.74 -50.2 74.42 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.499 ' CZ ' ' CE1' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -59.85 -37.26 78.76 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 tp -63.28 -47.58 81.75 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.631 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 192' ' ' LEU . 44.6 t -57.68 -28.76 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.508 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.11 -45.62 80.49 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.855 0.836 . . . . 0.0 111.039 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.458 ' HG ' HD13 ' A' ' 132' ' ' ILE . 4.3 tt -59.46 -51.95 67.67 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.851 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 204' ' ' MET . 6.6 mt -66.62 -40.25 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.96 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 4.9 tppt? -52.68 -36.91 57.94 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.626 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -113.18 -34.57 5.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 121.157 3.762 . . . . 0.0 121.157 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -63.73 -80.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.967 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.08 -9.67 27.58 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.563 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 4.8 ptt? 42.15 36.24 0.68 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.611 ' O ' ' HB3' ' A' ' 206' ' ' ALA . 0.7 OUTLIER -145.16 -73.34 0.25 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.743 ' HB1' HD11 ' A' ' 151' ' ' LEU . . . 84.41 37.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -97.74 -3.08 39.79 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 34.8 p -55.08 117.19 3.25 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.97 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.91 -173.64 4.17 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.3 p90 -70.63 -45.28 65.49 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 1.7 t -73.72 -32.73 64.03 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.711 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.75 -48.66 23.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.74 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.01 -32.19 70.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.06 -45.36 92.57 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 218' ' ' ASN . . . -58.75 -40.73 84.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.959 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.21 -57.09 10.72 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.09 -29.52 69.87 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.419 ' HB2' ' HA ' ' A' ' 215' ' ' ALA . 0.7 OUTLIER -52.69 -37.45 58.93 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.443 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -74.24 -23.89 59.22 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.04 53.63 5.65 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 114.7 0.64 . . . . 0.0 114.7 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -124.5 37.64 4.36 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.35 1.075 . . . . 0.0 111.609 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.83 HG21 ' N ' ' A' ' 148' ' ' MET . 2.2 m -142.22 140.9 32.45 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.731 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -113.13 38.79 2.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.618 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.658 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER 178.85 126.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 177.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.746 HG23 ' CG2' ' A' ' 116' ' ' ILE . 1.8 t -147.16 165.99 28.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.433 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.533 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 0.1 OUTLIER -100.49 146.02 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 172.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 114' ' ' SER . 2.3 t-20 -146.4 166.33 26.68 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.182 1.355 . . . . 0.0 109.953 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 112' ' ' ALA . . . -176.11 130.41 1.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.294 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.67 -29.66 3.59 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.846 2.364 . . . . 0.0 113.219 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.421 ' HA ' ' CG ' ' A' ' 111' ' ' GLU . 29.7 t-105 -33.66 -72.87 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.94 -41.9 8.18 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.24 166.53 18.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.907 0.384 . . . . 0.0 111.714 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 t -124.49 -62.07 1.28 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.52 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -99.32 139.69 34.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.691 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.8 HD11 ' CE1' ' A' ' 242' ' ' TYR . 25.4 pt -84.07 173.7 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.283 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.17 176.15 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.722 0.296 . . . . 0.0 110.995 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.05 83.43 0.33 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.965 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . 0.405 ' O ' ' CE1' ' A' ' 242' ' ' TYR . 41.2 t -129.77 70.51 1.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.786 0.327 . . . . 0.0 110.682 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.429 ' O ' ' CZ ' ' A' ' 242' ' ' TYR . 0.0 OUTLIER 65.83 109.72 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.607 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.43 ' O ' ' CD2' ' A' ' 242' ' ' TYR . 58.4 t -45.29 -34.66 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.854 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -79.76 107.23 12.37 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.69 0.281 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.8 ' CE1' HD11 ' A' ' 235' ' ' ILE . 48.0 m-85 -118.46 134.04 55.39 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.245 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.96 105.25 2.3 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.202 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.0 t -90.96 111.59 23.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.78 167.41 18.12 Favored 'General case' 0 CA--C 1.527 0.067 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.1 m -73.36 153.66 7.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.522 HD23 ' OG ' ' A' ' 255' ' ' SER . 0.3 OUTLIER -59.26 159.04 16.74 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 119.784 1.175 . . . . 0.0 111.414 -178.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.706 ' HD3' HD13 ' A' ' 115' ' ' LEU . 90.4 Cg_endo -79.51 -165.08 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.035 2.49 . . . . 0.0 112.496 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -119.27 175.58 5.73 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.929 0.395 . . . . 0.0 111.763 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.499 ' CE1' ' CZ ' ' A' ' 194' ' ' PHE . 98.0 m-85 -166.13 111.05 0.82 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.957 0.884 . . . . 0.0 108.811 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 7.8 mttp 62.43 31.09 17.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.809 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.0 31.14 40.12 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.302 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.405 ' N ' HG22 ' A' ' 249' ' ' THR . 1.1 mm-40 -156.59 153.03 23.84 Favored Pre-proline 0 N--CA 1.463 0.179 0 CA-C-N 117.381 0.59 . . . . 0.0 112.251 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -87.88 170.36 6.25 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.209 2.606 . . . . 0.0 112.189 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.522 ' OG ' HD23 ' A' ' 247' ' ' LEU . 0.0 OUTLIER -91.03 144.34 25.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.803 0.335 . . . . 0.0 111.411 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 2.2 mttt -86.58 108.3 17.42 Favored Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.066 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.642 ' CB ' HD21 ' A' ' 113' ' ' LEU . 88.2 Cg_endo -79.55 153.35 23.5 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.273 1.982 . . . . 0.0 112.717 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 2.5 t80 -79.19 164.39 24.24 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.767 ' CB ' HG22 ' A' ' 329' ' ' ILE . 15.5 t -121.8 127.56 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.6 ' HA3' ' HB2' ' A' ' 111' ' ' GLU . . . -123.69 117.79 3.28 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 119.257 -1.449 . . . . 0.0 115.871 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.759 HG22 ' HB1' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -103.87 115.31 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.527 179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 1.015 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.5 mm? -94.22 93.63 7.87 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -111.28 -177.71 3.27 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -172.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.631 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -108.67 128.31 54.74 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 60' ' ' ILE . . . -122.87 127.8 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.82 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.639 HD12 HG12 ' A' ' 79' ' ' ILE . 24.7 mt -87.84 121.48 38.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.65 142.9 56.88 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.868 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -57.35 -26.46 61.02 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.149 -0.345 . . . . 0.0 110.78 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.749 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . . . -50.82 -59.89 3.64 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.921 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 271' ' ' PRO . 19.2 p -135.64 154.11 77.95 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.728 0.299 . . . . 0.0 111.413 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 270' ' ' SER . 15.3 Cg_endo -88.58 -66.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.054 2.503 . . . . 0.0 112.735 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 55.4 45.77 24.67 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 110.125 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 2.0 ttpt -60.32 -54.19 48.7 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.782 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 24.6 tp10 -50.2 -57.6 7.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.902 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.667 HD21 HD11 ' A' ' 33' ' ' ILE . 10.0 tp -64.93 -58.09 7.06 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.98 -56.69 5.65 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.2 OUTLIER -54.22 -38.55 65.83 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 1.9 tp10 -76.34 -53.14 8.6 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -56.17 -56.36 21.91 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.611 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.733 HD21 HD22 ' A' ' 284' ' ' LEU . 7.2 tt -52.32 -43.91 64.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.675 0.75 . . . . 0.0 111.67 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.698 ' O ' HD23 ' A' ' 285' ' ' LEU . 31.0 tt0 -73.2 -34.27 65.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.651 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -91.57 -14.71 29.82 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.874 ' O ' HG22 ' A' ' 286' ' ' THR . 0.2 OUTLIER -102.45 -65.49 0.99 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.733 HD22 HD21 ' A' ' 280' ' ' LEU . 6.3 tp -43.2 -22.7 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.601 -0.44 . . . . 0.0 112.097 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 1.067 HD13 HD11 ' A' ' 304' ' ' LEU . 3.8 mm? -101.37 37.38 1.8 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.002 -0.436 . . . . 0.0 110.721 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.874 HG22 ' O ' ' A' ' 283' ' ' TYR . 11.3 t -145.01 158.72 43.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 4.4 p30 -65.97 -11.66 49.3 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.603 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 5.5 tp10 -77.89 -47.12 19.47 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 109.993 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.607 ' O ' ' HB ' ' A' ' 293' ' ' VAL . . . -82.64 -49.49 5.11 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 1.027 HD11 HD13 ' A' ' 304' ' ' LEU . 8.4 mt -61.75 -51.24 69.17 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.631 0.254 . . . . 0.0 111.383 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.509 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 2.9 tp10 -76.08 -27.9 57.37 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.059 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.603 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -71.57 -27.73 63.35 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.957 HG13 ' HG3' ' A' ' 298' ' ' PRO . 1.1 t -65.72 -61.0 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.798 175.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.571 ' N ' HG12 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -35.02 -50.31 0.49 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.313 1.445 . . . . 0.0 112.323 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 296' ' ' ASP . 20.2 ttpt -48.79 -43.9 38.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.254 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 295' ' ' LYS . 2.6 m-20 154.41 68.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.721 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.841 ' H ' ' HD2' ' A' ' 298' ' ' PRO . 0.5 OUTLIER -120.75 -37.95 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.023 171.293 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.957 ' HG3' HG13 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -91.61 -120.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 124.761 3.641 . . . . 0.0 113.283 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.847 HD13 ' CD1' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -160.78 -41.38 0.05 OUTLIER 'General case' 0 C--N 1.356 0.883 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -129.08 -155.59 8.6 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.56 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.898 ' HB3' ' CG1' ' A' ' 317' ' ' ILE . . . -133.25 48.15 2.42 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.115 0.958 . . . . 0.0 112.46 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 1.031 HG21 HG22 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -140.78 92.26 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.686 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.801 ' O ' HD12 ' A' ' 304' ' ' LEU . . . 177.69 48.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 1.067 HD11 HD13 ' A' ' 285' ' ' LEU . 0.0 OUTLIER 158.48 99.11 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.314 0.246 . . . . 0.0 111.42 178.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -38.37 -32.64 0.08 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 20.0 m -78.66 -44.22 24.25 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.473 1.13 . . . . 0.0 109.572 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.908 ' CD2' HD22 ' A' ' 290' ' ' LEU . 19.6 t80 -70.57 -20.03 62.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 112.87 -1.968 . . . . 0.0 110.249 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.777 ' OE2' HG21 ' A' ' 317' ' ' ILE . 7.9 tp10 -76.28 -43.14 43.02 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.0 -58.6 5.67 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.724 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -54.09 -52.9 59.49 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.246 0.546 . . . . 0.0 110.5 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 311' ' ' LEU . 2.3 tt -70.91 -28.04 64.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.932 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -45.92 -20.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -34.19 -42.67 0.13 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.543 0.61 . . . . 0.0 109.704 178.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -88.76 121.7 69.7 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.58 9.51 1.87 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.591 2.194 . . . . 0.0 115.467 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.404 ' O ' ' OG1' ' A' ' 320' ' ' THR . 5.6 mtm-85 -60.23 -59.82 4.81 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.706 0.684 . . . . 0.0 111.256 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.898 ' CG1' ' HB3' ' A' ' 301' ' ' ALA . 5.2 mm -49.76 -55.35 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.68 -52.05 11.43 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.38 0.536 . . . . 0.0 111.757 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -71.66 -33.42 68.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.543 0.687 . . . . 0.0 109.351 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 1.038 HG23 ' HB3' ' A' ' 112' ' ' ALA . 94.6 m -62.02 -37.06 83.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.387 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.451 ' HG2' ' CD2' ' A' ' 92' ' ' PHE . 5.6 ttm -79.03 -44.93 21.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.693 0.282 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -54.0 -45.91 71.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.221 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.512 ' ND2' HD13 ' A' ' 247' ' ' LEU . 2.8 t-20 -78.3 -51.95 9.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.226 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . . . -48.64 -33.82 10.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.694 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . 0.462 ' HA ' ' CE1' ' A' ' 92' ' ' PHE . 0.2 OUTLIER -63.33 -39.94 95.94 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.51 0.195 . . . . 0.0 110.998 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -104.74 60.67 0.7 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.595 0.236 . . . . 0.0 111.08 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 257' ' ' PRO . . . -140.71 -147.18 4.91 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.12 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -127.32 111.77 14.29 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.767 HG22 ' CB ' ' A' ' 259' ' ' VAL . 1.8 pp -87.15 134.11 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.455 ' HG2' ' CE2' ' A' ' 258' ' ' PHE . 0.0 OUTLIER -41.03 105.33 0.38 Allowed Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.428 ' HD2' ' CE ' ' A' ' 330' ' ' MET . 96.2 Cg_exo -43.9 -34.89 6.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.676 2.251 . . . . 0.0 112.603 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.433 ' CG ' ' HH ' ' A' ' 99' ' ' TYR . 9.5 m120 79.06 51.3 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.478 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 335' ' ' GLN . 4.0 pt -133.82 156.65 79.19 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.804 0.335 . . . . 0.0 111.143 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.71 -31.51 39.8 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.636 2.224 . . . . 0.0 112.76 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.732 ' HB2' HD12 ' A' ' 333' ' ' ILE . 8.9 mm100 -59.85 -21.83 61.48 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.421 ' HG2' ' HE3' ' A' ' 330' ' ' MET . 12.0 tpp -45.56 -36.7 4.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.589 0.233 . . . . 0.0 111.372 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 2.1 p -58.1 -38.88 77.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.698 0.285 . . . . 0.0 110.348 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.948 ' HB1' ' CD1' ' A' ' 368' ' ' ILE . . . -55.6 -33.37 63.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.962 0.411 . . . . 0.0 111.307 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 343' ' ' VAL . 0.2 OUTLIER -78.51 -55.83 4.91 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.499 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.412 ' CE3' ' HA ' ' A' ' 340' ' ' TRP . 0.1 OUTLIER -44.33 -43.0 7.18 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.795 0.331 . . . . 0.0 111.025 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.99 -42.77 56.89 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.692 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.27 -45.84 72.03 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.706 ' CG2' HG21 ' A' ' 347' ' ' VAL . 9.9 p -69.62 -42.06 80.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.439 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -58.55 -59.29 5.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.698 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 9.8 m -56.39 -56.7 17.84 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.83 -60.83 2.06 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.706 HG21 ' CG2' ' A' ' 343' ' ' VAL . 48.5 t -54.56 -53.45 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.57 HD11 ' NE2' ' A' ' 152' ' ' GLN . 1.9 tt -62.31 -46.68 95.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.031 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.419 ' N ' ' CG2' ' A' ' 348' ' ' ILE . 64.8 t-20 -64.64 -47.7 77.56 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' A' ' 355' ' ' GLN . . . -73.37 -26.65 61.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -53.22 -11.26 0.26 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.3 p -110.46 36.77 2.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.585 0.63 . . . . 0.0 110.088 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.53 -3.42 87.06 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 118.711 -1.709 . . . . 0.0 113.691 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -87.3 34.92 0.69 Allowed 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 115.65 -2.119 . . . . 0.0 107.886 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.685 ' HA ' ' HB1' ' A' ' 350' ' ' ALA . 2.9 pp0? -71.17 -173.71 0.89 Allowed 'General case' 0 C--N 1.348 0.543 1 N-CA-C 123.34 4.57 . . . . 0.0 123.34 -159.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.504 ' HB ' ' CB ' ' A' ' 359' ' ' GLU . 0.0 OUTLIER -179.62 46.8 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.54 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.557 HG23 ' OE1' ' A' ' 355' ' ' GLN . 84.3 t -42.27 -49.85 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.863 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -61.33 -35.04 76.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 119.948 1.249 . . . . 0.0 109.611 178.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.504 ' CB ' ' HB ' ' A' ' 356' ' ' THR . 1.5 mm-40 -79.18 -26.97 42.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.441 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 356' ' ' THR . . . -66.8 -53.26 34.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 122.085 0.945 . . . . 0.0 111.824 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.923 HD23 ' HB2' ' A' ' 184' ' ' ASP . 0.2 OUTLIER -82.24 -50.48 8.94 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.787 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.654 ' O ' HG23 ' A' ' 366' ' ' THR . 2.3 mmpt? -45.18 -53.04 8.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -65.13 -41.42 94.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.402 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.525 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -66.52 -58.19 5.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.611 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.525 ' HB2' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -62.16 -44.32 96.87 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.984 -0.447 . . . . 0.0 111.969 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 362' ' ' LYS . 52.7 p -56.24 -59.79 4.43 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -51.57 25.65 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.511 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.948 ' CD1' ' HB1' ' A' ' 338' ' ' ALA . 32.8 mm -60.47 -42.84 92.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.421 HG22 ' CD1' ' A' ' 178' ' ' ILE . 1.3 p -114.15 55.63 0.73 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.917 0.389 . . . . 0.0 111.103 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.828 179.759 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.67 0.271 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -145.01 173.91 11.48 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.91 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -111.31 68.3 0.22 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.493 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.0 159.04 44.58 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -156.12 118.37 4.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 58' ' ' ASP . 15.3 t -108.72 140.47 27.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 118.771 -1.172 . . . . 0.0 110.003 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.804 HD12 HD11 ' A' ' 59' ' ' ILE . 10.3 tt -136.51 124.74 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.402 0.62 . . . . 0.0 111.122 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 1.002 ' CH2' HD22 ' A' ' 43' ' ' LEU . 30.7 t90 -101.46 133.32 46.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.226 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.686 HD11 HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -149.18 165.09 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.488 ' HA ' ' CG ' ' A' ' 40' ' ' PRO . 9.4 p30 -91.85 61.64 4.17 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.543 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.75 41.47 57.84 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.059 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 58.4 t0 -50.35 -31.66 15.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 111.438 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 105.15 -18.06 0.02 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.246 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.444 ' HA2' ' CG ' ' A' ' 296' ' ' ASP . . . -75.48 56.42 2.9 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 115.921 1.129 . . . . 0.0 115.921 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -75.96 -31.8 59.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.495 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 1.4 t30 -67.98 -47.14 69.37 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.152 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.569 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -72.14 -49.16 22.5 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.739 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.7 mt -60.02 -51.03 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.394 0.597 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.37 -37.08 84.48 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.591 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 9.6 tt0 -67.02 -37.44 84.14 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.449 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 19' ' ' GLY . 2.7 p -68.0 -61.03 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.14 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' H ' HG13 ' A' ' 23' ' ' VAL . . . -49.12 -33.03 13.59 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.803 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -50.5 72.68 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 122.481 1.134 . . . . 0.0 108.418 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 21.8 mttt -51.81 -41.2 61.56 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 112.865 -1.971 . . . . 0.0 108.202 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.732 ' HB3' ' CB ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.84 -35.9 81.97 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.915 0.864 . . . . 0.0 111.052 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.784 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 5.1 tt0 -69.78 -50.63 41.31 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.331 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -51.23 -30.27 16.93 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 124.909 1.381 . . . . 0.0 111.25 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.84 ' O ' HG23 ' A' ' 31' ' ' THR . 1.5 t70 -82.72 -39.15 22.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 116.921 -1.514 . . . . 0.0 108.872 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.84 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 162.29 37.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 116.616 -2.033 . . . . 0.0 116.35 170.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.694 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 155.5 38.58 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 115.428 -3.273 . . . . 0.0 117.354 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.784 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 4.1 mp -139.31 100.94 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 121.09 2.445 . . . . 0.0 114.86 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -107.21 105.24 15.12 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 7.8 m -97.14 132.75 40.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.05 146.67 45.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.315 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.794 HG12 ' CG2' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -133.22 122.74 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 122.199 -0.313 . . . . 0.0 110.687 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -107.19 137.24 45.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.945 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.488 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -71.56 -177.9 0.54 Allowed Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.392 0.677 . . . . 0.0 111.912 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 30.7 Cg_endo -91.96 -172.67 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.302 2.668 . . . . 0.0 113.757 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 40' ' ' PRO . 9.8 t70 144.81 -72.29 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.862 0.865 . . . . 0.0 109.39 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -108.4 1.05 21.46 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.716 178.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.002 HD22 ' CH2' ' A' ' 10' ' ' TRP . 2.2 tp -19.37 -56.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.996 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 2.1 tm-20 -60.42 -55.11 37.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -75.53 -55.46 5.65 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.581 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -55.49 -57.96 9.74 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.923 -178.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -49.62 -57.72 11.28 Favored Pre-proline 0 C--N 1.353 0.76 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.25 -177.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 1.097 ' HA ' HD13 ' A' ' 75' ' ' LEU . 24.6 Cg_exo -62.76 -21.2 72.81 Favored 'Trans proline' 0 C--O 1.252 1.2 0 CA-C-N 121.6 1.607 . . . . 0.0 112.325 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.68 ' O ' HG23 ' A' ' 53' ' ' THR . 61.1 tt0 -81.97 -39.72 23.25 Favored 'General case' 0 C--O 1.258 1.529 0 CA-C-O 122.561 1.172 . . . . 0.0 111.711 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 47' ' ' PHE . 17.1 m -77.93 -40.71 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.552 0 CA-C-O 122.247 1.023 . . . . 0.0 110.536 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.678 ' CB ' ' HB2' ' A' ' 269' ' ' ALA . . . -49.68 -37.88 30.56 Favored 'General case' 0 C--N 1.378 1.831 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.438 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.18 -33.57 32.92 Favored 'General case' 0 C--N 1.368 1.403 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.437 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 49' ' ' GLN . 19.0 p -65.62 -41.06 93.15 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.186 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 55' ' ' ASP . . . -114.69 -70.73 0.51 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.458 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 5.8 m-20 89.02 47.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.851 0.826 . . . . 0.0 109.888 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.11 175.94 21.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 120.531 -0.842 . . . . 0.0 114.642 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 58' ' ' ASP . 82.4 Cg_exo -43.86 131.98 8.05 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.567 2.845 . . . . 0.0 111.909 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.569 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 2.0 p30 158.2 125.96 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.804 HD11 HD12 ' A' ' 9' ' ' ILE . 1.8 pt -117.15 178.38 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 76' ' ' LEU . 2.7 pt -149.29 136.7 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.505 ' CZ ' HD11 ' A' ' 108' ' ' ILE . 4.7 t80 -109.99 122.76 48.31 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 23.2 t-105 -166.75 166.37 15.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -45.35 158.73 0.07 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.63 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.595 ' CG ' ' CG1' ' A' ' 97' ' ' VAL . 4.5 t-80 -77.27 -27.09 53.02 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 331' ' ' PRO . 9.9 p30 -53.34 -52.99 57.43 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-O 121.808 0.813 . . . . 0.0 111.893 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 18.9 mmm180 -73.4 -31.77 64.07 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.446 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.671 ' HA ' HD22 ' A' ' 76' ' ' LEU . 6.2 m-30 -60.26 -32.72 71.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 174.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -54.69 -66.87 2.5 Favored Glycine 0 C--O 1.25 1.152 0 CA-C-O 123.038 1.355 . . . . 0.0 111.616 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 70' ' ' TYR . . . -78.54 -55.67 3.86 Favored Glycine 0 C--N 1.357 1.73 0 CA-C-N 113.095 -1.553 . . . . 0.0 112.734 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.999 ' O ' ' N ' ' A' ' 75' ' ' LEU . 6.9 m-30 -42.01 -37.37 1.34 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.992 ' CB ' HG21 ' A' ' 104' ' ' ILE . . . -73.37 -58.76 3.09 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 117.852 -1.539 . . . . 0.0 112.432 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -46.96 68.35 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.434 1.016 . . . . 0.0 112.72 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 p -114.58 25.72 10.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.2 -87.48 0.06 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 118.539 -1.791 . . . . 0.0 114.909 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.097 HD13 ' HA ' ' A' ' 48' ' ' PRO . 1.2 tp -155.32 97.22 1.88 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.79 HD12 ' HA ' ' A' ' 267' ' ' ASN . 1.2 tp 179.33 144.36 0.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.068 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 1.02 ' O ' HD11 ' A' ' 266' ' ' ILE . . . -95.68 109.42 21.7 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.504 ' HA ' HG12 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -49.07 103.27 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.963 HG23 HD13 ' A' ' 266' ' ' ILE . 0.0 OUTLIER -61.91 173.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.128 0.489 . . . . 0.0 111.193 -179.047 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.487 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -88.06 175.38 4.22 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.086 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 80' ' ' THR . 79.1 Cg_endo -79.55 133.18 10.38 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.336 2.024 . . . . 0.0 113.629 -178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -152.87 68.06 0.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.323 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -47.36 -32.27 4.71 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -47.71 -29.03 2.75 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.489 ' CE1' HD21 ' A' ' 285' ' ' LEU . 1.3 m-85 -74.71 -59.32 2.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.805 0.335 . . . . 0.0 111.19 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.486 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 8.2 tm0? -70.36 -24.48 62.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -76.04 -43.89 41.76 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -11.07 59.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.88 ' CD2' ' HB1' ' A' ' 303' ' ' ALA . 0.3 OUTLIER -105.57 -170.61 1.77 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.976 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -78.19 145.96 69.99 Favored Pre-proline 0 C--O 1.232 0.154 0 CA-C-O 120.649 0.261 . . . . 0.0 110.543 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 95' ' ' ASP . 53.1 Cg_endo -69.75 -39.74 6.17 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.479 2.119 . . . . 0.0 112.596 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 325' ' ' GLN . 1.9 m-85 -59.74 -57.34 13.35 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -28.06 68.81 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.799 ' CZ3' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -93.68 -22.86 18.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.735 ' O ' HD11 ' A' ' 329' ' ' ILE . 15.8 t0 -71.64 -24.69 61.91 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.949 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 329' ' ' ILE . . . -69.0 -23.38 64.09 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.882 HG13 HG11 ' A' ' 261' ' ' VAL . 22.9 m -122.37 48.76 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.159 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' ' CD1' ' A' ' 103' ' ' LEU . 6.8 tmm_? -125.51 100.41 6.46 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 101' ' ' GLY . 3.6 m-85 -87.43 90.97 8.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.288 0.494 . . . . 0.0 110.197 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 48.14 -86.88 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.882 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . -132.67 42.15 1.41 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -145.48 -177.58 5.64 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 119.519 -0.277 . . . . 0.0 111.193 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.58 HD21 ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER 167.82 112.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.624 0.647 . . . . 0.0 110.617 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.992 HG21 ' CB ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -98.67 38.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.479 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.755 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . 166.01 174.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.582 ' OH ' HD13 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -129.64 129.47 23.14 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.071 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.675 ' HG3' HG21 ' A' ' 97' ' ' VAL . 3.6 Cg_exo -79.72 162.26 24.31 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.866 2.377 . . . . 0.0 112.416 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 262' ' ' LEU . 1.1 pt -156.15 38.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.092 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.774 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 1.066 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -176.21 145.38 0.61 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.724 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 110' ' ' VAL . 14.0 p -128.73 114.03 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 324' ' ' ALA . 17.4 mm-40 -102.99 161.79 13.46 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.279 0.561 . . . . 0.0 109.749 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -165.25 147.24 7.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.758 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 HD11 ' A' ' 247' ' ' LEU . 3.0 tt -79.06 129.3 34.3 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.4 OUTLIER -135.12 159.65 40.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.511 HD11 ' HE1' ' A' ' 224' ' ' MET . 7.2 tt -92.61 131.18 37.94 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.749 HD12 HG22 ' A' ' 244' ' ' VAL . 0.9 OUTLIER -114.82 137.6 47.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.412 ' CE2' ' CD2' ' A' ' 115' ' ' LEU . 13.5 m-85 -106.07 133.38 50.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.916 ' HB3' HD23 ' A' ' 122' ' ' LEU . 14.8 m120 -88.58 125.9 35.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.559 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.33 -59.25 2.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.43 0.559 . . . . 0.0 112.209 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.5 ' OD2' HG13 ' A' ' 240' ' ' VAL . 0.4 OUTLIER -38.31 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 122.426 1.108 . . . . 0.0 111.203 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.84 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -102.82 42.42 1.15 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 112.739 -2.028 . . . . 0.0 112.442 -175.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.093 HD12 ' HB2' ' A' ' 223' ' ' ALA . 1.7 mm? -147.5 140.25 14.64 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 118.847 -1.141 . . . . 0.0 113.068 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 223' ' ' ALA . 50.9 Cg_endo -90.97 163.51 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.789 1 C-N-CA 125.492 4.128 . . . . 0.0 113.493 -179.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -61.42 106.07 0.73 Allowed Pre-proline 0 N--CA 1.465 0.296 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.773 -174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 95.3 Cg_endo -99.0 168.27 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 124.882 3.721 . . . . 0.0 114.808 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.794 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 35.8 Cg_exo -27.5 153.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 125.276 3.984 . . . . 0.0 116.19 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -135.81 -21.33 1.48 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.895 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.52 154.47 51.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -59.9 -53.93 52.13 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.137 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 133' ' ' PRO . 13.5 tt0 -45.45 -24.22 0.29 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.479 ' HG2' HD12 ' A' ' 135' ' ' LEU . 2.7 tt0 -73.61 -28.2 61.69 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.802 HG21 HD21 ' A' ' 198' ' ' LEU . 47.5 mt -42.11 -56.02 5.74 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 121.374 0.607 . . . . 0.0 112.215 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.582 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 2.7 Cg_endo -46.48 -38.61 21.47 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 120.565 0.843 . . . . 0.0 109.95 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.84 -59.99 2.51 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.785 HD13 ' CD ' ' A' ' 126' ' ' PRO . 1.4 mt -69.17 -33.12 72.9 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.212 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 1.075 ' HA ' ' CD1' ' A' ' 139' ' ' LEU . 10.0 t70 -68.32 -43.89 76.58 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -46.18 -49.2 17.24 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 118.208 -1.397 . . . . 0.0 110.079 177.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.677 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 3.1 tm-20 -63.73 -43.28 96.98 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.784 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 1.075 ' CD1' ' HA ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -52.94 -56.13 18.27 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -49.52 -44.01 46.04 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.704 0.764 . . . . 0.0 108.962 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -45.86 -26.0 0.61 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.29 -1.323 . . . . 0.0 114.343 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.21 -62.38 1.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.526 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.41 53.76 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -172.44 -174.23 1.17 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.885 1.343 . . . . 0.0 109.769 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.8 ' HA ' ' HB3' ' A' ' 139' ' ' LEU . 8.6 t -144.81 150.27 36.88 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.786 0.435 . . . . 0.0 110.42 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.794 ' HB1' ' HD2' ' A' ' 126' ' ' PRO . . . -68.93 -22.99 64.12 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.509 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 224' ' ' MET . 0.7 OUTLIER -142.92 129.4 20.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -176.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.755 ' HB2' HG21 ' A' ' 222' ' ' THR . 0.3 OUTLIER -132.53 139.93 48.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.521 -0.871 . . . . 0.0 111.726 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 227' ' ' ASN . 3.7 t80 -172.48 175.57 3.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.698 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 149' ' ' PHE . 2.6 m-80 -38.76 161.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.931 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.862 HD13 ' CB ' ' A' ' 206' ' ' ALA . 3.2 mt -115.06 -50.35 2.76 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.19 34.48 3.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 116.04 -2.264 . . . . 0.0 113.897 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.777 ' O ' ' HB ' ' A' ' 157' ' ' THR . 17.9 mm-40 -79.49 145.75 64.2 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 121.6 2.0 . . . . 0.0 114.488 -175.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.993 ' O ' ' N ' ' A' ' 156' ' ' PHE . 5.8 Cg_exo -78.05 -135.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 1 C-N-CA 125.55 4.167 . . . . 0.0 106.242 176.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 1.117 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 36.0 m-85 16.15 -49.75 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.993 ' N ' ' O ' ' A' ' 154' ' ' PRO . 10.4 t80 -84.44 -60.03 2.2 Favored 'General case' 0 C--O 1.258 1.511 0 CA-C-N 119.406 1.003 . . . . 0.0 111.903 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.777 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -56.83 -42.61 79.94 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.469 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 2.3 m95 -51.61 -55.81 26.42 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 1.117 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 79.3 Cg_exo -43.19 -47.87 8.4 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.892 2.395 . . . . 0.0 113.065 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 250' ' ' PHE . 49.9 mt -62.48 -56.81 14.59 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.072 0.851 . . . . 0.0 109.968 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.722 HG21 HD12 ' A' ' 192' ' ' LEU . 20.6 pt -53.91 -18.01 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.904 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -78.06 -24.7 47.63 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.598 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -41.85 -56.71 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.57 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 1.8 m-20 -64.1 -39.34 93.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 119.211 0.914 . . . . 0.0 112.896 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 156.92 24.23 0.03 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 117.872 -2.109 . . . . 0.0 117.632 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.05 89.64 0.72 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-N 119.375 1.587 . . . . 0.0 112.633 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -73.68 158.58 34.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.29 0.545 . . . . 0.0 110.898 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.829 ' HA ' HG12 ' A' ' 183' ' ' VAL . . . -61.28 -80.59 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.956 0.884 . . . . 0.0 111.604 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.796 ' HB2' ' CG ' ' A' ' 176' ' ' TYR . 58.5 m-85 -113.86 173.66 6.32 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.792 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 1.209 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -106.49 116.28 31.66 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.974 1.261 . . . . 0.0 107.729 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.463 ' CE1' ' HA ' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -78.75 113.22 16.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.456 176.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 1.4 tt0 -137.29 113.61 10.05 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.778 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 1.9 t-20 82.48 -32.33 0.09 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.848 0.356 . . . . 0.0 111.112 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 157.81 15.48 0.04 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.648 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.463 ' HA ' ' CE1' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -173.29 142.02 0.97 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.863 1.332 . . . . 0.0 110.391 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 1.209 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.6 m-85 -66.84 -25.11 66.27 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.506 1.146 . . . . 0.0 109.961 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.757 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.6 t70 62.09 -85.7 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 112.793 -2.003 . . . . 0.0 111.51 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER 179.18 -54.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HA ' ' CG2' ' A' ' 369' ' ' THR . 0.0 OUTLIER -51.17 -17.37 0.65 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 5.5 m-20 -117.27 94.99 4.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 119.68 1.127 . . . . 0.0 109.332 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.426 ' CG2' ' CG ' ' A' ' 365' ' ' GLN . 3.3 m -116.73 112.45 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -117.74 39.96 2.47 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.586 -1.292 . . . . 0.0 113.806 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.829 HG12 ' HA ' ' A' ' 168' ' ' ALA . 1.8 m -79.09 -46.06 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.452 ' N ' ' CG2' ' A' ' 183' ' ' VAL . 18.5 t0 -81.49 57.25 3.22 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.08 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -102.77 177.93 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.345 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.48 -31.56 35.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.462 0.648 . . . . 0.0 111.429 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.57 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -74.91 -40.2 36.57 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.523 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -61.38 -46.09 91.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 174.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.61 -60.62 3.52 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.08 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.23 -41.62 50.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.09 0.948 . . . . 0.0 111.768 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -65.9 -60.6 6.32 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.535 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.722 HD12 HG21 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -58.91 -24.28 62.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.086 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.876 ' O ' HG12 ' A' ' 196' ' ' VAL . 23.5 m -63.99 -48.33 76.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 3.0 p90 -60.6 -35.22 75.58 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' A' ' 194' ' ' PHE . 4.5 mt -64.66 -47.64 77.73 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.876 HG12 ' O ' ' A' ' 193' ' ' THR . 0.5 OUTLIER -58.53 -28.33 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.18 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.77 -46.3 85.88 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.302 0.572 . . . . 0.0 110.229 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.802 HD21 HG21 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -62.93 -59.32 4.99 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.039 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 204' ' ' MET . 15.0 pt -54.14 -43.91 61.82 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -61.52 -34.26 75.21 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -89.95 2.31 55.24 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.96 -84.32 0.66 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.583 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.401 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.4 OUTLIER -120.73 -23.61 5.94 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 199' ' ' ILE . 0.3 OUTLIER 74.5 16.46 3.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.891 0.314 . . . . 0.0 110.645 -178.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -158.56 82.97 0.82 Allowed 'General case' 0 C--N 1.34 0.187 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.862 ' CB ' HD13 ' A' ' 151' ' ' LEU . . . -76.0 84.82 2.9 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -97.9 -2.77 39.97 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.272 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.672 HG22 ' HB2' ' A' ' 213' ' ' ALA . 89.4 m -56.66 121.1 8.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.95 -175.39 3.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -69.05 -45.36 70.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.138 0.495 . . . . 0.0 110.139 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.2 m -77.33 -25.53 51.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.613 0.72 . . . . 0.0 111.281 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.648 HG22 HG23 ' A' ' 208' ' ' THR . 0.9 OUTLIER -81.15 -50.82 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.801 178.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -53.46 -36.56 61.74 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.77 -46.16 89.32 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.05 -39.47 69.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.128 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.65 -56.98 13.98 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.407 ' CD2' HG21 ' A' ' 225' ' ' THR . 35.1 t80 -60.52 -28.46 68.42 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.38 -43.41 75.13 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.286 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -23.98 59.18 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.71 45.09 78.43 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -109.44 37.19 2.68 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.86 1.33 . . . . 0.0 110.496 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.755 HG21 ' HB2' ' A' ' 148' ' ' MET . 0.6 OUTLIER -141.96 141.85 32.95 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.966 0.889 . . . . 0.0 109.166 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 1.093 ' HB2' HD12 ' A' ' 122' ' ' LEU . . . -103.16 38.66 1.71 Allowed 'General case' 0 C--N 1.345 0.391 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.511 ' HE1' HD11 ' A' ' 115' ' ' LEU . 0.9 OUTLIER 168.7 138.45 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 148' ' ' MET . 5.2 p -148.06 159.78 43.55 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 226' ' ' ILE . 3.1 mp -116.48 112.44 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 114' ' ' SER . 2.2 p-10 -147.53 165.09 31.37 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 118.94 -0.553 . . . . 0.0 112.15 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -129.3 149.7 18.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.799 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.49 69.75 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.557 2.171 . . . . 0.0 112.298 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.689 ' CZ3' HD11 ' A' ' 262' ' ' LEU . 9.2 t-105 -159.02 -74.07 0.08 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.299 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.39 58.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.713 0.292 . . . . 0.0 110.997 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -152.07 95.7 2.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.256 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.9 m 53.2 176.28 0.02 OUTLIER 'General case' 0 C--O 1.231 0.079 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.339 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -109.24 94.99 5.33 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.632 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 12.6 tt -45.7 155.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.106 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.23 -171.29 0.09 Allowed 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.582 0.23 . . . . 0.0 110.501 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.9 m 67.02 35.55 4.59 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.707 0.289 . . . . 0.0 110.767 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 10.5 t -148.69 -62.06 0.24 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.544 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 14.9 mmtt -131.53 -85.97 0.49 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.402 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 2.7 p 158.38 -45.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -92.38 117.73 30.21 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.666 0.27 . . . . 0.0 111.266 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.637 ' CD1' HD11 ' A' ' 116' ' ' ILE . 7.8 p90 -149.29 129.86 13.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.428 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.99 176.21 54.74 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.668 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.749 HG22 HD12 ' A' ' 116' ' ' ILE . 19.3 t -146.55 113.16 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.557 0.678 . . . . 0.0 112.442 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.95 167.11 17.9 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -172.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.7 153.96 7.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.208 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.653 HD11 HD23 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -58.73 159.88 11.86 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 119.515 1.052 . . . . 0.0 110.996 -179.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.49 -163.45 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 111.957 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -120.79 177.58 5.03 Favored 'General case' 0 CA--C 1.526 0.052 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 160' ' ' LEU . 46.4 m-85 -162.35 110.42 1.36 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.534 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.86 33.08 17.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.379 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.28 41.34 21.63 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.524 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.434 ' C ' HG22 ' A' ' 249' ' ' THR . 0.0 OUTLIER -156.74 151.57 20.9 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.559 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 86.0 Cg_endo -86.51 -172.32 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.321 2.68 . . . . 0.0 111.891 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.513 ' OG ' HD22 ' A' ' 247' ' ' LEU . 10.2 p -108.57 148.33 30.47 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.4 OUTLIER -85.62 109.31 21.01 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.421 -178.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.491 ' HG2' ' O ' ' A' ' 323' ' ' ASN . 2.7 Cg_exo -79.36 149.45 21.7 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.305 2.67 . . . . 0.0 113.174 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.401 ' CB ' ' CD1' ' A' ' 155' ' ' TYR . 25.5 p90 -79.01 132.63 36.71 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 175.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.589 HG11 ' HA ' ' A' ' 329' ' ' ILE . 12.6 p -89.85 130.09 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -120.12 121.86 5.05 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 119.271 -1.442 . . . . 0.0 115.355 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.882 HG11 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -113.01 109.51 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 1.066 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 2.4 mm? -89.72 99.78 12.72 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 118.27 -1.372 . . . . 0.0 107.706 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.603 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -110.16 177.16 4.79 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -173.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.449 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . . . -116.2 124.06 49.33 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.666 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -127.4 164.33 20.91 Favored Glycine 0 CA--C 1.547 2.033 0 C-N-CA 119.062 -1.542 . . . . 0.0 112.776 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 1.02 HD11 ' O ' ' A' ' 77' ' ' ALA . 33.8 pt -81.93 -179.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 2 C-N-CA 139.311 7.044 . . . . 0.0 92.25 172.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.79 ' HA ' HD12 ' A' ' 76' ' ' LEU . 12.1 t30 -151.89 168.73 24.21 Favored 'General case' 0 CA--C 1.547 0.831 2 CA-C-N 133.603 7.456 . . . . 0.0 103.403 177.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 1.062 ' HB3' HD12 ' A' ' 75' ' ' LEU . . . -56.88 -52.27 65.78 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.203 0.911 . . . . 0.0 111.304 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.678 ' HB2' ' CB ' ' A' ' 51' ' ' ALA . . . -33.93 -64.16 0.24 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.96 127.88 2.82 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.596 0.236 . . . . 0.0 111.036 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -80.64 -41.3 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.359 2.04 . . . . 0.0 113.397 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.6 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 1.9 m-80 55.65 72.81 0.46 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.595 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 18.6 mtpt -56.64 -54.27 48.03 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 278' ' ' GLU . 4.2 mt-10 -55.65 -58.16 8.98 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.982 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.9 mt -69.46 -57.91 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.764 ' O ' HD12 ' A' ' 280' ' ' LEU . . . -64.88 -55.74 17.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.595 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -57.53 -42.49 82.98 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 274' ' ' GLU . 5.3 mt-10 -76.25 -53.88 7.6 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.445 ' HB2' ' CE2' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -55.6 -56.36 21.22 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.661 179.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 276' ' ' ALA . 1.2 mt -54.37 -43.4 71.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.359 0.599 . . . . 0.0 111.768 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.893 ' O ' HD23 ' A' ' 285' ' ' LEU . 17.8 tt0 -75.4 -33.24 60.97 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.214 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -97.14 -13.57 22.05 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 1.007 ' O ' HG22 ' A' ' 286' ' ' THR . 17.2 m-85 -114.32 -54.5 2.58 Favored 'General case' 0 CA--C 1.512 -0.513 0 O-C-N 122.008 -0.433 . . . . 0.0 110.659 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 284' ' ' LEU . 9.6 tp -45.28 -25.46 0.39 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.93 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.893 HD23 ' O ' ' A' ' 281' ' ' GLU . 2.6 mm? -94.93 43.39 1.09 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-O 120.832 0.349 . . . . 0.0 111.47 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 1.007 HG22 ' O ' ' A' ' 283' ' ' TYR . 13.2 t -143.7 156.93 44.69 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.532 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 49.4 p30 -66.13 -12.16 53.9 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.472 0.578 . . . . 0.0 110.55 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.764 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 10.9 tt0 -77.58 -47.48 19.31 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.029 -0.419 . . . . 0.0 111.054 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 286' ' ' THR . . . -84.71 -57.07 2.36 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.795 ' CD2' HG11 ' A' ' 302' ' ' VAL . 0.4 OUTLIER -48.29 -48.75 35.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.265 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -78.96 -26.77 43.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.077 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.764 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -65.8 -41.79 91.49 Favored 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 121.459 -0.776 . . . . 0.0 108.937 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.0 t -71.02 -64.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 116.704 -1.998 . . . . 0.0 105.856 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -51.43 3.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 129.119 2.967 . . . . 0.0 115.064 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -110.94 -57.0 2.29 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.444 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 57.6 m-20 -52.97 -36.85 60.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.868 ' HE3' HD12 ' A' ' 299' ' ' LEU . 16.7 ttpt -111.61 98.19 39.88 Favored Pre-proline 0 C--N 1.35 0.593 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.939 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -95.25 76.08 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.416 2.744 . . . . 0.0 112.091 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.868 HD12 ' HE3' ' A' ' 297' ' ' LYS . 16.3 mt -101.55 -74.83 0.61 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.449 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -142.62 -142.68 4.06 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.522 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.903 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . . . -79.79 178.42 8.2 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.741 0.305 . . . . 0.0 111.457 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.795 HG11 ' CD2' ' A' ' 290' ' ' LEU . 0.0 OUTLIER -126.83 -171.76 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.929 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.88 ' HB1' ' CD2' ' A' ' 89' ' ' LEU . . . -106.98 66.37 0.68 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.479 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.812 HD23 ' HB2' ' A' ' 307' ' ' TYR . 10.4 tp -159.95 108.89 1.76 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.763 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.61 -60.36 0.71 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.78 -48.03 63.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.022 0.915 . . . . 0.0 111.529 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.812 ' HB2' HD23 ' A' ' 304' ' ' LEU . 1.9 t80 -70.07 -19.73 63.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.128 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 3.0 tp10 -65.55 -39.95 92.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.82 -57.27 5.29 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.435 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -51.07 -57.21 9.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.248 0.547 . . . . 0.0 109.802 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.897 HD22 HG21 ' A' ' 317' ' ' ILE . 1.2 tt -61.93 -38.68 89.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.241 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.771 ' HA ' HD11 ' A' ' 317' ' ' ILE . . . -46.32 -29.11 1.51 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -40.31 -39.17 0.91 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.809 0.337 . . . . 0.0 110.241 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -78.53 118.34 71.75 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.09 -20.36 37.32 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.681 2.254 . . . . 0.0 114.287 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -59.15 5.61 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.903 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 2.4 pp -50.04 -53.44 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 317' ' ' ILE . . . -45.77 -44.95 14.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.448 0.567 . . . . 0.0 111.518 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.52 -40.09 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.551 0.691 . . . . 0.0 110.242 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.836 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER -62.0 -56.6 17.37 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.528 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 9.0 ttp -53.1 -42.68 66.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.701 0.286 . . . . 0.0 110.691 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.18 -39.26 81.97 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.93 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.743 ' CB ' ' HB1' ' A' ' 112' ' ' ALA . 7.3 m-80 -78.31 -48.11 16.36 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.659 0.266 . . . . 0.0 111.161 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 111' ' ' GLU . . . -48.53 -40.79 28.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.621 0.248 . . . . 0.0 111.576 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . 0.433 ' HB2' ' CD1' ' A' ' 92' ' ' PHE . 5.3 pt20 -67.08 -28.43 68.18 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.607 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -76.54 -10.46 59.41 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 257' ' ' PRO . . . -79.91 161.2 45.55 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.815 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -96.6 139.62 32.41 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.735 HD11 ' O ' ' A' ' 95' ' ' ASP . 9.7 mt -51.58 102.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 119.891 1.223 . . . . 0.0 111.235 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.529 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 32.9 mtm -47.95 -48.33 62.4 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 330' ' ' MET . 57.9 Cg_endo -72.19 121.7 7.75 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.279 1.986 . . . . 0.0 113.218 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.578 HD22 HD12 ' A' ' 333' ' ' ILE . 0.1 OUTLIER -160.69 -70.28 0.07 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.473 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.578 HD12 HD22 ' A' ' 332' ' ' ASN . 0.3 OUTLIER -137.32 140.42 30.71 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.001 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.561 ' HD2' HG22 ' A' ' 333' ' ' ILE . 10.9 Cg_endo -53.38 -18.27 10.64 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.881 2.388 . . . . 0.0 113.037 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.652 ' HG2' HG22 ' A' ' 178' ' ' ILE . 1.4 mp0 -44.07 -24.67 0.16 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.606 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -45.71 -35.26 4.09 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.039 0.381 . . . . 0.0 111.372 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . 0.494 ' HA ' ' CD2' ' A' ' 340' ' ' TRP . 3.0 t -56.26 -53.17 60.45 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 110.241 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.6 ' HB1' HD11 ' A' ' 368' ' ' ILE . . . -52.13 -27.23 13.52 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.172 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.744 ' O ' HG13 ' A' ' 343' ' ' VAL . 25.2 m-85 -78.09 -55.74 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.344 -0.543 . . . . 0.0 112.459 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.494 ' CD2' ' HA ' ' A' ' 337' ' ' SER . 1.2 p90 -54.95 -31.93 60.98 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.26 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 340' ' ' TRP . 0.1 OUTLIER -75.57 -52.16 11.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.024 0.44 . . . . 0.0 110.994 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.33 88.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.731 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 339' ' ' PHE . 4.8 m -69.17 -42.3 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.375 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 30.2 mtt-85 -57.79 -55.4 35.42 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.882 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -58.2 9.49 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.34 -60.69 2.13 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.582 HG11 HD11 ' A' ' 192' ' ' LEU . 42.7 t -53.03 -49.78 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 36.3 mt -67.87 -49.56 67.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.57 -55.06 19.71 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.552 ' HB1' ' HB2' ' A' ' 355' ' ' GLN . . . -63.63 -26.55 68.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.905 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -65.48 -10.27 32.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.49 0.586 . . . . 0.0 112.327 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.3 p -110.77 14.8 22.18 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 122.059 -0.401 . . . . 0.0 110.785 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 97.73 29.74 7.58 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 116.815 -2.612 . . . . 0.0 116.08 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.46 35.65 4.36 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 116.252 -1.833 . . . . 0.0 106.328 174.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.608 ' O ' HG23 ' A' ' 356' ' ' THR . 3.9 pt20 -70.98 -174.77 1.0 Allowed 'General case' 0 CA--C 1.549 0.912 1 N-CA-C 125.704 5.446 . . . . 0.0 125.704 -157.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.7 OUTLIER 158.34 41.78 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.415 -3.084 . . . . 0.0 104.538 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 358' ' ' ASP . 12.3 p -72.36 -51.62 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.57 ' O ' ' HB3' ' A' ' 362' ' ' LYS . 10.0 t0 -47.77 -45.36 29.14 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.772 0.796 . . . . 0.0 111.31 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.644 ' HA ' ' HG2' ' A' ' 362' ' ' LYS . 8.1 mp0 -77.14 -56.32 4.67 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 113.885 -1.507 . . . . 0.0 113.62 -174.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -54.45 -43.09 71.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.416 1.103 . . . . 0.0 112.645 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.669 ' O ' ' HB3' ' A' ' 364' ' ' ALA . 0.1 OUTLIER -76.17 -45.75 31.83 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.087 -1.87 . . . . 0.0 111.358 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.644 ' HG2' ' HA ' ' A' ' 359' ' ' GLU . 43.3 pttt -58.01 -54.89 41.79 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 121.961 0.886 . . . . 0.0 110.419 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 362' ' ' LYS . 9.0 m-20 -58.75 -36.15 73.89 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 114.611 -1.177 . . . . 0.0 107.832 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 361' ' ' LEU . . . -49.66 -45.54 48.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.426 ' CG ' ' CG2' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -58.93 -44.77 91.43 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.6 m -52.09 -42.54 63.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.112 0.482 . . . . 0.0 109.864 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.15 -37.06 85.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.909 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.648 HG23 ' HG3' ' A' ' 335' ' ' GLN . 4.2 mm -71.64 -35.29 55.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.934 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.446 ' CG2' ' HA ' ' A' ' 179' ' ' LYS . 7.4 p -118.64 51.35 1.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.936 0.398 . . . . 0.0 111.843 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.3 tptp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.195 179.79 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.626 0.251 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 63.3 68.49 0.61 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.063 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.46 -112.11 2.31 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.219 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HG3' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -118.21 -171.18 2.02 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 114.143 -1.028 . . . . 0.0 109.919 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.96 HD21 ' CZ ' ' A' ' 279' ' ' PHE . 0.1 OUTLIER -127.42 120.41 28.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.062 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -116.24 117.14 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.341 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.952 ' CG1' HG12 ' A' ' 37' ' ' VAL . 1.7 pp -123.51 129.88 74.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.691 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.997 ' HB2' HG22 ' A' ' 60' ' ' ILE . 8.5 m95 -107.58 122.44 46.69 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.407 HG22 ' CD1' ' A' ' 9' ' ' ILE . 2.6 tt -159.23 139.02 3.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.7 113.29 20.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.624 0.249 . . . . 0.0 111.111 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.29 -9.15 15.36 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.755 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 39.0 t0 -72.59 -82.11 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.853 0.827 . . . . 0.0 111.057 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 5.8 tmtm? 100.84 -2.75 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.531 0.733 . . . . 0.0 110.313 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.559 ' O ' HD23 ' A' ' 20' ' ' LEU . . . -76.72 66.01 2.8 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 115.271 0.868 . . . . 0.0 115.271 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -77.39 -39.23 47.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.139 -0.531 . . . . 0.0 110.682 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 1.7 m120 -61.48 -47.0 87.66 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.058 0.456 . . . . 0.0 111.052 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.899 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.37 -47.51 35.43 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.054 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 16' ' ' GLY . 4.2 mm? -59.99 -49.6 77.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.381 0.59 . . . . 0.0 110.153 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.79 -38.46 80.01 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 2.1 tp10 -65.67 -36.93 85.08 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.063 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.899 HG23 ' O ' ' A' ' 19' ' ' GLY . 61.0 t -66.82 -61.1 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.851 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . -48.95 -32.42 11.68 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 119.685 -1.245 . . . . 0.0 111.491 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -55.29 -50.18 70.23 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.4 mttt -53.03 -41.72 65.0 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-N 112.862 -1.972 . . . . 0.0 108.374 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.762 ' HB3' HD13 ' A' ' 33' ' ' ILE . 47.4 m-85 -65.49 -34.31 77.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.777 0.799 . . . . 0.0 110.78 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.781 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 1.1 tm-20 -69.08 -51.26 40.65 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.963 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttp -50.99 -30.14 14.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 125.133 1.521 . . . . 0.0 110.867 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.841 ' O ' HG23 ' A' ' 31' ' ' THR . 0.4 OUTLIER -83.62 -38.2 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.428 179.085 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.75 37.71 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 171.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.822 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.09 38.58 0.02 OUTLIER Glycine 0 N--CA 1.468 0.805 0 C-N-CA 115.071 -3.443 . . . . 0.0 119.035 174.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.822 HD12 ' C ' ' A' ' 32' ' ' GLY . 2.0 mp -140.02 136.8 38.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 121.861 2.831 . . . . 0.0 116.417 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' CD ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -142.42 105.13 4.52 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.89 HG22 ' CB ' ' A' ' 7' ' ' LEU . 42.6 t -86.89 131.61 34.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -174.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.8 p -117.3 145.1 44.21 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.44 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.952 HG12 ' CG1' ' A' ' 9' ' ' ILE . 16.0 m -129.08 120.6 52.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 5.8 mt-10 -110.36 130.7 55.5 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -119.75 71.18 14.39 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.307 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 43' ' ' LEU . 7.8 Cg_endo -94.93 -170.2 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.514 2.809 . . . . 0.0 112.857 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -109.74 -40.32 4.85 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.42 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.406 ' HB3' ' CG ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -86.23 0.32 54.02 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.921 HD23 ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -31.68 -39.27 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 1.02 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 73.7 mt-10 -62.86 -54.61 36.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.467 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 11.9 pt-20 -74.2 -38.36 63.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -60.12 -57.53 12.42 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.705 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.743 ' CD2' HD13 ' A' ' 60' ' ' ILE . 1.1 t80 -42.94 -59.16 3.24 Favored Pre-proline 0 C--N 1.352 0.694 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.516 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 1.02 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 26.8 Cg_exo -62.66 -22.65 74.16 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 120.948 1.099 . . . . 0.0 113.171 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -82.23 -36.93 26.7 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 122.28 1.038 . . . . 0.0 111.271 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.3 m -78.59 -39.81 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.506 0 CA-C-O 122.254 1.026 . . . . 0.0 109.863 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 269' ' ' ALA . . . -50.56 -37.46 39.76 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 125.957 1.703 . . . . 0.0 110.906 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 53' ' ' THR . . . -81.52 -40.1 23.69 Favored 'General case' 0 C--N 1.372 1.567 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.701 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 52' ' ' ALA . 33.6 p -159.56 51.52 0.35 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.054 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -160.02 48.87 0.39 Allowed Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.333 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t0 70.67 104.24 0.06 Allowed 'General case' 0 C--O 1.23 0.077 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.07 112.15 4.73 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.836 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.492 ' CG ' ' CE1' ' A' ' 47' ' ' PHE . 86.1 Cg_endo -79.85 -164.68 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.956 2.437 . . . . 0.0 113.444 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 1.062 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 6.7 t0 -79.96 -135.57 0.03 OUTLIER 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 123.946 0.898 . . . . 0.0 110.521 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.682 HD12 ' OD2' ' A' ' 58' ' ' ASP . 1.3 mp -101.7 165.17 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.997 HG22 ' HB2' ' A' ' 10' ' ' TRP . 1.2 pt -127.16 130.69 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.5 OUTLIER -115.34 117.57 30.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.71 ' CZ3' HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -167.26 165.38 15.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 62' ' ' TRP . . . -37.45 152.46 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.809 ' CG ' HG12 ' A' ' 97' ' ' VAL . 10.7 t-160 -77.35 -28.62 53.05 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.408 ' HA ' ' ND2' ' A' ' 332' ' ' ASN . 3.4 m-20 -49.19 -58.29 5.25 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-O 121.979 0.895 . . . . 0.0 112.279 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.57 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -73.9 -30.59 62.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.546 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.571 ' CD1' HD12 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -63.35 -25.43 68.29 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -62.04 -65.37 3.24 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.62 -47.85 89.15 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 113.616 -1.292 . . . . 0.0 110.309 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.724 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 23.2 t80 -48.02 -46.56 33.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.525 ' HA ' ' CB ' ' A' ' 76' ' ' LEU . . . -57.87 -37.43 73.92 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.299 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -78.94 -54.72 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.303 . . . . 0.0 111.764 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -113.34 -26.15 8.5 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' TYR . . . -65.41 -85.37 0.07 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.178 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.983 HD23 ' HB3' ' A' ' 268' ' ' ALA . 0.2 OUTLIER 165.58 71.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.142 0.496 . . . . 0.0 109.726 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 77' ' ' ALA . 2.5 tt -112.64 133.22 54.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.273 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 1.056 ' HB3' HG23 ' A' ' 266' ' ' ILE . . . -86.45 91.92 8.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.631 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -56.3 85.49 0.01 OUTLIER 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.881 HD12 ' HD3' ' A' ' 81' ' ' PRO . 2.0 pp -49.24 119.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.224 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.7 p -105.84 82.79 0.91 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.365 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.881 ' HD3' HD12 ' A' ' 79' ' ' ILE . 42.8 Cg_endo -89.44 -168.58 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.122 2.548 . . . . 0.0 112.422 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -172.89 4.42 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.638 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -35.66 21.0 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.3 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.44 -23.64 58.04 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.93 -59.21 2.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.576 ' HA ' HD21 ' A' ' 89' ' ' LEU . 10.0 tt0 -60.99 -24.74 66.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.389 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -75.8 -35.39 60.07 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.58 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -19.68 64.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.092 HD13 ' CG ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER -97.4 -179.57 4.53 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -94.58 143.32 26.06 Favored Pre-proline 0 C--N 1.343 0.304 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 31.8 Cg_exo -58.92 -50.58 8.66 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.422 2.081 . . . . 0.0 113.513 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' ' CG ' ' A' ' 325' ' ' GLN . 6.8 m-85 -56.76 -62.78 1.5 Allowed 'General case' 0 C--O 1.246 0.878 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.748 HG21 ' HA ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -62.85 -25.25 68.18 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 1.092 ' CG ' HD13 ' A' ' 89' ' ' LEU . 31.6 m95 -93.86 -23.39 18.14 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 14.7 t70 -72.65 -22.2 60.97 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.476 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.597 ' HB1' HG22 ' A' ' 261' ' ' VAL . . . -53.29 -45.53 68.96 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 1.073 HG13 HG11 ' A' ' 261' ' ' VAL . 20.2 m -113.93 39.25 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.407 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.437 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 12.0 ttp180 -104.94 138.96 40.37 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.289 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -124.15 90.99 3.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 119.172 0.896 . . . . 0.0 110.052 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.5 m120 51.73 -91.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.208 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.1 44.73 1.21 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.79 -177.03 5.37 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.486 0.314 . . . . 0.0 110.484 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.765 ' CD2' HD11 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -158.66 126.68 5.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.391 0.541 . . . . 0.0 110.742 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.702 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 1.4 pp -128.25 39.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.55 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 159.61 162.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.569 ' OH ' HD13 ' A' ' 79' ' ' ILE . 23.2 m-85 -124.7 119.81 25.78 Favored Pre-proline 0 C--O 1.223 -0.32 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.803 ' O ' HG23 ' A' ' 108' ' ' ILE . 66.9 Cg_endo -79.14 162.48 25.83 Favored 'Trans proline' 0 N--CA 1.474 0.333 0 C-N-CA 122.284 1.989 . . . . 0.0 114.776 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -171.82 38.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 1.043 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -179.56 137.58 0.13 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.916 HG12 ' HB3' ' A' ' 301' ' ' ALA . 0.3 OUTLIER -124.09 119.48 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 259' ' ' VAL . 5.4 tt0 -99.03 135.04 41.0 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 323' ' ' ASN . . . -168.06 -174.67 2.41 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 123.366 1.555 . . . . 0.0 110.204 -167.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.862 HD21 HG22 ' A' ' 226' ' ' ILE . 2.7 tt -147.3 135.44 21.49 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 110.995 -2.821 . . . . 0.0 115.846 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.4 OUTLIER -130.31 168.42 16.93 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.893 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.669 HD12 HG13 ' A' ' 226' ' ' ILE . 6.8 tp -92.45 132.41 36.81 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 121.877 -0.514 . . . . 0.0 110.267 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.695 HD11 ' HB2' ' A' ' 242' ' ' TYR . 0.5 OUTLIER -116.41 134.51 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.669 0.747 . . . . 0.0 111.175 -178.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.46 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 8.3 m-85 -93.23 -174.32 3.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.05 2.54 . . . . 0.0 110.037 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 122' ' ' LEU . 0.7 OUTLIER -93.05 -135.43 0.17 Allowed 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 126.625 1.97 . . . . 0.0 113.615 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.919 ' O ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -152.46 -108.26 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.085 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -67.94 -26.55 66.01 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.513 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -104.89 51.47 0.76 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.164 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.919 HD23 ' O ' ' A' ' 119' ' ' LYS . 1.2 pp -118.83 73.22 11.82 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 121.439 0.638 . . . . 0.0 109.788 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.548 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 12.5 Cg_exo -70.16 160.82 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.407 2.071 . . . . 0.0 112.508 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 49.7 t30 -61.56 108.19 1.44 Allowed Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.417 -173.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 57.2 Cg_endo -69.63 167.94 22.82 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 124.094 3.196 . . . . 0.0 113.574 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -76.16 -162.0 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.762 2.308 . . . . 0.0 113.592 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -126.23 -93.03 0.49 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.6 t -45.0 152.99 0.2 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.352 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.523 ' HH2' HD11 ' A' ' 226' ' ' ILE . 13.9 t-105 -69.96 -26.51 64.14 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 174.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.425 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 62.5 mt-10 -44.55 -23.72 0.14 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 134' ' ' ALA . 22.1 mt-10 -73.5 -26.2 60.78 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.886 ' CD1' HD22 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -40.44 -52.81 5.84 Favored Pre-proline 0 N--CA 1.487 1.385 0 CA-C-N 119.122 0.874 . . . . 0.0 112.288 -178.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.587 ' HD3' HG13 ' A' ' 132' ' ' ILE . 53.1 Cg_exo -46.33 -39.94 21.95 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 120.699 0.933 . . . . 0.0 109.892 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.38 -58.92 2.99 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -68.14 -36.65 80.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.159 -178.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.537 ' OD2' HG22 ' A' ' 132' ' ' ILE . 1.9 m-20 -73.51 -41.09 63.51 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -48.22 -43.88 32.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.69 177.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 0.2 OUTLIER -66.4 -37.48 85.34 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.7 OUTLIER -65.55 -46.47 79.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -48.91 -43.26 39.14 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.12 -22.93 0.26 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.296 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -115.79 -60.31 1.89 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.774 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.62 56.85 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.659 ' HG3' HD23 ' A' ' 139' ' ' LEU . 24.2 pttt -169.08 -173.43 1.77 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.829 1.815 . . . . 0.0 110.246 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.721 ' C ' HD22 ' A' ' 139' ' ' LEU . 38.5 m -142.65 164.82 29.08 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.965 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -81.84 -23.01 36.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.931 0.395 . . . . 0.0 111.919 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.681 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.3 pp -144.82 128.76 17.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.78 ' N ' HG21 ' A' ' 222' ' ' THR . 11.2 mmm -132.41 141.59 48.93 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.702 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.497 ' HB3' HG23 ' A' ' 225' ' ' THR . 52.6 p90 -172.55 174.94 3.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.742 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -37.54 158.42 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.013 178.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.006 HD13 ' HA ' ' A' ' 206' ' ' ALA . 3.3 mt -110.65 -51.66 2.85 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.17 34.35 3.1 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 115.752 -2.379 . . . . 0.0 113.765 -175.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.751 ' O ' HG23 ' A' ' 157' ' ' THR . 0.5 OUTLIER -79.63 142.32 57.26 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 121.067 1.758 . . . . 0.0 114.087 -176.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.968 ' O ' ' N ' ' A' ' 156' ' ' PHE . 67.3 Cg_endo -78.18 -134.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 1 C-N-CA 125.336 4.024 . . . . 0.0 105.2 175.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 1.167 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 12.3 m-85 21.13 -55.63 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.883 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.968 ' N ' ' O ' ' A' ' 154' ' ' PRO . 15.1 t80 -84.72 -55.81 3.92 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-N 119.561 1.073 . . . . 0.0 112.641 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 153' ' ' GLU . 20.6 p -58.04 -39.77 79.25 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 117.913 -1.515 . . . . 0.0 107.336 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.543 ' HZ2' HG21 ' A' ' 343' ' ' VAL . 24.2 m95 -53.0 -55.7 30.93 Favored Pre-proline 0 C--N 1.352 0.702 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.825 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 1.167 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 67.5 Cg_exo -43.04 -48.91 7.41 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.187 2.591 . . . . 0.0 112.425 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.699 HD21 ' CZ ' ' A' ' 250' ' ' PHE . 0.1 OUTLIER -58.19 -53.55 57.03 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 119.361 0.982 . . . . 0.0 109.411 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.625 HG22 ' HA ' ' A' ' 188' ' ' ALA . 4.7 mt -55.42 -20.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.001 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.718 ' HB1' ' HG3' ' A' ' 256' ' ' LYS . . . -78.9 -25.16 43.77 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -42.85 -56.02 3.43 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.492 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 7.1 m-20 -64.54 -11.18 31.6 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.172 0.896 . . . . 0.0 112.777 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.91 27.76 0.7 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 119.545 -1.312 . . . . 0.0 115.561 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.85 162.06 38.82 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 118.557 1.178 . . . . 0.0 111.847 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.673 ' O ' ' N ' ' A' ' 169' ' ' PHE . 25.9 m-85 -151.28 30.18 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.992 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 50.04 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.024 0.916 . . . . 0.0 111.411 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.691 ' CB ' ' HB3' ' A' ' 176' ' ' TYR . 12.4 m-85 -112.88 170.72 8.0 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.423 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.957 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -108.01 114.74 28.88 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.487 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 5.9 t80 -79.23 114.03 17.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 113.473 -1.694 . . . . 0.0 110.36 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -137.54 124.53 21.43 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.202 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 t30 76.77 -31.69 0.18 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.872 -0.149 . . . . 0.0 111.109 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.487 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 163.83 11.77 0.03 OUTLIER Glycine 0 CA--C 1.532 1.123 0 C-N-CA 120.17 -1.014 . . . . 0.0 114.626 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.402 ' C ' ' HA ' ' A' ' 171' ' ' TYR . 3.4 mtmt -173.93 150.6 1.65 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.962 1.381 . . . . 0.0 110.031 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.957 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 7.0 m-85 -66.57 -26.32 67.06 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.151 0.977 . . . . 0.0 109.579 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.64 -103.98 0.08 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.403 -1.726 . . . . 0.0 112.163 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 179' ' ' LYS . 8.3 tp -173.38 -46.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.43 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.1 OUTLIER -64.42 -15.6 60.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.718 0.294 . . . . 0.0 110.872 179.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 170' ' ' LYS . 3.2 p-10 -129.19 94.3 3.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 169' ' ' PHE . 20.3 m -122.03 140.79 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.387 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.69 55.5 4.17 Favored Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.185 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.799 HG11 HD11 ' A' ' 368' ' ' ILE . 30.4 m -87.03 -13.31 10.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.526 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 7.3 p-10 -124.62 62.68 1.13 Allowed 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.774 0.321 . . . . 0.0 110.844 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -116.93 135.1 53.98 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.282 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 189' ' ' LYS . . . -39.25 -40.31 0.74 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.424 0.63 . . . . 0.0 112.264 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.492 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -76.78 -35.94 38.54 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 114.955 -1.02 . . . . 0.0 114.113 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.625 ' HA ' HG22 ' A' ' 161' ' ' ILE . . . -60.0 -51.43 69.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.771 ' HE3' HD21 ' A' ' 361' ' ' LEU . 9.2 mttt -58.16 -60.45 3.73 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.651 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -50.36 -42.03 52.55 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.835 0.826 . . . . 0.0 111.959 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.46 -60.51 5.41 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.146 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.5 OUTLIER -56.98 -28.32 62.22 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 122.841 -0.211 . . . . 0.0 110.48 179.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 189' ' ' LYS . 7.6 p -69.65 -42.37 74.34 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.666 0.27 . . . . 0.0 111.375 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.48 ' CZ ' HD21 ' A' ' 198' ' ' LEU . 86.7 t80 -61.68 -34.27 75.45 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.345 0.593 . . . . 0.0 109.606 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.67 -47.76 79.93 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.892 HG21 ' OE1' ' A' ' 355' ' ' GLN . 43.8 t -56.88 -31.64 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.467 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.11 -44.87 87.37 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.797 0.808 . . . . 0.0 111.508 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.886 HD22 ' CD1' ' A' ' 132' ' ' ILE . 13.0 mt -58.59 -55.39 35.64 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 204' ' ' MET . 26.9 pt -64.06 -39.82 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.102 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 2.9 tttt -52.67 -37.32 58.52 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.695 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.26 -34.53 5.62 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 121.141 3.756 . . . . 0.0 121.141 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -60.72 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.773 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -105.19 -1.94 24.79 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.668 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 9.0 mtm 43.39 36.02 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.773 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.09 159.36 42.34 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 1.006 ' HA ' HD13 ' A' ' 151' ' ' LEU . . . -149.38 30.1 0.77 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -100.6 -3.51 30.34 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 213' ' ' ALA . 5.3 m -57.45 119.82 7.16 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.563 ' OD2' HD12 ' A' ' 212' ' ' ILE . 3.5 p30 -95.5 -174.24 3.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.875 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 211' ' ' SER . 53.5 p90 -68.05 -45.5 73.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.421 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -76.67 -25.49 53.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.588 0.709 . . . . 0.0 111.382 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.563 HD12 ' OD2' ' A' ' 209' ' ' ASP . 4.5 mt -81.63 -50.91 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.063 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -52.47 -37.37 56.98 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.482 ' HA ' ' CD2' ' A' ' 217' ' ' PHE . 2.7 tt0 -60.17 -46.89 88.17 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.9 -36.24 69.91 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.481 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.55 -57.34 13.11 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.482 ' CD2' ' HA ' ' A' ' 214' ' ' GLU . 0.4 OUTLIER -63.08 -28.32 70.0 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -55.14 -41.12 71.35 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.558 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.98 59.14 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.2 41.27 69.9 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -109.64 37.13 2.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.034 1.417 . . . . 0.0 110.822 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.78 HG21 ' N ' ' A' ' 148' ' ' MET . 1.6 m -140.44 140.75 35.46 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -105.09 38.42 1.94 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.349 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 2.7 ttm 171.6 135.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.497 HG23 ' HB3' ' A' ' 149' ' ' PHE . 90.4 m -148.19 157.58 43.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.153 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.862 HG22 HD21 ' A' ' 113' ' ' LEU . 2.7 mp -115.84 111.41 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.427 173.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 114' ' ' SER . 10.1 p30 -149.18 164.72 33.93 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 122.095 -0.378 . . . . 0.0 111.837 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -80.76 -172.82 46.25 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.124 -1.513 . . . . 0.0 109.784 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.435 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 57.5 Cg_endo -73.51 -40.7 1.43 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 121.759 1.639 . . . . 0.0 112.522 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.508 ' CZ2' ' HA3' ' A' ' 300' ' ' GLY . 0.3 OUTLIER -137.49 23.87 2.93 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.631 ' HB3' ' CE3' ' A' ' 232' ' ' TRP . . . -96.48 -33.79 11.73 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.631 ' CE3' ' HB3' ' A' ' 231' ' ' ALA . 1.7 m-90 -105.21 79.96 1.54 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.1 m 62.59 -175.69 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.91 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -83.0 129.5 35.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.813 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.427 HG13 ' CE2' ' A' ' 242' ' ' TYR . 8.4 tp -87.61 -32.55 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.368 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -46.2 -38.66 8.63 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.603 0.24 . . . . 0.0 111.294 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 237' ' ' THR . 9.0 t -87.05 65.2 8.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.702 0.287 . . . . 0.0 110.814 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 39.1 p -116.44 -60.3 1.87 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.812 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.48 -67.51 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.301 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.41 ' HB ' ' HD3' ' A' ' 119' ' ' LYS . 22.1 t -154.43 -60.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.526 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -136.74 157.46 46.7 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.876 0.37 . . . . 0.0 111.317 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.695 ' HB2' HD11 ' A' ' 116' ' ' ILE . 6.2 p90 -149.31 156.68 42.47 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.632 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.485 ' O ' HD12 ' A' ' 116' ' ' ILE . . . -107.34 172.82 18.22 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.42 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.0 t -146.51 119.98 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.139 0.469 . . . . 0.0 111.976 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.55 167.52 20.64 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -173.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.2 m -73.01 153.22 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.646 ' CD1' HG21 ' A' ' 226' ' ' ILE . 2.8 mm? -59.03 159.15 14.72 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-N 120.396 1.453 . . . . 0.0 111.885 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.11 -156.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.461 2.774 . . . . 0.0 112.242 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -128.51 172.99 10.63 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.913 -178.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.699 ' CZ ' HD21 ' A' ' 160' ' ' LEU . 97.4 m-85 -164.15 110.47 1.06 Allowed 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 121.791 0.805 . . . . 0.0 109.402 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt 61.16 33.0 19.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.678 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.01 36.64 35.12 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.118 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 163' ' ' ALA . 1.4 mt-30 -156.83 155.17 28.07 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -92.14 157.88 3.22 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.598 2.865 . . . . 0.0 111.986 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.4 p -79.73 153.41 29.27 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.718 ' HG3' ' HB1' ' A' ' 162' ' ' ALA . 3.2 mmmm -85.4 110.82 32.18 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.391 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.477 ' HB2' ' CA ' ' A' ' 327' ' ' GLY . 6.2 Cg_exo -79.23 147.83 20.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.928 2.419 . . . . 0.0 112.39 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 155' ' ' TYR . 3.2 p90 -105.09 133.93 49.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' A' ' 324' ' ' ALA . 30.9 t -140.68 108.41 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.25 163.88 43.47 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.152 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 1.073 HG11 HG13 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -104.3 113.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 122.893 -0.181 . . . . 0.0 111.342 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 1.043 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 1.7 tt -89.04 99.67 12.6 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 117.502 -1.679 . . . . 0.0 106.68 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.552 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 23.3 p -134.85 142.06 46.52 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -172.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . -73.88 131.59 41.64 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.827 0.451 . . . . 0.0 110.061 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.513 ' O ' HG13 ' A' ' 60' ' ' ILE . . . -122.01 135.51 10.41 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.005 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 1.056 HG23 ' HB3' ' A' ' 77' ' ' ALA . 4.4 tp -89.98 123.6 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -64.43 145.37 56.18 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.983 ' HB3' HD23 ' A' ' 75' ' ' LEU . . . -58.74 -22.86 58.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.995 0.426 . . . . 0.0 111.436 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.425 ' HB2' ' HB1' ' A' ' 51' ' ' ALA . . . -61.5 -61.15 2.73 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.704 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . 0.845 ' O ' HD11 ' A' ' 266' ' ' ILE . 5.7 m -127.13 102.11 24.67 Favored Pre-proline 0 C--N 1.333 -0.13 0 CA-C-O 120.619 0.247 . . . . 0.0 111.29 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.439 ' HA ' ' CG1' ' A' ' 266' ' ' ILE . 55.4 Cg_endo -71.25 -42.72 1.83 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.336 2.024 . . . . 0.0 112.276 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.53 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 2.5 m120 45.73 80.12 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.97 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 10.1 ttmt -75.06 -54.12 7.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.626 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -57.28 11.58 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.652 0.263 . . . . 0.0 111.68 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.14 -57.95 10.38 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.213 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -59.59 -25.0 64.24 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.592 ' O ' ' CB ' ' A' ' 281' ' ' GLU . 24.0 tttt -69.95 -58.09 4.26 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 121.325 0.583 . . . . 0.0 111.687 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 13.4 pt-20 -69.97 -35.44 74.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.328 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.96 ' CZ ' HD21 ' A' ' 7' ' ' LEU . 12.1 t80 -73.95 -61.13 1.95 Allowed 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.195 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.59 -44.45 64.44 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.179 -1.008 . . . . 0.0 113.175 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.761 ' O ' HD12 ' A' ' 285' ' ' LEU . 4.0 tt0 -75.45 -34.77 60.98 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.527 -1.215 . . . . 0.0 113.428 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 1.7 t-20 -92.15 -16.74 25.88 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.935 ' O ' HG22 ' A' ' 286' ' ' THR . 0.5 OUTLIER -108.78 -66.53 1.04 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 290' ' ' LEU . 0.1 OUTLIER -39.54 -32.89 0.14 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.944 0.793 . . . . 0.0 111.203 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 281' ' ' GLU . 20.4 mt -91.05 42.03 1.09 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.79 0.328 . . . . 0.0 111.383 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.935 HG22 ' O ' ' A' ' 283' ' ' TYR . 6.3 t -145.06 158.01 43.94 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 0.8 OUTLIER -66.23 -11.02 47.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.617 0.644 . . . . 0.0 110.297 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.706 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -77.4 -47.09 20.69 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 118.175 0.443 . . . . 0.0 111.157 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -83.74 -57.34 2.45 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.654 HD12 ' CD2' ' A' ' 307' ' ' TYR . 0.2 OUTLIER -50.8 -49.06 59.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.589 -0.305 . . . . 0.0 110.586 178.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.1 OUTLIER -79.28 -26.39 42.35 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.104 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -68.04 -39.61 83.03 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 289' ' ' GLY . 58.3 t -68.34 -62.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 297' ' ' LYS . 9.3 m-80 -44.59 -47.79 10.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.78 1.232 . . . . 0.0 112.427 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -57.93 -54.97 40.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.44 ' HB3' ' CA ' ' A' ' 16' ' ' GLY . 32.8 m-20 -53.6 -44.75 69.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 294' ' ' ASN . 0.7 OUTLIER -49.7 165.83 0.28 Allowed Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.866 -178.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 299' ' ' LEU . 6.6 Cg_exo -73.09 -8.78 22.66 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.241 2.628 . . . . 0.0 113.547 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 298' ' ' PRO . 6.7 tp 90.38 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.924 0.392 . . . . 0.0 111.66 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.508 ' HA3' ' CZ2' ' A' ' 230' ' ' TRP . . . -152.98 -156.67 7.68 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.947 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.916 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -79.97 164.47 23.45 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.44 0.62 . . . . 0.0 110.7 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.553 HG22 ' CD1' ' A' ' 311' ' ' LEU . 16.5 m -153.81 -151.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.748 ' HA ' HG21 ' A' ' 93' ' ' THR . . . -116.1 -138.75 0.37 Allowed 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.552 HD23 ' HG ' ' A' ' 290' ' ' LEU . 13.5 tp 48.24 101.41 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.712 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -41.9 -58.44 2.04 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.5 p -53.39 -49.35 67.42 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.734 0.778 . . . . 0.0 112.073 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.654 ' CD2' HD12 ' A' ' 290' ' ' LEU . 9.1 t80 -69.48 -19.42 63.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.171 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.3 OUTLIER -63.1 -39.02 93.48 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 9.1 mt-10 -70.63 -57.8 4.34 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.539 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -56.49 12.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.458 0.647 . . . . 0.0 109.279 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.768 ' O ' HG21 ' A' ' 317' ' ' ILE . 0.8 OUTLIER -59.09 -40.32 84.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.277 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 317' ' ' ILE . . . -46.96 -34.39 5.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.524 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.52 -38.39 6.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.518 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.72 ' HB2' HG22 ' A' ' 317' ' ' ILE . 14.3 m-20 -67.55 146.19 98.53 Favored Pre-proline 0 N--CA 1.462 0.132 0 CA-C-O 120.616 0.246 . . . . 0.0 110.667 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 17.3 Cg_exo -67.15 -42.81 7.25 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.665 2.243 . . . . 0.0 113.054 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 229' ' ' PRO . 7.8 mtt85 -58.79 -59.73 4.97 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -51.45 -54.13 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.432 ' N ' HD13 ' A' ' 317' ' ' ILE . . . -46.05 -51.91 12.88 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.419 0.554 . . . . 0.0 111.584 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.62 -46.72 70.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.217 1.008 . . . . 0.0 109.032 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.767 HG22 HG13 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -58.38 -40.51 82.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 113.472 -1.694 . . . . 0.0 109.786 178.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.1 ttp -66.46 -50.25 63.98 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.646 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -53.17 -57.6 9.92 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.571 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 22.4 m120 -64.55 -30.24 71.27 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.364 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.727 ' HB1' HG21 ' A' ' 110' ' ' VAL . . . -60.08 -53.13 61.4 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . 0.449 ' CG ' ' CZ ' ' A' ' 92' ' ' PHE . 2.4 tt0 -67.42 -30.06 69.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.39 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.28 -17.98 40.68 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.496 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.689 ' HA3' HG23 ' A' ' 259' ' ' VAL . . . -79.9 169.23 52.98 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.199 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 257' ' ' PRO . 1.9 mm-40 -96.46 137.4 35.58 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 96' ' ' ALA . 4.6 mp -83.88 113.67 23.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 119.595 1.089 . . . . 0.0 110.301 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.472 ' C ' ' O ' ' A' ' 329' ' ' ILE . 0.0 OUTLIER -25.93 137.55 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 332' ' ' ASN . 36.3 Cg_endo -64.93 -38.44 29.28 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.629 2.22 . . . . 0.0 112.528 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 65' ' ' ASP . 1.5 m-20 71.49 57.14 0.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.661 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.98 160.34 68.18 Favored Pre-proline 0 C--N 1.326 -0.415 0 O-C-N 121.945 -0.472 . . . . 0.0 111.593 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.13 -42.29 8.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.644 2.229 . . . . 0.0 112.476 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.417 ' HB3' HD13 ' A' ' 178' ' ' ILE . 6.3 mm100 -47.83 -25.2 1.2 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 32.0 tpp -45.72 -35.55 4.33 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 122.357 -0.214 . . . . 0.0 111.181 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.2 m -57.31 -42.51 81.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.761 0.315 . . . . 0.0 110.455 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -57.27 -31.51 65.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.04 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.414 ' O ' HG12 ' A' ' 343' ' ' VAL . 2.9 t80 -78.1 -48.62 15.61 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.34 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -47.01 68.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.619 0.247 . . . . 0.0 111.474 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -74.33 -50.87 16.97 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.497 ' CB ' HG22 ' A' ' 368' ' ' ILE . . . -67.62 -43.68 79.84 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.984 HG22 HG21 ' A' ' 347' ' ' VAL . 0.3 OUTLIER -70.74 -41.42 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.42 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.484 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 0.8 OUTLIER -58.67 -59.56 5.22 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.458 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 53.0 p -54.36 -57.86 9.65 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.51 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -65.09 -60.56 2.89 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.984 HG21 HG22 ' A' ' 343' ' ' VAL . 44.1 t -59.08 -45.74 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 1.7 tt -68.5 -52.7 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.603 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 348' ' ' ILE . 29.6 m-20 -66.26 -53.39 37.39 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.554 ' HA ' ' HG2' ' A' ' 354' ' ' ARG . . . -63.54 -26.42 68.69 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.356 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -54.53 -17.92 3.78 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.574 0.625 . . . . 0.0 111.503 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 13.2 p -106.73 24.08 13.26 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 171.1 -57.21 0.18 Allowed Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 119.697 -1.239 . . . . 0.0 113.254 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . 0.554 ' HG2' ' HA ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -103.17 34.05 3.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 113.792 -3.163 . . . . 0.0 116.971 -174.222 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.892 ' OE1' HG21 ' A' ' 196' ' ' VAL . 0.8 OUTLIER -95.77 54.58 1.54 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.13 167.32 11.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.645 HG23 ' HG2' ' A' ' 189' ' ' LYS . 7.1 p -48.96 -49.34 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.533 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 62.2 m-20 -64.84 -49.3 71.11 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.72 -33.7 46.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 111.975 -177.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 364' ' ' ALA . . . -61.44 -53.27 58.66 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.961 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.771 HD21 ' HE3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -78.91 -47.18 16.94 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.746 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.704 ' O ' HG23 ' A' ' 366' ' ' THR . 6.3 mmtp -50.35 -56.01 13.16 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.71 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.66 -53.3 14.05 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.435 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 368' ' ' ILE . . . -58.76 -57.25 13.85 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.119 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.411 ' HG2' HG21 ' A' ' 369' ' ' THR . 0.8 OUTLIER -61.0 -54.86 39.77 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 362' ' ' LYS . 64.0 p -51.11 -52.71 41.07 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -66.4 -38.04 86.59 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.799 HD11 HG11 ' A' ' 183' ' ' VAL . 12.5 pt -79.42 -30.1 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.411 HG21 ' HG2' ' A' ' 365' ' ' GLN . 63.9 p -94.84 -18.91 20.76 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 366' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.252 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.623 0.249 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -155.1 156.37 35.71 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -125.36 75.32 0.4 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.227 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -158.39 163.9 36.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.496 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -169.21 124.28 0.86 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.96 ' H ' ' CB ' ' A' ' 58' ' ' ASP . 4.9 p -124.7 112.26 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.399 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.475 HG23 HG23 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -96.82 143.56 12.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.887 -175.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.824 ' HB3' HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -104.29 127.21 51.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.635 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 39' ' ' HIS . 10.8 tt -158.55 164.89 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.016 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.57 HD22 HD22 ' A' ' 43' ' ' LEU . 1.8 m-80 -132.65 39.99 3.3 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.08 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.71 -15.46 58.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.482 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER 61.18 65.18 1.01 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.054 0.427 . . . . 0.0 109.921 -179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 2.3 mtmt 162.63 -170.78 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 296' ' ' ASP . . . 75.96 24.34 69.55 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CE1' HG23 ' A' ' 37' ' ' VAL . 38.8 m-85 -76.2 -36.71 58.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.793 0.797 . . . . 0.0 111.03 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 2.7 m120 -64.75 -49.37 71.04 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.637 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -72.27 -49.73 19.57 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.673 -0.775 . . . . 0.0 114.212 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.726 ' O ' HG21 ' A' ' 35' ' ' VAL . 3.5 mm? -59.22 -51.16 71.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.75 0.775 . . . . 0.0 110.193 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.443 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -66.0 -37.7 86.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 111.973 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -67.16 -37.5 83.88 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.747 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 19' ' ' GLY . 4.5 m -68.1 -61.18 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 121.76 -0.588 . . . . 0.0 110.087 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.511 ' H ' HG23 ' A' ' 23' ' ' VAL . . . -49.09 -34.16 16.0 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.374 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -50.43 69.42 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.447 1.117 . . . . 0.0 108.444 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -52.26 -42.31 63.56 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 112.874 -1.966 . . . . 0.0 108.677 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.823 ' HB3' HD13 ' A' ' 33' ' ' ILE . 71.7 m-85 -65.98 -32.22 73.57 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.756 0.789 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.791 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 7.2 tt0 -70.09 -51.8 28.88 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.022 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -52.07 -29.7 22.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 125.327 1.642 . . . . 0.0 111.254 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.804 ' O ' ' HB ' ' A' ' 31' ' ' THR . 3.5 m-20 -84.29 -38.07 20.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.187 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.804 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 4.5 t 159.79 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.84 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.38 38.7 0.02 OUTLIER Glycine 0 N--CA 1.466 0.658 0 C-N-CA 114.968 -3.491 . . . . 0.0 118.914 174.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.84 HD12 ' C ' ' A' ' 32' ' ' GLY . 2.1 mp -140.16 130.25 29.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 121.513 2.657 . . . . 0.0 115.65 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -137.16 105.16 5.64 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.726 HG21 ' O ' ' A' ' 20' ' ' LEU . 34.2 m -99.74 133.21 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.847 ' HB ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.0 147.19 45.09 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.532 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.445 HG23 ' CE1' ' A' ' 17' ' ' TYR . 17.9 m -133.34 123.32 46.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 122.164 -0.335 . . . . 0.0 110.404 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -111.59 139.8 46.74 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.1 78.95 25.75 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-O 120.841 0.353 . . . . 0.0 110.739 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 43' ' ' LEU . 60.7 Cg_endo -92.69 163.11 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.261 2.64 . . . . 0.0 113.307 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -90.72 -35.45 14.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -82.76 0.49 43.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.482 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 10' ' ' TRP . 54.1 tp -19.78 -49.31 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 1.081 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 mt-10 -67.29 -54.51 20.18 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.556 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.74 -43.62 62.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.905 0.383 . . . . 0.0 110.324 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.616 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.11 -56.13 23.27 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.955 0.883 . . . . 0.0 109.764 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.728 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 9.1 t80 -48.17 -60.95 3.59 Favored Pre-proline 0 C--O 1.219 -0.525 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.919 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 1.081 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 32.2 Cg_exo -60.22 -26.53 82.82 Favored 'Trans proline' 0 C--O 1.25 1.114 0 C-N-CA 121.278 1.318 . . . . 0.0 113.679 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -81.82 -38.76 25.03 Favored 'General case' 0 C--O 1.256 1.443 0 CA-C-O 122.161 0.981 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 54' ' ' GLY . 17.9 m -75.09 -39.26 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 CA-C-O 121.849 0.833 . . . . 0.0 109.832 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB1' ' OD1' ' A' ' 267' ' ' ASN . . . -50.16 -39.78 44.61 Favored 'General case' 0 C--N 1.372 1.553 0 C-N-CA 127.748 2.419 . . . . 0.0 111.593 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.46 -40.2 26.7 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.011 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -83.5 -7.23 59.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 77.82 -74.51 1.97 Allowed Glycine 0 C--N 1.352 1.45 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.184 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 t70 72.05 13.14 5.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.167 -1.016 . . . . 0.0 110.265 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . 57.72 59.38 10.93 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.094 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -101.39 171.36 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.38 2.72 . . . . 0.0 114.213 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.96 ' CB ' ' H ' ' A' ' 8' ' ' VAL . 25.1 m-20 -94.28 -133.12 0.17 Allowed 'General case' 0 N--CA 1.414 -2.257 0 C-N-CA 125.098 1.359 . . . . 0.0 109.137 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.64 HG13 ' HA ' ' A' ' 266' ' ' ILE . 9.6 tt -99.73 168.11 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 124.089 0.955 . . . . 0.0 112.477 -177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.804 HG23 ' HB2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -134.31 126.35 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 3.2 m-85 -108.15 125.4 51.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.603 ' CH2' ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -166.81 166.77 15.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.586 0.354 . . . . 0.0 110.062 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 62' ' ' TRP . . . -45.35 158.32 0.07 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.518 0.599 . . . . 0.0 112.519 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.942 ' HB2' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -77.5 -29.27 52.44 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -47.82 -53.72 14.64 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.825 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.39 -26.08 42.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.043 0.449 . . . . 0.0 110.098 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.609 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -57.44 -34.33 68.85 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 171.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.762 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -55.2 -69.65 1.2 Allowed Glycine 0 C--N 1.357 1.74 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 177.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.87 -54.16 23.39 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-N 112.996 -1.602 . . . . 0.0 111.363 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.493 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.4 m-30 -50.56 -40.53 52.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -48.63 -48.36 39.58 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.61 -31.08 46.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.138 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -70.26 -26.77 63.98 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.561 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.25 23.28 44.91 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.574 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 48' ' ' PRO . 4.0 mt -106.16 54.58 0.69 Allowed 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.911 0.386 . . . . 0.0 110.392 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.813 ' CG ' HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.13 145.13 0.25 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.877 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.966 ' HB3' HG23 ' A' ' 266' ' ' ILE . . . -72.2 74.65 0.97 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.208 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 1.7 pm0 -53.0 125.1 16.09 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.8 0.333 . . . . 0.0 110.495 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.642 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.1 mm -70.88 173.38 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.856 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.582 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -87.95 175.54 4.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 80' ' ' THR . 72.2 Cg_endo -79.2 101.49 1.43 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.052 1.835 . . . . 0.0 113.031 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 84' ' ' ALA . 18.1 t70 -145.46 107.76 4.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.251 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.18 0.22 52.47 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.499 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . . . -51.19 -32.99 25.44 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.579 0.228 . . . . 0.0 111.579 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.509 ' O ' HD12 ' A' ' 89' ' ' LEU . 22.7 m-85 -79.31 -59.06 2.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.882 0.372 . . . . 0.0 110.075 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.45 -27.92 40.71 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.544 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -76.32 -47.01 25.08 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.664 0.269 . . . . 0.0 110.833 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -67.86 -20.41 65.13 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.521 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.75 HD22 ' HZ2' ' A' ' 94' ' ' TRP . 5.1 mp -112.82 -163.46 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 121.454 -0.098 . . . . 0.0 110.879 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.458 ' CG ' ' HD2' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -84.68 146.78 47.41 Favored Pre-proline 0 C--N 1.34 0.175 0 O-C-N 121.992 -0.442 . . . . 0.0 111.641 -178.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 95' ' ' ASP . 61.0 Cg_endo -73.32 -35.03 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.234 1.956 . . . . 0.0 111.703 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CD2' ' HG2' ' A' ' 325' ' ' GLN . 63.2 m-85 -57.81 -62.43 1.81 Allowed 'General case' 0 C--O 1.246 0.872 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.884 HG23 ' CD1' ' A' ' 94' ' ' TRP . 1.8 t -62.58 -24.68 67.67 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.884 ' CD1' HG23 ' A' ' 93' ' ' THR . 36.5 m95 -93.43 -24.45 18.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.145 0.498 . . . . 0.0 111.877 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 91' ' ' PRO . 8.3 m-20 -71.08 -23.49 62.13 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.711 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.651 ' HA ' HD12 ' A' ' 329' ' ' ILE . . . -71.91 -43.21 65.7 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.942 HG12 ' HB2' ' A' ' 64' ' ' HIS . 27.2 m -102.54 43.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.45 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -128.81 139.47 52.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.507 ' O ' ' N ' ' A' ' 101' ' ' GLY . 3.2 t80 -118.48 90.74 3.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 119.262 0.937 . . . . 0.0 109.874 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.6 t30 48.29 -86.72 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . -127.63 39.2 1.97 Allowed Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.66 -177.34 5.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.48 0.312 . . . . 0.0 111.225 -178.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 97' ' ' VAL . 0.7 OUTLIER 168.71 128.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.399 0.545 . . . . 0.0 110.032 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.813 HD11 ' CG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -114.24 38.01 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.315 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 168.81 169.67 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.07 132.88 23.78 Favored Pre-proline 0 CA--C 1.528 0.122 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.277 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.768 ' HD3' HG21 ' A' ' 97' ' ' VAL . 90.8 Cg_endo -79.61 166.91 21.4 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.463 2.109 . . . . 0.0 113.211 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.822 ' O ' HG13 ' A' ' 302' ' ' VAL . 0.6 OUTLIER -162.31 38.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.364 178.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.729 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -179.8 136.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.166 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.708 ' O ' HG21 ' A' ' 320' ' ' THR . 21.7 t -123.58 105.89 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.541 ' HG2' ' HG3' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -116.68 131.16 57.02 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 -178.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.456 ' N ' HG23 ' A' ' 320' ' ' THR . . . -158.19 143.26 16.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.468 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.509 HD21 ' OE1' ' A' ' 153' ' ' GLU . 6.5 mp -77.89 143.43 37.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.936 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.409 ' OG ' ' HB1' ' A' ' 319' ' ' ALA . 1.8 m -133.3 169.46 16.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.76 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -91.16 128.41 36.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 1.021 HG23 HG23 ' A' ' 225' ' ' THR . 8.0 tp -116.95 140.43 39.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -153.63 161.44 42.16 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.396 0.279 . . . . 0.0 111.554 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.408 ' CB ' ' HB3' ' A' ' 121' ' ' LEU . 18.7 m120 -97.52 139.03 34.04 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -109.9 -4.84 15.73 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-N 113.096 -1.865 . . . . 0.0 111.23 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -43.56 6.78 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 124.781 2.229 . . . . 0.0 105.455 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.592 HD13 HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -76.35 -135.45 0.02 OUTLIER 'General case' 0 N--CA 1.396 -3.169 1 CA-C-N 107.678 -4.328 . . . . 0.0 113.216 -170.548 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.635 HD23 ' HD2' ' A' ' 123' ' ' PRO . 1.6 mt -82.66 148.26 57.61 Favored Pre-proline 0 C--N 1.287 -2.132 0 N-CA-C 119.98 3.326 . . . . 0.0 119.98 -167.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.635 ' HD2' HD23 ' A' ' 122' ' ' LEU . 1.4 Cg_exo -27.33 166.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 1 C-N-CA 130.354 7.369 . . . . 0.0 120.34 176.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.808 ' O ' HD11 ' A' ' 135' ' ' LEU . 18.8 m-80 -62.03 111.81 5.19 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.365 -172.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.96 167.78 25.45 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 124.055 3.17 . . . . 0.0 112.904 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.49 ' HD2' HD11 ' A' ' 147' ' ' LEU . 77.4 Cg_exo -49.66 111.13 0.45 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 123.324 2.683 . . . . 0.0 115.573 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -76.45 -25.64 54.58 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.084 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.91 147.31 43.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.489 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.579 ' HE3' HD21 ' A' ' 198' ' ' LEU . 65.3 m95 -67.92 -37.89 82.23 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 175.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.461 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.9 mp0 -58.82 -23.84 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.563 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 0.5 OUTLIER -87.03 -16.14 36.55 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.579 ' CG1' ' HD3' ' A' ' 133' ' ' PRO . 4.0 pt -52.37 -37.98 50.33 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 118.683 0.674 . . . . 0.0 111.417 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.881 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 52.3 Cg_exo -52.93 -33.26 61.1 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 N-CA-C 109.549 -0.981 . . . . 0.0 109.549 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.99 -58.59 3.19 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.808 HD11 ' O ' ' A' ' 124' ' ' ASN . 0.2 OUTLIER -68.21 -42.28 80.06 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.653 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.7 OUTLIER -69.21 -32.41 71.65 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.881 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -47.92 -50.14 27.84 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.061 176.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 35.3 mt-10 -62.35 -43.5 98.68 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.924 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.828 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.6 OUTLIER -60.36 -49.4 77.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -47.9 -44.11 29.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.04 -27.35 0.91 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.507 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -60.03 1.69 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.288 0.566 . . . . 0.0 109.891 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.84 42.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 118.934 -0.925 . . . . 0.0 111.073 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.687 ' HG3' HD23 ' A' ' 139' ' ' LEU . 9.0 ptpt -154.27 -171.88 4.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 119.514 1.657 . . . . 0.0 111.419 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.779 ' C ' HD22 ' A' ' 139' ' ' LEU . 2.5 m -141.56 161.8 37.04 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.828 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -75.47 -28.91 59.43 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.755 HD12 ' C ' ' A' ' 146' ' ' ALA . 5.7 mp -123.74 127.16 47.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.911 ' HB2' HG21 ' A' ' 222' ' ' THR . 8.8 tpt -134.1 127.9 33.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 120.039 1.29 . . . . 0.0 109.845 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.968 ' O ' ' O ' ' A' ' 150' ' ' ASN . 37.3 p90 -170.4 177.22 4.15 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.968 ' O ' ' O ' ' A' ' 149' ' ' PHE . 2.9 t-20 -28.42 -156.79 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 208' ' ' THR . 1.0 OUTLIER -178.15 40.58 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 120.992 -1.068 . . . . 0.0 111.055 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 151' ' ' LEU . 1.9 pp0? 172.86 32.92 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 168.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 157' ' ' THR . 0.2 OUTLIER -103.87 114.45 64.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 119.991 1.269 . . . . 0.0 107.585 177.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.787 ' HA ' ' OG1' ' A' ' 157' ' ' THR . 5.8 Cg_exo -79.77 36.98 0.64 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 119.265 0.773 . . . . 0.0 113.706 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 1.227 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 3.7 m-85 -97.79 -52.01 3.89 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 172.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.731 ' CZ ' HD12 ' A' ' 226' ' ' ILE . 42.5 t80 -74.66 -42.63 58.16 Favored 'General case' 0 C--O 1.251 1.141 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 153' ' ' GLU . 1.5 p -58.05 -57.03 14.63 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.487 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.559 ' HA ' HG12 ' A' ' 161' ' ' ILE . 7.5 m0 -49.54 -52.51 49.55 Favored Pre-proline 0 C--N 1.351 0.648 0 CA-C-O 120.78 0.324 . . . . 0.0 110.75 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 1.227 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 51.5 Cg_exo -44.44 -50.05 8.42 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.625 2.217 . . . . 0.0 113.171 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.48 ' HG ' ' CZ ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -60.4 -56.84 16.55 Favored 'General case' 0 CA--C 1.51 -0.567 0 O-C-N 122.026 -0.421 . . . . 0.0 109.908 -179.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 158' ' ' TRP . 14.1 pt -53.94 -22.6 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.831 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -77.23 -24.5 51.23 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.895 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 253' ' ' GLN . . . -41.19 -58.83 1.68 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.403 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 13.1 t70 -63.84 -58.06 7.96 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.345 -0.847 . . . . 0.0 112.6 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.69 21.38 0.03 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 117.648 -2.215 . . . . 0.0 116.823 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.12 160.13 40.15 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 119.086 1.443 . . . . 0.0 111.573 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -139.49 122.56 16.81 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.429 0.615 . . . . 0.0 109.743 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.878 ' O ' HG13 ' A' ' 183' ' ' VAL . . . -38.49 -78.54 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.291 0.567 . . . . 0.0 111.971 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.753 ' HB3' ' CB ' ' A' ' 176' ' ' TYR . 9.8 m-85 -113.64 176.07 5.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 1.159 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -101.54 102.1 12.78 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.05 114.51 18.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.53 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 23.9 tt0 -137.22 109.36 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.517 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 1.4 m-20 84.1 -32.38 0.07 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.862 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 160.28 13.9 0.03 OUTLIER Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.036 -0.869 . . . . 0.0 114.072 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -174.0 143.12 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.577 1.689 . . . . 0.0 110.943 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 1.159 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 37.0 p90 -64.98 -25.45 67.87 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.193 0.997 . . . . 0.0 110.805 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.471 ' O ' HD13 ' A' ' 178' ' ' ILE . 55.8 m-20 72.37 -106.91 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.743 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 177' ' ' ASP . 38.0 mm -159.16 -48.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -70.83 -4.01 21.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.72 95.56 3.5 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.276 -0.569 . . . . 0.0 112.12 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 18.9 t -117.98 131.04 71.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.434 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . -121.4 39.73 2.3 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 119.47 -1.348 . . . . 0.0 114.092 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 168' ' ' ALA . 6.4 m -79.1 -40.78 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.848 ' OD1' HD13 ' A' ' 361' ' ' LEU . 58.8 t0 -69.9 58.61 0.15 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.899 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 182' ' ' GLY . 5.9 p30 -110.33 175.94 5.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.982 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -80.45 -19.57 45.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.835 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -69.64 -48.84 40.58 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.3 98.6 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 193' ' ' THR . 0.0 OUTLIER -56.99 -59.4 5.12 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.215 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 193' ' ' THR . . . -50.43 -41.66 52.87 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.253 1.025 . . . . 0.0 112.051 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -70.45 -60.51 4.67 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.659 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.628 ' O ' HG23 ' A' ' 196' ' ' VAL . 9.2 tt -56.05 -29.26 60.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 189' ' ' LYS . 14.8 p -66.87 -41.09 87.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 194' ' ' PHE . 0.0 OUTLIER -59.48 -37.74 79.02 Favored 'General case' 0 C--N 1.349 0.563 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.512 HD23 HD11 ' A' ' 199' ' ' ILE . 0.4 OUTLIER -62.72 -47.56 83.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.782 178.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 192' ' ' LEU . 43.6 t -58.22 -29.88 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.28 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.18 -45.4 85.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.732 0.777 . . . . 0.0 110.969 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.579 HD21 ' HE3' ' A' ' 129' ' ' TRP . 11.2 mp -57.34 -57.02 14.47 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.77 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.512 HD11 HD23 ' A' ' 195' ' ' LEU . 3.8 mt -65.16 -32.33 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.969 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -56.4 -38.61 71.73 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 118.56 -0.734 . . . . 0.0 111.042 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -113.41 -34.97 5.43 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 121.086 3.735 . . . . 0.0 121.086 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.67 -66.1 1.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 199' ' ' ILE . 0.2 OUTLIER -36.45 -34.54 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 203' ' ' HIS . 2.2 ttp -36.0 97.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.707 0.289 . . . . 0.0 111.63 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.95 -173.19 3.83 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.064 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -85.61 58.66 5.17 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.626 ' HA ' HD23 ' A' ' 151' ' ' LEU . 2.3 p30 37.85 74.13 0.09 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 30.8 p -55.18 121.4 8.74 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.59 -173.65 4.43 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.0 p90 -69.49 -45.39 69.05 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 1.7 m -70.18 -35.93 74.3 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.89 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.17 -48.44 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.745 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.0 -30.93 71.97 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -47.66 85.03 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.54 77.65 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.276 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.44 ' CB ' ' HG2' ' A' ' 148' ' ' MET . . . -54.27 -57.68 10.29 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.947 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.787 ' CB ' HD11 ' A' ' 235' ' ' ILE . 2.6 t80 -58.57 -29.6 66.53 Favored 'General case' 0 C--O 1.23 0.071 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -53.79 -40.41 66.27 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -74.66 -23.92 58.73 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 65.66 54.79 23.65 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.419 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -116.03 37.2 3.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.452 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.911 HG21 ' HB2' ' A' ' 148' ' ' MET . 82.8 p -144.56 143.53 30.86 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.773 0.796 . . . . 0.0 110.213 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -102.08 38.3 1.69 Allowed 'General case' 0 C--N 1.352 0.674 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 36.1 ttm 177.24 147.06 0.12 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 1.021 HG23 HG23 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -142.43 170.26 16.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.701 0.762 . . . . 0.0 111.558 -176.106 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.731 HD12 ' CZ ' ' A' ' 156' ' ' PHE . 24.8 mm -120.68 130.34 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 172.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -147.31 166.69 26.33 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 123.759 0.823 . . . . 0.0 110.474 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -108.15 -162.88 21.02 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.47 -0.395 . . . . 0.0 112.741 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.541 ' HG3' ' HG2' ' A' ' 111' ' ' GLU . 56.2 Cg_endo -87.54 -20.72 2.01 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.128 2.552 . . . . 0.0 114.081 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.464 ' CB ' ' HB3' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -178.65 -42.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.65 62.37 6.46 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.803 0.335 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -107.7 -63.06 1.35 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.781 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 169.2 -176.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.658 0.266 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.83 58.85 2.31 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.795 0.331 . . . . 0.0 110.72 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.787 HD11 ' CB ' ' A' ' 217' ' ' PHE . 14.6 tt -86.69 145.47 7.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.174 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -100.67 123.5 44.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.5 p -61.3 137.72 58.24 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.871 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -43.94 84.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.45 159.74 41.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.771 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.2 m -55.9 -40.02 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.648 0.261 . . . . 0.0 111.372 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 137.26 37.2 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.651 0.262 . . . . 0.0 110.741 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.413 ' CD1' HD11 ' A' ' 116' ' ' ILE . 10.5 p90 -149.23 137.31 20.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 111.323 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.531 ' O ' HD12 ' A' ' 116' ' ' ILE . . . -95.0 133.4 11.52 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.007 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.967 HG22 HD13 ' A' ' 116' ' ' ILE . 1.7 t -115.16 133.87 60.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.867 0.334 . . . . 0.0 111.268 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.76 167.56 17.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -170.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 45.9 t -73.29 154.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 113.893 -1.503 . . . . 0.0 107.871 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.525 HD11 HD21 ' A' ' 323' ' ' ASN . 1.8 mt -57.61 159.29 9.69 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.627 -177.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -78.26 -157.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.926 2.417 . . . . 0.0 112.906 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 253' ' ' GLN . 11.0 p -125.29 169.47 12.26 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.48 ' CZ ' ' HG ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -162.59 110.57 1.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.075 178.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.34 32.08 17.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.421 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.69 38.41 24.1 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.033 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.514 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 3.7 mt-30 -156.54 153.94 25.88 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 74.8 Cg_endo -86.37 -171.19 0.78 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.444 2.763 . . . . 0.0 113.263 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -109.28 141.02 42.19 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.988 0.423 . . . . 0.0 111.812 -179.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 5.5 ttmm -88.17 121.41 70.49 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.072 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.476 ' O ' ' HA2' ' A' ' 327' ' ' GLY . 55.1 Cg_endo -91.61 152.6 3.51 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.538 2.825 . . . . 0.0 114.417 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' A' ' 155' ' ' TYR . 5.9 m-85 -78.12 157.28 29.52 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 329' ' ' ILE . 20.8 t -110.56 121.82 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -125.11 119.52 3.63 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 118.673 -1.727 . . . . 0.0 117.069 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.769 HG21 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -114.38 108.53 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.729 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 1.6 tp -83.41 109.12 17.05 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.585 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -113.05 -178.12 3.3 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.509 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -111.01 128.81 55.97 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.743 ' O ' HD12 ' A' ' 60' ' ' ILE . . . -123.27 122.62 5.01 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.932 -1.128 . . . . 0.0 115.022 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.966 HG23 ' HB3' ' A' ' 77' ' ' ALA . 4.6 tp -90.86 122.47 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.596 ' HB2' HD11 ' A' ' 60' ' ' ILE . 62.7 t30 -61.82 141.89 57.66 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.23 -23.42 47.86 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.948 -0.47 . . . . 0.0 111.105 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.439 ' HB3' ' ND2' ' A' ' 267' ' ' ASN . . . -98.5 49.07 0.98 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.36 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 38.8 t -171.9 89.5 0.43 Allowed Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 272' ' ' ASN . 72.7 Cg_endo -76.42 164.19 31.12 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.625 2.217 . . . . 0.0 111.906 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.612 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 0.2 OUTLIER 165.69 57.24 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.709 0.29 . . . . 0.0 110.938 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -56.3 -54.1 49.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.452 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -56.68 7.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.16 -48.58 79.43 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -76.78 -56.84 4.25 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.1 OUTLIER -55.67 -41.02 73.09 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.513 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -53.17 8.62 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 27' ' ' PHE . 2.4 t80 -55.09 -59.44 4.75 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.59 -43.19 35.78 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.815 0.817 . . . . 0.0 111.245 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 285' ' ' LEU . 51.9 mt-10 -73.8 -35.36 64.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.37 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.414 ' O ' ' CG2' ' A' ' 286' ' ' THR . 3.6 m-20 -89.99 -16.39 29.94 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.479 ' O ' ' CG2' ' A' ' 286' ' ' THR . 28.0 t80 -103.72 -74.36 0.64 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 290' ' ' LEU . 0.1 OUTLIER -46.08 -27.57 0.98 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -102.07 39.41 1.48 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 283' ' ' TYR . 0.0 OUTLIER -140.72 152.83 45.6 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 175.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.795 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -62.93 -42.37 99.78 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -75.36 -19.39 59.61 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.548 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.463 ' HA3' HG23 ' A' ' 286' ' ' THR . . . -82.54 -55.13 3.09 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.897 HD21 ' HA ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -68.23 -28.46 67.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.795 ' HB2' ' O ' ' A' ' 287' ' ' ASP . 32.0 mt-10 -71.91 -32.39 67.34 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.453 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.39 80.37 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 296' ' ' ASP . 61.0 t -67.64 -61.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 297' ' ' LYS . 36.9 t-20 -46.41 -46.8 18.85 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.713 1.205 . . . . 0.0 112.545 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -48.87 79.49 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.8 ' O ' ' HD3' ' A' ' 298' ' ' PRO . 76.7 m-20 -58.04 -47.02 84.36 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 294' ' ' ASN . 0.9 OUTLIER -96.37 91.05 0.8 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.623 -178.101 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.8 ' HD3' ' O ' ' A' ' 296' ' ' ASP . 75.9 Cg_endo -106.83 93.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 124.318 3.346 . . . . 0.0 112.752 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.584 HD12 ' HD2' ' A' ' 298' ' ' PRO . 1.5 mp -161.1 -80.72 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.103 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -108.39 -160.28 20.16 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.573 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.795 ' HB2' HG23 ' A' ' 317' ' ' ILE . . . -79.17 74.32 5.73 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.074 0.464 . . . . 0.0 111.613 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.822 HG13 ' O ' ' A' ' 108' ' ' ILE . 53.7 t -97.22 76.13 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.897 ' HA ' HD21 ' A' ' 290' ' ' LEU . . . -177.28 107.51 0.06 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.718 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 303' ' ' ALA . 5.9 mp -22.84 179.68 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.627 ' H ' HD23 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -55.08 -55.47 30.7 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -177.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 83.2 p -57.09 -47.95 79.79 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-O 121.479 0.657 . . . . 0.0 111.761 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.642 ' CD2' HD13 ' A' ' 290' ' ' LEU . 88.7 m-85 -67.42 -54.57 19.19 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.158 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.735 ' CD ' ' HB1' ' A' ' 301' ' ' ALA . 4.4 mt-10 -61.11 -36.83 80.75 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.717 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.406 ' HG3' ' CD ' ' A' ' 305' ' ' LYS . 2.7 mm-40 -48.12 -49.66 31.3 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.889 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -71.36 -41.27 69.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.087 0.946 . . . . 0.0 109.529 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 311' ' ' LEU . 0.9 OUTLIER -55.97 -16.63 5.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.036 176.256 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 308' ' ' GLU . . . -46.22 -30.46 2.0 Allowed 'General case' 0 C--N 1.342 0.271 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.455 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -48.38 -34.79 11.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.53 158.26 11.71 Favored Pre-proline 0 N--CA 1.462 0.145 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.489 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -85.85 -46.67 0.04 OUTLIER 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.485 2.124 . . . . 0.0 114.521 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -58.9 6.24 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' A' ' 301' ' ' ALA . 1.3 mm -49.67 -56.24 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.81 -51.87 12.16 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.356 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.409 ' HB1' ' OG ' ' A' ' 114' ' ' SER . . . -65.15 -39.01 92.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.725 0.774 . . . . 0.0 109.812 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.708 HG21 ' O ' ' A' ' 110' ' ' VAL . 29.8 m -58.81 -42.83 90.09 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.49 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.5 ttp -63.64 -53.21 55.11 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -39.0 58.46 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.156 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.525 HD21 HD11 ' A' ' 247' ' ' LEU . 0.9 OUTLIER -74.94 -44.23 49.72 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.017 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -48.76 -45.39 39.74 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 110.333 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . 0.449 ' HG2' ' CD2' ' A' ' 92' ' ' PHE . 10.6 mt-30 -63.68 -39.06 93.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.952 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -69.7 -20.04 63.55 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.389 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 257' ' ' PRO . . . -79.85 155.7 39.29 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.131 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 259' ' ' VAL . 0.6 OUTLIER -96.23 138.23 34.13 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 96' ' ' ALA . 23.5 mm -61.85 106.16 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 119.525 1.057 . . . . 0.0 110.904 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.14 107.03 0.73 Allowed Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 120.548 0.214 . . . . 0.0 111.14 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.15 -30.6 32.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.365 2.044 . . . . 0.0 112.141 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 68.2 91.56 0.09 Allowed 'General case' 0 C--N 1.339 0.12 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.295 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 335' ' ' GLN . 1.0 OUTLIER -133.91 144.91 53.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.195 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.36 -27.86 60.15 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.55 2.166 . . . . 0.0 111.979 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.755 ' HB2' HD12 ' A' ' 333' ' ' ILE . 2.1 mp0 -61.1 -25.21 66.8 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.136 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.2 mmt -46.13 -41.0 11.85 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.687 0.279 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.99 -39.27 65.92 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 1.074 ' HB1' HG22 ' A' ' 368' ' ' ILE . . . -55.07 -29.42 57.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.319 0.58 . . . . 0.0 110.8 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 343' ' ' VAL . 2.2 m-85 -78.77 -55.73 4.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.048 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -42.88 -44.69 4.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.842 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -76.57 -38.52 54.8 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.52 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.538 ' HB1' ' CB ' ' A' ' 364' ' ' ALA . . . -68.08 -44.55 76.04 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 17.8 m -73.13 -42.23 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.347 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.406 ' N ' HG23 ' A' ' 343' ' ' VAL . 0.0 OUTLIER -55.38 -57.14 13.1 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.006 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 1.1 m -58.1 -55.63 32.41 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.06 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.34 -60.96 2.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 351' ' ' ALA . 48.7 t -51.73 -47.05 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.1 mt -72.27 -47.91 51.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.911 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 345' ' ' THR . 76.6 m-20 -67.57 -43.28 81.0 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.836 ' HB1' ' HA ' ' A' ' 355' ' ' GLN . . . -78.38 -26.57 46.61 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -58.6 -10.12 2.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 23.2 t -110.63 31.24 6.12 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 91.21 33.15 8.3 Favored Glycine 0 N--CA 1.417 -2.595 0 C-N-CA 116.844 -2.598 . . . . 0.0 114.779 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -127.8 35.12 4.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.836 ' HA ' ' HB1' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -70.01 -174.48 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 1 N-CA-C 122.295 4.183 . . . . 0.0 122.295 -159.352 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.1 OUTLIER 173.9 57.7 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.347 179.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.829 ' O ' HD12 ' A' ' 361' ' ' LEU . 79.1 t -46.28 -41.85 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 3.0 t0 -63.13 -38.5 91.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 118.902 0.774 . . . . 0.0 110.395 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.537 ' CB ' ' HB ' ' A' ' 356' ' ' THR . 0.4 OUTLIER -80.14 -29.59 38.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.634 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -67.05 -54.02 25.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.919 0.866 . . . . 0.0 112.507 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.848 HD13 ' OD1' ' A' ' 184' ' ' ASP . 0.8 OUTLIER -82.64 -36.4 26.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.758 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 23.1 tttp -59.75 -51.97 67.47 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.823 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -44.77 65.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.239 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 368' ' ' ILE . . . -72.54 -57.81 3.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.422 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.493 ' HA ' ' CG1' ' A' ' 368' ' ' ILE . 28.0 tt0 -55.94 -42.25 75.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.9 m -65.25 -48.09 74.46 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.654 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -73.78 -44.37 56.22 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.019 -0.425 . . . . 0.0 111.154 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 1.074 HG22 ' HB1' ' A' ' 338' ' ' ALA . 2.1 pp -62.13 -32.95 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.507 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.651 HG23 HD12 ' A' ' 368' ' ' ILE . 0.6 OUTLIER -131.46 61.49 1.64 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.908 0.385 . . . . 0.0 111.154 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 56.7 tptt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.849 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.613 0.244 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -154.24 139.98 18.04 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.062 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -129.61 47.39 1.02 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.545 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -140.78 162.09 36.26 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.718 ' CB ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -132.4 122.56 25.18 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.839 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.037 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -116.47 115.52 49.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.737 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.949 HD12 HD22 ' A' ' 20' ' ' LEU . 7.8 mt -120.74 131.11 73.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.935 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.868 ' HE3' HD12 ' A' ' 43' ' ' LEU . 3.3 m0 -107.38 123.44 48.37 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.48 HD11 HG21 ' A' ' 9' ' ' ILE . 3.4 mt -155.67 166.12 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.846 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.671 ' O ' ' N ' ' A' ' 14' ' ' ASP . 3.5 m120 -78.84 48.84 0.86 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 120.014 1.279 . . . . 0.0 111.255 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.541 ' HA3' ' HB3' ' A' ' 39' ' ' HIS . . . -8.28 59.78 0.0 OUTLIER Glycine 0 C--N 1.348 1.202 0 C-N-CA 124.843 1.211 . . . . 0.0 115.923 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.671 ' N ' ' O ' ' A' ' 12' ' ' ASN . 72.2 m-20 -100.0 3.77 44.42 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.017 0.437 . . . . 0.0 110.177 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 162.99 -164.62 0.0 OUTLIER 'General case' 0 C--N 1.347 0.491 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.863 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.682 ' O ' HD12 ' A' ' 20' ' ' LEU . . . 70.66 34.3 66.99 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 117.038 1.575 . . . . 0.0 117.038 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.18 -59.72 2.54 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 11.5 p-10 -46.35 -42.39 14.8 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.055 0.455 . . . . 0.0 111.945 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.637 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -70.34 -45.41 55.01 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.578 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.956 HD13 HG11 ' A' ' 37' ' ' VAL . 18.7 mt -60.77 -49.69 76.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.446 0.623 . . . . 0.0 111.081 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.05 -39.49 63.47 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 3.1 mm-40 -64.52 -36.08 83.05 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.762 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 19' ' ' GLY . 23.2 m -67.87 -57.19 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.663 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.678 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . -49.58 -45.84 37.9 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.111 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 -50.41 41.21 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.263 1.03 . . . . 0.0 109.7 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -41.9 60.13 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.155 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.665 ' HB3' HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.65 -25.94 67.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.088 0.947 . . . . 0.0 111.084 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.773 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 7.9 tt0 -73.2 -52.05 15.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.654 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -52.73 -28.54 22.58 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 124.514 1.134 . . . . 0.0 110.576 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.838 ' O ' HG23 ' A' ' 31' ' ' THR . 0.5 OUTLIER -84.09 -37.68 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 117.626 -1.178 . . . . 0.0 108.844 178.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.85 37.79 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 171.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.811 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.26 38.57 0.02 OUTLIER Glycine 0 N--CA 1.463 0.494 0 C-N-CA 114.989 -3.482 . . . . 0.0 119.299 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.811 HD12 ' C ' ' A' ' 32' ' ' GLY . 1.8 mp -139.89 139.0 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 122.243 3.021 . . . . 0.0 117.005 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -142.36 104.51 4.43 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.718 HG22 ' CB ' ' A' ' 7' ' ' LEU . 38.1 t -82.8 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.9 p -117.5 137.43 52.55 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.008 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.956 HG11 HD13 ' A' ' 20' ' ' LEU . 6.9 m -130.69 121.55 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 O-C-N 122.231 -0.293 . . . . 0.0 110.507 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.435 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 2.5 tt0 -111.83 133.83 53.79 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.541 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . 46.1 p-80 -106.08 71.29 0.25 Allowed Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 120.682 0.277 . . . . 0.0 111.462 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.551 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 86.6 Cg_endo -78.07 -171.68 1.27 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.274 2.649 . . . . 0.0 113.627 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -125.22 -60.24 1.35 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 0.57 34.12 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.045 0.45 . . . . 0.0 110.92 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.868 HD12 ' HE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -32.91 -45.68 0.13 Allowed 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 1.014 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 3.6 tm-20 -47.11 -54.93 9.35 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.042 -0.411 . . . . 0.0 112.104 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.12 -48.8 21.98 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.785 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 50' ' ' VAL . 24.5 mtpt -63.51 -56.81 13.07 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.167 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.78 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.9 t80 -45.42 -58.44 5.89 Favored Pre-proline 0 C--O 1.225 -0.191 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 1.014 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 38.9 Cg_exo -65.78 -36.38 32.25 Favored 'Trans proline' 0 C--O 1.249 1.031 0 C-N-CA 121.088 1.192 . . . . 0.0 114.628 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -66.81 -52.18 46.93 Favored 'General case' 0 C--O 1.259 1.588 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 175.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 46' ' ' LYS . 12.0 m -61.56 -21.22 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 122.231 1.015 . . . . 0.0 111.637 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 48' ' ' PRO . . . -60.85 -29.31 69.45 Favored 'General case' 0 C--N 1.393 2.459 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.643 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -82.46 -26.8 32.33 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.411 1.484 . . . . 0.0 112.946 -178.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 53' ' ' THR . 13.1 t -92.47 95.79 9.85 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.083 -0.647 . . . . 0.0 112.073 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 102.27 -71.24 0.33 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.487 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 21.2 m-20 94.77 107.03 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.115 1.457 . . . . 0.0 110.461 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 57' ' ' PRO . . . -163.41 -59.05 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.388 -0.91 . . . . 0.0 114.039 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.525 ' O ' ' O ' ' A' ' 56' ' ' GLY . 59.0 Cg_exo -22.9 157.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.797 3.665 . . . . 0.0 115.937 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 1.037 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 5.1 t70 -79.95 -133.86 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.822 0 C-N-CA 125.241 1.416 . . . . 0.0 112.286 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 265' ' ' GLY . 5.5 mm -105.77 159.31 5.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.857 HG23 ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -128.52 136.01 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.45 -178.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.936 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -117.97 113.85 22.31 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 34.6 t-105 -166.48 165.14 17.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.988 0.515 . . . . 0.0 109.846 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -37.74 154.48 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.822 0.737 . . . . 0.0 112.11 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.82 ' CD2' HG13 ' A' ' 97' ' ' VAL . 9.1 t-80 -77.24 -28.3 53.62 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.436 ' OD2' ' HB1' ' A' ' 63' ' ' ALA . 1.3 p30 -50.46 -51.49 46.45 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.984 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -77.85 -27.3 49.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.303 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.857 ' CZ ' HG23 ' A' ' 60' ' ' ILE . 4.6 m-85 -64.73 -28.62 69.71 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 174.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.48 -63.89 4.6 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 332' ' ' ASN . . . -54.9 -52.29 47.49 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 113.471 -1.365 . . . . 0.0 111.656 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HB2' HD12 ' A' ' 76' ' ' LEU . 4.8 m-30 -54.52 -45.87 73.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.786 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . . . -50.84 -40.7 56.59 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.852 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.22 -60.33 2.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 m -113.78 -26.76 8.05 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' LEU . . . -56.78 -86.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.078 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.999 HD23 ' HB3' ' A' ' 268' ' ' ALA . 0.0 OUTLIER 167.98 66.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.007 HD22 HD12 ' A' ' 104' ' ' ILE . 1.7 mt -110.54 136.37 49.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 110.926 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -102.23 106.33 17.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.456 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.437 ' CG ' HG12 ' A' ' 104' ' ' ILE . 77.7 mt-10 -47.75 154.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.927 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 105' ' ' ALA . 20.1 mt -109.41 136.81 44.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.053 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 m -112.97 82.74 5.46 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.834 0.349 . . . . 0.0 110.764 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.05 -173.86 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.738 2.292 . . . . 0.0 112.229 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -88.49 117.91 27.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.593 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -33.24 4.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.462 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -57.55 -27.12 62.36 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.879 ' CE1' HD11 ' A' ' 285' ' ' LEU . 11.6 t80 -79.23 -59.22 2.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.832 0.349 . . . . 0.0 110.314 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.492 ' HG2' ' CD1' ' A' ' 94' ' ' TRP . 1.3 tt0 -60.94 -33.25 72.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.966 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -76.68 -31.9 57.56 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.972 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 7.1 mtpm? -80.34 -1.6 41.79 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.456 HD21 ' N ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -122.71 -171.25 2.24 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.323 0.51 . . . . 0.0 110.994 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.23 117.24 52.69 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.667 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.55 -41.51 67.71 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.581 2.187 . . . . 0.0 112.671 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -50.03 -45.3 51.91 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.726 0.298 . . . . 0.0 111.323 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.708 ' CG2' HG22 ' A' ' 302' ' ' VAL . 2.4 m -61.17 -28.23 68.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.492 ' CD1' ' HG2' ' A' ' 86' ' ' GLN . 17.8 m95 -92.95 -24.72 18.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.317 0.58 . . . . 0.0 111.985 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -73.91 -22.65 59.61 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.842 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.82 ' HB1' HG13 ' A' ' 261' ' ' VAL . . . -53.19 -48.16 68.3 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.82 HG13 ' CD2' ' A' ' 64' ' ' HIS . 3.8 t -103.09 39.6 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 134.58 40.31 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.4 OUTLIER -113.84 91.06 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.806 0.73 . . . . 0.0 110.751 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 99' ' ' TYR . 31.5 t30 69.62 -70.2 0.15 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.085 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.96 -41.65 0.98 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.281 -0.962 . . . . 0.0 114.207 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -125.96 -178.28 4.24 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.369 0.584 . . . . 0.0 109.869 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 103' ' ' LEU . 0.5 OUTLIER -116.82 139.26 50.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.007 HD12 HD22 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -96.13 38.0 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.977 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 160.72 -179.67 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 264' ' ' ALA . 20.6 p90 -118.94 127.5 26.49 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.708 ' HB3' HG12 ' A' ' 261' ' ' VAL . 72.6 Cg_endo -79.58 165.66 22.57 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 C-N-CA 122.265 1.977 . . . . 0.0 112.731 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 107' ' ' PRO . 1.7 pt -160.89 38.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.807 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.929 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . 178.56 110.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.833 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.037 HG23 HG11 ' A' ' 302' ' ' VAL . 17.0 t -98.43 111.26 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -103.15 163.12 12.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.624 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.676 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -164.88 150.29 9.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.537 0.684 . . . . 0.0 111.981 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.814 ' O ' HD12 ' A' ' 113' ' ' LEU . 4.6 pp -79.19 127.66 32.32 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.407 ' HA ' ' CD2' ' A' ' 247' ' ' LEU . 0.3 OUTLIER -130.56 166.77 19.91 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 116' ' ' ILE . 6.7 tt -106.22 136.44 45.92 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.801 ' CD1' HD11 ' A' ' 235' ' ' ILE . 1.8 mp -112.93 129.65 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.501 0.667 . . . . 0.0 111.764 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.578 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 24.6 p90 -94.33 -174.22 3.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.864 2.466 . . . . 0.0 110.156 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.597 ' CB ' ' HB2' ' A' ' 122' ' ' LEU . 0.4 OUTLIER -154.0 130.82 10.84 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.991 0.814 . . . . 0.0 110.002 177.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 43.15 1.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.151 0.887 . . . . 0.0 111.421 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.67 -71.76 0.34 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 110.474 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -142.35 38.48 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.406 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.597 ' HB2' ' CB ' ' A' ' 118' ' ' ASN . 71.2 mt -157.97 72.91 4.1 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.647 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.36 133.28 25.89 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.445 2.097 . . . . 0.0 113.398 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.547 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 1.8 p-10 -71.22 159.98 83.9 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 67.7 Cg_endo -72.97 167.84 26.28 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.551 2.834 . . . . 0.0 111.946 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.63 -139.56 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.662 2.241 . . . . 0.0 113.312 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 128' ' ' THR . 0.0 OUTLIER -85.5 -17.62 35.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.91 0.777 . . . . 0.0 112.518 -179.028 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.473 HG22 ' HG2' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -118.13 142.17 47.71 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.567 ' CZ2' HD22 ' A' ' 147' ' ' LEU . 6.3 t-105 -71.23 -28.39 64.15 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 173.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.539 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -44.49 -23.49 0.12 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.61 -21.25 62.67 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.834 HG23 ' HD3' ' A' ' 133' ' ' PRO . 2.1 tp -45.94 -47.28 41.88 Favored Pre-proline 0 N--CA 1.475 0.782 0 CA-C-N 118.579 0.627 . . . . 0.0 112.297 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.834 ' HD3' HG23 ' A' ' 132' ' ' ILE . 11.9 Cg_endo -52.48 -42.2 62.89 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 109.398 -1.039 . . . . 0.0 109.398 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.3 -58.7 3.12 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 139' ' ' LEU . 3.1 mm? -67.79 -35.51 78.79 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.689 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 132' ' ' ILE . 20.0 t0 -74.97 -41.55 59.35 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -49.86 -42.17 46.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.806 177.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.2 mm-40 -67.59 -36.26 80.54 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.906 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -65.21 -46.68 79.68 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.78 -44.1 38.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -45.97 -23.48 0.3 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.645 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -113.06 -58.75 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.446 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.78 53.41 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.75 ' HG3' HD23 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -167.01 -172.99 2.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 120.15 1.975 . . . . 0.0 110.013 -177.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.804 ' O ' HD22 ' A' ' 139' ' ' LEU . 54.5 m -144.27 165.13 28.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.906 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -79.51 -20.34 47.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.567 HD22 ' CZ2' ' A' ' 129' ' ' TRP . 4.4 pp -152.48 178.26 9.74 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.871 ' HB2' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -179.21 143.34 0.2 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.336 178.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.486 ' O ' ' O ' ' A' ' 150' ' ' ASN . 26.4 p90 -172.85 175.93 3.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.746 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 149' ' ' PHE . 3.0 m120 -37.01 164.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.767 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 208' ' ' THR . 1.0 OUTLIER -110.51 -58.69 2.05 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -102.71 35.59 2.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 116.92 -1.912 . . . . 0.0 114.035 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.766 ' O ' ' HB ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -79.63 144.23 60.41 Favored Pre-proline 0 C--O 1.221 -0.42 0 CA-C-N 121.957 2.162 . . . . 0.0 114.932 -175.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.941 ' O ' ' N ' ' A' ' 156' ' ' PHE . 6.3 Cg_exo -78.07 -135.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 1 C-N-CA 125.72 4.28 . . . . 0.0 106.945 177.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 1.123 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 1.8 m-85 16.96 -51.87 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.941 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.2 OUTLIER -84.61 -55.92 3.87 Favored 'General case' 0 C--O 1.259 1.562 0 C-N-CA 124.452 1.101 . . . . 0.0 112.129 -178.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.766 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 95.9 m -57.71 -42.53 83.97 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.51 ' CE3' ' HA ' ' A' ' 154' ' ' PRO . 0.7 OUTLIER -51.16 -55.71 26.1 Favored Pre-proline 0 C--N 1.349 0.564 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 1.123 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 40.1 Cg_exo -43.13 -50.65 6.25 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.166 2.578 . . . . 0.0 113.284 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mt -61.83 -56.75 16.11 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 119.925 1.238 . . . . 0.0 109.832 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 192' ' ' LEU . 4.6 mm -52.85 -18.74 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.153 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -78.03 -25.88 48.09 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -43.09 -58.61 2.38 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.51 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 9.3 t0 -65.0 -28.64 69.64 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.416 ' N ' ' HA3' ' A' ' 187' ' ' GLY . . . 147.32 23.44 0.09 OUTLIER Glycine 0 CA--C 1.526 0.721 0 C-N-CA 118.516 -1.802 . . . . 0.0 116.946 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -104.2 86.77 0.53 Allowed Glycine 0 C--N 1.335 0.503 0 CA-C-N 119.021 1.411 . . . . 0.0 113.225 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -104.74 -179.46 3.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.007 0.403 . . . . 0.0 110.04 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.71 -78.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.152 0.501 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.645 ' HB3' ' CD1' ' A' ' 176' ' ' TYR . 1.1 m-85 -125.89 172.78 9.61 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.041 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 1.226 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.8 OUTLIER -112.57 139.3 48.27 Favored 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -174.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.97 116.56 29.13 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.641 ' O ' ' C ' ' A' ' 173' ' ' ASN . 2.7 mm-40 -137.44 178.66 6.93 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.147 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.641 ' C ' ' O ' ' A' ' 172' ' ' GLU . 4.8 m120 -20.05 -64.4 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -80.79 -71.9 1.25 Allowed Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -174.57 170.02 3.55 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.891 1.346 . . . . 0.0 107.439 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 1.226 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 1.3 p90 -49.95 -33.43 17.59 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 123.102 1.43 . . . . 0.0 109.908 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.556 ' C ' HG22 ' A' ' 178' ' ' ILE . 12.9 m-20 65.2 -76.84 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.463 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 1.0 HD11 ' HB ' ' A' ' 369' ' ' THR . 0.0 OUTLIER 174.7 -51.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.834 ' N ' HD13 ' A' ' 178' ' ' ILE . 6.6 mmtt -51.78 -47.73 64.07 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.502 ' CB ' ' HD3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -77.96 91.66 4.24 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.825 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.477 HG12 HG13 ' A' ' 183' ' ' VAL . 4.2 t -112.54 152.41 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.536 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -115.09 40.11 2.56 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 114.84 -1.073 . . . . 0.0 114.579 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.72 HG12 ' CE1' ' A' ' 339' ' ' PHE . 35.4 m -90.17 -32.41 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.812 0.306 . . . . 0.0 111.135 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -100.67 59.39 0.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.274 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -115.72 145.89 42.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.643 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.54 -25.64 67.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.173 0.511 . . . . 0.0 111.69 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -77.29 -33.58 43.81 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-O 119.093 -0.837 . . . . 0.0 114.938 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.99 -56.51 21.04 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -57.53 -60.15 4.1 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.002 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.47 -41.85 53.59 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.685 0.755 . . . . 0.0 112.035 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -62.27 -60.66 7.59 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.412 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.92 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -58.29 -24.41 59.41 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 122.539 -0.389 . . . . 0.0 110.175 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 32.3 m -66.83 -49.26 66.34 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 2.7 p90 -61.59 -34.41 75.57 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 199' ' ' ILE . 0.7 OUTLIER -63.93 -47.94 78.5 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 192' ' ' LEU . 48.5 t -56.59 -29.89 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.223 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.85 -46.92 82.81 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.599 0.714 . . . . 0.0 110.905 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.587 ' CD1' HG21 ' A' ' 132' ' ' ILE . 7.1 tp -61.07 -53.65 54.49 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.1 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 204' ' ' MET . 3.6 mt -62.37 -44.54 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.806 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -52.32 -36.93 54.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.907 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -113.18 -34.51 5.65 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 121.051 3.722 . . . . 0.0 121.051 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -62.22 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.863 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -5.4 26.92 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.565 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 6.1 ptm 41.7 37.6 0.78 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.533 ' O ' HG23 ' A' ' 199' ' ' ILE . 4.5 m120 -139.56 162.07 35.98 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.427 ' HA ' ' HG ' ' A' ' 151' ' ' LEU . . . -147.93 24.03 1.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.45 -3.06 34.5 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -56.19 117.92 4.22 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.544 ' OD2' HD12 ' A' ' 212' ' ' ILE . 2.7 p30 -95.71 -174.15 3.07 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.735 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -67.27 -47.09 71.74 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.017 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -77.2 -25.38 51.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.572 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.544 HD12 ' OD2' ' A' ' 209' ' ' ASP . 3.7 mt -81.62 -52.08 14.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.691 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 150' ' ' ASN . . . -52.4 -38.07 58.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -61.61 -44.94 96.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.61 -38.38 71.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.186 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.63 -56.82 15.85 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -66.54 -28.45 68.55 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -58.52 -34.33 70.85 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.174 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.19 -23.73 59.26 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.96 28.51 58.6 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 119.204 -0.776 . . . . 0.0 114.829 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -107.67 37.19 2.49 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.914 1.357 . . . . 0.0 111.082 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.871 HG21 ' HB2' ' A' ' 148' ' ' MET . 82.4 p -138.81 139.38 38.19 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.576 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -104.87 38.55 1.89 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.446 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.9 OUTLIER 170.54 134.59 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 86.3 m -147.88 158.89 44.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.74 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.457 ' O ' ' CE2' ' A' ' 156' ' ' PHE . 12.0 pt -115.7 112.87 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.765 ' CB ' HD12 ' A' ' 235' ' ' ILE . 37.1 m-20 -147.76 165.3 30.95 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.969 -0.457 . . . . 0.0 112.141 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -136.39 -163.98 10.05 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 119.42 1.009 . . . . 0.0 111.297 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.538 ' HG3' HG21 ' A' ' 320' ' ' THR . 77.2 Cg_endo -98.99 5.97 0.99 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.346 2.698 . . . . 0.0 114.129 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 232' ' ' TRP . 36.7 t-105 -85.58 -80.99 0.21 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.302 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.98 42.84 1.68 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.693 0.282 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.512 ' CZ3' ' HB3' ' A' ' 230' ' ' TRP . 5.1 m-90 -149.07 59.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.891 0.377 . . . . 0.0 110.961 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 p -57.82 -43.02 85.45 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -67.26 74.19 0.13 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.731 0.3 . . . . 0.0 110.575 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.801 HD11 ' CD1' ' A' ' 116' ' ' ILE . 12.8 tt -147.02 153.98 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.11 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.425 ' HB3' ' CG ' ' A' ' 242' ' ' TYR . 83.6 m-20 61.86 41.59 11.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.637 0.256 . . . . 0.0 110.858 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.0 t -142.09 48.37 1.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.771 0.32 . . . . 0.0 110.983 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.96 -65.08 1.05 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.732 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.742 ' O ' HG13 ' A' ' 240' ' ' VAL . 0.3 OUTLIER -125.68 -62.47 1.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.735 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 239' ' ' LYS . 0.2 OUTLIER -168.73 -52.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.616 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.62 95.06 10.1 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.625 0.25 . . . . 0.0 111.079 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.425 ' CG ' ' HB3' ' A' ' 236' ' ' ASP . 44.1 p90 -98.99 146.68 25.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.466 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 116' ' ' ILE . . . -130.44 160.25 23.03 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.112 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.604 HG12 HG13 ' A' ' 116' ' ' ILE . 29.3 m -135.78 134.54 51.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.764 0.282 . . . . 0.0 110.889 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.04 167.57 21.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.839 0.855 . . . . 0.0 110.506 -174.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.76 152.24 7.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.501 ' CD2' HD12 ' A' ' 113' ' ' LEU . 4.3 mm? -62.71 159.4 44.17 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 120.513 1.506 . . . . 0.0 111.204 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.45 ' HD2' HD12 ' A' ' 247' ' ' LEU . 93.2 Cg_endo -79.32 -164.49 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.598 2.198 . . . . 0.0 111.532 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.463 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -116.34 177.62 4.62 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.501 -178.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 249' ' ' THR . 55.1 m-85 -164.57 110.05 0.98 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.847 0.832 . . . . 0.0 109.749 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.91 33.43 21.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.956 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.72 39.03 30.24 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.747 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.78 147.59 17.16 Favored Pre-proline 0 N--CA 1.464 0.255 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -91.15 125.73 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.466 2.777 . . . . 0.0 111.89 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.429 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 12.2 t -47.02 150.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 159' ' ' PRO . 6.7 tppt? -85.21 108.97 17.71 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.013 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.577 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 5.4 Cg_exo -79.29 142.53 16.86 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.144 2.562 . . . . 0.0 112.737 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.91 154.61 28.21 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.695 HG11 HG12 ' A' ' 329' ' ' ILE . 54.6 t -113.08 135.59 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -123.51 118.41 3.5 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 118.873 -1.632 . . . . 0.0 115.912 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.82 HG13 ' HB1' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -110.63 111.9 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.929 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -88.73 99.68 12.54 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 117.659 -1.616 . . . . 0.0 107.518 177.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.549 ' CB ' HG21 ' A' ' 97' ' ' VAL . 43.7 p -136.55 135.44 38.46 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 118.878 2.918 . . . . 0.0 118.878 -173.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.936 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -88.48 112.86 23.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.551 ' CA ' ' HB2' ' A' ' 105' ' ' ALA . . . -102.86 162.83 16.2 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.508 HG21 ' HA ' ' A' ' 271' ' ' PRO . 87.0 mt -88.2 123.58 40.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 118.929 1.364 . . . . 0.0 107.726 176.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -65.51 146.22 55.13 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.999 ' HB3' HD23 ' A' ' 75' ' ' LEU . . . -58.2 -23.47 55.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.162 0.437 . . . . 0.0 111.284 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.514 ' HB1' ' H ' ' A' ' 56' ' ' GLY . . . -53.05 -59.1 4.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.573 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.3 m -143.23 127.87 9.68 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.607 0.242 . . . . 0.0 111.231 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.508 ' HA ' HG21 ' A' ' 266' ' ' ILE . 76.1 Cg_endo -78.88 -39.64 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.541 2.16 . . . . 0.0 112.96 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.788 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 2.7 m120 55.54 85.05 0.07 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-O 120.62 0.248 . . . . 0.0 110.519 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.1 OUTLIER -72.24 -54.17 10.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -75.41 -57.34 3.95 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 5.9 mt -53.52 -49.09 68.33 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.788 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -71.09 -51.85 22.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 273' ' ' LYS . 9.8 mtpp -48.84 -53.22 20.23 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.306 0.574 . . . . 0.0 112.277 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 47.4 mm-40 -68.73 -30.2 68.78 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.944 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.631 ' CZ ' HD21 ' A' ' 7' ' ' LEU . 14.8 t80 -73.71 -40.33 63.68 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.575 HD12 ' HD1' ' A' ' 279' ' ' PHE . 5.7 mp -81.69 -43.89 17.87 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.94 0.876 . . . . 0.0 112.654 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 285' ' ' LEU . 13.5 mt-10 -70.45 -43.53 69.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 113.912 -1.494 . . . . 0.0 112.643 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 3.7 t-20 -80.89 -32.23 34.9 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.996 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.897 ' O ' HG22 ' A' ' 286' ' ' THR . 4.3 m-85 -101.89 -82.34 0.48 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -39.38 -33.98 0.18 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.879 HD11 ' CE1' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -94.45 39.98 1.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.897 HG22 ' O ' ' A' ' 283' ' ' TYR . 11.3 t -146.62 161.91 39.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 1.2 m-20 -62.49 -13.07 26.35 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.049 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 41.2 mt-10 -77.94 -46.65 20.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.662 0.664 . . . . 0.0 111.22 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.723 ' O ' HG13 ' A' ' 293' ' ' VAL . . . -87.02 -41.79 6.54 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.741 HD12 ' CD2' ' A' ' 307' ' ' TYR . 0.1 OUTLIER -59.9 -46.55 88.98 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 287' ' ' ASP . 3.4 mm-40 -79.0 -26.66 43.26 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -71.33 -37.54 71.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.671 1.123 . . . . 0.0 109.159 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 289' ' ' GLY . 33.1 m -67.5 -40.03 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -80.22 -39.39 29.19 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 123.838 0.855 . . . . 0.0 113.003 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -64.78 -40.17 94.8 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.571 ' CA ' ' HA2' ' A' ' 16' ' ' GLY . 10.9 m-20 -59.99 -64.43 0.95 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.616 ' CG ' HD21 ' A' ' 299' ' ' LEU . 0.0 OUTLIER -103.38 103.52 35.84 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.758 -177.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.488 ' C ' HD23 ' A' ' 299' ' ' LEU . 45.6 Cg_endo -95.99 90.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.621 2.88 . . . . 0.0 112.424 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.616 HD21 ' CG ' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -141.24 -74.74 0.32 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.153 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -98.71 156.08 20.16 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.165 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.852 ' HB3' ' HB ' ' A' ' 317' ' ' ILE . . . -121.47 52.73 1.21 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 117.046 0.423 . . . . 0.0 111.62 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 1.037 HG11 HG23 ' A' ' 110' ' ' VAL . 10.8 p -136.4 84.12 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.888 0.375 . . . . 0.0 111.521 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 304' ' ' LEU . . . -166.33 95.23 0.55 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.845 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 307' ' ' TYR . 8.4 tp 93.76 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.94 0.496 . . . . 0.0 112.015 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.456 ' N ' HD21 ' A' ' 89' ' ' LEU . 3.3 tmtm? -32.63 -35.07 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.784 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -44.83 47.09 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.961 0.886 . . . . 0.0 110.257 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.828 ' CZ ' HD12 ' A' ' 311' ' ' LEU . 1.2 t80 -76.65 -23.26 53.28 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.016 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -76.6 -42.84 40.96 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.08 -43.8 86.3 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.963 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -67.32 -53.4 29.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.919 0.39 . . . . 0.0 110.624 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.828 HD12 ' CZ ' ' A' ' 307' ' ' TYR . 1.1 tt -67.06 -41.24 86.76 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.291 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -46.59 -15.5 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 312' ' ' ALA . 8.8 tttp -31.04 -43.48 0.05 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.512 0.596 . . . . 0.0 110.433 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 3.6 t0 -87.73 139.17 31.25 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 3.0 Cg_exo -75.48 3.89 5.46 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.659 2.239 . . . . 0.0 114.578 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -59.22 5.75 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.852 ' HB ' ' HB3' ' A' ' 301' ' ' ALA . 2.8 tp -49.78 -55.61 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.62 -50.35 13.38 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.375 0.534 . . . . 0.0 111.758 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.6 -44.29 85.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.858 0.837 . . . . 0.0 110.026 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.676 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -65.55 -32.61 74.3 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.896 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.619 ' HA ' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -78.95 -46.35 18.5 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.723 0.296 . . . . 0.0 110.437 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.67 -42.51 79.12 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.444 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.538 ' HB3' ' HB1' ' A' ' 112' ' ' ALA . 27.3 t-20 -78.4 -38.62 41.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.637 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -51.88 -52.74 47.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.26 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -58.19 -29.64 65.81 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.858 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -12.67 60.08 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.381 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.577 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -79.79 163.81 48.1 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.936 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.35 139.69 32.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.695 HG12 HG11 ' A' ' 259' ' ' VAL . 5.0 mt -91.47 110.26 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 119.572 1.078 . . . . 0.0 110.5 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.467 ' HA ' ' HD2' ' A' ' 331' ' ' PRO . 1.4 ptp -45.2 101.88 0.28 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.132 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.468 ' HG3' ' CD2' ' A' ' 176' ' ' TYR . 4.4 Cg_endo -46.49 -35.67 16.85 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.025 2.483 . . . . 0.0 112.14 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 331' ' ' PRO . 0.6 OUTLIER 85.56 83.33 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.768 HG21 ' OH ' ' A' ' 176' ' ' TYR . 1.0 OUTLIER -132.2 158.2 76.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 118.338 0.517 . . . . 0.0 111.758 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.2 -50.72 5.47 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.963 2.442 . . . . 0.0 112.693 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.768 ' HB3' HG23 ' A' ' 368' ' ' ILE . 79.2 mm-40 -53.22 -21.82 5.84 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 3.6 tpt -45.49 -35.07 3.57 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 122.222 -0.299 . . . . 0.0 111.323 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 14.9 p -59.77 -40.21 87.43 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.615 0.245 . . . . 0.0 110.542 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.836 ' HB3' ' CD1' ' A' ' 368' ' ' ILE . . . -58.11 -32.03 67.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.112 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.72 ' CE1' HG12 ' A' ' 183' ' ' VAL . 2.3 t80 -77.96 -55.66 5.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.448 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.456 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 6.6 t-105 -46.98 -42.83 18.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.862 0.363 . . . . 0.0 110.913 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.96 -49.92 40.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.658 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.15 -44.63 87.99 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.909 HG22 HD22 ' A' ' 361' ' ' LEU . 19.6 t -71.13 -29.68 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.723 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -74.82 -43.9 52.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 348' ' ' ILE . 1.7 p -64.48 -58.32 6.76 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.94 -38.65 4.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.637 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.1 t -58.82 -48.59 85.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 345' ' ' THR . 58.5 mt -64.41 -27.97 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 346' ' ' ALA . 6.0 m120 -64.43 -36.9 85.68 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.459 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.82 ' HA ' ' HG3' ' A' ' 355' ' ' GLN . . . -78.78 -26.59 44.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.56 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.94 -14.36 62.91 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 354' ' ' ARG . 2.5 t -110.66 16.96 21.13 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.56 5.91 1.4 Allowed Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 119.71 1.141 . . . . 0.0 112.382 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 352' ' ' SER . 26.4 ttt85 -93.63 35.75 1.11 Allowed 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 115.522 -2.18 . . . . 0.0 107.812 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.82 ' HG3' ' HA ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -66.98 -170.42 0.11 Allowed 'General case' 0 CA--C 1.547 0.843 1 N-CA-C 123.881 4.771 . . . . 0.0 123.881 -156.917 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.6 OUTLIER 159.59 39.95 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 112.47 -2.15 . . . . 0.0 108.174 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.62 HG22 HD12 ' A' ' 361' ' ' LEU . 7.5 p -57.67 -48.84 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.757 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 1.2 m-20 -52.21 -43.85 64.46 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.388 0.613 . . . . 0.0 110.986 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -75.8 -53.83 7.87 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 114.784 -1.098 . . . . 0.0 113.025 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -54.32 -44.31 71.94 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.956 0.884 . . . . 0.0 112.791 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.909 HD22 HG22 ' A' ' 343' ' ' VAL . 79.7 mt -77.82 -37.13 49.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.681 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 1.2 tmtm? -63.88 -56.34 16.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.977 0.894 . . . . 0.0 109.631 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.07 -32.24 70.75 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.252 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -58.14 -42.43 85.87 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.829 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.619 ' HB3' HG21 ' A' ' 183' ' ' VAL . 0.7 OUTLIER -64.4 -36.12 83.13 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.482 ' N ' ' HG3' ' A' ' 365' ' ' GLN . 87.7 m -57.93 -34.57 70.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -71.1 -35.58 71.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.08 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.836 ' CD1' ' HB3' ' A' ' 338' ' ' ALA . 4.2 mm -75.83 -39.53 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.675 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 1.0 ' HB ' HD11 ' A' ' 178' ' ' ILE . 13.9 p -88.01 -20.93 25.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.022 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 366' ' ' THR . 2.0 mtmp? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.989 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.738 0.304 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -177.12 154.74 1.09 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.244 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -128.66 63.17 0.62 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.469 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.477 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -153.29 160.77 42.79 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.921 ' CB ' HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -155.25 122.62 5.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.189 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.735 HG11 ' HB3' ' A' ' 57' ' ' PRO . 24.0 t -116.94 124.95 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.482 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.722 HG13 HD12 ' A' ' 59' ' ' ILE . 3.1 mp -123.7 130.47 74.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.63 ' HB2' HG23 ' A' ' 60' ' ' ILE . 73.3 m95 -102.66 128.67 49.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.024 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.767 HD12 ' CD1' ' A' ' 61' ' ' PHE . 1.5 tt -158.49 137.84 3.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 O-C-N 122.163 -0.336 . . . . 0.0 111.298 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -114.18 39.98 2.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.749 0.309 . . . . 0.0 111.081 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.1 -11.55 58.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.604 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.3 m-20 65.54 60.92 0.71 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.022 0.411 . . . . 0.0 110.743 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 1.2 mtpt 162.69 -173.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.183 0.516 . . . . 0.0 111.917 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 296' ' ' ASP . . . 76.38 23.46 70.7 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 20.9 p90 -80.83 -34.46 33.85 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.78 0.79 . . . . 0.0 111.378 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 1.2 t-20 -66.69 -50.66 62.13 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.769 0.319 . . . . 0.0 111.742 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.515 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -71.57 -48.79 27.62 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.841 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.9 -49.19 78.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.845 0.823 . . . . 0.0 110.055 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -67.47 -37.72 83.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -67.19 -37.6 83.95 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.634 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.748 HG23 ' CE2' ' A' ' 283' ' ' TYR . 3.7 p -67.65 -58.72 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.636 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.483 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . -49.12 -34.18 16.26 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.246 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -50.47 67.62 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.51 1.148 . . . . 0.0 107.907 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -42.23 63.61 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-N 112.793 -2.003 . . . . 0.0 108.543 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.785 ' HB3' HD13 ' A' ' 33' ' ' ILE . 22.0 m-85 -65.75 -35.71 81.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.657 0.741 . . . . 0.0 111.083 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.817 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -70.85 -51.35 27.06 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.407 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -52.36 -28.56 19.99 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 125.076 1.485 . . . . 0.0 111.365 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.814 ' O ' HG23 ' A' ' 31' ' ' THR . 20.6 t70 -85.78 -38.71 17.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.581 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 162.88 38.05 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 172.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.837 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.43 38.7 0.02 OUTLIER Glycine 0 N--CA 1.466 0.682 0 C-N-CA 114.986 -3.483 . . . . 0.0 118.837 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.837 HD12 ' C ' ' A' ' 32' ' ' GLY . 1.8 mp -139.89 107.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 121.532 2.666 . . . . 0.0 116.022 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.14 104.72 12.4 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.921 HG12 ' CB ' ' A' ' 7' ' ' LEU . 33.6 m -100.95 133.9 42.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -174.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -119.12 146.8 44.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.05 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.686 HG12 ' HB ' ' A' ' 9' ' ' ILE . 4.7 m -132.98 122.15 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.692 0.282 . . . . 0.0 110.302 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.51 134.03 48.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.263 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 9.1 p80 -139.7 71.03 37.25 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-O 120.927 0.394 . . . . 0.0 111.172 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.794 ' HD2' HD12 ' A' ' 43' ' ' LEU . 58.2 Cg_endo -87.99 -177.73 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.218 2.612 . . . . 0.0 112.362 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.37 -40.14 14.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.67 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 43' ' ' LEU . 68.8 mmtt -86.47 0.68 53.68 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.312 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.794 HD12 ' HD2' ' A' ' 40' ' ' PRO . 10.2 tt -19.53 -62.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 1.059 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -46.52 -50.86 16.54 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -178.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.471 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 3.1 tt0 -71.98 -44.04 64.17 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.936 0.398 . . . . 0.0 110.782 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.6 ' O ' HG13 ' A' ' 50' ' ' VAL . 6.6 mttp -56.62 -56.02 26.59 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.129 0.966 . . . . 0.0 110.496 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.864 ' CZ ' HD12 ' A' ' 75' ' ' LEU . 1.8 t80 -45.37 -60.75 2.93 Favored Pre-proline 0 C--N 1.346 0.414 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.0 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 1.059 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 35.2 Cg_exo -61.91 -28.08 80.68 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 121.327 1.351 . . . . 0.0 113.858 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -80.98 -37.29 29.56 Favored 'General case' 0 C--O 1.256 1.416 0 CA-C-O 122.365 1.078 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.87 ' O ' ' N ' ' A' ' 54' ' ' GLY . 18.5 m -75.69 -40.51 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 CA-C-O 121.996 0.903 . . . . 0.0 109.686 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.38 -38.65 19.97 Favored 'General case' 0 C--N 1.365 1.261 0 C-N-CA 125.945 1.698 . . . . 0.0 111.275 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.94 -37.32 29.72 Favored 'General case' 0 C--N 1.37 1.465 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.974 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -118.09 17.48 14.04 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.911 0.778 . . . . 0.0 109.035 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.87 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -137.81 62.82 0.57 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -82.0 38.69 0.54 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.751 0.776 . . . . 0.0 112.731 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 57' ' ' PRO . . . -93.78 -39.85 4.83 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.602 -0.809 . . . . 0.0 114.451 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.735 ' HB3' HG11 ' A' ' 8' ' ' VAL . 34.0 Cg_endo -91.94 157.86 3.35 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.49 2.793 . . . . 0.0 112.953 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 266' ' ' ILE . 0.4 OUTLIER -130.07 35.43 4.12 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 117.663 -1.615 . . . . 0.0 114.823 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.774 HD11 ' HG ' ' A' ' 7' ' ' LEU . 1.9 mt -152.45 127.91 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 118.181 -1.408 . . . . 0.0 114.443 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.772 HG22 ' CE3' ' A' ' 62' ' ' TRP . 3.9 mp -139.27 122.83 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.613 0.244 . . . . 0.0 111.629 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.767 ' CD1' HD12 ' A' ' 11' ' ' ILE . 35.9 t80 -113.88 121.29 43.53 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.977 0.417 . . . . 0.0 110.151 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.772 ' CE3' HG22 ' A' ' 60' ' ' ILE . 3.1 p90 -166.43 167.29 15.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.995 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -45.66 160.13 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.956 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.73 ' CB ' ' HB ' ' A' ' 261' ' ' VAL . 23.0 t-80 -77.63 -29.45 51.76 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -48.91 -54.13 16.74 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.629 0.728 . . . . 0.0 112.398 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -78.37 -30.73 48.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.181 0.515 . . . . 0.0 109.968 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.663 ' HB3' ' HA ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -56.37 -33.08 65.37 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.711 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -55.58 -68.0 1.92 Allowed Glycine 0 C--N 1.354 1.558 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.03 -54.49 31.07 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 112.451 -1.875 . . . . 0.0 111.218 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.436 ' HB3' ' CB ' ' A' ' 75' ' ' LEU . 16.5 m-85 -48.66 -41.19 30.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -51.8 -44.78 63.6 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -42.75 25.58 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 p -69.94 -26.65 64.23 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.97 4.02 10.51 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 119.968 -1.11 . . . . 0.0 114.283 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.864 HD12 ' CZ ' ' A' ' 47' ' ' PHE . 1.1 mm? -96.9 45.86 1.05 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.271 1.036 . . . . 0.0 110.738 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 67' ' ' PHE . 0.5 OUTLIER 176.88 138.04 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 113.273 -1.785 . . . . 0.0 106.571 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.726 ' CB ' ' HB3' ' A' ' 268' ' ' ALA . . . -135.16 138.78 44.02 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 118.391 -1.323 . . . . 0.0 111.585 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -47.42 137.07 9.0 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.554 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.546 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 7.8 mt -122.46 162.3 22.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.115 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.9 p -106.18 82.87 1.0 Allowed Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.399 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 67.0 Cg_endo -84.48 -171.51 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.949 2.433 . . . . 0.0 112.345 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -105.46 156.06 18.56 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.822 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -92.26 -38.88 11.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.364 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.5 -23.25 57.53 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.87 ' CZ ' HD21 ' A' ' 285' ' ' LEU . 10.2 t80 -69.09 -59.3 3.12 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.904 0.383 . . . . 0.0 110.05 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.435 ' HB3' ' CD1' ' A' ' 94' ' ' TRP . 1.3 mt-30 -66.48 -24.63 66.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.677 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.62 -34.04 62.72 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -76.46 -10.01 59.07 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.813 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -125.15 -159.76 0.91 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.28 -179.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.657 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -80.0 119.23 75.96 Favored Pre-proline 0 C--N 1.339 0.151 0 O-C-N 122.292 -0.255 . . . . 0.0 111.574 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.32 -32.93 97.14 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.369 2.046 . . . . 0.0 112.206 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.465 ' CE1' ' HG3' ' A' ' 325' ' ' GLN . 17.3 m-85 -52.99 -53.69 46.23 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.158 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.773 HG23 ' CD2' ' A' ' 94' ' ' TRP . 10.0 t -62.62 -23.38 67.04 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.813 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 6.1 m95 -93.18 -25.6 17.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.054 0.454 . . . . 0.0 111.798 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -75.41 -20.78 58.7 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.66 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.739 ' HB1' HG13 ' A' ' 261' ' ' VAL . . . -56.03 -50.41 71.0 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 105' ' ' ALA . 9.1 p -100.42 41.38 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -97.82 135.77 39.11 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.668 -0.645 . . . . 0.0 109.872 178.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.4 t80 -99.94 174.86 5.99 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.02 -0.425 . . . . 0.0 110.081 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -64.87 73.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.674 0.273 . . . . 0.0 110.703 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 138.57 -47.8 0.91 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.051 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -145.99 175.57 10.35 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 117.179 0.49 . . . . 0.0 110.926 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -118.89 119.69 35.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.654 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 3.3 mp -94.99 39.38 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.93 ' HB1' ' O ' ' A' ' 264' ' ' ALA . . . 167.14 -178.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.804 ' CE2' HD11 ' A' ' 280' ' ' LEU . 48.3 p90 -132.97 121.5 16.94 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.015 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.679 ' HA ' ' CB ' ' A' ' 263' ' ' SER . 6.3 Cg_exo -79.41 172.39 14.61 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.177 2.585 . . . . 0.0 113.727 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.519 HG22 ' CE2' ' A' ' 61' ' ' PHE . 2.2 tt -168.9 39.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 119.586 -0.846 . . . . 0.0 112.713 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.957 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -174.92 110.4 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.905 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.554 HG23 ' OG1' ' A' ' 320' ' ' THR . 15.5 m -96.89 117.14 40.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.599 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.452 ' HG2' ' CH2' ' A' ' 230' ' ' TRP . 33.1 mt-10 -102.89 146.85 27.67 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.552 0.691 . . . . 0.0 110.766 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.894 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -165.26 139.05 4.72 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.385 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.838 HD21 ' HA ' ' A' ' 257' ' ' PRO . 0.4 OUTLIER -77.94 137.74 38.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.642 -179.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.15 163.5 28.38 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 116' ' ' ILE . 1.5 tt -93.63 130.11 39.67 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.585 ' N ' HD23 ' A' ' 115' ' ' LEU . 12.1 tt -115.62 138.74 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.619 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.729 ' CD1' HD21 ' A' ' 122' ' ' LEU . 3.9 m-85 -117.2 138.58 51.6 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -85.17 119.78 25.93 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -90.82 60.83 4.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.899 0.38 . . . . 0.0 111.421 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.89 -51.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.86 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' CB ' ' A' ' 223' ' ' ALA . 5.6 mt -118.96 38.4 3.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.43 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 224' ' ' MET . 0.4 OUTLIER -157.69 108.06 1.8 Allowed Pre-proline 0 CA--C 1.521 -0.15 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.687 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 9.2 Cg_endo -90.51 130.3 1.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.302 2.001 . . . . 0.0 112.443 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.485 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 81.4 m-20 -64.4 127.13 91.85 Favored Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -172.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 124' ' ' ASN . 55.5 Cg_endo -93.42 167.62 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 124.038 3.159 . . . . 0.0 109.66 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.49 -51.14 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 121.806 1.671 . . . . 0.0 114.246 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.64 -3.48 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 49.5 p -118.03 139.35 51.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 121.252 1.842 . . . . 0.0 114.287 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.521 ' CD2' HD11 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -69.63 -23.27 63.47 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 171.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.591 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 24.3 mt-10 -44.13 -23.61 0.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.359 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 40.4 mm-40 -75.91 -19.16 59.03 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.77 ' CG2' HD21 ' A' ' 147' ' ' LEU . 96.7 mt -46.59 -50.61 40.97 Favored Pre-proline 0 N--CA 1.479 0.994 0 CA-C-O 121.709 0.766 . . . . 0.0 111.346 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.603 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 58.7 Cg_exo -46.4 -36.26 17.47 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 120.826 1.017 . . . . 0.0 109.57 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 137' ' ' LYS . . . -75.36 -59.03 2.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 139' ' ' LEU . 64.3 mt -68.75 -37.34 79.32 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.881 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.1 -40.65 68.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.603 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 3.4 tptm -47.48 -49.0 26.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.81 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 139' ' ' LEU . 1.2 pt-20 -62.83 -37.23 85.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.59 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.84 HD23 ' CG ' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -58.89 -51.03 71.77 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -47.69 -45.68 28.62 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.03 -27.58 0.97 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.09 -56.66 2.16 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.244 0.545 . . . . 0.0 110.671 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.96 39.87 0.02 OUTLIER Glycine 0 CA--C 1.52 0.351 0 CA-C-O 119.029 -0.873 . . . . 0.0 111.216 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.84 ' CG ' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -149.42 -172.06 4.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 119.183 1.492 . . . . 0.0 111.629 -175.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.828 ' C ' HD22 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -143.72 127.12 16.81 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.644 ' CA ' HD13 ' A' ' 139' ' ' LEU . . . -41.52 -33.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.77 HD21 ' CG2' ' A' ' 132' ' ' ILE . 0.6 OUTLIER -141.3 130.26 23.18 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 -176.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.86 ' O ' HG22 ' A' ' 225' ' ' THR . 0.0 OUTLIER -132.22 138.75 48.06 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.739 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.934 ' O ' ' O ' ' A' ' 150' ' ' ASN . 17.3 p90 -171.92 174.73 4.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.693 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.934 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -27.86 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.757 0.661 . . . . 0.0 112.17 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.965 HD13 ' OG1' ' A' ' 208' ' ' THR . 0.1 OUTLIER -160.66 39.0 0.16 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.261 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.527 ' OE1' HD11 ' A' ' 348' ' ' ILE . 0.0 OUTLIER 171.68 33.09 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.998 169.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.634 ' O ' ' HB ' ' A' ' 157' ' ' THR . 3.3 mt-10 -79.96 152.52 74.42 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 121.986 2.175 . . . . 0.0 115.833 -174.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.975 ' O ' ' N ' ' A' ' 156' ' ' PHE . 67.0 Cg_endo -78.67 -135.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.802 1 C-N-CA 125.559 4.172 . . . . 0.0 107.095 176.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 1.12 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 4.7 p90 3.01 -39.82 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.975 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -86.14 -55.48 3.91 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-N 120.262 1.392 . . . . 0.0 111.55 -179.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.845 HG22 ' CD1' ' A' ' 161' ' ' ILE . 61.6 m -56.6 -43.82 80.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.427 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 2.6 m0 -51.26 -55.73 26.18 Favored Pre-proline 0 C--N 1.346 0.416 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.735 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 1.12 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 89.4 Cg_exo -43.11 -50.3 6.48 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.081 2.521 . . . . 0.0 113.026 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.461 HD11 ' HE1' ' A' ' 156' ' ' PHE . 81.3 mt -62.45 -53.82 49.15 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 119.671 1.123 . . . . 0.0 108.645 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.845 ' CD1' HG22 ' A' ' 157' ' ' THR . 1.5 mp -51.86 -25.82 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.421 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -78.59 -22.67 46.73 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.668 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -41.86 -58.35 2.06 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -64.37 5.57 0.26 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.303 1.224 . . . . 0.0 114.303 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.59 22.69 5.34 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 119.588 -1.291 . . . . 0.0 115.262 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.9 163.41 41.83 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.707 -1.235 . . . . 0.0 111.447 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -146.09 120.94 9.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.126 0.463 . . . . 0.0 109.967 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.674 ' HA ' HG22 ' A' ' 183' ' ' VAL . . . -39.14 -79.01 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.675 0.75 . . . . 0.0 111.148 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.633 ' HB3' ' CB ' ' A' ' 176' ' ' TYR . 1.7 m-85 -113.43 172.73 6.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.768 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 1.22 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -101.88 106.87 17.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.08 114.42 18.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.053 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 28.2 tt0 -136.66 102.04 4.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.259 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 0.2 OUTLIER 90.28 -31.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.379 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 154.77 17.04 0.05 OUTLIER Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.151 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -174.18 127.73 0.36 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.175 1.487 . . . . 0.0 111.257 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 1.22 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 47.9 p90 -55.47 -24.45 31.22 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 122.181 0.991 . . . . 0.0 110.987 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 78.8 m-20 76.74 -78.57 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.008 -1.905 . . . . 0.0 111.773 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 369' ' ' THR . 0.8 OUTLIER 168.88 -41.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.498 ' HA ' HG22 ' A' ' 369' ' ' THR . 9.6 tttm -72.75 -5.66 39.33 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 4.4 m-20 -120.24 94.14 4.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.253 0.933 . . . . 0.0 109.634 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.617 HG11 ' CE1' ' A' ' 339' ' ' PHE . 6.4 t -115.78 111.29 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.433 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . -119.76 39.91 2.36 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.852 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.674 HG22 ' HA ' ' A' ' 168' ' ' ALA . 31.0 t -80.41 -44.72 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-O 121.275 0.56 . . . . 0.0 109.865 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -83.83 61.28 6.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.984 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 182' ' ' GLY . 7.4 p30 -110.94 173.92 6.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.712 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.58 -26.43 65.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.274 0.559 . . . . 0.0 111.28 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.95 -46.79 42.5 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.675 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.612 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -56.93 -51.4 69.28 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 175.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -56.06 18.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.979 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.765 ' HB1' ' HE3' ' A' ' 251' ' ' LYS . . . -50.07 -41.18 47.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.006 0.908 . . . . 0.0 112.096 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -66.76 -60.65 5.95 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.715 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.537 HD12 HG12 ' A' ' 161' ' ' ILE . 0.5 OUTLIER -56.54 -27.62 58.03 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 42.2 m -62.36 -47.62 83.41 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.816 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.531 ' CZ ' ' CZ ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -60.71 -36.7 79.48 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-O 121.542 0.687 . . . . 0.0 109.54 177.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.77 -51.02 71.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.983 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 192' ' ' LEU . 43.1 t -57.29 -31.5 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.562 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 2.6 t0 -57.03 -49.9 74.38 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 121.286 0.565 . . . . 0.0 110.717 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.9 tp -61.97 -59.24 5.4 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.285 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.583 HG22 ' HA ' ' A' ' 204' ' ' MET . 39.4 mm -56.93 -41.13 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.83 -31.73 72.54 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.49 178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 6.0 m-80 -107.54 13.12 27.09 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -173.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 203' ' ' HIS . 1.4 ttmp? -121.92 -91.87 0.55 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.946 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' A' ' 205' ' ' ASN . 0.5 OUTLIER -122.02 -10.82 8.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -178.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.583 ' HA ' HG22 ' A' ' 199' ' ' ILE . 0.0 OUTLIER 69.35 -71.69 0.12 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -176.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 203' ' ' HIS . 3.0 m120 64.43 162.49 0.12 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.26 78.88 3.1 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.603 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 39.46 70.75 0.2 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.965 ' OG1' HD13 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -55.05 124.19 16.02 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 213' ' ' ALA . 0.4 OUTLIER -92.13 -174.65 3.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -69.92 -45.55 67.31 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.3 m -75.18 -30.01 60.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.502 0.668 . . . . 0.0 111.024 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.743 HG22 HG22 ' A' ' 208' ' ' THR . 1.2 mp -79.33 -49.74 19.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.207 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -57.61 -34.05 68.88 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -60.02 -48.24 82.53 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.91 -36.59 67.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.247 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.77 -57.6 11.74 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.963 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.538 ' CE1' ' HA ' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -60.09 -30.04 68.98 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -53.18 -42.03 65.81 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.396 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.84 59.12 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.74 57.96 7.44 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.672 -0.695 . . . . 0.0 114.588 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -125.29 37.29 4.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.378 1.089 . . . . 0.0 111.037 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.45 ' CB ' ' HB2' ' A' ' 148' ' ' MET . 12.2 t -142.5 140.48 31.86 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -114.45 38.5 3.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.064 -1.426 . . . . 0.0 113.328 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.789 ' HB2' HD13 ' A' ' 122' ' ' LEU . 25.8 ttm -178.08 129.22 0.13 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.77 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 148' ' ' MET . 69.1 p -145.51 169.32 18.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.566 0.698 . . . . 0.0 111.534 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.566 HD12 ' CZ ' ' A' ' 156' ' ' PHE . 21.9 mt -109.06 145.44 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -146.86 167.05 24.89 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.849 0.86 . . . . 0.0 111.232 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -110.4 -159.8 17.26 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.446 -0.406 . . . . 0.0 112.782 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.429 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 11.7 Cg_endo -55.49 -59.44 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.82 2.346 . . . . 0.0 112.451 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.452 ' CH2' ' HG2' ' A' ' 111' ' ' GLU . 18.6 p90 -173.34 -43.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.474 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.28 70.99 1.2 Allowed 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.786 0.326 . . . . 0.0 110.803 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.423 ' O ' ' N ' ' A' ' 234' ' ' ASN . 1.5 m95 -125.72 39.77 3.88 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 11.3 t 64.87 -72.74 0.06 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.544 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 232' ' ' TRP . 4.6 t-20 -145.64 85.12 1.69 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.575 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.406 ' O ' ' N ' ' A' ' 237' ' ' THR . 18.1 tt -44.55 154.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.434 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.511 ' OD1' HG21 ' A' ' 225' ' ' THR . 37.2 t70 -47.9 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.707 0.289 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.48 ' O ' HG22 ' A' ' 237' ' ' THR . 19.7 m -121.4 39.37 3.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.744 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 83.0 p -63.2 -43.62 97.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.689 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.57 -174.91 2.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.816 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.0 -57.26 4.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.193 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.02 126.32 35.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.543 ' CG ' HD11 ' A' ' 116' ' ' ILE . 9.8 p90 -144.44 164.22 31.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.167 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.4 122.14 5.85 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.425 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 244' ' ' VAL . 34.7 m -91.58 115.31 30.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.743 0.271 . . . . 0.0 111.384 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.6 p -127.62 167.18 16.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.47 153.91 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.807 HD11 ' CD1' ' A' ' 113' ' ' LEU . 58.5 mt -58.29 158.67 13.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 120.31 1.414 . . . . 0.0 110.092 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.437 ' HD3' HD12 ' A' ' 115' ' ' LEU . 72.7 Cg_endo -79.21 -174.65 2.37 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.453 2.102 . . . . 0.0 113.144 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.449 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -105.3 171.16 7.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.091 0.472 . . . . 0.0 111.488 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.531 ' CZ ' ' CZ ' ' A' ' 194' ' ' PHE . 35.6 m-85 -167.31 111.08 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.765 ' HE3' ' HB1' ' A' ' 190' ' ' ALA . 13.2 mttt 62.72 31.71 16.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.637 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.94 33.58 36.45 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.318 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 13.8 mp0 -156.75 154.43 26.65 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 68.7 Cg_endo -90.61 162.91 4.28 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.592 2.861 . . . . 0.0 112.213 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.569 ' OG ' HD13 ' A' ' 247' ' ' LEU . 1.0 OUTLIER -84.41 148.71 26.45 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.1 OUTLIER -86.0 109.81 25.69 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.531 -178.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.838 ' HA ' HD21 ' A' ' 113' ' ' LEU . 6.2 Cg_exo -79.84 149.38 20.48 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.998 2.465 . . . . 0.0 112.89 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 155' ' ' TYR . 23.2 p90 -78.86 146.35 33.68 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.979 HG21 HD13 ' A' ' 329' ' ' ILE . 15.6 t -103.53 122.83 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -118.02 123.45 5.74 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.135 -1.507 . . . . 0.0 114.771 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.739 HG13 ' HB1' ' A' ' 96' ' ' ALA . 15.7 t -109.09 110.06 30.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.957 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.7 tp -89.85 99.15 12.21 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 117.881 -1.528 . . . . 0.0 107.257 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.679 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 32.8 p -134.46 141.17 46.69 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 118.501 2.778 . . . . 0.0 118.501 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.93 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -74.04 132.71 42.61 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.025 -0.422 . . . . 0.0 110.292 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -122.18 139.59 12.88 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.652 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 58' ' ' ASP . 3.7 mp -114.39 127.16 71.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.646 ' C ' ' H ' ' A' ' 269' ' ' ALA . 96.1 m-20 -61.07 126.38 27.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.726 ' HB3' ' CB ' ' A' ' 77' ' ' ALA . . . -51.6 5.11 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 119.883 1.219 . . . . 0.0 113.177 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.646 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -81.99 -38.1 25.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.854 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 75.5 m -133.89 69.4 75.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.91 0.386 . . . . 0.0 110.925 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.655 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 6.4 Cg_exo -73.97 -36.21 3.67 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.842 2.362 . . . . 0.0 112.734 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.472 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 23.2 m-20 50.64 68.17 0.81 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 6.5 mttt -48.98 -54.44 15.6 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 2.9 mt-10 -62.98 -57.94 9.03 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.282 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.6 mt -68.01 -58.0 5.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 271' ' ' PRO . . . -69.45 -51.97 31.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 1.1 tpmp? -64.98 -35.76 82.23 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 12.4 tt0 -76.49 -53.09 8.58 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -56.23 -52.01 66.0 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.787 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.804 HD11 ' CE2' ' A' ' 106' ' ' TYR . 8.2 tt -57.41 -43.42 83.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.524 0.678 . . . . 0.0 111.777 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -73.77 -34.3 64.63 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.558 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -94.16 -13.54 26.59 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.748 ' CE2' HG23 ' A' ' 23' ' ' VAL . 1.6 t80 -109.41 -62.2 1.52 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 119.241 -0.409 . . . . 0.0 109.936 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 284' ' ' LEU . 1.7 tt -40.19 -33.57 0.24 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.809 0.731 . . . . 0.0 110.87 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.87 HD21 ' CZ ' ' A' ' 85' ' ' PHE . 80.5 mt -86.59 42.21 0.99 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.959 0.409 . . . . 0.0 110.257 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 283' ' ' TYR . 17.4 p -145.21 155.93 43.55 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 44.1 m-20 -62.7 -15.04 50.87 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.611 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 0.9 OUTLIER -78.27 -47.38 18.02 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.882 -0.511 . . . . 0.0 110.922 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.531 ' O ' HG12 ' A' ' 293' ' ' VAL . . . -79.96 -55.58 3.51 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.291 -0.957 . . . . 0.0 110.972 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.835 ' CD1' HD13 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -55.26 -46.14 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.226 . . . . 0.0 111.066 179.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -79.05 -26.32 43.12 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.707 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -68.33 -41.55 80.64 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 119.441 1.019 . . . . 0.0 109.117 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 289' ' ' GLY . 2.7 p -68.4 -61.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.502 ' H ' HG13 ' A' ' 293' ' ' VAL . 0.6 OUTLIER -50.14 -45.14 52.84 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.682 1.193 . . . . 0.0 112.546 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -59.33 -50.36 74.27 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.515 ' O ' ' HD3' ' A' ' 298' ' ' PRO . 42.0 m-20 -56.17 -47.86 77.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 176.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 294' ' ' ASN . 0.0 OUTLIER -69.04 104.67 0.78 Allowed Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.951 -178.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.697 ' O ' HD23 ' A' ' 299' ' ' LEU . 93.1 Cg_endo -99.64 54.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.322 2.681 . . . . 0.0 112.675 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 298' ' ' PRO . 0.4 OUTLIER -138.88 -67.83 0.45 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.57 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.63 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . -172.91 -166.31 31.21 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.853 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.725 ' HB3' ' CD1' ' A' ' 311' ' ' LEU . . . 160.0 177.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.579 0.228 . . . . 0.0 111.141 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 302' ' ' VAL . 5.8 p 174.52 62.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.486 ' HA ' HG21 ' A' ' 93' ' ' THR . . . -113.78 -138.6 0.37 Allowed 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.835 HD13 ' CD1' ' A' ' 290' ' ' LEU . 0.4 OUTLIER -4.51 110.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.38 1.072 . . . . 0.0 113.803 -179.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -34.22 -60.88 0.39 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.099 0.476 . . . . 0.0 112.085 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.14 -47.1 54.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.988 0.899 . . . . 0.0 111.272 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.817 ' CG ' HD22 ' A' ' 290' ' ' LEU . 2.4 t80 -73.0 -20.12 61.08 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.319 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 12.0 tt0 -66.64 -39.88 88.45 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.46 -51.85 38.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.335 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -56.83 -56.31 23.23 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.012 0.434 . . . . 0.0 110.174 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.845 HD22 HD13 ' A' ' 317' ' ' ILE . 0.9 OUTLIER -63.76 -41.02 98.06 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.776 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.908 ' HA ' HD11 ' A' ' 317' ' ' ILE . . . -46.23 -26.77 0.85 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 312' ' ' ALA . 10.5 mtpp -37.76 -40.04 0.4 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.753 0.311 . . . . 0.0 110.599 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -82.82 124.35 77.14 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.903 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.21 -13.51 40.19 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.637 2.225 . . . . 0.0 114.214 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.8 ' O ' HG23 ' A' ' 320' ' ' THR . 5.3 mtp85 -62.08 -58.89 6.12 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.908 HD11 ' HA ' ' A' ' 312' ' ' ALA . 10.3 pt -50.12 -52.36 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.78 -45.14 14.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.84 0.291 . . . . 0.0 111.71 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.73 -38.96 73.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.299 0.571 . . . . 0.0 110.322 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.894 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 19.9 p -65.17 -33.61 76.42 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.408 ' HG3' HG21 ' A' ' 302' ' ' VAL . 0.0 OUTLIER -76.89 -49.19 16.23 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.603 0.24 . . . . 0.0 111.04 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -43.52 84.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.307 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.667 ' CB ' ' HB1' ' A' ' 112' ' ' ALA . 16.2 m-80 -71.58 -41.56 68.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.584 0.231 . . . . 0.0 111.17 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -23.08 67.16 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . 0.465 ' HG3' ' CE1' ' A' ' 92' ' ' PHE . 3.0 tm0? -85.27 -34.09 22.02 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -101.48 62.74 0.95 Allowed 'General case' 0 C--O 1.232 0.151 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.478 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -154.96 -140.79 3.09 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.681 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -128.32 118.84 23.94 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.979 HD13 HG21 ' A' ' 259' ' ' VAL . 3.5 mm -75.34 131.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.77 133.08 2.96 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.725 0.297 . . . . 0.0 111.326 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.556 ' HB3' ' CE2' ' A' ' 176' ' ' TYR . 12.6 Cg_endo -56.05 -161.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.092 2.528 . . . . 0.0 111.975 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -159.21 40.78 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.589 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 5.1 pt -136.55 170.78 9.99 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.893 -0.139 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 87.5 Cg_endo -84.83 -20.51 3.63 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.628 2.219 . . . . 0.0 113.927 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 368' ' ' ILE . 14.6 mm-40 -56.13 -21.04 20.15 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.482 ' HE1' ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -44.72 -33.36 1.84 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 23.2 m -57.16 -33.17 67.16 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.649 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.0 78.08 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.928 0.394 . . . . 0.0 111.92 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.617 ' CE1' HG11 ' A' ' 181' ' ' VAL . 0.1 OUTLIER -78.35 -55.66 5.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.772 -178.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.419 ' HA ' ' CE3' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -44.0 -44.73 7.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.045 -179.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 345' ' ' THR . 7.0 m-85 -74.79 -44.01 51.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.972 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.21 76.48 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.987 HG12 HD21 ' A' ' 361' ' ' LEU . 5.5 m -71.94 -41.31 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.034 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.381 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 348' ' ' ILE . 6.7 mmp_? -56.34 -55.29 35.25 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.212 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 341' ' ' TYR . 43.9 p -59.45 -56.23 24.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.064 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.62 -60.67 2.17 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.596 ' CG2' HD11 ' A' ' 361' ' ' LEU . 48.3 t -51.17 -50.52 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.527 HD11 ' OE1' ' A' ' 152' ' ' GLN . 2.1 tt -69.88 -46.14 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.837 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 345' ' ' THR . 3.5 t30 -66.35 -53.97 30.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 355' ' ' GLN . . . -66.21 -26.55 67.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -57.07 -12.31 2.06 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.0 p -110.42 26.75 10.34 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.48 0.582 . . . . 0.0 111.424 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 89.41 -5.72 83.78 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 118.463 -1.827 . . . . 0.0 114.482 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 34.98 0.72 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 116.199 -2.2 . . . . 0.0 107.956 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 356' ' ' THR . 1.0 OUTLIER -72.15 -174.81 1.34 Allowed 'General case' 0 CA--C 1.548 0.868 1 N-CA-C 126.385 5.698 . . . . 0.0 126.385 -158.057 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.6 OUTLIER 158.22 40.48 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 109.833 -3.349 . . . . 0.0 104.283 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.689 ' CG2' HD12 ' A' ' 361' ' ' LEU . 12.8 p -72.56 -52.58 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -174.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 13.4 t0 -47.34 -45.64 24.85 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.596 0.712 . . . . 0.0 111.28 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -77.07 -56.34 4.66 Favored 'General case' 0 C--N 1.353 0.74 0 CA-C-N 114.073 -1.421 . . . . 0.0 113.733 -175.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -51.49 -41.72 61.15 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 122.583 1.182 . . . . 0.0 112.253 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.987 HD21 HG12 ' A' ' 343' ' ' VAL . 5.7 mt -79.03 -34.95 43.4 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 112.745 -2.025 . . . . 0.0 110.494 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 5.2 mmmt -65.75 -56.6 11.17 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.391 1.091 . . . . 0.0 109.599 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 366' ' ' THR . 1.4 t70 -59.46 -36.03 75.21 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.372 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -52.18 -44.01 64.45 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 369' ' ' THR . 4.2 tt0 -60.21 -46.42 89.8 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 363' ' ' ASP . 53.1 m -51.03 -42.88 60.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.09 0.471 . . . . 0.0 110.138 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 10.3 ttm105 -59.12 -52.57 65.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.122 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 178' ' ' ILE . 15.7 tt -73.55 -30.31 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 178' ' ' ILE . 80.9 p -82.52 -30.24 29.91 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 8.2 tptt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.962 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.527 0.203 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -156.08 160.24 39.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.784 0.326 . . . . 0.0 111.213 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . 90.88 25.56 24.54 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.415 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.34 152.79 42.04 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.585 HD13 HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -129.76 121.27 26.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.152 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -117.04 118.23 58.07 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.849 HG23 ' CE1' ' A' ' 61' ' ' PHE . 24.4 mt -123.04 130.07 74.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.435 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.609 ' HB3' HD11 ' A' ' 43' ' ' LEU . 8.6 m95 -108.99 122.29 46.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.681 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -145.74 143.07 21.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 122.881 0.473 . . . . 0.0 109.813 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -79.8 72.62 6.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 119.014 0.824 . . . . 0.0 112.015 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.64 65.88 2.9 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.098 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.814 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -87.11 -32.82 19.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.814 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 102.12 -156.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -177.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.756 ' O ' HD23 ' A' ' 20' ' ' LEU . . . 71.39 52.56 12.59 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 116.089 1.196 . . . . 0.0 116.089 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -58.71 2.92 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 2.0 t-20 -46.18 -43.33 15.08 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.122 0.487 . . . . 0.0 111.127 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.782 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.12 -45.54 49.22 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.302 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 16' ' ' GLY . 3.5 mm? -61.13 -51.47 68.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.944 0.372 . . . . 0.0 110.678 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.17 74.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 34.8 tt0 -65.3 -36.09 82.99 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.754 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 19' ' ' GLY . 74.8 t -67.7 -61.27 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.54 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . -49.22 -34.22 17.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.205 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.41 -50.38 67.74 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 177.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -41.63 62.77 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 112.826 -1.988 . . . . 0.0 108.593 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.785 ' HB3' HD13 ' A' ' 33' ' ' ILE . 21.7 m-30 -66.91 -34.32 77.53 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.128 0.966 . . . . 0.0 111.367 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.76 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -72.6 -51.96 17.48 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.914 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tpmp? -53.1 -27.55 21.04 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 124.807 1.317 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 31' ' ' THR . 3.7 m-20 -86.03 -37.42 18.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 117.732 -1.128 . . . . 0.0 108.97 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.829 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.92 38.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 172.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.808 ' O ' HD12 ' A' ' 33' ' ' ILE . . . 156.88 39.25 0.02 OUTLIER Glycine 0 N--CA 1.465 0.582 0 C-N-CA 114.537 -3.697 . . . . 0.0 119.337 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.083 HD11 HD21 ' A' ' 275' ' ' LEU . 1.5 mp -139.46 136.27 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 121.961 2.88 . . . . 0.0 116.637 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -142.32 104.46 4.43 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.585 HG22 HD13 ' A' ' 7' ' ' LEU . 37.4 t -88.48 128.97 40.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 m -118.51 140.11 50.39 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.645 -1.162 . . . . 0.0 110.853 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.694 HG12 ' HB ' ' A' ' 9' ' ' ILE . 15.2 m -129.85 122.47 54.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 O-C-N 122.133 -0.354 . . . . 0.0 110.703 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.425 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 3.0 tp10 -113.4 134.03 54.86 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER -117.98 74.83 10.29 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 122.355 0.262 . . . . 0.0 111.208 178.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 38' ' ' GLU . 6.0 Cg_endo -89.18 -167.47 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.546 2.831 . . . . 0.0 113.262 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -109.42 -54.85 2.5 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.347 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -78.03 0.12 25.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.41 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.996 HD21 HD11 ' A' ' 60' ' ' ILE . 2.0 tt -26.08 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 1.062 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 3.5 mt-10 -70.59 -55.02 9.81 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -68.34 -50.06 55.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.113 0.482 . . . . 0.0 111.454 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.665 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.4 mmtm -61.82 -56.27 21.21 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.682 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 73.4 t80 -47.03 -55.01 16.73 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 1.062 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 30.8 Cg_exo -66.96 -39.69 13.54 Favored 'Trans proline' 0 C--O 1.25 1.12 0 C-N-CA 121.478 1.452 . . . . 0.0 115.196 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.44 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 34.4 tt0 -67.54 -51.15 54.22 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 46' ' ' LYS . 9.0 m -61.37 -22.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.114 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 48' ' ' PRO . . . -59.05 -30.03 67.74 Favored 'General case' 0 C--N 1.394 2.535 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.058 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -82.38 -28.94 31.18 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.227 1.411 . . . . 0.0 113.029 -178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 50' ' ' VAL . 5.7 t -88.3 129.66 35.32 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.126 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.93 -67.95 0.05 OUTLIER Glycine 0 C--N 1.337 0.587 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.396 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -165.29 -84.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.417 1.609 . . . . 0.0 111.427 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.03 142.86 4.34 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.517 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.18 -146.6 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.84 2.36 . . . . 0.0 112.767 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 1.152 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -79.99 -135.65 0.03 OUTLIER 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 123.744 0.818 . . . . 0.0 110.069 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.639 HD12 ' HB1' ' A' ' 264' ' ' ALA . 16.6 pt -104.48 166.89 2.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.996 HD11 HD21 ' A' ' 43' ' ' LEU . 1.7 tt -127.69 134.87 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 1.026 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -110.69 120.08 41.25 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.973 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -166.99 162.91 15.88 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.393 0.542 . . . . 0.0 110.437 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.515 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . . . -38.34 154.84 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.831 ' HB3' HG13 ' A' ' 261' ' ' VAL . 16.6 t-160 -77.29 -30.04 54.02 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.99 -36.96 75.77 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.693 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.515 ' HD3' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -84.29 -33.11 24.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.933 178.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.606 ' HZ ' HG23 ' A' ' 104' ' ' ILE . 4.5 t80 -59.94 -30.35 69.01 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.07 -68.51 1.66 Allowed Glycine 0 C--N 1.353 1.502 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.99 45.08 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.541 ' CZ ' ' HG3' ' A' ' 48' ' ' PRO . 1.2 m-85 -48.03 -46.35 33.03 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -51.08 -48.83 61.53 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.884 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -63.87 -16.89 62.47 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 m -69.36 -26.88 64.9 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.936 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.759 ' O ' HD22 ' A' ' 75' ' ' LEU . . . 83.69 28.94 33.73 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.697 -0.763 . . . . 0.0 114.996 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.759 HD22 ' O ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -139.45 38.5 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.502 1.151 . . . . 0.0 111.99 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.711 ' HB3' HD11 ' A' ' 104' ' ' ILE . 3.2 mm? -110.15 131.61 54.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.93 0.395 . . . . 0.0 111.306 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.825 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -95.68 121.64 37.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.645 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.911 ' HG3' HD12 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -82.78 133.15 35.15 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.974 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.535 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 18.6 tt -78.29 159.63 4.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.119 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.5 p -108.61 82.76 1.79 Allowed Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 48.1 Cg_endo -90.08 -169.9 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.126 2.55 . . . . 0.0 112.244 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -127.94 156.2 43.02 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.557 0.218 . . . . 0.0 110.921 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -57.52 -45.62 84.77 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.672 0.272 . . . . 0.0 110.946 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.6 -23.13 64.45 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.637 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.477 ' CE2' ' CH2' ' A' ' 94' ' ' TRP . 8.6 t80 -79.23 -59.19 2.87 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 23.2 tt0 -55.65 -38.2 69.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.705 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -76.71 -34.58 58.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.682 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.87 -31.8 1.37 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.914 HD13 ' HA ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -126.21 -90.1 0.55 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.123 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.47 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 2.4 m-85 -136.26 111.24 9.97 Favored Pre-proline 0 CA--C 1.53 0.192 0 O-C-N 122.005 -0.434 . . . . 0.0 111.686 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 90' ' ' TYR . 19.3 Cg_endo -57.45 -22.34 50.03 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.592 2.195 . . . . 0.0 112.504 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -56.94 -53.81 53.82 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.578 0.228 . . . . 0.0 111.589 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.542 HG22 ' CG ' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -62.19 -45.51 93.05 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 110.267 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.78 ' CZ2' HD11 ' A' ' 89' ' ' LEU . 71.7 m95 -60.26 -40.39 90.18 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 121.7 0.762 . . . . 0.0 109.861 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.78 -22.08 61.63 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.953 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.496 ' HB1' HG21 ' A' ' 261' ' ' VAL . . . -75.59 -17.67 59.96 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.657 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 13.1 m -121.74 46.22 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -128.92 139.54 52.08 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.42 0.554 . . . . 0.0 109.533 178.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -142.55 114.37 8.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 119.178 0.899 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 78.21 25.96 0.59 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.74 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.48 -27.98 17.96 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.998 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -102.34 163.85 12.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.561 0.681 . . . . 0.0 111.226 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -91.08 137.99 31.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.83 0.348 . . . . 0.0 110.616 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.911 HD12 ' HG3' ' A' ' 78' ' ' GLU . 15.6 tt -137.57 48.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.344 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 159.61 -177.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 264' ' ' ALA . 49.5 m-85 -142.29 122.82 8.31 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.633 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.64 ' HB3' HG23 ' A' ' 261' ' ' VAL . 88.5 Cg_endo -79.48 166.13 22.38 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.271 1.98 . . . . 0.0 112.37 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.699 ' HA ' ' HB2' ' A' ' 303' ' ' ALA . 3.1 tt -168.61 39.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.136 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.599 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.849 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 176.08 122.37 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 110' ' ' VAL . 11.3 p -113.7 105.62 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.525 ' HA ' ' CG2' ' A' ' 320' ' ' THR . 2.0 mp0 -103.08 162.91 12.56 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.672 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -164.86 150.1 9.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.591 0.71 . . . . 0.0 112.131 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.883 HD11 HD11 ' A' ' 247' ' ' LEU . 2.6 pp -79.51 126.9 31.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.3 171.72 11.24 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 122.178 -0.326 . . . . 0.0 111.118 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.811 HD22 ' CE1' ' A' ' 117' ' ' TYR . 1.3 tt -110.99 136.29 50.22 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.716 HD13 ' OD1' ' A' ' 227' ' ' ASN . 3.3 mp -112.11 128.8 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.811 ' CE1' HD22 ' A' ' 115' ' ' LEU . 22.6 m-30 -110.36 134.87 51.88 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -84.41 119.12 24.75 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -109.54 29.21 7.78 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.715 0.293 . . . . 0.0 111.675 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.1 -54.0 1.12 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -136.74 0.02 OUTLIER 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.406 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.917 HD22 HD11 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -84.27 128.96 59.96 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 41.4 Cg_exo -55.91 161.45 8.39 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.411 2.74 . . . . 0.0 111.604 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.539 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 4.9 p-10 -101.38 169.25 7.98 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.858 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 50.1 Cg_exo -53.84 167.55 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.675 2.25 . . . . 0.0 111.915 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -92.53 -118.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 122.816 2.344 . . . . 0.0 112.868 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.769 ' HD2' HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -84.38 -18.17 36.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.309 0.959 . . . . 0.0 111.747 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.769 HG23 ' HD2' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -117.75 141.25 48.61 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.552 ' CH2' HD22 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -69.71 -25.82 64.04 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 173.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.533 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.4 OUTLIER -44.83 -23.9 0.17 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.989 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.416 ' CD ' HD23 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -70.78 -23.48 62.4 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.774 HG21 ' CD2' ' A' ' 198' ' ' LEU . 1.5 mp -40.44 -60.23 1.62 Allowed Pre-proline 0 N--CA 1.477 0.906 0 CA-C-O 121.446 0.641 . . . . 0.0 111.425 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 67.5 Cg_exo -46.45 -40.87 23.23 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 120.891 1.06 . . . . 0.0 109.861 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.3 -58.84 3.03 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 139' ' ' LEU . 4.0 mm? -68.03 -36.79 80.52 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.393 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.71 ' OD2' HG23 ' A' ' 132' ' ' ILE . 1.3 m-20 -74.16 -40.53 62.52 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 3.0 ttpt -49.87 -46.78 51.86 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 118.949 -1.1 . . . . 0.0 109.29 177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.5 mm-40 -62.59 -37.1 84.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.194 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.972 HD22 ' O ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -62.43 -47.86 82.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -47.59 -45.14 27.05 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.06 -24.43 0.43 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -99.01 -57.63 2.13 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.04 39.57 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.717 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.684 ' HB2' ' O ' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -174.04 177.28 2.38 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.703 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.972 ' O ' HD22 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -107.1 177.66 4.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.754 ' O ' ' C ' ' A' ' 223' ' ' ALA . . . -86.84 -14.25 42.65 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.552 HD22 ' CH2' ' A' ' 129' ' ' TRP . 2.5 pp -138.95 128.68 24.78 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.602 ' O ' HG22 ' A' ' 225' ' ' THR . 2.1 tpt -132.47 136.29 46.6 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 227' ' ' ASN . 6.2 t80 -171.63 173.66 4.59 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.948 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.548 ' O ' ' O ' ' A' ' 208' ' ' THR . 2.5 m120 -23.08 -70.34 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.726 HD22 ' HB1' ' A' ' 206' ' ' ALA . 0.1 OUTLIER 97.53 38.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.88 0.872 . . . . 0.0 109.226 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 172.36 34.73 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 117.637 -1.173 . . . . 0.0 114.113 170.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' OG1' ' A' ' 157' ' ' THR . 13.5 mt-10 -102.59 151.04 38.19 Favored Pre-proline 0 C--O 1.218 -0.589 0 CA-C-N 122.349 2.34 . . . . 0.0 116.025 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.923 ' O ' ' N ' ' A' ' 156' ' ' PHE . 65.9 Cg_endo -78.14 -134.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 1 C-N-CA 125.922 4.415 . . . . 0.0 106.285 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 1.149 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 12.9 m-85 26.08 -60.33 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 119.335 0.97 . . . . 0.0 113.431 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.923 ' N ' ' O ' ' A' ' 154' ' ' PRO . 56.1 m-85 -83.48 -56.6 3.65 Favored 'General case' 0 C--O 1.257 1.471 0 C-N-CA 123.65 0.78 . . . . 0.0 112.097 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.859 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 27.8 p -59.33 -40.5 86.51 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.215 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.539 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 29.4 m0 -52.41 -55.48 31.45 Favored Pre-proline 0 C--N 1.352 0.703 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 1.149 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 86.2 Cg_exo -43.39 -49.26 7.68 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.68 2.253 . . . . 0.0 112.241 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.718 HD11 HD13 ' A' ' 226' ' ' ILE . 5.7 mt -56.91 -56.89 15.88 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 119.514 1.052 . . . . 0.0 109.341 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.452 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 4.4 mt -51.57 -20.94 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.095 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.493 ' HB3' ' H ' ' A' ' 256' ' ' LYS . . . -83.97 -19.45 34.57 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.045 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 250' ' ' PHE . . . -46.79 -47.11 20.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.532 ' CB ' ' CA ' ' A' ' 187' ' ' GLY . 6.6 m-20 -65.29 -58.32 6.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 120.744 1.611 . . . . 0.0 112.831 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.78 31.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.085 -1.531 . . . . 0.0 115.181 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -106.3 100.36 1.63 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.111 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.416 ' O ' ' CA ' ' A' ' 183' ' ' VAL . 60.9 m-85 -77.72 151.09 34.32 Favored 'General case' 0 C--N 1.337 0.048 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.15 -72.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.575 ' HB3' ' CD2' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -111.99 169.83 8.57 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.903 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 1.19 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.5 OUTLIER -102.25 111.48 23.78 Favored 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 328' ' ' GLU . 28.6 m-85 -84.26 115.03 22.25 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.914 -1.494 . . . . 0.0 108.616 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.928 ' O ' ' N ' ' A' ' 174' ' ' GLY . 5.4 mm-40 -137.1 101.59 4.6 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.52 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 41.54 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 123.93 0.769 . . . . 0.0 110.475 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.928 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -75.2 -73.35 0.97 Allowed Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -175.87 143.51 0.58 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.768 1.284 . . . . 0.0 111.154 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 1.19 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 21.8 p90 -45.4 -32.51 2.13 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.061 0.934 . . . . 0.0 109.609 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 40.8 t0 59.38 -98.3 0.08 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.773 -1.558 . . . . 0.0 111.592 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 178' ' ' ILE . 7.4 tp -176.77 32.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -132.54 -18.5 2.48 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.079 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 3.7 m-20 -121.87 93.02 3.86 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.962 HG21 ' CD1' ' A' ' 368' ' ' ILE . 29.0 m -116.72 116.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.85 39.77 2.39 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.617 -1.277 . . . . 0.0 113.494 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.781 ' O ' ' HB2' ' A' ' 188' ' ' ALA . 11.5 p -79.92 -46.13 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.451 ' N ' HG13 ' A' ' 183' ' ' VAL . 13.5 p-10 -75.59 54.49 0.77 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.751 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.6 -171.79 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -49.82 -37.33 30.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.773 0.797 . . . . 0.0 111.807 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.532 ' CA ' ' CB ' ' A' ' 164' ' ' ASP . . . -75.38 -37.14 42.41 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.583 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -64.17 -42.9 96.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -50.3 -40.26 48.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.094 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 194' ' ' PHE . . . -69.59 -47.64 62.86 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -66.7 -60.47 6.14 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.189 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.842 ' O ' HG23 ' A' ' 196' ' ' VAL . 3.8 tt -50.04 -39.37 41.56 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 98.8 m -75.78 -42.33 50.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -60.17 -35.66 75.84 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -47.04 78.58 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 192' ' ' LEU . 46.7 t -56.38 -30.6 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.968 177.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -62.62 -47.57 83.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.827 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.774 ' CD2' HG21 ' A' ' 132' ' ' ILE . 2.0 mt -62.75 -59.1 5.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.663 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 206' ' ' ALA . 33.5 mm -52.01 -47.96 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.651 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -59.69 -34.56 73.04 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.91 0.77 52.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -120.33 -80.77 0.63 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.722 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -120.19 -26.54 5.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.461 ' HA ' HG22 ' A' ' 199' ' ' ILE . 0.0 OUTLIER 75.91 14.03 2.69 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.81 0.277 . . . . 0.0 111.369 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -144.39 -59.56 0.38 Allowed 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.726 ' HB1' HD22 ' A' ' 151' ' ' LEU . . . 67.09 81.08 0.2 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.39 -2.7 35.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.42 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.822 HG22 ' HB2' ' A' ' 213' ' ' ALA . 27.5 m -56.88 127.05 29.79 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.613 ' OD1' HD12 ' A' ' 212' ' ' ILE . 2.8 p-10 -101.65 -175.67 2.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.632 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.5 p90 -69.35 -45.28 69.78 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.208 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.422 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -77.12 -26.72 53.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.428 0.633 . . . . 0.0 111.133 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.613 HD12 ' OD1' ' A' ' 209' ' ' ASP . 5.7 mt -81.56 -51.53 15.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.857 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.822 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -54.82 -33.7 61.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -48.89 76.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 218' ' ' ASN . . . -52.91 -42.75 65.67 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.065 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.518 ' HB3' ' HG2' ' A' ' 148' ' ' MET . . . -53.31 -55.95 20.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.103 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.597 ' CD2' HG21 ' A' ' 222' ' ' THR . 30.0 t80 -60.25 -31.41 70.18 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 215' ' ' ALA . 1.3 t30 -55.01 -39.87 69.53 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -23.78 58.89 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.18 61.0 3.87 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.684 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 11.7 pt-20 -123.55 37.92 4.31 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 123.049 1.404 . . . . 0.0 111.534 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.636 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 0.0 OUTLIER -92.56 -166.06 1.47 Allowed 'General case' 0 N--CA 1.424 -1.751 2 C-N-CA 135.562 5.545 . . . . 0.0 121.939 -170.204 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.786 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . 158.7 34.58 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.14 1 CA-C-N 104.421 -5.808 . . . . 0.0 112.062 168.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.786 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 158.38 131.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 174.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 148' ' ' MET . 0.9 OUTLIER -148.57 155.45 41.13 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.718 HD13 HD11 ' A' ' 160' ' ' LEU . 10.3 pt -115.88 112.47 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.809 1.186 . . . . 0.0 108.503 174.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.716 ' OD1' HD13 ' A' ' 116' ' ' ILE . 2.2 p-10 -147.93 165.23 31.31 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-O 118.95 -0.548 . . . . 0.0 112.411 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -122.85 -176.36 14.88 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.575 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' A' ' 232' ' ' TRP . 74.7 Cg_exo -47.43 -32.4 15.13 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.533 2.156 . . . . 0.0 112.354 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -47.14 -43.15 20.55 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.26 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.62 41.15 3.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.639 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.556 ' HZ2' HG22 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -93.04 -44.03 8.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.801 0.334 . . . . 0.0 110.758 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.8 m -69.6 -33.53 72.82 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.229 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.54 -42.06 6.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.618 0.247 . . . . 0.0 111.419 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.4 -60.77 2.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.954 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 44.91 42.37 6.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.575 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.62 -71.89 0.34 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.93 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.92 42.02 11.63 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.377 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.491 ' O ' HG13 ' A' ' 240' ' ' VAL . 0.0 OUTLIER 67.0 -72.11 0.09 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.017 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 239' ' ' LYS . 0.7 OUTLIER -157.56 -53.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -126.84 119.5 26.97 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.638 0.256 . . . . 0.0 111.0 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -108.46 155.36 20.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.83 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -122.36 111.52 1.8 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.671 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.556 HG22 ' HZ2' ' A' ' 232' ' ' TRP . 13.1 t -91.04 135.28 27.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.685 0.242 . . . . 0.0 110.46 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.403 HG21 ' HE2' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -137.17 167.28 21.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.914 0.485 . . . . 0.0 111.798 -173.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.06 152.68 7.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.883 HD11 HD11 ' A' ' 113' ' ' LEU . 7.1 mt -59.48 159.66 16.3 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 121.279 1.854 . . . . 0.0 110.132 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.794 ' HD3' HD12 ' A' ' 115' ' ' LEU . 5.8 Cg_exo -78.94 -165.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.47 2.114 . . . . 0.0 112.069 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.484 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -112.95 175.72 5.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.813 0.339 . . . . 0.0 111.68 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.514 ' HB2' ' HB1' ' A' ' 163' ' ' ALA . 97.3 m-85 -164.13 110.38 1.06 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.364 0.602 . . . . 0.0 109.384 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt 61.18 34.19 18.97 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.521 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.05 40.63 34.4 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.899 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.423 ' HB3' ' O ' ' A' ' 163' ' ' ALA . 7.8 mt-30 -156.99 158.68 31.34 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.506 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 79.9 Cg_endo -93.98 160.81 2.18 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.887 3.058 . . . . 0.0 111.776 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 247' ' ' LEU . 1.3 p -84.43 156.05 21.96 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.493 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 6.1 tmmm? -85.93 112.95 48.89 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.181 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.477 ' HG2' ' CA ' ' A' ' 327' ' ' GLY . 71.6 Cg_endo -84.59 145.0 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.829 2.353 . . . . 0.0 112.417 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 155' ' ' TYR . 1.3 m-85 -79.64 148.79 31.51 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 328' ' ' GLU . 1.9 m -104.8 139.69 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -176.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -125.25 118.85 3.38 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 118.787 -1.673 . . . . 0.0 116.985 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.831 HG13 ' HB3' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -129.87 97.62 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 176.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.849 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -78.19 115.3 17.82 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.507 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 53.6 p -133.87 138.59 45.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 1.026 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -89.74 109.65 20.61 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 105' ' ' ALA . . . -97.75 165.42 22.2 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 176.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 59' ' ' ILE . 10.4 mt -91.13 123.3 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 118.495 1.148 . . . . 0.0 108.022 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.493 ' ND2' ' HB3' ' A' ' 269' ' ' ALA . 11.5 p-10 -61.97 138.19 58.34 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.987 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.825 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -51.13 -18.42 0.86 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.705 1.139 . . . . 0.0 110.892 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 55' ' ' ASP . . . -56.5 -37.79 70.89 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.49 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 78.8 82.74 0.1 OUTLIER Pre-proline 0 N--CA 1.463 0.221 0 CA-C-O 120.769 0.319 . . . . 0.0 110.9 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -91.65 99.76 0.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.24 2.627 . . . . 0.0 112.612 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.551 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 1.6 m-20 47.83 73.44 0.2 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.797 0.332 . . . . 0.0 110.629 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 5.4 mttm -53.1 -54.05 41.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.656 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 13.5 mm-40 -63.28 -57.4 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 1.083 HD21 HD11 ' A' ' 33' ' ' ILE . 9.0 tt -65.66 -57.93 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -60.45 -56.73 17.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 7.3 ttpp -60.69 -30.31 69.86 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 2.4 tt0 -76.41 -52.82 9.13 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.532 ' CD1' ' CE2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -57.2 -50.0 74.23 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.781 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 279' ' ' PHE . 2.1 tp -56.94 -43.08 81.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.622 0.725 . . . . 0.0 111.227 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -73.42 -34.78 65.64 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.664 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -93.88 -14.02 26.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.486 ' CE2' HG13 ' A' ' 23' ' ' VAL . 26.1 t80 -109.13 -63.14 1.39 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 284' ' ' LEU . 0.2 OUTLIER -39.92 -31.82 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.983 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.774 HD13 HD21 ' A' ' 304' ' ' LEU . 3.5 mm? -90.01 42.53 1.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.737 0.303 . . . . 0.0 111.131 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.9 p -144.18 155.1 43.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 1.0 OUTLIER -64.42 -13.57 51.99 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.721 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 1.1 mp0 -77.91 -47.47 18.59 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 117.999 0.363 . . . . 0.0 110.149 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.576 ' O ' HG12 ' A' ' 293' ' ' VAL . . . -84.23 -55.03 2.84 Favored Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.953 HD22 HD23 ' A' ' 304' ' ' LEU . 10.7 tp -47.42 -51.57 19.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.538 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 8.6 tt0 -79.23 -26.21 42.54 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.616 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -68.54 -40.15 80.83 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 289' ' ' GLY . 3.0 p -67.97 -61.45 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.508 ' H ' HG13 ' A' ' 293' ' ' VAL . 16.5 t30 -37.57 -50.91 1.16 Allowed 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.408 1.483 . . . . 0.0 112.289 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -60.08 -45.69 92.06 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.4 OUTLIER -57.87 -52.59 64.84 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.804 ' HZ1' ' HB3' ' A' ' 301' ' ' ALA . 0.0 OUTLIER -42.48 162.49 0.16 Allowed Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.359 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.07 -72.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.0 2.467 . . . . 0.0 113.405 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.462 ' N ' ' HD2' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -157.78 -62.99 0.09 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.536 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.603 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . -79.87 138.83 20.66 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.951 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.804 ' HB3' ' HZ1' ' A' ' 297' ' ' LYS . . . 168.56 -172.95 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.612 ' HA ' HD21 ' A' ' 311' ' ' LEU . 8.3 p -178.04 137.38 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.22 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' A' ' 108' ' ' ILE . . . 167.59 96.04 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.953 HD23 HD22 ' A' ' 290' ' ' LEU . 5.9 tp 96.59 116.73 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.234 0.614 . . . . 0.0 110.752 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 304' ' ' LEU . 13.9 ttmt -26.54 -64.44 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.569 0.543 . . . . 0.0 111.12 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.2 m -48.3 -40.82 26.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.8 0.809 . . . . 0.0 110.277 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.717 ' CD2' HD23 ' A' ' 311' ' ' LEU . 42.5 t80 -75.85 -33.58 60.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.005 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.565 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 7.0 pt-20 -72.51 -41.31 66.06 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 120.561 -0.456 . . . . 0.0 109.987 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.65 -56.93 6.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.14 -57.38 8.87 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.722 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.939 HD11 HG21 ' A' ' 317' ' ' ILE . 2.7 pp -61.52 -43.0 99.65 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.154 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.726 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -46.78 -29.67 2.05 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -35.54 -41.52 0.2 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.719 0.295 . . . . 0.0 110.886 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.05 127.89 85.92 Favored Pre-proline 0 CA--C 1.528 0.126 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.38 -22.69 34.85 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.614 2.209 . . . . 0.0 113.714 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -60.7 -59.12 5.89 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.939 HG21 HD11 ' A' ' 311' ' ' LEU . 2.6 mp -49.82 -55.8 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.89 -52.0 12.18 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.08 0.4 . . . . 0.0 111.659 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.15 -41.48 92.86 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.843 0.83 . . . . 0.0 109.738 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 111' ' ' GLU . 1.5 m -60.9 -41.94 97.07 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.614 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.459 ' HG2' HG21 ' A' ' 110' ' ' VAL . 1.7 tmm? -77.13 -39.43 49.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.69 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.08 -41.73 79.37 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.852 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.477 ' HB3' ' HB1' ' A' ' 112' ' ' ALA . 2.8 m120 -75.58 -42.01 53.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.715 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 111' ' ' GLU . . . -65.73 -42.43 91.04 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.852 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.1 -31.84 53.19 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.278 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -100.61 41.59 1.17 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.592 0.234 . . . . 0.0 111.15 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.477 ' CA ' ' HG2' ' A' ' 257' ' ' PRO . . . -120.85 172.11 15.0 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.992 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.697 ' O ' HG13 ' A' ' 259' ' ' VAL . 0.6 OUTLIER -94.46 138.38 32.46 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 175.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.611 ' HA ' ' CG2' ' A' ' 259' ' ' VAL . 1.3 pp -83.62 109.56 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 119.105 0.866 . . . . 0.0 112.226 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.454 ' HE2' ' HA ' ' A' ' 330' ' ' MET . 0.0 OUTLIER -44.14 98.48 0.18 Allowed Pre-proline 0 C--N 1.344 0.348 0 CA-C-O 120.791 0.329 . . . . 0.0 110.802 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.648 ' HG2' ' CE1' ' A' ' 176' ' ' TYR . 32.5 Cg_exo -60.79 -42.48 38.08 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.002 2.468 . . . . 0.0 112.045 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 331' ' ' PRO . 3.0 t30 86.34 93.08 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.611 HD12 ' H ' ' A' ' 336' ' ' MET . 1.9 pp -133.82 146.69 61.24 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 118.457 0.571 . . . . 0.0 110.833 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.64 -48.19 16.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.782 2.321 . . . . 0.0 113.319 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.445 ' HB2' HD13 ' A' ' 333' ' ' ILE . 4.0 mp0 -54.2 -21.43 8.9 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.611 ' H ' HD12 ' A' ' 333' ' ' ILE . 12.5 mtt -45.49 -35.63 3.95 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.892 0.315 . . . . 0.0 111.459 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 m -58.29 -34.17 70.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 110.482 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.49 82.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.065 0.459 . . . . 0.0 111.709 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.76 ' O ' HG12 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -78.4 -55.69 5.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.614 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -44.67 -45.14 9.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.327 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.465 ' O ' HG23 ' A' ' 345' ' ' THR . 8.8 m-85 -76.01 -43.47 44.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.27 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.49 90.86 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.878 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.9 p -76.85 -29.92 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.555 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -46.76 57.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.653 ' O ' HG22 ' A' ' 348' ' ' ILE . 29.9 p -62.77 -57.82 9.6 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.79 -38.87 4.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.63 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 343' ' ' VAL . 24.8 t -60.76 -57.2 13.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 345' ' ' THR . 3.5 tt -60.06 -27.85 39.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.8 OUTLIER -63.84 -30.13 71.25 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 355' ' ' GLN . . . -75.52 -46.14 33.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -84.18 -9.8 58.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 348' ' ' ILE . 86.7 p -97.8 -49.76 4.69 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 147.52 -2.92 0.82 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 117.923 -2.084 . . . . 0.0 117.404 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.74 34.3 4.66 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 115.328 -2.549 . . . . 0.0 115.818 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.595 ' C ' ' HB2' ' A' ' 360' ' ' ALA . 1.0 OUTLIER -72.12 -130.01 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 129.855 3.262 . . . . 0.0 106.476 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.76 ' OG1' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER 153.12 86.57 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.249 1 N-CA-C 94.539 -6.097 . . . . 0.0 94.539 177.091 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.565 ' C ' ' O ' ' A' ' 356' ' ' THR . 1.3 p -40.26 -60.72 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.46 0 CA-C-N 122.833 2.56 . . . . 0.0 112.491 -166.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.473 ' H ' HG13 ' A' ' 357' ' ' VAL . 35.8 t0 -72.9 -44.48 61.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.48 -38.92 62.76 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.02 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.76 ' HB2' ' OG1' ' A' ' 356' ' ' THR . . . -62.18 -50.34 72.19 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.834 HD11 HD13 ' A' ' 192' ' ' LEU . 13.3 mt -72.25 -36.27 69.02 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.564 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -56.07 15.17 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.254 1.026 . . . . 0.0 110.059 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 366' ' ' THR . 13.5 t0 -62.63 -36.01 81.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.522 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -49.78 -43.07 48.05 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' A' ' 181' ' ' VAL . 0.2 OUTLIER -63.33 -43.16 98.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.359 177.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 363' ' ' ASP . 23.6 m -50.46 -42.58 54.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.322 0.582 . . . . 0.0 110.193 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -60.17 3.49 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.098 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.962 ' CD1' HG21 ' A' ' 181' ' ' VAL . 17.8 pt -58.4 -27.01 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.993 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.71 ' CG2' HG22 ' A' ' 181' ' ' VAL . 77.4 p -118.26 48.26 1.45 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.825 0.345 . . . . 0.0 110.513 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.3 mttm . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.664 0.269 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.95 103.63 5.44 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.907 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -120.04 146.37 45.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.32 179.81 6.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -137.07 47.56 0.95 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.413 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -149.6 155.34 40.11 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -152.12 117.64 5.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 58' ' ' ASP . 47.6 t -111.61 135.94 49.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.127 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.993 HG23 HG13 ' A' ' 37' ' ' VAL . 11.7 tt -132.3 127.45 57.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.329 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.712 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -103.53 126.77 50.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.407 178.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.896 HD13 ' HB3' ' A' ' 61' ' ' PHE . 4.6 mm -146.35 139.19 20.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -112.84 39.79 2.44 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.816 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.47 -11.43 35.86 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.636 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.9 t70 65.92 68.82 0.45 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.15 0.475 . . . . 0.0 110.395 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 162.64 -172.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.167 0.508 . . . . 0.0 111.74 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.06 22.73 67.84 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 116.26 1.264 . . . . 0.0 116.26 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -35.33 33.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.972 0.886 . . . . 0.0 111.205 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 11.3 t30 -65.54 -52.57 51.49 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 111.786 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.919 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.61 -48.96 26.52 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.83 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.763 ' CD1' HG21 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -59.5 -50.51 73.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.904 0.852 . . . . 0.0 110.331 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.97 -37.87 87.1 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 56.7 mt-10 -66.28 -36.84 84.01 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.46 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 19' ' ' GLY . 41.0 t -68.03 -61.61 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.96 -0.462 . . . . 0.0 110.46 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . -49.22 -35.16 19.28 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.288 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -50.14 67.42 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 122.515 1.15 . . . . 0.0 108.479 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -52.1 -43.21 63.8 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.32 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.783 ' HB3' HD13 ' A' ' 33' ' ' ILE . 1.5 m-30 -65.77 -29.71 70.25 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.762 0.791 . . . . 0.0 111.013 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.797 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 1.1 tm-20 -71.14 -52.54 18.69 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.029 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -52.36 -28.42 19.42 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 125.159 1.537 . . . . 0.0 111.245 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.78 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -86.07 -37.5 18.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.188 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.78 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 3.5 t 160.0 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.801 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.75 38.55 0.02 OUTLIER Glycine 0 N--CA 1.465 0.581 0 C-N-CA 114.712 -3.613 . . . . 0.0 119.318 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.801 HD12 ' C ' ' A' ' 32' ' ' GLY . 1.6 mp -139.92 134.98 37.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 121.576 2.688 . . . . 0.0 115.422 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -140.89 104.76 4.75 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.763 HG21 ' CD1' ' A' ' 20' ' ' LEU . 9.4 p -103.7 134.1 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.473 ' OG1' HG22 ' A' ' 8' ' ' VAL . 34.5 p -118.33 146.82 44.07 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.136 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.993 HG13 HG23 ' A' ' 9' ' ' ILE . 9.5 t -130.9 120.79 48.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.517 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 30.8 tt0 -112.99 144.44 42.57 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -131.79 73.9 78.2 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.724 0.297 . . . . 0.0 111.236 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.786 ' HD2' HD12 ' A' ' 43' ' ' LEU . 43.0 Cg_endo -89.98 -173.75 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.057 2.505 . . . . 0.0 112.82 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -96.01 -40.31 9.33 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -85.38 0.35 52.42 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.619 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.786 HD12 ' HD2' ' A' ' 40' ' ' PRO . 4.9 tt -21.57 -45.97 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 1.062 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 1.5 pp20? -68.68 -54.16 17.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.399 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 3.5 tt0 -69.66 -41.22 75.83 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.055 0.455 . . . . 0.0 109.797 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' O ' HG13 ' A' ' 50' ' ' VAL . 9.5 mtpt -56.28 -56.24 23.49 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.011 0.91 . . . . 0.0 109.834 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.612 ' CG ' HG12 ' A' ' 60' ' ' ILE . 1.3 t80 -44.15 -61.26 2.14 Favored Pre-proline 0 C--N 1.349 0.556 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.127 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 1.062 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 37.0 Cg_exo -61.5 -25.36 79.55 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 121.347 1.365 . . . . 0.0 113.341 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -81.58 -37.1 28.22 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 122.143 0.973 . . . . 0.0 111.034 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 46' ' ' LYS . 19.2 m -77.28 -40.0 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.59 0 CA-C-O 122.001 0.905 . . . . 0.0 109.797 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.78 -37.98 32.26 Favored 'General case' 0 C--N 1.374 1.666 0 C-N-CA 126.074 1.75 . . . . 0.0 110.999 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.25 -40.64 23.45 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-N 114.144 -1.389 . . . . 0.0 113.519 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -63.22 1.15 Allowed 'General case' 0 C--N 1.346 0.429 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.015 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.08 69.39 0.05 OUTLIER Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.216 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -96.37 -64.94 1.0 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.8 -120.78 5.58 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.661 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 72.4 Cg_exo -49.83 109.56 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.187 1.925 . . . . 0.0 110.978 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 15.6 t0 159.27 113.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.608 0.363 . . . . 0.0 110.77 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 265' ' ' GLY . 0.7 OUTLIER -98.5 173.24 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.957 -177.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.815 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -131.06 130.08 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.697 -177.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.896 ' HB3' HD13 ' A' ' 11' ' ' ILE . 70.2 t80 -121.8 112.21 18.08 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -166.84 161.94 15.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HA ' HD23 ' A' ' 262' ' ' LEU . . . -34.95 151.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.791 ' HB3' HG23 ' A' ' 261' ' ' VAL . 2.7 t60 -77.26 -28.94 53.69 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' OD2' ' HE1' ' A' ' 330' ' ' MET . 33.5 m-20 -47.37 -59.29 3.31 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.6 mtp85 -78.51 -26.95 45.99 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.712 -0.617 . . . . 0.0 109.648 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.946 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.64 -28.69 70.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -61.97 -58.74 11.47 Favored Glycine 0 CA--C 1.49 -1.495 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.29 -60.43 8.84 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 111.848 -2.176 . . . . 0.0 111.598 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.642 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 22.2 m-85 -48.81 -37.56 19.62 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.007 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . . . -56.5 -38.95 72.47 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.338 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -78.51 -56.3 4.54 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.342 -0.224 . . . . 0.0 111.556 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 m -113.91 -27.19 7.83 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.642 ' HA3' ' HA ' ' A' ' 70' ' ' TYR . . . -63.41 -89.7 0.03 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.861 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.094 ' C ' ' HB2' ' A' ' 268' ' ' ALA . 0.2 OUTLIER -179.02 63.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.007 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -116.36 140.11 49.68 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 173.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.959 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . -90.33 88.13 7.08 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.763 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HA ' ' CG1' ' A' ' 104' ' ' ILE . 1.2 mt-10 -47.36 100.09 0.02 OUTLIER 'General case' 0 C--O 1.23 0.076 0 CA-C-O 120.821 0.343 . . . . 0.0 110.434 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 104' ' ' ILE . 4.4 mt -47.66 159.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.554 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.586 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -88.26 175.15 4.37 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 80' ' ' THR . 76.1 Cg_endo -79.76 133.56 10.38 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.344 2.029 . . . . 0.0 113.399 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.71 -170.11 2.15 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.809 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 -78.18 0.59 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.237 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.03 -23.02 67.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -62.12 -59.31 5.24 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.77 0.319 . . . . 0.0 110.236 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -77.08 -28.43 54.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.71 -10.84 59.67 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -92.26 -18.19 23.75 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.754 HD22 ' CD1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -90.59 -176.84 4.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.277 0.49 . . . . 0.0 111.297 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.557 ' CB ' ' CZ3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -94.49 165.72 16.81 Favored Pre-proline 0 C--N 1.341 0.238 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.581 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 6.3 Cg_exo -75.4 -24.09 12.53 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.826 2.351 . . . . 0.0 115.248 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CE1' ' NE2' ' A' ' 325' ' ' GLN . 4.2 m-85 -87.31 -63.5 1.3 Allowed 'General case' 0 C--O 1.245 0.832 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.925 HG21 HG21 ' A' ' 302' ' ' VAL . 0.2 OUTLIER -63.19 -24.68 67.99 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.754 ' CD1' HD22 ' A' ' 89' ' ' LEU . 5.9 m-90 -93.75 -24.31 17.86 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.48 0.712 . . . . 0.0 111.345 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 8.1 t0 -73.63 -23.53 59.89 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.653 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.641 ' HB3' HG11 ' A' ' 261' ' ' VAL . . . -62.91 -42.95 99.96 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.904 HG23 HG11 ' A' ' 261' ' ' VAL . 44.5 t -108.62 54.13 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . 0.9 OUTLIER -130.85 140.28 50.23 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.03 -0.419 . . . . 0.0 110.786 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 101' ' ' GLY . 57.0 m-85 -112.34 174.72 5.75 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -48.05 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 56.16 38.14 75.65 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.268 -0.968 . . . . 0.0 110.752 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 -177.27 5.5 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 97' ' ' VAL . 0.7 OUTLIER 168.34 130.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.913 ' CD1' HD12 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -115.67 38.86 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 165.22 175.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.767 ' CE1' ' HB3' ' A' ' 264' ' ' ALA . 5.3 p90 -117.51 133.41 23.26 Favored Pre-proline 0 C--N 1.343 0.288 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.985 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.855 ' O ' HD13 ' A' ' 108' ' ' ILE . 96.0 Cg_endo -79.37 149.76 21.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.433 2.088 . . . . 0.0 113.315 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 107' ' ' PRO . 1.3 mm -149.32 38.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.009 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.913 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 177.33 124.65 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.399 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.6 HG22 HG22 ' A' ' 320' ' ' THR . 4.1 p -107.01 114.99 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.325 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 229' ' ' PRO . 18.6 mt-10 -99.36 132.79 44.44 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.641 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -168.3 -174.13 2.18 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.493 1.517 . . . . 0.0 110.077 -167.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.569 HD23 HG13 ' A' ' 226' ' ' ILE . 2.0 tp -146.65 136.98 23.73 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 111.542 -2.572 . . . . 0.0 116.35 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.874 ' O ' HD12 ' A' ' 226' ' ' ILE . 0.2 OUTLIER -131.42 164.74 25.05 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.59 -178.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.497 HD12 ' HD3' ' A' ' 248' ' ' PRO . 0.9 OUTLIER -92.6 132.17 37.09 Favored 'General case' 0 C--N 1.342 0.257 0 O-C-N 121.972 -0.455 . . . . 0.0 110.289 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.792 HD11 ' CD2' ' A' ' 242' ' ' TYR . 19.1 tt -113.88 131.19 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.258 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -104.24 132.64 50.27 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.753 ' CB ' ' HB2' ' A' ' 122' ' ' LEU . 45.8 m-80 -87.29 123.98 32.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.203 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -98.03 -87.98 0.32 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 119' ' ' LYS . 26.4 t0 -19.72 -63.67 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.776 HD12 ' HG ' ' A' ' 122' ' ' LEU . 2.5 pp -125.87 38.9 4.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.776 ' HG ' HD12 ' A' ' 121' ' ' LEU . 90.9 mt -158.41 113.22 1.7 Allowed Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.101 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -92.63 124.17 0.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.196 1.264 . . . . 0.0 111.45 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.575 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 11.9 p-10 -97.47 161.64 25.28 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 81.5 Cg_endo -77.1 167.86 24.25 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.676 2.917 . . . . 0.0 112.315 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.34 -47.94 0.08 OUTLIER 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.084 2.522 . . . . 0.0 113.654 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.663 ' CE ' HG23 ' A' ' 128' ' ' THR . 0.4 OUTLIER -155.63 -10.06 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -178.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.663 HG23 ' CE ' ' A' ' 127' ' ' LYS . 1.4 p -117.2 140.21 49.82 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.218 0.917 . . . . 0.0 113.278 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.604 ' O ' HD12 ' A' ' 132' ' ' ILE . 1.8 m0 -71.14 -27.73 63.77 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.486 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.5 OUTLIER -44.61 -24.0 0.16 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.682 ' HB3' HD12 ' A' ' 135' ' ' LEU . 3.4 mp0 -63.19 -23.3 67.37 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.778 HD13 HD11 ' A' ' 198' ' ' LEU . 5.8 mt -40.52 -59.73 1.86 Allowed Pre-proline 0 N--CA 1.477 0.924 0 CA-C-O 121.11 0.481 . . . . 0.0 112.147 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 4.6 Cg_endo -46.63 -45.39 19.87 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 121.251 1.301 . . . . 0.0 110.701 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.13 -58.91 2.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 131' ' ' GLU . 36.9 mt -67.37 -36.84 82.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.68 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.751 ' HA ' HD12 ' A' ' 139' ' ' LEU . 7.7 t0 -73.43 -41.41 63.27 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 5.2 tttt -48.77 -41.94 34.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.123 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 4.0 tm-20 -67.37 -38.1 84.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.189 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.916 HD13 ' N ' ' A' ' 146' ' ' ALA . 1.2 mt -63.18 -47.96 80.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.87 -44.6 29.55 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.05 -24.25 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.601 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -111.7 -60.56 1.83 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.62 46.76 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 CA-C-O 118.777 -1.013 . . . . 0.0 111.379 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.607 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.1 OUTLIER -157.04 -172.41 4.02 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.939 1.87 . . . . 0.0 111.128 -176.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.876 ' C ' HD13 ' A' ' 139' ' ' LEU . 49.3 m -139.82 167.17 22.72 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.916 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -83.57 -30.57 26.91 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.695 HD21 ' CG1' ' A' ' 132' ' ' ILE . 0.8 OUTLIER -137.54 127.94 26.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -176.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.852 ' HB3' HG21 ' A' ' 222' ' ' THR . 0.4 OUTLIER -132.21 137.87 47.74 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.975 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 1.026 ' O ' ' O ' ' A' ' 150' ' ' ASN . 7.1 p90 -171.33 174.72 4.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.53 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 1.026 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -20.45 -169.77 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 150' ' ' ASN . 0.1 OUTLIER -168.64 33.58 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.351 -0.843 . . . . 0.0 110.544 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.455 ' CB ' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER 172.05 33.99 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 169.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.879 ' O ' ' OG1' ' A' ' 157' ' ' THR . 14.1 pt-20 -115.16 152.74 47.03 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 121.125 1.784 . . . . 0.0 114.376 -176.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.815 ' O ' ' N ' ' A' ' 156' ' ' PHE . 5.1 Cg_exo -77.27 -136.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 124.643 3.562 . . . . 0.0 105.044 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 1.189 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 20.1 m-85 40.88 -68.37 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 120.51 1.505 . . . . 0.0 112.991 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.815 ' N ' ' O ' ' A' ' 154' ' ' PRO . 2.2 t80 -88.51 -58.63 2.48 Favored 'General case' 0 C--O 1.26 1.616 0 CA-C-N 118.705 0.684 . . . . 0.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.879 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 7.0 p -60.16 -42.92 95.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 118.276 -1.37 . . . . 0.0 107.854 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.453 ' HA ' ' CE3' ' A' ' 158' ' ' TRP . 0.0 OUTLIER -49.65 -55.75 21.04 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 1.189 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 84.0 Cg_exo -43.7 -47.26 9.81 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.025 2.483 . . . . 0.0 113.493 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.672 HD12 ' OG ' ' A' ' 255' ' ' SER . 4.9 mp -60.84 -56.38 21.91 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.07 0.85 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.669 HG22 ' HA ' ' A' ' 188' ' ' ALA . 3.7 mt -51.73 -23.6 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.388 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.452 ' CB ' ' HB2' ' A' ' 256' ' ' LYS . . . -79.83 -22.4 43.04 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.047 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 253' ' ' GLN . . . -42.03 -55.81 3.04 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.543 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 1.3 m-20 -64.19 -51.89 61.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 119.449 1.022 . . . . 0.0 112.393 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 169.34 26.14 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 117.924 -2.084 . . . . 0.0 117.117 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.59 89.65 0.7 Allowed Glycine 0 CA--C 1.522 0.526 0 CA-C-N 119.157 1.479 . . . . 0.0 112.66 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 27.1 m-85 -75.11 157.75 34.21 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.184 0.492 . . . . 0.0 111.061 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.674 ' HA ' HG13 ' A' ' 183' ' ' VAL . . . -61.82 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 111.352 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.893 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 4.9 m-85 -112.98 171.87 7.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.215 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 1.208 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER -101.21 107.96 19.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.13 115.42 23.7 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.577 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.877 ' O ' ' N ' ' A' ' 174' ' ' GLY . 19.7 mt-10 -136.35 101.53 4.7 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.449 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 53.0 t30 44.28 -64.31 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 123.796 0.685 . . . . 0.0 111.079 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.877 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -71.64 -73.35 0.83 Allowed Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 116.016 -0.538 . . . . 0.0 114.172 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -175.19 158.12 2.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.797 0.799 . . . . 0.0 109.688 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 1.208 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 17.4 p90 -44.37 -35.89 2.59 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.006 1.384 . . . . 0.0 109.068 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.577 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 0.9 OUTLIER 72.92 -79.48 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.778 -2.465 . . . . 0.0 110.839 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.743 HD11 HD13 ' A' ' 368' ' ' ILE . 8.1 tp 168.66 -41.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -8.15 51.93 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 4.6 m-20 -119.72 93.84 4.2 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.357 0.98 . . . . 0.0 109.36 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.495 HG11 ' CZ ' ' A' ' 339' ' ' PHE . 2.6 t -116.33 112.41 39.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -118.48 40.05 2.4 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.745 -1.217 . . . . 0.0 113.553 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.708 ' O ' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -79.97 -47.52 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -81.43 57.26 3.21 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.149 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -102.06 179.52 4.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.244 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.09 -30.49 36.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.486 0.66 . . . . 0.0 111.559 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.543 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -74.71 -40.69 36.83 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.39 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -59.69 -48.93 79.74 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -59.62 -60.27 4.11 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.551 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.38 -40.69 50.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.972 0.891 . . . . 0.0 112.004 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -64.86 -60.61 6.69 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.431 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 196' ' ' VAL . 5.6 tp -58.97 -25.79 63.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 3.1 m -61.94 -49.56 75.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.448 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 1.3 p90 -61.28 -35.52 77.55 Favored 'General case' 0 C--N 1.345 0.413 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.88 -46.84 83.09 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 192' ' ' LEU . 44.8 t -57.78 -31.42 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.454 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -45.72 89.35 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.725 0.774 . . . . 0.0 110.841 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.778 HD11 HD13 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -57.85 -54.37 47.63 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.903 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.667 ' CD1' ' HB2' ' A' ' 206' ' ' ALA . 10.8 tt -65.98 -35.13 74.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.387 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.07 -38.58 70.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.148 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -113.03 -34.85 5.59 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 120.785 3.624 . . . . 0.0 120.785 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.72 -70.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.514 ' NE2' HD11 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -47.8 -37.11 12.88 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.22 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.1 mtp 61.68 -77.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 203' ' ' HIS . 4.9 t-20 -86.38 -178.75 6.53 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.667 ' HB2' ' CD1' ' A' ' 199' ' ' ILE . . . -155.24 36.44 0.38 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -97.24 -2.81 41.96 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.762 HG22 ' HB2' ' A' ' 213' ' ' ALA . 29.5 m -55.2 118.98 4.83 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.53 -174.28 4.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -70.12 -45.45 66.86 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.69 -33.63 66.63 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.829 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.686 HG22 HG23 ' A' ' 208' ' ' THR . 1.4 mp -77.38 -48.71 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.881 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.762 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -58.1 -32.41 68.07 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.534 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 2.5 tp10 -60.58 -46.3 90.73 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.16 -36.11 74.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.641 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.13 -57.79 11.31 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -61.12 -28.35 69.04 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -53.45 -45.49 69.51 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -23.96 58.96 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.89 53.63 22.23 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.404 -0.817 . . . . 0.0 115.009 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -109.33 37.01 2.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.516 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.852 HG21 ' HB3' ' A' ' 148' ' ' MET . 14.3 t -140.33 140.02 35.53 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.736 ' HA ' HD13 ' A' ' 122' ' ' LEU . . . -104.11 38.53 1.83 Allowed 'General case' 0 C--N 1.349 0.559 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -176.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.613 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 3.0 tmm? 167.69 137.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.597 HG23 ' HB3' ' A' ' 149' ' ' PHE . 89.1 m -147.78 159.92 43.3 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.674 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.874 HD12 ' O ' ' A' ' 114' ' ' SER . 2.3 tp -115.68 112.13 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 232' ' ' TRP . 1.7 p30 -148.07 165.01 32.09 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.877 -0.514 . . . . 0.0 112.152 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 113' ' ' LEU . . . -160.23 -177.75 33.61 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 119.905 -1.14 . . . . 0.0 111.092 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 36.7 Cg_exo -61.93 69.73 0.11 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.225 1.95 . . . . 0.0 111.979 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.86 ' CZ3' ' HB2' ' A' ' 231' ' ' ALA . 9.2 t90 -157.93 -59.6 0.08 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.86 ' HB2' ' CZ3' ' A' ' 230' ' ' TRP . . . -89.69 -34.68 16.15 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.777 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.501 ' CD1' ' HB2' ' A' ' 227' ' ' ASN . 0.3 OUTLIER -124.56 79.93 1.8 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.716 0.293 . . . . 0.0 111.287 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.3 m -71.04 -43.89 66.93 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.316 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -100.5 77.22 1.9 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.476 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 tt -45.7 136.94 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.605 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.09 -172.93 3.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.594 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.49 78.42 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.658 0.266 . . . . 0.0 110.937 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.0 m -113.14 52.58 0.79 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 61.63 112.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.705 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.2 m -52.9 -40.11 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.533 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -83.36 104.3 13.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.716 0.293 . . . . 0.0 110.727 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.792 ' CD2' HD11 ' A' ' 116' ' ' ILE . 47.7 p90 -148.55 142.54 25.87 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.336 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -85.53 162.7 36.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.075 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.8 106.49 13.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.911 0.356 . . . . 0.0 111.524 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.56 166.9 16.43 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -172.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.8 154.21 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.169 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.849 HD12 HD11 ' A' ' 226' ' ' ILE . 0.1 OUTLIER -58.23 156.17 22.51 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 120.327 1.421 . . . . 0.0 110.256 -178.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.497 ' HD3' HD12 ' A' ' 115' ' ' LEU . 72.2 Cg_endo -79.44 -165.97 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.532 2.155 . . . . 0.0 112.466 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 40.8 p -106.3 168.16 9.34 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.308 0.575 . . . . 0.0 111.444 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' A' ' 253' ' ' GLN . 0.5 OUTLIER -166.05 126.44 1.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.851 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 36.93 31.11 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.992 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.36 27.49 48.05 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.612 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.476 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 23.7 mm100 -156.6 151.17 20.34 Favored Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 117.479 0.639 . . . . 0.0 112.661 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -91.89 138.88 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.392 2.728 . . . . 0.0 112.093 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.672 ' OG ' HD12 ' A' ' 160' ' ' LEU . 52.6 m -57.85 142.7 45.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.201 0.524 . . . . 0.0 112.176 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -86.16 108.91 19.24 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.981 -178.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.46 ' HD2' ' HA3' ' A' ' 327' ' ' GLY . 4.8 Cg_exo -79.82 147.2 19.12 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.984 2.456 . . . . 0.0 112.501 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 1.1 m-85 -79.78 136.51 36.75 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.653 HG21 HG13 ' A' ' 329' ' ' ILE . 27.2 t -92.09 124.46 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -117.59 125.78 6.64 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.196 -1.478 . . . . 0.0 114.764 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.904 HG11 HG23 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.89 103.5 13.57 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.913 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 69.7 mt -86.11 103.84 15.14 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.563 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.641 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 68.9 p -133.05 139.68 47.31 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 118.142 2.645 . . . . 0.0 118.142 -172.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.873 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . . . -95.06 113.36 25.05 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.677 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -102.55 163.26 16.51 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.367 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.624 ' O ' ' O ' ' A' ' 267' ' ' ASN . 0.8 OUTLIER -89.78 134.49 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 176.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.959 ' O ' ' N ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -13.52 -167.38 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.956 1 C-N-CA 132.156 4.183 . . . . 0.0 117.165 -171.525 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 1.094 ' HB2' ' C ' ' A' ' 75' ' ' LEU . . . -107.39 119.91 40.71 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 110.651 -2.977 . . . . 0.0 104.143 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 268' ' ' ALA . . . 104.94 -65.8 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.217 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 269' ' ' ALA . 2.4 p 155.46 103.07 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.476 ' O ' ' C ' ' A' ' 272' ' ' ASN . 15.5 Cg_endo -99.38 102.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.457 2.772 . . . . 0.0 113.446 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 271' ' ' PRO . 91.1 m-20 26.76 74.19 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.946 0.403 . . . . 0.0 111.646 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -64.67 -31.61 72.9 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 277' ' ' LYS . 0.7 OUTLIER -53.48 -57.5 10.44 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.875 -0.515 . . . . 0.0 112.366 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.91 -53.48 49.71 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.59 94.15 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -63.29 -40.59 97.8 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 -54.15 7.19 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.553 ' HE2' HG12 ' A' ' 23' ' ' VAL . 8.8 t80 -55.52 -58.72 6.61 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.714 HD11 HD22 ' A' ' 284' ' ' LEU . 0.9 OUTLIER -48.71 -43.17 37.02 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.776 0.798 . . . . 0.0 111.065 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -74.27 -34.56 63.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.095 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -93.6 -15.89 24.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.622 ' CZ ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -112.5 -60.2 1.9 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.463 0.574 . . . . 0.0 110.594 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.743 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.1 tp -43.12 -33.01 0.79 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.862 0.755 . . . . 0.0 109.798 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 285' ' ' LEU . 6.5 mp -86.29 42.24 0.98 Allowed 'General case' 0 C--N 1.342 0.239 0 CA-C-O 120.92 0.391 . . . . 0.0 110.481 178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 283' ' ' TYR . 12.9 p -144.47 154.58 43.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 1.7 m-20 -63.8 -13.98 49.0 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.586 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 2.0 tp10 -77.86 -48.24 16.92 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 121.719 -0.613 . . . . 0.0 110.986 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.669 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -75.66 -61.81 2.84 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.627 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER -57.39 -47.74 80.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.0 OUTLIER -79.42 -26.39 41.85 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -68.36 -38.41 81.4 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.823 HG12 ' CD ' ' A' ' 297' ' ' LYS . 61.3 t -66.07 -61.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.645 ' HB2' ' CE1' ' A' ' 307' ' ' TYR . 57.8 t30 -33.53 -52.33 0.39 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.738 1.215 . . . . 0.0 112.516 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -58.41 -49.62 76.62 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER -57.19 -45.7 83.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.823 ' CD ' HG12 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -47.57 169.06 0.13 Allowed Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.28 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.407 ' HD3' ' HG3' ' A' ' 297' ' ' LYS . 11.0 Cg_endo -90.67 -72.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.549 2.833 . . . . 0.0 112.853 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.616 HD11 ' CG ' ' A' ' 314' ' ' ASP . 0.4 OUTLIER -156.31 -69.14 0.11 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.644 0.259 . . . . 0.0 110.482 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.663 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . -79.9 139.25 21.15 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . 159.98 -174.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.242 0.521 . . . . 0.0 110.861 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.925 HG21 HG21 ' A' ' 93' ' ' THR . 0.3 OUTLIER -149.91 175.07 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.421 179.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.964 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . 172.02 70.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.709 ' HB3' HD21 ' A' ' 290' ' ' LEU . 3.1 tp 82.26 142.56 0.07 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -48.07 -55.95 8.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -177.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.7 t -53.67 -48.93 69.0 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.879 0.847 . . . . 0.0 111.549 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.964 ' CD2' ' HB3' ' A' ' 303' ' ' ALA . 33.0 t80 -70.46 -19.66 62.94 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.282 176.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -65.14 -38.15 89.68 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' A' ' 308' ' ' GLU . 3.4 tt0 -66.19 -54.62 23.01 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.838 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.4 -51.23 70.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.244 0.545 . . . . 0.0 109.614 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.589 HD22 HG13 ' A' ' 317' ' ' ILE . 0.2 OUTLIER -59.79 -41.87 92.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.628 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 313' ' ' LYS . . . -47.22 -29.83 2.61 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 312' ' ' ALA . 5.2 ttpt -31.16 -42.96 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.637 0.256 . . . . 0.0 111.506 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.616 ' CG ' HD11 ' A' ' 299' ' ' LEU . 1.1 t70 -76.34 135.82 69.02 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.384 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 31.1 Cg_exo -59.26 -20.66 56.39 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.529 2.153 . . . . 0.0 113.575 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.553 ' O ' ' OG1' ' A' ' 320' ' ' THR . 7.3 mmt180 -61.42 -58.91 6.28 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.589 HG13 HD22 ' A' ' 311' ' ' LEU . 3.3 mm -49.3 -55.35 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.48 -45.4 13.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.791 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.34 -35.64 63.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.397 0.618 . . . . 0.0 110.267 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.641 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -59.44 -42.69 92.49 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.249 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.45 ' CE ' HG22 ' A' ' 317' ' ' ILE . 60.1 mtm -76.31 -42.01 46.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.143 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -46.96 60.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.446 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -78.28 -41.96 32.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.486 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.508 ' O ' HG22 ' A' ' 259' ' ' VAL . . . -49.54 -36.7 24.35 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.422 ' NE2' ' CE1' ' A' ' 92' ' ' PHE . 2.1 tt0 -85.28 -34.03 22.0 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -93.41 60.68 3.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 111.028 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.46 ' HA3' ' HD2' ' A' ' 257' ' ' PRO . . . -160.67 -139.57 2.69 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.338 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -128.84 117.27 20.77 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.653 HG13 HG21 ' A' ' 259' ' ' VAL . 34.5 mt -83.88 124.09 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.51 ' O ' ' O ' ' A' ' 331' ' ' PRO . 10.9 mtm -42.53 132.43 2.84 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.855 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 176' ' ' TYR . 75.8 Cg_exo -50.28 -156.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.052 2.502 . . . . 0.0 112.605 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.475 ' CG ' ' HH ' ' A' ' 176' ' ' TYR . 8.8 p-10 -146.65 40.32 1.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.954 0.407 . . . . 0.0 111.158 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 335' ' ' GLN . 1.8 pp -138.2 160.4 64.27 Favored Pre-proline 0 C--N 1.34 0.185 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.714 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.11 -13.56 23.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.626 2.217 . . . . 0.0 113.515 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.698 ' HB2' HD13 ' A' ' 333' ' ' ILE . 0.9 OUTLIER -60.56 -21.17 62.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.17 -34.58 2.78 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.144 -0.347 . . . . 0.0 111.827 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.43 -35.31 71.9 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.834 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.429 ' HB3' ' CG1' ' A' ' 368' ' ' ILE . . . -58.09 -36.24 72.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.919 0.39 . . . . 0.0 111.723 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.564 ' CZ ' HG21 ' A' ' 183' ' ' VAL . 0.2 OUTLIER -78.39 -55.75 4.99 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.79 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -43.42 -45.28 6.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.061 0.458 . . . . 0.0 110.177 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.476 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 34.7 t80 -70.72 -41.08 72.37 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.662 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.78 ' HB1' HD22 ' A' ' 361' ' ' LEU . . . -69.68 -46.05 66.94 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.813 ' O ' HG23 ' A' ' 347' ' ' VAL . 31.7 t -70.51 -35.03 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.15 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 341' ' ' TYR . 0.0 OUTLIER -69.73 -36.73 76.12 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 349' ' ' ASN . 95.0 m -66.71 -58.52 4.94 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.969 ' HB1' HG23 ' A' ' 357' ' ' VAL . . . -49.58 -50.39 42.69 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.394 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 343' ' ' VAL . 63.0 t -50.99 -56.93 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 24.8 mt -59.03 -27.39 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.627 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.6 OUTLIER -64.47 -38.68 91.87 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.297 0.57 . . . . 0.0 111.242 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -80.13 -26.58 39.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.359 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.18 -16.88 51.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 2.9 p -111.26 -6.68 14.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.561 1.073 . . . . 0.0 113.376 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 85.61 -2.65 87.88 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.604 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -88.58 35.18 0.76 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 115.808 -2.044 . . . . 0.0 107.605 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -70.82 -174.53 0.94 Allowed 'General case' 0 CA--C 1.547 0.838 1 N-CA-C 125.303 5.297 . . . . 0.0 125.303 -158.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.421 ' N ' ' OD1' ' A' ' 349' ' ' ASN . 4.5 t 159.84 44.76 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 110.365 -3.107 . . . . 0.0 104.252 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.969 HG23 ' HB1' ' A' ' 346' ' ' ALA . 7.7 p -72.44 -56.4 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.516 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 1.6 m-20 -48.78 -45.06 39.49 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.563 0.697 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.19 -55.78 5.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.938 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -52.37 -44.71 65.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 122.413 1.101 . . . . 0.0 112.65 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.78 HD22 ' HB1' ' A' ' 342' ' ' ALA . 1.7 tm? -77.28 -41.56 40.38 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.052 -1.885 . . . . 0.0 110.594 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.607 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 5.2 tttt -60.19 -56.42 21.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.083 0.944 . . . . 0.0 109.129 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -53.05 -37.21 61.4 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.596 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 361' ' ' LEU . . . -49.96 -48.12 52.25 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.524 ' HA ' HG22 ' A' ' 368' ' ' ILE . 41.5 tt0 -54.3 -44.89 72.37 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.5 m -57.16 -43.33 82.43 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.495 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -71.2 -57.47 4.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.025 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 368' ' ' ILE . 0.0 OUTLIER -54.45 -33.21 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.265 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.538 HG23 HG23 ' A' ' 368' ' ' ILE . 41.2 p -94.86 -15.91 23.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.651 0.262 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.56 146.66 44.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.786 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.27 152.85 22.98 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.949 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.657 ' CG ' HD12 ' A' ' 275' ' ' LEU . 2.4 tm-20 -142.93 136.86 29.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.954 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.82 -101.72 0.65 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.28 -170.9 1.94 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.319 -0.94 . . . . 0.0 110.01 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.928 HD12 HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -119.59 123.25 43.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.922 HG11 ' HG3' ' A' ' 57' ' ' PRO . 1.7 t -121.88 111.94 32.89 Favored 'Isoleucine or valine' 0 C--O 1.26 1.62 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.71 ' CG1' HD12 ' A' ' 59' ' ' ILE . 4.0 mt -133.52 126.79 52.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.544 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.686 ' HD1' HG22 ' A' ' 60' ' ' ILE . 1.9 p-90 -98.72 135.29 40.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.611 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 11' ' ' ILE . 1.5 mp -154.27 137.59 7.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 O-C-N 122.102 -0.374 . . . . 0.0 110.763 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -120.73 125.74 48.39 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.782 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.44 29.37 14.31 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.882 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 58.8 t0 -102.03 -80.23 0.51 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.166 0.483 . . . . 0.0 110.436 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 6.2 mttm 101.42 -5.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.898 0.879 . . . . 0.0 111.162 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.667 ' O ' HD12 ' A' ' 20' ' ' LEU . . . -76.38 64.76 2.82 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 115.359 0.904 . . . . 0.0 115.359 -176.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -78.72 -32.49 46.84 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.348 -0.426 . . . . 0.0 111.284 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 3.3 t-20 -68.47 -46.79 68.81 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 111.347 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.692 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -70.67 -47.52 40.48 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.983 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.036 HD13 HG11 ' A' ' 37' ' ' VAL . 1.2 mt -59.56 -50.78 72.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.434 0.617 . . . . 0.0 110.336 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -68.76 -39.27 80.33 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.516 ' HG2' ' HA2' ' A' ' 19' ' ' GLY . 11.0 pt-20 -66.21 -35.91 81.66 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.244 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 19' ' ' GLY . 11.3 m -68.63 -60.34 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.464 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.614 ' HA3' HG13 ' A' ' 35' ' ' VAL . . . -49.54 -34.19 19.49 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.736 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -57.77 -50.14 74.26 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 122.442 1.115 . . . . 0.0 109.005 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.67 -43.59 62.77 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 112.977 -1.92 . . . . 0.0 109.787 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.749 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -66.36 -26.05 67.09 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.096 -1.003 . . . . 0.0 111.151 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.748 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -73.15 -52.01 15.78 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.304 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -52.76 -28.01 20.41 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 124.683 1.24 . . . . 0.0 110.478 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.842 ' O ' HG23 ' A' ' 31' ' ' THR . 1.2 m-20 -84.64 -37.93 20.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 117.634 -1.174 . . . . 0.0 108.819 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.89 37.74 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 171.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.35 38.62 0.02 OUTLIER Glycine 0 N--CA 1.465 0.633 0 C-N-CA 114.796 -3.573 . . . . 0.0 119.545 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.928 HD12 HD12 ' A' ' 7' ' ' LEU . 22.3 mm -140.05 138.73 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 122.157 2.979 . . . . 0.0 116.956 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -142.36 104.4 4.42 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.965 HG21 ' O ' ' A' ' 20' ' ' LEU . 28.6 m -89.35 130.34 38.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -174.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 p -116.51 140.47 49.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.135 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.036 HG11 HD13 ' A' ' 20' ' ' LEU . 6.2 m -130.05 119.68 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.522 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -110.43 134.82 51.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.63 71.26 3.55 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 120.829 0.347 . . . . 0.0 111.617 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.873 ' CG ' HD13 ' A' ' 43' ' ' LEU . 39.1 Cg_endo -95.12 -160.95 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.931 3.088 . . . . 0.0 112.72 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.91 -62.63 1.11 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 0.15 34.45 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.873 HD13 ' CG ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -56.8 -28.37 61.29 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.218 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 1.047 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -47.32 -54.26 11.5 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.547 -0.721 . . . . 0.0 110.25 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mt-10 -71.85 -50.16 31.93 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.279 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 50' ' ' VAL . 32.7 mtmt -59.71 -56.36 22.87 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.122 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.688 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 7.2 t80 -44.38 -57.92 5.8 Favored Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 1.047 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 25.6 Cg_exo -66.03 -35.91 32.15 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 120.977 1.118 . . . . 0.0 114.251 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 17.0 mt-30 -66.63 -52.24 47.24 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 123.038 1.399 . . . . 0.0 107.549 175.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 46' ' ' LYS . 14.7 m -61.22 -21.85 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.555 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 48' ' ' PRO . . . -59.84 -29.47 68.29 Favored 'General case' 0 C--N 1.395 2.563 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.644 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -82.16 -24.59 34.93 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 124.991 1.316 . . . . 0.0 112.008 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.5 m -47.89 -30.96 4.57 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 167.93 -19.09 0.08 OUTLIER Glycine 0 CA--C 1.526 0.724 0 C-N-CA 119.891 -1.147 . . . . 0.0 114.644 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.629 ' O ' ' HB1' ' A' ' 269' ' ' ALA . 1.0 OUTLIER 155.77 -71.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.719 1.26 . . . . 0.0 111.561 179.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 40.44 -158.46 0.03 OUTLIER Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.031 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.922 ' HG3' HG11 ' A' ' 8' ' ' VAL . 10.9 Cg_exo -35.81 143.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.887 3.058 . . . . 0.0 112.78 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 59' ' ' ILE . 30.7 m-20 -123.51 35.44 4.85 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 117.478 -1.689 . . . . 0.0 113.877 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.71 HD12 ' CG1' ' A' ' 9' ' ' ILE . 2.8 mt -150.57 127.92 2.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 119.662 1.119 . . . . 0.0 113.692 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.686 HG22 ' HD1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -139.4 123.29 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 118.872 0.76 . . . . 0.0 110.034 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.523 ' O ' ' CZ2' ' A' ' 10' ' ' TRP . 2.6 m-85 -104.62 128.53 52.68 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.13 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -166.0 166.67 17.17 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 119.188 0.904 . . . . 0.0 109.723 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.11 165.99 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 120.479 1.49 . . . . 0.0 110.319 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.858 ' HB3' HG13 ' A' ' 261' ' ' VAL . 2.7 p80 -77.05 -29.3 55.1 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.477 0.656 . . . . 0.0 112.059 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -58.46 -36.08 73.15 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.425 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -85.43 -35.26 21.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.644 ' CE1' HD22 ' A' ' 76' ' ' LEU . 3.2 t80 -54.85 -32.82 61.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 172.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -58.19 -65.35 3.58 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.32 -41.44 16.46 Favored Glycine 0 C--N 1.355 1.639 0 CA-C-N 113.268 -1.466 . . . . 0.0 110.609 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.57 ' HB3' HD12 ' A' ' 76' ' ' LEU . 5.3 m-85 -59.49 -46.46 88.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.684 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . . . -50.35 -51.32 46.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.843 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -78.25 -27.15 47.49 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.641 ' HB3' HD23 ' A' ' 75' ' ' LEU . 1.7 t -71.63 -17.67 62.25 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.739 ' C ' HD22 ' A' ' 75' ' ' LEU . . . 83.69 37.85 11.34 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.231 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.739 HD22 ' C ' ' A' ' 74' ' ' GLY . 3.6 mm? -121.76 57.15 1.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.941 0.4 . . . . 0.0 111.533 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.829 HD23 ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -179.07 142.01 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.401 0.62 . . . . 0.0 112.127 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.982 ' O ' HG21 ' A' ' 104' ' ' ILE . . . -59.94 176.98 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.527 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' HA ' ' HB ' ' A' ' 104' ' ' ILE . 2.6 tm-20 -139.74 80.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.375 0.27 . . . . 0.0 110.489 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.0 pt -70.99 162.19 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.108 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.92 118.35 69.17 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.875 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.576 ' HB3' HD13 ' A' ' 103' ' ' LEU . 2.7 Cg_endo -79.87 146.79 18.75 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.571 2.181 . . . . 0.0 112.158 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -136.0 163.67 29.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.863 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -49.06 78.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.631 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.73 -23.64 63.36 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.822 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.5 ' CE2' ' CZ2' ' A' ' 94' ' ' TRP . 19.3 t80 -68.74 -58.65 3.91 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.916 0.389 . . . . 0.0 110.352 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -77.12 -24.7 51.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -76.36 -45.24 32.87 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 89' ' ' LEU . 3.9 pttp -51.54 -41.71 61.27 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.495 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.445 ' N ' ' HG3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -103.92 -175.14 2.71 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.6 0.238 . . . . 0.0 110.663 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CG ' ' CE2' ' A' ' 92' ' ' PHE . 0.9 OUTLIER -69.5 131.0 90.19 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.693 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.44 -38.0 82.52 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.515 2.143 . . . . 0.0 112.711 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.452 ' CE2' ' CG ' ' A' ' 90' ' ' TYR . 45.1 p90 -73.22 -43.61 60.97 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 120.549 0.214 . . . . 0.0 111.275 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 302' ' ' VAL . 45.0 m -62.14 -25.42 67.73 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.5 ' CZ2' ' CE2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -92.45 -26.49 17.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.216 0.531 . . . . 0.0 111.202 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -21.29 60.07 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.813 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.644 ' HB1' ' HB ' ' A' ' 261' ' ' VAL . . . -66.08 -50.17 65.04 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.685 0.278 . . . . 0.0 110.722 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.688 HG11 ' HD3' ' A' ' 107' ' ' PRO . 11.7 p -94.7 60.11 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.01 138.83 48.39 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.063 -1.023 . . . . 0.0 109.753 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.684 ' CE1' ' HB3' ' A' ' 71' ' ' ALA . 31.5 t80 -107.64 138.68 43.43 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.344 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -59.11 78.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.811 0.339 . . . . 0.0 110.108 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 133.11 -18.23 4.49 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.36 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.526 ' HD3' ' HB1' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -144.7 123.75 12.83 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.125 0.962 . . . . 0.0 111.843 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.576 HD13 ' HB3' ' A' ' 81' ' ' PRO . 0.5 OUTLIER -105.82 74.68 1.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.982 HG21 ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -129.46 91.3 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 121.668 0.747 . . . . 0.0 112.634 -177.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 159.54 -177.22 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.502 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -136.63 142.86 40.68 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.16 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.688 ' HD3' HG11 ' A' ' 97' ' ' VAL . 84.4 Cg_endo -82.02 156.88 17.77 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.499 2.132 . . . . 0.0 112.437 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.697 HG22 ' H ' ' A' ' 109' ' ' ALA . 28.2 mt -119.44 -135.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.697 ' H ' HG22 ' A' ' 108' ' ' ILE . . . -79.48 157.44 27.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.007 ' CG1' HG11 ' A' ' 302' ' ' VAL . 4.2 m -110.02 114.41 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.817 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -101.9 164.94 11.46 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.154 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.8 146.72 8.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.848 0.832 . . . . 0.0 111.267 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.868 ' CD1' HD21 ' A' ' 247' ' ' LEU . 3.2 pp -79.02 128.06 32.78 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.101 -1.408 . . . . 0.0 107.482 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 227' ' ' ASN . 24.8 p -131.35 165.85 22.55 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.513 HD12 ' CG2' ' A' ' 226' ' ' ILE . 4.3 tp -99.2 135.13 41.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.408 HD13 ' C ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -114.99 133.84 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.541 ' HE2' HG23 ' A' ' 245' ' ' THR . 12.1 p90 -122.08 142.02 50.79 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.855 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 1.4 t-20 -89.29 126.91 35.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.488 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.34 -3.61 28.5 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.064 -0.398 . . . . 0.0 110.37 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.22 -62.76 1.19 Allowed 'General case' 0 C--N 1.34 0.177 0 CA-C-O 121.252 0.548 . . . . 0.0 110.498 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 39.82 2.31 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.644 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.993 HD13 ' HB1' ' A' ' 223' ' ' ALA . 1.3 tp -131.68 89.72 38.83 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.354 0.597 . . . . 0.0 110.65 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.435 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 81.0 Cg_exo -44.5 162.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.465 2.777 . . . . 0.0 112.571 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 23.0 m-20 -60.12 110.7 3.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 122.449 1.119 . . . . 0.0 111.793 -170.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.9 Cg_endo -69.88 168.31 22.09 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 125.238 3.959 . . . . 0.0 114.14 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.668 ' HD3' HD22 ' A' ' 135' ' ' LEU . 56.9 Cg_endo -92.34 -154.05 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 123.34 2.693 . . . . 0.0 115.501 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -125.52 -91.7 0.52 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 t -46.4 155.53 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.058 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.642 ' CZ2' HD22 ' A' ' 147' ' ' LEU . 10.0 t-105 -69.67 -33.49 72.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 174.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 133' ' ' PRO . 1.9 mm-40 -44.98 -24.17 0.2 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.731 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -72.67 -26.51 61.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.494 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 25.6 mm -40.64 -57.33 3.19 Favored Pre-proline 0 N--CA 1.478 0.974 0 CA-C-O 121.29 0.567 . . . . 0.0 111.982 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 6.0 Cg_endo -48.27 -39.09 34.76 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 N-CA-C 109.399 -1.039 . . . . 0.0 109.399 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.35 -58.56 3.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.668 HD22 ' HD3' ' A' ' 126' ' ' PRO . 0.3 OUTLIER -68.65 -36.34 78.44 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.039 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 132' ' ' ILE . 21.6 t0 -72.85 -40.15 65.95 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -46.82 -47.37 21.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.402 176.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -63.74 -39.6 94.69 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.405 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.833 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -60.81 -49.84 75.87 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -44.52 29.67 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -45.89 -26.3 0.67 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -108.04 -58.57 1.96 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.058 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.8 43.93 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 CA-C-O 118.824 -0.986 . . . . 0.0 111.036 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.512 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 4.0 mttt -155.34 -172.22 4.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.636 1.718 . . . . 0.0 111.086 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.606 ' O ' HD22 ' A' ' 139' ' ' LEU . 47.9 m -142.4 160.71 39.74 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.833 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -75.15 -28.67 60.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.642 HD22 ' CZ2' ' A' ' 129' ' ' TRP . 0.7 OUTLIER -152.6 133.05 13.74 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -176.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.968 ' HB3' HG21 ' A' ' 222' ' ' THR . 7.9 tpt -132.3 140.72 48.7 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.907 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 150' ' ' ASN . 34.8 p90 -172.7 175.21 3.48 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.665 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 149' ' ' PHE . 45.2 m-80 -37.74 170.69 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.683 0.615 . . . . 0.0 110.828 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.569 HD11 ' HB1' ' A' ' 206' ' ' ALA . 2.1 tm? -114.64 -59.66 1.99 Allowed 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.404 ' HB3' ' NH2' ' A' ' 344' ' ' ARG . 2.0 mt-30 -102.75 36.01 2.32 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 116.788 -1.965 . . . . 0.0 114.862 -174.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.662 ' O ' ' HB ' ' A' ' 157' ' ' THR . 4.6 mm-40 -88.3 144.35 33.95 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 121.18 1.809 . . . . 0.0 114.61 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.934 ' O ' ' N ' ' A' ' 156' ' ' PHE . 6.0 Cg_exo -77.71 -135.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.285 1 C-N-CA 125.787 4.325 . . . . 0.0 106.04 176.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 1.149 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 1.2 m-85 27.17 -54.88 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.934 ' N ' ' O ' ' A' ' 154' ' ' PRO . 14.9 m-85 -87.88 -58.8 2.44 Favored 'General case' 0 C--O 1.26 1.625 0 C-N-CA 124.486 1.114 . . . . 0.0 110.761 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 24.1 m -57.24 -44.6 83.99 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.83 ' CE3' HD11 ' A' ' 161' ' ' ILE . 4.8 m95 -52.31 -55.02 35.51 Favored Pre-proline 0 C--N 1.348 0.521 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.534 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 1.149 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 87.5 Cg_exo -43.4 -49.53 7.47 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.387 2.058 . . . . 0.0 114.124 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.708 HD12 HG23 ' A' ' 161' ' ' ILE . 1.5 pp -79.18 -56.95 3.98 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 120.529 -1.357 . . . . 0.0 113.241 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.83 HD11 ' CE3' ' A' ' 158' ' ' TRP . 1.1 pt -61.19 -13.17 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 158' ' ' TRP . . . -124.95 -46.4 1.83 Allowed 'General case' 0 N--CA 1.471 0.622 1 N-CA-C 124.147 4.869 . . . . 0.0 124.147 -178.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.07 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . . . -54.58 49.72 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -176.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 162' ' ' ALA . 10.2 m-20 -122.1 -58.83 1.7 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.727 0.694 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.68 1.68 2.09 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.23 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.12 95.79 1.09 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.104 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -67.08 139.55 57.57 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.026 0.413 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.749 ' HA ' HG22 ' A' ' 183' ' ' VAL . . . -43.6 -74.65 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.742 0.782 . . . . 0.0 111.643 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.632 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 32.3 m-85 -112.33 173.9 6.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.708 ' O ' ' O ' ' A' ' 175' ' ' LYS . 6.3 ttmt -100.68 108.06 19.83 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.949 ' HA ' ' O ' ' A' ' 175' ' ' LYS . 27.5 m-85 -84.05 111.33 19.2 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.134 176.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 173' ' ' ASN . 18.0 mt-10 -104.89 101.17 10.77 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.597 ' C ' ' O ' ' A' ' 172' ' ' GLU . 8.8 m120 34.8 73.52 0.08 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 65.67 70.69 1.04 Allowed Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.171 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.949 ' O ' ' HA ' ' A' ' 171' ' ' TYR . 3.8 tptp -177.67 122.75 0.12 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.522 1.161 . . . . 0.0 112.98 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.632 ' HB2' ' HB3' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -114.63 -19.8 10.96 Favored 'General case' 0 N--CA 1.512 2.653 0 CA-C-O 122.907 1.337 . . . . 0.0 109.14 175.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.487 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 6.5 m-20 38.84 -85.8 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 111.523 -2.58 . . . . 0.0 111.725 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.739 HD13 ' HB3' ' A' ' 335' ' ' GLN . 7.3 tp 171.86 -41.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -65.9 -12.7 56.62 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 71.9 m-20 -120.59 93.53 4.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.994 0.816 . . . . 0.0 109.127 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.859 HG11 HD12 ' A' ' 368' ' ' ILE . 32.2 m -115.95 112.55 40.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.69 39.79 2.39 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.736 -1.221 . . . . 0.0 114.065 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.749 HG22 ' HA ' ' A' ' 168' ' ' ALA . 2.1 t -78.27 -43.54 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.524 ' HA ' ' CB ' ' A' ' 188' ' ' ALA . 5.8 p-10 -66.22 57.01 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.458 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 183' ' ' VAL . 0.7 OUTLIER -102.98 -172.34 2.1 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.37 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.696 ' O ' ' HG3' ' A' ' 189' ' ' LYS . . . -38.79 -48.59 1.54 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.244 0.545 . . . . 0.0 112.346 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.13 -32.3 52.89 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-O 118.975 -0.903 . . . . 0.0 113.053 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -60.07 -54.96 39.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.33 1.565 . . . . 0.0 107.301 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -52.64 -39.42 61.77 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.481 ' HB2' ' HD2' ' A' ' 251' ' ' LYS . . . -69.1 -42.31 76.29 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 111.954 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 161' ' ' ILE . . . -56.48 -60.59 8.7 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.711 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.893 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.6 OUTLIER -59.76 -30.93 69.2 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.194 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.5 m -74.94 -53.7 8.53 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.489 ' CD2' ' HA2' ' A' ' 191' ' ' GLY . 0.1 OUTLIER -62.09 -33.62 74.78 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.863 0.364 . . . . 0.0 110.16 178.149 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.92 -48.32 77.04 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 192' ' ' LEU . 76.1 t -56.48 -30.66 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.11 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -46.65 84.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.569 0.699 . . . . 0.0 111.006 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -51.42 68.27 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.151 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.71 HG23 ' O ' ' A' ' 205' ' ' ASN . 46.3 mm -63.41 -45.97 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.686 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.19 -36.71 52.67 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 118.437 -0.792 . . . . 0.0 112.02 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -113.0 -34.61 5.68 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 120.962 3.69 . . . . 0.0 120.962 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -79.41 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.702 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -101.47 -6.01 24.51 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.564 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 8.4 ttt 45.18 35.44 1.72 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.597 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.71 ' O ' HG23 ' A' ' 199' ' ' ILE . 19.8 m-20 -146.52 165.96 27.88 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 151' ' ' LEU . . . -152.35 32.57 0.52 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -99.0 -3.45 34.88 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -55.18 120.27 6.76 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 119.757 -0.777 . . . . 0.0 108.92 178.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.63 ' OD2' HD12 ' A' ' 212' ' ' ILE . 8.5 m-20 -94.77 -175.29 3.53 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.158 -0.339 . . . . 0.0 111.621 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -70.71 -45.26 65.27 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.136 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.95 -25.54 48.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.449 0.642 . . . . 0.0 110.771 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.63 HD12 ' OD2' ' A' ' 209' ' ' ASP . 1.7 mt -81.47 -52.01 14.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -51.11 -36.81 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.46 -45.55 86.9 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.26 -39.38 69.73 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.795 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.54 -56.06 25.98 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.97 -28.69 70.26 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -55.79 -41.56 74.27 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.512 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -23.9 59.13 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 71.12 42.71 58.02 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.445 ' HB3' ' HG3' ' A' ' 144' ' ' LYS . 1.4 mp0 -110.57 37.09 2.86 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.94 1.37 . . . . 0.0 110.794 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.968 HG21 ' HB3' ' A' ' 148' ' ' MET . 8.9 t -139.2 138.62 37.04 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.993 ' HB1' HD13 ' A' ' 122' ' ' LEU . . . -92.93 38.2 1.03 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -177.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 162.4 149.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 176.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.412 HG22 ' OD1' ' A' ' 227' ' ' ASN . 87.0 m -147.89 160.05 43.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.137 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 156' ' ' PHE . 2.2 pt -116.5 113.26 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -146.85 165.48 29.6 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.283 -177.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 232' ' ' TRP . . . -79.82 -154.4 9.18 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 119.341 -1.409 . . . . 0.0 113.495 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.71 -50.91 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.816 2.344 . . . . 0.0 114.115 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.456 ' CZ2' ' HB3' ' A' ' 299' ' ' LEU . 12.7 p-90 -135.78 -54.72 0.77 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.11 46.37 2.43 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.413 ' CB ' ' HA3' ' A' ' 228' ' ' GLY . 6.0 t-105 -91.64 -44.4 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.665 0.269 . . . . 0.0 110.432 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -114.42 38.14 3.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.045 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 54.07 87.92 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.634 0.254 . . . . 0.0 111.105 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.649 ' N ' HD13 ' A' ' 235' ' ' ILE . 0.2 OUTLIER -155.08 -43.82 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.402 ' N ' HG12 ' A' ' 235' ' ' ILE . 0.0 OUTLIER 45.09 -84.88 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 235' ' ' ILE . 15.6 p -67.18 138.0 56.66 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.651 0.262 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 22.1 p -134.51 158.87 42.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.898 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.85 176.62 0.07 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.984 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.64 -60.86 2.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.024 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -108.99 99.9 9.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.722 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -117.46 127.59 54.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.075 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 117' ' ' TYR . . . -96.71 114.13 4.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.205 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.72 137.01 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.579 -0.365 . . . . 0.0 110.829 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.541 HG23 ' HE2' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -141.18 167.93 21.0 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.071 0.548 . . . . 0.0 111.613 -172.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.6 m -72.75 152.23 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.868 HD21 ' CD1' ' A' ' 113' ' ' LEU . 1.9 mp -58.73 159.54 12.64 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 119.903 1.229 . . . . 0.0 110.682 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 247' ' ' LEU . 72.4 Cg_endo -78.66 -162.67 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.552 2.168 . . . . 0.0 113.063 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.4 p -94.91 144.31 25.77 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 160' ' ' LEU . 62.2 m-85 -144.61 111.2 5.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.96 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 190' ' ' ALA . 0.0 OUTLIER 37.04 31.98 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.196 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 105.78 29.98 4.75 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 254' ' ' PRO . 0.1 OUTLIER -156.68 167.1 15.14 Favored Pre-proline 0 N--CA 1.467 0.375 0 CA-C-N 119.1 1.45 . . . . 0.0 112.302 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 253' ' ' GLN . 67.7 Cg_endo -93.08 23.73 0.5 Allowed 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.43 2.753 . . . . 0.0 114.48 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.659 ' HB2' HD13 ' A' ' 247' ' ' LEU . 0.7 OUTLIER 72.21 133.61 0.04 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 178.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 1.07 ' HB2' ' HB2' ' A' ' 163' ' ' ALA . 10.5 mttt -86.38 106.39 10.11 Favored Pre-proline 0 CA--C 1.512 -0.499 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.795 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.745 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 94.8 Cg_endo -78.9 143.87 18.62 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.201 1.267 . . . . 0.0 109.719 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -89.19 119.32 29.58 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.898 HG11 ' HA ' ' A' ' 324' ' ' ALA . 6.2 m -115.2 99.86 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 118.247 0.476 . . . . 0.0 112.148 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -90.86 156.69 24.7 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.782 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.858 HG13 ' HB3' ' A' ' 64' ' ' HIS . 2.1 p -118.19 106.49 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -72.3 129.61 38.82 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 117.54 -1.664 . . . . 0.0 107.115 178.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.542 ' HA ' HG13 ' A' ' 108' ' ' ILE . 2.9 p -140.85 130.0 23.48 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 118.624 2.824 . . . . 0.0 118.624 -172.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.516 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . . . -88.88 111.98 22.72 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.643 ' HA3' HD21 ' A' ' 76' ' ' LEU . . . -100.78 164.27 18.64 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.543 ' HB ' HD11 ' A' ' 104' ' ' ILE . 3.7 mt -88.21 123.05 40.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 118.723 1.262 . . . . 0.0 107.617 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -64.59 145.73 55.71 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.515 ' HB2' ' H ' ' A' ' 76' ' ' LEU . . . -57.73 -25.5 60.48 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.132 -0.355 . . . . 0.0 110.947 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 55' ' ' ASP . . . -49.5 -60.0 3.25 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.471 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.94 131.77 8.87 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.652 0.263 . . . . 0.0 111.279 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.37 -42.57 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.497 2.131 . . . . 0.0 112.999 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 4.2 m-20 47.8 81.08 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.533 0.206 . . . . 0.0 110.787 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.12 -54.07 7.77 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -58.48 -57.29 13.58 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.657 HD12 ' CG ' ' A' ' 4' ' ' GLU . 8.3 tt -59.72 -42.88 94.08 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.658 0.266 . . . . 0.0 111.472 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.596 ' HB1' HD13 ' A' ' 280' ' ' LEU . . . -72.9 -33.41 65.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.612 ' O ' ' CB ' ' A' ' 281' ' ' GLU . 1.1 tmtt? -63.58 -58.7 6.13 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 121.413 0.625 . . . . 0.0 112.165 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.508 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 3.6 tp10 -68.06 -34.55 76.66 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.699 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.494 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 54.9 t80 -74.04 -60.02 2.45 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.963 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.596 HD13 ' HB1' ' A' ' 276' ' ' ALA . 5.8 mp -75.01 -43.13 55.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 118.373 -1.331 . . . . 0.0 113.05 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.826 ' HA ' HD23 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -73.65 -37.73 65.21 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.518 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 3.9 t30 -87.99 -20.61 25.61 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.639 ' CE1' HG12 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -104.06 -74.45 0.64 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 177.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.501 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 0.5 OUTLIER -36.22 -30.63 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.841 HD12 HD13 ' A' ' 304' ' ' LEU . 3.2 mm? -98.35 43.49 1.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.896 0.316 . . . . 0.0 111.792 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.5 p -144.89 157.78 44.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 11.2 m-20 -61.18 -15.17 31.15 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 2.3 mm-40 -78.32 -46.91 18.92 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.316 0.507 . . . . 0.0 110.498 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -81.06 -53.46 3.92 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.922 HD11 HD23 ' A' ' 304' ' ' LEU . 17.6 mt -50.07 -49.24 51.97 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.452 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 1.4 tp10 -78.14 -27.41 48.2 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.912 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -71.92 -38.06 69.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 119.776 1.171 . . . . 0.0 108.405 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 290' ' ' LEU . 14.7 p -65.92 -38.03 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -74.95 -41.88 58.75 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.458 1.103 . . . . 0.0 113.374 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -65.09 -42.74 93.76 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.499 ' CB ' ' HA3' ' A' ' 16' ' ' GLY . 33.4 m-20 -56.68 -64.53 0.84 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.48 ' HB3' HD11 ' A' ' 299' ' ' LEU . 17.4 mtmm -97.63 105.24 25.12 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.814 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -100.18 93.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.62 2.88 . . . . 0.0 112.305 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -143.33 -74.29 0.27 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.526 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -144.0 173.6 24.71 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.084 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 1.019 ' HB2' HD13 ' A' ' 311' ' ' LEU . . . -129.93 131.24 45.93 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 1.007 HG11 ' CG1' ' A' ' 110' ' ' VAL . 10.9 p -179.8 39.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.085 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.465 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . -111.06 -138.21 0.37 Allowed 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.922 HD23 HD11 ' A' ' 290' ' ' LEU . 22.0 tp -39.63 121.24 1.2 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -30.33 -63.15 0.14 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.514 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 95.7 p -48.88 -44.73 40.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.966 0.889 . . . . 0.0 110.933 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.906 ' CE1' HD12 ' A' ' 311' ' ' LEU . 3.1 t80 -75.87 -25.05 55.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.909 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -68.54 -39.78 80.99 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -68.66 -61.33 1.87 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.288 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -46.78 -56.61 5.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.872 0.368 . . . . 0.0 111.169 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 1.019 HD13 ' HB2' ' A' ' 301' ' ' ALA . 0.3 OUTLIER -64.43 -45.58 86.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.641 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -46.84 -28.7 1.65 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -31.22 -42.21 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.477 ' HB2' HD12 ' A' ' 317' ' ' ILE . 28.6 m-20 -71.19 137.12 84.33 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.784 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.72 -21.8 70.94 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.631 2.22 . . . . 0.0 113.252 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -59.71 -59.14 5.9 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.646 0.26 . . . . 0.0 111.559 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 301' ' ' ALA . 3.0 mp -50.91 -55.6 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.91 -39.07 8.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.163 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.08 -52.74 64.43 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 122.058 0.932 . . . . 0.0 108.837 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.4 ' OG1' HG23 ' A' ' 110' ' ' VAL . 3.2 p -56.84 -37.57 71.43 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 113.625 -1.625 . . . . 0.0 109.85 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.414 ' O ' ' HB3' ' A' ' 324' ' ' ALA . 1.4 ttp -70.93 -44.59 65.86 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -58.56 -57.38 13.21 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' A' ' 327' ' ' GLY . 6.5 m-20 -50.45 -38.71 45.0 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.898 ' HA ' HG11 ' A' ' 259' ' ' VAL . . . -57.35 -43.19 83.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.603 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -57.33 -42.06 81.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.228 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -106.19 26.41 9.81 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.887 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.745 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -114.66 157.64 14.85 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.618 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.86 135.66 36.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 330' ' ' MET . 39.0 mt -86.45 115.43 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 118.906 0.775 . . . . 0.0 110.87 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.535 ' HE3' ' HE1' ' A' ' 336' ' ' MET . 0.0 OUTLIER -28.27 130.84 0.2 Allowed Pre-proline 0 N--CA 1.47 0.568 0 N-CA-C 111.412 0.153 . . . . 0.0 111.412 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.459 ' HG2' ' CE1' ' A' ' 169' ' ' PHE . 62.4 Cg_exo -51.79 -164.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.893 2.395 . . . . 0.0 113.152 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -150.73 39.29 0.71 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.343 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.448 HG13 ' CE1' ' A' ' 176' ' ' TYR . 1.2 pp -132.58 163.23 52.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.026 0.441 . . . . 0.0 111.911 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.21 -37.86 7.56 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.046 2.497 . . . . 0.0 112.403 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.739 ' HB3' HD13 ' A' ' 178' ' ' ILE . 8.8 mp0 -45.98 -21.79 0.16 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.535 ' HE1' ' HE3' ' A' ' 330' ' ' MET . 4.0 tpp -45.49 -35.61 3.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.956 0.344 . . . . 0.0 110.978 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.5 t -61.12 -40.33 93.36 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.78 0.324 . . . . 0.0 110.19 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.12 -37.61 85.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.764 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.724 ' O ' HG12 ' A' ' 343' ' ' VAL . 23.4 t80 -74.04 -55.74 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.624 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 344' ' ' ARG . 2.3 t-105 -49.91 -43.61 49.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.494 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.722 ' O ' HG23 ' A' ' 345' ' ' THR . 0.9 OUTLIER -69.79 -52.2 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.9 -44.17 81.5 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.939 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.0 p -71.7 -29.42 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -75.03 -49.18 20.63 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 341' ' ' TYR . 69.9 p -57.33 -57.94 10.42 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.729 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.79 -41.22 6.76 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.861 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 343' ' ' VAL . 54.9 t -59.04 -47.69 89.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 345' ' ' THR . 6.7 mt -66.97 -28.24 42.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.8 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.729 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.9 OUTLIER -67.94 -27.63 66.78 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.66 0.267 . . . . 0.0 110.913 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.51 -44.76 23.62 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.54 -9.39 59.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 9.4 t -101.72 -46.03 5.06 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 142.1 0.77 1.4 Allowed Glycine 0 N--CA 1.464 0.504 0 C-N-CA 117.054 -2.498 . . . . 0.0 118.074 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.46 32.38 4.66 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 113.232 -3.387 . . . . 0.0 114.916 173.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.804 ' HB3' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER -158.24 119.22 3.43 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 34.3 p -78.73 146.88 33.65 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 358' ' ' ASP . 12.5 p -41.97 -45.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.433 ' N ' HG13 ' A' ' 357' ' ' VAL . 16.0 m-20 -71.58 -49.67 38.26 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.01 -46.38 57.39 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.475 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.804 ' HB2' ' HB3' ' A' ' 355' ' ' GLN . . . -54.16 -49.47 69.21 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.282 1.039 . . . . 0.0 113.593 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 47.3 mt -74.71 -36.69 62.7 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.283 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 365' ' ' GLN . 14.7 tttm -65.13 -56.7 11.41 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 122.351 1.072 . . . . 0.0 110.581 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.34 -37.45 83.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.749 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -49.61 -43.98 46.87 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.698 ' HG3' HG23 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -60.62 -44.74 95.97 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.57 -44.15 56.57 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.34 0.591 . . . . 0.0 110.168 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.08 -46.22 90.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.269 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.859 HD12 HG11 ' A' ' 181' ' ' VAL . 6.7 pt -81.19 -5.65 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.837 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.757 ' CG2' HG22 ' A' ' 181' ' ' VAL . 10.8 p -135.28 42.81 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.619 0.247 . . . . 0.0 110.616 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.248 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.667 0.27 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.7 p -137.21 111.53 8.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.847 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -131.81 117.96 19.25 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -138.95 -179.45 5.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.98 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.7 66.04 0.55 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HA ' HG12 ' A' ' 33' ' ' ILE . 2.3 tttp -153.18 157.49 40.36 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.658 ' HG ' HD11 ' A' ' 9' ' ' ILE . 24.7 tp -146.48 124.75 12.24 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.79 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.773 ' O ' ' HA ' ' A' ' 58' ' ' ASP . 99.3 t -111.74 132.9 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.488 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.831 ' HB ' HG12 ' A' ' 37' ' ' VAL . 5.4 mp -135.21 125.15 43.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.063 0.459 . . . . 0.0 111.412 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.573 ' CH2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -106.04 121.04 43.31 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.802 HG23 ' HB2' ' A' ' 61' ' ' PHE . 15.3 mt -158.09 137.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.063 0.458 . . . . 0.0 111.252 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -156.07 41.98 0.39 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.59 -35.21 0.57 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.698 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 3.3 m-20 -90.05 -105.51 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER 161.91 -172.6 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.03 0.919 . . . . 0.0 113.204 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.66 100.58 0.32 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 113.733 -1.576 . . . . 0.0 115.423 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -36.33 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.984 -0.608 . . . . 0.0 111.167 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 12.1 t-20 -64.84 -43.94 91.4 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.87 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.99 -49.01 23.99 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.631 -0.795 . . . . 0.0 114.043 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.63 ' CD1' HG11 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -59.85 -50.18 74.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.789 0.795 . . . . 0.0 110.371 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.29 82.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 53.9 tt0 -65.8 -36.98 85.02 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.42 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 19' ' ' GLY . 57.5 t -68.6 -61.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 122.063 -0.398 . . . . 0.0 110.377 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.923 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -49.31 -32.49 14.32 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.278 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 8.7 tmtm? -58.37 -50.84 72.23 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 122.503 1.144 . . . . 0.0 109.183 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -42.81 61.96 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 113.05 -1.886 . . . . 0.0 109.515 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.599 ' O ' ' CB ' ' A' ' 31' ' ' THR . 10.8 t80 -64.26 -32.23 73.74 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.316 0.579 . . . . 0.0 110.691 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.592 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 26.8 tt0 -68.78 -46.62 68.25 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.897 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -25.6 54.27 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -176.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.7 -33.61 21.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.599 ' CB ' ' O ' ' A' ' 27' ' ' PHE . 1.8 m -95.75 -133.5 0.2 Allowed 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 111.115 -2.766 . . . . 0.0 104.792 173.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 28' ' ' GLU . . . -173.59 42.71 0.15 Allowed Glycine 0 C--N 1.291 -1.94 0 N-CA-C 106.869 -2.492 . . . . 0.0 106.869 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.608 HD11 ' N ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -113.95 152.14 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.583 ' N ' HD13 ' A' ' 33' ' ' ILE . 5.2 mtpt -105.71 105.78 15.98 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.655 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.923 HG11 ' HA3' ' A' ' 24' ' ' GLY . 10.7 p -84.49 131.32 34.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.0 p -116.71 141.24 48.46 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.379 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.831 HG12 ' HB ' ' A' ' 9' ' ' ILE . 27.0 m -136.74 119.97 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 1.7 mp0 -109.42 141.87 41.2 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -113.65 81.27 5.47 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 120.638 0.256 . . . . 0.0 111.483 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.492 ' CG ' ' HG ' ' A' ' 43' ' ' LEU . 38.1 Cg_endo -90.83 -172.55 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.31 2.673 . . . . 0.0 113.005 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -114.05 -44.97 3.1 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.622 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -81.03 0.61 35.01 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.667 HD22 HD11 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -19.77 -39.81 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 1.05 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -63.49 -55.06 27.06 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.273 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mp0 -74.07 -41.75 61.25 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.154 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.642 ' O ' HG13 ' A' ' 50' ' ' VAL . 23.4 mtpt -57.97 -57.82 11.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.24 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.716 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 34.7 t80 -41.73 -60.99 1.61 Allowed Pre-proline 0 C--N 1.355 0.828 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.26 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 1.05 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 25.0 Cg_exo -62.4 -19.83 68.51 Favored 'Trans proline' 0 C--O 1.25 1.106 0 CA-C-N 120.17 1.096 . . . . 0.0 111.704 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -81.07 -34.13 32.93 Favored 'General case' 0 C--O 1.259 1.599 0 CA-C-O 122.644 1.211 . . . . 0.0 110.683 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 46' ' ' LYS . 2.7 m -80.13 -40.86 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 CA-C-O 122.287 1.041 . . . . 0.0 110.308 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.06 -37.21 20.36 Favored 'General case' 0 C--N 1.381 1.958 0 CA-C-N 113.226 -1.806 . . . . 0.0 110.096 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 53' ' ' THR . . . -81.27 -35.74 30.77 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.555 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -172.49 64.57 0.03 OUTLIER 'General case' 0 C--N 1.34 0.169 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.606 179.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . -167.12 44.18 0.25 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 119.566 -1.302 . . . . 0.0 115.008 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 3.5 m-20 155.75 -86.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.74 -106.16 0.9 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.618 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 18.6 Cg_endo -57.11 132.99 54.77 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.938 1.759 . . . . 0.0 108.316 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.773 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 20.7 t0 157.97 126.9 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 118.717 0.69 . . . . 0.0 112.855 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.5 HG23 ' HA ' ' A' ' 266' ' ' ILE . 9.5 mt -107.87 162.85 5.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.667 HD11 HD22 ' A' ' 43' ' ' LEU . 6.3 tt -138.16 127.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.802 ' HB2' HG23 ' A' ' 11' ' ' ILE . 3.1 m-85 -85.94 148.07 25.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.717 ' HE3' ' O ' ' A' ' 61' ' ' PHE . 1.6 t-105 -168.54 153.38 6.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 120.119 1.327 . . . . 0.0 108.518 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 67' ' ' PHE . . . -77.21 -175.51 3.68 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.73 1.15 . . . . 0.0 108.746 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.687 ' HB3' HG23 ' A' ' 261' ' ' VAL . 22.4 t-80 -77.9 -44.89 25.71 Favored 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.59 ' HB3' ' CG ' ' A' ' 330' ' ' MET . 0.8 OUTLIER -52.91 -59.44 4.52 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 1.6 mtt85 -70.6 -29.86 66.37 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.796 ' HZ ' HG23 ' A' ' 104' ' ' ILE . 7.3 t80 -62.46 -39.7 94.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 72' ' ' GLN . . . -46.99 -67.62 1.4 Allowed Glycine 0 CA--C 1.488 -1.652 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.886 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 73' ' ' SER . . . -76.44 -71.84 1.15 Allowed Glycine 0 C--N 1.341 0.839 0 CA-C-N 114.485 -0.857 . . . . 0.0 112.612 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.761 ' HB3' HD21 ' A' ' 75' ' ' LEU . 12.7 m-30 -41.82 -57.5 2.33 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.423 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -75.61 -56.63 4.51 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.625 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 4.8 tm0? -63.8 -12.9 39.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.621 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 48.4 t -82.84 -26.75 31.36 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.119 -0.363 . . . . 0.0 111.78 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 166.99 -32.09 0.2 Allowed Glycine 0 C--N 1.339 0.735 0 C-N-CA 119.414 -1.374 . . . . 0.0 114.772 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.835 HD13 ' HG3' ' A' ' 48' ' ' PRO . 1.8 pp -86.72 61.8 7.03 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 118.195 0.998 . . . . 0.0 111.743 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.827 HD12 ' CG1' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.19 143.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.238 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.86 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -107.96 115.13 29.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.716 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -53.99 151.44 6.77 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.2 pt -90.96 155.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.276 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.43 ' HB ' ' CD ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -88.25 175.31 4.25 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.097 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.43 ' CD ' ' HB ' ' A' ' 80' ' ' THR . 5.9 Cg_exo -79.52 139.46 14.41 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.776 2.318 . . . . 0.0 112.952 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.21 -162.19 1.26 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.303 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.07 -58.6 2.04 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.318 -0.239 . . . . 0.0 111.237 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.69 70.18 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.634 0.254 . . . . 0.0 111.417 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.419 ' CD2' ' HG2' ' A' ' 281' ' ' GLU . 0.1 OUTLIER -73.75 -59.08 2.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.473 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -56.93 -27.33 60.86 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.3 -31.07 57.99 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.886 ' HG3' HD21 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -93.8 29.62 2.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.578 ' HA ' ' CD1' ' A' ' 94' ' ' TRP . 19.7 mt -104.8 107.8 18.95 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.173 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -89.1 -179.19 1.19 Allowed Pre-proline 0 N--CA 1.452 -0.361 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HD3' ' CG ' ' A' ' 90' ' ' TYR . 7.4 Cg_exo -74.08 -39.0 1.86 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.326 2.017 . . . . 0.0 115.603 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.576 ' HZ ' HG21 ' A' ' 259' ' ' VAL . 31.1 t80 -87.65 -63.61 1.28 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.648 HG21 HG21 ' A' ' 302' ' ' VAL . 1.2 p -64.78 -26.99 68.59 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -175.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.578 ' CD1' ' HA ' ' A' ' 89' ' ' LEU . 5.2 m-90 -89.2 -24.93 22.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.015 0.926 . . . . 0.0 111.001 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 2.5 t70 -72.97 -26.81 61.49 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.125 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.922 ' HB1' HG21 ' A' ' 261' ' ' VAL . . . -71.72 -38.63 70.47 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.778 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 40.7 t -100.02 44.74 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.03 140.21 51.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 119.16 -0.448 . . . . 0.0 109.9 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.9 t80 -109.3 174.7 5.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.529 1.059 . . . . 0.0 109.433 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -61.32 75.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.724 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 138.97 -55.69 0.66 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.173 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -145.93 -178.29 6.04 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 117.126 0.463 . . . . 0.0 111.316 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.36 146.28 42.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.226 0.536 . . . . 0.0 112.39 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.827 ' CG1' HD12 ' A' ' 76' ' ' LEU . 4.1 tt -122.32 58.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.131 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.778 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . . . 159.03 176.04 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.819 ' CD2' ' HB3' ' A' ' 264' ' ' ALA . 0.0 OUTLIER -139.02 127.91 14.0 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 115.542 -0.754 . . . . 0.0 108.974 177.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.765 ' O ' HG23 ' A' ' 108' ' ' ILE . 86.3 Cg_endo -79.6 162.06 24.71 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 122.886 2.391 . . . . 0.0 113.479 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 107' ' ' PRO . 1.4 pp -167.99 38.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.256 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.904 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -178.11 119.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.319 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 110' ' ' VAL . 14.4 p -110.7 105.5 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.861 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.513 ' HA ' HG21 ' A' ' 320' ' ' THR . 1.9 pt-20 -102.46 161.8 13.42 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.788 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.68 146.87 8.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.741 0.781 . . . . 0.0 111.614 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.735 HD13 ' CD1' ' A' ' 156' ' ' PHE . 2.1 pp -79.75 125.27 29.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.1 OUTLIER -135.09 160.5 38.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -176.262 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 226' ' ' ILE . 8.2 tt -92.55 132.07 37.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 242' ' ' TYR . 4.1 tt -114.48 133.69 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.45 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 9.8 p90 -118.46 140.05 50.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.781 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 0.7 OUTLIER -89.25 128.08 35.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.611 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.06 -43.82 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.223 -0.298 . . . . 0.0 110.59 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -65.21 0.71 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.638 0.733 . . . . 0.0 110.84 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 121' ' ' LEU . 1.1 tt -110.24 64.99 0.61 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.98 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.911 HD13 ' HB1' ' A' ' 223' ' ' ALA . 2.1 tp -157.18 88.68 2.59 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 119.976 -0.689 . . . . 0.0 112.638 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.539 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 9.1 Cg_endo -48.26 162.98 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.192 2.594 . . . . 0.0 110.176 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -59.48 108.38 1.35 Allowed Pre-proline 0 N--CA 1.468 0.436 0 C-N-CA 118.186 -1.406 . . . . 0.0 109.686 -172.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.88 ' HB3' HD11 ' A' ' 122' ' ' LEU . 58.2 Cg_endo -93.31 168.6 2.28 Favored 'Trans proline' 0 C--N 1.369 1.627 1 C-N-CA 125.812 4.341 . . . . 0.0 115.868 -175.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 135' ' ' LEU . 4.7 Cg_exo -39.94 156.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.618 3.546 . . . . 0.0 115.572 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -136.07 -20.88 1.45 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.28 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.7 m -133.82 155.23 50.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -59.47 -54.32 48.03 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.406 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -24.25 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.577 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 134' ' ' ALA . 6.8 mt-10 -79.17 -27.92 42.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.651 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 7.2 mt -43.99 -54.25 11.57 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 121.385 0.612 . . . . 0.0 111.368 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 51.9 Cg_exo -49.07 -39.22 41.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 N-CA-C 109.511 -0.996 . . . . 0.0 109.511 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.11 -58.57 3.2 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.596 ' HB3' ' HD3' ' A' ' 126' ' ' PRO . 0.2 OUTLIER -69.07 -37.09 78.3 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.171 -178.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 49.0 t0 -73.09 -40.77 64.73 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -47.52 -45.11 26.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 118.599 -1.24 . . . . 0.0 108.949 177.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 75.0 mm-40 -64.28 -39.81 94.68 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.698 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.774 ' CD1' ' HB2' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -61.22 -49.17 78.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.75 -44.62 28.27 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.04 -25.19 0.53 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.497 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -100.01 -63.68 1.11 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.73 39.39 0.02 OUTLIER Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.014 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.76 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 0.5 OUTLIER -173.77 176.18 2.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.516 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.767 ' O ' HD22 ' A' ' 139' ' ' LEU . 9.8 m -109.26 166.97 10.46 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.774 ' HB2' ' CD1' ' A' ' 139' ' ' LEU . . . -73.31 -16.1 61.38 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.658 HD12 ' CE2' ' A' ' 149' ' ' PHE . 1.6 pt? -148.74 133.07 17.49 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 117.633 2.457 . . . . 0.0 117.633 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.56 ' HB2' HG21 ' A' ' 222' ' ' THR . 28.3 mmt -132.34 138.89 47.94 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.671 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.975 ' O ' ' O ' ' A' ' 150' ' ' ASN . 2.3 p90 -172.48 175.28 3.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.65 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.975 ' O ' ' O ' ' A' ' 149' ' ' PHE . 1.3 m120 -28.68 -147.74 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 123.897 0.748 . . . . 0.0 112.201 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.064 HD22 ' HB1' ' A' ' 206' ' ' ALA . 2.8 mt 169.66 41.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.824 -1.172 . . . . 0.0 110.615 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.892 ' NE2' HD11 ' A' ' 348' ' ' ILE . 0.0 OUTLIER 173.11 34.05 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 169.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.66 ' O ' ' HB ' ' A' ' 157' ' ' THR . 4.1 mp0 -119.46 155.13 54.38 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 121.113 1.779 . . . . 0.0 114.405 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.859 ' O ' ' N ' ' A' ' 156' ' ' PHE . 86.1 Cg_endo -77.59 -135.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 125.201 3.934 . . . . 0.0 105.466 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 1.182 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 4.0 m-85 39.83 -65.19 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 120.312 1.415 . . . . 0.0 113.073 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.859 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -89.5 -59.89 2.09 Favored 'General case' 0 C--O 1.259 1.593 0 C-N-CA 124.483 1.113 . . . . 0.0 111.36 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.66 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 5.9 m -58.88 -43.29 90.89 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.43 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.54 -55.34 30.31 Favored Pre-proline 0 C--N 1.35 0.612 0 C-N-CA 120.299 -0.561 . . . . 0.0 109.96 177.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 1.182 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 87.6 Cg_exo -43.48 -50.62 6.7 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.596 2.197 . . . . 0.0 113.349 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.502 HD23 ' CZ ' ' A' ' 250' ' ' PHE . 9.5 mp -64.06 -56.8 12.34 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 119.571 1.078 . . . . 0.0 109.972 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 158' ' ' TRP . 42.3 pt -54.31 -17.32 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.707 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -77.38 -25.75 51.2 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.7 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -42.13 -59.31 1.81 Allowed 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.491 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 6.3 t70 -64.35 -17.45 63.72 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 136.61 23.0 0.53 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 118.722 -1.704 . . . . 0.0 117.146 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.5 160.25 41.51 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 119.331 1.565 . . . . 0.0 111.779 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -163.08 168.1 21.39 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.504 0.652 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.47 -79.31 0.42 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.614 0.721 . . . . 0.0 111.343 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 176' ' ' TYR . 14.3 m-85 -112.15 168.73 9.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.87 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 1.271 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -103.94 115.8 31.1 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.434 ' CE1' ' CD2' ' A' ' 176' ' ' TYR . 0.2 OUTLIER -86.48 114.38 23.18 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.378 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 173' ' ' ASN . 1.2 tt0 -106.47 100.71 10.22 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 172' ' ' GLU . 35.7 m-80 39.03 78.63 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.32 6.52 80.43 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.86 124.37 5.91 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 121.44 2.62 . . . . 0.0 113.388 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 1.271 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.2 p90 -96.92 -23.12 16.48 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.599 1.19 . . . . 0.0 109.724 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.497 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 2.8 m-20 65.82 -82.43 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.911 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.893 HD11 HG22 ' A' ' 368' ' ' ILE . 7.1 tp 172.21 -43.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.419 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.3 OUTLIER -58.67 -16.62 17.11 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 119.167 -0.444 . . . . 0.0 111.769 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 4.0 m-20 -112.92 93.93 4.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 178' ' ' ILE . 15.4 m -118.06 120.12 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.314 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.42 52.57 3.81 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 119.479 -1.344 . . . . 0.0 112.86 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.601 HG12 ' HB3' ' A' ' 361' ' ' LEU . 14.5 t -90.93 -17.84 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.409 -0.895 . . . . 0.0 109.366 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.72 52.24 0.72 Allowed 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.858 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.56 160.65 16.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.375 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.75 -25.92 59.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.383 0.611 . . . . 0.0 111.706 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -76.4 -36.43 39.08 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.866 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.17 66.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -60.44 3.85 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.544 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.31 -41.04 50.43 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.829 0.823 . . . . 0.0 111.609 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.48 ' HA2' ' CE2' ' A' ' 194' ' ' PHE . . . -58.89 -60.7 8.42 Favored Glycine 0 C--O 1.237 0.338 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.839 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.561 HD13 HG13 ' A' ' 347' ' ' VAL . 4.2 mt -61.32 -23.93 66.07 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.577 -0.367 . . . . 0.0 110.092 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.824 ' O ' HG12 ' A' ' 196' ' ' VAL . 98.1 m -62.69 -53.46 54.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.658 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.48 ' CE2' ' HA2' ' A' ' 191' ' ' GLY . 4.3 p90 -61.83 -33.88 74.95 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.638 ' CD1' HD11 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -61.33 -51.2 69.84 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.671 178.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 193' ' ' THR . 7.8 p -58.66 -28.75 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.958 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -57.87 -49.36 76.96 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 121.399 0.618 . . . . 0.0 109.779 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.4 tt -62.33 -59.14 5.42 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.748 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 195' ' ' LEU . 4.3 mt -53.8 -45.16 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -61.71 -34.14 75.27 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -91.09 3.35 55.0 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.4 -81.11 0.63 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.72 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.48 -24.07 5.94 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 199' ' ' ILE . 1.4 ptm 74.44 13.42 3.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.948 0.34 . . . . 0.0 110.8 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -148.88 104.96 3.5 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 1.064 ' HB1' HD22 ' A' ' 151' ' ' LEU . . . -99.16 72.01 1.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.22 -4.27 27.48 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.593 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.912 HG22 ' HB2' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -57.24 123.9 16.95 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.1 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.671 ' HB2' HD13 ' A' ' 212' ' ' ILE . 0.5 OUTLIER -94.48 -174.74 3.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.6 p90 -70.18 -45.1 67.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.239 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.432 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.4 OUTLIER -77.87 -25.53 48.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.943 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.671 HD13 ' HB2' ' A' ' 209' ' ' ASP . 2.9 mp -81.68 -51.76 14.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.568 ' HB2' HG23 ' A' ' 208' ' ' THR . . . -50.39 -37.35 37.03 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.61 -45.62 86.15 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.77 -38.8 67.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.874 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.01 -56.7 18.3 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -61.46 -29.13 69.76 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -56.8 -40.54 76.11 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.572 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.23 -23.93 59.24 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.4 33.12 61.63 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 115.3 0.88 . . . . 0.0 115.3 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -109.02 36.9 2.71 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.147 1.474 . . . . 0.0 111.4 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.56 HG21 ' HB2' ' A' ' 148' ' ' MET . 0.5 OUTLIER -140.23 137.91 34.66 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 178.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 122' ' ' LEU . . . -104.58 38.18 1.95 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.578 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 170.55 138.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.562 HG23 HG22 ' A' ' 116' ' ' ILE . 9.0 t -148.17 159.37 44.01 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.564 ' HB ' ' CE1' ' A' ' 156' ' ' PHE . 8.5 pt -116.05 111.92 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.755 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.618 ' HA ' ' HE2' ' A' ' 156' ' ' PHE . 89.6 m-20 -148.67 164.78 33.31 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 121.874 -0.516 . . . . 0.0 111.939 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 230' ' ' TRP . . . -86.57 114.89 4.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.413 -1.375 . . . . 0.0 109.861 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.668 ' O ' ' HB3' ' A' ' 230' ' ' TRP . 75.2 Cg_exo -50.15 72.94 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.974 2.45 . . . . 0.0 114.548 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.668 ' HB3' ' O ' ' A' ' 229' ' ' PRO . 0.4 OUTLIER 150.96 -30.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 177.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.32 -85.91 0.55 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -52.22 -31.89 34.18 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.346 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -54.47 3.48 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.585 0.231 . . . . 0.0 111.172 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.6 m120 65.91 -74.48 0.06 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.219 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.575 HG21 ' CB ' ' A' ' 238' ' ' SER . 5.8 mt 65.72 -68.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 74.76 -69.77 0.17 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.601 0.239 . . . . 0.0 110.388 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 7.1 p -106.85 60.83 0.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.757 0.313 . . . . 0.0 110.317 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.575 ' CB ' HG21 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -52.93 -177.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.252 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -84.46 67.4 9.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.763 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 14.4 t 75.06 -67.22 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.745 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.57 150.28 47.35 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.725 0.298 . . . . 0.0 110.922 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.568 ' HB2' HD11 ' A' ' 116' ' ' ILE . 43.3 p90 -149.22 130.37 14.51 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.248 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.45 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -96.66 175.23 31.31 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.122 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.445 HG11 ' CG ' ' A' ' 229' ' ' PRO . 19.4 m -145.76 136.67 19.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 117.05 0.425 . . . . 0.0 111.529 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 167.5 21.0 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.4 m -73.07 152.77 7.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.713 HD22 ' OG ' ' A' ' 255' ' ' SER . 2.8 mp -59.37 159.57 15.85 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 120.627 1.558 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.73 -159.81 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.959 2.44 . . . . 0.0 112.433 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 17.3 p -121.15 177.51 5.12 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 249' ' ' THR . 56.8 m-85 -165.64 110.33 0.86 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.234 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.3 mttp 60.88 34.55 19.56 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.714 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.15 43.32 21.57 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.301 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -156.48 148.82 17.72 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.494 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 95.8 Cg_endo -84.31 -169.59 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.17 2.58 . . . . 0.0 111.628 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.713 ' OG ' HD22 ' A' ' 247' ' ' LEU . 75.3 p -111.85 148.99 32.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.248 0.547 . . . . 0.0 112.244 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 3.1 ttpm? -85.32 109.24 19.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.725 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.578 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 2.7 Cg_exo -78.88 145.7 20.09 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.347 2.698 . . . . 0.0 112.466 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 155' ' ' TYR . 1.6 m-85 -102.12 94.13 5.59 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.513 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.657 HG13 ' HA3' ' A' ' 327' ' ' GLY . 35.5 m -94.35 106.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.757 0.313 . . . . 0.0 111.82 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.424 ' HA2' ' CE ' ' A' ' 330' ' ' MET . . . -86.2 160.52 33.49 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 119.637 -1.268 . . . . 0.0 112.606 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.922 HG21 ' HB1' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -111.59 111.15 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.904 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 3.8 tp -84.4 107.04 16.45 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 117.502 -1.679 . . . . 0.0 107.071 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 63.9 p -133.36 141.94 48.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.819 ' HB3' ' CD2' ' A' ' 106' ' ' TYR . . . -73.73 132.99 43.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.169 -0.332 . . . . 0.0 110.289 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.17 136.33 11.17 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.74 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.955 HG23 ' CG ' ' A' ' 271' ' ' PRO . 7.0 mt -88.0 119.78 35.99 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 CA-C-N 118.425 1.113 . . . . 0.0 108.245 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.545 ' HA ' ' HZ ' ' A' ' 47' ' ' PHE . 44.5 t-20 -59.27 137.55 57.94 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.86 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -53.86 -22.34 9.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.711 0.687 . . . . 0.0 110.468 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 270' ' ' SER . . . -55.77 -27.34 50.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.723 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 269' ' ' ALA . 0.9 OUTLIER 93.22 91.29 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 122.602 0.361 . . . . 0.0 111.191 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.955 ' CG ' HG23 ' A' ' 266' ' ' ILE . 47.6 Cg_endo -91.14 81.11 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.279 2.653 . . . . 0.0 112.939 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 6.6 m-80 37.23 82.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.721 0.296 . . . . 0.0 111.142 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 7.9 mmtt -51.58 -54.2 30.1 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -66.9 -57.4 7.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.8 mt -63.74 -53.75 46.24 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -65.83 -55.19 18.4 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -58.97 -32.59 69.79 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.32 -53.03 8.77 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.421 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 85.9 t80 -56.37 -54.66 42.97 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.85 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 284' ' ' LEU . 1.0 OUTLIER -53.9 -43.5 69.75 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.566 0.698 . . . . 0.0 111.402 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.706 ' O ' HD12 ' A' ' 285' ' ' LEU . 90.0 mt-10 -73.45 -34.36 65.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.787 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -93.15 -13.96 27.78 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 1.003 ' O ' HG22 ' A' ' 286' ' ' THR . 2.5 t80 -106.21 -65.72 1.05 Allowed 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.759 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.5 tp -36.48 -33.04 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.732 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.706 HD12 ' O ' ' A' ' 281' ' ' GLU . 26.2 mt -89.8 42.09 1.08 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.637 0.255 . . . . 0.0 111.665 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 1.003 HG22 ' O ' ' A' ' 283' ' ' TYR . 10.1 t -145.72 160.55 41.56 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 9.3 m-20 -63.81 -12.72 38.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.549 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.591 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 9.9 mt-10 -77.85 -46.94 20.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.598 0.636 . . . . 0.0 111.012 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.861 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -83.86 -54.99 2.91 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 284' ' ' LEU . 2.2 tp -48.86 -49.8 37.78 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 1.8 tt0 -78.65 -26.38 45.11 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.174 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -71.85 -35.12 69.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 119.838 1.199 . . . . 0.0 108.129 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 289' ' ' GLY . 66.1 t -65.77 -41.95 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.036 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -91.2 -33.88 15.22 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.632 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -46.27 85.98 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.471 ' HB3' ' HA3' ' A' ' 19' ' ' GLY . 1.2 p30 -61.49 -44.73 96.56 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 5.1 mttp -43.45 163.86 0.15 Allowed Pre-proline 0 N--CA 1.476 0.833 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.245 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -93.96 49.19 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.217 2.612 . . . . 0.0 114.699 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.2 mt 60.75 69.5 0.68 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.902 0.382 . . . . 0.0 111.533 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.673 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . 159.99 125.29 0.78 Allowed Glycine 0 C--O 1.231 -0.087 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.606 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . 159.61 -177.07 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.272 0.536 . . . . 0.0 111.571 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.648 HG21 HG21 ' A' ' 93' ' ' THR . 6.5 p -141.99 83.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.563 ' HB3' ' CD2' ' A' ' 307' ' ' TYR . . . -84.67 58.22 4.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.271 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.886 HD21 ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER 87.84 149.4 0.05 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -30.19 0.66 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 65.5 m -79.91 -47.24 15.38 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.064 0.935 . . . . 0.0 111.059 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.563 ' CD2' ' HB3' ' A' ' 303' ' ' ALA . 5.9 t80 -70.74 -19.2 62.76 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.607 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -42.24 62.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -56.81 -55.85 29.06 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.195 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.34 -42.99 99.84 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.942 0.401 . . . . 0.0 110.18 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.479 ' O ' HG21 ' A' ' 317' ' ' ILE . 10.7 mt -59.93 -44.84 94.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.804 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.642 ' O ' ' HB2' ' A' ' 318' ' ' ALA . . . -46.63 -33.61 4.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.6 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -57.38 -36.5 71.33 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.582 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.53 164.57 5.16 Favored Pre-proline 0 N--CA 1.462 0.139 0 CA-C-O 120.684 0.278 . . . . 0.0 110.714 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.21 -57.2 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.131 2.554 . . . . 0.0 113.48 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.7 mtt85 -58.89 -59.46 5.42 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.49 HD11 ' CG1' ' A' ' 110' ' ' VAL . 1.7 tp -52.26 -54.31 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 312' ' ' ALA . . . -45.71 -51.86 11.81 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.269 0.486 . . . . 0.0 111.623 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -50.71 -48.4 58.84 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.318 1.056 . . . . 0.0 108.748 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.689 ' O ' ' HB2' ' A' ' 324' ' ' ALA . 0.3 OUTLIER -60.95 -36.9 80.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 113.248 -1.797 . . . . 0.0 110.58 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -73.96 -42.83 59.92 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.95 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.31 -57.5 12.37 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.753 0.311 . . . . 0.0 110.377 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.507 HD21 HD12 ' A' ' 247' ' ' LEU . 0.9 OUTLIER -67.36 -29.36 68.88 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.263 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -51.99 -53.05 46.15 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.734 0.302 . . . . 0.0 111.031 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -52.94 -32.85 47.96 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.203 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -98.64 13.2 32.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.657 ' HA3' HG13 ' A' ' 259' ' ' VAL . . . -93.9 160.0 23.98 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.865 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -97.76 131.93 43.83 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.2 pp -68.96 101.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 120.425 1.466 . . . . 0.0 107.875 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.59 ' CG ' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -36.07 144.84 0.24 Allowed Pre-proline 0 C--N 1.347 0.495 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -44.81 169.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.175 2.583 . . . . 0.0 112.297 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.404 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 9.3 p30 -128.4 -14.27 4.78 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.596 HD12 ' CG ' ' A' ' 335' ' ' GLN . 11.8 pt -78.94 165.89 46.06 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 118.77 0.714 . . . . 0.0 111.956 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.417 ' CD ' ' HB ' ' A' ' 333' ' ' ILE . 12.5 Cg_exo -70.55 -26.29 24.01 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.353 2.702 . . . . 0.0 113.402 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.699 ' OE1' HG23 ' A' ' 368' ' ' ILE . 84.1 mm-40 -42.01 -21.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.8 mmt -45.24 -32.17 1.81 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.234 0.47 . . . . 0.0 111.431 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -43.28 99.19 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 368' ' ' ILE . . . -63.5 -34.81 78.6 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.09 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.609 ' O ' HG23 ' A' ' 343' ' ' VAL . 4.3 m-85 -75.46 -52.28 11.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.542 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.459 ' CZ2' ' HG3' ' A' ' 154' ' ' PRO . 0.7 OUTLIER -53.45 -40.83 65.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.345 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -52.44 16.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.95 -44.49 69.43 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 1.037 HG13 HG21 ' A' ' 347' ' ' VAL . 47.9 t -64.72 -50.36 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.803 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.456 ' O ' HG22 ' A' ' 348' ' ' ILE . 9.0 tpt180 -53.42 -56.99 12.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.987 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 6.3 m -56.77 -58.22 9.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.05 -60.75 2.09 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 1.037 HG21 HG13 ' A' ' 343' ' ' VAL . 51.7 t -51.95 -47.47 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.892 HD11 ' NE2' ' A' ' 152' ' ' GLN . 0.4 OUTLIER -69.93 -45.27 77.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.893 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -69.12 -51.8 34.77 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.692 ' HB1' ' HA ' ' A' ' 355' ' ' GLN . . . -73.12 -26.62 61.29 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -51.86 -10.56 0.12 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 1.4 m -110.47 35.26 3.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.568 0.622 . . . . 0.0 111.059 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 88.64 -4.77 85.08 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 118.713 -1.708 . . . . 0.0 114.511 176.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -87.67 34.97 0.71 Allowed 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 115.683 -2.103 . . . . 0.0 107.903 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.971 ' HG2' HG23 ' A' ' 357' ' ' VAL . 2.0 mt-30 -71.14 -175.86 1.29 Allowed 'General case' 0 CA--C 1.547 0.838 1 N-CA-C 126.255 5.65 . . . . 0.0 126.255 -157.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.7 OUTLIER 158.26 41.38 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 110.074 -3.239 . . . . 0.0 104.876 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.971 HG23 ' HG2' ' A' ' 355' ' ' GLN . 53.2 t -72.43 -54.61 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.84 -174.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 6.7 t70 -46.23 -45.66 17.19 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.702 0.763 . . . . 0.0 111.269 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -77.4 -56.14 4.8 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.71 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -54.68 -44.32 73.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.209 1.004 . . . . 0.0 112.72 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.601 ' HB3' HG12 ' A' ' 183' ' ' VAL . 32.7 mt -75.62 -33.93 60.55 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.787 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 12.1 tttt -67.81 -56.06 10.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.172 0.987 . . . . 0.0 109.903 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.22 -30.72 71.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.146 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -53.87 -53.72 48.66 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.69 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.571 ' O ' HG23 ' A' ' 369' ' ' THR . 1.0 OUTLIER -58.5 -36.43 73.79 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.893 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.43 ' N ' ' HG3' ' A' ' 365' ' ' GLN . 5.9 m -52.16 -41.24 62.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.409 0.623 . . . . 0.0 109.588 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -73.73 -42.77 60.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.938 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.893 HG22 HD11 ' A' ' 178' ' ' ILE . 21.8 mm -66.12 -34.68 71.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 365' ' ' GLN . 6.6 p -94.5 -14.19 25.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.985 179.963 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.664 0.269 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 2' ' ' THR . 15.1 t -128.46 108.2 10.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.739 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.97 111.03 9.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.89 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -149.09 135.23 19.13 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.14 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -108.89 67.47 0.22 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.379 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.93 156.25 44.36 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.007 HD22 HD11 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -138.55 118.59 13.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.001 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -114.45 120.79 65.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.716 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.007 HD11 HD22 ' A' ' 7' ' ' LEU . 2.7 mp -121.67 130.79 74.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.123 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.886 ' HB2' HG22 ' A' ' 60' ' ' ILE . 29.8 m95 -107.94 121.13 44.15 Favored 'General case' 0 CA--C 1.527 0.058 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.3 pt -150.96 142.3 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.707 ' HA ' HD13 ' A' ' 43' ' ' LEU . 2.8 t30 -79.8 67.51 5.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.102 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.71 66.28 2.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.525 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 4.1 m-20 -80.59 -34.55 35.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.291 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 6.7 mttp 105.99 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.34 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 297' ' ' LYS . . . -74.36 58.21 2.41 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CZ ' HG21 ' A' ' 37' ' ' VAL . 3.3 m-85 -78.24 -42.14 32.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.751 0.31 . . . . 0.0 110.277 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 4.1 m120 -58.03 -48.37 80.28 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.986 0.422 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.883 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.78 -47.86 30.92 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.357 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.908 HD11 HG21 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -60.48 -51.31 70.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.382 0.591 . . . . 0.0 110.535 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.79 81.75 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.859 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 4.0 tm-20 -65.56 -36.53 84.06 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 19' ' ' GLY . 84.3 t -66.93 -61.3 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.605 ' CA ' HG21 ' A' ' 33' ' ' ILE . . . -49.09 -33.64 14.84 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.649 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -50.03 70.14 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.1 -41.46 62.46 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 112.809 -1.996 . . . . 0.0 107.902 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.574 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.17 -35.11 79.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.72 0.772 . . . . 0.0 110.865 178.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.716 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 18.4 tt0 -72.4 -52.46 15.88 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.223 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -53.05 -25.66 13.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.614 1.196 . . . . 0.0 110.244 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.728 ' O ' HG23 ' A' ' 31' ' ' THR . 9.1 t70 -89.04 -40.43 12.98 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.296 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER 169.67 38.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 173.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' HA2' ' A' ' 5' ' ' GLY . . . 157.36 39.53 0.02 OUTLIER Glycine 0 N--CA 1.466 0.671 0 C-N-CA 114.892 -3.528 . . . . 0.0 119.796 175.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 3.1 mm -139.7 137.55 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 122.32 3.06 . . . . 0.0 118.152 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -142.55 104.33 4.37 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.651 HG11 HD22 ' A' ' 20' ' ' LEU . 6.4 t -93.4 130.53 42.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 -171.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.1 m -119.21 145.14 46.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.675 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.683 HG12 ' HB ' ' A' ' 9' ' ' ILE . 2.1 m -131.09 122.94 52.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 122.057 -0.402 . . . . 0.0 110.683 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.48 130.78 55.48 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.964 ' HA ' HD12 ' A' ' 43' ' ' LEU . 1.3 p80 -150.57 71.22 8.99 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.36 178.77 5.97 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.462 2.108 . . . . 0.0 112.219 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -66.01 -40.05 90.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.962 0.411 . . . . 0.0 110.369 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 44' ' ' GLU . 11.1 mptt -84.72 1.05 48.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.096 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 39' ' ' HIS . 7.0 tt -19.33 -46.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 1.069 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -68.48 -54.61 15.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.711 0.291 . . . . 0.0 110.857 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.505 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -70.09 -37.59 75.45 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -60.2 -56.59 19.72 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.846 0.832 . . . . 0.0 109.861 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.7 ' CZ ' HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -41.76 -60.7 1.79 Allowed Pre-proline 0 C--N 1.352 0.693 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.31 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 1.069 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 29.2 Cg_exo -63.16 -25.18 72.73 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 121.617 1.544 . . . . 0.0 113.426 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -82.17 -35.57 28.23 Favored 'General case' 0 C--O 1.255 1.37 0 CA-C-O 122.171 0.986 . . . . 0.0 111.08 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.463 HG21 ' CZ2' ' A' ' 10' ' ' TRP . 29.2 m -77.78 -39.71 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.504 0 CA-C-O 122.04 0.924 . . . . 0.0 109.089 178.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.38 -37.82 26.35 Favored 'General case' 0 C--N 1.373 1.615 0 C-N-CA 126.048 1.739 . . . . 0.0 110.85 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.95 -42.4 21.33 Favored 'General case' 0 C--N 1.371 1.512 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.967 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 55' ' ' ASP . 1.2 m -73.69 145.93 44.87 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.578 1.081 . . . . 0.0 108.893 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 64.97 -78.35 0.07 OUTLIER Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.741 ' C ' ' HB1' ' A' ' 269' ' ' ALA . 1.4 t0 85.39 56.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 117.613 0.707 . . . . 0.0 111.672 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.581 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . -156.07 47.4 0.49 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 119.967 -1.111 . . . . 0.0 114.449 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.749 ' HD2' ' HB3' ' A' ' 269' ' ' ALA . 43.1 Cg_endo -100.15 -169.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.184 2.589 . . . . 0.0 112.093 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 1.001 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 4.1 t70 -88.24 -135.52 0.09 Allowed 'General case' 0 N--CA 1.414 -2.242 0 C-N-CA 123.123 0.569 . . . . 0.0 110.543 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.514 HG13 ' HA ' ' A' ' 266' ' ' ILE . 20.8 tt -103.08 163.67 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.886 HG22 ' HB2' ' A' ' 10' ' ' TRP . 10.3 pt -130.17 128.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 4.0 m-85 -107.17 124.33 49.55 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.471 ' CZ2' ' HG2' ' A' ' 44' ' ' GLU . 8.3 t90 -167.44 161.38 13.93 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -49.09 160.8 0.18 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.137 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.645 ' CD2' HG23 ' A' ' 97' ' ' VAL . 22.1 t-80 -77.56 -28.69 51.84 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.82 -58.85 3.82 Favored 'General case' 0 C--O 1.251 1.173 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.454 ' CB ' ' CZ3' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -75.49 -30.46 59.88 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.32 0.581 . . . . 0.0 110.038 179.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.58 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 2.2 m-30 -62.52 -27.08 68.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 174.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -60.82 -66.21 2.83 Favored Glycine 0 CA--C 1.49 -1.496 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.15 -53.66 43.84 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 113.218 -1.491 . . . . 0.0 111.256 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.476 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.9 m-30 -51.4 -42.84 61.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.729 ' HB2' HG21 ' A' ' 104' ' ' ILE . . . -54.58 -39.33 67.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.74 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -78.79 -43.14 26.08 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 111.666 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -70.22 -14.86 62.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.91 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.6 29.62 8.63 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.656 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 48' ' ' PRO . 8.1 mp -106.69 39.89 1.75 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.995 0.426 . . . . 0.0 110.424 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.736 ' C ' HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.37 145.4 0.25 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.366 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.868 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -96.1 115.3 27.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.969 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -47.68 129.68 13.96 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.806 HD12 ' HA ' ' A' ' 105' ' ' ALA . 14.6 mt -95.95 110.21 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.752 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.8 p -88.82 101.41 2.85 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.964 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 83.3 Cg_endo -101.24 -170.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.61 2.873 . . . . 0.0 113.161 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.19 -169.9 2.75 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.257 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.71 -44.08 7.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.532 0.206 . . . . 0.0 111.454 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -74.83 -23.54 58.47 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.725 ' HE1' HD21 ' A' ' 285' ' ' LEU . 6.5 t80 -64.62 -59.22 4.53 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.507 ' HG3' ' CG ' ' A' ' 94' ' ' TRP . 3.0 tt0 -70.13 -29.49 66.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.808 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 84' ' ' ALA . 12.6 t70 -76.82 -12.88 60.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.9 OUTLIER -87.81 -7.66 56.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.705 HD23 ' HB1' ' A' ' 303' ' ' ALA . 3.3 mp -100.91 -101.23 0.25 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.158 0.89 . . . . 0.0 111.584 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.19 133.18 10.56 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 122.102 -0.374 . . . . 0.0 111.056 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.0 -52.97 7.61 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.66 2.24 . . . . 0.0 112.934 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.462 ' CE1' ' HA ' ' A' ' 325' ' ' GLN . 45.2 t80 -55.53 -44.53 76.79 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.704 0.288 . . . . 0.0 111.08 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 302' ' ' VAL . 29.8 m -61.27 -29.04 69.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.507 ' CG ' ' HG3' ' A' ' 86' ' ' GLN . 86.3 m95 -92.97 -24.1 18.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.508 0.67 . . . . 0.0 112.136 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -73.82 -24.09 59.74 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.759 ' HB1' HG22 ' A' ' 261' ' ' VAL . . . -65.76 -21.66 66.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.271 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.645 HG23 ' CD2' ' A' ' 64' ' ' HIS . 6.7 p -125.28 58.03 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 102' ' ' LYS . 26.6 ttt180 -124.84 100.93 6.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.433 ' HH ' ' CG ' ' A' ' 332' ' ' ASN . 4.4 m-85 -89.07 90.9 8.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.169 0.44 . . . . 0.0 110.426 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 42.72 66.35 0.78 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.709 0.29 . . . . 0.0 110.87 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.22 38.98 58.67 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.593 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 4.7 mmtt -139.84 -177.61 5.05 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 119.446 -0.312 . . . . 0.0 110.792 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 97' ' ' VAL . 0.3 OUTLIER 175.34 107.85 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.601 0.637 . . . . 0.0 109.661 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.736 HD11 ' C ' ' A' ' 76' ' ' LEU . 3.6 tt -100.96 37.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.441 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.806 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . 170.21 149.14 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.544 ' CZ ' HG21 ' A' ' 79' ' ' ILE . 12.7 m-30 -88.2 120.3 70.53 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.617 ' HB3' HG12 ' A' ' 261' ' ' VAL . 2.9 Cg_endo -78.94 155.28 26.36 Favored 'Trans proline' 0 CA--C 1.514 -0.478 0 C-N-CA 121.917 1.745 . . . . 0.0 112.847 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 262' ' ' LEU . 0.5 OUTLIER -157.11 38.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.142 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 1.015 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 170.23 134.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.937 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.031 HG22 HG21 ' A' ' 302' ' ' VAL . 17.2 m -114.8 133.74 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.936 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.6 ' HB2' ' HA3' ' A' ' 260' ' ' GLY . 0.6 OUTLIER -99.57 136.1 40.0 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 1.038 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -167.97 -173.68 2.15 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 123.411 1.577 . . . . 0.0 110.307 -167.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.73 HD13 ' CD1' ' A' ' 156' ' ' PHE . 0.1 OUTLIER -146.12 135.57 23.02 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 110.598 -3.001 . . . . 0.0 116.246 -176.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.46 ' HA ' HD12 ' A' ' 247' ' ' LEU . 0.9 OUTLIER -131.09 165.17 23.84 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.051 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.906 HD23 ' OH ' ' A' ' 117' ' ' TYR . 6.2 tp -93.21 130.79 38.78 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.848 HD13 ' N ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -115.25 136.16 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.169 -179.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.906 ' OH ' HD23 ' A' ' 115' ' ' LEU . 14.1 m-85 -121.48 140.83 51.67 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -86.1 122.0 29.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -106.2 29.06 7.1 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.956 0.407 . . . . 0.0 111.515 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -131.43 -51.05 1.0 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.23 -136.89 0.02 OUTLIER 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.249 -1.796 . . . . 0.0 107.685 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.768 HD23 ' HD2' ' A' ' 123' ' ' PRO . 2.0 mt -84.45 128.93 59.62 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.768 ' HD2' HD23 ' A' ' 122' ' ' LEU . 33.5 Cg_exo -56.28 161.78 8.68 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.374 2.716 . . . . 0.0 110.997 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 8.4 p-10 -106.36 158.21 33.15 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.631 0.253 . . . . 0.0 111.042 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 19.9 Cg_endo -60.26 164.4 12.77 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.4 2.066 . . . . 0.0 111.833 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.423 ' HB2' ' HG3' ' A' ' 127' ' ' LYS . 4.0 Cg_exo -77.39 -42.35 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.801 2.334 . . . . 0.0 112.726 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.423 ' HG3' ' HB2' ' A' ' 126' ' ' PRO . 2.8 mttp -153.49 -10.72 0.15 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -119.45 139.56 51.86 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.802 1.183 . . . . 0.0 112.961 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.707 ' CH2' HD21 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -69.25 -23.76 63.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 172.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -44.82 -23.89 0.17 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.458 ' OE2' ' HB3' ' A' ' 134' ' ' ALA . 5.3 tp10 -66.83 -26.4 66.91 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.593 HG13 ' HD2' ' A' ' 133' ' ' PRO . 0.2 OUTLIER -40.47 -53.06 5.76 Favored Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.813 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 6.6 Cg_endo -48.82 -43.83 33.59 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 120.699 0.933 . . . . 0.0 110.049 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.458 ' HB3' ' OE2' ' A' ' 131' ' ' GLU . . . -74.68 -58.6 3.19 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 139' ' ' LEU . 32.7 tp -66.32 -40.41 89.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.208 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.636 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 3.3 m-20 -70.74 -35.7 72.79 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -47.69 -50.23 25.52 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.455 176.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 4.3 mp0 -61.87 -40.48 95.52 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.337 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.835 HD22 ' O ' ' A' ' 145' ' ' SER . 0.4 OUTLIER -61.79 -48.44 80.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -48.07 -43.9 30.94 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.02 -27.8 1.02 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -58.95 1.83 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.285 0.564 . . . . 0.0 110.239 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.81 40.19 0.02 OUTLIER Glycine 0 CA--C 1.519 0.319 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.299 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.501 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -152.83 -171.81 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 119.298 1.549 . . . . 0.0 111.501 -175.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.835 ' O ' HD22 ' A' ' 139' ' ' LEU . 5.0 m -138.76 158.24 44.6 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.731 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -73.35 -33.34 65.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.1 pp -135.38 129.23 33.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.83 ' N ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -133.4 134.91 44.25 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.092 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.68 ' CE2' HD13 ' A' ' 147' ' ' LEU . 21.4 p90 -172.31 177.18 3.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.511 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -36.53 164.93 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.366 0.416 . . . . 0.0 111.485 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.743 HD11 ' HB1' ' A' ' 206' ' ' ALA . 2.8 tm? -114.03 -57.71 2.24 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.57 ' NE2' HD11 ' A' ' 348' ' ' ILE . 1.1 pt20 -104.47 34.59 3.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 116.166 -2.213 . . . . 0.0 114.693 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.792 ' O ' ' OG1' ' A' ' 157' ' ' THR . 0.0 OUTLIER -79.81 140.32 54.52 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 121.279 1.854 . . . . 0.0 113.391 -176.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.957 ' O ' ' N ' ' A' ' 156' ' ' PHE . 84.5 Cg_endo -77.88 -135.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.376 3.384 . . . . 0.0 104.322 175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 1.152 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 1.4 m-85 28.93 -59.95 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.038 1.29 . . . . 0.0 113.643 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.957 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -85.41 -61.85 1.67 Allowed 'General case' 0 C--O 1.258 1.544 0 CA-C-N 118.777 0.717 . . . . 0.0 112.534 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.792 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 8.5 p -59.2 -40.67 86.48 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.181 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.692 ' O ' HG13 ' A' ' 161' ' ' ILE . 1.1 m95 -51.24 -55.53 27.86 Favored Pre-proline 0 C--N 1.353 0.733 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 1.152 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 78.1 Cg_exo -43.38 -44.31 10.46 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.598 2.199 . . . . 0.0 113.201 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 255' ' ' SER . 7.3 mp -63.6 -56.69 13.94 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.002 0.819 . . . . 0.0 110.388 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.692 HG13 ' O ' ' A' ' 158' ' ' TRP . 2.4 pp -53.72 -19.33 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.296 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.666 ' N ' HD12 ' A' ' 161' ' ' ILE . . . -78.61 -22.03 47.63 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.254 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -41.87 -59.26 1.75 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' A' ' 190' ' ' ALA . 45.7 t0 -64.35 -14.26 55.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -175.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 134.06 20.26 0.85 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 118.73 -1.7 . . . . 0.0 116.525 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.51 160.14 41.38 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 119.064 1.432 . . . . 0.0 111.423 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -145.61 136.0 24.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.336 0.568 . . . . 0.0 110.374 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.2 -80.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.358 0.599 . . . . 0.0 111.765 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.637 ' HB2' ' CG ' ' A' ' 176' ' ' TYR . 14.5 m-85 -113.13 173.8 6.21 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.576 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 1.194 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 6.5 mmtt -100.48 103.75 15.11 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.485 ' CD2' ' CE1' ' A' ' 176' ' ' TYR . 0.4 OUTLIER -85.04 115.25 22.75 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.586 176.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.886 ' O ' ' N ' ' A' ' 174' ' ' GLY . 1.1 tp10 -137.28 101.67 4.59 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.056 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.0 m120 44.42 -66.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 O-C-N 123.619 0.575 . . . . 0.0 110.656 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.886 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -70.66 -73.35 0.79 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 115.664 -0.698 . . . . 0.0 114.346 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -174.66 158.04 2.64 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 117.994 0.897 . . . . 0.0 110.677 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 1.194 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -56.29 -33.66 65.73 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.33 1.062 . . . . 0.0 108.256 177.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 1.0 OUTLIER 67.94 -85.71 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.862 179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 6.7 tp 175.02 -41.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.0 OUTLIER -66.38 -10.55 44.6 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.441 ' CB ' ' HB2' ' A' ' 170' ' ' LYS . 2.1 m-20 -124.56 93.75 3.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.58 121.54 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -123.23 39.72 2.16 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.698 -1.239 . . . . 0.0 113.959 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 184' ' ' ASP . 12.8 p -80.2 -44.14 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.028 0.442 . . . . 0.0 109.982 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.923 ' HB2' HD23 ' A' ' 361' ' ' LEU . 9.4 t70 -81.27 59.08 3.8 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.758 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -104.76 173.2 6.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.464 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.19 -28.11 62.54 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.352 0.596 . . . . 0.0 111.571 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -71.31 -45.97 44.79 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.09 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -60.41 -44.79 95.37 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HG3' HG21 ' A' ' 357' ' ' VAL . 5.5 tttp -57.8 -60.01 4.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.325 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.37 -40.94 50.88 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.088 0.947 . . . . 0.0 112.017 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -62.88 -60.65 7.39 Favored Glycine 0 C--O 1.24 0.485 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.086 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 196' ' ' VAL . 5.6 tp -59.49 -25.05 64.12 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 99.0 m -60.74 -50.2 74.42 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.499 ' CZ ' ' CE1' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -59.85 -37.26 78.76 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 tp -63.28 -47.58 81.75 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.631 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 192' ' ' LEU . 44.6 t -57.68 -28.76 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.508 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.11 -45.62 80.49 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.855 0.836 . . . . 0.0 111.039 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.458 ' HG ' HD13 ' A' ' 132' ' ' ILE . 4.3 tt -59.46 -51.95 67.67 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.851 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 204' ' ' MET . 6.6 mt -66.62 -40.25 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.96 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 4.9 tppt? -52.68 -36.91 57.94 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.626 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -113.18 -34.57 5.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 121.157 3.762 . . . . 0.0 121.157 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -63.73 -80.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.967 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.08 -9.67 27.58 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.563 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 4.8 ptt? 42.15 36.24 0.68 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.611 ' O ' ' HB3' ' A' ' 206' ' ' ALA . 0.7 OUTLIER -145.16 -73.34 0.25 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.743 ' HB1' HD11 ' A' ' 151' ' ' LEU . . . 84.41 37.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -97.74 -3.08 39.79 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 34.8 p -55.08 117.19 3.25 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.97 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.91 -173.64 4.17 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.3 p90 -70.63 -45.28 65.49 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 1.7 t -73.72 -32.73 64.03 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.711 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.75 -48.66 23.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.74 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.01 -32.19 70.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.06 -45.36 92.57 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 218' ' ' ASN . . . -58.75 -40.73 84.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.959 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.21 -57.09 10.72 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.09 -29.52 69.87 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.419 ' HB2' ' HA ' ' A' ' 215' ' ' ALA . 0.7 OUTLIER -52.69 -37.45 58.93 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.443 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -74.24 -23.89 59.22 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.04 53.63 5.65 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 114.7 0.64 . . . . 0.0 114.7 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -124.5 37.64 4.36 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.35 1.075 . . . . 0.0 111.609 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.83 HG21 ' N ' ' A' ' 148' ' ' MET . 2.2 m -142.22 140.9 32.45 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.731 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -113.13 38.79 2.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.618 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.658 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER 178.85 126.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 177.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.746 HG23 ' CG2' ' A' ' 116' ' ' ILE . 1.8 t -147.16 165.99 28.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.433 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.533 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 0.1 OUTLIER -100.49 146.02 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 172.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 114' ' ' SER . 2.3 t-20 -146.4 166.33 26.68 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.182 1.355 . . . . 0.0 109.953 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 112' ' ' ALA . . . -176.11 130.41 1.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.294 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.67 -29.66 3.59 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.846 2.364 . . . . 0.0 113.219 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.421 ' HA ' ' CG ' ' A' ' 111' ' ' GLU . 29.7 t-105 -33.66 -72.87 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.94 -41.9 8.18 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.24 166.53 18.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.907 0.384 . . . . 0.0 111.714 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 t -124.49 -62.07 1.28 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.52 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -99.32 139.69 34.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.691 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.8 HD11 ' CE1' ' A' ' 242' ' ' TYR . 25.4 pt -84.07 173.7 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.283 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.17 176.15 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.722 0.296 . . . . 0.0 110.995 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.05 83.43 0.33 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.965 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.405 ' O ' ' CE1' ' A' ' 242' ' ' TYR . 41.2 t -129.77 70.51 1.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.786 0.327 . . . . 0.0 110.682 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.429 ' O ' ' CZ ' ' A' ' 242' ' ' TYR . 0.0 OUTLIER 65.83 109.72 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.607 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.43 ' O ' ' CD2' ' A' ' 242' ' ' TYR . 58.4 t -45.29 -34.66 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.854 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -79.76 107.23 12.37 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.69 0.281 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.8 ' CE1' HD11 ' A' ' 235' ' ' ILE . 48.0 m-85 -118.46 134.04 55.39 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.245 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.96 105.25 2.3 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.202 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.0 t -90.96 111.59 23.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.78 167.41 18.12 Favored 'General case' 0 CA--C 1.527 0.067 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.1 m -73.36 153.66 7.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.522 HD23 ' OG ' ' A' ' 255' ' ' SER . 0.3 OUTLIER -59.26 159.04 16.74 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 119.784 1.175 . . . . 0.0 111.414 -178.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.706 ' HD3' HD13 ' A' ' 115' ' ' LEU . 90.4 Cg_endo -79.51 -165.08 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.035 2.49 . . . . 0.0 112.496 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -119.27 175.58 5.73 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.929 0.395 . . . . 0.0 111.763 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.499 ' CE1' ' CZ ' ' A' ' 194' ' ' PHE . 98.0 m-85 -166.13 111.05 0.82 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.957 0.884 . . . . 0.0 108.811 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 7.8 mttp 62.43 31.09 17.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.809 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.0 31.14 40.12 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.302 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.405 ' N ' HG22 ' A' ' 249' ' ' THR . 1.1 mm-40 -156.59 153.03 23.84 Favored Pre-proline 0 N--CA 1.463 0.179 0 CA-C-N 117.381 0.59 . . . . 0.0 112.251 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -87.88 170.36 6.25 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.209 2.606 . . . . 0.0 112.189 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.522 ' OG ' HD23 ' A' ' 247' ' ' LEU . 0.0 OUTLIER -91.03 144.34 25.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.803 0.335 . . . . 0.0 111.411 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 2.2 mttt -86.58 108.3 17.42 Favored Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.066 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.642 ' CB ' HD21 ' A' ' 113' ' ' LEU . 88.2 Cg_endo -79.55 153.35 23.5 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.273 1.982 . . . . 0.0 112.717 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 2.5 t80 -79.19 164.39 24.24 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.767 ' CB ' HG22 ' A' ' 329' ' ' ILE . 15.5 t -121.8 127.56 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.6 ' HA3' ' HB2' ' A' ' 111' ' ' GLU . . . -123.69 117.79 3.28 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 119.257 -1.449 . . . . 0.0 115.871 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.759 HG22 ' HB1' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -103.87 115.31 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.527 179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 1.015 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.5 mm? -94.22 93.63 7.87 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -111.28 -177.71 3.27 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -172.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.631 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -108.67 128.31 54.74 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 60' ' ' ILE . . . -122.87 127.8 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.82 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.639 HD12 HG12 ' A' ' 79' ' ' ILE . 24.7 mt -87.84 121.48 38.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.65 142.9 56.88 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.868 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -57.35 -26.46 61.02 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.149 -0.345 . . . . 0.0 110.78 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.749 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . . . -50.82 -59.89 3.64 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.921 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 271' ' ' PRO . 19.2 p -135.64 154.11 77.95 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.728 0.299 . . . . 0.0 111.413 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 270' ' ' SER . 15.3 Cg_endo -88.58 -66.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.054 2.503 . . . . 0.0 112.735 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 55.4 45.77 24.67 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 110.125 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 2.0 ttpt -60.32 -54.19 48.7 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.782 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 24.6 tp10 -50.2 -57.6 7.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.902 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.667 HD21 HD11 ' A' ' 33' ' ' ILE . 10.0 tp -64.93 -58.09 7.06 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.98 -56.69 5.65 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.2 OUTLIER -54.22 -38.55 65.83 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 1.9 tp10 -76.34 -53.14 8.6 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -56.17 -56.36 21.91 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.611 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.733 HD21 HD22 ' A' ' 284' ' ' LEU . 7.2 tt -52.32 -43.91 64.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.675 0.75 . . . . 0.0 111.67 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.698 ' O ' HD23 ' A' ' 285' ' ' LEU . 31.0 tt0 -73.2 -34.27 65.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.651 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -91.57 -14.71 29.82 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.874 ' O ' HG22 ' A' ' 286' ' ' THR . 0.2 OUTLIER -102.45 -65.49 0.99 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.733 HD22 HD21 ' A' ' 280' ' ' LEU . 6.3 tp -43.2 -22.7 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.601 -0.44 . . . . 0.0 112.097 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 1.067 HD13 HD11 ' A' ' 304' ' ' LEU . 3.8 mm? -101.37 37.38 1.8 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.002 -0.436 . . . . 0.0 110.721 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.874 HG22 ' O ' ' A' ' 283' ' ' TYR . 11.3 t -145.01 158.72 43.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 4.4 p30 -65.97 -11.66 49.3 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.603 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 5.5 tp10 -77.89 -47.12 19.47 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 109.993 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.607 ' O ' ' HB ' ' A' ' 293' ' ' VAL . . . -82.64 -49.49 5.11 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 1.027 HD11 HD13 ' A' ' 304' ' ' LEU . 8.4 mt -61.75 -51.24 69.17 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.631 0.254 . . . . 0.0 111.383 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.509 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 2.9 tp10 -76.08 -27.9 57.37 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.059 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.603 ' CB ' ' O ' ' A' ' 288' ' ' GLU . . . -71.57 -27.73 63.35 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.957 HG13 ' HG3' ' A' ' 298' ' ' PRO . 1.1 t -65.72 -61.0 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.798 175.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.571 ' N ' HG12 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -35.02 -50.31 0.49 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 125.313 1.445 . . . . 0.0 112.323 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 296' ' ' ASP . 20.2 ttpt -48.79 -43.9 38.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.254 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 295' ' ' LYS . 2.6 m-20 154.41 68.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.721 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.841 ' H ' ' HD2' ' A' ' 298' ' ' PRO . 0.5 OUTLIER -120.75 -37.95 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.023 171.293 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.957 ' HG3' HG13 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -91.61 -120.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 124.761 3.641 . . . . 0.0 113.283 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.847 HD13 ' CD1' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -160.78 -41.38 0.05 OUTLIER 'General case' 0 C--N 1.356 0.883 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -129.08 -155.59 8.6 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.56 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.898 ' HB3' ' CG1' ' A' ' 317' ' ' ILE . . . -133.25 48.15 2.42 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.115 0.958 . . . . 0.0 112.46 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 1.031 HG21 HG22 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -140.78 92.26 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.686 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.801 ' O ' HD12 ' A' ' 304' ' ' LEU . . . 177.69 48.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 1.067 HD11 HD13 ' A' ' 285' ' ' LEU . 0.0 OUTLIER 158.48 99.11 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.314 0.246 . . . . 0.0 111.42 178.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -38.37 -32.64 0.08 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 20.0 m -78.66 -44.22 24.25 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.473 1.13 . . . . 0.0 109.572 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.908 ' CD2' HD22 ' A' ' 290' ' ' LEU . 19.6 t80 -70.57 -20.03 62.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 112.87 -1.968 . . . . 0.0 110.249 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.777 ' OE2' HG21 ' A' ' 317' ' ' ILE . 7.9 tp10 -76.28 -43.14 43.02 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.0 -58.6 5.67 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.724 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -54.09 -52.9 59.49 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.246 0.546 . . . . 0.0 110.5 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 311' ' ' LEU . 2.3 tt -70.91 -28.04 64.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.932 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -45.92 -20.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -34.19 -42.67 0.13 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.543 0.61 . . . . 0.0 109.704 178.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -88.76 121.7 69.7 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.58 9.51 1.87 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.591 2.194 . . . . 0.0 115.467 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.404 ' O ' ' OG1' ' A' ' 320' ' ' THR . 5.6 mtm-85 -60.23 -59.82 4.81 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.706 0.684 . . . . 0.0 111.256 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.898 ' CG1' ' HB3' ' A' ' 301' ' ' ALA . 5.2 mm -49.76 -55.35 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.68 -52.05 11.43 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.38 0.536 . . . . 0.0 111.757 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -71.66 -33.42 68.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.543 0.687 . . . . 0.0 109.351 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 1.038 HG23 ' HB3' ' A' ' 112' ' ' ALA . 94.6 m -62.02 -37.06 83.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.387 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.451 ' HG2' ' CD2' ' A' ' 92' ' ' PHE . 5.6 ttm -79.03 -44.93 21.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.693 0.282 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -54.0 -45.91 71.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.221 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.512 ' ND2' HD13 ' A' ' 247' ' ' LEU . 2.8 t-20 -78.3 -51.95 9.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.226 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . . . -48.64 -33.82 10.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.694 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.462 ' HA ' ' CE1' ' A' ' 92' ' ' PHE . 0.2 OUTLIER -63.33 -39.94 95.94 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.51 0.195 . . . . 0.0 110.998 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -104.74 60.67 0.7 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.595 0.236 . . . . 0.0 111.08 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 257' ' ' PRO . . . -140.71 -147.18 4.91 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.12 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -127.32 111.77 14.29 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.767 HG22 ' CB ' ' A' ' 259' ' ' VAL . 1.8 pp -87.15 134.11 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.455 ' HG2' ' CE2' ' A' ' 258' ' ' PHE . 0.0 OUTLIER -41.03 105.33 0.38 Allowed Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.428 ' HD2' ' CE ' ' A' ' 330' ' ' MET . 96.2 Cg_exo -43.9 -34.89 6.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.676 2.251 . . . . 0.0 112.603 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.433 ' CG ' ' HH ' ' A' ' 99' ' ' TYR . 9.5 m120 79.06 51.3 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.478 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 335' ' ' GLN . 4.0 pt -133.82 156.65 79.19 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.804 0.335 . . . . 0.0 111.143 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.71 -31.51 39.8 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.636 2.224 . . . . 0.0 112.76 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.732 ' HB2' HD12 ' A' ' 333' ' ' ILE . 8.9 mm100 -59.85 -21.83 61.48 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.421 ' HG2' ' HE3' ' A' ' 330' ' ' MET . 12.0 tpp -45.56 -36.7 4.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.589 0.233 . . . . 0.0 111.372 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 2.1 p -58.1 -38.88 77.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.698 0.285 . . . . 0.0 110.348 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.948 ' HB1' ' CD1' ' A' ' 368' ' ' ILE . . . -55.6 -33.37 63.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.962 0.411 . . . . 0.0 111.307 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 343' ' ' VAL . 0.2 OUTLIER -78.51 -55.83 4.91 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.499 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.412 ' CE3' ' HA ' ' A' ' 340' ' ' TRP . 0.1 OUTLIER -44.33 -43.0 7.18 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.795 0.331 . . . . 0.0 111.025 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.99 -42.77 56.89 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.692 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.27 -45.84 72.03 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.706 ' CG2' HG21 ' A' ' 347' ' ' VAL . 9.9 p -69.62 -42.06 80.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.439 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -58.55 -59.29 5.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.698 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 9.8 m -56.39 -56.7 17.84 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.83 -60.83 2.06 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.706 HG21 ' CG2' ' A' ' 343' ' ' VAL . 48.5 t -54.56 -53.45 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.57 HD11 ' NE2' ' A' ' 152' ' ' GLN . 1.9 tt -62.31 -46.68 95.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.031 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.419 ' N ' ' CG2' ' A' ' 348' ' ' ILE . 64.8 t-20 -64.64 -47.7 77.56 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' A' ' 355' ' ' GLN . . . -73.37 -26.65 61.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -53.22 -11.26 0.26 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.3 p -110.46 36.77 2.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.585 0.63 . . . . 0.0 110.088 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.53 -3.42 87.06 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 118.711 -1.709 . . . . 0.0 113.691 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -87.3 34.92 0.69 Allowed 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 115.65 -2.119 . . . . 0.0 107.886 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.685 ' HA ' ' HB1' ' A' ' 350' ' ' ALA . 2.9 pp0? -71.17 -173.71 0.89 Allowed 'General case' 0 C--N 1.348 0.543 1 N-CA-C 123.34 4.57 . . . . 0.0 123.34 -159.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.504 ' HB ' ' CB ' ' A' ' 359' ' ' GLU . 0.0 OUTLIER -179.62 46.8 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.54 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.557 HG23 ' OE1' ' A' ' 355' ' ' GLN . 84.3 t -42.27 -49.85 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.863 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -61.33 -35.04 76.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 119.948 1.249 . . . . 0.0 109.611 178.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.504 ' CB ' ' HB ' ' A' ' 356' ' ' THR . 1.5 mm-40 -79.18 -26.97 42.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.441 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 356' ' ' THR . . . -66.8 -53.26 34.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 122.085 0.945 . . . . 0.0 111.824 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.923 HD23 ' HB2' ' A' ' 184' ' ' ASP . 0.2 OUTLIER -82.24 -50.48 8.94 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.787 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.654 ' O ' HG23 ' A' ' 366' ' ' THR . 2.3 mmpt? -45.18 -53.04 8.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -65.13 -41.42 94.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.402 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.525 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -66.52 -58.19 5.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.611 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.525 ' HB2' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -62.16 -44.32 96.87 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.984 -0.447 . . . . 0.0 111.969 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 362' ' ' LYS . 52.7 p -56.24 -59.79 4.43 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -51.57 25.65 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.511 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.948 ' CD1' ' HB1' ' A' ' 338' ' ' ALA . 32.8 mm -60.47 -42.84 92.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.421 HG22 ' CD1' ' A' ' 178' ' ' ILE . 1.3 p -114.15 55.63 0.73 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.917 0.389 . . . . 0.0 111.103 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.828 179.759 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 tptp . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.637 0.256 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 p -112.64 134.69 54.04 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.873 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -134.96 111.02 9.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -145.01 173.91 11.48 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.91 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -111.31 68.3 0.22 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.493 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.0 159.04 44.58 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -156.12 118.37 4.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 58' ' ' ASP . 15.3 t -108.72 140.47 27.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 118.771 -1.172 . . . . 0.0 110.003 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.804 HD12 HD11 ' A' ' 59' ' ' ILE . 10.3 tt -136.51 124.74 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.402 0.62 . . . . 0.0 111.122 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 1.002 ' CH2' HD22 ' A' ' 43' ' ' LEU . 30.7 t90 -101.46 133.32 46.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.226 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.686 HD11 HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -149.18 165.09 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.488 ' HA ' ' CG ' ' A' ' 40' ' ' PRO . 9.4 p30 -91.85 61.64 4.17 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.543 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 52.75 41.47 57.84 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.059 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 58.4 t0 -50.35 -31.66 15.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 111.438 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 105.15 -18.06 0.02 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.246 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.444 ' HA2' ' CG ' ' A' ' 296' ' ' ASP . . . -75.48 56.42 2.9 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 115.921 1.129 . . . . 0.0 115.921 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -75.96 -31.8 59.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.495 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 1.4 t30 -67.98 -47.14 69.37 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.152 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.569 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -72.14 -49.16 22.5 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.739 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.7 mt -60.02 -51.03 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.394 0.597 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.37 -37.08 84.48 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.591 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 9.6 tt0 -67.02 -37.44 84.14 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.449 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 19' ' ' GLY . 2.7 p -68.0 -61.03 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.14 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' H ' HG13 ' A' ' 23' ' ' VAL . . . -49.12 -33.03 13.59 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.803 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -50.5 72.68 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 122.481 1.134 . . . . 0.0 108.418 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 21.8 mttt -51.81 -41.2 61.56 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 112.865 -1.971 . . . . 0.0 108.202 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.732 ' HB3' ' CB ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.84 -35.9 81.97 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.915 0.864 . . . . 0.0 111.052 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.784 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 5.1 tt0 -69.78 -50.63 41.31 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.331 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -51.23 -30.27 16.93 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 124.909 1.381 . . . . 0.0 111.25 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.84 ' O ' HG23 ' A' ' 31' ' ' THR . 1.5 t70 -82.72 -39.15 22.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 116.921 -1.514 . . . . 0.0 108.872 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.84 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 162.29 37.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 116.616 -2.033 . . . . 0.0 116.35 170.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.694 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 155.5 38.58 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 115.428 -3.273 . . . . 0.0 117.354 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.784 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 4.1 mp -139.31 100.94 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 121.09 2.445 . . . . 0.0 114.86 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -107.21 105.24 15.12 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 7.8 m -97.14 132.75 40.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.05 146.67 45.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.315 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.794 HG12 ' CG2' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -133.22 122.74 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 122.199 -0.313 . . . . 0.0 110.687 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -107.19 137.24 45.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.945 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.488 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -71.56 -177.9 0.54 Allowed Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.392 0.677 . . . . 0.0 111.912 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 30.7 Cg_endo -91.96 -172.67 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.302 2.668 . . . . 0.0 113.757 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 40' ' ' PRO . 9.8 t70 144.81 -72.29 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.862 0.865 . . . . 0.0 109.39 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -108.4 1.05 21.46 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.716 178.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.002 HD22 ' CH2' ' A' ' 10' ' ' TRP . 2.2 tp -19.37 -56.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.996 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 2.1 tm-20 -60.42 -55.11 37.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -75.53 -55.46 5.65 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.581 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -55.49 -57.96 9.74 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.923 -178.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -49.62 -57.72 11.28 Favored Pre-proline 0 C--N 1.353 0.76 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.25 -177.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 1.097 ' HA ' HD13 ' A' ' 75' ' ' LEU . 24.6 Cg_exo -62.76 -21.2 72.81 Favored 'Trans proline' 0 C--O 1.252 1.2 0 CA-C-N 121.6 1.607 . . . . 0.0 112.325 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.68 ' O ' HG23 ' A' ' 53' ' ' THR . 61.1 tt0 -81.97 -39.72 23.25 Favored 'General case' 0 C--O 1.258 1.529 0 CA-C-O 122.561 1.172 . . . . 0.0 111.711 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 47' ' ' PHE . 17.1 m -77.93 -40.71 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.552 0 CA-C-O 122.247 1.023 . . . . 0.0 110.536 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.678 ' CB ' ' HB2' ' A' ' 269' ' ' ALA . . . -49.68 -37.88 30.56 Favored 'General case' 0 C--N 1.378 1.831 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.438 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.18 -33.57 32.92 Favored 'General case' 0 C--N 1.368 1.403 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.437 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 49' ' ' GLN . 19.0 p -65.62 -41.06 93.15 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.186 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 55' ' ' ASP . . . -114.69 -70.73 0.51 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.458 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 5.8 m-20 89.02 47.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.851 0.826 . . . . 0.0 109.888 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.11 175.94 21.6 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 120.531 -0.842 . . . . 0.0 114.642 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 58' ' ' ASP . 82.4 Cg_exo -43.86 131.98 8.05 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.567 2.845 . . . . 0.0 111.909 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.569 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 2.0 p30 158.2 125.96 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.804 HD11 HD12 ' A' ' 9' ' ' ILE . 1.8 pt -117.15 178.38 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 76' ' ' LEU . 2.7 pt -149.29 136.7 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.505 ' CZ ' HD11 ' A' ' 108' ' ' ILE . 4.7 t80 -109.99 122.76 48.31 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 23.2 t-105 -166.75 166.37 15.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -45.35 158.73 0.07 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.63 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.595 ' CG ' ' CG1' ' A' ' 97' ' ' VAL . 4.5 t-80 -77.27 -27.09 53.02 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 331' ' ' PRO . 9.9 p30 -53.34 -52.99 57.43 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-O 121.808 0.813 . . . . 0.0 111.893 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 18.9 mmm180 -73.4 -31.77 64.07 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.446 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.671 ' HA ' HD22 ' A' ' 76' ' ' LEU . 6.2 m-30 -60.26 -32.72 71.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 174.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -54.69 -66.87 2.5 Favored Glycine 0 C--O 1.25 1.152 0 CA-C-O 123.038 1.355 . . . . 0.0 111.616 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 70' ' ' TYR . . . -78.54 -55.67 3.86 Favored Glycine 0 C--N 1.357 1.73 0 CA-C-N 113.095 -1.553 . . . . 0.0 112.734 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.999 ' O ' ' N ' ' A' ' 75' ' ' LEU . 6.9 m-30 -42.01 -37.37 1.34 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.992 ' CB ' HG21 ' A' ' 104' ' ' ILE . . . -73.37 -58.76 3.09 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 117.852 -1.539 . . . . 0.0 112.432 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -46.96 68.35 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.434 1.016 . . . . 0.0 112.72 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 p -114.58 25.72 10.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.2 -87.48 0.06 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 118.539 -1.791 . . . . 0.0 114.909 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.097 HD13 ' HA ' ' A' ' 48' ' ' PRO . 1.2 tp -155.32 97.22 1.88 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.79 HD12 ' HA ' ' A' ' 267' ' ' ASN . 1.2 tp 179.33 144.36 0.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.068 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 1.02 ' O ' HD11 ' A' ' 266' ' ' ILE . . . -95.68 109.42 21.7 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.504 ' HA ' HG12 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -49.07 103.27 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.963 HG23 HD13 ' A' ' 266' ' ' ILE . 0.0 OUTLIER -61.91 173.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.128 0.489 . . . . 0.0 111.193 -179.047 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.487 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -88.06 175.38 4.22 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.086 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 80' ' ' THR . 79.1 Cg_endo -79.55 133.18 10.38 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.336 2.024 . . . . 0.0 113.629 -178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -152.87 68.06 0.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.323 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -47.36 -32.27 4.71 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -47.71 -29.03 2.75 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.489 ' CE1' HD21 ' A' ' 285' ' ' LEU . 1.3 m-85 -74.71 -59.32 2.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.805 0.335 . . . . 0.0 111.19 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.486 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 8.2 tm0? -70.36 -24.48 62.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -76.04 -43.89 41.76 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -11.07 59.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.88 ' CD2' ' HB1' ' A' ' 303' ' ' ALA . 0.3 OUTLIER -105.57 -170.61 1.77 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.976 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -78.19 145.96 69.99 Favored Pre-proline 0 C--O 1.232 0.154 0 CA-C-O 120.649 0.261 . . . . 0.0 110.543 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 95' ' ' ASP . 53.1 Cg_endo -69.75 -39.74 6.17 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.479 2.119 . . . . 0.0 112.596 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 325' ' ' GLN . 1.9 m-85 -59.74 -57.34 13.35 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -28.06 68.81 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.799 ' CZ3' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -93.68 -22.86 18.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.735 ' O ' HD11 ' A' ' 329' ' ' ILE . 15.8 t0 -71.64 -24.69 61.91 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.949 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 329' ' ' ILE . . . -69.0 -23.38 64.09 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.882 HG13 HG11 ' A' ' 261' ' ' VAL . 22.9 m -122.37 48.76 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.159 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' ' CD1' ' A' ' 103' ' ' LEU . 6.8 tmm_? -125.51 100.41 6.46 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 101' ' ' GLY . 3.6 m-85 -87.43 90.97 8.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.288 0.494 . . . . 0.0 110.197 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 48.14 -86.88 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.882 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . -132.67 42.15 1.41 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -145.48 -177.58 5.64 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 119.519 -0.277 . . . . 0.0 111.193 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.58 HD21 ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER 167.82 112.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.624 0.647 . . . . 0.0 110.617 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.992 HG21 ' CB ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -98.67 38.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.479 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.755 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . 166.01 174.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.582 ' OH ' HD13 ' A' ' 280' ' ' LEU . 0.1 OUTLIER -129.64 129.47 23.14 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.071 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.675 ' HG3' HG21 ' A' ' 97' ' ' VAL . 3.6 Cg_exo -79.72 162.26 24.31 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.866 2.377 . . . . 0.0 112.416 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 262' ' ' LEU . 1.1 pt -156.15 38.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.092 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.774 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 1.066 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -176.21 145.38 0.61 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.724 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 110' ' ' VAL . 14.0 p -128.73 114.03 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 324' ' ' ALA . 17.4 mm-40 -102.99 161.79 13.46 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.279 0.561 . . . . 0.0 109.749 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -165.25 147.24 7.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.758 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 HD11 ' A' ' 247' ' ' LEU . 3.0 tt -79.06 129.3 34.3 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.4 OUTLIER -135.12 159.65 40.85 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.511 HD11 ' HE1' ' A' ' 224' ' ' MET . 7.2 tt -92.61 131.18 37.94 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.749 HD12 HG22 ' A' ' 244' ' ' VAL . 0.9 OUTLIER -114.82 137.6 47.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.412 ' CE2' ' CD2' ' A' ' 115' ' ' LEU . 13.5 m-85 -106.07 133.38 50.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.916 ' HB3' HD23 ' A' ' 122' ' ' LEU . 14.8 m120 -88.58 125.9 35.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.559 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.33 -59.25 2.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.43 0.559 . . . . 0.0 112.209 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.5 ' OD2' HG13 ' A' ' 240' ' ' VAL . 0.4 OUTLIER -38.31 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 122.426 1.108 . . . . 0.0 111.203 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.84 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -102.82 42.42 1.15 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 112.739 -2.028 . . . . 0.0 112.442 -175.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.093 HD12 ' HB2' ' A' ' 223' ' ' ALA . 1.7 mm? -147.5 140.25 14.64 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 118.847 -1.141 . . . . 0.0 113.068 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 223' ' ' ALA . 50.9 Cg_endo -90.97 163.51 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.789 1 C-N-CA 125.492 4.128 . . . . 0.0 113.493 -179.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -61.42 106.07 0.73 Allowed Pre-proline 0 N--CA 1.465 0.296 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.773 -174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 95.3 Cg_endo -99.0 168.27 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 124.882 3.721 . . . . 0.0 114.808 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.794 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 35.8 Cg_exo -27.5 153.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 125.276 3.984 . . . . 0.0 116.19 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -135.81 -21.33 1.48 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.895 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.52 154.47 51.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -59.9 -53.93 52.13 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.137 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 133' ' ' PRO . 13.5 tt0 -45.45 -24.22 0.29 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.479 ' HG2' HD12 ' A' ' 135' ' ' LEU . 2.7 tt0 -73.61 -28.2 61.69 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.802 HG21 HD21 ' A' ' 198' ' ' LEU . 47.5 mt -42.11 -56.02 5.74 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 121.374 0.607 . . . . 0.0 112.215 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.582 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 2.7 Cg_endo -46.48 -38.61 21.47 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 120.565 0.843 . . . . 0.0 109.95 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.84 -59.99 2.51 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.785 HD13 ' CD ' ' A' ' 126' ' ' PRO . 1.4 mt -69.17 -33.12 72.9 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.212 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 1.075 ' HA ' ' CD1' ' A' ' 139' ' ' LEU . 10.0 t70 -68.32 -43.89 76.58 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -46.18 -49.2 17.24 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 118.208 -1.397 . . . . 0.0 110.079 177.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.677 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 3.1 tm-20 -63.73 -43.28 96.98 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.784 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 1.075 ' CD1' ' HA ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -52.94 -56.13 18.27 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -49.52 -44.01 46.04 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.704 0.764 . . . . 0.0 108.962 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -45.86 -26.0 0.61 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.29 -1.323 . . . . 0.0 114.343 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.21 -62.38 1.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.526 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.41 53.76 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -172.44 -174.23 1.17 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.885 1.343 . . . . 0.0 109.769 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.8 ' HA ' ' HB3' ' A' ' 139' ' ' LEU . 8.6 t -144.81 150.27 36.88 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.786 0.435 . . . . 0.0 110.42 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.794 ' HB1' ' HD2' ' A' ' 126' ' ' PRO . . . -68.93 -22.99 64.12 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.509 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 224' ' ' MET . 0.7 OUTLIER -142.92 129.4 20.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -176.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.755 ' HB2' HG21 ' A' ' 222' ' ' THR . 0.3 OUTLIER -132.53 139.93 48.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.521 -0.871 . . . . 0.0 111.726 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 227' ' ' ASN . 3.7 t80 -172.48 175.57 3.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.698 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 149' ' ' PHE . 2.6 m-80 -38.76 161.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.931 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.862 HD13 ' CB ' ' A' ' 206' ' ' ALA . 3.2 mt -115.06 -50.35 2.76 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.19 34.48 3.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 116.04 -2.264 . . . . 0.0 113.897 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.777 ' O ' ' HB ' ' A' ' 157' ' ' THR . 17.9 mm-40 -79.49 145.75 64.2 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 121.6 2.0 . . . . 0.0 114.488 -175.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.993 ' O ' ' N ' ' A' ' 156' ' ' PHE . 5.8 Cg_exo -78.05 -135.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 1 C-N-CA 125.55 4.167 . . . . 0.0 106.242 176.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 1.117 ' O ' ' CG ' ' A' ' 159' ' ' PRO . 36.0 m-85 16.15 -49.75 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.993 ' N ' ' O ' ' A' ' 154' ' ' PRO . 10.4 t80 -84.44 -60.03 2.2 Favored 'General case' 0 C--O 1.258 1.511 0 CA-C-N 119.406 1.003 . . . . 0.0 111.903 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.777 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -56.83 -42.61 79.94 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.469 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 2.3 m95 -51.61 -55.81 26.42 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 1.117 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 79.3 Cg_exo -43.19 -47.87 8.4 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.892 2.395 . . . . 0.0 113.065 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 250' ' ' PHE . 49.9 mt -62.48 -56.81 14.59 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.072 0.851 . . . . 0.0 109.968 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.722 HG21 HD12 ' A' ' 192' ' ' LEU . 20.6 pt -53.91 -18.01 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.904 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -78.06 -24.7 47.63 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.598 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -41.85 -56.71 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.57 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 1.8 m-20 -64.1 -39.34 93.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 119.211 0.914 . . . . 0.0 112.896 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 156.92 24.23 0.03 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 117.872 -2.109 . . . . 0.0 117.632 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.05 89.64 0.72 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-N 119.375 1.587 . . . . 0.0 112.633 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -73.68 158.58 34.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.29 0.545 . . . . 0.0 110.898 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.829 ' HA ' HG12 ' A' ' 183' ' ' VAL . . . -61.28 -80.59 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.956 0.884 . . . . 0.0 111.604 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.796 ' HB2' ' CG ' ' A' ' 176' ' ' TYR . 58.5 m-85 -113.86 173.66 6.32 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.792 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 1.209 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -106.49 116.28 31.66 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.974 1.261 . . . . 0.0 107.729 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.463 ' CE1' ' HA ' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -78.75 113.22 16.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.456 176.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 1.4 tt0 -137.29 113.61 10.05 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.778 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 1.9 t-20 82.48 -32.33 0.09 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.848 0.356 . . . . 0.0 111.112 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 157.81 15.48 0.04 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.648 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.463 ' HA ' ' CE1' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -173.29 142.02 0.97 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.863 1.332 . . . . 0.0 110.391 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 1.209 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.6 m-85 -66.84 -25.11 66.27 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.506 1.146 . . . . 0.0 109.961 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.757 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.6 t70 62.09 -85.7 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 112.793 -2.003 . . . . 0.0 111.51 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER 179.18 -54.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HA ' ' CG2' ' A' ' 369' ' ' THR . 0.0 OUTLIER -51.17 -17.37 0.65 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 5.5 m-20 -117.27 94.99 4.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 119.68 1.127 . . . . 0.0 109.332 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.426 ' CG2' ' CG ' ' A' ' 365' ' ' GLN . 3.3 m -116.73 112.45 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -117.74 39.96 2.47 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.586 -1.292 . . . . 0.0 113.806 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.829 HG12 ' HA ' ' A' ' 168' ' ' ALA . 1.8 m -79.09 -46.06 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.452 ' N ' ' CG2' ' A' ' 183' ' ' VAL . 18.5 t0 -81.49 57.25 3.22 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.08 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -102.77 177.93 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.345 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.48 -31.56 35.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.462 0.648 . . . . 0.0 111.429 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.57 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -74.91 -40.2 36.57 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.523 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -61.38 -46.09 91.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 174.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.61 -60.62 3.52 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.08 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.23 -41.62 50.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.09 0.948 . . . . 0.0 111.768 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -65.9 -60.6 6.32 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.535 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.722 HD12 HG21 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -58.91 -24.28 62.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.086 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.876 ' O ' HG12 ' A' ' 196' ' ' VAL . 23.5 m -63.99 -48.33 76.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 3.0 p90 -60.6 -35.22 75.58 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' A' ' 194' ' ' PHE . 4.5 mt -64.66 -47.64 77.73 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.876 HG12 ' O ' ' A' ' 193' ' ' THR . 0.5 OUTLIER -58.53 -28.33 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.18 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.77 -46.3 85.88 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.302 0.572 . . . . 0.0 110.229 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.802 HD21 HG21 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -62.93 -59.32 4.99 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.039 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 204' ' ' MET . 15.0 pt -54.14 -43.91 61.82 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -61.52 -34.26 75.21 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -89.95 2.31 55.24 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.96 -84.32 0.66 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.583 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.401 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.4 OUTLIER -120.73 -23.61 5.94 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 199' ' ' ILE . 0.3 OUTLIER 74.5 16.46 3.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.891 0.314 . . . . 0.0 110.645 -178.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -158.56 82.97 0.82 Allowed 'General case' 0 C--N 1.34 0.187 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.862 ' CB ' HD13 ' A' ' 151' ' ' LEU . . . -76.0 84.82 2.9 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -97.9 -2.77 39.97 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.272 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.672 HG22 ' HB2' ' A' ' 213' ' ' ALA . 89.4 m -56.66 121.1 8.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.95 -175.39 3.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -69.05 -45.36 70.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.138 0.495 . . . . 0.0 110.139 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.2 m -77.33 -25.53 51.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.613 0.72 . . . . 0.0 111.281 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.648 HG22 HG23 ' A' ' 208' ' ' THR . 0.9 OUTLIER -81.15 -50.82 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.801 178.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -53.46 -36.56 61.74 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.77 -46.16 89.32 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.05 -39.47 69.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.128 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.65 -56.98 13.98 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.407 ' CD2' HG21 ' A' ' 225' ' ' THR . 35.1 t80 -60.52 -28.46 68.42 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.38 -43.41 75.13 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.286 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -23.98 59.18 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.71 45.09 78.43 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -109.44 37.19 2.68 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.86 1.33 . . . . 0.0 110.496 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.755 HG21 ' HB2' ' A' ' 148' ' ' MET . 0.6 OUTLIER -141.96 141.85 32.95 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.966 0.889 . . . . 0.0 109.166 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 1.093 ' HB2' HD12 ' A' ' 122' ' ' LEU . . . -103.16 38.66 1.71 Allowed 'General case' 0 C--N 1.345 0.391 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.511 ' HE1' HD11 ' A' ' 115' ' ' LEU . 0.9 OUTLIER 168.7 138.45 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 148' ' ' MET . 5.2 p -148.06 159.78 43.55 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 226' ' ' ILE . 3.1 mp -116.48 112.44 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 114' ' ' SER . 2.2 p-10 -147.53 165.09 31.37 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 118.94 -0.553 . . . . 0.0 112.15 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -129.3 149.7 18.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.799 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.49 69.75 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.557 2.171 . . . . 0.0 112.298 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.689 ' CZ3' HD11 ' A' ' 262' ' ' LEU . 9.2 t-105 -159.02 -74.07 0.08 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.299 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.39 58.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.713 0.292 . . . . 0.0 110.997 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -152.07 95.7 2.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.256 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.9 m 53.2 176.28 0.02 OUTLIER 'General case' 0 C--O 1.231 0.079 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.339 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -109.24 94.99 5.33 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.632 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 12.6 tt -45.7 155.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.106 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.23 -171.29 0.09 Allowed 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.582 0.23 . . . . 0.0 110.501 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.9 m 67.02 35.55 4.59 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.707 0.289 . . . . 0.0 110.767 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 10.5 t -148.69 -62.06 0.24 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.544 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 14.9 mmtt -131.53 -85.97 0.49 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.402 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 2.7 p 158.38 -45.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -92.38 117.73 30.21 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.666 0.27 . . . . 0.0 111.266 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.637 ' CD1' HD11 ' A' ' 116' ' ' ILE . 7.8 p90 -149.29 129.86 13.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.428 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.99 176.21 54.74 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.668 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.749 HG22 HD12 ' A' ' 116' ' ' ILE . 19.3 t -146.55 113.16 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.557 0.678 . . . . 0.0 112.442 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.95 167.11 17.9 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -172.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.7 153.96 7.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.208 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.653 HD11 HD23 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -58.73 159.88 11.86 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 119.515 1.052 . . . . 0.0 110.996 -179.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.49 -163.45 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 111.957 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -120.79 177.58 5.03 Favored 'General case' 0 CA--C 1.526 0.052 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 160' ' ' LEU . 46.4 m-85 -162.35 110.42 1.36 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.534 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.86 33.08 17.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.379 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.28 41.34 21.63 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.524 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.434 ' C ' HG22 ' A' ' 249' ' ' THR . 0.0 OUTLIER -156.74 151.57 20.9 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.559 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 86.0 Cg_endo -86.51 -172.32 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.321 2.68 . . . . 0.0 111.891 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.513 ' OG ' HD22 ' A' ' 247' ' ' LEU . 10.2 p -108.57 148.33 30.47 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.4 OUTLIER -85.62 109.31 21.01 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.421 -178.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.491 ' HG2' ' O ' ' A' ' 323' ' ' ASN . 2.7 Cg_exo -79.36 149.45 21.7 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.305 2.67 . . . . 0.0 113.174 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.401 ' CB ' ' CD1' ' A' ' 155' ' ' TYR . 25.5 p90 -79.01 132.63 36.71 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 175.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.589 HG11 ' HA ' ' A' ' 329' ' ' ILE . 12.6 p -89.85 130.09 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -120.12 121.86 5.05 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 119.271 -1.442 . . . . 0.0 115.355 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.882 HG11 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -113.01 109.51 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 1.066 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 2.4 mm? -89.72 99.78 12.72 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 118.27 -1.372 . . . . 0.0 107.706 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.603 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -110.16 177.16 4.79 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -173.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.449 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . . . -116.2 124.06 49.33 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.666 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -127.4 164.33 20.91 Favored Glycine 0 CA--C 1.547 2.033 0 C-N-CA 119.062 -1.542 . . . . 0.0 112.776 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 1.02 HD11 ' O ' ' A' ' 77' ' ' ALA . 33.8 pt -81.93 -179.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 2 C-N-CA 139.311 7.044 . . . . 0.0 92.25 172.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.79 ' HA ' HD12 ' A' ' 76' ' ' LEU . 12.1 t30 -151.89 168.73 24.21 Favored 'General case' 0 CA--C 1.547 0.831 2 CA-C-N 133.603 7.456 . . . . 0.0 103.403 177.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 1.062 ' HB3' HD12 ' A' ' 75' ' ' LEU . . . -56.88 -52.27 65.78 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.203 0.911 . . . . 0.0 111.304 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.678 ' HB2' ' CB ' ' A' ' 51' ' ' ALA . . . -33.93 -64.16 0.24 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.96 127.88 2.82 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.596 0.236 . . . . 0.0 111.036 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -80.64 -41.3 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.359 2.04 . . . . 0.0 113.397 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.6 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 1.9 m-80 55.65 72.81 0.46 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.595 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 18.6 mtpt -56.64 -54.27 48.03 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 278' ' ' GLU . 4.2 mt-10 -55.65 -58.16 8.98 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.982 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.9 mt -69.46 -57.91 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.764 ' O ' HD12 ' A' ' 280' ' ' LEU . . . -64.88 -55.74 17.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.595 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -57.53 -42.49 82.98 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 274' ' ' GLU . 5.3 mt-10 -76.25 -53.88 7.6 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.445 ' HB2' ' CE2' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -55.6 -56.36 21.22 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.661 179.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 276' ' ' ALA . 1.2 mt -54.37 -43.4 71.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.359 0.599 . . . . 0.0 111.768 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.893 ' O ' HD23 ' A' ' 285' ' ' LEU . 17.8 tt0 -75.4 -33.24 60.97 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.214 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -97.14 -13.57 22.05 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 1.007 ' O ' HG22 ' A' ' 286' ' ' THR . 17.2 m-85 -114.32 -54.5 2.58 Favored 'General case' 0 CA--C 1.512 -0.513 0 O-C-N 122.008 -0.433 . . . . 0.0 110.659 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 284' ' ' LEU . 9.6 tp -45.28 -25.46 0.39 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.93 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.893 HD23 ' O ' ' A' ' 281' ' ' GLU . 2.6 mm? -94.93 43.39 1.09 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-O 120.832 0.349 . . . . 0.0 111.47 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 1.007 HG22 ' O ' ' A' ' 283' ' ' TYR . 13.2 t -143.7 156.93 44.69 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.532 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 49.4 p30 -66.13 -12.16 53.9 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.472 0.578 . . . . 0.0 110.55 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.764 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 10.9 tt0 -77.58 -47.48 19.31 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.029 -0.419 . . . . 0.0 111.054 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 286' ' ' THR . . . -84.71 -57.07 2.36 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.795 ' CD2' HG11 ' A' ' 302' ' ' VAL . 0.4 OUTLIER -48.29 -48.75 35.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.265 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -78.96 -26.77 43.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.077 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.764 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -65.8 -41.79 91.49 Favored 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 121.459 -0.776 . . . . 0.0 108.937 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.0 t -71.02 -64.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 116.704 -1.998 . . . . 0.0 105.856 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -51.43 3.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 129.119 2.967 . . . . 0.0 115.064 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -110.94 -57.0 2.29 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.444 ' CG ' ' HA2' ' A' ' 16' ' ' GLY . 57.6 m-20 -52.97 -36.85 60.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.868 ' HE3' HD12 ' A' ' 299' ' ' LEU . 16.7 ttpt -111.61 98.19 39.88 Favored Pre-proline 0 C--N 1.35 0.593 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.939 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -95.25 76.08 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.416 2.744 . . . . 0.0 112.091 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.868 HD12 ' HE3' ' A' ' 297' ' ' LYS . 16.3 mt -101.55 -74.83 0.61 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.449 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -142.62 -142.68 4.06 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.522 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.903 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . . . -79.79 178.42 8.2 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.741 0.305 . . . . 0.0 111.457 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.795 HG11 ' CD2' ' A' ' 290' ' ' LEU . 0.0 OUTLIER -126.83 -171.76 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.929 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.88 ' HB1' ' CD2' ' A' ' 89' ' ' LEU . . . -106.98 66.37 0.68 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.479 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.812 HD23 ' HB2' ' A' ' 307' ' ' TYR . 10.4 tp -159.95 108.89 1.76 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.763 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.61 -60.36 0.71 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.78 -48.03 63.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.022 0.915 . . . . 0.0 111.529 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.812 ' HB2' HD23 ' A' ' 304' ' ' LEU . 1.9 t80 -70.07 -19.73 63.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.128 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 3.0 tp10 -65.55 -39.95 92.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.82 -57.27 5.29 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.435 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -51.07 -57.21 9.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.248 0.547 . . . . 0.0 109.802 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.897 HD22 HG21 ' A' ' 317' ' ' ILE . 1.2 tt -61.93 -38.68 89.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.241 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.771 ' HA ' HD11 ' A' ' 317' ' ' ILE . . . -46.32 -29.11 1.51 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -40.31 -39.17 0.91 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.809 0.337 . . . . 0.0 110.241 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -78.53 118.34 71.75 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.09 -20.36 37.32 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.681 2.254 . . . . 0.0 114.287 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -59.15 5.61 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.903 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 2.4 pp -50.04 -53.44 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 317' ' ' ILE . . . -45.77 -44.95 14.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.448 0.567 . . . . 0.0 111.518 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.52 -40.09 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.551 0.691 . . . . 0.0 110.242 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.836 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER -62.0 -56.6 17.37 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.528 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 9.0 ttp -53.1 -42.68 66.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.701 0.286 . . . . 0.0 110.691 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.18 -39.26 81.97 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.93 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.743 ' CB ' ' HB1' ' A' ' 112' ' ' ALA . 7.3 m-80 -78.31 -48.11 16.36 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.659 0.266 . . . . 0.0 111.161 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 111' ' ' GLU . . . -48.53 -40.79 28.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.621 0.248 . . . . 0.0 111.576 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.433 ' HB2' ' CD1' ' A' ' 92' ' ' PHE . 5.3 pt20 -67.08 -28.43 68.18 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.607 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -76.54 -10.46 59.41 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 257' ' ' PRO . . . -79.91 161.2 45.55 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.815 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -96.6 139.62 32.41 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.735 HD11 ' O ' ' A' ' 95' ' ' ASP . 9.7 mt -51.58 102.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 119.891 1.223 . . . . 0.0 111.235 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.529 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 32.9 mtm -47.95 -48.33 62.4 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 330' ' ' MET . 57.9 Cg_endo -72.19 121.7 7.75 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.279 1.986 . . . . 0.0 113.218 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.578 HD22 HD12 ' A' ' 333' ' ' ILE . 0.1 OUTLIER -160.69 -70.28 0.07 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.473 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.578 HD12 HD22 ' A' ' 332' ' ' ASN . 0.3 OUTLIER -137.32 140.42 30.71 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.001 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.561 ' HD2' HG22 ' A' ' 333' ' ' ILE . 10.9 Cg_endo -53.38 -18.27 10.64 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.881 2.388 . . . . 0.0 113.037 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.652 ' HG2' HG22 ' A' ' 178' ' ' ILE . 1.4 mp0 -44.07 -24.67 0.16 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.606 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -45.71 -35.26 4.09 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.039 0.381 . . . . 0.0 111.372 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . 0.494 ' HA ' ' CD2' ' A' ' 340' ' ' TRP . 3.0 t -56.26 -53.17 60.45 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 110.241 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.6 ' HB1' HD11 ' A' ' 368' ' ' ILE . . . -52.13 -27.23 13.52 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.172 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.744 ' O ' HG13 ' A' ' 343' ' ' VAL . 25.2 m-85 -78.09 -55.74 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.344 -0.543 . . . . 0.0 112.459 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.494 ' CD2' ' HA ' ' A' ' 337' ' ' SER . 1.2 p90 -54.95 -31.93 60.98 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.26 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 340' ' ' TRP . 0.1 OUTLIER -75.57 -52.16 11.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.024 0.44 . . . . 0.0 110.994 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.33 88.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.731 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 339' ' ' PHE . 4.8 m -69.17 -42.3 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.375 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 30.2 mtt-85 -57.79 -55.4 35.42 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.882 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -58.2 9.49 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.34 -60.69 2.13 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.582 HG11 HD11 ' A' ' 192' ' ' LEU . 42.7 t -53.03 -49.78 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 36.3 mt -67.87 -49.56 67.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.57 -55.06 19.71 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.552 ' HB1' ' HB2' ' A' ' 355' ' ' GLN . . . -63.63 -26.55 68.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.905 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -65.48 -10.27 32.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.49 0.586 . . . . 0.0 112.327 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.3 p -110.77 14.8 22.18 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 122.059 -0.401 . . . . 0.0 110.785 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 97.73 29.74 7.58 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 116.815 -2.612 . . . . 0.0 116.08 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.46 35.65 4.36 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 116.252 -1.833 . . . . 0.0 106.328 174.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.608 ' O ' HG23 ' A' ' 356' ' ' THR . 3.9 pt20 -70.98 -174.77 1.0 Allowed 'General case' 0 CA--C 1.549 0.912 1 N-CA-C 125.704 5.446 . . . . 0.0 125.704 -157.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.7 OUTLIER 158.34 41.78 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.415 -3.084 . . . . 0.0 104.538 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 358' ' ' ASP . 12.3 p -72.36 -51.62 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.57 ' O ' ' HB3' ' A' ' 362' ' ' LYS . 10.0 t0 -47.77 -45.36 29.14 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.772 0.796 . . . . 0.0 111.31 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.644 ' HA ' ' HG2' ' A' ' 362' ' ' LYS . 8.1 mp0 -77.14 -56.32 4.67 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 113.885 -1.507 . . . . 0.0 113.62 -174.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -54.45 -43.09 71.34 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.416 1.103 . . . . 0.0 112.645 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.669 ' O ' ' HB3' ' A' ' 364' ' ' ALA . 0.1 OUTLIER -76.17 -45.75 31.83 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.087 -1.87 . . . . 0.0 111.358 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.644 ' HG2' ' HA ' ' A' ' 359' ' ' GLU . 43.3 pttt -58.01 -54.89 41.79 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 121.961 0.886 . . . . 0.0 110.419 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 362' ' ' LYS . 9.0 m-20 -58.75 -36.15 73.89 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 114.611 -1.177 . . . . 0.0 107.832 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 361' ' ' LEU . . . -49.66 -45.54 48.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.426 ' CG ' ' CG2' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -58.93 -44.77 91.43 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.6 m -52.09 -42.54 63.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.112 0.482 . . . . 0.0 109.864 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.15 -37.06 85.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.909 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.648 HG23 ' HG3' ' A' ' 335' ' ' GLN . 4.2 mm -71.64 -35.29 55.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.934 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.446 ' CG2' ' HA ' ' A' ' 179' ' ' LYS . 7.4 p -118.64 51.35 1.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.936 0.398 . . . . 0.0 111.843 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.3 tptp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.195 179.79 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.663 0.268 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.78 107.84 10.22 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -112.8 146.37 38.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 63.3 68.49 0.61 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.063 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.46 -112.11 2.31 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.219 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HG3' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -118.21 -171.18 2.02 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 114.143 -1.028 . . . . 0.0 109.919 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.96 HD21 ' CZ ' ' A' ' 279' ' ' PHE . 0.1 OUTLIER -127.42 120.41 28.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.062 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -116.24 117.14 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.341 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.952 ' CG1' HG12 ' A' ' 37' ' ' VAL . 1.7 pp -123.51 129.88 74.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.691 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.997 ' HB2' HG22 ' A' ' 60' ' ' ILE . 8.5 m95 -107.58 122.44 46.69 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.407 HG22 ' CD1' ' A' ' 9' ' ' ILE . 2.6 tt -159.23 139.02 3.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.7 113.29 20.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.624 0.249 . . . . 0.0 111.111 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.29 -9.15 15.36 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.755 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 39.0 t0 -72.59 -82.11 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.853 0.827 . . . . 0.0 111.057 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 5.8 tmtm? 100.84 -2.75 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.531 0.733 . . . . 0.0 110.313 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.559 ' O ' HD23 ' A' ' 20' ' ' LEU . . . -76.72 66.01 2.8 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 115.271 0.868 . . . . 0.0 115.271 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -77.39 -39.23 47.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.139 -0.531 . . . . 0.0 110.682 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 1.7 m120 -61.48 -47.0 87.66 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.058 0.456 . . . . 0.0 111.052 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.899 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.37 -47.51 35.43 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.054 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 16' ' ' GLY . 4.2 mm? -59.99 -49.6 77.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.381 0.59 . . . . 0.0 110.153 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.79 -38.46 80.01 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 2.1 tp10 -65.67 -36.93 85.08 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.063 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.899 HG23 ' O ' ' A' ' 19' ' ' GLY . 61.0 t -66.82 -61.1 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.851 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . -48.95 -32.42 11.68 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 119.685 -1.245 . . . . 0.0 111.491 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -55.29 -50.18 70.23 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.4 mttt -53.03 -41.72 65.0 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-N 112.862 -1.972 . . . . 0.0 108.374 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.762 ' HB3' HD13 ' A' ' 33' ' ' ILE . 47.4 m-85 -65.49 -34.31 77.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.777 0.799 . . . . 0.0 110.78 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.781 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 1.1 tm-20 -69.08 -51.26 40.65 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.963 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttp -50.99 -30.14 14.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 125.133 1.521 . . . . 0.0 110.867 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.841 ' O ' HG23 ' A' ' 31' ' ' THR . 0.4 OUTLIER -83.62 -38.2 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.428 179.085 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.75 37.71 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 171.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.822 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.09 38.58 0.02 OUTLIER Glycine 0 N--CA 1.468 0.805 0 C-N-CA 115.071 -3.443 . . . . 0.0 119.035 174.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.822 HD12 ' C ' ' A' ' 32' ' ' GLY . 2.0 mp -140.02 136.8 38.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 121.861 2.831 . . . . 0.0 116.417 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' CD ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -142.42 105.13 4.52 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.89 HG22 ' CB ' ' A' ' 7' ' ' LEU . 42.6 t -86.89 131.61 34.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -174.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.8 p -117.3 145.1 44.21 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.44 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.952 HG12 ' CG1' ' A' ' 9' ' ' ILE . 16.0 m -129.08 120.6 52.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 5.8 mt-10 -110.36 130.7 55.5 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -119.75 71.18 14.39 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.307 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 43' ' ' LEU . 7.8 Cg_endo -94.93 -170.2 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.514 2.809 . . . . 0.0 112.857 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -109.74 -40.32 4.85 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.42 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.406 ' HB3' ' CG ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -86.23 0.32 54.02 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.921 HD23 ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -31.68 -39.27 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 1.02 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 73.7 mt-10 -62.86 -54.61 36.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.467 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 11.9 pt-20 -74.2 -38.36 63.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -60.12 -57.53 12.42 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.705 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.743 ' CD2' HD13 ' A' ' 60' ' ' ILE . 1.1 t80 -42.94 -59.16 3.24 Favored Pre-proline 0 C--N 1.352 0.694 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.516 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 1.02 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 26.8 Cg_exo -62.66 -22.65 74.16 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 120.948 1.099 . . . . 0.0 113.171 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -82.23 -36.93 26.7 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 122.28 1.038 . . . . 0.0 111.271 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.3 m -78.59 -39.81 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.506 0 CA-C-O 122.254 1.026 . . . . 0.0 109.863 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 269' ' ' ALA . . . -50.56 -37.46 39.76 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 125.957 1.703 . . . . 0.0 110.906 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 53' ' ' THR . . . -81.52 -40.1 23.69 Favored 'General case' 0 C--N 1.372 1.567 0 CA-C-N 114.433 -1.258 . . . . 0.0 113.701 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 52' ' ' ALA . 33.6 p -159.56 51.52 0.35 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.054 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -160.02 48.87 0.39 Allowed Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.333 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t0 70.67 104.24 0.06 Allowed 'General case' 0 C--O 1.23 0.077 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.07 112.15 4.73 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.836 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.492 ' CG ' ' CE1' ' A' ' 47' ' ' PHE . 86.1 Cg_endo -79.85 -164.68 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.956 2.437 . . . . 0.0 113.444 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 1.062 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 6.7 t0 -79.96 -135.57 0.03 OUTLIER 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 123.946 0.898 . . . . 0.0 110.521 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.682 HD12 ' OD2' ' A' ' 58' ' ' ASP . 1.3 mp -101.7 165.17 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.997 HG22 ' HB2' ' A' ' 10' ' ' TRP . 1.2 pt -127.16 130.69 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.5 OUTLIER -115.34 117.57 30.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.71 ' CZ3' HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -167.26 165.38 15.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 62' ' ' TRP . . . -37.45 152.46 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.809 ' CG ' HG12 ' A' ' 97' ' ' VAL . 10.7 t-160 -77.35 -28.62 53.05 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.408 ' HA ' ' ND2' ' A' ' 332' ' ' ASN . 3.4 m-20 -49.19 -58.29 5.25 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-O 121.979 0.895 . . . . 0.0 112.279 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.57 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -73.9 -30.59 62.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.546 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.571 ' CD1' HD12 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -63.35 -25.43 68.29 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 64' ' ' HIS . . . -62.04 -65.37 3.24 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.62 -47.85 89.15 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 113.616 -1.292 . . . . 0.0 110.309 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.724 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 23.2 t80 -48.02 -46.56 33.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.525 ' HA ' ' CB ' ' A' ' 76' ' ' LEU . . . -57.87 -37.43 73.92 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.299 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -78.94 -54.72 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.303 . . . . 0.0 111.764 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -113.34 -26.15 8.5 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' TYR . . . -65.41 -85.37 0.07 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.178 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.983 HD23 ' HB3' ' A' ' 268' ' ' ALA . 0.2 OUTLIER 165.58 71.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.142 0.496 . . . . 0.0 109.726 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 77' ' ' ALA . 2.5 tt -112.64 133.22 54.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.273 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 1.056 ' HB3' HG23 ' A' ' 266' ' ' ILE . . . -86.45 91.92 8.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.631 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -56.3 85.49 0.01 OUTLIER 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.881 HD12 ' HD3' ' A' ' 81' ' ' PRO . 2.0 pp -49.24 119.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.224 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.7 p -105.84 82.79 0.91 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.365 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.881 ' HD3' HD12 ' A' ' 79' ' ' ILE . 42.8 Cg_endo -89.44 -168.58 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.122 2.548 . . . . 0.0 112.422 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -172.89 4.42 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.638 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -35.66 21.0 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.3 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.44 -23.64 58.04 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.93 -59.21 2.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.576 ' HA ' HD21 ' A' ' 89' ' ' LEU . 10.0 tt0 -60.99 -24.74 66.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.389 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -75.8 -35.39 60.07 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.58 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -19.68 64.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.092 HD13 ' CG ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER -97.4 -179.57 4.53 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -94.58 143.32 26.06 Favored Pre-proline 0 C--N 1.343 0.304 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 95' ' ' ASP . 31.8 Cg_exo -58.92 -50.58 8.66 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.422 2.081 . . . . 0.0 113.513 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' ' CG ' ' A' ' 325' ' ' GLN . 6.8 m-85 -56.76 -62.78 1.5 Allowed 'General case' 0 C--O 1.246 0.878 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.748 HG21 ' HA ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -62.85 -25.25 68.18 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 1.092 ' CG ' HD13 ' A' ' 89' ' ' LEU . 31.6 m95 -93.86 -23.39 18.14 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 14.7 t70 -72.65 -22.2 60.97 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.476 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.597 ' HB1' HG22 ' A' ' 261' ' ' VAL . . . -53.29 -45.53 68.96 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.073 HG13 HG11 ' A' ' 261' ' ' VAL . 20.2 m -113.93 39.25 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.407 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.437 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 12.0 ttp180 -104.94 138.96 40.37 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.289 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -124.15 90.99 3.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 119.172 0.896 . . . . 0.0 110.052 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.5 m120 51.73 -91.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.208 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.1 44.73 1.21 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.79 -177.03 5.37 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.486 0.314 . . . . 0.0 110.484 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.765 ' CD2' HD11 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -158.66 126.68 5.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.391 0.541 . . . . 0.0 110.742 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.702 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 1.4 pp -128.25 39.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.55 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 159.61 162.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.569 ' OH ' HD13 ' A' ' 79' ' ' ILE . 23.2 m-85 -124.7 119.81 25.78 Favored Pre-proline 0 C--O 1.223 -0.32 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.803 ' O ' HG23 ' A' ' 108' ' ' ILE . 66.9 Cg_endo -79.14 162.48 25.83 Favored 'Trans proline' 0 N--CA 1.474 0.333 0 C-N-CA 122.284 1.989 . . . . 0.0 114.776 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -171.82 38.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 1.043 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -179.56 137.58 0.13 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.916 HG12 ' HB3' ' A' ' 301' ' ' ALA . 0.3 OUTLIER -124.09 119.48 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 259' ' ' VAL . 5.4 tt0 -99.03 135.04 41.0 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 323' ' ' ASN . . . -168.06 -174.67 2.41 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 123.366 1.555 . . . . 0.0 110.204 -167.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.862 HD21 HG22 ' A' ' 226' ' ' ILE . 2.7 tt -147.3 135.44 21.49 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 110.995 -2.821 . . . . 0.0 115.846 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 227' ' ' ASN . 0.4 OUTLIER -130.31 168.42 16.93 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.893 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.669 HD12 HG13 ' A' ' 226' ' ' ILE . 6.8 tp -92.45 132.41 36.81 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 121.877 -0.514 . . . . 0.0 110.267 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.695 HD11 ' HB2' ' A' ' 242' ' ' TYR . 0.5 OUTLIER -116.41 134.51 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.669 0.747 . . . . 0.0 111.175 -178.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.46 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 8.3 m-85 -93.23 -174.32 3.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.05 2.54 . . . . 0.0 110.037 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 122' ' ' LEU . 0.7 OUTLIER -93.05 -135.43 0.17 Allowed 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 126.625 1.97 . . . . 0.0 113.615 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.919 ' O ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -152.46 -108.26 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.085 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -67.94 -26.55 66.01 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.513 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -104.89 51.47 0.76 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.164 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.919 HD23 ' O ' ' A' ' 119' ' ' LYS . 1.2 pp -118.83 73.22 11.82 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 121.439 0.638 . . . . 0.0 109.788 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.548 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 12.5 Cg_exo -70.16 160.82 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.407 2.071 . . . . 0.0 112.508 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 49.7 t30 -61.56 108.19 1.44 Allowed Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.417 -173.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 57.2 Cg_endo -69.63 167.94 22.82 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 124.094 3.196 . . . . 0.0 113.574 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -76.16 -162.0 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.762 2.308 . . . . 0.0 113.592 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -126.23 -93.03 0.49 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.6 t -45.0 152.99 0.2 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.352 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.523 ' HH2' HD11 ' A' ' 226' ' ' ILE . 13.9 t-105 -69.96 -26.51 64.14 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 174.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.425 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 62.5 mt-10 -44.55 -23.72 0.14 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 134' ' ' ALA . 22.1 mt-10 -73.5 -26.2 60.78 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.886 ' CD1' HD22 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -40.44 -52.81 5.84 Favored Pre-proline 0 N--CA 1.487 1.385 0 CA-C-N 119.122 0.874 . . . . 0.0 112.288 -178.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.587 ' HD3' HG13 ' A' ' 132' ' ' ILE . 53.1 Cg_exo -46.33 -39.94 21.95 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 120.699 0.933 . . . . 0.0 109.892 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -75.38 -58.92 2.99 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -68.14 -36.65 80.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.159 -178.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.537 ' OD2' HG22 ' A' ' 132' ' ' ILE . 1.9 m-20 -73.51 -41.09 63.51 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -48.22 -43.88 32.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.69 177.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 0.2 OUTLIER -66.4 -37.48 85.34 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.7 OUTLIER -65.55 -46.47 79.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -48.91 -43.26 39.14 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.12 -22.93 0.26 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.296 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -115.79 -60.31 1.89 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.774 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.62 56.85 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.659 ' HG3' HD23 ' A' ' 139' ' ' LEU . 24.2 pttt -169.08 -173.43 1.77 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.829 1.815 . . . . 0.0 110.246 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.721 ' C ' HD22 ' A' ' 139' ' ' LEU . 38.5 m -142.65 164.82 29.08 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.965 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -81.84 -23.01 36.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.931 0.395 . . . . 0.0 111.919 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.681 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.3 pp -144.82 128.76 17.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.78 ' N ' HG21 ' A' ' 222' ' ' THR . 11.2 mmm -132.41 141.59 48.93 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.702 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.497 ' HB3' HG23 ' A' ' 225' ' ' THR . 52.6 p90 -172.55 174.94 3.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.742 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -37.54 158.42 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.013 178.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.006 HD13 ' HA ' ' A' ' 206' ' ' ALA . 3.3 mt -110.65 -51.66 2.85 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.17 34.35 3.1 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 115.752 -2.379 . . . . 0.0 113.765 -175.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.751 ' O ' HG23 ' A' ' 157' ' ' THR . 0.5 OUTLIER -79.63 142.32 57.26 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 121.067 1.758 . . . . 0.0 114.087 -176.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.968 ' O ' ' N ' ' A' ' 156' ' ' PHE . 67.3 Cg_endo -78.18 -134.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 1 C-N-CA 125.336 4.024 . . . . 0.0 105.2 175.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 1.167 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 12.3 m-85 21.13 -55.63 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.883 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.968 ' N ' ' O ' ' A' ' 154' ' ' PRO . 15.1 t80 -84.72 -55.81 3.92 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-N 119.561 1.073 . . . . 0.0 112.641 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 153' ' ' GLU . 20.6 p -58.04 -39.77 79.25 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 117.913 -1.515 . . . . 0.0 107.336 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.543 ' HZ2' HG21 ' A' ' 343' ' ' VAL . 24.2 m95 -53.0 -55.7 30.93 Favored Pre-proline 0 C--N 1.352 0.702 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.825 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 1.167 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 67.5 Cg_exo -43.04 -48.91 7.41 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.187 2.591 . . . . 0.0 112.425 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.699 HD21 ' CZ ' ' A' ' 250' ' ' PHE . 0.1 OUTLIER -58.19 -53.55 57.03 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 119.361 0.982 . . . . 0.0 109.411 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.625 HG22 ' HA ' ' A' ' 188' ' ' ALA . 4.7 mt -55.42 -20.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.001 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.718 ' HB1' ' HG3' ' A' ' 256' ' ' LYS . . . -78.9 -25.16 43.77 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 250' ' ' PHE . . . -42.85 -56.02 3.43 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.492 ' CB ' ' HA2' ' A' ' 187' ' ' GLY . 7.1 m-20 -64.54 -11.18 31.6 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.172 0.896 . . . . 0.0 112.777 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.91 27.76 0.7 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 119.545 -1.312 . . . . 0.0 115.561 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.85 162.06 38.82 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 118.557 1.178 . . . . 0.0 111.847 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.673 ' O ' ' N ' ' A' ' 169' ' ' PHE . 25.9 m-85 -151.28 30.18 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.992 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 50.04 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.024 0.916 . . . . 0.0 111.411 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.691 ' CB ' ' HB3' ' A' ' 176' ' ' TYR . 12.4 m-85 -112.88 170.72 8.0 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.423 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.957 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -108.01 114.74 28.88 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.487 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 5.9 t80 -79.23 114.03 17.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 113.473 -1.694 . . . . 0.0 110.36 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -137.54 124.53 21.43 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.202 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 t30 76.77 -31.69 0.18 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.872 -0.149 . . . . 0.0 111.109 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.487 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 163.83 11.77 0.03 OUTLIER Glycine 0 CA--C 1.532 1.123 0 C-N-CA 120.17 -1.014 . . . . 0.0 114.626 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.402 ' C ' ' HA ' ' A' ' 171' ' ' TYR . 3.4 mtmt -173.93 150.6 1.65 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.962 1.381 . . . . 0.0 110.031 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.957 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 7.0 m-85 -66.57 -26.32 67.06 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.151 0.977 . . . . 0.0 109.579 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.64 -103.98 0.08 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.403 -1.726 . . . . 0.0 112.163 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 179' ' ' LYS . 8.3 tp -173.38 -46.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.43 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.1 OUTLIER -64.42 -15.6 60.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.718 0.294 . . . . 0.0 110.872 179.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 170' ' ' LYS . 3.2 p-10 -129.19 94.3 3.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 169' ' ' PHE . 20.3 m -122.03 140.79 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.387 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.69 55.5 4.17 Favored Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.185 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.799 HG11 HD11 ' A' ' 368' ' ' ILE . 30.4 m -87.03 -13.31 10.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.526 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 7.3 p-10 -124.62 62.68 1.13 Allowed 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.774 0.321 . . . . 0.0 110.844 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -116.93 135.1 53.98 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.282 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 189' ' ' LYS . . . -39.25 -40.31 0.74 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.424 0.63 . . . . 0.0 112.264 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.492 ' HA2' ' CB ' ' A' ' 164' ' ' ASP . . . -76.78 -35.94 38.54 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 114.955 -1.02 . . . . 0.0 114.113 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.625 ' HA ' HG22 ' A' ' 161' ' ' ILE . . . -60.0 -51.43 69.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.771 ' HE3' HD21 ' A' ' 361' ' ' LEU . 9.2 mttt -58.16 -60.45 3.73 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.651 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -50.36 -42.03 52.55 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.835 0.826 . . . . 0.0 111.959 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.46 -60.51 5.41 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.146 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.5 OUTLIER -56.98 -28.32 62.22 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 122.841 -0.211 . . . . 0.0 110.48 179.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 189' ' ' LYS . 7.6 p -69.65 -42.37 74.34 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.666 0.27 . . . . 0.0 111.375 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.48 ' CZ ' HD21 ' A' ' 198' ' ' LEU . 86.7 t80 -61.68 -34.27 75.45 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.345 0.593 . . . . 0.0 109.606 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.67 -47.76 79.93 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.892 HG21 ' OE1' ' A' ' 355' ' ' GLN . 43.8 t -56.88 -31.64 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.467 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.11 -44.87 87.37 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.797 0.808 . . . . 0.0 111.508 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.886 HD22 ' CD1' ' A' ' 132' ' ' ILE . 13.0 mt -58.59 -55.39 35.64 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 204' ' ' MET . 26.9 pt -64.06 -39.82 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.102 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 2.9 tttt -52.67 -37.32 58.52 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.695 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.26 -34.53 5.62 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 121.141 3.756 . . . . 0.0 121.141 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -60.72 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.773 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -105.19 -1.94 24.79 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.668 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 9.0 mtm 43.39 36.02 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.773 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.09 159.36 42.34 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 1.006 ' HA ' HD13 ' A' ' 151' ' ' LEU . . . -149.38 30.1 0.77 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -100.6 -3.51 30.34 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 213' ' ' ALA . 5.3 m -57.45 119.82 7.16 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.563 ' OD2' HD12 ' A' ' 212' ' ' ILE . 3.5 p30 -95.5 -174.24 3.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.875 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 211' ' ' SER . 53.5 p90 -68.05 -45.5 73.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.421 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -76.67 -25.49 53.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.588 0.709 . . . . 0.0 111.382 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.563 HD12 ' OD2' ' A' ' 209' ' ' ASP . 4.5 mt -81.63 -50.91 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.063 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -52.47 -37.37 56.98 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.482 ' HA ' ' CD2' ' A' ' 217' ' ' PHE . 2.7 tt0 -60.17 -46.89 88.17 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.9 -36.24 69.91 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.481 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.55 -57.34 13.11 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.482 ' CD2' ' HA ' ' A' ' 214' ' ' GLU . 0.4 OUTLIER -63.08 -28.32 70.0 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -55.14 -41.12 71.35 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.558 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.98 59.14 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.2 41.27 69.9 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -109.64 37.13 2.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.034 1.417 . . . . 0.0 110.822 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.78 HG21 ' N ' ' A' ' 148' ' ' MET . 1.6 m -140.44 140.75 35.46 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -105.09 38.42 1.94 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.349 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 2.7 ttm 171.6 135.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.497 HG23 ' HB3' ' A' ' 149' ' ' PHE . 90.4 m -148.19 157.58 43.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.153 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.862 HG22 HD21 ' A' ' 113' ' ' LEU . 2.7 mp -115.84 111.41 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.427 173.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 114' ' ' SER . 10.1 p30 -149.18 164.72 33.93 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 122.095 -0.378 . . . . 0.0 111.837 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -80.76 -172.82 46.25 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.124 -1.513 . . . . 0.0 109.784 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.435 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 57.5 Cg_endo -73.51 -40.7 1.43 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 121.759 1.639 . . . . 0.0 112.522 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.508 ' CZ2' ' HA3' ' A' ' 300' ' ' GLY . 0.3 OUTLIER -137.49 23.87 2.93 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.631 ' HB3' ' CE3' ' A' ' 232' ' ' TRP . . . -96.48 -33.79 11.73 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.631 ' CE3' ' HB3' ' A' ' 231' ' ' ALA . 1.7 m-90 -105.21 79.96 1.54 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.1 m 62.59 -175.69 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.91 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -83.0 129.5 35.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.813 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.427 HG13 ' CE2' ' A' ' 242' ' ' TYR . 8.4 tp -87.61 -32.55 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.368 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -46.2 -38.66 8.63 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.603 0.24 . . . . 0.0 111.294 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 237' ' ' THR . 9.0 t -87.05 65.2 8.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.702 0.287 . . . . 0.0 110.814 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 39.1 p -116.44 -60.3 1.87 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.812 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.48 -67.51 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.301 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.41 ' HB ' ' HD3' ' A' ' 119' ' ' LYS . 22.1 t -154.43 -60.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.526 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -136.74 157.46 46.7 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.876 0.37 . . . . 0.0 111.317 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.695 ' HB2' HD11 ' A' ' 116' ' ' ILE . 6.2 p90 -149.31 156.68 42.47 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.632 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.485 ' O ' HD12 ' A' ' 116' ' ' ILE . . . -107.34 172.82 18.22 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.42 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.0 t -146.51 119.98 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.139 0.469 . . . . 0.0 111.976 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.55 167.52 20.64 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -173.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.2 m -73.01 153.22 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.646 ' CD1' HG21 ' A' ' 226' ' ' ILE . 2.8 mm? -59.03 159.15 14.72 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-N 120.396 1.453 . . . . 0.0 111.885 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.11 -156.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.461 2.774 . . . . 0.0 112.242 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -128.51 172.99 10.63 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.913 -178.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.699 ' CZ ' HD21 ' A' ' 160' ' ' LEU . 97.4 m-85 -164.15 110.47 1.06 Allowed 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 121.791 0.805 . . . . 0.0 109.402 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt 61.16 33.0 19.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.678 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.01 36.64 35.12 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.118 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 163' ' ' ALA . 1.4 mt-30 -156.83 155.17 28.07 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -92.14 157.88 3.22 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.598 2.865 . . . . 0.0 111.986 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.4 p -79.73 153.41 29.27 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.718 ' HG3' ' HB1' ' A' ' 162' ' ' ALA . 3.2 mmmm -85.4 110.82 32.18 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.391 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.477 ' HB2' ' CA ' ' A' ' 327' ' ' GLY . 6.2 Cg_exo -79.23 147.83 20.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.928 2.419 . . . . 0.0 112.39 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 155' ' ' TYR . 3.2 p90 -105.09 133.93 49.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' A' ' 324' ' ' ALA . 30.9 t -140.68 108.41 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.25 163.88 43.47 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.152 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 1.073 HG11 HG13 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -104.3 113.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 122.893 -0.181 . . . . 0.0 111.342 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 1.043 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 1.7 tt -89.04 99.67 12.6 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 117.502 -1.679 . . . . 0.0 106.68 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.552 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 23.3 p -134.85 142.06 46.52 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -172.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . -73.88 131.59 41.64 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.827 0.451 . . . . 0.0 110.061 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.513 ' O ' HG13 ' A' ' 60' ' ' ILE . . . -122.01 135.51 10.41 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.005 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 1.056 HG23 ' HB3' ' A' ' 77' ' ' ALA . 4.4 tp -89.98 123.6 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -64.43 145.37 56.18 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.983 ' HB3' HD23 ' A' ' 75' ' ' LEU . . . -58.74 -22.86 58.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.995 0.426 . . . . 0.0 111.436 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.425 ' HB2' ' HB1' ' A' ' 51' ' ' ALA . . . -61.5 -61.15 2.73 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.704 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.845 ' O ' HD11 ' A' ' 266' ' ' ILE . 5.7 m -127.13 102.11 24.67 Favored Pre-proline 0 C--N 1.333 -0.13 0 CA-C-O 120.619 0.247 . . . . 0.0 111.29 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.439 ' HA ' ' CG1' ' A' ' 266' ' ' ILE . 55.4 Cg_endo -71.25 -42.72 1.83 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.336 2.024 . . . . 0.0 112.276 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.53 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 2.5 m120 45.73 80.12 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.97 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 10.1 ttmt -75.06 -54.12 7.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.626 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -57.28 11.58 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.652 0.263 . . . . 0.0 111.68 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.14 -57.95 10.38 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.213 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -59.59 -25.0 64.24 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.592 ' O ' ' CB ' ' A' ' 281' ' ' GLU . 24.0 tttt -69.95 -58.09 4.26 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 121.325 0.583 . . . . 0.0 111.687 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 13.4 pt-20 -69.97 -35.44 74.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.328 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.96 ' CZ ' HD21 ' A' ' 7' ' ' LEU . 12.1 t80 -73.95 -61.13 1.95 Allowed 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.195 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.59 -44.45 64.44 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.179 -1.008 . . . . 0.0 113.175 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.761 ' O ' HD12 ' A' ' 285' ' ' LEU . 4.0 tt0 -75.45 -34.77 60.98 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.527 -1.215 . . . . 0.0 113.428 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 1.7 t-20 -92.15 -16.74 25.88 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.935 ' O ' HG22 ' A' ' 286' ' ' THR . 0.5 OUTLIER -108.78 -66.53 1.04 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 290' ' ' LEU . 0.1 OUTLIER -39.54 -32.89 0.14 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.944 0.793 . . . . 0.0 111.203 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 281' ' ' GLU . 20.4 mt -91.05 42.03 1.09 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.79 0.328 . . . . 0.0 111.383 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.935 HG22 ' O ' ' A' ' 283' ' ' TYR . 6.3 t -145.06 158.01 43.94 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 0.8 OUTLIER -66.23 -11.02 47.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.617 0.644 . . . . 0.0 110.297 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.706 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -77.4 -47.09 20.69 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 118.175 0.443 . . . . 0.0 111.157 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -83.74 -57.34 2.45 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.654 HD12 ' CD2' ' A' ' 307' ' ' TYR . 0.2 OUTLIER -50.8 -49.06 59.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.589 -0.305 . . . . 0.0 110.586 178.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.1 OUTLIER -79.28 -26.39 42.35 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.104 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -68.04 -39.61 83.03 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 289' ' ' GLY . 58.3 t -68.34 -62.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 297' ' ' LYS . 9.3 m-80 -44.59 -47.79 10.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.78 1.232 . . . . 0.0 112.427 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -57.93 -54.97 40.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.44 ' HB3' ' CA ' ' A' ' 16' ' ' GLY . 32.8 m-20 -53.6 -44.75 69.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 294' ' ' ASN . 0.7 OUTLIER -49.7 165.83 0.28 Allowed Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.866 -178.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 299' ' ' LEU . 6.6 Cg_exo -73.09 -8.78 22.66 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.241 2.628 . . . . 0.0 113.547 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 298' ' ' PRO . 6.7 tp 90.38 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.924 0.392 . . . . 0.0 111.66 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.508 ' HA3' ' CZ2' ' A' ' 230' ' ' TRP . . . -152.98 -156.67 7.68 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.947 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.916 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -79.97 164.47 23.45 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.44 0.62 . . . . 0.0 110.7 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.553 HG22 ' CD1' ' A' ' 311' ' ' LEU . 16.5 m -153.81 -151.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.748 ' HA ' HG21 ' A' ' 93' ' ' THR . . . -116.1 -138.75 0.37 Allowed 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.552 HD23 ' HG ' ' A' ' 290' ' ' LEU . 13.5 tp 48.24 101.41 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.712 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -41.9 -58.44 2.04 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.5 p -53.39 -49.35 67.42 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.734 0.778 . . . . 0.0 112.073 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.654 ' CD2' HD12 ' A' ' 290' ' ' LEU . 9.1 t80 -69.48 -19.42 63.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.171 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.3 OUTLIER -63.1 -39.02 93.48 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 9.1 mt-10 -70.63 -57.8 4.34 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.539 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -56.49 12.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.458 0.647 . . . . 0.0 109.279 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.768 ' O ' HG21 ' A' ' 317' ' ' ILE . 0.8 OUTLIER -59.09 -40.32 84.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.277 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 317' ' ' ILE . . . -46.96 -34.39 5.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.524 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.52 -38.39 6.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.518 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.72 ' HB2' HG22 ' A' ' 317' ' ' ILE . 14.3 m-20 -67.55 146.19 98.53 Favored Pre-proline 0 N--CA 1.462 0.132 0 CA-C-O 120.616 0.246 . . . . 0.0 110.667 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 17.3 Cg_exo -67.15 -42.81 7.25 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.665 2.243 . . . . 0.0 113.054 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 229' ' ' PRO . 7.8 mtt85 -58.79 -59.73 4.97 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -51.45 -54.13 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.432 ' N ' HD13 ' A' ' 317' ' ' ILE . . . -46.05 -51.91 12.88 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.419 0.554 . . . . 0.0 111.584 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.62 -46.72 70.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.217 1.008 . . . . 0.0 109.032 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.767 HG22 HG13 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -58.38 -40.51 82.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 113.472 -1.694 . . . . 0.0 109.786 178.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.1 ttp -66.46 -50.25 63.98 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.646 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -53.17 -57.6 9.92 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.571 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 22.4 m120 -64.55 -30.24 71.27 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.364 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.727 ' HB1' HG21 ' A' ' 110' ' ' VAL . . . -60.08 -53.13 61.4 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.449 ' CG ' ' CZ ' ' A' ' 92' ' ' PHE . 2.4 tt0 -67.42 -30.06 69.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.39 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.28 -17.98 40.68 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.496 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.689 ' HA3' HG23 ' A' ' 259' ' ' VAL . . . -79.9 169.23 52.98 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.199 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 257' ' ' PRO . 1.9 mm-40 -96.46 137.4 35.58 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 96' ' ' ALA . 4.6 mp -83.88 113.67 23.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 119.595 1.089 . . . . 0.0 110.301 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.472 ' C ' ' O ' ' A' ' 329' ' ' ILE . 0.0 OUTLIER -25.93 137.55 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 332' ' ' ASN . 36.3 Cg_endo -64.93 -38.44 29.28 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.629 2.22 . . . . 0.0 112.528 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 65' ' ' ASP . 1.5 m-20 71.49 57.14 0.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.661 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.98 160.34 68.18 Favored Pre-proline 0 C--N 1.326 -0.415 0 O-C-N 121.945 -0.472 . . . . 0.0 111.593 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.13 -42.29 8.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.644 2.229 . . . . 0.0 112.476 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.417 ' HB3' HD13 ' A' ' 178' ' ' ILE . 6.3 mm100 -47.83 -25.2 1.2 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 32.0 tpp -45.72 -35.55 4.33 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 122.357 -0.214 . . . . 0.0 111.181 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.2 m -57.31 -42.51 81.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.761 0.315 . . . . 0.0 110.455 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -57.27 -31.51 65.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.04 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.414 ' O ' HG12 ' A' ' 343' ' ' VAL . 2.9 t80 -78.1 -48.62 15.61 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.34 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -47.01 68.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.619 0.247 . . . . 0.0 111.474 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -74.33 -50.87 16.97 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.497 ' CB ' HG22 ' A' ' 368' ' ' ILE . . . -67.62 -43.68 79.84 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.984 HG22 HG21 ' A' ' 347' ' ' VAL . 0.3 OUTLIER -70.74 -41.42 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.42 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.484 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 0.8 OUTLIER -58.67 -59.56 5.22 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.458 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 53.0 p -54.36 -57.86 9.65 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.51 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -65.09 -60.56 2.89 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.984 HG21 HG22 ' A' ' 343' ' ' VAL . 44.1 t -59.08 -45.74 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 1.7 tt -68.5 -52.7 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.603 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 348' ' ' ILE . 29.6 m-20 -66.26 -53.39 37.39 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.554 ' HA ' ' HG2' ' A' ' 354' ' ' ARG . . . -63.54 -26.42 68.69 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.356 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -54.53 -17.92 3.78 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.574 0.625 . . . . 0.0 111.503 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 13.2 p -106.73 24.08 13.26 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 171.1 -57.21 0.18 Allowed Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 119.697 -1.239 . . . . 0.0 113.254 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . 0.554 ' HG2' ' HA ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -103.17 34.05 3.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 113.792 -3.163 . . . . 0.0 116.971 -174.222 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.892 ' OE1' HG21 ' A' ' 196' ' ' VAL . 0.8 OUTLIER -95.77 54.58 1.54 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -175.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.13 167.32 11.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.645 HG23 ' HG2' ' A' ' 189' ' ' LYS . 7.1 p -48.96 -49.34 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.533 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 62.2 m-20 -64.84 -49.3 71.11 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.72 -33.7 46.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 111.975 -177.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 364' ' ' ALA . . . -61.44 -53.27 58.66 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.961 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.771 HD21 ' HE3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -78.91 -47.18 16.94 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.746 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.704 ' O ' HG23 ' A' ' 366' ' ' THR . 6.3 mmtp -50.35 -56.01 13.16 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.71 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.66 -53.3 14.05 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.435 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 368' ' ' ILE . . . -58.76 -57.25 13.85 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.119 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.411 ' HG2' HG21 ' A' ' 369' ' ' THR . 0.8 OUTLIER -61.0 -54.86 39.77 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 362' ' ' LYS . 64.0 p -51.11 -52.71 41.07 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -66.4 -38.04 86.59 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.799 HD11 HG11 ' A' ' 183' ' ' VAL . 12.5 pt -79.42 -30.1 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.411 HG21 ' HG2' ' A' ' 365' ' ' GLN . 63.9 p -94.84 -18.91 20.76 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 366' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.252 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.643 0.259 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -137.72 96.84 3.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -135.0 119.68 18.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.951 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -155.1 156.37 35.71 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -125.36 75.32 0.4 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.227 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -158.39 163.9 36.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.496 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -169.21 124.28 0.86 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.96 ' H ' ' CB ' ' A' ' 58' ' ' ASP . 4.9 p -124.7 112.26 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.399 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.475 HG23 HG23 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -96.82 143.56 12.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.887 -175.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.824 ' HB3' HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -104.29 127.21 51.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.635 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 39' ' ' HIS . 10.8 tt -158.55 164.89 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.016 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.57 HD22 HD22 ' A' ' 43' ' ' LEU . 1.8 m-80 -132.65 39.99 3.3 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.08 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.71 -15.46 58.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.482 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER 61.18 65.18 1.01 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.054 0.427 . . . . 0.0 109.921 -179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 2.3 mtmt 162.63 -170.78 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 296' ' ' ASP . . . 75.96 24.34 69.55 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CE1' HG23 ' A' ' 37' ' ' VAL . 38.8 m-85 -76.2 -36.71 58.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.793 0.797 . . . . 0.0 111.03 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 2.7 m120 -64.75 -49.37 71.04 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.637 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -72.27 -49.73 19.57 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.673 -0.775 . . . . 0.0 114.212 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.726 ' O ' HG21 ' A' ' 35' ' ' VAL . 3.5 mm? -59.22 -51.16 71.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.75 0.775 . . . . 0.0 110.193 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.443 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -66.0 -37.7 86.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 111.973 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -67.16 -37.5 83.88 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.747 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 19' ' ' GLY . 4.5 m -68.1 -61.18 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 121.76 -0.588 . . . . 0.0 110.087 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.511 ' H ' HG23 ' A' ' 23' ' ' VAL . . . -49.09 -34.16 16.0 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.374 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -50.43 69.42 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.447 1.117 . . . . 0.0 108.444 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -52.26 -42.31 63.56 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 112.874 -1.966 . . . . 0.0 108.677 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.823 ' HB3' HD13 ' A' ' 33' ' ' ILE . 71.7 m-85 -65.98 -32.22 73.57 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.756 0.789 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.791 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 7.2 tt0 -70.09 -51.8 28.88 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.022 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -52.07 -29.7 22.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 125.327 1.642 . . . . 0.0 111.254 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.804 ' O ' ' HB ' ' A' ' 31' ' ' THR . 3.5 m-20 -84.29 -38.07 20.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.187 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.804 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 4.5 t 159.79 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.84 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.38 38.7 0.02 OUTLIER Glycine 0 N--CA 1.466 0.658 0 C-N-CA 114.968 -3.491 . . . . 0.0 118.914 174.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.84 HD12 ' C ' ' A' ' 32' ' ' GLY . 2.1 mp -140.16 130.25 29.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 121.513 2.657 . . . . 0.0 115.65 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -137.16 105.16 5.64 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.726 HG21 ' O ' ' A' ' 20' ' ' LEU . 34.2 m -99.74 133.21 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.847 ' HB ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.0 147.19 45.09 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.532 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.445 HG23 ' CE1' ' A' ' 17' ' ' TYR . 17.9 m -133.34 123.32 46.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 122.164 -0.335 . . . . 0.0 110.404 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -111.59 139.8 46.74 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.1 78.95 25.75 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-O 120.841 0.353 . . . . 0.0 110.739 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 43' ' ' LEU . 60.7 Cg_endo -92.69 163.11 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.261 2.64 . . . . 0.0 113.307 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -90.72 -35.45 14.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -82.76 0.49 43.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.482 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 10' ' ' TRP . 54.1 tp -19.78 -49.31 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 1.081 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 mt-10 -67.29 -54.51 20.18 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.556 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.74 -43.62 62.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.905 0.383 . . . . 0.0 110.324 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.616 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.11 -56.13 23.27 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.955 0.883 . . . . 0.0 109.764 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.728 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 9.1 t80 -48.17 -60.95 3.59 Favored Pre-proline 0 C--O 1.219 -0.525 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.919 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 1.081 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 32.2 Cg_exo -60.22 -26.53 82.82 Favored 'Trans proline' 0 C--O 1.25 1.114 0 C-N-CA 121.278 1.318 . . . . 0.0 113.679 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -81.82 -38.76 25.03 Favored 'General case' 0 C--O 1.256 1.443 0 CA-C-O 122.161 0.981 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 54' ' ' GLY . 17.9 m -75.09 -39.26 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 CA-C-O 121.849 0.833 . . . . 0.0 109.832 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB1' ' OD1' ' A' ' 267' ' ' ASN . . . -50.16 -39.78 44.61 Favored 'General case' 0 C--N 1.372 1.553 0 C-N-CA 127.748 2.419 . . . . 0.0 111.593 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.46 -40.2 26.7 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.011 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -83.5 -7.23 59.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 77.82 -74.51 1.97 Allowed Glycine 0 C--N 1.352 1.45 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.184 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 t70 72.05 13.14 5.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.167 -1.016 . . . . 0.0 110.265 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . 57.72 59.38 10.93 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.094 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -101.39 171.36 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.38 2.72 . . . . 0.0 114.213 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.96 ' CB ' ' H ' ' A' ' 8' ' ' VAL . 25.1 m-20 -94.28 -133.12 0.17 Allowed 'General case' 0 N--CA 1.414 -2.257 0 C-N-CA 125.098 1.359 . . . . 0.0 109.137 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.64 HG13 ' HA ' ' A' ' 266' ' ' ILE . 9.6 tt -99.73 168.11 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 124.089 0.955 . . . . 0.0 112.477 -177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.804 HG23 ' HB2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -134.31 126.35 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 3.2 m-85 -108.15 125.4 51.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.603 ' CH2' ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -166.81 166.77 15.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.586 0.354 . . . . 0.0 110.062 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 62' ' ' TRP . . . -45.35 158.32 0.07 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.518 0.599 . . . . 0.0 112.519 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.942 ' HB2' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -77.5 -29.27 52.44 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -47.82 -53.72 14.64 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.825 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.39 -26.08 42.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.043 0.449 . . . . 0.0 110.098 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.609 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -57.44 -34.33 68.85 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 171.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.762 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -55.2 -69.65 1.2 Allowed Glycine 0 C--N 1.357 1.74 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 177.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.87 -54.16 23.39 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-N 112.996 -1.602 . . . . 0.0 111.363 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.493 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 5.4 m-30 -50.56 -40.53 52.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -48.63 -48.36 39.58 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.61 -31.08 46.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.138 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -70.26 -26.77 63.98 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.561 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.25 23.28 44.91 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.574 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 48' ' ' PRO . 4.0 mt -106.16 54.58 0.69 Allowed 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.911 0.386 . . . . 0.0 110.392 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.813 ' CG ' HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -179.13 145.13 0.25 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.877 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.966 ' HB3' HG23 ' A' ' 266' ' ' ILE . . . -72.2 74.65 0.97 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.208 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 1.7 pm0 -53.0 125.1 16.09 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.8 0.333 . . . . 0.0 110.495 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.642 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.1 mm -70.88 173.38 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.856 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.582 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -87.95 175.54 4.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 80' ' ' THR . 72.2 Cg_endo -79.2 101.49 1.43 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.052 1.835 . . . . 0.0 113.031 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 84' ' ' ALA . 18.1 t70 -145.46 107.76 4.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.251 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.18 0.22 52.47 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.499 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . . . -51.19 -32.99 25.44 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.579 0.228 . . . . 0.0 111.579 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.509 ' O ' HD12 ' A' ' 89' ' ' LEU . 22.7 m-85 -79.31 -59.06 2.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.882 0.372 . . . . 0.0 110.075 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.45 -27.92 40.71 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.544 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -76.32 -47.01 25.08 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.664 0.269 . . . . 0.0 110.833 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -67.86 -20.41 65.13 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.521 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.75 HD22 ' HZ2' ' A' ' 94' ' ' TRP . 5.1 mp -112.82 -163.46 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 121.454 -0.098 . . . . 0.0 110.879 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.458 ' CG ' ' HD2' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -84.68 146.78 47.41 Favored Pre-proline 0 C--N 1.34 0.175 0 O-C-N 121.992 -0.442 . . . . 0.0 111.641 -178.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 95' ' ' ASP . 61.0 Cg_endo -73.32 -35.03 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.234 1.956 . . . . 0.0 111.703 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CD2' ' HG2' ' A' ' 325' ' ' GLN . 63.2 m-85 -57.81 -62.43 1.81 Allowed 'General case' 0 C--O 1.246 0.872 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.884 HG23 ' CD1' ' A' ' 94' ' ' TRP . 1.8 t -62.58 -24.68 67.67 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.884 ' CD1' HG23 ' A' ' 93' ' ' THR . 36.5 m95 -93.43 -24.45 18.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.145 0.498 . . . . 0.0 111.877 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 91' ' ' PRO . 8.3 m-20 -71.08 -23.49 62.13 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.711 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.651 ' HA ' HD12 ' A' ' 329' ' ' ILE . . . -71.91 -43.21 65.7 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.942 HG12 ' HB2' ' A' ' 64' ' ' HIS . 27.2 m -102.54 43.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.45 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -128.81 139.47 52.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.507 ' O ' ' N ' ' A' ' 101' ' ' GLY . 3.2 t80 -118.48 90.74 3.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 119.262 0.937 . . . . 0.0 109.874 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.6 t30 48.29 -86.72 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . -127.63 39.2 1.97 Allowed Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.66 -177.34 5.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.48 0.312 . . . . 0.0 111.225 -178.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 97' ' ' VAL . 0.7 OUTLIER 168.71 128.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.399 0.545 . . . . 0.0 110.032 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.813 HD11 ' CG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -114.24 38.01 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.315 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 168.81 169.67 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.07 132.88 23.78 Favored Pre-proline 0 CA--C 1.528 0.122 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.277 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.768 ' HD3' HG21 ' A' ' 97' ' ' VAL . 90.8 Cg_endo -79.61 166.91 21.4 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.463 2.109 . . . . 0.0 113.211 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.822 ' O ' HG13 ' A' ' 302' ' ' VAL . 0.6 OUTLIER -162.31 38.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.364 178.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.729 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -179.8 136.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.166 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.708 ' O ' HG21 ' A' ' 320' ' ' THR . 21.7 t -123.58 105.89 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.541 ' HG2' ' HG3' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -116.68 131.16 57.02 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 -178.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.456 ' N ' HG23 ' A' ' 320' ' ' THR . . . -158.19 143.26 16.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.468 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.509 HD21 ' OE1' ' A' ' 153' ' ' GLU . 6.5 mp -77.89 143.43 37.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.936 -177.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.409 ' OG ' ' HB1' ' A' ' 319' ' ' ALA . 1.8 m -133.3 169.46 16.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.76 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -91.16 128.41 36.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 1.021 HG23 HG23 ' A' ' 225' ' ' THR . 8.0 tp -116.95 140.43 39.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -153.63 161.44 42.16 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.396 0.279 . . . . 0.0 111.554 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.408 ' CB ' ' HB3' ' A' ' 121' ' ' LEU . 18.7 m120 -97.52 139.03 34.04 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -109.9 -4.84 15.73 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-N 113.096 -1.865 . . . . 0.0 111.23 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -43.56 6.78 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 124.781 2.229 . . . . 0.0 105.455 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.592 HD13 HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -76.35 -135.45 0.02 OUTLIER 'General case' 0 N--CA 1.396 -3.169 1 CA-C-N 107.678 -4.328 . . . . 0.0 113.216 -170.548 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.635 HD23 ' HD2' ' A' ' 123' ' ' PRO . 1.6 mt -82.66 148.26 57.61 Favored Pre-proline 0 C--N 1.287 -2.132 0 N-CA-C 119.98 3.326 . . . . 0.0 119.98 -167.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.635 ' HD2' HD23 ' A' ' 122' ' ' LEU . 1.4 Cg_exo -27.33 166.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 1 C-N-CA 130.354 7.369 . . . . 0.0 120.34 176.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.808 ' O ' HD11 ' A' ' 135' ' ' LEU . 18.8 m-80 -62.03 111.81 5.19 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.365 -172.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.96 167.78 25.45 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 124.055 3.17 . . . . 0.0 112.904 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.49 ' HD2' HD11 ' A' ' 147' ' ' LEU . 77.4 Cg_exo -49.66 111.13 0.45 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 123.324 2.683 . . . . 0.0 115.573 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -76.45 -25.64 54.58 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.084 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.91 147.31 43.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.489 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.579 ' HE3' HD21 ' A' ' 198' ' ' LEU . 65.3 m95 -67.92 -37.89 82.23 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 175.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.461 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.9 mp0 -58.82 -23.84 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.563 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 0.5 OUTLIER -87.03 -16.14 36.55 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.579 ' CG1' ' HD3' ' A' ' 133' ' ' PRO . 4.0 pt -52.37 -37.98 50.33 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 118.683 0.674 . . . . 0.0 111.417 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.881 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 52.3 Cg_exo -52.93 -33.26 61.1 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 N-CA-C 109.549 -0.981 . . . . 0.0 109.549 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.99 -58.59 3.19 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.808 HD11 ' O ' ' A' ' 124' ' ' ASN . 0.2 OUTLIER -68.21 -42.28 80.06 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.653 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.7 OUTLIER -69.21 -32.41 71.65 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.881 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -47.92 -50.14 27.84 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.061 176.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 35.3 mt-10 -62.35 -43.5 98.68 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.924 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.828 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.6 OUTLIER -60.36 -49.4 77.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -47.9 -44.11 29.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.04 -27.35 0.91 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.507 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -60.03 1.69 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.288 0.566 . . . . 0.0 109.891 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.84 42.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 118.934 -0.925 . . . . 0.0 111.073 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.687 ' HG3' HD23 ' A' ' 139' ' ' LEU . 9.0 ptpt -154.27 -171.88 4.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 119.514 1.657 . . . . 0.0 111.419 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.779 ' C ' HD22 ' A' ' 139' ' ' LEU . 2.5 m -141.56 161.8 37.04 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.828 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -75.47 -28.91 59.43 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.755 HD12 ' C ' ' A' ' 146' ' ' ALA . 5.7 mp -123.74 127.16 47.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.911 ' HB2' HG21 ' A' ' 222' ' ' THR . 8.8 tpt -134.1 127.9 33.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 120.039 1.29 . . . . 0.0 109.845 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.968 ' O ' ' O ' ' A' ' 150' ' ' ASN . 37.3 p90 -170.4 177.22 4.15 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.968 ' O ' ' O ' ' A' ' 149' ' ' PHE . 2.9 t-20 -28.42 -156.79 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 208' ' ' THR . 1.0 OUTLIER -178.15 40.58 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 120.992 -1.068 . . . . 0.0 111.055 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 151' ' ' LEU . 1.9 pp0? 172.86 32.92 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 168.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 157' ' ' THR . 0.2 OUTLIER -103.87 114.45 64.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 119.991 1.269 . . . . 0.0 107.585 177.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.787 ' HA ' ' OG1' ' A' ' 157' ' ' THR . 5.8 Cg_exo -79.77 36.98 0.64 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 119.265 0.773 . . . . 0.0 113.706 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 1.227 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 3.7 m-85 -97.79 -52.01 3.89 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 172.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.731 ' CZ ' HD12 ' A' ' 226' ' ' ILE . 42.5 t80 -74.66 -42.63 58.16 Favored 'General case' 0 C--O 1.251 1.141 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 153' ' ' GLU . 1.5 p -58.05 -57.03 14.63 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.487 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.559 ' HA ' HG12 ' A' ' 161' ' ' ILE . 7.5 m0 -49.54 -52.51 49.55 Favored Pre-proline 0 C--N 1.351 0.648 0 CA-C-O 120.78 0.324 . . . . 0.0 110.75 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 1.227 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 51.5 Cg_exo -44.44 -50.05 8.42 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.625 2.217 . . . . 0.0 113.171 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.48 ' HG ' ' CZ ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -60.4 -56.84 16.55 Favored 'General case' 0 CA--C 1.51 -0.567 0 O-C-N 122.026 -0.421 . . . . 0.0 109.908 -179.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 158' ' ' TRP . 14.1 pt -53.94 -22.6 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.831 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -77.23 -24.5 51.23 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.895 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 253' ' ' GLN . . . -41.19 -58.83 1.68 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.403 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 13.1 t70 -63.84 -58.06 7.96 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.345 -0.847 . . . . 0.0 112.6 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.69 21.38 0.03 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 117.648 -2.215 . . . . 0.0 116.823 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.12 160.13 40.15 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 119.086 1.443 . . . . 0.0 111.573 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -139.49 122.56 16.81 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.429 0.615 . . . . 0.0 109.743 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.878 ' O ' HG13 ' A' ' 183' ' ' VAL . . . -38.49 -78.54 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.291 0.567 . . . . 0.0 111.971 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.753 ' HB3' ' CB ' ' A' ' 176' ' ' TYR . 9.8 m-85 -113.64 176.07 5.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 1.159 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -101.54 102.1 12.78 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.05 114.51 18.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.53 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 23.9 tt0 -137.22 109.36 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.517 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 1.4 m-20 84.1 -32.38 0.07 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.862 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 160.28 13.9 0.03 OUTLIER Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.036 -0.869 . . . . 0.0 114.072 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -174.0 143.12 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.577 1.689 . . . . 0.0 110.943 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 1.159 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 37.0 p90 -64.98 -25.45 67.87 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.193 0.997 . . . . 0.0 110.805 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.471 ' O ' HD13 ' A' ' 178' ' ' ILE . 55.8 m-20 72.37 -106.91 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.743 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 177' ' ' ASP . 38.0 mm -159.16 -48.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -70.83 -4.01 21.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.72 95.56 3.5 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.276 -0.569 . . . . 0.0 112.12 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 18.9 t -117.98 131.04 71.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.434 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . -121.4 39.73 2.3 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 119.47 -1.348 . . . . 0.0 114.092 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 168' ' ' ALA . 6.4 m -79.1 -40.78 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.848 ' OD1' HD13 ' A' ' 361' ' ' LEU . 58.8 t0 -69.9 58.61 0.15 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.899 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 182' ' ' GLY . 5.9 p30 -110.33 175.94 5.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.982 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -80.45 -19.57 45.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.835 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -69.64 -48.84 40.58 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.3 98.6 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 193' ' ' THR . 0.0 OUTLIER -56.99 -59.4 5.12 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.215 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 193' ' ' THR . . . -50.43 -41.66 52.87 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.253 1.025 . . . . 0.0 112.051 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -70.45 -60.51 4.67 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.659 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.628 ' O ' HG23 ' A' ' 196' ' ' VAL . 9.2 tt -56.05 -29.26 60.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 189' ' ' LYS . 14.8 p -66.87 -41.09 87.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 194' ' ' PHE . 0.0 OUTLIER -59.48 -37.74 79.02 Favored 'General case' 0 C--N 1.349 0.563 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.512 HD23 HD11 ' A' ' 199' ' ' ILE . 0.4 OUTLIER -62.72 -47.56 83.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.782 178.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 192' ' ' LEU . 43.6 t -58.22 -29.88 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.28 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.18 -45.4 85.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.732 0.777 . . . . 0.0 110.969 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.579 HD21 ' HE3' ' A' ' 129' ' ' TRP . 11.2 mp -57.34 -57.02 14.47 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.77 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.512 HD11 HD23 ' A' ' 195' ' ' LEU . 3.8 mt -65.16 -32.33 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.969 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -56.4 -38.61 71.73 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 118.56 -0.734 . . . . 0.0 111.042 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -113.41 -34.97 5.43 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 121.086 3.735 . . . . 0.0 121.086 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.67 -66.1 1.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 199' ' ' ILE . 0.2 OUTLIER -36.45 -34.54 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 203' ' ' HIS . 2.2 ttp -36.0 97.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.707 0.289 . . . . 0.0 111.63 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.95 -173.19 3.83 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.064 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -85.61 58.66 5.17 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.626 ' HA ' HD23 ' A' ' 151' ' ' LEU . 2.3 p30 37.85 74.13 0.09 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 30.8 p -55.18 121.4 8.74 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.59 -173.65 4.43 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.0 p90 -69.49 -45.39 69.05 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 1.7 m -70.18 -35.93 74.3 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.89 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.17 -48.44 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.745 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.0 -30.93 71.97 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -47.66 85.03 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.54 77.65 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.276 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.44 ' CB ' ' HG2' ' A' ' 148' ' ' MET . . . -54.27 -57.68 10.29 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.947 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.787 ' CB ' HD11 ' A' ' 235' ' ' ILE . 2.6 t80 -58.57 -29.6 66.53 Favored 'General case' 0 C--O 1.23 0.071 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -53.79 -40.41 66.27 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -74.66 -23.92 58.73 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 65.66 54.79 23.65 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.419 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -116.03 37.2 3.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.452 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.911 HG21 ' HB2' ' A' ' 148' ' ' MET . 82.8 p -144.56 143.53 30.86 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.773 0.796 . . . . 0.0 110.213 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -102.08 38.3 1.69 Allowed 'General case' 0 C--N 1.352 0.674 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 147' ' ' LEU . 36.1 ttm 177.24 147.06 0.12 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 1.021 HG23 HG23 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -142.43 170.26 16.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.701 0.762 . . . . 0.0 111.558 -176.106 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.731 HD12 ' CZ ' ' A' ' 156' ' ' PHE . 24.8 mm -120.68 130.34 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 172.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -147.31 166.69 26.33 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 123.759 0.823 . . . . 0.0 110.474 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -108.15 -162.88 21.02 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.47 -0.395 . . . . 0.0 112.741 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.541 ' HG3' ' HG2' ' A' ' 111' ' ' GLU . 56.2 Cg_endo -87.54 -20.72 2.01 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.128 2.552 . . . . 0.0 114.081 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.464 ' CB ' ' HB3' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -178.65 -42.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.65 62.37 6.46 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.803 0.335 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -107.7 -63.06 1.35 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.781 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 169.2 -176.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.658 0.266 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.83 58.85 2.31 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.795 0.331 . . . . 0.0 110.72 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.787 HD11 ' CB ' ' A' ' 217' ' ' PHE . 14.6 tt -86.69 145.47 7.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.174 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -100.67 123.5 44.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.5 p -61.3 137.72 58.24 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.871 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -43.94 84.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.45 159.74 41.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.771 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.2 m -55.9 -40.02 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.648 0.261 . . . . 0.0 111.372 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 137.26 37.2 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.651 0.262 . . . . 0.0 110.741 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.413 ' CD1' HD11 ' A' ' 116' ' ' ILE . 10.5 p90 -149.23 137.31 20.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 111.323 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.531 ' O ' HD12 ' A' ' 116' ' ' ILE . . . -95.0 133.4 11.52 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.007 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.967 HG22 HD13 ' A' ' 116' ' ' ILE . 1.7 t -115.16 133.87 60.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.867 0.334 . . . . 0.0 111.268 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.76 167.56 17.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -170.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 45.9 t -73.29 154.12 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 113.893 -1.503 . . . . 0.0 107.871 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.525 HD11 HD21 ' A' ' 323' ' ' ASN . 1.8 mt -57.61 159.29 9.69 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.627 -177.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -78.26 -157.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.926 2.417 . . . . 0.0 112.906 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 253' ' ' GLN . 11.0 p -125.29 169.47 12.26 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.48 ' CZ ' ' HG ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -162.59 110.57 1.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.075 178.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.34 32.08 17.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.421 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.69 38.41 24.1 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.033 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.514 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 3.7 mt-30 -156.54 153.94 25.88 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 74.8 Cg_endo -86.37 -171.19 0.78 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.444 2.763 . . . . 0.0 113.263 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -109.28 141.02 42.19 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.988 0.423 . . . . 0.0 111.812 -179.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 5.5 ttmm -88.17 121.41 70.49 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.072 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.476 ' O ' ' HA2' ' A' ' 327' ' ' GLY . 55.1 Cg_endo -91.61 152.6 3.51 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.538 2.825 . . . . 0.0 114.417 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' A' ' 155' ' ' TYR . 5.9 m-85 -78.12 157.28 29.52 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 329' ' ' ILE . 20.8 t -110.56 121.82 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -125.11 119.52 3.63 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 118.673 -1.727 . . . . 0.0 117.069 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.769 HG21 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -114.38 108.53 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.729 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 1.6 tp -83.41 109.12 17.05 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.585 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -113.05 -178.12 3.3 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.509 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -111.01 128.81 55.97 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.743 ' O ' HD12 ' A' ' 60' ' ' ILE . . . -123.27 122.62 5.01 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.932 -1.128 . . . . 0.0 115.022 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.966 HG23 ' HB3' ' A' ' 77' ' ' ALA . 4.6 tp -90.86 122.47 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.596 ' HB2' HD11 ' A' ' 60' ' ' ILE . 62.7 t30 -61.82 141.89 57.66 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.23 -23.42 47.86 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.948 -0.47 . . . . 0.0 111.105 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.439 ' HB3' ' ND2' ' A' ' 267' ' ' ASN . . . -98.5 49.07 0.98 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.36 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 38.8 t -171.9 89.5 0.43 Allowed Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 272' ' ' ASN . 72.7 Cg_endo -76.42 164.19 31.12 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.625 2.217 . . . . 0.0 111.906 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.612 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 0.2 OUTLIER 165.69 57.24 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.709 0.29 . . . . 0.0 110.938 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -56.3 -54.1 49.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.452 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -56.68 7.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.16 -48.58 79.43 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -76.78 -56.84 4.25 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 0.1 OUTLIER -55.67 -41.02 73.09 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.513 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -53.17 8.62 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' A' ' 27' ' ' PHE . 2.4 t80 -55.09 -59.44 4.75 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.59 -43.19 35.78 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.815 0.817 . . . . 0.0 111.245 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 285' ' ' LEU . 51.9 mt-10 -73.8 -35.36 64.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.37 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.414 ' O ' ' CG2' ' A' ' 286' ' ' THR . 3.6 m-20 -89.99 -16.39 29.94 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.479 ' O ' ' CG2' ' A' ' 286' ' ' THR . 28.0 t80 -103.72 -74.36 0.64 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 290' ' ' LEU . 0.1 OUTLIER -46.08 -27.57 0.98 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -102.07 39.41 1.48 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 283' ' ' TYR . 0.0 OUTLIER -140.72 152.83 45.6 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 175.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.795 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -62.93 -42.37 99.78 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -75.36 -19.39 59.61 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.548 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.463 ' HA3' HG23 ' A' ' 286' ' ' THR . . . -82.54 -55.13 3.09 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.897 HD21 ' HA ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -68.23 -28.46 67.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.795 ' HB2' ' O ' ' A' ' 287' ' ' ASP . 32.0 mt-10 -71.91 -32.39 67.34 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.453 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.39 80.37 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 296' ' ' ASP . 61.0 t -67.64 -61.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 297' ' ' LYS . 36.9 t-20 -46.41 -46.8 18.85 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.713 1.205 . . . . 0.0 112.545 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -48.87 79.49 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.8 ' O ' ' HD3' ' A' ' 298' ' ' PRO . 76.7 m-20 -58.04 -47.02 84.36 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 294' ' ' ASN . 0.9 OUTLIER -96.37 91.05 0.8 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.623 -178.101 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.8 ' HD3' ' O ' ' A' ' 296' ' ' ASP . 75.9 Cg_endo -106.83 93.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 124.318 3.346 . . . . 0.0 112.752 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.584 HD12 ' HD2' ' A' ' 298' ' ' PRO . 1.5 mp -161.1 -80.72 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.103 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -108.39 -160.28 20.16 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.573 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.795 ' HB2' HG23 ' A' ' 317' ' ' ILE . . . -79.17 74.32 5.73 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.074 0.464 . . . . 0.0 111.613 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.822 HG13 ' O ' ' A' ' 108' ' ' ILE . 53.7 t -97.22 76.13 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.897 ' HA ' HD21 ' A' ' 290' ' ' LEU . . . -177.28 107.51 0.06 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.718 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 303' ' ' ALA . 5.9 mp -22.84 179.68 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.627 ' H ' HD23 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -55.08 -55.47 30.7 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -177.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 83.2 p -57.09 -47.95 79.79 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-O 121.479 0.657 . . . . 0.0 111.761 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.642 ' CD2' HD13 ' A' ' 290' ' ' LEU . 88.7 m-85 -67.42 -54.57 19.19 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.158 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.735 ' CD ' ' HB1' ' A' ' 301' ' ' ALA . 4.4 mt-10 -61.11 -36.83 80.75 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.717 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.406 ' HG3' ' CD ' ' A' ' 305' ' ' LYS . 2.7 mm-40 -48.12 -49.66 31.3 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.889 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -71.36 -41.27 69.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.087 0.946 . . . . 0.0 109.529 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 311' ' ' LEU . 0.9 OUTLIER -55.97 -16.63 5.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.036 176.256 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 308' ' ' GLU . . . -46.22 -30.46 2.0 Allowed 'General case' 0 C--N 1.342 0.271 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.455 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -48.38 -34.79 11.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.53 158.26 11.71 Favored Pre-proline 0 N--CA 1.462 0.145 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.489 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -85.85 -46.67 0.04 OUTLIER 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.485 2.124 . . . . 0.0 114.521 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -58.9 6.24 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' A' ' 301' ' ' ALA . 1.3 mm -49.67 -56.24 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.81 -51.87 12.16 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.356 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.409 ' HB1' ' OG ' ' A' ' 114' ' ' SER . . . -65.15 -39.01 92.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.725 0.774 . . . . 0.0 109.812 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.708 HG21 ' O ' ' A' ' 110' ' ' VAL . 29.8 m -58.81 -42.83 90.09 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.49 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.5 ttp -63.64 -53.21 55.11 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -39.0 58.46 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.156 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.525 HD21 HD11 ' A' ' 247' ' ' LEU . 0.9 OUTLIER -74.94 -44.23 49.72 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.017 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -48.76 -45.39 39.74 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 110.333 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.449 ' HG2' ' CD2' ' A' ' 92' ' ' PHE . 10.6 mt-30 -63.68 -39.06 93.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.952 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -69.7 -20.04 63.55 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.389 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 257' ' ' PRO . . . -79.85 155.7 39.29 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.131 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 259' ' ' VAL . 0.6 OUTLIER -96.23 138.23 34.13 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 96' ' ' ALA . 23.5 mm -61.85 106.16 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 119.525 1.057 . . . . 0.0 110.904 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.14 107.03 0.73 Allowed Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 120.548 0.214 . . . . 0.0 111.14 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.15 -30.6 32.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.365 2.044 . . . . 0.0 112.141 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 68.2 91.56 0.09 Allowed 'General case' 0 C--N 1.339 0.12 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.295 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 335' ' ' GLN . 1.0 OUTLIER -133.91 144.91 53.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.195 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.36 -27.86 60.15 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.55 2.166 . . . . 0.0 111.979 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.755 ' HB2' HD12 ' A' ' 333' ' ' ILE . 2.1 mp0 -61.1 -25.21 66.8 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.136 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.2 mmt -46.13 -41.0 11.85 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.687 0.279 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.99 -39.27 65.92 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 1.074 ' HB1' HG22 ' A' ' 368' ' ' ILE . . . -55.07 -29.42 57.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.319 0.58 . . . . 0.0 110.8 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 343' ' ' VAL . 2.2 m-85 -78.77 -55.73 4.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.048 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -42.88 -44.69 4.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.842 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -76.57 -38.52 54.8 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.52 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.538 ' HB1' ' CB ' ' A' ' 364' ' ' ALA . . . -68.08 -44.55 76.04 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 347' ' ' VAL . 17.8 m -73.13 -42.23 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.347 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.406 ' N ' HG23 ' A' ' 343' ' ' VAL . 0.0 OUTLIER -55.38 -57.14 13.1 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.006 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 1.1 m -58.1 -55.63 32.41 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.06 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.34 -60.96 2.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 351' ' ' ALA . 48.7 t -51.73 -47.05 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.1 mt -72.27 -47.91 51.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.911 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 345' ' ' THR . 76.6 m-20 -67.57 -43.28 81.0 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.836 ' HB1' ' HA ' ' A' ' 355' ' ' GLN . . . -78.38 -26.57 46.61 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -58.6 -10.12 2.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 23.2 t -110.63 31.24 6.12 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 91.21 33.15 8.3 Favored Glycine 0 N--CA 1.417 -2.595 0 C-N-CA 116.844 -2.598 . . . . 0.0 114.779 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -127.8 35.12 4.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.836 ' HA ' ' HB1' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -70.01 -174.48 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 1 N-CA-C 122.295 4.183 . . . . 0.0 122.295 -159.352 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.1 OUTLIER 173.9 57.7 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.347 179.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.829 ' O ' HD12 ' A' ' 361' ' ' LEU . 79.1 t -46.28 -41.85 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 3.0 t0 -63.13 -38.5 91.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 118.902 0.774 . . . . 0.0 110.395 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.537 ' CB ' ' HB ' ' A' ' 356' ' ' THR . 0.4 OUTLIER -80.14 -29.59 38.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.634 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -67.05 -54.02 25.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.919 0.866 . . . . 0.0 112.507 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.848 HD13 ' OD1' ' A' ' 184' ' ' ASP . 0.8 OUTLIER -82.64 -36.4 26.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.758 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 23.1 tttp -59.75 -51.97 67.47 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.823 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -44.77 65.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.239 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 368' ' ' ILE . . . -72.54 -57.81 3.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.422 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.493 ' HA ' ' CG1' ' A' ' 368' ' ' ILE . 28.0 tt0 -55.94 -42.25 75.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.9 m -65.25 -48.09 74.46 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.654 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -73.78 -44.37 56.22 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.019 -0.425 . . . . 0.0 111.154 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 1.074 HG22 ' HB1' ' A' ' 338' ' ' ALA . 2.1 pp -62.13 -32.95 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.507 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.651 HG23 HD12 ' A' ' 368' ' ' ILE . 0.6 OUTLIER -131.46 61.49 1.64 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.908 0.385 . . . . 0.0 111.154 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 56.7 tptt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.849 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.659 0.266 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.5 p -103.29 156.84 17.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.53 110.96 19.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -154.24 139.98 18.04 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.062 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -129.61 47.39 1.02 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.545 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -140.78 162.09 36.26 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.718 ' CB ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -132.4 122.56 25.18 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.839 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.037 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 1.6 t -116.47 115.52 49.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.737 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.949 HD12 HD22 ' A' ' 20' ' ' LEU . 7.8 mt -120.74 131.11 73.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.935 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.868 ' HE3' HD12 ' A' ' 43' ' ' LEU . 3.3 m0 -107.38 123.44 48.37 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.48 HD11 HG21 ' A' ' 9' ' ' ILE . 3.4 mt -155.67 166.12 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.846 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.671 ' O ' ' N ' ' A' ' 14' ' ' ASP . 3.5 m120 -78.84 48.84 0.86 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 120.014 1.279 . . . . 0.0 111.255 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.541 ' HA3' ' HB3' ' A' ' 39' ' ' HIS . . . -8.28 59.78 0.0 OUTLIER Glycine 0 C--N 1.348 1.202 0 C-N-CA 124.843 1.211 . . . . 0.0 115.923 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.671 ' N ' ' O ' ' A' ' 12' ' ' ASN . 72.2 m-20 -100.0 3.77 44.42 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.017 0.437 . . . . 0.0 110.177 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 162.99 -164.62 0.0 OUTLIER 'General case' 0 C--N 1.347 0.491 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.863 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.682 ' O ' HD12 ' A' ' 20' ' ' LEU . . . 70.66 34.3 66.99 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 117.038 1.575 . . . . 0.0 117.038 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.18 -59.72 2.54 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 11.5 p-10 -46.35 -42.39 14.8 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.055 0.455 . . . . 0.0 111.945 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.637 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -70.34 -45.41 55.01 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.578 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.956 HD13 HG11 ' A' ' 37' ' ' VAL . 18.7 mt -60.77 -49.69 76.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.446 0.623 . . . . 0.0 111.081 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.05 -39.49 63.47 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 3.1 mm-40 -64.52 -36.08 83.05 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.762 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 19' ' ' GLY . 23.2 m -67.87 -57.19 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.663 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.678 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . -49.58 -45.84 37.9 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.111 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.46 -50.41 41.21 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.263 1.03 . . . . 0.0 109.7 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -41.9 60.13 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.155 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.665 ' HB3' HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.65 -25.94 67.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.088 0.947 . . . . 0.0 111.084 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.773 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 7.9 tt0 -73.2 -52.05 15.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.654 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -52.73 -28.54 22.58 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 124.514 1.134 . . . . 0.0 110.576 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.838 ' O ' HG23 ' A' ' 31' ' ' THR . 0.5 OUTLIER -84.09 -37.68 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 117.626 -1.178 . . . . 0.0 108.844 178.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.85 37.79 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 171.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.811 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.26 38.57 0.02 OUTLIER Glycine 0 N--CA 1.463 0.494 0 C-N-CA 114.989 -3.482 . . . . 0.0 119.299 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.811 HD12 ' C ' ' A' ' 32' ' ' GLY . 1.8 mp -139.89 139.0 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 122.243 3.021 . . . . 0.0 117.005 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -142.36 104.51 4.43 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.718 HG22 ' CB ' ' A' ' 7' ' ' LEU . 38.1 t -82.8 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.9 p -117.5 137.43 52.55 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.008 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.956 HG11 HD13 ' A' ' 20' ' ' LEU . 6.9 m -130.69 121.55 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 O-C-N 122.231 -0.293 . . . . 0.0 110.507 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.435 ' C ' ' HD3' ' A' ' 40' ' ' PRO . 2.5 tt0 -111.83 133.83 53.79 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.541 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . 46.1 p-80 -106.08 71.29 0.25 Allowed Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 120.682 0.277 . . . . 0.0 111.462 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.551 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 86.6 Cg_endo -78.07 -171.68 1.27 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.274 2.649 . . . . 0.0 113.627 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -125.22 -60.24 1.35 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 0.57 34.12 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.045 0.45 . . . . 0.0 110.92 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.868 HD12 ' HE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -32.91 -45.68 0.13 Allowed 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 1.014 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 3.6 tm-20 -47.11 -54.93 9.35 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.042 -0.411 . . . . 0.0 112.104 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.12 -48.8 21.98 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.785 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 50' ' ' VAL . 24.5 mtpt -63.51 -56.81 13.07 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.167 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.78 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.9 t80 -45.42 -58.44 5.89 Favored Pre-proline 0 C--O 1.225 -0.191 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 1.014 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 38.9 Cg_exo -65.78 -36.38 32.25 Favored 'Trans proline' 0 C--O 1.249 1.031 0 C-N-CA 121.088 1.192 . . . . 0.0 114.628 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -66.81 -52.18 46.93 Favored 'General case' 0 C--O 1.259 1.588 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 175.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 46' ' ' LYS . 12.0 m -61.56 -21.22 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 122.231 1.015 . . . . 0.0 111.637 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 48' ' ' PRO . . . -60.85 -29.31 69.45 Favored 'General case' 0 C--N 1.393 2.459 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.643 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -82.46 -26.8 32.33 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.411 1.484 . . . . 0.0 112.946 -178.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 53' ' ' THR . 13.1 t -92.47 95.79 9.85 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.083 -0.647 . . . . 0.0 112.073 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' ASP . . . 102.27 -71.24 0.33 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.487 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 21.2 m-20 94.77 107.03 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.115 1.457 . . . . 0.0 110.461 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 57' ' ' PRO . . . -163.41 -59.05 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.388 -0.91 . . . . 0.0 114.039 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.525 ' O ' ' O ' ' A' ' 56' ' ' GLY . 59.0 Cg_exo -22.9 157.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.797 3.665 . . . . 0.0 115.937 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 1.037 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 5.1 t70 -79.95 -133.86 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.822 0 C-N-CA 125.241 1.416 . . . . 0.0 112.286 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 265' ' ' GLY . 5.5 mm -105.77 159.31 5.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.857 HG23 ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -128.52 136.01 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.45 -178.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.936 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -117.97 113.85 22.31 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 34.6 t-105 -166.48 165.14 17.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.988 0.515 . . . . 0.0 109.846 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -37.74 154.48 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.822 0.737 . . . . 0.0 112.11 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.82 ' CD2' HG13 ' A' ' 97' ' ' VAL . 9.1 t-80 -77.24 -28.3 53.62 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' OD2' ' HB1' ' A' ' 63' ' ' ALA . 1.3 p30 -50.46 -51.49 46.45 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.984 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -77.85 -27.3 49.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.303 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.857 ' CZ ' HG23 ' A' ' 60' ' ' ILE . 4.6 m-85 -64.73 -28.62 69.71 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 174.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.48 -63.89 4.6 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 332' ' ' ASN . . . -54.9 -52.29 47.49 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 113.471 -1.365 . . . . 0.0 111.656 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HB2' HD12 ' A' ' 76' ' ' LEU . 4.8 m-30 -54.52 -45.87 73.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.786 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . . . -50.84 -40.7 56.59 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.852 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.22 -60.33 2.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 m -113.78 -26.76 8.05 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' LEU . . . -56.78 -86.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.078 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.999 HD23 ' HB3' ' A' ' 268' ' ' ALA . 0.0 OUTLIER 167.98 66.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.007 HD22 HD12 ' A' ' 104' ' ' ILE . 1.7 mt -110.54 136.37 49.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 110.926 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -102.23 106.33 17.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.456 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.437 ' CG ' HG12 ' A' ' 104' ' ' ILE . 77.7 mt-10 -47.75 154.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.927 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 105' ' ' ALA . 20.1 mt -109.41 136.81 44.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.053 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 m -112.97 82.74 5.46 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.834 0.349 . . . . 0.0 110.764 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.05 -173.86 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.738 2.292 . . . . 0.0 112.229 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -88.49 117.91 27.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.593 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -33.24 4.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.462 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -57.55 -27.12 62.36 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.879 ' CE1' HD11 ' A' ' 285' ' ' LEU . 11.6 t80 -79.23 -59.22 2.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.832 0.349 . . . . 0.0 110.314 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.492 ' HG2' ' CD1' ' A' ' 94' ' ' TRP . 1.3 tt0 -60.94 -33.25 72.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.966 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -76.68 -31.9 57.56 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.972 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 7.1 mtpm? -80.34 -1.6 41.79 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.456 HD21 ' N ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -122.71 -171.25 2.24 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.323 0.51 . . . . 0.0 110.994 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.23 117.24 52.69 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.667 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.55 -41.51 67.71 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.581 2.187 . . . . 0.0 112.671 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -50.03 -45.3 51.91 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.726 0.298 . . . . 0.0 111.323 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.708 ' CG2' HG22 ' A' ' 302' ' ' VAL . 2.4 m -61.17 -28.23 68.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.492 ' CD1' ' HG2' ' A' ' 86' ' ' GLN . 17.8 m95 -92.95 -24.72 18.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.317 0.58 . . . . 0.0 111.985 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -73.91 -22.65 59.61 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.842 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.82 ' HB1' HG13 ' A' ' 261' ' ' VAL . . . -53.19 -48.16 68.3 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.82 HG13 ' CD2' ' A' ' 64' ' ' HIS . 3.8 t -103.09 39.6 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 134.58 40.31 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.4 OUTLIER -113.84 91.06 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.806 0.73 . . . . 0.0 110.751 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 99' ' ' TYR . 31.5 t30 69.62 -70.2 0.15 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.085 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.96 -41.65 0.98 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.281 -0.962 . . . . 0.0 114.207 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -125.96 -178.28 4.24 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.369 0.584 . . . . 0.0 109.869 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 103' ' ' LEU . 0.5 OUTLIER -116.82 139.26 50.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.007 HD12 HD22 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -96.13 38.0 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.977 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 160.72 -179.67 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 264' ' ' ALA . 20.6 p90 -118.94 127.5 26.49 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.708 ' HB3' HG12 ' A' ' 261' ' ' VAL . 72.6 Cg_endo -79.58 165.66 22.57 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 C-N-CA 122.265 1.977 . . . . 0.0 112.731 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 107' ' ' PRO . 1.7 pt -160.89 38.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.807 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.929 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . 178.56 110.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.833 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.037 HG23 HG11 ' A' ' 302' ' ' VAL . 17.0 t -98.43 111.26 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -103.15 163.12 12.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.624 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.676 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -164.88 150.29 9.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.537 0.684 . . . . 0.0 111.981 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.814 ' O ' HD12 ' A' ' 113' ' ' LEU . 4.6 pp -79.19 127.66 32.32 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.407 ' HA ' ' CD2' ' A' ' 247' ' ' LEU . 0.3 OUTLIER -130.56 166.77 19.91 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 116' ' ' ILE . 6.7 tt -106.22 136.44 45.92 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.801 ' CD1' HD11 ' A' ' 235' ' ' ILE . 1.8 mp -112.93 129.65 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.501 0.667 . . . . 0.0 111.764 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.578 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 24.6 p90 -94.33 -174.22 3.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.864 2.466 . . . . 0.0 110.156 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.597 ' CB ' ' HB2' ' A' ' 122' ' ' LEU . 0.4 OUTLIER -154.0 130.82 10.84 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.991 0.814 . . . . 0.0 110.002 177.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 43.15 1.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.151 0.887 . . . . 0.0 111.421 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.67 -71.76 0.34 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 110.474 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -142.35 38.48 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.406 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.597 ' HB2' ' CB ' ' A' ' 118' ' ' ASN . 71.2 mt -157.97 72.91 4.1 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.647 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.36 133.28 25.89 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.445 2.097 . . . . 0.0 113.398 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.547 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 1.8 p-10 -71.22 159.98 83.9 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 67.7 Cg_endo -72.97 167.84 26.28 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.551 2.834 . . . . 0.0 111.946 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.63 -139.56 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.662 2.241 . . . . 0.0 113.312 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 128' ' ' THR . 0.0 OUTLIER -85.5 -17.62 35.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.91 0.777 . . . . 0.0 112.518 -179.028 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.473 HG22 ' HG2' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -118.13 142.17 47.71 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.567 ' CZ2' HD22 ' A' ' 147' ' ' LEU . 6.3 t-105 -71.23 -28.39 64.15 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 173.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.539 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -44.49 -23.49 0.12 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.61 -21.25 62.67 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.834 HG23 ' HD3' ' A' ' 133' ' ' PRO . 2.1 tp -45.94 -47.28 41.88 Favored Pre-proline 0 N--CA 1.475 0.782 0 CA-C-N 118.579 0.627 . . . . 0.0 112.297 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.834 ' HD3' HG23 ' A' ' 132' ' ' ILE . 11.9 Cg_endo -52.48 -42.2 62.89 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 109.398 -1.039 . . . . 0.0 109.398 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.3 -58.7 3.12 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 139' ' ' LEU . 3.1 mm? -67.79 -35.51 78.79 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.689 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 132' ' ' ILE . 20.0 t0 -74.97 -41.55 59.35 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -49.86 -42.17 46.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.806 177.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.2 mm-40 -67.59 -36.26 80.54 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.906 HD13 ' N ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -65.21 -46.68 79.68 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.78 -44.1 38.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -45.97 -23.48 0.3 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.645 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -113.06 -58.75 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.446 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.78 53.41 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.75 ' HG3' HD23 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -167.01 -172.99 2.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 120.15 1.975 . . . . 0.0 110.013 -177.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.804 ' O ' HD22 ' A' ' 139' ' ' LEU . 54.5 m -144.27 165.13 28.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.906 ' N ' HD13 ' A' ' 139' ' ' LEU . . . -79.51 -20.34 47.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.567 HD22 ' CZ2' ' A' ' 129' ' ' TRP . 4.4 pp -152.48 178.26 9.74 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.871 ' HB2' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -179.21 143.34 0.2 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.336 178.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.486 ' O ' ' O ' ' A' ' 150' ' ' ASN . 26.4 p90 -172.85 175.93 3.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.746 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 149' ' ' PHE . 3.0 m120 -37.01 164.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.767 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 208' ' ' THR . 1.0 OUTLIER -110.51 -58.69 2.05 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -102.71 35.59 2.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 116.92 -1.912 . . . . 0.0 114.035 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.766 ' O ' ' HB ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -79.63 144.23 60.41 Favored Pre-proline 0 C--O 1.221 -0.42 0 CA-C-N 121.957 2.162 . . . . 0.0 114.932 -175.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.941 ' O ' ' N ' ' A' ' 156' ' ' PHE . 6.3 Cg_exo -78.07 -135.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 1 C-N-CA 125.72 4.28 . . . . 0.0 106.945 177.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 1.123 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 1.8 m-85 16.96 -51.87 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.941 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.2 OUTLIER -84.61 -55.92 3.87 Favored 'General case' 0 C--O 1.259 1.562 0 C-N-CA 124.452 1.101 . . . . 0.0 112.129 -178.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.766 ' HB ' ' O ' ' A' ' 153' ' ' GLU . 95.9 m -57.71 -42.53 83.97 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.51 ' CE3' ' HA ' ' A' ' 154' ' ' PRO . 0.7 OUTLIER -51.16 -55.71 26.1 Favored Pre-proline 0 C--N 1.349 0.564 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 1.123 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 40.1 Cg_exo -43.13 -50.65 6.25 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.166 2.578 . . . . 0.0 113.284 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mt -61.83 -56.75 16.11 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 119.925 1.238 . . . . 0.0 109.832 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 192' ' ' LEU . 4.6 mm -52.85 -18.74 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.153 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -78.03 -25.88 48.09 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -43.09 -58.61 2.38 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.51 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 9.3 t0 -65.0 -28.64 69.64 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.416 ' N ' ' HA3' ' A' ' 187' ' ' GLY . . . 147.32 23.44 0.09 OUTLIER Glycine 0 CA--C 1.526 0.721 0 C-N-CA 118.516 -1.802 . . . . 0.0 116.946 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -104.2 86.77 0.53 Allowed Glycine 0 C--N 1.335 0.503 0 CA-C-N 119.021 1.411 . . . . 0.0 113.225 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -104.74 -179.46 3.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.007 0.403 . . . . 0.0 110.04 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.71 -78.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.152 0.501 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.645 ' HB3' ' CD1' ' A' ' 176' ' ' TYR . 1.1 m-85 -125.89 172.78 9.61 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.041 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 1.226 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.8 OUTLIER -112.57 139.3 48.27 Favored 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -174.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.97 116.56 29.13 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.641 ' O ' ' C ' ' A' ' 173' ' ' ASN . 2.7 mm-40 -137.44 178.66 6.93 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.147 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.641 ' C ' ' O ' ' A' ' 172' ' ' GLU . 4.8 m120 -20.05 -64.4 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -80.79 -71.9 1.25 Allowed Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -174.57 170.02 3.55 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.891 1.346 . . . . 0.0 107.439 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 1.226 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 1.3 p90 -49.95 -33.43 17.59 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 123.102 1.43 . . . . 0.0 109.908 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.556 ' C ' HG22 ' A' ' 178' ' ' ILE . 12.9 m-20 65.2 -76.84 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.463 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 1.0 HD11 ' HB ' ' A' ' 369' ' ' THR . 0.0 OUTLIER 174.7 -51.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.834 ' N ' HD13 ' A' ' 178' ' ' ILE . 6.6 mmtt -51.78 -47.73 64.07 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.502 ' CB ' ' HD3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -77.96 91.66 4.24 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.825 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.477 HG12 HG13 ' A' ' 183' ' ' VAL . 4.2 t -112.54 152.41 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.536 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -115.09 40.11 2.56 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 114.84 -1.073 . . . . 0.0 114.579 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.72 HG12 ' CE1' ' A' ' 339' ' ' PHE . 35.4 m -90.17 -32.41 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.812 0.306 . . . . 0.0 111.135 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -100.67 59.39 0.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.274 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -115.72 145.89 42.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.643 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.54 -25.64 67.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.173 0.511 . . . . 0.0 111.69 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 164' ' ' ASP . . . -77.29 -33.58 43.81 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-O 119.093 -0.837 . . . . 0.0 114.938 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.99 -56.51 21.04 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -57.53 -60.15 4.1 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.002 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 193' ' ' THR . . . -50.47 -41.85 53.59 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.685 0.755 . . . . 0.0 112.035 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -62.27 -60.66 7.59 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.412 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.92 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -58.29 -24.41 59.41 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 122.539 -0.389 . . . . 0.0 110.175 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 32.3 m -66.83 -49.26 66.34 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' A' ' 191' ' ' GLY . 2.7 p90 -61.59 -34.41 75.57 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 199' ' ' ILE . 0.7 OUTLIER -63.93 -47.94 78.5 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 192' ' ' LEU . 48.5 t -56.59 -29.89 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.223 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.85 -46.92 82.81 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.599 0.714 . . . . 0.0 110.905 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.587 ' CD1' HG21 ' A' ' 132' ' ' ILE . 7.1 tp -61.07 -53.65 54.49 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.1 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 204' ' ' MET . 3.6 mt -62.37 -44.54 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.806 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -52.32 -36.93 54.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.907 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -113.18 -34.51 5.65 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 121.051 3.722 . . . . 0.0 121.051 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -62.22 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.863 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -5.4 26.92 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.565 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 6.1 ptm 41.7 37.6 0.78 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.533 ' O ' HG23 ' A' ' 199' ' ' ILE . 4.5 m120 -139.56 162.07 35.98 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.427 ' HA ' ' HG ' ' A' ' 151' ' ' LEU . . . -147.93 24.03 1.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.45 -3.06 34.5 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -56.19 117.92 4.22 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.544 ' OD2' HD12 ' A' ' 212' ' ' ILE . 2.7 p30 -95.71 -174.15 3.07 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.735 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -67.27 -47.09 71.74 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.017 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -77.2 -25.38 51.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.572 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.544 HD12 ' OD2' ' A' ' 209' ' ' ASP . 3.7 mt -81.62 -52.08 14.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.691 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 150' ' ' ASN . . . -52.4 -38.07 58.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -61.61 -44.94 96.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.61 -38.38 71.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.186 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.63 -56.82 15.85 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -66.54 -28.45 68.55 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -58.52 -34.33 70.85 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.174 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.19 -23.73 59.26 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.96 28.51 58.6 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 119.204 -0.776 . . . . 0.0 114.829 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -107.67 37.19 2.49 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.914 1.357 . . . . 0.0 111.082 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.871 HG21 ' HB2' ' A' ' 148' ' ' MET . 82.4 p -138.81 139.38 38.19 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.576 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -104.87 38.55 1.89 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.446 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.9 OUTLIER 170.54 134.59 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 86.3 m -147.88 158.89 44.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.74 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.457 ' O ' ' CE2' ' A' ' 156' ' ' PHE . 12.0 pt -115.7 112.87 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.765 ' CB ' HD12 ' A' ' 235' ' ' ILE . 37.1 m-20 -147.76 165.3 30.95 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.969 -0.457 . . . . 0.0 112.141 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -136.39 -163.98 10.05 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 119.42 1.009 . . . . 0.0 111.297 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.538 ' HG3' HG21 ' A' ' 320' ' ' THR . 77.2 Cg_endo -98.99 5.97 0.99 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.346 2.698 . . . . 0.0 114.129 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 232' ' ' TRP . 36.7 t-105 -85.58 -80.99 0.21 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.302 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.98 42.84 1.68 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.693 0.282 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.512 ' CZ3' ' HB3' ' A' ' 230' ' ' TRP . 5.1 m-90 -149.07 59.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.891 0.377 . . . . 0.0 110.961 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 p -57.82 -43.02 85.45 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -67.26 74.19 0.13 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.731 0.3 . . . . 0.0 110.575 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.801 HD11 ' CD1' ' A' ' 116' ' ' ILE . 12.8 tt -147.02 153.98 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.11 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.425 ' HB3' ' CG ' ' A' ' 242' ' ' TYR . 83.6 m-20 61.86 41.59 11.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.637 0.256 . . . . 0.0 110.858 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.0 t -142.09 48.37 1.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.771 0.32 . . . . 0.0 110.983 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.96 -65.08 1.05 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.732 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.742 ' O ' HG13 ' A' ' 240' ' ' VAL . 0.3 OUTLIER -125.68 -62.47 1.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.735 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 239' ' ' LYS . 0.2 OUTLIER -168.73 -52.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.616 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.62 95.06 10.1 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.625 0.25 . . . . 0.0 111.079 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.425 ' CG ' ' HB3' ' A' ' 236' ' ' ASP . 44.1 p90 -98.99 146.68 25.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.466 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 116' ' ' ILE . . . -130.44 160.25 23.03 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.112 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.604 HG12 HG13 ' A' ' 116' ' ' ILE . 29.3 m -135.78 134.54 51.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.764 0.282 . . . . 0.0 110.889 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.04 167.57 21.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.839 0.855 . . . . 0.0 110.506 -174.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.76 152.24 7.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.501 ' CD2' HD12 ' A' ' 113' ' ' LEU . 4.3 mm? -62.71 159.4 44.17 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 120.513 1.506 . . . . 0.0 111.204 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.45 ' HD2' HD12 ' A' ' 247' ' ' LEU . 93.2 Cg_endo -79.32 -164.49 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.598 2.198 . . . . 0.0 111.532 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.463 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -116.34 177.62 4.62 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.501 -178.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 249' ' ' THR . 55.1 m-85 -164.57 110.05 0.98 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.847 0.832 . . . . 0.0 109.749 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.91 33.43 21.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.956 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.72 39.03 30.24 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.747 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.78 147.59 17.16 Favored Pre-proline 0 N--CA 1.464 0.255 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -91.15 125.73 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.466 2.777 . . . . 0.0 111.89 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.429 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 12.2 t -47.02 150.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 159' ' ' PRO . 6.7 tppt? -85.21 108.97 17.71 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.013 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.577 ' HD2' ' HA2' ' A' ' 327' ' ' GLY . 5.4 Cg_exo -79.29 142.53 16.86 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.144 2.562 . . . . 0.0 112.737 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.91 154.61 28.21 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.695 HG11 HG12 ' A' ' 329' ' ' ILE . 54.6 t -113.08 135.59 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -123.51 118.41 3.5 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 118.873 -1.632 . . . . 0.0 115.912 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.82 HG13 ' HB1' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -110.63 111.9 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.929 ' CB ' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -88.73 99.68 12.54 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 117.659 -1.616 . . . . 0.0 107.518 177.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.549 ' CB ' HG21 ' A' ' 97' ' ' VAL . 43.7 p -136.55 135.44 38.46 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 118.878 2.918 . . . . 0.0 118.878 -173.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.936 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -88.48 112.86 23.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.551 ' CA ' ' HB2' ' A' ' 105' ' ' ALA . . . -102.86 162.83 16.2 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.508 HG21 ' HA ' ' A' ' 271' ' ' PRO . 87.0 mt -88.2 123.58 40.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 118.929 1.364 . . . . 0.0 107.726 176.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -65.51 146.22 55.13 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.999 ' HB3' HD23 ' A' ' 75' ' ' LEU . . . -58.2 -23.47 55.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.162 0.437 . . . . 0.0 111.284 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.514 ' HB1' ' H ' ' A' ' 56' ' ' GLY . . . -53.05 -59.1 4.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.573 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.3 m -143.23 127.87 9.68 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.607 0.242 . . . . 0.0 111.231 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.508 ' HA ' HG21 ' A' ' 266' ' ' ILE . 76.1 Cg_endo -78.88 -39.64 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.541 2.16 . . . . 0.0 112.96 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.788 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 2.7 m120 55.54 85.05 0.07 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-O 120.62 0.248 . . . . 0.0 110.519 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.1 OUTLIER -72.24 -54.17 10.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -75.41 -57.34 3.95 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 5.9 mt -53.52 -49.09 68.33 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.788 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -71.09 -51.85 22.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 273' ' ' LYS . 9.8 mtpp -48.84 -53.22 20.23 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.306 0.574 . . . . 0.0 112.277 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 282' ' ' ASN . 47.4 mm-40 -68.73 -30.2 68.78 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.944 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.631 ' CZ ' HD21 ' A' ' 7' ' ' LEU . 14.8 t80 -73.71 -40.33 63.68 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.575 HD12 ' HD1' ' A' ' 279' ' ' PHE . 5.7 mp -81.69 -43.89 17.87 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.94 0.876 . . . . 0.0 112.654 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 285' ' ' LEU . 13.5 mt-10 -70.45 -43.53 69.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 113.912 -1.494 . . . . 0.0 112.643 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 278' ' ' GLU . 3.7 t-20 -80.89 -32.23 34.9 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.996 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.897 ' O ' HG22 ' A' ' 286' ' ' THR . 4.3 m-85 -101.89 -82.34 0.48 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -39.38 -33.98 0.18 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.879 HD11 ' CE1' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -94.45 39.98 1.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.897 HG22 ' O ' ' A' ' 283' ' ' TYR . 11.3 t -146.62 161.91 39.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 1.2 m-20 -62.49 -13.07 26.35 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.049 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 41.2 mt-10 -77.94 -46.65 20.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.662 0.664 . . . . 0.0 111.22 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.723 ' O ' HG13 ' A' ' 293' ' ' VAL . . . -87.02 -41.79 6.54 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.741 HD12 ' CD2' ' A' ' 307' ' ' TYR . 0.1 OUTLIER -59.9 -46.55 88.98 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 287' ' ' ASP . 3.4 mm-40 -79.0 -26.66 43.26 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -71.33 -37.54 71.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.671 1.123 . . . . 0.0 109.159 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 289' ' ' GLY . 33.1 m -67.5 -40.03 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -80.22 -39.39 29.19 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 123.838 0.855 . . . . 0.0 113.003 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -64.78 -40.17 94.8 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.571 ' CA ' ' HA2' ' A' ' 16' ' ' GLY . 10.9 m-20 -59.99 -64.43 0.95 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.616 ' CG ' HD21 ' A' ' 299' ' ' LEU . 0.0 OUTLIER -103.38 103.52 35.84 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.758 -177.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.488 ' C ' HD23 ' A' ' 299' ' ' LEU . 45.6 Cg_endo -95.99 90.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.621 2.88 . . . . 0.0 112.424 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.616 HD21 ' CG ' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -141.24 -74.74 0.32 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.153 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -98.71 156.08 20.16 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.165 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.852 ' HB3' ' HB ' ' A' ' 317' ' ' ILE . . . -121.47 52.73 1.21 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 117.046 0.423 . . . . 0.0 111.62 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 1.037 HG11 HG23 ' A' ' 110' ' ' VAL . 10.8 p -136.4 84.12 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.888 0.375 . . . . 0.0 111.521 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 304' ' ' LEU . . . -166.33 95.23 0.55 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.845 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 307' ' ' TYR . 8.4 tp 93.76 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.94 0.496 . . . . 0.0 112.015 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.456 ' N ' HD21 ' A' ' 89' ' ' LEU . 3.3 tmtm? -32.63 -35.07 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.784 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -44.83 47.09 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.961 0.886 . . . . 0.0 110.257 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.828 ' CZ ' HD12 ' A' ' 311' ' ' LEU . 1.2 t80 -76.65 -23.26 53.28 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.016 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -76.6 -42.84 40.96 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.08 -43.8 86.3 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.963 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -67.32 -53.4 29.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.919 0.39 . . . . 0.0 110.624 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.828 HD12 ' CZ ' ' A' ' 307' ' ' TYR . 1.1 tt -67.06 -41.24 86.76 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.291 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -46.59 -15.5 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 312' ' ' ALA . 8.8 tttp -31.04 -43.48 0.05 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.512 0.596 . . . . 0.0 110.433 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 3.6 t0 -87.73 139.17 31.25 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 3.0 Cg_exo -75.48 3.89 5.46 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.659 2.239 . . . . 0.0 114.578 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -59.22 5.75 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.852 ' HB ' ' HB3' ' A' ' 301' ' ' ALA . 2.8 tp -49.78 -55.61 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.62 -50.35 13.38 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.375 0.534 . . . . 0.0 111.758 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.6 -44.29 85.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.858 0.837 . . . . 0.0 110.026 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.676 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -65.55 -32.61 74.3 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.896 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.619 ' HA ' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -78.95 -46.35 18.5 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.723 0.296 . . . . 0.0 110.437 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.67 -42.51 79.12 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.444 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.538 ' HB3' ' HB1' ' A' ' 112' ' ' ALA . 27.3 t-20 -78.4 -38.62 41.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.637 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -51.88 -52.74 47.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.26 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -58.19 -29.64 65.81 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.858 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -12.67 60.08 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.381 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.577 ' HA2' ' HD2' ' A' ' 257' ' ' PRO . . . -79.79 163.81 48.1 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.936 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.35 139.69 32.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.695 HG12 HG11 ' A' ' 259' ' ' VAL . 5.0 mt -91.47 110.26 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 119.572 1.078 . . . . 0.0 110.5 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.467 ' HA ' ' HD2' ' A' ' 331' ' ' PRO . 1.4 ptp -45.2 101.88 0.28 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.132 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.468 ' HG3' ' CD2' ' A' ' 176' ' ' TYR . 4.4 Cg_endo -46.49 -35.67 16.85 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.025 2.483 . . . . 0.0 112.14 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 331' ' ' PRO . 0.6 OUTLIER 85.56 83.33 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.768 HG21 ' OH ' ' A' ' 176' ' ' TYR . 1.0 OUTLIER -132.2 158.2 76.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 118.338 0.517 . . . . 0.0 111.758 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.2 -50.72 5.47 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.963 2.442 . . . . 0.0 112.693 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.768 ' HB3' HG23 ' A' ' 368' ' ' ILE . 79.2 mm-40 -53.22 -21.82 5.84 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 3.6 tpt -45.49 -35.07 3.57 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 122.222 -0.299 . . . . 0.0 111.323 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 14.9 p -59.77 -40.21 87.43 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.615 0.245 . . . . 0.0 110.542 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.836 ' HB3' ' CD1' ' A' ' 368' ' ' ILE . . . -58.11 -32.03 67.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.112 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.72 ' CE1' HG12 ' A' ' 183' ' ' VAL . 2.3 t80 -77.96 -55.66 5.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.448 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.456 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 6.6 t-105 -46.98 -42.83 18.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.862 0.363 . . . . 0.0 110.913 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.96 -49.92 40.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.658 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.15 -44.63 87.99 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.909 HG22 HD22 ' A' ' 361' ' ' LEU . 19.6 t -71.13 -29.68 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.723 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -74.82 -43.9 52.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 348' ' ' ILE . 1.7 p -64.48 -58.32 6.76 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.94 -38.65 4.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.637 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.1 t -58.82 -48.59 85.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 345' ' ' THR . 58.5 mt -64.41 -27.97 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 346' ' ' ALA . 6.0 m120 -64.43 -36.9 85.68 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.459 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.82 ' HA ' ' HG3' ' A' ' 355' ' ' GLN . . . -78.78 -26.59 44.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.56 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.94 -14.36 62.91 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 354' ' ' ARG . 2.5 t -110.66 16.96 21.13 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.56 5.91 1.4 Allowed Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 119.71 1.141 . . . . 0.0 112.382 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 352' ' ' SER . 26.4 ttt85 -93.63 35.75 1.11 Allowed 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 115.522 -2.18 . . . . 0.0 107.812 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.82 ' HG3' ' HA ' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -66.98 -170.42 0.11 Allowed 'General case' 0 CA--C 1.547 0.843 1 N-CA-C 123.881 4.771 . . . . 0.0 123.881 -156.917 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.6 OUTLIER 159.59 39.95 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 112.47 -2.15 . . . . 0.0 108.174 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.62 HG22 HD12 ' A' ' 361' ' ' LEU . 7.5 p -57.67 -48.84 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.757 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 362' ' ' LYS . 1.2 m-20 -52.21 -43.85 64.46 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.388 0.613 . . . . 0.0 110.986 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -75.8 -53.83 7.87 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 114.784 -1.098 . . . . 0.0 113.025 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -54.32 -44.31 71.94 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.956 0.884 . . . . 0.0 112.791 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.909 HD22 HG22 ' A' ' 343' ' ' VAL . 79.7 mt -77.82 -37.13 49.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.681 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 358' ' ' ASP . 1.2 tmtm? -63.88 -56.34 16.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.977 0.894 . . . . 0.0 109.631 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.07 -32.24 70.75 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.252 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -58.14 -42.43 85.87 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.829 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.619 ' HB3' HG21 ' A' ' 183' ' ' VAL . 0.7 OUTLIER -64.4 -36.12 83.13 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.482 ' N ' ' HG3' ' A' ' 365' ' ' GLN . 87.7 m -57.93 -34.57 70.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -71.1 -35.58 71.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.08 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.836 ' CD1' ' HB3' ' A' ' 338' ' ' ALA . 4.2 mm -75.83 -39.53 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.675 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 1.0 ' HB ' HD11 ' A' ' 178' ' ' ILE . 13.9 p -88.01 -20.93 25.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.022 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 366' ' ' THR . 2.0 mtmp? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.989 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.0 mtmm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.7 0.286 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.6 m -138.36 84.4 2.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.977 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.99 136.12 41.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.738 0.304 . . . . 0.0 110.945 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -177.12 154.74 1.09 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.244 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . -128.66 63.17 0.62 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.469 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.477 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -153.29 160.77 42.79 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.921 ' CB ' HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -155.25 122.62 5.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.189 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.735 HG11 ' HB3' ' A' ' 57' ' ' PRO . 24.0 t -116.94 124.95 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.482 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.722 HG13 HD12 ' A' ' 59' ' ' ILE . 3.1 mp -123.7 130.47 74.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.63 ' HB2' HG23 ' A' ' 60' ' ' ILE . 73.3 m95 -102.66 128.67 49.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.024 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.767 HD12 ' CD1' ' A' ' 61' ' ' PHE . 1.5 tt -158.49 137.84 3.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 O-C-N 122.163 -0.336 . . . . 0.0 111.298 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -114.18 39.98 2.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.749 0.309 . . . . 0.0 111.081 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.1 -11.55 58.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.604 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 1.3 m-20 65.54 60.92 0.71 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.022 0.411 . . . . 0.0 110.743 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 14' ' ' ASP . 1.2 mtpt 162.69 -173.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.183 0.516 . . . . 0.0 111.917 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 296' ' ' ASP . . . 76.38 23.46 70.7 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 20.9 p90 -80.83 -34.46 33.85 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.78 0.79 . . . . 0.0 111.378 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 1.2 t-20 -66.69 -50.66 62.13 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.769 0.319 . . . . 0.0 111.742 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.515 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -71.57 -48.79 27.62 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.841 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.9 -49.19 78.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.845 0.823 . . . . 0.0 110.055 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -67.47 -37.72 83.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -67.19 -37.6 83.95 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.634 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.748 HG23 ' CE2' ' A' ' 283' ' ' TYR . 3.7 p -67.65 -58.72 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.636 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.483 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . -49.12 -34.18 16.26 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.246 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -50.47 67.62 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.51 1.148 . . . . 0.0 107.907 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -42.23 63.61 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-N 112.793 -2.003 . . . . 0.0 108.543 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.785 ' HB3' HD13 ' A' ' 33' ' ' ILE . 22.0 m-85 -65.75 -35.71 81.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.657 0.741 . . . . 0.0 111.083 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.817 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -70.85 -51.35 27.06 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.407 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -52.36 -28.56 19.99 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 125.076 1.485 . . . . 0.0 111.365 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.814 ' O ' HG23 ' A' ' 31' ' ' THR . 20.6 t70 -85.78 -38.71 17.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.581 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 162.88 38.05 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 172.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.837 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.43 38.7 0.02 OUTLIER Glycine 0 N--CA 1.466 0.682 0 C-N-CA 114.986 -3.483 . . . . 0.0 118.837 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.837 HD12 ' C ' ' A' ' 32' ' ' GLY . 1.8 mp -139.89 107.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 121.532 2.666 . . . . 0.0 116.022 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.14 104.72 12.4 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.921 HG12 ' CB ' ' A' ' 7' ' ' LEU . 33.6 m -100.95 133.9 42.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -174.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -119.12 146.8 44.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.05 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.686 HG12 ' HB ' ' A' ' 9' ' ' ILE . 4.7 m -132.98 122.15 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.692 0.282 . . . . 0.0 110.302 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.51 134.03 48.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.263 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 9.1 p80 -139.7 71.03 37.25 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-O 120.927 0.394 . . . . 0.0 111.172 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.794 ' HD2' HD12 ' A' ' 43' ' ' LEU . 58.2 Cg_endo -87.99 -177.73 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.218 2.612 . . . . 0.0 112.362 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.37 -40.14 14.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.67 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 43' ' ' LEU . 68.8 mmtt -86.47 0.68 53.68 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.312 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.794 HD12 ' HD2' ' A' ' 40' ' ' PRO . 10.2 tt -19.53 -62.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 1.059 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -46.52 -50.86 16.54 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -178.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 3.1 tt0 -71.98 -44.04 64.17 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.936 0.398 . . . . 0.0 110.782 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.6 ' O ' HG13 ' A' ' 50' ' ' VAL . 6.6 mttp -56.62 -56.02 26.59 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.129 0.966 . . . . 0.0 110.496 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.864 ' CZ ' HD12 ' A' ' 75' ' ' LEU . 1.8 t80 -45.37 -60.75 2.93 Favored Pre-proline 0 C--N 1.346 0.414 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.0 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 1.059 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 35.2 Cg_exo -61.91 -28.08 80.68 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 121.327 1.351 . . . . 0.0 113.858 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -80.98 -37.29 29.56 Favored 'General case' 0 C--O 1.256 1.416 0 CA-C-O 122.365 1.078 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.87 ' O ' ' N ' ' A' ' 54' ' ' GLY . 18.5 m -75.69 -40.51 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 CA-C-O 121.996 0.903 . . . . 0.0 109.686 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.38 -38.65 19.97 Favored 'General case' 0 C--N 1.365 1.261 0 C-N-CA 125.945 1.698 . . . . 0.0 111.275 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.94 -37.32 29.72 Favored 'General case' 0 C--N 1.37 1.465 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.974 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -118.09 17.48 14.04 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.911 0.778 . . . . 0.0 109.035 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.87 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -137.81 62.82 0.57 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -82.0 38.69 0.54 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.751 0.776 . . . . 0.0 112.731 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 57' ' ' PRO . . . -93.78 -39.85 4.83 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.602 -0.809 . . . . 0.0 114.451 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.735 ' HB3' HG11 ' A' ' 8' ' ' VAL . 34.0 Cg_endo -91.94 157.86 3.35 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.49 2.793 . . . . 0.0 112.953 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 266' ' ' ILE . 0.4 OUTLIER -130.07 35.43 4.12 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 117.663 -1.615 . . . . 0.0 114.823 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.774 HD11 ' HG ' ' A' ' 7' ' ' LEU . 1.9 mt -152.45 127.91 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 118.181 -1.408 . . . . 0.0 114.443 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.772 HG22 ' CE3' ' A' ' 62' ' ' TRP . 3.9 mp -139.27 122.83 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.613 0.244 . . . . 0.0 111.629 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.767 ' CD1' HD12 ' A' ' 11' ' ' ILE . 35.9 t80 -113.88 121.29 43.53 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.977 0.417 . . . . 0.0 110.151 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.772 ' CE3' HG22 ' A' ' 60' ' ' ILE . 3.1 p90 -166.43 167.29 15.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.995 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 261' ' ' VAL . . . -45.66 160.13 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.956 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.73 ' CB ' ' HB ' ' A' ' 261' ' ' VAL . 23.0 t-80 -77.63 -29.45 51.76 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -48.91 -54.13 16.74 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.629 0.728 . . . . 0.0 112.398 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -78.37 -30.73 48.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.181 0.515 . . . . 0.0 109.968 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.663 ' HB3' ' HA ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -56.37 -33.08 65.37 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.711 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -55.58 -68.0 1.92 Allowed Glycine 0 C--N 1.354 1.558 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.03 -54.49 31.07 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 112.451 -1.875 . . . . 0.0 111.218 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.436 ' HB3' ' CB ' ' A' ' 75' ' ' LEU . 16.5 m-85 -48.66 -41.19 30.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -51.8 -44.78 63.6 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -42.75 25.58 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 p -69.94 -26.65 64.23 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.97 4.02 10.51 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 119.968 -1.11 . . . . 0.0 114.283 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.864 HD12 ' CZ ' ' A' ' 47' ' ' PHE . 1.1 mm? -96.9 45.86 1.05 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.271 1.036 . . . . 0.0 110.738 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 67' ' ' PHE . 0.5 OUTLIER 176.88 138.04 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 113.273 -1.785 . . . . 0.0 106.571 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.726 ' CB ' ' HB3' ' A' ' 268' ' ' ALA . . . -135.16 138.78 44.02 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 118.391 -1.323 . . . . 0.0 111.585 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -47.42 137.07 9.0 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.554 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.546 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 7.8 mt -122.46 162.3 22.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.115 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.9 p -106.18 82.87 1.0 Allowed Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.399 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 67.0 Cg_endo -84.48 -171.51 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.949 2.433 . . . . 0.0 112.345 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -105.46 156.06 18.56 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.822 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -92.26 -38.88 11.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.364 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.5 -23.25 57.53 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.87 ' CZ ' HD21 ' A' ' 285' ' ' LEU . 10.2 t80 -69.09 -59.3 3.12 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.904 0.383 . . . . 0.0 110.05 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.435 ' HB3' ' CD1' ' A' ' 94' ' ' TRP . 1.3 mt-30 -66.48 -24.63 66.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.677 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.62 -34.04 62.72 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -76.46 -10.01 59.07 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.813 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -125.15 -159.76 0.91 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.28 -179.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.657 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -80.0 119.23 75.96 Favored Pre-proline 0 C--N 1.339 0.151 0 O-C-N 122.292 -0.255 . . . . 0.0 111.574 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.32 -32.93 97.14 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.369 2.046 . . . . 0.0 112.206 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.465 ' CE1' ' HG3' ' A' ' 325' ' ' GLN . 17.3 m-85 -52.99 -53.69 46.23 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.158 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.773 HG23 ' CD2' ' A' ' 94' ' ' TRP . 10.0 t -62.62 -23.38 67.04 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.813 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 6.1 m95 -93.18 -25.6 17.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.054 0.454 . . . . 0.0 111.798 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -75.41 -20.78 58.7 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.66 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.739 ' HB1' HG13 ' A' ' 261' ' ' VAL . . . -56.03 -50.41 71.0 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 105' ' ' ALA . 9.1 p -100.42 41.38 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -97.82 135.77 39.11 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.668 -0.645 . . . . 0.0 109.872 178.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.4 t80 -99.94 174.86 5.99 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.02 -0.425 . . . . 0.0 110.081 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -64.87 73.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.674 0.273 . . . . 0.0 110.703 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 99' ' ' TYR . . . 138.57 -47.8 0.91 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.051 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -145.99 175.57 10.35 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 117.179 0.49 . . . . 0.0 110.926 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -118.89 119.69 35.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.654 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 3.3 mp -94.99 39.38 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.93 ' HB1' ' O ' ' A' ' 264' ' ' ALA . . . 167.14 -178.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.804 ' CE2' HD11 ' A' ' 280' ' ' LEU . 48.3 p90 -132.97 121.5 16.94 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.015 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.679 ' HA ' ' CB ' ' A' ' 263' ' ' SER . 6.3 Cg_exo -79.41 172.39 14.61 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.177 2.585 . . . . 0.0 113.727 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.519 HG22 ' CE2' ' A' ' 61' ' ' PHE . 2.2 tt -168.9 39.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 119.586 -0.846 . . . . 0.0 112.713 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.957 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -174.92 110.4 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.905 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.554 HG23 ' OG1' ' A' ' 320' ' ' THR . 15.5 m -96.89 117.14 40.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.599 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.452 ' HG2' ' CH2' ' A' ' 230' ' ' TRP . 33.1 mt-10 -102.89 146.85 27.67 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.552 0.691 . . . . 0.0 110.766 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.894 ' HB3' ' HA ' ' A' ' 320' ' ' THR . . . -165.26 139.05 4.72 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.385 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.838 HD21 ' HA ' ' A' ' 257' ' ' PRO . 0.4 OUTLIER -77.94 137.74 38.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.642 -179.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.15 163.5 28.38 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 116' ' ' ILE . 1.5 tt -93.63 130.11 39.67 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.585 ' N ' HD23 ' A' ' 115' ' ' LEU . 12.1 tt -115.62 138.74 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.619 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.729 ' CD1' HD21 ' A' ' 122' ' ' LEU . 3.9 m-85 -117.2 138.58 51.6 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -85.17 119.78 25.93 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -90.82 60.83 4.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.899 0.38 . . . . 0.0 111.421 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.89 -51.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.86 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' CB ' ' A' ' 223' ' ' ALA . 5.6 mt -118.96 38.4 3.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.43 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 224' ' ' MET . 0.4 OUTLIER -157.69 108.06 1.8 Allowed Pre-proline 0 CA--C 1.521 -0.15 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.687 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 9.2 Cg_endo -90.51 130.3 1.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.302 2.001 . . . . 0.0 112.443 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.485 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 81.4 m-20 -64.4 127.13 91.85 Favored Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -172.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 124' ' ' ASN . 55.5 Cg_endo -93.42 167.62 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 124.038 3.159 . . . . 0.0 109.66 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.49 -51.14 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 121.806 1.671 . . . . 0.0 114.246 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.64 -3.48 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 49.5 p -118.03 139.35 51.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 121.252 1.842 . . . . 0.0 114.287 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.521 ' CD2' HD11 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -69.63 -23.27 63.47 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 171.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.591 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 24.3 mt-10 -44.13 -23.61 0.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.359 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 40.4 mm-40 -75.91 -19.16 59.03 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.77 ' CG2' HD21 ' A' ' 147' ' ' LEU . 96.7 mt -46.59 -50.61 40.97 Favored Pre-proline 0 N--CA 1.479 0.994 0 CA-C-O 121.709 0.766 . . . . 0.0 111.346 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.603 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 58.7 Cg_exo -46.4 -36.26 17.47 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 120.826 1.017 . . . . 0.0 109.57 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 137' ' ' LYS . . . -75.36 -59.03 2.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 139' ' ' LEU . 64.3 mt -68.75 -37.34 79.32 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.881 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.1 -40.65 68.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.603 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 3.4 tptm -47.48 -49.0 26.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.81 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 139' ' ' LEU . 1.2 pt-20 -62.83 -37.23 85.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.59 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.84 HD23 ' CG ' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -58.89 -51.03 71.77 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -47.69 -45.68 28.62 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.03 -27.58 0.97 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.09 -56.66 2.16 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.244 0.545 . . . . 0.0 110.671 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.96 39.87 0.02 OUTLIER Glycine 0 CA--C 1.52 0.351 0 CA-C-O 119.029 -0.873 . . . . 0.0 111.216 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.84 ' CG ' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -149.42 -172.06 4.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 119.183 1.492 . . . . 0.0 111.629 -175.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.828 ' C ' HD22 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -143.72 127.12 16.81 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.644 ' CA ' HD13 ' A' ' 139' ' ' LEU . . . -41.52 -33.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.77 HD21 ' CG2' ' A' ' 132' ' ' ILE . 0.6 OUTLIER -141.3 130.26 23.18 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 -176.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.86 ' O ' HG22 ' A' ' 225' ' ' THR . 0.0 OUTLIER -132.22 138.75 48.06 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.739 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.934 ' O ' ' O ' ' A' ' 150' ' ' ASN . 17.3 p90 -171.92 174.73 4.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.693 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.934 ' O ' ' O ' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -27.86 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.757 0.661 . . . . 0.0 112.17 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.965 HD13 ' OG1' ' A' ' 208' ' ' THR . 0.1 OUTLIER -160.66 39.0 0.16 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.261 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.527 ' OE1' HD11 ' A' ' 348' ' ' ILE . 0.0 OUTLIER 171.68 33.09 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.998 169.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.634 ' O ' ' HB ' ' A' ' 157' ' ' THR . 3.3 mt-10 -79.96 152.52 74.42 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 121.986 2.175 . . . . 0.0 115.833 -174.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.975 ' O ' ' N ' ' A' ' 156' ' ' PHE . 67.0 Cg_endo -78.67 -135.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.802 1 C-N-CA 125.559 4.172 . . . . 0.0 107.095 176.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 1.12 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 4.7 p90 3.01 -39.82 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.975 ' N ' ' O ' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -86.14 -55.48 3.91 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-N 120.262 1.392 . . . . 0.0 111.55 -179.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.845 HG22 ' CD1' ' A' ' 161' ' ' ILE . 61.6 m -56.6 -43.82 80.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.427 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 2.6 m0 -51.26 -55.73 26.18 Favored Pre-proline 0 C--N 1.346 0.416 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.735 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 1.12 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 89.4 Cg_exo -43.11 -50.3 6.48 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.081 2.521 . . . . 0.0 113.026 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.461 HD11 ' HE1' ' A' ' 156' ' ' PHE . 81.3 mt -62.45 -53.82 49.15 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 119.671 1.123 . . . . 0.0 108.645 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.845 ' CD1' HG22 ' A' ' 157' ' ' THR . 1.5 mp -51.86 -25.82 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.421 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -78.59 -22.67 46.73 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.668 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -41.86 -58.35 2.06 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -64.37 5.57 0.26 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.303 1.224 . . . . 0.0 114.303 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.59 22.69 5.34 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 119.588 -1.291 . . . . 0.0 115.262 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.9 163.41 41.83 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.707 -1.235 . . . . 0.0 111.447 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -146.09 120.94 9.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.126 0.463 . . . . 0.0 109.967 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.674 ' HA ' HG22 ' A' ' 183' ' ' VAL . . . -39.14 -79.01 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.675 0.75 . . . . 0.0 111.148 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.633 ' HB3' ' CB ' ' A' ' 176' ' ' TYR . 1.7 m-85 -113.43 172.73 6.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.768 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 1.22 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -101.88 106.87 17.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.08 114.42 18.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.053 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 173' ' ' ASN . 28.2 tt0 -136.66 102.04 4.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.259 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 172' ' ' GLU . 0.2 OUTLIER 90.28 -31.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.379 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 154.77 17.04 0.05 OUTLIER Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.151 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -174.18 127.73 0.36 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.175 1.487 . . . . 0.0 111.257 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 1.22 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 47.9 p90 -55.47 -24.45 31.22 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 122.181 0.991 . . . . 0.0 110.987 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 178' ' ' ILE . 78.8 m-20 76.74 -78.57 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.008 -1.905 . . . . 0.0 111.773 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 369' ' ' THR . 0.8 OUTLIER 168.88 -41.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.498 ' HA ' HG22 ' A' ' 369' ' ' THR . 9.6 tttm -72.75 -5.66 39.33 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' A' ' 170' ' ' LYS . 4.4 m-20 -120.24 94.14 4.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.253 0.933 . . . . 0.0 109.634 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.617 HG11 ' CE1' ' A' ' 339' ' ' PHE . 6.4 t -115.78 111.29 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.433 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . -119.76 39.91 2.36 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.852 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.674 HG22 ' HA ' ' A' ' 168' ' ' ALA . 31.0 t -80.41 -44.72 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-O 121.275 0.56 . . . . 0.0 109.865 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -83.83 61.28 6.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.984 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 182' ' ' GLY . 7.4 p30 -110.94 173.92 6.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.712 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.58 -26.43 65.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.274 0.559 . . . . 0.0 111.28 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.95 -46.79 42.5 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.675 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.612 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -56.93 -51.4 69.28 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 175.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.65 -56.06 18.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.979 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.765 ' HB1' ' HE3' ' A' ' 251' ' ' LYS . . . -50.07 -41.18 47.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.006 0.908 . . . . 0.0 112.096 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 194' ' ' PHE . . . -66.76 -60.65 5.95 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.715 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.537 HD12 HG12 ' A' ' 161' ' ' ILE . 0.5 OUTLIER -56.54 -27.62 58.03 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 190' ' ' ALA . 42.2 m -62.36 -47.62 83.41 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.816 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.531 ' CZ ' ' CZ ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -60.71 -36.7 79.48 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-O 121.542 0.687 . . . . 0.0 109.54 177.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.77 -51.02 71.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.983 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 192' ' ' LEU . 43.1 t -57.29 -31.5 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.562 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 2.6 t0 -57.03 -49.9 74.38 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 121.286 0.565 . . . . 0.0 110.717 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.9 tp -61.97 -59.24 5.4 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.285 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.583 HG22 ' HA ' ' A' ' 204' ' ' MET . 39.4 mm -56.93 -41.13 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.83 -31.73 72.54 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.49 178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 6.0 m-80 -107.54 13.12 27.09 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -173.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 203' ' ' HIS . 1.4 ttmp? -121.92 -91.87 0.55 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.946 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' A' ' 205' ' ' ASN . 0.5 OUTLIER -122.02 -10.82 8.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -178.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.583 ' HA ' HG22 ' A' ' 199' ' ' ILE . 0.0 OUTLIER 69.35 -71.69 0.12 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -176.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 203' ' ' HIS . 3.0 m120 64.43 162.49 0.12 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.26 78.88 3.1 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.603 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 39.46 70.75 0.2 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.965 ' OG1' HD13 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -55.05 124.19 16.02 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 213' ' ' ALA . 0.4 OUTLIER -92.13 -174.65 3.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -69.92 -45.55 67.31 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.3 m -75.18 -30.01 60.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.502 0.668 . . . . 0.0 111.024 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.743 HG22 HG22 ' A' ' 208' ' ' THR . 1.2 mp -79.33 -49.74 19.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.207 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -57.61 -34.05 68.88 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -60.02 -48.24 82.53 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.91 -36.59 67.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.247 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.77 -57.6 11.74 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.963 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.538 ' CE1' ' HA ' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -60.09 -30.04 68.98 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -53.18 -42.03 65.81 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.396 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.84 59.12 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.74 57.96 7.44 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.672 -0.695 . . . . 0.0 114.588 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -125.29 37.29 4.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.378 1.089 . . . . 0.0 111.037 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.45 ' CB ' ' HB2' ' A' ' 148' ' ' MET . 12.2 t -142.5 140.48 31.86 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -114.45 38.5 3.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.064 -1.426 . . . . 0.0 113.328 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.789 ' HB2' HD13 ' A' ' 122' ' ' LEU . 25.8 ttm -178.08 129.22 0.13 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.77 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 148' ' ' MET . 69.1 p -145.51 169.32 18.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.566 0.698 . . . . 0.0 111.534 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.566 HD12 ' CZ ' ' A' ' 156' ' ' PHE . 21.9 mt -109.06 145.44 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -146.86 167.05 24.89 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.849 0.86 . . . . 0.0 111.232 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -110.4 -159.8 17.26 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.446 -0.406 . . . . 0.0 112.782 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.429 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 11.7 Cg_endo -55.49 -59.44 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.82 2.346 . . . . 0.0 112.451 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.452 ' CH2' ' HG2' ' A' ' 111' ' ' GLU . 18.6 p90 -173.34 -43.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.474 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.28 70.99 1.2 Allowed 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.786 0.326 . . . . 0.0 110.803 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.423 ' O ' ' N ' ' A' ' 234' ' ' ASN . 1.5 m95 -125.72 39.77 3.88 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 11.3 t 64.87 -72.74 0.06 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.544 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 232' ' ' TRP . 4.6 t-20 -145.64 85.12 1.69 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.575 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.406 ' O ' ' N ' ' A' ' 237' ' ' THR . 18.1 tt -44.55 154.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.434 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.511 ' OD1' HG21 ' A' ' 225' ' ' THR . 37.2 t70 -47.9 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.707 0.289 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.48 ' O ' HG22 ' A' ' 237' ' ' THR . 19.7 m -121.4 39.37 3.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.744 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 83.0 p -63.2 -43.62 97.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.689 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.57 -174.91 2.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.816 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.0 -57.26 4.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.193 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.02 126.32 35.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.543 ' CG ' HD11 ' A' ' 116' ' ' ILE . 9.8 p90 -144.44 164.22 31.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.167 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.4 122.14 5.85 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.425 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 244' ' ' VAL . 34.7 m -91.58 115.31 30.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.743 0.271 . . . . 0.0 111.384 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.6 p -127.62 167.18 16.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.47 153.91 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.807 HD11 ' CD1' ' A' ' 113' ' ' LEU . 58.5 mt -58.29 158.67 13.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 120.31 1.414 . . . . 0.0 110.092 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.437 ' HD3' HD12 ' A' ' 115' ' ' LEU . 72.7 Cg_endo -79.21 -174.65 2.37 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.453 2.102 . . . . 0.0 113.144 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.449 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -105.3 171.16 7.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.091 0.472 . . . . 0.0 111.488 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.531 ' CZ ' ' CZ ' ' A' ' 194' ' ' PHE . 35.6 m-85 -167.31 111.08 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.765 ' HE3' ' HB1' ' A' ' 190' ' ' ALA . 13.2 mttt 62.72 31.71 16.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.637 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.94 33.58 36.45 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.318 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 163' ' ' ALA . 13.8 mp0 -156.75 154.43 26.65 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 68.7 Cg_endo -90.61 162.91 4.28 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.592 2.861 . . . . 0.0 112.213 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.569 ' OG ' HD13 ' A' ' 247' ' ' LEU . 1.0 OUTLIER -84.41 148.71 26.45 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.1 OUTLIER -86.0 109.81 25.69 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.531 -178.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.838 ' HA ' HD21 ' A' ' 113' ' ' LEU . 6.2 Cg_exo -79.84 149.38 20.48 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.998 2.465 . . . . 0.0 112.89 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 155' ' ' TYR . 23.2 p90 -78.86 146.35 33.68 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.979 HG21 HD13 ' A' ' 329' ' ' ILE . 15.6 t -103.53 122.83 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -118.02 123.45 5.74 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.135 -1.507 . . . . 0.0 114.771 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.739 HG13 ' HB1' ' A' ' 96' ' ' ALA . 15.7 t -109.09 110.06 30.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.957 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.7 tp -89.85 99.15 12.21 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 117.881 -1.528 . . . . 0.0 107.257 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.679 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 32.8 p -134.46 141.17 46.69 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 118.501 2.778 . . . . 0.0 118.501 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.93 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -74.04 132.71 42.61 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.025 -0.422 . . . . 0.0 110.292 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -122.18 139.59 12.88 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.652 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 58' ' ' ASP . 3.7 mp -114.39 127.16 71.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.646 ' C ' ' H ' ' A' ' 269' ' ' ALA . 96.1 m-20 -61.07 126.38 27.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.726 ' HB3' ' CB ' ' A' ' 77' ' ' ALA . . . -51.6 5.11 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 119.883 1.219 . . . . 0.0 113.177 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.646 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -81.99 -38.1 25.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.854 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 75.5 m -133.89 69.4 75.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.91 0.386 . . . . 0.0 110.925 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.655 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 6.4 Cg_exo -73.97 -36.21 3.67 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.842 2.362 . . . . 0.0 112.734 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.472 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 23.2 m-20 50.64 68.17 0.81 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 6.5 mttt -48.98 -54.44 15.6 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 2.9 mt-10 -62.98 -57.94 9.03 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.282 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.6 mt -68.01 -58.0 5.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 271' ' ' PRO . . . -69.45 -51.97 31.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 1.1 tpmp? -64.98 -35.76 82.23 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 12.4 tt0 -76.49 -53.09 8.58 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -56.23 -52.01 66.0 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.787 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.804 HD11 ' CE2' ' A' ' 106' ' ' TYR . 8.2 tt -57.41 -43.42 83.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.524 0.678 . . . . 0.0 111.777 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -73.77 -34.3 64.63 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.558 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -94.16 -13.54 26.59 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.748 ' CE2' HG23 ' A' ' 23' ' ' VAL . 1.6 t80 -109.41 -62.2 1.52 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 119.241 -0.409 . . . . 0.0 109.936 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 284' ' ' LEU . 1.7 tt -40.19 -33.57 0.24 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.809 0.731 . . . . 0.0 110.87 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.87 HD21 ' CZ ' ' A' ' 85' ' ' PHE . 80.5 mt -86.59 42.21 0.99 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.959 0.409 . . . . 0.0 110.257 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 283' ' ' TYR . 17.4 p -145.21 155.93 43.55 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 44.1 m-20 -62.7 -15.04 50.87 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.611 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 0.9 OUTLIER -78.27 -47.38 18.02 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.882 -0.511 . . . . 0.0 110.922 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.531 ' O ' HG12 ' A' ' 293' ' ' VAL . . . -79.96 -55.58 3.51 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.291 -0.957 . . . . 0.0 110.972 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.835 ' CD1' HD13 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -55.26 -46.14 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.226 . . . . 0.0 111.066 179.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -79.05 -26.32 43.12 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.707 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -68.33 -41.55 80.64 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 119.441 1.019 . . . . 0.0 109.117 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 289' ' ' GLY . 2.7 p -68.4 -61.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.502 ' H ' HG13 ' A' ' 293' ' ' VAL . 0.6 OUTLIER -50.14 -45.14 52.84 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.682 1.193 . . . . 0.0 112.546 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -59.33 -50.36 74.27 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.515 ' O ' ' HD3' ' A' ' 298' ' ' PRO . 42.0 m-20 -56.17 -47.86 77.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 176.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 294' ' ' ASN . 0.0 OUTLIER -69.04 104.67 0.78 Allowed Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.951 -178.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.697 ' O ' HD23 ' A' ' 299' ' ' LEU . 93.1 Cg_endo -99.64 54.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.322 2.681 . . . . 0.0 112.675 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 298' ' ' PRO . 0.4 OUTLIER -138.88 -67.83 0.45 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.57 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.63 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . -172.91 -166.31 31.21 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.853 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.725 ' HB3' ' CD1' ' A' ' 311' ' ' LEU . . . 160.0 177.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.579 0.228 . . . . 0.0 111.141 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 302' ' ' VAL . 5.8 p 174.52 62.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.486 ' HA ' HG21 ' A' ' 93' ' ' THR . . . -113.78 -138.6 0.37 Allowed 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.835 HD13 ' CD1' ' A' ' 290' ' ' LEU . 0.4 OUTLIER -4.51 110.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.38 1.072 . . . . 0.0 113.803 -179.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -34.22 -60.88 0.39 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.099 0.476 . . . . 0.0 112.085 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.14 -47.1 54.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.988 0.899 . . . . 0.0 111.272 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.817 ' CG ' HD22 ' A' ' 290' ' ' LEU . 2.4 t80 -73.0 -20.12 61.08 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.319 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 12.0 tt0 -66.64 -39.88 88.45 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.46 -51.85 38.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.335 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -56.83 -56.31 23.23 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.012 0.434 . . . . 0.0 110.174 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.845 HD22 HD13 ' A' ' 317' ' ' ILE . 0.9 OUTLIER -63.76 -41.02 98.06 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.776 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.908 ' HA ' HD11 ' A' ' 317' ' ' ILE . . . -46.23 -26.77 0.85 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 312' ' ' ALA . 10.5 mtpp -37.76 -40.04 0.4 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.753 0.311 . . . . 0.0 110.599 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -82.82 124.35 77.14 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.903 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.21 -13.51 40.19 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.637 2.225 . . . . 0.0 114.214 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.8 ' O ' HG23 ' A' ' 320' ' ' THR . 5.3 mtp85 -62.08 -58.89 6.12 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.908 HD11 ' HA ' ' A' ' 312' ' ' ALA . 10.3 pt -50.12 -52.36 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.78 -45.14 14.48 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.84 0.291 . . . . 0.0 111.71 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.73 -38.96 73.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.299 0.571 . . . . 0.0 110.322 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.894 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 19.9 p -65.17 -33.61 76.42 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.408 ' HG3' HG21 ' A' ' 302' ' ' VAL . 0.0 OUTLIER -76.89 -49.19 16.23 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.603 0.24 . . . . 0.0 111.04 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -43.52 84.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.307 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.667 ' CB ' ' HB1' ' A' ' 112' ' ' ALA . 16.2 m-80 -71.58 -41.56 68.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.584 0.231 . . . . 0.0 111.17 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -23.08 67.16 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.465 ' HG3' ' CE1' ' A' ' 92' ' ' PHE . 3.0 tm0? -85.27 -34.09 22.02 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -101.48 62.74 0.95 Allowed 'General case' 0 C--O 1.232 0.151 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.478 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -154.96 -140.79 3.09 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.681 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -128.32 118.84 23.94 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.979 HD13 HG21 ' A' ' 259' ' ' VAL . 3.5 mm -75.34 131.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.77 133.08 2.96 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.725 0.297 . . . . 0.0 111.326 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.556 ' HB3' ' CE2' ' A' ' 176' ' ' TYR . 12.6 Cg_endo -56.05 -161.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.092 2.528 . . . . 0.0 111.975 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -159.21 40.78 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.589 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 5.1 pt -136.55 170.78 9.99 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.893 -0.139 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 87.5 Cg_endo -84.83 -20.51 3.63 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.628 2.219 . . . . 0.0 113.927 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 368' ' ' ILE . 14.6 mm-40 -56.13 -21.04 20.15 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.482 ' HE1' ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -44.72 -33.36 1.84 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 23.2 m -57.16 -33.17 67.16 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.649 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.0 78.08 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.928 0.394 . . . . 0.0 111.92 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.617 ' CE1' HG11 ' A' ' 181' ' ' VAL . 0.1 OUTLIER -78.35 -55.66 5.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.772 -178.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.419 ' HA ' ' CE3' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -44.0 -44.73 7.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.045 -179.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 345' ' ' THR . 7.0 m-85 -74.79 -44.01 51.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.972 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.21 76.48 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.987 HG12 HD21 ' A' ' 361' ' ' LEU . 5.5 m -71.94 -41.31 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.034 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.381 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 348' ' ' ILE . 6.7 mmp_? -56.34 -55.29 35.25 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.212 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 341' ' ' TYR . 43.9 p -59.45 -56.23 24.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.064 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.62 -60.67 2.17 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.596 ' CG2' HD11 ' A' ' 361' ' ' LEU . 48.3 t -51.17 -50.52 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.527 HD11 ' OE1' ' A' ' 152' ' ' GLN . 2.1 tt -69.88 -46.14 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.837 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 345' ' ' THR . 3.5 t30 -66.35 -53.97 30.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 355' ' ' GLN . . . -66.21 -26.55 67.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 347' ' ' VAL . . . -57.07 -12.31 2.06 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.0 p -110.42 26.75 10.34 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.48 0.582 . . . . 0.0 111.424 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 89.41 -5.72 83.78 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 118.463 -1.827 . . . . 0.0 114.482 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 34.98 0.72 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 116.199 -2.2 . . . . 0.0 107.956 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 356' ' ' THR . 1.0 OUTLIER -72.15 -174.81 1.34 Allowed 'General case' 0 CA--C 1.548 0.868 1 N-CA-C 126.385 5.698 . . . . 0.0 126.385 -158.057 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.6 OUTLIER 158.22 40.48 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 109.833 -3.349 . . . . 0.0 104.283 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.689 ' CG2' HD12 ' A' ' 361' ' ' LEU . 12.8 p -72.56 -52.58 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -174.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 13.4 t0 -47.34 -45.64 24.85 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.596 0.712 . . . . 0.0 111.28 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -77.07 -56.34 4.66 Favored 'General case' 0 C--N 1.353 0.74 0 CA-C-N 114.073 -1.421 . . . . 0.0 113.733 -175.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -51.49 -41.72 61.15 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 122.583 1.182 . . . . 0.0 112.253 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.987 HD21 HG12 ' A' ' 343' ' ' VAL . 5.7 mt -79.03 -34.95 43.4 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 112.745 -2.025 . . . . 0.0 110.494 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 5.2 mmmt -65.75 -56.6 11.17 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.391 1.091 . . . . 0.0 109.599 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 366' ' ' THR . 1.4 t70 -59.46 -36.03 75.21 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.372 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -52.18 -44.01 64.45 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 369' ' ' THR . 4.2 tt0 -60.21 -46.42 89.8 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 363' ' ' ASP . 53.1 m -51.03 -42.88 60.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.09 0.471 . . . . 0.0 110.138 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 10.3 ttm105 -59.12 -52.57 65.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.122 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 178' ' ' ILE . 15.7 tt -73.55 -30.31 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 178' ' ' ILE . 80.9 p -82.52 -30.24 29.91 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 8.2 tptt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.962 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.1 mttp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.622 0.249 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.2 p -137.51 179.68 6.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -80.4 123.41 28.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.777 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -156.08 160.24 39.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.784 0.326 . . . . 0.0 111.213 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 32' ' ' GLY . . . 90.88 25.56 24.54 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.415 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.34 152.79 42.04 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.585 HD13 HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -129.76 121.27 26.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.152 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -117.04 118.23 58.07 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.849 HG23 ' CE1' ' A' ' 61' ' ' PHE . 24.4 mt -123.04 130.07 74.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.435 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.609 ' HB3' HD11 ' A' ' 43' ' ' LEU . 8.6 m95 -108.99 122.29 46.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.681 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -145.74 143.07 21.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 122.881 0.473 . . . . 0.0 109.813 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -79.8 72.62 6.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 119.014 0.824 . . . . 0.0 112.015 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.64 65.88 2.9 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.098 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.814 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -87.11 -32.82 19.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.814 ' HB2' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 102.12 -156.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -177.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.756 ' O ' HD23 ' A' ' 20' ' ' LEU . . . 71.39 52.56 12.59 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 116.089 1.196 . . . . 0.0 116.089 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -58.71 2.92 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 22' ' ' GLU . 2.0 t-20 -46.18 -43.33 15.08 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.122 0.487 . . . . 0.0 111.127 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.782 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -71.12 -45.54 49.22 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.302 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 16' ' ' GLY . 3.5 mm? -61.13 -51.47 68.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.944 0.372 . . . . 0.0 110.678 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.17 74.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 18' ' ' ASN . 34.8 tt0 -65.3 -36.09 82.99 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.754 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 19' ' ' GLY . 74.8 t -67.7 -61.27 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.54 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . -49.22 -34.22 17.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.205 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.41 -50.38 67.74 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 177.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -41.63 62.77 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 112.826 -1.988 . . . . 0.0 108.593 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.785 ' HB3' HD13 ' A' ' 33' ' ' ILE . 21.7 m-30 -66.91 -34.32 77.53 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.128 0.966 . . . . 0.0 111.367 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.76 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -72.6 -51.96 17.48 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.914 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tpmp? -53.1 -27.55 21.04 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 124.807 1.317 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 31' ' ' THR . 3.7 m-20 -86.03 -37.42 18.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 117.732 -1.128 . . . . 0.0 108.97 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.829 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 159.92 38.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 172.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.808 ' O ' HD12 ' A' ' 33' ' ' ILE . . . 156.88 39.25 0.02 OUTLIER Glycine 0 N--CA 1.465 0.582 0 C-N-CA 114.537 -3.697 . . . . 0.0 119.337 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.083 HD11 HD21 ' A' ' 275' ' ' LEU . 1.5 mp -139.46 136.27 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 121.961 2.88 . . . . 0.0 116.637 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -142.32 104.46 4.43 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.585 HG22 HD13 ' A' ' 7' ' ' LEU . 37.4 t -88.48 128.97 40.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 m -118.51 140.11 50.39 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.645 -1.162 . . . . 0.0 110.853 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.694 HG12 ' HB ' ' A' ' 9' ' ' ILE . 15.2 m -129.85 122.47 54.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 O-C-N 122.133 -0.354 . . . . 0.0 110.703 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 3.0 tp10 -113.4 134.03 54.86 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER -117.98 74.83 10.29 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 122.355 0.262 . . . . 0.0 111.208 178.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 38' ' ' GLU . 6.0 Cg_endo -89.18 -167.47 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.546 2.831 . . . . 0.0 113.262 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -109.42 -54.85 2.5 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.347 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -78.03 0.12 25.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.41 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.996 HD21 HD11 ' A' ' 60' ' ' ILE . 2.0 tt -26.08 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 1.062 ' O ' ' CD ' ' A' ' 48' ' ' PRO . 3.5 mt-10 -70.59 -55.02 9.81 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -68.34 -50.06 55.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.113 0.482 . . . . 0.0 111.454 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.665 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.4 mmtm -61.82 -56.27 21.21 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.682 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 73.4 t80 -47.03 -55.01 16.73 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 1.062 ' CD ' ' O ' ' A' ' 44' ' ' GLU . 30.8 Cg_exo -66.96 -39.69 13.54 Favored 'Trans proline' 0 C--O 1.25 1.12 0 C-N-CA 121.478 1.452 . . . . 0.0 115.196 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.44 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 34.4 tt0 -67.54 -51.15 54.22 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 46' ' ' LYS . 9.0 m -61.37 -22.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.114 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 48' ' ' PRO . . . -59.05 -30.03 67.74 Favored 'General case' 0 C--N 1.394 2.535 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.058 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 49' ' ' GLN . . . -82.38 -28.94 31.18 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.227 1.411 . . . . 0.0 113.029 -178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 50' ' ' VAL . 5.7 t -88.3 129.66 35.32 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.126 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.93 -67.95 0.05 OUTLIER Glycine 0 C--N 1.337 0.587 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.396 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -165.29 -84.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.417 1.609 . . . . 0.0 111.427 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.03 142.86 4.34 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.517 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.18 -146.6 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.84 2.36 . . . . 0.0 112.767 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 1.152 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -79.99 -135.65 0.03 OUTLIER 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 123.744 0.818 . . . . 0.0 110.069 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.639 HD12 ' HB1' ' A' ' 264' ' ' ALA . 16.6 pt -104.48 166.89 2.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.996 HD11 HD21 ' A' ' 43' ' ' LEU . 1.7 tt -127.69 134.87 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 1.026 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 0.1 OUTLIER -110.69 120.08 41.25 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.973 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -166.99 162.91 15.88 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.393 0.542 . . . . 0.0 110.437 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.515 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . . . -38.34 154.84 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.831 ' HB3' HG13 ' A' ' 261' ' ' VAL . 16.6 t-160 -77.29 -30.04 54.02 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.99 -36.96 75.77 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.693 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.515 ' HD3' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -84.29 -33.11 24.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.933 178.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.606 ' HZ ' HG23 ' A' ' 104' ' ' ILE . 4.5 t80 -59.94 -30.35 69.01 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.07 -68.51 1.66 Allowed Glycine 0 C--N 1.353 1.502 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.99 45.08 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.541 ' CZ ' ' HG3' ' A' ' 48' ' ' PRO . 1.2 m-85 -48.03 -46.35 33.03 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 68' ' ' GLY . . . -51.08 -48.83 61.53 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.884 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -63.87 -16.89 62.47 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 m -69.36 -26.88 64.9 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.936 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.759 ' O ' HD22 ' A' ' 75' ' ' LEU . . . 83.69 28.94 33.73 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.697 -0.763 . . . . 0.0 114.996 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.759 HD22 ' O ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -139.45 38.5 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.502 1.151 . . . . 0.0 111.99 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.711 ' HB3' HD11 ' A' ' 104' ' ' ILE . 3.2 mm? -110.15 131.61 54.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.93 0.395 . . . . 0.0 111.306 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.825 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -95.68 121.64 37.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.645 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.911 ' HG3' HD12 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -82.78 133.15 35.15 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.974 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.535 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 18.6 tt -78.29 159.63 4.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.119 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.5 p -108.61 82.76 1.79 Allowed Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 79' ' ' ILE . 48.1 Cg_endo -90.08 -169.9 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.126 2.55 . . . . 0.0 112.244 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -127.94 156.2 43.02 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.557 0.218 . . . . 0.0 110.921 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -57.52 -45.62 84.77 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.672 0.272 . . . . 0.0 110.946 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.6 -23.13 64.45 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.637 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.477 ' CE2' ' CH2' ' A' ' 94' ' ' TRP . 8.6 t80 -79.23 -59.19 2.87 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 23.2 tt0 -55.65 -38.2 69.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.705 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -76.71 -34.58 58.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.682 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.87 -31.8 1.37 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.914 HD13 ' HA ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -126.21 -90.1 0.55 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.123 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.47 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 2.4 m-85 -136.26 111.24 9.97 Favored Pre-proline 0 CA--C 1.53 0.192 0 O-C-N 122.005 -0.434 . . . . 0.0 111.686 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 90' ' ' TYR . 19.3 Cg_endo -57.45 -22.34 50.03 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.592 2.195 . . . . 0.0 112.504 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -56.94 -53.81 53.82 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.578 0.228 . . . . 0.0 111.589 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.542 HG22 ' CG ' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -62.19 -45.51 93.05 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 110.267 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.78 ' CZ2' HD11 ' A' ' 89' ' ' LEU . 71.7 m95 -60.26 -40.39 90.18 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 121.7 0.762 . . . . 0.0 109.861 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.78 -22.08 61.63 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.953 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.496 ' HB1' HG21 ' A' ' 261' ' ' VAL . . . -75.59 -17.67 59.96 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.657 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 13.1 m -121.74 46.22 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -128.92 139.54 52.08 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.42 0.554 . . . . 0.0 109.533 178.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -142.55 114.37 8.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 119.178 0.899 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 78.21 25.96 0.59 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.74 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.48 -27.98 17.96 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.998 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -102.34 163.85 12.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.561 0.681 . . . . 0.0 111.226 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -91.08 137.99 31.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.83 0.348 . . . . 0.0 110.616 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.911 HD12 ' HG3' ' A' ' 78' ' ' GLU . 15.6 tt -137.57 48.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.344 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 159.61 -177.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 264' ' ' ALA . 49.5 m-85 -142.29 122.82 8.31 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.633 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.64 ' HB3' HG23 ' A' ' 261' ' ' VAL . 88.5 Cg_endo -79.48 166.13 22.38 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.271 1.98 . . . . 0.0 112.37 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.699 ' HA ' ' HB2' ' A' ' 303' ' ' ALA . 3.1 tt -168.61 39.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.136 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.599 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.849 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 176.08 122.37 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 110' ' ' VAL . 11.3 p -113.7 105.62 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.525 ' HA ' ' CG2' ' A' ' 320' ' ' THR . 2.0 mp0 -103.08 162.91 12.56 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.672 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -164.86 150.1 9.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.591 0.71 . . . . 0.0 112.131 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.883 HD11 HD11 ' A' ' 247' ' ' LEU . 2.6 pp -79.51 126.9 31.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.3 171.72 11.24 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 122.178 -0.326 . . . . 0.0 111.118 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.811 HD22 ' CE1' ' A' ' 117' ' ' TYR . 1.3 tt -110.99 136.29 50.22 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.716 HD13 ' OD1' ' A' ' 227' ' ' ASN . 3.3 mp -112.11 128.8 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.811 ' CE1' HD22 ' A' ' 115' ' ' LEU . 22.6 m-30 -110.36 134.87 51.88 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -84.41 119.12 24.75 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -109.54 29.21 7.78 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.715 0.293 . . . . 0.0 111.675 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.1 -54.0 1.12 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -136.74 0.02 OUTLIER 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.406 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.917 HD22 HD11 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -84.27 128.96 59.96 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 41.4 Cg_exo -55.91 161.45 8.39 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.411 2.74 . . . . 0.0 111.604 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.539 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 4.9 p-10 -101.38 169.25 7.98 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.858 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 50.1 Cg_exo -53.84 167.55 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.675 2.25 . . . . 0.0 111.915 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -92.53 -118.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 122.816 2.344 . . . . 0.0 112.868 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.769 ' HD2' HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -84.38 -18.17 36.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.309 0.959 . . . . 0.0 111.747 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.769 HG23 ' HD2' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -117.75 141.25 48.61 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.552 ' CH2' HD22 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -69.71 -25.82 64.04 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 173.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.533 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.4 OUTLIER -44.83 -23.9 0.17 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.989 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.416 ' CD ' HD23 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -70.78 -23.48 62.4 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.774 HG21 ' CD2' ' A' ' 198' ' ' LEU . 1.5 mp -40.44 -60.23 1.62 Allowed Pre-proline 0 N--CA 1.477 0.906 0 CA-C-O 121.446 0.641 . . . . 0.0 111.425 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 137' ' ' LYS . 67.5 Cg_exo -46.45 -40.87 23.23 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 120.891 1.06 . . . . 0.0 109.861 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.3 -58.84 3.03 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 139' ' ' LEU . 4.0 mm? -68.03 -36.79 80.52 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.393 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.71 ' OD2' HG23 ' A' ' 132' ' ' ILE . 1.3 m-20 -74.16 -40.53 62.52 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 3.0 ttpt -49.87 -46.78 51.86 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 118.949 -1.1 . . . . 0.0 109.29 177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.5 mm-40 -62.59 -37.1 84.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.194 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.972 HD22 ' O ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -62.43 -47.86 82.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -47.59 -45.14 27.05 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -46.06 -24.43 0.43 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -99.01 -57.63 2.13 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.04 39.57 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.717 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.684 ' HB2' ' O ' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -174.04 177.28 2.38 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.703 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.972 ' O ' HD22 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -107.1 177.66 4.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.754 ' O ' ' C ' ' A' ' 223' ' ' ALA . . . -86.84 -14.25 42.65 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.552 HD22 ' CH2' ' A' ' 129' ' ' TRP . 2.5 pp -138.95 128.68 24.78 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.602 ' O ' HG22 ' A' ' 225' ' ' THR . 2.1 tpt -132.47 136.29 46.6 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 227' ' ' ASN . 6.2 t80 -171.63 173.66 4.59 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.948 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.548 ' O ' ' O ' ' A' ' 208' ' ' THR . 2.5 m120 -23.08 -70.34 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.726 HD22 ' HB1' ' A' ' 206' ' ' ALA . 0.1 OUTLIER 97.53 38.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.88 0.872 . . . . 0.0 109.226 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 172.36 34.73 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 117.637 -1.173 . . . . 0.0 114.113 170.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' OG1' ' A' ' 157' ' ' THR . 13.5 mt-10 -102.59 151.04 38.19 Favored Pre-proline 0 C--O 1.218 -0.589 0 CA-C-N 122.349 2.34 . . . . 0.0 116.025 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.923 ' O ' ' N ' ' A' ' 156' ' ' PHE . 65.9 Cg_endo -78.14 -134.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 1 C-N-CA 125.922 4.415 . . . . 0.0 106.285 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 1.149 ' O ' ' CD ' ' A' ' 159' ' ' PRO . 12.9 m-85 26.08 -60.33 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 119.335 0.97 . . . . 0.0 113.431 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.923 ' N ' ' O ' ' A' ' 154' ' ' PRO . 56.1 m-85 -83.48 -56.6 3.65 Favored 'General case' 0 C--O 1.257 1.471 0 C-N-CA 123.65 0.78 . . . . 0.0 112.097 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.859 ' OG1' ' O ' ' A' ' 153' ' ' GLU . 27.8 p -59.33 -40.5 86.51 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.215 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.539 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 29.4 m0 -52.41 -55.48 31.45 Favored Pre-proline 0 C--N 1.352 0.703 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 1.149 ' CD ' ' O ' ' A' ' 155' ' ' TYR . 86.2 Cg_exo -43.39 -49.26 7.68 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.68 2.253 . . . . 0.0 112.241 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.718 HD11 HD13 ' A' ' 226' ' ' ILE . 5.7 mt -56.91 -56.89 15.88 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 119.514 1.052 . . . . 0.0 109.341 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.452 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 4.4 mt -51.57 -20.94 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.095 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.493 ' HB3' ' H ' ' A' ' 256' ' ' LYS . . . -83.97 -19.45 34.57 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.045 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 250' ' ' PHE . . . -46.79 -47.11 20.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.532 ' CB ' ' CA ' ' A' ' 187' ' ' GLY . 6.6 m-20 -65.29 -58.32 6.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 120.744 1.611 . . . . 0.0 112.831 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.78 31.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 119.085 -1.531 . . . . 0.0 115.181 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -106.3 100.36 1.63 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.111 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.416 ' O ' ' CA ' ' A' ' 183' ' ' VAL . 60.9 m-85 -77.72 151.09 34.32 Favored 'General case' 0 C--N 1.337 0.048 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.15 -72.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.575 ' HB3' ' CD2' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -111.99 169.83 8.57 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.903 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 1.19 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 0.5 OUTLIER -102.25 111.48 23.78 Favored 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 328' ' ' GLU . 28.6 m-85 -84.26 115.03 22.25 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.914 -1.494 . . . . 0.0 108.616 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.928 ' O ' ' N ' ' A' ' 174' ' ' GLY . 5.4 mm-40 -137.1 101.59 4.6 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.52 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 41.54 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 123.93 0.769 . . . . 0.0 110.475 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.928 ' N ' ' O ' ' A' ' 172' ' ' GLU . . . -75.2 -73.35 0.97 Allowed Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -175.87 143.51 0.58 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.768 1.284 . . . . 0.0 111.154 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 1.19 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 21.8 p90 -45.4 -32.51 2.13 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.061 0.934 . . . . 0.0 109.609 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 40.8 t0 59.38 -98.3 0.08 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.773 -1.558 . . . . 0.0 111.592 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 178' ' ' ILE . 7.4 tp -176.77 32.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -132.54 -18.5 2.48 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.079 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 3.7 m-20 -121.87 93.02 3.86 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.962 HG21 ' CD1' ' A' ' 368' ' ' ILE . 29.0 m -116.72 116.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.85 39.77 2.39 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.617 -1.277 . . . . 0.0 113.494 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.781 ' O ' ' HB2' ' A' ' 188' ' ' ALA . 11.5 p -79.92 -46.13 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.451 ' N ' HG13 ' A' ' 183' ' ' VAL . 13.5 p-10 -75.59 54.49 0.77 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.751 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.6 -171.79 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -49.82 -37.33 30.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.773 0.797 . . . . 0.0 111.807 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.532 ' CA ' ' CB ' ' A' ' 164' ' ' ASP . . . -75.38 -37.14 42.41 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.583 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 183' ' ' VAL . . . -64.17 -42.9 96.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -50.3 -40.26 48.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.094 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 194' ' ' PHE . . . -69.59 -47.64 62.86 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -66.7 -60.47 6.14 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.189 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.842 ' O ' HG23 ' A' ' 196' ' ' VAL . 3.8 tt -50.04 -39.37 41.56 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 98.8 m -75.78 -42.33 50.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -60.17 -35.66 75.84 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -47.04 78.58 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 192' ' ' LEU . 46.7 t -56.38 -30.6 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.968 177.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -62.62 -47.57 83.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.827 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.774 ' CD2' HG21 ' A' ' 132' ' ' ILE . 2.0 mt -62.75 -59.1 5.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.663 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 206' ' ' ALA . 33.5 mm -52.01 -47.96 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.651 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -59.69 -34.56 73.04 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.91 0.77 52.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -120.33 -80.77 0.63 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.722 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -120.19 -26.54 5.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.461 ' HA ' HG22 ' A' ' 199' ' ' ILE . 0.0 OUTLIER 75.91 14.03 2.69 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.81 0.277 . . . . 0.0 111.369 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -144.39 -59.56 0.38 Allowed 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.726 ' HB1' HD22 ' A' ' 151' ' ' LEU . . . 67.09 81.08 0.2 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.39 -2.7 35.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.42 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.822 HG22 ' HB2' ' A' ' 213' ' ' ALA . 27.5 m -56.88 127.05 29.79 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.613 ' OD1' HD12 ' A' ' 212' ' ' ILE . 2.8 p-10 -101.65 -175.67 2.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.632 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 211' ' ' SER . 50.5 p90 -69.35 -45.28 69.78 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.208 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.422 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -77.12 -26.72 53.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.428 0.633 . . . . 0.0 111.133 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.613 HD12 ' OD1' ' A' ' 209' ' ' ASP . 5.7 mt -81.56 -51.53 15.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.857 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.822 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -54.82 -33.7 61.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -48.89 76.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 218' ' ' ASN . . . -52.91 -42.75 65.67 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.065 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.518 ' HB3' ' HG2' ' A' ' 148' ' ' MET . . . -53.31 -55.95 20.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.103 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.597 ' CD2' HG21 ' A' ' 222' ' ' THR . 30.0 t80 -60.25 -31.41 70.18 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 215' ' ' ALA . 1.3 t30 -55.01 -39.87 69.53 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -23.78 58.89 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.18 61.0 3.87 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.684 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 11.7 pt-20 -123.55 37.92 4.31 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 123.049 1.404 . . . . 0.0 111.534 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.636 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 0.0 OUTLIER -92.56 -166.06 1.47 Allowed 'General case' 0 N--CA 1.424 -1.751 2 C-N-CA 135.562 5.545 . . . . 0.0 121.939 -170.204 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.786 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . 158.7 34.58 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.14 1 CA-C-N 104.421 -5.808 . . . . 0.0 112.062 168.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.786 ' HB2' ' O ' ' A' ' 223' ' ' ALA . 0.0 OUTLIER 158.38 131.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 174.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 148' ' ' MET . 0.9 OUTLIER -148.57 155.45 41.13 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.718 HD13 HD11 ' A' ' 160' ' ' LEU . 10.3 pt -115.88 112.47 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.809 1.186 . . . . 0.0 108.503 174.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.716 ' OD1' HD13 ' A' ' 116' ' ' ILE . 2.2 p-10 -147.93 165.23 31.31 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-O 118.95 -0.548 . . . . 0.0 112.411 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -122.85 -176.36 14.88 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.575 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' A' ' 232' ' ' TRP . 74.7 Cg_exo -47.43 -32.4 15.13 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.533 2.156 . . . . 0.0 112.354 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -47.14 -43.15 20.55 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.26 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.62 41.15 3.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.639 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.556 ' HZ2' HG22 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -93.04 -44.03 8.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.801 0.334 . . . . 0.0 110.758 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.8 m -69.6 -33.53 72.82 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.229 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.54 -42.06 6.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.618 0.247 . . . . 0.0 111.419 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.4 -60.77 2.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.954 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 44.91 42.37 6.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.575 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.62 -71.89 0.34 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.93 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.92 42.02 11.63 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.377 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.491 ' O ' HG13 ' A' ' 240' ' ' VAL . 0.0 OUTLIER 67.0 -72.11 0.09 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.017 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 239' ' ' LYS . 0.7 OUTLIER -157.56 -53.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -126.84 119.5 26.97 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.638 0.256 . . . . 0.0 111.0 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -108.46 155.36 20.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.83 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -122.36 111.52 1.8 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.671 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.556 HG22 ' HZ2' ' A' ' 232' ' ' TRP . 13.1 t -91.04 135.28 27.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.685 0.242 . . . . 0.0 110.46 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.403 HG21 ' HE2' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -137.17 167.28 21.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.914 0.485 . . . . 0.0 111.798 -173.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.06 152.68 7.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.883 HD11 HD11 ' A' ' 113' ' ' LEU . 7.1 mt -59.48 159.66 16.3 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 121.279 1.854 . . . . 0.0 110.132 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.794 ' HD3' HD12 ' A' ' 115' ' ' LEU . 5.8 Cg_exo -78.94 -165.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.47 2.114 . . . . 0.0 112.069 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.484 ' O ' ' CG ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER -112.95 175.72 5.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.813 0.339 . . . . 0.0 111.68 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.514 ' HB2' ' HB1' ' A' ' 163' ' ' ALA . 97.3 m-85 -164.13 110.38 1.06 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.364 0.602 . . . . 0.0 109.384 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt 61.18 34.19 18.97 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.521 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.05 40.63 34.4 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.899 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.423 ' HB3' ' O ' ' A' ' 163' ' ' ALA . 7.8 mt-30 -156.99 158.68 31.34 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.506 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 79.9 Cg_endo -93.98 160.81 2.18 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.887 3.058 . . . . 0.0 111.776 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 247' ' ' LEU . 1.3 p -84.43 156.05 21.96 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.493 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 6.1 tmmm? -85.93 112.95 48.89 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.181 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.477 ' HG2' ' CA ' ' A' ' 327' ' ' GLY . 71.6 Cg_endo -84.59 145.0 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.829 2.353 . . . . 0.0 112.417 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 155' ' ' TYR . 1.3 m-85 -79.64 148.79 31.51 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 328' ' ' GLU . 1.9 m -104.8 139.69 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -176.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -125.25 118.85 3.38 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 118.787 -1.673 . . . . 0.0 116.985 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.831 HG13 ' HB3' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -129.87 97.62 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 176.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.849 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -78.19 115.3 17.82 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.507 ' CB ' ' HA ' ' A' ' 107' ' ' PRO . 53.6 p -133.87 138.59 45.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 1.026 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -89.74 109.65 20.61 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 105' ' ' ALA . . . -97.75 165.42 22.2 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 176.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 59' ' ' ILE . 10.4 mt -91.13 123.3 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 118.495 1.148 . . . . 0.0 108.022 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.493 ' ND2' ' HB3' ' A' ' 269' ' ' ALA . 11.5 p-10 -61.97 138.19 58.34 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.987 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.825 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -51.13 -18.42 0.86 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.705 1.139 . . . . 0.0 110.892 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 55' ' ' ASP . . . -56.5 -37.79 70.89 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.49 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 78.8 82.74 0.1 OUTLIER Pre-proline 0 N--CA 1.463 0.221 0 CA-C-O 120.769 0.319 . . . . 0.0 110.9 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -91.65 99.76 0.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.24 2.627 . . . . 0.0 112.612 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.551 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 1.6 m-20 47.83 73.44 0.2 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.797 0.332 . . . . 0.0 110.629 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 277' ' ' LYS . 5.4 mttm -53.1 -54.05 41.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.656 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 278' ' ' GLU . 13.5 mm-40 -63.28 -57.4 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 1.083 HD21 HD11 ' A' ' 33' ' ' ILE . 9.0 tt -65.66 -57.93 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -60.45 -56.73 17.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 273' ' ' LYS . 7.3 ttpp -60.69 -30.31 69.86 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 274' ' ' GLU . 2.4 tt0 -76.41 -52.82 9.13 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.532 ' CD1' ' CE2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -57.2 -50.0 74.23 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.781 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 279' ' ' PHE . 2.1 tp -56.94 -43.08 81.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.622 0.725 . . . . 0.0 111.227 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -73.42 -34.78 65.64 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.664 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -93.88 -14.02 26.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.486 ' CE2' HG13 ' A' ' 23' ' ' VAL . 26.1 t80 -109.13 -63.14 1.39 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 284' ' ' LEU . 0.2 OUTLIER -39.92 -31.82 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.983 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.774 HD13 HD21 ' A' ' 304' ' ' LEU . 3.5 mm? -90.01 42.53 1.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.737 0.303 . . . . 0.0 111.131 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.9 p -144.18 155.1 43.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 291' ' ' GLU . 1.0 OUTLIER -64.42 -13.57 51.99 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.721 ' O ' ' HB2' ' A' ' 292' ' ' ALA . 1.1 mp0 -77.91 -47.47 18.59 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 117.999 0.363 . . . . 0.0 110.149 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.576 ' O ' HG12 ' A' ' 293' ' ' VAL . . . -84.23 -55.03 2.84 Favored Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.953 HD22 HD23 ' A' ' 304' ' ' LEU . 10.7 tp -47.42 -51.57 19.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.538 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 287' ' ' ASP . 8.6 tt0 -79.23 -26.21 42.54 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.616 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 288' ' ' GLU . . . -68.54 -40.15 80.83 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 289' ' ' GLY . 3.0 p -67.97 -61.45 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.508 ' H ' HG13 ' A' ' 293' ' ' VAL . 16.5 t30 -37.57 -50.91 1.16 Allowed 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.408 1.483 . . . . 0.0 112.289 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -60.08 -45.69 92.06 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.4 OUTLIER -57.87 -52.59 64.84 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.804 ' HZ1' ' HB3' ' A' ' 301' ' ' ALA . 0.0 OUTLIER -42.48 162.49 0.16 Allowed Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.359 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.07 -72.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.0 2.467 . . . . 0.0 113.405 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.462 ' N ' ' HD2' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -157.78 -62.99 0.09 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.536 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.603 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . -79.87 138.83 20.66 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.951 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.804 ' HB3' ' HZ1' ' A' ' 297' ' ' LYS . . . 168.56 -172.95 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.612 ' HA ' HD21 ' A' ' 311' ' ' LEU . 8.3 p -178.04 137.38 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.22 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' A' ' 108' ' ' ILE . . . 167.59 96.04 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.953 HD23 HD22 ' A' ' 290' ' ' LEU . 5.9 tp 96.59 116.73 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.234 0.614 . . . . 0.0 110.752 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 304' ' ' LEU . 13.9 ttmt -26.54 -64.44 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.569 0.543 . . . . 0.0 111.12 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.2 m -48.3 -40.82 26.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.8 0.809 . . . . 0.0 110.277 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.717 ' CD2' HD23 ' A' ' 311' ' ' LEU . 42.5 t80 -75.85 -33.58 60.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.005 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.565 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 7.0 pt-20 -72.51 -41.31 66.06 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 120.561 -0.456 . . . . 0.0 109.987 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.65 -56.93 6.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.14 -57.38 8.87 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.722 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.939 HD11 HG21 ' A' ' 317' ' ' ILE . 2.7 pp -61.52 -43.0 99.65 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.154 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.726 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -46.78 -29.67 2.05 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -35.54 -41.52 0.2 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.719 0.295 . . . . 0.0 110.886 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.05 127.89 85.92 Favored Pre-proline 0 CA--C 1.528 0.126 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.38 -22.69 34.85 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.614 2.209 . . . . 0.0 113.714 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -60.7 -59.12 5.89 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.939 HG21 HD11 ' A' ' 311' ' ' LEU . 2.6 mp -49.82 -55.8 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.89 -52.0 12.18 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.08 0.4 . . . . 0.0 111.659 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.15 -41.48 92.86 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.843 0.83 . . . . 0.0 109.738 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 111' ' ' GLU . 1.5 m -60.9 -41.94 97.07 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.614 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.459 ' HG2' HG21 ' A' ' 110' ' ' VAL . 1.7 tmm? -77.13 -39.43 49.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.69 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.08 -41.73 79.37 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.852 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.477 ' HB3' ' HB1' ' A' ' 112' ' ' ALA . 2.8 m120 -75.58 -42.01 53.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.715 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 111' ' ' GLU . . . -65.73 -42.43 91.04 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.852 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.1 -31.84 53.19 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.278 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -100.61 41.59 1.17 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.592 0.234 . . . . 0.0 111.15 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.477 ' CA ' ' HG2' ' A' ' 257' ' ' PRO . . . -120.85 172.11 15.0 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.992 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.697 ' O ' HG13 ' A' ' 259' ' ' VAL . 0.6 OUTLIER -94.46 138.38 32.46 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 175.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.611 ' HA ' ' CG2' ' A' ' 259' ' ' VAL . 1.3 pp -83.62 109.56 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 119.105 0.866 . . . . 0.0 112.226 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.454 ' HE2' ' HA ' ' A' ' 330' ' ' MET . 0.0 OUTLIER -44.14 98.48 0.18 Allowed Pre-proline 0 C--N 1.344 0.348 0 CA-C-O 120.791 0.329 . . . . 0.0 110.802 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.648 ' HG2' ' CE1' ' A' ' 176' ' ' TYR . 32.5 Cg_exo -60.79 -42.48 38.08 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.002 2.468 . . . . 0.0 112.045 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 331' ' ' PRO . 3.0 t30 86.34 93.08 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.611 HD12 ' H ' ' A' ' 336' ' ' MET . 1.9 pp -133.82 146.69 61.24 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 118.457 0.571 . . . . 0.0 110.833 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.64 -48.19 16.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.782 2.321 . . . . 0.0 113.319 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.445 ' HB2' HD13 ' A' ' 333' ' ' ILE . 4.0 mp0 -54.2 -21.43 8.9 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.611 ' H ' HD12 ' A' ' 333' ' ' ILE . 12.5 mtt -45.49 -35.63 3.95 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.892 0.315 . . . . 0.0 111.459 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 m -58.29 -34.17 70.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 110.482 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.49 82.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.065 0.459 . . . . 0.0 111.709 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.76 ' O ' HG12 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -78.4 -55.69 5.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.614 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -44.67 -45.14 9.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.327 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.465 ' O ' HG23 ' A' ' 345' ' ' THR . 8.8 m-85 -76.01 -43.47 44.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.27 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.49 90.86 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.878 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.9 p -76.85 -29.92 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.555 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -46.76 57.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.653 ' O ' HG22 ' A' ' 348' ' ' ILE . 29.9 p -62.77 -57.82 9.6 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . . . -44.79 -38.87 4.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.63 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 343' ' ' VAL . 24.8 t -60.76 -57.2 13.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 345' ' ' THR . 3.5 tt -60.06 -27.85 39.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . 0.8 OUTLIER -63.84 -30.13 71.25 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 355' ' ' GLN . . . -75.52 -46.14 33.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -84.18 -9.8 58.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 348' ' ' ILE . 86.7 p -97.8 -49.76 4.69 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 147.52 -2.92 0.82 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 117.923 -2.084 . . . . 0.0 117.404 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.74 34.3 4.66 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 115.328 -2.549 . . . . 0.0 115.818 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.595 ' C ' ' HB2' ' A' ' 360' ' ' ALA . 1.0 OUTLIER -72.12 -130.01 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 129.855 3.262 . . . . 0.0 106.476 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.76 ' OG1' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER 153.12 86.57 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.249 1 N-CA-C 94.539 -6.097 . . . . 0.0 94.539 177.091 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.565 ' C ' ' O ' ' A' ' 356' ' ' THR . 1.3 p -40.26 -60.72 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.46 0 CA-C-N 122.833 2.56 . . . . 0.0 112.491 -166.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.473 ' H ' HG13 ' A' ' 357' ' ' VAL . 35.8 t0 -72.9 -44.48 61.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.48 -38.92 62.76 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.02 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.76 ' HB2' ' OG1' ' A' ' 356' ' ' THR . . . -62.18 -50.34 72.19 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.834 HD11 HD13 ' A' ' 192' ' ' LEU . 13.3 mt -72.25 -36.27 69.02 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.564 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -56.07 15.17 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.254 1.026 . . . . 0.0 110.059 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 366' ' ' THR . 13.5 t0 -62.63 -36.01 81.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.522 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -49.78 -43.07 48.05 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' A' ' 181' ' ' VAL . 0.2 OUTLIER -63.33 -43.16 98.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.359 177.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 363' ' ' ASP . 23.6 m -50.46 -42.58 54.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.322 0.582 . . . . 0.0 110.193 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -60.17 3.49 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.098 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.962 ' CD1' HG21 ' A' ' 181' ' ' VAL . 17.8 pt -58.4 -27.01 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.993 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.71 ' CG2' HG22 ' A' ' 181' ' ' VAL . 77.4 p -118.26 48.26 1.45 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.825 0.345 . . . . 0.0 110.513 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 stop_ save_